-DOCSTART- JJ B-NP O
-EMPTYLINE- NN I-NP O
RECORD NNP I-NP O
#661 VBZ O O
753455514 CD O O
ACH NNP B-NP O
15453858 CD O O
0683793 CD O O
10/8/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
Hypotension NNP I-NP O
, , O O
NSTEMI NNP B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/25/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/20/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
URBIETA NNP I-NP O
, , O O
MARY NNP B-NP O
079-03-97-6 CD O O
Si NNP B-NP O
Service: NNP I-NP O
RNM NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
11/17/04 CD O O
AT NNP B-NP O
11:15 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
VANALSTIN NNP I-NP O
, , O O
MIKEL NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
hold NN I-NP O
on IN B-VP O
mornings NNS B-NP O
of IN B-VP O
dialysis NN B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/20/04 CD O O
by IN B-VP O
: : O O
DEFINITE NNP B-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
ACE NNP B-NP O
INHIBITORS NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
following VBG O O
K NNP B-NP O
, , O O
HD NNP B-NP O
MWF NNP I-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/14/04 CD O O
by IN B-VP O
: : O O
DEFINITE NNP B-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
ACE NNP B-NP O
INHIBITORS NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
following VBG O O
k NN B-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/29/04 CD O O
by IN B-VP O
: : O O
DEFINITE NNP B-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
ACE NNP B-NP O
INHIBITORS NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP O
regimen NNS I-NP O
, , O O
following VBG O O
k NN B-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/29/04 CD O O
by IN B-VP O
VREELAND NNP B-NP O
, , O O
DARIO NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
DEFINITE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
ACE NNP B-NP O
INHIBITORS NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP O
regimen NNS I-NP O
, , O O
following VBG O O
k NN B-NP O
NPH NNP I-NP B-m
NPH NNP I-NP B-m
NPH NNP I-NP B-m
NPH NNP I-NP B-m
HUMULIN NNP I-NP I-m
HUMULIN NNP I-NP I-m
HUMULIN NNP I-NP I-m
HUMULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
INSULIN NNP B-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
2 CD O B-do
UNITS NNP B-NP I-do
QAM; NNP I-NP B-f
3 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
SC NNP I-NP B-mo
2 CD O B-do
UNITS NNP B-NP I-do
QAM NNP I-NP B-f
3 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
NTG NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
NITROGLYCERIN NNP B-NP I-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5MIN NNP I-NP B-f
X NNP I-NP I-f
3 CD O I-f
PRN NNP B-NP I-f
Chest NNP I-NP B-r
Pain NNP I-NP I-r
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/29/04 CD O O
by IN B-VP O
HASSEL NNP B-NP O
, , O O
EDWARDO NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
NEPHROCAPS NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
12327843 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP O
regimen NNS I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/29/04 CD O O
by IN B-VP O
GALIPEAU NNP B-NP O
, , O O
ENRIQUE NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
DEFINITE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
HMG NNP B-NP O
CoA NNP I-NP O
REDUCTASE NNP I-NP O
INHIBITORS NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ O O
, , O O
home NN B-NP O
regimen NNS I-NP O
IMDUR NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONIT.( NNP I-NP I-m
SR NNP I-NP I-m
) ) O I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
NEPHROCAPS NNP B-NP B-m
( ( O I-m
NEPHRO-VIT NNP B-NP I-m
RX NNP I-NP I-m
) ) O I-m
2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/29/04 CD O O
by IN B-VP O
SCHMALZRIED NNP B-NP O
, , O O
EZEQUIEL NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP O
regimen NNS I-NP O
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
2 CD O O
gm NN B-NP O
Na NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/day NN B-NP O
/ NNP I-NP O
Low NNP I-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
/ NNP I-NP O
Renal NNP I-NP O
diet JJ B-NP O
(FDI) NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Alan NNP I-NP O
Mcratt NNP I-NP O
( ( O O
cardiology NN B-NP O
at IN B-VP O
Lumamer NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
) ) O O
4:00pm CD O O
5/19/04 CD O O
scheduled VBN O O
, , O O
Primary NNP B-NP O
care NN I-NP O
physician JJ O O
2 CD O O
weeks NNS B-NP O
, , O O
ALLERGY: NNP B-NP O
Lisinopril NNP I-NP O
, , O O
Zocor NNP B-NP O
( ( O O
hmg JJ B-NP O
coa NN I-NP O
reductase NN I-NP O
inhibitors NNS I-NP O
) ) O O
ADMIT VBP O O
DIAGNOSIS: NNP B-NP O
hypotension NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Hypotension NNP B-NP O
, , O O
NSTEMI NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
1 CD O O
NIDDM NNP B-NP O
2 CD O O
AI/AS NNP B-NP O
, , O O
bicuspid JJ B-NP O
aortic JJ I-NP O
valve NN I-NP O
, , O O
LVH NNP B-NP O
3 CD O O
HTN NNP B-NP O
4 CD O O
s/p NN B-NP O
thyroglossal NN I-NP O
duct NN I-NP O
cyst NN I-NP O
excision NN I-NP O
5 CD O O
h/o NN B-NP O
noncompliance NN I-NP O
with IN B-VP O
meds NNS B-NP O
6 CD O O
3 CD O O
vessel NN B-NP O
cad NN I-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
7 CD O O
ESRD NNP B-NP O
ON NNP I-NP O
HD NNP I-NP O
( ( O O
end JJ B-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
) ) O O
8 CD O O
CHF NNP B-NP O
, , O O
unclear JJ B-NP O
etiology NN I-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
9 CD O O
hyperlipidemia NN B-NP O
( ( O O
hyperlipidemia NN B-NP O
) ) O O
10 CD O O
h/o NN B-NP O
syphilis NN I-NP O
( ( O O
H/O NNP B-NP O
syphilis NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Persantine NNP B-NP B-m
and CC O O
viability NN B-NP O
cardiac VBP O O
PET NNP B-NP O
scan JJ O O
5/19/04 CD O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
erate NN I-NP O
global JJ B-NP O
LV NNP I-NP O
systolic JJ B-NP O
dysfunction NN I-NP O
3 CD O O
The DT B-NP O
results NNS I-NP O
are VBP O O
essentially RB O O
unchanged JJ O O
from IN B-VP O
his PRP$ O O
prior JJ B-NP O
study NN I-NP O
of IN B-VP O
February NNP B-NP O
, , O O
2003 CD O O
CC: NNP B-NP O
Hypotension NNP I-NP O
after IN B-VP O
dialysis NN B-NP O
HPI: NNP I-NP O
56 CD O O
yo NNS B-NP O
male JJ O O
with IN B-VP O
h/o JJ B-NP O
ESRD NNP I-NP O
, , O O
CAD NNP B-NP O
, , O O
CHF NNP B-NP O
( ( O O
EF NNP B-NP O
20-25% CD O O
) ) O O
admitted VBN O O
for IN B-VP O
hypotension NN B-NP O
after IN B-VP O
HD NNP B-NP O
He PRP O O
was VBD B-VP O
in IN B-VP O
his PRP$ O O
USOH NNP B-NP O
until IN B-VP O
2 CD O O
days NNS B-NP O
PTA NNP I-NP O
when WRB O O
he PRP O O
developed VBD B-VP O
stomach NN B-NP O
upset NN I-NP O
, , O O
diarrhea NN B-NP O
, , O O
dry JJ B-NP O
heaves NNS I-NP O
, , O O
and CC O O
a DT B-NP O
dry JJ I-NP O
cough NN I-NP O
He PRP O O
denied VBD B-VP O
recent JJ B-NP O
travels NNS I-NP O
, , O O
and CC O O
had VBD B-VP O
remote VBN O O
Abx NNP B-NP B-m
use NN I-NP O
At IN B-VP O
Stodun NNP B-NP O
Hospital NNP I-NP O
, , O O
he PRP O O
had VBD B-VP O
5.5 CD O O
liters NNS B-NP O
removed VBD B-VP O
and CC O O
afterwards NNS B-NP O
his PRP$ O O
BP NNP B-NP O
was VBD B-VP O
66/30 CD O O
1 CD O B-do
liter NN B-NP I-do
of IN B-VP O
NS NNP B-NP B-m
was VBD B-VP O
given VBN O O
and CC O O
his PRP$ O B-r
BP NNP B-NP I-r
rose VBD B-VP O
to TO O O
73/40 CD O O
ROS: NNP B-NP O
Chronic NNP I-NP O
PND NNP I-NP O
, , O O
uses VBZ O O
1 CD O O
pillow NN B-NP O
, , O O
gained VBD B-VP O
8kg CD O O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
but CC O O
compliant JJ O O
with IN B-VP O
meds NNS B-NP O
, , O O
no DT B-NP O
melena NN I-NP O
, , O O
no DT B-NP O
BRBPR NNP I-NP O
Physical NNP I-NP O
Exam NNP I-NP O
T NNP I-NP O
97 CD O O
p85 NN B-NP O
BP NNP I-NP O
114/67-&gt;160/97 JJ B-NP O
rr NN I-NP O
16-24 JJ O O
89% CD O O
RA NNP B-NP O
Chronically NNP I-NP O
ill VB O O
appearing VBG O O
, , O O
NAD NNP B-NP O
Neck: NNP I-NP O
Supple NNP I-NP O
Chest: NNP I-NP O
Bibasilar NNP I-NP O
rales VBZ O O
CVS: NNP B-NP O
palpable JJ B-NP O
S3 NNP I-NP O
, , O O
Lat NNP B-NP O
displaced VBD B-VP O
PMI NNP B-NP O
, , O O
II/VI NNP B-NP O
SEM NNP I-NP O
at IN B-VP O
RUSB NNP B-NP O
, , O O
JVP NNP B-NP O
&lt; VBZ O O
7cm CD O O
Abd: NNP B-NP O
Soft NNP I-NP O
NT NNP I-NP O
ND NNP I-NP O
, , O O
+ NNP B-NP O
BS NNP I-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
Ext: NNP I-NP O
Trace NNP I-NP O
pedal NN I-NP O
edema NN I-NP O
, , O O
hyperpigmentation NN B-NP O
in IN B-VP O
sock NN B-NP O
distribution NN I-NP O
Labs: NNP I-NP O
WBC NNP I-NP O
5 CD O O
, , O O
TnI NNP B-NP O
0.37 CD O O
, , O O
CK NNP B-NP O
153 CD O O
, , O O
CKMB8.2 NNP B-NP O
( ( O O
chronically RB O O
elevated VBN O O
cardiac JJ B-NP O
enzymes NNS I-NP O
) ) O O
EKG: NNP B-NP O
NSR NNP I-NP O
, , O O
1st CD O O
deg NN B-NP O
AVB NNP I-NP O
, , O O
LAE NNP B-NP O
, , O O
LVH NNP B-NP O
, , O O
old JJ B-NP O
TWI NNP I-NP O
in IN B-VP O
1 CD O O
, , O O
L NNP B-NP O
, , O O
V5 NNP B-NP O
, , O O
V6 NNP B-NP O
, , O O
more RBR O O
pronounced JJ B-NP O
ST NNP I-NP O
dep NN I-NP O
in IN B-VP O
V5 NNP B-NP O
than IN B-VP O
6/4 CD O O
CXR: NNP B-NP O
R NNP I-NP O
pl NN I-NP O
effusion NN I-NP O
, , O O
CMG NNP B-NP O
Assessment: NNP I-NP O
Hypotension NNP I-NP O
after IN B-VP O
dialysis NN B-NP O
in IN B-VP O
setting VBG O O
of IN B-VP O
GI NNP B-NP O
upset/diarrhea/vomiting NN I-NP O
, , O O
likely RB O O
was VBD B-VP O
dehydrated VBN O O
The DT B-NP O
BP NNP I-NP O
rose VBD B-VP O
after IN B-VP O
fluids NNS B-NP O
and CC O O
his PRP$ O O
current JJ B-NP O
hypoxia NN I-NP O
is VBZ O O
likely JJ O O
from IN B-VP O
mild JJ B-NP O
pulm NN I-NP O
edema NN I-NP O
Although IN B-VP O
chronically RB O O
elevated VBN O O
cardiac JJ B-NP O
enzymes NNS I-NP O
, , O O
there EX O O
is VBZ O O
concern NN B-NP O
about IN B-VP O
new JJ B-NP O
ishemia NN I-NP O
, , O O
and CC O O
concern NN B-NP O
for IN B-VP O
PE NNP B-NP O
given VBN O O
hypoxia NN B-NP O
in IN B-VP O
ED NNP B-NP O
Hospital NNP I-NP O
course NN I-NP O
1 CD O O
CVS: NNP B-NP O
Ischemia: NNP I-NP O
NSTEMI: NNP I-NP B-r
NSTEMI: NNP I-NP B-r
NSTEMI: NNP I-NP B-r
NSTEMI: NNP I-NP B-r
NSTEMI: NNP I-NP B-r
contined VBD B-VP O
medical JJ B-NP O
management NN I-NP O
with IN B-VP O
asa NN B-NP B-m
, , O O
beta NN B-NP B-m
blocker NN I-NP O
, , O O
imdur NN B-NP B-m
, , O O
zocor NN B-NP B-m
, , O O
ntg JJ O B-m
prn VBP O B-f
The DT B-NP O
CkMB NNP I-NP O
peaked VBD B-VP O
at IN B-VP O
12 CD O O
and CC O O
Tni NNP B-NP O
to TO O O
4 CD O O
His PRP$ O O
cardiologist NN B-NP O
( ( O O
Dr NNP B-NP O
Benisek NNP I-NP O
) ) O O
recommended VBD B-VP O
PET JJ O O
scan JJ O O
to TO O O
assess VB O O
for IN B-VP O
viable JJ B-NP O
myocardium NN I-NP O
and CC O O
ischemia VB O O
His PRP$ O O
last JJ B-NP O
stress JJ I-NP O
test NN I-NP O
1 CD O O
year NN B-NP O
ago RB O O
showed VBD B-VP O
only RB O O
scarring VBG O O
with IN B-VP O
no DT B-NP O
ischemia NN I-NP O
In IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
pt's JJ B-NP O
wife NN I-NP O
refused VBD B-VP O
for IN B-VP O
him PRP O O
to TO O O
go VB O O
for IN B-VP O
CABG NNP B-NP O
They PRP O O
are VBP O O
reconsidering VBG O O
this DT B-NP O
option NN I-NP O
currently RB O O
The DT B-NP O
results NNS I-NP O
of IN B-VP O
the DT B-NP O
PET NNP I-NP O
scan JJ O O
are VBP O O
as IN B-VP O
follows: JJ O O
- : O O
A DT B-NP O
small JJ I-NP O
region NN I-NP O
of IN B-VP O
myocardial JJ B-NP O
scar/hibernation NN I-NP O
along IN B-VP O
with IN B-VP O
mild JJ B-NP O
residual JJ I-NP O
stress NN I-NP O
induced VBD B-VP O
peri-infarct JJ B-NP O
ischemia NN I-NP O
in IN B-VP O
the DT B-NP O
distal JJ I-NP O
LAD NNP I-NP O
distribution NN I-NP O
- : O O
Moderate NNP B-NP O
global JJ B-NP O
LV NNP I-NP O
systolic JJ B-NP O
dysfunction NN I-NP O
- : O O
The DT B-NP O
results NNS I-NP O
are VBP O O
essentially RB O O
unchanged JJ O O
from IN B-VP O
his PRP$ O O
prior JJ B-NP O
study NN I-NP O
of IN B-VP O
February NNP B-NP O
, , O O
2003 CD O O
The DT B-NP O
family NN I-NP O
was VBD B-VP O
called VBN O O
to TO O O
stress VB O O
the DT B-NP O
importance NN I-NP O
of IN B-VP O
follow JJ O O
up IN B-VP O
with IN B-VP O
cardiology NN B-NP O
( ( O O
They PRP O O
have VBP O O
missed VBN O O
appointments NNS B-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
) ) O O
Pump: NNP B-NP O
( ( O O
EF NNP B-NP O
20-25% CD O O
) ) O O
, , O O
increased VBD B-VP O
enalapril NN B-NP B-m
to TO O O
10mg CD O B-do
bid NN B-NP B-f
, , O O
BNP NNP B-NP O
was VBD B-VP O
sent VBN O O
and CC O O
pending VBG O O
and CC O O
echo VB O O
revealed VBN O O
EF NNP B-NP O
30% CD O O
, , O O
Mod NNP B-NP O
AI NNP I-NP O
Rhythm: NNP I-NP O
no DT B-NP O
events NNS I-NP O
occurred VBD B-VP O
on IN B-VP O
telemetry NN B-NP O
2 CD O O
Pulm: NNP B-NP O
monitored VBD B-VP O
sats NNS B-NP O
with IN B-VP O
fluid JJ B-NP O
restriction NN I-NP O
RA NNP I-NP O
sats VBZ O O
improved VBN O O
to TO O O
97% CD O O
3 CD O O
Renal: NNP B-NP O
HD NNP I-NP O
MWF NNP I-NP O
, , O O
home NN B-NP O
renal NN I-NP B-m
meds NNS I-NP I-m
He PRP O O
was VBD B-VP O
dialyzed VBN O O
to TO O O
a DT B-NP O
weight NN I-NP O
below IN B-VP O
his PRP$ O O
previous JJ B-NP O
baseline NN I-NP O
per IN B-VP O
cardiology NN B-NP O
recommendations NNS I-NP O
In IN B-VP O
the DT B-NP O
past NN I-NP O
he PRP O O
has VBZ O O
had VBN O O
elevated VBN O O
RH NNP B-NP O
filling NN I-NP O
pressures NNS I-NP O
after IN B-VP O
HD NNP B-NP O
The DT B-NP O
Ryi NNP I-NP O
was VBD B-VP O
called VBN O O
by IN B-VP O
the DT O O
attendting VBG O O
renal JJ B-NP O
physician NN I-NP O
( ( O O
Dr NNP B-NP O
Slemp NNP I-NP O
) ) O O
about IN B-VP O
his PRP$ O O
goal NN B-NP O
weight VBD B-VP O
4 CD O O
ID: NNP B-NP O
Blood NNP I-NP O
cx NN I-NP O
were VBD B-VP O
no DT B-NP O
growth NN I-NP O
5 CD O O
GI: NNP B-NP O
He PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
home NN B-NP B-m
nexium NN I-NP I-m
6 CD O O
Proph: NNP B-NP O
SQ NNP I-NP B-mo
heparin NN I-NP B-m
was VBD B-VP O
used VBN O O
for IN B-VP O
DVT NNP B-NP B-r
prophylaxis VBP O I-r
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
It PRP O O
is VBZ O O
very RB O O
important JJ O O
that IN B-VP O
you PRP O O
attend VBP O O
your PRP$ O O
follow VBP O O
up RP O O
appointment NN B-NP O
with IN B-VP O
the DT B-NP O
cardiologist NN I-NP O
, , O O
Dr NNP B-NP O
Ivrin NNP I-NP O
Please NNP I-NP O
take VB O O
the DT B-NP O
medications NNS I-NP O
listed VBN O O
above IN B-VP O
and CC O O
do VB O O
not RB O O
take VB O O
enalapril NN B-NP O
on IN B-VP O
mornings NNS B-NP O
of IN B-VP O
dialysis NN B-NP O
Please NNP I-NP O
adhere RB O O
to TO O O
your PRP$ O O
dietary JJ B-NP O
restrictions NNS I-NP O
If IN B-VP O
you PRP O O
gain VBP O O
more JJR O O
than IN B-VP O
3 CD O O
kg NN B-NP O
between IN B-VP O
dialysis NN B-NP O
sessions NNS I-NP O
please VBP O O
restrict VB O O
your PRP$ O O
fluid NNS B-NP O
intake VBP O O
The DT B-NP O
diet JJ I-NP O
guidelines NNS I-NP O
will MD O O
be VB O O
coordinated VBN O O
by IN B-VP O
the DT B-NP O
staff NN I-NP O
at IN B-VP O
Chapmed NNP B-NP O
Gamette NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
see VB O O
above IN B-VP O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
PASSINO NNP I-NP O
, , O O
TERRY NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
EN8 NNP B-NP O
) ) O O
11/17/04 CD O O
@ $ O O
11 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#5091 VBZ O O
798348513 CD O O
CMC NNP B-NP O
42176106 CD O O
6273542 CD O O
0/12/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
LEFT NNP I-NP O
IST NNP I-NP O
TOE NNP I-NP O
INFECTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/12/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/7/2006 CD O O
ATTENDING: NNP B-NP O
KIRTLAND NNP I-NP O
, , O O
AHMAD NNP B-NP O
F NNP I-NP O
D NNP I-NP O
C NNP I-NP O
ADMITTING NNP I-NP O
DIAGNOSIS: NNP I-NP O
Peripheral NNP I-NP O
vascular JJ B-NP O
disease NN I-NP O
LIST NNP I-NP O
OF NNP I-NP O
PROBLEMS NNP I-NP O
AND NNP I-NP O
DIAGNOSES: NNP I-NP O
Chronic NNP I-NP O
kidney NN I-NP O
disease NN I-NP O
, , O O
diabetes VBZ O O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
aortic JJ B-NP O
stenosis NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
, , O O
anemia NN B-NP O
, , O O
hypertension NN B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
A NNP I-NP O
79-year-old JJ B-NP O
male NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
non-insulin JJ B-NP O
dependent NN I-NP O
diabetes NNS I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
recently RB O O
1.5 CD O O
months NNS B-NP O
status NN I-NP O
post NN I-NP O
left VBD B-VP O
toe JJ B-NP O
amputation NN I-NP O
on IN B-VP O
7/1/06 CD O O
complicated VBN O O
by IN B-VP O
acute NN B-NP O
on IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
and CC O O
delirium NN B-NP O
requiring VBG O O
postoperative JJ B-NP O
dialysis NN I-NP O
from IN B-VP O
9/8/06 CD O O
through IN B-VP O
9/27/06 CD O O
The DT B-NP O
patient NN I-NP O
presented VBD B-VP O
on IN B-VP O
3/26/05 CD O O
for IN B-VP O
a DT B-NP B-r
nonhealing JJ I-NP I-r
ulcer NN I-NP I-r
for IN B-VP O
three CD O O
weeks' JJ B-NP O
duration NN I-NP O
, , O O
exposed VBD B-VP O
bone NN B-NP O
on IN B-VP O
the DT B-NP O
left JJ I-NP O
great JJ I-NP O
toe NN I-NP O
and CC O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
debridement NN B-NP O
and CC O O
antibiotics NNS B-NP B-m
An DT B-NP O
MRA NNP I-NP O
on IN B-VP O
10/3/06 CD O O
demonstrated VBN O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
a DT B-NP O
multifocal JJ I-NP O
high-grade JJ I-NP O
stenosis NN I-NP O
of IN B-VP O
the DT B-NP O
proximal NN I-NP O
, , O O
anterior JJ B-NP O
tibial NN I-NP O
, , O O
the DT B-NP O
tibioperoneal JJ I-NP O
trunk NN I-NP O
and CC O O
the DT B-NP O
proximal NN I-NP O
, , O O
posterior JJ B-NP O
tibial JJ I-NP O
arteries NNS I-NP O
and CC O O
included VBD B-VP O
peroneal JJ B-NP O
artery NN I-NP O
at IN B-VP O
the DT B-NP O
midcalf NN I-NP O
, , O O
two-vessel JJ B-NP O
runoff NN I-NP O
and CC O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
diffuse NN I-NP O
high-grade JJ B-NP O
stenoses NNS I-NP O
of IN B-VP O
the DT B-NP O
anterior JJ I-NP O
tibial NN I-NP O
, , O O
posterior JJ B-NP O
tibial JJ I-NP O
arteries NNS I-NP O
and CC O O
occlusion NN B-NP O
of IN B-VP O
the DT B-NP O
peroneal JJ I-NP O
artery NN I-NP O
in IN B-VP O
the DT B-NP O
dorsalis NN I-NP O
pedis VBZ O O
The DT B-NP O
patient NN I-NP O
now RB O O
presents VBZ O O
with IN B-VP O
bleeding VBG O O
from IN B-VP O
the DT B-NP O
site NN I-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
toe NN I-NP O
amputation NN I-NP O
beginning VBG O O
two CD O O
weeks NNS B-NP O
ago RB O O
associated VBN O O
with IN B-VP O
throbbing VBG O B-r
pain NN B-NP O
, , O O
soreness NN B-NP O
, , O O
erythema NN B-NP O
and CC O O
swelling NN B-NP O
and CC O O
exacerbated VBD B-VP O
blood NN B-NP O
pressure NN I-NP O
when WRB O O
walking NN B-NP O
and CC O O
only RB O O
treated VBN O O
by IN B-VP O
narcotics NNS B-NP B-m
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Stage NNP I-NP O
IV NNP I-NP O
chronic JJ B-NP O
kidney NN I-NP O
disease NN I-NP O
secondary JJ O O
to TO O O
diabetes NNS B-NP O
with IN B-VP O
the DT B-NP O
baseline NN I-NP O
creatinine NN I-NP O
of IN B-VP O
2.3 CD O O
, , O O
non-insulin-dependent JJ B-NP O
diabetes NNS I-NP O
since IN B-VP O
1998 CD O O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
55% CD O O
on IN B-VP O
7/13/06 CD O O
, , O O
aortic JJ B-NP O
stenosis NN I-NP O
status NN I-NP O
post NN I-NP O
AVR NNP I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
, , O O
anemia NN B-NP O
and CC O O
hypertension NN B-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Aortic NNP I-NP O
valve FW O O
replacement NN B-NP O
with IN B-VP O
a DT B-NP O
Carpentier-Edwards NNP I-NP O
valve NN I-NP O
, , O O
pulmonary JJ B-NP O
hypertension NN I-NP O
prior RB O O
to TO O O
the DT B-NP O
AVR NNP I-NP O
, , O O
status NN B-NP O
post NN I-NP O
ablation NN I-NP O
for IN B-VP O
atrioventricular JJ B-NP O
nodal JJ I-NP O
reentry NN I-NP O
, , O O
tachycardia NN B-NP O
, , O O
CABG NNP B-NP O
x4 NNP I-NP O
, , O O
and CC O O
PFO NNP B-NP O
closure VBP O O
7/13/06 CD O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
first JJ B-NP O
toe JJ I-NP O
amputation NN I-NP O
10/3/06 CD O O
complicated VBN O O
by IN B-VP O
delirium NN B-NP O
and CC O O
acute JJ B-NP O
renal JJ I-NP O
dysfunction NN I-NP O
MEDICATIONS: NNP I-NP O
Aspirin NNP I-NP B-m
, , O O
Lopressor NNP B-NP B-m
, , O O
Norvasc NNP B-NP B-m
, , O O
Zocor NNP B-NP B-m
, , O O
Plavix NNP B-NP B-m
, , O O
PhosLo NNP B-NP B-m
, , O O
Prandin NNP B-NP B-m
, , O O
Nephrocaps NNP B-NP B-m
, , O O
Epogen NNP B-NP B-m
, , O O
Calcitriol NNP B-NP B-m
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Lives VBZ O O
alone RB O O
, , O O
separated VBN O O
from IN B-VP O
wife NN B-NP O
, , O O
retired JJ B-NP O
firefighter NN I-NP O
Former NNP I-NP O
smoker NN I-NP O
with IN B-VP O
a DT B-NP O
distant JJ I-NP O
history NN I-NP O
of IN B-VP O
five-pack JJ B-NP O
years NNS I-NP O
Seldom NNP I-NP O
alcohol NN I-NP O
use NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Diabetes NNP I-NP O
in IN B-VP O
the DT B-NP O
father NN I-NP O
and CC O O
the DT B-NP O
daughter NN I-NP O
Father NNP I-NP O
had VBD B-VP O
diabetes NNS B-NP O
, , O O
was VBD B-VP O
a DT B-NP O
smoker NN I-NP O
and CC O O
an DT O O
alcoholic JJ O O
and CC O O
died VBD B-VP O
of IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
at IN B-VP O
age NN B-NP O
65 CD O O
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
VITAL NNP I-NP O
SIGNS: NNP I-NP O
Temperature NNP I-NP O
99.8 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
79 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
170/90 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
20 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
100% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
On IN B-VP O
exam NN B-NP O
, , O O
in IN B-VP O
general JJ O O
, , O O
elderly JJ B-NP O
man NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
HEENT: NNP I-NP O
Normocephalic NNP I-NP O
, , O O
atraumatic JJ B-NP O
No NNP I-NP O
scleral JJ B-NP O
icterus NN I-NP O
NEURO: NNP I-NP O
Alert NNP I-NP O
and CC O O
oriented VBN O O
x3 NNP B-NP O
CARDIAC: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
Split NNP I-NP O
S2 NNP I-NP O
, , O O
mild JJ B-NP O
systolic JJ I-NP O
murmur NN I-NP O
, , O O
2/6 CD O O
radiating NN B-NP O
to TO O O
the DT B-NP O
carotids NNS I-NP O
bilaterally RB O O
, , O O
heard RB O O
best JJS O O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
second JJ I-NP O
intercostal JJ I-NP O
space NN I-NP O
No NNP I-NP O
bruits VBZ O O
bilaterally RB O O
RESPIRATORY: NNP B-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
, , O O
no DT B-NP O
rales NNS I-NP O
, , O O
wheezing VBG O O
or CC O O
rhonchi VB O O
GI: NNP B-NP O
Soft NNP I-NP O
, , O O
nontender NN B-NP O
, , O O
firm NN B-NP O
, , O O
nondistended VBD B-VP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
no DT B-NP O
rebound NN I-NP O
, , O O
no DT B-NP O
guarding NN I-NP O
, , O O
no DT B-NP O
masses NNS I-NP O
EXTREMITIES: VBP O O
2+ CD O O
edema NNS B-NP O
bilaterally RB O O
No NNP B-NP O
clubbing NN I-NP O
, , O O
no DT B-NP O
cyanosis NN I-NP O
A NNP I-NP O
cold NN I-NP O
right JJ B-NP O
foot NN I-NP O
, , O O
left VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
great JJ B-NP O
toe JJ I-NP O
amputation NN I-NP O
site NN I-NP O
bandage NN I-NP O
with IN B-VP O
bloody JJ B-NP O
drainage NN I-NP O
Radial NNP I-NP O
pulses VBZ O O
2+ CD O O
bilaterally RB O O
Femoral JJ B-NP O
pulses NNS I-NP O
2+ CD O O
bilaterally RB O O
PT NNP B-NP O
pulse NN I-NP O
palpable NN I-NP O
, , O O
DP NNP B-NP O
pulse RB O O
palpable JJ O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
and CC O O
the DT B-NP O
left NN I-NP O
PT NNP I-NP O
pulse VBZ O O
1+ CD O O
and CC O O
DP NNP B-NP O
pulse NN I-NP O
was VBD B-VP O
not RB O O
palpable JJ B-NP O
EKG: NNP I-NP O
Left NNP I-NP O
axis VBZ O O
deviation NN B-NP O
with IN B-VP O
left JJ B-NP O
ventricular JJ I-NP O
hypertrophy NN I-NP O
, , O O
question NN B-NP O
of IN B-VP O
lateral JJ B-NP O
ischemia JJ I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Procedures: NNP I-NP O
0/9/06 CD O O
, , O O
Irrigation NNP B-NP O
and CC O O
debridement NN B-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
great JJ I-NP O
toe NN I-NP O
with IN B-VP O
extension NN B-NP O
of IN B-VP O
amputation NN B-NP O
to TO O O
the DT B-NP O
transmetatarsal NN I-NP O
joint JJ O O
8/14/06 CD O O
and CC O O
6/21/06 CD O O
, , O O
left VBD B-VP O
toe RP O O
I&amp;D NNP B-NP O
with IN B-VP O
left JJ B-NP O
popliteal JJ I-NP O
bypass NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
anterior JJ I-NP O
tibial JJ I-NP O
artery NN I-NP O
with IN B-VP O
right JJ B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
and CC O O
Vac NNP B-NP O
placement VBP O O
Serial JJ B-NP O
debridements NNS I-NP O
on IN B-VP O
4/25/06 CD O O
, , O O
1/30/06 CD O O
and CC O O
8/26/06 CD O O
Foot NNP B-NP O
had VBD B-VP O
been VBN O O
debrided VBN O O
so RB O O
that IN B-VP O
the DT B-NP O
amputation NN I-NP O
on IN B-VP O
the DT O O
first JJ O O
and CC O O
second JJ B-NP O
toes NNS I-NP O
are VBP O O
down RB O O
to TO O O
the DT B-NP O
level NN I-NP O
of IN B-VP O
the DT B-NP O
tarsometatarsal NN I-NP O
joint JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
5/22/06 CD O O
for IN B-VP O
treatment NN B-NP O
with IN B-VP O
IV NNP B-NP B-mo
antibiotics NNS I-NP B-m
and CC O O
presumed JJ B-NP O
operative JJ I-NP O
intervention NN I-NP O
Neuro NNP I-NP O
and CC O O
Psych: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
delirium VBN O B-r
postoperatively RB O O
for IN B-VP O
which WDT O O
he PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
soft JJ B-NP O
restraints NNS I-NP O
and CC O O
received VBN O O
Zyprexa NNP B-NP B-m
This DT O O
resolved VBD B-VP O
quickly RB O O
Did NNP B-NP O
well RB O O
for IN B-VP O
the DT B-NP O
duration NN I-NP O
of IN B-VP O
admission NN B-NP O
in IN B-VP O
terms NNS B-NP O
of IN B-VP O
mental JJ B-NP O
status NN I-NP O
Alert NNP I-NP O
and CC O O
oriented VBN O O
x3 NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
Cardiac: NNP I-NP O
Upon NNP I-NP O
admission NN I-NP O
, , O O
potassium NN B-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
elevated VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
EKG NNP B-NP O
changes NNS I-NP O
associated VBN O O
with IN B-VP O
hyperkalemia NN B-NP O
Both NNP I-NP O
the DT B-NP O
Renal NNP I-NP O
and CC O O
Cardiology NNP B-NP O
services NNS I-NP O
were VBD B-VP O
consulted VBN O O
and CC O O
assisted VBN O O
with IN B-VP O
his PRP$ O O
perioperative JJ B-NP O
management NN I-NP O
in IN B-VP O
terms NNS B-NP O
of IN B-VP O
cardioprotection NN B-NP O
and CC O O
possible JJ B-NP O
need NN I-NP O
for IN B-VP O
dialysis NN B-NP O
No NNP I-NP O
further JJ B-NP O
events NNS I-NP O
The DT B-NP O
hyperkalemia NN I-NP O
resolved VBD B-VP O
He PRP O O
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
He PRP O O
received VBD B-VP O
aspirin RB O B-m
and CC O O
Zocor NNP B-NP B-m
for IN B-VP O
coronary JJ B-NP B-r
coronary JJ I-NP B-r
artery NN I-NP O
disease NN I-NP O
related JJ B-NP O
event NN I-NP O
prophylaxis NN I-NP O
Blood NNP I-NP B-r
Blood NNP I-NP B-r
Blood NNP I-NP B-r
Blood NNP I-NP B-r
pressure NN I-NP I-r
pressure NN I-NP I-r
pressure NN I-NP I-r
pressure NN I-NP I-r
was VBD B-VP O
controlled VBN O O
with IN B-VP O
isosorbide JJ B-NP B-m
dinitrate NN I-NP O
, , O O
Norvasc NNP B-NP B-m
, , O O
lisinopril NN B-NP B-m
, , O O
and CC O O
Lopressor NNP B-NP B-m
Pulmonary: NNP I-NP O
No NNP I-NP O
events NNS I-NP O
Maintained VBD B-VP O
oxygen RP O O
saturation NN B-NP O
greater JJR O O
than IN B-VP O
90% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Renal: NNP I-NP O
Creatinine NNP I-NP O
was VBD B-VP O
stable JJ O O
in IN B-VP O
the DT B-NP O
mid NN I-NP O
3s CD O O
and CC O O
trended VBD B-VP O
down RB O O
to TO O O
2.6 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
below IN B-VP O
his PRP$ O O
baseline NN B-NP O
of IN B-VP O
4-5 JJ B-NP O
Voiding NNP I-NP O
without IN B-VP O
difficulty NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
Maintained VBN O O
on IN B-VP O
his PRP$ O O
renal JJ B-NP B-m
medications NNS I-NP I-m
FEN/GI: NNP I-NP O
Tolerated VBD B-VP O
regular JJ B-NP O
diet JJ I-NP O
Lactulose NNP I-NP B-m
and CC O O
Colace NNP B-NP B-m
to TO O O
prevent VB O O
constipation NN B-NP B-r
constipation NN I-NP B-r
while IN B-VP O
taking VBG O O
narcotics NNS B-NP B-m
, , O O
also RB O O
had VBD B-VP O
Dulcolax NNP B-NP B-m
p.r.n JJ B-NP B-f
p.r.n NN I-NP B-f
Zinc NNP I-NP B-m
and CC O O
vitamin NNP B-NP B-m
C NNP I-NP I-m
was VBD B-VP O
started VBN O O
per IN B-VP O
the DT B-NP O
Nutrition NNP I-NP O
consult NN I-NP O
Hematology: NNP I-NP O
He PRP O O
received VBD B-VP O
heparin NN B-NP B-m
for IN B-VP O
DVT NNP B-NP B-r
prophylaxis VBD B-VP I-r
His PRP$ O O
hematocrit NN B-NP O
remained VBD B-VP O
stable JJ O O
He PRP O O
had VBD B-VP O
some DT O O
oozing VBG O O
from IN B-VP O
the DT B-NP O
right JJ I-NP O
thigh NN I-NP O
but CC O O
this DT O O
resolved VBN O O
with IN B-VP O
a DT B-NP O
pressure NN I-NP O
dressing VBG O O
ID: NNP B-NP O
He PRP O O
was VBD B-VP O
treated VBN O O
throughout IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
with IN B-VP O
vancomycin NN B-NP B-m
, , O O
levofloxacin NN B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
for IN B-VP O
methicillin-resistant JJ B-NP B-r
methicillin-resistant JJ I-NP B-r
methicillin-resistant JJ I-NP B-r
Staphylococcus NNP I-NP O
aureus NN I-NP O
that WDT O O
grew VBD B-VP O
from IN B-VP O
the DT B-NP O
wound NN I-NP O
after IN B-VP O
the DT O O
first JJ O O
and CC O O
second JJ B-NP O
irrigation NN I-NP O
and CC O O
debridement VB O O
The DT B-NP O
levofloxacin NN I-NP B-m
and CC O O
Flagyl NNP B-NP B-m
were VBD B-VP O
discontinued VBN O O
prior RB O O
to TO O O
discharge VB O O
He PRP O O
will MD O O
continue VB O O
his PRP$ O O
vancomycin NN B-NP B-m
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
Please NNP I-NP O
see VB O O
addendum NN B-NP O
for IN B-VP O
antibiotic JJ B-NP B-m
plan NN I-NP O
Endocrine: NNP I-NP O
Diabetes VBZ O O
controlled VBD B-VP O
He PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
his PRP$ O O
Prandin NNP B-NP B-m
and CC O O
insulin NN B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
for IN B-VP O
glycemic JJ B-NP B-r
glycemic JJ I-NP B-r
control NN I-NP I-r
control NN I-NP I-r
He PRP O O
also RB O O
received VBD B-VP O
vitamin JJ B-NP B-m
D NNP I-NP I-m
His PRP$ O O
incision NN B-NP O
remained VBD B-VP O
clean JJ O O
, , O O
dry JJ O O
and CC O O
intact JJ O O
without IN B-VP O
erythema NN B-NP O
or CC O O
exudate NN B-NP O
He PRP O O
was VBD B-VP O
afebrile JJ O O
with IN B-VP O
stable JJ B-NP O
signs NNS I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
ACTIVITY NNP I-NP O
INSTRUCTIONS: NNP I-NP O
He PRP O O
is VBZ O O
nonweightbearing VBG O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
to TO O O
protect VB O O
the DT B-NP O
open JJ I-NP O
toe NN I-NP O
COMPLICATIONS: NNP I-NP O
None NNP I-NP O
DISCHARGE NNP I-NP O
LABS: NNP I-NP O
Laboratory NNP I-NP O
tests NNS I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
include VBP O O
sodium NN B-NP O
138 CD O O
, , O O
potassium NN B-NP O
4.1 CD O O
, , O O
chloride RB O O
111 CD O O
, , O O
bicarbonate NN B-NP O
21 CD O O
, , O O
BUN NNP B-NP O
35 CD O O
, , O O
creatinine NN B-NP O
2.6 CD O O
, , O O
calcium NN B-NP O
9.0 CD O O
, , O O
magnesium NN B-NP O
1.9 CD O O
, , O O
vancomycin FW O O
19.5 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
7.3 CD O O
, , O O
hemoglobin NN B-NP O
9.9 CD O O
, , O O
hematocrit NN B-NP O
30.2 CD O O
, , O O
platelets NNS B-NP O
221 CD O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
His PRP$ O O
medications NNS B-NP O
at IN B-VP O
discharge NN B-NP O
include VBP O O
aspirin JJ O B-m
325 CD O B-do
mg JJ O I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
vitamin JJ B-NP B-m
C NNP I-NP I-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
calcitriol VBP O B-m
0.5 CD O B-do
mcg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
heparin JJ O B-m
5000 CD O B-do
units NNS B-NP I-do
subcutaneous JJ B-NP B-mo
t.i.d NN I-NP B-f
, , O O
isosorbide JJ B-NP B-m
dinitrate NN I-NP I-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
lactulose JJ O B-m
30 CD O B-do
mL NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
lisinopril VBZ O B-m
50 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.6h VBD B-VP B-f
Simethicone NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
, , O O
vancomycin FW O B-m
1 CD O B-do
g NN B-NP I-do
IV NNP I-NP B-mo
every DT B-NP B-f
other JJ I-NP I-f
day NN I-NP I-f
, , O O
zinc NN B-NP B-m
sulfate NN I-NP I-m
220 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
for IN B-VP B-du
two CD O I-du
weeks NNS B-NP I-du
, , O O
Zocor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Norvasc NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
Nephro-Vite JJ O B-m
one CD O B-do
tab NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Prandin NNP B-NP B-m
0.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
with IN B-VP B-f
each DT B-NP I-f
meal NN I-NP I-f
, , O O
Aranesp NNP B-NP B-m
40 CD O B-do
mcg NN B-NP I-do
subcutaneous JJ O B-mo
every DT B-NP B-f
week NN I-NP I-f
, , O O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP B-m
, , O O
insulin JJ O B-m
aspart RB O I-m
4 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
with IN B-VP B-f
breakfast NN B-NP I-f
and CC O I-f
dinner NN B-NP I-f
, , O O
Dulcolax NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
PR NNP I-NP B-mo
daily RB O B-f
, , O O
Tylenol NNP B-NP B-m
p.r.n NN I-NP B-f
, , O O
Dilaudid NNP B-NP B-m
2-4 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.4h NN I-NP B-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
, , O O
milk NN B-NP B-m
of IN B-VP I-m
magnesia NN B-NP I-m
as IN B-VP B-f
needed VBN O I-f
for IN B-VP O
constipation NN B-NP B-r
, , O O
Reglan NNP B-NP B-m
for IN B-VP O
nausea NN B-NP B-r
, , O O
oxycodone NN B-NP B-m
for IN B-VP O
pain NN B-NP O
5-10 JJ B-NP B-do
mg NN I-NP I-do
p.o NN I-NP B-mo
q.4h NN I-NP B-f
hours NNS I-NP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
, , O O
Zyprexa NNP B-NP B-m
Zyprexa NNP I-NP B-m
5 CD O B-do
5 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
p.o NN I-NP B-mo
p.o NN I-NP B-mo
q.8h NN I-NP B-f
q.8h NN I-NP B-f
as IN B-VP I-f
as IN B-VP I-f
needed VBN O I-f
needed VBN O I-f
for IN B-VP O
anxiety NN B-NP B-r
or CC O O
agitation NN B-NP B-r
, , O O
Maalox NNP B-NP B-m
p.r.n NN I-NP B-f
upset JJ B-NP B-r
stomach NN I-NP I-r
DISPOSITION: NNP I-NP O
To TO O O
rehabilitation VB O O
PHYSICIAN NNP B-NP O
FOLLOWUP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Odo NNP I-NP O
at IN B-VP O
030-524-6194 NNP B-NP O
To TO O O
call VB O O
Dr NNP B-NP O
Barkalow NNP I-NP O
to TO O O
be VB O O
seen VBN O O
within IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
after IN B-VP O
discharge NN B-NP O
eScription NN I-NP O
document: VBZ O O
8-9296036 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
TEAR NNP I-NP O
, , O O
DON NNP B-NP O
Attending: NNP I-NP O
BOHRER NNP I-NP O
, , O O
DENVER NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
3849823 CD O O
D: NNP B-NP O
11/5/06 CD O O
T: NNP B-NP O
11/5/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#21234 VBZ O O
676980641 CD O O
VUOC NNP B-NP O
41868797 CD O O
7675401 CD O O
10/24/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
VOLUME NNP I-NP O
OVERLOAD NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/24/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/21/2003 CD O O
ATTENDING: NNP B-NP O
JONAS NNP I-NP O
STARNS NNP I-NP O
M.D NNP I-NP O
Discharge NNP I-NP O
date NN I-NP O
to TO O O
be VB O O
determined VBN O O
DISCHARGE NNP B-NP O
DIAGNOSIS: NNP I-NP O
Congestive NNP I-NP O
heart NN I-NP O
failure NN I-NP O
OTHER NNP I-NP O
ASSOCIATED NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
Congestive NNP B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
EF NNP B-NP O
of IN B-VP O
33% CD O O
, , O O
etiology NN B-NP O
unknown JJ O O
2 CD O O
Hypertension NNP B-NP O
3 CD O O
Dyslipidemia NNP B-NP O
4 CD O O
Acute NNP B-NP O
renal JJ B-NP O
failure NN I-NP O
5 CD O O
History NN B-NP O
of IN B-VP O
paroxysmal JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
with IN B-VP O
rapid JJ B-NP O
ventricular JJ I-NP O
response NN I-NP O
6 CD O O
Anemia NNP B-NP O
7 CD O O
Gastritis NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
63-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
55% CD O O
to TO O O
60% CD O O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
2003 CD O O
, , O O
who WP O O
presented VBD B-VP O
with IN B-VP O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
as RB O O
well RB O O
as IN B-VP O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
that IN B-VP O
she PRP O O
has VBZ O O
not RB O O
been VBN O O
taking VBG O O
her PRP$ O O
Lasix NN B-NP B-m
as IN B-VP O
she PRP O O
was VBD B-VP O
prescribed VBN O O
due JJ O O
to TO O O
the DT B-NP O
inconvenience NN I-NP O
of IN B-VP O
going VBG O O
to TO O O
the DT B-NP O
bathroom NN I-NP O
frequently RB O O
She PRP O O
was VBD B-VP O
feeling VBG O O
overwhelmed VBN O O
by IN B-VP O
so RB O O
many JJ B-NP O
medicines NNS I-NP O
Currently RB O O
, , O O
she PRP O O
is VBZ O O
feeling VBG O O
better RBR O O
with IN B-VP O
improved JJ B-NP O
breathing NN I-NP O
No NNP I-NP O
fever NN I-NP O
, , O O
chills NNS B-NP O
, , O O
or CC O O
chest JJS B-NP O
pain NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Congestive NNP B-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
55% CD O O
to TO O O
60% CD O O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
2003 CD O O
2 CD O O
Deep NNP B-NP O
venous JJ B-NP O
thrombosis NN I-NP O
bilaterally RB O O
with IN B-VP O
PE NNP B-NP O
in IN B-VP O
March NNP B-NP O
2003 CD O O
3 CD O O
Acute NNP B-NP O
renal JJ B-NP O
failure NN I-NP O
, , O O
nephrotic JJ B-NP O
syndrome NN I-NP O
4 CD O O
Pneumonia NNP B-NP O
5 CD O O
Iron NNP B-NP O
and CC O O
folate JJ B-NP O
deficiency NN I-NP O
anemia VBD B-VP O
6 CD O O
Paroxysmal NNP B-NP O
atrial JJ B-NP O
fibrillation NN I-NP O
with IN B-VP O
rapid JJ B-NP O
ventricular JJ I-NP O
response NN I-NP O
7 CD O O
Nonsustained VBD B-VP O
ventricular JJ B-NP O
tachycardia NN I-NP O
8 CD O O
Insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus VBP O O
9 CD O O
Hypertension NNP B-NP O
10 CD O O
Cholesterol NNP B-NP O
11 CD O O
Chronic NNP B-NP O
knee NN I-NP O
and CC O O
back RB O O
pain NN B-NP O
12 CD O O
Arthroscopic NNP B-NP O
knee NN I-NP O
surgery NN I-NP O
bilaterally RB O O
13 CD O O
Gastritis NNP B-NP O
14 CD O O
Benign NNP B-NP O
colon NN I-NP O
polyps NNS I-NP O
greater JJR O O
than IN B-VP O
10 CD O O
15 CD O O
Cataracts NNS B-NP O
16 CD O O
Glaucoma NNP B-NP O
MEDICATIONS NNP I-NP O
AT NNP I-NP O
HOME: NNP I-NP O
1 CD O O
Lasix NNP B-NP B-m
120 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
2 CD O O
Atenolol NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d $ O B-f
3 CD O O
Iron NNP B-NP B-m
sulfate NN I-NP I-m
300 CD O B-do
b.i.d NN B-NP B-f
4 CD O O
Folate NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
5 CD O O
NPH NNP B-NP B-m
insulin NN I-NP I-m
20 CD O B-do
units NNS B-NP I-do
q.d RB O B-f
6 CD O O
Oxycodone NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
to TO O I-do
10 CD O I-do
mg NNS B-NP I-do
q.4-6h JJ B-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
7 CD O O
Senna NNP B-NP B-m
8 CD O O
Multivitamins NNP B-NP B-m
9 CD O O
Zocor NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
10 CD O O
Norvasc NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
11 CD O O
Accupril NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
12 CD O O
Miconazole NNP B-NP B-m
2% CD O I-m
topical JJ B-NP B-mo
b.i.d NN I-NP B-f
13 CD O O
Celexa NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
14 CD O O
Avandia NNP B-NP B-m
8 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
15 CD O O
Nexium NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
16 CD O O
Albuterol NNP B-NP B-m
p.r.n JJ B-NP B-f
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
3-packs-per-day JJ B-NP O
smoking NN I-NP O
for IN B-VP O
30 CD O O
years NNS B-NP O
and CC O O
no DT B-NP O
alcohol NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
heart NN B-NP O
disease NN I-NP O
PHYSICAL NNP I-NP O
EXAM: NNP I-NP O
On IN B-VP O
presentation NN B-NP O
, , O O
T NNP B-NP O
97.3 CD O O
, , O O
BP NNP B-NP O
143/70 CD O O
, , O O
pulse RB O O
57 CD O O
, , O O
98% CD O O
on IN B-VP O
2 CD O O
liters NNS B-NP O
This DT O O
is VBZ O O
an DT B-NP O
obese JJ I-NP O
female NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
, , O O
sitting VBG O O
up RP O O
in IN B-VP O
bed NN B-NP O
HEENT: NNP I-NP O
Extraocular NNP I-NP O
movements NNS I-NP O
intact JJ B-NP O
Sclerae NNP I-NP O
anicteric NN I-NP O
Neck: NNP I-NP O
Supple NNP I-NP O
, , O O
JVP NNP B-NP O
at IN B-VP O
14 CD O O
cm NN B-NP O
Chest: NNP I-NP O
Crackles NNP I-NP O
bilaterally RB O O
, , O O
left VBD B-VP O
greater JJR O O
than IN B-VP O
right RB O O
, , O O
half DT B-NP O
way NN I-NP O
up IN B-VP O
both DT B-NP O
lung NN I-NP O
fields NNS I-NP O
with IN B-VP O
mild NNS B-NP O
decreased VBN O O
breath NN B-NP O
sounds NNS I-NP O
at IN B-VP O
the DT B-NP O
bases NNS I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
Normal NNP I-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
No NNP I-NP O
murmur NN I-NP O
, , O O
rubs NN B-NP O
, , O O
or CC O O
gallops NNS B-NP O
Abdomen: NNP I-NP O
Soft NNP I-NP O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sound NN I-NP O
and CC O O
no DT B-NP O
hepatosplenomegaly NN I-NP O
Extremities VBZ O O
with IN B-VP O
3+ CD O O
edema NN B-NP O
as RB O O
well RB O O
as IN B-VP O
areas NNS B-NP O
of IN B-VP O
erythematous JJ O O
and CC O O
shiny JJ B-NP O
shallow JJ I-NP O
ulcerations NNS I-NP O
Neurologically RB O O
, , O O
euthymic JJ O O
without IN B-VP O
focal JJ B-NP O
deficits NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
significant JJ O O
for IN B-VP O
sodium NN B-NP O
147 CD O O
, , O O
potassium NN B-NP O
3.4 CD O O
, , O O
chloride RB O O
110 CD O O
, , O O
CO2 NNP B-NP O
26 CD O O
, , O O
BUN NNP B-NP O
23 CD O O
, , O O
creatinine NN B-NP O
1.6 CD O O
, , O O
and CC O O
glucose VB O O
69 CD O O
CBC NNP B-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
white JJ B-NP O
count NN I-NP O
of IN B-VP O
6.7 CD O O
, , O O
hematocrit NN B-NP O
39.4 CD O O
, , O O
and CC O O
platelets NNS B-NP O
of IN B-VP O
258 CD O O
Her NNP B-NP O
CK NNP I-NP O
was VBD B-VP O
432 CD O O
Her NNP B-NP O
troponin NN I-NP O
was VBD B-VP O
less JJR O O
than IN B-VP O
assay VB O O
Her PRP$ O O
BNP NNP B-NP O
was VBD B-VP O
greater JJR O O
than IN B-VP O
assay NN B-NP O
and CC O O
D-dimer NNP B-NP O
was VBD B-VP O
50 CD O O
and CC O O
69 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
showed VBD B-VP O
decreased JJ B-NP O
lung NN I-NP O
volumes NNS I-NP O
with IN B-VP O
moderate JJ B-NP O
cardiac JJ I-NP O
enlargement NN I-NP O
EKG NNP I-NP O
showed VBD B-VP O
sinus JJ B-NP O
bradycardia NN I-NP O
with IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
59 CD O O
, , O O
axis NN B-NP O
of IN B-VP O
-36 NNP B-NP O
and CC O O
no DT B-NP O
acute NN I-NP O
changes VBZ O O
ASSESSMENT: NNP B-NP O
This DT O O
is VBZ O O
a DT B-NP O
63-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
likely JJ B-NP O
congestive JJ I-NP O
heart NN I-NP O
failure NN I-NP O
exacerbation NN I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEM: NNP I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
Ischemia: NNP I-NP O
There EX O O
was VBD B-VP O
concern NN B-NP O
regarding VBG O O
acute NN B-NP O
and CC O O
subacute JJ B-NP O
silent NN I-NP O
ischemia NN I-NP O
given VBN O O
new JJ B-NP O
ST-T NNP I-NP O
wave NN I-NP O
changes NNS I-NP O
in IN B-VP O
lateral JJ B-NP O
leads NNS I-NP O
on IN B-VP O
the DT B-NP O
EKG NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
aspirin NN B-NP B-m
as RB O O
well RB O O
as IN B-VP O
statin NN B-NP B-m
She PRP O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
an DT B-NP O
MI NNP I-NP O
with IN B-VP O
negative JJ B-NP O
troponins NNS I-NP O
x VBP O O
3 CD O O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
a DT B-NP O
low-dose JJ I-NP B-do
short-acting JJ I-NP O
beta-blocker NN I-NP B-m
( ( O I-m
Lopressor NNP B-NP I-m
) ) O I-m
She PRP O O
was VBD B-VP O
also RB O O
continued VBN O O
on IN B-VP O
an DT B-NP O
ACE NNP I-NP B-m
inhibitor NN I-NP I-m
with IN B-VP O
this DT O O
switched VBN O O
to TO O O
captopril VB O B-m
as IN B-VP O
a DT B-NP O
short-acting JJ I-NP O
ACE NNP I-NP B-m
inhibitor NN I-NP I-m
, , O O
which WDT O O
was VBD B-VP O
titrated VBN O O
up RP O O
as IN B-VP O
tolerated VBN O O
for IN B-VP O
a DT B-NP B-r
goal NN I-NP I-r
blood NN I-NP I-r
pressure NN I-NP I-r
of IN B-VP O
systolic NN B-NP O
of IN B-VP O
120 CD O O
An DT B-NP O
adenosine NN I-NP B-m
MIBI NNP I-NP O
was VBD B-VP O
performed VBN O O
which WDT O O
was VBD B-VP O
negative JJ O O
for IN B-VP O
perfusion NN B-NP O
defects NNS I-NP O
However RB O O
, , O O
echo VBP O O
showed VBN O O
global JJ B-NP O
hypokinesis NN I-NP O
with IN B-VP O
depressed JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
Cardiology NNP I-NP O
consult NN I-NP O
was VBD B-VP O
called VBN O O
and CC O O
they PRP O O
recommended VBD B-VP O
further RBR O O
workup NN B-NP O
with IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
refused VBD B-VP O
the DT B-NP O
catheterization NN I-NP O
Rhythm: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
However RB O O
, , O O
she PRP O O
remained VBD B-VP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
throughout IN B-VP O
her PRP$ O O
admission NN B-NP O
She PRP O O
was VBD B-VP O
monitored VBN O O
by IN B-VP O
cardiac JJ B-NP O
telemetry NN I-NP O
with IN B-VP O
several JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
6 CD O O
to TO O O
10 CD O O
beats NNS B-NP O
of IN B-VP O
nonsustained JJ B-NP O
ventricular JJ I-NP O
tachycardia NN I-NP O
Her PRP$ O O
electrolytes NNS B-NP O
were VBD B-VP O
carefully RB O O
monitored VBN O O
and CC O O
repleted VBN O O
as IN B-VP O
necessary JJ O O
She PRP O O
remained VBD B-VP O
asymptomatic JJ O O
with IN B-VP O
the DT B-NP O
runs NNS I-NP O
of IN B-VP O
NSVT NNP B-NP O
and CC O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
beta-blocker NN B-NP B-m
Given NNP I-NP O
her PRP$ O O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
as RB O O
well RB O O
as IN B-VP O
depressed JJ B-NP B-r
ejection NN I-NP I-r
fraction NN I-NP I-r
, , O O
she PRP O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
Coumadin NNP I-NP B-m
Pump: NNP I-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
a DT B-NP O
frank JJ I-NP O
fluid NN I-NP O
overload NN I-NP O
with IN B-VP O
elevated JJ B-NP O
JVP NNP I-NP O
, , O O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
, , O O
and CC O O
a DT B-NP O
BNP NNP I-NP O
greater JJR O O
than IN B-VP O
assay VB O O
She PRP O O
was VBD B-VP O
aggressively RB O O
diuresed VBN O O
with IN B-VP O
a DT B-NP O
goal NN I-NP O
of IN B-VP O
greater JJR O O
than IN B-VP O
-2 JJR B-NP O
liters NNS I-NP O
a DT B-NP O
day NN I-NP O
She PRP O O
responded VBD B-VP O
to TO O O
80 CD O B-do
mg NN B-NP I-do
of IN B-VP O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
t.i.d VBD B-VP B-f
Her PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
carefully RB O O
followed VBN O O
and CC O O
did VBD B-VP O
increase VB O O
on IN B-VP O
8/21/03 CD O O
, , O O
at IN B-VP O
which WDT O O
point NN B-NP O
diuresis NN I-NP O
was VBD B-VP O
put VBN O O
on IN B-VP O
hold NN B-NP O
The DT B-NP O
patient NN I-NP O
diuresed VBD B-VP O
about RB O O
3 CD O O
to TO O O
4 CD O O
liters NNS B-NP O
each DT B-NP O
day NN I-NP O
during IN B-VP O
her PRP$ O O
hospital JJ B-NP O
stay NN I-NP O
until IN B-VP O
2/16/03 CD O O
At IN B-VP O
this DT B-NP O
point NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
very RB O O
close RB O O
to TO O O
euvolemic VB O O
Given NNP B-NP O
the DT B-NP O
patient's NN I-NP O
echo JJ B-NP O
findings NNS I-NP O
with IN B-VP O
depressed JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
and CC O O
global JJ B-NP O
hypokinesis NN I-NP O
, , O O
a DT B-NP O
workup NN I-NP O
for IN B-VP O
dilated VBN O O
cardiomyopathy NN B-NP O
was VBD B-VP O
begun VBN O O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
wish VB O O
for IN B-VP O
further JJ B-NP O
investigation NN I-NP O
with IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
or CC O O
a DT B-NP O
cardiac JJ I-NP O
MRI NNP I-NP O
Her NNP I-NP O
other JJ B-NP O
labs NN I-NP O
were VBD B-VP O
unremarkable JJ O O
including VBG O O
a DT B-NP O
TSH NNP I-NP O
, , O O
which WDT O O
was VBD B-VP O
normal JJ O O
, , O O
an DT B-NP O
ANA NNP I-NP O
which WDT O O
was VBD B-VP O
negative JJ O O
, , O O
iron NN B-NP O
studies NNS I-NP O
which WDT O O
did VBD B-VP O
not RB O O
show VB O O
iron NN B-NP O
overload NN I-NP O
, , O O
and CC O O
thiamine NN B-NP O
which WDT O O
is VBZ O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
require VB O O
close JJ B-NP O
followup NNS I-NP O
with IN B-VP O
careful JJ B-NP O
fluid JJ I-NP O
balance NN I-NP O
monitoring NN I-NP O
as RB O O
well RB O O
as IN B-VP O
followup NN B-NP O
with IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
service NN I-NP O
Pulmonary: NNP I-NP O
She PRP O O
initially RB O O
presented VBD B-VP O
with IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
However RB O O
, , O O
this DT O O
resolved VBN O O
with IN B-VP O
diuresis NN B-NP O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
PE NNP B-NP O
as RB O O
well RB O O
as IN B-VP O
DVT NNP B-NP O
and CC O O
an DT B-NP O
elevated JJ I-NP O
dimer NN I-NP O
was VBD B-VP O
found VBN O O
on IN B-VP O
admission NN B-NP O
There EX O O
was VBD B-VP O
initial JJ B-NP O
concern NN I-NP O
for IN B-VP O
pulmonary JJ B-NP O
embolism NN I-NP O
, , O O
but CC O O
the DT B-NP O
resolution NN I-NP O
of IN B-VP O
symptoms NNS B-NP O
with IN B-VP O
diuresis NN B-NP O
and CC O O
a DT B-NP O
history NN I-NP O
that WDT O O
was VBD B-VP O
not RB O O
suggestive JJ O O
of IN B-VP O
pulmonary JJ B-NP O
emboli NN I-NP O
, , O O
did VBD B-VP O
not RB O O
require VB O O
further JJ B-NP O
followup NN I-NP O
with IN B-VP O
spiral JJ B-NP O
chest NN I-NP O
CT NNP I-NP O
Heme: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
hematocrit NN I-NP O
was VBD B-VP O
followed VBN O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
chronic JJ B-NP B-r
folate NN I-NP I-r
and CC O O
iron-deficiency NN B-NP B-r
anemia NN I-NP I-r
and CC O O
she PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
folate NN B-NP B-m
and CC O O
iron NN B-NP B-m
replacement NN I-NP O
Endocrine: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
NPH NNP B-NP B-m
20 CD O B-do
units NNS B-NP I-do
for IN B-VP O
her PRP$ O B-r
known JJ O O
diabetes VBZ O O
Her PRP$ O O
blood NN B-NP O
sugars NNS I-NP O
were VBD B-VP O
in IN B-VP O
excellent JJ B-NP O
control NN I-NP O
on IN B-VP O
this DT B-NP O
regimen JJ I-NP O
Avandia NNP I-NP B-m
was VBD B-VP O
held VBN O O
given VBN O O
it PRP O O
contraindication NN B-NP O
in IN B-VP O
heart NN B-NP O
failure NN I-NP O
Renal: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
was VBD B-VP O
1.6 CD O O
on IN B-VP O
admission NN B-NP O
, , O O
which WDT O O
is VBZ O O
up IN B-VP O
from IN B-VP O
about IN B-VP O
0.8 CD O O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
2003 CD O O
Her NNP B-NP O
urine NN I-NP O
eosinophils NNS I-NP O
and CC O O
sediment NN B-NP O
were VBD B-VP O
unremarkable JJ O O
, , O O
but CC O O
frank VBD B-VP O
proteinuria NNS B-NP O
was VBD B-VP O
noted VBN O O
which WDT O O
is VBZ O O
consistent JJ O O
with IN B-VP O
her PRP$ O O
known VBN O O
nephrotic JJ B-NP O
syndrome NN I-NP O
Her NNP I-NP O
creatinine NN I-NP O
remained VBD B-VP O
stable JJ O O
in IN B-VP O
the DT O O
1.5 CD O O
to TO O O
1.6 CD O O
range NN B-NP O
until IN B-VP O
8/21/03 CD O O
, , O O
when WRB O O
her PRP$ O O
creatinine NN B-NP O
bumped VBD B-VP O
to TO O O
2 CD O O
and CC O O
kept VBD B-VP O
rising VBG O O
until IN B-VP O
8/3/03 CD O O
, , O O
when WRB O O
it PRP O O
reached VBD B-VP O
2.7 CD O O
Repeat NNP B-NP O
urine JJ B-NP O
electrolytes NNS I-NP O
, , O O
urine JJ B-NP O
eosinophils NNS I-NP O
and CC O O
sediment NN B-NP O
were VBD B-VP O
sent VBN O O
at IN B-VP O
this DT B-NP O
point NN I-NP O
and CC O O
they PRP O O
are VBP O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
The DT O O
most RBS O O
likely JJ B-NP O
explanation NN I-NP O
for IN B-VP O
increasing VBG O O
creatinine NN B-NP O
was VBD B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
and CC O O
intravascular JJ B-NP O
volume NN I-NP O
depletion NN I-NP O
Diuresis NNP I-NP O
was VBD B-VP O
put VBN O O
on IN B-VP O
hold NN B-NP O
on IN B-VP O
3/15/03 CD O O
and CC O O
10/5/03 CD O O
Given NNP B-NP O
her PRP$ O O
increased JJ B-NP O
creatinine NN I-NP O
, , O O
her PRP$ O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
dose NN I-NP O
was VBD B-VP O
halfed VBN O O
on IN B-VP O
10/5/03 CD O O
The DT B-NP O
plan NN I-NP O
is VBZ O O
to TO O O
continue VB O O
to TO O O
monitor VB O O
her PRP$ O O
creatinine NN B-NP O
function NN I-NP O
, , O O
follow VBP O O
up RP O O
on IN B-VP O
her PRP$ O O
urine JJ B-NP O
chemistries NNS I-NP O
and CC O O
if IN B-VP O
her PRP$ O O
creatinine NN B-NP O
resolves NNS I-NP O
, , O O
to TO O O
resume VB O O
gentle JJ B-NP O
diuresis NN I-NP O
as IN B-VP O
necessary JJ B-NP O
Infectious NNP I-NP O
Disease: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT O B-r
a DT B-NP B-r
UTI NNP I-NP I-r
UTI NNP I-NP I-r
with IN B-VP O
E NNP B-NP O
Coli NNP I-NP O
that WDT O O
was VBD B-VP O
sensitive JJ O O
to TO O O
Bactrim NNP B-NP B-m
and CC O O
she PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Bactrim NNP B-NP B-m
with IN B-VP O
resolution NN B-NP O
Rheumatological: NNP I-NP O
The DT B-NP O
patient NN I-NP O
with IN B-VP O
known VBN O O
chronic JJ B-NP O
pain NN I-NP O
as RB O O
well RB O O
as IN B-VP O
arthritis NN B-NP O
Her NNP I-NP O
Celebrex NNP I-NP B-m
was VBD B-VP O
held VBN O O
given VBN O O
her PRP$ O O
increased JJ B-NP O
creatinine NN I-NP O
and CC O O
its PRP$ O O
propensity NN B-NP O
to TO O O
cause VB O O
fluid JJ B-NP O
retention NN I-NP O
Her PRP$ O O
joint JJ B-NP O
exam NN I-NP O
revealed VBD B-VP O
swollen JJ B-NP O
PIP NNP I-NP O
joints NNS I-NP O
of IN B-VP O
both DT B-NP O
hands NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
marked VBN O O
swelling NN B-NP O
over IN B-VP O
both DT B-NP O
wrists NNS I-NP O
A VBP O O
rheumatoid JJ B-NP O
factor NN I-NP O
was VBD B-VP O
sent VBN O O
and CC O O
that IN B-VP O
came VBD B-VP O
back RB O O
negative JJ O O
For IN B-VP O
her PRP$ O B-r
pain NN B-NP I-r
, , O O
she PRP O O
was VBD B-VP O
given VBN O O
oxycodone RP O B-m
p.r.n JJ O B-f
Once RB O O
her PRP$ O O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
resolves NNS I-NP O
, , O O
she PRP O O
may MD O O
be VB O O
transitioned VBN O O
to TO O O
Celebrex NNP B-NP B-m
or CC O O
other JJ B-NP O
antiinflammatory NN I-NP B-m
medications NNS I-NP I-m
which WDT O O
may MD O O
be VB O O
more JJR O O
effected JJ O O
for IN B-VP O
her PRP$ O B-r
arthritis NN B-NP I-r
arthritis NN I-NP B-r
ANA NNP I-NP O
came VBD B-VP O
back RB O O
negative JJ B-NP O
Psyche: NNP I-NP O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Celexa NNP B-NP B-m
for IN B-VP O
depression NN B-NP B-r
Code NNP I-NP O
status: CC O O
Full NNP B-NP O
code NN I-NP O
FOLLOWUP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
needs VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
the DT B-NP O
congestive JJ I-NP O
heart NN I-NP O
failure NN I-NP O
service NN I-NP O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician JJ B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
( ( O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
on IN B-VP O
8/3/03 CD O O
): JJ O O
1 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
2 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
3 CD O O
Iron NNP B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
4 CD O O
Prozac NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
5 CD O O
Folate NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
6 CD O O
Lasix NNP B-NP B-m
160 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
( ( O O
this DT B-NP O
dose NN I-NP O
was VBD B-VP O
held VBN O O
on IN B-VP O
3/15/03 CD O O
and CC O O
8/3/03 CD O O
and CC O O
should MD O O
be VB O O
held VBN O O
until IN B-VP O
creatinine JJ B-NP O
increases NNS I-NP O
and CC O O
restarted VBN O O
once RB O O
symptoms NNS B-NP O
and CC O O
sign NN B-NP O
of IN B-VP O
fluid NN B-NP O
overload NN I-NP O
occur NN I-NP O
) ) O O
7 CD O O
NPH NNP B-NP B-m
human JJ B-NP I-m
insulin NN I-NP I-m
20 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
q.p.m RB O B-f
8 CD O O
Zestril NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
9 CD O O
Oxycodone NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
to TO O I-do
10 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.4-6h JJ I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
10 CD O O
Senna NNP B-NP B-m
tablets NNS I-NP I-m
2 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
b.i.d RB O B-f
11 CD O O
Aldactone NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
( ( O O
this DT B-NP B-m
medication NN I-NP I-m
was VBD B-VP O
held VBN O O
on IN B-VP O
3/15/03 CD O O
and CC O O
8/3/03 CD O O
given VBN O O
increasing VBG O O
creatinine NN B-NP O
and CC O O
should MD O O
be VB O O
held VBN O O
until IN B-VP B-du
creatinine JJ B-NP I-du
decreases NNS I-NP I-du
) ) O O
12 CD O O
Multivitamins NNS B-NP B-m
with IN B-VP I-m
minerals NNS B-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
13 CD O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s VBD B-VP B-f
14 CD O O
Zocor NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s VBD B-VP B-f
15 CD O O
Toprol NNP B-NP B-m
XL NNP I-NP I-m
p.o NN I-NP B-mo
q.d NN I-NP B-f
16 CD O O
Imdur NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
17 CD O O
Bactrim NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
for IN B-VP B-du
7 CD O I-du
days NNS B-NP I-du
( ( O O
started VBN O O
on IN B-VP O
4/12/03 CD O O
) ) O O
18 CD O O
Prednisolone NNP B-NP B-m
acetate NN I-NP I-m
0.125% CD O I-m
one CD O B-do
drop NN B-NP I-do
OU NNP I-NP B-mo
q.i.d VBZ O B-f
19 CD O O
Nexium NN B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
20 CD O O
Albuterol NNP B-NP B-m
inhaler NN I-NP I-m
2 CD O B-do
puffs NNS B-NP I-do
inhaler JJ B-NP B-mo
q.i.d NN I-NP B-f
p.r.n NN I-NP I-f
wheezing VBG O B-r
21 CD O O
Miconazole NNP B-NP B-m
nitrate JJ B-NP I-m
powder NN I-NP I-m
topical JJ B-NP B-mo
b.i.d NN I-NP B-f
p.r.n NN I-NP I-f
ADDENDUM: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
on IN B-VP O
4/12/03 CD O O
for IN B-VP O
known VBN O B-r
paroxysmal JJ B-NP I-r
atrial JJ I-NP I-r
fibrillation NN I-NP I-r
Her NNP I-NP O
INR NNP I-NP O
needs VBZ O O
monitoring NN B-NP O
with IN B-VP O
a DT B-NP O
goal NN I-NP O
INR NNP I-NP O
of IN B-VP O
2 CD O O
to TO O O
3 CD O O
The DT B-NP O
patient's NN I-NP O
discharge NN I-NP O
is VBZ O O
pending VBG O O
resolution NN B-NP O
of IN B-VP O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
, , O O
creatinine NN B-NP O
is VBZ O O
still RB O O
elevated VBN O O
and CC O O
this DT B-NP O
dictation NN I-NP O
will MD O O
be VB O O
updated VBN O O
with IN B-VP O
medications NNS B-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
resolution NN B-NP O
of IN B-VP O
her PRP$ O O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
eScription NN I-NP O
document: VBZ O O
2-6024257 JJ B-NP O
ISSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
WINDOVER NNP I-NP O
, , O O
COURTNEY NNP B-NP O
Attending: NNP I-NP O
FLOCKHART NNP I-NP O
, , O O
JAKE NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
0246887 CD O O
D: NNP B-NP O
8/3/03 CD O O
T: NNP B-NP O
8/3/03 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#28218 VBZ O O
325114627 CD O O
TVMC NNP B-NP O
43861883 CD O O
9103772 CD O O
5/0/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
URINARY NNP I-NP O
TRACT NNP I-NP O
INFECTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/28/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/17/2006 CD O O
ATTENDING: NNP B-NP O
VENIER NNP I-NP O
, , O O
IRWIN NNP B-NP O
MD NNP I-NP O
INTERIM NNP I-NP O
SUMMARY NNP I-NP O
DATE NNP I-NP O
OF NNP I-NP O
DISCHARGE: NNP I-NP O
To TO O O
be VB O O
determined VBN O O
ADMISSION NNP B-NP O
DIAGNOSIS: NNP I-NP O
Altered NNP I-NP O
mental JJ B-NP O
status NN I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Altered NNP I-NP O
mental JJ B-NP O
status NN I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
Non-small NNP B-NP O
cell NN I-NP O
lung NN I-NP O
cancer NN I-NP O
2 CD O O
Right NNP B-NP O
MCA NNP I-NP O
embolic JJ O O
stroke VBD B-VP O
3 CD O O
Graves' NNP B-NP O
disease NN I-NP O
4 CD O O
Depression NNP B-NP O
5 CD O O
Attention NNP B-NP O
deficit NN I-NP O
disorder NN I-NP O
6 CD O O
Hypertension NNP B-NP O
7 CD O O
Asthma NNP B-NP O
8 CD O O
Temporal NNP B-NP O
lobe NN I-NP O
epilepsy NN I-NP O
9 CD O O
History NNP B-NP O
of IN B-VP O
subclavian JJ B-NP O
steal JJ I-NP O
syndrome NN I-NP O
10 CD O O
Urinary NNP B-NP O
tract JJ B-NP O
infection NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
64-year-old JJ I-NP O
lady NN I-NP O
who WP O O
has VBZ O O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
of IN B-VP O
right JJ B-NP O
upper JJ I-NP O
lobe NN I-NP O
lung NN I-NP O
cancer NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
chemotherapy NN I-NP O
x2 NN I-NP O
cycles NNS I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
x-ray JJ B-NP O
therapy NN I-NP O
Her NNP I-NP O
chemotherapy NN I-NP O
has VBZ O O
included VBN O O
VP-16 NNP B-NP B-m
and CC O O
cisplatin VB O B-m
She PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT B-NP O
large JJ I-NP O
right NN I-NP O
middle JJ B-NP O
cerebral JJ I-NP O
artery NN I-NP O
stroke NN I-NP O
in IN B-VP O
10/22 CD O O
, , O O
status NN B-NP O
post NN I-NP O
a DT B-NP O
right JJ I-NP O
carotid NN I-NP O
endarterectomy NN I-NP O
on IN B-VP O
0/23/06 CD O O
She PRP O O
has VBZ O O
been VBN O O
at IN B-VP O
the DT B-NP O
Neot NNP I-NP O
Addy NNP I-NP O
Hospital NNP I-NP O
since IN B-VP O
her PRP$ O O
last JJ B-NP O
Ry NNP I-NP O
Hospital NNP I-NP O
admission NN I-NP O
She PRP O O
was VBD B-VP O
there RB O O
for IN B-VP O
stroke NN B-NP O
rehabilitation NN I-NP O
and CC O O
completed VBD B-VP O
a DT B-NP B-du
ten-day JJ I-NP I-du
course NN I-NP I-du
of IN B-VP O
vancomycin NN B-NP B-m
for IN B-VP O
a DT B-NP B-r
MRSA NNP I-NP O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
She PRP O O
was VBD B-VP O
found VBN O O
, , O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
by IN B-VP O
her PRP$ O O
son NN B-NP O
to TO O O
be VB O O
difficult JJ O O
to TO O O
arouse VB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
Dalupe NNP I-NP O
Health NNP I-NP O
Systems NNP I-NP O
by IN B-VP O
Emergency NNP B-NP O
Services NNPS I-NP O
The DT B-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
66/44 CD O O
, , O O
a DT B-NP O
pulse NN I-NP O
of IN B-VP O
100 CD O O
, , O O
a DT B-NP O
respiratory NN I-NP O
rate NN I-NP O
that WDT O O
was VBD B-VP O
normal JJ O O
and CC O O
blood NN B-NP O
sugar NN I-NP O
of IN B-VP O
133 CD O O
She PRP O O
denied VBD B-VP O
complaints NNS B-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
diaphoresis NN B-NP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
other JJ I-NP O
pain NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Non-small NNP B-NP O
cell NN I-NP O
lung NN I-NP O
cancer NN I-NP O
, , O O
diagnosed VBD B-VP O
7/24 CD O O
, , O O
stage NN B-NP O
3 CD O O
, , O O
present NN B-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
upper NN I-NP O
lung NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
neoadjuvant JJ B-NP O
XRT NNP I-NP O
and CC O O
two CD O O
cycles NNS B-NP O
of IN B-VP O
chemotherapy NN B-NP O
2 CD O O
Right NNP B-NP O
MC NNP I-NP O
embolic JJ B-NP O
stroke NN I-NP O
in IN B-VP O
4/10 CD O O
3 CD O O
Status NNP B-NP O
post NN I-NP O
right RB O O
carotid VBZ O O
endarterectomy NN B-NP O
on IN B-VP O
0/23/06 CD O O
4 CD O O
Graves NNS B-NP O
disease VBD B-VP O
5 CD O O
Depression NNP B-NP O
6 CD O O
Diabetes VBZ O O
7 CD O O
Hypertension NNP B-NP O
8 CD O O
Asthma NNP B-NP O
9 CD O O
Temporal NNP B-NP O
lobe NN I-NP O
epilepsy NN I-NP O
10 CD O O
History NNP B-NP O
of IN B-VP O
subclavian JJ B-NP O
steal NN I-NP O
syndrome NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Bilateral NNP B-NP O
salpingo-oophorectomy JJ O O
30 CD O O
years NNS B-NP O
ago RB O O
2 CD O O
History NNP B-NP O
of IN B-VP O
radioactive JJ B-NP O
iodine NN I-NP O
for IN B-VP O
Graves' NNP B-NP O
disease NN I-NP O
30 CD O O
years NNS B-NP O
ago RB O O
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
being VBG O O
alert JJ O O
and CC O O
oriented JJ B-NP O
x2 NN I-NP O
, , O O
nonconversant JJ O O
, , O O
angry JJ O O
and CC O O
in IN B-VP O
pain JJ B-NP O
Neurological NNP I-NP O
exam NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
left JJ I-NP O
upper JJ I-NP O
femoral JJ I-NP O
paralysis NN I-NP O
with IN B-VP O
increased JJ B-NP O
deep JJ I-NP O
tendon NN I-NP O
reflex NN I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
, , O O
bilateral JJ B-NP O
lower JJR I-NP O
extremities NNS I-NP O
with IN B-VP O
2+ CD O O
Achilles NNS B-NP O
patellar JJ B-NP O
reflexes NNS I-NP O
Her PRP$ O O
heart NN B-NP O
was VBD B-VP O
tachycardic JJ O O
, , O O
but CC O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
or CC O O
gallops NNS B-NP O
Lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
except IN B-VP O
for IN B-VP O
bibasilar JJ B-NP O
rales NNS I-NP O
Her PRP$ O O
abdomen NNS B-NP O
was VBD B-VP O
full JJ O O
, , O O
nontender NN B-NP O
and CC O O
nondistended VBD B-VP O
Her NNP B-NP O
extremities NNS I-NP O
had VBD B-VP O
no DT B-NP O
cyanosis NN I-NP O
or CC O O
edema NN B-NP O
and CC O O
had VBD B-VP O
2+ CD O O
DP NNP B-NP O
pulses NNS I-NP O
In IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
, , O O
her PRP$ O O
pulse NN B-NP O
was VBD B-VP O
100 CD O O
and CC O O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
148/60 CD O O
She PRP O O
was VBD B-VP O
somnolent JJ O O
She PRP O O
had VBD B-VP O
1 CD O B-do
gm NN B-NP I-do
of IN B-VP O
vancomycin NN B-NP B-m
, , O O
magnesium NN B-NP B-m
and CC O O
Levaquin NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
ALLERGIES: NNP I-NP O
Penicillin NNP I-NP O
, , O O
for IN B-VP O
which WDT O O
she PRP O O
has VBZ O O
a DT B-NP O
hive JJ I-NP O
reaction; NN I-NP O
valproic NN I-NP O
acid NN I-NP O
, , O O
sulfa NN B-NP O
drugs NNS I-NP O
Demerol NNP I-NP O
causes VBZ O O
hypotension NN B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Mechanical NNP I-NP O
soft JJ B-NP O
diet NN I-NP O
, , O O
aspirin RB O B-m
81 CD O B-do
mg NN B-NP I-do
, , O O
baclofen VBD B-VP B-m
5 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
B12 NNP B-NP B-m
1000 CD O B-do
mg NN B-NP I-do
daily RB O B-f
, , O O
iron NN B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Cymbalta NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Neurontin NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Lamictal NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Prilosec NNP B-NP B-m
20 CD O B-do
daily RB O B-f
, , O O
levothyroxine NN B-NP B-m
, , O O
Glucophage NNP B-NP B-m
500 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Reglan NNP B-NP B-m
10 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
niacin RB O B-m
500 CD O B-do
once RB O B-f
a DT B-NP O
day NN I-NP O
, , O O
Senna NNP B-NP B-m
2 CD O B-do
tabs NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Zocor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Nicoderm NNP B-NP B-m
patch NN I-NP O
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
lidoderm VBZ O B-m
5% CD O I-m
patch NN B-NP I-m
to TO O O
the DT O O
low JJ O O
back RB O O
She PRP O O
also RB O O
had VBD B-VP O
p.r.n VBN O B-f
p.r.n JJ B-NP B-f
p.r.n NN I-NP B-f
p.r.n NN I-NP B-f
p.r.n NN I-NP B-f
p.r.n NN I-NP B-f
p.r.n NN I-NP B-f
of IN B-VP O
Tylenol NNP B-NP B-m
, , O O
ducolox NN B-NP B-m
, , O O
Mylanta NNP B-NP B-m
, , O O
lactulose RB O B-m
, , O O
Seroquel NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
, , O O
prednisone NN B-NP B-m
50 CD O B-do
mg NN B-NP I-do
, , O O
and CC O O
Dilaudid NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Divorced NNP I-NP O
with IN B-VP O
two CD O O
children NNS B-NP O
No DT B-NP O
alcohol NN I-NP O
use NN I-NP O
recently RB O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Father NNP I-NP O
died VBD B-VP O
of IN B-VP O
a DT B-NP O
MI NNP I-NP O
at IN B-VP O
73 CD O O
Her PRP$ O O
mother NN B-NP O
died VBD B-VP O
in IN B-VP O
her PRP$ O O
80s CD O O
of IN B-VP O
emphysema JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1 CD O O
, , O O
her PRP$ O O
ALT NNP B-NP O
was VBD B-VP O
25 CD O O
, , O O
AST NNP B-NP O
was VBD B-VP O
35 CD O O
, , O O
her PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
33 CD O O
, , O O
her PRP$ O O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
6.6 CD O O
, , O O
and CC O O
her PRP$ O O
platelets NNS B-NP O
were VBD B-VP O
241 CD O O
, , O O
000 CD O O
She PRP O O
had VBD B-VP O
normal JJ O O
differential JJ O O
Her PRP$ O O
albumin NN B-NP O
was VBD B-VP O
3.5 CD O O
Her NNP B-NP O
urinalysis NN I-NP O
was VBD B-VP O
dark JJ O O
, , O O
with IN B-VP O
3+ CD O O
leukoesterase NN B-NP O
, , O O
negative JJ B-NP O
nitrates NNS I-NP O
, , O O
greater JJR O O
than IN B-VP O
200 CD O O
white JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
per IN B-VP O
high JJ B-NP O
peripheral NN I-NP O
, , O O
2-4 JJ B-NP O
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
per IN B-VP O
high JJ B-NP O
peripheral NN I-NP O
, , O O
1+ CD O O
bacteria NNS B-NP O
Her PRP$ O O
EKG NNP B-NP O
showed VBD B-VP O
a DT B-NP O
sinus NN I-NP O
rhythm NN I-NP O
of IN B-VP O
100 CD O O
Her PRP$ O O
left JJ B-NP O
bundle JJ I-NP O
branch NN I-NP O
block NN I-NP O
with IN B-VP O
a DT B-NP O
QTc NNP I-NP O
of IN B-VP O
500 CD O O
, , O O
but CC O O
no DT B-NP O
change NN I-NP O
compared VBN O O
to TO O O
baseline VB O O
Her NNP B-NP O
head NN I-NP O
CT NNP I-NP O
showed VBD B-VP O
an DT B-NP O
old JJ I-NP O
right NN I-NP O
middle VBZ O O
cerebral JJ B-NP O
artery NN I-NP O
implant JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
initial JJ B-NP O
presentation NN I-NP O
with IN B-VP O
somnolence NN B-NP O
and CC O O
altered VBD B-VP O
mental JJ B-NP O
status NN I-NP O
with IN B-VP O
one CD O O
hypotensive JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
by IN B-VP O
EMS NNP B-NP O
, , O O
but CC O O
subsequently RB O O
no DT B-NP O
hypotension NN I-NP O
in IN B-VP O
the DT B-NP O
absence NN I-NP O
of IN B-VP O
fluid JJ B-NP O
resuscitation NN I-NP O
Her NNP I-NP O
urine JJ B-NP O
culture NN I-NP O
appeared VBD B-VP O
to TO O O
indicate VB O O
an DT B-NP B-r
infection NN I-NP I-r
, , O O
and CC O O
so RB O O
she PRP O O
was VBD B-VP O
covered VBN O O
with IN B-VP O
antibiotics NNS B-NP B-m
initially RB O O
It PRP O O
was VBD B-VP O
also RB O O
determined VBN O O
that IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
significant JJ I-NP O
polypharmacy NN I-NP O
and CC O O
enumerable JJ B-NP O
sedating NN I-NP B-m
medications NNS I-NP I-m
at IN B-VP O
her PRP$ O O
rehabilitation NN B-NP O
and CC O O
there EX O O
was VBD B-VP O
suspicion NN B-NP O
that IN B-VP O
the DT B-NP O
medications NNS I-NP O
contributed VBD B-VP O
to TO O O
her PRP$ O O
initial JJ B-NP O
presentation NN I-NP O
of IN B-VP O
somnolence NN B-NP O
and CC O O
altered VBD B-VP O
mental JJ B-NP O
status NN I-NP O
1 CD O O
Infectious NNP B-NP O
disease: VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
vancomycin NN B-NP B-m
for IN B-VP O
a DT B-NP B-r
presumed JJ I-NP I-r
repeated JJ I-NP I-r
MRSA NNP I-NP I-r
UTI NNP I-NP I-r
However RB O O
, , O O
her PRP O O
urine JJ B-NP O
culture NN I-NP O
did VBD B-VP O
not RB O O
grow VB O O
any DT B-NP O
bacteria NNS I-NP O
, , O O
it PRP O O
only RB O O
drew VBD B-VP O
out RP O O
yeast JJ O O
Thus RB O O
, , O O
she PRP O O
was VBD B-VP O
transitioned VBN O O
over IN B-VP O
to TO O O
a DT B-NP O
ciprofloxacin NN I-NP B-m
700 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
regime NN I-NP O
for IN B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
12 CD O B-du
days NNS B-NP I-du
for IN B-VP O
a DT B-NP B-r
presumed JJ I-NP O
urinary JJ I-NP O
tract NN I-NP O
infection NN I-NP O
2 CD O O
F/E/N: NNP B-NP O
She PRP O O
was VBD B-VP O
tolerating VBG O O
oral JJ B-NP O
food NN I-NP O
and CC O O
medications NNS B-NP O
and CC O O
a DT B-NP O
Nutrition NNP I-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
She PRP O O
had VBD B-VP O
calorie NN B-NP O
counts NNS I-NP O
which WDT O O
showed VBD B-VP O
adequate JJ B-NP O
intake NN I-NP O
She PRP O O
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP O
other JJ I-NP O
metabolic JJ I-NP O
abnormality NN I-NP O
that WDT O O
required VBD B-VP O
correction NN B-NP O
3 CD O O
Cardiovascular: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
primary JJ B-NP O
cardiovascular JJ I-NP O
abnormality NN I-NP O
was VBD B-VP O
a DT B-NP O
prolonged JJ I-NP O
QTc NNP I-NP O
which WDT O O
occurred VBD B-VP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
prior JJ B-NP O
use NN I-NP O
of IN B-VP O
Haldol NNP B-NP B-m
and CC O O
other JJ B-NP O
antipsychotics NNS I-NP B-m
for IN B-VP O
behavioral JJ B-NP B-r
behavioral JJ I-NP B-r
modification NN I-NP O
Her NNP I-NP O
QTc NNP I-NP O
was VBD B-VP O
monitored VBN O O
with IN B-VP O
serial JJ B-NP O
EKGs NNP I-NP O
The DT O O
longest JJS O O
it PRP O O
had VBD B-VP O
reached VBN O O
was VBD B-VP O
530 CD O O
ms NN B-NP O
Haldol NNP I-NP B-m
was VBD B-VP O
discontinued VBN O O
in IN B-VP O
order NN B-NP O
to TO O O
preserve VB O O
the DT B-NP O
QTc NNP I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
given VBN O O
some DT B-NP O
amounts NNS I-NP O
of IN B-VP O
Seroquel NNP B-NP B-m
and CC O O
her PRP$ O O
QTc NN B-NP O
was VBD B-VP O
continued VBN O O
to TO O O
be VB O O
monitored VBN O O
4 CD O O
Heme/Oncology: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
stage NN B-NP O
III NNP I-NP O
non-small NN I-NP B-r
cell NN I-NP I-r
lung NN I-NP I-r
cancer NN I-NP I-r
status NN I-NP O
post NN I-NP O
XRT NNP I-NP O
and CC O O
chemotherapy NN B-NP B-m
and CC O O
is VBZ O O
followed VBN O O
by IN B-VP O
her PRP$ O O
outpatient JJ B-NP O
oncologist NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
outpatient JJ I-NP O
psychosocial JJ I-NP O
oncology NN I-NP O
social JJ B-NP O
worker NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
psychosocial JJ I-NP O
oncology NN I-NP O
physician NN I-NP O
whose WP$ O O
name NN B-NP O
is VBZ O O
Chet NNP B-NP O
Nave NNP I-NP O
5 CD O O
Neurological: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
status NN B-NP O
post NN I-NP O
both DT O O
a DT B-NP O
large JJ I-NP O
right JJ I-NP O
MCA NNP I-NP O
stroke NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
right-sided JJ I-NP O
carotid NN I-NP O
endarterectomy NN I-NP O
from IN B-VP O
a DT B-NP O
previous JJ I-NP O
admission NN I-NP O
Her NNP I-NP O
neurological JJ B-NP O
deficits NNS I-NP O
are VBP O O
consistent JJ O O
with IN B-VP O
her PRP$ O O
prior JJ B-NP O
neurological JJ I-NP O
deficits NNS I-NP O
Specifically RB O O
, , O O
they PRP O O
include VBP O O
a DT B-NP O
left-sided JJ I-NP O
hemiparesis NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
agnosia NN B-NP O
on IN B-VP O
the DT B-NP O
left JJ I-NP O
side NN I-NP O
Her NNP I-NP O
mental NN I-NP O
status NN I-NP O
included VBD B-VP O
intermittent JJ B-NP O
disorientation NN I-NP O
She PRP O O
was VBD B-VP O
generally RB O O
at IN B-VP O
her PRP$ O O
best JJS O O
, , O O
alert NN B-NP O
and CC O O
oriented VBN O O
to TO O O
herself VB O O
, , O O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
age NN B-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
location NN B-NP O
in IN B-VP O
the DT B-NP O
Domo NNP I-NP O
Ings NNP I-NP O
Hospital NNP I-NP O
However RB O O
, , O O
she PRP O O
would MD O O
intermittently RB O O
loose VB O O
track NN B-NP O
of IN B-VP O
where WRB O O
her PRP$ O O
location NN B-NP O
was VBD B-VP O
and CC O O
believed VBD B-VP O
that IN B-VP O
she PRP O O
was VBD B-VP O
in IN B-VP O
Naimas NNP B-NP O
West NNP I-NP O
Hospital NNP I-NP O
, , O O
not RB O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
She PRP O O
was VBD B-VP O
also RB O O
intermittently RB O O
confused VBN O O
She PRP O O
also RB O O
is VBZ O O
complicated VBN O O
, , O O
given VBN O O
her PRP$ O O
histories NNS B-NP O
of IN B-VP O
seizures NNS B-NP O
and CC O O
stroke VBD B-VP O
It PRP O O
was VBD B-VP O
considered VBN O O
initially RB O O
that IN B-VP O
her PRP$ O O
altered JJ B-NP O
mental JJ I-NP O
status NN I-NP O
was VBD B-VP O
due JJ O O
to TO O O
polypharmacy VB O O
However RB O O
, , O O
her PRP O O
sedating VBG O B-m
medications NNS B-NP I-m
were VBD B-VP O
discontinued VBN O O
including VBG O O
her PRP$ O O
Reglan NN B-NP B-m
was VBD B-VP O
discontinued VBN O O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
baclofen NN B-NP B-m
, , O O
Dilaudid NNP B-NP B-m
and CC O O
trazodone VB O B-m
Her PRP$ O O
Cymbalta NNP B-NP B-m
was VBD B-VP O
continued VBN O O
per IN B-VP O
the DT B-NP O
recommendations NNS I-NP O
of IN B-VP O
the DT B-NP O
Psychiatry NNP I-NP O
consult VBD B-VP O
The DT B-NP O
psychiatric JJ I-NP O
consultants NNS I-NP O
also RB O O
suggested VBD B-VP O
a DT B-NP O
one-to-one JJ I-NP O
sitter NN I-NP O
At IN B-VP O
no DT B-NP O
time NN I-NP O
was VBD B-VP O
the DT B-NP O
patient NN I-NP O
actively RB O O
suicidal VBD B-VP O
or CC O O
homicidal VB O O
It PRP O O
was VBD B-VP O
also RB O O
later RB O O
decided VBD B-VP O
that IN B-VP O
her PRP$ O O
Dilaudid NNP B-NP B-m
would MD O O
be VB O O
discontinued VBN O O
In IN B-VP O
addition NN B-NP O
, , O O
her PRP O O
standing VBG O O
Seroquel NNP B-NP B-m
was VBD B-VP O
made VBN O O
p.r.n NN B-NP B-f
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
family NN I-NP O
also RB O O
suggested VBD B-VP O
that IN B-VP O
the DT B-NP O
patient's JJ I-NP O
base NN I-NP O
mental JJ B-NP O
status NN I-NP O
did VBD B-VP O
not RB O O
improve VB O O
despite IN B-VP O
removing VBG O O
all PDT O O
the DT B-NP O
medications NNS I-NP O
At IN B-VP O
this DT B-NP O
point NN I-NP O
, , O O
a DT B-NP O
Neurology NNP I-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
This DT B-NP O
Neurology NNP I-NP O
consult NN I-NP O
is VBZ O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
and CC O O
will MD O O
be VB O O
reported VBN O O
in IN B-VP O
a DT B-NP O
later JJ I-NP O
dictation NN I-NP O
Given VBN O O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
complex JJ B-NP B-r
seizures NNS I-NP I-r
and CC O O
olfactory JJ B-NP B-r
hallucinations NNS I-NP I-r
, , O O
she PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
Lamictal JJ B-NP B-m
Lamictal NNP I-NP B-m
, , O O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
Cymbalta NNP B-NP B-m
, , O O
which WDT O O
was VBD B-VP O
for IN B-VP O
her PRP$ O O
history NN B-NP O
of IN B-VP O
depression NN B-NP B-r
6 CD O O
Pain: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
pain NN I-NP O
in IN B-VP O
her PRP$ O O
left JJ B-NP O
hand NN I-NP O
existed VBD B-VP O
and CC O O
she PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
tramadol NN B-NP B-m
and CC O O
Tylenol NNP B-NP B-m
for IN B-VP O
this DT O B-r
this DT B-NP B-r
pain NN I-NP I-r
pain NN I-NP I-r
She PRP O O
could MD O O
not RB O O
specifically RB O O
describe VB O O
this DT B-NP O
pain NN I-NP O
7 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
Novolog NNP B-NP B-m
sliding VBG O B-do
scale NN B-NP O
for IN B-VP O
diabetes NNS B-NP B-r
She PRP O O
was VBD B-VP O
also RB O O
continued VBN O O
on IN B-VP O
a DT B-NP O
replacement NN I-NP O
dose NN I-NP O
levothyroxine JJ B-NP B-m
levothyroxine NN I-NP B-m
for IN B-VP O
her PRP$ O O
history NN B-NP O
of IN B-VP O
Graves' NNP B-NP B-r
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
radioiodine NN B-NP B-r
ablation NN I-NP I-r
For IN B-VP O
behavioral JJ B-NP O
modification NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
for IN B-VP O
intermittent JJ B-NP B-r
agitation NN I-NP I-r
and CC O O
disorientation NN B-NP B-r
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
p.r.n NN B-NP O
Seroquel NNP I-NP B-m
Seroquel NNP I-NP B-m
100 CD O B-do
100 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
p.o NN I-NP B-mo
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
b.i.d NN I-NP B-f
, , O O
as RB O O
well RB O O
as IN B-VP O
Zydis NNP B-NP B-m
Zydis NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
p.r.n NN I-NP I-f
This DT O O
was VBD B-VP O
titrated VBN O O
from IN B-VP O
standing VBG O O
to TO O O
p.r.n VB O B-f
over IN B-VP B-du
the DT B-NP I-du
course NN I-NP I-du
of IN B-VP I-du
her PRP$ O I-du
hospitalization NN B-NP I-du
in IN B-VP O
order NN B-NP O
to TO O O
try VB O O
to TO O O
decrease VB O O
any DT B-NP O
sedating JJ I-NP B-m
medications NNS I-NP I-m
that WDT O O
may MD O O
be VB O O
altering VBG O O
her PRP$ O O
alertness NN B-NP O
and CC O O
orientation NN B-NP O
NOTE: NNP I-NP O
This DT B-NP O
dictation NN I-NP O
will MD O O
be VB O O
addended VBN O O
at IN B-VP O
a DT B-NP O
later JJ I-NP O
date NN I-NP O
with IN B-VP O
discharge NN B-NP O
medications NNS I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
further JJ B-NP O
hospital NN I-NP O
course NN I-NP O
and CC O O
the DT B-NP O
patient's JJ I-NP O
neurological JJ I-NP O
state NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
any DT O O
follow VBP O O
up RP O O
that DT O O
is VBZ O O
to TO O O
be VB O O
planned VBN O O
eScription NN B-NP O
document: NN I-NP O
1-9584080 JJ B-NP O
SSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
OCHILTREE NNP I-NP O
, , O O
RYAN NNP B-NP O
Attending: NNP I-NP O
LAMORE NNP I-NP O
, , O O
SERGIO NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6454134 CD O O
D: NNP B-NP O
7/3/06 CD O O
T: NNP B-NP O
7/3/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#29786 VBZ O O
369675973 CD O O
BSMC NNP B-NP O
15255122 CD O O
7520614 CD O O
6/11/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
Esophagitis NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/2/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/8/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
STANSBURY NNP I-NP O
, , O O
ELLSWORTH NNP B-NP O
977-84-02-0 CD O O
Na NNP B-NP O
Port NNP I-NP O
Gardvi NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
6/19/04 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SAMLAND NNP I-NP O
, , O O
ABRAHAM NNP B-NP O
BENTON NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
CLONAZEPAM NNP I-NP B-m
0.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/8/04 CD O O
by IN B-VP O
BLASING NNP B-NP O
, , O O
TITUS NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DIFLUCAN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
62332050 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CLONAZEPAM NNP I-NP B-m
&amp; NNP I-NP O
FLUCONAZOLE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Aware JJ B-NP O
DIFLUCAN NNP I-NP B-m
( ( O I-m
FLUCONAZOLE NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
X NNP I-NP B-du
12 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
9/4 CD O O
) ) O O
INDICATIONS: NNP B-NP O
Other: NNP I-NP O
suspected VBD B-VP O
esophageal JJ B-NP O
candidiasis NN I-NP O
in IN B-VP O
poorly RB O O
cnotroled VBN O O
diabetic JJ B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/8/04 CD O O
by IN B-VP O
SHRIMPLIN NNP B-NP O
, , O O
BRYANT NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CLONAZEPAM NNP I-NP B-m
&amp; NNP I-NP O
FLUCONAZOLE NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CLONAZEPAM NNP I-NP B-m
&amp; NNP I-NP O
FLUCONAZOLE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Aware NNP I-NP O
LISINOPRIL NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/19/04 CD O O
by IN B-VP O
BERDAR NNP B-NP O
, , O O
EZRA NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
57130577 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Aware NNP I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/19/04 CD O O
by IN B-VP O
INGARGIOLA NNP B-NP O
, , O O
DENNY NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IV NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
64707487 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Aware NNP I-NP O
MOM NNP I-NP B-m
( ( O I-m
MAGNESIUM NNP B-NP I-m
HYDROXIDE NNP I-NP I-m
) ) O I-m
30 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
9/4 CD O O
) ) O O
PRN NNP B-NP O
Constipation NNP I-NP B-r
, , O O
Upset NNP B-NP O
Stomach NNP I-NP O
MAALOX-TABLETS NNP I-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
PROTONIX NNP I-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
ATENOLOL NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
REMERON NNP I-NP B-m
( ( O I-m
MIRTAZAPINE NNP B-NP I-m
) ) O I-m
15 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
CELEXA NNP I-NP B-m
( ( O I-m
CITALOPRAM NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
METFORMIN NNP I-NP B-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Please NNP I-NP O
call VB O O
you PRP O O
MD NNP B-NP O
on IN B-VP O
Monday NNP B-NP O
to TO O O
schedule VB O O
an DT B-NP O
appointment NN I-NP O
in IN B-VP O
the DT O O
next JJ O O
2 CD O O
weeks NNS B-NP O
Monday NNP I-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
esophagitis NN I-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
coronary JJ B-NP O
heart NN I-NP O
disease NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
NIDDM NNP B-NP O
, , O O
depression NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Esophagitis NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
NIDDM NNP I-NP O
anxiety NN I-NP O
s/p NN I-NP O
appy JJ B-NP O
HTN NNP I-NP O
cad NN I-NP O
s/p VBD B-VP O
10/6 CD O O
cath NN B-NP O
with IN B-VP O
Lcirc NNP B-NP O
stent NN I-NP O
dyslipidemia NN I-NP O
depression NN I-NP O
( ( O O
depression NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
MIBI NNP I-NP O
4/11/04 CD O O
with IN B-VP O
small JJ B-NP O
perfusion NN I-NP O
defect NN I-NP O
and CC O O
no DT B-NP O
reversibility NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
59 CD O O
yo NNS B-NP O
female JJ O O
with IN B-VP O
NID NNP B-NP O
DM NNP I-NP O
, , O O
GERD NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
Depression NNP B-NP O
, , O O
known VBN O O
CAD NNP B-NP O
s/p NN I-NP O
circumflex NN I-NP O
stent NN I-NP O
2002 CD O O
, , O O
admitted VBN O O
with IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
Cath NNP I-NP O
in IN B-VP O
2003 CD O O
showed VBD B-VP O
2-V JJ B-NP O
disease NN I-NP O
, , O O
admission NN B-NP O
for IN B-VP O
chest NN B-NP O
pain NN I-NP O
in IN B-VP O
2003 CD O O
resulted VBD B-VP O
in IN B-VP O
a DT B-NP O
mibi NN I-NP O
being VBG O O
done VBN O O
, , O O
revealing VBG O O
no DT B-NP O
ischemia NN I-NP O
, , O O
no DT B-NP O
arrhythmias NN I-NP O
, , O O
negative JJ B-NP O
enzymes NNS I-NP O
Presented VBN O O
with IN B-VP O
36-48 JJ B-NP O
hours NNS I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
deep JJ B-NP O
boring/squeezing NN I-NP O
in IN B-VP O
lower JJR B-NP O
left NN I-NP O
chest NN I-NP O
, , O O
xyphoid JJ B-NP O
region NN I-NP O
, , O O
suprasternal JJ B-NP O
notch NN I-NP O
Pain NNP I-NP B-r
Pain NNP I-NP B-r
is VBZ O O
reproducible JJ O O
on IN B-VP O
palpation NN B-NP O
, , O O
does VBZ O O
not RB O O
radiate VB O O
, , O O
is VBZ O O
accompanied VBN O O
by IN B-VP O
diaphoresis NN B-NP O
, , O O
no DT B-NP O
dyspnea NN I-NP O
, , O O
nausea/vomiting VBG O O
Unrelieved VBN O O
by IN B-VP O
nitroglycerin JJ B-NP B-m
Minimal NNP I-NP O
relief NN I-NP O
with IN B-VP O
morphine JJ O B-m
4 CD O B-do
mg NN B-NP O
in IN B-VP O
ED NNP B-NP O
No NNP I-NP O
relief NN I-NP O
with IN B-VP O
maalox NN B-NP B-m
, , O O
po JJ B-NP B-mo
lidocaine NN I-NP B-m
susp NN I-NP I-m
First NNP I-NP O
set VBD B-VP O
cardiac JJ B-NP O
enzymes NNS I-NP O
negative JJ B-NP O
PE: NNP I-NP O
Nl NNP I-NP O
cardiac JJ B-NP O
exam NN I-NP O
Chest NNP I-NP O
wall NN I-NP O
compression NN I-NP O
over IN B-VP O
left VBD B-VP O
lower JJR B-NP O
ribs NN I-NP O
reproduces NNS I-NP O
pain-no JJ B-NP O
superficial JJ I-NP O
erythema NN I-NP O
, , O O
swelling VBG O O
Lungs NNS B-NP O
CTAB NNP I-NP O
Abd NNP I-NP O
benign NN I-NP O
Ext NNP I-NP O
without IN B-VP O
C/C/E; NNP B-NP O
pulses VBZ O O
symmetric JJ B-NP O
EKG: NNP I-NP O
NSR NNP I-NP O
79 CD O O
bpm NN B-NP O
, , O O
normal JJ B-NP O
axis NN I-NP O
and CC O O
intervals NNS B-NP O
1 CD O O
mm NNS B-NP O
ST NNP I-NP O
segment NN I-NP O
depression NN I-NP O
V3-V5 NNP I-NP O
, , O O
inverted VBD B-VP O
Ts NNP B-NP O
in IN B-VP O
V3-V5 NNP B-NP O
C/W NNP I-NP O
EKG NNP I-NP O
findings NNS I-NP O
in IN B-VP O
July NNP B-NP O
2004 CD O O
CXR: NNP B-NP O
negative JJ O O
for IN B-VP O
effusions NNS B-NP O
, , O O
infiltrates NNS B-NP O
, , O O
edema RB O O
, , O O
normal JJ B-NP O
bony NN I-NP O
structures NNS I-NP O
A/P: VBP O O
59 CD O O
yo NNS B-NP O
woman NN I-NP O
with IN B-VP O
known JJ B-NP O
coronary JJ I-NP O
diseae NN I-NP O
presenting VBG O O
with IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
CV: NNP I-NP O
r/o NN I-NP O
MI NNP I-NP O
with IN B-VP O
negative JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
mibi VBP O O
on IN B-VP O
10/22 CD O O
showed VBD B-VP O
small JJ B-NP O
perfusion NN I-NP O
defect NN I-NP O
without IN B-VP O
reversibility NN B-NP O
Pulm: NNP I-NP O
No NNP I-NP O
active JJ B-NP O
issue NN I-NP O
Endo: NNP I-NP O
NIDDM NNP I-NP O
SSI NNP I-NP O
Renal: NNP I-NP O
No NNP I-NP O
active JJ B-NP O
issues NNS I-NP O
Neuro: NNP I-NP O
No NNP I-NP O
active JJ B-NP O
issues NNS I-NP O
Psych: NNP I-NP O
MDD-continue NNP I-NP B-r
MDD-continue NNP I-NP B-r
MDD-continue NNP I-NP B-r
remeron NN I-NP B-m
, , O O
celexa NN B-NP B-m
, , O O
clonazepam NN B-NP B-m
GI: NNP I-NP O
Esophagitis NNP I-NP B-r
responded VBD B-VP O
quickly RB O O
to TO O O
KBL NNP B-NP O
and CC O O
diflucan JJ B-NP B-m
Tolerating NNP I-NP O
PO NNP I-NP O
on IN B-VP O
AM NNP B-NP O
of IN B-VP O
discharge NN B-NP O
Will NNP I-NP O
complete VB O O
two CD O B-du
week NN B-NP I-du
course NN I-NP I-du
of IN B-VP O
Fluconazole NNP B-NP B-m
Consider NNP I-NP O
outpatient NN I-NP O
EGD NNP I-NP O
if IN B-VP O
sx VBN O O
do VBP O O
not RB O O
improve VB O O
with IN B-VP O
tx JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
ELIZARRARAS NNP I-NP O
, , O O
HERSCHEL NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
UD060 NNP B-NP O
) ) O O
6/19/04 CD O O
@ $ O O
12:06 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#43317 VBZ O O
490509054 CD O O
LTH NNP B-NP O
72565548 CD O O
3910463 CD O O
5/26/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
atrial JJ B-NP O
fibrillation NN I-NP O
, , O O
calcaneous JJ B-NP O
fracture NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/26/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/18/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
STRAUSBERG NNP I-NP O
, , O O
EMILIO NNP B-NP O
R NNP I-NP O
557-96-58-8 JJ B-NP O
Car NNP I-NP O
Rock NNP I-NP O
E NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
4/14/04 CD O O
AT NNP B-NP O
07:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
CT NNP I-NP O
scan NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BLEICHNER NNP I-NP O
, , O O
DERICK NNP B-NP O
STUART NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/9/04 CD O O
by IN B-VP O
LOESER NNP B-NP O
, , O O
VALENTIN NNP B-NP O
GUADALUPE NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ASPIRIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
heart NN I-NP O
VITAMIN NNP I-NP B-m
B12 NNP I-NP I-m
( ( O I-m
CYANOCOBALAMIN NNP B-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
DIGOXIN NNP B-NP B-m
0.25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;105 NN I-NP O
and CC O O
call VB O O
HO NNP B-NP O
OXYCODONE NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
March NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/9/04 CD O O
by IN B-VP O
GLUSZEK NNP B-NP O
, , O O
MAX NNP B-NP O
JORDON NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ECASA NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
23344198 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ASPIRIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
heart NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/9/04 CD O O
by IN B-VP O
TUMMINIA NNP B-NP O
, , O O
KING NNP B-NP O
G NNP I-NP O
VALENTINE NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LIPITOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
90217884 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NNP B-NP O
home NN I-NP O
40mg CD O O
METOPROLOL NNP B-NP B-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;100 NN I-NP O
, , O O
hr&lt;55 JJ B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/9/04 CD O O
by IN B-VP O
TRAUTMAN NNP B-NP O
, , O O
BRENTON NNP B-NP O
STAN NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DILTIAZEM NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
68655693 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
METOPROLOL NNP I-NP B-m
TARTRATE NNP I-NP I-m
&amp; NNP I-NP O
DILTIAZEM NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP B-m
med VBD B-VP I-m
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/9/04 CD O O
by IN B-VP O
RYKERT NNP B-NP O
, , O O
DARRIN NNP B-NP O
Q NNP I-NP O
PORFIRIO NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
TIAZAC NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
86614276 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
METOPROLOL NNP I-NP B-m
TARTRATE NNP I-NP I-m
&amp; NNP I-NP O
DILTIAZEM NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP B-m
med VBD B-VP I-m
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/9/04 CD O O
by IN B-VP O
WEIGHT NNP B-NP O
, , O O
YONG NNP B-NP O
E NNP I-NP O
ANTOINE NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DILTIAZEM NNP B-NP B-m
SUSTAINED NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
76960054 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
METOPROLOL NNP I-NP B-m
TARTRATE NNP I-NP I-m
&amp; NNP I-NP O
DILTIAZEM NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP O
emd IN B-VP O
Number NNP B-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
ACCUPRIL NNP B-NP B-m
( ( O I-m
QUINAPRIL NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;105 NN I-NP O
and CC O O
call VB O O
HO NNP B-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
4 CD O I-du
TIAZAC NNP B-NP B-m
( ( O I-m
DILTIAZEM NNP B-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
240 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
March NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/9/04 CD O O
by IN B-VP O
PLACK NNP B-NP O
, , O O
MILES NNP B-NP O
ALONSO NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
METOPROLOL NNP I-NP B-m
TARTRATE NNP I-NP I-m
&amp; NNP I-NP O
DILTIAZEM NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP O
med VBN O O
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/9/04 CD O O
by IN B-VP O
ALLGIER NNP B-NP O
, , O O
JOEL NNP B-NP O
JUNIOR NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NNP B-NP O
home NN I-NP O
40mg CD O O
NIASPAN NNP B-NP B-m
( ( O I-m
NICOTINIC NNP B-NP I-m
ACID NNP I-NP I-m
SUSTAINED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
1 CD O B-do
GM NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/9/04 CD O O
by IN B-VP O
RATTEE NNP B-NP O
, , O O
LEWIS NNP B-NP O
IRA NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LIPITOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
90217884 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NNP B-NP O
home NN I-NP O
40mg CD O O
LANTUS NNP B-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
66 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QPM NNP I-NP B-f
INSULIN NNP I-NP B-m
LISPRO NNP I-NP I-m
MIX NNP I-NP I-m
75/25 CD O I-m
74 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
INSULIN NNP I-NP B-m
LISPRO NNP I-NP I-m
MIX NNP I-NP I-m
75/25 CD O I-m
54 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QPM NNP I-NP B-f
QPM NNP I-NP B-f
GLUCOMETER NNP I-NP B-m
1 CD O B-do
EA NNP B-NP I-do
SC NNP I-NP B-mo
x1 NNP I-NP B-du
MAALOX-TABLETS NNP I-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
Partial NNP I-NP O
weight-bearing: JJ O O
no DT B-NP O
weight NN I-NP O
on IN B-VP O
Lt NNP B-NP O
foot NN I-NP O
Use NNP I-NP O
air NN I-NP O
cast VBD B-VP O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Orthopedics NNP I-NP O
, , O O
first JJ B-NP O
week NN I-NP O
February NNP I-NP O
768 CD O O
302-6808 JJ O O
, , O O
Dr NNP B-NP O
magouyrk NNP I-NP O
PCP NNP I-NP O
November NNP I-NP O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
1/5/04 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
30 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Morrin NNP I-NP O
ALLERGY: NNP I-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
atrial JJ B-NP O
fibrillation' NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
atrial JJ B-NP O
fibrillation NN I-NP O
, , O O
calcaneous JJ B-NP O
fracture NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
diabetes NNS I-NP O
, , O O
HTN NNP B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
CT NNP B-NP O
foot NN I-NP O
, , O O
Plain NNP B-NP O
film NN I-NP O
foot NN I-NP O
3views CD O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Mr NNP I-NP O
Schmider NNP I-NP O
is VBZ O O
a DT B-NP O
64yo JJ I-NP O
man NN I-NP O
with IN B-VP O
T2DM NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
chronic JJ B-NP O
afib NN I-NP O
, , O O
and CC O O
several JJ B-NP O
hospital NN I-NP O
admissions NNS I-NP O
for IN B-VP O
CHF NNP B-NP O
who WP O O
presents VBZ O O
after IN B-VP O
becoming VBG O O
dizzy NN B-NP O
while IN B-VP O
shovelling VBG O O
snow VBP O O
The DT B-NP O
pateint NN I-NP O
had VBD B-VP O
not RB O O
taken VBN O O
his PRP$ O O
rate NN B-NP O
control NN I-NP O
medications VBZ O O
this DT B-NP O
AM NNP I-NP O
, , O O
and CC O O
was VBD B-VP O
shovelling VBG O O
snow NN B-NP O
when WRB O O
he PRP O O
experienced VBD B-VP O
dizziness/lightheadedness NN B-NP O
and CC O O
fell VBD B-VP O
to TO O O
his PRP$ O O
kness NN B-NP O
No NNP I-NP O
loss NN I-NP O
of IN B-VP O
consciousness NN B-NP O
, , O O
no DT B-NP O
head NN I-NP O
trauma NN I-NP O
Did NNP I-NP O
expereince VB O O
generalized JJ B-NP O
weakness NN I-NP O
, , O O
but CC O O
no DT B-NP O
slurred JJ I-NP O
speech NN I-NP O
, , O O
focal JJ B-NP O
weakness NN I-NP O
, , O O
or CC O O
incontinence NN B-NP O
No RB O O
chest NN B-NP O
pain NN I-NP O
, , O O
no DT B-NP O
SOB NNP I-NP O
, , O O
no DT B-NP O
orthopnea NN I-NP O
, , O O
no DT B-NP O
PND NNP I-NP O
, , O O
no DT B-NP O
palpitation NN I-NP O
s VBD B-VP O
EMS-HR NNP B-NP O
140s-160s NNS I-NP O
, , O O
BP NNP B-NP O
190/90 CD O O
, , O O
in IN B-VP O
ED NNP B-NP O
rate NN I-NP B-r
rate NN I-NP B-r
controlled VBN O I-r
controlled VBN O I-r
with IN B-VP O
IV NNP B-NP B-mo
metoprolol NN I-NP B-m
and CC O O
diltiazem NN B-NP B-m
HR NNP I-NP O
100s CD O O
, , O O
SBP NNP B-NP O
100s CD O O
Exam NNP B-NP O
JVP NNP I-NP O
8-10 CD O O
, , O O
chest JJS B-NP O
CTA NNP I-NP O
, , O O
CV NNP B-NP O
irreg NN I-NP O
, , O O
no DT B-NP O
MRG NNP I-NP O
, , O O
Abd NNP B-NP O
obese UH O O
, , O O
LE NNP B-NP O
trace NN I-NP O
edema NN I-NP O
, , O O
possible JJ B-NP O
absent NN I-NP O
left VBD B-VP O
DP NNP B-NP O
Labs NNP I-NP O
creat NN I-NP O
2.1 CD O O
( ( O O
base~1.7 NN B-NP O
) ) O O
, , O O
dig JJ O O
0.8 CD O O
, , O O
trop NN B-NP O
0.1 CD O O
, , O O
ckmb NN B-NP O
10.5 CD O O
, , O O
ck VBD B-VP O
383 CD O O
****HOSP NNP B-NP O
COURSE*** NNP I-NP O
1 CD O O
CV NNP B-NP O
Isch: NNP I-NP O
Most NNP I-NP O
c/w JJ B-NP O
demand NN I-NP O
ischemia NN I-NP B-r
Gave NNP I-NP O
ASA NNP I-NP B-m
, , O O
continue VBP O O
rate NN B-NP B-r
control NN I-NP I-r
with IN B-VP O
home NN B-NP B-m
meds NNS I-NP I-m
, , O O
continue VBP O O
lipitor/niacin NN B-NP B-m
( ( O O
incr JJ B-NP O
lipitor NN I-NP B-m
40--&gt;80 JJ O B-do
) ) O O
INR VBZ O O
3.3 CD O O
so RB O O
no RB O O
heparin JJ B-NP O
Enzymes NNP I-NP O
trended VBD B-VP O
down RB O O
from IN B-VP O
0/1-&gt;0.24-&gt;0.23 JJ B-NP O
Pump: NNP I-NP O
Mildly NNP I-NP O
incr JJ B-NP O
JVP NNP I-NP O
, , O O
trace NN B-NP B-r
trace NN I-NP B-r
edema; NN I-NP I-r
edema; NN I-NP I-r
continue VBP O O
lasix NN B-NP B-m
lasix NN I-NP B-m
, , O O
60 CD O B-do
bid NN B-NP B-f
( ( O O
was VBD B-VP O
40po CD O B-do
40po CD O B-mo
TID NNP B-NP B-f
at IN B-VP O
home NN B-NP O
) ) O O
Telemetry NN B-NP O
2 CD O O
Endo: NNP B-NP O
Continue NNP I-NP O
home NN I-NP O
insulin NN I-NP B-m
Provided NNP I-NP O
diabetes VBZ O O
education NN B-NP O
Provided VBD B-VP O
glucometer RB O O
3 CD O O
Renal: NNP B-NP O
CRI NNP I-NP O
, , O O
stable JJ O O
4 CD O O
Pulm: NNP B-NP O
Low NNP I-NP O
susp NN I-NP O
PE NNP I-NP O
, , O O
given VBN O O
INR NNP B-NP O
3.3 CD O O
and CC O O
no DT B-NP O
pain NN I-NP O
or CC O O
asym NN B-NP O
LE NNP I-NP O
swelling VBG O O
5.MSK:sustained CD O O
fall NN B-NP O
to TO O O
Lt NNP B-NP O
heel NN I-NP O
during IN B-VP O
presyncope NN B-NP O
Initially NNP I-NP O
p VBZ O O
ain NN B-NP O
with IN B-VP O
ambulation NN B-NP O
On IN B-VP O
HD NNP B-NP O
2 CD O O
difficulty NN B-NP O
with IN B-VP O
weight JJ O O
bearting VBG O O
Tenderness NN B-NP O
over IN B-VP O
tallus JJ B-NP O
Plain NNP I-NP O
films NNS I-NP O
showed VBD B-VP O
question NN B-NP O
of IN B-VP O
anterior JJ O O
cal JJ O O
caneous JJ O O
and CC O O
tallus JJ B-NP O
fracture NN I-NP O
Discussed VBN O O
with IN B-VP O
orthopedics NNS B-NP O
Provided NNP I-NP O
hard RB O O
boot VBZ O O
told VBD B-VP O
to TO O O
not RB O O
bear VB O O
full JJ B-NP O
weight NN I-NP O
on IN B-VP O
left JJ B-NP O
foot NN I-NP O
CT NNP I-NP O
performed VBD B-VP O
with IN B-VP O
reconstitutions NNS B-NP O
to TO O O
rule VB O O
out RP O O
avulsion NN B-NP O
Patient NNP I-NP O
was VBD B-VP O
stable JJ O O
to TO O O
be VB O O
discharged VBN O O
with IN B-VP O
outpatient JJ B-NP O
regimen NNS I-NP O
with IN B-VP O
follow VBP O O
up RP O O
one CD O O
week NN B-NP O
from IN B-VP O
discharge NN B-NP O
with IN B-VP O
orthopedics NNS B-NP O
ambulatory JJ B-NP O
clinic JJ I-NP O
Code: NNP I-NP O
FULL NNP I-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
take VB O O
all DT B-NP O
medications NNS I-NP O
as IN B-VP O
indicated JJ B-NP O
Please NNP I-NP O
call NN I-NP O
orthopedics NNS I-NP O
for IN B-VP O
your PRP$ O O
appointment NN B-NP O
You PRP O O
need VBP O O
to TO O O
be VB O O
seen VBN O O
next JJ B-NP O
week NN I-NP O
to TO O O
evaluate VB O O
your PRP$ O O
foot NN B-NP O
fracture NN I-NP O
242 CD O O
672 CD O O
4668 CD O O
Please NNP B-NP O
take VB O O
your PRP$ O O
blood NN B-NP O
sugar NN I-NP O
as IN B-VP O
you PRP O O
were VBD B-VP O
taught VBN O O
here RB O O
Please NNP B-NP O
follow VB O O
up RP O O
with IN B-VP O
yoru NNS B-NP O
cardiologist VBP O O
within IN B-VP O
2 CD O O
weeks NNS B-NP O
of IN B-VP O
discharge NN B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
QUILLER NNP I-NP O
, , O O
ELBERT NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.PHIL NNP B-NP O
( ( O O
NH177 NNP B-NP O
) ) O O
4/14/04 CD O O
@ $ O O
05:27 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#55056 VBZ O O
447820941 CD O O
TSH NNP B-NP O
87152485 CD O O
102781 CD O O
1/10/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
NSTE NNP I-NP O
MI NNP I-NP O
, , O O
refused VBD B-VP O
cath NN B-NP O
treated VBN O O
medically RB O O
with IN B-VP O
lovenox/integrilin JJ B-NP B-m
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/10/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/4/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
BIGLER NNP I-NP O
, , O O
MANUEL NNP B-NP O
637-16-52-7 NNP I-NP O
Ca NNP I-NP O
Parkway NNP I-NP O
, , O O
Ale NNP B-NP O
Ph NNP I-NP O
Por NNP I-NP O
, , O O
Mississippi NNP B-NP O
02896 CD O O
Service: NNP B-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/18/01 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SPANIER NNP I-NP O
, , O O
DOUGLAS NNP B-NP O
MOSE NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
MICRONASE NNP I-NP B-m
( ( O I-m
GLYBURIDE NNP B-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HCTZ NNP I-NP B-m
( ( O I-m
HYDROCHLOROTHIAZIDE NNP B-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O O
3 CD O O
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
ZOCOR NNP B-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
LEVOFLOXACIN NNP B-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
X NNP I-NP B-du
4 CD O I-du
Days NNPS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
10/16 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
ZESTRIL NNP I-NP B-m
( ( O I-m
LISINOPRIL NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/18/01 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok JJ B-NP O
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
PRILOSEC NNP I-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/18/01 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
HYDROCHLOROTHIAZIDE NNP I-NP B-m
&amp; NNP I-NP O
OMEPRAZOLE NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
HYDROCHLOROTHIAZIDE NNP I-NP B-m
&amp; NNP I-NP O
OMEPRAZOLE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Not RB O O
Applicable NNP B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Truman NNP I-NP O
Thro NNP I-NP O
1-2 JJ B-NP O
wks NN I-NP O
, , O O
Dr NNP B-NP O
Stevie NNP I-NP O
Gilani NNP I-NP O
, , O O
cardiology NN B-NP O
, , O O
Mon NNP B-NP O
, , O O
1/2/02 CD O O
1:00 CD O O
pm NN B-NP O
, , O O
Bock NNP B-NP O
0/12/02 CD O O
, , O O
No DT B-NP O
Known NNP I-NP O
Allergies NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
NSTE NNP B-NP O
MI NNP I-NP O
, , O O
refused VBD B-VP O
cath NN B-NP O
treated VBN O O
medically RB O O
with IN B-VP O
lovenox/integrilin NN B-NP B-m
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
LGIB NNP I-NP O
TOBACCO NNP I-NP O
PAF-no NNP I-NP O
anticoag NN I-NP O
for IN B-VP O
distant JJ B-NP O
h/o NN I-NP O
lgi NN I-NP O
bleed VBD B-VP O
htn JJ B-NP O
dm NN I-NP O
hyperchol NN I-NP O
periph NN I-NP O
neuropathy JJ B-NP O
h NN I-NP O
pylori JJ B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
medical JJ B-NP O
treatment NN I-NP O
of IN B-VP O
NSTE NNP B-NP O
MI: NNP I-NP O
lovenox/integrilin NN I-NP B-m
( ( O O
pt NN B-NP O
refused VBD B-VP O
cath NN B-NP O
) ) O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
70 CD O O
yo NNP B-NP O
woman NN I-NP O
with IN B-VP O
no DT O O
known VBN O O
CAD NNP B-NP O
, , O O
cardiac JJ B-NP O
RF: NNP I-NP O
HTN NNP I-NP O
, , O O
DM NNP B-NP O
, , O O
hyperchol NN B-NP O
, , O O
current JJ B-NP O
tob NN I-NP O
, , O O
H/O NNP B-NP O
PAF NNP I-NP O
on IN B-VP O
no DT B-NP O
anticoag NN I-NP O
2/2 CD O O
distant JJ B-NP O
h/o NN I-NP O
LGIB NNP I-NP O
, , O O
a/w NN B-NP O
palpitations NNS I-NP O
followed VBN O O
by IN B-VP O
10 CD O O
hrs NN B-NP O
of IN B-VP O
chest NN B-NP O
tightness NN I-NP O
Pt NNP I-NP O
at IN B-VP O
baseline NN B-NP O
able JJ O O
to TO O O
do VB O O
1-2 JJ B-NP O
flights NNS I-NP O
of IN B-VP O
stairs NNS B-NP O
before IN B-VP O
SOB NNP B-NP O
No NNP I-NP O
sx NN I-NP O
of IN B-VP O
CHF NNP B-NP O
Pt NNP I-NP O
in IN B-VP O
her PRP$ O O
USOH NNP B-NP O
, , O O
eating VBG O O
potato JJ B-NP O
chips NNS I-NP O
at IN B-VP O
home NN B-NP O
, , O O
when WRB O O
she PRP O O
had VBD B-VP O
palpitations NNS B-NP O
for IN B-VP O
a DT B-NP O
couple NN I-NP O
of IN B-VP O
minutes NNS B-NP O
, , O O
+LH NNP B-NP O
, , O O
felt VBD B-VP O
weak JJ O O
, , O O
SOB NNP B-NP O
, , O O
then RB O O
had VBD B-VP O
tightness NN B-NP O
in IN B-VP O
chest NN B-NP O
which WDT O O
she PRP O O
has VBZ O O
never RB O O
had VBN O O
before IN B-VP O
with IN B-VP O
her PRP$ O O
palpitations NNS B-NP O
Palp NNP I-NP O
resolved VBD B-VP O
, , O O
but CC O O
CP NNP B-NP O
lingered VBD B-VP O
through IN B-VP O
night NN B-NP O
5/10 CD O O
SSCP NNP B-NP O
"squeezing" NNP I-NP O
, , O O
also RB O O
in IN B-VP O
back RB O O
, , O O
and CC O O
L NNP B-NP O
arm NN I-NP O
?relief NN I-NP O
with IN B-VP O
burping VBG O O
Pt NNP B-NP O
last JJ O O
had VBD B-VP O
tachyarrhythmia JJ O O
2 CD O O
yrs NN B-NP O
ago RB O O
and CC O O
has VBZ O O
had VBN O O
none NN B-NP O
since IN B-VP O
IN NNP B-NP O
ED NNP I-NP O
, , O O
pt NN B-NP O
pain NN I-NP B-r
pain NN I-NP B-r
releived VBD B-VP O
with IN B-VP O
SLNG NNP B-NP B-m
, , O O
and CC O O
2" CD O B-do
NTP NNP B-NP B-m
EKG NNP I-NP O
with IN B-VP O
TWflattening NNP B-NP O
v5-6 NN I-NP O
but CC O O
no DT B-NP O
ST NNP I-NP O
elevations NNS I-NP O
, , O O
and CC O O
CK160 NNP B-NP O
, , O O
TnI NNP B-NP O
0.3 CD O O
Pt NNP B-NP O
started VBD B-VP O
on IN B-VP O
heparin NN B-NP B-m
, , O O
integrelin NN B-NP B-m
for IN B-VP O
NSTE NNP B-NP B-r
NSTE NNP I-NP B-r
MI NNP I-NP I-r
MI NNP I-NP I-r
, , O O
and CC O O
cont NN B-NP O
on IN B-VP O
ASA NNP B-NP B-m
, , O O
BB NNP B-NP B-m
, , O O
ACEI NNP B-NP B-m
, , O O
statin NN B-NP B-m
Exam NNP I-NP O
notable JJ O O
for IN B-VP O
VSS NNP B-NP O
, , O O
no DT B-NP O
JVD NNP I-NP O
, , O O
distant JJ B-NP O
heart NN I-NP O
sounds VBZ O O
I-II/VI JJ B-NP O
SEM NNP I-NP O
at IN B-VP O
USB NNP B-NP O
, , O O
nl JJ B-NP O
S2 NNP I-NP O
, , O O
clear JJ B-NP O
lungs NNS I-NP O
, , O O
neuro JJ B-NP O
intact NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
in IN B-VP O
past JJ O O
, , O O
pt NN B-NP O
has VBZ O O
refused VBN O O
multiple RB O O
medical JJ B-NP O
procedures NNS I-NP O
( ( O O
mammos NN B-NP O
, , O O
colonoscopy NN B-NP O
, , O O
EP NNP B-NP O
study NN I-NP O
) ) O O
, , O O
and CC O O
at IN B-VP O
this DT B-NP O
point NN I-NP O
, , O O
does VBZ O O
not RB O O
want VB O O
to TO O O
have VB O O
a DT B-NP O
cardiac JJ I-NP O
cath NN I-NP O
Admit NNP I-NP O
to TO O O
Coness- NNP B-NP O
Ther NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
further JJ B-NP O
management/potential JJ I-NP O
cath NN I-NP O
if IN B-VP O
she PRP O O
changes VBZ O O
mind RB O O
1 CD O O
Cardiac--acute JJ B-NP O
NSTE NNP I-NP O
MI NNP I-NP O
vs POS O O
demand-induced JJ B-NP O
NSTE NNP I-NP O
MI NNP I-NP O
from IN B-VP O
tachyarrythmia NN B-NP O
Cont NNP I-NP O
ASA NNP I-NP B-m
, , O O
BB NNP B-NP B-m
, , O O
ACEinh NNP B-NP B-m
, , O O
statin NN B-NP B-m
, , O O
heparin NN B-NP B-m
, , O O
integrilin NN B-NP B-m
Was NNP I-NP O
discussed VBN O O
many JJ B-NP O
times NNS I-NP O
w/ VBP O O
pt JJ O O
by IN B-VP O
different JJ B-NP O
staff NN I-NP O
benefits NNS I-NP O
and CC O O
info VB O O
about IN B-VP O
cath NN B-NP O
, , O O
but CC O O
pt RB O O
deciced VBD B-VP O
on IN B-VP O
medical JJ B-NP O
rx NN I-NP O
Pt NNP I-NP O
switched VBD B-VP O
from IN B-VP O
heparin NN B-NP B-m
to TO O O
lovenox/integrilin VB O B-m
for IN B-VP O
proven JJ B-NP O
benefits NNS I-NP O
if IN B-VP O
noninvasive JJ B-NP O
managmemetn NN I-NP O
for IN B-VP B-du
total NN B-NP I-du
of IN B-VP I-du
72 CD O I-du
hr JJ B-NP I-du
course NN I-NP I-du
integ/hep NN I-NP B-m
( ( O O
finished VBN O O
Wed NNP B-NP O
, , O O
monitor NN B-NP O
until IN B-VP O
Thurs NNP B-NP O
) ) O O
Titrating VBG O B-do
BP NNP B-NP B-m
meds NNS I-NP I-m
for IN B-VP O
better JJR B-NP O
control NN I-NP O
( ( O O
130-160 JJ B-NP O
)--because NN I-NP O
HR NNP I-NP O
has VBZ O O
been VBN O O
in IN B-VP O
50's CD O O
, , O O
added VBD B-VP O
HCTZ NNP B-NP B-m
for IN B-VP O
BP NNP B-NP B-r
control NN I-NP O
PUMP: NNP I-NP O
repeat NN I-NP O
echo NN I-NP O
( ( O O
last JJ O O
one CD O O
'88 POS O O
) ) O O
for IN B-VP O
change NN B-NP O
in IN B-VP O
fxn: JJ B-NP O
prelim: NN I-NP O
mild JJ B-NP O
hypokinesis NN I-NP O
in IN B-VP O
lat JJ B-NP O
wall NN I-NP O
, , O O
awaiting VBG O O
final JJ B-NP O
report NN I-NP O
RATE/RHYTHM: NNP I-NP O
cardiac JJ B-NP O
telemetry NN I-NP O
, , O O
HR's NNP B-NP O
tend VBP O O
to TO O O
be VB O O
low JJ O O
50's CD O O
in IN B-VP O
AM NNP B-NP O
asymptomatic JJ O O
, , O O
cont JJ B-NP O
regimen NNS I-NP O
First JJ B-NP O
time NN I-NP O
she PRP O O
has VBZ O O
had VBN O O
palpitations NNS B-NP O
in IN B-VP O
2 CD O O
yrs NN B-NP O
, , O O
will MD O O
need VB O O
f/u NN B-NP O
of IN B-VP O
this DT B-NP O
issue--no JJ I-NP O
arrythmias NN I-NP O
in IN B-VP O
ho NN B-NP O
use NN I-NP O
2 CD O O
Endo: NNP B-NP O
DM NNP I-NP B-r
II--CZI NNP I-NP B-m
ss NN I-NP O
, , O O
cont JJ B-NP O
micronase NN I-NP B-m
3 CD O O
GI: NNP B-NP O
nexium NN I-NP B-m
, , O O
colace NN B-NP B-m
4 CD O O
ID: NNP B-NP O
pt NN I-NP O
with IN B-VP O
UTI--rx NNP B-NP B-r
levoflox NN I-NP B-m
x VBZ O B-du
7 CD O I-du
days NNS B-NP I-du
4 CD O O
DVT NNP B-NP B-r
proph: NN I-NP I-r
on IN B-VP O
lovenox $ O B-m
5 CD O O
code NN B-NP O
status: NN I-NP O
FULL NNP I-NP O
6 CD O O
Dispo: NNP B-NP O
PT NNP I-NP O
eval NN I-NP O
, , O O
discharge NN B-NP O
Thursday NNP I-NP O
when WRB O O
72 CD O B-du
hr NN B-NP I-du
course NN I-NP I-du
lovenox/integrilin VBD B-VP B-m
complete JJ O O
for IN B-VP O
rx JJ B-NP B-r
NSTE NNP I-NP I-r
MI NNP I-NP I-r
Pt NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
a DT B-NP O
nd NN I-NP O
will MD O O
d/c VB O O
on IN B-VP O
new JJ B-NP O
meds: NN I-NP O
HCTZ NNP I-NP B-m
, , O O
nexium NN B-NP B-m
( ( O O
LGIB NNP B-NP B-r
history NN I-NP I-r
) ) O O
, , O O
SLNG NNP B-NP B-m
prn NN I-NP B-f
, , O O
levoflox JJ O B-m
x VBP O B-du
4 CD O I-du
more JJR B-NP I-du
days NNS I-NP I-du
Pt NNP I-NP O
f/u NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Ezequiel NNP I-NP O
Drzewicki NNP I-NP O
in IN B-VP O
1-2 JJ B-NP O
wks NN I-NP O
, , O O
and CC O O
with IN B-VP O
a DT B-NP O
new JJ I-NP O
cardiologist NN I-NP O
in IN B-VP O
2-4 JJ B-NP O
wks JJ I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
You PRP O O
have VBP O O
had VBN O O
a DT B-NP O
heart NN I-NP O
attack NN I-NP O
and CC O O
because IN B-VP O
you PRP O O
did VBD B-VP O
not RB O O
want VB O O
to TO O O
have VB O O
a DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
to TO O O
fix VB O O
any DT B-NP O
blockages NNS I-NP O
that WDT O O
may MD O O
be VB O O
in IN B-VP O
your PRP$ O O
heart NN B-NP O
arteries VBZ O O
supplying VBG O O
your PRP$ O O
heart NN B-NP O
, , O O
we PRP O O
have VBP O O
treated VBN O O
you PRP O O
with IN B-VP O
medicines NNS B-NP O
Your PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
high JJ O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
so RB O O
we've RB O O
started VBN O O
you PRP O O
on IN B-VP O
a DT B-NP O
medicine NN I-NP O
HCTZ NNP I-NP B-m
, , O O
and CC O O
also RB O O
an DT O O
antibiotic JJ O B-m
, , O O
levofloxacin JJ O B-m
, , O O
for IN B-VP O
a DT O B-r
a DT B-NP B-r
urinary JJ I-NP O
tract NN I-NP O
infection NN I-NP O
which WDT O O
you PRP O O
should MD O O
take VB O O
for IN B-VP B-du
4 CD O I-du
more JJR B-NP I-du
days NNS I-NP I-du
See NNP I-NP O
Dr NNP I-NP O
Garhart NNP I-NP O
in IN B-VP O
1-2 JJ B-NP O
wks NN I-NP O
, , O O
and CC O O
a DT B-NP O
cardiologist NN I-NP O
in IN B-VP O
2-4 JJ B-NP O
wks NN I-NP O
Call NN I-NP O
if IN B-VP O
you PRP O O
have VBP O O
more JJR B-NP O
chest JJ I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
ANAYA NNP I-NP O
, , O O
EDUARDO NNP B-NP O
SAMMIE NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
NV48 NNP B-NP O
) ) O O
7/18/01 CD O O
@ $ O O
11:46 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#64589 VBZ O O
220253841 CD O O
HH NNP B-NP O
55640268 CD O O
7682221 CD O O
9/7/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/28/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
ATTENDING: NNP I-NP O
KETTMANN NNP I-NP O
, , O O
QUENTIN NNP B-NP O
M.D NNP I-NP O
ADMISSION NNP I-NP O
DIAGNOSIS: NNP I-NP O
Cardiac NNP I-NP O
arrest NN I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Sepsis/line NNP I-NP O
infection NN I-NP O
, , O O
end-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
on IN B-VP O
hemodialysis NN B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
54-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
cardiomyopathy NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
type JJ O O
2 CD O O
, , O O
end-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
on IN B-VP O
hemodialysis NN B-NP O
who WP O O
had VBD B-VP O
a DT O O
reported VBN O O
cardiac JJ B-NP O
arrest NN I-NP O
while IN B-VP O
receiving VBG O O
dialysis NN B-NP O
on IN B-VP O
8/1/06 CD O O
in IN B-VP O
her PRP$ O O
outpatient JJ B-NP O
clinic NN I-NP O
at IN B-VP O
Richgo NNP B-NP O
Ster NNP I-NP O
Ha NNP I-NP O
She PRP O O
began VBD B-VP O
to TO O O
feel VB O O
nauseated JJ O O
and CC O O
then RB O O
vomited VBD B-VP O
The DT B-NP O
patient NN I-NP O
then RB O O
reportedly RB O O
went VBD B-VP O
into IN B-VP O
VFib NNP B-NP O
and CC O O
was VBD B-VP O
shocked VBN O O
once RB O O
by IN B-VP O
EMS NNP B-NP O
, , O O
resulting VBG O O
in IN B-VP O
a DT B-NP O
narrow JJ I-NP O
QRS NNP I-NP O
complex NN I-NP O
rhythm NN I-NP O
She PRP O O
was VBD B-VP O
intubated VBN O O
, , O O
received VBD B-VP O
amiodarone NN B-NP B-m
and CC O O
dopamine NN B-NP B-m
, , O O
as IN B-VP O
her PRP$ O B-r
her PRP$ O B-r
BP NNP B-NP I-r
BP NNP I-NP I-r
was VBD B-VP O
approximately RB O O
70s CD O O
systolic NN B-NP O
over IN B-VP O
palpable JJ B-NP O
diastolic NN I-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
a DT B-NP O
portable JJ I-NP O
chest NN I-NP O
x-ray NN I-NP O
revealed VBD B-VP O
diffuse RB O O
bilateral JJ B-NP O
opacities NNS I-NP O
, , O O
risk NN B-NP O
of IN B-VP O
pulmonary JJ B-NP O
edema NN I-NP O
and CC O O
ABG NNP B-NP O
showed VBD B-VP O
respiratory JJ B-NP O
acidosis NN I-NP O
Pt NNP I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
ICU NNP I-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
recently RB O O
hospitalized VBN O O
at IN B-VP O
Somver NNP B-NP O
Vasky NNP I-NP O
University NNP I-NP O
Of IN B-VP O
Medical NNP B-NP O
Center NNP I-NP O
on IN B-VP O
1/5/06 CD O O
through IN B-VP O
11/11/07 CD O O
for IN B-VP O
initiation NN B-NP O
of IN B-VP O
dialysis NN B-NP O
after IN B-VP O
her PRP$ O O
BUN NNP B-NP O
and CC O O
creatinine NN B-NP O
had VBD B-VP O
risen VBN O O
remarkably RB O O
from IN B-VP O
baseline NN B-NP O
She PRP O O
was VBD B-VP O
then RB O O
asymptomatic JJ O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
A DT B-NP O
fistulogram NN I-NP O
and CC O O
angioplasty NN B-NP O
of IN B-VP O
her PRP$ O O
right JJ B-NP O
AV NNP I-NP O
fistula NN I-NP O
was VBD B-VP O
performed VBN O O
on IN B-VP O
9/14/06 CD O O
with IN B-VP O
prednisone NN B-NP B-m
premedication NN I-NP O
but CC O O
it PRP O O
was VBD B-VP O
unsuccessful JJ O O
and CC O O
therefore RB O O
a DT B-NP O
left NN I-NP O
IJ NNP I-NP O
tunneled VBD B-VP O
dialysis NN B-NP O
catheter NN I-NP O
was VBD B-VP O
inserted VBN O O
on IN B-VP O
10/18/06 CD O O
with IN B-VP O
the DT B-NP O
tip NN I-NP O
ending VBG O O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
atrium NN I-NP O
She PRP O O
has VBZ O O
since IN B-VP O
received VBN O O
dialysis NN B-NP O
treatments NNS I-NP O
with IN B-VP O
no DT B-NP O
complication NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
CHF NNP B-NP O
, , O O
echo NN B-NP O
in IN B-VP O
August NNP B-NP O
of IN B-VP O
1999 CD O O
shows NNS B-NP O
moderate VBP O O
left VBN O O
ventricular JJ B-NP O
hypertrophy NN I-NP O
of IN B-VP O
about IN B-VP O
65% CD O O
, , O O
diabetes VBZ O O
type VBP O O
2 CD O O
20 CD O O
years NNS B-NP O
including VBG O O
with IN B-VP O
retinopathy NN B-NP O
, , O O
nephropathy JJ O O
and CC O O
neuropathic JJ B-NP O
pain NN I-NP O
, , O O
hypertension NN B-NP O
for IN B-VP O
the DT O O
past JJ O O
20 CD O O
years NNS B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
medullary JJ B-NP O
CVA NNP I-NP O
August NNP I-NP O
1999 CD O O
, , O O
right RB O O
PICA NNP B-NP O
resulting VBG O O
Wallenberg's NNP B-NP O
syndrome NN I-NP O
, , O O
morbid NN B-NP O
obesity NN I-NP O
, , O O
left VBD B-VP O
knee JJ B-NP O
degenerative JJ I-NP O
joint NN I-NP O
disease NN I-NP O
, , O O
iron-deficiency NN B-NP O
anemia NN I-NP O
ALLERGIES: NNP I-NP O
IV NNP I-NP O
contrast NN I-NP O
, , O O
which WDT O O
gives VBZ O O
her PRP$ O O
anaphylaxis NN B-NP O
, , O O
tetracycline NN B-NP O
to TO O O
an DT B-NP O
unknown JJ I-NP O
reaction NN I-NP O
, , O O
lisinopril JJ B-NP O
HOME NNP I-NP O
MEDICATIONS: NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
include VBP O O
amitriptyline JJ O B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
bedtime NN I-NP B-f
, , O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
enalapril VBZ O B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Losartan NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
Toprol-XL JJ O B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Advair NNP B-NP B-m
Diskus NNP I-NP O
250/50 CD O O
one CD O B-do
puff NN B-NP I-do
inhaler NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
insulin JJ B-NP B-m
insulin NN I-NP B-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
50 CD O B-do
units NNS B-NP I-do
q.a.m JJ B-NP B-f
subcu NN I-NP B-mo
and CC O O
25 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
subcu VBP O B-mo
, , O O
insulin JJ O B-m
lispro FW O I-m
18 CD O B-do
units NNS B-NP I-do
subcu VBP O B-mo
at IN B-VP O
dinner NN B-NP B-f
time NN I-NP I-f
, , O O
Protonix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
sevelamer JJ O B-m
1200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
tramadol VBZ O B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.6 NN I-NP B-f
h NN I-NP I-f
p.r.n NN I-NP I-f
pain VBP O B-r
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
This DT B-NP O
patient NN I-NP O
is VBZ O O
single JJ O O
and CC O O
has VBZ O O
one CD O O
son NN B-NP O
and CC O O
one CD O O
grandson NN B-NP O
Arturo NNP I-NP O
Randklev NNP I-NP O
is VBZ O O
the DT B-NP O
healthcare NN I-NP O
proxy NN I-NP O
and CC O O
is VBZ O O
her PRP$ O O
son NN B-NP O
She PRP O O
worked VBD B-VP O
30 CD O O
years NNS B-NP O
for IN B-VP O
Wi NNP B-NP O
Co NNP I-NP O
Baya NNP I-NP O
and CC O O
is VBZ O O
currently RB O O
retired VBN O O
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Her NNP I-NP O
vital JJ B-NP O
signs NNS I-NP O
were VBD B-VP O
temperature JJ O O
97.6 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
72 CD O O
, , O O
BP NNP B-NP O
of IN B-VP O
115/66 CD O O
with IN B-VP O
mean JJ B-NP O
arterial JJ I-NP O
pressure NN I-NP O
of IN B-VP O
83 CD O O
, , O O
respiratory NN B-NP O
14 CD O O
, , O O
sating VBG O O
100% CD O O
on IN B-VP O
60% CD O O
inspired JJ B-NP O
FiO2 NNP I-NP O
Her NNP I-NP O
CVP NNP I-NP O
at IN B-VP O
admission NN B-NP O
was VBD B-VP O
17 CD O O
to TO O O
20 CD O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
an DT B-NP O
obese JJ I-NP O
woman NN I-NP O
who WP O O
was VBD B-VP O
intubated VBN O O
and CC O O
responded VBN O O
to TO O O
voice VB O O
Her PRP$ O O
pupils NNS B-NP O
were VBD B-VP O
3 CD O O
to TO O O
2 CD O O
mm NNS B-NP O
bilaterally RB O O
Her NNP B-NP O
extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
Her NNP I-NP O
chest NN I-NP O
exam NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
diffuse NN B-NP O
crackles NNS I-NP O
throughout IN B-VP O
with IN B-VP O
good JJ B-NP O
air NN I-NP O
movement NN I-NP O
Cardiac NNP I-NP O
auscultation NN I-NP O
revealed VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
rubs NNS B-NP O
or CC O O
gallops VBZ O O
Her PRP$ O O
abdomen NNS B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP O
and CC O O
nondistended VBN O O
with IN B-VP O
normal JJ B-NP O
active JJ I-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities NNS B-NP O
showed VBD B-VP O
no DT B-NP O
edema NN I-NP O
Distal NNP I-NP O
pulses NNS I-NP O
were VBD B-VP O
not RB O O
palpable JJ O O
bilaterally RB O O
She PRP O O
has VBZ O O
thickened VBN O O
hyperpigmented VBN O O
skin JJ B-NP O
changes NNS I-NP O
on IN B-VP O
both DT B-NP O
feet NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Significant NNP I-NP O
labs NN I-NP O
on IN B-VP O
admission NN B-NP O
included VBD B-VP O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
141 CD O O
, , O O
potassium NN B-NP O
4.1 CD O O
, , O O
chloride NN B-NP O
of IN B-VP O
102 CD O O
, , O O
bicarb NN B-NP O
of IN B-VP O
31 CD O O
, , O O
BUN NNP B-NP O
33 CD O O
, , O O
creatinine NN B-NP O
4.2 CD O O
with IN B-VP O
a DT B-NP O
glucose NN I-NP O
of IN B-VP O
156 CD O O
Her NNP B-NP O
hematocrit NN I-NP O
was VBD B-VP O
32 CD O O
An DT B-NP O
ABG NNP I-NP O
at IN B-VP O
10 CD O O
p.m NN B-NP O
of IN B-VP O
admission NN B-NP O
on IN B-VP O
FiO2 NNP B-NP O
of IN B-VP O
60% CD O O
revealed VBD B-VP O
a DT B-NP O
pH NN I-NP O
of IN B-VP O
7.36 CD O O
, , O O
pCO2 NN B-NP O
of IN B-VP O
52 CD O O
, , O O
pO2 NN B-NP O
91 CD O O
Her NNP B-NP O
first JJ B-NP O
set NN I-NP O
of IN B-VP O
cardiac JJ B-NP O
enzyme NN I-NP O
revealed VBD B-VP O
a DT B-NP O
creatinine JJ I-NP O
kinase NN I-NP O
of IN B-VP O
116 CD O O
and CC O O
the DT B-NP O
MB NNP I-NP O
fraction NN I-NP O
of IN B-VP O
0.7 CD O O
and CC O O
troponin JJ B-NP O
T NNP I-NP O
of IN B-VP O
less JJR O O
than IN B-VP O
assay NN B-NP O
and CC O O
lactate NN B-NP O
of IN B-VP O
1.8 CD O O
Tox NNP B-NP O
screen NN I-NP O
was VBD B-VP O
negative JJ B-NP O
Urinalysis NNP I-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
2+ CD O O
protein NN B-NP O
, , O O
3+ CD O O
blood NN B-NP O
and CC O O
positive JJ O O
for IN B-VP O
nitrates NNS B-NP O
, , O O
and CC O O
negative JJ O O
for IN B-VP O
leuks NN B-NP O
, , O O
4 CD O O
to TO O O
10 CD O O
white JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
15 CD O O
to TO O O
25 CD O O
red JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
2+ CD O O
bacteria NNS B-NP O
, , O O
1+ CD O O
squamous JJ B-NP O
epithelial JJ I-NP O
cells NNS I-NP O
IMAGING: NNP I-NP O
Significant NNP I-NP O
imaging VBG O O
at IN B-VP O
admission NN B-NP O
was VBD B-VP O
an DT O O
x-ray JJ O O
for IN B-VP O
chest JJS B-NP O
x-ray JJ I-NP O
revealing NN I-NP O
diffuse NN I-NP O
bilateral JJ B-NP O
opacities NNS I-NP O
, , O O
possible JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
versus NN I-NP O
aspiration NN I-NP O
pneumonia NN I-NP O
, , O O
an DT B-NP O
EKG NNP I-NP O
showing VBG O O
normal JJ B-NP O
sinus NN I-NP O
rhythm VBD B-VP O
100 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
with IN B-VP O
no DT B-NP O
acute NN I-NP O
ST NNP I-NP O
changes NNS I-NP O
and CC O O
old JJ B-NP O
T-wave JJ I-NP O
inversion NN I-NP O
in IN B-VP O
V2 NNP B-NP O
ASSESSMENT: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
55-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
end-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
on IN B-VP O
hemodialysis NN B-NP O
secondary JJ O O
to TO O O
diabetes NNS B-NP O
who WP O O
had VBD B-VP O
an DT B-NP O
apparent JJ I-NP O
VFib NNP I-NP O
arrest NN I-NP O
at IN B-VP O
hemodialysis NN B-NP O
on IN B-VP O
0/9/06 CD O O
and CC O O
was VBD B-VP O
shocked VBN O O
and CC O O
admitted VBN O O
to TO O O
the DT B-NP O
CCU NNP I-NP O
after IN B-VP O
being VBG O O
intubated VBN O O
in IN B-VP O
the DT B-NP O
Vibay NNP I-NP O
General NNP I-NP O
Hospital NNP I-NP O
ED NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
difficulty NN B-NP O
weaning VBG O O
from IN B-VP O
vent NN B-NP O
and CC O O
was VBD B-VP O
finally RB O O
extubated VBN O O
on IN B-VP O
0/22/06 CD O O
The DT B-NP O
CCU NNP I-NP O
course NN I-NP O
was VBD B-VP O
also RB O O
complicated VBN O O
by IN B-VP O
coag-negative JJ B-NP O
Staph NNP I-NP O
grown NN I-NP O
from IN B-VP O
a DT B-NP O
Quinton NNP I-NP O
catheter NN I-NP O
blood NN I-NP O
draw VB O O
The DT B-NP O
catheter NN I-NP O
was VBD B-VP O
changed VBN O O
to TO O O
over IN B-VP O
a DT B-NP O
wire NN I-NP O
on IN B-VP O
0/22/06 CD O O
Blood NNP B-NP O
cultures NNS I-NP O
on IN B-VP O
1/10/06 CD O O
revealed VBD B-VP O
likely JJ B-NP B-r
Staph NNP I-NP I-r
aureus NN I-NP I-r
growth NN I-NP I-r
for IN B-VP O
which WDT O O
the DT B-NP O
patient NN I-NP O
received VBD B-VP O
continuous JJ B-NP O
vancomycin JJ I-NP B-m
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
Question NNP B-NP O
of IN B-VP O
VFib NNP B-NP O
arrest VBP O O
Whether NNP B-NP O
or CC O O
not RB O O
the DT B-NP O
patient NN I-NP O
actually RB O O
had VBD B-VP O
a DT B-NP O
VFib NNP I-NP O
arrest NN I-NP O
seems VBZ O O
to TO O O
be VB O O
in IN B-VP O
some DT B-NP O
doubt NN I-NP O
as IN B-VP O
she PRP O O
never RB O O
had VBD B-VP O
an DT B-NP O
arrhythmia NN I-NP O
on IN B-VP O
tele NN B-NP O
here RB O O
by IN B-VP O
report NN B-NP O
and CC O O
her PRP$ O O
troponin NN B-NP O
when WRB O O
peaked VBN O O
at IN B-VP O
0.14 CD O O
on IN B-VP O
8/1/06 CD O O
after IN B-VP O
receiving VBG O O
one CD O O
external JJ B-NP O
defibrillator NN I-NP O
shock NN I-NP O
at IN B-VP O
hemodialysis NN B-NP O
We PRP O O
believe VBP O O
what WP O O
likely JJ O O
happened VBD B-VP O
was VBD B-VP O
a DT B-NP O
vagal JJ I-NP O
event NN I-NP O
during IN B-VP O
hemodialysis NN B-NP O
, , O O
possibly RB O O
including VBG O O
a DT B-NP O
pause NN I-NP O
misread NN I-NP O
at IN B-VP O
VF NNP B-NP O
by IN B-VP O
the DT B-NP O
defibrillator NN I-NP O
This DT B-NP O
explantation NN I-NP O
is VBZ O O
supported VBN O O
by IN B-VP O
the DT B-NP O
observation NN I-NP O
that IN B-VP O
she PRP O O
has VBZ O O
been VBN O O
continuously RB O O
having VBG O O
nausea NN B-NP O
with IN B-VP O
dialysis NN B-NP O
and CC O O
her PRP$ O O
known VBN O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
vasovagal JJ B-NP O
episodes NNS I-NP O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
Echo NNP I-NP O
on IN B-VP O
8/1/06 CD O O
shows NNS B-NP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
60 CD O O
to TO O O
65% CD O O
with IN B-VP O
mild JJ O B-r
concentric JJ O I-r
left VBD B-VP I-r
ventricular JJ B-NP I-r
hypertrophy NN I-NP I-r
and CC O O
no DT B-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
telemetry NN B-NP O
and CC O O
treated VBD B-VP O
with IN B-VP O
her PRP$ O O
home NN B-NP B-do
dose NN I-NP I-do
of IN B-VP O
beta-blocker NN B-NP B-m
with IN B-VP O
good JJ B-NP O
response NN I-NP O
2 CD O O
Volume NN B-NP O
status NN I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
very RB O O
close JJ O O
to TO O O
her PRP$ O O
dry JJ B-NP O
weight NN I-NP O
upon IN B-VP O
discharge NN B-NP O
, , O O
which WDT O O
she PRP O O
gives VBZ O O
at IN B-VP O
354 CD O O
pounds NNS B-NP O
by IN B-VP O
wet NN B-NP O
scale NN I-NP O
She PRP O O
has VBZ O O
been VBN O O
continued VBN O O
on IN B-VP O
hemodialysis NN B-NP O
with IN B-VP O
good JJ B-NP O
results NNS I-NP O
3 CD O O
Possibly RB O O
infected VBN O O
hemodialysis NN B-NP O
catheter NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
single JJ I-NP O
set NN I-NP O
of IN B-VP O
coag-negative JJ B-NP B-r
Staph NNP I-NP I-r
positive JJ B-NP I-r
blood NN I-NP I-r
cultures NNS I-NP I-r
from IN B-VP O
Quinton NNP B-NP O
catheter NN I-NP O
on IN B-VP O
8/8/06 CD O O
Line NNP B-NP O
was VBD B-VP O
changed VBN O O
over IN B-VP O
wire NN B-NP O
4/28/06 CD O O
and CC O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
vancomycin NNS B-NP B-m
dose JJ O O
by IN B-VP O
renal JJ B-NP O
levels NNS I-NP O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
grow VB O O
out RP O O
coag-negative JJ B-NP O
Staph NNP I-NP O
, , O O
positive JJ B-NP O
blood NN I-NP O
cultures NNS I-NP O
from IN B-VP O
2 CD O O
out IN B-VP O
of IN B-VP O
2 CD O O
sets NNS B-NP O
drawn VBN O O
on IN B-VP O
8/8/06 CD O O
4 CD O O
Anemia NNP B-NP O
In IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
end-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
her PRP$ O O
baseline NN B-NP O
hematocrit NN I-NP O
is VBZ O O
about IN B-VP O
30 CD O O
and CC O O
stable JJ O O
5 CD O O
Diabetes NNPS B-NP O
type NN I-NP O
2 CD O O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
a DT B-NP O
Portland NNP I-NP O
protocol NN I-NP O
during IN B-VP O
her PRP$ O O
ICU NNP B-NP O
course NN I-NP O
wand NN I-NP O
was VBD B-VP O
switched VBN O O
to TO O O
a DT O O
long JJ O O
and CC O O
short-acting JJ B-NP O
subcutaneous JJ I-NP B-mo
subcutaneous JJ I-NP B-mo
insulin NN I-NP O
approaching VBG O O
her PRP$ O O
home NN B-NP B-do
dose NN I-NP I-do
of IN B-VP O
NPH NNP B-NP B-m
BID NNP I-NP B-f
6 CD O O
FEN NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
gradually RB O O
advanced JJ O O
to TO O O
an DT B-NP O
oral JJ I-NP O
diet NN I-NP O
with IN B-VP O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
aspiration NN B-NP O
status NN I-NP O
post NN I-NP O
extubation NN I-NP O
7 CD O O
Prophylaxis NNP B-NP O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
heparin JJ O B-m
subcutaneously RB O B-mo
and CC O O
Nexium NNP B-NP B-m
8 CD O O
Code NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
full JJ B-NP O
code NN I-NP O
Her NNP I-NP O
healthcare NN I-NP O
proxy NN I-NP O
is VBZ O O
her PRP$ O O
son NN B-NP O
Noble JJ B-NP O
Schomberg NNP I-NP O
, , O O
030-855-6086 JJ B-NP O
DISPOSITION: NNP I-NP O
This DT B-NP O
patient NN I-NP O
will MD O O
likely RB O O
need VB O O
rehab NNS B-NP O
and CC O O
is VBZ O O
being VBG O O
screened VBN O O
by IN B-VP O
PT NNP B-NP O
and CC O O
OT NNP B-NP O
and CC O O
will MD O O
likely RB O O
be VB O O
discharged VBN O O
to TO O O
rehab VB O O
when WRB O O
bed NN B-NP O
is VBZ O O
available JJ B-NP O
eScription NN I-NP O
document: VBZ O O
5-2572147 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
ARTOLA NNP I-NP O
, , O O
GARY NNP B-NP O
Attending: NNP I-NP O
DIX NNP I-NP O
, , O O
REGGIE NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
5231801 CD O O
D: NNP B-NP O
4/18/06 CD O O
T: NNP B-NP O
4/18/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#66947 VBZ O O
165924793 CD O O
ARCCH NNP B-NP O
42505562 CD O O
4965709 CD O O
1/30/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
s/p JJ B-NP O
angioplasty NN I-NP O
and CC O O
stenting VBG O O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/8/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/14/2007 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
COOLBAUGH NNP I-NP O
, , O O
OMAR NNP B-NP O
J NNP I-NP O
598-85-46-5 JJ B-NP O
South NNP I-NP O
Dakota NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
6/21/07 CD O O
AT NNP B-NP O
10:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
labs/ekg NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KEASER NNP I-NP O
, , O O
JR NNP B-NP O
, , O O
OMER NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
MYCOPHENOLATE NNP B-NP B-m
MOFETIL NNP I-NP I-m
1000 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
2 CD O O
OXYBUTYNIN NNP B-NP B-m
CHLORIDE NNP I-NP I-m
XL NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
3 CD O O
INSULIN NNP B-NP B-m
GLARGINE NNP I-NP I-m
20 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
4 CD O O
FUROSEMIDE NNP B-NP B-m
PO NNP I-NP B-mo
QD NNP I-NP B-f
5 CD O O
CLOPIDOGREL NNP B-NP B-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
6 CD O O
PRAVASTATIN NNP B-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
7 CD O O
PREDNISONE NNP B-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
8 CD O O
CYCLOSPORINE NNP B-NP B-m
( ( O I-m
SANDIMMUNE NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
9 CD O O
METOPROLOL NNP B-NP B-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
10 CD O O
FENOFIBRATE NNP B-NP B-m
( ( O I-m
TRICOR NNP B-NP I-m
) ) O I-m
48 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
ENTERIC NNP I-NP B-m
COATED NNP I-NP I-m
ASA NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
Tomorrow NNP I-NP O
( ( O O
5/25 CD O O
) ) O O
CYCLOSPORINE NNP B-NP B-m
( ( O I-m
SANDIMMUNE NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Give VBP O O
with IN B-VP O
meals NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/17/07 CD O O
by IN B-VP O
REGES NNP B-NP O
, , O O
FAUSTO NNP B-NP O
T NNP I-NP O
BUCK NNP I-NP O
JERRY NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
TRICOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
438676570 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CYCLOSPORINE NNP I-NP B-m
&amp; NNP I-NP O
FENOFIBRATE NNP I-NP B-m
, , O I-m
MICRONIZED NNP B-NP I-m
MICRONIZED NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
patient NN I-NP O
home NN I-NP B-m
meds NNS I-NP I-m
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/17/07 CD O O
by IN B-VP O
KELLETT NNP B-NP O
, , O O
WILTON NNP B-NP O
GAYLORD NNP I-NP O
MILO NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
PRAVASTATIN NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
CYCLOSPORINE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
patient NN I-NP O
home NN I-NP B-m
meds NNS I-NP I-m
TRICOR NNP I-NP B-m
( ( O I-m
FENOFIBRATE NNP B-NP I-m
( ( O I-m
TRICOR NNP B-NP I-m
) ) O I-m
) ) O I-m
48 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/17/07 CD O O
by IN B-VP O
RAGONE NNP B-NP O
, , O O
JAMAL NNP B-NP O
F NNP I-NP O
BERNARD NNP I-NP O
HOUSTON NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
PRAVASTATIN NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
FENOFIBRATE NNP I-NP B-m
, , O I-m
MICRONIZED NNP B-NP I-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CYCLOSPORINE NNP I-NP B-m
&amp; NNP I-NP O
FENOFIBRATE NNP I-NP B-m
, , O I-m
MICRONIZED NNP B-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
patient NN I-NP O
home NN I-NP O
meds NNS I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
4 CD O I-du
LASIX NNP B-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
INSULIN NNP I-NP B-m
GLARGINE NNP I-NP I-m
20 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
DAILY NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
3 CD O I-du
CELLCEPT NNP B-NP B-m
( ( O I-m
MYCOPHENOLATE NNP B-NP I-m
MOFETIL NNP I-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
Food NN B-NP O
decreases NNS I-NP O
peak NN I-NP O
by IN B-VP O
up IN B-VP O
to TO O O
40% CD O O
TNG NNP B-NP B-m
0.4 CD O I-m
MG NNP B-NP I-m
( ( O I-m
NITROGLYCERIN NNP B-NP I-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5MIN NNP I-NP B-f
X NNP I-NP I-f
3 CD O I-f
3 CD O B-do
doses NNS B-NP I-f
doses VBZ O I-do
PRN NNP B-NP I-f
PRN NNP I-NP B-f
Chest NNP I-NP B-r
Pain NNP I-NP I-r
DITROPAN NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
OXYBUTYNIN NNP B-NP I-m
CHLORIDE NNP I-NP I-m
XL NNP I-NP I-m
) ) O I-m
10 CD O O
MG NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
3 CD O I-du
PRAVACHOL NNP B-NP B-m
( ( O I-m
PRAVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/17/07 CD O O
by IN B-VP O
KWAN NNP B-NP O
, , O O
JOHNSON NNP B-NP O
A NNP I-NP O
EDMUNDO NNP I-NP O
TAD NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
TRICOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
438676570 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
PRAVASTATIN NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
FENOFIBRATE NNP I-NP B-m
, , O I-m
MICRONIZED NNP B-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
patient NN I-NP O
home NN I-NP B-m
meds NNS I-NP I-m
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/17/07 CD O O
by IN B-VP O
LAMOREE NNP B-NP O
, , O O
MARCELLUS NNP B-NP O
VICENTE NNP I-NP O
RONALD NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
CYCLOSPORINE NNP B-NP B-m
( ( O I-m
SANDIMMUNE NNP B-NP I-m
) ) O I-m
PO NNP B-NP B-mo
( ( O O
ref JJ O O
# # O O
472656194 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
PRAVASTATIN NNP I-NP B-m
SODIUM NNP I-NP I-m
&amp; NNP I-NP O
CYCLOSPORINE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
patient NN I-NP O
home NN I-NP B-m
meds NNS I-NP I-m
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/17/07 CD O O
by IN B-VP O
SLEIMAN NNP B-NP O
, , O O
CARTER NNP B-NP O
ERNESTO NNP I-NP O
BRUNO NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
PRAVACHOL NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
214437202 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
SIMVASTATIN; NNP B-NP O
reaction NN I-NP O
is VBZ O O
muscle JJ B-NP O
aches NNS I-NP O
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
patient NN I-NP O
home NN I-NP O
meds NNS I-NP O
PREDNISOLONE NNP I-NP B-m
SODIUM NNP I-NP I-m
PHOSPHATE NNP I-NP I-m
5MG/5ML CD O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
light NN I-NP O
activity NN I-NP O
, , O O
no DT B-NP O
heavy JJ I-NP O
lifting NN I-NP O
or CC O O
driving VBG O O
x JJ O O
2 CD O O
days NNS B-NP O
ok RB O O
to TO O O
shower VB O O
, , O O
no DT B-NP O
swimming NN I-NP O
or CC O O
bathing VBG O O
x JJ O O
5 CD O O
days NNS B-NP O
Lift NNP I-NP O
restrictions: NN I-NP O
Do NNP I-NP O
not RB O O
lift VB O O
greater JJR O O
then RB O O
10-15 CD O O
pounds NNS B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Heart NNP I-NP O
failure NN I-NP O
Clinic NNP I-NP O
2-4 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
SIMVASTATIN NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
s/p VBD B-VP O
cardiac JJ B-NP O
transplant NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
s/p NN B-NP O
angioplasty NN I-NP O
and CC O O
stenting VBG O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
s/p JJ B-NP O
cardiac NN I-NP O
transplant NN I-NP O
1992 CD O O
( ( O O
S/P NNP B-NP O
cardiac VBP O O
transplant NN B-NP O
) ) O O
Diabetes VBZ O O
mellitus JJ B-NP O
type NN I-NP O
II NNP I-NP O
( ( O O
diabetes VBZ O O
mellitus VBP O O
type JJ O O
2 CD O O
) ) O O
Trochanteric NNP B-NP O
bursitis NN I-NP O
( ( O O
trochanteric JJ B-NP O
bursitis NN I-NP O
) ) O O
Dyslipidemia NNP B-NP O
( ( O O
dyslipidemia NN B-NP O
) ) O O
DJD NNP B-NP O
spine NN I-NP O
( ( O O
OA NNP B-NP O
of IN B-VP O
cervical JJ B-NP O
spine NN I-NP O
) ) O O
Hx NNP B-NP O
vocal JJ B-NP O
cord NN I-NP O
injury NN I-NP O
postop NN I-NP O
Hx NNP I-NP O
gastritis NN I-NP O
with IN B-VP O
UGIB NNP B-NP O
( ( O O
H/O NNP B-NP O
upper NNP I-NP O
GI NNP I-NP O
bleeding VBG O O
) ) O O
Hx NNP B-NP O
postop JJ B-NP O
seizure NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
s/p NN B-NP O
LAD NNP I-NP O
angioplasty NN I-NP O
and CC O O
stenting VBG O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
71 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
that WDT O O
is VBZ O O
now RB O O
15 CD O O
years NNS B-NP O
following VBG O O
cardiac JJ B-NP O
transplantation NN I-NP O
, , O O
with IN B-VP O
a DT B-NP O
multiplicity NN I-NP O
of IN B-VP O
medical JJ B-NP O
issues NNS I-NP O
, , O O
including VBG O O
allograft NN B-NP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
bilateral JJ B-NP O
carotid NN I-NP O
disease NN I-NP O
( ( O O
underwent JJ B-NP O
carotid NN I-NP O
stenting NN I-NP O
in IN B-VP O
March NNP B-NP O
2006 CD O O
) ) O O
, , O O
History NNP B-NP O
of IN B-VP O
TIA NNP B-NP O
, , O O
diabetes VBZ O O
and CC O O
significant JJ B-NP O
obesity.Her JJ I-NP O
baseline NN I-NP O
renal JJ B-NP O
cr NN I-NP O
was VBD B-VP O
1.7 CD O O
The DT B-NP O
LCX NNP I-NP O
was VBD B-VP O
stented VBN O O
in IN B-VP O
June NNP B-NP O
2006 CD O O
Current NNP B-NP O
meds NNS I-NP O
includes VBZ O O
CellCept IN B-VP B-m
1000 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
prednisone NN B-NP B-m
5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
cyclosporine VB O B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Toprol-XL NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
daily RB O B-f
, , O O
TriCor NNP B-NP B-m
, , O O
once RB O B-f
daily JJ O I-f
, , O O
Pravachol NNP B-NP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Plavix NNP B-NP B-m
75 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Lasix NNP B-NP B-m
, , O O
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
insulin NN B-NP B-m
, , O O
aspirin NN B-NP B-m
, , O O
Ditropan NNP B-NP B-m
10 CD O B-do
mg JJ O I-do
daily JJ O B-f
and CC O O
vitamins NNS B-NP B-m
Elective NNP I-NP O
cardiac JJ B-NP O
catheterization NN I-NP O
Was NNP I-NP O
performed VBN O O
today NN B-NP O
for IN B-VP O
her PRP$ O O
annual JJ B-NP O
post NN I-NP O
cardiac JJ B-NP O
transplant NN I-NP O
evaluation NN I-NP O
revealed VBD B-VP O
double JJ B-NP O
vessel NN I-NP O
disease NN I-NP O
proximal JJ B-NP O
LAD NNP I-NP O
95% CD O O
lesion NN B-NP O
, , O O
LeftnCX NNP B-NP O
( ( O O
Proximal NNP B-NP O
) ) O O
, , O O
75% CD O O
lesion NN B-NP O
CX NNP I-NP O
( ( O O
Mid NNP B-NP O
) ) O O
, , O O
95% CD O O
lesion NN B-NP O
, , O O
MARG1 NNP B-NP O
( ( O O
Ostial NNP B-NP O
) ) O O
, , O O
95% CD O O
lesion NN B-NP O
Successful NNP I-NP O
PTCA/Stenting NNP I-NP O
- : O O
LAD NNP B-NP O
using VBG O O
XB3.5guide NNP B-NP O
, , O O
BMW NNP B-NP O
, , O O
which WDT O O
was VBD B-VP O
predilated VBN O O
with IN B-VP O
a DT O O
2mm CD O O
balloon NN B-NP O
, , O O
2 CD O O
DES NNP B-NP O
was VBD B-VP O
used VBN O O
( ( O O
3 CD O O
by IN B-VP O
18 CD O O
) ) O O
and( NN B-NP O
3 CD O O
by IN B-VP O
18 CD O O
) ) O O
cypher NN B-NP O
stents NNS I-NP O
which WDT O O
was VBD B-VP O
subsequently RB O O
postdilated VBN O O
to TO O O
3.2 CD O O
, , O O
no DT B-NP O
residual JJ I-NP O
stenosis NN I-NP O
Right NNP I-NP O
groin NN I-NP O
access NN I-NP O
was VBD B-VP O
closed VBN O O
with IN B-VP O
Starclose NNP B-NP O
PCI NNP I-NP O
of IN B-VP O
the DT B-NP O
LAD NNP I-NP O
today NN I-NP O
and CC O O
possible JJ O O
planned VBN O O
PCI NNP B-NP O
of IN B-VP O
LCX NNP B-NP O
in IN B-VP O
1-3 JJ B-NP O
weeks NNS I-NP O
Check NNP I-NP O
renal JJ B-NP O
function NN I-NP O
over IN B-VP O
the DT O O
next JJ O O
2 CD O O
days NNS B-NP O
Plan: NNP I-NP O
PCI NNP I-NP O
of IN B-VP O
the DT B-NP O
LAD NNP I-NP O
today NN I-NP O
and CC O O
possible JJ O O
planned VBN O O
PCI NNP B-NP O
of IN B-VP O
LCX NNP B-NP O
in IN B-VP O
1-3 JJ B-NP O
weeks NNS I-NP O
Check NNP I-NP O
renal JJ B-NP O
function NN I-NP O
over IN B-VP O
the DT O O
next JJ O O
2 CD O O
days NNS B-NP O
0/7/07 CD O O
Up NNP B-NP O
, , O O
eating VBG O O
and CC O O
voiding VBG O O
well RB O O
Ambulating VBG O O
on IN B-VP O
POD NNP B-NP O
- : O O
"tired" NN B-NP O
but CC O O
no DT B-NP O
change NN I-NP O
from IN B-VP O
baseline NN B-NP O
No NNP I-NP O
Chest NNP I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
groin NN B-NP O
or CC O O
flank NN B-NP O
pain VBP O O
No DT B-NP O
palpitations NNS I-NP O
Multiple NNP I-NP O
questions NNS I-NP O
regarding VBG O O
activity NN B-NP O
, , O O
medications NNS B-NP O
reviewed VBD B-VP O
with IN B-VP O
patient JJ B-NP O
PHYSICAL NNP I-NP O
EXAM: NNP I-NP O
96.4 CD O O
80-90s JJ O O
110/60 CD O O
97%ra CD O O
voiding NN B-NP O
to TO O O
BR NNP B-NP O
NAD NNP I-NP O
JVP NNP I-NP O
not RB O O
elevated VBD B-VP O
COR NNP B-NP O
RRR NNP I-NP O
, , O O
S1S2 NNP B-NP O
, , O O
no DT B-NP O
murmur NN I-NP O
appreciated VBD B-VP O
Lungs NNP B-NP O
- : O O
CTA NNP B-NP O
bilat NN I-NP O
, , O O
no DT B-NP O
RRW NNP I-NP O
EXT NNP I-NP O
- : O O
warm NN B-NP O
, , O O
no DT B-NP O
edema NN I-NP O
Right RB O O
Groin-soft NNP B-NP O
, , O O
no DT B-NP O
ecchymosis NN I-NP O
, , O O
no DT B-NP O
hematoma NN I-NP O
or CC O O
bruit NN B-NP O
Palpable JJ B-NP O
femoral JJ I-NP O
pulse NN I-NP O
EKG: NNP I-NP O
SR NNP I-NP O
at IN B-VP O
95 CD O O
wtih NN B-NP O
inc NN I-NP O
RBBB NNP I-NP O
, , O O
flat JJ B-NP O
T NNP I-NP O
1 CD O O
, , O O
L NNP B-NP O
, , O O
no DT B-NP O
change NN I-NP O
from IN B-VP O
prior JJ B-NP O
TELE: NNP I-NP O
no DT B-NP O
tele JJ I-NP O
events NNS I-NP O
A/P: NNP I-NP O
**CV:12 CD O O
years NNS B-NP O
post NN I-NP O
transplant NN I-NP O
, , O O
resume VB O O
meds NNS B-NP O
per IN B-VP O
transplant NN B-NP O
team NN I-NP O
*CAD: VBD B-VP O
1 CD O O
day NN B-NP O
post NN I-NP O
Cypher NNP I-NP O
DES NNP I-NP O
to TO O O
LAD VB O O
with IN B-VP O
significant JJ B-NP O
residual JJ I-NP O
disease NN I-NP O
, , O O
please VB O O
see VB O O
cath JJ B-NP O
report NN I-NP O
for IN B-VP O
full JJ B-NP O
details NNS I-NP O
Will MD O O
need VB O O
ASA NNP B-NP B-m
325 CD O B-do
daily JJ B-NP B-f
x NNP I-NP O
life NN I-NP O
, , O O
Plavix NNP B-NP B-m
75 CD O B-do
daily RB O B-f
for IN B-VP B-du
minimum NN B-NP I-du
of IN B-VP I-du
12 CD O I-du
months NNS B-NP I-du
and CC O O
should MD O O
continue VB O O
out RP O O
indef JJ B-NP O
Importance NN I-NP O
of IN B-VP O
both DT O O
stressed JJ O O
and CC O O
patient JJ B-NP O
understands! JJ I-NP O
SL NNP I-NP B-mo
TNG NNP I-NP B-m
prn NN I-NP B-f
chest NN I-NP B-r
pain NN I-NP O
AM NNP I-NP O
enzymes RB O O
pending VBG O O
*PUMP: NNP B-NP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
volume NN B-NP O
overload NN I-NP O
, , O O
CHF NNP B-NP O
*RHYTHM: NNP I-NP O
no DT B-NP O
palps NN I-NP O
, , O O
no DT B-NP O
tachy/brady JJ I-NP O
tele NN I-NP O
events NNS I-NP O
*HTN: VBP O O
BP NNP B-NP B-r
BP NNP I-NP B-r
well RB O O
controlled VBD B-VP O
HR NNP B-NP O
up RP O O
some DT O O
on IN B-VP O
Toprol NNP B-NP B-m
XL NNP I-NP I-m
50 CD O B-do
, , O O
lasix VBD B-VP B-m
40 CD O B-do
*LIPIDS: NN B-NP O
will MD O O
cont VB O O
pravachol NN B-NP B-m
40 CD O B-do
, , O O
tricor VBD B-VP B-m
48 CD O B-do
**PULM: JJ O O
no DT B-NP O
issues NNS I-NP O
**RENAL: VBP O O
baseline NN B-NP O
1.5 CD O O
- : O O
1.7 CD O O
, , O O
AM NNP B-NP O
pending VBG O O
encouraged VBD B-VP O
increased VBN O O
PO NNP B-NP O
intake NN I-NP O
over IN B-VP O
next JJ B-NP O
several JJ I-NP O
days NNS I-NP O
, , O O
if IN B-VP O
urine JJ B-NP O
output NN I-NP O
falls VBZ O O
she PRP O O
will MD O O
call VB O O
, , O O
she PRP O O
should MD O O
have VB O O
renal JJ B-NP O
fx NN I-NP O
rechecked VBD B-VP O
on IN B-VP O
monday NN B-NP O
with IN B-VP O
local JJ B-NP O
MD NNP I-NP O
**ENDO: NNP I-NP O
check VB O O
hgb NN B-NP O
a1c NN I-NP O
as IN B-VP O
outpt JJ B-NP O
cont NN I-NP O
insulin NN I-NP B-m
**DISPO: NNP I-NP O
stable JJ O O
and CC O O
ready JJ O O
for IN B-VP O
DC NNP B-NP O
this DT O O
am VBP O O
pending VBG O O
labs NN B-NP O
, , O O
attending VBG O O
eval JJ B-NP O
FU NNP I-NP O
with IN B-VP O
Transplant NNP B-NP O
team NN I-NP O
, , O O
they PRP O O
will MD O O
be VB O O
in IN B-VP O
contact JJ O O
regarding VBG O O
date NN B-NP O
of IN B-VP O
staged JJ B-NP O
PCI NNP I-NP O
to TO O O
LCx VB O O
To TO O O
call VB O O
with IN B-VP O
any DT B-NP O
concerns NNS I-NP O
All DT B-NP O
Questions NNS I-NP O
answered VBD B-VP O
Addendum: NNP B-NP O
renal JJ B-NP O
fx NN I-NP O
fine NN I-NP O
but CC O O
asxatic JJ B-NP O
MB NNP I-NP O
bump NN I-NP O
to TO O O
25 CD O O
, , O O
rechecking VBG O O
and CC O O
dc VB O O
if IN B-VP O
stable JJ O O
, , O O
keep VB O O
until IN B-VP O
tomorrow NN B-NP O
if IN B-VP O
up IN B-VP O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
-you NNP I-NP O
must MD O O
take VB O O
aspirin NN B-NP B-m
for IN B-VP B-du
life NN B-NP I-du
-you NN I-NP O
must MD O O
take VB O O
plavix NN B-NP B-m
for IN B-VP B-du
a DT B-NP I-du
minimum NN I-NP I-du
of IN B-VP I-du
1 CD O I-du
year- NNS B-NP I-du
DO NNP I-NP O
NOT NNP I-NP O
STOP NNP I-NP O
ASPIRIN NNP I-NP B-m
OR NNP I-NP O
PLAVIX NNP I-NP B-m
FOR NNP I-NP O
ANY NNP I-NP O
REASON NNP I-NP O
UNLESS NNP I-NP O
SPEAK NNP I-NP O
WITH NNP I-NP O
YOUR NNP I-NP O
CARDIOLOGIST NNP I-NP O
FIRST!!! NNP I-NP O
-resume NNP I-NP O
other JJ B-NP B-m
medications NNS I-NP I-m
at IN B-VP O
usual JJ B-NP O
doses NNS I-NP O
-you VBP O O
will MD O O
need VB O O
your PRP$ O O
kidney NN B-NP O
function NN I-NP O
test NN I-NP O
on IN B-VP O
monday NN B-NP O
10/23 CD O O
after IN B-VP O
receiving VBG O O
contrast- NN B-NP O
this DT O O
should MD O O
be VB O O
followed VBN O O
by IN B-VP O
heart NN B-NP O
transplant NN I-NP O
clinic JJ B-NP O
-drink NNP I-NP O
plenty NN I-NP O
of IN B-VP O
fluids NNS B-NP O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
, , O O
if IN B-VP O
your PRP$ O O
urine NN B-NP O
output NN I-NP O
falls VBZ O O
please VB O O
call VB O O
-you NNP B-NP O
will MD O O
need VB O O
to TO O O
return VB O O
for IN B-VP O
another DT B-NP O
intervention NN I-NP O
in IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
weeks- NN I-NP O
this DT O O
should MD O O
be VB O O
set VBN O O
up RP O O
through IN B-VP O
transplant NN B-NP O
clinic JJ B-NP O
-call NN I-NP O
with IN B-VP O
questions NNS B-NP O
or CC O O
concerns NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
DANES NNP I-NP O
, , O O
CRUZ NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
XO06 NNP B-NP O
) ) O O
6/21/07 CD O O
@ $ O O
09:39 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#71200 VBZ O O
051009128 CD O O
GRHC NNP B-NP O
36066753 CD O O
457914 CD O O
3/11/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
RT NNP I-NP O
LUNG NNP I-NP O
CARCINOMA NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/11/1999 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/29/1999 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Seventy-year-old NNP I-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
complex JJ I-NP O
past NN I-NP O
medical JJ B-NP O
history NN I-NP O
which WDT O O
includes VBZ O O
cerebrovascular JJ B-NP O
accident NN I-NP O
x NN I-NP O
two CD O O
in IN B-VP O
1980s CD O O
without IN B-VP O
deficits NNS B-NP O
, , O O
seizure NN B-NP O
history NN I-NP O
probably RB O O
secondary JJ O O
to TO O O
ETOH NNP B-NP O
withdrawal NN I-NP O
( ( O O
none NN B-NP O
since IN B-VP O
1993 CD O O
) ) O O
, , O O
hypertension NN B-NP O
x VBD B-VP O
30 CD O O
years NNS B-NP O
, , O O
asthma RB O O
, , O O
gout NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
repair NN I-NP O
of IN B-VP O
subclavian JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
in IN B-VP O
1993 CD O O
The DT B-NP O
patient NN I-NP O
presented VBD B-VP O
to TO O O
the DT B-NP O
Dagha NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
10/5 CD O O
with IN B-VP O
severe JJ B-NP O
chest NN I-NP O
pain NN I-NP O
The DT B-NP O
patient NN I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
but CC O O
chest JJS O O
x-ray JJ O O
showed VBD B-VP O
a DT B-NP O
right JJ I-NP O
lung NN I-NP O
mass NN I-NP O
A NNP I-NP O
chest NN I-NP O
CT NNP I-NP O
on IN B-VP O
9/21 CD O O
revealed VBD B-VP O
a DT O O
2.3 CD O O
x NN B-NP O
2.8 CD O O
cm NN B-NP O
lobulated VBD B-VP O
mass NN B-NP O
in IN B-VP O
the DT B-NP O
right NN I-NP O
lower JJR B-NP O
lobe NN I-NP O
involving VBG O O
the DT B-NP O
pleura NN I-NP O
There EX O O
were VBD B-VP O
extensive JJ B-NP O
hilar NN I-NP O
and CC O O
mediastinal JJ B-NP O
constitutions NNS I-NP O
consistent JJ O O
with IN B-VP O
prior JJ B-NP O
granulomatous JJ I-NP O
disease NN I-NP O
Tests NNS I-NP O
were VBD B-VP O
positive JJ O O
for IN B-VP O
multiple JJ O O
precarinal JJ O O
and CC O O
right JJ B-NP O
peritracheal NN I-NP O
areas NNS I-NP O
of IN B-VP O
adenopathy JJ O O
recent JJ O O
from IN B-VP O
metastatic JJ B-NP O
disease NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Cerebrovascular NNP I-NP O
accident NN I-NP O
x NN I-NP O
without IN B-VP O
versus NN B-NP O
reversal NN I-NP O
ischemic JJ B-NP O
neurological JJ I-NP O
deficits NNS I-NP O
in IN B-VP O
1987 CD O O
, , O O
history NN B-NP O
of IN B-VP O
ETOH NNP B-NP O
withdrawal NN I-NP O
, , O O
B12 NNP B-NP O
deficiency NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
gout NN B-NP O
, , O O
E NNP B-NP O
coli NNS I-NP O
, , O O
sepsis NN B-NP O
in IN B-VP O
1990 CD O O
, , O O
status NN B-NP O
post NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
( ( O O
per IN B-VP O
M.D NNP B-NP O
note NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
denies NNS I-NP O
) ) O O
, , O O
asthma JJ B-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Right NNP I-NP O
total JJ B-NP O
knee NN I-NP O
replacement NN I-NP O
in IN B-VP O
1982 CD O O
, , O O
innominate NN B-NP O
and CC O O
left VBD B-VP O
subclavian JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
- : O O
bypassed VBN O O
( ( O O
with IN B-VP O
re-op NN B-NP O
in IN B-VP O
1993 CD O O
) ) O O
, , O O
left VBD B-VP O
total JJ B-NP O
knee JJ I-NP O
replacement NN I-NP O
in IN B-VP O
1994 CD O O
, , O O
ovarian JJ B-NP O
cyst NN I-NP O
excision NN I-NP O
ALLERGIES: NNP I-NP O
Aspirin NNP I-NP O
causes VBZ O O
epistaxis FW O O
( ( O O
this DT O O
was VBD B-VP O
in IN B-VP O
combination NN B-NP O
with IN B-VP O
Motrin NNP B-NP O
) ) O O
MEDICATIONS: NNP B-NP O
Adalat NNP I-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Magnesium NNP B-NP B-m
Oxide NNP I-NP I-m
40 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Ultram NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Trazodone NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
q.h.s NN I-NP B-f
, , O O
Azmacort NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.r.n NN I-NP B-f
, , O O
aspirin RB O B-m
81 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Dyazide NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
nose JJ B-NP B-m
spray NN I-NP I-m
b.i.d NN I-NP B-f
, , O O
calcium NN B-NP B-m
chloride NN I-NP I-m
pills NNS I-NP I-m
q.d RB O B-f
, , O O
Colchicine NNP B-NP B-m
600 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
cyproheptadine VB O B-m
hydrochloride RB O I-m
4 CD O B-do
mg NNS B-NP I-do
b.i.d JJ B-NP B-f
q.h.s NN I-NP O
, , O O
anticholesterol NN B-NP B-m
med VBD B-VP I-m
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Clinic NNP I-NP O
- : O O
Blood NN B-NP O
pressure NN I-NP O
146/78 CD O O
, , O O
pulse RB O O
76 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
16 CD O O
In IN B-VP O
general JJ O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Normocephalic NNP I-NP O
, , O O
atraumatic VBZ O O
The DT B-NP O
patient's JJ I-NP O
emotions NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
Heart NNP I-NP O
in IN B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
gallops NNS B-NP O
or CC O O
rubs VB O O
Lungs NNS B-NP O
had VBD B-VP O
fine JJ B-NP O
crackles NNS I-NP O
posterior RB O O
chest VBP O O
The DT B-NP O
bases NNS I-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
obese JJ O O
, , O O
soft JJ O O
, , O O
non-tender JJ O O
without IN B-VP O
hepatosplenomegaly JJ B-NP O
No NNP I-NP O
costovertebral JJ O O
angle RB O O
tenderness JJ B-NP O
Extremities NNS I-NP O
were VBD B-VP O
without IN B-VP O
clubbing VBG O O
, , O O
cyanosis NN B-NP O
or CC O O
edema VB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
x NNP B-NP O
three CD O O
Non-focal JJ B-NP O
Speech NNP I-NP O
was VBD B-VP O
fluent JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
White NNP I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
9.03 CD O O
, , O O
hematocrit NN B-NP O
38.2 CD O O
, , O O
platelets NNS B-NP O
215 CD O O
Coagulation NNP B-NP O
status NN I-NP O
was VBD B-VP O
normal JJ O O
with IN B-VP O
INR NNP B-NP O
of IN B-VP O
1.2 CD O O
Sodium NNP B-NP O
of IN B-VP O
41 CD O O
, , O O
potassium NN B-NP O
3.8 CD O O
, , O O
BUN/creatinine NNP B-NP O
16/0.8 CD O O
, , O O
glucose VBD B-VP O
126 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
admitted VBD B-VP O
to TO O O
the DT B-NP O
Thoracic NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
on IN B-VP O
3/27/99 CD O O
and CC O O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
for IN B-VP O
a DT B-NP O
video NN I-NP O
assisted VBN O O
thorascopic RB O O
right JJ B-NP O
lower JJR I-NP O
lobe NN I-NP O
lobectomy NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Minick NNP I-NP O
The DT B-NP O
procedure NN I-NP O
went VBD B-VP O
without IN B-VP O
complications NNS B-NP O
Postoperatively RB O O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
The DT B-NP O
chest JJS I-NP O
tube NN I-NP O
that WDT O O
was VBD B-VP O
placed VBN O O
intraoperatively RB O O
did VBD B-VP O
not RB O O
have VB O O
a DT B-NP O
leak NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
followed VBN O O
by IN B-VP O
the DT B-NP O
Internal NNP I-NP O
Medicine NNP I-NP O
Service NNP I-NP O
The DT O O
patient JJ O O
went VBD B-VP O
into IN B-VP O
rapid JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
postoperatively RB O O
She PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP O
rule NN I-NP O
out IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
and CC O O
seen VBN O O
by IN B-VP O
the DT B-NP O
Cardiology NNP I-NP O
Service NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
successfully RB O O
converted VBN O O
into IN B-VP O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
using VBG O O
Diltiazem NNP B-NP B-m
IV NNP I-NP B-mo
This DT O O
was VBD B-VP O
converted VBN O O
to TO O O
p.o VB O B-mo
Diltiazem NNP B-NP B-m
The DT B-NP O
patient's JJ I-NP O
postoperative JJ I-NP O
course NN I-NP O
was VBD B-VP O
largely RB O O
unremarkable JJ O O
but CC O O
for IN B-VP O
dysrhythmia NN B-NP O
She PRP O O
was VBD B-VP O
on IN B-VP O
no DT B-NP O
antibiotics NNS I-NP O
She PRP O O
required VBD B-VP O
diuresis NN B-NP O
with IN B-VP O
Lasix NNP B-NP B-m
40 CD O B-do
q.d NN B-NP B-f
for IN B-VP O
home NN B-NP O
The DT B-NP B-r
patient's NN I-NP B-r
patient's NN I-NP I-r
pain NN I-NP I-r
pain NN I-NP I-r
was VBD B-VP O
well RB O O
controlled VBN O O
with IN B-VP O
p.o NN B-NP B-mo
pain NN I-NP B-m
medications NNS I-NP I-m
, , O O
Percocet NNP B-NP B-m
Final NNP I-NP O
pathology NN I-NP O
was VBD B-VP O
read VBN O O
as IN B-VP O
squamous JJ B-NP O
cell NN I-NP O
carcinoma NN I-NP O
, , O O
4.0 CD O O
cm NN B-NP O
, , O O
moderately RB O O
differentiated VBN O O
with IN B-VP O
focal JJ B-NP O
characterization NN I-NP O
with IN B-VP O
extensive JJ B-NP O
necrosis NN I-NP O
No NNP I-NP O
lymphatic NN I-NP O
or CC O O
vascularization NN B-NP O
was VBD B-VP O
identified VBN O O
Tumor NNP B-NP O
abuts NNS I-NP O
but CC O O
did VBD B-VP O
not RB O O
invade VB O O
the DT B-NP O
pleura NN I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
FOLLOW-UP: NNP B-NP O
With IN B-VP O
Thoracic NNP B-NP O
Surgery NNP I-NP O
Service NNP I-NP O
as IN B-VP O
has VBZ O O
been VBN O O
arranged VBN O O
as RB O O
well RB O O
as IN B-VP O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
and CC O O
Cardiology NNP B-NP O
as IN B-VP O
needed VBN O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
Albuterol NNP I-NP B-m
nebulizers VBZ O I-m
250 CD O B-do
mg NN B-NP I-do
q.4h NN I-NP B-f
, , O O
Allopurinol NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Colchicine NNP B-NP B-m
0.6 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
cyproheptadine NN B-NP B-m
hydrochloride NN I-NP I-m
by IN B-VP B-mo
mouth NN B-NP I-mo
400 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Digoxin NNP B-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Diltiazem NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Percocet NNP B-NP B-m
1-2 JJ B-NP B-do
tablets NNS I-NP I-do
p.o VBP O B-mo
q.4h JJ B-NP B-f
p.r.n NN I-NP I-f
, , O O
Dilantin NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Trazodone NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
SQUAMOUS NNP I-NP O
CELL NNP I-NP O
CARCINOMA NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
LUNG NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
Attending: NNP I-NP O
EFREN NNP I-NP O
B NNP I-NP O
MUSHETT NNP I-NP O
, , O O
M.D NNP B-NP O
OH8 NNP I-NP O
LW748/7644 NNP I-NP O
Batch: NNP I-NP O
21957 CD O O
Index NNP B-NP O
No NNP I-NP O
F8XZ8FXAE5 NNP I-NP O
D: NNP I-NP O
3/7/99 CD O O
T: NNP B-NP O
7/14/99 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#72791 VBZ O O
447546077 CD O O
OH NNP B-NP O
06972217 CD O O
7590252 CD O O
4/21/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHRONIC NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
, , O O
PNEUMONIA NNP B-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/7/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/16/2005 CD O O
ATTENDING: NNP B-NP O
LEIFER NNP I-NP O
, , O O
JEFFEREY NNP B-NP O
GRAHAM NNP I-NP O
MD NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSES: NNP I-NP O
Endocarditis NNP I-NP O
, , O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
Mitral NNP I-NP O
regurgitation NN I-NP O
, , O O
diabetes VBZ O O
, , O O
hypertension NN B-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
recurrent NN B-NP O
UTIs NNP I-NP O
, , O O
uterine JJ B-NP O
prolapse NN I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
hiatal JJ B-NP O
hernia NN I-NP O
, , O O
right JJ B-NP O
breast NN I-NP O
nodule JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
76-year-old JJ O O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
severe JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
60% CD O O
in IN B-VP O
7/24 CD O O
, , O O
chronic JJ B-NP O
abdominal JJ I-NP O
discomfort NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
recurrent NN B-NP O
UTIs NNP I-NP O
, , O O
and CC O O
uterine JJ B-NP O
prolapse NN I-NP O
, , O O
who WP O O
one CD O O
week NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
developed NNS I-NP O
increased VBD B-VP O
nausea NN B-NP O
, , O O
decreased VBN O O
appetite NN B-NP O
, , O O
weakness NN B-NP O
, , O O
fatigue NN B-NP O
and CC O O
increased VBD B-VP O
low JJ O O
back RB O O
pain NN B-NP O
No NNP I-NP O
vomiting NN I-NP O
, , O O
diarrhea NN B-NP O
, , O O
cough NN B-NP O
, , O O
or CC O O
dysuria NNS B-NP O
On IN B-VP O
presentation NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
hypotensive JJ O O
, , O O
in IN B-VP O
septic JJ B-NP O
shock NN I-NP O
, , O O
with IN B-VP O
bacteremia NN B-NP O
in IN B-VP O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
and CC O O
admitted VBN O O
to TO O O
the DT B-NP O
Medical NNP I-NP O
ICU NNP I-NP O
for IN B-VP O
pressure NN B-NP O
support NN I-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
heart NN B-NP O
rate NN I-NP O
of IN B-VP O
94 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
of IN B-VP O
80-90/50 JJ B-NP O
Notable NNP I-NP O
for IN B-VP O
heart NN B-NP O
exam NN I-NP O
with IN B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
with IN B-VP O
3/6 CD O O
systolic JJ B-NP O
crescendo NN I-NP O
murmur NN I-NP O
and CC O O
decrescendo NN B-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
radiating VBG O O
to TO O O
the DT B-NP O
clavicles NNS I-NP O
and CC O O
carotids NNS B-NP O
, , O O
and CC O O
3/6 CD O O
holosystolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
apex NN I-NP O
radiating VBG O O
to TO O O
the DT B-NP O
axilla NN I-NP O
, , O O
and CC O O
an DT B-NP O
apical JJ I-NP O
heave NN I-NP O
JVP NNP I-NP O
flat JJ B-NP O
Chest NNP I-NP O
with IN B-VP O
crackles NNS B-NP O
in IN B-VP O
the DT B-NP O
right NN I-NP O
middle NN I-NP O
lung NN I-NP O
fields NNS I-NP O
and CC O O
leg VB O O
basilar JJ B-NP O
crackles NNS I-NP O
Abdominal NNP I-NP O
exam NN I-NP O
was VBD B-VP O
benign JJ B-NP O
Guaiac NNP I-NP O
negative JJ B-NP O
Extremities NNS I-NP O
with IN B-VP O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
, , O O
or CC O O
edema NN B-NP O
and CC O O
1+ CD O O
dorsalis NNS B-NP O
pedis JJ B-NP O
pulses NNS I-NP O
bilaterally RB O O
RELEVANT NNP B-NP O
STUDIES NNP I-NP O
AND NNP I-NP O
TESTS: NNP I-NP O
Blood NNP I-NP O
culture NN I-NP O
on IN B-VP O
9/10 CD O O
Streptococcus NNP B-NP O
viridans NNS I-NP O
, , O O
levofloxacin RB O O
sensitive JJ O O
, , O O
penicillin JJ B-NP O
MIC NNP I-NP O
0.19 CD O O
Urine NNP B-NP O
culture NN I-NP O
on IN B-VP O
9/10 CD O O
Greater NNP B-NP O
than IN B-VP O
100 CD O O
, , O O
000 CD O O
Klebsiella NNP B-NP O
pneumoniae NN I-NP O
, , O O
ampicillin NN B-NP O
resistant NN I-NP O
, , O O
gentamicin NN B-NP O
sensitive JJ O O
, , O O
and CC O O
levofloxacin RB O O
sensitive JJ B-NP O
TEE NNP I-NP O
on IN B-VP O
0/14 CD O O
Severe JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
, , O O
posterior JJ B-NP O
leaflet NN I-NP O
with IN B-VP O
mitral JJ B-NP O
calcifications NNS I-NP O
and CC O O
linear JJ B-NP O
density NN I-NP O
concerning VBG O O
for IN B-VP O
endocarditis NN B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
IMPRESSION: NNP I-NP O
A NNP I-NP O
76-year-old JJ B-NP O
female NN I-NP O
with IN B-VP O
mitral JJ B-NP O
regurgitation NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
CHF NNP B-NP O
, , O O
history NN B-NP O
of IN B-VP O
recurrent NN B-NP O
UTI NNP I-NP O
, , O O
who WP O O
presented VBD B-VP O
with IN B-VP O
nausea NN B-NP O
and CC O O
chills NNS B-NP O
, , O O
had VBD B-VP O
hypotension NN B-NP O
requiring VBG O O
a DT B-NP O
medical JJ I-NP O
ICU NNP I-NP O
stay NN I-NP O
x RB O O
2 CD O O
days NNS B-NP O
, , O O
with IN B-VP O
Streptococcus NNP B-NP O
viridans NNS I-NP O
bacteremia NN I-NP O
and CC O O
mitral JJ B-NP O
calcifications NNS I-NP O
in IN B-VP O
linear JJ B-NP O
density NN I-NP O
concerning VBG O O
for IN B-VP O
endocarditis NN B-NP O
plus CC O O
Klebsiella NNP B-NP O
UTI NNP I-NP O
1 CD O O
Infectious NNP B-NP O
disease: VBD B-VP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
chills NNS B-NP O
and CC O O
hypotension NN B-NP O
and CC O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
MICU NNP I-NP O
from IN B-VP O
the DT B-NP O
ED NNP I-NP O
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
septic JJ B-NP O
shock NN I-NP O
Her PRP$ O O
mean JJ B-NP B-r
arterial JJ I-NP I-r
pressures NNS I-NP I-r
were VBD B-VP O
kept VBN O O
above IN B-VP O
65 CD O O
with IN B-VP O
Levophed NNP B-NP B-m
She PRP O O
initially RB O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
levofloxacin JJ B-NP B-m
levofloxacin NN I-NP B-m
and CC O O
vancomycin NN B-NP B-m
vancomycin NN I-NP B-m
to TO O O
treat VB O O
Gram-positive JJ B-NP B-r
Gram-positive JJ I-NP B-r
cocci NN I-NP O
bacteremia NN I-NP O
and CC O O
UTI NNP B-NP B-r
UTI NNP I-NP B-r
Blood NNP I-NP O
culture NN I-NP O
from IN B-VP O
10/22 CD O O
, , O O
grew VBD B-VP O
out RP O O
Streptococcus NNP B-NP O
viridans NNS I-NP O
, , O O
levofloxacin RB O O
sensitive JJ O O
, , O O
penicillin JJ B-NP O
MIC NNP I-NP O
0.19 CD O O
Urine NNP B-NP O
culture NN I-NP O
was VBD B-VP O
positive JJ O O
for IN B-VP O
Klebsiella NNP B-NP O
, , O O
ampicillin NN B-NP O
resistant NN I-NP O
, , O O
gentamicin NN B-NP O
and CC O O
levofloxacin JJ O O
sensitive JJ O O
On IN B-VP O
3/18 CD O O
, , O O
antibiotics NNS B-NP B-m
were VBD B-VP O
changed VBN O O
to TO O O
penicillin VB O B-m
3 CD O B-do
million CD O I-do
units NNS B-NP I-do
IV NNP I-NP B-mo
q.4h NN I-NP B-f
and CC O O
gentamicin $ O B-m
50 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
q.8h NNP I-NP B-f
ATEE NNP I-NP O
on IN B-VP O
10/19 CD O O
showed VBD B-VP O
severe JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
with IN B-VP O
posterior JJ B-NP O
leaflet NN I-NP O
calcifications NNS I-NP O
and CC O O
linear JJ B-NP O
density NN I-NP O
concerning VBG O O
for IN B-VP O
endocarditis NN B-NP O
Therefore NNP I-NP O
, , O O
a DT B-NP O
PICC NNP I-NP O
line NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
1/19 CD O O
for IN B-VP O
continuation NN B-NP O
of IN B-VP O
a DT B-NP O
six-week JJ I-NP O
course NN I-NP O
of IN B-VP O
penicillin $ O B-m
3 CD O B-do
million CD O I-do
units NNS B-NP I-do
IV NNP I-NP B-mo
q.4h NN I-NP B-f
until IN B-VP O
0/12 CD O O
and CC O O
two-week JJ B-NP O
course NN I-NP O
of IN B-VP O
gentamicin JJ O B-m
50 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
q.8h NN I-NP B-f
until IN B-VP O
2/25 CD O O
She PRP O O
will MD O O
follow VB O O
up RP O O
in IN B-VP O
the DT B-NP O
Infectious JJ I-NP O
Disease NNP I-NP O
Clinic NNP I-NP O
with IN B-VP O
Dr NNP B-NP O
Ramiro NNP I-NP O
Halcom NNP I-NP O
on IN B-VP O
0/9/05 CD O O
at IN B-VP O
8 CD O O
a.m JJ O O
2 CD O O
Cardiovascular: NNP B-NP O
Ischemia: NNP I-NP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
aspirin NN B-NP B-m
Lipitor NNP I-NP B-m
was VBD B-VP O
initially RB O O
helped VBN O O
for IN B-VP O
an DT B-NP B-r
initial JJ I-NP O
transaminitis NN I-NP O
presumed VBD B-VP O
to TO O O
be VB O O
secondary JJ O O
to TO O O
shock VB O O
liver NN B-NP O
, , O O
that WDT O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
her PRP$ O O
liver NN B-NP O
enzymes NNS I-NP O
had VBD B-VP O
normalized VBN O O
and CC O O
she PRP O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
her PRP$ O O
Lipitor NNP B-NP B-m
Pump: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
60% CD O O
in IN B-VP O
7/24 CD O O
She PRP O O
had VBD B-VP B-r
hypotension NN B-NP O
, , O O
requiring VBG O B-m
Levophed VBN O B-du
until IN B-VP I-du
11/0 CD O O
She PRP O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
flash JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
on IN B-VP O
11/9 CD O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
fluid JJ B-NP O
bolus NN I-NP O
and CC O O
one CD O B-do
unit NN B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
She PRP O O
has VBZ O O
a DT O O
very RB O O
attenuatus JJ B-NP O
balance NN I-NP O
between IN B-VP O
preload NN B-NP O
dependence NN I-NP O
and CC O O
overload NN B-NP O
Her NNP I-NP O
Lasix NNP I-NP B-m
and CC O O
ACE-I NNP B-NP B-m
were VBD B-VP O
held VBN O O
while IN B-VP O
she PRP O O
was VBD B-VP O
hypotensive JJ O O
Because IN B-VP O
her PRP$ O O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
continued VBD B-VP O
to TO O O
be VB O O
low JJ O O
in IN B-VP O
the DT O O
90s CD O O
and CC O O
low JJ O O
100s CD O O
, , O O
attempt NN B-NP O
was VBD B-VP O
not RB O O
made VBN O O
to TO O O
re-add VB O O
the DT B-NP O
ACE NNP I-NP B-m
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
It PRP O O
is VBZ O O
anticipated JJ O O
that IN B-VP O
her PRP$ O O
cardiologist NN B-NP O
and CC O O
outpatient JJ B-NP O
physicians NNS I-NP O
will MD O O
attempt VB O O
to TO O O
add VB O O
the DT B-NP O
ACE NNP I-NP B-m
back RB O O
onto IN B-VP O
her PRP$ O O
medical JJ B-NP O
regimen NN I-NP O
for IN B-VP O
better JJR B-NP B-r
afterload NN I-NP I-r
reduction NN I-NP I-r
as IN B-VP O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
tolerates VBZ O O
The DT B-NP O
patient NN I-NP O
also RB O O
has VBZ O O
a DT O B-r
very RB O O
severe JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
, , O O
which WDT O O
would MD O O
be VB O O
one CD O O
of IN B-VP O
the DT B-NP O
reasons NNS I-NP O
that IN B-VP O
an DT B-NP O
ACE NNP I-NP B-m
on IN B-VP O
her PRP$ O B-m
medication NN B-NP I-m
regimen NNS I-NP O
would MD O O
be VB O O
beneficial JJ B-NP O
Rhythm: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
telemetry NN B-NP O
, , O O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
with IN B-VP O
ectopy NN B-NP O
, , O O
including VBG O O
short JJ O O
once RB O O
of IN B-VP O
nonsustained VBN O B-r
nonsustained JJ B-NP B-r
ventricular JJ I-NP O
tachycardia NN I-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Lopressor NNP B-NP B-m
Lopressor NNP I-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
on IN B-VP O
3/18 CD O O
, , O O
and CC O O
this DT O O
was VBD B-VP O
increased VBN O O
to TO O O
25 CD O B-do
mg NNS B-NP I-do
b.i.d NN I-NP B-f
at IN B-VP O
discharge NN B-NP O
, , O O
with IN B-VP O
her PRP$ O O
heart NN B-NP O
rates NNS I-NP O
continuing VBG O O
to TO O O
be VB O O
between IN B-VP O
the DT O O
70s CD O O
and CC O O
the DT O O
90s CD O O
, , O O
however RB O O
, , O O
with IN B-VP O
less JJR B-NP O
episodes NNS I-NP O
of IN B-VP O
ectopy NN B-NP O
Her PRP$ O O
electrolytes NNS B-NP O
were VBD B-VP O
also RB O O
well RB O O
repleted VBD B-VP O
3 CD O O
Gastrointestinal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
evidence NN B-NP O
of IN B-VP O
shock NN B-NP O
liver NN I-NP O
( ( O O
0/24 CD O O
with IN B-VP O
an DT B-NP O
ALT NNP I-NP O
of IN B-VP O
135 CD O O
, , O O
AST NNP B-NP O
of IN B-VP O
177 CD O O
, , O O
alkaline JJ B-NP O
phosphatase NN I-NP O
of IN B-VP O
251 CD O O
, , O O
and CC O O
T NNP B-NP O
bili NN I-NP O
of IN B-VP O
1.7 CD O O
) ) O O
that WDT O O
is VBZ O O
now RB O O
resolving VBG O O
Lipitor NNP B-NP B-m
was VBD B-VP O
held VBN O O
, , O O
and CC O O
was VBD B-VP O
started VBN O O
as IN B-VP O
a DT B-NP O
transaminitis NN I-NP O
resolved VBN O O
Non-contrast NNP B-NP O
CT NNP I-NP O
of IN B-VP O
the DT B-NP O
abdomen NNS I-NP O
showed VBD B-VP O
biliary JJ B-NP O
sludge NN I-NP O
and CC O O
gallstones NNS B-NP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
acute JJ B-NP O
cholecystitis NN I-NP O
Right NNP I-NP O
upper NN I-NP O
quadrant NN I-NP O
ultrasound NN I-NP O
confirmed VBD B-VP O
the DT B-NP O
CT NNP I-NP O
findings NNS I-NP O
Colon NNP I-NP O
cancer NN I-NP O
is VBZ O O
a DT B-NP O
concern NN I-NP O
with IN B-VP O
the DT B-NP O
patient's NN I-NP O
anemia NN I-NP O
being VBG O O
new JJ O O
since IN B-VP O
0/29 CD O O
Her NNP B-NP O
last JJ B-NP O
colonoscopy NN I-NP O
was VBD B-VP O
in IN B-VP O
2000 CD O O
, , O O
and CC O O
she PRP O O
will MD O O
benefit VB O O
from IN B-VP O
repeat NN B-NP O
colonoscopy NN I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Nexium NNP B-NP B-m
for IN B-VP O
prophylaxis NN B-NP B-r
Heme: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
guaiac JJ B-NP O
positive JJ I-NP O
stools NNS I-NP O
in IN B-VP O
the DT B-NP O
medical JJ I-NP O
ICU NNP I-NP O
, , O O
her PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
stable JJ O O
around IN B-VP O
33% CD O O
She PRP O O
has VBZ O O
a DT B-NP O
microcytic JJ I-NP O
anemia NN I-NP O
with IN B-VP O
an DT B-NP O
MCV NNP I-NP O
of IN B-VP O
79 CD O O
, , O O
her PRP$ O O
iron NN B-NP O
studies NNS I-NP O
( ( O O
iron NN B-NP O
of IN B-VP O
10 CD O O
, , O O
TIBC NNP B-NP O
of IN B-VP O
191 CD O O
, , O O
ferritin NN B-NP O
is VBZ O O
744 CD O O
) ) O O
suggesting VBG O O
anemia NN B-NP O
of IN B-VP O
chronic JJ B-NP O
disease NN I-NP O
with IN B-VP O
possibly RB O O
overlying VBG O O
iron NN B-NP O
deficiency NN I-NP O
4 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
random NN I-NP O
cortisol JJ B-NP O
level NN I-NP O
of IN B-VP O
35.3 CD O O
She PRP O O
had VBD B-VP O
an DT B-NP O
uncertain JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
and CC O O
was VBD B-VP O
on IN B-VP O
the DT B-NP O
Portland NNP I-NP O
protocol NN I-NP O
in IN B-VP O
the DT B-NP O
medical JJ I-NP O
ICU NNP I-NP O
Hemoglobin NNP I-NP O
A1c NNP I-NP O
, , O O
however RB O O
, , O O
was VBD B-VP O
6.5 CD O O
Therefore RB O O
, , O O
she PRP O O
was VBD B-VP O
maintained VBN O O
thereafter RB O O
only RB O O
on IN B-VP O
insulin NN B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
and CC O O
rarely RB O O
required JJ O O
any DT B-NP O
coverage NN I-NP O
5 CD O O
Prophylaxis: NNP B-NP B-r
Prophylaxis: NNP I-NP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
kept VBN O O
on IN B-VP O
Lovenox NNP B-NP B-m
and CC O O
Protonix NNP B-NP B-m
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Aspirin NNP I-NP B-m
81 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
iron NN B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
gentamicin JJ B-NP B-m
sulfate NN I-NP I-m
50 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
q.8h NN I-NP B-f
until IN B-VP B-du
2/25 CD O O
for IN B-VP O
a DT B-NP O
two-week JJ I-NP O
course NN I-NP O
, , O O
penicillin JJ B-NP B-m
G NNP I-NP I-m
potassium NN I-NP I-m
3 CD O B-do
million CD O I-do
units NNS B-NP I-do
IV NNP I-NP B-mo
q.4h NN I-NP B-f
until IN B-VP B-du
0/12 CD O I-du
for IN B-VP I-du
a DT B-NP I-du
six-week JJ I-NP I-du
course NN I-NP I-du
, , O O
Lopressor NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Caltrate NNP B-NP B-m
plus CC O I-m
D2 NNP B-NP I-m
tablets NNS I-NP I-m
p.o VBP O B-mo
daily RB O B-f
, , O O
Lipitor NNP B-NP B-m
10 CD O B-do
mg JJ O I-do
daily JJ O B-f
, , O O
and CC O O
Protonix NNP B-NP B-m
40 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
The DT B-NP O
patient NN I-NP O
has VBZ O O
not RB O O
been VBN O O
restarted VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
Lasix NNP I-NP O
and CC O O
lisinopril JJ O O
secondary JJ O O
to TO O O
persistently RB O O
low JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
between IN B-VP O
the DT O O
90s CD O O
and CC O O
100s CD O O
It PRP O O
is VBZ O O
anticipated VBN O O
that IN B-VP O
especially RB O O
her PRP$ O O
Lisinopril NNP B-NP B-m
and CC O O
her PRP$ O O
Lasix NNP B-NP B-m
will MD O O
be VB O O
added VBN O O
back RB O O
on IN B-VP O
to TO O O
her PRP$ O O
medical JJ B-NP O
regimen NN I-NP O
as IN B-VP O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
tolerates VBZ O O
Given VBN O O
that IN B-VP O
she PRP O O
was VBD B-VP O
no RB O O
longer JJR O O
on IN B-VP O
Lasix NNP B-NP B-m
, , O O
she PRP O O
was VBD B-VP O
also RB O O
taken VBN O O
potassium NN B-NP B-m
chloride NN I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
to TO O O
rehabilitation NN B-NP O
at IN B-VP O
Acanmingpeerra NNP B-NP O
Virg NNP I-NP O
Tantblu NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
in IN B-VP O
order NN B-NP O
to TO O O
be VB O O
able JJ O O
to TO O O
get VB O O
her PRP$ O O
antibiotic JJ B-NP B-m
therapy NN I-NP O
She PRP O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
stable JJ B-NP O
condition NN I-NP O
PHYSICIANS NNP I-NP O
FOLLOW-UP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
following VBG O O
follow-up JJ O O
appointments: JJ O O
1 CD O O
Stress NNP B-NP O
test NN I-NP O
in IN B-VP O
7/27/05 CD O O
at IN B-VP O
3 CD O O
p.m RB O O
2 CD O O
Dr NNP B-NP O
Gale NNP I-NP O
Montante NNP I-NP O
( ( O O
general JJ B-NP O
cardiology NN I-NP O
) ) O O
on IN B-VP O
11/13/05 CD O O
at IN B-VP O
10 CD O O
a.m JJ O O
3 CD O O
Dr NNP B-NP O
Ed NNP I-NP O
Storti NNP I-NP O
3/15/05 CD O O
at IN B-VP O
12 CD O O
p.m RB O O
4 CD O O
Dr NNP B-NP O
Stacey NNP I-NP O
Koers NNP I-NP O
( ( O O
infectious JJ B-NP O
disease NN I-NP O
) ) O O
0/9/05 CD O O
at IN B-VP O
8 CD O O
a.m IN B-VP O
The DT B-NP O
patient NN I-NP O
will MD O O
follow VB O O
up RP O O
regarding VBG O O
the DT B-NP O
success NN I-NP O
of IN B-VP O
her PRP$ O O
antibiotic JJ B-NP B-m
therapy NN I-NP O
It PRP O O
is VBZ O O
also RB O O
anticipated JJ O O
that IN B-VP O
her PRP$ O O
cardiologist NN B-NP O
will MD O O
re-add VB O O
back RB O O
on IN B-VP O
her PRP$ O O
ACE NNP B-NP B-m
for IN B-VP O
better JJR B-NP B-r
better JJR I-NP B-r
afterload NN I-NP I-r
afterload NN I-NP I-r
reduction NN I-NP I-r
reduction NN I-NP I-r
as IN B-VP O
her PRP$ O O
blood NN B-NP O
pressures NNS I-NP O
tolerates VBZ O O
, , O O
and CC O O
potentially RB O O
we PRP O O
will MD O O
add VB O O
her PRP$ O O
back NN B-NP O
on IN B-VP O
to TO O O
the DT B-NP O
Lasix NNP I-NP B-m
as IN B-VP O
well RB O O
She PRP O O
will MD O O
require VB O O
weekly JJ B-NP O
lab NN I-NP O
draws NN I-NP O
to TO O O
check VB O O
her PRP$ O O
electrolytes NNS B-NP O
and CC O O
CBC NNP B-NP O
while IN B-VP O
she PRP O O
is VBZ O O
on IN B-VP O
the DT B-NP O
antibiotics NNS I-NP B-m
CONSULTANTS: NNP I-NP O
Infectious NNP I-NP O
disease NN I-NP O
, , O O
Dr NNP B-NP O
Rupert NNP I-NP O
Zenon NNP I-NP O
, , O O
pager NN B-NP O
number NN I-NP O
25215 CD O O
PRIMARY NNP B-NP O
CARE NNP I-NP O
PHYSICIAN: NNP I-NP O
Dr NNP I-NP O
Abel NNP I-NP O
Guignard NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
full JJ B-NP O
code NN I-NP O
Her PRP$ O O
family NN B-NP O
is VBZ O O
aware JJ O O
of IN B-VP O
the DT B-NP O
situation NN I-NP O
eScription NN I-NP O
document: IN B-VP O
9-5297905 CD O O
CSSten NNP B-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Xavier NNP I-NP O
Tapaha NNP I-NP O
M.D NNP I-NP O
BEAUKO NNP I-NP O
, , O O
Tanro NNP B-NP O
Hospital NNP I-NP O
Center NNP I-NP O
Bercop NNP I-NP O
Blvd NNP I-NP O
, , O O
Ca NNP B-NP O
, , O O
Texas NNP B-NP O
46829 CD O O
CC: NNP B-NP O
Moses NNP I-NP O
Ludtke NNP I-NP O
Hamnoy NNP I-NP O
Iclare NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Leahlit NNP I-NP O
CC: NNP I-NP O
Bob NNP I-NP O
Penland NNP I-NP O
MD NNP I-NP O
S NNP I-NP O
Ra NNP I-NP O
Clevecra NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BENAGE NNP I-NP O
, , O O
SONNY NNP B-NP O
WES NNP I-NP O
KEVIN NNP I-NP O
Attending: NNP I-NP O
JOO NNP I-NP O
, , O O
LUCAS NNP B-NP O
LINCOLN NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6496241 CD O O
D: NNP B-NP O
8/24/05 CD O O
T: NNP B-NP O
7/0/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#73301 VBZ O O
108580724 CD O O
MSH NNP B-NP O
40855000 CD O O
3134917 CD O O
5/15/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
SEPSIS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/22/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/28/2006 CD O O
ATTENDING: NNP B-NP O
TAJIMA NNP I-NP O
, , O O
BURT NNP B-NP O
MD NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Urosepsis NNP I-NP O
LIST NNP I-NP O
OF NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
Urosepsis NNP B-NP O
2 CD O O
Hypoxic NNP B-NP O
respiratory NN I-NP O
failure NN I-NP O
3 CD O O
Pneumonia NNP B-NP O
4 CD O O
Aspiration NNP B-NP O
5 CD O O
Pulmonary NNP B-NP O
embolism NN I-NP O
6 CD O O
Diabetes VBZ O O
7 CD O O
Obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
8 CD O O
Spinal JJ B-NP O
sarcoidosis NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
66-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
spinal JJ B-NP O
sarcoidosis NN I-NP O
with IN B-VP O
secondary JJ B-NP O
paraplegia NNS I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
altered JJ B-NP O
mental JJ I-NP O
status NN I-NP O
, , O O
hypoxemic JJ B-NP O
respiratory NN I-NP O
failure NN I-NP O
and CC O O
hypotension NN B-NP O
He PRP O O
was VBD B-VP O
doing VBG O O
well RB O O
until IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
1/22/2006 CD O O
when WRB O O
he PRP O O
complained VBD B-VP O
of IN B-VP O
difficulty NN B-NP O
breathing NN I-NP O
and CC O O
his PRP$ O O
wife NN B-NP O
placed VBD B-VP O
him PRP O O
on IN B-VP O
home NN B-NP O
CPAP NNP I-NP O
machine NN I-NP O
that IN B-VP O
he PRP O O
usually RB O O
uses VBZ O O
at IN B-VP O
night NN B-NP O
Despite IN B-VP O
being VBG O O
placed VBN O O
on IN B-VP O
the DT B-NP O
machine NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
still RB O O
having VBG O O
air NN B-NP O
hunger NN I-NP O
and CC O O
complaining NN B-NP O
of IN B-VP O
feeling VBG O O
unwell IN B-VP O
His PRP$ O O
wife NN B-NP O
also RB O O
noted VBD B-VP O
him PRP O O
to TO O O
have VB O O
increasing VBG O O
lethargy JJ O O
and CC O O
decreased JJ B-NP O
responsiveness NN I-NP O
and CC O O
called VBD B-VP O
EMS NNP B-NP O
to TO O O
have VB O O
him PRP O O
brought VBN O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
He PRP O O
also RB O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
decreased JJ I-NP O
urine NN I-NP O
output NN I-NP O
from IN B-VP O
his PRP$ O O
chronic JJ B-NP O
suprapubic JJ I-NP O
catheter NN I-NP O
x2 NNP I-NP O
days NNS I-NP O
In IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
unresponsive JJ O O
, , O O
grunting NN B-NP O
, , O O
and CC O O
in IN B-VP O
respiratory NN B-NP O
distress NN I-NP O
His PRP$ O O
initial JJ B-NP O
room NN I-NP O
air NN I-NP O
saturation NN I-NP O
was VBD B-VP O
in IN B-VP O
the DT O O
high JJ O O
60's CD O O
to TO O O
low VB O O
70's CD O O
He PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
100% CD O O
nonrebreather NN B-NP O
with IN B-VP O
some DT B-NP O
improvement NN I-NP O
of IN B-VP O
his PRP$ O O
saturations NNS B-NP O
in IN B-VP O
the DT O O
low JJ O O
90's CD O O
and CC O O
an DT B-NP O
ABG NNP I-NP O
of IN B-VP O
7.37/43/77 CD O O
on IN B-VP O
100% CD O O
nonrebreather CC O O
He PRP O O
was VBD B-VP O
therefore RB O O
intubated VBN O O
for IN B-VP O
hypoxic JJ B-NP O
respiratory JJ I-NP O
failure NN I-NP O
He PRP O O
became VBD B-VP O
hypotensive JJ O O
with IN B-VP O
intubation NN B-NP O
despite IN B-VP O
using VBG O O
etomidate NN B-NP B-m
with IN B-VP O
blood NN B-NP O
pressures NNS I-NP O
in IN B-VP O
the DT O O
60's/40's CD O O
, , O O
and CC O O
an DT B-NP O
initial JJ I-NP O
CVP NNP I-NP O
of IN B-VP O
16 CD O O
, , O O
so RB O O
he PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Levophed NNP B-NP B-m
with IN B-VP O
a DT B-NP O
systolic JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
in IN B-VP O
the DT O O
130's CD O O
on IN B-VP O
7 CD O B-do
to TO O I-do
10 CD O I-do
of IN B-VP O
Levophed NNP B-NP B-m
He PRP O O
received VBD B-VP O
1 CD O B-do
liter NN B-NP I-do
of IN B-VP O
IV NNP B-NP B-mo
fluid NN I-NP B-m
He PRP O O
received VBD B-VP O
a DT B-NP O
head NN I-NP O
CT NNP I-NP O
without IN B-VP O
contrast NN B-NP O
that WDT O O
showed VBD B-VP O
no DT B-NP O
acute JJ I-NP O
bleeding NN I-NP O
or CC O O
acute JJ B-NP O
infarction NN I-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
chest JJ I-NP O
x-ray NN I-NP O
that WDT O O
showed VBD B-VP O
no DT O O
obvious JJ O O
infiltrate VB O O
His PRP$ O O
INR NNP B-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
elevated VBN O O
Given NNP B-NP O
the DT B-NP O
CT NNP I-NP O
of IN B-VP O
his PRP$ O O
abdomen NNS B-NP O
without IN B-VP O
contrast NN B-NP O
that WDT O O
showed VBD B-VP O
a DT B-NP O
suprapubic JJ I-NP O
catheter NN I-NP O
obstruction NN I-NP O
with IN B-VP O
bilateral JJ B-NP O
hydronephrosis NN I-NP O
and CC O O
distended VBD B-VP O
bladder VB O O
His PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
2.9 CD O O
, , O O
elevated VBN O O
from IN B-VP O
his PRP$ O O
baseline NN B-NP O
of IN B-VP O
0.9 CD O O
Urology NNP B-NP O
was VBD B-VP O
consulted VBN O O
to TO O O
change VB O O
the DT B-NP O
suprapubic JJ I-NP O
catheter NN I-NP O
tube NN I-NP O
and CC O O
pus NN B-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
aspirated VBN O O
from IN B-VP O
the DT B-NP O
suprapubic JJ I-NP O
catheter NN I-NP O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
vancomycin NN B-NP B-m
, , O O
gentamicin NN B-NP B-m
, , O O
Flagyl NNP B-NP B-m
, , O O
and CC O O
stress NN B-NP O
dose NN I-NP O
steroids NNS I-NP B-m
, , O O
and CC O O
blood NN B-NP O
and CC O O
urine JJ B-NP O
cultures NNS I-NP O
were VBD B-VP O
sent VBN O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
and CC O O
he PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
MICU NNP I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Sarcoid NNP I-NP O
disease NN I-NP O
20 CD O O
years NNS B-NP O
ago RB O O
, , O O
paraplegia JJ O O
x18 CD O O
years NNS B-NP O
, , O O
chronic JJ B-NP O
suprapubic JJ I-NP O
catheter/ostomy NN I-NP O
for IN B-VP O
12 CD O O
years NNS B-NP O
, , O O
diabetes VBZ O O
type JJ B-NP O
II NNP I-NP O
, , O O
right JJ B-NP B-r
DVT NNP I-NP O
, , O O
on IN B-VP O
Coumadin NNP B-NP B-m
, , O O
status NN B-NP O
post NN I-NP O
chronic NN I-NP O
UTI NNP I-NP O
, , O O
and CC O O
CPAP NNP B-NP O
at IN B-VP O
night NN B-NP O
for IN B-VP O
obstructive JJ B-NP O
sleep JJ I-NP O
apnea NN I-NP O
HOME NNP I-NP O
MEDICATIONS: NNP I-NP O
Include NNP I-NP O
Regular NNP I-NP B-m
Regular NNP I-NP B-m
Insulin NNP I-NP I-m
Insulin NNP I-NP I-m
sliding VBG O B-do
sliding VBG O B-do
scale JJ B-NP I-do
scale NN I-NP I-do
a.c NN I-NP B-f
and CC O O
at IN B-VP O
bedtime NN B-NP B-f
, , O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
54 CD O B-do
units NNS B-NP O
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
and CC O O
68 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
night NN I-NP I-f
, , O O
baclofen VBD B-VP B-m
10 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
amitriptyline VBP O B-m
25 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
bedtime NN B-NP I-f
, , O O
oxybutynin VBZ O B-m
5 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
gabapentin NN B-NP B-m
300 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
iron NN B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
vitamin VBP O B-m
C NNP B-NP I-m
500 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
magnesium NN B-NP B-m
420 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
ranitidine VB O B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
and CC O O
calcium NN B-NP B-m
950 CD O B-do
mg JJ B-NP I-do
daily JJ I-NP B-f
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
His PRP$ O O
temperature NN B-NP O
was VBD B-VP O
97.4 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
105 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
136/67 CD O O
, , O O
his PRP$ O O
O2 NNP B-NP O
saturation NN I-NP O
was VBD B-VP O
100% CD O O
on IN B-VP O
AC NNP B-NP O
700 CD O O
with IN B-VP O
PEEP NNP B-NP O
of IN B-VP O
5 CD O O
In IN B-VP O
general JJ O O
, , O O
he PRP O O
was VBD B-VP O
intubated VBN O O
and CC O O
responsive JJ O O
to TO O O
simple VB O O
commands NNS B-NP O
HEENT: NNP I-NP O
Sluggish NNP I-NP O
pupils VBZ O O
His PRP$ O O
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
anteriorly RB O O
His PRP$ O O
heart NN B-NP O
was VBD B-VP O
in IN B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
rubs NNS B-NP O
or CC O O
gallops VB O O
His PRP$ O O
abdomen NNS B-NP O
was VBD B-VP O
obese JJ O O
, , O O
large JJ O O
, , O O
soft JJ O O
, , O O
nondistended JJ O O
and CC O O
nontender NN B-NP O
, , O O
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
His PRP$ O O
extremities NNS B-NP O
had VBD B-VP O
chronic JJ B-NP O
venous JJ I-NP O
stasis NN I-NP O
changes NNS I-NP O
of IN B-VP O
right NN B-NP O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
with IN B-VP O
areas NNS B-NP O
of IN B-VP O
no DT B-NP O
skin NN I-NP O
breakdown NN I-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
large JJ I-NP O
sacral JJ I-NP O
decubitus NN I-NP O
ulcer NN I-NP O
with IN B-VP O
bone NN B-NP O
exposed VBD B-VP O
that DT O O
was VBD B-VP O
foul JJ O O
smelling VBG O O
on IN B-VP O
his PRP$ O O
sacrum NN B-NP O
He PRP O O
was VBD B-VP O
neurologically RB O O
moving VBG O O
all DT O O
four CD O O
extremities NNS B-NP O
and CC O O
following VBG O O
commands NNS B-NP O
He PRP O O
had VBD B-VP O
an DT B-NP O
ostomy NN I-NP O
and CC O O
suprapubic JJ B-NP O
catheter NN I-NP O
in IN B-VP O
place NN B-NP O
LABORATORY NNP I-NP O
STUDIES: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
an DT B-NP O
elevated JJ I-NP O
creatinine NN I-NP O
of IN B-VP O
2.9 CD O O
, , O O
otherwise RB O O
, , O O
his PRP$ O O
Chem-7 NNP B-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
His PRP$ O O
LFTs NNP B-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
His PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
34.6 CD O O
, , O O
his PRP$ O O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
9.4 CD O O
, , O O
and CC O O
his PRP$ O O
platelets NNS B-NP O
were VBD B-VP O
343 CD O O
, , O O
000 CD O O
He PRP O O
had VBD B-VP O
negative JJ O O
cardiac JJ O O
enzymes VBZ O O
His PRP$ O O
urine JJ O O
and CC O O
blood NN B-NP O
tox NN I-NP O
screens NNS I-NP O
were VBD B-VP O
negative JJ O O
His PRP$ O O
UA NNP B-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
3+ CD O O
protein NN B-NP O
, , O O
trace NN B-NP O
glucose NN I-NP O
, , O O
negative JJ B-NP O
ketones NNS I-NP O
, , O O
3+ CD O O
leukocyte NN B-NP O
esterase NN I-NP O
, , O O
negative JJ B-NP O
nitrites NNS I-NP O
, , O O
4-10 JJ B-NP O
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
4+ CD O O
bacteria NNS B-NP O
, , O O
and CC O O
3+ CD O O
triple JJ B-NP O
phosphate NN I-NP O
crystals NNS I-NP O
His PRP$ O O
EKG NNP B-NP O
was VBD B-VP O
in IN B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
an DT B-NP O
old JJ I-NP O
right JJ I-NP O
bundle-branch NN I-NP O
block NN I-NP O
and CC O O
left VBD B-VP O
axis JJ B-NP O
deviation NN I-NP O
, , O O
first-degree JJ B-NP O
AV NNP I-NP O
block VB O O
His PRP$ O O
chest JJS O O
x-ray JJ O O
showed VBD B-VP O
retrocardiac JJ B-NP O
opacity NN I-NP O
that WDT O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
aspiration JJ B-NP O
versus NN I-NP O
pneumonia NN I-NP O
Abdominal NNP I-NP O
and CC O O
chest JJS B-NP O
CT NN I-NP O
showed VBD B-VP O
bibasilar JJ B-NP O
airspace NN I-NP O
opacities NNS I-NP O
, , O O
left VBD B-VP O
greater JJR O O
than IN B-VP O
right RB O O
, , O O
with IN B-VP O
aspiration NN B-NP O
versus NN I-NP O
pneumonia NN I-NP O
, , O O
bilateral JJ B-NP O
hydronephrosis NN I-NP O
, , O O
severe JJ B-NP O
decubitus NN I-NP O
ulcers NNS I-NP O
, , O O
and CC O O
large JJ B-NP O
gastrohepatic JJ I-NP O
lymph NN I-NP O
nodes NNS I-NP O
slightly RB O O
enlarged VBD B-VP O
and CC O O
calcified VBD B-VP O
ASSESSMENT: NNP B-NP O
This DT O O
is VBZ O O
a DT B-NP O
66-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
spinal JJ B-NP O
sarcoidosis NN I-NP O
and CC O O
secondary JJ B-NP O
paraplegia NN I-NP O
, , O O
who WP O O
presented VBD B-VP O
with IN B-VP O
altered JJ B-NP O
mental JJ I-NP O
status NN I-NP O
, , O O
hypoxemic JJ B-NP O
respiratory NN I-NP O
failure NN I-NP O
, , O O
and CC O O
hypotension NN B-NP O
, , O O
who WP O O
had VBD B-VP O
urosepsis NN B-NP O
and CC O O
pneumonia NN B-NP O
and CC O O
found VBN O O
later RB O O
on IN B-VP O
admission NN B-NP O
to TO O O
have VB O O
pulmonary JJ B-NP O
embolism NN I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEM: NNP I-NP O
1 CD O O
Hypoxemia: NNP B-NP O
He PRP O O
was VBD B-VP O
intubated VBN O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
and CC O O
extubated VBD B-VP O
a DT B-NP O
day NN I-NP O
later RB O O
on IN B-VP O
5/9/2006 CD O O
BiPAP NNP B-NP O
was VBD B-VP O
used VBN O O
at IN B-VP O
night NN B-NP O
as IN B-VP O
he PRP O O
had VBD B-VP O
used VBN O O
at IN B-VP O
home NN B-NP O
for IN B-VP O
a DT B-NP O
sleep JJ I-NP O
apnea NN I-NP O
with IN B-VP O
O2 NNP B-NP O
saturations NNS I-NP O
in IN B-VP O
the DT O O
high JJ O O
90's CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
during IN B-VP O
the DT B-NP O
day NN I-NP O
He PRP O O
was VBD B-VP O
initially RB O O
treated VBN O O
for IN B-VP O
pneumonia NN B-NP B-r
pneumonia NN I-NP B-r
pneumonia NN I-NP B-r
with IN B-VP O
ceftazidime NN B-NP B-m
, , O O
levofloxacin NN B-NP B-m
, , O O
and CC O O
vancomycin VBZ O B-m
The DT B-NP O
vancomycin NN I-NP B-m
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
4/3/2006 CD O O
, , O O
and CC O O
the DT B-NP O
ceftazidime NN I-NP B-m
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
2/4/206 CD O O
His PRP$ O O
levofloxacin NN B-NP B-m
levofloxacin NN I-NP B-m
was VBD B-VP O
continued VBN O O
at IN B-VP O
500 CD O B-do
500 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
per IN B-VP B-f
per IN B-VP B-f
day NN B-NP I-f
day NN I-NP I-f
for IN B-VP B-du
for IN B-VP B-du
a DT O I-du
a DT B-NP I-du
total JJ I-NP I-du
total JJ I-NP I-du
10-day JJ I-NP I-du
10-day JJ I-NP I-du
course NN I-NP I-du
course NN I-NP I-du
on IN B-VP O
6/10/2006 CD O O
This DT O O
is VBZ O O
to TO O O
be VB O O
used VBN O O
for IN B-VP O
a DT B-NP O
UTI NNP I-NP B-r
and CC O O
pneumonia NN B-NP B-r
On IN B-VP O
2/23/2006 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
supposed VBN O O
to TO O O
go VB O O
home NN B-NP O
and CC O O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
desaturation NN I-NP O
to TO O O
high JJ O O
80's CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
He PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
chest JJ I-NP O
x-ray NN I-NP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
A DT B-NP O
pulmonary JJ I-NP O
embolism NN I-NP O
CT NNP I-NP O
was VBD B-VP O
done VBN O O
that IN B-VP O
demonstrated VBD B-VP O
a DT B-NP O
small JJ I-NP O
nonocclusive JJ I-NP O
pulmonary JJ I-NP O
embolism NN I-NP O
in IN B-VP O
the DT B-NP O
posterobasilar JJ I-NP O
segment NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
lower JJR I-NP O
lobe NN I-NP O
with IN B-VP O
involving VBG O O
right JJ B-NP O
lower JJR I-NP O
lobe NN I-NP O
infarct NN I-NP O
suggestive NN I-NP O
that IN B-VP O
he PRP O O
had VBD B-VP O
had VBN O O
a DT B-NP O
PE NNP I-NP O
that WDT O O
was VBD B-VP O
resolving VBG O O
At IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
his PRP$ O O
INR NNP B-NP O
had VBD B-VP O
been VBN O O
subtherapeutic JJ O O
for IN B-VP O
three CD O O
days NNS B-NP O
at IN B-VP O
1.7 CD O O
to TO O O
1.9 CD O O
and CC O O
he PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
Coumadin NNP B-NP B-m
The DT B-NP O
following JJ I-NP O
day NN I-NP O
, , O O
his PRP$ O O
INR NNP B-NP O
was VBD B-VP O
therapeutic JJ O O
at IN B-VP O
2 CD O O
, , O O
and CC O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
it PRP O O
was VBD B-VP O
2.2 CD O O
It PRP O O
was VBD B-VP O
thought VBN O O
that IN B-VP O
the DT B-NP O
PE NNP I-NP O
was VBD B-VP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
a DT B-NP O
subtherapeutic JJ I-NP O
INR NNP I-NP O
His PRP$ O O
oxygen NN B-NP O
requirement NN I-NP O
was VBD B-VP O
back RB O O
to TO O O
baseline NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
and CC O O
his PRP$ O O
goal NN B-NP O
INR NNP I-NP O
was VBD B-VP O
to TO O O
be VB O O
on IN B-VP O
the DT B-NP O
higher JJR I-NP O
end NN I-NP O
of IN B-VP O
the DT O O
2 CD O O
to TO O O
3 CD O O
range NN B-NP O
, , O O
which WDT O O
was VBD B-VP O
goal NN B-NP O
previously RB O O
He PRP O O
was VBD B-VP O
also RB O O
given VBN O O
nebulizer NN B-NP O
treatments NNS I-NP O
throughout IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
2 CD O O
ID: NNP B-NP O
His PRP$ O O
urine NN B-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
Proteus NNP B-NP O
, , O O
resistant NN B-NP O
to TO O O
Macrobid NNP B-NP O
, , O O
and CC O O
Klebsiella NNP B-NP O
, , O O
resistant NN B-NP O
to TO O O
ampicillin VB O O
Levofloxacin NNP B-NP B-m
was VBD B-VP O
started VBN O O
for IN B-VP O
this DT O O
and CC O O
for IN B-VP O
the DT B-NP B-r
presumed JJ I-NP I-r
pneumonia NN I-NP I-r
seen VBN O O
on IN B-VP O
chest JJS B-NP O
x-ray NN I-NP O
for IN B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
a DT B-NP B-du
10-day JJ I-NP I-du
course NN I-NP I-du
Sputum NNP I-NP O
and CC O O
blood NN B-NP O
cultures NNS I-NP O
have VBP O O
been VBN O O
no DT B-NP O
growth NN I-NP O
to TO O O
date NN B-NP O
He PRP O O
had VBD B-VP O
no DT B-NP O
fevers NNS I-NP O
and CC O O
no DT B-NP O
elevated JJ I-NP O
white JJ I-NP O
counts NNS I-NP O
3 CD O O
Cardiac: NNP B-NP O
He PRP O O
was VBD B-VP O
thought VBN O O
to TO O O
have VB O O
an DT B-NP O
element NN I-NP O
of IN B-VP O
autonomic JJ B-NP O
insufficiency NN I-NP O
secondary JJ O O
to TO O O
sarcoid VB O O
with IN B-VP O
episodes NNS B-NP O
of IN B-VP O
hypo NN B-NP O
and CC O O
hypertension NN B-NP O
in IN B-VP O
the DT B-NP O
MICU NNP I-NP O
His PRP$ O O
cortisol NN B-NP O
stim NN I-NP O
test NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
it PRP O O
was VBD B-VP O
14.5 CD O O
before IN B-VP O
stim NN B-NP O
and CC O O
23.6 CD O O
after IN B-VP O
stim NN B-NP O
, , O O
so IN B-VP O
he PRP O O
was VBD B-VP O
not RB O O
treated VBN O O
with IN B-VP O
steroids NNS B-NP O
His PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
in IN B-VP O
the DT O O
30's CD O O
to TO O O
160's CD O O
with IN B-VP O
pauses NNS B-NP O
in IN B-VP O
the DT O O
100's CD O O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
with IN B-VP O
frequent JJ B-NP O
bigeminy NN I-NP O
and CC O O
trigeminy NN B-NP O
and CC O O
many JJ B-NP O
PVCs NNP I-NP O
, , O O
so IN B-VP O
he PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
12.5 CD O B-do
b.i.d NN B-NP B-f
metoprolol NN I-NP B-m
on IN B-VP O
0/14/2006 CD O O
with IN B-VP O
good JJ B-NP O
results NNS I-NP O
He PRP O O
continued VBD B-VP O
to TO O O
have VB O O
ectopy NN B-NP O
and CC O O
continued VBD B-VP O
to TO O O
be VB O O
hypertensive JJ O O
, , O O
and CC O O
given VBN O O
his PRP$ O O
diabetes NNS B-NP O
, , O O
he PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
low JJ I-NP B-do
dose NN I-NP I-do
of IN B-VP O
captopril NN B-NP B-m
on IN B-VP O
8/14/2006 CD O O
with IN B-VP O
no DT B-NP O
complications NNS I-NP O
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
maintain VB O O
blood NN B-NP B-r
pressures NNS I-NP I-r
in IN B-VP O
ideal JJ B-NP O
ranges NNS I-NP O
4 CD O O
GU: NNP B-NP O
Urology NNP I-NP O
replaces VBZ O O
suprapubic JJ O O
catheter RB O O
early RB O O
on IN B-VP O
admission NN B-NP O
He PRP O O
was VBD B-VP O
continued VBN O O
to TO O O
have VB O O
bladder VBN O O
irrigation NN B-NP O
with IN B-VP O
good JJ B-NP O
effect NN I-NP O
, , O O
and CC O O
Urology NNP B-NP O
signed VBD B-VP O
off RP O O
on IN B-VP O
9/24/2007 CD O O
5 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
NPH NNP B-NP B-m
20 CD O B-do
b.i.d NN B-NP B-f
through IN B-VP B-du
his PRP$ O O
hospitalization NN B-NP O
and CC O O
Regular JJ B-NP B-m
Insulin NNP I-NP I-m
sliding VBG O B-do
scale NN B-NP I-do
His PRP$ O O
sugars NNS B-NP O
were VBD B-VP O
high JJ O O
on IN B-VP O
this DT O O
reduced VBN O O
regimen NNS B-NP O
and CC O O
so RB O O
he PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
his PRP$ O O
home NN B-NP O
NPH NNP I-NP B-m
doses VBZ O O
for IN B-VP O
discharge NN B-NP O
6 CD O O
Decubitus NNP B-NP O
ulcer: JJ B-NP O
Plastic NNP I-NP O
Surgery NNP I-NP O
was VBD B-VP O
consulted VBN O O
on IN B-VP O
1/22/2006 CD O O
and CC O O
the DT B-NP O
wound NN I-NP O
did VBD B-VP O
not RB O O
look VB O O
infected VBD B-VP O
It PRP O O
was VBD B-VP O
debrided VBN O O
and CC O O
wet-to-dry JJ B-NP O
t.i.d NN I-NP O
dressing NN I-NP O
changes NNS I-NP O
were VBD B-VP O
recommended VBN O O
as RB O O
well RB O O
as IN B-VP O
Panafil NNP B-NP B-m
t.i.d IN B-VP B-f
dressing VBG O O
changes NNS B-NP O
He PRP O O
was VBD B-VP O
prescribed VBN O O
Panafil NNP B-NP B-m
to TO O O
go VB O O
home NN B-NP O
on IN B-VP O
7 CD O O
Renal: NNP B-NP O
The DT B-NP O
creatinine NN I-NP O
was VBD B-VP O
initially RB O O
2.7 CD O O
, , O O
and CC O O
after IN B-VP O
receiving VBG O O
IV NNP B-NP B-mo
fluids NNS I-NP B-m
, , O O
it PRP O O
came VBD B-VP O
down RB O O
to TO O O
1.2 CD O O
He PRP O O
likely RB O O
had VBD B-VP O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
secondary JJ O O
to TO O O
postrenal JJ B-NP O
obstructive JJ I-NP O
etiology NN I-NP O
His PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
stable JJ O O
at IN B-VP O
around IN B-VP O
1 CD O O
for IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
his PRP$ O O
admission NN B-NP O
8 CD O O
Heme: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
DVT NNP B-NP O
Initially NNP I-NP O
, , O O
his PRP$ O O
INR NNP B-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
therapeutic JJ O O
and CC O O
he PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
levofloxacin NN B-NP B-m
, , O O
so IN B-VP O
the DT B-NP O
plan NN I-NP O
was VBD B-VP O
that IN B-VP O
he PRP O O
should MD O O
have VB O O
half NN B-NP O
of IN B-VP O
his PRP$ O O
home NN B-NP O
Coumadin NNP I-NP B-m
dose NN I-NP O
while IN B-VP O
he PRP O O
was VBD B-VP O
on IN B-VP O
levofloxacin NN B-NP B-m
, , O O
so IN B-VP O
he PRP O O
was VBD B-VP O
given VBN O O
half NN B-NP O
of IN B-VP O
dose NN B-NP O
and CC O O
his PRP$ O O
INRs NN B-NP O
came VBD B-VP O
down RB O O
to TO O O
a DT B-NP O
nadir NN I-NP O
of IN B-VP O
1.7 CD O O
His PRP$ O O
INR NNP B-NP O
was VBD B-VP O
subtherapeutic JJ O O
for IN B-VP O
three CD O O
days NNS B-NP O
, , O O
and CC O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
a DT B-NP O
PE NNP I-NP O
was VBD B-VP O
found VBN O O
, , O O
his PRP$ O O
INR NNP B-NP O
was VBD B-VP O
1.8 CD O O
The DT B-NP O
day NN I-NP O
after IN B-VP O
this DT O O
, , O O
his PRP$ O O
INR NNP B-NP O
was VBD B-VP O
2 CD O O
and CC O O
then RB O O
came VBD B-VP O
up RB O O
to TO O O
2.2 CD O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
He PRP O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
, , O O
which WDT O O
is VBZ O O
his PRP$ O O
home NN B-NP O
dose NN I-NP O
to TO O O
follow VB O O
up RP O O
at IN B-VP O
his PRP$ O O
Coumadin NNP B-NP O
Clinic NNP I-NP O
9 CD O O
FEN: NNP B-NP O
He PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
maintenance NN B-NP O
IV NNP I-NP B-mo
fluids NNS I-NP B-m
until IN B-VP B-du
cleared VBN O O
to TO O O
eat VB O O
by IN B-VP O
Speech NNP B-NP O
and CC O O
Swallow NNP B-NP O
Speech NNP I-NP O
and CC O O
Swallow NNP B-NP O
estimates NNS I-NP O
having VBG O O
baseline NN B-NP O
aspiration NN I-NP O
risk NN I-NP O
and CC O O
he PRP O O
was VBD B-VP O
known VBN O O
to TO O O
cough VB O O
and CC O O
aspirate VB O O
at IN B-VP O
home NN B-NP O
He PRP O O
had VBD B-VP O
been VBN O O
recently RB O O
worked VBN O O
up RP O O
at IN B-VP O
the DT B-NP O
A NNP I-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
a DT B-NP O
recent JJ I-NP O
admission NN I-NP O
for IN B-VP O
aspiration NN B-NP O
pneumonia NN I-NP O
They PRP O O
recommended VBD B-VP O
thickened VBN O O
puree JJ B-NP O
diets NNS I-NP O
and CC O O
felt VBD B-VP O
that IN B-VP O
even RB O O
this DT O O
he PRP O O
was VBD B-VP O
likely JJ O O
to TO O O
aspirate VB O O
The DT B-NP O
risks NNS I-NP O
and CC O O
benefits NNS B-NP O
of IN B-VP O
eating VBG O O
were VBD B-VP O
explained VBN O O
to TO O O
his PRP$ O O
wife NN B-NP O
and CC O O
him PRP O O
and CC O O
he PRP O O
decided VBD B-VP O
to TO O O
continue VB O O
to TO O O
eat VB O O
as IN B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
ideal JJ I-NP O
option NN I-NP O
10 CD O O
Pain: NN B-NP O
He PRP O O
continued VBD B-VP O
gabapentin NN B-NP B-m
, , O O
oxybutynin NN B-NP B-m
, , O O
and CC O O
amitriptyline NN B-NP B-m
as IN B-VP O
at IN B-VP O
home NN B-NP O
11 CD O O
Prophylaxis: NNP B-NP B-r
Prophylaxis: NNP I-NP B-r
He PRP O O
was VBD B-VP O
given VBN O O
Nexium NNP B-NP B-m
and CC O O
Coumadin NNP B-NP B-m
12 CD O O
Code NNP B-NP O
status: NN I-NP O
He PRP O O
was VBD B-VP O
full JJ B-NP O
code NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
discussed VBN O O
with IN B-VP O
his PRP$ O O
wife NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
AT NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
current JJ I-NP O
temperature NN I-NP O
was VBD B-VP O
98 CD O O
, , O O
the DT B-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
91 CD O O
to TO O O
114 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
100-114/54-70 CD O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
of IN B-VP O
20 CD O O
, , O O
and CC O O
saturating VBG O O
97-100% JJ O O
on IN B-VP O
1-2 JJ B-NP O
liters NNS I-NP O
In IN B-VP O
general JJ O O
, , O O
he PRP O O
was VBD B-VP O
responsive JJ O O
, , O O
alert JJ O O
, , O O
and CC O O
appropriate VB O O
His PRP$ O O
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
His PRP$ O O
heart NN B-NP O
had VBD B-VP O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
soft JJ B-NP O
systolic JJ I-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
His PRP$ O O
abdomen NNS B-NP O
had VBD B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
distended VBD B-VP O
, , O O
soft JJ O O
and CC O O
nontender NN B-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
suprapubic JJ I-NP O
catheter NN I-NP O
as RB O O
well RB O O
as IN B-VP O
an DT B-NP O
ostomy NN I-NP O
that WDT O O
were VBD B-VP O
clean JJ O O
, , O O
dry JJ O O
and CC O O
intact JJ B-NP O
Extremities NNS I-NP O
, , O O
he PRP O O
had VBD B-VP O
2+ CD O O
peripheral JJ B-NP O
edema NN I-NP O
that WDT O O
was VBD B-VP O
stable JJ O O
with IN B-VP O
no DT B-NP O
skin NN I-NP O
breakdown RB O O
LABORATORY NNP B-NP O
VALUES: NNP I-NP O
His PRP$ O O
labs NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
were VBD B-VP O
stable JJ O O
His PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
27.2 CD O O
, , O O
down RB O O
from IN B-VP O
29 CD O O
, , O O
which WDT O O
was VBD B-VP O
closed VBN O O
to TO O O
his PRP$ O O
baseline NN B-NP O
of IN B-VP O
34 CD O O
His PRP$ O O
INR NNP B-NP O
was VBD B-VP O
2.1 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
discharge NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Amitriptyline NNP I-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
bedtime NN B-NP I-f
, , O O
vitamin VBP O B-m
C NNP B-NP I-m
500 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
baclofen VBD B-VP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Caltrate NNP B-NP B-m
600 CD O I-m
Plus NNP B-NP I-m
D NNP I-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
ferrous JJ B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
gabapentin NN B-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
human JJ B-NP I-m
human JJ I-NP I-m
insulin NN I-NP I-m
insulin NN I-NP I-m
54 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
, , O O
68 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
evening NN I-NP I-f
, , O O
Regular JJ B-NP B-m
Insulin NNP I-NP I-m
sliding VBG O B-do
scale NN B-NP I-do
, , O O
levofloxacin VBZ O B-m
500 CD O B-do
mg NN B-NP O
p.o JJ O B-mo
daily RB O B-f
, , O O
to TO O O
end VB O O
on IN B-VP O
10/16/2006 CD O O
for IN B-VP B-du
a DT B-NP O
total JJ I-NP O
course NN I-NP O
of IN B-VP O
10 CD O O
days NNS B-NP O
, , O O
magnesium NN B-NP B-m
oxide RB O I-m
420 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
t.i.d NN I-NP B-f
, , O O
metoprolol FW O B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
oxybutynin VBZ O B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Panafil NNP B-NP B-m
ointment NN I-NP I-m
t.i.d NN I-NP B-f
, , O O
ranitidine VB O B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
and CC O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
FOLLOW NNP B-NP O
UP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
follow VB O O
up RP O O
his PRP$ O O
PCP NNP B-NP O
, , O O
Dr NNP B-NP O
Dunstan NNP I-NP O
The DT B-NP O
appointment NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Carros NNP I-NP O
will MD O O
be VB O O
within IN B-VP O
the DT B-NP O
next JJ I-NP O
week NN I-NP O
, , O O
and CC O O
the DT B-NP O
appointment NN I-NP O
with IN B-VP O
the DT B-NP O
Coumadin NNP I-NP O
Clinic NNP I-NP O
will MD O O
be VB O O
tomorrow NN B-NP O
or CC O O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
ISSUES NNP I-NP O
FOR NNP I-NP O
FOLLOW NNP I-NP O
UP: NNP I-NP O
Include NNP I-NP O
following VBG O O
up RP O O
on IN B-VP O
his PRP$ O O
aspiration NN B-NP O
risk NN I-NP O
and CC O O
continuing VBG O O
to TO O O
discourage VB O O
thin JJ B-NP O
liquids NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
encourage NN B-NP O
him PRP O O
sitting VBG O O
upright JJ O O
when WRB O O
eating NN B-NP O
and CC O O
being VBG O O
observed VBN O O
and CC O O
stopping VBG O O
when WRB O O
he PRP O O
coughs VBZ O O
He PRP O O
will MD O O
need VB O O
continuous JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
and CC O O
heart NN B-NP O
rate NN I-NP O
monitoring NN I-NP O
given VBN O O
the DT B-NP O
new JJ I-NP O
beta-blocker NN I-NP B-m
and CC O O
the DT B-NP O
ACE NNP I-NP B-m
inhibitor NN I-NP I-m
as RB O O
well RB O O
as IN B-VP O
assessment NN B-NP O
of IN B-VP O
his PRP$ O O
frequent JJ B-NP O
PVCs NNP I-NP O
We PRP O O
will MD O O
continue VB O O
to TO O O
follow VB O O
his PRP$ O O
diabetes NNS B-NP O
and CC O O
continue VB O O
to TO O O
follow VB O O
his PRP$ O O
INR NNP B-NP O
with IN B-VP O
a DT B-NP O
goal NN I-NP O
being VBG O O
2 CD O O
to TO O O
3 CD O O
with IN B-VP O
ideal JJ B-NP O
goal NN I-NP O
on IN B-VP O
the DT B-NP O
higher JJR I-NP O
end NN I-NP O
8 CD O O
range NN B-NP O
eScription NN I-NP O
document: IN B-VP O
2-8481192 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
PITTARI NNP I-NP O
, , O O
NIGEL NNP B-NP O
Attending: NNP I-NP O
SIFFERT NNP I-NP O
, , O O
TROY NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
1933790 CD O O
D: NNP B-NP O
7/1/06 CD O O
T: NNP B-NP O
7/1/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#74976 VBZ O O
999570460 CD O O
NRH NNP B-NP O
64850592 CD O O
846474 CD O O
7/22/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/28/1992 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/19/1992 CD O O
PRINCIPAL NNP B-NP O
DISCHARGE: NNP I-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
, , O O
STATUS NNP B-NP O
POST NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
OTHER NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
STATUS NNP B-NP O
POST NNP I-NP O
ATHERECTOMY NNP I-NP O
COMPLICATED NNP I-NP O
BY NNP I-NP O
REOCCLUSION NNP I-NP O
AND NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
2 CD O O
INSULIN NNP B-NP O
DEPENDENT NNP I-NP O
DIABETES NNP I-NP O
MELLITUS NNP I-NP O
3 CD O O
ELEVATED NNP B-NP O
CHOLESTEROL NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
59 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
who WP O O
presents VBP O O
with IN B-VP O
exertional JJ B-NP O
chest NN I-NP O
discomfort NN I-NP O
and CC O O
early JJ B-NP O
positive JJ I-NP O
ETT NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
of IN B-VP O
obesity NN B-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
and CC O O
cholesterol VB O O
The DT B-NP O
patient NN I-NP O
describes VBZ O O
a DT B-NP O
6-month JJ I-NP O
history NN I-NP O
of IN B-VP O
exertional JJ B-NP O
angina NN I-NP O
described VBD B-VP O
as IN B-VP O
chest NN B-NP O
heaviness NN I-NP O
with IN B-VP O
mild JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
whenever WRB O O
she PRP O O
walked VBD B-VP O
more JJR O O
than IN B-VP O
one CD O O
block NN B-NP O
or CC O O
climbed VBN O O
stairs IN B-VP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Garrett NNP I-NP O
H NNP I-NP O
Lipkind NNP I-NP O
, , O O
LMD NNP B-NP O
at IN B-VP O
Skaemp NNP B-NP O
Center NNP I-NP O
She PRP O O
had VBD B-VP O
an DT B-NP O
ETT NNP I-NP O
on IN B-VP O
7/19/92 CD O O
, , O O
modified VBN O O
Bruce NNP B-NP O
protocol NN I-NP O
, , O O
in IN B-VP O
which WDT O O
she PRP O O
went VBD B-VP O
2 CD O O
minutes NNS B-NP O
and CC O O
2 CD O O
seconds NNS B-NP O
, , O O
stopped VBD B-VP O
secondary JJ O O
to TO O O
typical JJ B-NP O
anterior JJ I-NP O
chest NN I-NP O
discomfort NN I-NP O
The DT B-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
135 CD O O
, , O O
83% CD O O
predicted VBD B-VP O
EKG NNP B-NP O
changes NNS I-NP O
were VBD B-VP O
significant JJ O O
for IN B-VP O
20 CD O O
mm JJ B-NP O
horizontal JJ I-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
1 CD O O
, , O O
V4-5 NNP B-NP O
, , O O
1 CD O O
mm NN B-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
II NNP B-NP O
, , O O
III NNP B-NP O
and CC O O
F NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
referred VBN O O
for IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
orthopnea NN B-NP O
, , O O
PND NNP B-NP O
, , O O
and CC O O
has VBZ O O
mild VBN O O
occasoinal JJ B-NP O
hypertension NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Noninsulin NNP I-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
oral JJ B-NP O
agent NN I-NP O
times NNS I-NP O
six CD O O
months NNS B-NP O
Asthma NNP I-NP O
, , O O
no DT B-NP O
recent JJ I-NP O
symptoms NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Glucotrol NNP I-NP B-m
7.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q-day JJ O B-f
, , O O
Mevacor NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Isoril NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Propranolol NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Nitroglycerin NNP B-NP B-m
sublingual JJ B-NP B-mo
p.r.n NN I-NP B-f
ALLERGIES: NNP I-NP O
? . B-VP O
ALLERGY NNP B-NP O
TO NNP I-NP O
UNRECALLED NNP I-NP O
ANTIBIOTIC NNP I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Brother NNP I-NP O
required VBD B-VP O
CABG NNP B-NP O
in IN B-VP O
his PRP$ O O
50's CD O O
, , O O
mother JJR O O
died VBD B-VP O
of IN B-VP O
heart NN B-NP O
disease NN I-NP O
, , O O
age NN B-NP O
unknown JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Blood NNP I-NP O
pressure NN I-NP O
140/70 CD O O
, , O O
pulse RB O O
70 CD O O
Neck: NNP B-NP O
negative JJ B-NP O
JVD NNP I-NP O
, , O O
2+ CD O O
carotids NNS B-NP O
, , O O
without IN B-VP O
bruits NNS B-NP O
Chest: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
Cardiac: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
, , O O
a DT B-NP O
I/IV NNP I-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur FW O O
heard NN B-NP O
best JJS O O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
Abdomen: NNP I-NP O
Plus NNP I-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
nontender FW O O
Extremities: NNP B-NP O
+2 NNP I-NP O
femorals NNS I-NP O
, , O O
no DT B-NP O
bruits NNS I-NP O
, , O O
positive JJ O O
left VBD B-VP O
DP NNP B-NP O
, , O O
trace NN B-NP O
PT NNP I-NP O
, , O O
right RB O O
positive JJ O O
2 CD O O
DP NNP B-NP O
and CC O O
plus CC O O
2 CD O O
PT NNP B-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
BUN/creatinine NNP I-NP O
12/1.2 CD O O
, , O O
glucose RB O O
318 CD O O
, , O O
hematocrit NN B-NP O
42.3 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
8.38 CD O O
, , O O
cholesterol NN B-NP O
222 CD O O
, , O O
triglycerides NNS B-NP O
173 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
2/13/92 CD O O
She PRP O O
had VBD B-VP O
a DT O O
proximal JJ O O
95% CD O O
LAD NNP B-NP O
lesion NN I-NP O
and CC O O
diagonal JJ O O
1 CD O O
40% CD O O
stenosis NN B-NP O
She PRP O O
had VBD B-VP O
an DT B-NP O
anomalous JJ I-NP O
posterior NN I-NP O
circumflex NN I-NP O
with IN B-VP O
luminal JJ B-NP O
irregularities NNS I-NP O
Her PRP$ O O
mean JJ B-NP O
RA NNP I-NP O
was VBD B-VP O
5 CD O O
, , O O
and CC O O
her PRP$ O O
mean JJ B-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
was VBD B-VP O
11 CD O O
Her NNP B-NP O
cardiac NN I-NP O
output NN I-NP O
was VBD B-VP O
6.2 CD O O
, , O O
wifh VBD B-VP O
an DT B-NP O
FCR NNP I-NP O
of IN B-VP O
1226 CD O O
The DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
athrectomy NN I-NP O
of IN B-VP O
her PRP$ O O
proximal JJ B-NP O
LAD NNP I-NP O
lesion NN I-NP O
through IN B-VP O
a DT O O
10 CD O O
French JJ B-NP O
arterial JJ I-NP O
sheath NN I-NP O
The DT B-NP O
stenosis NN I-NP O
was VBD B-VP O
reduced VBN O O
from IN B-VP O
an DT O O
80% CD O O
to TO O O
20% CD O O
residual JJ O O
The DT B-NP O
Heparin NNP I-NP B-m
was VBD B-VP O
shut VBN O O
off RP O O
, , O O
and CC O O
sheaths NNS B-NP O
were VBD B-VP O
pulled VBN O O
later RB O O
that DT B-NP O
afternoon NN I-NP O
Her PRP$ O O
post NN B-NP O
atherectomy JJ B-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
on IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
10/9/92 CD O O
by IN B-VP O
the DT B-NP O
onset NN I-NP O
of IN B-VP O
severe JJ B-NP O
chest NN I-NP O
discomfort NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
significant JJ O O
flipped VBN O O
T-waves NNS B-NP O
in IN B-VP O
III NNP B-NP O
and CC O O
F NNP B-NP O
and CC O O
2 CD O O
mm NN B-NP O
ST NNP I-NP O
depressions NNS I-NP O
as RB O O
well RB O O
in IN B-VP O
III NNP B-NP O
and CC O O
F NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
subsequently RB O O
brought VBN O O
to TO O O
the DT B-NP O
cath NN I-NP O
lab NN I-NP O
on IN B-VP O
10/9/92 CD O O
where WRB O O
the DT B-NP O
LAD NNP I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
100% CD O O
occluded JJ O O
and CC O O
was VBD B-VP O
dilated VBN O O
to TO O O
a DT O O
30% CD O O
residual JJ O O
with IN B-VP O
balloon NN B-NP O
PTCA NNP I-NP O
Thrombus NNP I-NP O
was VBD B-VP O
found VBN O O
at IN B-VP O
the DT B-NP O
prior JJ I-NP O
athrectomy NN I-NP O
site NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
after IN B-VP O
the DT B-NP O
PTCA NNP I-NP O
which WDT O O
she PRP O O
proceeded VBD B-VP O
to TO O O
rule VB O O
in IN B-VP O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
with IN B-VP O
peak JJ B-NP O
CPK's NNP I-NP O
of IN B-VP O
1390 CD O O
with IN B-VP O
MB's NNP B-NP O
of IN B-VP O
55 CD O O
The DT B-NP O
patient's NN I-NP O
post NN I-NP O
PTCA NNP I-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
several JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
transient JJ B-NP B-r
transient NN I-NP B-r
chest NN I-NP O
discomfort NN I-NP O
which WDT O O
was VBD B-VP O
relieved VBN O O
both DT O O
by IN B-VP O
Mylanta NNP B-NP B-m
and CC O O
sublingual JJ B-NP B-mo
TNG NNP I-NP B-m
These DT B-NP O
episodes NNS I-NP O
were VBD B-VP O
not RB O O
compared VBN O O
with IN B-VP O
EKG NNP B-NP O
nor CC O O
felt VBD B-VP O
to TO O O
be VB O O
secondary JJ O O
to TO O O
recurrent VB O O
dyspepsia VB O O
The DT B-NP O
patient NN I-NP O
on IN B-VP O
9/9/92 CD O O
, , O O
seven CD O O
days NNS B-NP O
post RB O O
MI NNP B-NP O
, , O O
had VBD B-VP O
a DT O O
modified VBN O O
Bruce NNP B-NP O
ETT NNP I-NP O
where WRB O O
she PRP O O
went VBD B-VP O
9 CD O O
minutes NNS B-NP O
without IN B-VP O
any DT B-NP O
ischemic JJ I-NP O
changes NNS I-NP O
The DT B-NP O
patient's NN I-NP O
blood NN I-NP O
sugars NNS I-NP O
remained VBD B-VP O
elevated JJ O O
throughout IN B-VP O
her PRP$ O O
hospital NN B-NP O
course NN I-NP O
She PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
Glucotrol NNP B-NP B-m
with IN B-VP O
NPH NNP B-NP B-m
subcu NN I-NP B-mo
subcu NN I-NP B-mo
q.a.m NN I-NP B-f
q.a.m NN I-NP B-f
was VBD B-VP O
added VBN O O
with IN B-VP O
the DT B-NP O
hope NN I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
eventually RB O O
after IN B-VP O
the DT B-NP O
stress NN I-NP O
of IN B-VP O
her PRP$ O O
MI NNP B-NP O
, , O O
her PRP$ O B-r
her PRP$ O B-r
blood NN B-NP O
sugars NNS I-NP O
would MD O O
return VB O O
to TO O O
prior JJ B-NP O
levels NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
thus RB O O
treated VBN O O
with IN B-VP O
Mevacor NNP B-NP B-m
for IN B-VP O
hypercholesterolemia NN B-NP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
on IN B-VP O
10/11/92 CD O O
with IN B-VP O
followup NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Kneisel NNP I-NP O
in IN B-VP O
Frejames NNP B-NP O
Ny'smiss NNP I-NP O
Hospital NNP I-NP O
DISPOSITION: NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Mevacor NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q-day JJ O B-f
, , O O
Aspirin NNP B-NP B-m
one CD O B-do
p.o NN B-NP B-mo
q-day NN I-NP B-f
, , O O
Glucotrol NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Isordil NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
NPH NNP B-NP B-m
26 CD O B-do
units NNS B-NP O
subcutaneously RB O B-mo
each DT B-NP B-f
morning NN I-NP I-f
RT688/9972 NNP I-NP O
YONG NNP I-NP O
S NNP I-NP O
UGARTE NNP I-NP O
, , O O
M.D NNP B-NP O
ZE69 NNP I-NP O
D: NNP I-NP O
2/27/92 CD O O
Batch: NNP B-NP O
4948 CD O O
Report: NNP B-NP O
I2158Q2 NNP I-NP O
T: NNP I-NP O
6/29/92 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
ANDREAS NNP I-NP O
D NNP I-NP O
DECONTI NNP I-NP O
, , O O
M.D NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#80815 VBZ O O
394520578 CD O O
GEMC NNP B-NP O
37110469 CD O O
7719852 CD O O
6/19/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
C-DIFF.COLITIS NNP I-NP O
Unsigned NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/2/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/16/2006 CD O O
ATTENDING: NNP B-NP O
TRENTHAM NNP I-NP O
, , O O
DEL NNP B-NP O
GUADALUPE NNP I-NP O
MD NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Klaja NNP I-NP O
is VBZ O O
an DT B-NP O
81-year-old JJ I-NP O
gentleman NN I-NP O
whose WP$ O O
chief JJ B-NP O
complaint NN I-NP O
was VBD B-VP O
abdominal JJ B-NP O
pain NN I-NP O
and CC O O
diarrhea NN B-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
of IN B-VP O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
and CC O O
recent JJ B-NP O
complex JJ I-NP O
medical JJ I-NP O
history NN I-NP O
including VBG O O
a DT B-NP O
septic JJ I-NP O
right NN I-NP O
knee NN I-NP O
arthritis NN I-NP O
with IN B-VP O
MRSA NNP B-NP O
complicated VBN O O
by IN B-VP O
a DT B-NP O
PICC NNP I-NP O
line-induced JJ B-NP O
right JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
DVT NNP I-NP O
followed VBN O O
by IN B-VP O
bacteremia NN B-NP B-r
with IN B-VP O
multi-resistant JJ B-NP O
Klebsiella NNP I-NP O
pneumoniae NN I-NP O
, , O O
treated VBN O O
with IN B-VP O
meropenem NN B-NP B-m
for IN B-VP B-du
14 CD O I-du
days NNS B-NP I-du
with IN B-VP O
the DT B-NP O
course NN I-NP O
ending VBG O O
on IN B-VP O
11/12/2006 CD O O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
left JJ B-NP O
lower JJR I-NP O
quadrant JJ I-NP O
abdominal JJ I-NP O
pain NN I-NP O
during IN B-VP O
his PRP$ O O
last JJ B-NP O
admission NN I-NP O
2 CD O O
weeks NNS B-NP O
ago RB O O
associated VBN O O
with IN B-VP O
low-volume JJ B-NP O
mucus NN I-NP O
diarrhea NN I-NP O
, , O O
C NNP B-NP O
diff NN I-NP O
toxin NN I-NP O
assay NN I-NP O
was VBD B-VP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
negative JJ O O
on IN B-VP O
6/11 CD O O
Abdominal NNP B-NP O
CT NNP I-NP O
showed VBD B-VP O
diverticulosis NN B-NP O
with IN B-VP O
stranding NN B-NP O
of IN B-VP O
the DT B-NP O
sigmoid JJ I-NP O
colon NN I-NP O
Blood NNP I-NP O
cultures NNS I-NP O
grew VBD B-VP O
klebsiella NN B-NP B-r
, , O O
treated VBN O O
with IN B-VP O
14 CD O B-du
days NNS B-NP I-du
of IN B-VP O
meropenem NN B-NP B-m
as IN B-VP O
previously RB O O
noted VBN O O
However RB O O
, , O O
since IN B-VP O
this DT B-NP O
discharge NN I-NP O
, , O O
the DT B-NP O
mild JJ I-NP O
abdominal JJ I-NP O
pain NN I-NP O
persisted VBD B-VP O
He PRP O O
continues VBZ O O
to TO O O
have VB O O
low-grade JJ B-NP O
mucus NN I-NP O
diarrhea NN I-NP O
about IN B-VP O
5 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
, , O O
not RB O O
associated VBN O O
with IN B-VP O
fever NN B-NP O
, , O O
chills NNS B-NP O
or CC O O
anorexia NN B-NP O
Over IN B-VP O
the DT O O
last JJ O O
2 CD O O
days NNS B-NP O
prior RB O O
to TO O O
this DT B-NP O
admission NN I-NP O
, , O O
the DT B-NP O
diarrhea NN I-NP O
became VBD B-VP O
high JJ B-NP O
volume NN I-NP O
, , O O
still RB O O
nonbloody NN B-NP O
and CC O O
not RB O O
associated VBN O O
again RB O O
with IN B-VP O
fever NN B-NP O
or CC O O
chills NNS B-NP O
He PRP O O
was VBD B-VP O
brought VBN O O
into IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
at IN B-VP O
which WDT O O
time NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
afebrile RB O O
with IN B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
85/49 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
in IN B-VP O
the DT O O
80s CD O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
of IN B-VP O
20 CD O O
, , O O
O2 NNP B-NP O
saturation NN I-NP O
93% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
he PRP O O
received VBD B-VP O
volume NN B-NP O
resuscitation NN I-NP O
with IN B-VP O
2 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
IV NNP B-NP B-mo
fluids NNS I-NP B-m
, , O O
stool NN B-NP O
samples NNS I-NP O
for IN B-VP O
C NNP B-NP O
diff NN I-NP O
assay NN I-NP O
were VBD B-VP O
sent VBN O O
He PRP O O
received VBD B-VP O
empiric JJ B-NP O
therapy NN I-NP O
with IN B-VP O
p.o NN B-NP B-mo
vancomycin VBP O B-m
An DT B-NP O
abdominal JJ I-NP O
CT NNP I-NP O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
showed VBD B-VP O
thickening NN B-NP O
of IN B-VP O
the DT B-NP O
sigmoid NN I-NP O
colon NN I-NP O
and CC O O
rectum NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Includes NNP I-NP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
as IN B-VP O
noted VBN O O
with IN B-VP O
an DT B-NP O
anterior JJ I-NP O
MI NNP I-NP O
in IN B-VP O
2003 CD O O
, , O O
that WDT O O
had VBD B-VP O
complicated VBN O O
to TO O O
VT NNP B-NP O
arrest NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
CABG NNP I-NP O
in IN B-VP O
2003 CD O O
that WDT O O
was VBD B-VP O
a DT B-NP O
left JJ I-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
LAD NNP B-NP O
with IN B-VP O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
PTA NNP I-NP O
and CC O O
obtuse RB O O
marginal JJ O O
He PRP O O
has VBZ O O
had VBD B-VP O
a DT B-NP O
catheterization NN I-NP O
in IN B-VP O
8/23 CD O O
that WDT O O
showed VBD B-VP O
patent JJ B-NP O
grafts NNS I-NP O
and CC O O
drug-eluting JJ B-NP B-m
stent NN I-NP I-m
to TO O O
the DT B-NP O
left NN I-NP O
circumflex NN I-NP O
He PRP O O
has VBZ O O
chronic JJ B-NP O
kidney NN I-NP O
disease NN I-NP O
, , O O
baseline JJ B-NP O
creatinine NN I-NP O
between IN B-VP O
1.3 CD O O
and CC O O
1.5 CD O O
, , O O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
C NNP B-NP O
diff NN I-NP O
colitis NN I-NP O
in IN B-VP O
2003 CD O O
, , O O
BPH NNP B-NP O
, , O O
asthma NN B-NP O
, , O O
GERD NNP B-NP O
, , O O
status NN B-NP O
post NN I-NP O
right RB O O
upper JJ B-NP O
extremity NN I-NP O
PICC-related NNP I-NP O
DVT NNP I-NP O
and CC O O
right JJ B-NP O
knee NN I-NP O
septic JJ B-NP O
arthritis NN I-NP O
MEDICATIONS: NNP I-NP O
aspirin VBZ O B-m
81 CD O B-do
mg NN B-NP I-do
, , O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
, , O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
, , O O
digoxin NN B-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
, , O O
Lasix NNP B-NP B-m
49 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
lisinopril VBD B-VP B-m
10 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Lopressor NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Zocor NNP B-NP B-m
80 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Flomax NNP B-NP B-m
0.4 CD O B-do
mg JJ O I-do
daily JJ O B-f
and CC O O
Flovent JJ O B-m
110 CD O B-do
mcg NN B-NP I-do
b.i.d NN I-NP B-f
ALLERGIES: NNP I-NP O
penicillin NN I-NP O
which WDT O O
caused VBD B-VP O
hives NNS B-NP O
and CC O O
swelling VBG O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
He PRP O O
previously RB O O
a DT B-NP O
smoker NN I-NP O
He PRP O O
does VBZ O O
not RB O O
drink VB O O
He PRP O O
is VBZ O O
a DT B-NP O
nursing NN I-NP O
home NN I-NP O
resident NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
two CD O O
brothers NNS B-NP O
who WP O O
had VBD B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
in IN B-VP O
their PRP$ O O
60s CD O O
No NNPS B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
cancer NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Vitals NNP I-NP O
as IN B-VP O
previous JJ O O
noted VBD B-VP O
, , O O
blood NN B-NP O
pressure NN I-NP O
in IN B-VP O
the DT O O
80s/49 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
80 CD O O
, , O O
regular JJ O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
20 CD O O
, , O O
O2 NNP B-NP O
saturation NN I-NP O
93% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Patient NNP I-NP O
was VBD B-VP O
afebrile JJ B-NP O
Pertinent NNP I-NP O
physical JJ B-NP O
findings NNS I-NP O
included: NN I-NP O
Pulmonary: NNP I-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
prolonged JJ I-NP O
expiratory NN I-NP O
phase NN I-NP O
, , O O
but CC O O
no DT B-NP O
crackles NNS I-NP O
Cardiovascular: NNP I-NP O
Distant NNP I-NP O
heart NN I-NP O
sounds VBZ O O
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
Normal NNP I-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
No NNP I-NP O
rubs NN I-NP O
or CC O O
gallops NNS B-NP O
Systolic JJ B-NP O
ejection NN I-NP O
or CC O O
murmur VB O O
3/6 CD O O
at IN B-VP O
the DT B-NP O
left NN I-NP O
lower RBR O O
sternal JJ B-NP O
border NN I-NP O
Abdomen: NNP I-NP O
Obese NNP I-NP O
, , O O
distended VBD B-VP O
abdomen NNS B-NP O
, , O O
left VBD B-VP O
lower JJR B-NP O
quadrant JJ I-NP O
tenderness NN I-NP O
to TO O O
palpation VB O O
No DT B-NP O
rebound NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
Extremities NNS I-NP O
are VBP O O
warm JJ O O
, , O O
2+ CD O O
pulses NNS B-NP O
with IN B-VP O
1+ CD O O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
to TO O O
the DT B-NP O
shins NNS I-NP O
Neurologic: NNP I-NP O
Alert NNP I-NP O
and CC O O
oriented VBN O O
x3 NN B-NP O
, , O O
cranial JJ B-NP O
nerves NNS I-NP O
grossly RB O O
intact JJ O O
, , O O
no DT B-NP O
abnormalities NNS I-NP O
admission VBP O O
abdominal JJ B-NP O
CT NNP I-NP O
showed VBD B-VP O
bowel IN B-VP O
wall NN B-NP O
thickening NN I-NP O
in IN B-VP O
the DT O O
descending VBG O O
sigmoid JJ B-NP O
colon NN I-NP O
and CC O O
rectum NN B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
showed VBD B-VP O
left-sided JJ B-NP O
pleural JJ I-NP O
effusion NN I-NP O
, , O O
atelectasis NN B-NP O
in IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
lobe NN I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Labs NNP I-NP O
were VBD B-VP O
significant JJ O O
for IN B-VP O
a DT B-NP O
white JJ I-NP O
count NN I-NP O
of IN B-VP O
15.7 CD O O
, , O O
hematocrit NN B-NP O
of IN B-VP O
35.5 CD O O
and CC O O
INR NNP B-NP O
of IN B-VP O
3.2 CD O O
Electrolytes NNS B-NP O
were VBD B-VP O
normal JJ B-NP O
Patient NNP I-NP O
was VBD B-VP O
initially RB O O
admitted VBN O O
to TO O O
the DT B-NP O
MICU NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
and CC O O
infectious JJ B-NP O
etiology NN I-NP O
He PRP O O
was VBD B-VP O
stabilized VBN O O
there RB O O
and CC O O
transferred VBD B-VP O
to TO O O
the DT B-NP O
floor NN I-NP O
within IN B-VP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
Colitis NNP B-NP O
, , O O
presumed VBD B-VP O
infectious JJ B-NP O
etiology NN I-NP O
, , O O
descending VBG O O
and CC O O
sigmoid JJ B-NP O
colon NN I-NP O
Colitis NNP I-NP O
was VBD B-VP O
worse JJR O O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
month NN I-NP O
, , O O
associated VBN O O
with IN B-VP O
diarrhea JJ B-NP O
Abdominal NNP I-NP O
CT NNP I-NP O
is VBZ O O
consistent JJ O O
with IN B-VP O
an DT B-NP O
infectious JJ I-NP O
inflammatory NN I-NP O
bowel NN I-NP O
process NN I-NP O
Given NNP I-NP O
history NN I-NP O
of IN B-VP O
C NNP B-NP O
diff NN I-NP O
colitis NN I-NP O
, , O O
C NNP B-NP O
diff NN I-NP O
was VBD B-VP O
the DT O O
most RBS O O
likely JJ B-NP O
infectious JJ I-NP O
etiology NN I-NP O
, , O O
but CC O O
others NNS B-NP O
were VBD B-VP O
possible JJ B-NP O
Ischemic NNP I-NP O
colitis NN I-NP O
was VBD B-VP O
considered VBN O O
secondary JJ O O
to TO O O
low JJ O O
forward RB O O
flow NN B-NP O
, , O O
given VBN O O
patient's NN B-NP O
cardiomyopathy NN I-NP O
and CC O O
low JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
20% CD O O
to TO O O
35% CD O O
and CC O O
he PRP O O
also RB O O
got VBD B-VP O
a DT B-NP O
pattern NN I-NP O
of IN B-VP O
inflammatory JJ B-NP O
colitis NN I-NP O
or CC O O
nonspecific JJ B-NP O
colitis NN I-NP O
Stool NNP I-NP O
samples NNS I-NP O
were VBD B-VP O
sent VBN O O
for IN B-VP O
a DT B-NP O
C NNP I-NP O
diff NN I-NP O
toxin NN I-NP O
and CC O O
assay NN B-NP O
and CC O O
all DT O O
were VBD B-VP O
negative JJ B-NP O
x NN I-NP O
at IN B-VP O
least JJS O O
3 CD O O
samples NNS B-NP O
Stool NNP I-NP O
cultures NNS I-NP O
were VBD B-VP O
sent VBN O O
and CC O O
did VBD B-VP O
not RB O O
grow VB O O
anything NN B-NP O
out RP O O
during IN B-VP O
admission NN B-NP O
Empiric NNP I-NP O
treatment NN I-NP O
was VBD B-VP O
started VBN O O
with IN B-VP O
p.o NN B-NP B-mo
vancomycin NN I-NP B-m
Patient's NNP I-NP O
abdominal NN I-NP O
pain NN I-NP O
continued VBD B-VP O
to TO O O
improve VB O O
and CC O O
completely RB O O
resolved VBN O O
By IN B-VP O
discharge NN B-NP O
, , O O
patient NN B-NP O
remained VBD B-VP O
afebrile JJ O O
and CC O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
decreased VBD B-VP O
Advance NNP B-NP O
patient's NN I-NP O
diet NN I-NP O
as IN B-VP O
tolerated VBN O O
and CC O O
by IN B-VP O
discharge NN B-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
up RB O O
to TO O O
soft JJ B-NP O
solids NNS I-NP O
We PRP O O
added VBD B-VP O
lactobacillus CC O B-m
p.o NN B-NP B-mo
for IN B-VP O
probiotics NNS B-NP O
and CC O O
patient NN B-NP O
also RB O O
had VBD B-VP O
flex VBN O O
sig RB O O
two CD O O
days NNS B-NP O
before IN B-VP O
discharge NN B-NP O
, , O O
showing VBG O O
resolving VBG O O
inflammation NN B-NP O
consistent NN I-NP O
with IN B-VP O
colitis NN B-NP O
of IN B-VP O
inflammatory JJ B-NP O
etiology NN I-NP O
The DT B-NP O
flex JJ I-NP O
sig NN I-NP O
did VBD B-VP O
not RB O O
change VB O O
his PRP$ O O
management NN B-NP O
We PRP O O
did VBD B-VP O
discharge VB O O
the DT B-NP O
patient NN I-NP O
on IN B-VP O
a DT B-NP O
2-week JJ I-NP B-du
course NN I-NP I-du
p.o NN I-NP B-mo
vancomycin VBP O B-m
alone RB O O
2 CD O O
Coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
Patient NNP I-NP O
had VBD B-VP O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
acute JJ B-NP O
coronary JJ I-NP O
syndrome NN I-NP O
on IN B-VP O
admission NN B-NP O
We PRP O O
continued VBD B-VP O
his PRP$ O O
aspirin NN B-NP B-m
, , O O
Plavix NNP B-NP B-m
, , O O
statin NN B-NP B-m
and CC O O
beta-blocker NN B-NP B-m
Patient NNP I-NP O
had VBD B-VP O
no DT B-NP O
ischemic JJ I-NP O
issues NNS I-NP O
or CC O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
issues NNS I-NP O
during IN B-VP O
his PRP$ O O
admission NN B-NP O
3 CD O O
CHF NNP B-NP O
Patient NNP I-NP O
has VBZ O O
previous JJ B-NP O
EF NNP I-NP O
noted VBD B-VP O
at IN B-VP O
20% CD O O
to TO O O
35% CD O O
, , O O
so RB O O
a DT B-NP O
gentle JJ I-NP B-m
hydration NN I-NP I-m
therapy NN I-NP I-m
at IN B-VP O
first JJ O O
in IN B-VP O
the DT B-NP O
MICU NNP I-NP O
for IN B-VP O
hypertension NN B-NP B-r
and CC O O
then RB O O
as IN B-VP O
patient's NN B-NP O
blood NN I-NP O
pressure NN I-NP O
increased VBD B-VP O
, , O O
was VBD B-VP O
able JJ O O
to TO O O
restart VB O O
patient's NN B-NP O
Lasix NNP I-NP B-m
dose NN I-NP O
in IN B-VP O
order NN B-NP O
to TO O O
diurese VB O O
all DT O O
of IN B-VP O
the DT B-NP O
extra JJ I-NP B-r
fluid NN I-NP O
gained VBN O O
during IN B-VP O
the DT B-NP O
rehydration NN I-NP O
therapy NN I-NP O
, , O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
the DT B-NP O
Lasix NNP I-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
his PRP$ O O
daily JJ B-NP O
dose NN I-NP O
at IN B-VP O
home NN B-NP O
Also RB O O
considered VBD B-VP O
restarting VBG O O
lisinopril NN B-NP B-m
, , O O
but CC O O
deferred VBD B-VP O
discharge NN B-NP O
to TO O O
outpatient VB O O
follow VB O O
up RP O O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
for IN B-VP O
restart NN B-NP O
of IN B-VP O
lisinopril NN B-NP B-m
, , O O
once RB O O
patient NN B-NP O
is VBZ O O
fully RB O O
recovered VBN O O
4 CD O O
Chronic NNP B-NP O
kidney NN I-NP O
disease NN I-NP O
Patient NNP I-NP O
had VBD B-VP O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
creatinine NN B-NP O
1.2 CD O O
to TO O O
1.5 CD O O
and CC O O
he PRP O O
came VBD B-VP O
into IN B-VP O
the DT B-NP O
hospital NN I-NP O
with IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1.0 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
below IN B-VP O
baseline NN B-NP O
and CC O O
remained VBD B-VP O
below IN B-VP O
baseline NN B-NP O
during IN B-VP O
admission NN B-NP O
He PRP O O
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP O
renal JJ I-NP O
issues NNS I-NP O
5 CD O O
Hematology NNP B-NP O
Patient NNP I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
a DT B-NP O
line-induced JJ I-NP O
DVT NNP I-NP O
, , O O
has VBZ O O
been VBN O O
treated VBN O O
with IN B-VP O
Coumadin NNP B-NP B-m
, , O O
with IN B-VP O
no DT B-NP O
definitive JJ I-NP O
evidence NN I-NP O
as IN B-VP O
to TO O O
how WRB O O
along JJ B-NP O
patient NN I-NP O
should MD O O
be VB O O
treated VBN O O
, , O O
given VBN O O
that IN B-VP O
the DT B-NP O
DVT NNP I-NP O
was VBD B-VP O
line NN B-NP O
induced VBN O O
Coumadin NNP B-NP B-m
was VBD B-VP O
therapeutic JJ O O
on IN B-VP O
admission NN B-NP O
, , O O
became VBD B-VP O
supertherapeutic JJ O O
in IN B-VP O
the DT B-NP O
MICU NNP I-NP O
Held NNP I-NP O
Coumadin NNP I-NP B-m
until IN B-VP B-du
INR NNP B-NP O
fell VBD B-VP O
below IN B-VP O
3 CD O O
, , O O
restarted VBN O O
Coumadin NNP B-NP B-m
afterwards NNS I-NP O
at IN B-VP O
6 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
patient's NN B-NP O
normal JJ B-NP O
dose JJ I-NP O
Patient NNP I-NP O
was VBD B-VP O
therapeutic JJ O O
on IN B-VP O
discharge NN B-NP O
Will NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
for IN B-VP O
Coumadin NNP B-NP B-m
monitoring VBG O O
6 CD O O
Nutrition NNP B-NP O
Patient NNP I-NP O
was VBD B-VP O
in IN B-VP O
the DT B-NP O
MICU NNP I-NP O
and CC O O
was VBD B-VP O
n.p.o RB O O
given VBN O O
abdominal JJ B-NP O
pain NN I-NP O
and CC O O
colitis NN B-NP O
When WRB O O
transferred VBN O O
to TO O O
floor NN B-NP O
, , O O
was VBD B-VP O
started VBN O O
on IN B-VP O
liquid NN B-NP O
diet NN I-NP O
and CC O O
advanced VBD B-VP O
to TO O O
soft JJ B-NP O
solid JJ I-NP O
diet NN I-NP O
By IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
have VB O O
abdominal JJ B-NP O
pain NN I-NP O
and CC O O
most JJS O O
of IN B-VP O
the DT B-NP O
diarrhea NN I-NP O
had VBD B-VP O
resolved VBN O O
PROCEDURES NNP B-NP O
PERFORMED: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
flexible JJ I-NP O
sigmoidoscopy NN I-NP O
during IN B-VP O
the DT B-NP O
admission NN I-NP O
that WDT O O
showed VBD B-VP O
colitis NNS B-NP O
consistent JJ O O
with IN B-VP O
inflammatory JJ B-NP O
etiology NN I-NP O
DIAGNOSIS: NNP I-NP O
Patient NNP I-NP O
had VBD B-VP O
repeated VBN O O
negative JJ B-NP O
C NNP I-NP O
diff NN I-NP O
toxin NN I-NP O
assays NNS I-NP O
, , O O
but CC O O
colitis NN B-NP O
was VBD B-VP O
presumed VBN O O
to TO O O
be VB O O
C NNP B-NP O
diff NN I-NP O
and CC O O
given VBN O O
history NN B-NP O
, , O O
could MD O O
have VB O O
been VBN O O
other JJ O O
infectious JJ O O
or CC O O
inflammatory JJ B-NP O
etiologies NNS I-NP O
Patient NNP I-NP O
continued VBD B-VP O
to TO O O
improve VB O O
on IN B-VP O
vancomycin NN B-NP B-m
and CC O O
thus RB O O
was VBD B-VP O
discharged VBN O O
with IN B-VP O
presumed JJ B-NP O
C NNP I-NP O
diff NN I-NP O
colitis NN I-NP O
diagnosis NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Included NNP I-NP O
aspirin VBD B-VP B-m
81 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
digoxin NN B-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Nexium NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Flovent NNP B-NP B-m
110 CD O B-do
mcg NN B-NP I-do
inhale NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
lactobacillus CC O B-m
2 CD O B-do
tabs NNS B-NP I-do
p.o JJ B-NP B-mo
t.i.d NN I-NP B-f
, , O O
metoprolol FW O B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
simvastatin VBD B-VP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
bed NN B-NP I-f
time NN I-NP I-f
, , O O
Flomax NNP B-NP B-m
0.4 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
every DT B-NP B-f
evening NN I-NP O
, , O O
vancomycin FW O B-m
250 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
every DT O B-f
6 CD O I-f
hours NNS B-NP I-f
x8 JJ B-NP B-du
days NNS I-NP I-du
at IN B-VP O
discharge NN B-NP O
and CC O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
every DT B-NP B-f
evening NN I-NP I-f
Patient NNP I-NP O
had VBD B-VP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
setup NN B-NP O
for IN B-VP O
2 CD O O
to TO O O
3 CD O O
weeks NNS B-NP O
after IN B-VP O
discharge NN B-NP O
eScription NN I-NP O
document: VBZ O O
5-3515128 JJ B-NP O
HFFocus NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
SOLLOCK NNP I-NP O
, , O O
SHELTON NNP B-NP O
Attending: NNP I-NP O
VALLEJOS NNP I-NP O
, , O O
JAIME NNP B-NP O
TERRANCE NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6974267 CD O O
D: NNP B-NP O
1/25/06 CD O O
T: NNP B-NP O
11/21/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#87290 VBZ O O
280126400 CD O O
BHSH NNP B-NP O
01276695 CD O O
7973693 CD O O
7/15/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
s/p JJ B-NP O
pacemaker NN I-NP O
placement NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/17/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/17/2007 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
FRIGGE NNP I-NP O
, , O O
ELI NNP B-NP O
047-45-81-2 NNP I-NP O
S NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
5/2/07 CD O O
AT NNP B-NP O
03:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
PIEDRA NNP I-NP O
, , O O
AUGUSTINE NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
CLINDAMYCIN NNP I-NP B-m
HCL NNP I-NP I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
X NNP I-NP B-du
12 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
after IN B-VP O
IV NNP B-NP B-mo
ANTIBIOTICS NNP I-NP B-m
END NNP I-NP O
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
GLIPIZIDE NNP I-NP B-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
120 CD O O
Alert NNP B-NP O
overridden: MD O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
3/22/07 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
Previous NNP I-NP O
Override NNP I-NP O
Notice NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
3/22/07 CD O O
by IN B-VP O
YANCE NNP B-NP O
, , O O
LAZARO NNP B-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IV NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
762756022 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
REGLAN NNP I-NP B-m
( ( O I-m
METOCLOPRAMIDE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
SENNA NNP I-NP B-m
TABLETS NNP I-NP I-m
( ( O I-m
SENNOSIDES NNP B-NP I-m
) ) O I-m
2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Not RB O O
Applicable NNP B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Colonnese NNP I-NP O
( ( O O
cardiac JJ B-NP O
cath NN I-NP O
) ) O O
813.650-9721 CD O O
4/0/07 CD O O
@ NN B-NP O
11:20am CD O O
, , O O
Dr NNP B-NP O
Neville NNP I-NP O
Lemmen NNP I-NP O
( ( O O
pcp NN B-NP O
) ) O O
10/10/07 CD O O
@ $ O O
11:45am CD O O
, , O O
Dr NNP B-NP O
Randolph NNP I-NP O
Beren NNP I-NP O
( ( O O
cardiology NN B-NP O
) ) O O
1/15/07 CD O O
@ $ O O
4:30pm CD O O
, , O O
Dr NNP B-NP O
Woten NNP I-NP O
( ( O O
EP-pacemaker NNP B-NP O
) ) O O
813.650-9721 CD O O
6/9/07 CD O O
@ NN B-NP O
8:30am CD O O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
lightheadedness NN I-NP O
, , O O
hypertension NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
s/p NN B-NP O
pacemaker NN I-NP O
placement NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CAD NNP I-NP O
s/p VBD B-VP O
CABG NNP B-NP O
x NNP I-NP O
2 CD O O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
, , O O
RAS NNP B-NP O
c VBZ O O
L NNP B-NP O
renal JJ B-NP O
stent NN I-NP O
, , O O
bilateral JJ B-NP O
common JJ I-NP O
iliac JJ I-NP O
artery NN I-NP O
stents NNS I-NP O
, , O O
PAF NNP B-NP O
( ( O O
paroxysmal JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
) ) O O
, , O O
DM NNP B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
pacemaker NN B-NP O
placement NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
lightheadedness NN I-NP O
, , O O
hypertension NN B-NP O
HPI: NNP I-NP O
83yo CD O O
W NNP B-NP O
c NN I-NP O
4 CD O O
recent JJ B-NP O
admits NNS I-NP O
for IN B-VP O
LH NNP B-NP O
and CC O O
elevated VBD B-VP O
BP NNP B-NP O
, , O O
with IN B-VP O
h/o JJ B-NP O
paroxysmal JJ I-NP O
rapid JJ I-NP O
afib NN I-NP O
and CC O O
tachy-brady JJ B-NP O
syndrome NN I-NP O
, , O O
admitted VBN O O
for IN B-VP O
LH NNP B-NP O
, , O O
SBP NNP B-NP O
in IN B-VP O
190s CD O O
No NNP B-NP O
CP NNP I-NP O
, , O O
no DT B-NP O
palps NN I-NP O
, , O O
no DT B-NP O
n/v NN I-NP O
In IN B-VP O
ED NNP B-NP O
SBP NNP I-NP O
to TO O O
170s CD O O
to TO O O
130s CD O O
without IN B-VP O
intervention NN B-NP O
On IN B-VP O
prior JJ B-NP O
admits NNS I-NP O
has VBZ O O
had VBN O O
intermittent JJ B-NP O
HTN NNP I-NP O
, , O O
a DT B-NP O
fib JJ I-NP O
c NN I-NP O
RVR NNP I-NP O
c NN I-NP O
bradycardia/pauses NNS I-NP O
c VBP O O
lopressor NN B-NP B-m
On IN B-VP O
last JJ B-NP O
admit NN I-NP O
, , O O
pt NN B-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
EP NNP B-NP O
and CC O O
BB NNP B-NP O
and CC O O
amiodarone NN B-NP B-m
were VBD B-VP O
stopped VBN O O
2/2 CD O O
bradycardia/pauses NNS B-NP O
with IN B-VP O
plan NN B-NP O
for IN B-VP O
f/u NN B-NP O
with IN B-VP O
outpatient JJ B-NP O
cardiology NN I-NP O
Pt NNP I-NP O
represents VBZ O O
with IN B-VP O
similar JJ B-NP O
sxs NN I-NP O
( ( O O
has VBZ O O
not RB O O
seen VBN O O
cardiologist NN B-NP O
yet RB O O
) ) O O
PMH: NNP B-NP O
CAD NNP I-NP O
s/p NN I-NP O
CABG NNP I-NP O
, , O O
RAS NNP B-NP O
s/p VBD B-VP O
stenting VBG O O
x2 NN B-NP O
, , O O
atherosclerosis NN B-NP O
of IN B-VP O
abd JJ B-NP O
aorta NN I-NP O
and CC O O
celiac JJ B-NP O
artery NN I-NP O
, , O O
b/l JJ B-NP O
common JJ I-NP O
iliac NN I-NP O
stents NNS I-NP O
, , O O
afib NN B-NP O
, , O O
DM NNP B-NP O
Home NNP I-NP O
Meds: NNP I-NP O
ASA NNP I-NP B-m
325qd CD O B-do
, , O O
Lipitor NNP B-NP B-m
80qd CD O B-do
, , O O
plavix NN B-NP B-m
75qd CD O B-do
, , O O
colace NN B-NP B-m
100bid CD O B-do
, , O O
nexium NN B-NP B-m
40qd CD O B-do
, , O O
glipizide RB O B-m
2.5qd CD O B-do
, , O O
lisinopril VBD B-VP B-m
5 CD O B-do
bid NN B-NP B-f
, , O O
reglan NN B-NP B-m
10tid CD O B-do
, , O O
mom NN B-NP B-m
qhs NN I-NP B-f
All: NNP I-NP O
PCN--&gt;hives NNP I-NP O
SocHx: NNP I-NP O
retired; NN I-NP O
lives VBZ O O
w/son; JJ O O
no DT B-NP O
etoh/tob/illicits NNS I-NP O
STATUS: NNP I-NP O
afebrile NN I-NP O
, , O O
HR NNP B-NP O
NSR NNP I-NP O
70s CD O O
, , O O
130s/70s CD O O
PROC/STUDIES: NNP B-NP O
1/5 CD O O
EKG: NNP B-NP O
NSR NNP I-NP O
, , O O
lat JJ B-NP O
TW NNP I-NP O
flattening VBG O O
unchanged JJ O O
1/5 CD O O
CXR: NNP B-NP O
no DT B-NP O
acute JJ I-NP O
process NN I-NP O
1/5 CD O O
KUB: NNP B-NP O
nonspecific NN I-NP O
gas NN I-NP O
pattern NN I-NP O
1/8 CD O O
pacemaker NN B-NP O
placement NN I-NP O
CONSULTS: NNP I-NP O
EP NNP I-NP O
Hospital NNP I-NP O
course: VBD B-VP O
1 CD O O
) ) O O
CV: NNP B-NP O
HTN: NNP I-NP O
Unclear NNP I-NP O
precipitant NN I-NP O
for IN B-VP O
intermittent NN B-NP O
HTN NNP I-NP O
- : O O
?2/2 JJ O O
renal JJ O O
known VBN O O
renal JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
, , O O
HR NNP B-NP O
lability NN I-NP O
, , O O
autonomic JJ B-NP O
syndrome NN I-NP O
Given NNP I-NP O
h/o VBD B-VP O
tachy-brady JJ O O
and CC O O
difficult JJ O O
to TO O O
control VB O O
afib JJ B-NP O
w/bradycardia NN I-NP O
and CC O O
documented JJ B-NP O
pauses NNS I-NP O
, , O O
EP NNP B-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
a DT B-NP O
dual JJ I-NP O
chamber NN I-NP O
GUIDANT NNP I-NP O
pacemaker NN I-NP O
inserted VBD B-VP O
without IN B-VP O
difficulty NN B-NP O
on IN B-VP O
10/13 CD O O
- : O O
programmed VBN O O
to TO O O
DDI NNP B-NP O
60 CD O O
mode NN B-NP O
BB NNP I-NP B-m
was VBD B-VP O
initiated VBN O O
and CC O O
plan NN B-NP O
to TO O O
continue VB O O
Toprol NNP B-NP B-m
XL NNP I-NP I-m
upon IN B-VP O
discharge NN B-NP O
Plan NN I-NP O
to TO O O
continue VB O O
clindamycin JJ B-NP B-m
qid NN I-NP B-f
to TO O O
complete VB O O
3 CD O B-du
day NN B-NP I-du
course NN I-NP I-du
and CC O O
to TO O O
f/u VB O O
with IN B-VP O
EP NNP B-NP O
in IN B-VP O
2wks CD O O
Upon IN B-VP O
discharge NN B-NP O
, , O O
pt's NN B-NP O
hr NN I-NP O
60 CD O O
, , O O
bp VBD B-VP O
130s/70s CD O O
Anticoagulation-discussion NN B-NP O
on IN B-VP O
previous JJ B-NP O
admit NN I-NP O
initiated VBN O O
with IN B-VP O
cardiology NN B-NP O
who WP O O
recommended VBD B-VP O
dc'ing VBG O O
Aspirin NNP B-NP B-m
and CC O O
adding VBG O O
Coumadin NNP B-NP B-m
with IN B-VP O
Plavix NNP B-NP B-m
for IN B-VP O
anticoagulation NN B-NP B-r
anticoagulation NN I-NP B-r
, , O O
but CC O O
deferred VBD B-VP O
decision NN B-NP O
to TO O O
pt's VB O O
outpatient JJ B-NP O
cardiologist NN I-NP O
Dr NNP I-NP O
Duenke NNP I-NP O
Plan NNP I-NP O
for IN B-VP O
this DT B-NP O
admission NN I-NP O
is VBZ O O
the DT B-NP O
same- JJ I-NP O
continue NN I-NP O
pt's NN I-NP O
home NN I-NP O
ASA NNP I-NP B-m
and CC O O
Plavix NNP B-NP B-m
now RB O O
, , O O
with IN B-VP O
plan NN B-NP O
to TO O O
f/u VB O O
with IN B-VP O
Dr NNP B-NP O
Breck NNP I-NP O
for IN B-VP O
discussion NN B-NP O
of IN B-VP O
risks/benefits NNS B-NP O
of IN B-VP O
initiating VBG O O
coumadin JJ O B-m
2 CD O O
) ) O O
Heme+ NNP B-NP O
stool: JJ B-NP O
Trace NNP I-NP O
in IN B-VP O
ED NNP B-NP O
, , O O
HCT NNP B-NP O
stable JJ B-NP O
Got NNP I-NP O
IV NNP I-NP B-mo
nexium NN I-NP B-m
, , O O
IVF NNP B-NP O
, , O O
large JJ B-NP O
bore NN I-NP O
IVs NNP I-NP O
initially RB O O
but CC O O
no DT B-NP O
melena NN I-NP O
Hct NNP I-NP O
remained VBD B-VP O
stable JJ O O
throughout IN B-VP O
hospital JJ B-NP O
course NN I-NP O
Would NNP I-NP O
recommend VB O O
outpatient JJ B-NP O
colonoscopy NN I-NP O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
3 CD O O
) ) O O
DM: NNP B-NP O
while IN B-VP B-du
in-house NN B-NP I-du
, , O O
pt NN B-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
NPH NNP B-NP B-m
and CC O O
RISS; NNP B-NP B-m
plan NN I-NP O
to TO O O
resume VB O O
home NN B-NP B-m
meds NNS I-NP I-m
upon IN B-VP O
discharge NN B-NP O
4 CD O O
) ) O O
Renal JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
- : O O
s/p NN B-NP O
stenting VBG O O
x $ O O
2 CD O O
Cr NNP B-NP O
at IN B-VP O
baseline NN B-NP O
5 CD O O
) ) O O
Constipation: NNP B-NP O
pt NN I-NP O
came VBD B-VP O
in IN B-VP O
with IN B-VP O
constipation NN B-NP B-r
constipation NN I-NP B-r
with IN B-VP O
no DT B-NP O
bm NN I-NP O
x1wk VBZ O O
pta JJ B-NP O
Dulcolax NNP I-NP B-m
and CC O O
stool JJ B-NP B-m
softeners NNS I-NP I-m
given VBN O O
with IN B-VP O
good JJ B-NP O
response NN I-NP O
Plan NN I-NP O
to TO O O
cont VB O O
stool NN B-NP B-m
softeners NNS I-NP O
upon IN B-VP O
discharge NN B-NP O
6 CD O O
) ) O O
Code: NNP B-NP O
DNI NNP I-NP O
, , O O
not RB O O
DNR NNP B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
For IN B-VP O
VNA: NNP B-NP O
pls NN I-NP O
check NN I-NP O
pt's NN I-NP O
vital JJ B-NP O
signs NNS I-NP O
, , O O
cardiopulmonary JJ B-NP O
assessment NN I-NP O
, , O O
assist NN B-NP O
with IN B-VP O
medications NNS B-NP O
For IN B-VP O
Pt: NNP B-NP O
1 CD O O
Please NNP B-NP O
continue VB O O
to TO O O
take VB O O
the DT B-NP O
antibiotic JJ I-NP B-m
antibiotic JJ I-NP B-m
Clindamycin NNP I-NP I-m
Clindamycin NNP I-NP B-m
until IN B-VP B-du
until IN B-VP B-du
until IN B-VP B-du
you PRP O O
run VBP O O
out IN B-VP O
of IN B-VP O
pills NNS B-NP O
2 CD O O
Please NNP B-NP O
call VB O O
your PRP$ O O
doctor NN B-NP O
or CC O O
go VB O O
to TO O O
the DT B-NP O
nearest JJS I-NP O
ER NN I-NP O
if IN B-VP O
you PRP O O
have VBP O O
fever&gt;100.4 VBN O O
, , O O
chills NNS B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
chest JJS B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
anything NN B-NP O
else RB O O
concerning VBG O O
to TO O O
you PRP O O
3 CD O O
Continue NNP B-NP O
stool NN I-NP B-m
softeners NNS I-NP I-m
for IN B-VP O
constipation NN B-NP B-r
Resume NNP I-NP O
all DT B-NP O
home NN I-NP B-m
meds NNS I-NP I-m
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BRIDENBECKER NNP I-NP O
, , O O
PIERRE NNP B-NP O
J NNP I-NP O
, , O O
MD NNP B-NP O
( ( O O
QN41 NNP B-NP O
) ) O O
5/2/07 CD O O
@ $ O O
03:16 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#89464 VBZ O O
555294245 CD O O
HMC NNP B-NP O
78160786 CD O O
533045 CD O O
8/20/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/20/1999 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/20/1999 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
BILATERAL NNP I-NP O
LOWER NNP I-NP O
EXTREMITY NNP I-NP O
WEAKNESS NNP I-NP O
OTHER NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
MORBID NNP I-NP O
OBESITY NNP I-NP O
2 CD O O
OBSTRUCTIVE NNP B-NP O
SLEEP NNP I-NP O
APNEA NNP I-NP O
3 CD O O
ATRIAL NNP B-NP O
FIBRILLATION NNP I-NP O
4 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
CELLULITIS NNP I-NP O
5 CD O O
EJECTION NNP B-NP O
FRACTION NNP I-NP O
OF IN B-VP O
40 CD O O
PERCENT NN B-NP O
WITH NNP I-NP O
LEFT NNP I-NP O
ATRIAL NNP I-NP O
ENLARGEMENT NNP I-NP O
6 CD O O
URINARY NNP B-NP O
TRACT NNP I-NP O
INFECTION NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Mr NNP I-NP O
Foller NNP I-NP O
is VBZ O O
a DT O O
very RB O O
pleasant JJ O O
59 CD O O
year-old JJ B-NP O
man NN I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
morbid NN B-NP O
obesity NN I-NP O
, , O O
paroxysmal JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
and CC O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
40 CD O O
percent NN B-NP O
who WP O O
presents VBZ O O
status NN B-NP O
post NN I-NP O
a DT B-NP O
fall NN I-NP O
and CC O O
with IN B-VP O
increasing VBG O O
urinary JJ B-NP O
frequency NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Neilsen NNP I-NP O
has VBZ O O
morbid VBN O O
obesity NN B-NP O
and CC O O
is VBZ O O
currently RB O O
at IN B-VP O
a DT B-NP O
weight NN I-NP O
of IN B-VP O
450 CD O O
pounds NNS B-NP O
and CC O O
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
fluctuating VBG O O
weight NN B-NP O
with IN B-VP O
decrease NN B-NP O
in IN B-VP O
weight NN B-NP O
to TO O O
200 CD O O
pounds NNS B-NP O
with IN B-VP O
dieting VBG O O
He PRP O O
also RB O O
has VBZ O O
obstructive JJ B-NP O
sleep JJ I-NP O
apnea NN I-NP O
on IN B-VP O
continuous JJ B-NP O
positive JJ I-NP O
airway NN I-NP O
pressure NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
and CC O O
is VBZ O O
not RB O O
anticoagulated VBN O O
per IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
He PRP O O
has VBZ O O
a DT O O
mildly RB O O
decreased JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
with IN B-VP O
mitral JJ B-NP O
regurgitation NN I-NP O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
cellulitis NN B-NP O
He PRP O O
presented VBD B-VP O
in IN B-VP O
4/10 CD O O
for IN B-VP O
a DT B-NP O
short JJ I-NP O
stay NN I-NP O
unit NN I-NP O
admission NN I-NP O
with IN B-VP O
progressive JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
weakness NN I-NP O
bilaterally RB O O
and CC O O
urinary JJ B-NP O
incontinence NN I-NP O
It PRP O O
was VBD B-VP O
felt VBN O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
by IN B-VP O
neurosurgery NN B-NP O
and CC O O
neurology NN B-NP O
to TO O O
be VB O O
multifactorial JJ O O
and CC O O
no DT O O
consistent JJ O O
with IN B-VP O
disk NN B-NP O
or CC O O
cord NN B-NP O
impingement NN I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
work NN I-NP O
up RB O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
including VBG O O
B12 NNP B-NP O
, , O O
ANA NNP B-NP O
and CC O O
HIV NNP B-NP O
all DT O O
of IN B-VP O
which WDT O O
were VBD B-VP O
negative JJ B-NP O
EMG NNP I-NP O
showed VBD B-VP O
decreased JJ B-NP O
recruitment NN I-NP O
in IN B-VP O
the DT B-NP O
tibialis NN I-NP O
anterior NN I-NP O
and CC O O
gastrocnemius NN B-NP O
bilaterally RB O O
His PRP$ O O
rectus NN B-NP O
femoris NN I-NP O
were VBD B-VP O
normal JJ O O
bilaterally RB O O
He PRP O O
was VBD B-VP O
treated VBN O O
for IN B-VP O
a DT B-NP B-r
urinary JJ I-NP I-r
tract NN I-NP I-r
infection NN I-NP I-r
at IN B-VP O
that DT B-NP O
time NN I-NP O
with IN B-VP O
Bactrim NNP B-NP B-m
Bactrim NNP I-NP B-m
for IN B-VP O
resolution NN B-NP O
of IN B-VP O
his PRP$ O B-r
incontinence NN B-NP I-r
and CC O O
he PRP O O
was VBD B-VP O
not RB O O
anticoagulated VBN O O
by IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
Since IN B-VP O
discharge NN B-NP O
he PRP O O
noted VBD B-VP O
continued JJ O O
right RB O O
greater JJR O O
than IN B-VP O
left VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
weakness NN I-NP O
otherwise RB O O
at IN B-VP O
baseline NN B-NP O
health NN I-NP O
until IN B-VP O
two CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
he PRP O O
noted VBD B-VP O
some DT B-NP O
lumbar NN I-NP O
and CC O O
sacral JJ B-NP O
pain NN I-NP O
, , O O
nonradiating NN B-NP O
, , O O
worse JJR O O
while IN B-VP O
moving VBG O O
his PRP$ O O
right NN B-NP O
leg NN I-NP O
Over IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
days NNS I-NP O
he PRP O O
noted VBD B-VP O
also RB O O
increasing VBG O O
urinary JJ B-NP O
frequency NN I-NP O
without IN B-VP O
burning VBG O O
or CC O O
urinary JJ B-NP O
incontinence NN I-NP O
, , O O
no DT B-NP O
fever NN I-NP O
or CC O O
chills NNS B-NP O
and CC O O
no DT B-NP O
costovertebral JJ I-NP O
angle NN I-NP O
tenderness NN I-NP O
or CC O O
pain NN B-NP O
No DT B-NP O
bowel NN I-NP O
incontinence NN I-NP O
or CC O O
perianal JJ B-NP O
numbness NN I-NP O
or CC O O
pain VB O O
The DT B-NP O
night NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
at IN B-VP O
7:30 CD O O
p.m NN B-NP O
while IN B-VP O
getting VBG O O
up RP O O
from IN B-VP O
a DT B-NP O
chair NN I-NP O
, , O O
his PRP$ O O
right JJ B-NP O
leg NN I-NP O
gave VBD B-VP O
out RB O O
and CC O O
he PRP O O
fell VBD B-VP O
to TO O O
the DT B-NP O
floor NN I-NP O
"gracefully" NN I-NP O
without IN B-VP O
injury NN B-NP O
or CC O O
head NN B-NP O
trauma NN I-NP O
, , O O
no DT B-NP O
loss NN I-NP O
of IN B-VP O
consciousness NN B-NP O
He PRP O O
had VBD B-VP O
no DT B-NP O
preceeding NN I-NP O
dizziness NN I-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
paresthesia NN B-NP O
and CC O O
presented VBN O O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
at IN B-VP O
the DT B-NP O
Onven NNP I-NP O
County NNP I-NP O
Hospital NNP I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
As IN B-VP O
above IN B-VP O
ALLERGIES: NNP B-NP O
Penicillin NNP I-NP O
gives VBZ O O
him PRP O O
hives VBZ O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
He PRP O O
is VBZ O O
a DT B-NP O
psychology NN I-NP O
Professor NNP I-NP O
, , O O
therapist NN B-NP O
, , O O
former JJ B-NP O
illicit NNS I-NP O
drug NN I-NP O
use NN I-NP O
including VBG O O
LSD NNP B-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
use NN I-NP O
, , O O
currently RB O O
Rare NNP B-NP O
alcohol NN I-NP O
use NN I-NP O
and CC O O
lives NNS B-NP O
with IN B-VP O
his PRP$ O O
wife NN B-NP O
of IN B-VP O
15 CD O O
years NNS B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Varicose NNP I-NP O
veins NNS I-NP O
, , O O
early JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
in IN B-VP O
a DT B-NP O
brother NN I-NP O
who WP O O
was VBD B-VP O
50 CD O O
years NNS B-NP O
old JJ O O
His PRP$ O O
parents NNS B-NP O
passed VBN O O
away RB O O
in IN B-VP O
a DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
accident NN I-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
clots NNS B-NP O
PHYSICAL NNP I-NP O
EXAM: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
morbidly RB O O
obese JJ B-NP O
man NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
, , O O
sitting VBG O O
in IN B-VP O
a DT B-NP O
chair NN I-NP O
Vital NNP I-NP O
signs NNS I-NP O
showed VBD B-VP O
temperature NN B-NP O
of IN B-VP O
97.1 CD O O
, , O O
pulse RB O O
80 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
148/90 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
with IN B-VP O
a DT B-NP O
respiratory JJ I-NP O
rate NN I-NP O
of IN B-VP O
20 CD O O
HEENT: NNP B-NP O
Obese NNP I-NP O
neck NN I-NP O
Pupils NNP I-NP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
No NNP I-NP O
conjunctivitis NN I-NP O
Oropharynx NNP I-NP O
is VBZ O O
clear JJ B-NP O
Mucous JJ I-NP O
membranes NNS I-NP O
were VBD B-VP O
moist JJ B-NP O
Jugular NNP I-NP O
venous JJ B-NP O
distention NN I-NP O
not RB O O
appreciated VBN O O
CHEST: NNP B-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
HEART: NNP B-NP O
II/VI NNP I-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
apex NN I-NP O
radiating VBG O O
to TO O O
the DT B-NP O
axilla NN I-NP O
Irregular NNP I-NP O
, , O O
irregular JJ B-NP O
rhythm NN I-NP O
No NNP I-NP O
S3 NNP I-NP O
or CC O O
S4 NNP B-NP O
ABDOMEN: NNP I-NP O
Obese NNP I-NP O
, , O O
soft JJ O O
and CC O O
nontender JJ B-NP O
ABDOMEN: NNP I-NP O
Obese NNP I-NP O
, , O O
soft JJ O O
and CC O O
nontender NN B-NP O
Nondistended VBD B-VP O
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
and CC O O
a DT B-NP O
significant JJ I-NP O
rash NN I-NP O
of IN B-VP O
his PRP$ O O
pannus NN B-NP O
RECTAL: NNP I-NP O
Strong NNP I-NP O
rectal JJ B-NP O
tone NN I-NP O
EXTREMITIES: NNP I-NP O
Right NNP I-NP O
calf NN I-NP O
was VBD B-VP O
with IN B-VP O
a DT B-NP O
shallow NN I-NP O
, , O O
erythematous JJ B-NP O
dry JJ I-NP O
ulcer NN I-NP O
which WDT O O
was VBD B-VP O
chronic JJ O O
with IN B-VP O
changes NNS B-NP O
consistent JJ O O
with IN B-VP O
venous JJ B-NP O
insufficiency NN I-NP O
and CC O O
varicose JJ B-NP O
veins NNS I-NP O
NEUROLOGICAL: NNP I-NP O
Nonfocal NNP I-NP O
Strength NNP I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
flexor NN I-NP O
was VBD B-VP O
decreased VBN O O
to TO O O
4/5 CD O O
and CC O O
on IN B-VP O
the DT O O
right JJ O O
his PRP$ O O
plantar NN B-NP O
dorsiflexion NN I-NP O
strength NN I-NP O
was VBD B-VP O
4/5 CD O O
bilaterally RB O O
Sensation NNP B-NP O
was VBD B-VP O
grossly RB O O
intact JJ O O
to TO O O
touch VB O O
Finger-to-nose NNP B-NP O
was VBD B-VP O
normal JJ B-NP O
LABORATORY NNP I-NP O
DATA NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Sodium NNP I-NP O
140 CD O O
, , O O
potassium NN B-NP O
4.5 CD O O
, , O O
chloride RB O O
102 CD O O
, , O O
bicarbonate NN B-NP O
26 CD O O
, , O O
BUN NNP B-NP O
20 CD O O
, , O O
creatinine NN B-NP O
0.9 CD O O
, , O O
glucose RB O O
101 CD O O
He PRP O O
had VBD B-VP O
a DT B-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
9 CD O O
with IN B-VP O
76 CD O O
polys NNS B-NP O
, , O O
4 CD O O
bands NNS B-NP O
, , O O
hematocrit NN B-NP O
37.6 CD O O
and CC O O
a DT B-NP O
platelet NN I-NP O
count NN I-NP O
of IN B-VP O
236 CD O O
His PRP$ O O
urinalysis NN B-NP O
showed VBD B-VP O
3+ CD O O
blood NN B-NP O
and CC O O
positive JJ B-NP O
leukocyte NN I-NP O
esterase NN I-NP O
with IN B-VP O
15-20 JJ B-NP O
white JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
one CD O O
plus CC O O
bacteria NNS B-NP O
and CC O O
one CD O O
plus CC O O
squamous JJ B-NP O
cells NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
Neurological: NNP B-NP O
The DT B-NP O
neurology NN I-NP O
service NN I-NP O
came VBD B-VP O
by IN B-VP O
to TO O O
see VB O O
the DT B-NP O
patient NN I-NP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
and CC O O
felt VBD B-VP O
that IN B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
acute JJ I-NP O
neurologic JJ I-NP O
change NN I-NP O
but CC O O
if IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
unable JJ O O
to TO O O
walk VB O O
he PRP O O
should MD O O
be VB O O
sent VBN O O
to TO O O
rehabilitation NN B-NP O
They PRP O O
saw VBD B-VP O
no DT B-NP O
new JJ I-NP O
acute NN I-NP O
change NN I-NP O
and CC O O
he PRP O O
should MD O O
continue VB O O
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
neurology NN B-NP O
in IN B-VP O
clinic JJ O O
2 CD O O
Cardiac: NNPS B-NP O
He PRP O O
does VBZ O O
have VB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
paroxysmal JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
and CC O O
echocardiogram NN B-NP O
with IN B-VP O
decreased JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
was VBD B-VP O
noted VBN O O
previously RB O O
He PRP O O
will MD O O
be VB O O
started VBN O O
on IN B-VP O
a DT B-NP O
trial NN I-NP O
of IN B-VP O
Lasix NNP B-NP B-m
p.o JJ O B-mo
q RB O B-f
day NN B-NP I-f
to TO O O
decrease VB O O
his PRP$ O B-r
peripheral JJ B-NP I-r
edema NN I-NP I-r
to TO O O
help VB O O
him PRP O O
with IN B-VP O
rehabilitation NN B-NP O
and CC O O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
will MD O O
continue VB O O
to TO O O
follow VB O O
him PRP O O
for IN B-VP O
his PRP$ O O
atrial JJ B-NP O
fibrillation NN I-NP O
and CC O O
he PRP O O
does VBZ O O
elect VB O O
not RB O O
to TO O O
anticoagulate VB O O
him PRP O O
at IN B-VP O
the DT B-NP O
moment NN I-NP O
though IN B-VP O
Coumadin NNP B-NP B-m
should MD O O
be VB O O
a DT B-NP O
consideration NN I-NP O
given VBN O O
his PRP$ O O
risk NN B-NP O
of IN B-VP O
stroke NN B-NP O
3 CD O O
Skin NNP B-NP O
care: NN I-NP O
Right NNP I-NP O
calf NN I-NP O
demonstrates VBZ O O
a DT B-NP O
pressure NN I-NP O
ulcer NN I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
should MD O O
apply VB O O
Nystatin NNP B-NP B-m
powder NN I-NP I-m
for IN B-VP O
his PRP$ O B-r
pannus NN B-NP I-r
rash NN I-NP I-r
4 CD O O
Infectious JJ B-NP O
disease: NN I-NP O
His PRP$ O B-r
urinary JJ B-NP I-r
tract NN I-NP I-r
infection NN I-NP I-r
will MD O O
be VB O O
treated VBN O O
with IN B-VP O
seven CD O B-du
days NNS B-NP I-du
of IN B-VP O
Bactrim NNP B-NP B-m
and CC O O
follow JJ B-NP O
urine NN I-NP O
cultures NNS I-NP O
DISPOSITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
discharged VBN O O
to TO O O
rehabilitation VB O O
care NN B-NP O
for IN B-VP O
leg NN B-NP O
strengthening VBG O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Aspirin NNP I-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
a.m NN I-NP I-f
, , O O
Indomethacin NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
Lisinopril NNP B-NP B-m
15 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP O
, , O O
multivitamin VB O B-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Bactrim NNP B-NP B-m
DS NNP I-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Tamsulosin NNP B-NP B-m
0.4 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Miconazole NNP B-NP B-m
2% CD O I-m
topical JJ B-NP I-m
powder NN I-NP I-m
b.i.d NN I-NP B-f
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Stable NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
JOSE NNP I-NP O
FLICKNER NNP I-NP O
, , O O
M.D NNP B-NP O
EL24 NNP I-NP O
Attending: NNP I-NP O
ANTOINE NNP I-NP O
SCHWERTNER NNP I-NP O
, , O O
M.D NNP B-NP O
ZO12 NNP I-NP O
ZF589/3744 NNP I-NP O
Batch: NNP I-NP O
5136 CD O O
Index NNP B-NP O
No NNP I-NP O
L7GO4H06PR NNP I-NP O
D: NNP I-NP O
2/7/99 CD O O
T: NNP B-NP O
2/7/99 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#90349 VBZ O O
819093619 CD O O
TTTMC NNP B-NP O
73833058 CD O O
9531316 CD O O
7/5/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
pre-syncope NN I-NP O
, , O O
non-cardiac JJ B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/23/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/1/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
BONETTI NNP I-NP O
, , O O
RASHAD NNP B-NP O
520-60-47-1 CD O O
Ficonmipa NNP B-NP O
Ln NNP I-NP O
Room: NNP I-NP O
Southsterter NNP I-NP O
Tes NNP I-NP O
Ter NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/15/04 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
PFLUGER NNP I-NP O
, , O O
CARY NNP B-NP O
K NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
J.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
650 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Headache NNP I-NP B-r
ALBUTEROL NNP I-NP B-m
INHALER NNP I-NP I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
2/9 CD O O
) ) O O
ECASA NNP B-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LEVOXYL NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
75 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/12/04 CD O O
by IN B-VP O
BINGGELI NNP B-NP O
, , O O
LONNIE NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ZOCOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
63128567 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
ATORVASTATIN; NNP B-NP O
reaction NN I-NP O
is VBZ O O
unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
IMDUR NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONIT.( NNP I-NP I-m
SR NNP I-NP I-m
) ) O I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
ZANTAC NNP B-NP B-m
( ( O I-m
RANITIDINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
CELEBREX NNP I-NP B-m
( ( O I-m
CELECOXIB NNP B-NP I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Beeler NNP I-NP O
, , O O
pt NN B-NP O
to TO O O
call VB O O
for IN B-VP O
appt JJ B-NP O
1-2 JJ I-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
ATORVASTATIN NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Pre-syncope NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
pre-syncope NN B-NP O
, , O O
non-cardiac JJ B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
htn NN I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
asthma NN B-NP O
( ( O O
asthma NN B-NP O
) ) O O
hypothyroidism NN B-NP O
( ( O O
hypothyroidism NN B-NP O
) ) O O
elevated VBD B-VP O
cholesterol NN B-NP O
( ( O O
elevated VBN O O
cholesterol NN B-NP O
) ) O O
varicose NN B-NP O
veins NNS I-NP O
( ( O O
varicose JJ B-NP O
veins NNS I-NP O
) ) O O
UTIs NNP B-NP O
( ( O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
75 CD O O
yo NN B-NP O
Spanish JJ B-NP O
speaking NN I-NP O
F NNP I-NP O
w/ NN I-NP O
HTN NNP I-NP O
, , O O
high JJ B-NP O
cholesterol NN I-NP O
, , O O
hypothyroidism NN B-NP O
, , O O
asthma NN B-NP O
, , O O
presents NNS B-NP O
w/ VBP O O
pre-syncope JJ B-NP O
********* NN I-NP O
Seen NNP I-NP O
by IN B-VP O
PCP NNP B-NP O
3d CD O O
PTA NNP B-NP O
for IN B-VP O
L NNP B-NP O
hip NN I-NP O
pain NN I-NP O
, , O O
HA NNP B-NP O
, , O O
polyarthralgias NN B-NP O
EKG NNP I-NP O
then RB O O
showed VBD B-VP O
sinus NNS B-NP O
brady JJ B-NP O
TSH NNP I-NP O
noted VBD B-VP O
to TO O O
be VB O O
mildly RB O O
elevated VBN O O
at IN B-VP O
that DT B-NP O
visit NN I-NP O
at IN B-VP O
5.3 CD O O
, , O O
RF NNP B-NP O
and CC O O
ANA NNP B-NP O
neg RB O O
Now RB O O
p/w VBZ O O
1-2 JJ B-NP O
days NNS I-NP O
presyncopal VBP O O
episodes JJ B-NP O
x2 NNP I-NP O
, , O O
one CD O O
while IN B-VP O
walking VBG O O
then RB O O
this DT O O
am VBP O O
at IN B-VP O
church NN B-NP O
while IN B-VP O
seated VBN O O
No NNP B-NP O
SOB NNP I-NP O
, , O O
CP NNP B-NP O
, , O O
palps NN B-NP O
, , O O
no DT B-NP O
LOC NNP I-NP O
, , O O
no DT B-NP O
f/s/c NN I-NP O
, , O O
wt JJ B-NP O
loss NN I-NP O
, , O O
+ NNP B-NP O
dec VBZ O O
'd MD O O
po's VB O O
x2 NNP B-NP O
days NNS I-NP O
2/2 CD O O
n/dyspepsia NN B-NP O
, , O O
also RB O O
+BRBPR VBP O O
w/ JJ B-NP O
minimal JJ I-NP O
blood NN I-NP O
x1-2d JJ B-NP O
+chronic JJ I-NP O
L&gt;R NNP I-NP O
hip NN I-NP O
pain NN I-NP O
In IN B-VP O
ED: NNP B-NP O
afeb NN I-NP O
, , O O
normotensive JJ O O
, , O O
rec'd JJ B-NP O
CXR: NNP I-NP O
clear JJ B-NP O
EKG: NNP I-NP O
NSR NNP I-NP O
51 CD O O
Has NNP B-NP O
been VBN O O
taking VBG O O
meds NNS B-NP O
as IN B-VP O
directed JJ B-NP O
PE: NNP I-NP O
98.5 CD O O
65 CD O O
147/80 CD O O
12 CD O O
99%RA CD O O
, , O O
NAD NNP B-NP O
, , O O
mm NN B-NP O
dry NN I-NP O
, , O O
OP NNP B-NP O
clear JJ O O
, , O O
JVP NNP B-NP O
flat JJ O O
, , O O
CTAB NNP B-NP O
, , O O
rrr NN B-NP O
, , O O
no DT B-NP O
m/g/r NN I-NP O
, , O O
ABd NNP B-NP O
soft JJ O O
, , O O
NT/ND NNP B-NP O
, , O O
heme NN B-NP O
pos NN I-NP O
brown JJ B-NP O
stool NN I-NP O
, , O O
+ext JJ B-NP O
hemorrhoids NNS I-NP O
, , O O
TR NNP B-NP O
edema NN I-NP O
bilat NN I-NP O
, , O O
2+ CD O O
pulses NNS B-NP O
, , O O
+L&gt;R NNP B-NP O
trochanteric VBD B-VP O
bursa JJ B-NP O
point NN I-NP O
tenderness NN I-NP O
, , O O
neuro JJ B-NP O
non-focal JJ I-NP O
LABS: NNP I-NP O
cardiac NN I-NP O
enzymes NNS I-NP O
neg JJ B-NP O
x1 NNP I-NP O
, , O O
UA NNP B-NP O
neg NN I-NP O
, , O O
TSH NNP B-NP O
5.3 CD O O
, , O O
otherwise RB O O
unremarkable JJ O O
, , O O
Hct NNP B-NP O
40 CD O O
at IN B-VP O
baseline NN B-NP O
*****HOSP NNP I-NP O
COURSE******* NNP I-NP O
CV: NNP I-NP O
unlikely JJ B-NP O
cardiac JJ I-NP O
origin NN I-NP O
of IN B-VP O
presyncope NN B-NP O
, , O O
more RBR O O
likely JJ B-NP O
mild JJ I-NP O
hypovolemia NN I-NP O
R/R: NNP I-NP O
monitored VBD B-VP O
on IN B-VP O
tele NN B-NP O
, , O O
noted VBD B-VP O
to TO O O
brady VB O O
to TO O O
low VB O O
50s CD O O
after IN B-VP O
ta NN B-NP O
king NN I-NP O
atenolol NN I-NP B-m
, , O O
which WDT O O
could MD O O
be VB O O
a DT B-NP O
contributing JJ I-NP O
factor NN I-NP O
ISCHEMIA: NNP I-NP O
R/o'd NNP I-NP O
for IN B-VP O
MI NNP B-NP O
by IN B-VP O
enzymes NNS B-NP O
LDL NNP I-NP O
elevated VBD B-VP O
, , O O
vague JJ B-NP O
rxn NN I-NP O
to TO O O
lipitor NN B-NP B-m
Started NNP I-NP O
zocor NN I-NP B-m
, , O O
aspirin JJ B-NP B-m
Cont'd NNP I-NP O
BB NNP I-NP B-m
, , O O
imdur NN B-NP B-m
aMIBI VBD B-VP O
3/24 CD O O
showed: NN B-NP O
small JJ B-NP O
reversible JJ I-NP O
defect NN I-NP O
of IN B-VP O
mild JJ B-NP O
intensity NN I-NP O
in IN B-VP O
distal JJ B-NP O
ant NN I-NP O
wall NN I-NP O
and CC O O
apex JJ B-NP O
c/w NN I-NP O
small JJ B-NP O
area NN I-NP O
ischemia NN I-NP O
in IN B-VP O
distal JJ B-NP O
LAD NNP I-NP O
Pt NNP I-NP O
reports NNS I-NP O
prior RB O O
h/o VBP O O
blood NN B-NP O
in IN B-VP O
stool NN B-NP O
while IN B-VP O
on IN B-VP O
ASA NNP B-NP B-m
Advised NNP I-NP O
of IN B-VP O
benefits NNS B-NP O
of IN B-VP O
ASA NNP B-NP B-m
for IN B-VP O
her PRP$ O O
, , O O
and CC O O
started VBD B-VP O
on IN B-VP O
81mg CD O B-do
qd NN B-NP B-f
, , O O
advised VBD B-VP O
to TO O O
try VB O O
this DT O O
and CC O O
discuss VB O O
further JJ O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician JJ B-NP O
PUMP: NNP I-NP O
gave VBD B-VP O
500cc CD O O
NS NNP B-NP O
Pt NNP I-NP O
w/ VBZ O O
no DT B-NP O
further JJ I-NP O
episodes NNS I-NP O
on IN B-VP O
ambulation NN B-NP O
Unable JJ O O
to TO O O
perform VB O O
echo JJ O O
prior RB O O
to TO O O
discharge VB O O
but CC O O
may MD O O
pursue VB O O
this DT O O
as IN B-VP O
an DT B-NP O
outpatient JJ I-NP O
Pt NNP I-NP O
noted VBD B-VP O
to TO O O
be VB O O
hypertensive JJ O O
to TO O O
180 CD O O
SBP NNP B-NP O
20-24h JJ O O
after IN B-VP O
atenolol NN B-NP B-m
dose NN I-NP O
Therefore NNP I-NP O
switched VBD B-VP O
to TO O O
bid VB O B-f
frequency NN B-NP O
with IN B-VP O
1/2 CD O B-do
dose NN B-NP I-do
( ( O I-do
25mg CD O I-do
) ) O I-do
given VBN O O
bradycardia NN B-NP O
May NNP I-NP O
consider VB O O
increasing VBG O O
imdur NN B-NP B-m
if IN B-VP O
persistent JJ B-NP B-r
hypertension NN I-NP I-r
GI: NNP I-NP O
dyspepsia NN I-NP O
Started NNP I-NP O
PPI NNP I-NP B-m
, , O O
chk'd NN B-NP O
H.pylori NNP I-NP O
May NNP I-NP O
benefit NN I-NP O
from IN B-VP O
EGD NNP B-NP O
as IN B-VP O
outpt JJ B-NP O
D/c'd NNP I-NP O
on IN B-VP O
H2 NNP B-NP O
blker NN I-NP O
ENDO: NNP I-NP O
mildly RB O O
subtherapeutic JJ O O
on IN B-VP O
levoxyl NN B-NP B-m
levoxyl NN I-NP B-m
, , O O
increased VBD B-VP O
to TO O O
75mcg CD O B-do
qd NNS B-NP B-f
MSK: NNP I-NP O
trochanteric JJ B-NP B-r
bursitis NN I-NP I-r
Rx'd NNP I-NP O
w/ NN I-NP O
NSAIDS NNP I-NP B-m
, , O O
d/c'd NN B-NP O
on IN B-VP O
celebrex NN B-NP B-m
, , O O
but CC O O
may MD O O
consider VB O O
changing VBG O O
to TO O O
hi VB O O
dose JJ B-NP O
ibuprofen JJ I-NP B-m
PULM: NNP I-NP O
asthma NN I-NP B-r
, , O O
cont'd NN B-NP O
albuterol NN I-NP B-m
inh NN I-NP B-mo
prn NN I-NP B-f
PPX: NNP I-NP O
lovenox NN I-NP B-m
for IN B-VP O
DVT NNP B-NP B-r
ppx VBP O I-r
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
It PRP O O
is VBZ O O
important JJ O O
that IN B-VP O
you PRP O O
call VBP O O
Dr NNP B-NP O
Mcquade NNP I-NP O
for IN B-VP O
a DT O O
follow JJ O O
up RP O O
appointment NN B-NP O
within IN B-VP O
the DT B-NP O
next JJ I-NP O
1-2 JJ I-NP O
weeks NNS I-NP O
You PRP O O
should MD O O
take VB O O
all DT B-NP O
medications NNS I-NP O
on IN B-VP O
the DT B-NP O
discharge NN I-NP O
list NN I-NP O
at IN B-VP O
the DT B-NP O
doses NNS I-NP O
specified VBD B-VP O
It PRP O O
is VBZ O O
important JJ O O
that IN B-VP O
you PRP O O
stay VBP O O
well RB O O
hydrated VBN O O
If IN B-VP O
you PRP O O
feel VBP O O
lightheaded VBN O O
, , O O
fall NN B-NP O
, , O O
or CC O O
lose VB O O
consciousness NN B-NP O
, , O O
call VB O O
your PRP$ O O
doctor NN B-NP O
or CC O O
seek JJ B-NP O
attention NN I-NP O
at IN B-VP O
the DT B-NP O
nearest JJS I-NP O
emergency NN I-NP O
room NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
CASTILLIO NNP I-NP O
, , O O
GLENN NNP B-NP O
QUINTON NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
XS689 NNP B-NP O
) ) O O
9/15/04 CD O O
@ $ O O
04 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#91996 VBZ O O
150823816 CD O O
DMC NNP B-NP O
60956989 CD O O
948914 CD O O
1/29/1990 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/26/1990 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/3/1990 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
22 CD O O
year NN B-NP O
old JJ O O
, , O O
gravida JJ B-NP O
V NNP I-NP O
para NN I-NP O
0314 CD O O
, , O O
at IN B-VP O
24 CD O O
weeks NNS B-NP O
, , O O
now RB O O
with IN B-VP O
severe JJ B-NP O
frontal JJ I-NP O
headache NN I-NP O
and CC O O
scintillations NNS B-NP O
Dating NNP I-NP O
is VBZ O O
by IN B-VP O
the DT B-NP O
last JJ I-NP O
menstrual JJ I-NP O
period NN I-NP O
and CC O O
an DT B-NP O
early JJ I-NP O
ultrasound NN I-NP O
which WDT O O
placed VBD B-VP O
her PRP O O
at IN B-VP O
approximately RB O O
24 CD O O
weeks NNS B-NP O
She PRP O O
presented VBD B-VP O
with IN B-VP O
a DT O O
three CD O O
and CC O O
a DT B-NP O
half JJ I-NP O
day NN I-NP O
history NN I-NP O
of IN B-VP O
severe JJ B-NP B-r
severe JJ I-NP B-r
severe JJ I-NP B-r
frontal JJ I-NP I-r
frontal JJ I-NP I-r
frontal JJ I-NP I-r
headaches NNS I-NP I-r
headaches NNS I-NP I-r
headaches NNS I-NP I-r
with IN B-VP I-r
with IN B-VP I-r
with IN B-VP I-r
scintillations NNS B-NP I-r
scintillations NNS I-NP I-r
scintillations NNS I-NP I-r
There EX O O
was VBD B-VP O
no DT B-NP O
relief NN I-NP O
with IN B-VP O
Tylenol NNP B-NP B-m
, , O O
aspirin NN B-NP B-m
or CC O O
Fioricet NNP B-NP B-m
She PRP O O
also RB O O
stated VBD B-VP O
she PRP O O
had VBD B-VP O
marked VBN O O
polydipsia NN B-NP O
for IN B-VP O
four CD O O
days NNS B-NP O
She PRP O O
denied VBD B-VP O
abdominal JJ B-NP O
pain NN I-NP O
or CC O O
swelling VBG O O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
preeclampsia NN B-NP O
with IN B-VP O
a DT B-NP O
previous JJ I-NP O
twin NN I-NP O
gestation NN I-NP O
She PRP O O
does VBZ O O
note JJ B-NP O
fetal JJ I-NP O
activity NN I-NP O
At IN B-VP O
this DT B-NP O
juncture NN I-NP O
, , O O
I PRP O O
should MD O O
note VB O O
that IN B-VP O
much RB O O
of IN B-VP O
this DT B-NP O
history NN I-NP O
is VBZ O O
as IN B-VP O
per IN B-VP O
patient NN B-NP O
and CC O O
is VBZ O O
somewhat RB O O
unreliable JJ B-NP O
PAST NNP I-NP O
OBSTETRICAL NNP I-NP O
HISTORY: NNP I-NP O
C-section NNP I-NP O
for IN B-VP O
twins; RB O O
previous JJ B-NP O
C-section NN I-NP O
for IN B-VP O
singleton; JJ B-NP O
history NN I-NP O
by IN B-VP O
patient NN B-NP O
of IN B-VP O
preeclampsia NN B-NP O
PAST NNP I-NP O
HISTORY: NNP I-NP O
Initially NNP I-NP O
she PRP O O
admitted VBD B-VP O
to TO O O
no DT B-NP O
past JJ I-NP O
medical JJ I-NP O
problems NNS I-NP O
, , O O
however RB O O
, , O O
upon IN B-VP O
reviewing VBG O O
her PRP$ O O
chart NN B-NP O
the DT B-NP O
following NN I-NP O
is VBZ O O
obvious: JJ B-NP O
chronic JJ I-NP O
hypertension; NN I-NP O
seizure NN I-NP B-r
disorder NN I-NP I-r
following VBG O O
motor NN B-NP O
vehicle NN I-NP O
accident NN I-NP O
for IN B-VP O
which WDT O O
she PRP O O
is VBZ O O
on IN B-VP O
valproic NN B-NP B-m
acid NN I-NP I-m
, , O O
no DT O O
clearly RB O O
documented VBN O O
recent JJ B-NP O
seizures; JJ I-NP O
history NN I-NP O
of IN B-VP O
asthma NN B-NP B-r
for IN B-VP O
which WDT O O
she PRP O O
takes VBZ O O
medicines NNS B-NP B-m
p.r.n.; JJ B-NP B-f
history NN I-NP O
of IN B-VP O
behavioral JJ B-NP O
disorders NNS I-NP O
with IN B-VP O
question NN B-NP O
of IN B-VP O
pseudoseizures NNS B-NP O
in IN B-VP O
the DT B-NP O
past; NN I-NP O
obesity; JJ B-NP O
multiple JJ I-NP O
drug NN I-NP O
allergies; NN I-NP O
cholecystectomy NN I-NP O
in IN B-VP O
1990; CD O O
appendectomy NN B-NP O
at IN B-VP O
age NN B-NP O
14; CD O O
motor NN B-NP O
vehicle NN I-NP O
accident NN I-NP O
with IN B-VP O
V-P NNP B-NP O
shunt NN I-NP O
placement NN I-NP O
in IN B-VP O
1980; CD O O
facial JJ B-NP O
reconstruction NN I-NP O
times NNS I-NP O
three CD O O
in IN B-VP O
1980; CD O O
superficial JJ B-NP O
vascular NN I-NP O
surgery NN I-NP O
in IN B-VP O
1989 CD O O
for IN B-VP O
varicosities NNS B-NP O
of IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremities NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
denies VBZ O O
tobacco NN B-NP O
, , O O
ethanol '' O O
or CC O O
drug NN B-NP O
use VBP O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Revealed VBD B-VP O
an DT B-NP O
obese JJ I-NP O
white JJ I-NP O
female NN I-NP O
in IN B-VP O
mild JJ B-NP O
distress NN I-NP O
The DT B-NP O
pupils NNS I-NP O
are VBP O O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation; JJ B-NP O
fundi NN I-NP O
well RB O O
visualized VBN O O
, , O O
no DT B-NP O
papilledema NN I-NP O
Good NNP I-NP O
facial NN I-NP O
movements NNS I-NP O
No DT B-NP O
oral JJ I-NP O
lesions NNS I-NP O
The DT B-NP O
chest NN I-NP O
was VBD B-VP O
clear JJ O O
The DT B-NP O
heart NN I-NP O
showed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm VB O O
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP O
with IN B-VP O
a DT B-NP O
fetal JJ I-NP O
heart NN I-NP O
rate NN I-NP O
in IN B-VP O
the DT O O
140's CD O O
The DT B-NP O
extremities NNS I-NP O
showed VBD B-VP O
trace NN B-NP O
edema IN B-VP O
The DT B-NP O
neuro NN I-NP O
exam NN I-NP O
showed VBD B-VP O
cranial JJ B-NP O
nerves NNS I-NP O
II-XII NNP I-NP O
grossly RB O O
intact JJ B-NP O
Reflexes NNP I-NP O
were VBD B-VP O
1+ CD O O
without IN B-VP O
clonus NN B-NP O
The DT B-NP O
strength NN I-NP O
was VBD B-VP O
reduced VBN O O
to TO O O
4/5 CD O O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
upper NN I-NP O
and CC O O
right JJ B-NP O
lower JJR I-NP O
extremities NNS I-NP O
, , O O
however RB O O
, , O O
the DT B-NP O
exam NN I-NP O
was VBD B-VP O
questionable JJ O O
as IN B-VP O
she PRP O O
seemed VBD B-VP O
to TO O O
have VB O O
a DT B-NP O
varying NN I-NP O
exam NN I-NP O
depending VBG O O
on IN B-VP O
the DT B-NP O
examiner NN I-NP O
and CC O O
time NN B-NP O
of IN B-VP O
exam NN B-NP O
She PRP O O
also RB O O
demonstrated VBD B-VP O
decreased JJ B-NP O
fine JJ I-NP O
finger NN I-NP O
movements NNS I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Problem NNP I-NP O
#1 NNP I-NP O
) ) O O
Headache NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chronic JJ B-NP B-r
headaches NNS I-NP I-r
for IN B-VP O
which WDT O O
she PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
Fioricet NNP B-NP B-m
in IN B-VP O
the DT B-NP O
past NN I-NP O
Over IN B-VP O
the DT B-NP O
first JJ I-NP O
week NN I-NP O
of IN B-VP O
hospitalization NN B-NP O
, , O O
she PRP O O
complained VBD B-VP O
of IN B-VP O
increasing VBG O O
headache NN B-NP O
that WDT O O
prevented VBD B-VP O
her PRP O O
from IN B-VP O
looking VBG O O
into IN B-VP O
the DT B-NP O
light NN I-NP O
as RB O O
well RB O O
as IN B-VP O
prevented VBN O O
her PRP$ O O
from IN B-VP O
ambulating VBG O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
bed NN I-NP O
At IN B-VP O
times NNS B-NP O
, , O O
she PRP O O
complained VBD B-VP O
of IN B-VP O
intermittent JJ B-NP O
visual JJ I-NP O
symptoms NNS I-NP O
These DT B-NP O
headaches NNS I-NP B-r
headaches NNS I-NP B-r
headaches NNS I-NP B-r
were VBD B-VP O
not RB O O
completely RB O O
relieved VBN O O
by IN B-VP O
Demerol NNP B-NP B-m
, , O O
Percocet NNP B-NP B-m
or CC O O
Tylenol NNP B-NP B-m
She PRP O O
was VBD B-VP O
eventually RB O O
tried VBN O O
on IN B-VP O
Fioricet NNP B-NP B-m
which WDT O O
apparently RB O O
produced VBD B-VP O
good JJ B-NP O
relief NN I-NP O
of IN B-VP O
the DT B-NP O
headaches NNS I-NP B-r
She PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
neurology NN B-NP O
and CC O O
noted VBD B-VP O
with IN B-VP O
a DT O O
questionably RB O O
abnormal JJ B-NP O
neuro NNS I-NP O
exam VBP O O
with IN B-VP O
findings NNS B-NP O
localized VBN O O
to TO O O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
Apparently NNP I-NP O
she PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
this DT B-NP O
abnormality NN I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
A NNP I-NP O
CT NNP I-NP O
scan NN I-NP O
revealed VBD B-VP O
what WP O O
was VBD B-VP O
apparently RB O O
old JJ B-NP O
damage NN I-NP O
from IN B-VP O
the DT B-NP O
previous JJ I-NP O
motor NN I-NP O
vehicle NN I-NP O
accident VBD B-VP O
An DT B-NP O
MRI NNP I-NP O
was VBD B-VP O
entirely RB O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
She PRP O O
refused VBD B-VP O
a DT B-NP O
lumbar NN I-NP O
puncture NN I-NP O
At IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
the DT B-NP O
headaches NNS I-NP B-r
are VBP O O
thought VBN O O
to TO O O
be VB O O
either RB O O
vascular JJ O O
in IN B-VP O
origin NN B-NP O
or CC O O
psychogenic JJ O O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Fioricet NNP B-NP B-m
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
Problem NNP I-NP O
#2 NNP I-NP O
) ) O O
Hypertension NNP B-NP O
She PRP O O
had VBD B-VP O
elevated VBN O O
blood NN B-NP O
pressures NNS I-NP O
of IN B-VP O
150-160 JJ O O
over IN B-VP O
as RB O O
high JJ O O
as IN B-VP O
110 CD O O
upon IN B-VP O
admission NN B-NP O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chronic JJ B-NP B-r
hypertension NN I-NP I-r
in IN B-VP O
the DT B-NP O
past NN I-NP O
and CC O O
was VBD B-VP O
at IN B-VP O
least JJS B-NP O
briefly NN I-NP O
maintained VBD B-VP O
on IN B-VP O
hydrochlorothiazide NN B-NP B-m
before IN B-VP O
She PRP O O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
work NN I-NP O
up RB O O
for IN B-VP O
PET NNP B-NP O
, , O O
including VBG O O
repeat NN B-NP O
24 CD O O
hour NN B-NP O
urines NNS I-NP O
and CC O O
repeat NN B-NP O
PET NNP I-NP O
labs NN I-NP O
As NNP I-NP O
well RB O O
, , O O
she PRP O O
had VBD B-VP O
no DT B-NP O
physical JJ I-NP O
findings NNS I-NP O
consistent JJ O O
with IN B-VP O
PET NNP B-NP O
Given NNP I-NP O
her PRP$ O O
history NN B-NP O
of IN B-VP O
chronic JJ B-NP O
hypertension NN I-NP O
, , O O
we PRP O O
felt VBD B-VP O
this DT O O
was VBD B-VP O
most RBS O O
likely JJ B-NP O
chronic JJ I-NP B-r
chronic JJ I-NP B-r
hypertension NN I-NP I-r
hypertension NN I-NP I-r
aggravated VBN O O
by IN B-VP O
pregnancy NN B-NP O
She PRP O O
was VBD B-VP O
begun VBN O O
on IN B-VP O
a DT B-NP O
beta NN I-NP B-m
blocker NN I-NP I-m
, , O O
namely RB O O
labetolol JJ O B-m
, , O O
with IN B-VP O
good JJ B-NP O
control NN I-NP O
She PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
on IN B-VP O
labetolol NN B-NP B-m
Problem NNP I-NP O
#3 NN I-NP O
) ) O O
History NN B-NP O
of IN B-VP O
seizure NN B-NP O
disorder NN I-NP O
She PRP O O
carries VBZ O O
the DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
a DT B-NP O
seizure NN I-NP B-r
disorder NN I-NP I-r
, , O O
although IN B-VP O
this DT O O
is VBZ O O
, , O O
at IN B-VP O
least JJS O O
recently RB O O
, , O O
poorly RB O O
documented VBN O O
She PRP O O
has VBZ O O
been VBN O O
on IN B-VP O
valproic JJ B-NP B-m
acid NN I-NP I-m
in IN B-VP O
the DT B-NP O
past NN I-NP O
and CC O O
has VBZ O O
been VBN O O
taking VBG O O
a DT B-NP O
small JJ I-NP B-do
dose NN I-NP I-do
of IN B-VP O
valproic NN B-NP B-m
valproic NN I-NP B-m
acid NN I-NP I-m
acid NN I-NP I-m
apparently RB O O
on IN B-VP O
her PRP$ O O
own JJ O O
throughout IN B-VP B-du
throughout IN B-VP B-du
this DT O I-du
this DT B-NP I-du
pregnancy NN I-NP I-du
pregnancy NN I-NP I-du
She PRP O O
has VBZ O O
been VBN O O
taking VBG O O
250 CD O B-do
mg NN B-NP I-do
a DT B-NP B-f
week NN I-NP I-f
She PRP O O
last JJ O O
noted VBD B-VP O
an DT B-NP O
obvious JJ I-NP O
seizure NN I-NP O
three CD O O
years NNS B-NP O
ago IN B-VP O
It PRP O O
is VBZ O O
not RB O O
clear JJ O O
that IN B-VP O
this DT O O
was VBD B-VP O
witnessed VBN O O
by IN B-VP O
anyone NN B-NP O
else RB O O
While IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
an DT B-NP O
EEG NNP I-NP O
which WDT O O
suggested VBD B-VP O
some DT B-NP O
slowing NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
parietal JJ I-NP O
region NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
clear JJ I-NP O
seizure NN I-NP O
activity NN I-NP O
seen VBN O O
on IN B-VP O
EEG NNP B-NP O
She PRP O O
called VBD B-VP O
us PRP O O
to TO O O
her PRP$ O O
room NN B-NP O
on IN B-VP O
several JJ B-NP O
episodes NNS I-NP O
which WDT O O
she PRP O O
described VBD B-VP O
as IN B-VP O
seizures NNS B-NP O
These DT B-NP O
seizures NNS I-NP O
were VBD B-VP O
witnessed VBN O O
by IN B-VP O
several JJ B-NP O
physicians NNS I-NP O
and CC O O
were VBD B-VP O
remarkable JJ O O
for IN B-VP O
absence NN B-NP O
of IN B-VP O
a DT B-NP O
postictal JJ I-NP O
period NN I-NP O
as RB O O
well RB O O
as IN B-VP O
abnormal JJ B-NP O
idiosyncratic JJ I-NP O
behaviors NNS I-NP O
during IN B-VP O
the DT B-NP O
events NNS I-NP O
It PRP O O
was VBD B-VP O
our PRP$ O O
feeling NN B-NP O
that IN B-VP O
these DT O O
were VBD B-VP O
not RB O O
true JJ B-NP O
seizures NNS I-NP O
Indeed RB O O
, , O O
reviewing VBG O O
her PRP$ O O
chart NN B-NP O
, , O O
she PRP O O
has VBZ O O
had VBD B-VP O
episodes NNS B-NP O
of IN B-VP O
what WDT O O
have VBP O O
been VBN O O
called VBN O O
pseudoseizures NNS B-NP O
similar JJ O O
to TO O O
these DT O O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
Given NNP I-NP O
her PRP$ O O
multiple JJ B-NP O
drug NN I-NP O
allergies NNS I-NP O
, , O O
including VBG O O
Dilantin NNP B-NP O
, , O O
phenobarb NN B-NP O
and CC O O
tegretol NN B-NP O
, , O O
we PRP O O
felt VBD B-VP O
limited VBN O O
in IN B-VP O
our PRP$ O O
therapeutic JJ B-NP O
options NNS I-NP O
We PRP O O
did VBD B-VP O
elect VB O O
to TO O O
increase VB O O
her PRP$ O O
dose NN B-NP O
of IN B-VP O
valproic JJ B-NP B-m
acid NN I-NP O
as IN B-VP O
this DT O O
has VBZ O O
apparently RB O O
been VBN O O
effective JJ O O
in IN B-VP O
the DT O O
past JJ O O
She PRP O O
will MD O O
continue VB O O
this DT O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
Problem NNP I-NP O
#4 NNP I-NP O
) ) O O
Nausea NN B-NP O
and CC O O
vomiting VBG O O
She PRP O O
complained VBD B-VP O
of IN B-VP O
persistent JJ B-NP O
nausea NN I-NP O
and CC O O
vomiting NN B-NP O
during IN B-VP O
the DT B-NP O
latter JJ I-NP O
part NN I-NP O
of IN B-VP O
her PRP$ O O
hospitalization NN B-NP O
and CC O O
declined VBD B-VP O
to TO O O
take VB O O
anything NN B-NP O
p.o IN B-VP O
The DT B-NP O
etiology NN I-NP O
of IN B-VP O
this DT B-NP O
nausea NN I-NP O
and CC O O
vomiting NN B-NP O
was VBD B-VP O
unclear JJ O O
, , O O
although IN B-VP O
apparently RB O O
associated VBN O O
with IN B-VP O
some DT B-NP O
diarrhea NN I-NP O
As RB O O
much JJ O O
as IN B-VP O
was VBD B-VP O
possible JJ O O
, , O O
work VB O O
up RP O O
for IN B-VP O
an DT B-NP O
organic JJ I-NP O
cause NN I-NP O
of IN B-VP O
the DT B-NP O
problem NN I-NP O
was VBD B-VP O
negative JJ O O
We PRP O O
elected VBD B-VP O
initially RB O O
to TO O O
treat VB O O
her PRP O O
with IN B-VP O
intravenous JJ B-NP B-mo
hydration NN I-NP B-m
, , O O
however RB O O
, , O O
she PRP O O
declined VBD B-VP O
further JJ B-NP O
IV's NNP I-NP O
In IN B-VP O
fact NN B-NP O
, , O O
she PRP O O
became VBD B-VP O
quite RB O O
vocal JJ O O
in IN B-VP O
her PRP$ O O
demand NN B-NP O
to TO O O
go VB O O
home NN B-NP O
She PRP O O
understands VBZ O O
our PRP$ O O
concerns NNS B-NP O
as IN B-VP O
to TO O O
the DT B-NP O
risks NNS I-NP O
of IN B-VP O
poor JJ B-NP O
p.o NNS I-NP O
intake VBP O O
and CC O O
insists VBZ O O
she PRP O O
will MD O O
be VB O O
able JJ O O
to TO O O
take VB O O
in IN B-VP O
p.o.'s NN B-NP O
at IN B-VP O
home NN B-NP O
Given NNP I-NP O
her PRP$ O O
feelings NNS B-NP O
in IN B-VP O
this DT B-NP O
regard NN I-NP O
, , O O
we PRP O O
have VBP O O
elected VBN O O
to TO O O
discharge VB O O
her PRP$ O O
for IN B-VP O
a DT B-NP O
trial NN I-NP O
of IN B-VP O
outpatient JJ B-NP O
management NN I-NP O
Follow NNP I-NP O
up RP O O
will MD O O
be VB O O
in IN B-VP O
the DT B-NP O
clinic NN I-NP O
Should MD O O
she PRP O O
show VB O O
evidence NN B-NP O
of IN B-VP O
compromise NN B-NP O
or CC O O
dehydration NN B-NP O
, , O O
she PRP O O
will MD O O
be VB O O
readmitted VBN O O
Problem NNP B-NP O
#5 NNP I-NP O
) ) O O
Psychosocial NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
seen VBN O O
several JJ B-NP O
times NNS I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
for IN B-VP O
behavioral JJ B-NP O
disorders NNS I-NP O
It PRP O O
is VBZ O O
difficult JJ O O
to TO O O
sort VB O O
out RP O O
what WP O O
part NN B-NP O
of IN B-VP O
her PRP$ O O
symptomatology NN B-NP O
is VBZ O O
organic JJ O O
and CC O O
what WP O O
, , O O
if IN B-VP O
any DT O O
, , O O
is VBZ O O
inorganic JJ O O
She PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
psychiatry NN B-NP O
during IN B-VP O
her PRP$ O O
stay NN B-NP O
here RB O O
who WP O O
felt VBD B-VP O
that IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
significant JJ I-NP O
conflict NN I-NP O
in IN B-VP O
her PRP$ O O
home NN B-NP O
life NN I-NP O
We PRP O O
have VBP O O
counseled VBN O O
her PRP O O
as RB O O
much JJ O O
as IN B-VP O
possible JJ O O
throughout IN B-VP O
her PRP$ O O
stay NN B-NP O
She PRP O O
has VBZ O O
seen VBN O O
both DT B-NP O
social JJ I-NP O
services NNS I-NP O
and CC O O
psychiatry NN B-NP O
, , O O
however RB O O
, , O O
she PRP O O
is VBZ O O
at IN B-VP O
best RBS O O
reluctant JJ O O
to TO O O
avail VB O O
herself NN B-NP O
of IN B-VP O
these DT B-NP O
services NNS I-NP O
Our PRP$ O O
plan NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
is VBZ O O
for IN B-VP O
follow JJ O O
up RP O O
with IN B-VP O
DSS NNP B-NP O
As NNP I-NP O
well RB O O
, , O O
we PRP O O
have VBP O O
emphasized VBN O O
our PRP$ O O
availability NN B-NP O
to TO O O
the DT B-NP O
patient NN I-NP O
at IN B-VP O
all DT B-NP O
times NNS I-NP O
and CC O O
tried VBD B-VP O
to TO O O
be VB O O
as RB O O
supportive JJ O O
as IN B-VP O
possible JJ O O
in IN B-VP O
these DT B-NP O
circumstances NNS I-NP O
DISPOSITION: VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
for IN B-VP O
a DT B-NP O
trial NN I-NP O
of IN B-VP O
management NN B-NP O
at IN B-VP O
home NN B-NP O
The DT B-NP O
etiology NN I-NP O
of IN B-VP O
her PRP$ O O
discomfort NN B-NP O
is VBZ O O
somewhat RB O O
obscure JJ O O
, , O O
however RB O O
, , O O
we PRP O O
have VBP O O
as RB O O
best RB O O
as IN B-VP O
possible JJ O O
ruled VBD B-VP O
out RP O O
obvious JJ B-NP O
major JJ I-NP O
organic JJ I-NP O
pathology NN I-NP O
, , O O
including VBG O O
PET NNP B-NP O
, , O O
central JJ B-NP O
CNS NNP I-NP O
processes NNS I-NP O
and CC O O
fulminant JJ B-NP O
hypertension NN I-NP O
DISCHARGE NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
INTRAUTERINE NNP B-NP O
PREGNANCY NNP I-NP O
AT NNP I-NP O
24 CD O O
WEEKS NNP B-NP O
2 CD O O
HEADACHE NNP B-NP O
3 CD O O
SEIZURE NNP B-NP O
DISORDER NNP I-NP O
4 CD O O
CHRONIC NNP B-NP O
HYPERTENSION NNP I-NP O
5 CD O O
RULE NNP B-NP O
OUT NNP I-NP O
PRE-ECLAMPTIC NNP I-NP O
TOXEMIA NNP I-NP O
6 CD O O
NAUSEA NNP B-NP O
AND NNP I-NP O
VOMITING NNP I-NP O
OPERATIONS/PROCEDURES: NNP I-NP O
CT NNP I-NP O
MRI NNP I-NP O
EEG NNP I-NP O
TIMES NNP I-NP O
TWO NNP I-NP O
Batch: NNP I-NP O
4395 CD O O
Report: NNP B-NP O
N9695L1 NNP I-NP O
T: NNP I-NP O
________________________________ NNP I-NP O
FI216/6976 NNP I-NP O
TYRONE NNP I-NP O
SNIDER NNP I-NP O
, , O O
M.D NNP B-NP O
PM91 NNP I-NP O
D: NNP I-NP O
6/12/90 CD O O
Batch: NNP B-NP O
9922 CD O O
Report: NNP B-NP O
B8548X7 NNP I-NP O
T: NNP I-NP O
7/21/90 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
TRACY NNP I-NP O
MUNOZ NNP I-NP O
, , O O
M.D NNP B-NP O
cc: NN I-NP O
WENDELL NNP I-NP O
W NNP I-NP O
HEMM NNP I-NP O
, , O O
M.D NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#95821 VBZ O O
773007983 CD O O
SMUOMC NNP B-NP O
76581417 CD O O
046135 CD O O
11/14/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
NON NNP I-NP O
Q NNP I-NP O
WAVE NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/3/2002 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/7/2002 CD O O
DIAGNOSIS: NNP B-NP O
THE NNP I-NP O
PATIENT NNP I-NP O
IS NNP I-NP O
STATUS NNP I-NP O
POST NNP I-NP O
NON NNP I-NP O
ST NNP I-NP O
ELEVATION NNP I-NP O
MI NNP I-NP O
MEDICAL NNP I-NP O
MANAGEMENT NNP I-NP O
PROCEDURES: NNP I-NP O
Echocardiogram NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Syncope NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
75 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
hyperlipidemia NN B-NP O
and CC O O
past JJ B-NP O
tobacco NN I-NP O
use NN I-NP O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
angina NN B-NP O
but CC O O
no DT O O
previously RB O O
known VBN O O
CAD NNP B-NP O
who WP O O
is VBZ O O
now RB O O
presenting VBG O O
with IN B-VP O
syncope NN B-NP O
at IN B-VP O
baseline NN B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
angina NN B-NP O
with IN B-VP O
substernal JJ B-NP O
sharp JJ I-NP O
pain NN I-NP O
only RB O O
with IN B-VP O
exertion NN B-NP O
and CC O O
no DT B-NP O
radiation NN I-NP O
or CC O O
associated VBN O O
symptoms NNS B-NP O
and CC O O
with IN B-VP O
a DT B-NP O
frequency NN I-NP O
approximately RB O O
once RB O O
every DT B-NP O
several JJ I-NP O
months NNS I-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
baseline NN I-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
with IN B-VP O
one CD O O
flight NN B-NP O
of IN B-VP O
stairs NNS B-NP O
and CC O O
walking VBG O O
around IN B-VP O
the DT B-NP O
house NN I-NP O
nor CC O O
orthopnea NN B-NP O
, , O O
no DT B-NP O
paroxysmal JJ I-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
or CC O O
leg NN B-NP O
edema NN I-NP O
She PRP O O
had VBD B-VP O
"a JJ B-NP O
couple NN I-NP O
of IN B-VP O
falls/syncope NN B-NP O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
year" NN I-NP O
Most NNP I-NP O
recently RB O O
, , O O
about IN B-VP O
three CD O O
months NNS B-NP O
ago RB O O
, , O O
without IN B-VP O
symptoms NNS B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
seek VB O O
medical JJ B-NP O
attention NN I-NP O
The DT B-NP O
night NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
at IN B-VP O
approximately RB O O
11:30 CD O O
p.m VBD B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
hanging VBG O O
laundry NN B-NP O
and CC O O
had VBD B-VP O
a DT B-NP O
sudden JJ I-NP O
episode NN I-NP O
of IN B-VP O
syncope NN B-NP O
with IN B-VP O
likely JJ B-NP O
loss NN I-NP O
of IN B-VP O
consciousness NN B-NP O
of IN B-VP O
unclear JJ B-NP O
duration NN I-NP O
but CC O O
likely JJ O O
for IN B-VP O
minutes NNS B-NP O
The DT B-NP O
patient NN I-NP O
denied VBD B-VP O
any DT B-NP O
prodromal JJ I-NP O
symptoms NNS I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
light-headnessness JJ O O
, , O O
visual JJ B-NP O
changes NNS I-NP O
, , O O
balance NN B-NP O
, , O O
bowel NN B-NP O
or CC O O
bladder NN B-NP O
incontinence NN I-NP O
, , O O
tonoclonic JJ B-NP O
movements NNS I-NP O
She PRP O O
subsequently RB O O
felt VBD B-VP O
weak JJ O O
and CC O O
was VBD B-VP O
unable JJ O O
to TO O O
get VB O O
up RP O O
until IN B-VP O
on IN B-VP O
the DT B-NP O
afternoon NN I-NP O
admission NN I-NP O
where WRB O O
she PRP O O
was VBD B-VP O
found VBN O O
by IN B-VP O
her PRP$ O O
apartment NN B-NP O
manager NN I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Unremarkable NNP I-NP O
She PRP O O
denied VBD B-VP O
URI NNP B-NP O
symptoms NNS I-NP O
, , O O
UTI NNP B-NP O
symptoms NNS I-NP O
, , O O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
, , O O
melena NN B-NP O
, , O O
normal JJ B-NP O
appetite NN I-NP O
, , O O
stable JJ B-NP O
weight NN I-NP O
, , O O
arthralgias NN B-NP O
, , O O
except IN B-VP O
for IN B-VP O
mild JJ B-NP O
knee NN I-NP O
pain NN I-NP O
after IN B-VP O
the DT B-NP O
fall NN I-NP O
She PRP O O
did VBD B-VP O
note VB O O
right NN B-NP O
sided VBN O O
arm NN B-NP O
and CC O O
leg NN B-NP O
weakness NN I-NP O
for IN B-VP O
about IN B-VP O
a DT B-NP O
year NN I-NP O
that WDT O O
invoked VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
CVA NNP B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Hypertension NNP I-NP O
, , O O
hypothymia NN B-NP O
, , O O
past JJ B-NP O
tobacco NN I-NP O
use NN I-NP O
, , O O
question NN B-NP O
of IN B-VP O
an DT B-NP O
old JJ I-NP O
CVA NNP I-NP O
, , O O
COPD NNP B-NP O
not RB O O
O2 NNP B-NP O
dependent NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
appendectomy NN I-NP O
MEDICATIONS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
aspirin NN B-NP B-m
, , O O
lisinopril NN B-NP B-m
, , O O
atenolol JJ B-NP B-m
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT O O
known VBN O O
medical JJ B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
alone RB O O
in IN B-VP O
none NN B-NP O
She PRP O O
has VBZ O O
two CD O O
daughters NNS B-NP O
who WP O O
live VBP O O
in IN B-VP O
In IN B-VP O
Na NNP B-NP O
The DT B-NP O
granddaughter NN I-NP O
lives VBZ O O
in IN B-VP O
Porttempe NNP B-NP O
His PRP$ O O
Coucla NNP B-NP O
Her NNP I-NP O
son NN I-NP O
is VBZ O O
in IN B-VP O
Font NNP B-NP O
She PRP O O
is VBZ O O
a DT B-NP O
smoker NN I-NP O
with IN B-VP O
one CD O O
cigarette NN B-NP O
every DT B-NP O
few JJ I-NP O
days NNS I-NP O
for IN B-VP O
about IN B-VP O
45 CD O O
years NNS B-NP O
The DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
use VB O O
ethanol JJ B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
father NN I-NP O
died VBD B-VP O
of IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
at IN B-VP O
79 CD O O
and CC O O
mother RB O O
died VBD B-VP O
at IN B-VP O
27 CD O O
during IN B-VP O
pregnancy NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
97.3 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
of IN B-VP O
108 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
of IN B-VP O
152/102 CD O O
satting VBG O O
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Her PRP$ O O
examination NN B-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
poor JJ B-NP O
hygiene NN I-NP O
, , O O
incontinence NN B-NP O
of IN B-VP O
urine NN B-NP O
, , O O
stool NN B-NP O
and CC O O
a DT B-NP O
tachycardia NN I-NP O
wheeze NN I-NP O
, , O O
poor JJ B-NP O
strength NN I-NP O
throughout IN B-VP O
On IN B-VP O
the DT B-NP O
floor NN I-NP O
her PRP$ O O
physical JJ B-NP O
examination NN I-NP O
showed VBD B-VP O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
in IN B-VP O
the DT O O
90s CD O O
, , O O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
110 CD O O
She PRP O O
is VBZ O O
satting VBG O O
96% CD O O
on IN B-VP O
four CD O O
liters NNS B-NP O
In IN B-VP O
general JJ O O
she PRP O O
was VBD B-VP O
comfortable JJ O O
but CC O O
in IN B-VP O
mild JJ B-NP O
respiratory NN I-NP O
distress NN I-NP O
with IN B-VP O
a DT B-NP O
wheeze NN I-NP O
She PRP O O
was VBD B-VP O
using VBG O O
her PRP$ O O
respiratory NN B-NP O
muscles NNS I-NP O
HEENT NNP I-NP O
, , O O
extraocular JJ B-NP O
muscles NNS I-NP O
are VBP O O
intact JJ O O
, , O O
PERRL NNP B-NP O
Cranial NNP I-NP O
nerves NNS I-NP O
II NNP I-NP O
through IN B-VP O
XII NNP B-NP O
are VBP O O
intact JJ B-NP O
Neck NNP I-NP O
- : O O
she PRP O O
had VBD B-VP O
no DT B-NP O
adenopathy NN I-NP O
, , O O
thyromegaly NN B-NP O
or CC O O
GP6 NNP B-NP O
Cardiovascular NNP I-NP O
- : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
or CC O O
gallops NNS B-NP O
, , O O
distant JJ B-NP O
heart NN I-NP O
sounds VBZ O O
Respirations NNPS B-NP O
- : O O
she PRP O O
had VBD B-VP O
some DT B-NP O
wheezes NNS I-NP O
, , O O
no DT B-NP O
crackles NNS I-NP O
She PRP O O
had VBD B-VP O
increased VBN O O
respiratory JJ B-NP O
phase NN I-NP O
Abdomen NNP I-NP O
- : O O
she PRP O O
was VBD B-VP O
obese JJ O O
, , O O
non-tender JJ O O
and CC O O
non-distended JJ O O
with IN B-VP O
left JJ B-NP O
groin NN I-NP O
erythematous JJ O O
and CC O O
scaling VBG O O
with IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
fungal JJ B-NP O
infection NN I-NP O
Extremities NNP I-NP O
- : O O
no DT B-NP O
edema NN I-NP O
She PRP O O
had VBD B-VP O
1+ CD O O
dorsalis NNS B-NP O
pedis JJ B-NP O
pulses NNS I-NP O
Neuro NNP I-NP O
examination NN I-NP O
- : O O
she PRP O O
was VBD B-VP O
alert JJ O O
She PRP O O
knew VBD B-VP O
she PRP O O
was VBD B-VP O
at IN B-VP O
the DT B-NP O
Dellsbrothers NNP I-NP O
Loitmette NNP I-NP O
Hospital NNP I-NP O
She PRP O O
said VBD B-VP O
it PRP O O
was VBD B-VP O
1982 CD O O
, , O O
July NNP B-NP O
, , O O
Thursday NNP B-NP O
Cranial NNP I-NP O
nerves NNS I-NP O
II NNP I-NP O
through IN B-VP O
XII NNP B-NP O
are VBP O O
intact JJ O O
as IN B-VP O
previously RB O O
noted VBN O O
She PRP O O
had VBD B-VP O
4/5 CD O O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
strength NN I-NP O
She PRP O O
had VBD B-VP O
1+ CD O O
deep JJ B-NP O
tendon NN I-NP O
reflexes NNS I-NP O
with IN B-VP O
toes NNS B-NP O
down RP O O
going VBG O O
She PRP O O
had VBD B-VP O
normal JJ B-NP O
sensation NN I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Sodium NNP I-NP O
134 CD O O
, , O O
potassium NN B-NP O
3.9 CD O O
, , O O
chloride RB O O
101 CD O O
, , O O
CO2 NNP B-NP O
26 CD O O
, , O O
BUN NNP B-NP O
14 CD O O
, , O O
creatinine NN B-NP O
1.1 CD O O
, , O O
glucose VBD B-VP O
139 CD O O
She PRP O O
had VBD B-VP O
an DT B-NP O
anion NN I-NP O
gap NN I-NP O
of IN B-VP O
12 CD O O
White NNP B-NP O
count NN I-NP O
was VBD B-VP O
15.7 CD O O
with IN B-VP O
71% CD O O
polys NNS B-NP O
, , O O
14% CD O O
bands NNS B-NP O
, , O O
8% CD O O
lymphs NN B-NP O
, , O O
2% CD O O
monos VBD B-VP O
Her NNP B-NP O
hematocrit NN I-NP O
was VBD B-VP O
47.0 CD O O
, , O O
her PRP$ O O
platelets NNS B-NP O
were VBD B-VP O
366 CD O O
, , O O
Troponin NNP B-NP O
was VBD B-VP O
3.99 CD O O
, , O O
CK NNP B-NP O
1161 CD O O
, , O O
MB NNP B-NP O
31.2 CD O O
Her NNP B-NP O
albumin NN I-NP O
was VBD B-VP O
4.1 CD O O
, , O O
total JJ B-NP O
bilirubin NN I-NP O
0.4 CD O O
, , O O
alkaline JJ B-NP O
phosphatase NN I-NP O
66 CD O O
, , O O
ALT NNP B-NP O
13 CD O O
, , O O
AST NNP B-NP O
51 CD O O
Her NNP B-NP O
lipids NNS I-NP O
- : O O
her PRP$ O O
LDLs NNP B-NP O
149 CD O O
, , O O
total JJ B-NP O
cholesterol NN I-NP O
232 CD O O
, , O O
HDL NNP B-NP O
49 CD O O
, , O O
coags SYM O O
- : O O
her PRP$ O O
PTT NNP B-NP O
is VBZ O O
30.1 CD O O
, , O O
INR NNP B-NP O
1.0 CD O O
Her NNP B-NP O
head NN I-NP O
CT NNP I-NP O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
bleed NN B-NP O
She PRP O O
had VBD B-VP O
an DT B-NP O
old JJ I-NP O
lacunar NN I-NP O
in IN B-VP O
the DT B-NP O
thalamus NN I-NP O
She PRP O O
had VBD B-VP O
an DT B-NP O
old JJ I-NP O
infarct NN I-NP O
in IN B-VP O
her PRP$ O O
PTM NNP B-NP O
internal JJ B-NP O
capsule NN I-NP O
He PRP O O
EKG NNP B-NP O
showed VBD B-VP O
sinus JJ B-NP O
tachycardia NN I-NP O
at IN B-VP O
102 CD O O
normal JJ O O
axis RB O O
, , O O
normal JJ B-NP O
intervals NNS I-NP O
, , O O
diffuse NN B-NP O
T NNP I-NP O
wave VBP O O
inversions NNS B-NP O
in IN B-VP O
1 CD O O
, , O O
2 CD O O
, , O O
3 CD O O
AVF NNP B-NP O
, , O O
V2 NNP B-NP O
to TO O O
V6 NNP B-NP O
Her NNP I-NP O
chest NN I-NP O
x-ray NN I-NP O
showed VBD B-VP O
no DT B-NP O
active JJ I-NP O
process NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
non JJ B-NP O
ST NNP I-NP O
elevation NN I-NP O
MRI NNP I-NP O
and CC O O
there EX O O
was VBD B-VP O
possible JJ B-NP O
cause NN I-NP O
of IN B-VP O
her PRP$ O O
syncope NN B-NP O
and CC O O
was VBD B-VP O
treated VBN O O
conservatively RB O O
with IN B-VP O
medical JJ B-NP O
management NN I-NP O
Cardiovascular NNP I-NP O
- : O O
ischemia NN B-NP B-r
ischemia NN I-NP B-r
ischemia NN I-NP B-r
ischemia NN I-NP B-r
ischemia NN I-NP B-r
, , O O
ST NNP B-NP B-r
ST NNP I-NP B-r
ST NNP I-NP B-r
ST NNP I-NP B-r
ST NNP I-NP B-r
elevation NN I-NP I-r
elevation NN I-NP I-r
elevation NN I-NP I-r
elevation NN I-NP I-r
elevation NN I-NP I-r
, , O O
myocardial JJ B-NP B-r
myocardial JJ I-NP B-r
myocardial JJ I-NP B-r
myocardial JJ I-NP B-r
myocardial JJ I-NP B-r
infarction NN I-NP I-r
infarction NN I-NP I-r
infarction NN I-NP I-r
infarction NN I-NP I-r
infarction NN I-NP I-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
aspirin JJ B-NP B-m
aspirin NN I-NP B-m
aspirin NN I-NP B-m
, , O O
heparin NN B-NP B-m
heparin NN I-NP B-m
heparin NN I-NP B-m
, , O O
Lopressor NNP B-NP B-m
Lopressor NNP I-NP B-m
Lopressor NNP I-NP B-m
, , O O
captopril NN B-NP B-m
captopril NN I-NP B-m
captopril NN I-NP B-m
, , O O
cozaar NN B-NP B-m
cozaar NN I-NP B-m
cozaar NN I-NP B-m
initially RB O O
with IN B-VP O
heart NN B-NP O
rate NN I-NP O
and CC O O
blood NN B-NP O
pressure NN I-NP O
controlled VBD B-VP O
An DT B-NP O
echocardiogram NN I-NP O
showed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
30% CD O O
with IN B-VP O
apical JJ B-NP O
anterolateral JJ I-NP O
wall NN I-NP O
motion NN I-NP O
abnormality NN I-NP O
and CC O O
heparin NN B-NP B-m
was VBD B-VP O
discontinued VBN O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
further JJ I-NP O
chest NN I-NP O
pain NN I-NP O
Pulmonary NNP I-NP O
- : O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
some DT O B-r
wheezing VBG O I-r
on IN B-VP O
examination NN B-NP O
secondary JJ O O
to TO O O
COPD NNP B-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
Atrovent NNP B-NP B-m
nebs NN I-NP B-mo
and CC O O
subsequently RB O O
had VBD B-VP O
no DT B-NP O
further JJ I-NP O
wheezing NN I-NP O
I.D NNP I-NP O
- : O O
the DT B-NP O
patient NN I-NP O
initially RB O O
had VBD B-VP O
an DT O O
increased VBN O O
white JJ B-NP O
count NN I-NP O
with IN B-VP O
bandemia NN B-NP O
of IN B-VP O
an DT B-NP O
unclear JJ I-NP O
cause NN I-NP O
Her NNP I-NP O
workup NN I-NP O
was VBD B-VP O
negative JJ B-NP O
Her NNP I-NP O
UA NNP I-NP O
and CC O O
chest JJS O O
x-ray JJ O O
were VBD B-VP O
negative JJ O O
She PRP O O
had VBD B-VP O
no DT B-NP O
fevers NNS I-NP O
Her NNP I-NP O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
ultimately RB O O
declined VBD B-VP O
to TO O O
normal JJ B-NP O
Renal NNP I-NP O
- : O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
most RBS O B-r
most RBS O B-r
likely JJ O I-r
likely JJ O I-r
dehydrated VBN O I-r
dehydrated VBN O I-r
initially RB O O
and CC O O
was VBD B-VP O
given VBN O O
fluids NNS B-NP B-m
until IN B-VP B-du
she PRP O I-du
had VBD B-VP I-du
good JJ B-NP I-du
urine NN I-NP I-du
output NN I-NP I-du
Her NNP I-NP O
IV NNP I-NP B-mo
fluids VBZ O B-m
ultimately RB O O
discontinued VBN O O
Renal NNP B-NP O
ultrasound NN I-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
hydronephrosis NN B-NP O
or CC O O
obstruction NN B-NP O
Neuro NNP I-NP O
- : O O
Although IN B-VP O
the DT B-NP O
patient's NN I-NP O
CT NNP I-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
acute JJ B-NP O
stroke NN I-NP O
and CC O O
positive JJ O O
for IN B-VP O
possible JJ B-NP O
infarct NN I-NP O
the DT B-NP O
patient NN I-NP O
declined VBD B-VP O
MRI NNP B-NP O
of IN B-VP O
the DT B-NP O
brain NN I-NP O
to TO O O
workup VB O O
for IN B-VP O
a DT B-NP O
possible JJ I-NP O
TIA NNP I-NP O
PLAN NNP I-NP O
FOLLOWING NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
somewhat RB O O
debilitated JJ O O
following VBG O O
her PRP$ O O
hospitalization NN B-NP O
, , O O
requires VBZ O O
physical JJ B-NP O
therapy NN I-NP O
to TO O O
regain VB O O
her PRP$ O O
ability NN B-NP O
to TO O O
perform VB O O
activities NNS B-NP O
of IN B-VP O
daily JJ O O
living VBG O O
Additionally RB O O
the DT B-NP O
patient NN I-NP O
should MD O O
follow VB O O
with IN B-VP O
Gynecology NNP B-NP O
, , O O
is VBZ O O
scheduled VBN O O
for IN B-VP O
a DT B-NP O
workup NN I-NP O
for IN B-VP O
her PRP$ O O
incontinence NN B-NP O
which WDT O O
may MD O O
also RB O O
include VB O O
an DT B-NP O
issue NN I-NP O
of IN B-VP O
uterine JJ B-NP O
prolapse NN I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
RICKIE NNP I-NP O
RILES NNP I-NP O
, , O O
M.D NNP B-NP O
AA89 NNP I-NP O
Attending: NNP I-NP O
GUY NNP I-NP O
G NNP I-NP O
DELFAVERO NNP I-NP O
, , O O
M.D NNP B-NP O
WV48 NNP I-NP O
DP536/960504 NNP I-NP O
Batch: NNP I-NP O
7826 CD O O
Index NNP B-NP O
No NNP I-NP O
L1GGAHHQR3 NNP I-NP O
D: NNP I-NP O
7/14/02 CD O O
T: NNP B-NP O
3/5/02 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#97948 VBZ O O
212707884 CD O O
NUMC NNP B-NP O
02730170 CD O O
7874231 CD O O
5/12/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/4/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/3/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
PITPITAN NNP I-NP O
, , O O
CHAS NNP B-NP O
533-43-09-8 CD O O
Asssho NNP B-NP O
Dr NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
1/10/04 CD O O
AT NNP B-NP O
07:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
LANGBEIN NNP I-NP O
, , O O
GARLAND NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
VENTOLIN NNP I-NP B-m
NEBULIZER NNP I-NP I-m
( ( O I-m
ALBUTEROL NNP B-NP I-m
NEBULIZER NNP I-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
NEB NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP O
Shortness NNP I-NP B-r
of IN B-VP I-r
Breath NNP B-NP I-r
ATENOLOL NNP I-NP B-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
8/7 CD O O
) ) O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
NPH NNP I-NP B-m
NPH NNP I-NP B-m
HUMULIN NNP I-NP I-m
HUMULIN NNP I-NP I-m
HUMULIN NNP I-NP I-m
HUMULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
INSULIN NNP B-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
60 CD O B-do
UNITS NNP B-NP I-do
QAM; NNP I-NP B-f
70 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
SC NNP I-NP B-mo
60 CD O B-do
UNITS NNP B-NP I-do
QAM NNP I-NP B-f
70 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/10/04 CD O O
by IN B-VP O
VANABEL NNP B-NP O
, , O O
SAMUEL NNP B-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
FLOVENT NNP B-NP B-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE NNP I-NP I-m
) ) O I-m
44 CD O B-do
MCG NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
COMBIVENT NNP I-NP B-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
AND NNP I-NP I-m
ALBUTEROL NNP I-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Nico NNP I-NP O
within IN B-VP O
4-6 JJ B-NP O
weeks NNS I-NP O
, , O O
please VB O O
call VB O O
079.422.5908 CD O O
4-6 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Williams NNP I-NP O
Dulkis NNP I-NP O
, , O O
OTH NNP B-NP O
, , O O
317.160.9552 CD O O
, , O O
please NN B-NP O
see VB O O
Dr NNP B-NP O
Faulker NNP I-NP O
within IN B-VP O
the DT B-NP O
week NN I-NP O
within IN B-VP O
1 CD O O
week NN B-NP O
, , O O
ALLERGY: NNP B-NP O
Aspirin NNP I-NP O
, , O O
Sulfa NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
chest JJS B-NP O
pain NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
ASTHMA/COPD NNP I-NP O
FEV1 NNP I-NP O
.97 NNP I-NP O
, , O O
FEV1/FVC NNP B-NP O
.46 NNP I-NP O
INSULIN NNP I-NP O
REQ NNP I-NP O
TYPE NNP I-NP O
II NNP I-NP O
DM NNP I-NP O
SEASONAL NNP I-NP O
RHINITIS NNP I-NP O
DIVERTICULOSIS NNP I-NP O
NEPHROLITHIASIS NNP I-NP O
S/P NNP I-NP O
INTUBATION NNP I-NP O
1/8 CD O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
( ( O O
0/0/04 CD O O
): NNP B-NP O
LAD NNP I-NP O
prox VBD B-VP O
40% CD O O
, , O O
no DT B-NP O
LCX NNP I-NP O
lesions NNS I-NP O
, , O O
No NNP B-NP O
RCA NNP I-NP O
lesions NNS I-NP O
, , O O
R NNP B-NP O
PDA NNP I-NP O
mid VBD B-VP O
30% CD O O
lesion NN B-NP O
Conclusion: NNP I-NP O
non-obstructive JJ B-NP O
CAD NNP I-NP O
, , O O
normal JJ B-NP O
L NNP I-NP O
heart NN I-NP O
filling NN I-NP O
pressures VBZ O O
OTHER NNP B-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Mr NNP I-NP O
Gerache NNP I-NP O
is VBZ O O
a DT B-NP O
59 JJ I-NP O
yo NN I-NP O
man NN I-NP O
with IN B-VP O
poorly RB O O
controlled VBN O O
diabetes NNS B-NP O
, , O O
asthma NNS B-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
Over IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
weeks NNS I-NP O
he PRP O O
has VBZ O O
had VBN O O
intermittent VBN O O
chest JJS B-NP O
pain NN I-NP O
with IN B-VP O
activity NN B-NP O
, , O O
lasting VBG O O
5 CD O O
minutes NNS B-NP O
, , O O
relieved VBN O O
with IN B-VP O
rest NN B-NP O
He PRP O O
also RB O O
has VBZ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
when WRB O O
he PRP O O
climbs VBZ O O
stairs NNS B-NP O
, , O O
but CC O O
he PRP O O
said VBD B-VP O
that IN B-VP O
this DT O O
is VBZ O O
more RBR O O
from IN B-VP O
his PRP$ O O
asthma NN B-NP O
He PRP O O
presented VBD B-VP O
to TO O O
his PRP$ O O
PCP NNP B-NP O
because IN B-VP O
of IN B-VP O
a DT B-NP O
finger NN I-NP O
injury NN I-NP O
, , O O
and CC O O
then RB O O
told VBD B-VP O
him PRP O O
about IN B-VP O
the DT B-NP O
chest JJS I-NP O
pain NN I-NP O
Pt NNP I-NP O
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
ED NNP I-NP O
He PRP O O
has VBZ O O
been VBN O O
chest JJS B-NP O
pain NN I-NP O
free JJ O O
since IN B-VP O
the DT B-NP O
day NN I-NP O
before IN B-VP O
admission NN B-NP O
His PRP$ O O
finger NN B-NP O
sticks NNS I-NP O
at IN B-VP O
home NN B-NP O
have VBP O O
been VBN O O
in IN B-VP O
the DT B-NP O
200-300 JJ I-NP O
range NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
CV NNP B-NP O
- : O O
ischemia: NN B-NP O
Mr NNP I-NP O
Wanzer NNP I-NP O
had VBD B-VP O
a DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
the DT B-NP O
mor NN I-NP O
ning NN I-NP O
of IN B-VP O
5/13 CD O O
He PRP O O
has VBZ O O
had VBD B-VP O
3 CD O O
sets NNS B-NP O
of IN B-VP O
negative JJ B-NP O
enzymes NNS I-NP O
( ( O O
elevated VBN O O
CKMB NNP B-NP O
but CC O O
negative JJ B-NP O
troponins NNS I-NP O
) ) O O
EKG NNP B-NP O
significant JJ O O
only RB O O
for IN B-VP O
j NN B-NP O
point NN I-NP O
elevation NN I-NP O
diffusely RB O O
-beta JJ B-NP B-m
blocker NN I-NP I-m
was VBD B-VP O
started VBN O O
-cholesterol NN B-NP O
was VBD B-VP O
checked VBN O O
( ( O O
elevated VBN O O
triglycerides NNS B-NP O
308 CD O O
, , O O
total JJ B-NP O
cholesterol NN I-NP O
146 CD O O
, , O O
HDL NNP B-NP O
29 CD O O
) ) O O
Baseline NNP B-NP O
LFTs NNP I-NP O
checked VBD B-VP O
-statin NNP B-NP B-m
was VBD B-VP O
started VBN O O
-aspirin NNP B-NP B-m
was VBD B-VP O
held VBN O O
because IN B-VP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
stated VBD B-VP O
allergy NN B-NP O
to TO O O
aspirin VB O O
( ( O O
causes NNS B-NP O
asthma VBP O O
type NN B-NP O
symptoms NNS I-NP O
) ) O O
-will VBP O O
start JJ B-NP O
patient NN I-NP O
on IN B-VP O
low-dose JJ B-NP B-do
lisinopril NN I-NP B-m
PUMP: NNP I-NP O
no DT B-NP O
prior JJ I-NP O
echo NN I-NP O
, , O O
consider VB O O
as IN B-VP O
outpatient NN B-NP O
appears VBZ O O
euvolemic JJ B-NP O
rhythm: NN I-NP O
no DT B-NP O
active JJ I-NP O
issues NNS I-NP O
2 CD O O
ENDO NNP B-NP O
- : O O
on IN B-VP O
insulin NN B-NP B-m
at IN B-VP O
home NN B-NP O
but CC O O
rarely RB O O
checks VBZ O O
his PRP$ O O
sugars NNS B-NP O
when WRB O O
he PRP O O
does VBZ O O
it's VB O O
usually RB O O
200-300s JJ B-NP O
Hemoglobin NNP I-NP O
A1c NNP I-NP O
is VBZ O O
10.7 CD O O
Patient NN B-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
home NN B-NP O
regimen NNS I-NP O
of IN B-VP O
NPH NNP B-NP B-m
insulin NN I-NP I-m
but CC O O
clearly RB O O
needs VBZ O O
better RBR O O
control NN B-NP O
of IN B-VP O
his PRP$ O B-r
sugars NNS B-NP I-r
as IN B-VP O
outpatient JJ O O
3 CD O O
PULM: NNP B-NP O
pt NN I-NP O
says VBZ O O
he PRP O O
has VBZ O O
had VBN O O
asthma VBN O O
as IN B-VP O
a DT B-NP O
child NN I-NP O
no DT B-NP O
record NN I-NP O
of IN B-VP O
PFTs NNP B-NP O
but CC O O
should MD O O
obtain VB O O
as IN B-VP O
outpatient JJ B-NP O
Home NNP I-NP O
inhalers NNS I-NP O
continued VBD B-VP O
4 CD O O
RENAL: NNP B-NP O
Mr NNP I-NP O
Gaulding NNP I-NP O
currently RB O O
has VBZ O O
good JJ B-NP O
renal JJ I-NP O
function NN I-NP O
but CC O O
needs VBZ O O
to TO O O
have VB O O
his PRP$ O O
Cr NNP B-NP O
checked VBD B-VP O
after IN B-VP O
starting VBG O O
the DT B-NP O
lisinopril JJ I-NP B-m
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
You PRP O O
must MD O O
have VB O O
your PRP$ O O
kidney NN B-NP O
function NN I-NP O
checked VBD B-VP O
within IN B-VP O
1 CD O O
week NN B-NP O
, , O O
please VB O O
make VB O O
an DT B-NP O
appointment NN I-NP O
with IN B-VP O
your PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
Please NNP I-NP O
take VB O O
your PRP$ O B-m
medications NNS B-NP O
as IN B-VP O
instructed JJ B-NP O
Please NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Shiley NNP I-NP O
, , O O
your PRP$ O O
cardiologist NN B-NP O
within IN B-VP O
4-6 JJ B-NP O
weeks NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Please NNP I-NP O
consider VB O O
carefully RB O O
your PRP$ O O
lifestyle NN B-NP O
, , O O
including VBG O O
your PRP$ O O
diet NN B-NP O
and CC O O
exercise NN B-NP O
plans NNS I-NP O
Although IN B-VP O
you PRP O O
did VBD B-VP O
not RB O O
have VB O O
blockages NNS B-NP O
in IN B-VP O
your PRP$ O O
heart NN B-NP O
vessels NNS I-NP O
requiring VBG O O
stenting NN B-NP O
, , O O
you PRP O O
have VBP O O
started VBN O O
to TO O O
have VB O O
blockages NNS B-NP O
, , O O
so IN B-VP O
the DT B-NP O
best JJS I-NP O
thing NN I-NP O
you PRP O O
can MD O O
do VB O O
is VBZ O O
to TO O O
slow VB O O
this DT B-NP O
process NN I-NP O
down RP O O
This DT O O
includes VBZ O O
losing VBG O O
weight NN B-NP O
through IN B-VP O
diet JJ O O
and CC O O
exercise NN B-NP O
, , O O
taking VBG O O
medications NNS B-NP O
including VBG O O
statin NN B-NP B-m
, , O O
beta NN B-NP B-m
blocker NN I-NP I-m
( ( O I-m
atenolol NN B-NP I-m
) ) O I-m
and CC O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
( ( O I-m
lisinopril NN B-NP I-m
) ) O I-m
No RB O O
dictated JJ B-NP O
summary NN I-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
KOZATEK NNP I-NP O
, , O O
EUSEBIO NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
GX5 NNP B-NP O
) ) O O
1/10/04 CD O O
@ $ O O
06:39 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#98358 VBZ O O
441230814 CD O O
PTHKMC NNP B-NP O
75713869 CD O O
8014229 CD O O
1/5/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
heart NN I-NP O
failure NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/4/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/24/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
TABIOS NNP I-NP O
, , O O
MARLIN NNP B-NP O
196-97-89-3 CD O O
Road NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
6/30/04 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BOYSEN NNP I-NP O
, , O O
ANDREA NNP B-NP O
JORDAN NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ATENOLOL NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
REGLAN NNP I-NP B-m
( ( O I-m
METOCLOPRAMIDE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Instructions: NNP I-NP O
Give NNP I-NP O
with IN B-VP O
warm JJ B-NP O
water NN I-NP O
, , O O
separately RB O O
from IN B-VP O
other JJ B-NP O
pills NNS I-NP O
before IN B-VP O
meals NNS B-NP O
Thanks NNP I-NP O
, , O O
COUMADIN NNP B-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
3.75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
Standard NNP B-NP O
Admin NNP I-NP O
Time NNP I-NP O
) ) O O
( ( O O
3/23 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
4/15/04 CD O O
by IN B-VP O
ROMANI NNP B-NP O
, , O O
LONG NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
SIMVASTATIN NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/04 CD O O
by IN B-VP O
STUBBE NNP B-NP O
, , O O
SAMMIE NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
09689542 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/14/04 CD O O
by IN B-VP O
SISEMORE NNP B-NP O
, , O O
AL NNP B-NP O
MANUAL NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
70/30 CD O I-m
70/30 CD O I-m
70/30 CD O I-m
70/30 CD O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
HUMAN NNP B-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
10 CD O B-do
UNITS NNP B-NP I-do
QAM; NNP I-NP B-f
0 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
SC NNP I-NP B-mo
10 CD O B-do
UNITS NNP B-NP I-do
QAM NNP I-NP B-f
0 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
COZAAR NNP I-NP B-m
( ( O I-m
LOSARTAN NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
PROTONIX NNP B-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
Fluid NNP I-NP O
restriction: VBD B-VP O
2 CD O O
liters NNS B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
asselmeier RB O O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
8/16/04 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
7 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
keiffer NN B-NP O
ALLERGY: NNP I-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
heart NN B-NP O
failure NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
idiopathic JJ O O
dilated VBD B-VP O
CM NNP B-NP O
hx NN I-NP O
asthma NN I-NP O
hx NN I-NP O
CVA NNP I-NP O
( ( O O
hemorrhage NN B-NP O
) ) O O
IDDM NNP B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
Nephrotic NNP B-NP O
Syndrome NNP I-NP O
2/2 CD O O
DM NNP B-NP O
( ( O O
nephrotic JJ B-NP O
syndrome NN I-NP O
) ) O O
AICD NNP B-NP O
( ( O O
for IN B-VP O
h/o NN B-NP O
VT NNP I-NP O
) ) O O
( ( O O
ventricular JJ B-NP O
tachycardia NN I-NP O
) ) O O
CAD NNP B-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
56F CD O O
with IN B-VP O
hx NN B-NP O
of IN B-VP O
idiopathic JJ B-NP O
cmp NN I-NP O
( ( O O
ef JJ O O
25% CD O O
) ) O O
, , O O
presents VBZ O O
with IN B-VP O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
orthopnea NN B-NP O
, , O O
lower JJR B-NP O
extermity NN I-NP O
edema VBP O O
HPI: NNP B-NP O
reports NNS I-NP O
1 CD O O
wk JJ B-NP O
history NN I-NP O
of IN B-VP O
increasing VBG O O
lower JJR B-NP O
extermity NN I-NP O
edema NN I-NP O
, , O O
orthopnea NN B-NP O
Has NNP I-NP O
been VBN O O
taking VBG O O
all DT B-NP O
meds NNS I-NP O
but CC O O
has VBZ O O
recently RB O O
had VBN O O
multiple JJ B-NP O
dietary JJ I-NP O
indiscretions NNS I-NP O
including VBG O O
chicken NN B-NP O
noodle JJ B-NP O
soup NN I-NP O
and CC O O
grilled VBD B-VP O
ham NNS B-NP O
cheese JJ B-NP O
sandwich NN I-NP O
In IN B-VP O
addition NN B-NP O
patient NN I-NP O
has VBZ O O
episodes NNS B-NP O
of IN B-VP O
nausea NN B-NP O
and CC O O
also RB O O
hypoglycemia NN B-NP O
when WRB O O
she PRP O O
discontinues VBZ O O
her PRP$ O O
medications NNS B-NP O
No DT B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
no DT B-NP O
palpitations NNS I-NP O
, , O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
with IN B-VP O
stairs NNS B-NP O
In IN B-VP O
emergency NN B-NP O
department NN I-NP O
d NN I-NP O
, , O O
70 CD O O
/ VBD B-VP O
138/87/ CD O O
100% CD O O
CXR: NNP B-NP O
mod NN I-NP O
pulm NN I-NP O
edema NN I-NP O
, , O O
L NNP B-NP O
small JJ B-NP O
pleural JJ I-NP O
effusion NN I-NP O
and CC O O
LLL NNP B-NP O
opacity NN I-NP O
PE: NNP I-NP O
jvp NN I-NP O
10 CD O O
chest: NN B-NP O
crackles NNS I-NP O
1/4 CD O O
bases NNS B-NP O
b/l JJ B-NP O
cv: NNS I-NP O
enlarged VBD B-VP O
pmi NN B-NP O
, , O O
rv NN B-NP O
heave NN I-NP O
, , O O
3/6 CD O O
hsm NN B-NP O
lsb NN I-NP O
, , O O
apex NN B-NP O
, , O O
no DT B-NP O
gallops NNS I-NP O
abd: VBP O O
no DT B-NP O
organomegaly; NN I-NP O
ext: VBZ O O
warm JJ O O
3+ CD O O
LE NNP B-NP O
edema NN I-NP O
PMH: NNP I-NP O
cardiomyopathy NN I-NP O
, , O O
Asthma NNP B-NP O
, , O O
cva/brain NN B-NP O
aneurysm NN I-NP O
, , O O
AICD NNP B-NP O
for IN B-VP O
VT NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
dvt NN B-NP O
R.leg NNP I-NP O
, , O O
gerd NN B-NP O
, , O O
chronic JJ B-NP O
leg NN I-NP O
swelling NN I-NP O
, , O O
Hypertension NNP B-NP O
SH: NNP I-NP O
lives VBZ O O
with IN B-VP O
son NN B-NP O
, , O O
1 CD O O
cig/day NN B-NP O
, , O O
no DT B-NP O
etoh NN I-NP O
EKG: NNP I-NP O
nsr CC O O
nl JJ B-NP O
axis NN I-NP O
, , O O
qtc RB O O
473 CD O O
lae NN B-NP O
, , O O
lvh NN B-NP O
, , O O
lat JJ B-NP O
twi NN I-NP O
, , O O
st NN B-NP O
elev NN I-NP O
, , O O
v1 NN B-NP O
, , O O
v2--old JJ B-NP O
LABS: NNP I-NP O
bnp: NN I-NP O
3726 CD O O
ck NN B-NP O
937 CD O O
mb NN B-NP O
7.3 CD O O
tn&lt;assay NN B-NP O
echo: NN I-NP O
ECHO: NNP I-NP O
1/23/03 CD O O
severe JJ B-NP O
global JJ I-NP O
lvhk NN I-NP O
20% CD O O
lae NN B-NP O
, , O O
decraesed VBD B-VP O
rv NN B-NP O
f( NN I-NP O
x NNP I-NP O
) ) O O
, , O O
MR NNP B-NP O
, , O O
mild JJ B-NP O
tr NN I-NP O
, , O O
pasp VBP O O
28 CD O O
Assessment NNP B-NP O
56 CD O O
female JJ B-NP O
idiopathic JJ I-NP O
CMP NNP I-NP O
Presents NNPS I-NP O
with IN B-VP O
CHF NNP B-NP O
exacerbation NN I-NP O
2/2 CD O O
dietary JJ B-NP O
indiscretion NN I-NP O
*************************Hospital NNP I-NP O
Course******************** NNP I-NP O
1.CV CD O O
ISCH: NNP B-NP O
Elevated NNP I-NP O
ck NN I-NP O
, , O O
tni NN B-NP O
( ( O O
- : O O
) ) O O
, , O O
ckmb RB O O
low JJ O O
, , O O
ruled VBD B-VP O
out RP O O
X3 NNP B-NP O
cont NN I-NP O
Beta NNP I-NP B-m
Blocker NNP I-NP I-m
, , O O
ASA NNP B-NP B-m
, , O O
non-occlusive JJ O O
2vd CD O O
on IN B-VP O
cath NN B-NP O
PUMP: NNP I-NP O
warm NN I-NP O
and CC O O
wet; VB O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
diresed VBN O O
approximately RB O O
6 CD O O
Liters NNS B-NP O
to TO O O
her PRP$ O O
dry JJ B-NP O
weight NN I-NP O
of IN B-VP O
149 CD O O
kilograms NNS B-NP O
At IN B-VP O
dry JJ B-NP O
weight NN I-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
BNP NNP I-NP O
of IN B-VP O
3700 CD O O
In IN B-VP O
house NN B-NP O
her PRP$ O O
ACE NNP B-NP O
was VBD B-VP O
switched VBN O O
to TO O O
Cozaar NNP B-NP B-m
secondary JJ O O
to TO O O
cough VB O O
Beta NNP B-NP B-m
Blocker NNP I-NP I-m
was VBD B-VP O
changed VBN O O
to TO O O
once RB O B-f
once RB O B-f
a DT O I-f
a DT B-NP I-f
day NN I-NP I-f
day NN I-NP I-f
Atenolol NNP I-NP B-m
An DT B-NP O
echo NN I-NP O
on IN B-VP O
4/15 CD O O
revealed VBD B-VP O
EF NNP B-NP O
21% CD O O
mV NN B-NP O
moderate JJ B-NP O
mr NN I-NP O
, , O O
incomplete JJ B-NP O
closure NN I-NP O
, , O O
TV: NNP B-NP O
moderate NNP I-NP O
tr NN I-NP O
, , O O
incomplete JJ B-NP O
closure;LV NN I-NP O
globak NN I-NP O
HK NNP I-NP O
, , O O
rv VBZ O O
mildly RB O O
to TO O O
moderately RB O O
decreased JJ O O
, , O O
incomplete JJ B-NP O
study NN I-NP O
due JJ O O
to TO O O
patient VB O O
not RB O O
fully RB O O
cooperating VBG O O
On IN B-VP O
the DT B-NP O
patients NNS I-NP O
final JJ B-NP O
day NN I-NP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
she PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
symptomatic JJ B-NP O
dehydra NN I-NP O
tion NN I-NP O
and CC O O
was VBD B-VP O
orthostatic JJ O O
- : O O
symptoms NNS B-NP O
resoved VBN O O
with IN B-VP O
a DT O O
500 CD O O
cc NN B-NP O
NS NNP I-NP O
bolus CC O O
2.ENDO CD O O
: : O O
the DT B-NP O
patient's NN I-NP O
insulin NN I-NP B-m
regiment NN I-NP O
was VBD B-VP O
modified VBN O O
and CC O O
she PRP O O
was VBD B-VP O
dc'd VBN O O
on IN B-VP O
insulin NN B-NP B-m
70/30 CD O I-m
10 CD O O
am VBP O O
THe NNP B-NP O
patient's NN I-NP O
admission NN I-NP O
regimine NN I-NP O
of IN B-VP O
Lantus NNP B-NP B-m
40 CD O B-do
q NN B-NP B-f
d NN I-NP O
was VBD B-VP O
causing VBG O O
both DT O O
hyper JJR O O
and CC O O
hypoglycemia NN B-NP O
in IN B-VP O
house NN B-NP O
Her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
few JJ I-NP O
episodes NNS I-NP O
of IN B-VP O
hypoglycemia NN B-NP O
resulting VBG O O
in IN B-VP O
down JJ B-NP B-do
titration NN I-NP O
of IN B-VP O
insulin NN B-NP B-m
AM NNP I-NP O
and CC O O
PM NNP B-NP O
doses VBZ O O
THe NNP B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
extremely RB O O
hypoglycmeic JJ O O
on IN B-VP O
8 CD O B-do
units NNS B-NP I-do
of IN B-VP O
70/30 CD O O
in IN B-VP O
the DT B-NP O
PM NNP I-NP O
and CC O O
the DT B-NP O
PM NNP I-NP B-f
insulin NN I-NP B-m
was VBD B-VP O
discontinued VBN O O
for IN B-VP O
the DT B-NP O
time NN I-NP O
being VBG O O
It PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
the DT B-NP O
patient's NN I-NP O
diet NN I-NP O
at IN B-VP O
home NN B-NP O
would MD O O
have VB O O
higher JJR B-NP O
glucose NN I-NP O
and CC O O
carbohydrate NN B-NP O
content NN I-NP O
and CC O O
her PRP$ O O
Fs's NNP B-NP O
will MD O O
need VB O O
further RB O O
w/up VB O O
as IN B-VP O
outpatient NN B-NP O
We PRP O O
reccomend VBP O O
titrating VBG O B-do
the DT O O
70/30 CD O O
insulin NN B-NP B-m
up RB O O
as RB O B-f
needed VBN O I-f
3.GI: CD O O
she PRP O O
complained VBD B-VP O
of IN B-VP O
mild JJ B-NP O
epigastric JJ I-NP O
pain NN I-NP O
after IN B-VP O
meals NNS B-NP O
, , O O
and CC O O
said VBD B-VP O
it PRP O O
is VBZ O O
thought VBN O O
that IN B-VP O
this DT O O
represents VBZ O O
diabetic JJ B-NP B-r
gastroparesis NN I-NP I-r
Her NNP I-NP O
reglan NN I-NP B-m
dose NN I-NP O
was VBD B-VP O
increased VBN O O
to TO O O
10 CD O B-do
and CC O O
she PRP O O
tolerated VBD B-VP O
PO's NNP B-NP O
better RBR O O
subsequently RB O O
and CC O O
was VBD B-VP O
less RBR O O
symptomatic JJ O O
4.HEME: CD O O
cont NN B-NP O
coumadin NN I-NP B-m
5.PROPHYLAXIS: CD O O
coumadin NN B-NP B-m
, , O O
nexium NN B-NP B-m
6.CODE CD O O
full JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
Please NNP B-NP O
followup NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Scarles NNP I-NP O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
2 CD O O
Please NNP B-NP O
switch VB O O
your PRP$ O O
insulin NN B-NP B-m
to TO O O
10 CD O B-do
units NNS B-NP I-do
of IN B-VP O
70/30 CD O O
insulin NN B-NP B-m
the DT B-NP O
morning NN I-NP B-f
Your PRP$ O O
primary JJ B-NP O
doctor NN I-NP O
may MD O O
make VB O O
changes NNS B-NP O
in IN B-VP O
your PRP$ O O
insulin NN B-NP B-m
regimin NN I-NP O
based VBN O O
on IN B-VP O
your PRP$ O O
recorded VBN O O
blood NN B-NP B-r
sugars NNS I-NP I-r
3 CD O O
Please NNP B-NP O
stop VB O O
taking VBG O O
Metoprolol NNP B-NP B-m
and CC O O
Lisinopril NNP B-NP B-m
4 CD O O
Please NNP B-NP O
start VB O O
taking VBG O O
Cozaar NNP B-NP B-m
and CC O O
Atenolol NNP B-NP B-m
Your NNP I-NP O
Reglan NNP I-NP B-m
dose VBP O O
is VBZ O O
increased JJ O O
5 CD O O
VNA NNP B-NP O
for IN B-VP O
diabetes JJ B-NP O
management NN I-NP O
, , O O
CHF NNP B-NP O
management NN I-NP O
, , O O
and CC O O
medical JJ B-NP O
compliance NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
WOHLWENDI NNP I-NP O
, , O O
BARRETT NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
RL81 NNP B-NP O
) ) O O
6/30/04 CD O O
@ $ O O
03 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#98718 VBZ O O
192629344 CD O O
VCH NNP B-NP O
68247963 CD O O
4374625 CD O O
4/13/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
LEFT NNP I-NP O
LEG NNP I-NP O
CELLULITIS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/18/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/23/2006 CD O O
ATTENDING: NNP B-NP O
DIFABIO NNP I-NP O
III NNP I-NP O
, , O O
ARNOLD NNP B-NP O
IGNACIO NNP I-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Slunaker NNP I-NP O
is VBZ O O
a DT B-NP O
56-year-old JJ I-NP O
gentleman NN I-NP O
who WP O O
underwent VBD B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
x4 NN B-NP O
on IN B-VP O
0/16/06 CD O O
with IN B-VP O
left JJ B-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
left VB O O
anterior RP O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
, , O O
a DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
ramus NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
, , O O
a DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
second JJ I-NP O
obtuse NN I-NP O
marginal JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
, , O O
and CC O O
a DT B-NP O
left JJ I-NP O
radial JJ I-NP O
artery NN I-NP O
graft NN I-NP O
to TO O O
the DT O O
right JJ O O
coronary JJ O O
artery IN B-VP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
postoperatively RB O O
He PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
on IN B-VP O
10/20/06 CD O O
The DT B-NP O
patient NN I-NP O
noted VBD B-VP O
his PRP$ O O
left JJ B-NP O
lower JJR I-NP O
leg NN I-NP O
to TO O O
be VB O O
warm JJ O O
and CC O O
swollen JJ O O
with IN B-VP O
redness NN B-NP O
and CC O O
presented VBN O O
to TO O O
see VB O O
Dr NNP B-NP O
Emory NNP I-NP O
Bebeau NNP I-NP O
in IN B-VP O
clinic JJ B-NP O
Dr NNP I-NP O
Odor NNP I-NP O
placed VBD B-VP O
the DT B-NP O
patient NN I-NP O
on IN B-VP O
levofloxacin NN B-NP B-m
and CC O O
vancomycin NN B-NP B-m
and CC O O
had VBD B-VP O
him PRP O O
admitted VBN O O
for IN B-VP O
left NN B-NP B-r
left VBD B-VP B-r
lower JJR B-NP O
leg NN I-NP O
cellulitis NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
AND NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
, , O O
dyslipidemia NN B-NP O
, , O O
lumbar NN B-NP O
disc NN I-NP O
disease NN I-NP O
, , O O
nephrolithiasis NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
cholecystectomy NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
as IN B-VP O
stated VBN O O
above IN B-VP O
ALLERGIES: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
allergies NNS B-NP O
to TO O O
tetanus VB O O
, , O O
where WRB O O
he PRP O O
develops VBZ O O
swelling VBG O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Toprol NNP I-NP B-m
25 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
diltiazem VBZ O B-m
30 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
aspirin RB O B-m
325 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
atorvastatin VBD B-VP B-m
40 CD O B-do
mg JJ O O
daily RB O B-f
, , O O
Tricor NNP B-NP B-m
145 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Zetia NNP B-NP B-m
10 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
metformin VBD B-VP B-m
500 CD O B-do
mg JJ O O
daily JJ O B-f
, , O O
and CC O O
potassium NN B-NP B-m
chloride NN I-NP I-m
slow JJ B-NP I-m
release NN I-NP I-m
20 CD O B-do
mEq JJ B-NP I-do
daily JJ I-NP B-f
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Five NNP I-NP O
feet NNS I-NP O
10 CD O O
inches NNS B-NP O
tall JJ O O
, , O O
temperature NN B-NP O
97 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
52 CD O O
and CC O O
regular JJ O O
, , O O
blood NN B-NP O
pressure NN I-NP O
right JJ B-NP O
arm NN I-NP O
142/76 CD O O
, , O O
left VBD B-VP O
arm NN B-NP O
148/76 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT O O
2/6 CD O O
systolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
Peripheral NNP I-NP O
vascular NN I-NP O
2+ CD O O
pulses NNS B-NP O
bilaterally RB O O
throughout IN B-VP O
Extremities: NNP B-NP O
Left NNP I-NP O
anterior JJ B-NP O
tibial JJ I-NP O
cellulitis NN I-NP O
ADMISSION NNP I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Admission NNP I-NP O
labs NN I-NP O
, , O O
sodium NN B-NP O
135 CD O O
, , O O
potassium NN B-NP O
4.4 CD O O
, , O O
chloride NN B-NP O
of IN B-VP O
101 CD O O
, , O O
CO2 NNP B-NP O
27 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
29 CD O O
, , O O
creatinine NN B-NP O
1.3 CD O O
, , O O
glucose NN B-NP O
of IN B-VP O
113 CD O O
, , O O
WBC NNP B-NP O
is VBZ O O
11.62 CD O O
, , O O
hemoglobin NN B-NP O
11.9 CD O O
, , O O
hematocrit NN B-NP O
34.1 CD O O
, , O O
and CC O O
platelets NNS B-NP O
of IN B-VP O
573 CD O O
PT NNP B-NP O
13.2 CD O O
, , O O
PTT NNP B-NP O
of IN B-VP O
31.5 CD O O
, , O O
and CC O O
PT/INR NNP B-NP O
of IN B-VP O
1.0 CD O O
Urinalysis NNP B-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
a DT O B-r
a DT B-NP B-r
left JJ I-NP O
lower JJR I-NP O
leg NN I-NP O
cellulitis NN I-NP O
and CC O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
levofloxacin NN B-NP B-m
and CC O O
vancomycin NN B-NP B-m
Infectious NNP I-NP O
disease NN I-NP O
consult NN I-NP O
was VBD B-VP O
called VBN O O
, , O O
and CC O O
recommendations NNS B-NP O
were VBD B-VP O
followed VBN O O
, , O O
which WDT O O
were VBD B-VP O
to TO O O
discontinue VB O O
the DT B-NP O
vancomycin NN I-NP B-m
and CC O O
levofloxacin NN B-NP B-m
, , O O
and CC O O
change NN B-NP O
to TO O O
Ancef NNP B-NP B-m
1 CD O B-do
gm NN B-NP I-do
IV NNP I-NP B-mo
q.8h NN I-NP B-f
and CC O O
monitor VB O O
his PRP$ O O
wound NN B-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
afebrile JJ B-NP O
White NNP I-NP O
count NN I-NP O
trended VBD B-VP O
down RB O O
and CC O O
leg JJ B-NP O
wound NN I-NP O
improved VBD B-VP O
on IN B-VP O
exam NN B-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
an DT O O
improved VBN O O
left VBD B-VP O
lower JJR B-NP O
leg NN I-NP O
wound NN I-NP O
, , O O
he PRP O O
remained VBD B-VP O
afebrile JJ O O
, , O O
and CC O O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
Dr NNP B-NP O
Manvelyan NNP I-NP O
, , O O
and CC O O
cleared VBD B-VP O
for IN B-VP O
discharge NN B-NP O
to TO O O
home NN B-NP O
Infectious NNP I-NP O
disease NN I-NP O
wanted VBD B-VP O
him PRP O O
to TO O O
continue VB O O
on IN B-VP O
an DT B-NP O
oral JJ I-NP B-mo
dose NN I-NP O
of IN B-VP O
Augmentin NNP B-NP B-m
875/125 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
for IN B-VP B-du
a DT B-NP O
total NN I-NP O
of IN B-VP O
10 CD O O
days NNS B-NP O
DISCHARGE NNP I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Discharge NNP I-NP O
labs NNS I-NP O
are VBP O O
as IN B-VP O
follows VBZ O O
, , O O
glucose JJ O O
137 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
21 CD O O
, , O O
creatinine NN B-NP O
1.2 CD O O
, , O O
sodium NN B-NP O
136 CD O O
, , O O
potassium NN B-NP O
4.2 CD O O
, , O O
chloride NN B-NP O
of IN B-VP O
102 CD O O
, , O O
CO2 NNP B-NP O
of IN B-VP O
26 CD O O
, , O O
magnesium NN B-NP O
1.8 CD O O
, , O O
WBC NNP B-NP O
is VBZ O O
11.11 CD O O
, , O O
hemoglobin NN B-NP O
12.6 CD O O
, , O O
hematocrit NN B-NP O
36.9 CD O O
, , O O
and CC O O
platelets NNS B-NP O
of IN B-VP O
695 CD O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
Discharge NNP I-NP O
medications NNS I-NP O
are VBP O O
as IN B-VP O
follows VBZ O O
, , O O
Augmentin NNP B-NP B-m
875/125 CD O I-m
1 CD O B-do
tab NN B-NP I-do
b.i.d NN I-NP B-f
for IN B-VP B-du
10 CD O I-du
days NNS B-NP I-du
, , O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP O
325 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Lipitor NNP B-NP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
diltiazem VBZ O B-m
30 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Zetia NNP B-NP B-m
10 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Tricor NNP B-NP B-m
145 CD O B-do
mg NN B-NP I-do
nightly RB O B-f
, , O O
Diflucan NNP B-NP B-m
200 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
for IN B-VP B-du
one CD O I-du
dose NN B-NP I-du
for IN B-VP O
a DT B-NP B-r
penile JJ I-NP I-r
yeast NN I-NP I-r
infection NN I-NP I-r
, , O O
due JJ O O
to TO O O
antibiotic JJ B-NP O
use NN I-NP O
Metformin NNP I-NP B-m
500 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
, , O O
Toprol-XL NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
daily RB O B-f
, , O O
and CC O O
oxycodone RB O B-m
5-10 JJ B-NP B-do
mg NN I-NP I-do
q.4h NN I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
FOLLOWUP: NNP I-NP O
Mr NNP I-NP O
Ansari NNP I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Noah NNP I-NP O
Schaffhauser NNP I-NP O
on IN B-VP O
5/7/06 CD O O
at IN B-VP O
1 CD O O
o'clock NN B-NP O
, , O O
Dr NNP B-NP O
Aaron NNP I-NP O
Phung NNP I-NP O
in IN B-VP O
three-four JJ B-NP O
days NNS I-NP O
, , O O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
and CC O O
his PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Jonathon NNP I-NP O
Sopata NNP I-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
DISCHARGE NNP I-NP O
INSTRUCTIONS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
monitor VB O O
his PRP$ O O
leg NN B-NP O
wound NN I-NP O
and CC O O
call VB O O
if IN B-VP O
he PRP O O
had VBD B-VP O
any DT O O
increased VBN O O
weight NN B-NP O
, , O O
temperature NN B-NP O
greater JJR O O
than IN B-VP O
101 CD O O
degrees NNS B-NP O
, , O O
any DT B-NP O
drainage NN I-NP O
from IN B-VP O
the DT B-NP O
wound NN I-NP O
, , O O
redness NN B-NP O
, , O O
swelling VBG O O
or CC O O
change NN B-NP O
of IN B-VP O
any DT B-NP O
kind NN I-NP O
in IN B-VP O
his PRP$ O O
leg NN B-NP O
wound IN B-VP O
He PRP O O
was VBD B-VP O
cleared VBN O O
by IN B-VP O
Infectious NNP B-NP O
Disease NNP I-NP O
Service NNP I-NP O
and CC O O
discharged VBD B-VP O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
eScription NN I-NP O
document: VBZ O O
8-0219144 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
SHEAHAN NNP I-NP O
, , O O
WILMER NNP B-NP O
Attending: NNP I-NP O
KITTELMAN NNP I-NP O
III NNP I-NP O
, , O O
CARROL NNP B-NP O
JAMES NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
8010511 CD O O
D: NNP B-NP O
4/3/06 CD O O
T: NNP B-NP O
4/3/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#106650 VBZ O O
912344838 CD O O
CDHMC NNP B-NP O
57611498 CD O O
246241 CD O O
1/1/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/16/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/24/1995 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Ms NNP I-NP O
Loften NNP I-NP O
is VBZ O O
a DT O O
62 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
including VBG O O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
postmenopausal NN B-NP O
, , O O
who WP O O
presents VBZ O O
with IN B-VP O
exertional JJ B-NP O
angina NNS I-NP O
x VBP O O
four CD O O
months NNS B-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
nondiagnostic JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
, , O O
and CC O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
on IN B-VP O
January NNP B-NP O
, , O O
1995 CD O O
Upon IN B-VP O
further JJ O O
questioning VBG O O
when WRB O O
the DT B-NP O
patient NN I-NP O
presented VBD B-VP O
for IN B-VP O
catheterization NN B-NP O
, , O O
it PRP O O
was VBD B-VP O
found VBN O O
that IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
previous JJ I-NP O
allergic JJ I-NP O
reaction NN I-NP O
to TO O O
intravenous JJ B-NP B-mo
contrast NN I-NP B-m
dye NN I-NP I-m
that WDT O O
caused VBD B-VP O
laryngeal JJ B-NP O
edema NN I-NP O
For IN B-VP O
that DT B-NP O
reason NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
premedication NN B-NP O
overnight JJ O O
prior RB O O
to TO O O
catheterization VB O O
The DT B-NP O
patient NN I-NP O
, , O O
again RB O O
, , O O
is VBZ O O
a DT O O
62 CD O O
year NN B-NP O
old JJ O O
, , O O
and CC O O
is VBZ O O
a DT B-NP O
patient NN I-NP O
of IN B-VP O
Dr NNP B-NP O
Mayer NNP I-NP O
, , O O
with IN B-VP O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
including VBG O O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
, , O O
elevated VBD B-VP O
cholesterol NN B-NP O
, , O O
a DT B-NP O
positive JJ I-NP O
family NN I-NP O
history NN I-NP O
, , O O
and CC O O
being VBG O O
a DT B-NP O
postmenopausal NN I-NP O
woman NN I-NP O
She PRP O O
first RB O O
noted VBD B-VP O
exertional JJ B-NP O
substernal JJ I-NP O
chest NN I-NP O
pain NN I-NP O
about IN B-VP O
four CD O O
months NNS B-NP O
prior RB O O
to TO O O
admission VB O O
The DT B-NP O
pain NN I-NP O
radiates VBZ O O
to TO O O
her PRP$ O O
left JJ B-NP O
arm NN I-NP O
, , O O
and CC O O
is VBZ O O
associated VBN O O
with IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
but CC O O
no DT B-NP O
diaphoresis NN I-NP O
or CC O O
nausea NN B-NP O
or CC O O
vomiting VBG O O
The DT B-NP B-r
pain NN I-NP I-r
is VBZ O O
relieved VBN O O
by IN B-VP O
rest NN B-NP O
within IN B-VP O
two CD O O
minutes NNS B-NP O
, , O O
or CC O O
by IN B-VP O
a DT B-NP O
sublingual JJ I-NP B-mo
Nitroglycerin NNP I-NP B-m
, , O O
which WDT O O
she PRP O O
has VBZ O O
used VBN O O
in IN B-VP B-du
the DT B-NP I-du
past JJ I-NP I-du
week NN I-NP I-du
x NN I-NP I-du
two CD O I-du
Her NNP B-NP O
exercise NN I-NP O
tolerance NN I-NP O
is VBZ O O
limited VBN O O
by IN B-VP O
this DT B-NP O
pain NN I-NP O
, , O O
and CC O O
is VBZ O O
diminished VBN O O
to TO O O
+/- JJ O O
50 CD O O
yards NNS B-NP O
on IN B-VP O
the DT B-NP O
flat JJ I-NP O
surface NN I-NP O
at IN B-VP O
present JJ O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
one CD O O
episode NN B-NP O
of IN B-VP O
pain NN B-NP O
at IN B-VP O
rest NN B-NP O
three CD O O
nights NNS B-NP O
prior RB O O
to TO O O
admission VB O O
She PRP O O
denies VBZ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
orthopnea NN B-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
rule NN B-NP O
out IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
1995 CD O O
, , O O
and CC O O
ruled VBD B-VP O
out RP O O
by IN B-VP O
enzymes NNS B-NP O
and CC O O
electrocardiogram VB O O
She PRP O O
had VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
done VBN O O
which WDT O O
revealed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
60 CD O O
percent NN B-NP O
, , O O
with IN B-VP O
no DT B-NP O
regional JJ I-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities NNS I-NP O
She PRP O O
had VBD B-VP O
2+ CD O O
mitral JJ B-NP O
regurgitation NN I-NP O
, , O O
1+ CD O O
aortic JJ B-NP O
regurgitation NN I-NP O
, , O O
and CC O O
1+ CD O O
tricuspid JJ B-NP O
regurgitation NN I-NP O
The DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
she PRP O O
underwent VBD B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
She PRP O O
went VBD B-VP O
two CD O O
minutes NNS B-NP O
on IN B-VP O
standard JJ B-NP O
Bruce NNP I-NP O
protocol NN I-NP O
, , O O
stopped VBD B-VP O
secondary JJ O O
to TO O O
diaphoresis VB O O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
without IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
and CC O O
she PRP O O
had VBD B-VP O
nondiagnostic JJ B-NP O
electrocardiogram NN I-NP O
changes VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
premedication NN B-NP O
for IN B-VP O
her PRP$ O O
dye NN B-NP O
allergy NN I-NP O
and CC O O
subsequently RB O O
catheterization NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Her NNP I-NP O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
significant JJ O O
for: JJ O O
1 CD O O
Hypertension NNP B-NP O
2 CD O O
Diabetes VBZ O O
3 CD O O
Hypercholesterolemia NN B-NP O
4 CD O O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
a DT B-NP O
deep JJ I-NP O
venous JJ I-NP O
thrombosis NN I-NP O
in IN B-VP O
1994 CD O O
5 CD O O
She PRP O O
has VBZ O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
with IN B-VP O
a DT B-NP O
GFR NNP I-NP O
of IN B-VP O
48 CD O O
, , O O
and CC O O
the DT B-NP O
twenty-four JJ I-NP O
hour NN I-NP O
urine NN I-NP O
shows VBZ O O
3.8 CD O O
grams NNS B-NP O
of IN B-VP O
protein NN B-NP O
6 CD O O
She PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
cholecystectomy NN I-NP O
7 CD O O
She PRP O O
has VBZ O O
vitiligo JJ B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
q.d VBD B-VP B-f
2 CD O O
Enalapril NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
3 CD O O
Cardizem NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
4 CD O O
Insulin NNP B-NP B-m
Insulin NNP I-NP B-m
mixed VBD B-VP I-m
mixed JJ O I-m
70/30 CD O I-m
70/30 CD O I-m
with IN B-VP O
60 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
and CC O O
30 CD O B-do
in IN B-VP B-f
the DT B-NP O
evening NN I-NP O
5 CD O O
Atenolol NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
ALLERGIES: NNP I-NP O
Her NNP I-NP O
allergies NNS I-NP O
include VBP O O
contrast NN B-NP O
dye NN I-NP O
which WDT O O
gives VBZ O O
her PRP O O
a DT B-NP O
rash NN I-NP O
and CC O O
laryngeal NN B-NP O
edema NN I-NP O
, , O O
Penicillin NNP B-NP O
which WDT O O
gives VBZ O O
her PRP$ O O
edema JJ B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
alone RB O O
, , O O
but CC O O
has VBZ O O
two CD O O
very RB O O
supportive JJ B-NP O
daughters NNS I-NP O
She PRP O O
has VBZ O O
no DT B-NP O
smoking NN I-NP O
or CC O O
alcohol NN B-NP O
history NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Her NNP I-NP O
family NN I-NP O
history NN I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
brothers NNS B-NP O
who WP O O
had VBD B-VP O
myocardial JJ B-NP O
infarctions NNS I-NP O
in IN B-VP O
their PRP$ O O
50's CD O O
and CC O O
60's CD O O
, , O O
and CC O O
a DT B-NP O
mother NN I-NP O
who WP O O
had VBD B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
when WRB O O
she PRP O O
was VBD B-VP O
69 CD O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
examination NN B-NP O
, , O O
this DT O O
is VBZ O O
a DT O O
very RB O O
pleasant JJ B-NP O
Clarkant NNP I-NP O
Prings NNP I-NP O
U NNP I-NP O
woman NN I-NP O
, , O O
who WP O O
speaks VBZ O O
predominantly RB O O
Spanish JJ O O
, , O O
who WP O O
is VBZ O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Her NNP I-NP O
vital JJ B-NP O
signs NNS I-NP O
were VBD B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
98.6 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
71 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
168/70 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
18 CD O O
The DT B-NP O
remainder NN I-NP O
of IN B-VP O
her PRP$ O O
examination NN B-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
flat JJ B-NP O
jugular JJ I-NP O
venous JJ I-NP O
pressure NN I-NP O
, , O O
but CC O O
questionable JJ B-NP O
bruit NN I-NP O
in IN B-VP O
the DT B-NP O
left NN I-NP O
carotid NN I-NP O
Cardiac NNP I-NP O
examination NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
a DT B-NP O
normal JJ I-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
with IN B-VP O
an DT B-NP O
S3 NNP I-NP O
noted VBD B-VP O
, , O O
no DT B-NP O
murmur NN I-NP O
Her PRP$ O O
extremities NNS B-NP O
showed VBD B-VP O
trace NN B-NP O
edema NN I-NP O
bilaterally RB O O
, , O O
2+ CD O O
pulse NN B-NP O
in IN B-VP O
the DT O O
left JJ O O
femoral JJ O O
, , O O
no DT B-NP O
pulses NNS I-NP O
palpated VBN O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
, , O O
and CC O O
1+ CD O O
dorsalis NNS B-NP O
pedis JJ B-NP O
pulses NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Her NNP I-NP O
labs NN I-NP O
are VBP O O
significant JJ O O
for IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1.7 CD O O
, , O O
an DT O O
elevated VBN O O
cholesterol NN B-NP O
at IN B-VP O
294 CD O O
Her PRP$ O O
urine NN B-NP O
showed VBD B-VP O
3+ CD O O
protein NN B-NP O
, , O O
1+ CD O O
glucose VBD B-VP O
Her NNP B-NP O
electrocardiogram NN I-NP O
was VBD B-VP O
normal JJ B-NP O
sinus JJ I-NP O
rhythm NN I-NP O
at IN B-VP O
78 CD O O
, , O O
with IN B-VP O
normal JJ B-NP O
axis NNS I-NP O
and CC O O
interval NN B-NP O
, , O O
and CC O O
lateral JJ B-NP O
V4 NNP I-NP O
through IN B-VP O
V6 NNP B-NP O
T NNP I-NP O
wave VBP O O
flattening VBG O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
catheterized VBN O O
on IN B-VP O
January NNP B-NP O
, , O O
1995 CD O O
, , O O
with IN B-VP O
results NNS B-NP O
showing VBG O O
proximal JJ O O
left JJ O O
anterior JJ O O
descending VBG O O
stenosis NN B-NP O
of IN B-VP O
50 CD O O
percent NN B-NP O
, , O O
mid NN B-NP O
left VBD B-VP O
anterior JJ O O
descending VBG O O
stenosis NN B-NP O
of IN B-VP O
70 CD O O
percent NN B-NP O
The DT B-NP O
distal NN I-NP O
left VBD B-VP O
anterior JJ B-NP O
descending NN I-NP O
was VBD B-VP O
diffusely RB O O
diseased VBN O O
, , O O
and CC O O
her PRP$ O O
first JJ O O
diagonal JJ O O
showed VBD B-VP O
a DT B-NP O
discrete JJ I-NP O
stenosis NN I-NP O
of IN B-VP O
80 CD O O
percent NN B-NP O
On IN B-VP O
the DT B-NP O
right NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
in IN B-VP O
the DT B-NP O
proximal JJ I-NP O
right JJ I-NP O
coronary NN I-NP O
artery VBD B-VP O
a DT B-NP O
discrete JJ I-NP O
lesion NN I-NP O
of IN B-VP O
50 CD O O
percent NN B-NP O
, , O O
and CC O O
in IN B-VP O
the DT B-NP O
mid NN I-NP O
right JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
diffusely RB O O
diseased VBD B-VP O
at IN B-VP O
50 CD O O
percent NN B-NP O
The DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
successful JJ I-NP O
balloon NN I-NP O
angioplasty NN I-NP O
of IN B-VP O
the DT B-NP O
mid NN I-NP O
left VBD B-VP O
anterior JJ O O
descending VBG O O
artery JJ B-NP O
stenosis NN I-NP O
from IN B-VP O
70 CD O O
percent NN B-NP O
to TO O O
10 CD O O
percent NN B-NP O
The DT B-NP O
patient's NN I-NP O
post NN I-NP O
catheterization NN I-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
a DT B-NP O
loss NN I-NP O
of IN B-VP O
150 CD O O
cc NN B-NP O
of IN B-VP O
blood NN B-NP O
after IN B-VP O
her PRP$ O O
right JJ B-NP O
groin NN I-NP O
sheath NN I-NP O
was VBD B-VP O
removed VBN O O
, , O O
but CC O O
the DT B-NP O
bleeding NN I-NP O
was VBD B-VP O
stopped VBN O O
after IN B-VP O
90 CD O O
minutes NNS B-NP O
of IN B-VP O
compression NN B-NP O
Her NNP I-NP O
hematocrit NN I-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
35.9 CD O O
, , O O
which WDT O O
dropped VBD B-VP O
to TO O O
30.1 CD O O
after IN B-VP O
the DT B-NP O
sheath NN I-NP O
removal NN I-NP O
, , O O
but CC O O
remained VBD B-VP O
stable JJ O O
and CC O O
she PRP O O
was VBD B-VP O
discharged VBN O O
with IN B-VP O
a DT B-NP O
hematocrit NN I-NP O
of IN B-VP O
30.8 CD O O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
one CD O O
mild JJ B-NP O
occurrence NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
post NN I-NP O
catheterization NN I-NP O
which WDT O O
was VBD B-VP O
relieved VBN O O
with IN B-VP O
two CD O O
sublinguals NNS B-NP O
, , O O
and CC O O
showed VBD B-VP O
no DT B-NP O
electrocardiogram NN I-NP O
changes VBZ O O
Upon NNP B-NP O
discharge NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
elevated VBN O O
liver JJ B-NP O
function NN I-NP O
tests NNS I-NP O
, , O O
with IN B-VP O
an DT B-NP O
ALT NNP I-NP O
going VBG O O
from IN B-VP O
16 CD O O
to TO O O
156 CD O O
, , O O
an DT B-NP O
AST NNP I-NP O
going VBG O O
from IN B-VP O
16 CD O O
to TO O O
65 CD O O
, , O O
an DT B-NP O
alkaline JJ I-NP O
phosphatase NN I-NP O
going VBG O O
from IN B-VP O
87 CD O O
to TO O O
171 CD O O
The DT B-NP O
patient's NN I-NP O
primary JJ B-NP O
medical JJ I-NP O
doctor NN I-NP O
, , O O
Dr NNP B-NP O
Schummer NNP I-NP O
, , O O
was VBD B-VP O
notified VBN O O
and CC O O
agreed VBN O O
to TO O O
workup VB O O
the DT B-NP O
elevated JJ I-NP O
liver NN I-NP O
function NN I-NP O
tests VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
her PRP O O
admitting VBG O O
medications NNS B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
2 CD O O
Enalapril NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
3 CD O O
Cardizem NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
4 CD O O
Atenolol NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
5 CD O O
Additionally RB O O
, , O O
she PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Simvastatin NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
q.h.s JJ B-NP B-f
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
FOLLOW-UP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
with IN B-VP O
a DT B-NP O
scheduled JJ I-NP O
appointment NN I-NP O
the DT B-NP O
day NN I-NP O
after IN B-VP O
discharge NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Mondone NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
IRA NNP I-NP O
ZARELLA NNP I-NP O
, , O O
DBE NNP B-NP O
Attending: NNP I-NP O
EMMETT NNP I-NP O
FARREL NNP I-NP O
, , O O
M.D NNP B-NP O
NY6 NNP I-NP O
DO451/1343 NNP I-NP O
Batch: NNP I-NP O
62407 CD O O
Index NNP B-NP O
No NNP I-NP O
D3WLB4259P NNP I-NP O
D: NNP I-NP O
6/25/95 CD O O
T: NNP B-NP O
6/25/95 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#108014 VBZ O O
596789724 CD O O
JH NNP B-NP O
82413662 CD O O
3294450 CD O O
0/7/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
RENAL NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/7/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/11/2003 CD O O
ATTENDING: NNP B-NP O
DALE NNP I-NP O
NED NNP I-NP O
SAVITCH NNP I-NP O
MD NNP I-NP O
ATTENDING NNP I-NP O
PHYSICIAN NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Emmitt NNP I-NP O
Marc NNP I-NP O
Guier NNP I-NP O
, , O O
M.D NNP B-NP O
ATTENDING NNP I-NP O
PHYSICIAN NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Marco NNP I-NP O
Mccaster NNP I-NP O
, , O O
M.D NNP B-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Mr NNP I-NP O
Gramby NNP I-NP O
is VBZ O O
a DT B-NP O
43-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
morbid JJ B-NP O
obesity NN I-NP O
, , O O
type NN B-NP O
II NNP I-NP O
diabetes VBZ O O
, , O O
hypertension NN B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
and CC O O
severe JJ B-NP O
peripheral JJ I-NP O
arterial JJ I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
femoral JJ B-NP O
popliteal NN I-NP O
bypass NN I-NP O
in IN B-VP O
July NNP B-NP O
which WDT O O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
repeated JJ B-NP O
return NN I-NP O
of IN B-VP O
cellulitis NN B-NP O
x $ O O
2 CD O O
who WP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
cellulitis NN B-NP O
and CC O O
volume NN B-NP O
overload JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
two CD O O
wound JJ B-NP B-r
complications NNS I-NP I-r
after IN B-VP O
his PRP$ O O
femoral JJ B-NP O
popliteal NN I-NP O
bypass NN I-NP O
requiring VBG O O
two CD O O
separate JJ B-NP O
incisions NNS I-NP O
and CC O O
drainages NNS B-NP O
including VBG O O
courses NNS B-NP O
of IN B-VP O
intravenous JJ B-NP B-mo
nafcillin NNS I-NP B-m
x VBP O B-du
4 CD O I-du
weeks NNS B-NP I-du
and CC O O
with IN B-VP O
vancomycin JJ O B-m
x $ O B-du
4 CD O I-du
weeks NNS B-NP I-du
He PRP O O
had VBD B-VP O
been VBN O O
seen VBN O O
by IN B-VP O
Vascular JJ B-NP O
Surgery NNP I-NP O
five CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
and CC O O
had VBD B-VP O
been VBN O O
started VBN O O
on IN B-VP O
dicloxacillin NN B-NP B-m
for IN B-VP O
a DT B-NP O
third JJ I-NP O
episode NN I-NP O
of IN B-VP O
cellulitis NN B-NP B-r
He PRP O O
had VBD B-VP O
also RB O O
presented VBN O O
with IN B-VP O
fluid JJ B-NP B-r
fluid NN I-NP B-r
overload NN I-NP O
and CC O O
spironolactone NN B-NP B-m
was VBD B-VP O
added VBN O O
to TO O O
his PRP$ O O
diuretic JJ B-NP B-m
regimen NNS I-NP I-m
His PRP$ O O
primary JJ B-NP O
care NN I-NP O
provider NN I-NP O
saw VBD B-VP O
him PRP O O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
reported VBD B-VP O
a DT B-NP O
recent JJ I-NP O
fall NN I-NP O
and CC O O
the DT B-NP O
primary JJ I-NP O
care NN I-NP O
physician NN I-NP O
recommended VBD B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
hospital NN I-NP O
The DT B-NP O
patient NN I-NP O
does VBZ O O
report VB O O
some DT B-NP O
fever NN I-NP O
and CC O O
shaking VBG O O
chills NNS B-NP O
and CC O O
decreased VBN O O
appetite NN B-NP O
Also RB O O
, , O O
reported VBD B-VP O
weakness NN B-NP O
in IN B-VP O
bilateral JJ B-NP O
lower JJR I-NP O
extremities NNS I-NP O
and CC O O
right JJ B-NP O
foot NN I-NP O
pain NN I-NP O
He PRP O O
has VBZ O O
chronic JJ B-NP O
loss NN I-NP O
of IN B-VP O
sensation NN B-NP O
in IN B-VP O
both DT B-NP O
feet NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Morbid NNP I-NP O
obesity NN I-NP O
, , O O
type NN B-NP O
II NNP I-NP O
diabetes VBZ O O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
with IN B-VP O
a DT B-NP O
baseline JJ I-NP O
creatinine NN I-NP O
of IN B-VP O
2-2.5 JJ O O
, , O O
dyslipidemia NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
anemia NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
deep JJ B-NP O
vein NN I-NP O
thrombosis NN I-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
anger NN B-NP O
disorder NN I-NP O
, , O O
peptic JJ B-NP O
ulcer NN I-NP O
disease NN I-NP O
, , O O
and CC O O
tinea NN B-NP O
pedis VBP O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Atenolol NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
spironolactone NN B-NP B-m
, , O O
torsemide RB O B-m
160 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Hyzaar NNP B-NP B-m
50/12.5 CD O I-m
q NN B-NP B-f
day NN I-NP I-f
, , O O
lisinopril VBZ O B-m
60 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
day NN I-NP I-f
, , O O
Neurontin NNP B-NP B-m
1200 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Norvasc NNP B-NP B-m
Norvasc NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
and CC O O
5 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
, , O O
Coumadin NNP B-NP B-m
8 CD O B-do
mg NN B-NP I-do
, , O O
aspirin NN B-NP B-m
, , O O
Humalog NNP B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
, , O O
Percocet NNP B-NP B-m
, , O O
Pletal NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Procrit NNP B-NP B-m
, , O O
Zantac NNP B-NP B-m
, , O O
nitroglycerin JJ B-NP B-m
p.r.n NN I-NP B-f
, , O O
and CC O O
NPH NNP B-NP B-m
80 CD O B-do
q.a.m NN B-NP B-f
and CC O O
q.p.m JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
physical JJ B-NP O
exam NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile JJ O O
and CC O O
had VBD B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
99 CD O O
, , O O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
70 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
200/79 CD O O
possibly RB O O
taken VBN O O
with IN B-VP O
an DT B-NP O
undersized JJ I-NP O
cuff NN I-NP O
, , O O
18 CD O O
and CC O O
99% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
He PRP O O
is VBZ O O
obese JJ O O
and CC O O
comfortable JJ B-NP O
man NN I-NP O
in IN B-VP O
bed NN B-NP O
and CC O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress VB O O
His PRP$ O O
JVP NNP B-NP O
could MD O O
not RB O O
be VB O O
assessed VBN O O
from IN B-VP O
the DT B-NP O
size NN I-NP O
of IN B-VP O
his PRP$ O O
neck NN B-NP O
Heart NNP I-NP O
sounds VBZ O O
were VBD B-VP O
distant JJ B-NP O
Chest NNP I-NP O
was VBD B-VP O
clear JJ O O
His PRP$ O O
abdomen NNS B-NP O
is VBZ O O
obese JJ O O
with IN B-VP O
bowel NN B-NP O
sounds NNS I-NP O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
Extremities: NNP B-NP O
Notable NNP I-NP O
for IN B-VP O
3+ CD O O
edema NN B-NP O
, , O O
and CC O O
including VBG O O
1+ CD O O
extending VBG O O
to TO O O
the DT B-NP O
groin NN I-NP O
His PRP$ O O
pulses NNS B-NP O
were VBD B-VP O
Dopplerable JJ O O
bilaterally RB O O
with IN B-VP O
a DT B-NP O
triphasic JJ I-NP O
wave NN I-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
and CC O O
biphasic VB O O
on IN B-VP O
the DT O O
left VBN O O
The DT B-NP O
medial JJ I-NP O
aspect NN I-NP O
of IN B-VP O
his PRP$ O O
right JJ B-NP O
leg NN I-NP O
had VBD B-VP O
a DT B-NP O
surgical JJ I-NP O
scar NN I-NP O
A NNP I-NP O
healed VBD B-VP O
annular JJ B-NP O
burn NN I-NP O
wound NN I-NP O
in IN B-VP O
the DT B-NP O
medial JJ I-NP O
knee NN I-NP O
and CC O O
an DT B-NP O
area NN I-NP O
of IN B-VP O
erythema NN B-NP O
along IN B-VP O
the DT B-NP O
scar NN I-NP O
with IN B-VP O
warmth NN B-NP O
, , O O
moderate JJ B-NP O
tenderness NN I-NP O
, , O O
no DT B-NP O
fluctuance NN I-NP O
and CC O O
minimal JJ B-NP O
induration NN I-NP O
, , O O
no DT B-NP O
discharge NN I-NP O
The DT B-NP O
diameter NN I-NP O
of IN B-VP O
his PRP$ O O
right JJ B-NP O
leg NN I-NP O
was VBD B-VP O
greater JJR O O
than IN B-VP O
his PRP$ O O
left VBD B-VP O
His PRP$ O O
right JJ B-NP O
heel NN I-NP O
had VBD B-VP O
an DT B-NP O
intact JJ I-NP O
??blough?? NN I-NP O
and CC O O
his PRP$ O O
left JJ B-NP O
heel NN I-NP O
had VBD B-VP O
a DT B-NP O
dry JJ I-NP O
pressure NN I-NP O
sore VBD B-VP O
His PRP$ O O
right JJ B-NP O
big JJ I-NP O
toe NN I-NP O
was VBD B-VP O
tender NN B-NP O
to TO O O
palpation VB O O
LABORATORY NNP B-NP O
STUDIES: NNP I-NP O
Labs NNP I-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
3.4 CD O O
and CC O O
an DT B-NP O
INR NNP I-NP O
of IN B-VP O
7.1 CD O O
His PRP$ O O
EKG NN B-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
75 CD O O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEMS: NNP I-NP O
Problem NNP I-NP O
#1 NNP I-NP O
Infectious NNP I-NP O
Disease: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
vancomycin NN B-NP B-m
IV NNP I-NP B-mo
on IN B-VP O
admission NN B-NP O
for IN B-VP O
his PRP$ O B-r
right JJ B-NP I-r
medial JJ I-NP I-r
thigh JJ I-NP I-r
cellulitis NN I-NP I-r
at IN B-VP O
the DT B-NP O
site NN I-NP O
of IN B-VP O
the DT B-NP O
femoropopliteal JJ I-NP O
bypass NN I-NP O
with IN B-VP O
rapid JJ B-NP O
defervescence NN I-NP O
and CC O O
improvement NN B-NP O
No NNP I-NP O
drainage NN I-NP O
, , O O
no DT B-NP O
fluctuance NN I-NP O
Additional NNP I-NP O
antibiotic JJ B-NP B-m
coverage NN I-NP O
was VBD B-VP O
added VBN O O
specifically RB O O
of IN B-VP O
fluoroquinolone NN B-NP B-m
for IN B-VP O
anti-psuedomonal JJ B-NP B-r
anti-psuedomonal JJ I-NP B-r
coverage NN I-NP O
for IN B-VP O
his PRP$ O O
diabetic JJ B-NP O
foot NN I-NP O
ulcers NNS I-NP O
The DT B-NP O
right NN I-NP O
heel NN I-NP O
also RB O O
looked VBD B-VP O
increasingly RB O O
purulent JJ O O
during IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
and CC O O
bilateral JJ B-NP O
foot NN I-NP O
plain NN I-NP O
films NNS I-NP O
were VBD B-VP O
done VBN O O
These DT O O
were VBD B-VP O
negative JJ O O
for IN B-VP O
osteomyelitis NN B-NP O
but CC O O
showed VBD B-VP O
a DT B-NP O
metal NN I-NP O
sliver NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
foot NN I-NP O
and CC O O
an DT B-NP O
acute JJ I-NP O
fracture NN I-NP O
of IN B-VP O
the DT B-NP O
first JJ I-NP O
metatarsal NN I-NP O
Surgical NNP I-NP O
debridement NN I-NP O
was VBD B-VP O
done VBN O O
in IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
with IN B-VP O
drainage NN B-NP O
of IN B-VP O
pus NN B-NP O
, , O O
but CC O O
the DT B-NP O
metal NN I-NP O
showed VBD B-VP O
could MD O O
not RB O O
be VB O O
located VBN O O
even RB O O
with IN B-VP O
fluoroscopy PDT O O
The DT B-NP O
patient NN I-NP O
will MD O O
complete VB O O
a DT B-NP B-du
14-day JJ I-NP B-du
14-day JJ I-NP I-du
course NN I-NP I-du
course NN I-NP I-du
of IN B-VP O
levofloxacin NN B-NP B-m
and CC O O
clindamycin NN B-NP B-m
for IN B-VP O
these DT O B-r
these DT B-NP B-r
foot NNS I-NP I-r
foot VBP O I-r
ulcers NNS B-NP I-r
ulcers NNS I-NP I-r
, , O O
and CC O O
will MD O O
be VB O O
discharged VBN O O
home NN B-NP O
with IN B-VP O
visiting VBG O O
nursing NN B-NP O
care NN I-NP O
for IN B-VP O
b.i.d JJ B-NP O
wet-to-dry JJ I-NP O
dressing NN I-NP O
changes NNS I-NP O
He PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Jerold NNP B-NP O
Cristopher NNP I-NP O
Blazon NNP I-NP O
, , O O
M.D NNP B-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
Problem NNP I-NP O
#2 NNP I-NP O
Renal: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
volume NN B-NP O
overloaded VBN O O
on IN B-VP O
admission NN B-NP O
His PRP$ O O
torsemide NN B-NP B-m
was VBD B-VP O
changed VBN O O
to TO O O
IV NNP B-NP B-mo
and CC O O
metolazone NN B-NP B-m
was VBD B-VP O
added VBN O O
and CC O O
was VBD B-VP O
given VBN O O
30 CD O O
minutes NNS B-NP O
prior RB O O
to TO O O
his PRP$ O O
first JJ B-NP O
torsemide NN I-NP B-m
dose NN I-NP O
of IN B-VP O
the DT B-NP O
day NN I-NP O
A NNP I-NP O
diuresis NN I-NP O
of IN B-VP O
1.5-2 JJ B-NP O
liters NNS I-NP O
a DT B-NP O
day NN I-NP O
was VBD B-VP O
achieved VBN O O
with IN B-VP O
this DT B-NP O
regimen NNS I-NP O
with IN B-VP O
the DT B-NP O
exception NN I-NP O
of IN B-VP O
a DT O O
4 CD O O
liter NN B-NP O
diuresis NN I-NP O
overnight VBD B-VP O
on IN B-VP O
the DT B-NP O
first JJ I-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
His PRP$ O O
electrolytes NNS B-NP B-m
were VBD B-VP O
replaced VBN O O
as IN B-VP B-f
needed VBN O O
I PRP O O
have VBP O O
expected VBN O O
his PRP$ O O
creatinine JJ B-NP O
increase NN I-NP O
to TO O O
4.5 CD O O
by IN B-VP O
discharge NN B-NP O
He PRP O O
will MD O O
need VB O O
close JJ B-NP O
renal JJ I-NP O
follow NN I-NP O
ups NNS I-NP O
as IN B-VP O
he PRP O O
may MD O O
be VB O O
approaching VBG O O
need NN B-NP O
for IN B-VP O
dialysis NN B-NP O
The DT B-NP O
Renal NNP I-NP O
Service NNP I-NP O
followed VBD B-VP O
him PRP O O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
and CC O O
at IN B-VP O
their PRP$ O O
recommendation NN B-NP O
, , O O
spironolactone NN B-NP B-m
will MD O O
be VB O O
discontinued VBN O O
upon IN B-VP O
discharge NN B-NP O
since IN B-VP O
his PRP$ O O
diuresis NN B-NP O
will MD O O
be VB O O
slowed VBN O O
Problem NNP B-NP O
#3 NNP I-NP O
Vascular: NNP I-NP O
Diuresis NNP I-NP O
was VBD B-VP O
essential JJ O O
for IN B-VP O
resolution NN B-NP O
of IN B-VP O
his PRP$ O O
cellulitis NN B-NP O
Pletal NNP I-NP B-m
was VBD B-VP O
continued VBN O O
and CC O O
because IN B-VP O
of IN B-VP O
his PRP$ O O
severe JJ B-NP O
peripheral JJ I-NP O
arterial JJ I-NP O
disease NN I-NP O
, , O O
he PRP O O
will MD O O
require VB O O
excellent JJ B-NP O
wound NN I-NP O
care NN I-NP O
to TO O O
optimize VB O O
healing VBG O O
Problem NNP B-NP O
#4 NNP I-NP O
Heme: NNP I-NP O
Initially NNP I-NP O
, , O O
his PRP$ O O
Coumadin NNP B-NP B-m
was VBD B-VP O
held VBN O O
for IN B-VP O
a DT B-NP O
supratherapeutic JJ I-NP O
INR NNP I-NP O
This DT O O
was VBD B-VP O
restarted VBN O O
when WRB O O
his PRP$ O O
INR NNP B-NP O
was VBD B-VP O
2.2 CD O O
and CC O O
he PRP O O
his PRP$ O O
now RB O O
in IN B-VP O
the DT B-NP O
therapeutic JJ I-NP O
range NN I-NP O
and CC O O
will MD O O
need VB O O
to TO O O
be VB O O
followed VBN O O
Problem NNP B-NP O
#5 NNP I-NP O
Cardiovascular: NNP I-NP O
He PRP O O
was VBD B-VP O
hypertensive JJ O B-r
on IN B-VP O
arrival NN B-NP O
which WDT O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Hydralazine NNP B-NP B-m
initially RB O O
and CC O O
transitioned VBD B-VP O
to TO O O
his PRP$ O O
p.o NN B-NP B-mo
home NN I-NP B-m
medicines NNS I-NP I-m
Even RB O O
with IN B-VP O
a DT B-NP O
large JJ I-NP O
cuff NN I-NP O
, , O O
his PRP$ O O
blood NN B-NP O
pressure NN I-NP O
continued VBD B-VP O
to TO O O
run VB O O
high RB O O
in IN B-VP O
the DT B-NP O
150s-180s NNS I-NP O
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#9 NNP I-NP O
, , O O
Hydralazine NNP B-NP B-m
p.o NN I-NP B-mo
was VBD B-VP O
added VBN O O
with IN B-VP O
good JJ B-NP O
effect NN I-NP O
which WDT O O
lowered VBD B-VP O
his PRP$ O B-r
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
to TO O O
the DT B-NP O
range NN I-NP O
of IN B-VP O
the DT B-NP O
120s-130s JJ I-NP O
Goal NNP I-NP O
is VBZ O O
below IN B-VP O
130/80 CD O O
Problem NNP B-NP O
#6 NNP I-NP O
Endocrine: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
NPH NNP B-NP B-m
and CC O O
Humalog NNP B-NP B-m
The DT B-NP O
Diabetes NNP I-NP O
Service NNP I-NP O
saw VBD B-VP O
the DT B-NP O
patient NN I-NP O
and CC O O
at IN B-VP O
their PRP$ O O
recommendation NN B-NP O
NPH NNP I-NP B-m
NPH NNP I-NP B-m
doses NNS I-NP O
were VBD B-VP O
increased VBN O O
, , O O
and CC O O
he PRP O O
is VBZ O O
now RB O O
on IN B-VP O
90 CD O B-do
units NNS B-NP O
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
and CC O O
85 CD O B-do
units NNS B-NP I-do
at IN B-VP B-f
night NN B-NP I-f
The DT B-NP O
goal NN I-NP O
for IN B-VP O
this DT B-NP O
patient NN I-NP O
is VBZ O O
below IN B-VP O
150 CD O O
particularly RB O O
given VBN O O
the DT B-NP O
need NN I-NP O
for IN B-VP O
wound NN B-NP B-r
healing NN I-NP O
Problem NNP I-NP O
#7: NNP I-NP O
GI: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Nutrition NNP B-NP O
and CC O O
will MD O O
be VB O O
evaluated VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
by IN B-VP O
Bariatric NNP B-NP O
Surgery NNP I-NP O
pending VBG O O
next JJ B-NP O
week NN I-NP O
This DT O O
is VBZ O O
of IN B-VP O
utmost JJ B-NP O
importance NN I-NP O
for IN B-VP O
this DT B-NP O
patient NN I-NP O
with IN B-VP O
life-threatening JJ B-NP O
morbid NN I-NP O
obesity NN I-NP O
who WP O O
already RB O O
has VBZ O O
severe JJ B-NP O
complications NNS I-NP O
of IN B-VP O
obesity-related JJ B-NP O
conditions NNS I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
obesity NN B-NP O
, , O O
hyperventilation NN B-NP O
syndrome NN I-NP O
Problem NNP I-NP O
#8 NNP I-NP O
Pulmonary: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
A NNP I-NP O
CPAP NNP I-NP O
machine NN I-NP O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
patient NN I-NP O
bedside NN I-NP O
, , O O
but CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
unable JJ O O
to TO O O
tolerate VB O O
the DT B-NP O
nose JJ I-NP O
mask NN I-NP O
He PRP O O
will MD O O
use VB O O
his PRP$ O O
own JJ B-NP O
device NN I-NP O
when WRB O O
he PRP O O
returns VBZ O O
home NN B-NP O
DISCHARGE NNP I-NP O
INSTRUCTIONS: NNP I-NP O
He PRP O O
will MD O O
go VB O O
home NN B-NP O
with IN B-VP O
visiting VBG O O
nurse JJ B-NP O
care NN I-NP O
and CC O O
will MD O O
need VB O O
to TO O O
see VB O O
his PRP$ O O
nephrologist NN B-NP O
, , O O
vascular JJ B-NP O
surgeons NNS I-NP O
, , O O
primary JJ B-NP O
care NN I-NP O
provider NN I-NP O
, , O O
and CC O O
Bariatric NNP B-NP O
Surgery NNP I-NP O
following VBG O O
discharge NN B-NP O
eScription NN I-NP O
document: VBZ O O
1-9252905 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
GREIBER NNP I-NP O
, , O O
JORDON NNP B-NP O
Attending: NNP I-NP O
BARTOSIK NNP I-NP O
, , O O
RICK NNP B-NP O
ARMAND NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
4807831 CD O O
D: NNP B-NP O
2/2/03 CD O O
T: NNP B-NP O
2/2/03 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#108881 VBZ O O
242314196 CD O O
RGH NNP B-NP O
69457618 CD O O
7356086 CD O O
7/17/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
EXACERBATION NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/3/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/4/2007 CD O O
ATTENDING: NNP B-NP O
LACINSKI NNP I-NP O
, , O O
OLLIE NNP B-NP O
WARNER NNP I-NP O
MD NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
fall NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
61-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
severe JJ B-NP O
pulmonary JJ I-NP O
hypertension NN I-NP O
secondary JJ O O
to TO O O
chronic JJ B-NP O
PEs NNP I-NP O
, , O O
OSA NNP B-NP O
, , O O
gout NN B-NP O
, , O O
bilateral JJ B-NP O
hip NN I-NP O
replacements NNS I-NP O
who WP O O
presents VBP O O
with IN B-VP O
two CD O O
falls NNS B-NP O
in IN B-VP O
the DT O O
past JJ O O
two CD O O
days NNS B-NP O
The DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
fell VBD B-VP O
while IN B-VP O
he PRP O O
was VBD B-VP O
standing VBG O O
at IN B-VP O
the DT B-NP O
sink NN I-NP O
He PRP O O
has VBZ O O
poor JJ B-NP O
recall NN I-NP O
of IN B-VP O
events NNS B-NP O
but CC O O
thinks VBZ O O
he PRP O O
landed VBD B-VP O
on IN B-VP O
his PRP$ O O
leg NN B-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
he PRP O O
fell VBD B-VP O
after IN B-VP O
getting VBG O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
shower NN I-NP O
He PRP O O
grabbed VBD B-VP O
a DT B-NP O
chair NN I-NP O
, , O O
but CC O O
slipped VBD B-VP O
and CC O O
landed VBD B-VP O
on IN B-VP O
his PRP$ O O
buttocks NNS B-NP O
, , O O
then RB O O
he PRP O O
fell VBD B-VP O
backwards NNS B-NP O
and CC O O
hit VBD B-VP O
the DT B-NP O
back NN I-NP O
of IN B-VP O
his PRP$ O O
head NN B-NP O
He PRP O O
denies VBZ O O
any DT B-NP O
loss NN I-NP O
of IN B-VP O
consciousness NN B-NP O
EMS NNP I-NP O
was VBD B-VP O
called VBN O O
and CC O O
brought VBD B-VP O
him PRP O O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
He PRP O O
did VBD B-VP O
note VB O O
a DT B-NP O
brief JJ I-NP O
episode NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
after IN B-VP O
the DT B-NP O
fall NN I-NP O
He PRP O O
says VBZ O O
he PRP O O
is VBZ O O
compliant JJ O O
with IN B-VP O
his PRP$ O O
medication NN B-NP B-m
regimen NNS I-NP I-m
and CC O O
denies NNS B-NP O
dietary JJ B-NP O
indiscretion NN I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Review NNP I-NP O
of IN B-VP O
systems NNS B-NP O
also RB O O
notable JJ O O
for IN B-VP O
complaints NNS B-NP O
of IN B-VP O
more JJR B-NP O
labored JJ I-NP O
breathing NN I-NP O
, , O O
increased VBD B-VP O
swelling NN B-NP O
, , O O
especially RB O O
in IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
as RB O O
well RB O O
as IN B-VP O
worsening VBG O O
orthopnea NN B-NP O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
several JJ I-NP O
days NNS I-NP O
He PRP O O
uses VBZ O O
BiPAP NNP B-NP O
at IN B-VP O
home NN B-NP O
at IN B-VP O
baseline NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
pulmonary JJ B-NP O
hypertension NN I-NP O
, , O O
last JJ B-NP O
catheterization NN I-NP O
was VBD B-VP O
in IN B-VP O
July NNP B-NP O
2005 CD O O
, , O O
which WDT O O
showed VBD B-VP O
no DT B-NP O
obstructive JJ I-NP O
lesions NNS I-NP O
, , O O
PASP NNP B-NP O
of IN B-VP O
104 CD O O
He PRP O O
has VBZ O O
OSA VBN O O
and CC O O
is VBZ O O
on IN B-VP O
BiPAP NNP B-NP O
, , O O
he PRP O O
has VBZ O O
history NN B-NP O
of IN B-VP O
DVTs NNP B-NP O
, , O O
history NN B-NP O
of IN B-VP O
lower JJR B-NP O
extremity NN I-NP O
ulcers NNS I-NP O
and CC O O
cellulitis NN B-NP O
, , O O
hypertriglyceridemia NN B-NP O
, , O O
gout NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
obesity NN B-NP O
He PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
bilateral JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
as RB O O
well RB O O
as IN B-VP O
knee NN B-NP O
replacement NN I-NP O
ALLERGIES: NNP I-NP O
He PRP O O
is VBZ O O
allergic JJ O O
to TO O O
Versed VBN O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
He PRP O O
lives VBZ O O
in IN B-VP O
Chuhern NNP B-NP O
Boulevard NNP I-NP O
, , O O
Tra NNP B-NP O
Berke NNP I-NP O
Call NNP I-NP O
, , O O
North NNP B-NP O
Dakota NNP I-NP O
02692 CD O O
part NN B-NP O
of IN B-VP O
the DT B-NP O
year NN I-NP O
and CC O O
owns VBZ O O
a DT B-NP O
car NN I-NP O
dealership NN I-NP O
No NNP I-NP O
tobacco NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
He PRP O O
was VBD B-VP O
afebrile RB O O
, , O O
heart NN B-NP O
rate NN I-NP O
94 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
126/60 CD O O
, , O O
92% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Head NNP I-NP O
atraumatic NN I-NP O
, , O O
no DT B-NP O
nuchal JJ I-NP O
rigidity NN I-NP O
JVP NNP I-NP O
was VBD B-VP O
10 CD O O
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
with IN B-VP O
distant JJ B-NP O
breath NN I-NP O
sounds VBZ O O
Cardiovascular JJ B-NP O
exam: NNS I-NP O
Tachycardic VBP O O
with IN B-VP O
a DT B-NP O
loud JJ I-NP O
S2 NNP I-NP O
Extremities NNP I-NP O
showed VBD B-VP O
swelling VBG O O
over IN B-VP O
the DT B-NP O
right JJ I-NP O
wrist NN I-NP O
without IN B-VP O
warmth WP O O
Lower NNP B-NP O
extremities NNS I-NP O
had VBD B-VP O
brawny VBN O O
skin JJ B-NP O
changes NNS I-NP O
bilaterally RB O O
with IN B-VP O
2+ CD O O
edema NN B-NP O
in IN B-VP O
the DT B-NP O
legs NN I-NP O
to TO O O
the DT B-NP O
mid NN I-NP O
shin JJ B-NP O
Neuro NNP I-NP O
exam: NN I-NP O
cranial JJ B-NP O
nerves NNS I-NP O
II-XII NNP I-NP O
were VBD B-VP O
grossly RB O O
intact JJ O O
He PRP O O
had VBD B-VP O
4/5 CD O O
strength NN B-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
hip NN I-NP O
flexor NN I-NP O
, , O O
5/5 CD O O
otherwise RB O O
in IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremities NNS I-NP O
LABORATORY NNP I-NP O
DATA NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Included VBD B-VP O
a DT B-NP O
hematocrit NN I-NP O
of IN B-VP O
58.7 CD O O
within IN B-VP O
the DT B-NP O
patient's JJ I-NP O
baseline NN I-NP O
of IN B-VP O
53 CD O O
to TO O O
58 CD O O
, , O O
creatinine NN B-NP O
of IN B-VP O
1 CD O O
, , O O
INR NNP B-NP O
4.4 CD O O
, , O O
troponin VBD B-VP O
0.04 CD O O
EKG NNP B-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
left JJ B-NP O
atrial JJ I-NP O
enlargement NN I-NP O
and CC O O
right JJ B-NP O
atrial JJ I-NP O
enlargement NN I-NP O
Head NNP I-NP O
CT NNP I-NP O
was VBD B-VP O
negative JJ B-NP O
Plain NNP I-NP O
films NNS I-NP O
of IN B-VP O
the DT B-NP O
pelvis NN I-NP O
were VBD B-VP O
negative JJ O O
for IN B-VP O
fracture NN B-NP O
Hardware NNP I-NP O
was VBD B-VP O
in IN B-VP O
place NN B-NP O
Right NNP I-NP O
wrist NN I-NP O
showed VBD B-VP O
no DT B-NP O
fracture NN I-NP O
, , O O
but CC O O
did VBD B-VP O
show VB O O
erosive JJ B-NP O
changes NNS I-NP O
suggestive VBP O O
of IN B-VP O
crystal JJ B-NP O
deposition NN I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
showed VBD B-VP O
no DT B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
Additional NNP I-NP O
studies NNS I-NP O
included VBD B-VP O
a DT B-NP O
repeat NN I-NP O
head NN I-NP O
CT NNP I-NP O
, , O O
which WDT O O
was VBD B-VP O
again RB O O
negative JJ B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEM: NNP I-NP O
In IN B-VP O
summary JJ O O
, , O O
this DT O O
is VBZ O O
a DT B-NP O
61-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
pulmonary JJ B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP O
and CC O O
chronic JJ B-NP O
PEs NNP I-NP O
on IN B-VP O
anticoagulation NN B-NP B-m
who WP O O
presents VBZ O O
after IN B-VP O
falls NNS B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
worsening VBG O O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
as RB O O
well RB O O
as IN B-VP O
orthopnea NN B-NP O
CARDIAC: NNP I-NP O
ISCHEMIA: NNP I-NP O
he PRP O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
MI NNP B-NP O
His PRP$ O O
last JJ B-NP O
catheterization NN I-NP O
was VBD B-VP O
negative JJ O O
in IN B-VP O
July NNP B-NP O
2005 CD O O
He PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
beta-blocker NN B-NP B-m
and CC O O
he PRP O O
was VBD B-VP O
anticoagulated VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
PUMP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
severe JJ B-NP O
pulmonary JJ I-NP O
hypertension NN I-NP O
The DT B-NP O
PVMC NNP I-NP O
team NN I-NP O
followed VBD B-VP O
this DT B-NP O
patient NN I-NP O
carefully RB O O
He PRP O O
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
a DT B-NP O
daily JJ I-NP O
goal NN I-NP O
of IN B-VP O
negative JJ O O
500 CD O O
to TO O O
1 CD O O
L NNP B-NP O
with IN B-VP O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
once RB O B-f
or CC O O
twice VB O O
a DT B-NP O
day NN I-NP O
as IN B-VP O
needed VBN O O
His PRP$ O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
Lasix NNP B-NP B-m
Lasix NNP I-NP B-m
Lasix NNP I-NP B-m
Lasix NNP I-NP B-m
is VBZ O O
160 CD O B-do
160 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
p.o NN I-NP B-mo
p.o NN I-NP B-mo
He PRP O O
responded VBD B-VP O
very RB O O
well RB O O
to TO O O
two CD O B-du
doses NNS B-NP I-du
of IN B-VP O
160 CD O B-do
mg NNS B-NP I-do
IV NNP I-NP B-mo
twice RB O B-f
twice RB O B-f
per IN B-VP I-f
per IN B-VP I-f
day NN B-NP I-f
day NN I-NP I-f
, , O O
but CC O O
this DT O O
was VBD B-VP O
titrated VBN O O
down RB O O
to TO O O
160 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
given VBN O O
the DT B-NP O
goal NN I-NP O
of IN B-VP O
keeping VBG O O
the DT B-NP O
patient NN I-NP O
approximately RB O O
500 CD O O
mL NNS B-NP O
to TO O O
1 CD O O
L NNP B-NP O
negative JJ O O
per IN B-VP O
day NN B-NP O
to TO O O
minimize VB O O
fluid NN B-NP O
and CC O O
electrolyte JJ B-NP O
shifts NNS I-NP O
His PRP$ O O
weight NN B-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
440 CD O O
pounds NNS B-NP O
At IN B-VP O
discharge NN B-NP O
, , O O
his PRP$ O O
weight NN B-NP O
was VBD B-VP O
429 CD O O
His PRP$ O O
dry JJ B-NP O
weight NN I-NP O
according VBG O O
to TO O O
his PRP$ O O
primary JJ B-NP O
cardiologist's NN I-NP O
notes NNS I-NP O
suggest VBP O O
a DT B-NP O
dry JJ I-NP O
weight NN I-NP O
of IN B-VP O
419 CD O O
pounds NNS B-NP O
He PRP O O
was VBD B-VP O
otherwise RB O O
maintained VBN O O
on IN B-VP O
his PRP$ O O
home NN B-NP O
regimen NNS I-NP O
of IN B-VP O
Procardia NNP B-NP B-m
, , O O
hydrochlorothiazide NN B-NP B-m
, , O O
Revatio NNP B-NP B-m
, , O O
and CC O O
Toprol NNP B-NP B-m
He PRP O O
will MD O O
need VB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Santor NNP I-NP O
, , O O
his PRP$ O O
cardiologist NN B-NP O
, , O O
on IN B-VP O
5/11/07 CD O O
2 CD O O
Rhythm: NNPS B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
He PRP O O
did VBD B-VP O
have VB O O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
missed JJ B-NP O
beats NNS I-NP O
, , O O
likely RB O O
Wenckebach NNP B-NP O
on IN B-VP O
6/3/07 CD O O
as RB O O
well RB O O
as IN B-VP O
some DT O O
ectopy IN B-VP O
These DT O O
were VBD B-VP O
thought VBN O O
secondary JJ O O
to TO O O
fluid VB O O
shifts VB O O
His PRP$ O O
electrolytes NNS B-NP O
were VBD B-VP O
thus RB O O
repleted VBN O O
aggressively RB O O
and CC O O
he PRP O O
was VBD B-VP O
monitored VBN O O
on IN B-VP O
telemetry NN B-NP O
3 CD O O
Pulmonary: NNP B-NP O
His PRP$ O O
baseline NN B-NP O
room NN I-NP O
air NN I-NP O
oxygen IN B-VP O
saturation NN B-NP O
was VBD B-VP O
90-93% CD O O
He PRP O O
should MD O O
use VB O O
oxygen NN B-NP B-m
as IN B-VP O
treatment NN B-NP O
for IN B-VP O
his PRP$ O B-r
pulmonary JJ B-NP O
hypertension NN I-NP O
He PRP O O
should MD O O
also RB O O
be VB O O
provided VBN O O
with IN B-VP O
oxygen NN B-NP B-m
at IN B-VP O
home NN B-NP O
when WRB O O
he PRP O O
is VBZ O O
discharged VBN O O
Chest NNP B-NP O
x-ray NN I-NP O
was VBD B-VP O
clear JJ O O
In IN B-VP O
addition NN B-NP O
, , O O
he PRP O O
uses VBZ O O
BiPAP NNP B-NP O
at IN B-VP O
night NN B-NP O
and CC O O
this DT O O
should MD O O
be VB O O
continued VBN O O
while IN B-VP O
he PRP O O
is VBZ O O
at IN B-VP O
rehabilitation NN B-NP O
and CC O O
after IN B-VP O
he PRP O O
is VBZ O O
discharged VBN O O
4 CD O O
Heme: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
DVT NNP B-NP O
with IN B-VP O
PEs NNP B-NP O
He PRP O O
is VBZ O O
on IN B-VP O
Coumadin NNP B-NP B-m
with IN B-VP O
an DT B-NP O
INR NNP I-NP B-r
goal NN I-NP I-r
of IN B-VP O
2.5 CD O O
Initially RB O O
, , O O
he PRP O O
was VBD B-VP O
supertherapeutic JJ O O
on IN B-VP O
admission NN B-NP O
, , O O
but CC O O
his PRP$ O O
regimen NN B-NP O
was VBD B-VP O
restarted VBN O O
after IN B-VP O
holding VBG O O
2 CD O O
doses NNS B-NP O
Of IN B-VP O
note NN B-NP O
, , O O
on IN B-VP O
11/6 CD O O
, , O O
he PRP O O
did VBD B-VP O
miss VB O O
a DT B-NP O
dose NN I-NP O
of IN B-VP O
Coumadin NNP B-NP B-m
Coumadin NNP I-NP B-m
Coumadin NNP I-NP B-m
inadvertently RB O O
, , O O
but CC O O
he PRP O O
should MD O O
be VB O O
continued VBN O O
on IN B-VP O
his PRP$ O O
home NN B-NP B-m
regimen NNS I-NP I-m
, , O O
which WDT O O
is VBZ O O
11 CD O B-do
11 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
on IN B-VP B-f
on IN B-VP B-f
Monday NNP B-NP O
, , O O
Wednesday NNP B-NP O
and CC O O
Friday NNP B-NP O
and CC O O
12 CD O B-do
mg NN B-NP I-do
the DT B-NP B-f
other JJ I-NP O
days NNS I-NP O
of IN B-VP O
the DT B-NP O
week NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
because IN B-VP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
asymmetric JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
, , O O
LENIS NNP B-NP O
were VBD B-VP O
obtained VBN O O
and CC O O
were VBD B-VP O
negative JJ O O
The DT B-NP O
patient's NN I-NP O
elevated VBD B-VP O
hematocrit NN B-NP O
was VBD B-VP O
likely JJ O O
secondary JJ O O
to TO O O
pulmonary JJ B-NP O
hypertension NN I-NP O
and CC O O
hypoxia NN B-NP O
and CC O O
was VBD B-VP O
within IN B-VP O
his PRP$ O O
baseline NN B-NP O
5 CD O O
Fluids NNP B-NP O
, , O O
electrolytes VBZ O O
and CC O O
nutrition: VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
K NNP B-NP O
and CC O O
mag NN B-NP O
scales NNS I-NP O
He PRP O O
was VBD B-VP O
also RB O O
on IN B-VP O
a DT O O
2 CD O O
L NNP B-NP O
fluid NN I-NP O
restriction NN I-NP O
The DT B-NP O
patient NN I-NP O
refused VBD B-VP O
a DT B-NP O
cardiac JJ I-NP O
diet; NN I-NP O
however RB O O
, , O O
he PRP O O
was VBD B-VP O
willing JJ O O
to TO O O
accept VB O O
a DT O O
diet JJ O O
that WDT O O
was VBD B-VP O
had VBN O O
no DT B-NP O
added JJ I-NP O
salt NN I-NP O
6 CD O O
Neurologic: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
neuro JJ B-NP O
exam NN I-NP O
was VBD B-VP O
completely RB O O
nonfocal JJ O O
He PRP O O
had VBD B-VP O
a DT B-NP O
repeat NN I-NP O
head NN I-NP O
CT NNP I-NP O
, , O O
which WDT O O
was VBD B-VP O
also RB O O
negative JJ O O
This DT O O
was VBD B-VP O
on IN B-VP O
5/12/07 CD O O
7 CD O O
Musculoskeletal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Physical JJ B-NP O
Therapy NN I-NP O
He PRP O O
was VBD B-VP O
treated VBN O O
for IN B-VP O
his PRP$ O B-r
hip NN B-NP I-r
pain NN I-NP I-r
initially RB O O
with IN B-VP O
oxycodone NN B-NP B-m
This DT O O
was VBD B-VP O
changed VBN O O
to TO O O
Dilaudid NNP B-NP B-m
for IN B-VP O
better JJR B-NP B-r
pain NN I-NP I-r
control NN I-NP I-r
He PRP O O
said VBD B-VP O
that IN B-VP O
he PRP O O
would MD O O
like VB O O
to TO O O
be VB O O
changed VBN O O
back RB O O
to TO O O
his PRP$ O O
home NN B-NP B-do
dose NN I-NP I-do
of IN B-VP O
oxycodone NN B-NP B-m
when WRB O O
he PRP O O
is VBZ O O
discharged VBN O O
, , O O
as IN B-VP O
he PRP O O
feels VBZ O O
the DT B-NP O
Dilaudid NNP I-NP B-m
is VBZ O O
fairly RB O O
strong JJ B-NP O
X-rays NNS I-NP O
were VBD B-VP O
negative JJ O O
for IN B-VP O
any DT B-NP O
fracture NN I-NP O
8 CD O O
Rheumatological: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
gout NN B-NP O
This DT O O
appeared VBD B-VP O
to TO O O
be VB O O
exacerbated VBN O O
with IN B-VP O
diuresis NN B-NP O
His PRP$ O O
gouty NN B-NP O
pain NN I-NP O
was VBD B-VP O
initially RB O O
in IN B-VP O
his PRP$ O O
right JJ B-NP O
wrist NN I-NP O
He PRP O O
also RB O O
describes VBZ O O
pain NN B-NP O
in IN B-VP O
his PRP$ O O
right JJ B-NP O
knee NN I-NP O
He PRP O O
is VBZ O O
on IN B-VP O
his PRP$ O O
home NN B-NP B-do
home NN I-NP B-do
doses VBZ O I-do
doses NNS B-NP I-do
of IN B-VP O
allopurinol NN B-NP B-m
and CC O O
colchicine NN B-NP B-m
Indocin NNP I-NP B-m
was VBD B-VP O
added VBN O O
and CC O O
at IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
received VBN O O
two CD O B-du
two CD O B-du
days NNS B-NP I-du
days NNS I-NP I-du
of IN B-VP O
Indocin NNP B-NP B-m
We PRP O O
would MD O O
like VB O O
him PRP O O
to TO O O
receive VB O O
a DT B-NP B-du
total NN I-NP O
of IN B-VP O
three CD O O
days NNS B-NP O
of IN B-VP O
Indocin NNP B-NP B-m
Tylenol NNP I-NP B-m
and CC O O
narcotics NNS B-NP B-m
as IN B-VP O
previously RB O O
described VBN O O
can MD O O
be VB O O
used VBN O O
to TO O O
help VB O O
with IN B-VP O
his PRP$ O B-r
his PRP$ O B-r
gouty NN B-NP I-r
gouty NN I-NP I-r
pain NN I-NP I-r
pain VBP O I-r
9 CD O O
GI: NNP B-NP O
The DT B-NP O
patient NN I-NP O
takes VBZ O O
Nexium NNP B-NP B-m
at IN B-VP O
home NN B-NP O
and CC O O
he PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Prilosec NNP B-NP B-m
while IN B-VP B-du
an DT B-NP I-du
inpatient NN I-NP I-du
He PRP O O
should MD O O
be VB O O
switched VBN O O
back RB O O
to TO O O
Nexium NN B-NP B-m
when WRB O O
he PRP O O
is VBZ O O
discharged VBN O O
from IN B-VP O
rehabilitation NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
AT NNP I-NP O
DISCHARGE: NNP I-NP O
At IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile IN B-VP O
His PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
between IN B-VP O
110-140 JJ O O
over IN B-VP O
66-80 JJ O O
, , O O
heart NN B-NP O
rate NN I-NP O
is VBZ O O
between IN B-VP O
76 CD O O
and CC O O
87 CD O O
His PRP$ O O
room NN B-NP O
air NN I-NP O
saturation NN I-NP O
was VBD B-VP O
91% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
He PRP O O
was VBD B-VP O
breathing VBG O O
very RB O O
comfortably RB O O
and CC O O
complained VBD B-VP O
only RB O O
of IN B-VP O
right JJ B-NP O
wrist NN I-NP O
pain VB O O
His PRP$ O O
lungs NNS B-NP O
were VBD B-VP O
clear JJ B-NP O
JVP NNP I-NP O
is VBZ O O
less JJR O O
than IN B-VP O
10 CD O O
His PRP$ O O
cardiac JJ B-NP O
exam NN I-NP O
was VBD B-VP O
tachy VBN O O
with IN B-VP O
a DT B-NP O
regular JJ I-NP O
rhythm NN I-NP O
and CC O O
a DT B-NP O
loud JJ I-NP O
S2 NNP I-NP O
LABORATORY NNP I-NP O
DATA NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Include NNP I-NP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1 CD O O
and CC O O
include VBP O O
a DT B-NP O
hematocrit NN I-NP O
of IN B-VP O
53.1 CD O O
and CC O O
INR NNP B-NP O
of IN B-VP O
2.3 CD O O
Potassium NNP B-NP O
was VBD B-VP O
3.9 CD O O
and CC O O
magnesium NN B-NP O
was VBD B-VP O
2.0 CD O O
DISPOSITION: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
being VBG O O
discharged VBN O O
to TO O O
rehab VB O O
FOLLOWUP: NNP B-NP O
He PRP O O
should MD O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Insco NNP I-NP O
He PRP O O
also RB O O
has VBZ O O
an DT B-NP O
appointment NN I-NP O
scheduled VBN O O
with IN B-VP O
Endocrinology NNP B-NP O
in IN B-VP O
the DT B-NP O
near JJ I-NP O
future NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Coumadin NNP I-NP B-m
Coumadin NNP I-NP B-m
11 CD O B-do
mg NN B-NP I-do
Monday NNP I-NP B-f
, , O O
Wednesday NNP B-NP O
and CC O O
Friday NNP B-NP O
and CC O O
12 CD O B-do
mg NNS B-NP I-do
nightly RB O B-f
on IN B-VP O
Tuesdays NNP B-NP O
, , O O
Thursdays NNP B-NP O
, , O O
Saturday NNP B-NP O
and CC O O
Sunday NNP B-NP O
, , O O
Diovan NNP B-NP B-m
320 CD O B-do
a DT B-NP B-f
day NN I-NP I-f
, , O O
multivitamin RB O B-m
1 CD O B-do
tab JJ O I-do
daily RB O B-f
, , O O
Toprol-XL NNP B-NP B-m
50 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
nifedipine NN B-NP B-m
extended VBD B-VP I-m
release NN B-NP I-m
30 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Revatio NNP B-NP B-m
20 CD O B-do
mg NN B-NP O
3 CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
hydrochlorothiazide RB O B-m
25 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Lasix NNP B-NP B-m
160 CD O B-do
IV NNP B-NP B-mo
once RB O B-f
per IN B-VP I-f
day NN B-NP I-f
, , O O
allopurinol RB O B-m
200 CD O B-do
once RB O B-f
per IN B-VP I-f
day NN B-NP I-f
, , O O
colchicine VB O B-m
0.6 CD O B-do
once RB O B-f
per IN B-VP O
day NN B-NP O
, , O O
Colace NNP B-NP B-m
, , O O
Prilosec NNP B-NP B-m
20 CD O B-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Dilaudid NNP B-NP B-m
2 CD O B-do
mg NN B-NP I-do
q.4 NN I-NP O
h NN I-NP O
p.o NN I-NP B-mo
p.r.n NN I-NP O
pain NN I-NP B-r
pain NN I-NP B-r
, , O O
Tylenol NNP B-NP B-m
500-1000 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.6 NN I-NP B-f
h NN I-NP I-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
not RB O O
to TO O O
exceed VB O O
4 CD O O
gm JJ B-NP O
total NN I-NP O
from IN B-VP O
all DT B-NP O
sources NNS I-NP O
in IN B-VP O
a DT B-NP O
24-hour JJ I-NP O
period NN I-NP O
, , O O
Ambien NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
nightly RB O B-f
p.r.n VBZ O I-f
insomnia JJ B-NP B-r
eScription NN I-NP O
document: VBZ O O
9-7953231 CD O O
CSSten NNP B-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
TOPLK NNP I-NP O
, , O O
JEREMIAH NNP B-NP O
Attending: NNP I-NP O
OVIEDO NNP I-NP O
, , O O
RICK NNP B-NP O
ARNOLDO NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
0340302 CD O O
D: NNP B-NP O
5/18/07 CD O O
T: NNP B-NP O
5/18/07 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#122190 VBZ O O
382610871 CD O O
SH NNP B-NP O
65942396 CD O O
484692 CD O O
10/1/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/1/1997 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/4/1998 CD O O
ADMISSION NNP B-NP O
DIAGNOSIS: NNP I-NP O
CHEST NNP I-NP O
PAIN NNP I-NP O
PROBLEM NNP I-NP O
LIST: NNP I-NP O
1 CD O O
) ) O O
CORONARY NNPS B-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
2 CD O O
) ) O O
HYPOTHYROIDISM NNP B-NP O
3 CD O O
) ) O O
PEPTIC NNP B-NP O
ULCER NNP I-NP O
DISEASE NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
70 CD O O
year-old JJ B-NP O
woman NN I-NP O
who WP O O
had VBD B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
in IN B-VP O
1993 CD O O
who WP O O
presents VBZ O O
with IN B-VP O
ten JJ B-NP O
minutes NNS I-NP O
of IN B-VP O
acute JJ B-NP O
chest NN I-NP O
pain NN I-NP O
today NN I-NP O
In IN B-VP O
November NNP B-NP O
of IN B-VP O
1992 CD O O
, , O O
she PRP O O
had VBD B-VP O
quadruple JJ B-NP O
bypass NN I-NP O
surgery NN I-NP O
with IN B-VP O
LIMA NNP B-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
and CC O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
PDA NNP I-NP O
, , O O
OM2 NNP B-NP O
and CC O O
diagonal JJ B-NP O
branch NN I-NP O
She PRP O O
was VBD B-VP O
feeling VBG O O
generally RB O O
well RB O O
until IN B-VP O
the DT B-NP O
beginning NN I-NP O
of IN B-VP O
May NNP B-NP O
at IN B-VP O
home NN B-NP O
From NNP I-NP O
November NNP I-NP O
, , O O
1997 CD O O
to TO O O
March NNP B-NP O
, , O O
1997 CD O O
, , O O
she PRP O O
was VBD B-VP O
in IN B-VP O
O NNP B-NP O
and CC O O
began VBD B-VP O
to TO O O
experience VB O O
intermittent JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
diaphoresis NN B-NP O
These DT O O
tended VBD B-VP O
to TO O O
occur VB O O
with IN B-VP O
ambulation NN B-NP O
on IN B-VP O
a DT B-NP O
flat JJ I-NP O
surface NN I-NP O
, , O O
although IN B-VP O
she PRP O O
did VBD B-VP O
have VB O O
one CD O O
episode NN B-NP O
that WDT O O
awakened VBD B-VP O
her PRP O O
from IN B-VP O
sleep VBG O O
The DT B-NP O
second JJ I-NP O
time NN I-NP O
this DT O O
happened VBD B-VP O
, , O O
she PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
Faxtpaul NNP I-NP O
Dekan NNP I-NP O
Health NNP I-NP O
Care NNP I-NP O
there RB O O
in IN B-VP O
Ton NNP B-NP O
with IN B-VP O
the DT B-NP O
complaints NNS I-NP O
of IN B-VP O
diaphoresis NN B-NP O
and CC O O
some DT B-NP O
nausea NN I-NP O
, , O O
although IN B-VP O
she PRP O O
did VBD B-VP O
not RB O O
have VB O O
chest JJS B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
vomiting VBG O O
or CC O O
palpitations NNS B-NP O
No DT B-NP O
EKG NNP I-NP O
was VBD B-VP O
done VBN O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
She PRP O O
said VBD B-VP O
that IN B-VP O
she PRP O O
was VBD B-VP O
definitely RB O O
more RBR O O
comfortable JJ B-NP O
lying NN I-NP O
or CC O O
sitting VBG O O
than IN B-VP O
standing VBG O O
It PRP O O
is VBZ O O
of IN B-VP O
note NN B-NP O
that IN B-VP O
she PRP O O
had VBD B-VP O
had VBN O O
her PRP$ O O
Beta NNP B-NP B-m
blocker NN I-NP I-m
, , O O
Pendalol NNP B-NP B-m
Pendalol NNP I-NP B-m
decreased VBD B-VP O
from IN B-VP O
5 CD O B-do
mg NNS B-NP I-do
to TO O O
2.5 CD O B-do
mg NNS B-NP I-do
prior RB O O
to TO O O
this DT B-NP O
trip NN I-NP O
to TO O O
Glension NNP B-NP O
Street NNP I-NP O
On IN B-VP O
return NN B-NP O
to TO O O
the DT B-NP O
Gene NNP I-NP O
Er NNP I-NP O
Za NNP I-NP O
, , O O
she PRP O O
had VBD B-VP O
upper JJ B-NP B-r
respiratory NN I-NP I-r
and CC O I-r
pharyngeal NN B-NP I-r
symptoms NNS I-NP I-r
with IN B-VP O
low JJ B-NP B-r
grade NN I-NP I-r
fevers NNS I-NP I-r
and CC O O
a DT B-NP B-r
cough JJ I-NP I-r
productive NN I-NP O
of IN B-VP O
a DT B-NP O
green JJ I-NP O
sputum NN I-NP O
This DT O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Amoxicillin NNP B-NP B-m
Amoxicillin NNP I-NP B-m
Amoxicillin NNP I-NP B-m
given VBN O O
to TO O O
her PRP$ O O
by IN B-VP O
her PRP$ O O
son NN B-NP O
who WP O O
is VBZ O O
a DT O O
pharmacist JJ O O
These DT B-NP O
symptoms NNS I-NP O
gradually RB O O
resolved VBD B-VP O
and CC O O
she PRP O O
saw VBD B-VP O
Dr NNP B-NP O
Jessie NNP I-NP O
on IN B-VP O
January NNP B-NP O
, , O O
1997 CD O O
and CC O O
was VBD B-VP O
given VBN O O
a DT B-NP O
clean JJ I-NP O
bill NN I-NP O
of IN B-VP O
health NN B-NP O
At IN B-VP O
this DT B-NP O
visit NN I-NP O
, , O O
he PRP O O
did VBD B-VP O
start VB O O
her PRP$ O O
on IN B-VP O
Prinivil NNP B-NP B-m
Since IN B-VP O
she PRP O O
had VBD B-VP O
been VBN O O
home VBN O O
from IN B-VP O
Er NNP B-NP O
Dr NNP I-NP O
, , O O
Win NNP B-NP O
Ca NNP I-NP O
S NNP I-NP O
, , O O
she PRP O O
really RB O O
had VBD B-VP O
not RB O O
had VBN O O
repeat NN B-NP O
episodes NNS I-NP O
of IN B-VP O
diaphoresis NN B-NP O
Then RB O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
when WRB O O
she PRP O O
went VBD B-VP O
shopping NN B-NP O
and CC O O
had VBD B-VP O
a DT B-NP O
recurrent JJ I-NP O
episode NN I-NP O
of IN B-VP O
diaphoresis NN B-NP O
while IN B-VP O
carrying VBG O O
bags NNS B-NP O
, , O O
this DT B-NP O
time NN I-NP O
with IN B-VP O
substernal JJ B-NP B-r
chest NN I-NP I-r
pain NN I-NP I-r
that WDT O O
radiated VBD B-VP O
down IN B-VP O
both DT B-NP O
arms NNS I-NP O
She PRP O O
also RB O O
had VBD B-VP O
a DT B-NP O
general JJ I-NP O
sense NN I-NP O
of IN B-VP O
heaviness NN B-NP O
across IN B-VP O
her PRP$ O O
chest NN B-NP O
She PRP O O
drove VBD B-VP O
home NN B-NP O
and CC O O
took VBD B-VP O
a DT B-NP O
sublingual JJ I-NP B-mo
nitroglycerin NN I-NP B-m
that WDT O O
completely RB O O
resolved VBD B-VP O
her PRP O O
pain NN B-NP O
She PRP O O
describes VBZ O O
this DT B-NP O
pain NN I-NP O
as IN B-VP O
exactly RB O O
like IN B-VP O
the DT B-NP O
anginal JJ I-NP O
pain NN I-NP O
that IN B-VP O
she PRP O O
had VBD B-VP O
prior RB O O
to TO O O
her PRP$ O O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft VBD B-VP O
The DT B-NP O
total JJ I-NP O
duration NN I-NP O
of IN B-VP O
this DT B-NP O
episode NN I-NP O
was VBD B-VP O
approximately RB O O
ten JJ B-NP O
minutes NNS I-NP O
By IN B-VP O
the DT B-NP O
time NN I-NP O
she PRP O O
presented VBD B-VP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
, , O O
she PRP O O
had VBD B-VP O
no DT B-NP O
diaphoresis NN I-NP O
and CC O O
no DT B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
was VBD B-VP O
feeling VBG O O
perfectly RB O O
normal JJ O O
The DT B-NP O
latest JJS I-NP O
echocardiogram NN I-NP O
in IN B-VP O
May NNP B-NP O
of IN B-VP O
1997 CD O O
showed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
35% CD O O
with IN B-VP O
mid NN B-NP O
to TO O O
distal VB O O
septal JJ O O
and CC O O
apical JJ B-NP O
akinesis NN I-NP O
and CC O O
inferior JJ B-NP O
akinesis NN I-NP O
with IN B-VP O
mild JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
In IN B-VP O
August NNP B-NP O
of IN B-VP O
1997 CD O O
, , O O
she PRP O O
went VBD B-VP O
4 CD O O
minutes NNS B-NP O
and CC O O
18 CD O O
seconds NNS B-NP O
on IN B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
with IN B-VP O
Thallium NNP B-NP O
which WDT O O
showed VBD B-VP O
only RB O O
fixed VBN O O
defects NNS B-NP O
, , O O
no DT B-NP O
reversible JJ I-NP O
defects NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
and CC O O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
with IN B-VP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
family NN B-NP O
history NN I-NP O
and CC O O
high JJ B-NP O
cholesterol NN I-NP O
, , O O
hypothyroidism NN B-NP O
and CC O O
remote VB O O
peptic JJ B-NP O
ulcer JJ I-NP O
disease NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
cholecystectomy NN B-NP O
and CC O O
appendectomy JJ B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
) ) O O
Zocor NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s $ O B-f
2 CD O O
) ) O O
Prinivil VBD B-VP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
3 CD O O
) ) O O
Pendalol VBD B-VP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
4 CD O O
) ) O O
Aspirin $ O B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
5 CD O O
) ) O O
Synthroid NNP B-NP B-m
Synthroid NNP I-NP B-m
0.100 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q NN I-NP B-f
Monday NNP I-NP I-f
, , O I-f
Wednesday NNP B-NP I-f
and CC O I-f
Friday NNP B-NP I-f
and CC O O
0.12 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
Tuesday NNP I-NP B-f
, , O O
Thursday NNP B-NP O
, , O O
Saturday NNP B-NP O
and CC O O
Sunday NNP B-NP O
6 CD O O
) ) O O
Pepcid NNP B-NP B-m
p.r.n NN I-NP B-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
in IN B-VP O
Full NNP B-NP O
Quer NNP I-NP O
Dienson NNP I-NP O
with IN B-VP O
her PRP$ O O
husband NN B-NP O
and CC O O
has VBZ O O
two CD O O
married JJ B-NP O
sons NNS I-NP O
She PRP O O
does VBZ O O
not RB O O
smoke VB O O
and CC O O
drinks VB O O
wine NN B-NP O
occasionally RB O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Mother NNP I-NP O
died VBD B-VP O
of IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
at IN B-VP O
age NN B-NP O
58 CD O O
and CC O O
her PRP$ O O
brother NN B-NP O
had VBD B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
at IN B-VP O
age NN B-NP O
79 CD O O
and CC O O
she PRP O O
has VBZ O O
a DT B-NP O
sister NN I-NP O
with IN B-VP O
Alzheimer's NNP B-NP O
disease NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
pleasant JJ O O
, , O O
elderly JJ B-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Vital NNP I-NP O
signs: NN I-NP O
Temperature NN I-NP O
99.4 CD O O
degrees NNS B-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
87 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
115/78 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
18 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
98% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
The DT B-NP O
rest NN I-NP O
of IN B-VP O
the DT B-NP O
physical JJ I-NP O
examination NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
a DT B-NP O
clear JJ I-NP O
oropharynx JJ I-NP O
Lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
Cardiovascular JJ B-NP O
examination NN I-NP O
was VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
and CC O O
a DT O O
two CD O O
out IN B-VP O
of IN B-VP O
six CD O O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
with IN B-VP O
no DT B-NP O
gallop NN I-NP O
or CC O O
rub VB O O
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
with IN B-VP O
good JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities NNS B-NP O
revealed VBD B-VP O
no DT B-NP O
edema JJ I-NP O
Neurological NNP I-NP O
examination NN I-NP O
was VBD B-VP O
non-focal JJ B-NP O
Rectal NNP I-NP O
examination NN I-NP O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
with IN B-VP O
no DT B-NP O
masses NNS I-NP O
LABORATORY: NNP I-NP O
Laboratory NNP I-NP O
studies NNS I-NP O
were VBD B-VP O
significant JJ O O
for IN B-VP O
a DT B-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
5.46 CD O O
, , O O
hematocrit NN B-NP O
40.1 CD O O
, , O O
platelets NNS B-NP O
190 CD O O
Cardiac NNP B-NP O
Troponin NNP I-NP O
I PRP O O
was VBD B-VP O
0.0 CD O O
CK NNP B-NP O
was VBD B-VP O
102 CD O O
Urinalysis NNP B-NP O
was VBD B-VP O
negative JJ B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
was VBD B-VP O
clear JJ O O
with IN B-VP O
no DT B-NP O
infiltrates NNS I-NP O
EKG NNP I-NP O
was VBD B-VP O
normal JJ B-NP O
sinus JJ I-NP O
rhythm NN I-NP O
with IN B-VP O
normal JJ B-NP O
intervals NNS I-NP O
and CC O O
normal JJ B-NP O
axis NN I-NP O
with IN B-VP O
a DT B-NP O
left NN I-NP O
bundle NN I-NP O
branch NN I-NP O
block NN I-NP O
pattern NN I-NP O
and CC O O
first JJ B-NP O
degree NN I-NP O
atrioventricular JJ B-NP O
block NN I-NP O
with IN B-VP O
no DT B-NP O
change NN I-NP O
compared VBN O O
to TO O O
an DT B-NP O
EKG NNP I-NP O
done VBN O O
on IN B-VP O
January NNP B-NP O
, , O O
1997 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
impression NN I-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
that IN B-VP O
this DT O O
is VBZ O O
a DT B-NP O
woman NN I-NP O
with IN B-VP O
known JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
who WP O O
is VBZ O O
now RB O O
experiencing VBG O O
unstable JJ B-NP O
angina NN I-NP O
with IN B-VP O
diaphoretic JJ B-NP O
episodes NNS I-NP O
, , O O
both DT O O
at IN B-VP O
rest NN B-NP O
and CC O O
exertion NN B-NP O
and CC O O
now RB O O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
She PRP O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
On IN B-VP O
May NNP B-NP O
, , O O
1998 CD O O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
standard JJ I-NP O
Bruce NNP I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
in IN B-VP O
which WDT O O
she PRP O O
went VBD B-VP O
3 CD O O
minutes NNS B-NP O
, , O O
30 CD O O
seconds NNS B-NP O
and CC O O
stopped VBD B-VP O
because IN B-VP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
This DT O O
was VBD B-VP O
typical JJ O O
of IN B-VP O
anginal JJ B-NP O
pain NN I-NP O
and CC O O
resolved VBD B-VP O
eight CD O O
minutes NNS B-NP O
into IN B-VP O
recovery NN B-NP O
The DT B-NP O
EKG NNP I-NP O
had VBD B-VP O
no DT B-NP O
changes NNS I-NP O
with IN B-VP O
a DT B-NP O
left NN I-NP O
bundle NN I-NP O
branch NN I-NP O
block NN I-NP O
at IN B-VP O
baseline NN B-NP O
and CC O O
this DT O O
was VBD B-VP O
considered VBN O O
to TO O O
be VB O O
consistent JJ O O
with IN B-VP O
but CC O O
not RB O O
diagnostic JJ O O
of IN B-VP O
ischemia NN B-NP O
She PRP O O
subsequently RB O O
underwent JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
which WDT O O
revealed VBD B-VP O
patent NN B-NP O
grafts NNS I-NP O
with IN B-VP O
her PRP$ O O
known VBN O O
underlying JJ B-NP O
native JJ I-NP O
disease NN I-NP O
Her NNP I-NP O
right NN I-NP O
atrial JJ B-NP O
pressure NN I-NP O
was VBD B-VP O
4 CD O O
, , O O
right RB O O
ventricular JJ O O
46/8 CD O O
, , O O
PA NNP B-NP O
42/22 CD O O
, , O O
pulmonary JJ B-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
19 CD O O
From IN B-VP O
here RB O O
, , O O
she PRP O O
was VBD B-VP O
managed VBN O O
medically RB O O
with IN B-VP O
increases NNS B-NP O
in IN B-VP O
her PRP$ O O
ACE NNP B-NP B-m
inhibitor NN I-NP O
, , O O
Statin NNP B-NP B-m
and CC O O
the DT B-NP O
addition NN I-NP O
of IN B-VP O
nitrates NNS B-NP B-m
After IN B-VP O
the DT B-NP O
cardiac JJ I-NP B-r
catheterization NN I-NP O
, , O O
she PRP O O
developed VBD B-VP O
a DT B-NP O
large JJ I-NP O
right JJ I-NP O
groin NN I-NP O
hematoma NN I-NP O
at IN B-VP O
the DT B-NP O
puncture NN I-NP O
site NN I-NP O
and CC O O
a DT B-NP O
bruit NN I-NP O
was VBD B-VP O
noted VBN O O
An DT B-NP O
ultrasound NN I-NP O
was VBD B-VP O
done VBN O O
that WDT O O
revealed VBD B-VP O
a DT B-NP O
pseudoaneurysm NN I-NP O
of IN B-VP O
the DT B-NP O
common JJ I-NP O
femoral JJ I-NP O
artery NN I-NP O
She PRP O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
Vascular NNP B-NP O
Surgery NNP I-NP O
and CC O O
on IN B-VP O
March NNP B-NP O
, , O O
1998 CD O O
, , O O
had VBD B-VP O
a DT B-NP O
follow-up JJ I-NP O
ultrasound NN I-NP O
which WDT O O
confirmed VBD B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
a DT B-NP O
pseudoaneurysm NN I-NP O
in IN B-VP O
her PRP$ O O
common JJ B-NP O
femoral JJ I-NP O
artery NN I-NP O
measuring VBG O O
2 CD O O
X JJ O O
1.5 CD O O
cm NN B-NP O
surrounded VBN O O
by IN B-VP O
a DT B-NP O
large JJ I-NP O
hematoma NN I-NP O
On IN B-VP O
March NNP B-NP O
, , O O
1998 CD O O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
surgical JJ I-NP O
repair NN I-NP O
of IN B-VP O
the DT B-NP O
pseudoaneurysm NN I-NP O
without IN B-VP O
any DT B-NP O
complications NNS I-NP O
and CC O O
she PRP O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
January NNP B-NP O
, , O O
1998 CD O O
with IN B-VP O
follow-up JJ O O
with IN B-VP O
both DT B-NP O
Dr NNP I-NP O
Polito NNP I-NP O
of IN B-VP O
Vascular NNP B-NP O
Surgery NNP I-NP O
and CC O O
Dr NNP B-NP O
Khat NNP I-NP O
, , O O
her PRP$ O O
cardiologist JJ B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
) ) O O
Aspirin $ O B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
2 CD O O
) ) O O
Colace NN B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
3 CD O O
) ) O O
Synthroid NNP B-NP B-m
Synthroid NNP I-NP B-m
100 CD O B-do
mcg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
Monday NNP I-NP I-f
, , O I-f
Wednesday NNP B-NP I-f
and CC O I-f
Friday NNP B-NP I-f
, , O O
112 CD O B-do
mcg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
Tuesday NNP I-NP O
, , O O
Thursday NNP B-NP O
, , O O
Saturday NNP B-NP O
and CC O O
Sunday NNP B-NP O
4 CD O O
) ) O O
Lisinopril FW O B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
5 CD O O
) ) O O
Beclomethasone CD O B-m
diproprionate NN B-NP I-m
double JJ B-NP I-m
strength NN I-NP I-m
spray NN I-NP I-m
to TO O O
each DT B-NP B-mo
nostril NN I-NP I-mo
b.i.d RB O B-f
6 CD O O
) ) O O
Zocor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s $ O B-f
7 CD O O
) ) O O
Toprol NNP B-NP B-m
XL $ O I-m
75 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
8 CD O O
) ) O O
Imdur NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
9 CD O O
) ) O O
Augmentin NNP B-NP B-m
one CD O B-do
tablet NN B-NP O
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
for IN B-VP B-du
seven CD O I-du
additional JJ B-NP I-du
days NNS I-NP I-du
Dictated VBD B-VP O
By: NNP B-NP O
JEWELL NNP I-NP O
ROLFSEN NNP I-NP O
, , O O
M.D NNP B-NP O
YO53 NNP I-NP O
Attending: NNP I-NP O
OREN NNP I-NP O
STANOVICH NNP I-NP O
, , O O
M.D NNP B-NP O
MK60 NNP I-NP O
IL970/1869 NNP I-NP O
Batch: NNP I-NP O
91777 CD O O
Index NNP B-NP O
No NNP I-NP O
ZWEAXN002T NNP I-NP O
D: NNP I-NP O
8/21/98 CD O O
T: NNP B-NP O
8/21/98 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#133198 VBZ O O
974726289 CD O O
SH NNP B-NP O
63436693 CD O O
9978052 CD O O
3/13/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHEST NNP I-NP O
PAIN NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/20/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/18/2005 CD O O
ATTENDING: NNP B-NP O
LANGLAIS NNP I-NP O
, , O O
EZEQUIEL NNP B-NP O
MD NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
A NNP I-NP O
66-year-old JJ B-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
and CC O O
two CD O O
prior JJ B-NP O
MIs NNP I-NP O
He PRP O O
is VBZ O O
also RB O O
status NN B-NP O
post NN I-NP O
angioplasty NN I-NP O
and CC O O
an DT B-NP O
LAD NNP I-NP O
stent NN I-NP O
, , O O
he PRP O O
has VBZ O O
hypertension NN B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
and CC O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
and CC O O
presents NNS B-NP O
now RB O O
with IN B-VP O
chest NN B-NP O
pain VBP O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
in IN B-VP O
his PRP$ O O
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
when WRB O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
he PRP O O
developed VBD B-VP O
substernal JJ B-NP B-r
chest NN I-NP O
pain NN I-NP O
while IN B-VP O
walking VBG O O
and CC O O
lasted VBD B-VP O
2-3 JJ B-NP O
hours NNS I-NP O
and CC O O
was VBD B-VP O
relieved VBN O O
by IN B-VP O
rest NN B-NP O
and CC O O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
He PRP O O
denies VBZ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
nausea NN B-NP O
, , O O
or CC O O
diaphoresis NN B-NP O
He PRP O O
presented VBD B-VP O
to TO O O
Renba NNP B-NP O
Memorial NNP I-NP O
Urgent NNP I-NP O
Care NNP I-NP O
where WRB O O
he PRP O O
was VBD B-VP O
evaluated VBN O O
and CC O O
sent VBN O O
to TO O O
the DT B-NP O
Crossdick NNP I-NP O
Hospital NNP I-NP O
Of IN B-VP O
emergency NN B-NP O
department NN I-NP O
, , O O
where WRB O O
he PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
troponin NN I-NP O
of IN B-VP O
5.6 CD O O
, , O O
which WDT O O
peaked VBD B-VP O
at IN B-VP O
6.7 CD O O
He PRP O O
was VBD B-VP O
admitted VBN O O
, , O O
and CC O O
cardiac JJ B-NP O
catheterization NN I-NP O
revealed VBD B-VP O
diffuse NN B-NP O
disease NN I-NP O
He PRP O O
is VBZ O O
being VBG O O
evaluated VBN O O
for IN B-VP O
possible JJ B-NP O
surgical JJ I-NP O
intervention NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Hypertension NNP I-NP O
, , O O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
hypothyroidism NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
B12 NNP B-NP O
deficiency NN I-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
on IN B-VP O
home NN B-NP O
CPAP NNP I-NP O
, , O O
nephrolithiasis NN B-NP O
, , O O
restless JJ B-NP O
legs JJ I-NP O
syndrome NN I-NP O
, , O O
and CC O O
diabetic JJ B-NP O
retinopathy NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Congenital NNP I-NP O
Schatzki's NNP I-NP O
ring NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
dilation NN I-NP O
via IN B-VP O
EGD NNP B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Positive NNP I-NP O
for IN B-VP O
a DT B-NP O
rare JJ I-NP O
alcohol NN I-NP O
use IN B-VP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
three CD O O
children NNS B-NP O
, , O O
and CC O O
is VBZ O O
semi-retired JJ O O
as IN B-VP O
an DT B-NP O
architect NN I-NP O
ALLERGIES: NNP I-NP O
Sulfa NNP I-NP O
causing VBG O O
rash NN B-NP O
and CC O O
joint JJ B-NP O
swelling NN I-NP O
, , O O
and CC O O
enalaprilat JJ B-NP O
causing NN I-NP O
cough NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Lopressor NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
, , O O
valsartan JJ O B-m
160 CD O B-do
mg JJ O I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
aspirin JJ O B-m
325 CD O B-do
mg JJ O I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
atorvastatin JJ O B-m
80 CD O B-do
mg JJ O I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
B12 NNP B-NP B-m
100 CD O B-do
mcg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
folate NN B-NP B-m
, , O O
Levoxyl NNP B-NP B-m
, , O O
Nexium NNP B-NP B-m
, , O O
Lantus NNP B-NP B-m
, , O O
and CC O O
NovoLog NNP B-NP B-m
insulin VBP O I-m
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Height NNP I-NP O
5 CD O O
feet NNS B-NP O
7 CD O O
inches NNS B-NP O
tall JJ O O
, , O O
weight VBD B-VP O
67 CD O O
kg NNS B-NP O
Vital NNP I-NP O
signs: VBD B-VP O
Not RB O O
listed VBN O O
HEENT: NNP B-NP O
PERRL NNP I-NP O
Oropharynx NNP I-NP O
is VBZ O O
benign JJ B-NP O
Neck: NNP I-NP O
Without NNP I-NP O
carotid NN I-NP O
bruits NNS I-NP O
Chest: NNP I-NP O
Without IN B-VP O
incisions NNS B-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmurs NNS I-NP O
Respiratory: NNP I-NP O
Breath NNP I-NP O
sounds NNS I-NP O
are VBP O O
clear JJ O O
bilaterally RB O O
Abdomen: NNP B-NP O
No NNP I-NP O
incisions NNS I-NP O
, , O O
soft JJ O O
, , O O
no DT B-NP O
masses NNS I-NP O
Rectal: NNP I-NP O
Normal NNP I-NP O
tone NN I-NP O
, , O O
no DT B-NP O
masses NNS I-NP O
, , O O
guaiac JJ B-NP O
negative JJ I-NP O
Extremities: NNP I-NP O
Without NNP I-NP O
scarring NN I-NP O
, , O O
varicosities NNS B-NP O
or CC O O
edema VB O O
Pedal NNP B-NP O
pulses NNS I-NP O
are VBP O O
1+ CD O O
bilaterally RB O O
Radial JJ B-NP O
pulses NNS I-NP O
are VBP O O
2+ CD O O
bilaterally RB O O
Allen's NNP B-NP O
test NN I-NP O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
is VBZ O O
normal JJ O O
by IN B-VP O
pulse JJ B-NP O
oximeter NN I-NP O
Neuro: NNP I-NP O
Alert NNP I-NP O
and CC O O
oriented VBN O O
, , O O
grossly RB O O
nonfocal JJ B-NP O
exam NN I-NP O
, , O O
although IN B-VP O
there EX O O
is VBZ O O
slightly RB O O
decreased VBN O O
light JJ B-NP O
touch JJ I-NP O
sensation NN I-NP O
in IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremities NNS I-NP O
around IN B-VP O
the DT B-NP O
great JJ I-NP O
toe NN I-NP O
bilaterally RB O O
LABORATORY NNP B-NP O
VALUES NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Include NNP I-NP O
sodium NN I-NP O
of IN B-VP O
139 CD O O
, , O O
potassium NN B-NP O
of IN B-VP O
4.3 CD O O
BUN NNP B-NP O
of IN B-VP O
12 CD O O
, , O O
creatinine NN B-NP O
of IN B-VP O
1.2 CD O O
, , O O
and CC O O
glucose NN B-NP O
of IN B-VP O
106 CD O O
Hematology NNP B-NP O
includes VBZ O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
7.4 CD O O
, , O O
hematocrit NN B-NP O
of IN B-VP O
33 CD O O
, , O O
INR NNP B-NP O
of IN B-VP O
1 CD O O
, , O O
PTT NNP B-NP O
of IN B-VP O
104 CD O O
Cardiac NNP B-NP O
catheterization NN I-NP O
data: NN I-NP O
EKG NNP I-NP O
, , O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
67 CD O O
with IN B-VP O
a DT B-NP O
nonspecific JJ I-NP O
T-wave NNP I-NP O
abnormality NN I-NP O
in IN B-VP O
1 CD O O
, , O O
aVL NN B-NP O
, , O O
V5 NNP B-NP O
, , O O
and CC O O
V6 NNP B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
is VBZ O O
without IN B-VP O
acute JJ B-NP O
disease NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
3/10/05 CD O O
and CC O O
underwent JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
90% CD O O
proximal JJ B-NP O
LAD NNP I-NP O
stenosis NN I-NP O
, , O O
90% CD O O
mid NN B-NP O
LAD NNP I-NP O
and CC O O
100% CD O O
distal JJ B-NP O
LAD NNP I-NP O
stenosis NN I-NP O
, , O O
100% CD O O
mid NN B-NP O
LVB1 NNP I-NP O
, , O O
80% CD O O
mid NN B-NP O
circumflex NN I-NP O
, , O O
70% CD O O
proximal JJ B-NP O
D1 NNP I-NP O
, , O O
70% CD O O
proximal JJ B-NP O
PDA NNP I-NP O
, , O O
and CC O O
a DT B-NP O
right JJ I-NP O
dominant JJ I-NP O
circulation NN I-NP O
There EX O O
is VBZ O O
diffuse JJ B-NP O
coronary JJ I-NP O
calcification NN I-NP O
and CC O O
extensive JJ B-NP O
diffuse NN I-NP O
disease NN I-NP O
with IN B-VP O
small JJ B-NP O
distal JJ I-NP O
vessels NNS I-NP O
LAD NNP I-NP O
in IN B-VP O
stent JJ B-NP O
restenosis NN I-NP O
There EX O O
is VBZ O O
collateral JJ B-NP O
flow NN I-NP O
diffusely RB O O
small JJ O O
left VBD B-VP O
main JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
4/15/05 CD O O
and CC O O
underwent JJ B-NP O
CABG NNP I-NP O
x4 NN I-NP O
with IN B-VP O
SVG1 NNP B-NP O
to TO O O
RCA NNP B-NP O
, , O O
and CC O O
sequential JJ B-NP O
graft NN I-NP O
of IN B-VP O
SVG2 NNP B-NP O
to TO O O
D1 NNP B-NP O
and CC O O
then RB O O
OM1 NNP B-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
LIMA NNP B-NP O
to TO O O
LAD NNP B-NP O
and CC O O
an DT B-NP O
LAD NNP I-NP O
endarterectomy VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
following VBG O O
surgery NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
He PRP O O
was VBD B-VP O
given VBN O O
150 CD O B-do
mg NN B-NP I-do
of IN B-VP O
Plavix NNP B-NP B-m
Plavix NNP I-NP B-m
on IN B-VP O
arrival NN B-NP O
to TO O O
the DT B-NP O
ICU NNP I-NP O
, , O O
and CC O O
a DT B-NP B-do
second JJ I-NP I-do
dose NN I-NP I-do
6 CD O O
hours NNS B-NP O
later RB O O
He PRP O O
was VBD B-VP O
also RB O O
started VBN O O
on IN B-VP O
heparin NN B-NP B-m
500 CD O B-do
units NNS B-NP I-do
for IN B-VP B-du
48 CD O I-du
hours NNS B-NP I-du
and CC O O
given VBN O O
aspirin NNS B-NP B-m
that WDT O O
same JJ B-NP O
night NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
extubated VBN O O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
and CC O O
was VBD B-VP O
noted VBN O O
to TO O O
require VB O O
the DT B-NP O
transfusion NN I-NP B-mo
of IN B-VP O
a DT B-NP B-do
unit NN I-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
He PRP O O
required VBD B-VP O
neosynephrine RB O B-m
transiently RB O B-du
, , O O
which WDT O O
was VBD B-VP O
weaned VBN O O
off RP O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#2 VBD B-VP O
That DT B-NP O
same JJ I-NP O
day NN I-NP O
, , O O
he PRP O O
transferred VBD B-VP O
to TO O O
the DT B-NP O
Step-Down JJ I-NP O
Unit NNP I-NP O
, , O O
neurologically RB O O
intact JJ O O
, , O O
with IN B-VP O
pain NN B-NP O
well RB O O
controlled VBN O O
, , O O
hemodynamically RB O O
stable JJ O O
, , O O
started VBD B-VP O
on IN B-VP O
aspirin NN B-NP B-m
, , O O
Lopressor NNP B-NP B-m
, , O O
and CC O O
Plavix NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
on IN B-VP O
2 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
oxygen NN B-NP B-m
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
, , O O
and CC O O
had VBD B-VP O
chest JJS B-NP O
tube NN I-NP O
in IN B-VP O
that DT O O
still RB O O
had VBD B-VP O
output NN B-NP O
The DT B-NP O
patient's NN I-NP O
diet NN I-NP O
was VBD B-VP O
being VBG O O
advanced VBN O O
, , O O
and CC O O
he PRP O O
was VBD B-VP O
being VBG O O
diuresed VBN O O
with IN B-VP O
Lasix NNP B-NP B-m
with IN B-VP O
good JJ B-NP O
effect NN I-NP O
Perioperatively RB O O
, , O O
he PRP O O
was VBD B-VP O
also RB O O
followed VBN O O
by IN B-VP O
the DT B-NP O
Diabetes NNP I-NP O
Management NNP I-NP O
Service NNP I-NP O
for IN B-VP O
blood NN B-NP B-r
blood NN I-NP B-r
sugar NN I-NP I-r
sugar NN I-NP I-r
control NN I-NP I-r
control NN I-NP I-r
and CC O O
was VBD B-VP O
transitioned VBN O O
from IN B-VP O
IV NNP B-NP B-mo
insulin NN I-NP B-m
to TO O O
subcutaneous JJ B-NP B-mo
insulin NN I-NP B-m
postoperatively RB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP B-r
preoperative JJ I-NP O
urinary JJ I-NP O
tract NN I-NP O
infection NN I-NP O
of IN B-VP O
E NNP B-NP O
coli NNS I-NP O
for IN B-VP O
which WDT O O
he PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
levofloxacin NN B-NP B-m
on IN B-VP O
0/5/05 CD O O
and CC O O
treated VBD B-VP O
for IN B-VP B-du
five CD O I-du
days NNS B-NP I-du
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#3 NNP I-NP O
, , O O
his PRP$ O O
wires NNS B-NP O
, , O O
chest JJS B-NP O
tubes NNS I-NP O
and CC O O
Foley NNP B-NP O
were VBD B-VP O
removed VBN O O
He PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
loose JJ B-NP O
lower JJR I-NP O
front NN I-NP O
teeth NNS I-NP O
following VBG O O
his PRP$ O O
difficult JJ B-NP O
intubation NN I-NP O
, , O O
and CC O O
the DT B-NP O
Dental NNP I-NP O
Service NNP I-NP O
was VBD B-VP O
called VBN O O
to TO O O
see VB O O
the DT B-NP O
patient NN I-NP O
The DT B-NP O
recommendation NN I-NP O
was VBD B-VP O
simply RB O O
to TO O O
avoid VB O O
putting VBG O O
pressure NN B-NP O
on IN B-VP O
those DT B-NP O
teeth NNS I-NP O
and CC O O
they PRP O O
advised VBD B-VP O
that IN B-VP O
this DT O O
would MD O O
allow VB O O
the DT B-NP O
teeth NN I-NP O
to TO O O
retighten VB O O
in IN B-VP O
the DT B-NP O
jaw NN I-NP O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
couple NN I-NP O
of IN B-VP O
weeks NNS B-NP O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
do VB O O
well RB O O
, , O O
remained VBD B-VP O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
, , O O
and CC O O
was VBD B-VP O
weaned VBN O O
off RP O O
oxygen NN B-NP B-m
, , O O
saturating VBG O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
He PRP O O
progressed VBD B-VP O
daily RB O O
and CC O O
walked VBD B-VP O
first RB O O
with IN B-VP O
assistance NN B-NP O
and CC O O
then RB O O
steadily RB O O
on IN B-VP O
his PRP$ O O
own JJ O O
He PRP O O
is VBZ O O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#7 VB O O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications: NN I-NP O
Enteric-coated NNP I-NP B-m
aspirin NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
atenolol VBZ O B-m
75 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
oxycodone RB O B-m
5 CD O B-do
mg NNS B-NP I-do
to TO O I-do
10 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.6h JJ I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Lantus NNP B-NP B-m
38 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
at IN B-VP B-f
bedtime NN B-NP I-f
, , O O
NovoLog NNP B-NP B-m
18 CD O B-do
units NNS B-NP I-do
subcutaneous JJ B-NP B-mo
q.a.m NN I-NP B-f
, , O O
NovoLog NNP B-NP B-m
12 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
with IN B-VP B-f
lunch NN B-NP I-f
and CC O I-f
supper NN B-NP I-f
, , O O
and CC O O
atorvastatin RB O B-m
80 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
He PRP O O
is VBZ O O
to TO O O
have VB O O
a DT B-NP O
follow-up JJ I-NP O
appointment NN I-NP O
with IN B-VP O
his PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Abusufait NNP I-NP O
, , O O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
, , O O
and CC O O
with IN B-VP O
his PRP$ O O
cardiac NN B-NP O
surgeon NN I-NP O
, , O O
Dr NNP B-NP O
Cederberg NNP I-NP O
, , O O
in IN B-VP O
four CD O O
to TO O O
six CD O O
weeks NNS B-NP O
eScription NN I-NP O
document: IN B-VP O
7-8654026 JJ B-NP O
EMSFocus NNP I-NP O
transcriptionists NNS I-NP O
Dictated VBD B-VP O
By: NNP B-NP O
GOTTDENGER NNP I-NP O
, , O O
NEWTON NNP B-NP O
Attending: NNP I-NP O
ROTHERHAM NNP I-NP O
, , O O
KENT NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
1407522 CD O O
D: NNP B-NP O
5/18/05 CD O O
T: NNP B-NP O
5/18/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#140999 VBZ O O
889331222 CD O O
CCMC NNP B-NP O
70201597 CD O O
486489 CD O O
2/5/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
STENOSIS NNP I-NP O
LEFT NNP I-NP O
BYPASS NNP I-NP O
GRAFT NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/5/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/9/2002 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
63 JJ I-NP O
year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
non-insulin JJ B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
aortic JJ B-NP O
stenosis NN I-NP O
, , O O
and CC O O
status NN B-NP O
post NN I-NP O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
bypass NN I-NP O
grafts NNS I-NP O
who WP O O
presented VBD B-VP O
to TO O O
the DT B-NP O
hospital NN I-NP O
with IN B-VP O
increasing VBG O O
left VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
pain NN I-NP O
He PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
angiography VB O O
at IN B-VP O
which WDT O O
time NN B-NP O
tPA NN I-NP B-m
infusion NN I-NP B-mo
was VBD B-VP O
commenced VBN O O
He PRP O O
is VBZ O O
most RBS O O
recently RB O O
status NN B-NP O
post NN I-NP O
a DT O O
left JJ O O
femoral JJ O O
to TO O O
peroneal VB O O
bypass NN B-NP O
graft NN I-NP O
in IN B-VP O
August NNP B-NP O
of IN B-VP O
2001 CD O O
and CC O O
has VBZ O O
noticed VBN O O
that IN B-VP O
, , O O
in IN B-VP O
the DT O O
past JJ O O
two CD O O
to TO O O
three CD O O
weeks NNS B-NP O
, , O O
has VBZ O O
been VBN O O
developing VBG O O
increasing VBG O O
rest NN B-NP O
pain NN I-NP O
and CC O O
coolness NN B-NP O
to TO O O
the DT B-NP O
left JJ I-NP O
foot NN I-NP O
to TO O O
the DT B-NP O
point NN I-NP O
where WRB O O
he PRP O O
was VBD B-VP O
not RB O O
able JJ O O
to TO O O
ambulate VB O O
In IN B-VP O
angiography NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
an DT B-NP O
occlusion NN I-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
vein NN I-NP O
graft NN I-NP O
in IN B-VP O
the DT B-NP O
area NN I-NP O
of IN B-VP O
the DT O O
mid-thigh JJ O O
with IN B-VP O
no DT B-NP O
passage NN I-NP O
of IN B-VP O
contrast NN B-NP O
and CC O O
minimal JJ B-NP O
reconstitution NN I-NP O
of IN B-VP O
collaterals NNS B-NP O
to TO O O
his PRP$ O O
foot NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Peripheral NNP I-NP O
vascular JJ B-NP O
disease NN I-NP O
Myocardial NNP I-NP O
infarction NN I-NP O
Hypertension NNP I-NP O
Non-insulin NNP I-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
Aortic JJ B-NP O
stenosis NN I-NP O
He PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT O O
left JJ O O
femoral JJ O O
to TO O O
peroneal VB O O
bypass NN B-NP O
graft NN I-NP O
in IN B-VP O
August NNP B-NP O
of IN B-VP O
2001 CD O O
A DT B-NP O
revision NN I-NP O
with IN B-VP O
cephalic JJ B-NP O
vein NN I-NP O
to TO O O
dorsalis VB O O
pedis NN B-NP O
in IN B-VP O
August NNP B-NP O
of IN B-VP O
2001 CD O O
He PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT B-NP O
right JJ I-NP O
femoral NN I-NP O
to TO O O
peroneal VB O O
in IN B-VP O
July NNP B-NP O
of IN B-VP O
2000 CD O O
and CC O O
a DT B-NP O
right JJ I-NP O
fourth JJ I-NP O
toe NN I-NP O
amputation NN I-NP O
in IN B-VP O
July NNP B-NP O
of IN B-VP O
2000 CD O O
MEDICATIONS: NNP B-NP O
Glipizide NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Hydrochlorothiazide NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Lisinopril NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Simvastatin NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Amlodipine NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Imdur NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
and CC O O
Toprol NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
and CC O O
enteric JJ O B-m
coated VBN O I-m
aspirin NN B-NP I-m
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
first RB O O
underwent JJ B-NP O
angiography NN I-NP O
at IN B-VP O
which WDT O O
time NN B-NP O
they PRP O O
found VBD B-VP O
that IN B-VP O
the DT B-NP O
vein NN I-NP O
graft NN I-NP O
was VBD B-VP O
occluded VBN O O
He PRP O O
underwent JJ B-NP O
tPA JJ I-NP B-m
treatment NN I-NP O
and CC O O
was VBD B-VP O
brought VBN O O
back RB O O
to TO O O
angiography VB O O
This DT B-NP O
time NN I-NP O
they PRP O O
did VBD B-VP O
not RB O O
find VB O O
necessarily RB O O
any DT B-NP O
improvement NN I-NP O
The DT B-NP O
conduit NN I-NP O
actually RB O O
opened VBN O O
but CC O O
it PRP O O
was VBD B-VP O
found VBN O O
that IN B-VP O
he PRP O O
does VBZ O O
have VB O O
a DT B-NP O
high JJ I-NP O
grade NN I-NP O
anastomotic JJ B-NP O
stricture NN I-NP O
of IN B-VP O
the DT B-NP O
distal JJ I-NP O
anastomosis NN I-NP O
He PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
6/11/01 CD O O
for IN B-VP O
a DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
thrombectomy NN I-NP O
via IN B-VP O
groin NN B-NP O
and CC O O
foot NN B-NP O
cutdown NN I-NP O
Status NNP I-NP O
post NN I-NP O
that WDT O O
procedure NN B-NP O
he PRP O O
developed VBD B-VP O
symptoms NNS B-NP O
of IN B-VP O
acute JJ B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
hypotension NN B-NP O
An DT B-NP O
ECG NNP I-NP O
was VBD B-VP O
performed VBN O O
, , O O
as RB O O
well RB O O
as IN B-VP O
troponin NN B-NP O
drawn NN I-NP O
, , O O
revealing VBG O O
that IN B-VP O
he PRP O O
has VBZ O O
an DT B-NP O
acute JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
The DT B-NP O
cardiology NN I-NP O
service NN I-NP O
was VBD B-VP O
called VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
post-thrombectomy NN B-NP O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
care NN I-NP O
unit NN I-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
he PRP O O
was VBD B-VP O
managed VBN O O
medically RB O O
for IN B-VP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
Based VBN O O
on IN B-VP O
his PRP$ O O
severe JJ B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
and CC O O
difficulty NN B-NP O
in IN B-VP O
managing VBG O O
his PRP$ O O
blood NN B-NP O
pressure NN I-NP O
, , O O
the DT B-NP O
cardiac JJ I-NP O
surgery NN I-NP O
service NN I-NP O
was VBD B-VP O
consulted VBN O O
He PRP O O
was VBD B-VP O
scheduled VBN O O
to TO O O
see VB O O
cardiac JJ B-NP O
surgery NN I-NP O
in IN B-VP O
office NN B-NP O
setting NN I-NP O
but CC O O
, , O O
given VBN O O
his PRP$ O O
current JJ B-NP O
condition NN I-NP O
, , O O
we PRP O O
were VBD B-VP O
going VBG O O
to TO O O
perform VB O O
his PRP$ O O
surgery NN B-NP O
a DT B-NP O
little JJ I-NP O
bit NN I-NP O
sooner RBR O O
He PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
bout NN I-NP O
of IN B-VP O
pneumonia NN B-NP O
which WDT O O
mildly RB O O
delayed VBD B-VP O
his PRP$ O O
surgery NN B-NP O
On IN B-VP O
8/14/02 CD O O
he PRP O O
underwent JJ B-NP O
catheterization NN I-NP O
which WDT O O
revealed VBD B-VP O
a DT B-NP O
right JJ I-NP O
dominant NN I-NP O
system NN I-NP O
, , O O
a DT B-NP O
discreet NN I-NP O
40% CD O O
lesion NN B-NP O
in IN B-VP O
the DT B-NP O
proximal JJ I-NP O
left NN I-NP O
main JJ O O
, , O O
a DT B-NP O
discreet NN I-NP O
30% CD O O
lesion NN B-NP O
in IN B-VP O
the DT O O
proximal JJ O O
left VBD B-VP O
anterior JJ O O
descending VBG O O
artery NN B-NP O
, , O O
100% CD O O
lesion NN B-NP O
in IN B-VP O
the DT B-NP O
first JJ I-NP O
marginal JJ I-NP O
branch NN I-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
circumflex JJ B-NP O
artery NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
100% CD O O
lesion NN B-NP O
in IN B-VP O
the DT B-NP O
second JJ I-NP O
marginal JJ I-NP O
branch NN I-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
circumflex JJ B-NP O
artery NN I-NP O
He PRP O O
has VBZ O O
a DT B-NP O
discreet NN I-NP O
80% CD O O
lesion NN B-NP O
in IN B-VP O
the DT B-NP O
proximal JJ I-NP O
right JJ I-NP O
coronary NN I-NP O
artery NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
evidence NN B-NP O
of IN B-VP O
severe JJ B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
During IN B-VP O
catheterization NN B-NP O
this DT O O
revealed VBD B-VP O
an DT B-NP O
RA NNP I-NP O
pressure NN I-NP O
of IN B-VP O
10 CD O O
, , O O
a DT B-NP O
pulmonary JJ I-NP O
artery NN I-NP O
pressure NN I-NP O
of IN B-VP O
49/20 CD O O
, , O O
with IN B-VP O
wedge NN B-NP O
of IN B-VP O
31 CD O O
He PRP O O
had VBD B-VP O
a DT B-NP O
thick JJ I-NP O
cardiac JJ I-NP O
output NN I-NP O
of IN B-VP O
4.77 CD O O
and CC O O
cardiac JJ B-NP O
index NN I-NP O
of IN B-VP O
2.1 CD O O
Based VBN O O
on IN B-VP O
the DT B-NP O
findings NNS I-NP O
of IN B-VP O
these DT B-NP O
catheterization NN I-NP O
results NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
0/27/02 CD O O
with IN B-VP O
Dr NNP B-NP O
Opfer NNP I-NP O
and CC O O
Dr NNP B-NP O
Gack NNP I-NP O
for IN B-VP O
an DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
replacement NN I-NP O
with IN B-VP O
a DT B-NP O
#23 JJ I-NP O
Carpentier-Edwards NNP I-NP O
pericardial NN I-NP O
valve NN I-NP O
and CC O O
mitral JJ B-NP O
valvuloplasty NN I-NP O
with IN B-VP O
an DT B-NP O
Alfieri NNP I-NP O
suture NN I-NP O
repair NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
times NNS I-NP O
three CD O O
with IN B-VP O
left VBN O O
internal JJ B-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
the DT O O
left VBN O O
anterior JJ O O
descending VBG O O
artery NN B-NP O
, , O O
left VBD B-VP O
radial JJ O O
to TO O O
obtuse VB O O
marginal JJ O O
one CD O O
, , O O
and CC O O
left VBD B-VP O
radial JJ O O
to TO O O
posterior VB O O
descending VBG O O
artery RB O O
Postoperatively RB O O
he PRP O O
underwent VBD B-VP O
our PRP$ O O
routine JJ B-NP O
care NN I-NP O
and CC O O
went VBD B-VP O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
where WRB O O
he PRP O O
generally RB O O
did VBD B-VP O
well RB O O
He PRP O O
remained VBD B-VP O
on IN B-VP O
his PRP$ O O
aspirin NN B-NP B-m
and CC O O
Lopressor NNP B-NP B-m
, , O O
as RB O O
well RB O O
as IN B-VP O
Coumadin NNP B-NP B-m
He PRP O O
was VBD B-VP O
mildly RB O B-r
tachycardic JJ O I-r
and CC O O
his PRP$ O O
Lopressor NNP B-NP B-m
dose NN I-NP O
was VBD B-VP O
adjusted VBN O O
Because IN B-VP O
of IN B-VP O
his PRP$ O O
diabetes NNS B-NP O
mellitus RB O O
, , O O
he PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
the DT B-NP O
Portland NNP I-NP O
protocol NN I-NP O
and CC O O
remained VBD B-VP O
on IN B-VP O
a DT B-NP O
full JJ I-NP O
ten-day JJ I-NP B-du
ten-day JJ I-NP B-du
course NN I-NP I-du
course NN I-NP I-du
of IN B-VP O
Flagyl NNP B-NP B-m
and CC O O
Cefotaxime NNP B-NP B-m
for IN B-VP O
his PRP$ O B-r
his PRP$ O B-r
preoperative JJ B-NP I-r
preoperative JJ I-NP I-r
pneumonia NN I-NP I-r
pneumonia NN I-NP I-r
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 VBD B-VP O
he PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
where WRB O O
he PRP O O
did VBD B-VP O
well RB O O
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
ambulate VB O O
at IN B-VP O
least JJS O O
to TO O O
a DT B-NP O
chair NN I-NP O
and CC O O
was VBD B-VP O
deemed VBN O O
that IN B-VP O
he PRP O O
probably RB O O
is VBZ O O
not RB O O
a DT B-NP O
candidate NN I-NP O
to TO O O
go VB O O
home NN B-NP O
immediately RB O O
but CC O O
a DT B-NP O
candidate NN I-NP O
for IN B-VP O
rehabilitation NN B-NP O
He PRP O O
has VBZ O O
been VBN O O
taken VBN O O
off RP O O
his PRP$ O O
Portland NNP B-NP O
protocol NN I-NP O
and CC O O
his PRP$ O O
staples NNS B-NP O
have VBP O O
been VBN O O
discontinued VBN O O
On IN B-VP O
his PRP$ O O
pre-discharge NN B-NP O
examination NN I-NP O
he PRP O O
is VBZ O O
stable JJ O O
with IN B-VP O
clean JJ B-NP O
incisions NNS I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
stable JJ B-NP O
sternum NN I-NP O
He PRP O O
is VBZ O O
now RB O O
currently RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
and CC O O
will MD O O
be VB O O
discharged VBN O O
to TO O O
rehabilitation VB O O
DISPOSITION: NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Coumadin NNP I-NP B-m
4 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.hs NN I-NP B-f
to TO O O
maintain VB O O
INR NNP B-NP B-r
between IN B-VP O
2 CD O O
and CC O O
3 CD O O
, , O O
aspirin NN B-NP B-m
, , O O
Diltiazem NNP B-NP B-m
30 CD O B-do
mg NN B-NP O
t.i.d NN I-NP B-f
, , O O
Simvastatin NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Nexium NNP B-NP B-m
20 CD O B-do
mg NN B-NP O
q.d NN I-NP B-f
, , O O
Niferex-150 NNP B-NP B-m
b.i.d NN I-NP B-f
, , O O
Glipizide NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
and CC O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
with IN B-VP O
CZI NNP B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
Dictated NNP I-NP O
By: NNP I-NP O
MYRON NNP I-NP O
MANCUSI NNP I-NP O
, , O O
M.D NNP B-NP O
UQ80 NNP I-NP O
Attending: NNP I-NP O
HORACIO NNP I-NP O
D NNP I-NP O
RATCLIFF NNP I-NP O
, , O O
M.D NNP B-NP O
US4 NNP I-NP O
RZ720/557904 NNP I-NP O
Batch: NNP I-NP O
1811 CD O O
Index NNP B-NP O
No NNP I-NP O
VCGWLQER75 NNP I-NP O
D: NNP I-NP O
11/17/02 CD O O
T: NNP B-NP O
11/17/02 CD O O
CC: NNP B-NP O
1 CD O O
BURT NNP B-NP O
D NNP I-NP O
CROPSEY NNP I-NP O
, , O O
M.D NNP B-NP O
QM26 NNP I-NP O
2 CD O O
PORBON NNP B-NP O
HOSPITALS NNP I-NP O
AND NNP I-NP O
CLINICS NNP I-NP O
CARDIOLOGY NNP I-NP O
CLINIC NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#141408 VBZ O O
962087273 CD O O
TH NNP B-NP O
12854369 CD O O
6752923 CD O O
1/9/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
POST NNP I-NP O
OP NNP I-NP O
LOWER NNP I-NP O
EXTREMITY NNP I-NP O
EDEMA NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/9/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/22/2007 CD O O
ATTENDING: NNP B-NP O
MONTIETH NNP I-NP O
, , O O
LUCIANO NNP B-NP O
M.D NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Congestive NNP I-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
question NN B-NP O
incisional JJ B-NP O
cellulitis NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
68-year-old JJ B-NP O
woman NN I-NP O
who WP O O
underwent JJ B-NP O
mitral JJ I-NP O
valvuloplasty NN I-NP O
and CC O O
CABG NNP B-NP O
on IN B-VP O
8/26/06 CD O O
, , O O
postoperative JJ B-NP O
issues NNS I-NP O
included VBD B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
She PRP O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
5/15/06 CD O O
and CC O O
now RB O O
returns VBZ O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
with IN B-VP O
lower JJR B-NP O
extremity NN I-NP O
swelling VBG O O
as RB O O
well RB O O
as IN B-VP O
erythema NN B-NP O
noted VBD B-VP O
at IN B-VP O
the DT B-NP O
lower JJR I-NP O
pole NN I-NP O
of IN B-VP O
her PRP$ O O
sternal JJ O O
wound IN B-VP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
purulent JJ B-NP O
drainage NN I-NP O
from IN B-VP O
wound NN B-NP O
, , O O
chills NNS B-NP O
or CC O O
nausea NN B-NP O
and CC O O
vomiting VBG O O
She PRP O O
reports VBZ O O
recent JJ B-NP O
low-grade JJ I-NP O
temperatures NNS I-NP O
of IN B-VP O
100 CD O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Hypertension NNP I-NP O
, , O O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
hypothyroidism NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
COPD NNP B-NP O
, , O O
GERD NNP B-NP O
, , O O
depression NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
GI NNP B-NP O
bleed NN I-NP O
on IN B-VP O
Coumadin NNP B-NP B-m
therapy NN I-NP O
and CC O O
pulmonary JJ B-NP O
hypertension NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
appendectomy NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
cholecystectomy NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
tonsils NNS I-NP O
and CC O O
adenoids NNS B-NP O
, , O O
status NN B-NP O
post NN I-NP O
tubal JJ B-NP O
ligation NN I-NP O
and CC O O
removal NN B-NP O
of IN B-VP O
left JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
lipoma VBP O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Mother NNP I-NP O
died VBD B-VP O
of IN B-VP O
cervical JJ B-NP O
cancer NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
remote JJ I-NP O
history NN I-NP O
of IN B-VP O
smoking NN B-NP O
, , O O
quit VBP O O
9 CD O O
years NNS B-NP O
ago RB O O
, , O O
no DT B-NP O
alcohol NN I-NP O
use IN B-VP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
with IN B-VP O
her PRP$ O O
husband NN B-NP O
on IN B-VP O
the DT B-NP O
Ard NNP I-NP O
Ont NNP I-NP O
Esnowi NNP I-NP O
She PRP O O
is VBZ O O
a DT B-NP O
retired JJ I-NP O
clothing NN I-NP O
company NN I-NP O
worker NN I-NP O
ALLERGIES: NNP I-NP O
Bactrim NNP I-NP O
causing VBG O O
hives NNS B-NP O
and CC O O
erythromycin VB O O
causing VBG O O
abdominal JJ B-NP O
cramps NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Toprol NNP B-NP B-m
25 CD O B-do
p.o JJ O B-mo
daily RB O B-f
2 CD O O
Valsartan NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
4 CD O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
5 CD O O
Coumadin NNP B-NP B-m
variable JJ O B-do
dose JJ O I-do
daily JJ O B-f
6 CD O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
7 CD O O
Spironolactone NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
8 CD O O
Simvastatin NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
9 CD O O
Nortriptyline NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
10 CD O O
Fluoxetine NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
11 CD O O
Synthroid NNP B-NP B-m
88 CD O B-do
mcg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Height NNP I-NP O
5 CD O O
feet NNS B-NP O
2 CD O O
inches NNS B-NP O
tall JJ O O
and CC O O
weight VBD B-VP O
97 CD O O
kg NNS B-NP O
Vital NNP I-NP O
signs NNS I-NP O
, , O O
temperature NN B-NP O
98.8 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
90 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
120/72 CD O O
and CC O O
oxygen JJ B-NP O
saturation NN I-NP O
98% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
HEENT NNP I-NP O
, , O O
PERRL NNP B-NP O
, , O O
oropharynx JJ B-NP O
benign NN I-NP O
Chest NNP I-NP O
with IN B-VP O
midline JJ B-NP O
incision NN I-NP O
Cardiovascular NNP I-NP O
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
stable JJ B-NP O
sternum NN I-NP O
No NNP I-NP O
clicks VBZ O O
Respiratory NNP B-NP O
, , O O
breath NN B-NP O
sounds NNS I-NP O
are VBP O O
clear JJ O O
bilaterally RB O O
Abdomen NNP B-NP O
without IN B-VP O
incisions NNS B-NP O
, , O O
soft JJ O O
, , O O
no DT B-NP O
masses NNS I-NP O
Extremities NNS I-NP O
with IN B-VP O
2+ CD O O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
, , O O
erythema NN B-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
Pedal NNP I-NP O
pulses NNS I-NP O
are VBP O O
1+ CD O O
bilaterally RB O O
Radial JJ B-NP O
pulses NNS I-NP O
2+ CD O O
bilaterally RB O O
Neuro NNP B-NP O
, , O O
alert NN B-NP O
and CC O O
oriented VBN O O
, , O O
grossly RB O O
nonfocal JJ B-NP O
exam NN I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Chemistries NNP I-NP O
include VBP O O
the DT O O
following JJ O O
, , O O
sodium NN B-NP O
of IN B-VP O
132 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
15 CD O O
, , O O
creatinine NN B-NP O
of IN B-VP O
0.8 CD O O
and CC O O
BNP NNP B-NP O
of IN B-VP O
2520 CD O O
Hematology NNP B-NP O
includes VBZ O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
6.8 CD O O
and CC O O
hematocrit NN B-NP O
of IN B-VP O
24.6 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
2/28/06 CD O O
Her PRP$ O O
exam NN B-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
significant JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
with IN B-VP O
probable JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
cellulitis NN I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
as RB O O
well RB O O
as IN B-VP O
pulmonary JJ O O
wheezing VBG O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
dyspnea NN B-NP O
and CC O O
underwent JJ B-NP O
transthoracic NN I-NP O
echocardiogram NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
40% CD O O
to TO O O
45% CD O O
and CC O O
a DT O O
stable JJ O O
mitral JJ O O
valve IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
Lasix NNP I-NP B-m
drip NN I-NP B-mo
and CC O O
Diuril NNP B-NP B-m
with IN B-VP O
improvement NN B-NP O
of IN B-VP O
symptoms NNS B-NP O
She PRP O O
was VBD B-VP O
also RB O O
started VBN O O
on IN B-VP O
antibiotics NNS B-NP B-m
for IN B-VP O
coverage NN B-NP O
of IN B-VP O
possible JJ B-NP B-r
lower JJR I-NP I-r
extremity NN I-NP I-r
cellulitis VBP O I-r
The DT B-NP O
Pulmonary NNP I-NP O
team NN I-NP O
was VBD B-VP O
consulted VBN O O
, , O O
as IN B-VP O
the DT B-NP O
patient NN I-NP O
has VBZ O O
history NN B-NP O
of IN B-VP O
COPD NNP B-NP O
and CC O O
they PRP O O
recommended VBD B-VP O
regimen NNS B-NP O
of IN B-VP O
Advair NNP B-NP B-m
and CC O O
steroid JJ B-NP B-m
taper NN I-NP O
for IN B-VP O
her PRP$ O B-r
her PRP$ O B-r
COPD NNP B-NP I-r
COPD NNP I-NP I-r
She PRP O O
was VBD B-VP O
empirically RB O O
covered VBN O O
for IN B-VP O
pneumonia NN B-NP B-r
pneumonia NN I-NP B-r
with IN B-VP O
levofloxacin NN B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
and CC O O
continued VBD B-VP O
to TO O O
diurese VB O O
well RB O O
on IN B-VP O
a DT B-NP O
Lasix NNP I-NP B-m
drip NN I-NP B-mo
She PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Step-Down JJ I-NP O
Unit NNP I-NP O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
Her NNP I-NP O
preadmission NN I-NP O
cardiac NN I-NP B-m
meds NNS I-NP I-m
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
Coumadin NNP B-NP B-m
for IN B-VP O
atrial JJ B-NP B-r
atrial JJ I-NP B-r
fibrillation NN I-NP I-r
fibrillation NN I-NP I-r
were VBD B-VP O
restarted VBN O O
The DT B-NP O
patient NN I-NP O
required VBN O O
ongoing JJ B-NP O
aggressive JJ I-NP O
diuresis NN I-NP O
to TO O O
eventually RB O O
achieve VB O O
a DT B-NP O
fluid JJ I-NP O
balance NN I-NP O
of IN B-VP O
is VBZ O O
negative JJ O O
1 CD O O
liter JJ O O
daily JJ O O
With IN B-VP O
diuresis NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
complained VBD B-VP O
of IN B-VP O
postural JJ B-NP O
dizziness NN I-NP O
, , O O
lightheadedness NN B-NP O
and CC O O
nausea NN B-NP O
Liver NNP I-NP O
function NN I-NP O
tests NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
amylase NN B-NP O
and CC O O
lipase NN B-NP O
were VBD B-VP O
checked VBN O O
and CC O O
noted VBN O O
to TO O O
be VB O O
normal JJ B-NP O
KUB NNP I-NP O
was VBD B-VP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
small-bowel JJ B-NP O
obstruction NN I-NP O
or CC O O
perforation NN B-NP O
, , O O
and CC O O
with IN B-VP O
stool NN B-NP O
throughout IN B-VP O
the DT B-NP O
colon NN I-NP O
The DT B-NP O
patient's NN I-NP O
nausea NN I-NP O
and CC O O
vomiting VBG O O
resolved VBD B-VP O
when WRB O O
her PRP$ O O
bowels NNS B-NP O
began VBD B-VP O
to TO O O
move VB O O
The DT B-NP O
patient NN I-NP O
continues VBZ O O
her PRP$ O O
course NN B-NP O
of IN B-VP O
antibiotics NNS B-NP B-m
antibiotics NNS I-NP B-m
both DT O O
to TO O O
cover VB O O
lower JJR B-NP B-r
extremity NN I-NP I-r
cellulitis NN I-NP I-r
and CC O O
pneumonia NN B-NP B-r
DISPOSITION: NNP I-NP O
She PRP O O
is VBZ O O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#8 VB O O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications: NN I-NP O
1 CD O O
Enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
2 CD O O
Zetia NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Fluoxetine NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
4 CD O O
Advair NNP B-NP B-m
Diskus NNP I-NP I-m
one CD O B-do
puff NN B-NP I-do
nebulized VBD B-VP B-mo
b.i.d RB O B-f
5 CD O O
Lasix NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
6 CD O O
NPH NNP B-NP B-m
insulin NN I-NP I-m
30 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
q.p.m RB O B-f
7 CD O O
NPH NNP B-NP B-m
insulin NN I-NP I-m
20 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
q.a.m VBP O B-f
8 CD O O
Potassium NNP B-NP B-m
slow JJ B-NP I-m
release NN I-NP I-m
30 CD O B-do
mEq NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
9 CD O O
Levofloxacin NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.24 NN I-NP B-f
h NN I-NP I-f
x4 NNP I-NP B-du
doses VBZ O I-du
10 CD O O
Levothyroxine NNP B-NP B-m
88 CD O B-do
mcg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
11 CD O O
Toprol-XL JJ O B-m
100 CD O B-do
mg JJ O I-do
p.o JJ O B-mo
daily JJ O B-f
12 CD O O
Nortriptyline NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
nightly RB O B-f
13 CD O O
Prednisone NNP B-NP B-m
Prednisone NNP I-NP B-m
Prednisone NNP I-NP B-m
Prednisone NNP I-NP B-m
Prednisone NNP I-NP B-m
taper NN I-NP I-m
taper NN I-NP I-m
taper IN B-VP I-m
taper JJR B-NP I-m
taper NN I-NP I-m
30 CD O B-do
mg NN B-NP I-do
q.24 NN I-NP B-f
h NN I-NP I-f
x3 NN I-NP B-du
doses NNS I-NP I-du
, , O O
20 CD O B-do
mg NN B-NP I-do
q.24 NN I-NP B-f
h NN I-NP I-f
x3 NN I-NP B-du
doses NNS I-NP O
followed VBN O O
by IN B-VP O
a DT O O
10 CD O B-do
mg NN B-NP I-do
q.24 NN I-NP B-f
h NN I-NP I-f
x3 NN I-NP B-du
doses NNS I-NP I-du
, , O O
then RB O O
5 CD O B-do
5 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
q.24 NN I-NP B-f
q.24 NN I-NP B-f
h NN I-NP I-f
h NN I-NP I-f
x3 NNP I-NP B-du
x3 NNP I-NP B-du
doses VBZ O O
14 CD O O
Simvastatin NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
nightly RB O B-f
15 CD O O
Diovan NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
16 CD O O
Coumadin NNP B-NP B-m
Coumadin NNP I-NP B-m
to TO O O
be VB O O
taken VBN O O
as RB O B-f
directed VBN O I-f
to TO O O
maintain VB O O
INR NNP B-NP O
2 CD O O
to TO O O
2.5 CD O O
for IN B-VP O
atrial JJ B-NP B-r
atrial JJ I-NP B-r
fibrillation NN I-NP I-r
fibrillation NN I-NP I-r
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
have VB O O
followup JJ B-NP O
appointments NNS I-NP O
with IN B-VP O
her PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Schwarzkopf NNP I-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
with IN B-VP O
her PRP$ O O
cardiac JJ B-NP O
surgeon NN I-NP O
, , O O
Dr NNP B-NP O
Carlough NNP I-NP O
in IN B-VP O
four CD O O
to TO O O
six CD O O
weeks NNS B-NP O
VNA NNP I-NP O
will MD O O
monitor VB O O
her PRP$ O O
vital JJ B-NP O
signs NNS I-NP O
, , O O
weight NN B-NP O
and CC O O
wounds NNS B-NP O
and CC O O
the DT B-NP O
patient's NN I-NP O
INR NNP I-NP O
and CC O O
Coumadin NNP B-NP B-m
dosing NN I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
S NNP B-NP O
Community NNP I-NP O
Hospital NNP I-NP O
Anticoagulation NNP I-NP O
Service NNP I-NP O
at IN B-VP O
300-135-5841 JJ B-NP O
eScription NN I-NP O
document: IN B-VP O
9-7182888 CD O O
CSSten NNP B-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
GOODNOE NNP I-NP O
, , O O
IAN NNP B-NP O
Attending: NNP I-NP O
LEDLOW NNP I-NP O
, , O O
JEROMY NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
3198633 CD O O
D: NNP B-NP O
6/21/07 CD O O
T: NNP B-NP O
6/21/07 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#151931 VBZ O O
918306143 CD O O
DGH NNP B-NP O
12507329 CD O O
867015 CD O O
10/30/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
DILATED NNP I-NP O
CARDIOMYOPATHY NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/24/1997 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/9/1997 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
CARDIOMYOPATHY NNP I-NP O
SIGNIFICANT NNP I-NP O
PROBLEM: NNP I-NP O
NON-INSULIN NNP I-NP O
DEPENDENT NNP I-NP O
DIABETES NNP I-NP O
MELLITUS NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
57 JJ I-NP O
year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
dilated VBN O O
cardiomyopathy NN B-NP O
who WP O O
is VBZ O O
admitted VBN O O
for IN B-VP O
transplant JJ B-NP O
evaluation NN I-NP O
The DT B-NP O
patient NN I-NP O
initially RB O O
presented VBN O O
in IN B-VP O
1991 CD O O
with IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
it PRP O O
was VBD B-VP O
thought VBN O O
that IN B-VP O
she PRP O O
was VBD B-VP O
having VBG O O
a DT B-NP O
myocardial JJ I-NP B-r
infarction NN I-NP I-r
and CC O O
Streptokinase NNP B-NP B-m
was VBD B-VP O
given; VBN O O
however RB O O
details NNS B-NP O
are VBP O O
not RB O O
known VBN O O
An DT B-NP O
echocardiogram NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
showed VBD B-VP O
that IN B-VP O
her PRP$ O O
ejection NN B-NP O
fraction NN I-NP O
was VBD B-VP O
35-40% JJ O O
with IN B-VP O
evidence NN B-NP O
an DT B-NP O
anteroseptal JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
An DT B-NP O
ETT NNP I-NP O
Thallium NN I-NP O
showed VBD B-VP O
fixed JJ O O
anteroseptal JJ O O
and CC O O
apical JJ B-NP O
defects NNS I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
showed VBD B-VP O
clean JJ B-NP O
coronaries NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
referred VBN O O
to TO O O
Terself NNP B-NP O
Health NNP I-NP O
where WRB O O
an DT B-NP O
exercise NN I-NP O
bicycle NN I-NP O
test NN I-NP O
showed VBD B-VP O
6 CD O O
minutes NNS B-NP O
and CC O O
22 CD O O
seconds NNS B-NP O
of IN B-VP O
exercise NN B-NP O
Her NNP I-NP O
peak JJ B-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
113 CD O O
with IN B-VP O
a DT B-NP O
peak JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
140/60 CD O O
and CC O O
a DT B-NP O
peak JJ I-NP O
VO2 NNP I-NP O
of IN B-VP O
11.6 CD O O
ml NNS B-NP O
per IN B-VP O
kg NN B-NP O
per IN B-VP O
minute NN B-NP O
The DT B-NP O
patient NN I-NP O
apparently RB O O
did VBD B-VP O
well RB O O
until IN B-VP O
about IN B-VP O
a DT B-NP O
year NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
she PRP O O
noted VBD B-VP O
a DT B-NP O
gradual JJ I-NP O
decrease NN I-NP O
in IN B-VP O
her PRP$ O O
exercise NN B-NP O
tolerance NN I-NP O
At IN B-VP O
an DT B-NP O
outside NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
hospitalized VBN O O
for IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
symptoms NNS I-NP O
Lately RB O O
, , O O
the DT B-NP O
patient NN I-NP O
noticed VBD B-VP O
that IN B-VP O
she PRP O O
is VBZ O O
unable JJ O O
to TO O O
walk VB O O
without IN B-VP O
becoming VBG O O
short JJ O O
of IN B-VP O
breath NN B-NP O
In IN B-VP O
March NNP B-NP O
of IN B-VP O
1997 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
able JJ O O
to TO O O
walk VB O O
one CD O O
mile NN B-NP O
, , O O
but CC O O
is VBZ O O
now RB O O
unable JJ O O
to TO O O
do VB O O
so RB O O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
stopping VBG O O
several JJ B-NP O
times NNS I-NP O
while IN B-VP O
trying VBG O O
to TO O O
climb VB O O
one CD O O
flight NN B-NP O
of IN B-VP O
stairs NNS B-NP O
She PRP O O
does VBZ O O
report VB O O
orthopnea NN B-NP O
as RB O O
well RB O O
as IN B-VP O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
no DT B-NP O
light JJ I-NP O
headedness NN I-NP O
or CC O O
syncope NN B-NP O
She PRP O O
does VBZ O O
have VB O O
some DT B-NP O
palpitations NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
complaints NNS B-NP O
of IN B-VP O
twinges NNS B-NP O
under IN B-VP O
left VBD B-VP O
breast NN B-NP O
that IN B-VP O
occur VBP O O
randomly RB O O
She PRP O O
does VBZ O O
not RB O O
experience VB O O
any DT B-NP O
leg NN I-NP O
swelling VBG O O
The DT B-NP O
patient NN I-NP O
saw VBD B-VP O
Dr NNP B-NP O
Ontiveros NNP I-NP O
on IN B-VP O
July NNP B-NP O
, , O O
1997 CD O O
at IN B-VP O
which WDT O O
time NN B-NP O
an DT B-NP O
echocardiogram NN I-NP O
showed VBD B-VP O
a DT O O
massively RB O O
dilated VBN O O
left JJ B-NP O
ventricle NN I-NP O
with IN B-VP O
severely RB O O
depressed JJ B-NP O
systolic JJ I-NP O
function NN I-NP O
and CC O O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
15% CD O O
All DT B-NP O
walls NNS I-NP O
were VBD B-VP O
severely RB O O
hypokinetic JJ O O
There EX O O
was VBD B-VP O
moderate JJ O O
left VBD B-VP O
atrial JJ B-NP O
enlargement NN I-NP O
and CC O O
moderate JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
There EX O O
was VBD B-VP O
normal JJ B-NP O
right JJ I-NP O
ventricular NN I-NP O
size NN I-NP O
and CC O O
function NN B-NP O
and CC O O
no DT B-NP O
thrombus NN I-NP O
or CC O O
pericardial JJ B-NP O
effusion NN I-NP O
The DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
bicycle NN I-NP O
test NN I-NP O
for IN B-VP O
which WDT O O
achieved VBD B-VP O
5 CD O O
minutes NNS B-NP O
and CC O O
33 CD O O
seconds NNS B-NP O
with IN B-VP O
a DT B-NP O
maximal JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
108 CD O O
and CC O O
a DT B-NP O
VO2 NNP I-NP O
of IN B-VP O
6.4 CD O O
ml NNS B-NP O
per IN B-VP O
kg NN B-NP O
per IN B-VP O
minute NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
1 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
bronchitis NN B-NP O
2 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
cardiomyopathy NN B-NP O
as IN B-VP O
above IN B-VP O
3 CD O O
) ) O O
Non-insulin NNP B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RB O O
4 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
hysterectomy NN I-NP O
at IN B-VP O
age NN B-NP O
40 CD O O
5 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
cholecystectomy NN I-NP O
6 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
appendectomy RB O O
7 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
panic NN B-NP O
disorders NNS I-NP O
8 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
agoraphobia $ O O
9 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
alcohol NN B-NP O
use NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
) ) O O
Coumadin NNP B-NP B-m
Coumadin NNP I-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
four CD O B-f
times NNS B-NP O
a DT B-NP O
week NN I-NP O
and CC O O
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
three CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
week NN I-NP I-f
2 CD O O
) ) O O
Digoxin NN B-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
3 CD O O
) ) O O
Enalapril NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
4 CD O O
) ) O O
Micronase NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
5 CD O O
) ) O O
Multivitamins VBZ O B-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
6 CD O O
) ) O O
Lasix FW O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
7 CD O O
) ) O O
Xanax VBD B-VP B-m
0.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
p.r.n NN I-NP I-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Her PRP$ O O
parents NNS B-NP O
both DT O O
died VBD B-VP O
with IN B-VP O
cardiac JJ B-NP O
problems NNS I-NP O
with IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
( ( O O
father NN B-NP O
at IN B-VP O
age NN B-NP O
42 CD O O
, , O O
mother NN B-NP O
at IN B-VP O
age NN B-NP O
62 CD O O
) ) O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
alone RB O O
with IN B-VP O
an DT B-NP O
apartment NN I-NP O
next JJ O O
to TO O O
her PRP$ O O
son NN B-NP O
She PRP O O
has VBZ O O
worked VBN O O
as IN B-VP O
a DT B-NP O
house NN I-NP O
cleaner NN I-NP O
She PRP O O
has VBZ O O
an DT O O
18 CD O O
pack NN B-NP O
year NN I-NP O
history NN I-NP O
of IN B-VP O
cigarette NN B-NP O
smoking; NN I-NP O
she PRP O O
quit VBD B-VP O
smoking VBG O O
30 CD O O
years NNS B-NP O
ago RB O O
She PRP O O
does VBZ O O
have VB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
heavy JJ B-NP O
alcohol NN I-NP O
use NN I-NP O
She PRP O O
is VBZ O O
recently RB O O
divorced VBN O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
pleasant JJ O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
afebrile JJ O O
with IN B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
110/76 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
70 CD O O
and CC O O
a DT B-NP O
respiratory JJ I-NP O
rate NN I-NP O
of IN B-VP O
20 CD O O
with IN B-VP O
oxygen JJ B-NP O
saturation NN I-NP O
of IN B-VP O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Her PRP$ O O
head NN B-NP O
examination NN I-NP O
is VBZ O O
remarkable JJ O O
for IN B-VP O
upper JJ B-NP O
dentures NNS I-NP O
Neck NNP I-NP O
shows VBZ O O
jugular NN B-NP O
venous JJ B-NP O
pressure NN I-NP O
of IN B-VP O
7 CD O O
cm NNS B-NP O
Carotid NNP I-NP O
upstrokes NNS I-NP O
are VBP O O
decreased VBN O O
and CC O O
without IN B-VP O
bruits NNS B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
lymphadenopathy JJ I-NP O
Lungs NNP I-NP O
show VBP O O
occasional JJ B-NP O
bibasilar JJ I-NP O
rales NNS I-NP O
Heart NNP I-NP O
shows VBZ O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
distant JJ B-NP O
heart NN I-NP O
sounds VBZ O O
There EX O O
is VBZ O O
a DT B-NP O
left JJ I-NP O
ventricular NN I-NP O
heave NN I-NP O
and CC O O
an DT B-NP O
S3 NNP I-NP O
present VBD B-VP O
The DT B-NP O
abdomen NNS I-NP O
is VBZ O O
obese JJ O O
with IN B-VP O
bowel NN B-NP O
sounds NNS I-NP O
present JJ O O
, , O O
soft JJ O O
, , O O
non-tender JJ O O
without IN B-VP O
masses VBZ O O
The DT B-NP O
extremities NNS I-NP O
show VBP O O
1+ CD O O
pitting VBG O O
edema NN B-NP O
bilaterally RB O O
Pulses NNP B-NP O
are VBP O O
intact JJ O O
bilaterally RB O O
and CC O O
the DT B-NP O
extremities NNS I-NP O
are VBP O O
warm JJ B-NP O
Neurological NNP I-NP O
examination NN I-NP O
is VBZ O O
non-focal JJ O O
with IN B-VP O
intact JJ B-NP O
sensation NN I-NP O
and CC O O
motor NN B-NP O
examination NN I-NP O
Deep NNP I-NP O
tendon NN I-NP O
reflexes NNS I-NP O
are VBP O O
symmetric JJ O O
and CC O O
2+ CD O O
bilaterally RB O O
with IN B-VP O
downgoing VBG O O
toes NNS B-NP O
bilaterally RB O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
a DT B-NP O
transplantation NN I-NP O
work-up NN I-NP O
She PRP O O
was VBD B-VP O
catheterized VBN O O
on IN B-VP O
February NNP B-NP O
, , O O
1997 CD O O
The DT B-NP O
catheterization NN I-NP O
showed VBD B-VP O
no DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
noted VBD B-VP O
The DT B-NP O
atrium NN I-NP O
showed VBD B-VP O
16 CD O O
mm NN B-NP O
of IN B-VP O
mercury NN B-NP O
mean JJ B-NP O
pressure NN I-NP O
The DT B-NP O
right JJ I-NP O
ventricle NN I-NP O
showed VBD B-VP O
48/18 CD O O
mm NN B-NP O
of IN B-VP O
mercury NN B-NP O
The DT B-NP O
PA NNP I-NP O
showed VBD B-VP O
48/34 CD O O
mm NN B-NP O
of IN B-VP O
mercury NN B-NP O
with IN B-VP O
a DT B-NP O
mean JJ I-NP O
pressure NN I-NP O
of IN B-VP O
39 CD O O
mm NN B-NP O
of IN B-VP O
mercury NN B-NP O
The DT B-NP O
pulmonary JJ I-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
showed VBD B-VP O
a DT B-NP O
mean NN I-NP O
of IN B-VP O
30 CD O O
mm NN B-NP O
of IN B-VP O
mercury NN B-NP O
Cardiac NNP I-NP O
output NN I-NP O
and CC O O
cardiac JJ B-NP O
index NN I-NP O
showed VBD B-VP O
4.4 CD O O
liters NNS B-NP O
per IN B-VP O
minute NN B-NP O
and CC O O
2.2 CD O O
liters NNS B-NP O
per IN B-VP O
minute NN B-NP O
per IN B-VP O
meter NN B-NP O
squared VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
briefly RB O O
transferred VBN O O
to TO O O
the DT B-NP O
Coronary NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
secondary JJ O O
to TO O O
her PRP$ O O
elevated JJ B-NP O
pulmonary JJ I-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
and CC O O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
her PRP$ O O
Swan-Ganz JJ B-NP O
catheter NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
good JJ B-NP O
response NN I-NP O
She PRP O O
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
General NNP I-NP O
Medicine NNP I-NP O
Team NNP I-NP O
where WRB O O
diuresis NN B-NP O
with IN B-VP O
intravenous JJ B-NP B-mo
Lasix NNP I-NP B-m
was VBD B-VP O
continued VBN O O
She PRP O O
tolerated VBD B-VP O
Enalapril NNP B-NP B-m
and CC O O
Lasix NNP B-NP B-m
well RB O O
By IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
her PRP$ O O
hospitalization NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
taking VBG O O
12.5 CD O B-do
mg NN B-NP I-do
of IN B-VP O
Enalapril NNP B-NP B-m
b.i.d NN I-NP B-f
and CC O O
40 CD O B-do
mg NN B-NP I-do
of IN B-VP O
Lasix NNP B-NP B-m
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
She PRP O O
had VBD B-VP O
been VBN O O
taken VBN O O
off RP O O
her PRP$ O O
Coumadin NNP B-NP B-m
and CC O O
had VBD B-VP O
been VBN O O
placed VBN O O
on IN B-VP O
Heparin NNP B-NP B-m
during IN B-VP B-du
this DT B-NP I-du
hospitalization NN I-NP I-du
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
experience VB O O
some DT B-NP O
hematuria NNS I-NP O
toward IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
her PRP$ O O
hospitalization NN B-NP O
which WDT O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
Foley NNP B-NP O
trauma NN I-NP O
while IN B-VP O
she PRP O O
was VBD B-VP O
in IN B-VP O
the DT B-NP O
Coronary NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
As IN B-VP O
part NN B-NP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
transplant JJ B-NP O
evaluation NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
PPD NNP I-NP O
with IN B-VP O
controls NNS B-NP O
placed VBD B-VP O
which WDT O O
showed VBD B-VP O
that IN B-VP O
her PRP$ O O
PPD NNP B-NP O
was VBD B-VP O
negative JJ O O
and CC O O
her PRP$ O O
controls NNS B-NP O
were VBD B-VP O
positive JJ O O
The DT B-NP O
patient JJ I-NP O
underwent NN I-NP O
a DT B-NP O
Dental NNP I-NP O
consult NN I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
Psychiatric NNP I-NP O
consult NN I-NP O
The DT B-NP O
Psychiatric NNP I-NP O
evaluation NN I-NP O
was VBD B-VP O
favorable JJ O O
for IN B-VP O
transplantation NN B-NP O
The DT B-NP O
Dental NNP I-NP O
consult NN I-NP O
involved VBD B-VP O
the DT B-NP O
patient NN I-NP O
having VBG O O
panoramic JJ B-NP O
x-rays JJ I-NP O
Thyrology NN I-NP O
showed VBD B-VP O
a DT B-NP O
cytomegalovirus NN I-NP O
IgG NNP I-NP O
being VBG O O
positive JJ O O
, , O O
a DT B-NP O
cytomegalovirus NN I-NP O
IgM NNP I-NP O
being VBG O O
equivocal JJ O O
, , O O
and CC O O
Epstein-Barr NNP B-NP O
virus NN I-NP O
anti-VCA JJ B-NP O
IgG NNP I-NP O
at IN B-VP O
640 CD O O
, , O O
an DT B-NP O
Epstein-Barr JJ I-NP O
virus NN I-NP O
anti-VCA JJ B-NP O
IgM NNP I-NP O
being VBG O O
less JJR O O
than IN B-VP O
10 CD O O
and CC O O
a DT B-NP O
mucal JJ I-NP O
screen NN I-NP O
being VBG O O
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
32 CD O O
, , O O
a DT B-NP O
varicella NN I-NP O
zoster NN I-NP O
titer NN I-NP O
of IN B-VP O
512 CD O O
, , O O
a DT B-NP O
Toxoplasma NNP I-NP O
IgG NNP I-NP O
being VBG O O
positive JJ O O
, , O O
a DT B-NP O
Toxoplasma NNP I-NP O
IgM NNP I-NP O
being VBG O O
negative JJ B-NP O
Abdominal NNP I-NP O
ultrasound NN I-NP O
showed VBD B-VP O
a DT O O
mildly RB O O
dilated JJ B-NP O
common JJ I-NP O
bile NN I-NP O
and CC O O
pancreatic JJ B-NP O
duct NN I-NP O
and CC O O
showed VBD B-VP O
that IN B-VP O
this DT B-NP O
patient NN I-NP O
was VBD B-VP O
status NN B-NP O
post NN I-NP O
cholecystectomy NN I-NP O
While IN B-VP O
the DT B-NP O
patient NN I-NP O
maybe RB O O
a DT B-NP O
good JJ I-NP O
transplant NN I-NP O
candidate NN I-NP O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
her PRP$ O O
weight NN B-NP O
was VBD B-VP O
a DT B-NP O
negative JJ I-NP O
factor NN I-NP O
in IN B-VP O
her PRP$ O O
potential JJ O O
for IN B-VP O
transplant NN B-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
pursuing VBG O O
cardiac JJ B-NP O
rehabilitation NN I-NP O
and CC O O
weight JJ B-NP O
loss NN I-NP O
if IN B-VP O
she PRP O O
is VBZ O O
to TO O O
be VB O O
considered VBN O O
for IN B-VP O
transplant NN B-NP O
in IN B-VP O
the DT B-NP O
future NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
) ) O O
Tylenol $ O B-m
650 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.4h NN I-NP B-f
p.r.n NN I-NP I-f
headache NN I-NP B-r
2 CD O O
) ) O O
Xanax VBD B-VP B-m
0.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d $ O B-f
3 CD O O
) ) O O
Digoxin NN B-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
4 CD O O
) ) O O
Enalapril NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
5 CD O O
) ) O O
Lasix FW O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
6 CD O O
) ) O O
Micronase NNP B-NP B-m
1.25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP O
7 CD O O
) ) O O
Multivitamins VBZ O B-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
8 CD O O
) ) O O
Coumadin NNP B-NP B-m
Coumadin NNP I-NP B-m
2.5 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
p.o JJ B-NP B-mo
q JJ I-NP B-f
day NN I-NP I-f
on IN B-VP I-f
even JJ B-NP I-f
days NNS I-NP I-f
and CC O O
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP O
q JJ B-NP B-f
day NN I-NP I-f
on IN B-VP I-f
odd JJ B-NP I-f
days NNS I-NP I-f
INSTRUCTIONS: VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
that IN B-VP O
she PRP O O
should MD O O
increase VB O O
her PRP$ O O
diuresis NN B-NP O
at IN B-VP O
home NN B-NP O
if IN B-VP O
she PRP O O
noticed VBD B-VP O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
her PRP$ O O
weight NN B-NP O
and CC O O
was VBD B-VP O
instructed VBN O O
to TO O O
see VB O O
a DT B-NP O
physician NN I-NP O
for IN B-VP O
continued VBN O O
for IN B-VP O
weight NN B-NP O
increases NNS I-NP O
due JJ O O
to TO O O
fluid VB O O
accumulation NN B-NP O
Dictated NNP I-NP O
By: NNP I-NP O
WINFRED NNP I-NP O
WIECHMANN NNP I-NP O
, , O O
M.D NNP B-NP O
IP22 NNP I-NP O
Attending: NNP I-NP O
RUSSELL NNP I-NP O
SHUPERT NNP I-NP O
, , O O
M.D NNP B-NP O
SC8 NNP I-NP O
RG559/6002 NNP I-NP O
Batch: NNP I-NP O
10840 CD O O
Index NNP B-NP O
No NNP I-NP O
NFGMA3ZOO NNP I-NP O
D: NNP I-NP O
4/8/97 CD O O
T: NNP B-NP O
5/21/97 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#155926 VBZ O O
740149689 CD O O
GMH NNP B-NP O
94560560 CD O O
356656 CD O O
10/17/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/18/1992 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/19/1992 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
CORONARY NNP B-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
2 CD O O
HYPETENSION NNP B-NP O
3 CD O O
DYSPEPSIA NNP B-NP O
4 CD O O
ADJUSTMENT NNP B-NP O
DISORDER NNP I-NP O
WITH NNP I-NP O
ANXIETY NNP I-NP O
ID/CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
70 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
female NN I-NP O
status NN I-NP O
post NN I-NP O
non NN I-NP O
Q NNP I-NP O
wave VBP O O
MI NNP B-NP O
in IN B-VP O
28 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
with IN B-VP O
thrombolytic JJ B-NP O
therapy NN I-NP O
and CC O O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
of IN B-VP O
long JJ O O
standing VBG O O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
and CC O O
history NN B-NP O
of IN B-VP O
tobacco NN B-NP O
use NN I-NP O
, , O O
who WP O O
presents VBZ O O
upon IN B-VP O
transfer NN B-NP O
from IN B-VP O
Ra NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
with IN B-VP O
chief JJ B-NP O
complaint NN I-NP O
of IN B-VP O
post NN B-NP O
MI NNP I-NP O
unstable JJ B-NP O
angina JJ I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
the DT B-NP O
history NN I-NP O
of IN B-VP O
long JJ O O
standing VBG O O
hypertension NN B-NP O
and CC O O
has VBZ O O
had VBN O O
chest VBN O O
pain NN B-NP O
in IN B-VP O
the DT O O
past JJ O O
including VBG O O
at IN B-VP O
least JJS O O
one CD O O
previous JJ B-NP O
episode NN I-NP O
of IN B-VP O
rule NN B-NP O
out IN B-VP O
MI NNP B-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
22 CD O O
of IN B-VP O
April NNP B-NP O
, , O O
to TO O O
Hen NNP B-NP O
Mo NNP I-NP O
Gardensworth NNP I-NP O
Sent NNP I-NP O
Hospital NNP I-NP O
with IN B-VP O
signs NNS B-NP O
and CC O O
symptoms NNS B-NP O
consistent JJ O O
with IN B-VP O
acute JJ B-NP O
MI NNP I-NP O
, , O O
and CC O O
apparently RB O O
received VBN O O
salvage NN B-NP O
therapy NN I-NP O
with IN B-VP O
IV NNP B-NP B-mo
Streptokinase NNP I-NP B-m
and CC O O
TPA NNP B-NP B-m
Limited NNP I-NP O
records NNS I-NP O
are VBP O O
available JJ O O
from IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
The DT B-NP O
patient NN I-NP O
apparently RB O O
had VBD B-VP O
a DT B-NP O
submax JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
before IN B-VP O
discharge NN B-NP O
which WDT O O
is VBZ O O
reportedly RB O O
unremarkable JJ O O
Upon IN B-VP O
discharge NN B-NP O
from IN B-VP O
Woodgi NNP B-NP O
Hospital NNP I-NP O
the DT B-NP O
patient NN I-NP O
additionally RB O O
did VBD B-VP O
well RB O O
and CC O O
then RB O O
had VBD B-VP O
three CD O O
episodes NNS B-NP O
of IN B-VP O
typical JJ B-NP B-r
substernal JJ I-NP I-r
chest NN I-NP I-r
pain NN I-NP I-r
with IN B-VP O
minimal JJ B-NP O
exertion NN I-NP O
that WDT O O
were VBD B-VP O
relieved VBN O O
with IN B-VP O
SL NNP B-NP B-mo
Nitroglycerin NNP I-NP B-m
On IN B-VP O
0 CD O O
of IN B-VP O
August NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
presented VBD B-VP O
to TO O O
Cooker NNP B-NP O
View NNP I-NP O
Home NNP I-NP O
Hospital NNP I-NP O
with IN B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
heavy JJ B-NP O
substernal JJ I-NP O
chest NN I-NP O
pressure NN I-NP O
that WDT O O
was VBD B-VP O
similar JJ O O
in IN B-VP O
quality NN B-NP O
to TO O O
her PRP$ O O
previous JJ B-NP O
MI NNP I-NP O
This DT B-NP O
pain NN I-NP B-r
was VBD B-VP O
not RB O O
relieved VBN O O
with IN B-VP O
SL NNP B-NP B-mo
Nitroglycerin NNP I-NP B-m
There EX O O
was VBD B-VP O
no DT B-NP O
associated JJ I-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
or CC O O
diaphoresis NN B-NP O
In IN B-VP O
the DT B-NP O
Ist NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
ER NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
SL NNP B-NP B-mo
and CC O O
topical JJ B-NP B-mo
nitrates NNS I-NP B-m
nitrates NNS I-NP B-m
with IN B-VP O
subsequent JJ B-NP O
relief NN I-NP O
of IN B-VP O
her PRP$ O B-r
chest NN B-NP B-r
pain NN I-NP I-r
Her NNP I-NP O
presentation NN I-NP O
was VBD B-VP O
also RB O O
significant JJ O O
for IN B-VP O
a DT B-NP O
chest JJ I-NP O
x-ray JJ I-NP O
consistent NN I-NP O
with IN B-VP O
interstitial JJ B-NP O
edema NN I-NP O
Otherwise NNP I-NP O
, , O O
her PRP$ O O
examination NN B-NP O
was VBD B-VP O
unremarkable JJ O O
and CC O O
her PRP$ O O
EKG NNP B-NP O
showed VBD B-VP O
no DT B-NP O
worrisome JJ I-NP O
ischemic JJ I-NP O
changes NNS I-NP O
She PRP O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP O
and CC O O
on IN B-VP O
0 CD O O
of IN B-VP O
February NNP B-NP O
, , O O
was VBD B-VP O
transferred VBN O O
to TO O O
CNMC NNP B-NP O
on IN B-VP O
IV NNP B-NP B-mo
Heparin NNP I-NP B-m
, , O O
IV NNP B-NP B-mo
Nitroglycerin NNP I-NP B-m
, , O O
beta NN B-NP B-m
blockade NN I-NP I-m
and CC O O
aspirin NN B-NP B-m
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
her PRP$ O O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
without IN B-VP O
chest NN B-NP O
pain NN I-NP O
and CC O O
denied VBD B-VP O
other JJ O O
associated VBN O O
symptoms NNS B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
MI NNP I-NP O
in IN B-VP O
28 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
as IN B-VP O
above; NN B-NP O
long RB O O
standing VBG O O
hypertension NN B-NP O
, , O O
75 CD O O
pack NN B-NP O
year NN I-NP O
history NN I-NP O
of IN B-VP O
cigarette NN B-NP O
smoking NN I-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
chronic JJ B-NP O
dyspepsia NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
positive JJ B-NP O
PPD NNP I-NP O
with IN B-VP O
normal JJ B-NP O
chest JJ I-NP O
x-ray NN I-NP O
, , O O
remote JJ B-NP O
history NN I-NP O
of IN B-VP O
breast NN B-NP O
cancer NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
cholecystectomy NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
appendectomy NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
renal JJ B-NP O
stone NN I-NP O
removal NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
C NNP I-NP O
section NN I-NP O
x VBD B-VP O
3 CD O O
, , O O
status NN B-NP O
post NN I-NP O
breast NN I-NP O
lumpectomy JJ B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
TRANSFER: NNP I-NP O
IV NNP I-NP B-mo
Nitroglycerin NNP I-NP B-m
at IN B-VP O
140 CD O B-do
micrograms NNS B-NP O
per IN B-VP B-f
minute NN B-NP I-f
, , O O
IV NNP B-NP B-mo
Heparin NNP I-NP B-m
drip NN I-NP I-m
, , O O
Lopressor NNP B-NP B-m
, , O O
aspirin VBZ O B-m
one CD O B-do
a DT B-NP B-f
day NN I-NP O
ALLERGIES: NNP I-NP O
Penicillin NNP I-NP O
which WDT O O
causes VBZ O O
anaphylaxis JJ B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Negative NNP I-NP O
for IN B-VP O
premature NN B-NP O
cardiac JJ B-NP O
disease NN I-NP O
, , O O
negative JJ O O
for IN B-VP O
diabetes NNS B-NP O
mellitus VBP O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
Most NNP I-NP O
significant JJ O O
for IN B-VP O
her PRP$ O O
husband's JJ B-NP O
recent JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
GI NNP B-NP O
malignancy NN I-NP O
which WDT O O
will MD O O
require VB O O
inpatient JJ B-NP O
admission NN I-NP O
at IN B-VP O
ORMC NNP B-NP O
and CC O O
the DT B-NP O
recent JJ I-NP O
death NN I-NP O
of IN B-VP O
a DT B-NP O
brother-in-law NN I-NP O
at IN B-VP O
GH NNP B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
an DT B-NP O
obese JJ I-NP O
white JJ I-NP O
female NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
, , O O
pleasant JJ O O
and CC O O
cooperative JJ O O
The DT B-NP O
vital JJ I-NP O
signs NNS I-NP O
were VBD B-VP O
temp JJ O O
97.8 CD O O
, , O O
pulse RB O O
48 CD O O
, , O O
BP NNP B-NP O
140/60 CD O O
, , O O
respirations NNS B-NP O
16 CD O O
with IN B-VP O
O2 NNP B-NP O
sat NN I-NP O
of IN B-VP O
95% CD O O
on IN B-VP O
O2 NNP B-NP O
2 CD O O
liters NNS B-NP O
per IN B-VP O
minute NN B-NP O
HEENT NNP I-NP O
exam NN I-NP O
was VBD B-VP O
unremarkable JJ O O
There EX O O
were VBD B-VP O
normal JJ B-NP O
carotid JJ I-NP O
upstrokes NNS I-NP O
without IN B-VP O
bruit NN B-NP O
The DT B-NP O
chest JJS I-NP O
exam NN I-NP O
showed VBD B-VP O
bibasilar JJ B-NP O
rales NNS I-NP O
right RB O O
greater JJR O O
than IN B-VP O
left JJR O O
but CC O O
otherwise VBP O O
the DT B-NP O
lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
, , O O
no DT O O
wheezing VBG O O
CV NNP B-NP O
exam NN I-NP O
showed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
distant JJ B-NP O
heart NN I-NP O
sounds VBZ O O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
question NN B-NP O
of IN B-VP O
S4 NNP B-NP O
, , O O
no DT O O
appreciable JJ O O
murmurs VBZ O O
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
obese JJ O O
, , O O
soft JJ O O
with IN B-VP O
normoactive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
There EX O O
were VBD B-VP O
previous JJ B-NP O
surgical JJ I-NP O
scars NNS I-NP O
No DT B-NP O
masses NNS I-NP O
or CC O O
hepatosplenomegaly NN B-NP O
was VBD B-VP O
noted VBN O O
There EX O O
were VBD B-VP O
normal JJ O O
femoral JJ O O
and CC O O
distal JJ B-NP O
pulses NNS I-NP O
, , O O
no DT B-NP O
peripheral JJ I-NP O
edema NN I-NP O
, , O O
no DT B-NP O
peripheral JJ I-NP O
bruits NNS I-NP O
Neuro NNP I-NP O
exam NN I-NP O
was VBD B-VP O
unremarkable JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
The DT B-NP O
admission NN I-NP O
labs NN I-NP O
showed VBD B-VP O
hematocrit JJ O O
34.2 CD O O
, , O O
WBC NNP B-NP O
6.7 CD O O
, , O O
platelets NNS B-NP O
159 CD O O
, , O O
000 CD O O
, , O O
PTT NNP B-NP O
50.0 CD O O
on IN B-VP O
IV NNP B-NP B-mo
Heparin NNP I-NP B-m
Urinalysis NNP I-NP O
was VBD B-VP O
essentially RB O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Glucose NNP I-NP O
was VBD B-VP O
110 CD O O
, , O O
BUN NNP B-NP O
12 CD O O
, , O O
creatinine NN B-NP O
1.0 CD O O
, , O O
sodium NN B-NP O
142 CD O O
, , O O
potassium NN B-NP O
4.0 CD O O
, , O O
chloride RB O O
106 CD O O
and CC O O
bicarb $ O O
29 CD O O
LFT's NNP B-NP O
were VBD B-VP O
all DT O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Admission NNP I-NP O
CK NNP I-NP O
was VBD B-VP O
32 CD O O
, , O O
albumin RB O O
3.9 CD O O
, , O O
magnesium NN B-NP O
2.0 CD O O
, , O O
uric JJ B-NP O
acid NN I-NP O
6.2 CD O O
, , O O
cholesterol NN B-NP O
186 CD O O
The DT B-NP O
chest JJS I-NP O
x-ray NN I-NP O
was VBD B-VP O
unavailable JJ B-NP O
EKG NNP I-NP O
showed VBD B-VP O
sinus JJ B-NP O
bradycardia NN I-NP O
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
50 CD O O
, , O O
first RB O O
degree JJ B-NP O
AV NNP I-NP O
block NN I-NP O
axis NN I-NP O
+60 NN I-NP O
, , O O
ST NNP B-NP O
elevation NN I-NP O
in IN B-VP O
leads VBZ O O
V2-V4 NNP B-NP O
, , O O
poor JJ B-NP O
R NNP I-NP O
wave NN I-NP O
progression NN I-NP O
leads VBZ O O
V1-V3 NNP B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
over IN B-VP O
the DT O O
first JJ O O
24 CD O O
hours NNS B-NP O
of IN B-VP O
admission NN B-NP O
On IN B-VP O
16 CD O O
of IN B-VP O
June NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
went VBD B-VP O
to TO O O
cardiac VB O O
cath NN B-NP O
Angiogram NNP I-NP O
showed VBD B-VP O
50% CD O O
mid NN B-NP O
circumflex NN I-NP O
, , O O
60% CD O O
mid NN B-NP O
left VBD B-VP O
anterior JJ B-NP O
descending NN I-NP O
and CC O O
only RB O O
luminal JJ B-NP O
irregularities NNS I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
RCA NNP I-NP O
, , O O
anterior RB O O
wall JJ B-NP O
hypokinesis NN I-NP O
but CC O O
overall JJ B-NP O
good JJ I-NP O
LV NNP I-NP O
systolic JJ B-NP O
function NN I-NP O
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
approximately RB O O
72% CD O O
Average JJ B-NP O
pulmonary JJ I-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
was VBD B-VP O
20 CD O O
and CC O O
right JJ B-NP O
atrial JJ I-NP O
pressure NN I-NP O
9 CD O O
Cardiac NNP B-NP O
output NN I-NP O
was VBD B-VP O
4.5 CD O O
with IN B-VP O
cardiac JJ B-NP O
index NN I-NP O
of IN B-VP O
2.5 CD O O
Careful NNP B-NP O
review NN I-NP O
of IN B-VP O
the DT B-NP O
cath NN I-NP O
films NNS I-NP O
showed VBD B-VP O
no DT O O
hemodynamically RB O O
significant JJ B-NP O
lesions NNS I-NP O
felt VBD B-VP O
to TO O O
be VB O O
responsible JJ O O
for IN B-VP O
the DT B-NP O
patient's NN I-NP O
chest NN I-NP O
pain NN I-NP O
Echo NNP I-NP O
performed VBD B-VP O
on IN B-VP O
8 CD O O
of IN B-VP O
August NNP B-NP O
, , O O
showed VBD B-VP O
left JJ B-NP O
ventricular JJ I-NP O
hypertrophy NN I-NP O
with IN B-VP O
low JJ B-NP O
normal JJ I-NP O
LV NNP I-NP O
systolic NN I-NP O
function NN I-NP O
, , O O
estimated VBN O O
EF NNP B-NP O
of IN B-VP O
50-55% NNP B-NP O
, , O O
inferior JJ B-NP O
posterior JJ I-NP O
hypokinesis NN I-NP O
, , O O
and CC O O
trace NN B-NP O
of IN B-VP O
tricuspid JJ O O
and CC O O
mitral JJ B-NP O
regurgitation NN I-NP O
There EX O O
was VBD B-VP O
mild JJ B-NP O
right JJ I-NP O
ventricular NN I-NP O
hypertrophy NN I-NP O
and CC O O
normal JJ O O
estimated VBN O O
pulmonary JJ B-NP O
artery NN I-NP O
pressure NN I-NP O
Postcatheterization NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
showed VBD B-VP O
mild JJ B-NP B-r
hypertension NN I-NP I-r
which WDT O O
was VBD B-VP O
treated VBN O O
by IN B-VP O
the DT B-NP O
addition NN I-NP O
of IN B-VP O
a DT B-NP O
calcium NN I-NP B-m
channel NN I-NP I-m
blocker NN I-NP I-m
, , O O
and CC O O
she PRP O O
was VBD B-VP O
also RB O O
diuresed VBN O O
for IN B-VP O
fluid NN B-NP O
overload NN I-NP O
Prior NNP I-NP O
to TO O O
discharge VB O O
, , O O
she PRP O O
had VBD B-VP O
two CD O O
additional JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
chest NN B-NP B-r
chest NN I-NP B-r
pain NN I-NP I-r
pain NN I-NP I-r
that WDT O O
were VBD B-VP O
low JJ O O
in IN B-VP O
intensity NN B-NP O
but CC O O
prolonged VBD B-VP O
Each DT O O
of IN B-VP O
these DT B-NP O
required JJ I-NP O
several JJ I-NP O
Nitroglycerins NNS I-NP B-m
and CC O O
antacids NNS B-NP B-m
to TO O O
be VB O O
relieved VBN O O
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT B-NP O
chest JJS I-NP O
pain NN I-NP O
was VBD B-VP O
unlikely JJ O O
to TO O O
be VB O O
cardiac JJ O O
in IN B-VP O
origin NN B-NP O
and CC O O
more RBR O O
likely JJ O O
represented VBN O O
either RB O O
GI NNP B-NP O
symptomatology NN I-NP O
or CC O O
an DT B-NP O
anxiety NN I-NP O
reaction NN I-NP O
The DT B-NP O
patient NN I-NP O
repeatedly RB O O
expressed VBD B-VP O
great JJ B-NP O
concern NN I-NP O
over IN B-VP O
her PRP$ O O
husband's JJ B-NP O
illness NN I-NP O
and CC O O
understood VBD B-VP O
the DT B-NP O
possible JJ I-NP O
connection NN I-NP O
between IN B-VP O
this DT O O
and CC O O
her PRP$ O O
chest NN B-NP O
pain NN I-NP O
On IN B-VP O
13 CD O O
of IN B-VP O
August NNP B-NP O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
exercise NN I-NP O
treadmill NN I-NP O
test NN I-NP O
on IN B-VP O
the DT O O
modified VBN O O
Bruce NNP B-NP O
protocol NN I-NP O
She PRP O O
went VBD B-VP O
10 CD O O
minutes NNS B-NP O
and CC O O
30 CD O O
seconds NNS B-NP O
stopping VBG O O
secondary JJ O O
to TO O O
fatigue VB O O
Maximum NNP B-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
108 CD O O
, , O O
maximum JJ B-NP O
BP NNP I-NP O
164 CD O O
systolic NN B-NP O
, , O O
no DT B-NP O
symptoms NNS I-NP O
and CC O O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
, , O O
and CC O O
the DT B-NP O
test NN I-NP O
was VBD B-VP O
interpreted VBN O O
as IN B-VP O
showing VBG O O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
ischemia NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
and CC O O
is VBZ O O
to TO O O
follow VB O O
up RP O O
at IN B-VP O
AMC NNP B-NP O
COMPLICATIONS: NNP I-NP O
None NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Nifedipine NNP I-NP B-m
XL NNP I-NP I-m
90 CD O B-do
mg NN B-NP O
po NN I-NP B-mo
q NN I-NP B-f
am VBP O I-f
, , O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
hs NN I-NP I-f
, , O O
aspirin RB O B-m
81 CD O B-do
mg NNS B-NP I-do
po JJ B-NP B-mo
q JJ I-NP B-f
d NN I-NP I-f
, , O O
Serax NNP B-NP B-m
Serax NNP I-NP B-m
15 CD O B-do
15 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
po NN I-NP B-mo
po NN I-NP B-mo
q VBD B-VP B-f
6 CD O I-f
h NN B-NP I-f
or CC O O
q NN B-NP B-f
hs NN I-NP I-f
prn NN I-NP I-f
, , O O
Nitroglycerin NNP B-NP B-m
1/150 CD O B-do
grain NN B-NP I-do
q NN I-NP O
5 CD O O
minutes NNS B-NP O
x VBP O B-du
3 CD O I-du
SL NNP B-NP B-mo
prn NN I-NP O
chest NN I-NP B-r
pain NN I-NP I-r
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Good NNP I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
CARE: NNP I-NP O
With IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Gayle NNP I-NP O
Demeritt NNP I-NP O
, , O O
and CC O O
her PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Mark NNP I-NP O
Willians NNP I-NP O
, , O O
at IN B-VP O
ACSH NNP B-NP O
ZR634/9372 NNP I-NP O
LESLIE NNP I-NP O
F NNP I-NP O
BUZIS NNP I-NP O
, , O O
M.D NNP B-NP O
IK5 NNP I-NP O
D: NNP I-NP O
6/19/92 CD O O
Batch: NNP B-NP O
8454 CD O O
Report: NNP B-NP O
A0568G63 NNP I-NP O
T: NNP I-NP O
9/1/92 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
IAN NNP I-NP O
WALER NNP I-NP O
, , O O
M.D NNP B-NP O
cc: VBZ O O
1 CD O O
RICARDO NNP B-NP O
R NNP I-NP O
HEALD NNP I-NP O
, , O O
M.D NNP B-NP O
2 CD O O
FREDDIE NNP B-NP O
L NNP I-NP O
ZIPPERER NNP I-NP O
, , O O
M.D NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#156908 VBZ O O
326844120 CD O O
R NNP B-NP O
21669179 CD O O
8491274 CD O O
5/12/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
ROMI NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/18/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/26/2007 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
BRENCHLEY NNP I-NP O
, , O O
BRENT NNP B-NP O
L NNP I-NP O
246-19-65-4 JJ B-NP O
Naside NNP I-NP O
Roche NNP I-NP O
Enron NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/10/07 CD O O
AT NNP B-NP O
09:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
AMA NNP I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
ACETO NNP I-NP O
, , O O
PABLO NNP B-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.S NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
AMA NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
ACETYLSALICYLIC NNP B-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
2 CD O O
ATENOLOL NNP B-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
3 CD O O
ATORVASTATIN NNP B-NP B-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
4 CD O O
DOCUSATE NNP B-NP B-m
SODIUM NNP I-NP I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
5 CD O O
LOSARTAN NNP B-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
6 CD O O
METFORMIN NNP B-NP B-m
850 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
7 CD O O
TERAZOSIN NNP B-NP B-m
HCL NNP I-NP I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
8 CD O O
AMLODIPINE NNP B-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
9 CD O O
LOSARTAN NNP B-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
10 CD O O
PANTOPRAZOLE NNP B-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
10/14 CD O O
) ) O O
AMLODIPINE $ O B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
ATENOLOL NNP B-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LOSARTAN NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt; $ O O
100 CD O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/10/07 CD O O
by IN B-VP O
KETCHAM NNP B-NP O
, , O O
JAKE NNP B-NP O
WALDO NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IV NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
687673059 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LOSARTAN NNP I-NP B-m
POTASSIUM NNP I-NP I-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/8/07 CD O O
by IN B-VP O
DERNIER NNP B-NP O
, , O O
AUGUSTINE NNP B-NP O
A NNP I-NP O
, , O O
P.A.-C NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
856712835 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LOSARTAN NNP I-NP B-m
POTASSIUM NNP I-NP I-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
Number NNP B-NP B-do
of IN B-VP I-do
Doses NNP B-NP I-do
Required NNP I-NP I-do
( ( O I-do
approximate JJ B-NP I-do
): NN I-NP I-do
3 CD O I-do
MG NNP B-NP B-m
GLUCONATE NNP I-NP I-m
( ( O I-m
MAGNESIUM NNP B-NP I-m
GLUCONATE NNP I-NP I-m
) ) O I-m
400 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
10/14 CD O O
) ) O O
PROTONIX NNP B-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
TERAZOSIN NNP I-NP B-m
HCL NNP I-NP I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
2 CD O I-du
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
2 CD O O
gm NN B-NP O
Na NNP I-NP O
/ NNP I-NP O
Carbohydrate NNP I-NP O
Controlled NNP I-NP O
/ NNP I-NP O
Low NNP I-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
PCP NNP I-NP O
x VBD B-VP O
1 CD O O
week NN B-NP O
, , O O
ALLERGY: NNP B-NP O
HYDROCHLOROTHIAZIDE NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CP NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
ROMI NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
essential JJ B-NP O
HTN NNP I-NP O
, , O O
NIDDM NNP B-NP O
, , O O
CAD NNP B-NP O
, , O O
asystolic JJ B-NP O
arrest NN I-NP O
, , O O
Hypokalemia NNP B-NP O
, , O O
Chronic NNP B-NP O
right-sided VBD B-VP O
chest JJS B-NP O
wall NN I-NP O
pain NN I-NP O
: : O O
10/6 CD O O
ETT NNP B-NP O
6' CD O O
SBP NNP B-NP O
c VBD B-VP O
100%PHR CD O O
no DT B-NP O
isch NN I-NP O
, , O O
prostate NN B-NP O
nodules NNS I-NP O
, , O O
PUD/GERD NNP B-NP O
, , O O
headaches NNS B-NP O
, , O O
h/o JJ B-NP O
flash NN I-NP O
pulmonary JJ B-NP O
edema NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
PCP: NNP I-NP O
Dr NNP I-NP O
Marco NNP I-NP O
Labat NNP I-NP O
( ( O O
ING NNP B-NP O
SCEODE NNP I-NP O
HEALTHCARE NNP I-NP O
) ) O O
Cards: NNP B-NP O
none NN I-NP O
active JJ B-NP O
senior JJ I-NP O
living NN I-NP O
center: NN I-NP O
564 CD O O
071 CD O O
7165 CD O O
--------------------------------------------------- NN B-NP O
CC: NNP I-NP O
chest NN I-NP O
pain NN I-NP O
*** NNP I-NP O
HPI: NNP I-NP O
76 CD O O
yo NN B-NP O
Spanish JJ O O
speaking VBG O O
male JJ B-NP O
w/ JJ I-NP O
NIDDM NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
w/ JJ B-NP O
recent JJ I-NP O
CCU NNP I-NP O
admission NN I-NP O
@ NNP I-NP O
TMC NNP I-NP O
for IN B-VP O
NSTEMI/asystole NNP B-NP O
arrest/pulm NN I-NP O
edema NN I-NP O
, , O O
left VBD B-VP O
AMA NNP B-NP O
before IN B-VP O
stress/cath NN B-NP O
Then RB O O
ED NNP B-NP O
visit NN I-NP O
on IN B-VP O
9/27 CD O O
for IN B-VP O
weakness NN B-NP O
, , O O
c/o NN B-NP O
of IN B-VP O
cp NN B-NP O
, , O O
left VBD B-VP O
AMA NNP B-NP O
, , O O
then RB O O
admission NN B-NP O
on IN B-VP O
0/2 CD O O
where WRB O O
he PRP O O
again RB O O
left VBD B-VP O
AMA NNP B-NP O
before IN B-VP O
evaluation NN B-NP O
Presented VBN O O
to TO O O
AH NNP B-NP O
ED NNP I-NP O
for IN B-VP O
similar JJ B-NP O
ongoing JJ I-NP O
complaints NNS I-NP O
including VBG O O
constant JJ B-NP O
CP NNP I-NP O
"burning/nauseous JJ B-NP O
feeling" NN I-NP O
x $ O O
3 CD O O
days NNS B-NP O
with IN B-VP O
some DT O O
associated VBN O O
palpitations NNS B-NP O
and CC O O
sob NN B-NP O
He PRP O O
states VBZ O O
that IN B-VP O
the DT B-NP O
pain NN I-NP O
started VBD B-VP O
3 CD O O
days NNS B-NP O
PTA NNP I-NP O
while IN B-VP O
walking VBG O O
around RB O O
house NN B-NP O
, , O O
approx VBP O O
6/10 CD O O
however RB O O
didn't JJ O O
call VB O O
EMS NNP B-NP O
until IN B-VP O
today NN B-NP O
- : O O
mostly RB O O
b/c IN B-VP O
he PRP O O
has VBZ O O
began VBD B-VP O
to TO O O
get VB O O
dizzier JJR O O
and CC O O
weaker JJR O O
since IN B-VP O
seen VBN O O
in IN B-VP O
CADA NNP B-NP O
HOSPITAL NNP I-NP O
Denies NNP I-NP O
radiation NN I-NP O
of IN B-VP O
pain/chills/fevers/cough/weight JJ B-NP O
changes/urinary/bowel NN I-NP O
sxs NN I-NP O
Per NNP I-NP O
MH NNP I-NP O
pt NN I-NP O
seen VBN O O
in IN B-VP O
SOUTHNEY NNP B-NP O
TROTEN NNP I-NP O
GENERAL NNP I-NP O
HOSPITAL NNP I-NP O
on IN B-VP O
11/19/07 CD O O
with IN B-VP O
c/o NN B-NP O
continued VBD B-VP O
lack NN B-NP O
of IN B-VP O
appetite NN B-NP O
, , O O
lack NN B-NP O
of IN B-VP O
energy NN B-NP O
, , O O
dizziness NN B-NP O
x VBD B-VP O
10 CD O O
days NNS B-NP O
Denies NNPS I-NP O
orthostatic JJ B-NP O
sxs NN I-NP O
, , O O
but CC O O
does VBZ O O
feel VB O O
weak JJ O O
when WRB O O
standing VBG O O
up RP O O
No DT B-NP O
change NN I-NP O
in IN B-VP O
exercise NN B-NP O
tolerance NN I-NP O
, , O O
can MD O O
walk VB O O
5 CD O O
blocks NNS B-NP O
w/o VBP O O
difficulty NN B-NP O
( ( O O
unchanged JJ O O
) ) O O
In IN B-VP O
CYSANDERS NNP B-NP O
HE NNP I-NP O
HOSPITAL NNP I-NP O
he PRP O O
had VBD B-VP O
c/o VBN O O
occ RB O O
sharp JJ B-NP O
cp NN I-NP O
, , O O
bilateral JJ O O
, , O O
not RB O O
associated VBN O O
with IN B-VP O
exercise/food NN B-NP O
He PRP O O
stated VBD B-VP O
sxs NN B-NP O
are VBP O O
different JJ O O
from IN B-VP O
when WRB O O
he PRP O O
had VBD B-VP O
the DT B-NP O
NSTEMI NNP I-NP O
In IN B-VP O
ED NNP B-NP O
, , O O
pt RB O O
currently RB O O
pain VBP O O
free JJ O O
- : O O
enzymes RB O O
flat JJ B-NP O
x NN I-NP O
1 CD O O
, , O O
EKG NNP B-NP O
unchanged JJ O O
per IN B-VP O
ED NNP B-NP O
( ( O O
however RB O O
? . B-VP O
&lt;1 JJ B-NP O
mm NN I-NP O
ST NNP I-NP O
depression NN I-NP O
in IN B-VP O
lateral JJ B-NP O
leads NNS I-NP O
Given VBN O O
ASA NNP B-NP B-m
325 CD O B-do
x NNP B-NP B-du
1 CD O I-du
, , O O
Ativan NNP B-NP B-m
0.5 CD O B-do
mg NN B-NP I-do
x NN I-NP B-du
1 CD O I-du
, , O O
Mg NNP B-NP B-m
chloride VBP O I-m
500 CD O B-do
mg NN B-NP I-do
x VBD B-VP B-du
1 CD O I-du
*Cardiac JJ B-NP O
Hx NNP I-NP O
per IN B-VP O
ACH NNP B-NP O
note: FW O O
CAD: NNP B-NP O
MI NNP I-NP O
January NNP I-NP O
likely JJ B-NP O
sx NN I-NP O
of IN B-VP O
stable JJ B-NP O
angina NN I-NP O
, , O O
bradycardic NN B-NP O
to TO O O
30's CD O O
on IN B-VP O
atenolol NN B-NP B-m
, , O O
MIBI NNP B-NP O
9/4 CD O O
mild NN B-NP O
LV NNP I-NP O
enlargement NN I-NP O
with IN B-VP O
fixed JJ B-NP O
inferior JJ I-NP O
defect NN I-NP O
and CC O O
no DT B-NP O
reversible JJ I-NP O
defects NNS I-NP O
Echo: NNP I-NP O
EF NNP I-NP O
35% CD O O
, , O O
LAE NNP B-NP O
, , O O
mod NN B-NP O
MR NNP I-NP O
, , O O
mild NN B-NP O
AI NNP I-NP O
, , O O
trace NN B-NP O
TR NNP I-NP O
with IN B-VP O
inferior JJ B-NP O
wall NN I-NP O
HK NNP I-NP O
6/10 CD O O
left VBD B-VP O
TH NNP B-NP O
AMA NNP I-NP O
prior RB O O
to TO O O
MIBI NNP B-NP O
, , O O
did VBD B-VP O
not RB O O
f/u VB O O
outpt NN B-NP O
, , O O
hx NN B-NP O
med VBD B-VP O
noncompliance NN B-NP O
Pt NNP I-NP O
reported VBD B-VP O
cardiac JJ B-NP O
cath NN I-NP O
in IN B-VP O
Ra NNP B-NP O
Corpho NNP I-NP O
Pa NNP I-NP O
Diagnostic NNP I-NP O
cath NN I-NP O
only RB O O
( ( O O
no DT B-NP O
report NN I-NP O
available JJ O O
) ) O O
per IN B-VP O
ALT NNP B-NP O
HOSPITALS NNP I-NP O
note VBP O O
0/28 CD O O
*** NN B-NP O
ROS: NNP I-NP O
recent JJ B-NP O
urgent JJ I-NP O
care NN I-NP O
visit NN I-NP O
for IN B-VP O
c/o NN B-NP O
weakness NN I-NP O
and CC O O
decreased VBD B-VP O
po NNS B-NP O
intake NN I-NP O
( ( O O
per IN B-VP O
LMR NNP B-NP O
) ) O O
, , O O
+ JJ B-NP O
blurry NN I-NP O
vision NN I-NP O
, , O O
+ NNP B-NP O
dizziness NN I-NP O
and CC O O
racing VBG O O
heart NN B-NP O
rate NN I-NP O
intermittently RB O O
at IN B-VP O
night NN B-NP O
( ( O O
unclear JJ B-NP O
duration NN I-NP O
) ) O O
, , O O
as IN B-VP O
above IN B-VP O
otherwise RB O O
unremarkable JJ B-NP O
*** NN I-NP O
PMH: NNP I-NP O
See NNP I-NP O
problem NN I-NP O
List NNP I-NP O
*** NNP I-NP O
HOME NNP I-NP O
MEDS: NNP I-NP O
ASA NNP I-NP B-m
325 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
lipitor NN B-NP B-m
80 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
amlodipine JJ O B-m
5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
protonix VBD B-VP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
losartan VBD B-VP B-m
50 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
terazosin VBD B-VP B-m
1 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
atenolol VBZ O B-m
25 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
metformin VBD B-VP B-m
850 CD O B-do
mg NN B-NP I-do
qam NN I-NP B-f
( ( O O
Patient NNP B-NP O
states VBZ O O
compliance NN B-NP O
with IN B-VP O
all DT B-NP O
meds NNS I-NP O
) ) O O
*** VBP O O
ALLERGIES: NNP B-NP O
HCTZ NNP I-NP O
- : O O
renal JJ B-NP O
failure NN I-NP O
, , O O
hypokalemia NN B-NP O
, , O O
*** NNP B-NP O
FH: NNP I-NP O
Mother NNP I-NP O
died VBD B-VP O
2/2 CD O O
heart NN B-NP O
disease NN I-NP O
, , O O
Father NNP B-NP O
had VBD B-VP O
a DT B-NP O
sudden JJ I-NP O
cardiac NN I-NP O
death; NN I-NP O
no DT B-NP O
FH NNP I-NP O
of IN B-VP O
CA NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
HTN NNP B-NP O
*** NNP I-NP O
SH: NNP I-NP O
lives VBZ O O
alone RB O O
in IN B-VP O
assisted JJ B-NP O
living NN I-NP O
@ NNP I-NP O
Gocam NNP I-NP O
Trache NNP I-NP O
Boiseatl NNP I-NP O
no DT B-NP O
family NN I-NP O
member NN I-NP O
or CC O O
friends NNS B-NP O
former JJ B-NP O
heavy JJ I-NP O
smoker NN I-NP O
, , O O
no DT B-NP O
EtOH/IVDU NNP I-NP O
from IN B-VP O
Yonkers NNP B-NP O
Well NNP I-NP O
Westo NNP I-NP O
, , O O
immigrated VBD B-VP O
in IN B-VP O
70's CD O O
, , O O
previously RB O O
worked VBN O O
as IN B-VP O
janitor NN B-NP O
*** NNP I-NP O
PE NNP I-NP O
on IN B-VP O
ADMISSION: NNP B-NP O
VS: NNP I-NP O
Afeb NNP I-NP O
, , O O
Tc NNP B-NP O
96.6 CD O O
, , O O
HR NNP B-NP O
77 CD O O
, , O O
BP NNP B-NP O
147/72 CD O O
, , O O
RR NNP B-NP O
16 CD O O
, , O O
SaO2 NNP B-NP O
95% CD O O
2 CD O O
L NNP B-NP O
Gen: NNP I-NP O
NAD NNP I-NP O
, , O O
NARD NNP B-NP O
, , O O
sitting VBG O O
up RP O O
on IN B-VP O
stretcher NN B-NP O
, , O O
speaking VBG O O
Spanish JJ O O
in IN B-VP O
full JJ B-NP O
sentences NNS I-NP O
HEENT: NNP I-NP O
NCAT NNP I-NP O
, , O O
EOMI NNP B-NP O
, , O O
PERRL NNP B-NP O
, , O O
anicteric JJ O O
, , O O
mmm NN B-NP O
, , O O
OP NNP B-NP O
clear JJ B-NP O
NECK: NNP I-NP O
supple NN I-NP O
, , O O
no DT B-NP O
LAD NNP I-NP O
, , O O
no DT B-NP O
JVD NNP I-NP O
CHEST: NNP I-NP O
ctab VBZ O O
no DT B-NP O
w/r/c NN I-NP O
CV: NNP I-NP O
RRR NNP I-NP O
distant JJ B-NP O
S1S2 NNP I-NP O
ABD: NNP I-NP O
+BS NNP I-NP O
, , O O
soft JJ O O
, , O O
NTND NNP B-NP O
EXT: NNP I-NP O
no DT B-NP O
e/c/c; NN I-NP O
2+ CD O O
DP's NNP B-NP O
b/l NN I-NP O
SKIN: NNP I-NP O
intact NN I-NP O
, , O O
no DT B-NP O
rashes NNS I-NP O
NEURO: NNP I-NP O
A+O NNP I-NP O
x NNP I-NP O
3 CD O O
, , O O
nonfocal JJ B-NP O
exam NN I-NP O
*** NNP I-NP O
LABS: NNP I-NP O
Na NNP I-NP O
139 CD O O
K NNP B-NP O
3.3 CD O O
Mg NNP B-NP O
1.4 CD O O
CO2 NNP B-NP O
23 CD O O
BUN NNP B-NP O
23 CD O O
CRE NNP B-NP O
1.6 CD O O
( ( O O
baseline NN B-NP O
) ) O O
CBC NNP B-NP O
nrl JJ B-NP O
INR NNP I-NP O
1.1 CD O O
CKMB NNP B-NP O
+ NNP I-NP O
Ti NNP I-NP O
flat JJ B-NP O
x NNP I-NP O
3 CD O O
*** NNP B-NP O
RADIOLOGY: NNP I-NP O
Chest NNP I-NP O
PA NNP I-NP O
&amp; NNP I-NP O
Lateral: NNP I-NP O
No NNP I-NP O
significant JJ B-NP O
interval NN I-NP O
change NN I-NP O
without IN B-VP O
acute JJ B-NP O
cardiopulmonary JJ I-NP O
disease NN I-NP O
*** NNP I-NP O
HOSPITAL NNP I-NP O
COURSE:76 NNP I-NP O
yo NNP I-NP O
M NNP I-NP O
w/ NN I-NP O
significant JJ B-NP O
cardiac JJ I-NP O
history NN I-NP O
, , O O
recent JJ B-NP O
NSTEMI/asystole NNP I-NP O
arrest NN I-NP O
a/w NN I-NP O
ongoing VBG O O
c/o NN B-NP O
weakness NN I-NP O
, , O O
dizziness NN B-NP O
and CC O O
CP NNP B-NP O
x NNP I-NP O
3 CD O O
days NNS B-NP O
, , O O
currently RB O O
CP NNP B-NP O
free JJ O O
however RB O O
multiple JJ B-NP O
RF's NNP I-NP O
for IN B-VP O
ACS NNP B-NP O
thus RB O O
admitted VBD B-VP O
to TO O O
Medicine NNP B-NP O
for IN B-VP O
ROMI NNP B-NP O
and CC O O
further JJ B-NP O
eval/management NN I-NP O
* NNP I-NP O
CV: NNP I-NP O
significant JJ B-NP O
cardiac JJ I-NP O
hx NN I-NP O
appears VBZ O O
euvolemic JJ O O
on IN B-VP O
exam NN B-NP O
( ( O O
I PRP O O
) ) O O
subtle VBD B-VP O
EKG NNP B-NP O
changes NNS I-NP O
on IN B-VP O
admit NN B-NP O
, , O O
however RB O O
? . B-VP O
&lt; $ O O
1 CD O O
mm NN B-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
lateral JJ B-NP O
leads NNS I-NP O
( ( O O
more RBR O O
prominent NN B-NP O
in IN B-VP O
V5 NNP B-NP O
isolated JJ B-NP O
lead NN I-NP O
) ) O O
cycle NN B-NP O
enzymes VBZ O O
with IN B-VP O
repeat NN B-NP O
EKG NNP I-NP O
on IN B-VP O
admit NN B-NP O
( ( O O
no DT B-NP O
acute NN I-NP O
changes NNS I-NP O
) ) O O
and CC O O
serial JJ B-NP O
EKG's NNP I-NP O
with IN B-VP O
enzymes NNS B-NP O
R/O NNP I-NP O
complete VBP O O
on IN B-VP O
HD NNP B-NP O
#2 NNP I-NP O
Currently NNP I-NP O
CP NNP I-NP O
free JJ O O
however RB O O
will MD O O
continue VB O O
baseline VB O O
Statin/ASA/ARB NNP B-NP O
ETT NNP I-NP O
MIBI NNP I-NP O
ordered VBD B-VP O
continue VB O O
above IN B-VP B-m
meds NNS B-NP I-m
and CC O O
baseline NN B-NP O
BB/CCB NNP I-NP B-m
( ( O O
P NNP B-NP O
) ) O O
HD NNP B-NP O
stable JJ O O
yet RB O O
risk NN B-NP B-r
for IN B-VP O
cardiac JJ B-NP O
event NN I-NP O
thus RB O O
will MD O O
treat VB O O
with IN B-VP O
BB NNP B-NP B-m
and CC O O
titrate NN B-NP O
as IN B-VP O
tolerated JJ B-NP O
TTE NNP I-NP O
already RB O O
done VBN O O
on IN B-VP O
previous JJ B-NP O
admit NN I-NP O
( ( O O
R NNP B-NP O
) ) O O
tele VBD B-VP O
monitoring VBG O O
***Pt NN B-NP O
became VBD B-VP O
extremely RB O O
aggitated VBN O O
and CC O O
refusing VBG O O
treatment/testing VBG O O
on IN B-VP O
HD NNP B-NP O
#2 NNP I-NP O
and CC O O
left VBD B-VP O
AMA NNP B-NP O
after IN B-VP O
lengthly RB O O
d/w JJ B-NP O
pt NN I-NP O
, , O O
interpreter NN B-NP O
, , O O
and CC O O
SW NNP B-NP O
- : O O
However RB O O
, , O O
unfortunately RB O O
this DT O O
is VBZ O O
what WP O O
happens VBZ O O
repeatedly RB O O
on IN B-VP O
all DT B-NP O
admissions NNS I-NP O
- : O O
he PRP O O
signs NNS B-NP O
out RP O O
AMA NNP B-NP O
prior RB O O
to TO O O
MIBI NNP B-NP O
being VBG O O
obtained**** JJ B-NP O
* NNP I-NP O
Endo: NNP I-NP O
h/o NN I-NP O
NIDDM NNP I-NP O
on IN B-VP O
Metformin NNP B-NP B-m
at IN B-VP O
baseline NN B-NP O
A1C NNP I-NP O
and CC O O
fasting VBG O O
lipids NNS B-NP O
ordered VBD B-VP O
Held NNP B-NP O
metformin NN I-NP B-m
and CC O O
instituted JJ B-NP O
DM NNP I-NP O
protocol NN I-NP O
while IN B-VP B-du
in IN B-VP I-du
house NN B-NP I-du
* NN I-NP O
Renal/ NNP I-NP O
FEN: NNP I-NP O
Known NNP I-NP O
CRI NNP I-NP O
( ( O O
baseline JJ B-NP O
CRE NNP I-NP O
1.3-1.6 CD O O
) ) O O
gentle NN B-NP O
hydration NN I-NP O
in IN B-VP O
ED NNP B-NP O
for IN B-VP O
now RB O O
, , O O
careful JJ O O
given VBN O O
EF NNP B-NP O
20% CD O O
hypoMg NN B-NP O
and CC O O
hypoK NN B-NP O
on IN B-VP O
admit NN B-NP O
-received VBN O O
repletion NN B-NP O
monitor NN I-NP O
lytes/replete JJ B-NP O
prn NN I-NP O
2 CD O O
g NN B-NP O
Na/low NNP I-NP O
fat/chol NN I-NP O
carbo NN I-NP O
controlled VBD B-VP O
diet JJ B-NP O
Nutrition NNP I-NP O
consult NN I-NP O
ordered VBD B-VP O
given VBN O O
recent JJ B-NP O
decrease NN I-NP O
in IN B-VP O
appetite NN B-NP O
and CC O O
FTT NNP B-NP O
picture NN I-NP O
* NNP I-NP O
PPx: NNP I-NP O
statin NN I-NP B-m
, , O O
ASA NNP B-NP B-m
, , O O
lovenox NN B-NP B-m
SC NNP I-NP B-mo
, , O O
PPi NNP B-NP B-m
* NNP I-NP O
Misc: NNP I-NP O
SW NNP I-NP O
consulted VBD B-VP O
d/w JJ B-NP O
pt NN I-NP O
at IN B-VP O
length NN B-NP O
if IN B-VP O
he PRP O O
would MD O O
benefit VB O O
from IN B-VP O
services NNS B-NP O
at IN B-VP O
home NN B-NP O
when WRB O O
d/c' NN B-NP O
d SYM O O
- : O O
he PRP O O
will MD O O
think VB O O
it PRP O O
over RP O O
and CC O O
get VB O O
back RB O O
to TO O O
team NN B-NP O
* NNP I-NP O
FULL NNP I-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
UNFORTUNATELY NNP I-NP O
PATIENT NNP I-NP O
LEFT NNP I-NP O
AMA NNP I-NP O
DESPITE NNP I-NP O
LENGTHY NNP I-NP O
DISCUSSION NNP I-NP O
ABOUT NNP I-NP O
HIS NNP I-NP O
HEALTH NNP I-NP O
AND NNP I-NP O
RISK NNP I-NP O
FOR NNP I-NP O
MI/DEATH NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
MIBI NNP I-NP O
as IN B-VP O
outpatient NN B-NP O
if IN B-VP O
pt JJ B-NP O
compliant NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
DUBOW NNP I-NP O
, , O O
ALVARO NNP B-NP O
G NNP I-NP O
, , O O
P.A.-C NNP B-NP O
( ( O O
NM87 NNP B-NP O
) ) O O
7/10/07 CD O O
@ $ O O
09:46 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#158995 VBZ O O
694173251 CD O O
PEMH NNP B-NP O
39011682 CD O O
572341 CD O O
9/19/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/25/1992 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/19/1992 CD O O
DISCHARGE NNP B-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
) ) O O
DEGENERATIVE NNPS B-NP O
JOINT NNP I-NP O
DISEASE NNP I-NP O
, , O O
RIGHT NNP B-NP O
ANKLE NNP I-NP O
( ( O O
RIGHT NNP B-NP O
TIBIOTALAR NNP I-NP O
JOINT NNP I-NP O
) ) O O
SECONDARY NNP B-NP O
TO NNP I-NP O
TRAUMATIC NNP I-NP O
ARTHRITIS NNP I-NP O
2 CD O O
) ) O O
INSULIN NNP B-NP O
DEPENDENT NNP I-NP O
DIABETES NNP I-NP O
3 CD O O
) ) O O
HYPERTENSION NNP B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Tibiotalar NNP I-NP O
fusion NN I-NP O
with IN B-VP O
cross-cannulated JJ B-NP O
AO NNP I-NP O
screws NN I-NP O
times NNS I-NP O
three CD O O
and CC O O
local JJ B-NP O
bone NN I-NP O
graft NN I-NP O
performed VBD B-VP O
3/12/92 CD O O
by IN B-VP O
Dr NNP B-NP O
Tim NNP I-NP O
Fajen NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
44 CD O O
year NN B-NP O
old JJ B-NP O
Phys NNP I-NP O
Ed NNP I-NP O
teacher NN I-NP O
had VBD B-VP O
a DT B-NP O
long JJ I-NP O
history NN I-NP O
of IN B-VP O
ankle NN B-NP O
pain NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
fracture NN I-NP O
as IN B-VP O
a DT B-NP O
child NN I-NP O
which WDT O O
was VBD B-VP O
fixed VBN O O
with IN B-VP O
an DT B-NP O
open JJ I-NP O
reduction NN I-NP O
and CC O O
internal JJ B-NP O
fixation NN I-NP O
He PRP O O
sustained VBD B-VP O
a DT B-NP O
second JJ I-NP O
ankle NN I-NP O
fracture NN I-NP O
a DT B-NP O
number NN I-NP O
of IN B-VP O
years NNS B-NP O
later RB O O
when WRB O O
he PRP O O
fell VBD B-VP O
off RP O O
a DT B-NP O
ladder NN I-NP O
and CC O O
refractured VBD B-VP O
his PRP$ O O
ankle NN B-NP O
Currently RB O O
, , O O
he PRP O O
has VBZ O O
pain VBN O O
on IN B-VP O
all DT B-NP O
movements NNS I-NP O
of IN B-VP O
the DT B-NP O
ankle NN I-NP O
while IN B-VP O
walking VBG O O
and CC O O
performing VBG O O
any DT B-NP O
activity NN I-NP O
The DT B-NP O
pain NN I-NP O
is VBZ O O
primarily RB O O
in IN B-VP O
the DT B-NP O
ankle JJ I-NP O
joint NN I-NP O
but CC O O
also RB O O
in IN B-VP O
his PRP$ O O
mid JJ B-NP O
foot NN I-NP O
He PRP O O
has VBZ O O
been VBN O O
controlling VBG O O
his PRP$ O B-r
his PRP$ O B-r
pain NN B-NP I-r
pain NN I-NP I-r
with IN B-VP O
Darvocet NNP B-NP B-m
as RB O O
well RB O O
as IN B-VP O
intramuscular JJ B-NP B-mo
Tordal NNP I-NP B-m
15 CD O B-do
to TO O I-do
30 CD O I-do
mg NNS B-NP I-do
four CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
He PRP O O
denies VBZ O O
any DT B-NP O
other JJ I-NP O
joint JJ I-NP O
involvement NN I-NP O
and CC O O
he PRP O O
denies VBZ O O
any DT B-NP O
motor NN I-NP O
or CC O O
sensory JJ B-NP O
changes NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
Insulin NNP B-NP B-r
dependent JJ B-NP I-r
diabetes NNS I-NP I-r
currently RB O O
managed VBN O O
with IN B-VP O
32 CD O B-do
units NNS B-NP I-do
of IN B-VP O
NPH NNP B-NP B-m
Humulin NNP I-NP I-m
He PRP O O
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
hypertension NN B-NP O
He PRP O O
denies VBZ O O
bowel NN B-NP O
or CC O O
bladder NN B-NP O
dysfunction NN I-NP O
, , O O
he PRP O O
denies VBZ O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
dysrrhythmia NN B-NP O
, , O O
or CC O O
murmur NN B-NP O
, , O O
he PRP O O
denies VBZ O O
peptic JJ B-NP O
ulcer JJ I-NP O
disease NN I-NP O
, , O O
and CC O O
he PRP O O
denies VBZ O O
thyroid JJ B-NP O
gland NN I-NP O
abnormality NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
fracture NN B-NP O
times NNS I-NP O
two CD O O
of IN B-VP O
his PRP$ O O
right JJ B-NP O
ankle NN I-NP O
status NN I-NP O
post NN I-NP O
open JJ B-NP O
reduction NN I-NP O
and CC O O
internal JJ B-NP O
fixation NN I-NP O
first JJ B-NP O
time NN I-NP O
in IN B-VP O
1965 CD O O
and CC O O
second JJ B-NP O
time NN I-NP O
in IN B-VP O
1988 CD O O
, , O O
he PRP O O
had VBD B-VP O
herniorrhaphy NN B-NP O
in IN B-VP O
1978 CD O O
, , O O
he PRP O O
had VBD B-VP O
drainage NN B-NP O
of IN B-VP O
a DT B-NP O
right JJ I-NP O
thumb NN I-NP O
abscess NN I-NP O
in IN B-VP O
1988 CD O O
, , O O
and CC O O
he PRP O O
has VBZ O O
had VBN O O
septicemia VBN O O
treated VBN O O
at IN B-VP O
Vensperdon NNP B-NP O
Hospital NNP I-NP O
in IN B-VP O
February NNP B-NP O
and CC O O
July NNP B-NP O
of IN B-VP O
1991 CD O O
CURRENT NNP B-NP O
MEDICATIONS: NNP I-NP O
NPH NNP I-NP B-m
Insulin NNP I-NP I-m
32 CD O B-do
units NNS B-NP I-do
every DT B-NP B-f
morning NN I-NP I-f
, , O O
Procardia NNP B-NP B-m
XL NNP I-NP I-m
90 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
, , O O
Lotensin NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
potassium NN B-NP B-m
supplement NN I-NP I-m
, , O O
and CC O O
then RB O O
Ketorolac NNP B-NP B-m
15-30 JJ B-NP B-do
mg NNS I-NP I-do
intramuscularly RB O B-mo
q.i.d RB O B-f
, , O O
and CC O O
Darvocet NNP B-NP B-m
N-100 NNP I-NP I-m
one CD O B-do
to TO O O
four CD O O
tablets NNS B-NP O
q.d RB O B-f
ALLERGIES: NNP B-NP O
He PRP O O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
He PRP O O
denies VBZ O O
smoking VBG O O
history NN B-NP O
and CC O O
he PRP O O
denies VBZ O O
ethanol JJ O O
abuse IN B-VP O
REVIEW NNP B-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Negative NNP I-NP O
for IN B-VP O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
or CC O O
anginal JJ O O
like IN B-VP O
symptoms NNS B-NP O
He PRP O O
does VBZ O O
get VB O O
bilateral JJ B-NP O
leg NN I-NP O
edema NN I-NP O
He PRP O O
has VBZ O O
not RB O O
had VBN O O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
neuropathy JJ O O
, , O O
retinopathy JJ O O
, , O O
or CC O O
nephropathies NNS B-NP O
associated VBN O O
with IN B-VP O
his PRP$ O O
diabetes NNS B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Well-developed VBD B-VP O
44 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
who WP O O
appears VBZ O O
stated VBN O O
age NN B-NP O
HEENT: NNP I-NP O
Demonstrated NNP I-NP O
pupils VBZ O O
to TO O O
be VB O O
equal JJ O O
and CC O O
reactive JJ O O
, , O O
extraocular JJ B-NP O
muscles NNS I-NP O
intact JJ O O
, , O O
and CC O O
oropharynx NN B-NP O
was VBD B-VP O
clear JJ B-NP O
NECK: NNP I-NP O
Supple NNP I-NP O
with IN B-VP O
full JJ B-NP O
painless NN I-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
and CC O O
there EX O O
was VBD B-VP O
no DT B-NP O
goiter NN I-NP O
, , O O
adenopathy JJ O O
, , O O
or CC O O
jugular JJ B-NP O
venous JJ I-NP O
distention NN I-NP O
LUNGS: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
CARDIAC: NNP B-NP O
Demonstrated NNP I-NP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
without IN B-VP O
significant JJ B-NP O
murmur NN I-NP O
, , O O
rub NN B-NP O
, , O O
or CC O O
thrill VB O O
ABDOMEN: NNP B-NP O
Soft NNP I-NP O
, , O O
non-obese JJ O O
, , O O
and CC O O
non-tender NN B-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
hepatosplenomegaly NN B-NP O
ORTHOPEDIC: NNP I-NP O
Demonstrated VBD B-VP O
that IN B-VP O
he PRP O O
had VBD B-VP O
approximately RB O O
10 CD O O
degrees NNS B-NP O
of IN B-VP O
dorsiflexion NN B-NP O
, , O O
10 CD O O
degrees NNS B-NP O
of IN B-VP O
plantar NN B-NP O
flexion NN I-NP O
with IN B-VP O
very RB O O
limited JJ B-NP O
subtalar JJ I-NP O
motion NN I-NP O
, , O O
good JJ B-NP O
mid NN I-NP O
foot NN I-NP O
motion NN I-NP O
but CC O O
with IN B-VP O
some DT B-NP O
pain NN I-NP O
on IN B-VP O
motion NN B-NP O
of IN B-VP O
the DT B-NP O
mid JJ I-NP O
foot NN I-NP O
There EX O O
was VBD B-VP O
pain NN B-NP O
during IN B-VP O
movement NN B-NP O
of IN B-VP O
his PRP$ O O
tibiotalar JJ B-NP O
joint NN I-NP O
Specifically RB O O
, , O O
there EX O O
was VBD B-VP O
little JJ B-NP O
pain NN I-NP O
with IN B-VP O
motion NN B-NP O
of IN B-VP O
the DT B-NP O
subtalar JJ I-NP O
joint NN I-NP O
or CC O O
the DT B-NP O
mid JJ I-NP O
foot NN I-NP O
He PRP O O
had VBD B-VP O
good JJ B-NP O
dorsalis NN I-NP O
pedis NN I-NP O
and CC O O
posterior JJ B-NP O
tibialis NN I-NP O
pulses NNS I-NP O
, , O O
he PRP O O
had VBD B-VP O
normal JJ B-NP O
sensation NN I-NP O
at IN B-VP O
the DT B-NP O
first JJ I-NP O
dorsal NN I-NP O
web NN I-NP O
space NN I-NP O
, , O O
dorsum NN B-NP O
, , O O
and CC O O
plantar NN B-NP O
aspects NNS I-NP O
of IN B-VP O
the DT B-NP O
foot NN I-NP O
, , O O
and CC O O
the DT B-NP O
hindfoot NN I-NP O
appeared VBD B-VP O
to TO O O
be VB O O
in IN B-VP O
neutral JJ B-NP O
position NN I-NP O
There EX O O
did VBD B-VP O
not RB O O
appear VB O O
to TO O O
be VB O O
any DT B-NP O
supination NN I-NP O
or CC O O
pronation NN B-NP O
deformities NNS I-NP O
He PRP O O
had VBD B-VP O
full JJ B-NP O
painless NN I-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
at IN B-VP O
the DT B-NP O
hip NN I-NP O
and CC O O
at IN B-VP O
the DT B-NP O
knee NN I-NP O
on IN B-VP O
the DT B-NP O
ipsilateral JJ I-NP O
side NN I-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
X-Rays NNP I-NP O
demonstrated VBD B-VP O
marked JJ B-NP O
degenerative JJ I-NP O
joint JJ I-NP O
disease NN I-NP O
with IN B-VP O
a DT B-NP O
complete JJ I-NP O
obliteration NN I-NP O
of IN B-VP O
the DT B-NP O
articular JJ I-NP O
joint JJ I-NP O
space NN I-NP O
in IN B-VP O
the DT B-NP O
lateral JJ I-NP O
half NN I-NP O
of IN B-VP O
the DT O O
joint JJ O O
There EX O O
were VBD B-VP O
also RB O O
some DT B-NP O
degenerative JJ I-NP O
changes NNS I-NP O
in IN B-VP O
the DT B-NP O
mid JJ I-NP O
foot NN I-NP O
His PRP$ O O
pre-operative JJ B-NP O
laboratory NN I-NP O
evaluation NN I-NP O
demonstrated VBD B-VP O
EKG NNP B-NP O
with IN B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm NN I-NP O
and CC O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemic JJ B-NP O
changes NNS I-NP O
, , O O
glucose NN B-NP O
was VBD B-VP O
133 CD O O
, , O O
BUN NNP B-NP O
was VBD B-VP O
35 CD O O
, , O O
creatinine NN B-NP O
1.2 CD O O
, , O O
potassium NN B-NP O
of IN B-VP O
4.2 CD O O
, , O O
liver JJR B-NP O
function NN I-NP O
tests NNS I-NP O
were VBD B-VP O
entirely RB O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
hematocrit NN B-NP O
was VBD B-VP O
42.8 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
was VBD B-VP O
9 CD O O
, , O O
and CC O O
the DT B-NP O
PT NNP I-NP O
and CC O O
PTT NNP B-NP O
were VBD B-VP O
11.6 CD O O
and CC O O
28.2 CD O O
respectively RB O O
The DT B-NP O
patient's NN I-NP O
urinalysis NN I-NP O
was VBD B-VP O
entirely RB O O
clear JJ O O
for IN B-VP O
bacteria NNS B-NP O
and CC O O
negative JJ O O
for IN B-VP O
glucose NN B-NP O
and CC O O
ketones NNS B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
as IN B-VP O
a DT B-NP O
same JJ I-NP O
day NN I-NP O
surgery NN I-NP O
candidate NN I-NP O
with IN B-VP O
traumatic JJ B-NP O
arthritis NN I-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
tibiotalar NN I-NP O
joint NN I-NP O
and CC O O
he PRP O O
underwent VBD B-VP O
tibiotalar JJ B-NP O
fusion NN I-NP O
with IN B-VP O
cross-cannulated JJ B-NP O
AO NNP I-NP O
screws NNS I-NP O
and CC O O
local JJ B-NP O
bone NN I-NP O
graft NN I-NP O
The DT B-NP O
procedure NN I-NP O
involved VBN O O
partial JJ B-NP O
fibulectomy NN I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
partial JJ I-NP O
osteotomy NN I-NP O
of IN B-VP O
the DT B-NP O
medial JJ I-NP O
malleolus NN I-NP O
The DT B-NP O
position NN I-NP O
of IN B-VP O
the DT B-NP O
ankle NN I-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
procedure NN I-NP O
was VBD B-VP O
neutral JJ B-NP O
dorsiflexion NN I-NP O
, , O O
plantar NN B-NP O
flexion NN I-NP O
, , O O
and CC O O
neutral JJ B-NP O
varus/valgus NN I-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
general JJ I-NP O
endotracheal NN I-NP O
anesthetic JJ O O
for IN B-VP O
failed JJ B-NP O
sciatic JJ I-NP O
nerve NN I-NP O
block NN I-NP O
, , O O
estimated VBN O O
blood NN B-NP O
loss NN I-NP O
was VBD B-VP O
200 CD O O
cc NN B-NP O
, , O O
and CC O O
total JJ B-NP O
tourniquet NN I-NP O
time NN I-NP O
was VBD B-VP O
1 CD O O
hour NN B-NP O
and CC O O
57 CD O O
minutes NNS B-NP O
He PRP O O
received VBD B-VP O
2500 CD O B-do
cc NN B-NP I-do
of IN B-VP O
crystalloid NN B-NP B-m
intraoperatively RB O O
and CC O O
he PRP O O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
Post-operatively RB O O
, , O O
his PRP$ O O
motor NN B-NP O
and CC O O
sensory JJ B-NP O
examinations NNS I-NP O
were VBD B-VP O
intact JJ O O
with IN B-VP O
regard NN B-NP O
to TO O O
deep VB O O
and CC O O
superficial JJ B-NP O
peroneal NN I-NP O
and CC O O
posterior JJ B-NP O
tibialis NN I-NP O
nerves NNS I-NP O
His PRP$ O O
Hemovac NNP B-NP O
put VBD B-VP O
out RP O O
a DT B-NP O
total NN I-NP O
of IN B-VP O
150 CD O O
cc NN B-NP O
and CC O O
was VBD B-VP O
removed VBN O O
on IN B-VP O
post-operative JJ B-NP O
day NN I-NP O
number NN I-NP O
one CD O O
He PRP O O
initially RB O O
was VBD B-VP O
kept VBN O O
in IN B-VP O
a DT B-NP O
posterior JJ I-NP O
splint NN I-NP O
with IN B-VP O
anterior JJ B-NP O
wings NNS I-NP O
This DT O O
was VBD B-VP O
changed VBN O O
on IN B-VP O
post-operative JJ B-NP O
day NN I-NP O
two CD O O
The DT B-NP O
wound NN I-NP O
appeared VBD B-VP O
to TO O O
be VB O O
clean JJ O O
and CC O O
dry JJ O O
and CC O O
he PRP O O
was VBD B-VP O
placed VBN O O
in IN B-VP O
a DT B-NP O
short-leg JJ I-NP O
fiberglass NN I-NP O
cast NN I-NP O
since IN B-VP O
there EX O O
was VBD B-VP O
little JJ B-NP O
swelling JJ I-NP O
apparent NN I-NP O
He PRP O O
had VBD B-VP O
an DT O O
X-Ray JJ O O
after IN B-VP O
placement NN B-NP O
of IN B-VP O
the DT B-NP O
cast NN I-NP O
and CC O O
the DT B-NP O
position NN I-NP O
of IN B-VP O
the DT B-NP O
ankle NN I-NP O
looked VBD B-VP O
to TO O O
be VB O O
in IN B-VP O
neutral JJ B-NP O
position NN I-NP O
and CC O O
neutral JJ B-NP O
varus/valgus NN I-NP O
He PRP O O
was VBD B-VP O
cleared VBN O O
by IN B-VP O
Physical NNP B-NP O
Therapy NNP I-NP O
ambulatory NN I-NP O
, , O O
non-weight JJ B-NP O
bearing NN I-NP O
, , O O
with IN B-VP O
use NN B-NP O
of IN B-VP O
crutches NNS B-NP O
He PRP O O
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP O
difficulties NNS I-NP O
with IN B-VP O
the DT B-NP O
cast NN I-NP O
, , O O
no DT B-NP O
significant JJ I-NP O
swelling NN I-NP O
, , O O
and CC O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
post-operative JJ B-NP O
day NN I-NP O
three CD O O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
have VB O O
some DT O O
elevated VBN O O
temperatures NNS B-NP O
which WDT O O
were VBD B-VP O
attributed VBN O O
to TO O O
atelectasis NN B-NP O
and CC O O
was VBD B-VP O
encouraged VBN O O
to TO O O
cough VB O O
and CC O O
deep JJ B-NP O
breath NN I-NP O
DISPOSITION: NNP I-NP O
Patient NNP I-NP O
will MD O O
follow-up VB O O
with IN B-VP O
Dr NNP B-NP O
Norman NNP I-NP O
Dutko NNP I-NP O
in IN B-VP O
approximately RB O O
three CD O O
weeks NNS B-NP O
at IN B-VP O
which WDT O O
time NN B-NP O
the DT B-NP O
cast NN I-NP O
will MD O O
be VB O O
changed VBN O O
and CC O O
stitches NNS B-NP O
removed VBD B-VP O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
The DT B-NP O
medications NNS I-NP O
that IN B-VP O
he PRP O O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
with IN B-VP O
the DT B-NP O
addition NN I-NP O
of IN B-VP O
Vicodan NNP B-NP B-m
one CD O B-do
to TO O I-do
two CD O I-do
p.o NNS B-NP B-mo
q.3-4h JJ B-NP B-f
p.r.n NN I-NP I-f
, , O O
Naprosyn NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
as IN B-VP O
a DT B-NP O
substitute NN I-NP O
for IN B-VP O
the DT B-NP O
Tordal NNP I-NP B-m
, , O O
and CC O O
Halcion NNP B-NP B-m
0.125 CD O B-do
to TO O I-do
0.25 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.h.s JJ I-NP B-f
p.r.n NN I-NP O
AS273/4278 NNP I-NP O
ISSAC NNP I-NP O
B NNP I-NP O
CHEAIRS NNP I-NP O
, , O O
M.D NNP B-NP O
VB69 NNP I-NP O
D: NNP I-NP O
0/14/92 CD O O
Batch: NNP B-NP O
2482 CD O O
Report: NNP B-NP O
O7557E8 NNP I-NP O
T: NNP I-NP O
6/2/92 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#159637 VBZ O O
331676950 CD O O
GMC NNP B-NP O
88209373 CD O O
4083911 CD O O
4/28/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
non-ischemic JJ B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/22/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/4/2003 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
DISERENS NNP I-NP O
, , O O
JR NNP B-NP O
, , O O
GAYLE NNP B-NP O
034-41-95-4 CD O O
S NNP B-NP O
Mode NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
4/28/03 CD O O
AT NNP B-NP O
03:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SCHMELZER NNP I-NP O
, , O O
ALLAN NNP B-NP O
RODOLFO NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
0/12 CD O O
) ) O O
FOLIC NNP B-NP B-m
ACID NNP I-NP I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATIVAN NNP I-NP B-m
( ( O I-m
LORAZEPAM NNP B-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O O
3 CD O O
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
DARVOCET NNP I-NP B-m
N NNP I-NP I-m
100 CD O I-m
( ( O I-m
PROPOXYPHENE NNP B-NP I-m
NAP./ACETAMINOPHEN NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
NORVASC NNP B-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
TOPROL NNP B-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
3 CD O I-du
ALTACE NNP B-NP B-m
( ( O I-m
RAMIPRIL NNP B-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/28/03 CD O O
by IN B-VP O
RAMSDEN NNP B-NP O
, , O O
SAL NNP B-NP O
I PRP O O
MICHEAL NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IV NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
68076838 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
RAMIPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/28/03 CD O O
by IN B-VP O
SCHWINGEL NNP B-NP O
, , O O
WALLY NNP B-NP O
PRINCE NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IMMED NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
59620667 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
RAMIPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
awaer VBP O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/18/03 CD O O
by IN B-VP O
GOUGIS NNP B-NP O
, , O O
BLAKE NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
RAMIPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
RAMIPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ O O
and CC O O
monitoring NN B-NP O
CLOPIDOGREL NNP I-NP B-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
VIOXX NNP I-NP B-m
( ( O I-m
ROFECOXIB NNP B-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
PROTONIX NNP I-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Damon NNP I-NP O
Krzeczkowski NNP I-NP O
, , O O
229-213-3224 JJ O O
, , O O
in IN B-VP O
about RB O O
1 CD O O
week NN B-NP O
1 CD O O
week NN B-NP O
, , O O
Dr NNP B-NP O
Lon NNP I-NP O
Willims NNP I-NP O
, , O O
792-273-6290 JJ O O
, , O O
in IN B-VP O
about RB O O
4 CD O O
weeks NNS B-NP O
4 CD O O
weeks NNS B-NP O
, , O O
ALLERGY: NNP B-NP O
Atarax NNP I-NP O
( ( O O
hydroxyzine JJ B-NP O
hcl NN I-NP O
) ) O O
, , O O
Sulfa NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
non-ischemic JJ B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
, , O O
CAD NNP B-NP O
, , O O
high JJ B-NP O
cholesterol NN I-NP O
, , O O
OSA NNP B-NP O
, , O O
OA NNP B-NP O
, , O O
depression NN B-NP O
, , O O
anxiety NN B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
exercise NN B-NP O
tolerance NN I-NP O
test NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
45 CD O O
yo NN B-NP O
M NNP I-NP O
with IN B-VP O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
, , O O
including VBG O O
known VBN O O
CAD NNP B-NP O
s/p NN I-NP O
MI NNP I-NP O
( ( O O
4/14 CD O O
with IN B-VP O
PCI NNP B-NP O
to TO O O
LAD NNP B-NP O
, , O O
complicated VBN O O
by IN B-VP O
instent JJ B-NP O
thrombosis NN I-NP O
1 CD O O
week NN B-NP O
post-cath-&gt;successfully RB O O
restented VBN O O
) ) O O
, , O O
HTN NNP B-NP O
, , O O
dyslipidemia NN B-NP O
, , O O
obesity NN B-NP O
, , O O
and CC O O
positive JJ B-NP O
FHx NNP I-NP O
presents NNS I-NP O
with IN B-VP O
acute JJ B-NP O
onset NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
several JJ B-NP O
episodes/admissions NNS I-NP O
for IN B-VP O
recurrent NN B-NP O
c/p NN I-NP O
since IN B-VP O
then RB O O
with IN B-VP O
caths NNS B-NP O
consistently RB O O
demonstrating VBG O O
non-significant JJ B-NP O
disease NN I-NP O
Last JJ B-NP O
cath NN I-NP O
in IN B-VP O
8/24 CD O O
showed VBD B-VP O
R NNP B-NP O
dominant JJ B-NP O
system NN I-NP O
with IN B-VP O
30% CD O O
proximal JJ B-NP O
LAD NNP I-NP O
lesion NN I-NP O
ETT-MIBI NNP I-NP O
in IN B-VP O
5/12 CD O O
( ( O O
9:30 CD O O
, , O O
5.2 CD O O
METS NNP B-NP O
, , O O
HR NNP B-NP O
153 CD O O
, , O O
BP NNP B-NP O
130/80 CD O O
, , O O
was VBD B-VP O
non-ischemic JJ O O
but CC O O
terminated VBD B-VP O
2/2 CD O O
fatigue NN B-NP O
) ) O O
showed VBD B-VP O
large JJ B-NP O
fixed JJ I-NP O
defect NN I-NP O
in IN B-VP O
anterior JJ O O
, , O O
anteroseptal JJ O O
, , O O
anterolateral JJ O O
, , O O
inferior JJ O O
, , O O
LV NNP B-NP O
apex VBZ O O
with IN B-VP O
EF NNP B-NP O
of IN B-VP O
35% CD O O
Seen JJ O O
11/1 CD O O
at IN B-VP O
GH NNP B-NP O
for IN B-VP O
syncope NN B-NP O
, , O O
dx NN B-NP O
with IN B-VP O
VT NNP B-NP O
and CC O O
had VBD B-VP O
AICD NNP B-NP O
placed VBN O O
On IN B-VP O
this DT B-NP O
occasion NN I-NP O
he PRP O O
noted VBD B-VP O
sudden JJ B-NP O
onset NN I-NP O
of IN B-VP O
8/10 CD O O
chest JJS B-NP O
pain NN I-NP O
while IN B-VP O
at IN B-VP O
rest NN B-NP O
at IN B-VP O
6:30 CD O O
pm NN B-NP O
on IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
admission NN B-NP O
The DT B-NP O
pain NN I-NP O
was VBD B-VP O
sharp/stabbing VBG O O
and CC O O
was VBD B-VP O
bilateral JJ O O
with IN B-VP O
radiation NN B-NP O
to TO O O
the DT B-NP O
L NNP I-NP O
arm NN I-NP O
He PRP O O
also RB O O
had VBD B-VP O
diaphoresis NN B-NP O
, , O O
SOB NNP B-NP O
, , O O
and CC O O
nausea NN B-NP O
but CC O O
denies VBZ O O
vomitting VBG O O
, , O O
F/C NNP B-NP O
, , O O
LH NNP B-NP O
, , O O
dizziness NN B-NP O
He PRP O O
took VBD B-VP O
1 CD O B-do
TNG NNP B-NP B-m
SL NNP I-NP B-mo
with IN B-VP O
some DT B-NP O
relief NN I-NP O
EMS NNP I-NP O
transported VBD B-VP O
to TO O O
Greena NNP B-NP O
Hospital NNP I-NP O
where WRB O O
his PRP$ O O
vitals NNS B-NP O
were VBD B-VP O
98.2 CD O O
, , O O
73 CD O O
, , O O
92/62 CD O O
, , O O
15 CD O O
Rec'd NNP B-NP O
IV NNP I-NP B-mo
TNG NNP I-NP B-m
, , O O
heparin NN B-NP B-m
, , O O
MSO4 NNP B-NP B-m
, , O O
ASA NNP B-NP B-m
with IN B-VP O
pain VBP O O
down IN B-VP O
to TO O O
4/10 CD O O
Transfered NNP B-NP O
to TO O O
ITH NNP B-NP O
A: NNP I-NP O
45 CD O O
yo NN B-NP O
M NNP I-NP O
with IN B-VP O
known VBN O O
CAD NNP B-NP O
s/p NN I-NP O
MI NNP I-NP O
in IN B-VP O
4/14 CD O O
, , O O
s/p FW O O
recent JJ B-NP O
ICD NNP I-NP O
placement NN I-NP O
for IN B-VP O
syncope/VT NN B-NP O
at IN B-VP O
BMC NNP B-NP O
, , O O
now RB O O
with IN B-VP O
his PRP$ O O
angina NN B-NP O
at IN B-VP O
rest NN B-NP O
Given VBN O O
non-oclusive JJ B-NP O
CAD NNP I-NP O
on IN B-VP O
multiple JJ B-NP O
recent JJ I-NP O
caths NNS I-NP O
( ( O O
including VBG O O
2 CD O O
mos NN B-NP O
ago RB O O
at IN B-VP O
EHC NNP B-NP O
per IN B-VP O
patient NN B-NP O
) ) O O
, , O O
likelihood NN B-NP O
of IN B-VP O
ischemia NN B-NP O
now RB O O
is VBZ O O
low JJ B-NP O
P: NNP I-NP O
CV: NNP I-NP O
Ischemia-r/o NNP I-NP O
MI NNP I-NP O
, , O O
asa NN B-NP B-m
, , O O
toprol NN B-NP B-m
, , O O
heparin NN B-NP B-m
, , O O
plavix NN B-NP B-m
, , O O
zocor NN B-NP B-m
Ruled VBD B-VP O
out RP O O
by IN B-VP O
ensymes NNS B-NP O
, , O O
ETT NNP B-NP O
was VBD B-VP O
non-ischemic JJ B-NP O
Pump-euvolemic NNP I-NP O
, , O O
no DT B-NP O
h/o NN I-NP O
CHF NNP I-NP O
Rhythm-has NNP I-NP O
AICD NNP I-NP O
, , O O
on IN B-VP O
tele NN B-NP O
, , O O
replete JJ B-NP O
lytes NNS I-NP O
GI: NNP I-NP O
has VBZ O O
lost VBN O O
40 CD O O
lbs NN B-NP O
on IN B-VP O
liquid NN B-NP O
diet NN I-NP O
, , O O
consider VB O O
nutrition NN B-NP O
consult NN I-NP O
as IN B-VP O
outpatient JJ B-NP O
CODE: NNP I-NP O
FULL NNP I-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
be VB O O
sure JJ O O
to TO O O
contact VB O O
Dr NNP B-NP O
Klussmann NNP I-NP O
( ( O O
229-213-3224 JJ O O
) ) O O
to TO O O
set VB O O
up RP O O
an DT B-NP O
appointment NN I-NP O
to TO O O
be VB O O
seen VBN O O
in IN B-VP O
about RB O O
1 CD O O
week NN B-NP O
Also RB O O
, , O O
be VB O O
sure JJ O O
to TO O O
set VB O O
up RP O O
an DT B-NP O
appointment NN I-NP O
to TO O O
see VB O O
Dr NNP B-NP O
Helfgott NNP I-NP O
( ( O O
792-273-6290 JJ O O
) ) O O
in IN B-VP O
about RB O O
4 CD O O
weeks NNS B-NP O
You PRP O O
should MD O O
contact VB O O
your PRP$ O O
doctor NN B-NP O
or CC O O
return NN B-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
if IN B-VP O
you PRP O O
experience VBP O O
any DT O O
of IN B-VP O
the DT B-NP O
following JJ I-NP O
symptoms: NN I-NP O
chest JJS B-NP O
pain NN I-NP O
, , O O
chest NN B-NP O
pressure NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
dizziness NN B-NP O
, , O O
lightheadedness NN B-NP O
, , O O
nausea NN B-NP O
, , O O
vomitting NN B-NP O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
concerning NN I-NP O
symptoms NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Consider NNP B-NP O
increasing VBG O O
CCB NNP B-NP B-m
as IN B-VP O
patient NN B-NP O
seems VBZ O O
to TO O O
feel VB O O
it PRP O O
helps VBZ O O
his PRP$ O O
symptoms JJ O O
2 CD O O
Consider NNP B-NP O
adjusting VBG O O
HTN NNP B-NP B-m
meds NNS I-NP I-m
as IN B-VP O
patient NN B-NP O
was VBD B-VP O
relatively RB O O
hypotensive JJ O B-r
( ( O O
SBP NNP B-NP O
90-110 CD O O
) ) O O
in IN B-VP O
hospital NN B-NP O
( ( O O
althought JJ B-NP O
asymptomatic NN I-NP O
) ) O O
3 CD O O
Consider NNP B-NP O
outpatient JJ B-NP O
cardiac NN I-NP O
rehabillitation NN I-NP O
4 CD O O
Consider NNP B-NP O
nutrition NN I-NP O
consult NN I-NP O
as IN B-VP O
outpatient NN B-NP O
to TO O O
ensure VB O O
adequate JJ B-NP O
nutrition NN I-NP O
status NN I-NP O
on IN B-VP O
"liquid NNP B-NP O
diet" NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BOATMAN NNP I-NP O
, , O O
JOAN NNP B-NP O
LOWELL NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
NZ69 NNP B-NP O
) ) O O
4/28/03 CD O O
@ $ O O
02:37 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#163611 VBZ O O
235043506 CD O O
HSPHAC NNP B-NP O
37252645 CD O O
4811259 CD O O
5/15/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/22/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
ATTENDING: NNP I-NP O
TELLES NNP I-NP O
, , O O
MARCELO NNP B-NP O
M.D NNP I-NP O
ADMITTING NNP I-NP O
INTERN: NNP I-NP O
Darrin NNP I-NP O
Strzyzewski NNP I-NP O
, , O O
M.D NNP B-NP O
ADMITTING NNP I-NP O
RESIDENT: NNP I-NP O
Rigoberto NNP I-NP O
Shuford NNP I-NP O
, , O O
M.D NNP B-NP O
ESTIMATED NNP I-NP O
DATE NNP I-NP O
OF NNP I-NP O
DISCHARGE: NNP I-NP O
0/24/07 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
Congestive NNP I-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
amyloid NN B-NP O
, , O O
and CC O O
pneumonia NN B-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
Include NNP I-NP O
hypertension NN I-NP O
, , O O
diabetes VBZ O O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
left VBD B-VP O
BKA NNP B-NP O
, , O O
status NN B-NP O
post NN I-NP O
pacemaker NN I-NP O
for IN B-VP O
sick JJ B-NP O
sinus NN I-NP O
syndrome NN I-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
pseudogout NN B-NP O
, , O O
spinal JJ B-NP O
stenosis NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
an DT B-NP O
88-year-old JJ I-NP O
Tere NNP I-NP O
All NNP I-NP O
War NNP I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
CHF NNP B-NP O
with IN B-VP O
an DT O O
estimated VBN O O
EF NNP B-NP O
of IN B-VP O
45-50% JJ O O
and CC O O
diastolic JJ B-NP O
dysfunction NN I-NP O
as RB O O
well RB O O
, , O O
also RB O O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
a DT B-NP O
CVA NNP I-NP O
, , O O
history NN B-NP O
of IN B-VP O
hypercholesterolemia NN B-NP O
, , O O
who WP O O
was VBD B-VP O
recently RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Tiesville NNP I-NP O
Caing NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
a DT B-NP B-r
CHF NNP I-NP I-r
exacerbation NN I-NP I-r
During IN B-VP O
the DT B-NP O
recent JJ I-NP O
admission NN I-NP O
, , O O
his PRP$ O O
home NN B-NP O
Lasix NNP I-NP B-m
was VBD B-VP O
increased VBN O O
from IN B-VP O
20 CD O O
mg NNS B-NP O
p.o JJ O O
daily JJ O O
to TO O O
80 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
b.i.d NN I-NP B-f
During IN B-VP O
the DT B-NP O
past JJ I-NP O
admission NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
lower JJR I-NP O
extremity NN I-NP O
ultrasounds NNS I-NP O
for IN B-VP O
right JJ B-NP O
leg NN I-NP O
edema NN I-NP O
and CC O O
chronic JJ B-NP O
swelling NN I-NP O
and CC O O
during IN B-VP O
the DT B-NP O
last JJ I-NP O
admission NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
Lasix NNP B-NP B-m
and CC O O
discharged VBD B-VP O
home NN B-NP O
on IN B-VP O
5/23/07 CD O O
During IN B-VP O
the DT O O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
experienced VBD B-VP O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
orthopnea NN B-NP O
, , O O
and CC O O
PND NNP B-NP O
The DT B-NP O
VNA NNP I-NP O
who WP O O
visited VBD B-VP O
the DT B-NP O
patient NN I-NP O
noted VBD B-VP O
a DT B-NP O
fever NN I-NP O
of IN B-VP O
101 CD O O
Fahrenheit NNP B-NP O
and CC O O
so RB O O
the DT B-NP O
patient NN I-NP O
went VBD B-VP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile JJ O O
, , O O
had VBD B-VP O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
80 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
130/80s CD O O
, , O O
respirations NNS B-NP O
16 CD O O
satting VBG O O
95% CD O O
on IN B-VP O
2-4 JJ B-NP O
liters NNS I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
no DT B-NP O
oxygen NN I-NP O
requirement NN I-NP O
at IN B-VP O
home NN B-NP O
at IN B-VP O
baseline NN B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
crackles NNS B-NP O
on IN B-VP O
exam IN B-VP O
The DT O O
chest JJS O O
x-ray JJ O O
showed VBD B-VP O
improved JJ B-NP O
effusions NNS I-NP O
from IN B-VP O
prior JJ O O
but CC O O
did VBD B-VP O
not RB O O
rule VB O O
out RP O O
pneumonia IN B-VP O
His PRP$ O O
right JJ B-NP O
leg NN I-NP O
was VBD B-VP O
still RB O O
swollen VBN O O
but CC O O
unchanged JJ O O
from IN B-VP O
prior JJ O O
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
given VBN O O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
and CC O O
750 CD O B-do
mg NN B-NP I-do
of IN B-VP O
levofloxacin NN B-NP B-m
x1 VBP O B-du
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiology NNP I-NP O
Service NNP I-NP O
for IN B-VP O
volume NN B-NP O
overload NN I-NP O
and CC O O
the DT B-NP O
question NN I-NP O
of IN B-VP O
pneumonia NN B-NP O
HOME NNP I-NP O
MEDICATIONS: NNP I-NP O
Tylenol NNP I-NP B-m
p.r.n NN I-NP B-f
, , O O
aspirin RB O B-m
81 CD O B-do
mg NNS B-NP I-do
every DT O O
daily RB O B-f
, , O O
diltiazem NN B-NP B-m
extended VBD B-VP O
release NN B-NP O
120 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
twice RB O B-f
daily RB O I-f
, , O O
iron NN B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP O
three CD O B-f
times NNS B-NP I-f
daily RB O I-f
, , O O
folic JJ O B-m
acid VBP O I-m
1 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
daily RB O I-f
, , O O
gabapentin VBD B-VP B-m
100 CD O B-do
mg JJ O I-do
twice RB O B-f
daily RB O I-f
, , O O
NPH NNP B-NP B-m
insulin VBZ O I-m
20 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
daily RB O B-f
, , O O
regular JJ B-NP B-m
insulin NN I-NP I-m
sliding VBG O B-do
scale NN B-NP I-do
, , O O
Xalatan NNP B-NP B-m
eye NN I-NP O
drops VBZ O O
one CD O B-do
drop NN B-NP I-do
each DT B-NP B-mo
eye NN I-NP I-mo
q.p.m NN I-NP B-f
, , O O
metoprolol FW O B-m
12.5 CD O B-do
mg NN B-NP I-do
twice RB O B-f
daily RB O I-f
, , O O
senna JJ B-NP B-m
tablets NNS I-NP I-m
twice RB O B-f
daily RB O I-f
, , O O
simvastatin VBD B-VP B-m
40 CD O B-do
mg NN B-NP I-do
once RB O B-f
daily JJ B-NP I-f
ALLERGIES: NNP I-NP O
IV NNP I-NP O
contrast NN I-NP O
and CC O O
latex JJ B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
retired JJ I-NP O
cook NN I-NP O
He PRP O O
is VBZ O O
originally RB O O
from IN B-VP O
E NNP B-NP O
Vi NNP I-NP O
He PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
past JJ B-NP O
tobacco NN I-NP O
use NN I-NP O
, , O O
quit VBP O O
30 CD O O
years NNS B-NP O
ago RB O O
and CC O O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
drank NN I-NP O
alcohol NN I-NP O
rarely RB O O
He PRP O O
is VBZ O O
wheelchair-bound JJ O O
at IN B-VP O
baseline NN B-NP O
He PRP O O
lives VBZ O O
alone RB O O
VNA NNP B-NP O
visits VBZ O O
him PRP O O
He PRP O O
has VBZ O O
three CD O O
daughters NNS B-NP O
in IN B-VP O
Vale NNP B-NP O
, , O O
Georgia NNP B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
notes NNS I-NP O
there RB O O
has VBZ O O
been VBN O O
no DT B-NP O
one NN I-NP O
in IN B-VP O
his PRP$ O O
immediate JJ B-NP O
family NN I-NP O
who WP O O
had VBD B-VP O
an DT B-NP O
MI NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
VITAL NNP I-NP O
SIGNS: NNP I-NP O
Temperature NNP I-NP O
of IN B-VP O
100.0 CD O O
Fahrenheit NNP B-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
71 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
116/64 CD O O
satting VBG O O
100% CD O O
on IN B-VP O
2 CD O O
liters NNS B-NP O
His PRP$ O O
nasal JJ B-NP O
cannula NN I-NP O
oxygen NN I-NP O
respirations NNS I-NP O
16 CD O O
GENERAL: NNP B-NP O
In IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
, , O O
lying VBG O O
bed NN B-NP O
, , O O
speaking NN B-NP O
in IN B-VP O
full JJ B-NP O
sentences NNS I-NP O
HEENT: NNP I-NP O
OP NNP I-NP O
clear JJ O O
without IN B-VP O
erythema VBG O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
dentures NNS B-NP O
Pupils NNP I-NP O
were VBD B-VP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ B-NP O
Extraocular NNP I-NP O
muscle NN I-NP O
was VBD B-VP O
intact JJ B-NP O
NECK: NNP I-NP O
No NNP I-NP O
lymphadenopathy JJ B-NP O
No NNP I-NP O
carotid NN I-NP O
bruits NNS I-NP O
Neck NNP I-NP O
was VBD B-VP O
supple JJ B-NP O
JVP NNP I-NP O
listed VBN O O
in IN B-VP O
chart NN B-NP O
as IN B-VP O
12 CD O O
cm NN B-NP O
CARDIOVASCULAR: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
II/VI NNP B-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left NN I-NP O
lower RBR O O
sternal JJ B-NP O
border NN I-NP O
RESPIRATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
crackles NNS B-NP O
half NN I-NP O
way NN I-NP O
up IN B-VP O
each DT B-NP O
lung NN I-NP O
bilaterally RB O O
There EX O O
was VBD B-VP O
no DT B-NP O
egophony NN I-NP O
, , O O
there EX O O
was VBD B-VP O
no DT B-NP O
dullness NN I-NP O
to TO O O
percussion NN B-NP O
ABDOMEN: NNP I-NP O
Positive NNP I-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
soft JJ O O
and CC O O
nontender NN B-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
mild JJ I-NP O
distention NN I-NP O
and CC O O
no DT B-NP O
masses NNS I-NP O
EXTREMITIES: VBP O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT O O
left VBN O O
BKA NNP B-NP O
The DT B-NP O
right NN I-NP O
leg NN I-NP O
showed VBD B-VP O
2+ CD O O
pitting VBG O O
edema NN B-NP O
halfway NN I-NP O
up IN B-VP O
his PRP$ O O
anterior NN B-NP O
shin VB O O
His PRP$ O O
left JJ B-NP O
leg NN I-NP O
had VBD B-VP O
no DT B-NP O
ulceration NN I-NP O
or CC O O
lacerations NNS B-NP O
and CC O O
no DT B-NP O
tenderness NN I-NP O
NEURO: NNP I-NP O
Alert NNP I-NP O
and CC O O
oriented VBN O O
x3 NNP B-NP O
Cranial NNP I-NP O
nerves NNS I-NP O
II NNP I-NP O
through IN B-VP O
XII NNP B-NP O
intact JJ B-NP O
Generally NNP I-NP O
, , O O
nonfocal JJ B-NP O
exam NN I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
minimal JJ I-NP O
chest NN I-NP O
pain NN I-NP O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
couple NN I-NP O
of IN B-VP O
days NNS B-NP O
only RB O O
with IN B-VP O
cough NN B-NP O
, , O O
otherwise RB O O
no DT B-NP O
chest NN I-NP O
pain VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
chest JJ O O
pain-free JJ O O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
and CC O O
there EX O O
was VBD B-VP O
no DT B-NP O
nausea NN I-NP O
, , O O
vomiting VBG O O
, , O O
diaphoresis NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
no DT B-NP O
rash NN I-NP O
, , O O
no DT B-NP O
diarrhea NN I-NP O
, , O O
positive JJ B-NP O
constipation NN I-NP O
, , O O
increased VBD B-VP O
leg NN B-NP O
swelling VBG O O
since IN B-VP O
the DT B-NP O
last JJ I-NP O
admission NN I-NP O
, , O O
no DT B-NP O
hematuria NN I-NP O
, , O O
no DT B-NP O
dysuria NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
productive JJ I-NP O
cough NN I-NP O
of IN B-VP O
clear JJ B-NP O
phlegm NN I-NP O
and CC O O
no DT B-NP O
hemoptysis NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
good JJ I-NP O
medication NN I-NP O
compliance NN I-NP O
ADMISSION NNP I-NP O
LABS: NNP I-NP O
Of IN B-VP O
note NN B-NP O
on IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1.1 CD O O
which WDT O O
was VBD B-VP O
at IN B-VP O
his PRP$ O O
baseline NN B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
hematocrit NN I-NP O
of IN B-VP O
35.2 CD O O
Of IN B-VP O
note NN B-NP O
, , O O
his PRP$ O O
baseline NN B-NP O
hematocrit NN I-NP O
is VBZ O O
between IN B-VP O
31 CD O O
and CC O O
32 CD O O
BNP NNP B-NP O
was VBD B-VP O
570 CD O O
Troponin NNP B-NP O
was VBD B-VP O
0.78 CD O O
, , O O
AST NNP B-NP O
62 CD O O
, , O O
ALT NNP B-NP O
26 CD O O
, , O O
alkaline JJ B-NP O
phosphatase NN I-NP O
183 CD O O
, , O O
albumin RB O O
3.6 CD O O
Admission NNP B-NP O
EKG NNP I-NP O
was VBD B-VP O
V-paced JJ O O
with IN B-VP O
left JJ B-NP O
axis JJ I-NP O
deviation NN I-NP O
, , O O
no DT B-NP O
acute JJ I-NP O
ST-T NNP I-NP O
wave NN I-NP O
changes NNS I-NP O
It PRP O O
was VBD B-VP O
unchanged JJ O O
from IN B-VP O
prior JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
on IN B-VP O
the DT B-NP O
EKG NNP I-NP O
Admission NNP I-NP O
chest JJS B-NP O
x-ray NN I-NP O
from IN B-VP O
7/17/07 CD O O
, , O O
decreased VBD B-VP O
size NN B-NP O
small JJ B-NP O
bilateral JJ I-NP O
effusions NNS I-NP O
, , O O
associated VBN O O
with IN B-VP O
some DT B-NP O
segmental JJ I-NP O
bibasilar JJ I-NP O
atelectasis NN I-NP O
versus NN I-NP O
consolidation NN I-NP O
No NNP I-NP O
frank VBD B-VP O
evidence NN B-NP O
of IN B-VP O
CHF NNP B-NP O
CONSULTANTS: NNP I-NP O
Hematology NNP I-NP O
of IN B-VP O
BH NNP B-NP O
, , O O
Dr NNP B-NP O
Bradley NNP I-NP O
Ebanks NNP I-NP O
ASSESSMENT: NNP I-NP O
This DT O O
is VBZ O O
an DT B-NP O
88-year-old JJ I-NP O
Co NNP I-NP O
Louis NNP I-NP O
Awestinsde NNP I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
, , O O
CHF NNP B-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
likely JJ O O
secondary JJ O O
to TO O O
CHF NNP B-NP O
and CC O O
also RB O O
presented VBN O O
with IN B-VP O
a DT B-NP O
fever NN I-NP O
concerning VBG O O
for IN B-VP O
pneumonia NN B-NP B-r
for IN B-VP O
which WDT O O
he PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
antibiotics NNS B-NP B-m
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
a DT B-NP O
new JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
amyloid NN B-NP O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEM: NNP I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
A NNP I-NP O
Ischemia: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT O O
known VBN O O
diagnosis NN B-NP O
of IN B-VP O
CAD; NNP B-NP O
however RB O O
, , O O
he PRP O O
has VBZ O O
many JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
troponin NN I-NP O
of IN B-VP O
0.7 CD O O
on IN B-VP O
admit NN B-NP O
which WDT O O
subsequently RB O O
trended VBD B-VP O
down RP O O
This DT B-NP O
troponin NN I-NP O
leak NN I-NP O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
demand VB O O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
chest JJ O O
pain-free JJ O O
during IN B-VP O
his PRP$ O O
entire JJ B-NP O
hospital NN I-NP O
course NN I-NP O
, , O O
and CC O O
had VBD B-VP O
no DT B-NP O
acute JJ I-NP O
ischemic JJ I-NP O
issues NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
aspirin NN B-NP B-m
, , O O
beta-blocker NN B-NP B-m
and CC O O
statin NN B-NP B-m
medications NNS I-NP I-m
B NNP I-NP O
Pump: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
CHF NNP B-NP O
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
40-45% JJ O O
In IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
this DT B-NP O
congestive JJ I-NP O
heart NN I-NP O
failure NN I-NP O
had VBD B-VP O
been VBN O O
presumably RB O O
attributed VBN O O
to TO O O
ischemic VB O O
for IN B-VP O
hypertensive JJ B-NP O
etiology NN I-NP O
However RB O O
, , O O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
cardiac JJ I-NP O
biopsy NN I-NP O
that WDT O O
was VBD B-VP O
positive JJ O O
for IN B-VP O
amyloid JJ O O
suggesting VBG O O
that IN B-VP O
amyloid NN B-NP O
is VBZ O O
the DT B-NP O
cause NN I-NP O
underlying VBG O O
his PRP$ O O
CHF NNP B-NP O
The DT B-NP O
patient NN I-NP O
appeared VBD B-VP O
mildly RB O O
fluid JJ O O
overloaded VBN O O
on IN B-VP O
admission NN B-NP O
He PRP O O
was VBD B-VP O
successfully RB O O
diuresed VBN O O
with IN B-VP O
100 CD O B-do
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
for IN B-VP B-du
several JJ B-NP O
days NNS I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
switched VBN O O
to TO O O
his PRP$ O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
Lasix NNP B-NP B-m
of IN B-VP O
80 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
b.i.d NN I-NP B-f
and CC O O
was VBD B-VP O
euvolemic VBN O O
for IN B-VP O
several JJ B-NP O
days NNS I-NP O
prior RB O O
to TO O O
his PRP$ O O
discharge NN B-NP O
His PRP$ O O
euvolemic JJ B-NP O
weight NN I-NP O
on IN B-VP O
8/18/07 CD O O
was VBD B-VP O
64.5 CD O O
kilograms NNS B-NP O
His PRP$ O O
discharge NN B-NP O
weight NN I-NP O
will MD O O
be VB O O
reported VBN O O
in IN B-VP O
an DT B-NP O
addendum NN I-NP O
During IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
beta-blocker NN B-NP B-m
His PRP$ O O
calcium NN B-NP B-m
channel NN I-NP I-m
blocker NN I-NP I-m
and CC O O
diltiazem NN B-NP B-m
was VBD B-VP O
discontinued VBN O O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
given VBN O O
his PRP$ O O
likely JJ B-NP O
restrictive JJ I-NP O
heart NN I-NP O
physiology NN I-NP O
with IN B-VP O
his PRP$ O O
new JJ B-NP O
diagnosis NN I-NP O
of IN B-VP O
amyloid JJ O B-r
amyloid IN B-VP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
nitrate NN I-NP B-m
during IN B-VP B-du
this DT B-NP I-du
admission NN I-NP I-du
in IN B-VP O
order NN B-NP O
to TO O O
reduce VB O B-r
preload NN B-NP O
As IN B-VP O
mentioned VBN O O
above IN B-VP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
catheterization NN I-NP O
with IN B-VP O
an DT B-NP O
endomyocardial JJ I-NP O
biopsy NN I-NP O
that WDT O O
was VBD B-VP O
positive JJ O O
for IN B-VP O
amyloid VBG O O
A NNP B-NP O
panel NN I-NP O
of IN B-VP O
other JJ B-NP O
amyloid-related JJ I-NP O
tests NNS I-NP O
were VBD B-VP O
also RB O O
sent VBN O O
out IN B-VP O
Of IN B-VP O
note NN B-NP O
, , O O
serum JJ B-NP O
genetic JJ I-NP O
amyloid NN I-NP O
testing NN I-NP O
was VBD B-VP O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
serum JJ I-NP O
immunofixation NN I-NP O
test NN I-NP O
that WDT O O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
urine JJ I-NP O
immunofixation NN I-NP O
test NN I-NP O
with IN B-VP O
a DT B-NP O
positive JJ I-NP O
monoclonal NN I-NP O
spike NN I-NP O
with IN B-VP O
Lambda NNP B-NP O
light NN I-NP O
chain NN I-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
a DT B-NP O
serum-free JJ I-NP O
light NN I-NP O
chain NN I-NP O
assay VBP O O
that WDT O O
was VBD B-VP O
equivocal/positive JJ O O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
positive JJ B-NP O
proteinuria NNS I-NP O
on IN B-VP O
a DT B-NP O
spot NN I-NP O
urine IN B-VP O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
a DT B-NP O
bone NN I-NP O
marrow NN I-NP O
biopsy NN I-NP O
done VBN O O
by IN B-VP O
Dr NNP B-NP O
Jarred NNP I-NP O
Canner NNP I-NP O
of IN B-VP O
MOMH NNP B-NP O
in IN B-VP O
order NN B-NP O
to TO O O
further JJ B-NP O
define NN I-NP O
this DT B-NP O
subtype NN I-NP O
of IN B-VP O
amyloid NN B-NP O
that IN B-VP O
this DT B-NP O
patient NN I-NP O
has VBZ O O
and CC O O
in IN B-VP O
order NN B-NP O
to TO O O
facilitate VB O O
a DT B-NP O
screening NN I-NP O
of IN B-VP O
his PRP$ O O
family NN B-NP O
members NNS I-NP O
for IN B-VP O
amyloid NN B-NP O
He PRP O O
also RB O O
had VBD B-VP O
a DT B-NP O
bone NN I-NP O
marrow NN I-NP O
biopsy NN I-NP O
given VBN O O
the DT B-NP O
monoclonal JJ I-NP O
spike NN I-NP O
on IN B-VP O
his PRP$ O O
urine JJ B-NP O
immunofixation NN I-NP O
test NN I-NP O
C NNP I-NP O
Rhythm: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
pacemaker NN I-NP O
originally RB O O
put VBD B-VP O
in IN B-VP O
for IN B-VP O
sick JJ B-NP O
sinus NN I-NP O
syndrome NN I-NP O
He PRP O O
is VBZ O O
V-paced JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discovered VBN O O
to TO O O
be VB O O
in IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
On IN B-VP O
11/0/07 CD O O
, , O O
the DT B-NP O
EP NNP I-NP O
Service NNP I-NP O
changed VBD B-VP O
the DT B-NP O
pacemaker NN I-NP O
setting VBG O O
to TO O O
VVI NNP B-NP O
given VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
and CC O O
decreased VBD B-VP O
the DT B-NP O
heart NN I-NP O
rate NN I-NP O
to TO O O
the DT O O
60s-70s JJ O O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
on IN B-VP O
telemetry NN B-NP O
throughout IN B-VP O
his PRP$ O O
stay NN B-NP O
which WDT O O
was VBD B-VP O
uneventful JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
started VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
Coumadin NNP I-NP B-m
Coumadin NNP I-NP B-m
for IN B-VP O
anticoagulation NN B-NP B-r
given VBN O O
his PRP$ O O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
and CC O O
the DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
amyloid JJ O B-r
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
subtherapeutic JJ O O
and CC O O
on IN B-VP O
3/14/07 CD O O
, , O O
his PRP$ O O
INR NNP B-NP O
was VBD B-VP O
still RB O O
subtherapeutic JJ O O
at IN B-VP O
1.5 CD O O
, , O O
and CC O O
he PRP O O
will MD O O
most VB O O
likely RB O O
be VB O O
discharged VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
3.5 CD O B-do
mg NN B-NP I-do
every DT B-NP B-f
evening NN I-NP I-f
which WDT O O
will MD O O
be VB O O
adjusted VBN O O
as IN B-VP O
necessary JJ O O
at IN B-VP O
the DT B-NP O
Rehabilitation NNP I-NP O
Facility NNP I-NP O
2 CD O O
Infectious NNP B-NP O
Disease: NNP I-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
a DT B-NP O
mild JJ I-NP O
cough NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
fever NN I-NP O
on IN B-VP O
admit NN B-NP O
but CC O O
was VBD B-VP O
afebrile RB O O
after IN B-VP O
one CD O O
to TO O O
two CD O O
days NNS B-NP O
on IN B-VP O
antibiotics NNS B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
leukocytosis NN I-NP O
Again RB O O
, , O O
there EX O O
was VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
pneumonia NN B-NP O
on IN B-VP O
the DT O O
chest JJS O O
x-ray JJ O O
and CC O O
his PRP$ O O
clinical JJ B-NP O
findings NNS I-NP O
were VBD B-VP O
suspicious JJ O O
for IN B-VP O
pneumonia NN B-NP B-r
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
a DT B-NP O
five-day JJ I-NP B-du
course NN I-NP I-du
of IN B-VP O
levofloxacin NN B-NP B-m
at IN B-VP O
750 CD O B-do
mg JJ O I-do
daily RB O B-f
The DT B-NP O
course NN I-NP O
of IN B-VP O
antibiotics NNS B-NP B-m
ended VBD B-VP O
on IN B-VP O
3/25/07 CD O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
blood NN B-NP O
, , O O
urine JJ O O
and CC O O
sputum NN B-NP O
cultures NNS I-NP O
which WDT O O
were VBD B-VP O
negative JJ O O
3 CD O O
Heme: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
baseline VBN O O
anemia NN B-NP O
between IN B-VP O
hematocrit NN B-NP O
of IN B-VP O
31 CD O O
and CC O O
32 CD O O
which WDT O O
remained VBD B-VP O
stable JJ O O
during IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
has VBZ O O
a DT B-NP O
baseline NN I-NP O
thrombocytopenia NN I-NP O
with IN B-VP O
platelets NNS B-NP O
at IN B-VP O
approximately RB O O
170 CD O O
which WDT O O
remained VBD B-VP O
stable JJ O O
throughout IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
and CC O O
again RB O O
the DT B-NP O
patient NN I-NP O
as IN B-VP O
stated VBN O O
above IN B-VP O
was VBD B-VP O
started VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
Coumadin NNP I-NP B-m
during IN B-VP B-du
during IN B-VP B-du
this DT O I-du
this DT B-NP I-du
admission NN I-NP I-du
admission NN I-NP I-du
for IN B-VP O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
and CC O O
for IN B-VP O
amyloid JJ O B-r
The DT B-NP O
Coumadin NNP I-NP B-m
Coumadin NNP I-NP B-m
was VBD B-VP O
slowly RB O O
increased VBN O O
up RP O O
to TO O O
3.5 CD O B-do
mg NNS B-NP I-do
given VBN O O
subtherapeutic JJ B-NP B-r
INR NNP I-NP I-r
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
bone NN I-NP O
marrow NN I-NP O
biopsy NN I-NP O
done VBN O O
on IN B-VP O
6/17/07 CD O O
as IN B-VP O
mentioned VBN O O
above IN B-VP O
in IN B-VP O
order NN B-NP O
to TO O O
further JJ O O
define VB O O
the DT B-NP O
amyloid JJ I-NP O
??_?? NN I-NP O
and CC O O
because IN B-VP O
of IN B-VP O
the DT B-NP O
monoclonal JJ I-NP O
spike NN I-NP O
on IN B-VP O
the DT B-NP O
urine JJ I-NP O
immunofixation NN I-NP O
The DT B-NP O
final JJ I-NP O
results NNS I-NP O
of IN B-VP O
the DT B-NP O
bone NN I-NP O
marrow NN I-NP O
biopsy NN I-NP O
are VBP O O
pending VBG O O
4 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-r
diabetes NNS I-NP B-r
At IN B-VP O
first JJ O O
, , O O
he PRP O O
was VBD B-VP O
on IN B-VP O
his PRP$ O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
NPH NNP B-NP B-m
insulin NN I-NP I-m
which WDT O O
was VBD B-VP O
20 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
daily RB O B-f
as RB O O
well RB O O
as IN B-VP O
an DT B-NP O
insulin NN I-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
Because IN B-VP O
of IN B-VP O
persistent JJ B-NP B-r
persistent JJ I-NP B-r
hypoglycemia NN I-NP I-r
hypoglycemia NN I-NP I-r
, , O O
the DT B-NP O
patient's NN I-NP O
NPH NNP I-NP B-m
was VBD B-VP O
reduced VBN O O
to TO O O
10 CD O B-do
10 CD O B-do
units NNS B-NP O
of IN B-VP O
NPH NNP B-NP B-m
insulin VBP O I-m
subcutaneous JJ O B-mo
daily JJ O B-f
5 CD O O
FEN: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
low-salt JJ I-NP O
diet NN I-NP O
and CC O O
a DT B-NP O
2-liter JJ I-NP O
fluid NN I-NP O
restriction NN I-NP O
and CC O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Nutrition NNP B-NP O
inhouse RB O O
6 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
approximately RB O O
1.0 CD O O
which WDT O O
stayed VBD B-VP O
stable JJ O O
throughout IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
7 CD O O
GI: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
chronic JJ B-NP O
LFT NNP I-NP O
abnormalities NNS I-NP O
likely RB O O
secondary JJ O O
to TO O O
CHF; NNP B-NP O
however RB O O
, , O O
the DT B-NP O
etiology NN I-NP O
is VBZ O O
uncertain JJ O O
8 CD O O
Question NNP B-NP O
restless NN I-NP O
leg NN I-NP O
syndrome: NN I-NP O
On IN B-VP O
5/10/07 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
complaining VBG O O
of IN B-VP O
myoclonic JJ B-NP B-r
jerks NNS I-NP I-r
of IN B-VP O
his PRP$ O O
right NN B-NP O
leg NN I-NP O
which WDT O O
is VBZ O O
an DT B-NP O
old JJ I-NP O
problem NN I-NP O
His PRP$ O O
general JJ B-NP O
exam NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
He PRP O O
was VBD B-VP O
given VBN O O
a DT B-NP O
trial NN I-NP O
of IN B-VP O
magnesium NN B-NP B-m
supplementation NN I-NP I-m
inhouse NN I-NP O
for IN B-VP O
this DT O O
9 CD O O
Low NNP B-NP O
back RB O O
, , O O
sacral JJ O O
pain: IN B-VP O
His PRP$ O O
low JJ O B-r
back RB O I-r
pain NN B-NP I-r
appears VBZ O O
to TO O O
be VB O O
chronic JJ O O
and CC O O
it PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
oxycodone NN B-NP B-m
successfully RB O O
The DT B-NP O
patient NN I-NP O
also RB O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
skin JJ I-NP O
tear NN I-NP O
on IN B-VP O
his PRP$ O O
right NN B-NP O
buttock NN I-NP O
which WDT O O
showed VBD B-VP O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
infection NN B-NP O
and CC O O
a DT B-NP O
DuoDERM NNP I-NP O
was VBD B-VP O
placed VBN O O
over IN B-VP O
it PRP O O
for IN B-VP O
wound NN B-NP O
care NN I-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
a DT B-NP O
stage NN I-NP O
I PRP O O
sacral JJ B-NP O
decubitus NN I-NP O
ulcer NN I-NP O
and CC O O
a DT B-NP O
DuoDERM NNP I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
it PRP O O
for IN B-VP O
wound NN B-NP O
care NN I-NP O
and CC O O
for IN B-VP O
protection NN B-NP O
10 CD O O
Prophylaxis: NNP B-NP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
on IN B-VP O
DVT NNP B-NP B-r
dose JJ B-NP O
Lovenox NNP I-NP B-m
inhouse NN I-NP O
and CC O O
was VBD B-VP O
also RB O O
on IN B-VP O
Coumadin NNP B-NP B-m
11 CD O O
Physical NNP B-NP O
Therapy: NNP I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
a DT O O
left VBN O O
BKA NNP B-NP O
The DT B-NP O
patient's NN I-NP O
family NN I-NP O
brought VBD B-VP O
in IN B-VP O
his PRP$ O O
prosthetic JJ B-NP O
leg NN I-NP O
as RB O O
well RB O O
as IN B-VP O
his PRP$ O O
walker NN B-NP O
Physical NNP I-NP O
Therapy NNP I-NP O
inhouse NN I-NP O
worked VBD B-VP O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
, , O O
and CC O O
it PRP O O
was VBD B-VP O
determined VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
unsafe JJ O O
to TO O O
go VB O O
home NN B-NP O
and CC O O
it PRP O O
was VBD B-VP O
recommended VBN O O
that IN B-VP O
he PRP O O
go VB O O
to TO O O
a DT B-NP O
rehabilitation NN I-NP O
facility NN I-NP O
to TO O O
which WDT O O
the DT B-NP O
patient NN I-NP O
finally RB O O
agreed VBD B-VP O
CODE NNP B-NP O
STATUS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
full JJ B-NP O
code NN I-NP O
Healthcare NNP I-NP O
proxy NN I-NP O
is VBZ O O
daughter RB O O
, , O O
Wilford NNP B-NP O
A NNP I-NP O
Greaux NNP I-NP O
Home NNP I-NP O
phone NN I-NP O
number NN I-NP O
is VBZ O O
458-092-2461 JJ O O
, , O O
work VB O O
number NN B-NP O
727-352-1113 JJ B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Tylenol NNP B-NP B-m
650 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.4h NN I-NP B-f
p.r.n NN I-NP I-f
2 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
4 CD O O
Ferrous NNP B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
three CD O B-f
times NNS B-NP I-f
daily RB O I-f
5 CD O O
Folic NNP B-NP B-m
acid VBD B-VP I-m
1 CD O B-do
mg NN B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
once RB O B-f
daily JJ O I-f
6 CD O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
daily RB O I-f
7 CD O O
Gabapentin NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
b.i.d NN I-NP B-f
8 CD O O
Insulin NNP B-NP B-m
NPH NNP I-NP I-m
10 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
daily JJ O B-f
9 CD O O
Combivent NNP B-NP B-m
Combivent NNP I-NP B-m
2 CD O B-do
2 CD O B-do
puffs NNS B-NP I-do
puffs NNS I-NP I-do
inhaled VBD B-VP B-mo
inhaled JJ O B-mo
four CD O B-f
four CD O B-f
times NNS B-NP I-f
times NNS I-NP I-f
daily JJ B-NP I-f
daily JJ I-NP I-f
p.r.n NN I-NP I-f
p.r.n NN I-NP I-f
shortness NN I-NP B-r
of IN B-VP O
breath NN B-NP O
or CC O O
wheezing VBG O B-r
while IN B-VP B-du
while IN B-VP B-du
the DT B-NP O
patient NN I-NP O
is VBZ O O
recovering VBG O O
from IN B-VP O
his PRP$ O O
pneumonia NN B-NP O
10 CD O O
Isosorbide NNP B-NP B-m
dinitrate NN I-NP I-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
three CD O B-f
times NNS B-NP I-f
daily RB O I-f
11 CD O O
Xalatan NNP B-NP B-m
eye NN I-NP I-m
drops VBZ O I-m
one CD O B-do
drop NN B-NP I-do
each DT B-NP B-mo
eye NN I-NP I-mo
q.p.m RB O B-f
12 CD O O
Metoprolol NNP B-NP B-m
tartrate NN I-NP I-m
12.5 CD O B-do
mg NN B-NP I-do
by IN B-VP B-mo
mouth JJ O I-mo
twice JJ O B-f
daily RB O I-f
13 CD O O
Oxycodone NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
every DT O B-f
six CD O I-f
hours NNS B-NP I-f
p.r.n VBP O I-f
pain VBP O B-r
14 CD O O
Senna NNP B-NP B-m
tablets NNS I-NP I-m
two CD O B-do
tablets NNS B-NP I-do
by IN B-VP B-mo
mouth JJ O I-mo
twice JJ O B-f
daily RB O I-f
15 CD O O
Simvastatin NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
at IN B-VP B-f
bedtime JJ O I-f
16 CD O O
Multivitamin NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
by IN B-VP B-mo
mouth JJ O I-mo
daily JJ O B-f
17 CD O O
Coumadin NNP B-NP B-m
3.5 CD O B-do
mg NN B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
q.p.m JJ B-NP B-f
MEDICATION NNP I-NP O
CHANGES NNP I-NP O
MADE NNP I-NP O
DURING NNP I-NP O
THIS NNP I-NP O
ADMISSION: NNP I-NP O
Diltiazem NNP I-NP B-m
was VBD B-VP O
discontinued VBN O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
insulin NN I-NP I-m
insulin NN I-NP I-m
was VBD B-VP O
reduced VBN O O
from IN B-VP O
20 CD O O
units NNS B-NP O
daily RB O O
to TO O O
10 CD O B-do
10 CD O B-do
units NNS B-NP I-do
units NNS I-NP I-do
daily RB O B-f
daily RB O B-f
A NNP B-NP O
multivitamin NN I-NP B-m
was VBD B-VP O
added VBN O O
Isosorbide NNP B-NP B-m
dinitrate NN I-NP I-m
was VBD B-VP O
added VBN O O
Coumadin NNP B-NP B-m
was VBD B-VP O
added VBN O O
TO-DO NNP B-NP O
LIST NNP I-NP O
FOR NNP I-NP O
REHAB NNP I-NP O
AND NNP I-NP O
VNA: NNP I-NP O
1 CD O O
Monitor NNP B-NP O
blood NN I-NP O
pressure NN I-NP O
2 CD O O
Monitor NNP B-NP O
blood NN I-NP O
sugars NNS I-NP O
3 CD O O
Please NNP B-NP O
check VB O O
INR NNP B-NP O
on IN B-VP O
4/30/07 CD O O
and CC O O
every DT O O
two CD O O
to TO O O
three CD O O
days NNS B-NP O
thereafter RB O O
and CC O O
adjust VBP O O
the DT B-NP O
Coumadin NNP I-NP B-m
as IN B-VP B-f
necessary JJ O I-f
for IN B-VP O
target NN B-NP B-r
INR NNP I-NP I-r
of IN B-VP O
2-3 JJ O O
4 CD O O
Please NNP B-NP O
do VB O O
wound RB O O
care VB O O
on IN B-VP O
right JJ B-NP O
buttocks NNS I-NP O
and CC O O
sacrum NN B-NP O
( ( O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
skin JJ I-NP O
tear NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
buttocks NNS I-NP O
but CC O O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
infection NN B-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
stage NN I-NP O
I PRP O O
decubitus VBP O O
ulcer JJ O O
on IN B-VP O
the DT B-NP O
sacrum NN I-NP O
) ) O O
Please NNP B-NP O
apply VB O O
DuoDERM NNP B-NP O
and CC O O
do VBP O O
wound VB O O
care VB O O
5 CD O O
Please NNP B-NP O
have VBP O O
VNA NNP B-NP O
do VBP O O
home NN B-NP O
safety NN I-NP O
evaluation NN I-NP O
when WRB O O
the DT B-NP O
patient NN I-NP O
goes VBZ O O
home NN B-NP O
, , O O
and CC O O
please VB O O
continue VB O O
physical JJ B-NP O
therapy NN I-NP O
FOLLOW-UP NNP I-NP O
APPOINTMENTS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Cedric NNP I-NP O
D NNP I-NP O
Laite NNP I-NP O
, , O O
of IN B-VP O
RDH NNP B-NP O
His PRP$ O O
office NN B-NP O
is VBZ O O
aware JJ O O
that IN B-VP O
he PRP O O
needs VBZ O O
an DT B-NP O
appointment NN I-NP O
in IN B-VP O
the DT O O
next JJ O O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
and CC O O
his PRP$ O O
office NN B-NP O
will MD O O
call VB O O
the DT B-NP O
patient NN I-NP O
with IN B-VP O
confirmation NN B-NP O
of IN B-VP O
this DT B-NP O
appointment NN I-NP O
Dr NNP I-NP O
Petruso NNP I-NP O
office NN I-NP O
number NN I-NP O
is VBZ O O
852-385-4973 JJ B-NP O
CONTINUING NNP I-NP O
CARE NNP I-NP O
PLAN NNP I-NP O
FOR NNP I-NP O
M.D.s: NNP I-NP O
For IN B-VP O
cardiologist NN B-NP O
, , O O
1 CD O O
Follow NNP B-NP O
up RB O O
final JJ B-NP O
results NNS I-NP O
of IN B-VP O
amyloid JJ B-NP O
genetic JJ I-NP O
test NN I-NP O
2 CD O O
Follow NNP B-NP O
up RB O O
final JJ B-NP O
results NNS I-NP O
of IN B-VP O
bone NN B-NP O
marrow NN I-NP O
biopsy VBD B-VP O
3 CD O O
Follow NNP B-NP O
up RB O O
final JJ B-NP O
results NNS I-NP O
of IN B-VP O
the DT B-NP O
heart NN I-NP O
biopsy NN I-NP O
including VBG O O
special JJ B-NP O
stains NNS I-NP O
For IN B-VP O
Primary NNP B-NP O
Care NNP I-NP O
Physician NNP I-NP O
, , O O
1 CD O O
Manage NNP B-NP O
insulin NN I-NP B-m
regimen NNS I-NP O
2 CD O O
Follow NNP B-NP O
low JJ O O
back RB O O
pain NN B-NP O
which WDT O O
appears VBZ O O
to TO O O
be VB O O
chronic JJ O O
3 CD O O
Follow NNP B-NP O
decubitus NN I-NP O
ulcer NN I-NP O
stage NN I-NP O
I PRP O O
4 CD O O
Follow NNP B-NP O
INR NNP I-NP O
and CC O O
adjust RB O O
Coumadin NNP B-NP B-m
as IN B-VP B-f
needed VBN O I-f
5 CD O O
Monitor NNP B-NP O
LFT NNP I-NP O
which WDT O O
appear VBP O O
to TO O O
be VB O O
chronically RB O O
elevated VBN O O
and CC O O
workup NN B-NP O
as IN B-VP O
necessary JJ O O
6 CD O O
Question NN B-NP O
of IN B-VP O
restless NN B-NP O
leg NN I-NP O
syndrome JJ B-NP O
Please NNP I-NP O
reassess NN I-NP O
and CC O O
treat NN B-NP O
as IN B-VP O
needed VBN O O
7 CD O O
Monitor NNP B-NP O
hematocrit NN I-NP O
and CC O O
platelets NNS B-NP O
An DT B-NP O
addendum NN I-NP O
to TO O O
this DT B-NP O
stat JJ I-NP O
dictation NN I-NP O
will MD O O
follow VB O O
when WRB O O
the DT B-NP O
patient NN I-NP O
discharge NN I-NP O
is VBZ O O
confirmed VBN O O
including VBG O O
a DT B-NP O
finalized JJ I-NP O
medication NN I-NP O
list NN I-NP O
for IN B-VP O
discharge NN B-NP O
and CC O O
a DT B-NP O
final JJ I-NP O
discharge NN I-NP O
weight NN I-NP O
eScription NN I-NP O
document: VBZ O O
7-3368383 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Omar NNP I-NP O
Arnstein NNP I-NP O
M.D NNP I-NP O
Kaihend NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Tuc NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BITTING NNP I-NP O
, , O O
JORDAN NNP B-NP O
Attending: NNP I-NP O
HARCOURT NNP I-NP O
, , O O
DALE NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
0097732 CD O O
D: NNP B-NP O
3/14/07 CD O O
T: NNP B-NP O
3/14/07 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#163977 VBZ O O
072274871 CD O O
TH NNP B-NP O
93517091 CD O O
561631 CD O O
9/5/1990 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/20/1990 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/19/1990 CD O O
DISCHARGE NNP B-NP O
DIAGNOSIS: NNP I-NP O
PERIPHERAL NNP I-NP O
VASCULAR NNP I-NP O
DISEASE NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
55-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
smoking NN B-NP O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
a DT B-NP O
left NN I-NP O
sided VBN O O
hemisphere RB O O
stroke NN B-NP O
who WP O O
was VBD B-VP O
normotensive JJ O O
, , O O
nondiabetic JJ O O
and CC O O
does VBZ O O
not RB O O
have VB O O
known VBN O O
coronary JJ B-NP O
disease NN I-NP O
who WP O O
underwent VBD B-VP O
a DT O O
right-sided JJ O O
femoral JJ O O
to TO O O
popliteal VB O O
bypass NN B-NP O
graft NN I-NP O
in IN B-VP O
February NNP B-NP O
of IN B-VP O
1986 CD O O
for IN B-VP O
severe JJ B-NP O
claudication NN I-NP O
This DT O O
resulted VBD B-VP O
in IN B-VP O
relief NN B-NP O
He PRP O O
was VBD B-VP O
readmitted VBN O O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1988 CD O O
for IN B-VP O
increase NN B-NP O
in IN B-VP O
pain NN B-NP O
in IN B-VP O
the DT B-NP O
calves NNS I-NP O
which WDT O O
began VBD B-VP O
at IN B-VP O
ambulation NN B-NP O
of IN B-VP O
30 CD O O
feet NNS B-NP O
Angiographic JJ B-NP O
evaluation NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
showed VBD B-VP O
a DT B-NP O
thrombosed JJ I-NP O
graft NN I-NP O
and CC O O
he PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
for IN B-VP O
a DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
in IN B-VP O
situ NN B-NP O
right RB O O
femoral JJ O O
to TO O O
right JJ B-NP O
popliteal NN I-NP O
bypass NN I-NP O
graft NN I-NP O
This DT O O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
wound NN B-NP O
cellulitis NN I-NP O
which WDT O O
was VBD B-VP O
medicated VBN O O
in IN B-VP O
the DT B-NP O
appropriate JJ I-NP O
manner NN I-NP O
and CC O O
he PRP O O
was VBD B-VP O
therefore RB O O
discharged VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
readmitted VBN O O
in IN B-VP O
February NNP B-NP O
of IN B-VP O
1988 CD O O
with IN B-VP O
graft NN B-NP O
stenosis NN I-NP O
and CC O O
underwent JJ B-NP O
angioplasty NN I-NP O
After IN B-VP O
this DT B-NP O
procedure NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
palpable JJ B-NP O
pulses NNS I-NP O
He PRP O O
was VBD B-VP O
readmitted VBN O O
in IN B-VP O
July NNP B-NP O
of IN B-VP O
1989 CD O O
for IN B-VP O
angioplasty NN B-NP O
He PRP O O
presented VBD B-VP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
with IN B-VP O
progressive JJ B-NP O
pain NN I-NP O
and CC O O
three CD O O
months NNS B-NP O
of IN B-VP O
frank JJ B-NP O
rest NN I-NP O
pain NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
calf NN I-NP O
and CC O O
claudication NN B-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
calf NN I-NP O
at IN B-VP O
400 CD O O
yards NNS B-NP O
He PRP O O
denied VBD B-VP O
dependent JJ B-NP O
rubor NN I-NP O
pallor NN I-NP O
or CC O O
coldness NN B-NP O
in IN B-VP O
the DT B-NP O
foot NN I-NP O
but CC O O
he PRP O O
does VBZ O O
have VB O O
pain NN B-NP O
paresthesias NN I-NP O
He PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
and CC O O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
and CC O O
was VBD B-VP O
found VBN O O
not RB O O
to TO O O
have VB O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
but CC O O
was VBD B-VP O
felt VBN O O
to TO O O
have VB O O
esophageal NN B-NP O
dismotility NN I-NP O
which WDT O O
was VBD B-VP O
demonstrated VBN O O
on IN B-VP O
the DT B-NP O
study NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Esophageal NNP B-NP O
reflux NN I-NP O
2 CD O O
Left NNP B-NP O
hemisphere NN I-NP O
stroke VBD B-VP O
which WDT O O
resulted VBD B-VP O
in IN B-VP O
residual JJ B-NP O
right JJ I-NP O
hemiparesis NN I-NP O
3 CD O O
Anxiety NNP B-NP O
disorder NN I-NP O
4 CD O O
Chronic NNP B-NP O
low JJ O O
back RB O O
pain VBP O O
5 CD O O
Peptic JJ B-NP O
ulcer JJ I-NP O
disease NN I-NP O
6 CD O O
Herniated NNP B-NP O
nucleus JJ B-NP O
pulposus NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Femoral NNP B-NP O
popliteal JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
in IN B-VP O
1986 CD O O
2 CD O O
Femoral NNP B-NP O
popliteal NN I-NP O
saphenous JJ B-NP O
vein NN I-NP O
in IN B-VP O
situ NN B-NP O
graft NN I-NP O
in IN B-VP O
1988 CD O O
3 CD O O
Cholecystectomy NNP B-NP O
in IN B-VP O
1986 CD O O
4 CD O O
Lysis NN B-NP O
of IN B-VP O
adhesions NNS B-NP O
for IN B-VP O
small JJ B-NP O
bowel NN I-NP O
obstruction NN I-NP O
in IN B-VP O
1970 CD O O
, , O O
repeated VBN O O
in IN B-VP O
1970 CD O O
again RB O O
5 CD O O
Resection NNP B-NP O
of IN B-VP O
a DT O O
herniated VBN O O
nucleus NN B-NP O
pulposus NN I-NP O
in IN B-VP O
1985 CD O O
6 CD O O
Knee NNP B-NP O
operation NN I-NP O
in IN B-VP O
1974 CD O O
7 CD O O
Cystoscopy NNP B-NP O
in IN B-VP O
1986 CD O O
MEDICATIONS: NNP B-NP O
On IN B-VP O
admission NN B-NP O
included VBD B-VP O
Pepcid NNP B-NP B-m
, , O O
40 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
h.s.; NN B-NP I-f
trazodone NN I-NP B-m
, , O O
15 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
h.s.; NN B-NP I-f
Carafate NNP I-NP B-m
, , O O
one CD O B-do
q.i.d.; NN B-NP B-f
nitroglycerin CC O B-m
p.r.n NN B-NP B-f
and CC O O
Flexeril NNP B-NP B-m
, , O O
10 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
eight CD O I-f
hours NNS B-NP I-f
p.r.n VBP O I-f
back RB O B-r
pain VBP O O
ALLERGIES: NNP B-NP O
QUESTION NNP I-NP O
OF NNP I-NP O
PENICILLIN NNP I-NP O
AND NNP I-NP O
QUESTION NNP I-NP O
OF NNP I-NP O
DYE NNP I-NP O
HABITS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
smoked VBN O O
one CD O O
pack NN B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
45 CD O O
years NNS B-NP O
Alcohol NNP I-NP O
was VBD B-VP O
none RB O O
REVIEW NNP B-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Noteable NNP I-NP O
for IN B-VP O
five CD O O
episodes NNS B-NP O
of IN B-VP O
pneumonia NN B-NP O
Flaccid NNP I-NP O
urinary JJ B-NP O
bladder NN I-NP O
and CC O O
chronic JJ B-NP O
chest NN I-NP O
discomfort NN I-NP O
from IN B-VP O
esophageal JJ B-NP O
dismotility NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
admission NN B-NP O
revealed VBD B-VP O
a DT B-NP O
robust JJ I-NP O
white JJ I-NP O
male NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
He PRP O O
had VBD B-VP O
no DT O O
skin JJ O O
lesions VBZ O O
No DT B-NP O
lymphadenopathy JJ I-NP O
Head NNP I-NP O
and CC O O
neck JJ B-NP O
exams NNS I-NP O
were VBD B-VP O
noteable JJ O O
only RB O O
for IN B-VP O
partial JJ B-NP O
denture NN I-NP O
plates VBZ O O
The DT B-NP O
breasts NNS I-NP O
had VBD B-VP O
no DT B-NP O
masses NNS I-NP O
or CC O O
discharge NN B-NP O
Lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
Heart NNP B-NP O
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
without IN B-VP O
murmurs NNS B-NP O
, , O O
rubs NNS B-NP O
or CC O O
gallops VBZ O O
The DT B-NP O
pulses NNS I-NP O
were VBD B-VP O
palpable JJ O O
at IN B-VP O
the DT B-NP O
carotid NN I-NP O
and CC O O
radials NNS B-NP O
and CC O O
dopplerable JJ O O
at IN B-VP O
the DT B-NP O
popliteals NNS I-NP O
, , O O
dorsalis NN B-NP O
pedis NN I-NP O
and CC O O
posterior JJ B-NP O
tibials NNS I-NP O
bilaterally RB O O
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP O
, , O O
nondistended VBD B-VP O
Bowel NNP B-NP O
sounds NNS I-NP O
were VBD B-VP O
present JJ O O
There EX O O
was VBD B-VP O
no DT B-NP O
hepatosplenomegaly NN I-NP O
or CC O O
masses NNS B-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
right JJ I-NP O
paramedian NN I-NP O
scar NN I-NP O
Genital NNP I-NP O
examination NN I-NP O
revealed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
uncircumcised JJ I-NP O
phallus NN I-NP O
with IN B-VP O
a DT B-NP O
redundant JJ I-NP O
prepuce NN I-NP O
Cord NNP I-NP O
, , O O
scrotum NN B-NP O
, , O O
testes NNS B-NP O
and CC O O
external JJ B-NP O
rings NNS I-NP O
were VBD B-VP O
unremarkable JJ B-NP O
Stool NNP I-NP O
was VBD B-VP O
guaiac JJ B-NP O
negative JJ I-NP O
Musculoskeletal NNP I-NP O
examination NN I-NP O
was VBD B-VP O
otherwise RB O O
noteable JJ O O
for IN B-VP O
scars NNS B-NP O
in IN B-VP O
the DT B-NP O
knees NNS I-NP O
and CC O O
lower JJR O O
back RB O O
Neurological JJ B-NP O
examination NN I-NP O
revealed VBD B-VP O
a DT B-NP O
numb JJ I-NP O
right NN I-NP O
lower RBR O O
extremity NN B-NP O
with IN B-VP O
a DT B-NP O
negative JJ I-NP O
pinprick NN I-NP O
examination NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Angiography NNP I-NP O
Suite NNP I-NP O
on IN B-VP O
3/5/90 CD O O
where WRB O O
multiple JJ B-NP O
segmental JJ I-NP O
narrowings NNS I-NP O
of IN B-VP O
the DT B-NP O
right NN I-NP O
graft NN I-NP O
and CC O O
complete JJ B-NP O
occlusion NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
distal JJ I-NP O
SFA NNP I-NP O
with IN B-VP O
distal JJ B-NP O
reconstitution NN I-NP O
were VBD B-VP O
discovered VBN O O
He PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Dougherty NNP I-NP O
on IN B-VP O
5/1/90 CD O O
where WRB O O
a DT B-NP O
right JJ I-NP O
reverse NN I-NP O
saphenous JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
from IN B-VP O
the DT O O
in IN B-VP O
situ NN B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
below IN B-VP O
the DT B-NP O
knee NN I-NP O
popliteal NN I-NP O
artery NN I-NP O
was VBD B-VP O
performed VBN O O
by IN B-VP O
Dr NNP B-NP O
Bayani NNP I-NP O
assisted VBN O O
by IN B-VP O
Dr NNP B-NP O
Macgowan NNP I-NP O
and CC O O
Dr NNP B-NP O
Horwath NNP I-NP O
Postoperatively NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
excellent JJ B-NP O
palpable JJ I-NP O
pulses NNS I-NP O
in IN B-VP O
the DT B-NP O
foot NN I-NP O
and CC O O
he PRP O O
enjoyed VBD B-VP O
an DT B-NP O
unremarkable JJ I-NP O
hospital NN I-NP O
course NN I-NP O
and CC O O
was VBD B-VP O
sent VBN O O
home NN B-NP O
on IN B-VP O
INCOMPLETE NNP B-NP O
DICTATION NNP I-NP O
________________________________ NNP I-NP O
YO013/6073 NNP I-NP O
ELMER NNP I-NP O
P NNP I-NP O
KNEIFL NNP I-NP O
, , O O
M.D NNP B-NP O
QM26 NNP I-NP O
D: NNP I-NP O
11/28/90 CD O O
Batch: NNP B-NP O
9493 CD O O
Report: NNP B-NP O
Y0035C69 NNP I-NP O
T: NNP I-NP O
2/6/90 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#172366 VBZ O O
805770489 CD O O
CNHAMC NNP B-NP O
29803992 CD O O
0399681 CD O O
5/2/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
INFECTED NNP I-NP O
MESH NNP I-NP O
IN NNP I-NP O
ABDOMINAL NNP I-NP O
Signed NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/17/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/22/2006 CD O O
ATTENDING: NNP B-NP O
SWEED NNP I-NP O
, , O O
ZANE NNP B-NP O
MD NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
MRSA-infected NNP I-NP O
abdominal JJ B-NP O
mesh JJ I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
90+-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
complex JJ I-NP O
past NN I-NP O
medical JJ B-NP O
history NN I-NP O
including VBG O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
stent NN I-NP O
x2 NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
CHF NNP B-NP O
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
10-20% JJ O O
, , O O
AF NNP B-NP O
, , O O
on IN B-VP O
chronic JJ B-NP O
anticoagulation NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
pacer NN I-NP O
placement NN I-NP O
, , O O
and CC O O
diabetes VBZ O O
mellitus NNS B-NP O
who WP O O
presented VBD B-VP O
to TO O O
the DT B-NP O
SICU NNP I-NP O
status NN I-NP O
post NN I-NP O
exploratory NN I-NP O
laparotomy NN I-NP O
for IN B-VP O
removal NN B-NP O
of IN B-VP O
chronically RB O O
MRSA-infected JJ B-NP O
mesh NN I-NP O
from IN B-VP O
prior JJ B-NP O
abdominal JJ I-NP O
surgery NN I-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
ICU NNP I-NP O
for IN B-VP O
careful JJ B-NP O
monitoring NN I-NP O
and CC O O
fluid NN B-NP O
volume NN I-NP O
management NN I-NP O
postoperatively RB O O
He PRP O O
has VBZ O O
had VBN O O
multiple JJ B-NP O
abdominal JJ I-NP O
surgeries NNS I-NP O
The DT B-NP O
mesh NN I-NP O
was VBD B-VP O
originally RB O O
placed VBN O O
for IN B-VP O
ventral JJ B-NP O
hernia NN I-NP O
repair NN I-NP O
in IN B-VP O
2005 CD O O
He PRP O O
had VBD B-VP O
since IN B-VP O
developed VBN O O
draining VBG O O
sinus NN B-NP O
tracts NNS I-NP O
for IN B-VP O
which WDT O O
cultures NNS B-NP O
have VBP O O
grown VBN O O
out RP O O
MRSA NNP B-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
preoperatively RB O O
for IN B-VP O
reversal NN B-NP O
of IN B-VP O
anticoagulation NN B-NP O
and CC O O
semi-urgent JJ B-NP O
removal NN I-NP O
of IN B-VP O
the DT B-NP O
mesh NN I-NP O
In IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
, , O O
he PRP O O
underwent VBD B-VP O
an DT B-NP O
exploratory JJ I-NP O
laparotomy NN I-NP O
, , O O
lysis NN B-NP O
of IN B-VP O
adhesions NNS B-NP O
and CC O O
removal NN B-NP O
of IN B-VP O
the DT B-NP O
abdominal JJ I-NP O
mesh NN I-NP O
He PRP O O
was VBD B-VP O
closed VBN O O
and CC O O
one CD O O
Jackson-Pratt NNP B-NP O
drain NN I-NP O
was VBD B-VP O
left VBN O O
in IN B-VP O
place NN B-NP O
During IN B-VP O
the DT B-NP O
procedure NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
intubated VBN O O
with IN B-VP O
etomidate NN B-NP B-m
, , O O
succinylcholine NN B-NP B-m
and CC O O
kept VBD B-VP O
sedated VBN O B-r
sedated VBN O B-r
with IN B-VP O
Versed JJ O B-m
and CC O O
fentanyl NN B-NP B-m
He PRP O O
received VBD B-VP O
intraoperative JJ B-NP O
vancomycin NN I-NP B-m
and CC O O
levofloxacin NN B-NP B-m
as RB O O
well RB O O
as IN B-VP O
2200 CD O B-do
mL NN B-NP I-do
of IN B-VP O
lactated JJ B-NP B-m
Ringer's NNP I-NP I-m
In IN B-VP O
an DT B-NP B-r
attempt NN I-NP O
to TO O O
reverse VB O O
anticoagulation NN B-NP O
, , O O
one CD O B-do
unit NN B-NP I-do
of IN B-VP O
FFP NNP B-NP B-m
was VBD B-VP O
begun VBN O O
but CC O O
then RB O O
aborted VBD B-VP O
due JJ O O
to TO O O
hypotension NN B-NP B-r
, , O O
which WDT O O
resolved VBD B-VP O
with IN B-VP O
epinephrine JJ B-NP B-m
injection NN I-NP B-mo
, , O O
likely RB O O
due JJ O O
to TO O O
transfusion VB O O
reaction NN B-NP O
Another DT B-NP B-do
unit NN I-NP I-do
of IN B-VP O
FFP NNP B-NP B-m
was VBD B-VP O
hung VBN O O
and CC O O
tolerated VBN O O
well RB O O
EBL NNP B-NP O
was VBD B-VP O
300 CD O O
mL JJ B-NP O
Urine NNP I-NP O
output NN I-NP O
was VBD B-VP O
410 CD O O
mL NN B-NP O
for IN B-VP O
the DT B-NP O
four-hour JJ I-NP O
case NN I-NP O
He PRP O O
was VBD B-VP O
extubated VBN O O
uneventfully RB O O
and CC O O
transferred VBD B-VP O
to TO O O
the DT B-NP O
ICU NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Colon NNP B-NP O
cancer NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
colonoscopy NN I-NP O
in IN B-VP O
2005 CD O O
that WDT O O
was VBD B-VP O
negative JJ O O
2 CD O O
Prostate NNP B-NP O
cancer NN I-NP O
3 CD O O
History NNP B-NP O
of IN B-VP O
CVA NNP B-NP O
with IN B-VP O
a DT B-NP O
left JJ I-NP O
occipital JJ I-NP O
infarct NN I-NP O
thought VBD B-VP O
to TO O O
be VB O O
due JJ O O
to TO O O
embolic VB O O
phenomenon NN B-NP O
4 CD O O
History NNP B-NP O
of IN B-VP O
TIAs NNP B-NP O
5 CD O O
Osteoarthritis NNP B-NP O
of IN B-VP O
the DT B-NP O
cervical JJ I-NP O
spine NN I-NP O
6 CD O O
Chronic NNP B-NP O
atrial JJ B-NP O
fibrillation NN I-NP O
, , O O
on IN B-VP O
Coumadin NNP B-NP B-m
for IN B-VP O
anticoagulation NN B-NP B-r
7 CD O O
Sick NNP B-NP O
sinus NN I-NP O
syndrome NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
pacer NN I-NP O
placement NN I-NP O
8 CD O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
MI NNP I-NP O
in IN B-VP O
2005 CD O O
, , O O
status NN B-NP O
post NN I-NP O
stenting NN I-NP O
of IN B-VP O
LAD NNP B-NP O
and CC O O
RCA NNP B-NP O
9 CD O O
CHF NNP B-NP O
10 CD O O
Spindle-cell NNP B-NP O
tumors NNS I-NP O
from IN B-VP O
lung NN B-NP O
11 CD O O
Hypothyroidism NNP B-NP O
12 CD O O
MRSA NNP B-NP O
wound NN I-NP O
infection/mesh JJ B-NP O
infection NN I-NP O
13 CD O O
Status NNP B-NP O
post NN I-NP O
Mallory-Weiss NNP I-NP O
tear NN I-NP O
14 CD O O
Hiatal NNP B-NP O
hernia VBD B-VP O
15 CD O O
Status NNP B-NP O
post NN I-NP O
debridement NN I-NP O
of IN B-VP O
skin NN B-NP O
and CC O O
subcutaneous JJ B-NP O
tissue NN I-NP O
with IN B-VP O
partial JJ B-NP O
excision NN I-NP O
of IN B-VP O
mesh NN B-NP O
and CC O O
wound NN B-NP O
vac NN I-NP O
on IN B-VP O
3/25/05 CD O O
16 CD O O
Status NNP B-NP O
post NN I-NP O
ex NN I-NP O
lap VBZ O O
ventral JJ B-NP O
hernia NNS I-NP O
repair NN I-NP O
with IN B-VP O
Sepramesh NNP B-NP O
, , O O
3/28/05 CD O O
17 CD O O
Status NNP B-NP O
post NN I-NP O
right RB O O
colectomy NN B-NP O
in IN B-VP O
2002 CD O O
complicated VBN O O
by IN B-VP O
fascial JJ B-NP O
dehiscence NN I-NP O
requiring VBG O O
ex CC O O
lap JJ O O
and CC O O
repair NN B-NP O
of IN B-VP O
fascial JJ B-NP O
dehiscence NN I-NP O
18 CD O O
Status NNP B-NP O
post NN I-NP O
prostatectomy NN I-NP O
19 CD O O
Status NNP B-NP O
post NN I-NP O
right NN I-NP O
VATS NNP I-NP O
and CC O O
wedge VB O O
resection NN B-NP O
20 CD O O
Status NNP B-NP O
post NN I-NP O
fusion NN I-NP O
of IN B-VP O
cervical JJ B-NP O
spine NN I-NP O
21 CD O O
Status NNP B-NP O
post NN I-NP O
TNA NNP I-NP O
22 CD O O
Status NNP B-NP O
post NN I-NP O
appendectomy NN I-NP O
OUTPATIENT NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Amiodarone NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
by IN B-VP B-mo
mouth JJ O I-mo
daily JJ O B-f
2 CD O O
Calcium NN B-NP B-m
3 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
t.i.d NN I-NP B-f
4 CD O O
Coumadin NNP B-NP B-m
alternating VBG O B-do
doses NNS B-NP I-do
of IN B-VP I-do
4 CD O I-do
mg NNS B-NP I-do
and CC O I-do
3 CD O I-do
mg NN B-NP I-do
5 CD O O
Diltiazem NNP B-NP B-m
CD NN I-NP I-m
360 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
6 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
7 CD O O
Folate NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
8 CD O O
Lisinopril NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
9 CD O O
Metamucil NNP B-NP B-m
p.r.n VBD B-VP B-f
10 CD O O
Clopidogrel NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
11 CD O O
Potassium NN B-NP B-m
12 CD O O
Protonix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
13 CD O O
Simvastatin NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
14 CD O O
Synthroid NNP B-NP B-m
25 CD O B-do
mcg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
15 CD O O
Thiamine NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
16 CD O O
Metoprolol NNP B-NP B-m
SR NNP I-NP I-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
17 CD O O
Zyprexa NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
bedtime NN B-NP I-f
p.r.n NN I-NP I-f
ALLERGIES: NNP I-NP O
Ether NNP I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
alcohol NN I-NP O
or CC O O
tobacco NN B-NP O
use NN I-NP O
Married NNP I-NP O
, , O O
lives VBZ O O
with IN B-VP O
wife NN B-NP O
, , O O
retired VBD B-VP O
25 CD O O
years NNS B-NP O
ago RB O O
ADMISSION NNP B-NP O
LABS: NNP I-NP O
Remarkable NNP I-NP O
for IN B-VP O
creatinine NN B-NP O
of IN B-VP O
1 CD O O
, , O O
hematocrit NN B-NP O
of IN B-VP O
30.1% CD O O
, , O O
INR NNP B-NP O
of IN B-VP O
1.7 CD O O
EKG NNP B-NP O
V-paced NNP I-NP O
at IN B-VP O
60 CD O O
, , O O
no DT B-NP O
ST-T NNP I-NP O
wave NN I-NP O
abnormalities NNS I-NP O
compared VBN O O
to TO O O
preop VB O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Vital NNP I-NP O
Signs: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
temperature NN B-NP O
98 CD O O
, , O O
pulse RB O O
60 CD O O
and CC O O
V-paced NNP B-NP O
, , O O
blood NN B-NP O
pressure NN I-NP O
140/85 CD O O
, , O O
saturating VBG O O
96% CD O O
on IN B-VP O
3 CD O O
L NNP B-NP O
nasal JJ B-NP O
cannula NN I-NP O
Neuro: NNP I-NP O
Awake NNP I-NP O
, , O O
alert NN B-NP O
, , O O
appropriate JJ B-NP O
Pulmonary: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
, , O O
no DT B-NP O
rales NNS I-NP O
, , O O
no DT B-NP O
wheezes JJ I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
or CC O O
gallops NNS B-NP O
Abdomen: NNP I-NP O
Soft NNP I-NP O
, , O O
nondistended VBD B-VP O
, , O O
mildly RB O O
tender JJ B-NP O
midline NN I-NP O
incision NN I-NP O
with IN B-VP O
dressing VBG O O
clean JJ O O
, , O O
dry JJ O O
and CC O O
intact JJ B-NP O
JP NNP I-NP O
in IN B-VP O
midline NN B-NP O
with IN B-VP O
sanguinous JJ B-NP O
drainage NN I-NP O
Lax NNP I-NP O
abdominal VBZ O O
wall NN B-NP O
with IN B-VP O
protuberance NN B-NP O
but CC O O
soft JJ B-NP O
Extremities: NNP I-NP O
Warm NNP I-NP O
and CC O O
well RB O O
perfused JJ B-NP O
IMAGING: NNP I-NP O
Chest NNP I-NP O
x-ray JJ O O
negative JJ O O
for IN B-VP O
acute JJ B-NP O
disease NN I-NP O
and CC O O
cardiomegaly JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
90+-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
complex JJ I-NP O
past NN I-NP O
medical JJ B-NP O
history NN I-NP O
including VBG O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
MI NNP I-NP O
and CC O O
stent JJ B-NP O
x2 NN I-NP O
, , O O
CHF NNP B-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
SICU NNP I-NP O
, , O O
status NN B-NP O
post NN I-NP O
ex NN I-NP O
lap NN I-NP O
for IN B-VP O
removal NN B-NP O
of IN B-VP O
MRSA-infected NNP B-NP O
mesh NN I-NP O
for IN B-VP O
careful JJ B-NP O
monitoring NN I-NP O
and CC O O
fluid JJ B-NP O
resuscitation NN I-NP O
in IN B-VP O
light NN B-NP O
of IN B-VP O
cardiac JJ B-NP O
status NN I-NP O
His PRP$ O O
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
bleeding VBG O O
with IN B-VP O
sanguinous JJ B-NP O
output NN I-NP O
from IN B-VP O
the DT B-NP O
JP NNP I-NP O
drain NN I-NP O
, , O O
a DT B-NP O
question NN I-NP O
of IN B-VP O
an DT B-NP O
abdominal JJ I-NP O
hematoma NN I-NP O
and CC O O
a DT B-NP O
progressive JJ I-NP O
drop NN I-NP O
in IN B-VP O
his PRP$ O O
hematocrit NN B-NP O
The DT B-NP O
heparin NN I-NP B-m
drip NN I-NP B-mo
, , O O
which WDT O O
was VBD B-VP O
initiated VBN O O
given VBN O O
the DT B-NP B-r
patient's NN I-NP O
chronic JJ B-NP O
AF NNP I-NP O
, , O O
was VBD B-VP O
discontinued VBN O O
and CC O O
FFP NNP B-NP B-m
administered VBD B-VP O
Platelets NNS B-NP O
were VBD B-VP O
also RB O O
given VBN O O
at IN B-VP O
the DT B-NP O
request NN I-NP O
of IN B-VP O
the DT B-NP O
Plastic NNP I-NP O
Surgery NNP I-NP O
Team NNP I-NP O
in IN B-VP O
light NN B-NP O
of IN B-VP O
aspirin NN B-NP B-m
and CC O O
Plavix NNP B-NP B-m
, , O O
which WDT O O
were VBD B-VP O
continued VBN O O
due JJ O O
to TO O O
the DT O B-r
the DT B-NP B-r
patient's NN I-NP I-r
patient's NN I-NP I-r
cardiac JJ B-NP I-r
cardiac JJ I-NP I-r
stents NNS I-NP I-r
stents NNS I-NP I-r
Despite IN B-VP O
bolus JJ B-NP B-mo
Lasix NNP I-NP B-m
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
develop VB O O
CHF NNP B-NP O
with IN B-VP O
symptomatic JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
and CC O O
increased VBD B-VP O
oxygen NN B-NP O
requirement NN I-NP O
Concomitantly NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
also RB O O
became VBD B-VP O
delirious JJ O O
, , O O
as IN B-VP O
is VBZ O O
his PRP$ O O
historical JJ B-NP O
pattern NN I-NP O
with IN B-VP O
significant JJ B-NP O
agitation NN I-NP O
He PRP O O
developed VBD B-VP O
hypertension NN B-NP B-r
hypertension NN I-NP B-r
hypertension NN I-NP B-r
refractory NN I-NP O
to TO O O
beta-blockade NN B-NP B-m
, , O O
calcium NN B-NP B-m
channel NN I-NP O
blockers NNS I-NP O
and CC O O
IV NNP B-NP B-mo
ACE NNP I-NP B-m
inhibitors NNS I-NP I-m
in IN B-VP O
this DT O O
setting VBG O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
thus RB O O
placed VBN O O
on IN B-VP O
a DT B-NP O
nitroglycerin JJ I-NP B-m
drip NN I-NP B-mo
, , O O
a DT B-NP O
furosemide JJ I-NP B-m
furosemide NN I-NP B-m
drip NN I-NP B-mo
drip NN I-NP B-mo
drip NN I-NP B-mo
drip NN I-NP B-mo
with IN B-VP O
ginger NN B-NP B-m
ginger NN I-NP B-m
blood NN I-NP I-m
blood NN I-NP I-m
product NN I-NP I-m
product NN I-NP I-m
resuscitation NN I-NP O
to TO O O
address VB O O
bleeding VBG O B-r
bleeding NN B-NP B-r
and CC O O
an DT O B-r
an DT B-NP B-r
elevated JJ I-NP I-r
elevated JJ I-NP I-r
INR NNP I-NP I-r
INR NNP I-NP I-r
He PRP O O
responded VBD B-VP O
well RB O O
to TO O O
this DT B-NP O
regimen NNS I-NP O
and CC O O
aggressive JJ B-NP O
pulmonary JJ I-NP O
toilet NN I-NP O
Both NNP I-NP O
the DT B-NP O
patient's NN I-NP O
PCP NNP I-NP O
, , O O
Dr NNP B-NP O
Gillice NNP I-NP O
, , O O
and CC O O
his PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Keks NNP I-NP O
, , O O
did VBD B-VP O
follow VB O O
the DT B-NP O
patient NN I-NP O
His PRP$ O O
oxygenation NN B-NP O
never RB O O
suffered VBD B-VP O
during IN B-VP O
this DT B-NP O
time NN I-NP O
and CC O O
he PRP O O
did VBD B-VP O
not RB O O
have VB O O
significant JJ B-NP O
hypercarbia NN I-NP O
He PRP O O
was VBD B-VP O
eventually RB O O
weaned VBN O O
back RB O O
to TO O O
nasal VB O O
cannula NN B-NP O
He PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
mild JJ I-NP O
transient JJ I-NP O
elevation NN I-NP O
in IN B-VP O
creatinine NN B-NP O
while IN B-VP O
on IN B-VP O
the DT B-NP O
Lasix NNP I-NP B-m
drip NN I-NP B-mo
but CC O O
has VBZ O O
since IN B-VP O
recovered VBN O O
back RB O O
to TO O O
baseline VB O O
off IN B-VP O
of IN B-VP O
the DT B-NP O
Lasix NNP I-NP B-m
drip VB O B-mo
His PRP$ O O
nasogastric JJ B-NP O
tube NN I-NP O
was VBD B-VP O
removed VBN O O
on IN B-VP O
9/2/06 CD O O
and CC O O
he PRP O O
tolerated VBD B-VP O
ice JJ B-NP O
chips NNS I-NP O
without IN B-VP O
difficulty NN B-NP O
His PRP$ O O
home NN B-NP O
cardiac NN I-NP B-m
medications NNS I-NP I-m
were VBD B-VP O
restarted VBN O O
on IN B-VP O
9/28/06 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
and CC O O
ambulating VBG O O
without IN B-VP O
difficulty NN B-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
dictation NN B-NP O
, , O O
his PRP$ O O
nitroglycerin JJ B-NP B-m
drip NN I-NP B-mo
was VBD B-VP O
being VBG O O
weaned VBN O O
with IN B-VP O
the DT B-NP O
assistance NN I-NP O
of IN B-VP O
nitro JJ B-NP B-m
paste NN I-NP I-m
He PRP O O
is VBZ O O
anticipated VBN O O
to TO O O
be VB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
once RB O O
he PRP O O
receives VBZ O O
a DT B-NP O
red JJ I-NP B-m
blood NN I-NP O
cell NN I-NP O
transfusion NN I-NP B-mo
and CC O O
once RB O O
the DT B-NP O
nitroglycerin NN I-NP B-m
drip NN I-NP B-mo
is VBZ O O
off IN B-VP O
PLAN: NNP B-NP O
Neuro: NNP I-NP O
1 CD O O
The DT B-NP O
patient NN I-NP O
does VBZ O O
sundown VBN O O
at IN B-VP O
home NN B-NP O
and CC O O
has VBZ O O
done VBN O O
so RB O O
while IN B-VP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
He PRP O O
has VBZ O O
been VBN O O
much RB O O
more RBR O O
calm JJ O O
and CC O O
appropriate JJ O O
over IN B-VP O
the DT O O
past JJ O O
24 CD O O
to TO O O
36 CD O O
hours NNS B-NP O
2 CD O O
He PRP O O
does VBZ O O
experience VB O O
more RBR O O
significant JJ B-NP O
delirium NN I-NP O
with IN B-VP O
morphine NN B-NP B-m
and CC O O
less RBR O O
so RB O O
with IN B-VP O
sparing VBG O O
Dilaudid NNP B-NP B-m
p.r.n RB O B-f
3 CD O O
We PRP O O
will MD O O
continue VB O O
with IN B-VP O
sparing VBG O O
Dilaudid NNP B-NP B-m
p.r.n NN I-NP B-f
, , O O
and CC O O
Zyprexa NNP B-NP B-m
2.5 CD O B-do
at IN B-VP B-f
bedtime NN B-NP I-f
p.r.n NN I-NP I-f
per IN B-VP O
home NN B-NP O
regimen NNS I-NP O
Haldol NNP I-NP B-m
is VBZ O O
written VBN O O
p.r.n RB O B-f
as IN B-VP O
needed VBN O O
Cardiovascular: NNP B-NP O
1 CD O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
stent NN I-NP O
x2 NN I-NP O
, , O O
AF NNP B-NP O
on IN B-VP O
chronic JJ B-NP O
anticoagulation NN I-NP O
, , O O
CHF NNP B-NP O
, , O O
status NN B-NP O
post NN I-NP O
pacer NN I-NP O
for IN B-VP O
sick JJ B-NP O
sinus NN I-NP O
syndrome NN I-NP O
, , O O
currently RB O O
V NNP B-NP O
paced VBD B-VP O
2 CD O O
Outpatient NNP B-NP O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
150 CD O O
to TO O O
180 CD O O
, , O O
current JJ B-NP O
goal NN I-NP O
of IN B-VP O
SBP NNP B-NP O
140 CD O O
to TO O O
160 CD O O
3 CD O O
Weaning NNP B-NP O
off RP O O
nitroglycerin JJ B-NP B-m
drip NN I-NP B-mo
, , O O
nitro JJ B-NP B-m
paste NN I-NP I-m
added VBD B-VP O
4 CD O O
Diltiazem NNP B-NP B-m
CD NN I-NP I-m
360 CD O B-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Lopressor NNP B-NP B-m
SR NNP I-NP I-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
lisinopril VBZ O B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
amiodarone RB O B-m
200 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
restarted VBD B-VP O
per IN B-VP O
home NN B-NP O
regimen NNS I-NP O
5 CD O O
Aspirin NNP B-NP B-m
and CC O O
Plavix NNP B-NP B-m
to TO O O
continue VB O O
for IN B-VP O
cardiac JJ B-NP B-r
cardiac JJ I-NP B-r
stents NNS I-NP I-r
stents NNS I-NP I-r
6 CD O O
Watch NNP B-NP O
for IN B-VP O
overload NN B-NP O
Pulmonary: NNP I-NP O
1 CD O O
Pulmonary NNP B-NP O
edema NN I-NP O
with IN B-VP O
improving VBG O O
chest JJS O O
x-ray JJ O O
, , O O
currently RB O O
saturating VBG O O
well RB O O
on IN B-VP O
4 CD O O
L NNP B-NP O
of IN B-VP O
nasal JJ B-NP O
cannula NN I-NP O
2 CD O O
Aggressive NNP B-NP O
pulmonary JJ B-NP O
toilet NN I-NP O
, , O O
nebs RB O O
, , O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
and CC O O
ambulation NN B-NP O
3 CD O O
Lasix NNP B-NP B-m
with IN B-VP O
blood NN B-NP O
GI: NNP I-NP O
1 CD O O
Patient NNP B-NP O
advanced VBD B-VP O
to TO O O
clear VB O O
liquids NNS B-NP O
only RB O O
2 CD O O
All DT B-NP O
p.o NN I-NP O
meds VBZ O O
3 CD O O
Nexium NNP B-NP B-m
GU: NNP I-NP O
1 CD O O
Good NNP B-NP O
urine NN I-NP O
output NN I-NP O
off IN B-VP O
Lasix NNP B-NP B-m
2 CD O O
Creatinine NNP B-NP O
back RB O O
to TO O O
baseline NN B-NP O
of IN B-VP O
1 CD O O
3 CD O O
Lasix NNP B-NP B-m
to TO O O
be VB O O
given VBN O O
with IN B-VP O
blood NN B-NP O
as RB O O
well RB O O
as IN B-VP O
potassium NN B-NP B-m
4 CD O O
Slowly NNP B-NP O
trending VBG O O
back RB O O
to TO O O
preop VB O O
weight NN B-NP O
, , O O
would MD O O
recommend VB O O
gentle JJ B-NP O
diuresis NN I-NP O
p.r.n NN I-NP O
and CC O O
careful JJ B-NP O
observance NN I-NP O
of IN B-VP O
potassium NN B-NP O
Heme: NNP I-NP O
1 CD O O
Hematocrit NNP B-NP O
25% CD O O
today NN B-NP O
, , O O
we PRP O O
will MD O O
give VB O O
one CD O B-do
unit NN B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
with IN B-VP O
Lasix NNP B-NP B-m
and CC O O
potassium NN B-NP B-m
2 CD O O
Continue NNP B-NP O
with IN B-VP O
subcutaneous JJ B-NP B-mo
heparin NNS I-NP B-m
for IN B-VP O
now RB O O
and CC O O
Coumadin NNP B-NP B-m
to TO O O
restart VB O O
at IN B-VP O
discretion NN B-NP O
of IN B-VP O
primary JJ B-NP O
team NN I-NP O
ID: NNP I-NP O
1 CD O O
Vancomycin NNP B-NP B-m
for IN B-VP O
MRSA-infected NNP B-NP B-r
mesh JJ O I-r
2 CD O O
PICC NNP B-NP O
line NN I-NP O
consult NN I-NP O
ordered VBD B-VP O
for IN B-VP O
anticipated JJ B-NP O
long-term JJ I-NP B-du
vancomycin NN I-NP B-m
Endocrine: NNP I-NP O
1 CD O O
Synthroid NNP B-NP B-m
at IN B-VP O
home NN B-NP B-do
dose NN I-NP I-do
2 CD O O
RISS NNP B-NP B-m
SERVICES NNPS I-NP O
FOLLOWING NNP I-NP O
THE NNP I-NP O
PATIENT: NNP I-NP O
1 CD O O
Medicine NNP B-NP O
, , O O
Dr NNP B-NP O
Harcar NNP I-NP O
, , O O
patient's NN B-NP O
PCP NNP I-NP O
2 CD O O
Cardiology NNP B-NP O
, , O O
Dr NNP B-NP O
Pagliari NNP I-NP O
3 CD O O
Plastic NNP B-NP O
Surgery NNP I-NP O
, , O O
Dr NNP B-NP O
Dunshie NNP I-NP O
Patient NNP I-NP O
anticipated VBD B-VP O
to TO O O
be VB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
9/28/06 CD O O
eScription NN B-NP O
document: NN I-NP O
8-1765940 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
POSSINGER NNP I-NP O
, , O O
NICK NNP B-NP O
Attending: NNP I-NP O
BERKELEY NNP I-NP O
, , O O
MURRAY NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
7197007 CD O O
D: NNP B-NP O
11/29/06 CD O O
T: NNP B-NP O
11/29/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#174046 VBZ O O
765192522 CD O O
SFH NNP B-NP O
79392868 CD O O
2175092 CD O O
5/17/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
LOWER NNP I-NP O
GASTROINTESTINAL NNP I-NP O
BLEED NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/20/2002 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/13/2002 CD O O
PRINCIPLE NNP B-NP O
DIAGNOSIS: NNP I-NP O
LOWER NNP I-NP O
GASTROINTESTINAL NNP I-NP O
BLEED NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
75-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
five CD O O
catheterization NN B-NP O
with IN B-VP O
a DT B-NP O
pacemaker NN I-NP O
in IN B-VP O
place NN B-NP O
, , O O
arthritis NN B-NP O
, , O O
gout NN B-NP O
, , O O
benign JJ B-NP O
prostatic JJ I-NP O
hypertrophy NN I-NP O
, , O O
hypertension NN B-NP O
and CC O O
myelodysplasia NN B-NP O
who WP O O
presents VBZ O O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
lower JJR B-NP O
gastrointestinal NN I-NP O
bleeds NNS I-NP O
He PRP O O
has VBZ O O
had VBD B-VP O
three CD O O
episodes NNS B-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
He PRP O O
presented VBD B-VP O
to TO O O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
four CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
with IN B-VP O
symptoms NNS B-NP O
of IN B-VP O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
His PRP$ O O
vital JJ B-NP O
signs NNS I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
were VBD B-VP O
normal JJ O O
and CC O O
stable JJ O O
with IN B-VP O
a DT B-NP O
hematocrit NN I-NP O
of IN B-VP O
33 CD O O
A NNP B-NP O
tagged VBD B-VP O
red JJ B-NP O
blood NN I-NP O
cell NN I-NP O
scan NN I-NP O
was VBD B-VP O
negative JJ O O
during IN B-VP O
that DT B-NP O
hospitalization NN I-NP O
as IN B-VP O
was VBD B-VP O
an DT B-NP O
upper JJ I-NP O
endoscopy NN I-NP O
Colonoscopy NNP I-NP O
revealed VBD B-VP O
diverticula NN B-NP O
throughout IN B-VP O
the DT B-NP O
large JJ I-NP O
colon NN I-NP O
with IN B-VP O
more RBR O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
than IN B-VP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
During IN B-VP B-du
that DT B-NP O
hospitalization NN I-NP O
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
transfused VBN O O
with IN B-VP O
four CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
and CC O O
then RB O O
transferred VBD B-VP O
to TO O O
the DT B-NP O
Siter NNP I-NP O
Calvty NNP I-NP O
Valley NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
and CC O O
treatment NN B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
his PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
32.9 CD O O
Subsequent JJ B-NP O
serial JJ I-NP O
hematocrits NNS I-NP O
over IN B-VP O
the DT O O
following JJ O O
two CD O O
days NNS B-NP O
were VBD B-VP O
stable JJ O O
During IN B-VP O
the DT B-NP O
first JJ I-NP O
hospital NN I-NP O
day NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
two CD O O
grossly RB O O
heme-positive JJ B-NP O
bowel NN I-NP O
movements NNS I-NP O
and CC O O
, , O O
by IN B-VP O
the DT B-NP O
second JJ I-NP O
hospital NN I-NP O
day NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
bowel NN B-NP O
movements NNS I-NP O
that WDT O O
were VBD B-VP O
brown VBN O O
and CC O O
formed VBN O O
but CC O O
guaiac JJ O O
positive JJ O O
still RB O O
His PRP$ O O
hematocrit NN B-NP O
remained VBD B-VP O
stable JJ O O
between IN B-VP O
30 CD O O
and CC O O
35 CD O O
throughout IN B-VP O
his PRP$ O O
earlier JJR B-NP O
hospitalization NN I-NP O
Given IN B-VP O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
multiple JJ B-NP O
gastrointestinal JJ I-NP O
bleeds NNS I-NP O
, , O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
perform VB O O
a DT B-NP O
right JJ I-NP O
hemicolectomy NN I-NP O
to TO O O
prevent VB O O
further RB O O
episodes NNS B-NP O
This DT O O
was VBD B-VP O
performed VBN O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
three CD O O
See NNP B-NP O
Operative NNP I-NP O
Note NNP I-NP O
for IN B-VP O
details NNS B-NP O
The DT B-NP O
procedure NN I-NP O
and CC O O
recovery NN B-NP O
were VBD B-VP O
unremarkable JJ O O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
sips NNS B-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
one CD O O
and CC O O
clear JJ B-NP O
liquids NNS I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
He PRP O O
tolerated VBD B-VP O
all DT O O
of IN B-VP O
this DT B-NP O
well NN I-NP O
His PRP$ O O
Foley NNP B-NP O
catheter NN I-NP O
was VBD B-VP O
removed VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
His PRP$ O O
diet NN B-NP O
was VBD B-VP O
advanced VBN O O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
three CD O O
, , O O
he PRP O O
had VBD B-VP O
passed VBN O O
flatus RB O O
He PRP O O
began VBD B-VP O
to TO O O
have VB O O
loose JJ B-NP O
bowel NN I-NP O
movements NNS I-NP O
His PRP$ O O
diet NN B-NP O
was VBD B-VP O
advanced JJ O O
and CC O O
, , O O
by IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
four CD O O
, , O O
he PRP O O
was VBD B-VP O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
house NN I-NP O
diet NN I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
stable JJ O O
and CC O O
tolerating VBG O O
p.o.'s NN B-NP O
quite RB O O
well RB O O
His PRP$ O B-r
His PRP$ O B-r
pain NN B-NP I-r
pain NN I-NP I-r
was VBD B-VP O
well RB O O
controlled VBN O O
with IN B-VP O
p.o NN B-NP B-mo
p.o NN I-NP B-mo
pain NN I-NP B-m
medication NN I-NP O
of IN B-VP O
Percocet NNP B-NP B-m
and CC O O
he PRP O O
was VBD B-VP O
voiding VBG O O
freely RB O O
without IN B-VP O
difficulty NN B-NP O
He PRP O O
was VBD B-VP O
ambulating VBG O O
successfully RB O O
Therefore RB O O
, , O O
it PRP O O
was VBD B-VP O
deemed VBN O O
that IN B-VP O
he PRP O O
was VBD B-VP O
suitable JJ O O
for IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
his PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Poette NNP I-NP O
throughout IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
Prior NNP I-NP O
to TO O O
surgery VB O O
, , O O
he PRP O O
was VBD B-VP O
deemed VBN O O
suitable JJ O O
for IN B-VP O
surgery NN B-NP O
without IN B-VP O
any DT B-NP O
serious JJ I-NP O
cardiac JJ I-NP O
risks NNS I-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
run NN I-NP O
of IN B-VP O
V-tach NNP B-NP O
10 CD O O
beats NNS B-NP O
, , O O
asymptomatic JJ O O
, , O O
no DT B-NP O
chest NN I-NP O
pain NN I-NP O
or CC O O
discomfort NN B-NP O
, , O O
no DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
He PRP O O
said VBD B-VP O
that IN B-VP O
he PRP O O
was VBD B-VP O
coughing VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
that IN B-VP O
that DT B-NP O
tracing NN I-NP O
came VBD B-VP O
up RP O O
A NNP B-NP O
CK NNP I-NP O
and CC O O
troponin NN B-NP O
were VBD B-VP O
sent VBN O O
which WDT O O
were VBD B-VP O
both DT O O
flat JJ O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
previously RB O O
been VBN O O
ruled VBN O O
out RP O O
for IN B-VP O
MI NNP B-NP O
Postoperatively NNP I-NP O
, , O O
as IN B-VP O
a DT B-NP O
prophylactic JJ I-NP O
course NN I-NP O
, , O O
given VBN O O
that IN B-VP O
he PRP O O
has VBZ O O
a DT B-NP O
ventricular JJ I-NP O
pacemaker NN I-NP O
and CC O O
we PRP O O
could MD O O
not RB O O
follow VB O O
EKGs NNP B-NP O
based VBN O O
on IN B-VP O
that IN B-VP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
thereafter RB O O
, , O O
and CC O O
had VBD B-VP O
no DT B-NP O
further JJ I-NP O
cardiac NN I-NP O
symptoms NNS I-NP O
or CC O O
issues NNS B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
throughout IN B-VP O
his PRP$ O O
postoperative JJ B-NP O
course NN I-NP O
and CC O O
prior JJ O O
to TO O O
discharge VB O O
was VBD B-VP O
deemed VBN O O
suitable JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
home NN B-NP O
, , O O
was VBD B-VP O
able JJ O O
to TO O O
do VB O O
all DT B-NP O
necessary JJ I-NP O
activities NNS I-NP O
to TO O O
go VB O O
home NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Allopurinol NNP I-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
atenolol RB O B-m
25 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.d NN I-NP B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
p.r.n NN I-NP O
constipation NN I-NP B-r
, , O O
Percocet NNP B-NP B-m
1-2 JJ B-NP B-do
tablets NNS I-NP I-do
p.o VBP O B-mo
q.4h JJ B-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Flomax NNP B-NP B-m
0.8 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
He PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Weigold NNP I-NP O
, , O O
his PRP$ O O
hematologist NN B-NP O
, , O O
in IN B-VP O
2-4 JJ B-NP O
weeks NNS I-NP O
He PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Condiff NNP I-NP O
on IN B-VP O
8/28/02 CD O O
He PRP O O
was VBD B-VP O
stable JJ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
and CC O O
is VBZ O O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
Dictated VBN O O
By: NNP B-NP O
GUILLERMO NNP I-NP O
PICKINGS NNP I-NP O
, , O O
M.D NNP B-NP O
RZ88 NNP I-NP O
Attending: NNP I-NP O
LONNY NNP I-NP O
JURAS NNP I-NP O
, , O O
M.D NNP B-NP O
HU83 NNP I-NP O
GO568/513958 NNP I-NP O
Batch: NNP I-NP O
62628 CD O O
Index NNP B-NP O
No NNP I-NP O
XPBE4L64O2 NNP I-NP O
D: NNP I-NP O
7/25/02 CD O O
T: NNP B-NP O
7/25/02 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#180337 VBZ O O
443003187 CD O O
W NNP B-NP O
67626522 CD O O
3713536 CD O O
6/19/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
sleep JJ B-NP O
apnea NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/19/2000 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/10/2000 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
DAMBOISE NNP I-NP O
, , O O
GREGORIO NNP B-NP O
T NNP I-NP O
225-87-00-6 JJ B-NP O
Hend NNP I-NP O
Lake NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/7 CD O O
AT NNP B-NP O
08:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
CALK NNP I-NP O
, , O O
JAY NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
650-1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4-6H NNP I-NP B-f
PRN NNP I-NP O
headache NN I-NP B-r
TYLENOL NNP I-NP B-m
LIQUID NNP I-NP I-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
ELIXER NNP I-NP I-m
) ) O I-m
650-1 CD O O
, , O O
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4-6H NNP I-NP B-f
PRN NNP I-NP I-f
headache NN I-NP B-r
TYLENOL NNP I-NP B-m
#3 NNP I-NP I-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
W/CODEINE NNP I-NP I-m
30MG CD O I-m
) ) O I-m
1-2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP O
pain NN I-NP B-r
Instructions: NNP I-NP O
max NN I-NP O
dose NN I-NP O
tylenol NN I-NP B-m
= VBD B-VP O
4gram/day CD O B-do
LAC-HYDRIN JJ O B-m
12% CD O I-m
( ( O I-m
AMMONIUM NNP B-NP I-m
LACTATE NNP I-NP I-m
12% CD O I-m
) ) O I-m
TOPICAL NNP B-NP B-mo
TP NNP I-NP I-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
to TO O O
lower VB O O
extremities NNS B-NP O
CEPACOL NNP I-NP B-m
1 CD O B-do
LOZENGE NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
sore VBD B-VP B-r
throat NN B-NP I-r
FLAGYL NNP I-NP B-m
( ( O I-m
METRONIDAZOLE NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
X NNP I-NP B-du
5 CD O I-du
Days NNPS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
10/19 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
METAMUCIL NNP I-NP B-m
SUGAR NNP I-NP I-m
FREE NNP I-NP I-m
( ( O I-m
PSYLLIUM NNP B-NP I-m
( ( O I-m
METAMUCIL NNP B-NP I-m
) ) O I-m
SU NNP B-NP I-m
) ) O I-m
1 CD O B-do
PACKET NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PRN NNP I-NP I-f
CONSTIPATION NNP I-NP B-r
DICLOXACILLIN NNP I-NP B-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
X NNP I-NP B-du
12 CD O I-du
Days NNP B-NP I-du
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
LISINOPRIL NNP B-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Not RB O O
Applicable NNP B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Schak NNP I-NP O
one CD O O
week NN B-NP O
, , O O
Dr NNP B-NP O
Hartis NNP I-NP O
next JJ B-NP O
week NN I-NP O
, , O O
Dr NNP B-NP O
Chionchio NNP I-NP O
nest JJS O O
available JJ O O
, , O O
ALLERGY: NNP B-NP O
Aspirin NNP I-NP O
, , O O
Iron NNP B-NP O
( ( O O
ferrous JJ B-NP O
sulfate NN I-NP O
) ) O O
, , O O
Nsaid's NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chf NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
sleep VBP O O
apnea IN B-VP O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
vonWillebrand NN I-NP O
factor NN I-NP O
disease NN I-NP O
iron NN I-NP O
deficiency NN I-NP O
anemia NN I-NP O
s/p NN I-NP O
TAH NNP I-NP O
for IN B-VP O
chronic JJ O O
bleeding VBG O O
obstructive JJ B-NP O
sleep JJ I-NP O
apnea NN I-NP O
morbid NN I-NP O
obesity NN I-NP O
pickwickian/restrictive JJ B-NP O
lung NN I-NP O
disease NN I-NP O
hypertension NN I-NP O
Bacterial NNP I-NP O
vaginosis NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
*** VBZ O O
11/17 CD O O
*** NN B-NP O
43yo CD O O
morbidly RB O O
obese JJ B-NP O
F NNP I-NP O
c NN I-NP O
H/O NNP I-NP O
OSA NNP I-NP O
p/w NN I-NP O
fatigue NN I-NP O
, , O O
SOB NNP B-NP O
, , O O
orthopnea NN B-NP O
, , O O
cough NN B-NP O
, , O O
and CC O O
LEE NNP B-NP O
, , O O
thought VBD B-VP O
to TO O O
be VB O O
CHF NNP B-NP O
RA NNP I-NP O
sat VBD B-VP O
on IN B-VP O
adm NN B-NP O
was VBD B-VP O
85% CD O O
, , O O
up RB O O
to TO O O
91% CD O O
on IN B-VP O
5 CD O O
L NNP B-NP O
NC NNP I-NP O
Plan NNP I-NP O
is VBZ O O
to TO O O
get VB O O
echo JJ O O
, , O O
empirically RB O O
diurese JJ B-NP O
LEE NNP I-NP O
is VBZ O O
probably RB O O
venous JJ B-NP O
stasis: NN I-NP O
will MD O O
get VB O O
LENIs NNP B-NP O
, , O O
then RB O O
apply VB O O
compression NN B-NP O
stockings NNS I-NP O
if IN B-VP O
LENIs NNP B-NP O
neg FW O O
This DT O O
is VBZ O O
a DT O O
very RB O O
difficult JJ O O
and CC O O
demanding VBG O O
patient JJ O O
1/5 CD O O
sats NNS B-NP O
on IN B-VP O
4L CD O O
low JJ O O
90s CD O O
Pt NNP B-NP O
asking VBG O O
for IN B-VP O
tx NN B-NP O
for IN B-VP O
cellulitis NN B-NP O
, , O O
none NN B-NP O
seen VBN O O
clinically RB O O
only RB O O
longstanding VBG O O
venous JJ B-NP O
stasis NN I-NP O
Also RB O O
requesting VBG O O
coryza NN B-NP O
tx NN I-NP O
, , O O
refusing VBG O O
inh JJ B-NP B-mo
steroids NNS I-NP B-m
or CC O O
claritin VB O B-m
Spoke NNP B-NP O
w/ WRB O O
Dr NNP B-NP O
Loy NNP I-NP O
, , O O
outpt NN B-NP O
pulm NN I-NP O
, , O O
who WP O O
rec VBP O O
cpap JJ B-NP O
18-19 JJ I-NP O
cm NN I-NP O
H2O NNP I-NP O
for IN B-VP O
8 CD O O
w/ JJ B-NP O
O2 NNP I-NP O
Pt NNP I-NP O
refusing VBG O O
tx JJ B-NP O
LENIS NNP I-NP O
negative NN I-NP O
, , O O
limited JJ B-NP O
study NN I-NP O
Pt NNP I-NP O
refusing VBG O O
sc JJ B-NP O
hep NN I-NP O
4/29 CD O O
pt NN B-NP O
is VBZ O O
not RB O O
tolerating VBG O O
cpap NN B-NP O
at IN B-VP O
night NN B-NP O
second NN I-NP O
to TO O O
feeling NN B-NP O
of IN B-VP O
suffocating VBG O O
She PRP O O
is VBZ O O
also RB O O
refusing VBG O O
inpatient NN B-NP O
rehab NN I-NP O
despite IN B-VP O
social JJ B-NP O
work NN I-NP O
and CC O O
care NN B-NP O
coord NN I-NP O
assistance NN I-NP O
w/ NN I-NP O
home/bills NNS I-NP O
issues NNS I-NP O
Pt NNP I-NP O
has VBZ O O
definite VBN O O
IDA NNP B-NP O
and CC O O
would MD O O
benefit VB O O
from IN B-VP O
iron NN B-NP O
She PRP O O
doesn't VBZ O O
tolerate JJ B-NP O
po NN I-NP O
and CC O O
will MD O O
need VB O O
iv JJ B-NP O
Pt NNP I-NP O
was VBD B-VP O
consented VBN O O
Tolerated NNP B-NP O
iron NN I-NP B-m
iv NN I-NP B-mo
Gyn NNP I-NP O
appt NN I-NP O
rec NN I-NP O
flagyl NN I-NP B-m
for IN B-VP O
BV NNP B-NP B-r
Echo NNP I-NP O
showed VBD B-VP O
slightly RB O O
inc JJ B-NP O
ef NN I-NP O
and CC O O
lv/a JJ B-NP O
enlarg NN I-NP O
EKG NNP I-NP O
w/ VBZ O O
possible JJ B-NP O
lat JJ I-NP O
strain NN I-NP O
10/19 CD O O
Pt NNP B-NP O
is VBZ O O
still RB O O
not RB O O
compliant JJ B-NP O
w/ NN I-NP O
cpap NN I-NP O
because IN B-VP O
her PRP$ O O
nose JJ B-NP O
burns NNS I-NP O
w/ VBP O O
the DT B-NP O
oxygen NN I-NP O
despite IN B-VP O
humidification NN B-NP O
Exam NNP I-NP O
of IN B-VP O
nose NN B-NP O
is VBZ O O
unremarkable JJ O O
She PRP O O
is VBZ O O
also RB O O
refusing VBG O O
BP NNP B-NP B-m
medication NN I-NP I-m
because IN B-VP O
she PRP O O
claims VBZ O O
that IN B-VP O
she PRP O O
does VBZ O O
not RB O O
have VB O O
high JJ B-NP O
BP NNP I-NP O
She PRP O O
has VBZ O O
an DT O O
elevated VBN O O
wt NN B-NP O
ct NN I-NP O
and CC O O
some DT B-NP O
pain NN I-NP O
and CC O O
swelling NN B-NP O
of IN B-VP O
R NNP B-NP O
LE NNP I-NP O
Will NNP I-NP O
tx VB O O
w/ JJ B-NP O
diclox NN I-NP B-m
for IN B-VP O
cellulitis NN B-NP B-r
Pt NNP I-NP O
recd NN I-NP O
flu NN I-NP O
shot NN I-NP O
and CC O O
pneumovax NN B-NP B-m
She PRP O O
says VBZ O O
that IN B-VP O
she PRP O O
does VBZ O O
not RB O O
have VB O O
a DT B-NP O
fever NN I-NP O
, , O O
cough NN B-NP O
or CC O O
feels NNS B-NP O
ill VBP O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
Pt NNP I-NP O
suffered VBD B-VP O
very RB O O
minor JJ B-NP O
trauma NN I-NP O
to TO O O
Right NNP B-NP O
first RB O O
toe VBZ O O
on IN B-VP O
her PRP$ O O
car NN B-NP O
Examination NN I-NP O
is VBZ O O
unremarkable JJ O O
This DT O O
can MD O O
be VB O O
followed VBN O O
up RP O O
w/ JJ B-NP O
PCP NNP I-NP O
Dr NNP I-NP O
Pavoni NNP I-NP O
( ( O O
her PRP$ O O
hematologist NN B-NP O
) ) O O
said VBD B-VP O
that IN B-VP O
she PRP O O
is VBZ O O
not RB O O
a DT B-NP O
candidate NN I-NP O
for IN B-VP O
dvt NN B-NP O
prophylaxis JJ O O
second JJ O O
to TO O O
bleeding; VB O O
she PRP O O
should MD O O
not RB O O
receive VB O O
any DT B-NP O
anticoagulants NNS I-NP O
unless IN B-VP O
strong JJ B-NP O
clinical JJ I-NP O
indication NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
have VBP O O
appt VBN O O
w/ JJ B-NP O
Dr NNP I-NP O
Fridal NNP I-NP O
and CC O O
Dr NNP B-NP O
Trezza NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
See NNP I-NP O
Dr NNP I-NP O
Knipple NNP I-NP O
at IN B-VP O
next JJ B-NP O
available JJ I-NP O
appt NN I-NP O
Please NNP I-NP O
have VBP O O
VNA NNP B-NP O
for IN B-VP O
every DT B-NP O
other JJ I-NP O
day NN I-NP O
to TO O O
do VB O O
respiratory JJ B-NP O
eval NN I-NP O
and CC O O
assistance NN B-NP O
w/ NN I-NP O
medical JJ B-NP O
care NN I-NP O
Please NNP I-NP O
have VBP O O
PT/OT NNP B-NP O
to TO O O
see VB O O
pt JJ O O
twice RB O O
weekly JJ B-NP O
Pt NNP I-NP O
must MD O O
use VB O O
CPAP NNP B-NP O
at IN B-VP O
18-19 JJ B-NP O
cm NN I-NP O
H2O NNP I-NP O
for IN B-VP O
8hrs CD O O
night NN B-NP O
w/ NN I-NP O
O2 NNP I-NP O
at IN B-VP O
4-5 JJ B-NP O
L NNP I-NP O
&amp; NNP I-NP O
w/ POS O O
ambulation NN B-NP O
Sitz NNP I-NP O
bath NN I-NP O
to TO O O
vagina VB O O
twice/d JJ O O
Call VB O O
your PRP$ O O
doctor NN B-NP O
if IN B-VP O
short JJ O O
of IN B-VP O
breath NN B-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
nausea/vomiting NN B-NP O
, , O O
worsening VBG O O
leg NN B-NP O
pain NN I-NP O
, , O O
headaches NNS B-NP O
or CC O O
other JJ B-NP O
worrisome NN I-NP O
symptoms NNS I-NP O
Pt NNP I-NP O
is VBZ O O
to TO O O
go VB O O
to TO O O
Emjeaneser/ NNP B-NP O
Valley NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
as IN B-VP O
an DT B-NP O
outpatient JJ I-NP O
Home NNP I-NP O
health NN I-NP O
aid NN I-NP O
twice RB O O
per IN B-VP O
wk NN B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
TESORO NNP I-NP O
, , O O
NATHAN NNP B-NP O
T NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
HE59 NNP B-NP O
) ) O O
8/7 CD O O
@ $ O O
09:46 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#182634 VBZ O O
805705747 CD O O
PH NNP B-NP O
53859318 CD O O
4563124 CD O O
3/22/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
colonic JJ B-NP O
microperforation NN I-NP O
, , O O
afib JJ B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/11/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/2/2003 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
GVERRERO NNP I-NP O
, , O O
STAN NNP B-NP O
O NNP I-NP O
346-21-49-8 JJ B-NP O
Irv NNP I-NP O
Lu NNP I-NP O
Spo NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
5/27/03 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KERSON NNP I-NP O
, , O O
RODNEY NNP B-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
FESO4 NNP I-NP B-m
( ( O I-m
FERROUS NNP B-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
6/1 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
milk NN I-NP O
and CC O O
antacid JJ B-NP O
FOLATE NNP I-NP B-m
( ( O I-m
FOLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
SYNTHROID NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PREDNISONE NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/0/03 CD O O
by IN B-VP O
LIU NNP B-NP O
, , O O
HERMAN NNP B-NP O
ANTONIO NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
NEORAL NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
55336954 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
CYCLOSPORINE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
NEORAL NNP B-NP B-m
( ( O I-m
CYCLOSPORINE NNP B-NP I-m
MICRO NNP I-NP I-m
( ( O I-m
NEORAL NNP B-NP I-m
) ) O I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Give VBP O O
with IN B-VP O
meals NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/0/03 CD O O
by IN B-VP O
ELVEY NNP B-NP O
, , O O
EDMUND NNP B-NP O
LENNY NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LOSARTAN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
04133525 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CYCLOSPORINE NNP I-NP B-m
&amp; NNP I-NP O
LOSARTAN NNP I-NP B-m
POTASSIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
Previous JJ O O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/0/03 CD O O
by IN B-VP O
LYNADY NNP B-NP O
, , O O
LAMONT NNP B-NP O
LORENZO NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
CYCLOSPORINE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
LOSARTAN NNP B-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/0/03 CD O O
by IN B-VP O
CONOLEY NNP B-NP O
, , O O
KELLEY NNP B-NP O
OTHA NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CYCLOSPORINE NNP I-NP B-m
&amp; NNP I-NP O
LOSARTAN NNP I-NP B-m
POTASSIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
Number NNP B-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
3 CD O O
ATENOLOL NNP B-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PRILOSEC NNP I-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
AMIODARONE NNP I-NP B-m
AMIODARONE NNP I-NP B-m
AMIODARONE NNP I-NP B-m
AMIODARONE NNP I-NP B-m
400 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
400 CD O O
bid NN B-NP O
x VBD B-VP B-du
6 CD O I-du
days NNS B-NP I-du
, , O O
then RB O O
400 CD O B-do
400 CD O B-do
qd NN B-NP B-f
qd NN I-NP B-f
x VBD B-VP B-du
1 CD O B-du
1 CD O I-du
week NN B-NP I-du
week NN I-NP I-du
, , O O
then RB O O
200 CD O B-do
qd NNS B-NP B-f
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
5/27/03 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
8/7 CD O O
) ) O O
Instructions: NNP B-NP O
To TO O O
start VB O O
on IN B-VP O
0/12 CD O O
FLAGYL NNP B-NP B-m
( ( O I-m
METRONIDAZOLE NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
X NNP I-NP B-du
2 CD O I-du
Days NNP B-NP I-du
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
LEVOFLOXACIN NNP I-NP B-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
X NNP I-NP B-du
2 CD O I-du
Days NNPS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
8/7 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-m
products NNS I-NP I-m
a DT B-NP B-f
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-m
or CC O O
ciprofloxacin NN B-NP B-m
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
Alert NNP I-NP O
overridden: MD O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
5/27/03 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Schultheiss NNP I-NP O
( ( O O
cardiology NN B-NP O
) ) O O
5/30/03 CD O O
scheduled VBN O O
, , O O
Gastroenterology- NNP B-NP O
Dr NNP I-NP O
Degener NNP I-NP O
, , O O
call NN B-NP O
for IN B-VP O
appointment NN B-NP O
, , O O
ALLERGY: NNP B-NP O
Iv NNP I-NP O
contrast NN I-NP O
dyes NNS I-NP O
, , O O
Codeine NNP B-NP O
, , O O
Penicillins NNP B-NP O
, , O O
Erythromycins NNP B-NP O
, , O O
Morphine NNP B-NP O
, , O O
Demerol NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Aspiration NNP I-NP O
PNA NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
colonic NN B-NP O
microperforation NN I-NP O
, , O O
afib VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
cad NN I-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
hodgkin NN B-NP O
( ( O O
Hodgkins NNP B-NP O
disease NN I-NP O
) ) O O
renal NN B-NP O
transplant NN I-NP O
( ( O O
kidney VB O O
transplant NN B-NP O
) ) O O
htn NN B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
s/p NN B-NP O
appy JJ O O
( ( O O
S/P NNP B-NP O
appendectomy RB O O
) ) O O
h/o VBZ O O
A DT B-NP O
fib NN I-NP O
( ( O O
H/O NNP B-NP O
atrial JJ B-NP O
fibrillation NN I-NP O
) ) O O
hypothyroidism NN B-NP O
( ( O O
hypothyroidism NN B-NP O
) ) O O
polyarteritis NN B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Colonoscopy NNP I-NP O
under IN B-VP O
general JJ B-NP O
anesthesia NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
74 CD O O
yo NN B-NP O
woman NN I-NP O
in IN B-VP O
remission NN B-NP O
from IN B-VP O
Hodgkin's NNP B-NP O
Lymphoma NNP I-NP O
and CC O O
s/p JJ B-NP O
renal JJ I-NP O
transplant( NN I-NP O
11/12 CD O O
) ) O O
who WP O O
p/w VBP O O
hypoxia NNS B-NP O
, , O O
low JJ B-NP O
grade NN I-NP O
fever NN I-NP O
in IN B-VP O
setting VBG O O
of IN B-VP O
colonoscopy NN B-NP O
under IN B-VP O
general JJ B-NP O
anesthesia NN I-NP O
Pt NNP I-NP O
had VBD B-VP O
PET NNP B-NP O
scan JJ O O
on IN B-VP O
1/29 CD O O
which WDT O O
showed VBD B-VP O
uptake NN B-NP O
in IN B-VP O
asc JJ B-NP O
colon NN I-NP O
and CC O O
hep JJ B-NP O
flexure NN I-NP O
concerning VBG O O
for IN B-VP O
malignancy NN B-NP O
CT NNP I-NP O
colonoscopy NN I-NP O
showed VBD B-VP O
1.6 CD O O
les NNS B-NP O
in IN B-VP O
desc NN B-NP O
colon NN I-NP O
and CC O O
colonoscopy NN B-NP O
under IN B-VP O
GA NNP B-NP O
performed VBD B-VP O
due JJ O O
to TO O O
difficulty NN B-NP O
of IN B-VP O
going VBG O O
beyond IN B-VP O
hep JJ B-NP O
flexure NN I-NP O
Pt NNP I-NP O
had VBD B-VP O
hypoxia VBN O O
to TO O O
80s CD O O
when WRB O O
awakening VBG O O
from IN B-VP O
anesthesia JJ B-NP O
Temp NNP I-NP O
to TO O O
101.1 CD O O
CXR NNP B-NP O
showed VBD B-VP O
?LLL NNP B-NP O
opacity NN I-NP O
Thought NNP I-NP O
to TO O O
be VB O O
likely JJ B-NP O
Pneumonitis NNP I-NP O
vs NN I-NP O
asp NN I-NP O
PNA NNP I-NP O
In IN B-VP O
Pacu NNP B-NP O
Pt NNP I-NP O
also RB O O
had VBD B-VP O
EKG NNP B-NP O
changes NNS I-NP O
, , O O
TWIs NNP B-NP O
and CC O O
? . B-VP O
BBB NNP B-NP O
assoc NN I-NP O
with IN B-VP O
HR70s-80s NNP B-NP O
EKGs NNP I-NP O
resolved VBD B-VP O
when WRB O O
rate NN B-NP O
in IN B-VP O
60s CD O O
Physical JJ B-NP O
Exam NNP I-NP O
revealed VBD B-VP O
AOOx3 NNP B-NP O
woman NN I-NP O
in IN B-VP O
NAD NNP B-NP O
PERRL NNP I-NP O
No NNP I-NP O
carotid NN I-NP O
bruits NNS I-NP O
Cardiac NNP I-NP O
exam NN I-NP O
remarkable NN I-NP O
for IN B-VP O
RRR NNP B-NP O
, , O O
2/6 CD O O
murmur NN B-NP O
at IN B-VP O
RUSB NNP B-NP O
There EX O O
are VBP O O
crackles NNS B-NP O
at IN B-VP O
LL NNP B-NP O
base NN I-NP O
to TO O O
mid VB O O
lung JJ B-NP O
field NN I-NP O
Abd NNP I-NP O
exam NN I-NP O
there EX O O
is VBZ O O
rebound NN B-NP O
and CC O O
invol NN B-NP O
guarding VBG O O
Tenderness NNP B-NP O
in IN B-VP O
epigastric JJ O O
and CC O O
suprapubic JJ B-NP O
area NN I-NP O
+BS VBZ O O
No DT B-NP O
hepatomegaly NN I-NP O
Labs NNP I-NP O
significant JJ O O
for IN B-VP O
HCt NNP B-NP O
24 CD O O
from IN B-VP O
baseline NN B-NP O
of IN B-VP O
30 CD O O
, , O O
Cr NNP B-NP O
1.9 CD O O
from IN B-VP O
baseline NN B-NP O
of IN B-VP O
1.6 CD O O
Cardiac NNP B-NP O
enzymes NNS I-NP O
were VBD B-VP O
flat JJ B-NP O
HOSPITAL NNP I-NP O
COURSE:**************** NNP I-NP O
1 CD O O
Pulm-On NNP B-NP O
floor NN I-NP O
pt's NN I-NP O
oxygenation NN I-NP O
improved VBD B-VP O
within IN B-VP O
one CD O O
day NN B-NP O
to TO O O
96% CD O O
on IN B-VP O
RA NNP B-NP O
Likely NNP I-NP O
aspiration NN I-NP O
, , O O
but CC O O
final JJ B-NP O
read NN I-NP O
on IN B-VP O
CXR NNP B-NP O
shows VBZ O O
no DT B-NP O
infiltrate/opacity NN I-NP O
Levo/Flagyl NNP I-NP B-m
given VBN O O
empirically RB O O
x JJ O B-du
5days CD O I-du
though IN B-VP O
she PRP O O
remained VBD B-VP O
afeb JJ O O
2 CD O O
CV-Pt NN B-NP O
has VBZ O O
h/o VBN O O
MI NNP B-NP O
, , O O
RCA NNP B-NP O
stent NN I-NP O
, , O O
mod RB O O
AS IN B-VP O
Low NNP B-NP O
Hct NNP I-NP O
and CC O O
EKG NNP B-NP O
changes NNS I-NP O
concerning VBG O O
for IN B-VP O
myocardial JJ B-NP O
injury NN I-NP O
Her NNP I-NP O
cardiac NN I-NP O
enzymes NNS I-NP O
were VBD B-VP O
negative JJ O O
after IN B-VP O
the DT B-NP O
initial JJ I-NP O
hypoxic NN I-NP O
episode NN I-NP O
, , O O
and CC O O
EKG NNP B-NP O
changes NNS I-NP O
resolved VBD B-VP O
Transfused JJ O O
2u CD O B-do
PRBCs NNP B-NP B-m
On IN B-VP O
1/16 CD O O
she PRP O O
had VBD B-VP O
Afib NNP B-NP O
with IN B-VP O
RVR NNP B-NP O
to TO O O
130s CD O O
with IN B-VP O
chest NN B-NP O
arm NN I-NP O
pain NN I-NP O
which WDT O O
is VBZ O O
her PRP$ O O
anginal JJ B-NP O
equivalent JJ I-NP O
ECG NNP I-NP O
with IN B-VP O
rate NN B-NP O
related VBN O O
ischemia NN B-NP O
ST NNP I-NP O
depression NN I-NP O
V5-6 NNP I-NP O
, , O O
L NNP B-NP O
+Minimal NNP I-NP O
troponin NN I-NP O
leak NN I-NP O
to TO O O
0.19 CD O O
, , O O
which WDT O O
subseq VBZ O O
downtrended VBN O O
with IN B-VP O
nl JJ B-NP O
CK NNP I-NP O
She PRP O O
was VBD B-VP O
init RB O O
treated VBN O O
with IN B-VP O
lopressor NN B-NP B-m
5mg CD O B-do
IV NNP B-NP B-mo
but CC O O
had VBD B-VP O
hypotension NN B-NP B-r
to TO O O
80's CD O O
which WDT O O
resolved VBD B-VP O
quickly RB O O
with IN B-VP O
IVF NNP B-NP B-m
She PRP O O
was VBD B-VP O
eventually RB O O
rate NN B-NP O
controlled VBN O O
with IN B-VP O
dilt NN B-NP B-m
drip NN I-NP B-mo
She PRP O O
returned VBD B-VP O
to TO O O
sinus VB O O
rhythm NN B-NP O
within IN B-VP O
the DT B-NP O
day NN I-NP O
Cards NNP I-NP O
c/s'd NN I-NP O
and CC O O
recommended VBD B-VP O
amio NN B-NP B-m
load NN I-NP O
She PRP O O
had VBD B-VP O
PFT's NNP B-NP O
, , O O
LFT's NNP B-NP O
and CC O O
TFT's NNP B-NP O
prior RB O O
to TO O O
d/c VB O O
Plan NNP B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Lenberg NNP I-NP O
Consider NNP I-NP O
anticoagulation NN I-NP B-m
for IN B-VP O
PAF NNP B-NP B-r
, , O O
this DT O O
is VBZ O O
at IN B-VP O
least JJS O O
2nd CD O O
episode NN B-NP O
Pt NNP I-NP O
to TO O O
restart VB O O
ecasa VB O B-m
ecasa JJ O B-m
5d CD O B-du
p NN B-NP O
colonosco NN I-NP O
py VBD B-VP O
2 CD O O
GI-Pt NNP B-NP O
had VBD B-VP O
abd VBN O O
exam RB O O
concerning VBG O O
for IN B-VP O
focal JJ B-NP O
peritoneal NN I-NP O
irritation NN I-NP O
It PRP O O
is VBZ O O
likely JJ O O
that IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
microperforation NN I-NP O
during IN B-VP O
colonoscopy NN B-NP O
as IN B-VP O
CT NNP B-NP O
showed VBD B-VP O
fluid NN B-NP O
in IN B-VP O
pelvis NN B-NP O
and CC O O
she PRP O O
had VBD B-VP O
Hct NNP B-NP O
drop NN I-NP O
requiring VBG O O
2U CD O B-do
pRBC NN B-NP B-m
Her NNP I-NP O
exam NN I-NP O
improved VBD B-VP O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
tolerating VBG O O
PO NNP B-NP O
well RB O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
She PRP O O
has VBZ O O
been VBN O O
afeb VBN O O
and CC O O
well RB O O
appearing VBG O O
for IN B-VP O
several JJ B-NP O
days NNS I-NP O
prior RB O O
to TO O O
d/c VB O O
Plan NNP B-NP O
to TO O O
complete VB O O
5d CD O B-du
5d CD O B-du
abx NN B-NP B-m
As IN B-VP O
per IN B-VP O
Dr NNP B-NP O
Thorburn NNP I-NP O
her PRP$ O O
colonoscopy NN B-NP O
was VBD B-VP O
complex JJ O O
, , O O
and CC O O
she PRP O O
had VBD B-VP O
polypectomy NN B-NP O
of IN B-VP O
2.5 CD O O
cm NNS B-NP O
polyp JJ B-NP O
Path NNP I-NP O
is VBZ O O
pending VBG O O
If IN B-VP O
+ VBN O O
for IN B-VP O
cancer NN B-NP O
, , O O
the DT B-NP O
base NN I-NP O
looked VBD B-VP O
"clean" NNP B-NP O
, , O O
so RB O O
may MD O O
be VB O O
feasible JJ O O
to TO O O
re-scope VB O O
her PRP$ O O
for IN B-VP O
surveillance NN B-NP O
at IN B-VP O
a DT B-NP O
later JJ I-NP O
time NN I-NP O
, , O O
as IN B-VP O
per IN B-VP O
GI NNP B-NP O
3 CD O O
HEME- NNP B-NP O
Hct NNP I-NP O
after IN B-VP O
colonoscopy NN B-NP O
went VBD B-VP O
to TO O O
24 CD O O
( ( O O
baseline NN B-NP O
30 CD O O
); JJ B-NP O
post-transfusion NN I-NP O
HCt NNP I-NP O
of IN B-VP O
30 CD O O
5 CD O O
s/p JJ B-NP O
Renal NNP I-NP O
transplant NN I-NP O
Continuing NNP I-NP O
meds VBZ O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
HAJDUKIEWICZ NNP I-NP O
, , O O
CLIFFORD NNP B-NP O
NICHOLAS NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
ET412 NNP B-NP O
) ) O O
5/27/03 CD O O
@ $ O O
05:24 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#183745 VBZ O O
676331324 CD O O
TMH NNP B-NP O
12324822 CD O O
5221030 CD O O
4/1/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
same JJ B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/28/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/10/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
TAM NNP I-NP O
, , O O
MEL NNP B-NP O
506-68-15-3 CD O O
Ver NNP B-NP O
Ho NNP I-NP O
E NNP I-NP O
Service: NNP I-NP O
GGI NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/27/06 CD O O
AT NNP B-NP O
03:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
LEDAY NNP I-NP O
, , O O
EMERY NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ROCALTROL NNP I-NP B-m
( ( O I-m
CALCITRIOL NNP B-NP I-m
) ) O I-m
0.5 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
CALCIUM NNP I-NP B-m
CARBONATE NNP I-NP I-m
( ( O I-m
500 CD O I-m
MG NNP B-NP I-m
ELEMENTAL NNP I-NP I-m
CA++ NNP I-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
Instructions: NNP I-NP O
500mg CD O O
elemental JJ B-NP O
calcium NN I-NP O
is VBZ O O
the DT B-NP O
equivalent NN I-NP O
of IN B-VP O
1250mg CD O O
of IN B-VP O
calcium NN B-NP O
carbonate NN I-NP O
HYDROCHLOROTHIAZIDE NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
Tomorrow NNP I-NP O
( ( O O
11/6 CD O O
) ) O O
SYNTHROID NNP B-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
200 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
( ( O O
typical JJ B-NP O
dose NN I-NP O
is VBZ O O
1 CD O O
mcg NN B-NP O
per IN B-VP O
lb NN B-NP O
) ) O O
OXYCODONE NNP B-NP B-m
5-10 JJ B-NP B-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
ATENOLOL NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Tooles NNP I-NP O
please VB O O
call NN B-NP O
to TO O O
schedule NN B-NP O
, , O O
Primary NNP B-NP O
Care NNP I-NP O
please VB O O
call NN B-NP O
to TO O O
schedule NN B-NP O
, , O O
ALLERGY: NNP B-NP O
Erythromycins NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
metastatic JJ B-NP O
thyroid NN I-NP O
cancer NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
same JJ B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
OBESITY NNP I-NP O
SLEEP NNP I-NP O
APNEA NNP I-NP O
PNEUMONIA NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
LT NNP I-NP O
PARATRACHEAL NNP I-NP O
&amp; NNP I-NP O
MODIFIED NNP I-NP O
RADICAL NNP I-NP O
NECK NNP I-NP O
DISSECTION NNP I-NP O
DR NNP I-NP O
TROSPER NNP I-NP O
4/17/06 CD O O
OTHER NNP B-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
43 CD O O
yo NN B-NP O
F NNP I-NP O
with IN B-VP O
metastatic JJ B-NP O
tall NN I-NP O
cell NN I-NP O
papillary JJ O O
ca MD O O
to TO O O
bilateral VB O O
IJ NNP B-NP O
nodes NNS I-NP O
s/p VBP O O
RAI NNP B-NP O
s/p NN I-NP O
Left NNP I-NP O
paratracheal NN I-NP O
and CC O O
modified VBD B-VP O
radial JJ B-NP O
neck NN I-NP O
dissection NN I-NP O
Left NNP I-NP O
recurrent NN I-NP O
laryngeal NN I-NP O
nerve NN I-NP O
was VBD B-VP O
identified VBN O O
Left NNP B-NP O
parathyroids NNS I-NP O
were VBD B-VP O
not RB O O
identified VBN O O
, , O O
and CC O O
were VBD B-VP O
not RB O O
seen VBN O O
in IN B-VP O
the DT B-NP O
specimen NNS I-NP O
She PRP O O
is VBZ O O
already RB O O
moderately RB O O
hypoparathyroid JJ O O
from IN B-VP O
her PRP$ O O
total JJ B-NP O
thyroidectomy NN I-NP O
in IN B-VP O
1/24 CD O O
( ( O O
pre NN B-NP O
op NN I-NP O
ca MD O O
7.6 CD O O
) ) O O
The DT B-NP O
left JJ I-NP O
IJ NNP I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
clotted VBN O O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
case NN I-NP O
and CC O O
was VBD B-VP O
ligated VBN O O
mild JJ O O
oozing VBG O O
in IN B-VP O
the DT B-NP O
upper JJ I-NP O
portion NN I-NP O
of IN B-VP O
the DT B-NP O
surgical JJ I-NP O
bed NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
fibrillar JJ O O
( ( O O
cotton NN B-NP O
surgicel NN I-NP O
) ) O O
The DT B-NP O
inferior JJ I-NP O
aspect NN I-NP O
of IN B-VP O
the DT B-NP O
wound NN I-NP O
was VBD B-VP O
quite RB O O
deep JJ O O
( ( O O
thymus JJ O O
taken VBN O O
with IN B-VP O
the DT B-NP O
specimen NNS I-NP O
) ) O O
7 CD O O
JP NNP B-NP O
drain NN I-NP O
placed VBD B-VP O
along IN B-VP O
the DT B-NP O
dissection NN I-NP O
bed VBD B-VP O
PMH: NNP B-NP O
asthma NN I-NP O
, , O O
PSVT NNP B-NP O
in IN B-VP O
2001 CD O O
, , O O
obesity NN B-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
thalessemia JJ B-NP O
trait NN I-NP O
PSH: NNP I-NP O
gastric JJ B-NP O
bypass NN I-NP O
5 CD O O
of IN B-VP O
July NNP B-NP O
, , O O
s/p JJ B-NP O
cholecystectomy NN I-NP O
, , O O
bowel NN B-NP O
obstruction NN I-NP O
4/13 CD O O
total JJ B-NP O
thyroidectomy NN I-NP O
11/17 CD O O
Meds: NNP B-NP O
atenolol VBD B-VP B-m
100 CD O B-do
qd NN B-NP B-f
, , O O
hctz VBD B-VP B-m
25 CD O B-do
qd NN B-NP B-f
, , O O
levoxyl JJ O B-m
200 CD O B-do
bid NN B-NP B-f
, , O O
rocaltrol VB O B-m
0.5 CD O B-do
bid NN B-NP B-f
, , O O
calcium NN B-NP B-m
500 CD O B-do
mg NN B-NP I-do
elemental JJ O O
6 CD O B-f
times NNS B-NP I-f
per IN B-VP I-f
day NN B-NP I-f
All: NNP I-NP O
erythromycin VBZ O B-m
leads VBZ O O
to TO O O
GI NNP B-NP O
upset JJ B-NP O
pt NN I-NP O
underwent VBD B-VP O
the DT B-NP O
above JJ I-NP O
procedure NN I-NP O
, , O O
brief JJ B-NP O
desciption NN I-NP O
as IN B-VP O
above IN B-VP O
, , O O
please VB O O
see VB O O
operative JJ B-NP O
note NN I-NP O
for IN B-VP O
full JJ B-NP O
details NNS I-NP O
Pt NNP I-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
Pt's NNP B-NP O
diet NN I-NP O
was VBD B-VP O
advanced VBN O O
, , O O
pain NN B-NP B-r
was VBD B-VP O
well RB O O
controlled VBN O O
on IN B-VP O
oral JJ B-NP B-m
oral JJ I-NP B-mo
medications NNS I-NP I-m
ON NNP I-NP O
pod#0 NN I-NP O
pt NN I-NP O
was VBD B-VP O
hypertensive JJ O B-r
requiring VBG O O
multiple JJ B-NP O
doses NNS I-NP O
of IN B-VP O
IV NNP B-NP B-mo
IV NNP I-NP B-mo
medication NN I-NP O
( ( O O
labetalol JJ O B-m
and CC O O
hydralazine NN B-NP B-m
) ) O O
in IN B-VP O
order NN B-NP O
to TO O O
control VB O O
pod#1 JJ O O
she PRP O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
all DT O O
her PRP$ O O
oral JJ B-NP B-m
oral JJ I-NP B-mo
medications NNS I-NP I-m
and CC O O
her PRP$ O O
pressure NN B-NP O
lowered VBD B-VP O
appropriately RB O O
pod#1 JJ O O
, , O O
she PRP O O
ate VBD B-VP O
a DT B-NP O
fatty JJ I-NP O
meal NN I-NP O
as IN B-VP O
instructed VBN O O
for IN B-VP O
lunch NN B-NP O
and CC O O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
a DT B-NP O
chyle JJ I-NP O
leak NN I-NP O
and CC O O
her PRP$ O O
JP NNP B-NP O
drain NN I-NP O
was VBD B-VP O
d/c'd JJ B-NP O
Her NNP I-NP O
serum NN I-NP O
calcium NN I-NP O
levels NNS I-NP O
were VBD B-VP O
7.5 CD O O
and CC O O
a DT B-NP O
recheck NN I-NP O
was VBD B-VP O
8.1 CD O O
the DT B-NP O
pt NN I-NP O
was VBD B-VP O
neurologically RB O O
intact JJ O O
, , O O
af JJ O O
, , O O
hd JJ O O
stable JJ O O
and CC O O
wound NN B-NP O
was VBD B-VP O
c/d/i JJ B-NP O
Pt NNP I-NP O
was VBD B-VP O
deemed VBN O O
ready JJ O O
for IN B-VP O
d/c NN B-NP O
to TO O O
f/u VB O O
c JJ B-NP O
dr NN I-NP O
macky JJ B-NP O
pt NN I-NP O
to TO O O
call VB O O
to TO O O
schedule VB O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
1 CD O O
Please NNP B-NP O
call VB O O
if IN B-VP O
fever RB O O
greater JJR O O
than IN B-VP O
101.5 CD O O
, , O O
if IN B-VP O
increased VBN O O
redness NN B-NP O
around RB O O
wound RB O O
, , O O
if IN B-VP O
discharge NN B-NP O
from IN B-VP O
wound NN B-NP O
, , O O
if IN B-VP O
increased VBN O O
pain NN B-NP O
uncontrolled JJ O O
by IN B-VP O
pain NN B-NP B-m
medications NNS I-NP O
2 CD O O
Please NNP B-NP O
do VB O O
not RB O O
immerse VB O O
wound NN B-NP O
in IN B-VP O
bath NN B-NP O
, , O O
swimming NN B-NP O
, , O O
or CC O O
sauna NN B-NP O
for IN B-VP O
2 CD O O
weeks NNS B-NP O
3 CD O O
Please NNP B-NP O
do VB O O
not RB O O
drive VB O O
while IN B-VP O
taking VBG O O
narcotics NNS B-NP O
4 CD O O
Please NNP B-NP O
follow VB O O
up RP O O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
provider NN I-NP O
concerning VBG O O
hospitalization NN B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
KORTRIGHT NNP I-NP O
, , O O
ANTONIA NNP B-NP O
JAMISON NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
XX29 NNP B-NP O
) ) O O
9/27/06 CD O O
@ $ O O
03 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#188924 VBZ O O
429472380 CD O O
EMCO NNP B-NP O
98607374 CD O O
2554367 CD O O
9/6/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Congestive NNP I-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
dilated VBN O O
cardiomyopathy JJ B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/22/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/6/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SOLTOW NNP I-NP O
, , O O
TERENCE NNP B-NP O
161-86-99-2 CD O O
Mo NNP B-NP O
Clasmentale NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
6/7/05 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BROGLEY NNP I-NP O
, , O O
WILBURN NNP B-NP O
MICHAEL NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/7/05 CD O O
by IN B-VP O
FELCH NNP B-NP O
, , O O
LEN NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
55946845 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/7/05 CD O O
by IN B-VP O
SUTKUS NNP B-NP O
, , O O
STUART NNP B-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ASPIRIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Patient NNP I-NP O
has VBZ O O
been VBN O O
stable JJ O O
on IN B-VP O
this DT B-NP O
regimen NN I-NP O
at IN B-VP O
home NN B-NP O
PHOSLO NNP I-NP B-m
( ( O I-m
CALCIUM NNP B-NP I-m
ACETATE NNP I-NP I-m
) ) O I-m
667 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
FOLATE NNP I-NP B-m
( ( O I-m
FOLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIOVAN NNP I-NP B-m
( ( O I-m
VALSARTAN NNP B-NP I-m
) ) O I-m
160 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
his PRP$ O O
cardiologist NN B-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
4 CD O I-du
CARVEDILOL NNP B-NP B-m
6.25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
HR NNP I-NP O
&lt; NNP I-NP O
60 CD O O
, , O O
or CC O O
SBP NNP B-NP O
&lt; VBP O O
100 CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
his PRP$ O O
cardiologist JJ B-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
8 CD O O
NEPHROCAPS NNP B-NP B-m
( ( O I-m
NEPHRO-VIT NNP B-NP I-m
RX NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/7/05 CD O O
by IN B-VP O
ALAMIN NNP B-NP O
, , O O
NORMAN NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
Aware NNP I-NP O
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/7/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP O
med VBN O O
LASIX NNP B-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Sackrider NNP I-NP O
at IN B-VP O
ACH NNP B-NP O
5/6/05 CD O O
at IN B-VP O
1:30 CD O O
PM NNP B-NP O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Dauphin NNP I-NP O
at IN B-VP O
CMC NNP B-NP O
0/4/05 CD O O
at IN B-VP O
1:40 CD O O
PM NNP B-NP O
scheduled VBN O O
, , O O
Aaron NNP B-NP O
Searl NNP I-NP O
at IN B-VP O
MJH NNP B-NP O
, , O O
call NN B-NP O
to TO O O
schedule NN B-NP O
this DT O O
within IN B-VP O
2 CD O O
weeks NNS B-NP O
TBA NNP I-NP O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
, , O O
lisinopril NN B-NP O
, , O O
Hctz NNP B-NP O
, , O O
Advair NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Dyspnea NNP I-NP O
and CC O O
hypoxia NN B-NP O
on IN B-VP O
exertion NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Congestive NNP B-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
dilated VBN O O
cardiomyopathy NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
Asthma NNP I-NP O
, , O O
OSA NNP B-NP O
, , O O
CRF NNP B-NP O
, , O O
Recent NNP B-NP O
multifocal JJ B-NP O
PNA NNP I-NP O
, , O O
h/o NN B-NP O
DVT NNP I-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
obesity NN B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Chest NNP I-NP O
CT NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Pulmonary NNP B-NP O
consult NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
ID: NNP I-NP O
42 CD O O
yo NN B-NP O
man NN I-NP O
dilated VBD B-VP O
non-ischemic JJ B-NP O
CM NNP I-NP O
( ( O O
EF NNP B-NP O
23% CD O O
, , O O
cath NN B-NP O
4/13 CD O O
= NN B-NP O
no DT B-NP O
CAD NNP I-NP O
) ) O O
, , O O
OSA NNP B-NP O
, , O O
CRF NNP B-NP O
almost RB O O
ESRD NNP B-NP O
( ( O O
2/2 CD O O
HTN NNP B-NP O
vs NN I-NP O
obesity NN I-NP O
related VBN O O
GS NNP B-NP O
) ) O O
, , O O
DVT NNP B-NP O
( ( O O
4/30 CD O O
, , O O
on IN B-VP O
coumadin NN B-NP B-m
) ) O O
, , O O
asthma RB O O
, , O O
HTN NNP B-NP O
, , O O
OSA NNP B-NP O
, , O O
mild JJ B-NP O
hyperhomocysteinemia NN I-NP O
--- NNP I-NP O
CC: NNP I-NP O
5 CD O O
weeks NNS B-NP O
worsening VBG O O
DOE NNP B-NP O
3 CD O O
miles NNS B-NP O
flat JJ B-NP O
ground NN I-NP O
--&gt; VBD B-VP O
50 CD O O
ft JJ B-NP O
flat JJ I-NP O
ground NN I-NP O
--- NNP I-NP O
DX: NNP I-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
AND NNP I-NP O
? . B-VP O
multifocal JJ B-NP O
PNA NNP I-NP O
vs NN I-NP O
other JJ B-NP O
primary JJ I-NP O
lung NN I-NP O
etiology NN I-NP O
, , O O
CRF NNP B-NP O
almost RB O O
ESRD NNP B-NP O
--- NNP I-NP O
HPI: NNP I-NP O
42 CD O O
yo NN B-NP O
man NN I-NP O
w NN I-NP O
above IN B-VP O
hx NN B-NP O
, , O O
admitted VBD B-VP O
4/30 CD O O
dx'd JJ B-NP O
multifocal JJ I-NP B-r
PNA NNP I-NP I-r
tx'd NN I-NP O
14d CD O B-du
levoflox NN B-NP B-m
, , O O
D/C'd NNP B-NP O
feeling VBG O O
well RB O O
, , O O
then RB O O
progressive JJ B-NP O
inc NNS I-NP O
DOE NNP I-NP O
now RB O O
hypoxia VBZ O O
on IN B-VP O
exertion NN B-NP O
No NNP I-NP O
cough/F/C NN I-NP O
Last JJ B-NP O
admit NN I-NP O
4/30 CD O O
CT: NNP B-NP O
multifocal JJ B-NP O
PNA NNP I-NP O
, , O O
CTA NNP B-NP O
no DT B-NP O
PE NNP I-NP O
, , O O
LENIS NNP B-NP B-r
L NNP I-NP I-r
peroneal NN I-NP I-r
DVT NNP I-NP I-r
Started NNP I-NP O
Heparin NNP I-NP B-m
, , O O
VQ NNP B-NP O
negative JJ O O
, , O O
converted VBN O O
to TO O O
coumadin VB O B-m
INR NNP B-NP O
2-3 CD O O
for IN B-VP O
DVT NNP B-NP B-r
ECHO: NNP I-NP O
EF NNP I-NP O
25% CD O O
, , O O
mod FW O O
RV NNP B-NP O
dsyfn NN I-NP O
, , O O
severe JJ B-NP O
TR NNP I-NP O
( ( O O
then RB O O
F/U NNP B-NP O
cardiac VBD B-VP O
MRI NNP B-NP O
10/16 CD O O
EF NNP B-NP O
23% CD O O
, , O O
global JJ B-NP O
hypokinesis NN I-NP O
, , O O
no DT B-NP O
WMA NNP I-NP O
, , O O
nl JJ B-NP O
RV NNP I-NP O
, , O O
no DT B-NP O
valve NN I-NP O
dz NN I-NP O
) ) O O
Renal NNP B-NP O
consult NN I-NP O
for IN B-VP O
stable JJ B-NP O
CRF NNP I-NP O
Cr NNP I-NP O
5.5-6.0 JJ O O
, , O O
F/U NNP B-NP O
in IN B-VP O
outpatient JJ B-NP O
clinic NN I-NP O
, , O O
have VBP O O
discussed VBN O O
vascular JJ B-NP O
access NN I-NP O
but CC O O
none NN B-NP O
placed VBD B-VP O
yet RB O O
4/30 CD O O
Ddimer NN B-NP O
1400 CD O O
, , O O
BNP NNP B-NP O
2009 CD O O
, , O O
Trop NNP B-NP O
0.84--&gt;0.54 CD O O
not RB O O
considered VBN O O
ischemic JJ O O
, , O O
no DT B-NP O
tx NN I-NP O
C/O NNP I-NP O
10lb CD O O
weight NN B-NP O
gain NN I-NP O
over IN B-VP O
last JJ B-NP O
month NN I-NP O
, , O O
ROS NNP B-NP O
O/W NNP I-NP O
negative JJ O O
( ( O O
no DT B-NP O
F/C/CP NNP I-NP O
, , O O
etc FW O O
) ) O O
Now RB O O
DDimer NNP B-NP O
1207 CD O O
, , O O
BNP NNP B-NP O
2917 CD O O
, , O O
Trop NNP B-NP O
not RB O O
sent VBD B-VP O
--- NNP B-NP O
STATUS: NNP I-NP O
T NNP I-NP O
97.2 CD O O
HR NNP B-NP O
98-104 CD O O
BP NNP B-NP O
160/114 CD O O
RR NNP B-NP O
18 CD O O
95% CD O O
RA NNP B-NP O
desat VBD B-VP O
85% CD O O
RA NNP B-NP O
walking VBG O O
50 CD O O
ft JJ B-NP O
comfortable JJ I-NP O
breathing NN I-NP O
at IN B-VP O
rest NN B-NP O
, , O O
nice JJ B-NP O
guy NN I-NP O
, , O O
JVP NNP B-NP O
to TO O O
earlobe VB O O
, , O O
bibasilar JJ B-NP O
rales NNS I-NP O
, , O O
no DT B-NP O
wheezes NN I-NP O
, , O O
obese JJ O O
, , O O
S3 NNP B-NP O
, , O O
1+ CD O O
pitting VBG O O
edema NN B-NP O
to TO O O
B NNP B-NP O
shins NNS I-NP O
, , O O
diffuse NN B-NP O
PIPA NNP I-NP O
--- NNP I-NP O
EVENTS NNP I-NP O
In IN B-VP O
ED: NNP B-NP O
Duonebs NNP I-NP B-m
, , O O
ASA NNP B-NP B-m
325 CD O B-do
, , O O
Lasix NNP B-NP B-m
80mg CD O B-do
PO NNP B-NP B-mo
CXR: NNP I-NP O
increased VBD B-VP O
bilat JJ B-NP O
LL NNP I-NP O
opacities NNS I-NP O
to TO O O
periphery VB O O
with IN B-VP O
some DT B-NP O
cephalization NN I-NP O
of IN B-VP O
vessels NNS B-NP O
, , O O
some DT B-NP O
opacification NN I-NP O
ECG: NNP I-NP O
98 CD O O
bpm NN B-NP O
, , O O
LAE NNP B-NP O
, , O O
strain NN B-NP O
--- JJ B-NP O
TESTS/PROCEDURES NNP I-NP O
Chest NNP I-NP O
CT NNP I-NP O
8/18 CD O O
( ( O O
compare NN B-NP O
to TO O O
4/30 CD O O
): NNS B-NP O
Per NNP I-NP O
pulm NN I-NP O
c/w NN I-NP O
scarring/persistent NN I-NP O
changes NNS I-NP O
after IN B-VP O
recent JJ B-NP O
multifocal JJ I-NP O
PNA NNP I-NP O
4/30 CD O O
, , O O
no DT B-NP O
e/o NN I-NP O
of IN B-VP O
new JJ B-NP O
primary JJ I-NP O
lung NN I-NP O
path NN I-NP O
, , O O
ground NN B-NP O
glass NN I-NP O
c/w NN I-NP O
pulmonary JJ B-NP O
edema NN I-NP O
--- NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
SOB NNP I-NP O
secondary JJ O O
to TO O O
CHF NNP B-NP O
exacerbation NN I-NP O
and CC O O
fluid NN B-NP O
overload NN I-NP O
No NNP I-NP O
evidence NN I-NP O
of IN B-VP O
infectious JJ B-NP O
pulmonary JJ I-NP O
process NN I-NP O
contributing VBG O O
to TO O O
present VB O O
symptoms NNS B-NP O
CXR NNP I-NP O
and CC O O
CT NNP B-NP O
changes NNS I-NP O
are VBP O O
c/w JJ B-NP O
scarring/changes NNS I-NP O
from IN B-VP O
recent JJ B-NP O
multifocal JJ I-NP O
PNA NNP I-NP O
4/30 CD O O
, , O O
with IN B-VP O
additional JJ B-NP O
ground NN I-NP O
glass NN I-NP O
c/w NN I-NP O
pulmonary JJ B-NP O
edema NN I-NP O
No NNP I-NP O
clinical JJ O O
or CC O O
radiologic JJ B-NP O
e/o NN I-NP O
primary JJ B-NP O
lung NN I-NP O
etiology NN I-NP O
for IN B-VP O
DOE NNP B-NP O
Pulmonary NNP I-NP O
team NN I-NP O
assessed VBD B-VP O
patient NN B-NP O
and CC O O
reviewed VBD B-VP O
non JJ B-NP O
contrast NN I-NP O
chest JJS B-NP O
CT NN I-NP O
from IN B-VP O
this DT B-NP O
admssion NN I-NP O
- : O O
they PRP O O
confirmed VBD B-VP O
that IN B-VP O
current JJ B-NP O
sx NN I-NP O
are VBP O O
likely JJ O O
2/2 CD O O
pulomonary JJ B-NP O
edema NN I-NP O
Patient NNP I-NP O
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
Lasix NNP B-NP B-m
just RB O O
over IN B-VP O
3L CD O O
net JJ O O
negative JJ O O
with IN B-VP O
improvement NN B-NP O
in IN B-VP O
his PRP$ O O
oxygen NN B-NP O
saturations NNS I-NP O
( ( O O
rest NN B-NP O
and CC O O
ambulation NN B-NP O
) ) O O
At IN B-VP O
time NN B-NP O
of IN B-VP O
d/c NN B-NP O
JVP NNP I-NP O
10cm CD O O
Pt NNP B-NP O
will MD O O
diurese VB O O
further RBR O O
at IN B-VP O
home NN B-NP O
on IN B-VP O
Lasix NNP B-NP B-m
80 CD O B-do
BID NNP B-NP B-f
( ( O O
he PRP O O
had VBD B-VP O
not RB O O
been VBN O O
taking VBG O O
his PRP$ O O
lasix NN B-NP B-m
for IN B-VP O
2d CD O B-du
prior JJ O O
to TO O O
d/c VB O O
HTN NNP B-NP B-r
HTN NNP I-NP B-r
was VBD B-VP O
another DT B-NP O
issue NN I-NP O
on IN B-VP O
admission NN B-NP O
but CC O O
is VBZ O O
most JJS O O
likely JJ O O
due JJ O O
to TO O O
patient VB O O
taking VBG O O
wrong JJ B-NP O
dose NN I-NP O
of IN B-VP O
Coreg NNP B-NP B-m
Coreg NNP I-NP B-m
( ( O O
taking VBG O O
QOD NNP B-NP B-f
instead RB O O
of IN B-VP O
BID NNP B-NP B-f
) ) O O
On IN B-VP O
a DT B-NP O
BID NNP I-NP B-f
Coreg NNP I-NP B-m
regiments NNS I-NP O
, , O O
BP NNP B-NP B-r
much RB O O
better JJR O O
controlled VBN O O
Etiology NN B-NP O
of IN B-VP O
his PRP$ O O
CMP NNP B-NP O
still RB O O
remains VBZ O O
unclear JJ O O
despite IN B-VP O
extensive JJ B-NP O
outpt NN I-NP O
W/U NNP I-NP O
Additionally NNP I-NP O
, , O O
discrepancy NN B-NP O
between IN B-VP O
Echo NNP B-NP O
and CC O O
Cardiac NNP B-NP O
MRI NNP I-NP O
is VBZ O O
puzzling VBG O O
No NNP B-NP O
concern NN I-NP O
for IN B-VP O
ischemia NN B-NP O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
clean JJ B-NP O
cath NN I-NP O
in IN B-VP O
2002 CD O O
Started VBD B-VP O
on IN B-VP O
ASA NNP B-NP B-m
and CC O O
continued VBN O O
on IN B-VP O
Lipitor NNP B-NP B-m
Renal NNP I-NP O
function NN I-NP O
remained VBD B-VP O
stable JJ O O
but CC O O
impaired JJ O O
He PRP O O
is VBZ O O
being VBG O O
evaluated VBN O O
for IN B-VP O
dialysis NN B-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
but CC O O
no DT B-NP O
vasc JJ I-NP O
access NN I-NP O
placed VBN O O
yet RB O O
Phoslo NNP B-NP B-m
, , O O
nephrocaps NNS B-NP B-m
continued VBD B-VP O
here RB O O
Finally RB O O
, , O O
pt FW O O
continued VBN O O
on IN B-VP O
coumadin NN B-NP B-m
for IN B-VP O
h/o JJ B-NP O
recent JJ I-NP B-r
DVT NNP I-NP I-r
( ( O O
4/30 CD O O
) ) O O
and CC O O
INR NNP B-NP O
remained VBD B-VP O
in IN B-VP O
therapeutic JJ B-NP O
range NN I-NP O
Low NNP I-NP O
suspicion NN I-NP O
for IN B-VP O
PE NNP B-NP O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
He PRP O O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
with IN B-VP O
outpatient NN B-NP O
follow VBP O O
up RP O O
instructions NNS B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
Be NNP B-NP O
sure JJ O O
to TO O O
take VB O O
your PRP$ O O
Coreg NNP B-NP B-m
as IN B-VP O
instructed JJ O O
2 CD O O
Call NNPS B-NP O
your PRP$ O O
doctor NN B-NP O
if IN B-VP O
your PRP$ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
gets VBZ O O
worse JJR O O
or CC O O
if IN B-VP O
you PRP O O
have VBP O O
chest VBN O O
pain NN B-NP O
, , O O
fevers NNS B-NP O
or CC O O
dizziness NN B-NP O
3 CD O O
Take NNP B-NP O
your PRP$ O O
coumadin NN B-NP B-m
as IN B-VP O
regulated VBN O O
by IN B-VP O
the DT B-NP O
anticoagulation NN I-NP O
clinic JJ O O
4 CD O O
Check NNP B-NP O
your PRP$ O O
weight JJ O O
daily JJ O O
and CC O O
take VB O O
your PRP$ O O
lasix NN B-NP B-m
as IN B-VP O
prescribed JJ O O
5 CD O O
Call NNP B-NP O
you PRP O O
primary VBP O O
care VB O O
doctor NN B-NP O
and CC O O
cardiologist NN B-NP O
Monday NNP I-NP O
morning NN I-NP O
11/1 CD O O
Please NNP B-NP O
see VB O O
one CD O O
of IN B-VP O
them PRP O O
this DT O O
upcoming VBG O O
week NN B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Fair NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
your PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
, , O O
your PRP$ O O
cardiologist NN B-NP O
and CC O O
the DT B-NP O
renal JJ I-NP O
clinic NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
LAA NNP I-NP O
, , O O
TOM NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.B.A NNP B-NP O
( ( O O
BQ30 NNP B-NP O
) ) O O
6/7/05 CD O O
@ $ O O
10:25 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#191340 VBZ O O
853345880 CD O O
TLUMC NNP B-NP O
81063320 CD O O
450919 CD O O
4/22/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIBE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/22/1997 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/13/1997 CD O O
DISCHARGE NNP B-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
SHORTNESS NNP B-NP O
OF NNP I-NP O
BREATH NNP I-NP O
2 CD O O
HYPERTENSION NNP B-NP O
3 CD O O
DIABETES NNP B-NP O
4 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
MITRAL NNP I-NP O
REGURGITATION NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
68 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
long JJ O O
standing VBG O O
hypertension NN B-NP O
and CC O O
diabetes NNS B-NP O
who WP O O
says VBZ O O
that IN B-VP O
she PRP O O
had VBD B-VP O
been VBN O O
doing VBG O O
well RB O O
until IN B-VP O
approximately RB O O
one CD O O
week NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
she PRP O O
was VBD B-VP O
in IN B-VP O
Tempefayscot NNP B-NP O
, , O O
Michigan NNP B-NP O
76498 CD O O
for IN B-VP O
a DT B-NP O
wedding NN I-NP O
and CC O O
during IN B-VP O
that DT B-NP O
time NN I-NP O
she PRP O O
was VBD B-VP O
unable JJ O O
to TO O O
follow VB O O
her PRP$ O O
normal JJ B-NP O
strict JJ I-NP O
low JJ I-NP O
salt NN I-NP O
diet NN I-NP O
During IN B-VP O
that DT B-NP O
time NN I-NP O
and CC O O
since IN B-VP O
the DT B-NP O
time NN I-NP O
back RP O O
in IN B-VP O
Ette NNP B-NP O
Na NNP I-NP O
No NNP I-NP O
the DT B-NP O
patient NN I-NP O
began VBD B-VP O
having VBG O O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
and CC O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
The DT B-NP O
patient NN I-NP O
on IN B-VP O
the DT B-NP O
night NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
was VBD B-VP O
unable JJ O O
to TO O O
sleep VB O O
secondary JJ O O
to TO O O
shortness VB O O
of IN B-VP O
breath NN B-NP O
and CC O O
sitting VBG O O
up RP O O
most JJS O O
of IN B-VP O
the DT B-NP O
evening NN I-NP O
She PRP O O
went VBD B-VP O
to TO O O
see VB O O
her PRP$ O O
doctor NN B-NP O
, , O O
Dr NNP B-NP O
Sherbo NNP I-NP O
in IN B-VP O
Clinic NNP B-NP O
the DT B-NP O
next JJ I-NP O
morning NN I-NP O
who WP O O
found VBD B-VP O
her PRP O O
to TO O O
be VB O O
in IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
and CC O O
recommended VBD B-VP O
her PRP O O
to TO O O
go VB O O
to TO O O
May NNP B-NP O
While IN B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
Procardia NNP B-NP B-m
XL NNP I-NP I-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
x VBZ O B-du
1 CD O I-du
for IN B-VP O
a DT B-NP B-r
systolic JJ I-NP I-r
blood NN I-NP I-r
pressure NN I-NP I-r
greater JJR O O
than IN B-VP O
200 CD O O
, , O O
Aspirin NNP B-NP B-m
, , O O
Nitropaste NNP B-NP B-m
and CC O O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
significant JJ B-NP O
response NN I-NP O
to TO O O
the DT B-NP O
IV NNP I-NP B-mo
Lasix NNP I-NP B-m
with IN B-VP O
complete JJ B-NP O
resolution NN I-NP O
of IN B-VP O
her PRP$ O B-r
shortness NN B-NP I-r
of IN B-VP I-r
breath NN B-NP I-r
and CC O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Short NNP I-NP O
Stay NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
As NNP I-NP O
mentioned VBN O O
above IN B-VP O
and CC O O
included VBD B-VP O
a DT B-NP O
stress NN I-NP O
echocardiogram NN I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
which WDT O O
showed VBD B-VP O
mitral JJ B-NP O
regurgitation NN I-NP O
, , O O
hypokinesis NN B-NP O
of IN B-VP O
the DT B-NP O
septum NN I-NP O
and CC O O
AV NNP B-NP O
block NN I-NP O
on IN B-VP O
exertion NN B-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
about IN B-VP O
40% CD O O
MEDICATIONS NNS B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Cardura NNP I-NP B-m
, , O O
Vasotec NNP B-NP B-m
and CC O O
Metoprolol NNP B-NP B-m
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Denies VBZ O O
any DT B-NP O
tobacco NN I-NP O
Lives VBZ O O
with IN B-VP O
her PRP$ O O
husband NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
was VBD B-VP O
98.2 CD O O
, , O O
respirations NNS B-NP O
14 CD O O
Her NNP B-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
40 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
148/70 CD O O
, , O O
saturation NN B-NP O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
She PRP O O
was VBD B-VP O
a DT B-NP O
pleasant JJ I-NP O
woman NN I-NP O
, , O O
Spanish JJ O O
speaking VBG O O
only RB O O
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
speak VB O O
in IN B-VP O
full JJ B-NP O
sentences NNS I-NP O
Neck NNP I-NP O
was VBD B-VP O
supple JJ O O
with IN B-VP O
no DT B-NP O
carotid NN I-NP O
bruits VBZ O O
Jugular NNP B-NP O
venous JJ B-NP O
pressure NN I-NP O
was VBD B-VP O
approximately RB O O
8 CD O O
cm JJ B-NP O
Lungs NNS I-NP O
clear JJ O O
to TO O O
auscultation VB O O
without IN B-VP O
any DT B-NP O
crackles NNS I-NP O
Heart NNP I-NP O
was VBD B-VP O
in IN B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT B-NP O
II/VI NNP I-NP O
systolic JJ B-NP O
murmur NN I-NP O
radiating VBG O O
out RP O O
to TO O O
the DT B-NP O
apex JJ I-NP O
Abdomen NNP I-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender JJ B-NP O
Extremities NNS I-NP O
were VBD B-VP O
without IN B-VP O
any DT B-NP O
edema JJ I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Her NNP I-NP O
electrocardiogram NN I-NP O
showed VBD B-VP O
bradycardia NN B-NP O
at IN B-VP O
40 CD O O
with IN B-VP O
a DT B-NP O
left NN I-NP O
bundle NN I-NP O
branch NN I-NP O
pattern NN I-NP O
and CC O O
she PRP O O
had VBD B-VP O
2:1 CD O O
AV NNP B-NP O
block NN I-NP O
Her NNP I-NP O
chest NN I-NP O
x-ray NN I-NP O
showed VBD B-VP O
an DT B-NP O
enlarged JJ I-NP O
heart NN I-NP O
with IN B-VP O
pleural JJ B-NP O
effusions NNS I-NP O
and CC O O
cephalization NN B-NP O
which WDT O O
was VBD B-VP O
often RB O O
shown VBN O O
with IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
Her NNP I-NP O
laboratory NN I-NP O
data NNS I-NP O
SMA-7 NNP I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Her PRP$ O O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
3.8 CD O O
Her NNP B-NP O
Hematocrit NNP I-NP O
was VBD B-VP O
37.9 CD O O
, , O O
Platelet NNP B-NP O
Count NNP I-NP O
182 CD O O
Her NNP B-NP O
CPK NNP I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
as IN B-VP O
were VBD B-VP O
her PRP$ O O
coagulations NNS B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Short NNP I-NP O
Stay NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
and CC O O
was VBD B-VP O
ruled VBN O O
out RP O O
with IN B-VP O
serial JJ B-NP O
CPK's NNP I-NP O
She PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Cardiology NNP I-NP O
Group NNP I-NP O
who WP O O
on IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
her PRP$ O O
also RB O O
felt VBD B-VP O
that IN B-VP O
even RB O O
with IN B-VP O
the DT B-NP O
resolution NN I-NP O
of IN B-VP O
her PRP$ O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
she PRP O O
was VBD B-VP O
ready JJ O O
to TO O O
go VB O O
home NN B-NP O
with IN B-VP O
adjustment NN B-NP O
in IN B-VP O
her PRP$ O O
blood NN B-NP B-m
pressure NN I-NP I-m
medications NNS I-NP I-m
and CC O O
felt VBD B-VP O
that IN B-VP O
with IN B-VP O
her PRP$ O O
bradycardia NN B-NP O
she PRP O O
would MD O O
not RB O O
be VB O O
able JJ O O
to TO O O
tolerate VB O O
her PRP$ O O
Lopressor NNP B-NP B-m
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT B-NP O
Lopressor NNP I-NP B-m
was VBD B-VP O
extremely RB O O
important JJ O O
in IN B-VP O
her PRP$ O O
anti-ischemic JJ B-NP O
regimen NNS I-NP O
and CC O O
in IN B-VP O
discussing VBG O O
with IN B-VP O
her PRP$ O O
outpatient JJ B-NP O
Cardiologist NNP I-NP O
, , O O
Dr NNP B-NP O
Konczak NNP I-NP O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
a DT B-NP O
pacemaker NN I-NP O
placement NN I-NP O
would MD O O
be VB O O
in IN B-VP O
her PRP$ O O
best JJS B-NP O
interest NN I-NP O
In IN B-VP O
that DT B-NP O
way NN I-NP O
she PRP O O
could MD O O
have VB O O
good JJ B-NP O
control NN I-NP O
of IN B-VP O
her PRP$ O B-r
heart NN B-NP I-r
rate NN I-NP I-r
and CC O O
maximization NN B-NP O
of IN B-VP O
her PRP$ O O
blood NN B-NP B-m
pressure NN I-NP O
medications NNS I-NP O
and CC O O
her PRP$ O O
increased JJ B-NP O
tolerance NN I-NP O
of IN B-VP O
beta NN B-NP B-m
blockers NNS I-NP I-m
The DT B-NP O
patient NN I-NP O
then RB O O
underwent JJ B-NP O
pacemaker NN I-NP O
placement NN I-NP O
without IN B-VP O
any DT B-NP O
difficulty NN I-NP O
and CC O O
it PRP O O
was VBD B-VP O
interrogated VBN O O
the DT B-NP O
day NN I-NP O
after IN B-VP O
placement NN B-NP O
without IN B-VP O
any DT B-NP O
problem NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
doing VBG O O
well RB O O
with IN B-VP O
only RB O O
minimal JJ B-NP O
pain NN I-NP O
at IN B-VP O
the DT B-NP O
incision NN I-NP O
site NN I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
with IN B-VP O
no DT B-NP O
reportable JJ I-NP O
disease NN I-NP O
and CC O O
no DT B-NP O
adverse JJ I-NP O
drug NN I-NP O
reactions NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Keflex NNP I-NP B-m
250 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
for IN B-VP B-du
5 CD O I-du
days; NN B-NP I-du
Norvasc NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
qd; VBD B-VP B-f
Hydrochlorothiazide NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
qd NN I-NP B-f
and CC O O
Vasotec NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
FOLLOW-UP NNP B-NP O
CARE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
follow-up VB O O
with IN B-VP O
her PRP O O
Cardiologist NNP B-NP O
, , O O
Dr NNP B-NP O
Wes NNP I-NP O
Rounsville NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
and CC O O
will MD O O
probably RB O O
have VB O O
her PRP$ O O
blood NN B-NP B-m
pressure NN I-NP I-m
medications NNS I-NP I-m
further RBR O O
adjusted VBN O O
at IN B-VP O
that DT B-NP O
point NN I-NP O
Dictated VBD B-VP O
By: NNP B-NP O
JAMAL NNP I-NP O
GRANIERI NNP I-NP O
, , O O
M.D NNP B-NP O
HW45 NNP I-NP O
Attending: NNP I-NP O
KELLY NNP I-NP O
SHIRE NNP I-NP O
, , O O
M.D NNP B-NP O
UJ62 NNP I-NP O
XI621/7115 NNP I-NP O
Batch: NNP I-NP O
82857 CD O O
Index NNP B-NP O
No NNP I-NP O
P2DLM2571M NNP I-NP O
D: NNP I-NP O
0/29/97 CD O O
T: NNP B-NP O
3/8/97 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#197385 VBZ O O
878638236 CD O O
KH NNP B-NP O
56828582 CD O O
8585103 CD O O
11/17/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
NSTEMI NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/17/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/29/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
RUDLONG NNP I-NP O
, , O O
NUMBERS NNP B-NP O
288-16-61-4 CD O O
Chie NNP B-NP O
Sa NNP I-NP O
Sterlo NNP I-NP O
Van NNP I-NP O
S NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/28/05 CD O O
AT NNP B-NP O
08:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
7pm CD O B-f
dose NN B-NP O
of IN B-VP O
lovenox NN B-NP B-m
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BRUNECZ NNP I-NP O
, , O O
JULIAN NNP B-NP O
G NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/20/05 CD O O
by IN B-VP O
GANGLUFF NNP B-NP O
, , O O
CHONG NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
758570817 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
needs NNS I-NP O
Previous JJ O O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/5/05 CD O O
by IN B-VP O
IMHOLTE NNP B-NP O
, , O O
RENE NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
5 CD O B-do
MG NNP B-NP I-do
QPM NNP I-NP B-f
( ( O O
ref JJ O O
# # O O
370510168 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok VBP O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/5/05 CD O O
by IN B-VP O
BROGAN NNP B-NP O
, , O O
KARL NNP B-NP O
T NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
895728054 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ATENOLOL NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/10/05 CD O O
by IN B-VP O
FOOR NNP B-NP O
, , O O
RAY NNP B-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
needs NNS I-NP O
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O O
3 CD O O
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
Standard NNP B-NP O
Admin NNP I-NP O
Time NNP I-NP O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
9/20/05 CD O O
by IN B-VP O
MCDUFFEY NNP B-NP O
, , O O
BRYANT NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
needs NNS I-NP O
LOVENOX NNP I-NP B-m
( ( O I-m
ENOXAPARIN NNP B-NP I-m
) ) O I-m
90 CD O B-do
MG NNP B-NP I-do
SC NNP I-NP B-mo
BID NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/28/05 CD O O
by IN B-VP O
GAUDIOSO NNP B-NP O
, , O O
SHAWN NNP B-NP O
V NNP I-NP O
, , O O
M.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
HEPARIN NNP I-NP B-m
&amp; NNP I-NP O
ENOXAPARIN NNP I-NP B-m
SODIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
FLOVENT NNP I-NP B-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE NNP I-NP I-m
) ) O I-m
110 CD O B-do
MCG NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/20/05 CD O O
by IN B-VP O
HIPKINS NNP B-NP O
, , O O
TYRON NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
758570817 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
needs NNS I-NP O
Previous JJ O O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/5/05 CD O O
by IN B-VP O
KEMPT NNP B-NP O
, , O O
BORIS NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
5 CD O B-do
MG NNP B-NP I-do
QPM NNP I-NP B-f
( ( O O
ref JJ O O
# # O O
370510168 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok VBP O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/5/05 CD O O
by IN B-VP O
LAKIN NNP B-NP O
, , O O
IRWIN NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
895728054 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
Tomorrow NNP I-NP O
March NNP I-NP O
MAGNESIUM NNP I-NP B-m
OXIDE NNP I-NP I-m
( ( O I-m
241 CD O I-m
MG NNP B-NP I-m
ELEMENTAL NNP I-NP I-m
MG NNP I-NP I-m
) ) O I-m
800 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
Fluid NNP I-NP O
restriction NN I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
4 CD O O
gram NN B-NP O
Sodium NNP I-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Not RB O O
Applicable NNP B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Campolongo NNP I-NP O
within IN B-VP O
4 CD O O
weeks NNS B-NP O
, , O O
PCP NNP B-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
6/10/05 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
3 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
HWMH NNP B-NP O
anticoagulation NN I-NP O
service NN I-NP O
ALLERGY: NNP I-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
acute JJ B-NP O
coronary JJ I-NP O
syndrome NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
NSTEMI NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CHF NNP I-NP O
CAD NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Catheterization: NNP I-NP O
R NNP I-NP O
dominant NN I-NP O
, , O O
ostial JJ B-NP O
OM1 NNP I-NP O
95% CD O O
culprit NN B-NP O
lesion NN I-NP O
, , O O
stented VBN O O
with IN B-VP O
2.5x13-mm JJ B-NP O
DES; NNP I-NP O
diffuse NN I-NP O
OM2 NNP I-NP O
70% CD O O
lesion NN B-NP O
stented VBN O O
with IN B-VP O
2.5x13-mm JJ B-NP O
DES; NNP I-NP O
and CC O O
LCX NNP B-NP O
lesion NN I-NP O
stented VBD B-VP O
with IN B-VP O
3.5x13-mm JJ B-NP O
DES NNP I-NP O
, , O O
all RB O O
stented VBD B-VP O
to TO O O
0% CD O O
with IN B-VP O
TIMI NNP B-NP O
3 CD O O
flow NN B-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
ID/CC: NNP I-NP O
68 CD O O
yo NN B-NP O
retired VBN O O
social JJ B-NP O
worker NN I-NP O
with IN B-VP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
of IN B-VP O
obesity NN B-NP O
, , O O
hypertension NN B-NP O
and CC O O
possible JJ B-NP O
family NN I-NP O
history NN I-NP O
admitted VBN O O
with IN B-VP O
atrial JJ B-NP O
flutter NN I-NP O
and CC O O
found VBN O O
to TO O O
have VB O O
ACS NNP B-NP O
HPI: NNP I-NP O
Pt NNP I-NP O
is VBZ O O
fairly RB O O
inactive JJ O O
at IN B-VP O
baseline NN B-NP O
but CC O O
over IN B-VP O
the DT O O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
had VBD B-VP O
noted VBN O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
with IN B-VP O
walking VBG O O
even RB O O
a DT B-NP O
few JJ I-NP O
steps NNS I-NP O
On IN B-VP O
night NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
severe JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
unable JJ O O
to TO O O
breathe VB O O
in IN B-VP O
comfortably RB O O
even RB O O
sitting VBG O O
bolt NN B-NP O
upright; NN I-NP O
this DT O O
was VBD B-VP O
accompanied VBN O O
by IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pressure NN I-NP O
and CC O O
profuse NN B-NP O
diaphoresis NN I-NP O
She PRP O O
went VBD B-VP O
to TO O O
XMC VB O O
clinic JJ O O
the DT B-NP O
following JJ I-NP O
morning NN I-NP O
reporting VBG O O
the DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
in IN B-VP O
atrial JJ B-NP O
flutter NN I-NP O
with IN B-VP O
2:1 CD O O
block NN B-NP O
and CC O O
2-3mm JJ B-NP O
lateral JJ I-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
V4-V6 NNP B-NP O
The DT B-NP O
first JJ I-NP O
EKG NNP I-NP O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
showed VBD B-VP O
new JJ O O
deep JJ O O
, , O O
symmetrical JJ O O
T-wave CD O O
inversions NNS B-NP O
in IN B-VP O
V4-V6 NNP B-NP O
, , O O
1-mm JJ O O
concave VBP O O
down RP O O
ST NNP B-NP O
elevation NN I-NP O
in IN B-VP O
lead JJ B-NP O
III NNP I-NP O
and CC O O
similar JJ B-NP O
contour NN I-NP O
in IN B-VP O
II NNP B-NP O
and CC O O
aVF VB O O
although IN B-VP O
not RB O O
elevated VBN O O
First NNP B-NP O
TnI NNP I-NP O
7.39 CD O O
, , O O
MB NNP B-NP O
21.2 CD O O
Went NNP B-NP O
to TO O O
cath VB O O
lab NN B-NP O
and CC O O
found VBN O O
to TO O O
have VB O O
active JJ B-NP O
thrombus NN I-NP O
in IN B-VP O
the DT B-NP O
OM NNP I-NP O
distribution; NN I-NP O
received VBD B-VP O
drug-eluting JJ B-NP O
stents NNS I-NP O
to TO O O
OM1 NNP B-NP O
, , O O
OM2 NNP B-NP O
, , O O
and CC O O
LCX NNP B-NP O
and CC O O
monitored VBD B-VP O
overnight VBN O O
in IN B-VP O
the DT B-NP O
CCU NNP I-NP O
with IN B-VP O
18 CD O B-du
hours NNS B-NP I-du
of IN B-VP O
post-procedure JJ B-NP B-f
eptifibatide NN I-NP B-m
Home NNP I-NP O
meds: NN I-NP O
metoprolol NN I-NP B-m
, , O O
norvasc RB O B-m
, , O O
combivent JJ B-NP B-m
PEx: NNP I-NP O
On IN B-VP O
transfer NN B-NP O
to TO O O
floor NN B-NP O
, , O O
exam CC O O
notable JJ O O
for IN B-VP O
faint NN B-NP O
bibasilar NN I-NP O
crackles NNS I-NP O
, , O O
JVP NNP B-NP O
14 CD O O
, , O O
S1S2 NNP B-NP O
intermittent NN I-NP O
gallop NN I-NP O
, , O O
no DT B-NP O
LE NNP I-NP O
edema NN I-NP O
EKG: NNP I-NP O
atrial JJ B-NP O
flutter NN I-NP O
with IN B-VP O
variable JJ B-NP O
block NN I-NP O
, , O O
bifascicular JJ B-NP O
block NN I-NP O
( ( O O
LAFB NNP B-NP O
and CC O O
RBBB NNP B-NP O
) ) O O
Assessment NNP B-NP O
and CC O O
Hospital NNP B-NP O
Course: NNP I-NP O
68 CD O O
yo NNP B-NP O
woman NN I-NP O
with IN B-VP O
non-ST JJ B-NP O
elevation NN I-NP O
MI NNP I-NP O
and CC O O
atrial JJ B-NP O
flutter NN I-NP O
with IN B-VP O
variable JJ B-NP O
block NN I-NP O
, , O O
s/p NN B-NP O
facilitated VBD B-VP O
PCI NNP B-NP O
with IN B-VP O
3 CD O O
stents NNS B-NP O
in IN B-VP O
OM NNP B-NP O
and CC O O
LCX NNP B-NP O
distribution NN I-NP O
1 CD O O
) ) O O
CV NNP B-NP O
Ischemia: NNP I-NP O
s/p VBD B-VP O
NSTEMI: NNP B-NP O
ASA NNP I-NP B-m
, , O O
clopidogrel NN B-NP B-m
, , O O
atorvastatin RB O B-m
80 CD O B-do
, , O O
atenolol RB O B-m
100 CD O B-do
, , O O
captopril RB O B-m
converted VBN O O
to TO O O
lisinopril VB O B-m
Pump: NNP B-NP O
CHF NNP I-NP O
, , O O
with IN B-VP O
atrial JJ B-NP O
flutter NN I-NP O
and CC O O
ACS NNP B-NP O
the DT B-NP O
likely JJ I-NP O
precipitants NNS I-NP O
Initially RB O O
required VBD B-VP O
O2 NNP B-NP B-m
to TO O O
maintain VB O O
sat JJ O O
&gt; JJ O O
90 CD O O
but CC O O
gradually RB O O
titrated VBD B-VP O
to TO O O
off IN B-VP O
Diuresed VBN O O
well RB O O
with IN B-VP O
Lasix NNP B-NP B-m
80 CD O B-do
IV NNP B-NP B-mo
bid NN I-NP B-f
, , O O
negative JJ O O
1 CD O O
L/day NNP B-NP O
for IN B-VP B-du
3 CD O I-du
days NNS B-NP I-du
and CC O O
then RB O O
converted VBD B-VP O
to TO O O
PO NNP B-NP B-mo
lasix VBZ O B-m
40 CD O B-do
TTE NNP B-NP O
showed VBD B-VP O
normal JJ B-NP O
LV NNP I-NP O
size NN I-NP O
, , O O
concentric JJ B-NP O
LVH NNP I-NP O
, , O O
EF NNP B-NP O
50% CD O O
, , O O
abnormal JJ B-NP O
septal JJ I-NP O
motion NN I-NP O
, , O O
mild JJ B-NP O
diffuse NN I-NP O
HK NNP I-NP O
Nl NNP I-NP O
RV NNP I-NP O
size/function NN I-NP O
, , O O
mild JJ B-NP O
LAE NNP I-NP O
, , O O
mild JJ B-NP O
RAE NNP I-NP O
No NNP I-NP O
AI NNP I-NP O
, , O O
mild-mod JJ B-NP O
MR NNP I-NP O
, , O O
mild JJ B-NP O
TR NNP I-NP O
PA NNP I-NP O
29 CD O O
+ NNP B-NP O
RA NNP I-NP O
Trace NNP I-NP O
pulmonic JJ B-NP O
regurgitation NN I-NP O
Nutrition NNP I-NP O
was VBD B-VP O
consulted VBN O O
regarding VBG O O
low-fat JJ O O
and CC O O
low-salt JJ B-NP O
diets NNS I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
fluid JJ B-NP O
restriction NN I-NP O
Rhythm: NNP I-NP O
Initially NNP I-NP O
rate-controlled VBD B-VP O
on IN B-VP O
beta-blocker NN B-NP B-m
and CC O O
diltiazem NN B-NP B-m
for IN B-VP O
goal NN B-NP B-r
goal NN I-NP B-r
rate NN I-NP I-r
rate NN I-NP I-r
in IN B-VP O
60s; CD O O
she PRP O O
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
atenolol NN B-NP B-m
100 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
QD NNP I-NP B-f
She PRP O O
had VBD B-VP O
several JJ B-NP O
10-14-beat JJ I-NP O
runs NNS I-NP O
of IN B-VP O
NSVT NNP B-NP O
, , O O
treated VBD B-VP O
with IN B-VP O
aggressive JJ B-NP O
lyte JJ I-NP O
replacement NN I-NP O
particularly RB O O
in IN B-VP O
light NN B-NP O
of IN B-VP O
long JJ B-NP O
QTc NNP I-NP O
Initiated NNP I-NP O
heparin NN I-NP B-m
and CC O O
discharged VBN O O
on IN B-VP O
coumadin NN B-NP B-m
with IN B-VP O
a DT B-NP O
lovenox NN I-NP B-m
bridge NN I-NP O
She PRP O O
was VBD B-VP O
not RB O O
considered VBN O O
an DT B-NP O
ICD NNP I-NP O
candidate NN I-NP O
based VBN O O
on IN B-VP O
her PRP$ O O
EF NNP B-NP O
2 CD O O
) ) O O
Endo: NNP B-NP O
PEHC NNP I-NP O
chart NN I-NP O
shows VBZ O O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
diabetes VBZ O O
No DT B-NP O
fingersticks NNS I-NP O
were VBD B-VP O
elevated VBN O O
this DT O O
admission; VBZ O O
a DT B-NP O
hemoglobin NN I-NP O
A1C NNP I-NP O
was VBD B-VP O
6.2% CD O O
Likely JJ O O
to TO O O
have VB O O
glucose JJ B-NP O
intolerance NN I-NP O
and CC O O
will MD O O
benefit VB O O
from IN B-VP O
weight JJ B-NP O
loss NN I-NP O
3 CD O O
) ) O O
FEN: NNP B-NP O
Standing NNP I-NP O
Mg NNP I-NP B-m
oxide IN B-VP I-m
for IN B-VP O
long JJ B-NP B-r
QTc; NNP I-NP I-r
she PRP O O
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
800 CD O B-do
mg NNS B-NP I-do
po JJ B-NP B-mo
bid; NN I-NP B-f
&lt;2g NNP I-NP O
NaCl NNP I-NP O
, , O O
&lt;2L NNP B-NP O
Fluid NNP I-NP O
restriction NN I-NP O
restricted VBD B-VP O
, , O O
Cardiac NNP B-NP O
diet VBZ O O
4 CD O O
) ) O O
Renal: NNP B-NP O
Because IN B-VP O
of IN B-VP O
history NN B-NP O
of IN B-VP O
HTN NNP B-NP O
, , O O
renal JJ B-NP O
arteries NNS I-NP O
were VBD B-VP O
visualized VBN O O
during IN B-VP O
catheterization; NN B-NP O
study NN I-NP O
revealed VBD B-VP O
3 CD O O
left VBD B-VP O
renal JJ B-NP O
arteries NNS I-NP O
, , O O
one CD O O
of IN B-VP O
which WDT O O
had VBD B-VP O
a DT O O
40% CD O O
lesion NN B-NP O
, , O O
and CC O O
2 CD O O
right JJ B-NP O
renal JJ I-NP O
arteries NNS I-NP O
No DT B-NP O
intervention NN I-NP O
was VBD B-VP O
done VBN O O
Pt NNP B-NP O
will MD O O
be VB O O
discharged VBN O O
home NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
and CC O O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
the DT B-NP O
NH NNP I-NP O
heart NN I-NP O
failure NN I-NP O
service NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Take NNP I-NP O
all DT B-NP O
medicines NNS I-NP O
as IN B-VP O
directed VBN O O
DO NNP B-NP O
NOT NNP I-NP O
MISS NNP I-NP O
A NNP I-NP O
SINGLE NNP I-NP O
DOSE NNP I-NP O
OF NNP I-NP O
PLAVIX NNP I-NP B-m
THIS NNP I-NP O
MEDICINE NNP I-NP O
KEEPS NNP I-NP O
YOUR NNP I-NP O
NEW NNP I-NP O
STENTS NNP I-NP O
OPEN NNP I-NP O
AND NNP I-NP O
IS NNP I-NP O
VITALLY NNP I-NP O
IMPORTANT NNP I-NP O
TO NNP I-NP O
YOUR NNP I-NP O
HEALTH NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GUM NNP I-NP O
, , O O
LAWRENCE NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
LP51 NNP B-NP O
) ) O O
8/28/05 CD O O
@ $ O O
12:45 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#197702 VBZ O O
091761834 CD O O
CMLMC NNP B-NP O
07592927 CD O O
3017067 CD O O
9/27/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
b NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/8/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/3/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SCHEFFER NNP I-NP O
, , O O
FELTON NNP B-NP O
128-55-71-1 CD O O
Pend NNP B-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
2/22/06 CD O O
AT NNP B-NP O
06:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
TARKA NNP I-NP O
, , O O
FELTON NNP B-NP O
CHAD NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/17 CD O O
) ) O O
ATENOLOL $ O B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/17 CD O O
) ) O O
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/17 CD O O
) ) O O
Instructions: NNP B-NP O
Please NNP I-NP O
cut VB O O
your PRP$ O O
lipitor NN B-NP B-m
80mg CD O B-do
tablet NN B-NP I-do
in IN B-VP I-do
half JJ O I-do
using VBG O O
your PRP$ O O
pill NN B-NP O
cutter NN I-NP O
ZETIA NNP I-NP B-m
( ( O I-m
EZETIMIBE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HYDROCHLOROTHIAZIDE NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
IMDUR NNP I-NP B-m
ER NNP I-NP I-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONITRATE NNP I-NP I-m
( ( O I-m
SR NNP B-NP I-m
) ) O I-m
) ) O I-m
120 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
LISINOPRIL NNP B-NP B-m
LISINOPRIL NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/17 CD O O
) ) O O
Instructions: NNP B-NP O
Please NNP I-NP O
take VB O O
one CD O B-do
40mg CD O I-do
tablet NN B-NP I-do
daily JJ B-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/22/06 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
NIFEDIPINE NNP I-NP B-m
( ( O I-m
SUSTAINED NNP B-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
( ( O I-m
NIFEDIPINE NNP B-NP I-m
( ( O I-m
S NNP B-NP I-m
) ) O I-m
90 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
NITROGLYCERIN NNP B-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5MIN NNP I-NP B-f
X NNP I-NP O
3 CD O O
doses NNS B-NP O
PRN NNP I-NP O
Chest NNP I-NP B-r
Pain NNP I-NP I-r
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
After IN B-VP O
Appt NNP B-NP O
with IN B-VP O
local JJ B-NP O
physician NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
PCP NNP I-NP O
Dr NNP I-NP O
Deangelo NNP I-NP O
Shoobridge NNP I-NP O
Yshealt NNP I-NP O
Hill NNP I-NP O
Healthcare NNP I-NP O
Center NNP I-NP O
2/10 CD O O
at IN B-VP O
3pm CD O O
scheduled JJ O O
, , O O
Cardiologist NNP B-NP O
Dr NNP I-NP O
Kendrick NNP I-NP O
Lowin NNP I-NP O
230-881-8027 JJ B-NP O
Meaert NNP I-NP O
Mo NNP I-NP O
Rynei NNP I-NP O
Hospital NNP I-NP O
5/12 CD O O
at IN B-VP O
8: CD O O
scheduled JJ O O
, , O O
Cardiac JJ B-NP O
catheterization NN I-NP O
at IN B-VP O
AV NNP B-NP O
, , O O
please NN B-NP O
go VB O O
to TO O O
Admitting NNP B-NP O
in IN B-VP O
the DT B-NP O
lobby NN I-NP O
to TO O O
register VB O O
at IN B-VP O
7:30am CD O O
, , O O
do VBP O O
not RB O O
eat VB O O
breakfast NN B-NP O
7/21 CD O O
at IN B-VP O
7:30am CD O O
scheduled JJ O O
, , O O
ALLERGY: NNP B-NP O
GEMFIBROZIL NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
b VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
HYPERLIPIDEMIA NNP I-NP O
ATYPICAL NNP I-NP O
C.PAIN NNP I-NP O
STEMI NNP I-NP O
5/23 CD O O
Echo NNP B-NP O
5/23 CD O O
EF NNP B-NP O
60% CD O O
, , O O
mild JJ B-NP O
LVH NNP I-NP O
, , O O
RV NNP B-NP O
with IN B-VP O
HK NNP B-NP O
mi $ O O
3/6 CD O O
s/p NN B-NP O
RCA NNP I-NP O
stent VBD B-VP O
3/6 CD O O
DM NNP B-NP O
( ( O O
diet-controlled JJ O O
) ) O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
( ( O O
chronic JJ B-NP O
renal JJ I-NP O
dysfunction NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
stress NN B-NP O
test NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
***CC: NNP I-NP O
Chest NNP I-NP O
pain NN I-NP O
***HPI: VBD B-VP O
52M CD O O
pastor NN B-NP O
h/o NN I-NP O
NIDDM NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
and CC O O
known VBN O O
3-vessel JJ B-NP O
CAD NNP I-NP O
s/p NN I-NP O
NSTEMI NNP I-NP O
( ( O O
2002 CD O O
) ) O O
w/ NN B-NP O
failed VBD B-VP O
angioplasty JJ O O
to TO O O
Marg1 NNP B-NP O
occlusion NN I-NP O
, , O O
CYPHER NNP B-NP O
stent NN I-NP O
to TO O O
RCA NNP B-NP O
( ( O O
2003 CD O O
) ) O O
, , O O
recurrent JJ B-NP O
unstable JJ I-NP O
angina NN I-NP O
w/ NN I-NP O
last JJ B-NP O
cath NN I-NP O
( ( O O
0/0 CD O O
) ) O O
w/ NN B-NP O
diffuse NN I-NP O
CAD NNP I-NP O
precluding VBG O O
CABG/PTCA NNP B-NP O
but CC O O
w/ JJ B-NP O
patent NN I-NP O
RCA NNP I-NP O
stent NN I-NP O
, , O O
last JJ B-NP O
perfusion NN I-NP O
stress NN I-NP O
( ( O O
0/0 CD O O
) ) O O
w/ NN B-NP O
moderate JJ B-NP O
rev NN I-NP O
ischemia NN I-NP O
in IN B-VP O
Diag/PDA NNP B-NP O
territories NNS I-NP O
, , O O
ETT NNP B-NP O
( ( O O
6/10 CD O O
) ) O O
w/ NN B-NP O
CP NNP I-NP O
and CC O O
ST NNP B-NP O
depression NN I-NP O
in IN B-VP O
inferolateral JJ B-NP O
leads NNS I-NP O
, , O O
last JJ B-NP O
Echo NNP I-NP O
( ( O O
0/0 CD O O
) ) O O
w/ NN B-NP O
EF NNP I-NP O
55-60% JJ O O
no DT B-NP O
WMA NNP I-NP O
, , O O
physically RB O O
active JJ O O
at IN B-VP O
baseline NN B-NP O
p/w NN I-NP O
CP NNP I-NP O
At IN B-VP O
8:45am CD O O
pt NN B-NP O
first RB O O
noticed VBD B-VP O
left-sided JJ B-NP O
substernal JJ I-NP O
pain/pressure NN I-NP O
after IN B-VP O
breakfast NN B-NP O
and CC O O
coffee NN B-NP O
while IN B-VP O
walking VBG O O
to TO O O
living VBG O O
room NN B-NP O
, , O O
well-circumscribed JJ O O
, , O O
4/10 CD O O
intensity NN B-NP O
, , O O
constant JJ O O
, , O O
w/o JJ B-NP O
radiation NN I-NP O
to TO O O
jaw/arm/back NN B-NP O
, , O O
worse JJR O O
on IN B-VP O
deep JJ B-NP O
inspiration NN I-NP O
, , O O
w/ NN B-NP O
associated VBN O O
nausea NN B-NP O
and CC O O
dizziness NN B-NP O
Pt NNP I-NP O
sat VBD B-VP O
down RP O O
w/ NN B-NP O
pain NN I-NP O
2/10 CD O O
, , O O
administered VBN O O
nitro JJ B-NP B-m
spray NN I-NP I-m
x2 NNP I-NP B-f
w/o NN I-NP O
relief NN I-NP O
, , O O
wife NN B-NP O
measured VBD B-VP O
BP NNP B-NP O
158/90s CD O O
( ( O O
usu JJ O O
140/85 CD O O
) ) O O
No DT B-NP O
other JJ I-NP O
sx NN I-NP O
, , O O
but CC O O
pt VBP O O
describes NNS B-NP O
pain VBP O O
as IN B-VP O
similar JJ O O
but CC O O
less RBR O O
intense JJ O O
than IN B-VP O
that DT O O
experienced VBD B-VP O
in IN B-VP O
2002 CD O O
MI NNP B-NP O
Denies NNP I-NP O
h/o VBZ O O
CP NNP B-NP O
since IN B-VP O
then RB O O
despite IN B-VP O
recently RB O O
active JJ B-NP O
baseline NN I-NP O
( ( O O
yesterday NN B-NP O
washing VBG O O
windows/ JJ O O
climbing VBG O O
ladders NNS B-NP O
, , O O
over IN B-VP O
last JJ B-NP O
months NNS I-NP O
doing VBG O O
cement JJ B-NP O
work NN I-NP O
in IN B-VP O
church NN B-NP O
) ) O O
, , O O
but CC O O
notes NNS B-NP O
DOE NNP I-NP O
with IN B-VP O
walking VBG O O
2 CD O O
blocks NNS B-NP O
uphill JJ B-NP O
Pt NNP I-NP O
reports NNS I-NP O
frequent VBD B-VP O
prophylactic JJ B-NP O
use NN I-NP O
of IN B-VP O
nifedipine JJ B-NP B-m
sprays NNS I-NP I-m
immediately RB O O
prior RB O O
to TO O O
exertion/activity.On VB O O
6/1/06 CD O O
, , O O
pt NN B-NP O
was VBD B-VP O
evaluated VBN O O
for IN B-VP O
CABG NNP B-NP O
by IN B-VP O
surgeon NN B-NP O
Dr NNP I-NP O
Ashley NNP I-NP O
Starcher NNP I-NP O
, , O O
who WP O O
noted VBD B-VP O
possible JJ B-NP O
candidacy NN I-NP O
for IN B-VP O
combined VBN O O
CABG/TMLR NNP B-NP O
since IN B-VP O
diagonal JJ O O
likely JJ O O
too RB O O
small JJ O O
to TO O O
bypass VB O O
Since IN B-VP O
pt NN B-NP O
was VBD B-VP O
asymptomatic JJ B-NP O
w/ NN I-NP O
nlm NN I-NP O
LVEF NNP I-NP O
, , O O
he PRP O O
has VBZ O O
remained VBN O O
on IN B-VP O
medical JJ B-NP O
therapy NN I-NP O
Last JJ B-NP O
visit NN I-NP O
to TO O O
PCP NNP B-NP O
Dr NNP I-NP O
Rob NNP I-NP O
Holzinger NNP I-NP O
at IN B-VP O
Thbull NNP B-NP O
Carmonte NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
11/29/06 CD O O
was VBD B-VP O
routine JJ O O
, , O O
and CC O O
he PRP O O
is VBZ O O
followed VBN O O
by IN B-VP O
cardiologist NN B-NP O
Dr NNP I-NP O
Heath NNP I-NP O
Koerner NNP I-NP O
****ED NNP I-NP O
Course: NNP I-NP O
CP NNP I-NP O
spontaneously RB O O
resolved VBD B-VP O
( ( O O
total JJ B-NP O
duration NN I-NP O
1hr CD O O
) ) O O
prior RB O O
to TO O O
arrival VB O O
by IN B-VP O
car NN B-NP O
at IN B-VP O
BMC NNP B-NP O
ED NNP I-NP O
where WRB O O
VS NNP B-NP O
Afebrile NNP I-NP O
HR118 NNP I-NP O
BP NNP I-NP O
150/68 CD O O
RR18 NNP B-NP O
98%RA CD O O
Received NNP B-NP O
lopressor NN I-NP B-m
5mg CD O B-do
IV NNP B-NP B-mo
x1` NNP I-NP B-du
HR NNP I-NP O
80s CD O O
, , O O
ASA NNP B-NP B-m
ECG NNP I-NP O
showed VBD B-VP O
NSR@95bpm NNP B-NP O
w/ NN I-NP O
ST NNP I-NP O
depression NN I-NP O
and CC O O
T NNP B-NP O
wave VBP O O
flattening VBG O O
in IN B-VP O
2 CD O O
, , O O
3 CD O O
, , O O
V5 NNP B-NP O
, , O O
V6 NNP B-NP O
different JJ O O
from IN B-VP O
prior JJ B-NP O
ECG NNP I-NP O
10/0/06 CD O O
, , O O
high JJ B-NP O
voltage NN I-NP O
and CC O O
LVH NNP B-NP O
also RB O O
present VBD B-VP O
Received NNP B-NP O
heparin NN I-NP B-m
heparin VBD B-VP B-m
5000U CD O B-do
bolus NN B-NP B-mo
x1 NN I-NP B-f
and CC O O
1500U/hr CD O B-do
infusion NN B-NP B-mo
Labs: NNP I-NP O
CK NNP I-NP O
647 CD O O
( ( O O
h/o NN B-NP O
chronically RB O O
elev JJ B-NP O
CKs NNP I-NP O
400-1300s NN I-NP O
) ) O O
, , O O
CK-MB JJ O O
3.8 CD O O
, , O O
TnI NNP B-NP O
&lt;0.10 NNP I-NP O
, , O O
WBC NNP B-NP O
6.41 CD O O
, , O O
Hct NNP B-NP O
44.2 CD O O
, , O O
Plt NNP B-NP O
228 CD O O
, , O O
Cre NNP B-NP O
1.3 CD O O
, , O O
PTT NNP B-NP O
33.6 CD O O
****ROS: NNP B-NP O
Pt NNP I-NP O
notes NNS I-NP O
( ( O O
intentional JJ O O
) ) O O
20lb CD O O
weight JJ B-NP O
loss NN I-NP O
( ( O O
215`195lb CD O O
) ) O O
over IN B-VP O
last JJ B-NP O
month NN I-NP O
since IN B-VP O
starting VBG O O
metformin JJ B-NP B-m
Pertinent NNP I-NP O
negatives NNS I-NP O
include VBP O O
no DT B-NP O
systemic JJ I-NP O
complaints/ NN I-NP O
LOC/ NNP I-NP O
change NN I-NP O
in IN B-VP O
vision/ NN B-NP O
diaphoresis/ NN I-NP O
cough/ NN I-NP O
orthopnea/ NN I-NP O
edema/ NN I-NP O
leg NN I-NP O
pain NN I-NP O
or CC O O
claudication/ NN B-NP O
change NN I-NP O
in IN B-VP O
GU/GI NNP B-NP O
habits NNS I-NP O
****PMH/PSH: NNP I-NP O
*CAD NNP I-NP O
( ( O O
3-vessel JJ O O
as IN B-VP O
below IN B-VP O
) ) O O
-s/p FW O O
NSTEMI NNP B-NP O
( ( O O
2002 CD O O
) ) O O
w/ FW O O
recurrent NN B-NP O
UA NNP I-NP O
-L NNP I-NP O
Cath NNP I-NP O
5/23 CD O O
"Diffuse NNP B-NP O
CAD NNP I-NP O
precludes VBZ O O
CABG/PTCA;" NNP B-NP O
RCA NNP I-NP O
stents NNS I-NP O
patent; VBP O O
Diag1 NNP B-NP O
ostial JJ O O
80% CD O O
, , O O
Diag2 NNP B-NP O
prox VBZ O O
80% CD O O
, , O O
LCx NNP B-NP O
prox VBZ O O
40% CD O O
, , O O
LCx NNP B-NP O
mid VBD B-VP O
50% CD O O
, , O O
Marg1 NNP B-NP O
ostial JJ O O
100% CD O O
( ( O O
collat JJ B-NP O
LCx NNP I-NP O
) ) O O
, , O O
Marg2 NNP B-NP O
ostial JJ O O
50% CD O O
, , O O
RCA NNP B-NP O
dist NN I-NP O
100% CD O O
( ( O O
collat NN B-NP O
to TO O O
PDA NNP B-NP O
from IN B-VP O
RCA NNP B-NP O
intracoronary NN I-NP O
) ) O O
, , O O
no DT B-NP O
sig NN I-NP O
LM/LAD NNP I-NP O
lesions NNS I-NP O
L NNP I-NP O
cath VBD B-VP O
1/11 CD O O
Failed NNP B-NP O
angioplasty JJ B-NP O
Marg1 NNP I-NP O
ostial JJ O O
100% CD O O
( ( O O
inability NN B-NP O
to TO O O
cross VB O O
occlusion NN B-NP O
) ) O O
, , O O
no DT B-NP O
sig NN I-NP O
LM/LCx/LAD/RCA NNP I-NP O
lesions NNS I-NP O
L NNP I-NP O
cath NN I-NP O
4/8 CD O O
Cypher NNP B-NP O
stent NN I-NP O
to TO O O
RCA; NNP B-NP O
RCA NNP I-NP O
distal JJ O O
100% CD O O
, , O O
RCA NNP B-NP O
prox VBZ O O
60% CD O O
, , O O
RCA NNP B-NP O
mid VBD B-VP O
85% CD O O
, , O O
RCA NNP B-NP O
mid VBD B-VP O
95% CD O O
, , O O
LCx NNP B-NP O
mid VBD B-VP O
35% CD O O
, , O O
Marg1 NNP B-NP O
ostial VBD B-VP O
100% CD O O
2/12 CD O O
Failed VBD B-VP O
angioplasty NN B-NP O
to TO O O
Marg1 NNP B-NP O
100%; CD O O
RCA NNP B-NP O
90% CD O O
, , O O
PDA NNP B-NP O
100% CD O O
- : O O
Stress: NN B-NP O
8/5 CD O O
ETT NNP B-NP O
, , O O
std NN B-NP O
Bruce NNP I-NP O
, , O O
6.0 CD O O
METS: NNP B-NP O
4/10 CD O O
CP NNP B-NP O
3min CD O O
, , O O
1mm CD O O
ST NNP B-NP O
dep NN I-NP O
in IN B-VP O
2 CD O O
, , O O
3 CD O O
, , O O
F NNP B-NP O
, , O O
V5-6 NNP B-NP O
, , O O
Duke NNP B-NP O
-7 NNP I-NP O
( ( O O
mod NN B-NP O
) ) O O
, , O O
HRR NNP B-NP O
13 CD O O
5/23 CD O O
Exercise NN B-NP O
MIBI NNP I-NP O
SPECT NNP I-NP O
, , O O
7.0 CD O O
METS: NNP B-NP O
CP NNP I-NP O
, , O O
1mm CD O O
ST NNP B-NP O
dep NN I-NP O
in IN B-VP O
2 CD O O
, , O O
3 CD O O
, , O O
F NNP B-NP O
, , O O
V5-6 NNP B-NP O
, , O O
65% CD O O
APHR NNP B-NP O
, , O O
rev NN B-NP O
ischemia NN I-NP O
in IN B-VP O
Diag NNP B-NP O
, , O O
PDA NNP B-NP O
territories NNS I-NP O
( ( O O
sum VB O O
stress/diff NN B-NP O
7/7 CD O O
mild/mod NN B-NP O
) ) O O
3/18 CD O O
Ex NNP B-NP O
MIBI NNP I-NP O
SPECT NNP I-NP O
, , O O
7.6 CD O O
METS NNP B-NP O
, , O O
CP NNP B-NP O
, , O O
no DT B-NP O
perf NN I-NP O
defect VBP O O
10/21 CD O O
Ex NNP B-NP O
MIBI NNP I-NP O
SPECT NNP I-NP O
, , O O
6.4 CD O O
METS NNP B-NP O
, , O O
CP NNP B-NP O
, , O O
rev NN B-NP O
isch NN I-NP O
LCx NNP I-NP O
territory NN I-NP O
, , O O
sum NN B-NP O
stress/diff NN I-NP O
7/5 CD O O
) ) O O
8/11 CD O O
Ex NNP B-NP O
MIBI NNP I-NP O
SPECT NNP I-NP O
, , O O
7.6 CD O O
METS NNP B-NP O
, , O O
CP NNP B-NP O
, , O O
rev NN B-NP O
isch NN I-NP O
LCx NNP I-NP O
, , O O
PDA NNP B-NP O
territory NN I-NP O
scar NN I-NP O
, , O O
sum VB O O
stress/diff JJ O O
15/11 CD O O
) ) O O
0/21 CD O O
Adeno NNP B-NP O
MIBI NNP I-NP O
SPECT NNP I-NP O
, , O O
no DT B-NP O
perf NN I-NP O
defect NN I-NP O
, , O O
sum JJ B-NP O
stress NN I-NP O
2 CD O O
11/17 CD O O
ETT NNP B-NP O
, , O O
std NN B-NP O
Bruce NNP I-NP O
56%APHR CD O O
, , O O
CP NNP B-NP O
4min CD O O
, , O O
1mm CD O O
ST NNP B-NP O
dep NN I-NP O
2 CD O O
, , O O
3 CD O O
, , O O
F NNP B-NP O
-Echo: VBZ O O
5/23 CD O O
LV NNP B-NP O
nlm JJ B-NP O
size NN I-NP O
, , O O
EF NNP B-NP O
55-60% CD O O
, , O O
no DT B-NP O
WMA NNP I-NP O
, , O O
thick JJ B-NP O
MV NNP I-NP O
, , O O
mild JJ B-NP O
RVE/RAE NNP I-NP O
, , O O
trace NN B-NP O
MR/PR NNP I-NP O
10/7 CD O O
( ( O O
Stress NNP B-NP O
): NNP I-NP O
EF NNP I-NP O
55-60% JJ O O
, , O O
nlm JJ B-NP O
ventricular JJ I-NP O
contractility NN I-NP O
2/12 CD O O
EF NNP B-NP O
55-60% CD O O
, , O O
mild FW O O
concentric JJ B-NP O
LV NNP I-NP O
hypertrophy NN I-NP O
, , O O
no DT B-NP O
WMA NNP I-NP O
, , O O
thick JJ B-NP O
MV NNP I-NP O
, , O O
trace NN B-NP O
MR/PR NNP I-NP O
-CT/A NNP I-NP O
Ch/Abd/Pel NNP I-NP O
( ( O O
6/10 CD O O
): NNP B-NP O
nlm JJ B-NP O
Ao NNP I-NP O
w/o NN I-NP O
dissection/aneurysm NN I-NP O
*NIDDM NNP I-NP O
( ( O O
2005 CD O O
) ) O O
, , O O
HgbA1c NNP B-NP O
7.1 CD O O
` `` O O
Metformin RB O B-m
1mo CD O O
ago IN B-VP O
*Hypercholesterolemia NN B-NP O
( ( O O
&lt;2000 CD O O
) ) O O
-h/o FW O O
elev NN B-NP O
CKs NNP I-NP O
( ( O O
400-1300s JJ O O
on IN B-VP O
gemfibrozil NN B-NP B-m
, , O O
statins NNS B-NP B-m
) ) O O
*HTN VBP O O
( ( O O
1996 CD O O
) ) O O
*chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
bl JJ B-NP O
Cre NNP I-NP O
1.2 CD O O
refused VBD B-VP O
renal JJ B-NP O
MRA NNP I-NP O
11/11 CD O O
*Carotid NN B-NP O
stenoses NNS I-NP O
( ( O O
2006 CD O O
) ) O O
, , O O
R NNP B-NP O
ICA NNP I-NP O
55-60% JJ O O
, , O O
L NNP B-NP O
ICA NNP I-NP O
&gt;50% NNP I-NP O
asx NN I-NP O
*Erectile NNP I-NP O
dysfunction NN I-NP O
s/p NN I-NP O
penile JJ B-NP O
prosthesis NN I-NP O
placement NN I-NP O
****MEDS NNP I-NP O
( ( O O
pre- JJ B-NP O
admission NN I-NP O
): NNP I-NP O
ASA NNP I-NP B-m
81mg CD O B-do
PO NNP B-NP B-mo
qdayAtenolol VBD B-VP B-f
100mg CD O O
PO NNP B-NP O
BIDLisinopril NNP I-NP O
80mg CD O O
PO NNP B-NP O
qdayImdur NN I-NP O
ER NNP I-NP B-m
( ( O I-m
isosorbide NN B-NP I-m
) ) O I-m
120mg CD O B-do
PO NNP B-NP B-mo
qdayLipitor NN I-NP B-f
80mg CD O O
PO NNP B-NP O
qdayZetia NN I-NP O
( ( O B-m
ezetimibe NN B-NP I-m
) ) O I-m
10mg CD O B-do
PO NNP B-NP B-mo
qdayHCTZ VBD B-VP B-f
50mg CD O O
PO NNP B-NP O
qdayMetformin VBD B-VP O
500mg CD O O
PO NNP B-NP O
qdayNifedipine NN I-NP O
ER NNP I-NP B-m
90mg CD O B-do
PO NNP B-NP B-mo
qdayNitroglycerin VBD B-VP B-f
0.4MG/SPRAY CD O O
PO NNP B-NP O
x1 NNP I-NP O
PRN NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
****ALLERGIES: JJ B-NP O
Gemfibrozil NNP I-NP O
` `` O O
elev RB O O
CK NNP B-NP O
( ( O O
400-1300s JJ O O
) ) O O
****SH: NN B-NP O
Denies NNPS I-NP O
h/o VBZ O O
tob/EtOH/drugs NNS B-NP O
Pt NNP I-NP O
lives VBZ O O
in IN B-VP O
Orlwoodank NNP B-NP O
w/ JJ B-NP O
wife NN I-NP O
of IN B-VP O
30yrs CD O O
, , O O
3 CD O O
grown JJ B-NP O
children NNS I-NP O
, , O O
5 CD O O
grandchildren NNS B-NP O
all DT B-NP O
healthy JJ I-NP O
Pastor NNP I-NP O
at IN B-VP O
Leighfay NNP B-NP O
Che NNP I-NP O
O NNP I-NP O
Broke NNP I-NP O
Lo NNP I-NP O
x30yrs NNP I-NP O
****FH: NNP I-NP O
Significant NNP I-NP O
h/o NN I-NP O
DM NNP I-NP O
, , O O
HTN NNP B-NP O
Father NNP I-NP O
91yo CD O O
h/o NN B-NP O
MI NNP I-NP O
( ( O O
62yo CD O O
) ) O O
, , O O
CVA NNP B-NP O
( ( O O
76yo CD O O
) ) O O
, , O O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
Mother NNP I-NP O
80yo CD O O
h/o NN B-NP O
HTN NNP I-NP O
, , O O
DM NNP B-NP O
, , O O
identical JJ B-NP O
twin NN I-NP O
h/o NN I-NP O
HTN NNP I-NP O
, , O O
DM NNP B-NP O
Denies NNP I-NP O
h/o NN I-NP O
cancer NN I-NP O
****PHYSICAL NNP I-NP O
EXAM:VS: NNP I-NP O
T NNP I-NP O
98 CD O O
HR NNP B-NP O
63 CD O O
reg NN B-NP O
BP NNP I-NP O
126/67 CD O O
RR NNP B-NP O
18 CD O O
O2Sat NNP B-NP O
98% CD O O
RAGen: NNP B-NP O
black JJ B-NP O
male NN I-NP O
in IN B-VP O
NAD NNP B-NP O
, , O O
lying VBG O O
in IN B-VP O
bed NN B-NP O
, , O O
pleasantHEENT: NN B-NP O
PEERLA NNP I-NP O
, , O O
MMM NNP B-NP O
, , O O
oropharynx JJ B-NP O
clearCV: NN I-NP O
nlm NN I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmur NN I-NP O
JVP NNP I-NP O
~8cm NNP I-NP O
, , O O
No NNP B-NP O
obvious JJ B-NP O
carotid NN I-NP O
bruits NNS I-NP O
bilat VBP O O
, , O O
symmetric JJ B-NP O
No NNP I-NP O
bruit NN I-NP O
at IN B-VP O
fem JJ B-NP O
groove NN I-NP O
bilat NN I-NP O
, , O O
DP NNP B-NP O
2+ CD O O
bilatResp: NN B-NP O
mild NN I-NP O
bibasilar JJ B-NP O
crackles NNS I-NP O
, , O O
no DT B-NP O
wheeze NN I-NP O
, , O O
no DT B-NP O
accessory JJ I-NP O
muscle NN I-NP O
useAbd: JJ B-NP O
Soft NNP I-NP O
, , O O
NT NNP B-NP O
, , O O
obeseSkin FW O O
&amp; FW O O
Ext: NNP B-NP O
WWP NNP I-NP O
, , O O
no DT B-NP O
edema NN I-NP O
, , O O
nails NNS B-NP O
unremarkable JJ O O
( ( O O
remnant JJ B-NP O
red JJ I-NP O
paint NN I-NP O
)Neuro: NNP I-NP O
A&amp;Ox3 NNP I-NP O
, , O O
CN NNP B-NP O
II-XII NNP I-NP O
grossly RB O O
intact JJ B-NP O
****ADMISSION NNP I-NP O
LABS: NNP I-NP O
WBC NNP I-NP O
6.4 CD O O
, , O O
hct NN B-NP O
44 CD O O
, , O O
Cr NNP B-NP O
1.3 CD O O
, , O O
enz FW O O
neg FW O O
, , O O
ddimer VBZ O O
530s CD O O
****ADMISSION NN B-NP O
EKG NNP I-NP O
( ( O O
8/10 CD O O
): NNP B-NP O
NSR@95bpm NNP I-NP O
w/ VBD B-VP O
ST NNP B-NP O
depression NN I-NP O
and CC O O
T NNP B-NP O
wave VBP O O
flattening VBG O O
in IN B-VP O
2 CD O O
, , O O
3 CD O O
, , O O
V5 NNP B-NP O
, , O O
V6 NNP B-NP O
different JJ O O
from IN B-VP O
prior JJ B-NP O
ECG NNP I-NP O
10/0/06 CD O O
, , O O
high JJ B-NP O
voltage NN I-NP O
and CC O O
LVH NNP B-NP O
also RB O O
present.Radiology: VBZ O O
****ADMISSION JJ B-NP O
CXR NNP I-NP O
( ( O O
8/10 CD O O
): NNP B-NP O
nlm JJ B-NP O
heart NN I-NP O
, , O O
clear JJ B-NP O
lungs NNS I-NP O
, , O O
no DT B-NP O
PTX/edemaMicrobiology:UA NNP I-NP O
, , O O
USed NNP B-NP O
( ( O O
8/10 CD O O
): NNP B-NP O
WNL NNP I-NP O
****STUDIES: NNP I-NP O
-ETT NNP I-NP O
MIBI: NNP I-NP O
abnormal JJ O O
imaging VBG O O
- : O O
preliminary JJ B-NP O
results NNS I-NP O
showed VBD B-VP O
that IN B-VP O
he PRP O O
stopped VBD B-VP O
after IN B-VP O
5 CD O O
minutes NNS B-NP O
due JJ O O
to TO O O
chest VB O O
pain NN B-NP O
, , O O
1mm CD O O
ST NNP B-NP O
depressions NNS I-NP O
in IN B-VP O
inferior JJ O O
and CC O O
lateral JJ B-NP O
leads NNS I-NP O
, , O O
and CC O O
mild JJ B-NP O
ischemia NN I-NP O
in IN B-VP O
Diag1 NNP B-NP O
territory NN I-NP O
which WDT O O
raises VBZ O O
concern NN B-NP O
for IN B-VP O
balanced VBN O O
ischemia NN B-NP O
****ASSESSMENT NN I-NP O
and CC O O
PLAN: NNP B-NP O
52M CD O O
pastor NN B-NP O
w/ NN I-NP O
unstable JJ B-NP O
angina NN I-NP O
in IN B-VP O
setting NN B-NP O
of IN B-VP O
known VBN O O
3-vessel JJ B-NP O
CAD NNP I-NP O
s/p NN I-NP O
stent NN I-NP O
to TO O O
RCA NNP B-NP O
'03 NNP I-NP O
last JJ B-NP O
cath NN I-NP O
3 CD O O
of IN B-VP O
May NNP B-NP O
w/ NN I-NP O
diffuse NN I-NP O
CAD NNP I-NP O
precluding NN I-NP O
CABG/PTCA NNP I-NP O
, , O O
medically RB O O
managed VBN O O
and CC O O
asymptomatic JJ O O
until IN B-VP O
present JJ B-NP O
Vitals NNS I-NP O
stable JJ O O
, , O O
enzymes RB O O
negative JJ O O
, , O O
stress JJ B-NP O
test NN I-NP O
with IN B-VP O
abnormal JJ B-NP O
perfusion NN I-NP O
CV NNP I-NP O
*ischemia* NNP I-NP O
Known NNP I-NP O
3vd CD O O
s/p NN B-NP O
stent NN I-NP O
Rest NNP I-NP O
chest NN I-NP O
pain NN I-NP O
NSSTT NNP I-NP O
inferolaterally RB O O
, , O O
Negative NNP B-NP O
enzymes VBZ O O
Stress NNP B-NP O
test NN I-NP O
prelim NN I-NP O
read NN I-NP O
shows VBZ O O
abnormal JJ B-NP O
perfusion: NN I-NP O
stopped VBD B-VP O
after IN B-VP O
5 CD O O
minutes NNS B-NP O
due JJ O O
to TO O O
chest VB O O
pain NN B-NP O
, , O O
1mm CD O O
ST NNP B-NP O
depressions NNS I-NP O
in IN B-VP O
inferior JJ O O
and CC O O
lateral JJ B-NP O
leads NNS I-NP O
, , O O
mild JJ O O
ischemic JJ O O
in IN B-VP O
Diag1 NNP B-NP O
territory NN I-NP O
which WDT O O
is VBZ O O
concerning VBG O O
for IN B-VP O
"balanced NNP B-NP O
ischemia" NN I-NP O
rather RB O O
than IN B-VP O
an DT B-NP O
improvement NN I-NP O
compared VBN O O
to TO O O
previous JJ B-NP O
nuclear JJ I-NP O
imaging NN I-NP O
in IN B-VP O
0/12 CD O O
Inpatient NNP B-NP O
cardiac JJ B-NP O
cathterization NN I-NP O
advised VBN O O
by IN B-VP O
medical JJ B-NP O
team NN I-NP O
but CC O O
refused VBN O O
by IN B-VP O
pt NN B-NP O
Pt NNP I-NP O
opts VBZ O O
to TO O O
be VB O O
discharged VBN O O
and CC O O
follow VB O O
up RP O O
for IN B-VP O
elective JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
Tue NNP B-NP O
4/10 CD O O
The DT B-NP O
risks NNS I-NP O
of IN B-VP O
this DT B-NP O
plan NN I-NP O
were VBD B-VP O
discussed VBN O O
with IN B-VP O
him PRP O O
by IN B-VP O
his PRP$ O O
outpatient JJ B-NP O
cardiologist NN I-NP O
, , O O
Dr NNP B-NP O
Marion NNP I-NP O
Brzostowski NNP I-NP O
While IN B-VP O
an DT B-NP O
inpatient NN I-NP O
, , O O
patient NN B-NP O
was VBD B-VP O
medically RB O O
managed VBN O O
w/ NN B-NP O
ASA NNP I-NP B-m
, , O O
hep NN B-NP B-m
gtt NN I-NP I-m
, , O O
statin NN B-NP B-m
, , O O
bb NN B-NP B-m
, , O O
acei JJ B-NP B-m
Lipid NNP I-NP O
panel NN I-NP O
checked VBD B-VP O
with IN B-VP O
TC NNP B-NP O
101 CD O O
, , O O
tri NN B-NP O
89 CD O O
, , O O
HDL NNP B-NP O
41 CD O O
, , O O
LDL NNP B-NP O
31 CD O O
Statin NNP B-NP B-m
dose NN I-NP O
lowered VBD B-VP O
for IN B-VP O
persistently RB O O
high JJ B-NP O
CK NNP I-NP O
Acei NNP I-NP B-m
dose RB O O
lowered VBD B-VP O
as IN B-VP O
marginal JJ B-NP O
BP NNP I-NP O
effect NN I-NP O
above IN B-VP O
ULN NNP B-NP O
dose VBP O O
Heparin NNP B-NP B-m
gtt NN I-NP I-m
was VBD B-VP O
discontinued VBN O O
prior RB O O
to TO O O
discharge VB O O
On IN B-VP O
discharge NN B-NP O
, , O O
pt RB O O
instructed VBN O O
to TO O O
take VB O O
ASA NNP B-NP B-m
, , O O
bb NN B-NP B-m
, , O O
acei NN B-NP B-m
, , O O
imdur NN B-NP B-m
, , O O
lipitor NN B-NP B-m
, , O O
zetia NN B-NP B-m
He PRP O O
was VBD B-VP O
advised VBN O O
to TO O O
discontinue VB O O
metformin NN B-NP B-m
for IN B-VP B-du
2 CD O O
days NNS B-NP O
before IN B-VP O
and CC O O
2 CD O O
days NNS B-NP O
after IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
He PRP O O
was VBD B-VP O
advised VBN O O
to TO O O
be VB O O
minimally RB O O
active JJ O O
and CC O O
to TO O O
call VB O O
his PRP$ O O
physician NN B-NP O
or CC O O
911 CD O O
if IN B-VP O
he PRP O O
experienced VBD B-VP O
any DT B-NP O
further JJ I-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
lightheadedness NN B-NP O
or CC O O
any DT B-NP O
other JJ I-NP O
symptoms NNS I-NP O
c VBP O O
concerning VBG O O
to TO O O
him PRP O O
*pump* VB O O
Appears NNP B-NP O
euvolemic JJ B-NP O
Nl NNP I-NP O
EF NNP I-NP O
HTN NNP I-NP B-r
HTN NNP I-NP B-r
controlled VBD B-VP O
as IN B-VP O
above IN B-VP O
with IN B-VP O
bb NN B-NP B-m
, , O O
acei JJ B-NP B-m
*rhythm* NNP I-NP O
Sinus NNP I-NP O
rhythm NN I-NP O
Pt NNP I-NP O
continued VBD B-VP O
on IN B-VP O
home NN B-NP O
atenolol NN I-NP B-m
RENAL: NNP I-NP O
*CRI* NNP I-NP O
Possibly RB O O
related VBD B-VP O
to TO O O
HTN/DM NNP B-NP O
Pt NNP I-NP O
w/ VBD B-VP O
Cr NNP B-NP O
1.3 CD O O
, , O O
within IN B-VP O
baseline NN B-NP O
ENDO: NNP I-NP O
*DM* NNP I-NP O
Metformin NNP I-NP B-m
held VBD B-VP O
Pt NNP B-NP O
rx'ed NN I-NP O
w/ NN I-NP O
SSI NNP I-NP B-m
HgA1c NNP I-NP O
checked VBD B-VP O
and CC O O
pending VBG O O
TSH NNP B-NP O
also RB O O
checked VBD B-VP O
and CC O O
pending VBG O O
PROPH: NNP B-NP O
nexium/heparin JJ B-NP B-m
gtt NN I-NP B-mo
CODE: NNP I-NP O
FULL NNP I-NP O
DISPOSITION: NNP I-NP O
Pt NNP I-NP O
discharged VBD B-VP O
to TO O O
home VB O O
with IN B-VP O
plans NNS B-NP O
for IN B-VP O
elective JJ B-NP O
outpatient NN I-NP O
cardiac JJ B-NP O
cathterization NN I-NP O
, , O O
cardiology NN B-NP O
, , O O
PCP NNP B-NP O
f/u VBP O O
DISCHARGE NNP B-NP O
STATUS: NNP I-NP O
afebrile IN B-VP O
P NNP B-NP O
50s-90s JJ B-NP O
SBP NNP I-NP O
120s/70s CD O O
sat VBD B-VP O
RA NNP B-NP O
Exam NNP I-NP O
w/o NN I-NP O
significant JJ B-NP O
change NN I-NP O
from IN B-VP O
admission NN B-NP O
Labs NNP I-NP O
w/ VBD B-VP O
Hct NNP B-NP O
40.2 CD O O
, , O O
Cr NNP B-NP O
1.2 CD O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
You PRP O O
were VBD B-VP O
admitted VBN O O
with IN B-VP O
chest JJ B-NP O
pain NN I-NP O
Your PRP$ O O
blood NN B-NP O
tests NNS I-NP O
show VBP O O
that IN B-VP O
you PRP O O
did VBD B-VP O
not RB O O
have VB O O
a DT B-NP O
heart NN I-NP O
attack NN I-NP O
You PRP O O
had VBD B-VP O
a DT B-NP O
stress NN I-NP O
test NN I-NP O
which WDT O O
is VBZ O O
concerning VBG O O
for IN B-VP O
regions NNS B-NP O
of IN B-VP O
your PRP$ O O
heart NN B-NP O
not RB O O
receiving VBG O O
enough RB O O
blood NN B-NP O
flow VB O O
The DT B-NP O
medical JJ I-NP O
team NN I-NP O
advised VBD B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
but CC O O
your PRP$ O O
plan NN B-NP O
is VBZ O O
to TO O O
go VB O O
home NN B-NP O
today NN I-NP O
and CC O O
return NN B-NP O
for IN B-VP O
an DT B-NP O
elective JJ I-NP O
outpatient NN I-NP O
cardiac JJ B-NP O
catherization NN I-NP O
on IN B-VP O
Tuesday NNP B-NP O
7/21 CD O O
at IN B-VP O
7:30am CD O O
Please NNP B-NP O
go VB O O
to TO O O
the DT B-NP O
Admitting NNP I-NP O
Office NNP I-NP O
on IN B-VP O
the DT B-NP O
Ins NNP I-NP O
to TO O O
register VB O O
Do NNP B-NP O
not RB O O
eat VB O O
anything NN B-NP O
after IN B-VP O
midnight NN B-NP O
Monday NNP I-NP O
night NN I-NP O
Do NNP I-NP O
not RB O O
eat VB O O
breakfast NN B-NP O
or CC O O
drink VB O O
liquids NNS B-NP O
after IN B-VP O
midnight NN B-NP O
Your PRP$ O B-m
medications NNS B-NP O
have VBP O O
been VBN O O
changed VBN O O
as IN B-VP O
follows: NN B-NP O
a DT O O
) ) O O
stop NN B-NP O
taking VBG O O
metformin NN B-NP B-m
for IN B-VP B-du
2 CD O O
days NNS B-NP O
before IN B-VP O
and CC O O
2 CD O O
days NNS B-NP O
after IN B-VP O
your PRP$ O O
cardiac JJ B-NP O
catheterization NN I-NP O
b NN I-NP O
) ) O O
take VB O O
lisinopril JJ B-NP B-m
lisinopril NN I-NP B-m
40 CD O B-do
mg JJ O I-do
daily JJ O B-f
instead RB O O
of IN B-VP O
80 CD O B-do
mg JJ B-NP I-do
daily JJ I-NP B-f
c NN I-NP O
) ) O O
take VB O O
lipitor NN B-NP B-m
lipitor NN I-NP B-m
40 CD O B-do
mg JJ O I-do
daily JJ O B-f
instead RB O O
of IN B-VP O
80 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
Do NNP B-NP O
not RB O O
do VB O O
any DT B-NP O
significant JJ I-NP O
exertion NN I-NP O
until IN B-VP O
your PRP$ O O
cardiac JJ B-NP O
catheterization NN I-NP O
Call VB O O
your PRP$ O O
doctor NN B-NP O
or CC O O
go VB O O
to TO O O
the DT B-NP O
ED NNP I-NP O
if IN B-VP O
you PRP O O
experience VBP O O
any DT B-NP O
further JJ I-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
dizziness NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
or CC O O
other JJ B-NP O
symptoms NNS I-NP O
concerning VBG O O
to TO O O
you PRP O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Fair NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
PCP/cards: NNP I-NP O
-f/u NNP I-NP O
official NN I-NP O
results NNS I-NP O
of IN B-VP O
stress JJ B-NP O
test NN I-NP O
-f/u NN I-NP O
results NNS I-NP O
of IN B-VP O
outpatient JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
( ( O O
prehydration/mucomyst IN B-VP O
peri-cath NN B-NP O
) ) O O
-f/u VBZ O O
results NNS B-NP O
of IN B-VP O
HgA1c NNP B-NP O
and CC O O
TSH NNP B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
WEYKER NNP I-NP O
, , O O
MARCUS NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
LI54 NNP B-NP O
) ) O O
2/22/06 CD O O
@ $ O O
05 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#214865 VBZ O O
141207481 CD O O
MH NNP B-NP O
20518742 CD O O
4382552 CD O O
2/22/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
HIP NNP I-NP O
FRACTURE NNP I-NP O
, , O O
STATUS NNP B-NP O
POST NNP I-NP O
HEART NNP I-NP O
TRANSPLANT NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/15/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/28/2006 CD O O
ATTENDING: NNP B-NP O
HADDENHAM NNP I-NP O
, , O O
LONNIE NNP B-NP O
MD NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Right NNP I-NP O
Hip NNP I-NP O
fracture NN I-NP O
BRIEF NNP I-NP O
ADMISSION NNP I-NP O
HISTORY: NNP I-NP O
Ms NNP I-NP O
Heit NNP I-NP O
is VBZ O O
a DT B-NP O
67-year-old JJ I-NP O
lady NN I-NP O
who WP O O
received VBD B-VP O
a DT B-NP O
heart NN I-NP O
transplant NN I-NP O
in IN B-VP O
March NNP B-NP O
2006 CD O O
for IN B-VP O
idiopathic JJ O O
dilated VBN O O
cardiomyopathy NN B-NP O
and CC O O
who WP O O
was VBD B-VP O
transferred VBN O O
from IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
after IN B-VP O
sutaining VBG O O
a DT B-NP O
right JJ I-NP O
hip NN I-NP O
fracture NN I-NP O
She PRP O O
had VBD B-VP O
been VBN O O
in IN B-VP O
good JJ B-NP O
health NN I-NP O
until IN B-VP O
one CD O O
day NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
to TO O O
Storg NNP B-NP O
Hospital NNP I-NP O
when WRB O O
she PRP O O
tripped VBD B-VP O
over IN B-VP O
the DT B-NP O
carpet NN I-NP O
in IN B-VP O
her PRP$ O O
house NN B-NP O
and CC O O
fell VBD B-VP O
to TO O O
the DT B-NP O
ground NN I-NP O
and CC O O
fractured VBD B-VP O
her PRP$ O O
right JJ B-NP O
hip NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
loss NN I-NP O
of IN B-VP O
consciousness NN B-NP O
or CC O O
head NN B-NP O
trauma NNS I-NP O
nor CC O O
were VBD B-VP O
there EX O O
any DT O O
preceding VBG O O
symptoms NNS B-NP O
such JJ O O
as IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
or CC O O
palpitations NNS B-NP O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
osteoarthritis NN B-NP O
as RB O O
well RB O O
as IN B-VP O
known VBN O O
bilateral JJ B-NP O
hip NN I-NP O
insufficiency NN I-NP O
fractures NNS I-NP O
for IN B-VP O
which WDT O O
she PRP O O
has VBZ O O
been VBN O O
evaluated VBN O O
in IN B-VP O
the DT O O
past JJ O O
She PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
O'mead NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
orthopedic JJ B-NP O
surgery NN I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
felt VBN O O
in IN B-VP O
good JJ B-NP O
health NN I-NP O
with IN B-VP O
no DT B-NP O
recent JJ I-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
or CC O O
night NN B-NP O
sweats NNS I-NP O
She PRP O O
is VBZ O O
able JJ O O
to TO O O
do VB O O
her PRP$ O O
daily JJ B-NP O
activities NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
low JJ B-NP O
intensity NN I-NP O
aerobic JJ B-NP O
activities NNS I-NP O
without IN B-VP O
significant JJ B-NP O
dyspnea NN I-NP O
on IN B-VP O
exertion NN B-NP O
She PRP O O
notes VBZ O O
no DT B-NP O
recent JJ I-NP O
cough NN I-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
diarrhea NN B-NP O
, , O O
dysuria NN B-NP O
, , O O
or CC O O
lower JJR B-NP O
extremity NN I-NP O
swelling VBG O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Idiopathic NNP B-NP O
dilated VBD B-VP O
cardiomyopathy NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
heart NN I-NP O
transplant NN I-NP O
on IN B-VP O
7/16/2006 CD O O
She PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
biventricular JJ B-NP O
assist NN I-NP O
device NN I-NP O
x6 NNP I-NP O
months NNS I-NP O
and CC O O
AICD NNP B-NP O
, , O O
now RB O O
both DT O O
removed VBD B-VP O
2 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
with IN B-VP O
a DT B-NP O
baseline JJ I-NP O
creatinine NN I-NP O
of IN B-VP O
1.1-1.2 JJ O O
3 CD O O
Osteoarthritis NN B-NP O
in IN B-VP O
both DT B-NP O
hips NNS I-NP O
4 CD O O
Osteoporosis NN B-NP O
with IN B-VP O
bilateral JJ B-NP O
femoral JJ I-NP O
neck NN I-NP O
insufficiency NN I-NP O
fractures VBZ O O
5 CD O O
Hypercholesterolemia NNP B-NP O
6 CD O O
History NNP B-NP O
of IN B-VP O
recurring VBG O O
C NNP B-NP O
difficile NN I-NP O
colitis NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Neoral NNP I-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
prednisone NN B-NP B-m
8 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
CellCept NNP B-NP B-m
1500 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Protonix NNP B-NP B-m
20 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Pravachol NNP B-NP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
diltiazem VBZ O B-m
360 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
multivitamin PRP O B-m
one CD O B-do
daily RB O B-f
, , O O
magnesium NN B-NP B-m
oxide RB O I-m
400 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
calcium NN B-NP B-m
and CC O O
vitamin NN B-NP B-m
D NNP I-NP I-m
1800 CD O B-do
mg NN B-NP I-do
daily RB O B-f
, , O O
Fosamax NNP B-NP B-m
weekly RB O B-f
on IN B-VP I-f
Mondays NNS B-NP I-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Zocor NNP B-NP B-m
20 CD O B-do
mg JJ O O
daily RB O B-f
, , O O
Dulcolax NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
as IN B-VP B-f
needed VBN O I-f
for IN B-VP O
constipation NN B-NP B-r
, , O O
vitamin NN B-NP B-m
E NNP I-NP I-m
400 CD O B-do
units NNS B-NP I-do
daily RB O B-f
, , O O
and CC O O
vitamin JJ B-NP B-m
C NNP I-NP I-m
500 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
heparin-induced JJ B-NP O
thrombocytopenia NN I-NP O
Penicillin NNP I-NP O
causes VBZ O O
a DT B-NP O
rash JJ I-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
She PRP O O
was VBD B-VP O
afebrile RB O O
, , O O
98.6 CD O O
, , O O
pulse RB O O
115 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
118/80 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
18 CD O O
, , O O
and CC O O
oxygen NN B-NP O
saturation NN I-NP O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
She PRP O O
was VBD B-VP O
a DT B-NP O
well-appearing JJ I-NP O
lady NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
who WP O O
rated VBD B-VP O
her PRP O O
pain NN B-NP O
as IN B-VP O
2/10 CD O O
at IN B-VP O
rest NN B-NP O
and CC O O
yet RB O O
8/10 CD O O
upon IN B-VP O
movement NN B-NP O
of IN B-VP O
her PRP$ O O
lower JJR B-NP O
extremities NNS I-NP O
On IN B-VP O
head NN B-NP O
and CC O O
neck NN B-NP O
exam NN I-NP O
, , O O
her PRP$ O O
JVP NNP B-NP O
was VBD B-VP O
flat JJ B-NP O
Her NNP I-NP O
oropharynx NN I-NP O
was VBD B-VP O
without IN B-VP O
erythema NN B-NP O
or CC O O
exudates VBZ O O
Her PRP$ O O
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
bilaterally RB O O
On IN B-VP O
examination NN B-NP O
of IN B-VP O
the DT B-NP O
heart NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rhythm NN I-NP O
and CC O O
was VBD B-VP O
tachycardic JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
were VBD B-VP O
clearly RB O O
audible JJ O O
There EX O O
was VBD B-VP O
no DT B-NP O
rub NN I-NP O
or CC O O
murmur NN B-NP O
or CC O O
gallop VB O O
Her PRP$ O O
abdominal JJ B-NP O
exam NN I-NP O
was VBD B-VP O
benign JJ O O
, , O O
and CC O O
her PRP$ O O
extremities NNS B-NP O
were VBD B-VP O
warm JJ O O
and CC O O
without IN B-VP O
edema FW O O
Her PRP$ O O
right JJ B-NP O
leg NN I-NP O
was VBD B-VP O
shortened VBN O O
and CC O O
externally RB O O
rotated JJ B-NP O
LABORATORIES NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
sodium NN B-NP O
of IN B-VP O
146 CD O O
, , O O
potassium NN B-NP O
of IN B-VP O
4.2 CD O O
, , O O
chloride NN B-NP O
of IN B-VP O
111 CD O O
, , O O
bicarbonates NNS B-NP O
of IN B-VP O
24 CD O O
, , O O
BUN NNP B-NP O
39 CD O O
, , O O
creatinine NN B-NP O
1.4 CD O O
, , O O
PTT NNP B-NP O
26.2 CD O O
, , O O
and CC O O
INR NNP B-NP O
1.1 CD O O
Plain NNP B-NP O
films NNS I-NP O
of IN B-VP O
the DT B-NP O
hip NN I-NP O
revealed VBD B-VP O
a DT B-NP O
nondisplaced JJ I-NP O
right JJ I-NP O
femoral JJ I-NP O
fracture NN I-NP O
EKG NNP I-NP O
showed VBD B-VP O
sinus JJ B-NP O
tachycardia NN I-NP O
Echocardiogram NNP I-NP O
performed VBD B-VP O
on IN B-VP O
7/10/2006 CD O O
revealed VBD B-VP O
LVEF NNP B-NP O
of IN B-VP O
55-60% CD O O
without IN B-VP O
wall NN B-NP O
motion NN I-NP O
abnormality NN I-NP O
and CC O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
diastolic JJ B-NP O
dysfunction NN I-NP O
Her NNP I-NP O
RV NNP I-NP O
was VBD B-VP O
mildly RB O O
enlarged VBN O O
, , O O
mild JJ O O
left VBD B-VP O
atrial JJ B-NP O
enlargement NN I-NP O
, , O O
no DT B-NP O
AR NNP I-NP O
, , O O
and CC O O
mild JJ B-NP O
TR NNP I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
aortic JJ I-NP O
regurgitation NN I-NP O
, , O O
mild JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
, , O O
and CC O O
trace NN B-NP O
tricuspid JJ B-NP O
regurgitation NN I-NP O
Most NNP I-NP O
recent JJ B-NP O
right JJ I-NP O
heart NN I-NP O
catheterization NN I-NP O
results NNS I-NP O
performed VBD B-VP O
in IN B-VP O
May NNP B-NP O
2006 CD O O
showed VBD B-VP O
normal JJ B-NP O
right-sided JJ I-NP O
filling NN I-NP O
pressures NNS I-NP O
with IN B-VP O
a DT B-NP O
right JJ I-NP O
atrial JJ I-NP O
pressure NN I-NP O
of IN B-VP O
3 CD O O
mmHg NNS B-NP O
, , O O
RV NNP B-NP O
4 CD O O
, , O O
PA NNP B-NP O
24 CD O O
, , O O
and CC O O
pulmonary JJ B-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
of IN B-VP O
9 CD O O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS: NNP I-NP O
In IN B-VP O
summary JJ O O
, , O O
Ms NNP B-NP O
Hilz NNP I-NP O
is VBZ O O
a DT B-NP O
67-year-old JJ I-NP O
female NN I-NP O
status NN I-NP O
post NN I-NP O
heart NN I-NP O
transplant NN I-NP O
in IN B-VP O
March NNP B-NP O
2006 CD O O
who WP O O
was VBD B-VP O
stable JJ O O
from IN B-VP O
a DT B-NP O
cardiac JJ I-NP O
standpoint NN I-NP O
when WRB O O
she PRP O O
tripped VBD B-VP O
and CC O O
sustained VBD B-VP O
a DT B-NP O
right JJ I-NP O
hip NN I-NP O
fracture NN I-NP O
She PRP O O
was VBD B-VP O
transferred VBN O O
from IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
in IN B-VP O
Ing NNP B-NP O
Port NNP I-NP O
for IN B-VP O
surgical JJ B-NP O
evaluation NN I-NP O
Musculoskeletal: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
status NN B-NP O
post NN I-NP O
right RB O O
hip NN B-NP O
fracture NN I-NP O
She PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
OR NNP I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
and CC O O
received VBD B-VP O
a DT B-NP O
dynamic JJ I-NP O
hip NN I-NP O
screw VBD B-VP O
The DT B-NP O
procedure NN I-NP O
was VBD B-VP O
uncomplicated VBN O O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
able JJ O O
to TO O O
begin VB O O
weightbearing VBG O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
She PRP O O
worked VBD B-VP O
with IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
and CC O O
upon IN B-VP O
discharge NN B-NP O
was VBD B-VP O
able JJ O O
to TO O O
ambulate VB O O
around IN B-VP O
the DT B-NP O
Angeles NNP I-NP O
with IN B-VP O
a DT B-NP O
walker NN I-NP O
She PRP O O
should MD O O
continue VB O O
aspirin VB O B-m
325 CD O B-do
mg JJ O I-do
daily RB O B-f
for IN B-VP B-du
four CD O I-du
weeks NNS B-NP I-du
after IN B-VP O
the DT B-NP O
surgery NN I-NP O
There EX O O
is VBZ O O
no DT B-NP O
indication NN I-NP O
for IN B-VP O
systemic JJ B-NP O
anticoagulation NN I-NP O
after IN B-VP O
this DT B-NP O
particular JJ I-NP O
procedure NN I-NP O
She PRP O O
will MD O O
receive VB O O
oxycodone NN B-NP B-m
as IN B-VP B-f
needed VBN O I-f
Cardiovascular: NNP B-NP O
She PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
transplant NN I-NP O
with IN B-VP O
the DT B-NP O
last JJ I-NP O
echocardiogram NN I-NP O
revealing VBG O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
60% CD O O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
standard JJ B-NP O
immunosuppressive JJ I-NP B-m
medications NNS I-NP I-m
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemia NN B-NP O
throughout IN B-VP O
the DT B-NP O
hospital NN I-NP O
stay NN I-NP O
She PRP O O
was VBD B-VP O
euvolemic JJ O O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
She PRP O O
was VBD B-VP O
in IN B-VP O
sinus JJ B-NP O
rhythm NN I-NP O
on IN B-VP O
telemetry NN B-NP O
throughout IN B-VP O
her PRP$ O O
hospital NN B-NP O
stay NN I-NP O
Hematology: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
heparin-induced JJ B-NP B-r
thrombocytopenia NN I-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
fondaparinux JJ O B-m
daily JJ O B-f
prior RB O O
to TO O O
the DT B-NP O
procedure NN I-NP O
and CC O O
then RB O O
discharged VBD B-VP O
on IN B-VP O
aspirin NN B-NP B-m
for IN B-VP B-du
four CD O O
weeks NNS B-NP O
postprocedure NN I-NP O
Her NNP I-NP O
hematocrit NN I-NP O
dropped VBD B-VP O
from IN B-VP O
33.5% CD O O
to TO O O
24.9% CD O O
after IN B-VP O
the DT B-NP O
surgery NN I-NP O
She PRP O O
was VBD B-VP O
transfused VBN O O
with IN B-VP O
2 CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
after IN B-VP O
surgery NN B-NP O
with IN B-VP O
appropriate JJ B-NP O
hematocrit NN I-NP B-r
rise NN I-NP O
She PRP O O
received VBD B-VP O
additional JJ O O
2 CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
prior RB O O
to TO O O
discharge VB O O
, , O O
and CC O O
her PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
30.4% CD O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
Stools NNP I-NP O
were VBD B-VP O
guaiac JJ O O
negative JJ O O
, , O O
and CC O O
it PRP O O
was VBD B-VP O
thought VBN O O
that IN B-VP O
his PRP$ O O
hematocrit NN B-NP O
drop NN I-NP O
was VBD B-VP O
due JJ O O
to TO O O
the DT B-NP O
postoperative JJ I-NP O
blood NN I-NP O
loss NN I-NP O
as RB O O
well RB O O
as IN B-VP O
potential JJ B-NP O
hematoma NN I-NP O
formation NN I-NP O
at IN B-VP O
the DT B-NP O
site NN I-NP O
of IN B-VP O
the DT B-NP O
surgery NN I-NP O
Her NNP I-NP O
hematocrit NN I-NP O
will MD O O
be VB O O
followed VBN O O
closely RB O O
as IN B-VP O
an DT B-NP O
outpatient JJ I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Tylenol NNP I-NP B-m
650 CD O B-do
mg NN B-NP I-do
every DT O B-f
four CD O I-f
hours NNS B-NP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
, , O O
aspirin RB O B-m
325 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
for IN B-VP B-du
four CD O I-du
weeks NNS B-NP I-du
after IN B-VP O
the DT B-NP O
surgery NN I-NP O
, , O O
Fosamax NNP B-NP B-m
70 CD O B-do
mg NN B-NP I-do
weekly RB O B-f
, , O O
Dulcolax NNP B-NP B-m
p.r VBZ O B-mo
10 CD O B-do
mg NN B-NP I-do
as IN B-VP B-f
needed VBN O I-f
for IN B-VP O
constipation NN B-NP B-r
, , O O
Caltrate NNP B-NP B-m
plus CC O I-m
D NNP B-NP I-m
one CD O B-do
tablet NN B-NP I-do
daily RB O B-f
, , O O
Neoral NNP B-NP B-m
( ( O O
cyclosporine NN B-NP O
) ) O O
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
diltiazem NN B-NP B-m
extended VBD B-VP I-m
release NN B-NP I-m
360 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
magnesium NN B-NP B-m
oxide RB O I-m
420 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
CellCept NNP B-NP B-m
1500 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
oxycodone CD O B-m
5-10 JJ B-NP B-do
mg NN I-NP I-do
every DT O B-f
six CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-r
, , O O
Protonix NNP B-NP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Pravachol NNP B-NP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
prednisone NN B-NP B-m
8 CD O B-do
mg NN B-NP I-do
every DT B-NP B-f
morning NN I-NP I-f
, , O O
and CC O O
multivitamin VB O B-m
one CD O B-do
tablet NN B-NP I-do
daily JJ B-NP B-f
FOLLOWUP NNP I-NP O
PLANS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
continue VB O O
her PRP$ O O
home NN B-NP B-m
medication NN I-NP O
regimen NNS I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
should MD O O
be VB O O
maintained VBN O O
on IN B-VP O
aspirin NN B-NP B-m
325 CD O B-do
mg NN B-NP I-do
for IN B-VP B-du
four CD O I-du
weeks NNS B-NP I-du
to TO O O
prevent VB O O
clot NN B-NP B-r
formation NN I-NP O
postsurgery IN B-VP O
She PRP O O
should MD O O
take VB O O
oxycodone RP O B-m
as RB O B-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
She PRP O O
has VBZ O O
a DT B-NP O
followup JJ I-NP O
appointment NN I-NP O
with IN B-VP O
orthopedic JJ B-NP O
surgery NN I-NP O
The DT B-NP O
attending NN I-NP O
who WP O O
performed VBD B-VP O
her PRP$ O O
procedure NN B-NP O
was VBD B-VP O
Dr NNP B-NP O
Firkey NNP I-NP O
Her NNP I-NP O
appointment NN I-NP O
is VBZ O O
scheduled VBN O O
for IN B-VP O
4/13/2006 CD O O
at IN B-VP O
09:15 CD O O
a.m NNS B-NP O
She PRP O O
should MD O O
followup VB O O
with IN B-VP O
her PRP O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
within IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
of IN B-VP O
discharge NN B-NP O
and CC O O
will MD O O
also RB O O
be VB O O
closely RB O O
followed VBN O O
by IN B-VP O
transplant NN B-NP O
clinic NN I-NP O
She PRP O O
was VBD B-VP O
instructed VBN O O
to TO O O
have VB O O
her PRP$ O O
blood NN B-NP O
drawn NN I-NP O
on IN B-VP O
Monday NNP B-NP O
after IN B-VP O
discharge NN B-NP O
, , O O
9/24/2006 CD O O
, , O O
to TO O O
be VB O O
reviewed VBN O O
by IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
eScription NN I-NP O
document: VBZ O O
7-0558379 JJ B-NP O
HFFocus NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
CARLEW NNP I-NP O
, , O O
AGUSTIN NNP B-NP O
Attending: NNP I-NP O
GAUGER NNP I-NP O
, , O O
FILIBERTO NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
0495038 CD O O
D: NNP B-NP O
1/10/06 CD O O
T: NNP B-NP O
0/27/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#217805 VBZ O O
427263098 CD O O
VH NNP B-NP O
31474529 CD O O
2621953 CD O O
0/25/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
CAD NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/0/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/0/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
PREHN NNP I-NP O
, , O O
DAMION NNP B-NP O
426-57-09-1 CD O O
A NNP B-NP O
S NNP I-NP O
Sadenabirm NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/23/06 CD O O
AT NNP B-NP O
01:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
MOREDOCK NNP I-NP O
, , O O
ROLAND NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ATENOLOL NNP I-NP B-m
125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
11/9 CD O O
) ) O O
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Instructions: NNP I-NP O
p/w NN I-NP O
angina NN I-NP O
, , O O
s/p JJ B-NP O
PCI NNP I-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/24/06 CD O O
by IN B-VP O
KOTH NNP B-NP O
, , O O
JEFFERSON NNP B-NP O
KEVIN NNP I-NP O
, , O O
M.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
MICONAZOLE NNP I-NP B-m
NITRATE NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
MICONAZOLE NNP I-NP B-m
NITRATE NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
KEFLEX NNP I-NP B-m
( ( O I-m
CEPHALEXIN NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
11/9 CD O O
) ) O O
Instructions: NNP B-NP O
started VBD B-VP O
7/14 CD O O
, , O O
stop VBD B-VP O
10/21 CD O O
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
Tomorrow NNP I-NP O
( ( O O
2/14 CD O O
) ) O O
ENTERIC NNP B-NP B-m
COATED NNP I-NP I-m
ASA NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting NNP I-NP I-f
IN NNP I-NP I-f
AM NNP I-NP I-f
( ( O O
1/25 CD O O
) ) O O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
SLOW NNP I-NP I-m
REL NNP I-NP I-m
( ( O I-m
KCL NNP B-NP I-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
10 CD O B-do
MEQ NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
As IN B-VP O
per IN B-VP O
CGH NNP B-NP O
Potassium NNP I-NP O
Chloride NNP I-NP O
Policy: NNP I-NP O
each DT O O
20 CD O O
mEq NNS B-NP O
dose VB O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4 CD O O
oz NNS B-NP O
of IN B-VP O
fluid NN B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/23/06 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
LISINOPRIL NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/4/06 CD O O
by IN B-VP O
RAMSIER NNP B-NP O
, , O O
TRENTON NNP B-NP O
H NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IMMED NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
126584751 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
Previous JJ O O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/06 CD O O
by IN B-VP O
BI NNP B-NP O
, , O O
GLENN NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitering VBG O O
MICONAZOLE NNP B-NP B-m
NITRATE NNP I-NP I-m
2% CD O I-m
CREAM NNP B-NP I-m
TP NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
apply VB O O
in IN B-VP O
between IN B-VP O
toes NNS B-NP O
B/L NNP I-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/24/06 CD O O
by IN B-VP O
HESBY NNP B-NP O
, , O O
NICOLAS NNP B-NP O
DOMINICK NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LIPITOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
146549249 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
MICONAZOLE NNP I-NP B-m
NITRATE NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/06 CD O O
by IN B-VP O
POCAI NNP B-NP O
, , O O
GARY NNP B-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
MICONAZOLE NNP I-NP B-m
NITRATE NNP I-NP I-m
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
MICONAZOLE NNP I-NP B-m
NITRATE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
MICONAZOLE NNP I-NP B-m
NITRATE NNP I-NP I-m
2% CD O I-m
POWDER NNP B-NP I-m
TOPICAL NNP I-NP B-mo
TP NNP I-NP I-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
apply VB O O
to TO O O
groin VB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/24/06 CD O O
by IN B-VP O
MUEHL NNP B-NP O
, , O O
REID NNP B-NP O
GENE NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LIPITOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
146549249 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
MICONAZOLE NNP I-NP B-m
NITRATE NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
NIASPAN NNP I-NP B-m
( ( O I-m
NICOTINIC NNP B-NP I-m
ACID NNP I-NP I-m
SUSTAINED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
0.5 CD O B-do
GM NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Instructions: NNP I-NP O
Take NNP I-NP O
aspirin NN I-NP B-m
30 CD O O
minutes NNS B-NP O
before- JJ B-NP O
hand NN I-NP O
to TO O O
prevent VB O O
facial JJ O B-r
flushing VBG O I-r
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/24/06 CD O O
by IN B-VP O
HARTZFELD NNP B-NP O
, , O O
NICK NNP B-NP O
TIMMY NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LIPITOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
146549249 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/06 CD O O
by IN B-VP O
RAUHE NNP B-NP O
, , O O
WESTON NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Weakland NNP I-NP O
, , O O
Primary NNP B-NP O
Care NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
Please NNP I-NP O
call VB O O
the DT B-NP O
office NN I-NP O
if IN B-VP O
you PRP O O
do VBP O O
not RB O O
hear VB O O
from IN B-VP O
them PRP O O
in IN B-VP O
the DT O O
next JJ O O
2 CD O O
days NNS B-NP O
, , O O
Dr NNP B-NP O
Trouser NNP I-NP O
, , O O
Cardiology NNP B-NP O
571-491-1951 JJ B-NP O
Please NNP I-NP O
call NN I-NP O
in IN B-VP O
1-2 JJ B-NP O
days NNS I-NP O
if IN B-VP O
you PRP O O
do VBP O O
not RB O O
hear VB O O
from IN B-VP O
the DT B-NP O
office NN I-NP O
You PRP O O
must MD O O
be VB O O
seen VBN O O
in IN B-VP O
2-4 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
Shellfish NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
angina NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CAD NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
2 CD O O
VESSEL NNP B-NP O
CAD NNP I-NP O
HTN NNP I-NP O
+ETT VBD B-VP O
4/7 CD O O
W/ NNP B-NP O
ST NNP I-NP O
DEPRESSION NNP I-NP O
ANGINA NNP I-NP O
, , O O
? . B-VP O
UNSTABLE NNP B-NP O
CURRENTLY NNP I-NP O
STABLE NNP I-NP O
NO NNP I-NP O
CHEST NNP I-NP O
PAIN NNP I-NP O
SINCE NNP I-NP O
3/5 CD O O
S/P NNP B-NP O
CATH NNP I-NP O
5/24 CD O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
cardiac VBP O O
cath NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
cc: NN I-NP O
SOB/DOE NNP I-NP O
x VBZ O O
9 CD O O
months NNS B-NP O
HPI: NNP I-NP O
60M CD O O
HTN NNP B-NP O
, , O O
obese JJ O O
, , O O
CAD NNP B-NP O
S/P NNP I-NP O
stent NN I-NP O
in IN B-VP O
'96 CD O O
to TO O O
LCx NNP B-NP O
, , O O
w/ NN B-NP O
DOE NNP I-NP O
and CC O O
substernal JJ B-NP O
chest NN I-NP O
tightness NN I-NP O
w/ NN I-NP O
walking VBG O O
approx JJ O O
200 CD O O
yards NNS B-NP O
Sx NNP I-NP O
resolve VBP O O
with IN B-VP O
rest NN B-NP O
Associated VBN O O
with IN B-VP O
SOB NNP B-NP O
and CC O O
periodic JJ B-NP O
radiation NN I-NP O
to TO O O
the DT B-NP O
R NNP I-NP O
chest NN I-NP O
Have VBP O O
been VBN O O
slowly RB O O
progressing VBG O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
months NNS I-NP O
Since IN B-VP O
last JJ B-NP O
cath NN I-NP O
in IN B-VP O
'96 NNP B-NP O
, , O O
has VBZ O O
had VBN O O
few JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
chest NN B-NP B-r
pain NN I-NP I-r
releived VBD B-VP O
with IN B-VP O
sl JJ B-NP B-mo
nitro NNS I-NP B-m
On IN B-VP O
ROS NNP B-NP O
positive JJ B-NP O
orthopnea NN I-NP O
( ( O O
3 CD O O
pillows NNS B-NP O
) ) O O
, , O O
no DT B-NP O
PND NNP I-NP O
No NNP I-NP O
lightheadedness NN I-NP O
, , O O
dizziness NN B-NP O
, , O O
nausea NN B-NP O
, , O O
emesis NN B-NP O
, , O O
cough NN B-NP O
, , O O
abd RB O O
pain VBP O O
No DT B-NP O
fever NN I-NP O
or CC O O
chills NNS B-NP O
Recent JJ B-NP O
gain NN I-NP O
of IN B-VP O
100 CD O O
lb NNS B-NP O
in IN B-VP O
setting VBG O O
of IN B-VP O
family NN B-NP O
illnesses NNS I-NP O
In IN B-VP O
the DT B-NP O
last JJ I-NP O
week NN I-NP O
, , O O
got VBD B-VP O
PECT NNP B-NP O
( ( O O
neg NN B-NP O
) ) O O
, , O O
Stress NNP B-NP O
Echo NNP I-NP O
negative NN I-NP O
for IN B-VP O
ischimia NN B-NP O
w/ NN I-NP O
submax NN I-NP O
HR NNP I-NP O
, , O O
+ NNP B-NP O
MIBI NNP I-NP O
Admitted NNP I-NP O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
In IN B-VP O
ED: NNP B-NP O
T98.6 NNP I-NP O
P70 NNP I-NP O
BP141/69 NNP I-NP O
Sat NNP I-NP O
94%RA CD O O
Given NNP B-NP O
ASA NNP I-NP B-m
and CC O O
Keflex NNP B-NP B-m
( ( O O
for IN B-VP O
LE NNP B-NP B-r
LE NNP I-NP B-r
cellulitis NN I-NP O
) ) O O
******** VBZ O O
*PMHx: JJ B-NP O
CAD NNP I-NP O
( ( O O
s/p JJ O O
2 CD O O
stents NNS B-NP O
to TO O O
LCx NNP B-NP O
'96 NNP I-NP O
) ) O O
, , O O
HTN NNP B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
hepatitis NN B-NP O
( ( O O
resolved VBN O O
) ) O O
, , O O
colonic JJ B-NP O
polyps NNS I-NP O
, , O O
osteoarthritis NN B-NP O
, , O O
s/p NN B-NP O
appy JJ O O
, , O O
s/p JJ B-NP O
R NNP I-NP O
THR NNP I-NP O
*ALL: NNP I-NP O
Shellfish NNP I-NP O
--&gt; NNP I-NP O
Rash NNP I-NP O
*Home NNP I-NP O
Meds: NNP I-NP O
norvasc RB O B-m
10mg CD O B-do
, , O O
lasix VBD B-VP B-m
40mg CD O B-do
qd NN B-NP B-f
, , O O
lipitor NN B-NP B-m
80mg CD O B-do
qd NN B-NP B-f
, , O O
atenolol RB O B-m
100mg CD O B-do
qd NN B-NP B-f
, , O O
isordil JJ O B-m
20mg CD O B-do
tid NN B-NP B-f
, , O O
ASA NNP B-NP B-m
325mg CD O B-do
qd NN B-NP B-f
*Social JJ B-NP O
Hx: NNP I-NP O
married VBD B-VP O
, , O O
wife NN B-NP O
in IN B-VP O
EMC NNP B-NP O
w/ NN I-NP O
Alzheimer's NNP I-NP O
Lives VBZ O O
alone RB O O
Mother NNP B-NP O
died VBD B-VP O
a DT B-NP O
year NN I-NP O
ago RB O O
from IN B-VP O
malignancy NN B-NP O
, , O O
used VBD B-VP O
to TO O O
take VB O O
care NN B-NP O
of IN B-VP O
her PRP$ O O
Past NNP B-NP O
tobacco NN I-NP O
( ( O O
40pk CD O O
yrs NN B-NP O
) ) O O
, , O O
no DT B-NP O
ETOH NNP I-NP O
or CC O O
drugs NNS B-NP O
*Fam VBP O O
Hx: NNP B-NP O
no DT B-NP O
CAD NNP I-NP O
********* NNP I-NP O
**Stress NNP I-NP O
Echo NNP I-NP O
6/26 CD O O
EF NNP B-NP O
45% CD O O
, , O O
borderline NN B-NP O
LVE NNP I-NP O
, , O O
concentric JJ B-NP O
LVH NNP I-NP O
, , O O
post NN B-NP O
basilar JJ B-NP O
HK NNP I-NP O
and CC O O
mid-inf JJ B-NP O
HK NNP I-NP O
LAE NNP I-NP O
No NNP I-NP O
ischimia NN I-NP O
, , O O
but CC O O
submax JJ B-NP O
stress NN I-NP O
test NN I-NP O
( ( O O
peak JJ B-NP O
HR NNP I-NP O
85bmp CD O O
) ) O O
**MIVI NN B-NP O
( ( O O
10/15/06 CD O O
): RB O O
non-ischimic JJ B-NP O
Patchy NNP I-NP O
uptake NN I-NP O
diffusely RB O O
w/ VBD B-VP O
small JJ B-NP O
reversible JJ I-NP O
apical JJ I-NP O
defect NN I-NP O
-&gt; NNP I-NP O
? . B-VP O
mild JJ B-NP O
ischimia NN I-NP O
in IN B-VP O
LAD NNP B-NP O
territory NN I-NP O
Small NNP I-NP O
defect NN I-NP O
of IN B-VP O
medium NN B-NP O
intensity NN I-NP O
in IN B-VP O
the DT B-NP O
basal NN I-NP O
inferolateral JJ B-NP O
wall NN I-NP O
that WDT O O
is VBZ O O
fixed VBN O O
c/w JJ B-NP O
LCx/OM NNP I-NP O
scar NN I-NP O
**PECT VBD B-VP O
6/26 CD O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
PE NNP B-NP O
**CXR NNP I-NP O
( ( O O
admission NN B-NP O
): NNP I-NP O
R NNP I-NP O
hilar JJ B-NP O
opacity NN I-NP O
**EKG: NNP I-NP O
SR NNP I-NP O
75bmp CD O O
, , O O
RBBB NNP B-NP O
, , O O
LEA NNP B-NP O
, , O O
PVC NNP B-NP O
, , O O
strain NN B-NP O
pattern JJ B-NP O
Cath NNP I-NP O
11/4/06 CD O O
: : O O
Right JJ B-NP O
Dominant NNP I-NP O
, , O O
LAD NNP B-NP O
( ( O O
Proximal NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
55% CD O O
lesion NN B-NP O
, , O O
LCX NNP B-NP O
( ( O O
Mid NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
80% CD O O
lesion NN B-NP O
, , O O
RCA NNP B-NP O
( ( O O
Proximal NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
99% CD O O
lesion NN B-NP O
, , O O
RT NNP B-NP O
LV-BR NNP I-NP O
( ( O O
Ostial NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
55% CD O O
lesion NN B-NP O
, , O O
RT NNP B-NP O
PDA NNP I-NP O
( ( O O
Proximal NNP B-NP O
) ) O O
, , O O
Discrete NNP B-NP O
50% CD O O
lesion NN B-NP O
, , O O
Collateral NNP B-NP O
flow NN I-NP O
from IN B-VP O
LAD NNP B-NP O
to TO O O
RT NNP B-NP O
PDA NNP I-NP O
, , O O
Collateral NNP B-NP O
flow NN I-NP O
from IN B-VP O
CX NNP B-NP O
to TO O O
RT VB O O
LV-BR NNP B-NP O
Right NNP I-NP O
heart NN I-NP O
Cath NNP I-NP O
11/4/06 CD O O
: : O O
RA NNP B-NP O
13/13 CD O O
RV NNP B-NP O
41/-1 CD O O
, , O O
PA NNP B-NP O
47/16 CD O O
, , O O
PW NNP B-NP O
27/25 CD O O
PA:74% NNP B-NP O
Fick NNP I-NP O
CO:6.95 NNP I-NP O
Thermal NNP I-NP O
CO: NNP I-NP O
SVR:1163 NNP I-NP O
Fick NNP I-NP O
CI:2.76 NNP I-NP O
Thermal NNP I-NP O
CI: NNP I-NP O
PVR:69 NNP I-NP O
Cath NNP I-NP O
9/27/06 CD O O
: : O O
PCI NN B-NP O
and CC O O
stent NN B-NP O
to TO O O
LCx NNP B-NP O
********** NNP I-NP O
*Daily RB O O
Status: NNP B-NP O
T98.3 NNP I-NP O
P94 NNP I-NP O
BP130/80 NNP I-NP O
Sat NNP I-NP O
96%RA CD O O
GEN: NNP B-NP O
NAD NNP I-NP O
, , O O
A&amp;Ox3 NNP B-NP O
HEENT: NNP I-NP O
mmm NN I-NP O
, , O O
PERRLA NNP B-NP O
, , O O
JVP NNP B-NP O
8cm CD O O
, , O O
CEA NNP B-NP O
scars VBZ O O
b/l JJ B-NP O
CV: NNP I-NP O
RRR NNP I-NP O
, , O O
1/6 CD O O
RUSB NNP B-NP O
ejection NN I-NP O
murmur; VBD B-VP O
non-displaced JJ B-NP O
PMI NNP I-NP O
, , O O
B/L NNP B-NP O
CEA NNP I-NP O
scars NNS I-NP O
, , O O
no DT B-NP O
bruits NNS I-NP O
ABD: NNP I-NP O
obese JJ O O
, , O O
NABS NNP B-NP O
, , O O
nt RB O O
, , O O
nd UH O O
, , O O
no DT B-NP O
HSM NNP I-NP O
, , O O
B/L NNP B-NP O
femoral JJ B-NP O
bruits NNS I-NP O
PULM: NNP I-NP O
CTA NNP I-NP O
b/l VBD B-VP O
EXTR: NNP B-NP O
3+ CD O O
b/l NN B-NP O
edema NN I-NP O
to TO O O
knees NNS B-NP O
, , O O
b/l NN B-NP O
ankle NN I-NP O
erythema NN I-NP O
and CC O O
warmth NN B-NP O
w/ NN I-NP O
exudation NN I-NP O
on IN B-VP O
L NNP B-NP O
, , O O
+ NNP B-NP O
onchomycosis NN I-NP O
B/L NNP I-NP O
NEURO: NNP I-NP O
full JJ B-NP O
strength NN I-NP O
&amp; NNP I-NP O
sensation NN I-NP O
Limited NNP I-NP O
R NNP I-NP O
eye NN I-NP O
abduction NN I-NP O
( ( O O
Lateral NNP B-NP O
Rectus NNP I-NP O
) ) O O
PERRLA NNP B-NP O
*********** NNP I-NP O
A/P: NNP I-NP O
60 CD O O
yo NN B-NP O
M NNP I-NP O
with IN B-VP O
CAD NNP B-NP O
, , O O
HTN NNP B-NP O
and CC O O
Hyperlipidemia NNP B-NP O
admitted VBD B-VP O
with IN B-VP O
increasing VBG O O
DOE NNP B-NP O
and CC O O
intermidiate VB O O
MIBI NNP B-NP O
as IN B-VP O
out-pt NN B-NP O
in IN B-VP O
setting NN B-NP O
of IN B-VP O
significant JJ B-NP O
deconditioning NN I-NP O
and CC O O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
1 CD O O
CV: NNP B-NP O
i- JJ O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
active JJ B-NP O
ischemia NN I-NP O
Admission NNP I-NP O
cardiac VBZ O O
markers NNS B-NP O
negative JJ B-NP O
Continued NNP I-NP O
statin/high JJ B-NP B-do
statin/high NN I-NP B-m
dose NN I-NP I-do
ASA NNP I-NP B-m
( ( O O
post FW O O
stent NN B-NP O
)/started VBN O O
Plavix NNP B-NP B-m
( ( O O
post FW O O
stent NN B-NP O
)/increased VBD B-VP O
atenolol JJ B-NP B-m
atenolol NN I-NP B-m
from IN B-VP O
100mg CD O B-do
to TO O O
125 CD O B-do
mg NN B-NP O
Started VBD B-VP O
Niaspan NNP B-NP B-m
for IN B-VP O
low JJ B-NP B-r
HDL NNP I-NP I-r
( ( O O
Trig NNP B-NP O
138 CD O O
, , O O
HDL NNP B-NP O
38 CD O O
, , O O
LDL NNP B-NP O
85 CD O O
) ) O O
Subtotal NNP B-NP O
RCA NNP I-NP O
occlusion NN I-NP O
, , O O
80% CD O O
OM NNP B-NP O
, , O O
50% CD O O
mid NN B-NP O
LAD NNP I-NP O
Cypher NNP I-NP O
Stents NNP I-NP O
in IN B-VP O
mid NN B-NP O
RCA NNP I-NP O
to TO O O
os VB O O
Returned VBN O O
to TO O O
cath VB O O
lab NN B-NP O
for IN B-VP O
Lcx NNP B-NP O
PCI NNP I-NP O
1/8 CD O O
and CC O O
cypher JJR B-NP O
stent NN I-NP O
placed VBD B-VP O
Wedge NNP B-NP O
elevated VBD B-VP O
EF NNP B-NP O
45% CD O O
on IN B-VP O
stress NN B-NP O
echo NN I-NP O
Difficult NNP I-NP O
to TO O O
determine VB O O
volume NN B-NP O
status NN I-NP O
by IN B-VP O
clinical JJ B-NP O
exam NN I-NP O
alone RB O O
Increased VBD B-VP O
lasix JJ B-NP B-m
lasix NN I-NP B-m
from IN B-VP O
40 CD O B-do
mg NNS B-NP I-do
PO NNP I-NP B-mo
daily RB O B-f
to TO O O
80 CD O B-do
mg NNS B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
, , O O
increased VBD B-VP O
b-blocker NN B-NP B-m
, , O O
continued VBD B-VP O
norvasc JJ O B-m
and CC O O
stopped VBD B-VP O
isordil NNS B-NP B-m
Will NNP I-NP O
stop VB O O
norvasc NN B-NP B-m
to TO O O
allow VB O O
room NN B-NP O
for IN B-VP O
ACE-I JJ B-NP O
titration NN I-NP O
r-telemetry NN I-NP O
monitoring NN I-NP O
revealed VBD B-VP O
2 CD O O
episodes NNS B-NP O
of IN B-VP O
NSVT NNP B-NP O
post-PCI JJ B-NP O
Continue NNP I-NP O
ASA/Plavix NNP I-NP B-m
ASA/Plavix NNP I-NP B-m
at IN B-VP O
current JJ B-NP O
doses NNS I-NP O
x VBP O B-du
x JJ O B-du
1 CD O I-du
1 CD O I-du
year NN B-NP I-du
year NN I-NP I-du
2 CD O O
PULM: NNP B-NP O
likely RB O O
symptoms VBD B-VP O
related VBN O O
to TO O O
cardiac VB O O
etiology NN B-NP O
No NNP I-NP O
evidence NN I-NP O
of IN B-VP O
PE NNP B-NP O
per IN B-VP O
out-pt JJ B-NP O
scan NN I-NP O
within IN B-VP O
the DT B-NP O
last JJ I-NP O
week NN I-NP O
3 CD O O
ID: NNP B-NP O
lower JJR B-NP O
extremity NN I-NP O
cellulitis NN I-NP O
in IN B-VP O
setting VBG O O
of IN B-VP O
venous JJ B-NP O
stasis NN I-NP O
and CC O O
likely JJ B-NP O
peripheral JJ I-NP B-r
vascular JJ I-NP I-r
disease NN I-NP I-r
Treat NNP I-NP O
with IN B-VP O
keflex NNP B-NP B-m
x $ O B-du
2 CD O I-du
weeks NNS B-NP I-du
and CC O O
continue VB O O
longer JJR O O
if IN B-VP O
legs NNS B-NP O
still RB O O
erythematous JJ B-NP O
ABX NNP I-NP B-m
started VBD B-VP B-du
7/14 CD O I-du
, , O I-du
stop VBD B-VP I-du
9/22 CD O I-du
4 CD O O
FEN: NNP B-NP O
cardiac JJ B-NP O
diet NN I-NP O
Started VBD B-VP O
low JJ B-NP O
dose NN I-NP O
potassium NN I-NP B-m
10 CD O B-do
mEq JJ O I-do
daily JJ O B-f
as IN B-VP O
increased VBN O O
lasix NN B-NP B-m
Will NNP I-NP O
have VBP O O
patient JJ B-NP O
check NN I-NP O
lytes NNS I-NP O
in IN B-VP O
2 CD O O
days NNS B-NP O
FULL NNP I-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
You PRP O O
have VBP O O
been VBN O O
diagnosed VBN O O
with IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
You PRP O O
have VBP O O
new JJ B-NP O
stents NNS I-NP O
to TO O O
keep VB O O
blood NN B-NP O
flowing VBG O O
to TO O O
your PRP$ O O
heart NN B-NP O
You PRP O O
MUST NNP B-NP O
continue VB O O
your PRP$ O O
aspirin NN B-NP B-m
and CC O O
plavix NN B-NP B-m
Do NNP I-NP O
NOT NNP I-NP O
discontinue VB O O
these DT B-NP B-m
medications NNS I-NP I-m
without IN B-VP O
speaking VBG O O
to TO O O
your PRP$ O O
doctor NN B-NP O
We PRP O O
have VBP O O
increased VBN O O
your PRP$ O O
lasix NN B-NP B-m
and CC O O
your PRP$ O O
atenolol NN B-NP B-m
You PRP O O
are VBP O O
on IN B-VP O
antibiotics NNS B-NP B-m
for IN B-VP O
cellulitis NN B-NP B-r
( ( O O
a DT B-NP O
skin NN I-NP O
infection NN I-NP O
) ) O O
Continue VB O O
your PRP$ O O
toe NN B-NP B-m
cream NN I-NP O
Come NNP I-NP O
to TO O O
the DT B-NP O
ER NNP I-NP O
if IN B-VP O
you PRP O O
have VBP O O
any DT B-NP O
trouble NN I-NP O
breathing NN I-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
leg NN B-NP O
swelling NN I-NP O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
concerning NN I-NP O
symptoms NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Satisfactory NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Follow NNP B-NP O
lytes NNS I-NP O
, , O O
LFTs NNP B-NP O
on IN B-VP O
meds NNS B-NP O
2 CD O O
Follow NNP B-NP O
LE NNP I-NP O
cellulitis NN I-NP O
to TO O O
resolution VB O O
3 CD O O
ECHO NNP B-NP O
as IN B-VP O
outpt JJ O O
4 CD O O
Encourage NNP B-NP O
weight VBD B-VP O
reduction NN B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MUMBY NNP I-NP O
, , O O
FRANKLYN NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
PS482 NNP B-NP O
) ) O O
9/23/06 CD O O
@ $ O O
12 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#230210 VBZ O O
387873161 CD O O
RMC NNP B-NP O
91193823 CD O O
243791 CD O O
0/10/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/28/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/27/1995 CD O O
DIAGNOSIS: NNP B-NP O
MORBID NNP I-NP O
OBESITY NNP I-NP O
PROCEDURE: NNP I-NP O
Panniculectomy NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
42 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
nurse NN I-NP O
chronically RB O O
obese JJ O O
, , O O
whose WP$ O O
last JJ O O
weight JJ O O
two CD O O
weeks NNS B-NP O
ago RB O O
was VBD B-VP O
430 CD O O
pounds NNS B-NP O
, , O O
after IN B-VP O
a DT B-NP O
loss NN I-NP O
of IN B-VP O
90 CD O O
pounds NNS B-NP O
since IN B-VP O
February NNP B-NP O
The DT B-NP O
patient's NN I-NP O
mobility NN I-NP O
is VBZ O O
limited VBN O O
to TO O O
short VB O O
walks NNS B-NP O
around IN B-VP O
the DT B-NP O
house NN I-NP O
and CC O O
she PRP O O
has VBZ O O
had VBD B-VP O
some DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
with IN B-VP O
exertion NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
a DT B-NP O
congenital JJ I-NP O
heart NN I-NP O
murmur NN I-NP O
with IN B-VP O
major JJ B-NP O
depression NN I-NP O
, , O O
diagnosed VBN O O
in IN B-VP O
1990; CD O O
duodenal JJ B-NP O
ulcer NN I-NP O
in IN B-VP O
1972; CD O O
diabetes NNS B-NP O
mellitus RB O O
, , O O
type NN B-NP O
II NNP I-NP O
, , O O
diagnosed VBD B-VP O
in IN B-VP O
1995; CD O O
status NN B-NP O
post NN I-NP O
laparotomy NN I-NP O
in IN B-VP O
1974 CD O O
MEDICATIONS: NNP B-NP O
Paxil NNP I-NP B-m
, , O O
60 CD O B-do
mg NN B-NP I-do
P NNP I-NP B-mo
O NNP I-NP I-mo
q NN I-NP B-f
AM; NNP I-NP I-f
Diabeta NNP I-NP B-m
, , O O
5 CD O B-do
mg NN B-NP I-do
P NNP I-NP B-mo
O NNP I-NP I-mo
q NN I-NP B-f
AM; NNP I-NP I-f
Trazadone NNP I-NP B-m
, , O O
100 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
h.s.; NN I-NP I-f
Ultram NNP I-NP B-m
, , O O
100 CD O B-do
mg NN B-NP I-do
q JJ B-NP B-f
4-6 JJ I-NP O
hours NNS I-NP O
prn; NN I-NP O
Reglan NNP I-NP B-m
, , O O
10 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
6 CD O I-f
hours NNS B-NP I-f
prn JJ B-NP I-f
nausea; JJ I-NP B-r
Bactroban NNP I-NP B-m
ointment NN I-NP I-m
b.i.d.; NN I-NP B-f
Lotrisone NNP I-NP B-m
cream NN I-NP I-m
b.i.d NN I-NP B-f
topically; NN I-NP B-mo
Afrin NNP I-NP B-m
nasal NN I-NP I-m
spray NN I-NP I-m
q VBD B-VP B-f
12 CD O I-f
hours NNS B-NP I-f
PRN; NNP I-NP I-f
Proventil NNP I-NP B-m
inhalers NNS I-NP I-m
, , O O
two CD O B-do
puffs NNS B-NP I-do
PRN NNP I-NP B-f
ALLERGIES: NNP I-NP O
To TO O O
Penicillin NNP B-NP O
, , O O
which WDT O O
produces VBZ O O
a DT B-NP O
rash; NN I-NP O
Corticosteroids NNP I-NP O
Phenothiazine NNP I-NP O
and CC O O
aspirin RB O O
PHYSICAL NNP B-NP O
EXAM: NNP I-NP O
Vital NNP I-NP O
signs NNS I-NP O
on IN B-VP O
admission NN B-NP O
, , O O
temperature NN B-NP O
99 CD O O
, , O O
pulse RB O O
80 CD O O
, , O O
respirations NNS B-NP O
20 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
102/70; CD O O
height VBD B-VP O
4 CD O O
feet NNS B-NP O
, , O O
11 CD O O
inches; NN B-NP O
weight VBD B-VP O
430 CD O O
pounds NNS B-NP O
Physical JJ B-NP O
exam NN I-NP O
in IN B-VP O
general JJ O O
- : O O
this DT O O
is VBZ O O
a DT O O
massively RB O O
obese JJ B-NP O
woman NN I-NP O
lying VBG O O
down RP O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Her PRP$ O O
skin NN B-NP O
is VBZ O O
warm JJ O O
and CC O O
dry JJ B-NP O
Her NNP I-NP O
HEENT NNP I-NP O
is VBZ O O
benign JJ B-NP O
Lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
Heart NNP B-NP O
- : O O
normal JJ B-NP O
S1 NNP I-NP O
, , O O
normal JJ B-NP O
S2 NNP I-NP O
and CC O O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
and CC O O
without IN B-VP O
any DT B-NP O
appreciable JJ I-NP O
murmur NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
Abdomen NNP I-NP O
- : O O
morbidly RB O O
obese JJ O O
, , O O
with IN B-VP O
a DT B-NP O
pannus NN I-NP O
hanging VBG O O
down RP O O
to TO O O
below IN B-VP O
the DT B-NP O
knee NN I-NP O
level NN I-NP O
, , O O
it PRP O O
is VBZ O O
soft JJ O O
, , O O
non JJ B-NP O
tender NN I-NP O
and CC O O
with IN B-VP O
difficulty NN B-NP O
auscultating VBG O O
bowel NN B-NP O
sounds VBZ O O
Neurologically RB O O
, , O O
she PRP O O
is VBZ O O
alert JJ O O
and CC O O
oriented VBD B-VP O
x $ O O
3 CD O O
with IN B-VP O
no DT B-NP O
focal JJ I-NP O
deficits NNS I-NP O
Extremities NNPS I-NP O
- : O O
she PRP O O
is VBZ O O
able JJ O O
to TO O O
stand VB O O
on IN B-VP O
her PRP$ O O
feet NNS B-NP O
with IN B-VP O
no DT B-NP O
motor NN I-NP O
or CC O O
sensory JJ B-NP O
deficits NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
0/25/95 CD O O
with IN B-VP O
concern NN B-NP O
for IN B-VP O
her PRP$ O O
being VBG O O
at IN B-VP O
high JJ B-NP O
risk NN I-NP O
of IN B-VP O
skin JJ B-NP O
breakdown NN I-NP O
and CC O O
infection NN B-NP O
Plans NNS I-NP O
were VBD B-VP O
made VBN O O
for IN B-VP O
panniculectomy NN B-NP O
, , O O
however RB O O
, , O O
prior RB O O
to TO O O
this DT B-NP O
procedure NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
IV NNP B-NP B-mo
Ancef NNP I-NP B-m
t.i.d.; NN I-NP B-f
Hibiclenz NNP I-NP B-m
showers NNS I-NP B-mo
and CC O O
sub-q JJ B-NP B-mo
Heparin NNP I-NP B-m
Preoperatively NNP I-NP O
, , O O
her PRP$ O O
pulmonary JJ B-NP O
function NN I-NP O
was VBD B-VP O
assessed VBN O O
and CC O O
found VBN O O
to TO O O
have VB O O
an DT B-NP O
FEV-1 NNP I-NP O
of IN B-VP O
53% CD O O
of IN B-VP O
predicted; JJ B-NP O
FVC NNP I-NP O
of IN B-VP O
57% CD O O
of IN B-VP O
predicted VBN O O
and CC O O
an DT B-NP O
FEV-1/FVC NNP I-NP O
of IN B-VP O
93% CD O O
of IN B-VP O
predicted VBN O O
Chest NNP B-NP O
x-ray NN I-NP O
showed VBD B-VP O
no DT B-NP O
active JJ I-NP O
cardiopulmonary JJ I-NP O
disease NN I-NP O
and CC O O
an DT B-NP O
EKG NNP I-NP O
showed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
with IN B-VP O
a DT B-NP O
non NN I-NP O
specific JJ B-NP O
T NNP I-NP O
wave VBP O O
abnormality NN B-NP O
without IN B-VP O
change NN B-NP O
since IN B-VP O
1994 CD O O
Her NNP B-NP O
hematocrit NN I-NP O
preoperatively RB O O
was VBD B-VP O
39.8 CD O O
and CC O O
her PRP$ O O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
9 CD O O
A NNP B-NP O
pulmonary JJ B-NP O
consultation NN I-NP O
was VBD B-VP O
also RB O O
obtained VBN O O
because IN B-VP O
of IN B-VP O
concern NN B-NP O
about IN B-VP O
her PRP$ O O
pulmonary JJ B-NP O
status NN I-NP O
for IN B-VP O
the DT B-NP O
operation NN I-NP O
On IN B-VP O
their PRP$ O O
recommendation NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Azmacort NNP B-NP B-m
inhalers NNS I-NP I-m
, , O O
Albuterol NNP B-NP B-m
nebulizer NN I-NP I-m
, , O O
and CC O O
aggressive JJ B-NP O
chest NN I-NP O
PT NNP I-NP O
On IN B-VP O
0/13/95 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
where WRB O O
a DT B-NP O
panniculectomy NN I-NP O
was VBD B-VP O
performed VBN O O
by IN B-VP O
Dr NNP B-NP O
Stanczyk NNP I-NP O
, , O O
without IN B-VP O
any DT B-NP O
complications NNS I-NP O
Postoperatively RB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Co NNP I-NP O
Wauhendprings NNP I-NP O
Ton NNP I-NP O
ICU NNP I-NP O
, , O O
where WRB O O
she PRP O O
continued VBD B-VP O
to TO O O
be VB O O
intubated VBN O O
and CC O O
on IN B-VP O
ventilatory JJ B-NP O
support NN I-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
one CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
successfully RB O O
extubated VBN O O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
, , O O
had VBD B-VP O
100% CD O O
saturation NN B-NP O
on IN B-VP O
40% CD O O
face NN B-NP O
mask NN I-NP O
and CC O O
she PRP O O
was VBD B-VP O
mobilized VBN O O
early RB O O
with IN B-VP O
aggressive JJ B-NP O
chest NN I-NP O
PT NNP I-NP O
and CC O O
deep JJ B-NP O
breathing NN I-NP O
encouragement NN I-NP O
stopped VBD B-VP O
The DT O O
patient JJ O O
received VBN O O
two CD O B-do
( ( O I-do
2 CD O I-do
) ) O I-do
units NNS B-NP I-do
of IN B-VP O
autologous JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells; NN I-NP I-m
after IN B-VP O
which WDT O O
her PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
32% CD O O
Postoperative JJ B-NP O
day NN I-NP O
two CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
hematocrit NN I-NP O
down RB O O
to TO O O
25.2 CD O O
, , O O
likely RB O O
due JJ O O
to TO O O
re-equilibration NN B-NP O
and CC O O
over IN B-VP O
the DT O O
next JJ O O
two CD O O
days NNS B-NP O
received VBD B-VP O
two CD O B-do
( ( O I-do
2 CD O I-do
) ) O I-do
units NNS B-NP I-do
of IN B-VP O
blood NN B-NP B-m
with IN B-VP O
a DT B-NP O
hematocrit NN I-NP O
reaching VBG O O
29% CD O O
Though IN B-VP O
she PRP O O
complained VBD B-VP O
of IN B-VP O
light JJ B-NP O
headiness NN I-NP O
prior RB O O
to TO O O
the DT B-NP O
transfusion NN I-NP B-m
, , O O
afterwards IN B-VP O
she PRP O O
was VBD B-VP O
up RB O O
and CC O O
walking VBG O O
without IN B-VP O
difficulty NN B-NP O
From IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
two CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
saturating VBG O O
at IN B-VP O
greater JJR O O
than IN B-VP O
93% CD O O
on IN B-VP O
room NN B-NP O
air; NN I-NP O
had VBD B-VP O
a DT B-NP O
wound NN I-NP O
that WDT O O
was VBD B-VP O
clean JJ O O
and CC O O
dry JJ O O
and CC O O
intact JJ O O
with IN B-VP O
serosanguineous JJ B-NP O
drainage NN I-NP O
in IN B-VP O
the DT B-NP O
Jackson-Pratt NNP I-NP O
drains NNS I-NP O
and CC O O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
cellulitis NN B-NP O
, , O O
purulent JJ B-NP O
drainage NN I-NP O
or CC O O
fever NN B-NP O
, , O O
on IN B-VP O
IV NNP B-NP B-mo
Ancef NNP I-NP B-m
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
five CD O O
, , O O
two CD O O
of IN B-VP O
the DT O O
four CD O O
Jackson-Pratt JJ B-NP O
drains NNS I-NP O
were VBD B-VP O
removed VBN O O
after IN B-VP O
their PRP$ O O
output NN B-NP O
fell VBD B-VP O
below IN B-VP O
30 CD O O
ccs NNS B-NP O
per IN B-VP O
day NN B-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
six CD O O
with IN B-VP O
plans NNS B-NP O
for IN B-VP O
home NN B-NP O
visiting NN I-NP O
nurse NN I-NP O
for IN B-VP O
dressing VBG O O
changes NNS B-NP O
daily RB O O
and CC O O
P NNP B-NP B-mo
O NNP I-NP I-mo
Keflex NNP I-NP B-m
while IN B-VP B-du
two CD O I-du
Jackson-Pratt JJ B-NP I-du
drains NNS I-NP I-du
were VBD B-VP I-du
in IN B-VP I-du
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
following VBG O O
up RP O O
in IN B-VP O
outpatient JJ B-NP O
clinic NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Bartles NNP I-NP O
in IN B-VP O
one CD O O
( ( O O
1 CD O O
) ) O O
week NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
) ) O O
Keflex NNP B-NP B-m
, , O O
500 CD O B-do
mg NN B-NP I-do
P NNP I-NP B-mo
O NNP I-NP I-mo
q.i.d.; RB O B-f
2 CD O O
) ) O O
Percocet NNP B-NP B-m
one CD O B-do
to TO O I-do
two CD O I-do
P NNP B-NP B-mo
O NNP I-NP I-mo
q VBD B-VP B-f
4 CD O I-f
hours NNS B-NP I-f
prn VBP O I-f
pain; RB O B-r
3 CD O O
) ) O O
Lotrisone NNP B-NP B-m
topically RB O B-mo
, , O I-mo
TP NNP B-NP I-mo
b.i.d.; VBZ O B-f
4 CD O O
) ) O O
Paxil NNP B-NP B-m
, , O O
60 CD O B-do
mg NN B-NP I-do
P NNP I-NP B-mo
O NNP I-NP I-mo
q VBD B-VP B-f
AM; NNP B-NP I-f
5 CD O O
) ) O O
Azmacort NNP B-NP B-m
, , O O
four CD O B-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
q.i.d.; RB O B-f
6 CD O O
) ) O O
Bactroban NNP B-NP B-m
topically RB O B-mo
TP NNP B-NP I-mo
b.i.d.; VBD B-VP B-f
7 CD O O
) ) O O
Diabeta NNP B-NP B-m
, , O O
5 CD O B-do
mg NN B-NP I-do
P NNP I-NP B-mo
O NNP I-NP I-mo
q VBD B-VP B-f
AM; NNP B-NP I-f
8 CD O O
) ) O O
Ferrous JJ B-NP B-m
Sulfate NNP I-NP I-m
, , O O
300 CD O B-do
mg NN B-NP I-do
P NNP I-NP B-mo
O NNP I-NP I-mo
t.i.d.; VBD B-VP B-f
9 CD O O
) ) O O
Proventil NNP B-NP B-m
inhaler NN I-NP I-m
, , O O
two CD O B-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
q.i.d RB O B-f
Dictated VBN O O
By: NNP B-NP O
QUINCY NNP I-NP O
BUESING NNP I-NP O
, , O O
M.D NNP B-NP O
HU21 NNP I-NP O
Attending: NNP I-NP O
CURTIS NNP I-NP O
J NNP I-NP O
BUKER NNP I-NP O
, , O O
M.D NNP B-NP O
NX4 NNP I-NP O
ZF318/1886 NNP I-NP O
Batch: NNP I-NP O
63728 CD O O
Index NNP B-NP O
No NNP I-NP O
NUNKMK7P0A NNP I-NP O
D: NNP I-NP O
8/13/95 CD O O
T: NNP B-NP O
8/13/95 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#232166 VBZ O O
624809693 CD O O
NBC NNP B-NP O
86704114 CD O O
6671024 CD O O
0/12/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
morbid NN I-NP O
obesity NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/14/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/25/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
DABER NNP I-NP O
, , O O
MARVIN NNP B-NP O
017-27-50-5 CD O O
Na NNP B-NP O
Service: NNP I-NP O
GGI NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
10/1/06 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BAFFUTO NNP I-NP O
, , O O
JOSIAH NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ROXICET NNP I-NP B-m
ELIXIR NNP I-NP I-m
( ( O I-m
OXYCODONE+APAP NNP B-NP I-m
LIQUID NNP I-NP I-m
) ) O I-m
5 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
PHENERGAN NNP I-NP B-m
( ( O I-m
PROMETHAZINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PR NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Nausea NNP I-NP B-r
MULTIVITAMIN NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVI NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Instructions: NNP I-NP O
chewable JJ B-NP O
DIET: NNP I-NP O
stage NN I-NP O
2 CD O O
gastric JJ B-NP O
band NN I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Germano NNP I-NP O
2 CD O O
weeks NNS B-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
s/p VBD B-VP O
Lap NNP B-NP O
Band NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
morbid NN B-NP O
obesity NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
s/p NN I-NP O
lap NN I-NP O
band NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
11/10/06 CD O O
BETTIES NNP B-NP O
, , O O
HUNTER NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
LAPARO NNP I-NP O
PLACEMENT NNP I-NP O
ADJUSTABLE NNP I-NP O
GASTRIC NNP I-NP O
BAND NNP I-NP O
LAPAROSCOPIC NNP I-NP O
HIATAL NNP I-NP O
HERNIA NNP I-NP O
REP NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
All NNP I-NP O
Hospital NNP I-NP O
surgery NN I-NP O
service NN I-NP O
on IN B-VP O
0/12/2006 CD O O
after IN B-VP O
undergoing VBG O O
laparoscopic NN B-NP O
gastric JJ O O
banding VBG O O
No DT O O
concerning VBG O O
intraoperative JJ B-NP O
events NNS I-NP O
occurred; JJ B-NP O
please NN I-NP O
see VB O O
dictated JJ B-NP O
operative JJ I-NP O
note NN I-NP O
for IN B-VP O
details NNS B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
from IN B-VP O
the DT B-NP O
PACU NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
Patient NNP I-NP O
had VBD B-VP O
adequate JJ B-NP O
pain NN I-NP O
control NN I-NP O
and CC O O
no DT B-NP O
issues NNS I-NP O
overnight VBD B-VP O
into IN B-VP O
POD1 NNP B-NP O
and CC O O
that IN B-VP O
time NN B-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
Stage NN I-NP O
I PRP O O
diet VBP O O
which WDT O O
was VBD B-VP O
tolerated VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
then RB O O
advanced JJ O O
to TO O O
clears NNS B-NP O
and CC O O
discharged VBD B-VP O
to TO O O
home VB O O
a DT B-NP O
Stage NNP I-NP O
II NNP I-NP O
diet VBZ O O
The DT B-NP O
incision NN I-NP O
was VBD B-VP O
C/D/I NNP B-NP O
, , O O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
hematoma NN B-NP O
collection NN I-NP O
or CC O O
infection NN B-NP O
The DT B-NP O
remainder NN I-NP O
of IN B-VP O
the DT B-NP O
hospital NN I-NP O
course NN I-NP O
was VBD B-VP O
relatively RB O O
unremarkable JJ O O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
, , O O
ambulating VBG O O
and CC O O
voiding VBG O O
independently RB O O
, , O O
and CC O O
with IN B-VP O
adequate JJ B-NP O
pain NN I-NP O
control NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
explicit JJ B-NP O
instructions NNS I-NP O
to TO O O
follow-up NN B-NP O
in IN B-VP O
clinic NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Mcmenamy NNP I-NP O
in IN B-VP O
two CD O O
weeks NNS B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
May NNP I-NP O
shower VB O O
2 CD O O
days NNS B-NP O
after IN B-VP O
surgery NN B-NP O
, , O O
but CC O O
do VBP O O
not RB O O
tub VB O O
bathe NN B-NP O
, , O O
swim NN B-NP O
, , O O
soak NN B-NP O
, , O O
or CC O O
scrub JJ B-NP O
incision NN I-NP O
for IN B-VP O
2 CD O O
weeks NNS B-NP O
Bandage NNP I-NP O
strips NNS I-NP O
will MD O O
fall VB O O
off RP O O
over IN B-VP O
time NN B-NP O
Seek NNP I-NP O
medical JJ B-NP O
attention NN I-NP O
for IN B-VP O
fevers NNS B-NP O
( ( O O
temp&gt;101.5 NN B-NP O
) ) O O
, , O O
worsening VBG O O
pain NN B-NP O
, , O O
drainage NN B-NP O
or CC O O
excessive JJ B-NP O
bleeding NN I-NP O
from IN B-VP O
incision NN B-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
symptoms NNS I-NP O
of IN B-VP O
concern NN B-NP O
Follow NNP I-NP O
up RB O O
with IN B-VP O
your PRP$ O O
surgeon NN B-NP O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
Please NNP I-NP O
do VBP O O
not RB O O
drive VB O O
or CC O O
consume VB O O
alcohol NN B-NP O
while IN B-VP O
taking VBG O O
pain JJ B-NP B-m
medications NNS I-NP I-m
Crush NNP I-NP O
pills NNS I-NP O
, , O O
open JJ B-NP O
capsules NNS I-NP O
, , O O
or CC O O
take VB O O
elixirs NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
CHANGO NNP I-NP O
, , O O
JUSTIN NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
DD20 NNP B-NP O
) ) O O
11/10/06 CD O O
@ $ O O
07 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#237715 VBZ O O
593111043 CD O O
SMH NNP B-NP O
01580237 CD O O
0277843 CD O O
7/9/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
UNSTABLE NNP I-NP O
ANGINA NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/9/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/8/2005 CD O O
ATTENDING: NNP B-NP O
BOENISCH NNP I-NP O
, , O O
RAUL NNP B-NP O
MD NNP I-NP O
DEATH NNP I-NP O
SUMMARY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
a DT B-NP O
69-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
prior RB O O
myocardial JJ B-NP O
infarction NN I-NP O
and CC O O
surgery NN B-NP O
in IN B-VP O
2002 CD O O
who WP O O
presented VBD B-VP O
to TO O O
R.healt NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
Emergency NNP I-NP O
Department NNP I-NP O
on IN B-VP O
10/9/05 CD O O
with IN B-VP O
three CD O O
days NNS B-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
Of IN B-VP O
note NN B-NP O
she PRP O O
had VBD B-VP O
been VBN O O
noncompliant JJ O O
with IN B-VP O
prior JJ B-NP O
regimens NNS I-NP O
and CC O O
treatments NNS B-NP O
and CC O O
despite IN B-VP O
diuretics NNS B-NP B-m
started VBD B-VP O
three CD O B-du
days NNS B-NP I-du
by IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
she PRP O O
reported VBD B-VP O
new JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
chest JJS B-NP O
pain NN I-NP O
at IN B-VP O
rest NN B-NP O
An DT B-NP O
EKG NNP I-NP O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
revealed VBD B-VP O
widespread JJ B-NP O
ST NNP I-NP O
depressions NNS I-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
for IN B-VP O
pulmonary JJ B-NP B-r
pulmonary JJ I-NP B-r
pulmonary JJ I-NP B-r
pulmonary JJ I-NP B-r
pulmonary JJ I-NP B-r
edema NN I-NP I-r
edema NN I-NP I-r
edema NN I-NP I-r
edema NN I-NP I-r
edema NN I-NP I-r
with IN B-VP O
IV NNP B-NP B-mo
nitroglycerin NN I-NP B-m
, , O O
Lasix NNP B-NP B-m
, , O O
aspirin NN B-NP B-m
, , O O
heparin NN B-NP B-m
, , O O
beta-blockers NNS B-NP B-m
, , O O
and CC O O
then RB O O
she PRP O O
was VBD B-VP O
taken VBN O O
urgently RB O O
to TO O O
the DT B-NP O
cath NN I-NP O
lab NN I-NP O
where WRB O O
coronary JJ B-NP O
angiography NN I-NP O
revealed VBD B-VP O
a DT B-NP O
left NN I-NP O
main JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
thrombosis NN I-NP O
with IN B-VP O
proximal JJ O O
and CC O O
distal JJ B-NP O
stenoses NNS I-NP O
of IN B-VP O
about RB O O
70% CD O O
, , O O
50% CD O O
of IN B-VP O
her PRP$ O O
LAD NNP B-NP O
, , O O
and CC O O
60% CD O O
of IN B-VP O
her PRP$ O O
first JJ O O
diagonal JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
coronary JJ I-NP O
care NN I-NP O
unit NN I-NP O
after IN B-VP O
placement NN B-NP O
of IN B-VP O
an DT B-NP O
intraaortic JJ I-NP O
balloon NN I-NP O
pump NN I-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
and CC O O
evaluation NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
CHF NNP I-NP O
, , O O
hypertension NN B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
CAD NNP B-NP O
, , O O
prior RB O O
myocardial JJ B-NP O
infarction NN I-NP O
, , O O
restrictive JJ B-NP O
lung NN I-NP O
disease NN I-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
morbid NN B-NP O
obesity NN I-NP O
, , O O
and CC O O
iron NN B-NP O
deficiency NN I-NP O
anemia VBD B-VP O
HOME NNP B-NP O
MEDICATIONS: NNP I-NP O
Aspirin NNP I-NP B-m
, , O O
hydralazine NN B-NP B-m
, , O O
nitroglycerin RB O B-m
, , O O
quinine NN B-NP B-m
, , O O
Norvasc NNP B-NP B-m
, , O O
Lasix NNP B-NP B-m
, , O O
Toprol NNP B-NP B-m
, , O O
lisinopril NN B-NP B-m
, , O O
albuterol NN B-NP B-m
, , O O
and CC O O
famotidine NN B-NP B-m
ALLERGIES: NNP I-NP O
She PRP O O
was VBD B-VP O
allergic JJ O O
to TO O O
erythromycin VB O O
, , O O
Bactrim NNP B-NP O
, , O O
and CC O O
IV NNP B-NP O
contrast VBP O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Noncontributory NNP I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Noted NNP I-NP O
no DT B-NP O
fever NN I-NP O
, , O O
chills NNS B-NP O
, , O O
sweats NNS B-NP O
, , O O
coughs NNS B-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
nausea NN B-NP O
, , O O
or CC O O
vomiting VBG O O
PHYSICAL JJ B-NP O
EXAMINATION: NNP I-NP O
She PRP O O
was VBD B-VP O
morbidly RB O O
obese JJ O O
with IN B-VP O
moderate JJ B-NP O
respiratory NN I-NP O
distress NN I-NP O
lying VBG O O
at IN B-VP O
about IN B-VP O
30-degree JJ B-NP O
angle NN I-NP O
Her NNP I-NP O
O2 NNP I-NP O
saturation NN I-NP O
was VBD B-VP O
97% CD O O
on IN B-VP O
3L CD O O
nasal JJ B-NP O
cannula NN I-NP O
Temperature NNP I-NP O
was VBD B-VP O
99 CD O O
degrees NNS B-NP O
, , O O
pulse NN B-NP O
was VBD B-VP O
80 CD O O
and CC O O
regular JJ O O
, , O O
BP NNP B-NP O
was VBD B-VP O
140/50 CD O O
, , O O
and CC O O
respirations NNS B-NP O
about IN B-VP O
20 CD O O
Mucous JJ B-NP O
membranes NNS I-NP O
were VBD B-VP O
moist JJ O O
and CC O O
intact JJ B-NP O
Pupils NNP I-NP O
were VBD B-VP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ O O
to TO O O
light VB O O
Her PRP$ O O
sclerae NN B-NP O
were VBD B-VP O
anicteric JJ B-NP O
Her NNP I-NP O
conjunctivae NN I-NP O
were VBD B-VP O
pale JJ O O
She PRP O O
had VBD B-VP O
a DT O O
15-cm JJ O O
of IN B-VP O
JVD NNP B-NP O
with IN B-VP O
2+ CD O O
carotids NNS B-NP O
without IN B-VP O
bruits NNS B-NP O
Coarse NNP I-NP O
breath NN I-NP O
sounds VBZ O O
bilaterally RB O O
with IN B-VP O
crackles NNS B-NP O
two-thirds NNS I-NP O
of IN B-VP O
the DT B-NP O
way NN I-NP O
up IN B-VP O
the DT B-NP O
bases NNS I-NP O
Cardiac NNP I-NP O
exam NN I-NP O
was VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
2/6 CD O O
holosystolic JJ O O
murmur FW O O
Her PRP$ O O
abdomen NNS B-NP O
was VBD B-VP O
obese JJ O O
, , O O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
She PRP O O
had VBD B-VP O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
, , O O
or CC O O
palpable JJ B-NP O
edema NN I-NP O
She PRP O O
has VBZ O O
1+ CD O O
distal JJ B-NP O
pulses NNS I-NP O
noted VBD B-VP O
Her NNP B-NP O
EKG NNP I-NP O
was VBD B-VP O
normal JJ B-NP O
sinus JJ I-NP O
rhythm NN I-NP O
with IN B-VP O
ST NNP B-NP O
depressions NNS I-NP O
in IN B-VP O
the DT B-NP O
inferolateral JJ I-NP O
leads NNS I-NP O
and CC O O
a DT B-NP O
right JJ I-NP O
bundle-branch NN I-NP O
block NN I-NP O
was VBD B-VP O
present JJ B-NP O
Her NNP I-NP O
chest NN I-NP O
x-ray NN I-NP O
revealed VBD B-VP O
bilateral JJ B-NP O
pulmonary JJ I-NP O
infiltrates NNS I-NP O
consistent JJ O O
with IN B-VP O
edema NN B-NP O
So IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
coronary JJ I-NP O
care NN I-NP O
unit NN I-NP O
and CC O O
a DT B-NP O
consult NN I-NP O
with IN B-VP O
Cardiovascular NNP B-NP O
Surgery NNP I-NP O
and CC O O
serial JJ B-NP O
crits NNS I-NP O
were VBD B-VP O
performed VBN O O
The DT B-NP O
patient's NN I-NP O
condition NN I-NP O
continued VBD B-VP O
to TO O O
deteriorate VB O O
She PRP O O
developed VBD B-VP O
respiratory NN B-NP O
distress NN I-NP O
Anesthesia NNP I-NP O
was VBD B-VP O
called VBN O O
and CC O O
her PRP$ O O
airway NN B-NP O
was VBD B-VP O
secured VBN O O
via IN B-VP O
an DT B-NP O
emergent JJ I-NP O
intubation NN I-NP O
The DT B-NP O
patient NN I-NP O
subsequently RB O O
developed VBD B-VP O
signs NNS B-NP O
of IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
and CC O O
presumed VBN O O
sepsis NN B-NP O
and CC O O
ischemic JJ B-NP O
bowel NN I-NP O
She PRP O O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
an DT B-NP O
exploratory JJ I-NP O
laparotomy NN I-NP O
Status NNP I-NP O
post NN I-NP O
an DT B-NP O
exploratory NN I-NP O
laparotomy VBZ O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
complex JJ I-NP O
course NN I-NP O
in IN B-VP O
the DT B-NP O
surgical JJ I-NP O
ICU NNP I-NP O
where WRB O O
she PRP O O
underwent VBD B-VP O
multi-organ JJ B-NP O
system NN I-NP O
dysfunction NN I-NP O
Her NNP I-NP O
prognosis NN I-NP O
was VBD B-VP O
very RB O O
dire JJ O O
This DT O O
was VBD B-VP O
explained VBN O O
to TO O O
the DT B-NP O
family NN I-NP O
and CC O O
on IN B-VP O
11/12/05 CD O O
at IN B-VP O
2:20 CD O O
a.m IN B-VP O
the DT B-NP O
family NN I-NP O
decided VBD B-VP O
to TO O O
withdraw VB O O
care NN B-NP O
, , O O
which WDT O O
will MD O O
be VB O O
consistent JJ O O
with IN B-VP O
both DT O O
the DT B-NP O
patient NN I-NP O
and CC O O
family's NN B-NP O
wishes NNS I-NP O
and CC O O
desires NNS B-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
pronounced VBN O O
dead JJ O O
at IN B-VP O
2:24 CD O O
a.m NN B-NP O
on IN B-VP O
11/12/05 CD O O
DATE NN B-NP O
OF NNP I-NP O
DEATH: NNP I-NP O
11/12/05 CD O O
TIME NNP B-NP O
OF NNP I-NP O
DEATH: NNP I-NP O
02:24 CD O O
a.m NN B-NP O
eScription NN I-NP O
document: VBZ O O
4-0472746 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
GARZONE NNP I-NP O
, , O O
COREY NNP B-NP O
Attending: NNP I-NP O
AIKENS NNP I-NP O
, , O O
GIUSEPPE NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
5285156 CD O O
D: NNP B-NP O
7/15/06 CD O O
T: NNP B-NP O
7/15/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#244891 VBZ O O
963169421 CD O O
OCH NNP B-NP O
32248360 CD O O
7735873 CD O O
10/8/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/29/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/21/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
ORPEN NNP I-NP O
, , O O
SCOTTY NNP B-NP O
P NNP I-NP O
756-11-47-0 JJ B-NP O
Phh NNP I-NP O
Nacall NNP I-NP O
Franbirm NNP I-NP O
, , O O
KS NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
2/15/04 CD O O
AT NNP B-NP O
08:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Rib NNP I-NP O
film NN I-NP O
completion NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
WASER NNP I-NP O
, , O O
EMMETT NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
FAMOTIDINE NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
at IN B-VP O
2:00 CD O O
pm NNS B-NP O
July NNP I-NP O
MOTRIN NNP I-NP B-m
( ( O I-m
IBUPROFEN NNP B-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
Instructions: NNP I-NP O
syrup VBD B-VP O
form JJ O O
100mg/5ml CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
MAALOX-TABLETS NNP B-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Jericho NNP I-NP O
, , O O
one CD O O
week NN B-NP O
, , O O
pt NN B-NP O
to TO O O
call VB O O
for IN B-VP O
appointment NN B-NP O
, , O O
ALLERGY: NNP B-NP O
PROPOXYPHENE NNP I-NP O
NAPSYL NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
PVD NNP I-NP O
s/p NN I-NP O
surgery NN I-NP O
s/p NN I-NP O
MI NNP I-NP O
1984 CD O O
CHF NNP B-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
( ( O O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
) ) O O
s/p NN B-NP O
brainstem NN I-NP O
CVA NNP I-NP O
congenital NN I-NP O
R NNP I-NP O
hemiparesis NN I-NP O
supraglottic JJ B-NP O
laryngeal NN I-NP O
SCC NNP I-NP O
s/p NN I-NP O
XRT NNP I-NP O
chronic JJ B-NP O
RLE NNP I-NP O
circumf NN I-NP O
&gt; NNP I-NP O
LLE NNP I-NP O
( ( O O
) ) O O
esophageal VBP O O
stricture JJ B-NP O
s/p NN I-NP O
lye NN I-NP O
ingestion NN I-NP O
OA NNP I-NP O
( ( O O
osteoarthritis NN B-NP O
) ) O O
s/p VBZ O O
bilateral JJ B-NP O
rotator NN I-NP O
cuff NN I-NP O
repair NN I-NP O
recurrent JJ B-NP O
UTI NNP I-NP O
( ( O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
) ) O O
anemia NN B-NP O
of IN B-VP O
chronic JJ B-NP O
disease NN I-NP O
( ( O O
anemia NN B-NP O
) ) O O
persistent JJ B-NP O
thrombocytosis NN I-NP O
diet-controlled JJ B-NP O
DM NNP I-NP O
current JJ B-NP O
smoker NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
L-sided NNP I-NP O
CP NNP I-NP O
HPI: NNP I-NP O
76yoF CD O O
PMH NNP B-NP O
MI NNP I-NP O
( ( O O
1984 CD O O
) ) O O
, , O O
PVD NNP B-NP O
, , O O
CVA NNP B-NP O
, , O O
DVT NNP B-NP O
, , O O
supraglottic JJ B-NP O
laryngeal NN I-NP O
SCC NNP I-NP O
s/p NN I-NP O
XRT NNP I-NP O
( ( O O
2002 CD O O
) ) O O
, , O O
who WP O O
presents VBZ O O
from IN B-VP O
home NN B-NP O
c/o NN I-NP O
"stabbing VBG O O
pins" NN B-NP O
CP NNP I-NP O
that IN B-VP O
awoke VBD B-VP O
her PRP O O
from IN B-VP O
sleep NN B-NP O
at IN B-VP O
6 CD O O
am VBP O O
The DT B-NP O
pain NN I-NP O
initially RB O O
started VBD B-VP O
next JJ O O
to TO O O
the DT B-NP O
L NNP I-NP O
breast NN I-NP O
in IN B-VP O
the DT B-NP O
midaxillary JJ I-NP O
line NN I-NP O
, , O O
then RB O O
radiated VBD B-VP O
to TO O O
breast VB O O
, , O O
sternum NN B-NP O
, , O O
neck NN B-NP O
, , O O
and CC O O
back RB O O
around IN B-VP O
to TO O O
L NNP B-NP O
midaxillary JJ B-NP O
line NN I-NP O
After IN B-VP O
30 CD O O
min NN B-NP O
of IN B-VP O
pain NN B-NP O
, , O O
pt NN B-NP O
called VBD B-VP O
covering VBG O O
PCP NNP B-NP O
&amp; NN I-NP O
was VBD B-VP O
told VBN O O
to TO O O
come VB O O
to TO O O
ED VB O O
The DT B-NP O
"stabbing" NN I-NP O
has VBZ O O
faded VBN O O
to TO O O
a DT B-NP O
"soreness" NN I-NP O
that WDT O O
is VBZ O O
replicated VBN O O
with IN B-VP O
palpation NN B-NP O
The DT B-NP O
pain NN I-NP O
is VBZ O O
worse JJR O O
with IN B-VP O
mov't NN B-NP O
&amp; NNP I-NP O
inspiration; VBZ O O
not RB O O
assoc JJ O O
with IN B-VP O
n/v JJ O O
, , O O
diaphoresis NN B-NP O
, , O O
SOB NNP B-NP O
Basline NNP I-NP O
cough NN I-NP O
has VBZ O O
not RB O O
worsened; VBN O O
green JJ B-NP O
looser NN I-NP O
stools NNS I-NP O
x VBP O O
3 CD O O
wks; JJ B-NP O
denies NNS I-NP O
dysuria NN I-NP O
Has NNP I-NP O
perhaps RB O O
felt VBD B-VP O
more RBR O O
tired JJ O O
with IN B-VP O
walking NN B-NP O
in IN B-VP O
recent JJ B-NP O
weeks NNS I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
1984 CD O O
MI NNP B-NP O
p/w NN I-NP O
"squeezing" NNP I-NP O
sensation NN I-NP O
distinct NN I-NP O
from IN B-VP O
this DT B-NP O
pain; NN I-NP O
adm VBZ O O
0/29/01 CD O O
with IN B-VP O
similar JJ B-NP O
complaints NNS I-NP O
&amp; JJ B-NP O
labs; JJ I-NP O
ETT NNP I-NP O
&amp; NNP I-NP O
echo VBD B-VP O
non-ischemic JJ O O
In IN B-VP O
ED NNP B-NP O
, , O O
T NNP B-NP O
97.9; CD O O
HR NNP B-NP O
71; CD O O
BP NNP B-NP O
126/60; CD O O
RR NNP B-NP O
20; CD O O
99% CD O O
on IN B-VP O
RA NNP B-NP O
Reg NNP I-NP O
S1 NNP I-NP O
S2 NNP I-NP O
distant NN I-NP O
, , O O
chest VBP O O
diffusely RB O O
tender NN B-NP O
to TO O O
palp VB O O
, , O O
fine JJ B-NP O
rales NNS I-NP O
1/2 CD O O
up RB O O
bilat JJ O O
, , O O
abd JJ O O
soft JJ O O
, , O O
RLE NNP B-NP O
circumf NN I-NP O
&gt; NNP I-NP O
LLE NNP I-NP O
( ( O O
baseline NN B-NP O
) ) O O
, , O O
s/p JJ B-NP O
amp NN I-NP O
of IN B-VP O
L NNP B-NP O
3rd CD O O
finger NN B-NP O
, , O O
R NNP B-NP O
1st CD O O
toe NN B-NP O
A NNP I-NP O
set NN I-NP O
enzymes NNS I-NP O
neg; VBP O O
WBC NNP B-NP O
6 CD O O
, , O O
HCT NNP B-NP O
38.9 CD O O
, , O O
DDimer NNP B-NP O
951 CD O O
EKG: NNP B-NP O
NSR NNP I-NP O
@ NNP I-NP O
65 CD O O
, , O O
nl RB O O
axis NN B-NP O
, , O O
TWI NNP B-NP O
I PRP O O
, , O O
L NNP B-NP O
, , O O
V1-4 NNP B-NP O
NEXT NNP I-NP O
EKG: NNP I-NP O
NSR NNP I-NP O
@ VBD B-VP O
61 CD O O
with IN B-VP O
1 CD O O
deg NNS B-NP O
AVB NNP I-NP O
( ( O O
Both NNP B-NP O
these DT B-NP O
patterns NNS I-NP O
seen VBN O O
on IN B-VP O
old JJ B-NP O
EKGs NNP I-NP O
) ) O O
CXR NNP B-NP O
clear JJ B-NP O
Given NNP I-NP O
ASA NNP I-NP B-m
, , O O
NTG NNP B-NP B-m
( ( O O
partial JJ B-NP O
relief NN I-NP O
, , O O
but CC O O
dropped VBD B-VP O
BP NNP B-NP B-r
) ) O O
, , O O
heparin JJ B-NP B-m
bolus NN I-NP I-m
&amp; NNP I-NP O
cont NN I-NP O
infusion NN I-NP O
************* NNP I-NP O
PLAN NNP I-NP O
************************* NNP I-NP O
IMP--L NNP I-NP O
CP NNP I-NP O
seems VBZ O O
MSK NNP B-NP O
, , O O
? . B-VP O
rib NN B-NP O
fractures NNS I-NP O
, , O O
rib NN B-NP O
films NNS I-NP O
preliminary JJ O O
read VBD B-VP O
without IN B-VP O
fracture NN B-NP O
but CC O O
does VBZ O O
have VB O O
some DT B-NP O
loss NN I-NP O
of IN B-VP O
height NN B-NP O
of IN B-VP O
vertebral JJ B-NP O
bodies NNS I-NP O
suggestive VBP O O
of IN B-VP O
compression NN B-NP O
fractures NNS I-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
motrin NN B-NP B-m
for IN B-VP O
muscular JJ B-NP B-r
pain NN I-NP I-r
CV--ISCH--h/o NNP I-NP O
MI; NNP I-NP O
cont NN I-NP O
ASA NNP I-NP B-m
, , O O
statin NN B-NP B-m
, , O O
r/o'd VB O O
MI NNP B-NP O
Not RB O O
previously RB O O
on IN B-VP O
BB NNP B-NP O
, , O O
ACEI NNP B-NP O
PUMP--? NNP I-NP O
some DT B-NP O
CHF NNP I-NP O
I/O; NNP I-NP O
Lasix NNP I-NP B-m
80 CD O B-f
QD NNP B-NP I-f
RHYTHM--transient JJ O O
1 CD O O
deg NN B-NP O
AVB; NNP I-NP O
tele VBZ O O
PAIN--cont NNP B-NP O
Motrin NNP I-NP B-m
Motrin NNP I-NP B-m
Motrin NNP I-NP B-m
for IN B-VP O
chronic JJ B-NP B-r
throat NN I-NP I-r
pain NN I-NP I-r
, , O O
OA NNP B-NP B-r
, , O O
L NNP B-NP B-r
chest JJS B-NP O
pain NN I-NP O
GI--cont NNP I-NP O
famotidine NN I-NP B-m
, , O O
Colace NNP B-NP B-m
PULM--low NNP I-NP O
suspicion NN I-NP O
for IN B-VP O
PE; NNP B-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
an DT B-NP O
elevated JJ I-NP O
d NN I-NP O
dimer NN I-NP O
in IN B-VP O
past JJ O O
no DT B-NP O
furtehr NN I-NP O
workup NN I-NP O
at IN B-VP O
this DT B-NP O
time; NN I-NP O
no DT B-NP O
anticoagulation NN I-NP O
for IN B-VP O
now RB O O
Pt NNP B-NP O
rule NN I-NP O
dout NN I-NP O
for IN B-VP O
MI NNP B-NP O
whil NN I-NP O
in IN B-VP O
house NN B-NP O
Her PRP$ O O
pain NN B-NP B-r
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
musculoskeletal JJ O O
in IN B-VP O
origin NN B-NP O
and CC O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
NSAIDS NNP B-NP B-m
She PRP O O
will MD O O
need VB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Maccutcheon NNP I-NP O
as IN B-VP O
an DT B-NP O
outpt NN I-NP O
Her NNP I-NP O
rib NN I-NP O
film NN I-NP O
final JJ B-NP O
read NN I-NP O
was VBD B-VP O
pedning VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
and CC O O
will MD O O
need VB O O
to TO O O
be VB O O
followed VBN O O
up RP O O
on IN B-VP O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
1 CD O O
Please NNP B-NP O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Haddow NNP I-NP O
within IN B-VP O
1 CD O O
week NN B-NP O
of IN B-VP O
dsicharge NN B-NP O
2 CD O O
Please NNP B-NP O
continue VB O O
to TO O O
take VB O O
all DT O O
of IN B-VP O
your PRP$ O B-m
medications NNS B-NP I-m
as IN B-VP O
directed JJ B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Satisfactory NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Follow NNP B-NP O
up RB O O
with IN B-VP O
Dr NNP B-NP O
Hogy NNP I-NP O
2 CD O O
Follow NNP B-NP O
up RB O O
on IN B-VP O
final JJ B-NP O
read NN I-NP O
of IN B-VP O
rib JJ B-NP O
films NNS I-NP O
No RB O O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BOLTER NNP I-NP O
, , O O
CHARLIE NNP B-NP O
IRVING NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
RT74 NNP B-NP O
) ) O O
2/15/04 CD O O
@ $ O O
07:09 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#253290 VBZ O O
755494408 CD O O
NMC NNP B-NP O
20190911 CD O O
5782272 CD O O
6/30/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Asthma NNP I-NP O
exacerbation NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/6/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/15/2005 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
REINHOLTZ NNP I-NP O
, , O O
IVORY NNP B-NP O
261-40-05-7 JJ B-NP O
Minfran NNP I-NP O
Cin NNP I-NP O
Geneli NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
4/2/05 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
STRUVE NNP I-NP O
, , O O
FRANCISCO NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
CARDIZEM NNP I-NP B-m
SR NNP I-NP I-m
( ( O I-m
DILTIAZEM NNP B-NP I-m
SUSTAINED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
120 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/9/05 CD O O
by IN B-VP O
DUHART NNP B-NP O
, , O O
RANDY NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LOPRESSOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
31219927 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DILTIAZEM NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
METOPROLOL NNP I-NP B-m
TARTRATE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/11/05 CD O O
by IN B-VP O
EHRHARD NNP B-NP O
, , O O
STANLEY NNP B-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
METOPROLOL NNP I-NP B-m
TARTRATE NNP I-NP I-m
&amp; NNP I-NP O
DILTIAZEM NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok JJ B-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
99 CD O O
HYDROCHLOROTHIAZIDE NNP B-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/11/05 CD O O
by IN B-VP O
JACQUEMIN NNP B-NP O
, , O O
FOREST NNP B-NP O
G NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IMMED NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
73021085 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
LORAZEPAM NNP I-NP B-m
0.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRN NNP I-NP I-f
Anxiety NNP I-NP B-r
LOPRESSOR NNP I-NP B-m
( ( O I-m
METOPROLOL NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
2/19 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
HR&lt;50 NNP I-NP O
, , O O
SBP&lt;100 NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Reason: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/11/05 CD O O
by IN B-VP O
BOILEAU NNP B-NP O
, , O O
RAYFORD NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
CARDIZEM NNP B-NP B-m
SR NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
76249027 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
METOPROLOL NNP I-NP B-m
TARTRATE NNP I-NP I-m
&amp; NNP I-NP O
DILTIAZEM NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok VBP O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/11/05 CD O O
by IN B-VP O
UPHOLD NNP B-NP O
, , O O
DONNY NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
CARDIZEM NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
49626929 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
METOPROLOL NNP I-NP B-m
TARTRATE NNP I-NP I-m
&amp; NNP I-NP O
DILTIAZEM NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok JJ B-NP O
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
X NNP I-NP B-du
10 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
2/19 CD O O
) ) O O
Instructions: NNP B-NP O
Taper: NNP I-NP O
40mg CD O B-do
40mg CD O B-do
for IN B-VP B-du
2 CD O B-du
2 CD O I-du
days NNS B-NP I-du
days NNS I-NP I-du
, , O O
then RB O O
35mg CD O B-do
for IN B-VP B-du
2days CD O I-du
, , O O
then RB O O
30mg CD O B-do
for IN B-VP B-du
2days CD O I-du
, , O O
then RB O O
25mg CD O B-do
for IN B-VP B-du
2days CD O I-du
, , O O
then RB O O
20mg CD O B-do
indefinitely RB O B-du
ZOCOR NNP B-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
CLOPIDOGREL NNP B-NP B-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
CALCIUM NNP I-NP B-m
CARB NNP I-NP I-m
+ NNP I-NP I-m
D NNP I-NP I-m
( ( O I-m
600MG CD O I-m
ELEM NNP B-NP I-m
CA NNP I-NP I-m
+ NNP I-NP I-m
VIT NNP I-NP I-m
D/200 NNP I-NP I-m
IU NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
COMBIVENT NNP I-NP B-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
AND NNP I-NP I-m
ALBUTEROL NNP I-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
ATOVAQUONE NNP I-NP B-m
750 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
with IN B-VP O
meals NNS B-NP O
NAPROSYN NNP I-NP B-m
( ( O I-m
NAPROXEN NNP B-NP I-m
) ) O I-m
250-500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/2/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CLOPIDOGREL NNP I-NP B-m
BISULFATE NNP I-NP I-m
&amp; NNP I-NP O
NAPROXEN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
musculoskeletal NN I-NP O
pain NN I-NP O
ADVAIR NNP I-NP B-m
DISKUS NNP I-NP I-m
500/50 CD O I-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE/ NNP I-NP I-m
) ) O I-m
1 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
No NNP I-NP O
Restrictions NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
BALVANZ NNP I-NP O
, , O O
PCP NNP B-NP O
2 CD O O
weeks NNS B-NP O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
asthma VBZ O O
exacerbation NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Asthma NNP B-NP O
exacerbation NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CAD NNP I-NP O
s/p NN I-NP O
NSTEMI NNP I-NP O
, , O O
stent NN B-NP O
to TO O O
LAD NNP B-NP O
OBESITY NNP I-NP O
OSA NNP I-NP O
HTN NNP I-NP O
diabetes VBZ O O
mellitus $ O O
2/2 CD O O
chronic JJ B-NP O
steroid NN I-NP B-m
use NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
ECHO NNP B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
45 CD O O
Yo NNP B-NP O
obese JJ B-NP O
F NNP I-NP O
ho NN I-NP O
IDDM NNP I-NP O
, , O O
sleep JJ B-NP O
apnea NN I-NP O
, , O O
asthma NN B-NP B-r
on IN B-VP O
chronic JJ B-NP O
prednisone NN I-NP B-m
, , O O
HTN NNP B-NP O
, , O O
CAD NNP B-NP O
s/p VBD B-VP O
NSTEMI NNP B-NP O
in IN B-VP O
6/10 CD O O
w JJ B-NP O
stent NN I-NP O
to TO O O
LAD NNP B-NP O
presents NNS I-NP O
w VBP O O
SOB NNP B-NP O
x $ O O
3 CD O O
days NNS B-NP O
Pt NNP I-NP O
was VBD B-VP O
in IN B-VP O
USH NNP B-NP O
until IN B-VP O
2 CD O O
days NNS B-NP O
PTA NNP I-NP O
, , O O
when WRB O O
she PRP O O
noticed VBD B-VP O
sudden JJ B-NP O
onset NN I-NP O
of IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
chest NN B-NP O
pressure NN I-NP O
She PRP O O
states VBZ O O
that IN B-VP O
her PRP$ O O
chest NN B-NP O
feels NNS I-NP O
heavy VBP O O
at IN B-VP O
times NNS B-NP O
, , O O
sometimes RB O O
worse JJR O O
when WRB O O
taking VBG O O
a DT B-NP O
deep JJ I-NP O
breath NN I-NP O
She PRP O O
states VBZ O O
that IN B-VP O
since IN B-VP O
onset NN B-NP O
of IN B-VP O
chest JJ B-NP O
pressure NN I-NP O
, , O O
her PRP$ O O
chest NN B-NP O
tightness NN I-NP O
has VBZ O O
become VBN O O
more RBR O O
severe JJ O O
and CC O O
worse JJ B-NP O
w NN I-NP O
exertion NN I-NP O
She PRP O O
also RB O O
states VBZ O O
that IN B-VP O
she PRP O O
occasionally RB O O
gets VBZ O O
palpitations NNS B-NP O
since IN B-VP O
her PRP$ O O
MI NNP B-NP O
, , O O
but CC O O
no DT B-NP O
N/V/diaphoresis NNP I-NP O
Pt NNP I-NP O
states VBZ O O
that IN B-VP O
she PRP O O
has VBZ O O
also RB O O
developed VBN O O
a DT B-NP O
dry JJ I-NP O
cough NN I-NP O
over IN B-VP O
past JJ B-NP O
few JJ I-NP O
days NNS I-NP O
, , O O
no DT B-NP O
fevers NNS I-NP O
, , O O
no DT O O
sick JJ O O
contacts VBZ O O
No DT B-NP O
lower JJR I-NP O
ext NN I-NP O
edema NN I-NP O
, , O O
but CC O O
has VBZ O O
had VBN O O
stable JJ B-NP O
3-pillow JJ I-NP O
orthopnea NN I-NP O
and CC O O
PND NNP B-NP O
PE: NNP I-NP O
BP NNP I-NP O
170/105 CD O O
HR NNP B-NP O
80 CD O O
100%RA CD O O
NAD NNP B-NP O
, , O O
AOx3 NNP B-NP O
, , O O
JVP NNP B-NP O
8cm CD O O
, , O O
sternum NN B-NP O
tender NN I-NP O
to TO O O
palpation NN B-NP O
, , O O
bilat JJ B-NP O
exp NN I-NP O
wheezes VBZ O O
throughout IN B-VP O
, , O O
prolonged VBD B-VP O
expiratory JJ B-NP O
phase NN I-NP O
, , O O
s1 NN B-NP O
s2 NN I-NP O
, , O O
abd JJ O O
soft JJ O O
, , O O
no DT B-NP O
c/c/e NN I-NP O
labs: RB O O
trop JJ O O
neg FW O O
x3 NN B-NP O
, , O O
D-dimer&lt;200 NNP B-NP O
, , O O
BNP NNP B-NP O
19 CD O O
EKG: NNP B-NP O
NSR NNP I-NP O
, , O O
nl JJ B-NP O
Axis NNP I-NP O
, , O O
no DT B-NP O
ST NNP I-NP O
changes NNS I-NP O
CXR: NNP I-NP O
lungs NNS I-NP O
clear JJ O O
bilaterally RB O O
, , O O
costophrenic JJ B-NP O
sulci NN I-NP O
sharp JJ B-NP O
bilat NN I-NP O
, , O O
no DT B-NP O
acute JJ I-NP O
pulm NN I-NP O
process NN I-NP O
45 CD O O
yo NN B-NP O
F NNP I-NP O
IDDM NNP I-NP O
, , O O
known VBN O O
CAD NNP B-NP O
s/p JJ B-NP O
recent JJ I-NP O
MI NNP I-NP O
w NN I-NP O
stent NN I-NP O
to TO O O
LAD NNP B-NP O
, , O O
asthma NN B-NP B-r
on IN B-VP O
chronic JJ B-NP O
prednisone NN I-NP B-m
, , O O
presents NNS B-NP O
w VBP O O
3 CD O O
days NNS B-NP O
worsening VBG O O
dyspnea NN B-NP O
and CC O O
chest JJ B-NP O
pressure NN I-NP O
Pt NNP I-NP O
treated VBD B-VP O
for IN B-VP O
asthma JJ B-NP B-r
exacerbation NN I-NP I-r
w NN I-NP O
prednisone NN I-NP B-m
and CC O O
no DT B-NP O
relief NN I-NP O
of IN B-VP O
symptoms NNS B-NP O
Given NNP I-NP O
known VBP O O
CAD NNP B-NP O
, , O O
recent JJ B-NP O
MI NNP I-NP O
, , O O
ho NN B-NP O
PND NNP I-NP O
and CC O O
orthopnea NN B-NP O
, , O O
considered VBN O O
both DT O O
cardiac JJ O O
and CC O O
pulmonary JJ B-NP O
etiologies NNS I-NP O
of IN B-VP O
symptoms NNS B-NP O
CV: NNP I-NP O
ROMI NNP I-NP O
with IN B-VP O
neg JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
x3 VBP O O
, , O O
no DT B-NP O
ischemic JJ I-NP O
changes NNS I-NP O
on IN B-VP O
ECG NNP B-NP O
ECHO NNP I-NP O
shows VBZ O O
concentric JJ B-NP O
LVH NNP I-NP O
but CC O O
EF NNP B-NP O
65% CD O O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
wall NN B-NP O
motion NN I-NP O
abnormalities NNS I-NP O
or CC O O
systolic/diastolic JJ B-NP O
dysfunction NN I-NP O
BNP NNP I-NP O
, , O O
TnI NNP B-NP O
normal JJ B-NP O
JVP NNP I-NP O
8cm CD O O
One CD O O
episode NN B-NP O
of IN B-VP O
subjective JJ B-NP O
palpitations NNS I-NP O
during IN B-VP O
admission NN B-NP O
, , O O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
arrhythmia NN B-NP O
on IN B-VP O
telemetry NN B-NP O
She PRP O O
did VBD B-VP O
have VB O O
one CD O O
brief JJ B-NP O
episode NN I-NP O
of IN B-VP O
apparent JJ B-NP O
broad-complex JJ I-NP O
tachycardia NN I-NP O
on IN B-VP O
telemetry NN B-NP O
which WDT O O
, , O O
on IN B-VP O
closer JJR B-NP O
inspection NN I-NP O
and CC O O
review NN B-NP O
by IN B-VP O
the DT B-NP O
EP NNP I-NP O
fellow NN I-NP O
, , O O
was VBD B-VP O
clearly RB O O
shown VBN O O
to TO O O
be VB O O
artefactual JJ O O
( ( O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
observed VBD B-VP O
throughout IN B-VP O
in IN B-VP O
lead NN B-NP O
I PRP O O
) ) O O
Ischemia: NNP B-NP O
continue VBP O O
zocor NN B-NP B-m
, , O O
clopidogrel NN B-NP B-m
, , O O
ECASA NNP B-NP B-m
nitrates VBZ O B-m
as IN B-VP B-f
needed VBN O I-f
Pump: NNP B-NP O
continue VBP O O
lisinopril NN B-NP B-m
, , O O
HCTZ NNP B-NP B-m
, , O O
cardizem NN B-NP B-m
Lopressor NNP I-NP B-m
12.5mg CD O B-do
PO NNP B-NP B-mo
BID NNP I-NP B-f
Rhythm: NNP I-NP O
NSR NNP I-NP O
stable JJ B-NP O
Pulm: NNP I-NP O
Dyspnea NNP I-NP O
and CC O O
wheezing VBG O O
w JJ B-NP O
ho NN I-NP O
multiple JJ B-NP O
asthma JJ I-NP O
exacerbations NNS I-NP O
on IN B-VP O
presentation NN B-NP O
Never NNP I-NP O
hospitalized VBD B-VP O
, , O O
chronic JJ B-NP O
prednisone NN I-NP B-m
therapy NN I-NP I-m
s/p NN I-NP O
gentle JJ B-NP O
diuresis NN I-NP O
, , O O
pred VBN O B-m
, , O O
nebs JJ B-NP O
w NN I-NP O
improvement NN I-NP O
of IN B-VP O
symptoms NNS B-NP O
D-dimer&lt;200 NNP I-NP O
Admission NNP I-NP O
peak NN I-NP O
flow NN I-NP O
150 CD O O
( ( O O
baseline JJ O O
nl IN B-VP O
300-350 JJ O O
) ) O O
, , O O
at IN B-VP O
discharge JJ B-NP O
275-300 JJ I-NP O
Ambulatory NNP I-NP O
O2 NNP I-NP O
sat VBD B-VP O
WNL NNP B-NP O
-Combivent NNP I-NP B-m
, , O O
Advair NNP B-NP B-m
, , O O
steroid JJ B-NP B-m
steroid NN I-NP B-m
taper NN I-NP O
( ( O O
40mg CD O B-do
to TO O O
20mg CD O B-do
over IN B-VP B-du
over IN B-VP B-du
8 CD O I-du
8 CD O I-du
days NNS B-NP I-du
days NNS I-NP I-du
) ) O O
, , O O
PCP NNP B-NP B-m
ppx NN I-NP I-m
with IN B-VP O
BID NNP B-NP B-f
Atovaquone NNP I-NP B-m
in IN B-VP O
setting VBG O O
of IN B-VP O
chronic JJ B-NP O
prednisone NN I-NP B-m
ENDO: NNP I-NP O
Chronic NNP I-NP O
steroid NN I-NP B-m
use NN I-NP O
, , O O
Insulin NNP B-NP B-m
SS NNP I-NP O
in-house NN I-NP O
-calcium/vit NNP I-NP B-m
D NNP I-NP O
supplement NN I-NP O
MUSC: NNP I-NP O
Reproducible NNP I-NP O
sternal JJ B-NP O
pain NN I-NP O
on IN B-VP O
palpation NN B-NP O
consistent NN I-NP O
with IN B-VP O
costochondritis NN B-NP O
Naprosyn NNP I-NP B-m
PRN NNP I-NP B-f
pain NN I-NP B-r
Psych: NNP I-NP O
Continue NNP I-NP O
Zoloft NNP I-NP B-m
for IN B-VP O
depression NN B-NP B-r
and CC O O
Lorazepam NNP B-NP B-m
for IN B-VP O
anxiety NN B-NP B-r
PPx: NNP I-NP O
PPI NNP I-NP O
FULL NNP I-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
call VB O O
your PRP$ O O
PCP NNP B-NP O
or CC O O
come VBN O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
if IN B-VP O
you PRP O O
experience VBP O O
any DT O O
of IN B-VP O
the DT B-NP O
following: JJ I-NP O
loss NN I-NP O
of IN B-VP O
consciousness NN B-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
difficulty NN B-NP O
breathing NN I-NP O
, , O O
swelling VBG O O
in IN B-VP O
legs JJ B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Assess: NNP I-NP O
-efficacy NN I-NP O
of IN B-VP O
prednisone NN B-NP B-m
20mg CD O B-do
upon IN B-VP O
completion NN B-NP O
of IN B-VP O
taper JJ B-NP O
-status NN I-NP O
of IN B-VP O
dyspnea/asthma NN B-NP O
symptoms NNS I-NP O
on IN B-VP O
low JJ B-NP B-do
dose JJ I-NP I-do
beta-blocker NN I-NP B-m
-chest NNP I-NP O
pain/costochondritis NN I-NP O
with IN B-VP O
PRN NNP B-NP B-f
NSAIDs NNP I-NP B-m
-compliance NN I-NP O
with IN B-VP O
atovaquone NN B-NP B-m
ppx NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
KEPNER NNP I-NP O
, , O O
KENDRICK NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
CB41 NNP B-NP O
) ) O O
4/2/05 CD O O
@ $ O O
03 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#269404 VBZ O O
211892555 CD O O
AGH NNP B-NP O
34558636 CD O O
1187944 CD O O
8/14/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/13/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/8/2006 CD O O
ATTENDING: NNP B-NP O
SHELOR NNP I-NP O
, , O O
KENDRICK NNP B-NP O
M.D NNP I-NP O
SERVICE: NNP I-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
ADMITTING NNP I-NP O
DIAGNOSES: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
and CC O O
aortic JJ B-NP O
stenosis NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
79-year-old JJ I-NP O
male NN I-NP O
status NN I-NP O
post NN I-NP O
stenting NN I-NP O
of IN B-VP O
the DT B-NP O
PDA NNP I-NP O
and CC O O
PTCA NNP B-NP O
, , O O
radioablation NN B-NP O
and CC O O
stenting NN B-NP O
of IN B-VP O
his PRP$ O O
LAD NNP B-NP O
in IN B-VP O
2000 CD O O
He PRP O O
had VBD B-VP O
recurrent JJ B-NP O
ischemic JJ I-NP O
symptoms NNS I-NP O
four CD O O
months NNS B-NP O
later RB O O
and CC O O
cardiac JJ B-NP O
catheterization NN I-NP O
showed VBD B-VP O
restenosis NN B-NP O
of IN B-VP O
his PRP$ O O
LAD NNP B-NP O
with IN B-VP O
an DT O O
80% CD O O
lesion NN B-NP O
at IN B-VP O
D3 NNP B-NP O
He PRP O O
had VBD B-VP O
brachytherapy NN B-NP O
and CC O O
repeat NN B-NP O
PTCA NNP I-NP O
Since IN B-VP O
then RB O O
, , O O
he PRP O O
has VBZ O O
done VBN O O
well RB O O
but CC O O
he PRP O O
had VBD B-VP O
increasing VBG O O
dyspnea NN B-NP O
from IN B-VP O
CR NNP B-NP O
Exercise NNP I-NP O
thallium NN I-NP O
test NN I-NP O
, , O O
which WDT O O
showed VBD B-VP O
increasing VBG O O
LV NNP B-NP O
filling NN I-NP O
pressures NNS I-NP O
during IN B-VP O
exercise NN B-NP O
and CC O O
inferior JJ B-NP O
apical JJ I-NP O
ischemia NN I-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
done VBN O O
on IN B-VP O
6/14/06 CD O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT O O
45% CD O O
proximal JJ B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
50% CD O O
distal NN B-NP O
left VBD B-VP O
main JJ B-NP O
disease NN I-NP O
, , O O
and CC O O
95% CD O O
mid NN B-NP O
LAD NNP I-NP O
disease NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
, , O O
dyslipidemia NN B-NP O
, , O O
and CC O O
chest JJS B-NP O
radiation NN I-NP O
, , O O
prostate NN B-NP O
cancer NN I-NP O
, , O O
osteoporosis NN B-NP O
, , O O
and CC O O
urinary JJ B-NP O
incontinence NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
, , O O
made VBN O O
ready NN B-NP O
for IN B-VP O
surgery NN B-NP O
He PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
10/3/06 CD O O
At IN B-VP O
which WDT O O
time NN B-NP O
, , O O
he PRP O O
underwent VBD B-VP O
a DT B-NP O
CABG NNP I-NP O
x3 NN I-NP O
with IN B-VP O
a DT B-NP O
LIMA NNP I-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
, , O O
a DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
PDA NNP I-NP O
and CC O O
a DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
obtuse NN I-NP O
marginal VBZ O O
The DT B-NP O
patient's NN I-NP O
aortic JJ B-NP O
valve NN I-NP O
was VBD B-VP O
only RB O O
found VBN O O
to TO O O
be VB O O
mildly RB O O
stenotic JJ O O
with IN B-VP O
the DT B-NP O
valve JJ I-NP O
area NN I-NP O
of IN B-VP O
1.4 CD O O
and CC O O
a DT B-NP O
peak JJ I-NP O
gradient NN I-NP O
of IN B-VP O
30 CD O O
This DT O O
was VBD B-VP O
discussed VBN O O
with IN B-VP O
his PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Cletus NNP I-NP O
Columbres NNP I-NP O
and CC O O
a DT B-NP O
combined JJ I-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
not RB O O
to TO O O
replace VB O O
the DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
The DT B-NP O
patient's NN I-NP O
immediate JJ B-NP O
postoperative JJ I-NP O
course NN I-NP O
was VBD B-VP O
uncomplicated JJ O O
He PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
a DT B-NP O
stable JJ I-NP O
fashion NN I-NP O
He PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
an DT B-NP O
inferior JJ I-NP O
lateral JJ I-NP O
ischemia NN I-NP O
on IN B-VP O
EKG NNP B-NP O
, , O O
therefore RB O O
, , O O
he PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
cath NN I-NP O
lab NN I-NP O
, , O O
all DT B-NP O
grafts NNS I-NP O
were VBD B-VP O
found VBN O O
to TO O O
be VB O O
patent JJ O O
and CC O O
there EX O O
was VBD B-VP O
resolution NN B-NP O
of IN B-VP O
ischemia NN B-NP O
He PRP O O
was VBD B-VP O
weaned VBN O O
off RP O O
his PRP$ O O
pressors NNS B-NP B-m
and CC O O
he PRP O O
was VBD B-VP O
extubated VBN O O
He PRP O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
hemodynamically RB O O
stable JJ O O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Lopressor NNP B-NP B-m
and CC O O
gentle JJ B-NP O
diuresis NN I-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#3 NNP I-NP O
, , O O
we PRP O O
titrated VBD B-VP B-do
up RP O I-do
his PRP$ O O
Lopressor NNP B-NP B-m
and CC O O
started VBD B-VP O
on IN B-VP O
his PRP$ O O
Norvasc NNP B-NP B-m
and CC O O
transferred VBD B-VP O
him PRP O O
to TO O O
the DT B-NP O
Step-Down JJ I-NP O
Unit NNP I-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#4 NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
slightly RB O B-r
tachycardic JJ O I-r
with IN B-VP O
ambulation NN B-NP O
and CC O O
we PRP O O
titrated VBD B-VP B-do
up RP O I-do
on IN B-VP O
his PRP$ O O
beta-blockers NNS B-NP B-m
PA NNP I-NP O
and CC O O
chest JJS B-NP O
x-ray JJ I-NP O
look NN I-NP O
good JJ B-NP O
Physical NNP I-NP O
therapy NN I-NP O
was VBD B-VP O
consulted VBN O O
to TO O O
decide VB O O
whether IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
benefit VB O O
from IN B-VP O
rehabilitation NN B-NP O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
empiric JJ B-NP O
levofloxacin NN I-NP B-m
for IN B-VP O
questionable JJ B-NP B-r
pneumonia NN I-NP I-r
He PRP O O
was VBD B-VP O
found VBN O O
suitable JJ O O
for IN B-VP O
discharge NN B-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#5 NNP I-NP O
, , O O
however RB O O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
isolated VBN O O
temperature NN B-NP O
and CC O O
his PRP$ O O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
trending VBG O O
and CC O O
he PRP O O
was VBD B-VP O
hypertensive JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP B-r
positive JJ I-NP I-r
blood NN I-NP I-r
culture NN I-NP I-r
from IN B-VP O
when WRB O O
he PRP O O
had VBD B-VP O
been VBN O O
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
and CC O O
he PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
levofloxacin PDT O B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discovered VBN O O
to TO O O
have VB O O
left VBN O B-r
leg JJ B-NP I-r
cellulitis NN I-NP I-r
at IN B-VP O
the DT B-NP O
knee NN I-NP O
where WRB O O
his PRP$ O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
was VBD B-VP O
harvested VBN O O
from IN B-VP O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
vancomycin NN B-NP B-m
This DT B-NP O
area NN I-NP O
continued VBD B-VP O
to TO O O
be VB O O
watched VBN O O
while IN B-VP O
the DT B-NP O
patient NN I-NP O
remained VBD B-VP O
on IN B-VP O
IV NNP B-NP B-mo
antibiotics NNS I-NP B-m
He PRP O O
was VBD B-VP O
afebrile IN B-VP O
His PRP$ O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
was VBD B-VP O
12 CD O O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
stable JJ O O
but CC O O
he PRP O O
continued VBD B-VP O
to TO O O
have VB O O
a DT B-NP O
white JJ I-NP O
count NN I-NP O
and CC O O
left VBD B-VP O
leg NN B-NP O
ultrasound NN I-NP O
finally RB O O
done VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#10 NNP I-NP O
, , O O
revealed VBD B-VP O
a DT B-NP O
fluid JJ I-NP O
collection NN I-NP O
above IN B-VP O
the DT B-NP O
knee NN I-NP O
to TO O O
the DT B-NP O
mid NN I-NP O
calf NN I-NP O
mostly RB O O
behind IN B-VP O
his PRP$ O O
knee NN B-NP O
where WRB O O
the DT B-NP O
area NN I-NP O
of IN B-VP O
erythema NN B-NP O
was VBD B-VP O
and CC O O
his PRP$ O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
went VBD B-VP O
up RB O O
to TO O O
15 CD O O
Therefore NNP B-NP O
, , O O
on IN B-VP O
10/28/06 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
, , O O
at IN B-VP O
which WDT O O
time NN B-NP O
, , O O
he PRP O O
underwent VBD B-VP O
a DT B-NP O
drainage NN I-NP O
and CC O O
irrigation NN B-NP O
of IN B-VP O
his PRP$ O O
left JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
saphenous JJ B-NP O
vein NNS I-NP O
donor JJ B-NP O
site NN I-NP O
, , O O
moderate JJ B-NP O
amount NN I-NP O
of IN B-VP O
fluid NN B-NP O
were VBD B-VP O
expressed VBN O O
, , O O
and CC O O
cultures NNS B-NP O
were VBD B-VP O
taken VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
Step-Down NNP I-NP O
Unit NNP I-NP O
after IN B-VP O
this DT B-NP O
procedure NN I-NP O
Please NNP I-NP O
see VB O O
the DT O O
continuing VBG O O
dictation NN B-NP O
done VBN O O
by IN B-VP O
Valentin NNP B-NP O
Krull NNP I-NP O
for IN B-VP O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
the DT B-NP O
patient's JJ I-NP O
hospital NN I-NP O
course NN I-NP O
and CC O O
discharge NN B-NP O
status NN I-NP O
eScription NN I-NP O
document: VBZ O O
4-5978600 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
FRENKEL NNP I-NP O
, , O O
EMIL NNP B-NP O
Attending: NNP I-NP O
FINLEY NNP I-NP O
, , O O
RYAN NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
5169133 CD O O
D: NNP B-NP O
10/5/06 CD O O
T: NNP B-NP O
10/5/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#269991 VBZ O O
515955975 CD O O
OH NNP B-NP O
36437373 CD O O
166689 CD O O
0/25/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/11/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/18/1995 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
LIST NNP I-NP O
OF NNP I-NP O
SIGNIFICANT NNP I-NP O
PROBLEMS: NNP I-NP O
DIABETES NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
54 CD O O
year NN B-NP O
old JJ O O
, , O O
white JJ B-NP O
male NN I-NP O
with IN B-VP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
of IN B-VP O
diabetes NNS B-NP O
, , O O
borderline NN B-NP O
hypertension NN I-NP O
, , O O
male JJ B-NP O
gender NN I-NP O
, , O O
and CC O O
a DT B-NP O
positive JJ I-NP O
family NN I-NP O
history NN I-NP O
, , O O
who WP O O
has VBZ O O
no DT B-NP O
prior JJ I-NP O
cardiac JJ I-NP O
history NN I-NP O
, , O O
but CC O O
now RB O O
presents VBZ O O
to TO O O
Leyson NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
complaining NN I-NP O
of IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
Approximately RB O O
six CD O O
weeks NNS B-NP O
ago RB O O
, , O O
the DT B-NP O
patient NN I-NP O
lifted VBD B-VP O
a DT B-NP O
100-pound JJ I-NP O
bag NN I-NP O
and CC O O
the DT B-NP O
next JJ I-NP O
a.m NN I-NP O
, , O O
noted VBD B-VP O
substernal JJ B-NP O
chest NN I-NP O
pressure NN I-NP O
without IN B-VP O
associated VBN O O
symptoms NNS B-NP O
This DT B-NP O
pressure NN I-NP O
lasted VBD B-VP O
approximately RB O O
three CD O O
to TO O O
five CD O O
minutes NNS B-NP O
and CC O O
resolved VBD B-VP O
spontaneously RB O O
Since IN B-VP O
then RB O O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
two CD O O
similar JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pressure NN I-NP O
that WDT O O
have VBP O O
occurred VBN O O
while IN B-VP O
he PRP O O
was VBD B-VP O
exerting VBG O O
himself PRP O O
, , O O
once RB O O
while IN B-VP O
running VBG O O
during IN B-VP O
a DT B-NP O
basketball NN I-NP O
game NN I-NP O
and CC O O
once RB O O
again RB O O
while IN B-VP O
running VBG O O
on IN B-VP O
the DT B-NP O
beach NN I-NP O
in IN B-VP O
Westtpo NNP B-NP O
Racecon NNP I-NP O
Nari NNP I-NP O
Neither NNP I-NP O
episode NN I-NP O
had VBD B-VP O
associated VBN O O
symptoms NNS B-NP O
( ( O O
i.e NN B-NP O
, , O O
radiation NN B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
diaphoresis NN B-NP O
, , O O
palpitations NNS B-NP O
) ) O O
, , O O
and CC O O
both DT B-NP O
episodes NNS I-NP O
lasted VBD B-VP O
less JJR O O
than IN B-VP O
five CD O O
minutes NNS B-NP O
and CC O O
resolved VBN O O
with IN B-VP O
rest NN B-NP O
On IN B-VP O
the DT B-NP O
night NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
working VBG O O
regripping VBG O O
his PRP$ O O
golf NN B-NP O
clubs NNS I-NP O
and CC O O
noted VBD B-VP O
a DT O O
pulling VBG O O
sensation NN B-NP O
into IN B-VP O
his PRP$ O O
chest NN B-NP O
, , O O
which WDT O O
again RB O O
resolved VBD B-VP O
with IN B-VP O
rest NN B-NP O
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
awoke VBD B-VP O
at IN B-VP O
4:00 CD O O
a.m NNS B-NP O
, , O O
noting VBG O O
a DT B-NP O
6-7/10 JJ I-NP O
substernal JJ I-NP O
chest NN I-NP O
pressure NN I-NP O
associated VBN O O
with IN B-VP O
diaphoresis NN B-NP O
The DT B-NP O
pain NN I-NP O
persisted VBD B-VP O
for IN B-VP O
five CD O O
hours NNS B-NP O
, , O O
at IN B-VP O
which WDT O O
time NN B-NP O
the DT B-NP O
patient NN I-NP O
presented VBD B-VP O
to TO O O
MLMC NNP B-NP O
At IN B-VP O
KGH NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
152/88 CD O O
and CC O O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
76 CD O O
His PRP$ O O
physical JJ B-NP O
examination NN I-NP O
was VBD B-VP O
benign JJ O O
However RB O O
, , O O
the DT B-NP O
patient's NN I-NP O
electrocardiogram NN I-NP O
showed VBD B-VP O
new JJ B-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
V2-V5 NNP B-NP O
, , O O
T NNP B-NP O
wave VBP O O
inversions NNS B-NP O
in IN B-VP O
AVL NNP B-NP O
, , O O
and CC O O
flat JJ B-NP O
T's NNP I-NP O
in IN B-VP O
1 CD O O
and CC O O
V6 NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
two CD O B-do
sublingual JJ B-NP B-mo
nitroglycerins NNS I-NP B-m
and CC O O
sent VBD B-VP O
to TO O O
the DT B-NP O
Mendwood NNP I-NP O
Hospital NNP I-NP O
On IN B-VP O
route NN B-NP O
to TO O O
Icoson NNP B-NP O
Hospital NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
received VBD B-VP O
two CD O B-do
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
sprays NNS I-NP I-m
On IN B-VP O
arrival NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
pain NN I-NP O
had VBD B-VP O
dwindled VBN O O
to TO O O
1/10 CD O O
, , O O
without IN B-VP O
associated VBN O O
symptoms NNS B-NP O
The DT B-NP O
patient's NN I-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
126/80 CD O O
, , O O
with IN B-VP O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
80 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
an DT B-NP O
aspirin NN I-NP B-m
, , O O
a DT B-NP O
sublingual JJ I-NP B-mo
nitroglycerin NN I-NP B-m
, , O O
nitro JJ B-NP B-m
paste NN I-NP I-m
, , O O
Lopressor NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
x VBD B-VP B-du
1 CD O I-du
intravenously RB O B-mo
, , O O
and CC O O
intravenous JJ B-NP B-mo
heparin NN I-NP B-m
Upon NNP I-NP O
transfer NN I-NP O
to TO O O
the DT B-NP O
CCU NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
pain RB O O
free JJ B-NP O
A NNP I-NP O
repeat NN I-NP O
electrocardiogram NN I-NP O
demonstrated VBD B-VP O
resolution NN B-NP O
of IN B-VP O
ST NNP B-NP O
depressions NNS I-NP O
and CC O O
flat JJ B-NP O
T NNP I-NP O
waves NNS I-NP O
, , O O
but CC O O
persistence NN B-NP O
of IN B-VP O
the DT B-NP O
T NNP I-NP O
wave VBP O O
inversion NN B-NP O
in IN B-VP O
AVL NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
further JJ B-NP O
treatment NN I-NP O
and CC O O
to TO O O
rule VB O O
out RP O O
myocardial JJ B-NP O
infarction NN I-NP O
The DT B-NP O
patient NN I-NP O
gives VBZ O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
edema NN B-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
or CC O O
orthopnea IN B-VP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
fevers NNS B-NP O
, , O O
upper JJ B-NP O
respiratory NN I-NP O
infection NN I-NP O
symptoms NNS I-NP O
, , O O
cough NN B-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
diarrhea NN B-NP O
, , O O
dysuria NN B-NP O
, , O O
or CC O O
weight JJ B-NP O
loss NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
diabetes VBZ O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
kidney VBN O O
stones NNS B-NP O
, , O O
is VBZ O O
status NN B-NP O
post NN I-NP O
procedure NN I-NP O
three CD O O
to TO O O
four CD O O
years NNS B-NP O
ago RB O O
, , O O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
sinusitis NN B-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
medications NNS I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
included VBD B-VP O
only RB O O
Glyburide NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBP O B-f
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
unmarried JJ O O
He PRP O O
was VBD B-VP O
the DT B-NP O
part NN I-NP O
owner NN I-NP O
of IN B-VP O
a DT B-NP O
bar NN I-NP O
He PRP O O
does VBZ O O
not RB O O
smoke VB O O
, , O O
and CC O O
he PRP O O
does VBZ O O
not RB O O
drink VB O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
mother NN I-NP O
had VBD B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
in IN B-VP O
her PRP$ O O
60's CD O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
pleasant JJ O O
, , O O
tan JJ B-NP O
male NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
Blood NNP I-NP O
pressure NN I-NP O
, , O O
126/80 CD O O
Heart NNP B-NP O
rate NN I-NP O
, , O O
80 CD O O
Respiratory NNP B-NP O
rate NN I-NP O
, , O O
20 CD O O
Temperature NN B-NP O
, , O O
98 CD O O
Oxygen NNP B-NP O
saturation NN I-NP O
, , O O
100% CD O O
on IN B-VP O
two CD O O
liters NNS B-NP O
Head VBP O O
, , O O
eyes NNS B-NP O
, , O O
ears NNS B-NP O
, , O O
nose RB O O
, , O O
and CC O O
throat NN B-NP O
examination NN I-NP O
was VBD B-VP O
anicteric JJ O O
, , O O
with IN B-VP O
oropharynx JJ B-NP O
benign NN I-NP O
Neck NNP I-NP O
was VBD B-VP O
supple JJ O O
, , O O
with IN B-VP O
no DT B-NP O
lymphadenopathy JJ I-NP O
Carotids NNS I-NP O
were VBD B-VP O
2+ CD O O
, , O O
with IN B-VP O
no DT B-NP O
bruits NNS I-NP O
Lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
Back NNP B-NP O
examination NN I-NP O
demonstrated VBD B-VP O
no DT B-NP O
costovertebral JJ I-NP O
angle NN I-NP O
tenderness NN I-NP O
and CC O O
no DT B-NP O
spinal JJ I-NP O
tenderness NN I-NP O
Coronary NNP I-NP O
examination NN I-NP O
revealed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
distant JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
and CC O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
or CC O O
gallops NNS B-NP O
Abdominal NNP I-NP O
examination NN I-NP O
was VBD B-VP O
benign JJ B-NP O
Rectal NNP I-NP O
examination NN I-NP O
showed VBD B-VP O
guaiac JJ B-NP O
negative JJ I-NP O
stool NN I-NP O
Extremities NNS I-NP O
showed VBD B-VP O
no DT B-NP O
cyanosis NN I-NP O
, , O O
clubbing VBG O O
, , O O
or CC O O
edema NN B-NP O
, , O O
with IN B-VP O
pulses NNS B-NP O
2+ CD O O
throughout IN B-VP O
, , O O
and CC O O
no DT B-NP O
femoral JJ I-NP O
bruits NNS I-NP O
Neurologic NNP I-NP O
examination NN I-NP O
revealed VBD B-VP O
the DT B-NP O
patient NN I-NP O
to TO O O
be VB O O
alert JJ O O
and CC O O
oriented VBD B-VP O
x $ O O
3 CD O O
LABORATORY NNP B-NP O
DATA: NNP I-NP O
Laboratory NNP I-NP O
studies NNS I-NP O
on IN B-VP O
admission NN B-NP O
revealed VBD B-VP O
the DT B-NP O
patient's NN I-NP O
electrolytes VBZ O O
to TO O O
be VB O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
except IN B-VP O
for IN B-VP O
a DT B-NP O
glucose NN I-NP O
of IN B-VP O
293 CD O O
The DT B-NP O
first JJ I-NP O
CK NNP I-NP O
returned VBD B-VP O
970 CD O O
, , O O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
fraction NN I-NP O
of IN B-VP O
65.1 CD O O
Magnesium NNP B-NP O
was VBD B-VP O
1.6 CD O O
CBC NNP B-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
with IN B-VP O
a DT B-NP O
hematocrit NN I-NP O
of IN B-VP O
44.1 CD O O
Coag's NNP B-NP O
were VBD B-VP O
also RB O O
normal JJ O O
at IN B-VP O
12.7 CD O O
and CC O O
27.4 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
showed VBD B-VP O
no DT B-NP O
enlarged JJ I-NP O
heart NN I-NP O
and CC O O
no DT B-NP O
infiltrate NN I-NP O
Electrocardiogram NNP I-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
, , O O
with IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
60 CD O O
, , O O
and CC O O
no DT B-NP O
ST-T NNP I-NP O
changes NNS I-NP O
on IN B-VP O
the DT O O
19 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
1995 CD O O
However RB O O
, , O O
electrocardiogram VBP O O
at IN B-VP O
the DT B-NP O
Bertgrand NNP I-NP O
Hospital NNP I-NP O
, , O O
pain NN B-NP O
free JJ O O
, , O O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
, , O O
with IN B-VP O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
82 CD O O
, , O O
T NNP B-NP O
wave VBP O O
inversions NNS B-NP O
, , O O
AVL NNP B-NP O
, , O O
and CC O O
flat JJ B-NP O
T's NNP I-NP O
in IN B-VP O
lead JJ O O
1 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
acute JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
Electrocardiogram NNP I-NP O
changes NNS I-NP O
were VBD B-VP O
consistent JJ O O
with IN B-VP O
lateral JJ O O
or CC O O
anterolateral JJ B-NP O
ischemia NN I-NP O
His PRP$ O O
peak NN B-NP O
CK's NNP I-NP O
returned VBD B-VP O
at IN B-VP O
1 CD O O
, , O O
330 CD O O
, , O O
with IN B-VP O
54.5% CD O O
MB NNP B-NP O
fractions NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
heparin NN B-NP B-m
and CC O O
intravenous JJ B-NP B-mo
nitroglycerin NN I-NP B-m
for IN B-VP B-du
72 CD O O
hours NNS B-NP O
after IN B-VP O
admission NN B-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Lopressor NNP B-NP B-m
and CC O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
at IN B-VP O
admission NN B-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
free JJ O O
for IN B-VP O
the DT O O
five CD O O
days NNS B-NP O
post NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
and CC O O
underwent NN B-NP O
a DT B-NP O
submax JJ I-NP O
ETT NNP I-NP O
on IN B-VP O
the DT O O
1 CD O O
of IN B-VP O
January NNP B-NP O
, , O O
1995 CD O O
In IN B-VP O
addition NN B-NP O
, , O O
an DT B-NP O
electrocardiogram NN I-NP O
was VBD B-VP O
performed VBN O O
, , O O
which WDT O O
showed VBD B-VP O
a DT B-NP O
left JJ I-NP O
ventricle NN I-NP O
with IN B-VP O
73% CD O O
ejection NN B-NP O
fraction NN I-NP O
, , O O
upper JJ B-NP O
limits NNS I-NP O
of IN B-VP O
normal JJ B-NP O
size NN I-NP O
, , O O
and CC O O
a DT B-NP O
question NN I-NP O
of IN B-VP O
inferior JJ B-NP O
wall NN I-NP O
hypokinesis NN I-NP O
On IN B-VP O
the DT O O
14 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
submax NN I-NP O
ETT NNP I-NP O
, , O O
which WDT O O
was VBD B-VP O
stopped VBN O O
secondary JJ O O
to TO O O
chest VB O O
tightness NN B-NP O
, , O O
with IN B-VP O
diagnostic JJ B-NP O
electrocardiogram NN I-NP O
changes NNS I-NP O
, , O O
maximal JJ B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
96 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
of IN B-VP O
145/82 CD O O
, , O O
electrocardiogram NN B-NP O
with IN B-VP O
2 CD O O
mm NNS B-NP O
ST NNP I-NP O
depressions NNS I-NP O
, , O O
persisting VBG O O
into IN B-VP O
recovery NN B-NP O
Because IN B-VP O
of IN B-VP O
a DT B-NP O
positive JJ I-NP O
ETT NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
subsequently RB O O
underwent JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
, , O O
which WDT O O
showed VBD B-VP O
a DT B-NP O
proximal JJ I-NP O
left NN I-NP O
circ NN I-NP O
lesion NN I-NP O
70% CD O O
stenosed VBN O O
, , O O
which WDT O O
was VBD B-VP O
percutaneous JJ B-NP O
transhepatic JJ I-NP O
coronary NN I-NP O
angioplastied VBD B-VP O
to TO O O
20% CD O O
residual JJ O O
, , O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
mid-left JJ I-NP O
circ NN I-NP O
lesion NN I-NP O
70% CD O O
stenosed VBN O O
, , O O
which WDT O O
was VBD B-VP O
percutaneous JJ B-NP O
transhepatic JJ I-NP O
coronary NN I-NP O
angioplastied VBD B-VP O
to TO O O
a DT O O
30% CD O O
residual JJ O O
The DT B-NP O
left JJ I-NP O
anterior JJ I-NP O
descending NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
diffusely RB O O
diseased VBN O O
, , O O
without IN B-VP O
focal JJ B-NP O
stenoses NNS I-NP O
, , O O
and CC O O
the DT B-NP O
proximal JJ I-NP O
right JJ I-NP O
coronary NN I-NP O
artery NN I-NP O
showed VBD B-VP O
a DT O O
60% CD O O
shelf-like JJ B-NP O
lesion NN I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
experience VB O O
chest JJS B-NP O
pain NN I-NP O
or CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
during IN B-VP O
the DT B-NP O
procedure NN I-NP O
Post NNP I-NP O
cardiac VBP O O
catheterization/percutaneous JJ B-NP O
transhepatic JJ I-NP O
coronary NN I-NP O
angioplasty NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
his PRP$ O O
glipizide NN B-NP B-m
and CC O O
atenolol NN B-NP B-m
, , O O
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
and CC O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
, , O O
as RB O O
well RB O O
as IN B-VP O
heparin NNS B-NP B-m
overnight JJ O B-du
Two CD O O
days NNS B-NP O
after IN B-VP O
the DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
underwent VBD B-VP O
a DT B-NP O
second JJ I-NP O
submax NN I-NP O
ETT NNP I-NP O
This DT O O
he PRP O O
performed VBD B-VP O
without IN B-VP O
chest JJS B-NP O
discomfort NN I-NP O
or CC O O
electrocardiogram NN B-NP O
changes NNS I-NP O
DISPOSITION: VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
on IN B-VP O
the DT O O
30 CD O O
of IN B-VP O
November NNP B-NP O
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
patient's JJ I-NP O
condition NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
was VBD B-VP O
stable JJ B-NP O
DISCHARGE NNP I-NP O
PLAN: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
receive VB O O
diabetic JJ B-NP O
teaching NN I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
with IN B-VP O
CH NNP B-NP O
and CC O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Kalert NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Atenolol NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
sublingual JJ B-NP B-mo
nitroglycerins NNS I-NP B-m
p.r.n VBP O B-f
chest JJS B-NP B-r
pain NN I-NP I-r
, , O O
and CC O O
Glucotrol NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
Dictated NNP I-NP O
By: NNP I-NP O
HARLAND NNP I-NP O
DELAUGHTER NNP I-NP O
, , O O
M.D NNP B-NP O
Attending: NNP I-NP O
GREG NNP I-NP O
B NNP I-NP O
ADAM NNP I-NP O
, , O O
M.D NNP B-NP O
IA7 NNP I-NP O
FA178/8091 NNP I-NP O
Batch: NNP I-NP O
4678 CD O O
Index NNP B-NP O
No NNP I-NP O
CIMAHR8WJA NNP I-NP O
D: NNP I-NP O
11/10/95 CD O O
T: NNP B-NP O
2/12/95 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#275970 VBZ O O
550102522 CD O O
LHS NNP B-NP O
91830964 CD O O
513938 CD O O
8/3/1991 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/1/1991 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/23/1991 CD O O
CHIEF NNP B-NP O
COMPLAINT: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
42-year-old JJ I-NP O
woman NN I-NP O
admitted VBD B-VP O
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
two CD O O
pulmonary JJ B-NP O
embolisms NNS I-NP O
and CC O O
a DT B-NP O
urinary JJ I-NP O
tract NN I-NP O
infection NN I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
Pulmonary NNP B-NP O
embolisms NNS I-NP O
times NNS I-NP O
two CD O O
2 CD O O
Urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
3 CD O O
Status NNP B-NP O
post NN I-NP O
total JJ B-NP O
abdominal JJ I-NP O
hysterectomy NN I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Twenty NNP I-NP O
years NNS I-NP O
ago RB O O
the DT B-NP O
patient NN I-NP O
suffered VBD B-VP O
a DT B-NP O
pulmonary JJ I-NP B-r
pulmonary JJ I-NP B-r
embolism NN I-NP I-r
embolism NN I-NP I-r
which WDT O O
was VBD B-VP O
poorly RB O O
documented VBN O O
after IN B-VP O
a DT B-NP O
tubal JJ I-NP O
ligation NN I-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
heparin NN B-NP B-m
and CC O O
Coumadin NNP B-NP B-m
Since IN B-VP O
that DT B-NP O
time NN I-NP O
she PRP O O
has VBZ O O
been VBN O O
well RB O O
On IN B-VP O
1 CD O O
of IN B-VP O
October NNP B-NP O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
elective JJ I-NP O
total JJ I-NP O
abdominal JJ I-NP O
hysterectomy NN I-NP O
secondary JJ O O
to TO O O
fibroids NNS B-NP O
and CC O O
menorrhagia NN B-NP O
On IN B-VP O
6 CD O O
of IN B-VP O
March NNP B-NP O
, , O O
the DT B-NP O
night NN I-NP O
before IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
noted VBD B-VP O
the DT B-NP O
onset NN I-NP O
of IN B-VP O
sharp JJ B-NP O
pleuritic JJ I-NP O
chest NN I-NP O
pain NN I-NP O
upon IN B-VP O
movement NN B-NP O
in IN B-VP O
bed NN B-NP O
It PRP O O
was VBD B-VP O
felt VBN O O
this DT O O
was VBD B-VP O
musculo- JJ B-NP O
skeletal NN I-NP O
and CC O O
she PRP O O
was VBD B-VP O
discharged VBN O O
While IN B-VP O
at IN B-VP O
home NN B-NP O
before IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
noted VBD B-VP O
some DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
a DT B-NP O
temperature NN I-NP O
to TO O O
101 CD O O
She PRP O O
continued VBD B-VP O
to TO O O
have VB O O
a DT B-NP O
pleuritic JJ I-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
came VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
30 CD O O
of IN B-VP O
May NNP B-NP O
Past NNP I-NP O
medical JJ B-NP O
history: NN I-NP O
( ( O O
1 CD O O
) ) O O
Pulmonary JJ B-NP O
embolism NN I-NP O
( ( O O
2 CD O O
) ) O O
Cholecys- NNP B-NP O
tectomy NN I-NP O
( ( O O
3 CD O O
) ) O O
Costochondritis NNP B-NP O
( ( O O
4 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
TAH NNP I-NP O
for IN B-VP O
fibroids NNS B-NP O
( ( O O
5 CD O O
) ) O O
Asthma VBP O O
The DT B-NP O
patient's JJ I-NP O
family NN I-NP O
history NN I-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
a DT B-NP O
cousin NN I-NP O
with IN B-VP O
lupus PDT O O
The DT B-NP O
patient NN I-NP O
doesn't NN I-NP O
smoke VBD B-VP O
The DT B-NP O
patient JJ I-NP O
drinks NNS I-NP O
occasionally RB O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
an DT B-NP O
obese JJ I-NP O
women NNS I-NP O
who WP O O
appeared VBD B-VP O
tired JJ O O
and CC O O
was VBD B-VP O
having VBG O O
some DT B-NP O
discomfort NN I-NP O
breathing VBG O O
Her PRP$ O O
temperature NN B-NP O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
was VBD B-VP O
102.5 CD O O
Her NNP B-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
110/80 CD O O
Heart NNP B-NP O
rate NN I-NP O
was VBD B-VP O
120 CD O O
Respirations NNPS B-NP O
were VBD B-VP O
32 CD O O
which WDT O O
went VBD B-VP O
down IN B-VP O
to TO O O
24 CD O O
as IN B-VP O
she PRP O O
calmed VBD B-VP O
down RP O O
Her NNP B-NP O
O2 NNP I-NP O
saturation NN I-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
was VBD B-VP O
99% CD O O
An DT B-NP O
ABG NNP I-NP O
was VBD B-VP O
not RB O O
done VBN O O
Head NNP B-NP O
was VBD B-VP O
unremarkable JJ B-NP O
Neck NNP I-NP O
was VBD B-VP O
supple JJ B-NP O
Lungs NNP I-NP O
were VBD B-VP O
clear JJ O O
without IN B-VP O
a DT B-NP O
rub NN I-NP O
Cardiac NNP I-NP O
exam NN I-NP O
shows VBZ O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
without IN B-VP O
murmurs NNS B-NP O
appreciated VBD B-VP O
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
and CC O O
has VBZ O O
bowel VBN O O
sounds VBZ O O
The DT B-NP O
wound NN I-NP O
had VBD B-VP O
its PRP$ O O
dressing NN B-NP O
in IN B-VP O
place NN B-NP O
and CC O O
there EX O O
was VBD B-VP O
a DT B-NP O
small JJ I-NP O
amount NN I-NP O
of IN B-VP O
serosanguinous JJ B-NP O
drainage NN I-NP O
appreciated VBD B-VP O
It PRP O O
was VBD B-VP O
nontender JJ B-NP O
Neurologic NNP I-NP O
exam NN I-NP O
was VBD B-VP O
nonfocal JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Electrolytes NNP I-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
BUN NNP I-NP O
6 CD O O
, , O O
creatinine NN B-NP O
0.8 CD O O
, , O O
glucose RB O O
114 CD O O
, , O O
white JJ B-NP O
count NN I-NP O
12.2 CD O O
, , O O
hematocrit NN B-NP O
26 CD O O
, , O O
platelets NNS B-NP O
508 CD O O
, , O O
000 CD O O
PT NNP B-NP O
13.4 CD O O
, , O O
PTT NNP B-NP O
25.6 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
showed VBD B-VP O
bilateral JJ B-NP O
basilar JJ I-NP O
atelectasis NN I-NP O
EKG NNP I-NP O
showed VBD B-VP O
sinus JJ B-NP O
tachycardia NN I-NP O
at IN B-VP O
104 CD O O
with IN B-VP O
normal JJ B-NP O
interval NN I-NP O
and CC O O
axis NN B-NP O
There EX O O
was VBD B-VP O
T-wave JJ B-NP O
inversion NN I-NP O
in IN B-VP O
3 CD O O
and CC O O
V1 NNP B-NP O
without IN B-VP O
other JJ B-NP O
ST-T JJ I-NP O
wave NN I-NP O
changes NNS I-NP O
VQ NNP I-NP O
scan NN I-NP O
obtained VBD B-VP O
prior RB O O
to TO O O
admission NN B-NP O
was VBD B-VP O
read VBN O O
as IN B-VP O
low JJ B-NP O
probability NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
and CC O O
started VBN O O
on IN B-VP O
heparin NN B-NP B-m
The DT B-NP O
PTT NNP I-NP O
was VBD B-VP O
quickly RB O O
thera- JJ O O
peutic JJ O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
informal JJ B-NP O
noninvasive JJ I-NP O
studies NNS I-NP O
, , O O
mainly RB O O
ultrasound IN B-VP O
of IN B-VP O
the DT B-NP O
thighs NNS I-NP O
which WDT O O
failed VBD B-VP O
to TO O O
show VB O O
deep JJ B-NP O
venous JJ I-NP O
thrombosis NN I-NP O
She PRP O O
, , O O
therefore RB O O
, , O O
underwent NN B-NP O
on IN B-VP O
the DT B-NP O
second JJ I-NP O
hospital NN I-NP O
day NN I-NP O
pulmonary JJ B-NP O
angiography NN I-NP O
which WDT O O
showed VBD B-VP O
two CD O O
small JJ B-NP O
pulmonary JJ I-NP O
embolisms NNS I-NP O
on IN B-VP O
the DT B-NP O
left JJ I-NP O
side NN I-NP O
In IN B-VP O
the DT B-NP O
meantime NN I-NP O
, , O O
her PRP$ O O
VQ NNP B-NP O
scan NN I-NP O
had VBD B-VP O
been VBN O O
reinter- RB O O
preted VBN O O
as IN B-VP O
showing VBG O O
intermediate JJ B-NP O
probability NN I-NP O
with IN B-VP O
notch JJ B-NP O
defect NN I-NP O
on IN B-VP O
left NN B-NP O
and CC O O
right VBD B-VP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
started VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
In IN B-VP O
the DT B-NP O
meantime NN I-NP O
, , O O
after IN B-VP O
her PRP$ O O
procedure NN B-NP O
she PRP O O
developed VBD B-VP O
a DT B-NP O
procedure NN I-NP O
She PRP O O
had VBD B-VP O
some DT B-NP O
dysuria NNS I-NP O
Her PRP$ O O
urine JJ O O
had VBD B-VP O
white JJ B-NP O
cells NNS I-NP O
and CC O O
bacteria NNS B-NP O
and CC O O
eventually RB O O
grew VBD B-VP O
out RP O O
Enterobacter NNP B-NP O
aerogenes NNS I-NP O
In IN B-VP O
the DT B-NP O
meantime NN I-NP O
she PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
ceftizoxime NN B-NP B-m
and CC O O
defervesced VBD B-VP O
and CC O O
was VBD B-VP O
converted VBN O O
to TO O O
p.o VB O B-mo
Bactrim NNP B-NP B-m
and CC O O
remained VBD B-VP O
afebrile IN B-VP O
The DT B-NP O
Enterobacter NNP I-NP O
was VBD B-VP O
sensi- JJ O O
tive JJ O O
to TO O O
this DT O O
antibiotic JJ O B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
1 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
h.s NN I-NP I-f
of IN B-VP O
Coumadin NNP B-NP B-m
with IN B-VP O
a DT B-NP O
PT NNP I-NP O
the DT O O
preceding VBG O O
day NN B-NP O
of IN B-VP O
19 CD O O
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
patient's JJ I-NP O
condition NN I-NP O
is VBZ O O
good JJ B-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
transferred VBN O O
to TO O O
the DT B-NP O
Critmi NNP I-NP O
Ganstown NNP I-NP O
Community NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
under IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
Dr NNP B-NP O
Jamie NNP I-NP O
Perman NNP I-NP O
who WP O O
is VBZ O O
the DT B-NP O
patient's NN I-NP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
A NNP I-NP O
PT NNP I-NP O
will MD O O
need VB O O
to TO O O
be VB O O
checked VBN O O
on IN B-VP O
arrival NN B-NP O
Most NNP I-NP O
likely RB O O
the DT B-NP O
patient's NN I-NP O
PT NNP I-NP O
will MD O O
be VB O O
in IN B-VP O
the DT B-NP O
range NN I-NP O
of IN B-VP O
18 CD O O
to TO O O
20 CD O O
and CC O O
she PRP O O
will MD O O
need VB O O
approximately RB O O
1 CD O B-do
mg JJ B-NP I-do
p.o NN I-NP B-mo
of IN B-VP O
Coumadin NNP B-NP B-m
Discharge NNP I-NP O
medications: VBD B-VP O
Bactrim NNP B-NP B-m
one CD O B-do
double JJ B-NP I-do
strength NN I-NP I-do
tablet NN I-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
iron NN I-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d.; NN I-NP B-f
Motrin NNP I-NP B-m
800 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d.; VBD B-VP B-f
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d.; NN I-NP B-f
Coumadin NNP I-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
h.s NN I-NP I-f
Dictated NNP I-NP O
By: NNP I-NP O
WILLIAMS NNP I-NP O
A NNP I-NP O
LOERZEL NNP I-NP O
, , O O
M.D NNP B-NP O
AC60 NNP I-NP O
YL709/0015 NNP I-NP O
LONG NNP I-NP O
J NNP I-NP O
VLASAK NNP I-NP O
, , O O
M.D NNP B-NP O
WC5 NNP I-NP O
D: NNP I-NP O
3/22/91 CD O O
T: NNP B-NP O
6/25/91 CD O O
Batch: NNP B-NP O
O270 NNP I-NP O
Report: NNP I-NP O
NS047H22 NNP I-NP O
T: NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#276413 VBZ O O
759240036 CD O O
TMC NNP B-NP O
42253959 CD O O
2554216 CD O O
1/18/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/18/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
ATTENDING: NNP I-NP O
LINAHAN NNP I-NP O
, , O O
OMER NNP B-NP O
M.D NNP I-NP O
PRINCIPLE NNP I-NP O
ADMISSION NNP I-NP O
DIAGNOSIS: NNP I-NP O
Bacteremia NNP I-NP O
, , O O
peri-sepsis NN B-NP O
and CC O O
apnea NN B-NP O
PRINCIPLE NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Bacteremia NNP I-NP O
, , O O
peri-sepsis NN B-NP O
and CC O O
apnea NN B-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
failure NN B-NP O
to TO O O
tolerate VB O O
p.o JJ B-NP O
diets NNS I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
He PRP O O
is VBZ O O
an DT B-NP O
81-year-old JJ I-NP O
man NN I-NP O
primarily RB O O
Russian-speaking NNP B-NP O
, , O O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
multiple JJ B-NP O
medical JJ I-NP O
problems NNS I-NP O
including VBG O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
an DT B-NP O
MI NNP I-NP O
in IN B-VP O
2004 CD O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
cath NN I-NP O
at IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
with IN B-VP O
percutaneous JJ B-NP O
intervention NN I-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
45-50% JJ O O
, , O O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
on IN B-VP O
anticoagulation NN B-NP B-m
and CC O O
a DT B-NP O
partial JJ I-NP O
pacemaker NN I-NP O
for IN B-VP O
sick JJ B-NP O
sinus NN I-NP O
syndrome NN I-NP O
, , O O
multiple JJ B-NP O
strokes NNS I-NP O
x4 VBP O O
, , O O
diabetes VBZ O O
mellitus VBP O O
type JJ O O
2 CD O O
and CC O O
COPD NNP B-NP O
, , O O
who WP O O
was VBD B-VP O
recently RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Ghampemaw NNP I-NP O
A NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
bacteremia NN B-NP O
with IN B-VP O
Streptococcus NNP B-NP O
oralis NNS I-NP O
without IN B-VP O
a DT B-NP O
clear JJ I-NP O
source NN I-NP O
His PRP$ O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
had VBD B-VP O
increased VBN O O
to TO O O
20 CD O O
His PRP$ O O
INR NNP B-NP O
had VBD B-VP O
been VBN O O
supratherapeutic JJ O O
on IN B-VP O
admission NN B-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
to TO O O
14 CD O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
had VBN O O
a DT B-NP O
transesophageal NN I-NP O
echocardiogram NN I-NP O
which WDT O O
did VBD B-VP O
not RB O O
show VB O O
any DT B-NP O
vegetations NNS I-NP O
and CC O O
he PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
rehab VB O O
on IN B-VP O
3/14/06 CD O O
with IN B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
IV NNP B-NP B-mo
penicillin NN I-NP B-m
through IN B-VP O
a DT B-NP O
PICC NNP I-NP O
line NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
oral JJ B-NP B-mo
Flagyl NNP I-NP B-m
empirically RB O O
for IN B-VP O
an DT B-NP B-r
elevated JJ I-NP I-r
white JJ I-NP I-r
count NN I-NP I-r
At IN B-VP O
the DT B-NP O
rehab NN I-NP O
facility NN I-NP O
where WRB O O
he PRP O O
was VBD B-VP O
placed VBN O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
pulled VBN O O
his PRP$ O O
PICC NNP B-NP O
line NN I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
complaining VBG O O
of IN B-VP O
being VBG O O
short JJ O O
of IN B-VP O
breath NN B-NP O
and CC O O
having VBG O O
some DT B-NP O
mental JJ I-NP O
status NN I-NP O
changes NNS I-NP O
He PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
some DT B-NP O
sublingual JJ I-NP B-mo
nitroglycerin NN I-NP B-m
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
facility NN I-NP O
and CC O O
brought VBD B-VP O
to TO O O
the DT B-NP O
Ellwis NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Emergency NNP I-NP O
Room NNP I-NP O
, , O O
where WRB O O
a DT B-NP O
chest NN I-NP O
x-ray NN I-NP O
showed VBD B-VP O
some DT B-NP O
lack NN I-NP O
of IN B-VP O
the DT B-NP O
PICC NNP I-NP O
line NN I-NP O
and CC O O
the DT O O
short JJ O O
of IN B-VP O
breath JJ O O
quickly RB O O
improved VBN O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
He PRP O O
was VBD B-VP O
, , O O
however RB O O
, , O O
lethargic JJ O O
and CC O O
then RB O O
at IN B-VP O
times NNS B-NP O
, , O O
apneic NN B-NP O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
A NNP I-NP O
gas NN I-NP O
was VBD B-VP O
performed VBN O O
which WDT O O
showed VBD B-VP O
respiratory JJ B-NP O
alkalosis NN I-NP O
with IN B-VP O
a DT B-NP O
pH NN I-NP O
of IN B-VP O
7.5 CD O O
, , O O
a DT B-NP O
pCO2 NN I-NP O
of IN B-VP O
34 CD O O
and CC O O
a DT B-NP O
pAO2 NN I-NP O
of IN B-VP O
135 CD O O
The DT B-NP O
patient NN I-NP O
then RB O O
became VBD B-VP O
slightly RB O B-r
hypotensive JJ O I-r
with IN B-VP O
systolic JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
to TO O O
the DT O O
90s CD O O
, , O O
was VBD B-VP O
given VBN O O
IV NNP B-NP B-mo
fluid NN I-NP B-m
boluses NNS I-NP B-do
as RB O O
well RB O O
as IN B-VP O
treated VBN O O
empirically RB O O
with IN B-VP O
vancomycin NN B-NP B-m
and CC O O
ceftazidime NN B-NP B-m
, , O O
to TO O O
which WDT O O
his PRP$ O O
blood NN B-NP O
pressure NN I-NP O
responded VBN O O
by IN B-VP O
going VBG O O
up RP O O
to TO O O
around IN B-VP O
100-110/60 JJ B-NP O
Given NNP I-NP O
his PRP$ O O
apnea NN B-NP O
, , O O
a DT B-NP O
CPAP NNP I-NP O
was VBD B-VP O
initiated VBN O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
and CC O O
his PRP$ O O
oxygenation NN B-NP O
issues NNS I-NP O
quickly RB O O
resolved VBD B-VP O
A DT B-NP O
head NN I-NP O
CT NNP I-NP O
was VBD B-VP O
performed VBN O O
, , O O
which WDT O O
was VBD B-VP O
negative JJ B-NP O
A NNP I-NP O
right NN I-NP O
internal JJ B-NP O
jugular JJ I-NP O
line NN I-NP O
was VBD B-VP O
placed VBN O O
and CC O O
gentle JJ B-NP O
rehydration NN I-NP O
therapy NN I-NP O
according VBG O O
to TO O O
early JJ B-NP O
goal-directed JJ I-NP O
therapy NN I-NP O
for IN B-VP O
peri-sepsis NN B-NP O
was VBD B-VP O
initiated VBN O O
, , O O
given VBN O O
the DT B-NP O
presumption NN I-NP O
of IN B-VP O
repeat NN B-NP O
bacteremia NN I-NP O
and CC O O
early JJ B-NP O
sepsis NN I-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
medicine VB O O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
MI NNP I-NP O
in IN B-VP O
2004 CD O O
and CC O O
a DT B-NP O
cath NN I-NP O
in IN B-VP O
2005 CD O O
He PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT B-NP O
hip NN I-NP O
fracture NN I-NP O
in IN B-VP O
2005 CD O O
He PRP O O
has VBZ O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
diabetes VBZ O O
, , O O
COPD NNP B-NP O
but CC O O
not RB O O
reported VBD B-VP O
to TO O O
be VB O O
on IN B-VP O
any DT B-NP O
home NN I-NP O
oxygenation NN I-NP O
, , O O
dementia NN B-NP O
, , O O
Paget NNP B-NP O
disease NN I-NP O
, , O O
atrial JJ B-NP O
fibrillation NN I-NP O
, , O O
BPH NNP B-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
EF NNP B-NP O
of IN B-VP O
45-50% JJ O O
, , O O
hypertension NN B-NP O
, , O O
diabetes NNS B-NP O
and CC O O
hypercholesterolemia NN B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
included VBD B-VP O
the DT B-NP O
following: NN I-NP O
Glucotrol NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
and CC O O
lisinopril $ O B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
metformin RB O B-m
500 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
t.i.d NN I-NP B-f
, , O O
Flagyl NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
x10 NNP I-NP B-du
days NNS I-NP I-du
which WDT O O
was VBD B-VP O
started VBN O O
on IN B-VP O
2/5/06 CD O O
, , O O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
p.r.n NN I-NP B-f
, , O O
nystatin JJ B-NP B-m
suspension NN I-NP I-m
q.i.d NN I-NP B-f
, , O O
Zyprexa NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
h.s NN I-NP I-f
, , O O
Penicillin NNP B-NP B-m
G NNP I-NP I-m
3 CD O B-do
million CD O I-do
units NNS B-NP I-do
IV NNP I-NP B-mo
q VBD B-VP B-f
4h CD O I-f
x7 NNP B-NP B-du
days NNS I-NP I-du
, , O O
Milk NNP B-NP B-m
of IN B-VP I-m
Magnesia NNP B-NP I-m
, , O O
Tylenol NNP B-NP B-m
p.r.n NN I-NP B-f
, , O O
Dulcolax NNP B-NP B-m
p.r.n NN I-NP B-f
, , O O
Colace NNP B-NP B-m
p.r.n NN I-NP B-f
, , O O
atenolol RB O B-m
50 CD O B-do
mg NNS B-NP I-do
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Lipitor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
day NN I-NP O
, , O O
Senna NNP B-NP B-m
liquid VBZ O I-m
q NN B-NP B-f
h.s NN I-NP I-f
, , O O
Flomax NNP B-NP B-m
0.4 CD O B-do
q NN B-NP B-f
day NN I-NP I-f
ALLERGIES: NNP I-NP O
He PRP O O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
He PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
heavy JJ B-NP O
tobacco NN I-NP O
use NN I-NP O
He PRP O O
quit VBD B-VP O
40 CD O O
years NNS B-NP O
ago RB O O
He PRP O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
with IN B-VP O
a DT B-NP O
24-hour JJ I-NP O
attendant NN I-NP O
and CC O O
he PRP O O
rarely RB O O
uses VBZ O O
alcohol NN B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Noncontributory NNP I-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAM NNP I-NP O
notable JJ O O
for IN B-VP O
the DT B-NP O
following: NN I-NP O
His PRP$ O O
temperature NN B-NP O
was VBD B-VP O
95.9 CD O O
, , O O
his PRP$ O O
heart NN B-NP O
rate NN I-NP O
was VBD B-VP O
60 CD O O
, , O O
his PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
110/62 CD O O
He PRP O O
is VBZ O O
satting VBG O O
98% CD O O
on IN B-VP O
a DT B-NP O
CPAP NNP I-NP O
machine NN I-NP O
In IN B-VP O
general JJ O O
, , O O
he PRP O O
was VBD B-VP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
in IN B-VP O
restraints NNS B-NP O
His PRP$ O O
head NN B-NP O
and CC O O
neck NN B-NP O
exam NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
supple JJ I-NP O
neck NN I-NP O
Pupils NNS I-NP O
are VBP O O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive VB O O
His PRP$ O O
heart NN B-NP O
demonstrated VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm VB O O
His PRP$ O O
JVP NNP B-NP O
was VBD B-VP O
flat JJ O O
He PRP O O
did VBD B-VP O
not RB O O
demonstrate VB O O
any DT B-NP O
murmurs NNS I-NP O
, , O O
rubs NNS B-NP O
, , O O
or CC O O
gallops VB O O
His PRP$ O O
pulmonary JJ B-NP O
exam NN I-NP O
was VBD B-VP O
clear JJ O O
anteriorly RB O O
His PRP$ O O
abdominal JJ B-NP O
exam NN I-NP O
was VBD B-VP O
noted VBN O O
for IN B-VP O
being VBG O O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
and CC O O
mild JJ B-NP O
tympani NN I-NP O
He PRP O O
had VBD B-VP O
good JJ B-NP O
peripheral JJ I-NP O
pulses NNS I-NP O
with IN B-VP O
trace NN B-NP O
lower JJR B-NP O
extremity NN I-NP O
edema VB O O
His PRP$ O O
neuro JJ B-NP O
exam NN I-NP O
was VBD B-VP O
nonfocal JJ B-NP O
OPERATIONS: NNP I-NP O
During IN B-VP O
his PRP$ O O
hospital NN B-NP O
stay NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
included VBD B-VP O
a DT B-NP O
PEG NNP I-NP O
tube NN I-NP O
placement NN I-NP O
which WDT O O
happened VBD B-VP O
on IN B-VP O
4/2/06 CD O O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEM: NNP I-NP O
1 CD O O
ID: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
recent JJ B-NP O
strep NN I-NP O
oralis NN I-NP O
bacteremia NN I-NP O
and CC O O
leukocytosis NN B-NP O
He PRP O O
was VBD B-VP O
afebrile RB O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission; NN B-NP O
however RB O O
, , O O
given VBN O O
concern NN B-NP O
for IN B-VP O
possible JJ B-NP B-r
possible JJ I-NP B-r
possible JJ I-NP B-r
possible JJ I-NP B-r
early JJ I-NP I-r
early JJ I-NP I-r
early JJ I-NP I-r
early JJ I-NP I-r
sepsis NN I-NP I-r
sepsis NN I-NP I-r
sepsis NN I-NP I-r
sepsis NN I-NP I-r
given VBN O O
his PRP$ O O
blood NN B-NP O
pressure NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
empiric JJ B-NP O
IV NNP I-NP B-mo
IV NNP I-NP B-mo
fluids NNS I-NP B-m
and CC O O
antibiotics NNS B-NP B-m
with IN B-VP O
vancomycin NN B-NP B-m
and CC O O
ceftazidime VB O B-m
His PRP$ O O
chest JJS O O
x-ray JJ O O
looked VBD B-VP O
like IN B-VP O
it PRP O O
might MD O O
have VB O O
some DT B-NP O
aspiration NN I-NP O
and CC O O
he PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
an DT B-NP B-du
empiric JJ I-NP I-du
7-day JJ I-NP I-du
course NN I-NP I-du
of IN B-VP O
Ceptaz NNP B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
for IN B-VP O
aspiration NN B-NP B-r
aspiration NN I-NP B-r
pneumonia NN I-NP O
This DT B-NP O
course NN I-NP O
was VBD B-VP O
completed VBN O O
earlier RBR O O
in IN B-VP O
his PRP$ O O
hospital NN B-NP O
stay NN I-NP O
He PRP O O
was VBD B-VP O
also RB O O
initially RB O O
treated VBN O O
with IN B-VP O
vancomycin NN B-NP B-m
A NNP I-NP O
PICC NNP I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
11/0/06 CD O O
for IN B-VP O
further JJ B-NP O
antibiotic JJ I-NP B-m
management NN I-NP O
of IN B-VP O
his PRP$ O B-r
bacteremia NN B-NP O
His PRP$ O O
vancomycin NN B-NP B-m
was VBD B-VP O
switched VBN O O
to TO O O
IV NNP B-NP B-mo
penicillin NN I-NP B-m
and CC O O
this DT O O
will MD O O
be VB O O
continued VBN O O
for IN B-VP B-du
a DT B-NP I-du
full JJ I-NP I-du
3-4 JJ I-NP I-du
week NN I-NP I-du
course NN I-NP I-du
on IN B-VP O
8/14/07 CD O O
A NNP B-NP O
TEE NNP I-NP O
was VBD B-VP O
considered VBN O O
unnecessary JJ O O
given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
he PRP O O
was VBD B-VP O
going VBG O O
to TO O O
be VB O O
treated VBN O O
anyway RB O O
with IN B-VP O
antibiotics NNS B-NP B-m
for IN B-VP B-du
4 CD O I-du
weeks NNS B-NP I-du
All DT B-NP O
blood NN I-NP O
, , O O
urine NN B-NP O
, , O O
sputum NN B-NP O
cultures NNS I-NP O
and CC O O
stool JJ B-NP O
cultures NNS I-NP O
remained VBD B-VP O
no DT B-NP O
growth NN I-NP O
to TO O O
date NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
2 CD O O
Pulmonary: NNP B-NP O
As NNP I-NP O
mentioned VBD B-VP O
above IN B-VP O
, , O O
the DT B-NP O
patient NN I-NP O
demonstrated VBD B-VP O
some DT B-NP O
apnea NN I-NP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
which WDT O O
resolved VBD B-VP O
with IN B-VP O
CPAP; NNP B-NP O
however RB O O
, , O O
given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
a DT B-NP O
significant JJ I-NP O
aspiration NN I-NP O
risk NN I-NP O
, , O O
a DT B-NP O
CPAP NNP I-NP O
was VBD B-VP O
considered VBN O O
unnecessary JJ O O
and CC O O
possibly RB O O
would MD O O
increase VB O O
the DT B-NP O
risk NN I-NP O
of IN B-VP O
aspiration NN B-NP O
Pulmonary NNP I-NP O
was VBD B-VP O
consulted VBN O O
, , O O
who WP O O
felt VBD B-VP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
demonstrating VBG O O
Cheyne-Stokes JJ B-NP O
respirations NNS I-NP O
secondary JJ O O
to TO O O
possible JJ B-NP O
CHF NNP I-NP O
or CC O O
history NN B-NP O
of IN B-VP O
CVAs NNP B-NP O
that IN B-VP O
he PRP O O
has VBZ O O
had VBN O O
in IN B-VP O
the DT O O
past JJ O O
His PRP$ O O
ABG NNP B-NP O
, , O O
as IN B-VP O
I PRP O O
mentioned VBD B-VP O
above IN B-VP O
, , O O
demonstrated VBD B-VP O
respiratory JJ B-NP O
alkalosis NN I-NP O
with IN B-VP O
a DT B-NP O
mild JJ I-NP O
metabolic JJ I-NP O
alkalosis NN I-NP O
as RB O O
well RB O O
His PRP$ O O
repeat NN B-NP O
ABG NNP I-NP O
showed VBD B-VP O
no DT B-NP O
significant JJ I-NP O
change NN I-NP O
, , O O
which WDT O O
likely RB O O
indicates VBZ O O
a DT B-NP O
chronic JJ I-NP O
process NN I-NP O
He PRP O O
did VBD B-VP O
not RB O O
demonstrate VB O O
any DT B-NP O
PEs NNP I-NP O
on IN B-VP O
studies NNS B-NP O
that WDT O O
were VBD B-VP O
performed VBN O O
here RB O O
No NNP B-NP O
pneumonia NN I-NP O
was VBD B-VP O
noted VBN O O
and CC O O
the DT B-NP O
desaturations NNS I-NP O
that WDT O O
were VBD B-VP O
detected VBN O O
while IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
sleeping VBG O O
overnight RB O O
on IN B-VP O
15 CD O O
units NNS B-NP O
O2 NNP I-NP O
sat VBD B-VP O
monitor NN B-NP O
resolved VBD B-VP O
quickly RB O O
with IN B-VP O
2 CD O B-do
liters NNS B-NP O
of IN B-VP O
oxygen NN B-NP B-m
by IN B-VP B-mo
nasal JJ B-NP I-mo
cannula NN I-NP I-mo
A DT B-NP O
plan NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
not RB O O
reinitiate VB O O
CPAP NNP B-NP O
given VBN O O
the DT B-NP O
aspiration NN I-NP O
risk NN I-NP O
He PRP O O
was VBD B-VP O
initially RB O O
diuresed VBN O O
mildly RB O O
with IN B-VP O
Lasix NNP B-NP B-m
This DT O O
was VBD B-VP O
eventually RB O O
discontinued VBN O O
The DT B-NP O
patient NN I-NP O
should MD O O
receive VB O O
nighttime JJ B-NP O
supplemental JJ I-NP O
oxygen NN I-NP B-m
, , O O
particularly RB O O
if IN B-VP O
he PRP O O
desaturates VBZ O O
to TO O O
less JJR O O
than IN B-VP O
90% CD O O
3 CD O O
Cardiovascular: NNPS B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
status NN B-NP O
post NN I-NP O
an DT B-NP O
MI NNP I-NP O
, , O O
status NN B-NP O
post NN I-NP O
PCI NNP I-NP O
in IN B-VP O
2004 CD O O
His PRP$ O O
enzymes NNS B-NP O
were VBD B-VP O
negative JJ O O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
and CC O O
a DT B-NP O
repeat NN I-NP O
EKG NNP I-NP O
was VBD B-VP O
unchanged JJ O O
from IN B-VP O
previous JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
his PRP$ O O
home NN B-NP B-do
doses NNS I-NP I-do
of IN B-VP O
aspirin NN B-NP B-m
, , O O
statin NN B-NP B-m
, , O O
beta NN B-NP B-m
blocker NN I-NP I-m
2 CD O B-do
pump NN B-NP O
The DT B-NP O
patient's NN I-NP O
ejection NN I-NP O
fraction NN I-NP O
was VBD B-VP O
45-50% JJ O O
with IN B-VP O
inferior JJ B-NP O
wall NN I-NP O
hypokinesis NN I-NP O
Hypotension NNP I-NP O
improved VBD B-VP O
on IN B-VP O
admission NN B-NP O
, , O O
restarted VBD B-VP O
his PRP$ O O
beta NN B-NP B-m
blocker NN I-NP I-m
and CC O O
his PRP$ O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
and CC O O
IV NNP B-NP B-mo
fluids NNS I-NP B-m
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
Re NNP I-NP O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
a-fib NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
for IN B-VP O
the DT B-NP O
majority NN I-NP O
of IN B-VP O
his PRP$ O O
hospital NN B-NP O
stay NN I-NP O
Coumadin NNP I-NP B-m
was VBD B-VP O
held VBN O O
peri-procedure NN B-NP O
when WRB O O
he PRP O O
was VBD B-VP O
getting VBG O O
his PRP$ O O
PEG NN B-NP O
placed VBD B-VP O
and CC O O
vitamin JJ B-NP B-m
K NNP I-NP I-m
had VBD B-VP O
been VBN O O
administered VBN O O
in IN B-VP O
view NN B-NP O
of IN B-VP O
his PRP$ O O
supratherapeutic JJ B-NP O
Coumadin NNP I-NP B-m
His PRP$ O O
Coumadin NNP B-NP B-m
should MD O O
be VB O O
restarted VBN O O
on IN B-VP O
0/30/07 CD O O
Of IN B-VP O
note NN B-NP O
as IN B-VP O
well RB O O
for IN B-VP O
rhythm NN B-NP O
issues NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
kept VBN O O
on IN B-VP O
potassium NN B-NP B-m
and CC O O
magnesium NN B-NP B-m
scales NNS I-NP O
while IN B-VP B-du
while IN B-VP B-du
in IN B-VP I-du
in IN B-VP I-du
hospital JJ B-NP I-du
hospital NN I-NP I-du
and CC O O
he PRP O O
has VBZ O O
a DT B-NP O
partial JJ I-NP O
pacemaker NN I-NP O
placed VBD B-VP O
for IN B-VP O
his PRP$ O O
sick JJ B-NP O
sinus NN I-NP O
syndrome VBD B-VP O
4 CD O O
GI: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
constipation NN B-NP O
His PRP$ O O
abdomen NNS B-NP O
was VBD B-VP O
tympanitic JJ O O
when WRB O O
he PRP O O
first RB O O
presented VBD B-VP O
He PRP O O
was VBD B-VP O
given VBN O O
a DT B-NP O
bowel NN I-NP B-m
regimen NN I-NP O
and CC O O
has VBZ O O
subsequently RB O O
begun VBN O O
making VBG O O
good JJ B-NP O
solid JJ I-NP O
stool NN I-NP O
Midway NNP I-NP O
through IN B-VP O
his PRP$ O O
hospital NN B-NP O
course NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
developed VBD B-VP O
trouble NN B-NP O
with IN B-VP O
eating NN B-NP O
He PRP O O
had VBD B-VP O
multiple JJ B-NP O
NG NNP I-NP O
tubes NN I-NP O
placed VBD B-VP O
which WDT O O
he PRP O O
was VBD B-VP O
self-discontinuing VBG O O
requiring VBG O O
urgent JJ B-NP O
reconsideration NN I-NP O
of IN B-VP O
more RBR O O
permanent JJ B-NP O
feeding NN I-NP O
tubes VBZ O O
A DT B-NP O
discussion NN I-NP O
was VBD B-VP O
held VBN O O
between IN B-VP O
our PRP$ O O
service NN B-NP O
and CC O O
the DT B-NP O
GI NNP I-NP O
team NN I-NP O
, , O O
who WP O O
felt VBD B-VP O
that IN B-VP O
a DT B-NP O
PEG NNP I-NP O
would MD O O
be VB O O
useful JJ O O
for IN B-VP O
managing VBG O O
this DT B-NP O
patient's NN I-NP O
feeding NN I-NP O
in IN B-VP O
the DT B-NP O
future NN I-NP O
On IN B-VP O
2/25/06 CD O O
, , O O
GI NNP B-NP O
endoscopically RB O O
placed VBD B-VP O
a DT B-NP O
PEG NNP I-NP O
tube NN I-NP O
for IN B-VP O
future JJ O O
feeding VBG O O
Nutrition NN B-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
tube JJ B-NP O
feeds NNS I-NP O
were VBD B-VP O
re-initiated JJ O O
that IN B-VP O
evening VBG O O
Again NNP B-NP O
, , O O
his PRP$ O O
Coumadin NNP B-NP B-m
will MD O O
be VB O O
held VBN O O
until IN B-VP B-du
9/23/07 CD O I-du
so RB O O
as IN B-VP O
to TO O O
promote VB O O
appropriate JJ B-NP O
wound NN I-NP O
healing VBG O O
around IN B-VP O
the DT B-NP O
site NN I-NP O
of IN B-VP O
the DT B-NP O
PEG NNP I-NP O
placement NN I-NP O
5 CD O O
Heme: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
anemia NN B-NP O
but CC O O
did VBD B-VP O
not RB O O
demonstrate VB O O
any DT B-NP O
acute JJ I-NP O
hematocrit NN I-NP O
drops VBZ O O
His PRP$ O O
INR NN B-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
1.9 CD O O
We PRP O O
had VBD B-VP O
transiently RB O O
restarted VBN O O
Coumadin NNP B-NP B-m
but CC O O
he PRP O O
will MD O O
have VB O O
to TO O O
restart VB O O
that DT O O
again RB O O
on IN B-VP O
9/23/07 CD O O
, , O O
given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
it PRP O O
was VBD B-VP O
held VBN O O
for IN B-VP O
his PRP$ O O
PEG NNP B-NP O
placement NN I-NP O
He PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
iron NN B-NP B-m
supplements NNS I-NP I-m
during IN B-VP B-du
his PRP$ O I-du
hospital NN B-NP I-du
stay NN I-NP I-du
6 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
, , O O
as IN B-VP O
discussed VBN O O
above IN B-VP O
, , O O
has VBZ O O
demonstrated VBN O O
a DT B-NP O
respiratory JJ I-NP O
alkalosis NN I-NP O
with IN B-VP O
a DT B-NP O
mild JJ I-NP O
metabolic JJ I-NP O
alkalosis NN I-NP O
as RB O O
well RB O O
His PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
mildly RB O O
elevated JJ O O
which WDT O O
is VBZ O O
secondary JJ O O
to TO O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
for IN B-VP O
unclear JJ B-NP O
reasons NNS I-NP O
His PRP$ O O
creatinine NN B-NP O
by IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
had VBD B-VP O
improved VBN O O
dramatically RB O O
to TO O O
0.7 CD O O
7 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient's JJ I-NP O
oral JJ I-NP O
hypoglycemics NNS I-NP O
were VBD B-VP O
held VBN O O
during IN B-VP O
this DT B-NP O
hospital NN I-NP O
stay NN I-NP O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
insulin NN B-NP B-m
sliding-scale JJ O B-do
and CC O O
Lantus NNP B-NP B-m
As IN B-VP O
his PRP$ O O
feeding NN B-NP O
has VBZ O O
increased VBN O O
and CC O O
his PRP$ O O
tube NN B-NP O
feeds NNS I-NP O
have VBP O O
reached VBN O O
goal NN B-NP O
, , O O
his PRP$ O O
Lantus NNP B-NP B-m
has VBZ O O
had VBN O O
to TO O O
be VB O O
titrated VBN O O
up IN B-VP O
He PRP O O
is VBZ O O
currently RB O O
at IN B-VP O
15 CD O B-do
units NNS B-NP I-do
q RB O B-f
p.m IN B-VP I-f
He PRP O O
may MD O O
need VB O O
more JJR B-NP O
while NN I-NP O
at IN B-VP O
the DT B-NP O
facility NN I-NP O
that IN B-VP O
he PRP O O
is VBZ O O
going VBG O O
to TO O O
8 CD O O
GU: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
vesiculous JJ B-NP O
spermatocele NNS I-NP O
or CC O O
hydrocele NN B-NP O
, , O O
which WDT O O
is VBZ O O
going VBG O O
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
urology NN B-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
We PRP O O
had VBD B-VP O
held VBN O O
his PRP$ O O
Flomax NNP B-NP B-m
initially RB O O
given VBN O O
low JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
but CC O O
we PRP O O
restarted VBD B-VP O
it PRP O O
during IN B-VP B-du
his PRP$ O I-du
hospital NN B-NP I-du
stay NN I-NP I-du
here RB O O
9 CD O O
FEN: NNP B-NP O
As NNP I-NP O
mentioned VBD B-VP O
above IN B-VP O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
aspiration NN B-NP O
precautions NNS I-NP O
secondary VBP O O
to TO O O
speech VB O O
and CC O O
swallow VB O O
evaluation NN B-NP O
that WDT O O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
aspiration NN B-NP O
NG NNP I-NP O
tubes NNS I-NP O
were VBD B-VP O
placed VBN O O
multiple JJ B-NP O
times NNS I-NP O
but CC O O
were VBD B-VP O
self-discontinued VBN O O
by IN B-VP O
the DT B-NP O
patient NN I-NP O
Finally NNP I-NP O
, , O O
a DT B-NP O
PEG NNP I-NP O
tube NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
1/5 CD O O
and CC O O
tube JJ B-NP O
feeds NNS I-NP O
were VBD B-VP O
reinitiated VBN O O
that IN B-VP O
evening VBG O O
10: CD O O
Psych: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
being VBG O O
mildly RB O B-r
mildly RB O B-r
agitated VBN O I-r
agitated JJ B-NP I-r
Zyprexa NNP I-NP B-m
Zyprexa NNP I-NP B-m
was VBD B-VP O
initiated VBN O O
here RB O O
at IN B-VP O
home NN B-NP O
doses NNS I-NP O
of IN B-VP O
2.5 CD O B-do
mg NNS B-NP I-do
q JJ B-NP B-f
day NN I-NP I-f
and CC O O
then RB O O
titrated VBD B-VP O
up RB O O
to TO O O
2.5 CD O B-do
mg NNS B-NP I-do
b.i.d VBD B-VP B-f
The DT B-NP O
patient NN I-NP O
has VBZ O O
responded VBN O O
very RB O O
nicely RB O O
to TO O O
this DT O O
and CC O O
is VBZ O O
no DT O O
longer RB O O
agitated VBN O O
11 CD O O
Prophylaxis: NNP B-NP B-r
He PRP O O
was VBD B-VP O
kept VBN O O
on IN B-VP O
TEDS NNP B-NP O
and CC O O
P-boots NNP B-NP O
Coumadin NNP I-NP B-m
as IN B-VP O
mentioned VBN O O
above IN B-VP O
will MD O O
need VB O O
to TO O O
be VB O O
restarted VBN O O
on IN B-VP O
9/23/07 CD O O
and CC O O
Nexium NNP B-NP B-m
was VBD B-VP O
to TO O O
continue VB O O
while IN B-VP B-du
he PRP O I-du
is VBZ O I-du
here RB O I-du
The DT B-NP O
patient NN I-NP O
is VBZ O O
full JJ B-NP O
code NN I-NP O
His PRP$ O O
contacts NNS B-NP O
include VBP O O
his PRP$ O O
son NN B-NP O
( ( O O
053 CD O O
) ) O O
471-4960 CD O O
and CC O O
Hillesheim NNP B-NP O
, , O O
his PRP$ O O
daughter NN B-NP O
( ( O O
226 CD O O
) ) O O
407-4962 CD O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
See NNP I-NP O
addendum JJ B-NP O
DISCHARGE NNP I-NP O
PHYSICAL NNP I-NP O
EXAM: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
98.4 CD O O
T NNP B-NP O
max NN I-NP O
, , O O
his PRP$ O O
current JJ O O
is VBZ O O
96.6 CD O O
His PRP$ O O
heart NN B-NP O
rate NN I-NP O
is VBZ O O
in IN B-VP O
the DT O O
90s CD O O
His PRP$ O O
blood NN B-NP O
pressure NN I-NP O
has VBZ O O
been VBN O O
stable JJ O O
in IN B-VP O
the DT O O
110-120s/70-80s JJ O O
His PRP$ O O
respirations NNS B-NP O
have VBP O O
been VBN O O
18-20 JJ O O
, , O O
satting VBG O O
92-96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
In IN B-VP O
general JJ O O
, , O O
he PRP O O
is VBZ O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress VB O O
His PRP$ O O
lungs NNS B-NP O
are VBP O O
with IN B-VP O
coarse JJ B-NP O
bilateral JJ I-NP O
breath NN I-NP O
sounds VBZ O O
His PRP$ O O
rate NN B-NP O
and CC O O
rhythm NN B-NP O
were VBD B-VP O
regular JJ O O
without IN B-VP O
murmurs NNS B-NP O
His PRP$ O O
abdomen NNS B-NP O
is VBZ O O
soft JJ O O
and CC O O
nontender NN B-NP O
with IN B-VP O
good JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
His PRP$ O O
extremities NNS B-NP O
are VBP O O
without IN B-VP O
edema NN B-NP O
He PRP O O
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
today NN B-NP O
, , O O
1/26/06 CD O O
, , O O
to TO O O
rehabilitation VB O O
where WRB O O
they PRP O O
will MD O O
focus VB O O
primarily RB O O
on IN B-VP O
his PRP$ O O
physical JJ B-NP O
therapy NN I-NP O
and CC O O
rehab NN B-NP O
needs NNS I-NP O
eScription NN I-NP O
document: IN B-VP O
9-2621164 CD O O
HSSten NNP B-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MADONNA NNP I-NP O
, , O O
BRANDON NNP B-NP O
Attending: NNP I-NP O
EMMANUEL NNP I-NP O
CLEMENT NNP I-NP O
CRITTLE NNP I-NP O
, , O O
M.D NNP B-NP O
IO1 NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
3934773 CD O O
D: NNP B-NP O
1/26/06 CD O O
T: NNP B-NP O
1/26/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#280639 VBZ O O
051654496 CD O O
TMCO NNP B-NP O
96217849 CD O O
292122 CD O O
3/8/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/30/1993 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/25/1993 CD O O
DIAGNOSIS: NNP B-NP O
OSTEOARTHRITIS NNP I-NP O
LEFT NNP I-NP O
HIP NNP I-NP O
STATUS NNP I-NP O
POST NNP I-NP O
OSTEOTOMY NNP I-NP O
FOR NNP I-NP O
OSTEOARTHRITIS NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
RIGHT NNP I-NP O
HIP NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
SLEEP NNP I-NP O
APNEA NNP I-NP O
OPERATIONS/PROCEDURES: NNP I-NP O
LEFT NNP I-NP O
TOTAL NNP I-NP O
HIP NNP I-NP O
REPLACEMENT NNP I-NP O
BY NNP I-NP O
DR NNP I-NP O
KOBA NNP I-NP O
ON NNP I-NP O
0 CD O O
of IN B-VP O
May NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
46 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
with IN B-VP O
left JJ B-NP O
hip NN I-NP O
pain NN I-NP O
, , O O
now RB O O
worsening VBG O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
year NN I-NP O
, , O O
unrelieved JJ O O
with IN B-VP O
conservative JJ B-NP O
therapy NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
congenital JJ B-NP O
dysplasia NN I-NP O
of IN B-VP O
the DT B-NP O
hip NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
osteotomy NN B-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
in IN B-VP O
1988 CD O O
, , O O
with IN B-VP O
good JJ B-NP O
improvement NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
was VBD B-VP O
also RB O O
remarkable JJ O O
for IN B-VP O
sleep JJ B-NP O
apnea NN I-NP O
ALLERGIES NNP I-NP O
included VBD B-VP O
intravenous JJ B-NP O
pyelogram NN I-NP O
dye NN I-NP O
and CC O O
shrimp JJ B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
were VBD B-VP O
none RB O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
an DT B-NP O
obese JJ I-NP O
white JJ I-NP O
male NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
He PRP O O
ambulated VBD B-VP O
with IN B-VP O
a DT B-NP O
truncal JJ I-NP O
lurch NN I-NP O
to TO O O
the DT O O
left VBN O O
Head NNP B-NP O
and CC O O
neck NN B-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Lungs NNS I-NP O
were VBD B-VP O
clear JJ B-NP O
Cardiac NNP I-NP O
examination NN I-NP O
was VBD B-VP O
regular JJ B-NP O
Abdomen NNP I-NP O
was VBD B-VP O
obese JJ O O
, , O O
but CC O O
benign VBZ O O
The DT B-NP O
left JJ I-NP O
hip NN I-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
being VBG O O
3/4 CD O O
inch NN B-NP O
longer JJR O O
than IN B-VP O
the DT B-NP O
right JJ I-NP O
leg NN I-NP O
Flexion NNP I-NP O
was VBD B-VP O
limited VBN O O
to TO O O
90 CD O O
degrees NNS B-NP O
, , O O
with IN B-VP O
10 CD O O
degrees NNS B-NP O
lacking VBG O O
full JJ B-NP O
extension NN I-NP O
External NNP I-NP O
rotation NN I-NP O
was VBD B-VP O
30 CD O O
degrees NNS B-NP O
, , O O
internal JJ B-NP O
rotation NN I-NP O
0 CD O O
, , O O
abduction NN B-NP O
30 CD O O
degrees NNS B-NP O
with IN B-VP O
increased JJ B-NP O
pain NN I-NP O
, , O O
and CC O O
adduction NN B-NP O
20 CD O O
degrees VBZ O O
The DT B-NP O
patient's NN I-NP O
neurovascular JJ B-NP O
examination NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
0 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
and CC O O
underwent JJ O O
left VBD B-VP O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
which WDT O O
he PRP O O
tolerated VBD B-VP O
well RB O O
Estimated VBN O O
blood NN B-NP O
loss NN I-NP O
was VBD B-VP O
400 CD O O
cc NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
for IN B-VP O
the DT B-NP O
entire JJ I-NP O
hospital NN I-NP O
stay VB O O
His PRP$ O O
immediate JJ B-NP O
postoperative JJ I-NP O
hematocrit NN I-NP O
was VBD B-VP O
36.3 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
febrile JJ O O
for IN B-VP O
the DT B-NP O
first JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
, , O O
but CC O O
rapidly RB O O
defervesced VBD B-VP O
on IN B-VP O
perioperative JJ B-NP B-m
antibiotics NNS I-NP O
with IN B-VP O
Ancef NNP B-NP B-m
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
hematocrit NN B-NP B-r
had VBD B-VP O
dropped VBN O O
to TO O O
29 CD O O
and CC O O
the DT B-NP O
patient NN I-NP O
received VBD B-VP O
2 CD O B-do
units NNS B-NP I-do
of IN B-VP O
autologous JJ B-NP B-m
blood NN I-NP I-m
, , O O
which WDT O O
increased VBD B-VP O
his PRP$ O O
hematocrit NN B-NP O
to TO O O
36 CD O O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
stable JJ O O
over IN B-VP O
30 CD O O
for IN B-VP O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
his PRP$ O O
hospital NN B-NP O
course NN I-NP O
The DT B-NP O
incision NN I-NP O
was VBD B-VP O
examined VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
, , O O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
clean JJ O O
and CC O O
dry JJ O O
The DT B-NP O
patient NN I-NP O
started VBD B-VP O
physical JJ B-NP O
therapy NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
, , O O
and CC O O
made VBD B-VP O
rapid JJ O O
progress IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
anticoagulated VBN O O
with IN B-VP O
Coumadin NNP B-NP B-m
for IN B-VP O
a DT B-NP O
prothrombin JJ I-NP B-r
time NN I-NP I-r
in IN B-VP O
the DT B-NP O
range NN I-NP O
of IN B-VP O
14 CD O O
to TO O O
16 CD O O
, , O O
and CC O O
stabilized VBN O O
at IN B-VP O
a DT B-NP O
dose NN I-NP O
of IN B-VP O
8 CD O B-do
milligrams NNS B-NP I-do
per IN B-VP B-f
night NN B-NP I-f
At IN B-VP O
the DT B-NP O
last JJ I-NP O
dose NN I-NP O
, , O O
his PRP$ O O
prothrombin JJ B-NP O
time NN I-NP O
had VBD B-VP O
gone VBN O O
up RB O O
over IN B-VP O
16 CD O O
and CC O O
he PRP O O
was VBD B-VP O
changed VBN O O
to TO O O
Coumadin NNP B-NP B-m
5 CD O B-do
milligrams NNS B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
at IN B-VP B-f
hour NN B-NP I-f
of IN B-VP I-f
sleep NN B-NP I-f
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
cleared VBN O O
by IN B-VP O
the DT B-NP O
Physical NNP I-NP O
Therapy NNP I-NP O
Service NNP I-NP O
and CC O O
cleared VBN O O
medically RB O O
for IN B-VP O
discharge NN B-NP O
home NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#6 NNP I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
discharged VBN O O
to TO O O
home VB O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
FOLLOW-UP JJ O O
with IN B-VP O
Dr NNP B-NP O
Mcfadden NNP I-NP O
in IN B-VP O
5 CD O O
weeks NNS B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
included VBD B-VP O
Coumadin NNP B-NP B-m
for IN B-VP B-du
a DT B-NP O
full JJ I-NP O
6-week JJ I-NP O
course NN I-NP O
, , O O
Percocet NNP B-NP B-m
as IN B-VP B-f
needed VBN O I-f
The DT B-NP O
patient NN I-NP O
will MD O O
FOLLOW-UP NNP B-NP O
with IN B-VP O
the DT B-NP O
Coumadin NNP I-NP O
Program NNP I-NP O
through IN B-VP O
this DT B-NP O
hospital NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
problems NNS I-NP O
with IN B-VP O
his PRP$ O O
breathing NN B-NP O
and CC O O
will MD O O
require VB O O
no DT B-NP O
special JJ I-NP O
therapy NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
was VBD B-VP O
good JJ B-NP O
Dictated NNP I-NP O
By: NNP I-NP O
LOUIS NNP I-NP O
VORSE NNP I-NP O
, , O O
M.D NNP B-NP O
NF33 NNP I-NP O
Attending: NNP I-NP O
JEWELL NNP I-NP O
HUFFSTUTTER NNP I-NP O
, , O O
M.D NNP B-NP O
YQ1 NNP I-NP O
YM787/1854 NNP I-NP O
Batch: NNP I-NP O
0196 CD O O
Index NNP B-NP O
No NNP I-NP O
SRKZDD3V2W NNP I-NP O
D: NNP I-NP O
3/15/93 CD O O
T: NNP B-NP O
3/5/93 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#288166 VBZ O O
125371610 CD O O
GXMH NNP B-NP O
30499072 CD O O
300621 CD O O
2/16/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
PNEUMONIA NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/22/2000 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/16/2000 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
LEGIONELLA NNP I-NP O
PNEUMONIA NNP I-NP O
, , O O
BILATERAL NNP B-NP O
PLEURAL NNP I-NP O
EFFUSIONS NNP I-NP O
HISTORY NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
57-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
distant JJ I-NP O
history NN I-NP O
of IN B-VP O
ovarian JJ B-NP O
cancer NN I-NP O
, , O O
rheumatoid VB O O
arthritis NN B-NP O
with IN B-VP O
systemic JJ B-NP O
lupus NN I-NP O
erythematosus NN I-NP O
features NNS I-NP O
, , O O
and CC O O
history NN B-NP O
of IN B-VP O
TTP NNP B-NP O
, , O O
status NN B-NP O
post NN I-NP O
splenectomy NN I-NP O
, , O O
who WP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
fever NN B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
pleuritic JJ B-NP O
chest NN I-NP O
pain NN I-NP O
She PRP O O
was VBD B-VP O
in IN B-VP O
her PRP$ O O
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
March NNP B-NP O
of IN B-VP O
this DT B-NP O
year NN I-NP O
, , O O
when WRB O O
she PRP O O
began VBD B-VP O
to TO O O
experience VB O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
one CD O O
week NN B-NP O
after IN B-VP O
her PRP$ O O
husband NN B-NP O
died VBD B-VP O
Initially NNP B-NP O
she PRP O O
thought VBD B-VP O
it PRP O O
was VBD B-VP O
anxiety NN B-NP O
secondary JJ O O
to TO O O
her PRP$ O O
husband's JJ B-NP O
death NN I-NP O
, , O O
but CC O O
this DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
began VBD B-VP O
to TO O O
increase VB O O
and CC O O
occurred VBD B-VP O
on IN B-VP O
rest NN B-NP O
She PRP O O
also RB O O
reports VBZ O O
that IN B-VP O
she PRP O O
has VBZ O O
had VBD B-VP O
a DT B-NP O
recent JJ I-NP O
history NN I-NP O
of IN B-VP O
orthopnea NN B-NP O
and CC O O
says VBZ O O
that IN B-VP O
for IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
months NNS I-NP O
she PRP O O
has VBZ O O
had VBN O O
bilateral VBN O O
lower RBR O O
extremity NN B-NP O
edema NN I-NP O
with IN B-VP O
gradual JJ B-NP O
onset NN I-NP O
She PRP O O
also RB O O
has VBZ O O
had VBD B-VP O
a DT O O
dry JJ O O
, , O O
non JJ B-NP O
productive JJ I-NP O
cough NN I-NP O
for IN B-VP O
the DT B-NP O
past JJ I-NP O
month NN I-NP O
and CC O O
three CD O O
days NNS B-NP O
ago RB O O
began VBD B-VP O
to TO O O
have VB O O
fevers NNS B-NP O
up RB O O
to TO O O
102 CD O O
, , O O
chills NNS B-NP O
, , O O
nausea NN B-NP O
, , O O
dry JJ B-NP O
heaves NNS I-NP O
, , O O
headache NN B-NP O
and CC O O
diarrhea VB O O
The DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
has VBZ O O
increased VBN O O
in IN B-VP O
intensity NN B-NP O
and CC O O
yesterday NN B-NP O
she PRP O O
began VBD B-VP O
to TO O O
experience VB O O
sharp JJ B-NP O
pleuritic JJ I-NP O
right NN I-NP O
chest NN I-NP O
pain NN I-NP O
She PRP O O
denied VBD B-VP O
productive JJ B-NP O
cough NN I-NP O
, , O O
neck NN B-NP O
stiffness NN I-NP O
, , O O
photophobia NN B-NP O
, , O O
sick JJ B-NP O
contacts NNS I-NP O
, , O O
chest JJS B-NP O
pain NN I-NP O
, , O O
palpitations NNS B-NP O
, , O O
or CC O O
recent JJ B-NP O
travel NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
on IN B-VP O
Plaquenil NNP B-NP B-m
previously RB O O
but CC O O
she PRP O O
self VBD B-VP O
discontinued VBN O O
this DT O O
three CD O O
months NNS B-NP O
ago RB O O
because IN B-VP O
she PRP O O
has VBZ O O
been VBN O O
feeling VBG O O
well RB O O
She PRP O O
has VBZ O O
had VBD B-VP O
no DT B-NP O
recurrence NN I-NP O
of IN B-VP O
her PRP$ O O
rheumatoid JJ B-NP O
arthritis NN I-NP O
symptoms NNS I-NP O
, , O O
which WDT O O
for IN B-VP O
her PRP$ O O
include NN B-NP O
arthritis NN I-NP O
in IN B-VP O
her PRP$ O O
hands NNS B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Past NNP I-NP O
medical JJ B-NP O
history NN I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
diabetes NNS B-NP O
type JJ O O
2 CD O O
, , O O
hypertension NN B-NP O
, , O O
TTP NNP B-NP O
, , O O
history NN B-NP O
of IN B-VP O
splenectomy NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
Haemophilus NNP B-NP O
influenzae NN I-NP O
and CC O O
pneumococcal JJ B-NP O
sepsis NN I-NP O
, , O O
rheumatoid JJ B-NP O
arthritis NN I-NP O
with IN B-VP O
systemic JJ B-NP O
lupus NN I-NP O
erythematosus NN I-NP O
features NNS I-NP O
, , O O
history NN B-NP O
of IN B-VP O
osteomyelitis NN B-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
ankle NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
ovarian JJ B-NP O
cancer NN I-NP O
in IN B-VP O
1989 CD O O
, , O O
status NN B-NP O
post NN I-NP O
chemotherapy NN I-NP O
, , O O
total JJ B-NP O
abdominal JJ I-NP O
hysterectomy NN I-NP O
and CC O O
bilateral JJ B-NP O
salpingo-oophorectomy JJ I-NP O
ALLERGIES: NNP I-NP O
She PRP O O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
MEDICATIONS: NNP I-NP O
Her NNP I-NP O
medications NNS I-NP O
include VBP O O
diltiazem JJ O B-m
240 CD O B-do
mg NN B-NP I-do
a DT B-NP B-f
day NN I-NP I-f
, , O O
lisinopril VBZ O B-m
40 CD O B-do
mg NN B-NP I-do
a DT B-NP B-f
day NN I-NP I-f
, , O O
Naprosyn NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
NPH NNP B-NP B-m
insulin VBZ O O
24 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
q.a.m RB O B-f
, , O O
Entex-LA NNP B-NP B-m
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
lives VBZ O O
with IN B-VP O
her PRP$ O O
son NN B-NP O
Her PRP$ O O
husband NN B-NP O
recently RB O O
died VBD B-VP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
this DT B-NP O
year NN I-NP O
with IN B-VP O
esophageal NN B-NP O
cancer NN I-NP O
She PRP O O
has VBZ O O
no DT B-NP O
alcohol NN I-NP O
or CC O O
tobacco NN B-NP O
use NN I-NP O
She PRP O O
is VBZ O O
an DT B-NP O
elementary JJ I-NP O
school NN I-NP O
teacher RB O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Family NNP I-NP O
history NN I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
as RB O O
well RB O O
as IN B-VP O
breast NN B-NP O
carcinoma NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile JJ O O
with IN B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
98 CD O O
, , O O
pulse NN B-NP O
in IN B-VP O
the DT O O
100s CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
182/99 CD O O
The DT B-NP O
patient's NN I-NP O
oxygen NN I-NP O
saturation NN I-NP O
was VBD B-VP O
92% CD O O
on IN B-VP O
5 CD O O
liters NNS B-NP O
She PRP O O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBN O O
, , O O
in IN B-VP O
mild JJ B-NP O
respiratory NN I-NP O
distress NN I-NP O
The DT B-NP O
skin NN I-NP O
was VBD B-VP O
without IN B-VP O
rash NN B-NP O
HEENT: NNP I-NP O
Not RB O O
significant JJ B-NP O
NECK: NNP I-NP O
The DT B-NP O
neck NN I-NP O
was VBD B-VP O
supple JJ O O
with IN B-VP O
no DT B-NP O
lymphadenopathy NN I-NP O
or CC O O
thyromegaly NN B-NP O
CARDIOVASCULAR: NNP I-NP O
Tachycardic NNP I-NP O
, , O O
regular JJ B-NP O
rhythm NN I-NP O
, , O O
without IN B-VP O
murmurs NNS B-NP O
, , O O
gallops NNS B-NP O
or CC O O
rubs VB O O
She PRP O O
had VBD B-VP O
no DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
LUNGS: NNP I-NP O
The DT B-NP O
lungs NNS I-NP O
revealed VBD B-VP O
markedly RB O O
decreased VBN O O
breath NN B-NP O
sounds NNS I-NP O
at IN B-VP O
the DT B-NP O
bases NNS I-NP O
and CC O O
faint NN B-NP O
crackles NNS I-NP O
at IN B-VP O
the DT B-NP O
bases NNS I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
ABDOMEN: NNP I-NP O
Abdominal NNP I-NP O
examination NN I-NP O
was VBD B-VP O
completely RB O O
benign JJ B-NP O
No NNP I-NP O
hepatomegaly NN I-NP O
or CC O O
masses VBZ O O
She PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
scar NN I-NP O
from IN B-VP O
the DT B-NP O
splenectomy NN I-NP O
EXTREMITIES: NNP I-NP O
The DT B-NP O
extremities NNS I-NP O
showed VBD B-VP O
1+ CD O O
edema NN B-NP O
bilaterally RB O O
There EX O O
were VBD B-VP O
no DT B-NP O
cords NNS I-NP O
Negative NNP I-NP O
Homans' NNP I-NP O
sign NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
clubbing NN I-NP O
or CC O O
cyanosis NN B-NP O
NEUROLOGICAL: NNP I-NP O
The DT B-NP O
neurological JJ I-NP O
examination NN I-NP O
was VBD B-VP O
intact JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Significant NNP I-NP O
laboratory NN I-NP O
studies NNS I-NP O
included VBD B-VP O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
137 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
19.5 CD O O
with IN B-VP O
2 CD O O
bands NNS B-NP O
and CC O O
86 CD O O
polys NN B-NP O
as RB O O
well RB O O
as IN B-VP O
Howell-Jolly NNP B-NP O
bodies NNS I-NP O
Hematocrit NNP I-NP O
was VBD B-VP O
38.6 CD O O
, , O O
platelets NNS B-NP O
495 CD O O
, , O O
000 CD O O
CK NNP B-NP O
was VBD B-VP O
50 CD O O
, , O O
troponin NN B-NP O
was VBD B-VP O
0 CD O O
D-dimer NN B-NP O
was VBD B-VP O
greater JJR O O
than IN B-VP O
1 CD O O
, , O O
000 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
revealed VBD B-VP O
large JJ B-NP O
bilateral JJ I-NP O
pleural JJ I-NP O
effusions NNS I-NP O
, , O O
left VBD B-VP O
greater JJR O O
than IN B-VP O
right JJ O O
She PRP O O
had VBD B-VP O
a DT B-NP O
CT NNP I-NP O
scan NN I-NP O
which WDT O O
was VBD B-VP O
a DT B-NP O
limited JJ I-NP O
study NN I-NP O
that WDT O O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
a DT B-NP O
pulmonary JJ I-NP O
embolism NN I-NP O
It PRP O O
showed VBD B-VP O
a DT B-NP O
questionable JJ I-NP O
infiltrate NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
lung NN I-NP O
versus IN B-VP O
compressive JJ B-NP O
atelectasis NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
In IN B-VP O
summary JJ O O
, , O O
this DT O O
is VBZ O O
a DT B-NP O
57-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
distant JJ I-NP O
history NN I-NP O
of IN B-VP O
ovarian JJ B-NP O
cancer NN I-NP O
and CC O O
TTP NNP B-NP O
, , O O
who WP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
likely JJ B-NP O
community NN I-NP O
acquired VBD B-VP O
pneumonia NN B-NP O
and CC O O
bilateral JJ B-NP O
moderate NN I-NP O
to TO O O
large JJ B-NP O
pleural JJ I-NP O
effusions NNS I-NP O
Initially RB O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
cefuroxime NN B-NP B-m
and CC O O
levofloxacin NN B-NP B-m
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
for IN B-VP O
a DT O B-r
a DT B-NP B-r
presumed JJ I-NP O
community NN I-NP O
acquired VBD B-VP O
pneumonia NN B-NP O
She PRP O O
also RB O O
was VBD B-VP O
given VBN O O
Lasix NNP B-NP B-m
for IN B-VP O
diuresis NN B-NP O
, , O O
given VBN O O
there EX O O
was VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
whether IN B-VP O
or CC O O
not RB O O
she PRP O O
was VBD B-VP O
having VBG O O
any DT B-NP O
heart NN I-NP O
failure NN I-NP O
Given NNP I-NP O
her PRP$ O O
elevated JJ B-NP O
D-dimer NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
spiral JJ I-NP O
CT NNP I-NP O
scan NN I-NP O
of IN B-VP O
the DT O O
chest JJS O O
which WDT O O
did VBD B-VP O
not RB O O
reveal VB O O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
pulmonary JJ B-NP O
embolus NN I-NP O
and CC O O
also RB O O
had VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
Dopplers NNS I-NP O
which WDT O O
were VBD B-VP O
negative JJ O O
However RB O O
, , O O
there EX O O
was VBD B-VP O
a DT B-NP O
continuous JJ I-NP O
Doppler NNP I-NP O
wave VBP O O
form NN B-NP O
on IN B-VP O
the DT B-NP O
study NN I-NP O
which WDT O O
raised VBD B-VP O
the DT B-NP O
suspicion NN I-NP O
of IN B-VP O
a DT O O
more RBR O O
proximal JJ B-NP O
venous JJ I-NP O
compression NN I-NP O
Therefore NNP I-NP O
, , O O
she PRP O O
underwent VBD B-VP O
abdominal JJ B-NP O
CT NNP I-NP O
scan NN I-NP O
, , O O
which WDT O O
did VBD B-VP O
not RB O O
show VB O O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
venous JJ B-NP O
obstruction NN I-NP O
as RB O O
well RB O O
as IN B-VP O
lymphatic JJ B-NP O
obstruction NN I-NP O
1 CD O O
) ) O O
INFECTIOUS NNP B-NP O
DISEASE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
and CC O O
treated VBN O O
for IN B-VP O
what WP O O
was VBD B-VP O
thought VBN O O
to TO O O
initially RB O O
be VB O O
just RB O O
a DT O B-r
a DT B-NP B-r
community NN I-NP O
acquired VBN O O
pneumonia NN B-NP O
with IN B-VP O
large JJ B-NP O
effusions NNS I-NP O
, , O O
likely JJ B-NP O
peripneumonic NN I-NP O
in IN B-VP O
nature NN B-NP O
She PRP O O
initially RB O O
was VBD B-VP O
started VBN O O
on IN B-VP O
cefuroxime NN B-NP B-m
and CC O O
azithromycin NN B-NP B-m
by IN B-VP O
the DT B-NP O
General NNP I-NP O
Medicine NNP I-NP O
team NN I-NP O
She PRP O O
was VBD B-VP O
pancultured VBN O O
as RB O O
well RB O O
as IN B-VP O
had VBD B-VP O
Legionella NNP B-NP O
urine JJ B-NP O
antigen NN I-NP O
sent VBD B-VP O
Subsequently NNP B-NP O
her PRP$ O O
Legionella NNP B-NP B-r
urine JJ B-NP O
antigen NN I-NP O
became VBD B-VP O
positive JJ O O
and CC O O
repeat JJ B-NP O
test NN I-NP O
again RB O O
revealed VBD B-VP O
that IN B-VP O
this DT O O
was VBD B-VP O
in IN B-VP O
fact NN B-NP O
positive JJ O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
levofloxacin NN B-NP B-m
was VBD B-VP O
added VBN O O
given VBN O O
recommendations NNS B-NP O
from IN B-VP O
the DT B-NP O
Infectious NNP I-NP O
Disease NNP I-NP O
Service NNP I-NP O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
azithromycin; NN B-NP B-m
however RB O O
, , O O
cefuroxime NN B-NP B-m
was VBD B-VP O
discontinued VBN O O
as IN B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
other JJ B-NP O
etiology NN I-NP O
of IN B-VP O
her PRP$ O O
pneumonia NN B-NP O
She PRP O O
underwent JJ B-NP O
thoracentesis NN I-NP O
late RB O O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
her PRP$ O O
admission NN B-NP O
, , O O
which WDT O O
revealed VBD B-VP O
a DT B-NP O
transudate NN I-NP O
Cytology NNP I-NP O
was VBD B-VP O
sent VBN O O
on IN B-VP O
this DT O O
and CC O O
was VBD B-VP O
negative JJ O O
as RB O O
well RB O O
as IN B-VP O
all DT B-NP O
cultures NNS I-NP O
were VBD B-VP O
negative JJ O O
from IN B-VP O
this DT O O
She PRP O O
underwent JJ B-NP O
multiple JJ I-NP O
bilateral JJ I-NP O
therapeutic JJ I-NP O
pleuracentesis NN I-NP O
, , O O
given VBN O O
that IN B-VP O
the DT B-NP O
effusions NNS I-NP O
were VBD B-VP O
quite RB O O
large JJ B-NP O
Ultrasound NNP I-NP O
revealed VBD B-VP O
multiple JJ B-NP O
loculations NNS I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
and CC O O
she PRP O O
had VBD B-VP O
to TO O O
undergo VB O O
right RB O O
sided VBN O O
ultrasound NN B-NP O
guided VBD B-VP O
thoracentesis NN B-NP O
to TO O O
remove VB O O
fluid NN B-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
aggressively RB O O
diuresed VBN O O
with IN B-VP O
Lasix NNP B-NP B-m
to TO O O
help VB O O
with IN B-VP O
the DT B-NP O
effusions NNS I-NP O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
have VB O O
a DT B-NP O
high JJ I-NP O
oxygen NN I-NP O
requirement NN I-NP O
throughout IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
despite IN B-VP O
aggressive JJ B-NP O
thoracentesis NN I-NP O
However RB O O
, , O O
as IN B-VP O
she PRP O O
was VBD B-VP O
diuresed VBN O O
aggressively RB O O
, , O O
her PRP O O
oxygen VBP O B-m
requirement NN B-NP O
was VBD B-VP O
down RB O O
from IN B-VP O
initially RB O O
5 CD O B-do
to TO O I-do
6 CD O I-do
liters NNS B-NP I-do
per IN B-VP B-mo
nasal NN B-NP I-mo
cannula NN I-NP I-mo
Prior NNP I-NP O
to TO O O
discharge VB O O
, , O O
she PRP O O
was VBD B-VP O
off IN B-VP O
of IN B-VP O
O2 NNP B-NP B-m
except IN B-VP O
that IN B-VP O
she PRP O O
had VBD B-VP O
desaturations NNS B-NP O
to TO O O
86% CD O O
with IN B-VP O
ambulation NN B-NP O
Therefore NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
with IN B-VP O
p.r.n NN B-NP B-f
oxygen NN I-NP B-m
She PRP O O
remained VBD B-VP O
afebrile RB O O
throughout IN B-VP O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
and CC O O
her PRP$ O O
pulmonary JJ B-NP O
status NN I-NP O
continued VBD B-VP O
to TO O O
improve VB O O
prior RB O O
to TO O O
discharge VB O O
Other JJ B-NP O
complications NNS I-NP O
during IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
included VBD B-VP O
an DT B-NP O
elevated JJ I-NP O
platelet NN I-NP O
count NN I-NP O
up RB O O
to TO O O
800 CD O O
This DT O O
was VBD B-VP O
thought VBN O O
likely RB O O
to TO O O
be VB O O
acute JJ B-NP O
phase NN I-NP O
reactant NN I-NP O
secondary JJ O O
to TO O O
infection NN B-NP O
and CC O O
fever NN B-NP O
and CC O O
this DT O O
will MD O O
be VB O O
followed VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
In IN B-VP O
addition NN B-NP O
to TO O O
this DT O O
, , O O
she PRP O O
had VBD B-VP O
an DT O O
elevated VBN O O
CA-125 NNP B-NP O
level NN I-NP O
This DT O O
was VBD B-VP O
discussed VBN O O
with IN B-VP O
her PRP$ O O
GYN NNP B-NP O
oncologist NN I-NP O
and CC O O
he PRP O O
felt VBD B-VP O
that IN B-VP O
this DT O O
was VBD B-VP O
likely JJ O O
from IN B-VP O
the DT B-NP O
effusions NNS I-NP O
, , O O
but CC O O
again RB O O
should MD O O
be VB O O
followed VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
to TO O O
make VB O O
sure JJ O O
that IN B-VP O
this DT O O
resolves VBZ O O
as IN B-VP O
the DT B-NP O
effusions NNS I-NP O
continue VBP O O
to TO O O
resolve VB O O
Abdominal NNP B-NP O
CT NNP I-NP O
scan NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
done VBN O O
to TO O O
rule VB O O
out RB O O
more JJR B-NP O
proximal JJ I-NP O
venous JJ I-NP O
compression NN I-NP O
did VBD B-VP O
not RB O O
reveal VB O O
any DT B-NP O
recurrence NN I-NP O
of IN B-VP O
ovarian JJ B-NP O
cancer NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
on IN B-VP O
March NNP B-NP O
, , O O
2000 CD O O
, , O O
with IN B-VP O
services NNS B-NP O
as RB O O
well RB O O
as IN B-VP O
p.r.n NN B-NP B-f
oxygen IN B-VP B-m
She PRP O O
was VBD B-VP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
problems NNS I-NP O
with IN B-VP O
her PRP$ O O
diabetes NNS B-NP O
, , O O
hypertension NN B-NP O
, , O O
rheumatoid NN B-NP O
arthritis NN I-NP O
throughout IN B-VP O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
her PRP$ O O
hospitalization NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Her NNP I-NP O
discharge NN I-NP O
medications NNS I-NP O
include VBP O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
insulin NN B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
, , O O
lisinopril VBZ O B-m
40 CD O B-do
mg NN B-NP I-do
a DT B-NP B-f
day NN I-NP I-f
, , O O
levofloxacin VBZ O B-m
500 CD O B-do
mg NN B-NP I-do
times NNS I-NP B-du
14 CD O I-du
days NNS B-NP I-du
, , O O
Cardizem-CD JJ O B-m
240 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
FOLLOW-UP: NNP I-NP O
She PRP O O
is VBZ O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Michalek NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
and CC O O
she PRP O O
is VBZ O O
to TO O O
have VB O O
her PRP$ O O
platelets NNS B-NP O
checked VBN O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
CA-125 NNP I-NP O
as IN B-VP O
her PRP$ O O
Legionella NNP B-NP O
pneumonia NN I-NP O
resolves NNS I-NP O
Dictated VBD B-VP O
By: NNP B-NP O
ANDREA NNP I-NP O
MADRUENO NNP I-NP O
, , O O
M.D NNP B-NP O
EH81 NNP I-NP O
Attending: NNP I-NP O
CORDELL NNP I-NP O
D NNP I-NP O
GETER NNP I-NP O
, , O O
M.D NNP B-NP O
AA78 NNP I-NP O
NT155/4887 NNP I-NP O
Batch: NNP I-NP O
93541 CD O O
Index NNP B-NP O
No NNP I-NP O
B2QX3B4MPD NNP I-NP O
D: NNP I-NP O
9/9 CD O O
T: NNP B-NP O
0/30 CD O O
CC: NNP B-NP O
1 CD O O
HARLAND NNP B-NP O
E NNP I-NP O
GOYNE NNP I-NP O
, , O O
M.D NNP B-NP O
EO01 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#289431 VBZ O O
927243785 CD O O
RCHO NNP B-NP O
44245516 CD O O
4404996 CD O O
1/9/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
r/o NN I-NP O
MI NNP I-NP O
, , O O
SOB NNP B-NP O
multifactorial JJ B-NP O
deconditioning NN I-NP O
, , O O
pulmon JJ B-NP O
disease NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/9/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/29/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
REDRICK NNP I-NP O
, , O O
CRAIG NNP B-NP O
MATTHEW NNP I-NP O
639-51-79-1 JJ B-NP O
Arkansas NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
11/16/04 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
GIGGER NNP I-NP O
, , O O
JERALD NNP B-NP O
DARRYL NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
AMITRIPTYLINE NNP I-NP B-m
HCL NNP I-NP I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
FUROSEMIDE NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/23/04 CD O O
by IN B-VP O
ORMS NNP B-NP O
, , O O
EDDIE NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
FUROSEMIDE NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
73820170 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
Sulfa; NNP B-NP O
reaction NN I-NP O
is VBZ O O
renal JJ B-NP O
failure NN I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
tol NN I-NP O
at IN B-VP O
home NN B-NP O
GLYBURIDE NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/23/04 CD O O
by IN B-VP O
OAKES NNP B-NP O
, , O O
ROOSEVELT NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
GLYBURIDE NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
43601169 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
Sulfa; NNP B-NP O
reaction NN I-NP O
is VBZ O O
renal JJ B-NP O
failure NN I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
takes VBZ O O
at IN B-VP O
home NN B-NP O
NOVOLIN NNP I-NP B-m
INNOLET NNP I-NP I-m
70/30 CD O I-m
( ( O I-m
INSULIN NNP B-NP I-m
70/30 CD O I-m
( ( O I-m
HUMAN NNP B-NP I-m
) ) O I-m
) ) O I-m
100 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
BID NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
8 CD O I-du
NORVASC NNP B-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/23/04 CD O O
by IN B-VP O
GASTINEAU NNP B-NP O
, , O O
RAMIRO NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
CLOTRIMAZOLE NNP B-NP B-m
1% CD O I-m
CREAM NNP B-NP I-m
TP NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
17426481 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
&amp; NNP I-NP O
CLOTRIMAZOLE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
Previous JJ O O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/23/04 CD O O
by IN B-VP O
ARDELEAN NNP B-NP O
, , O O
TRACY NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LIPITOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
90735952 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
SIMVASTATIN; NNP B-NP O
reaction NN I-NP O
is VBZ O O
myalgia JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
tol NN I-NP O
lipitor NN I-NP B-m
at IN B-VP O
home NN B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Giangrosso NNP I-NP O
SH NNP I-NP O
call NN I-NP O
to TO O O
schedule NN B-NP O
1wk CD O O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
, , O O
Sulfa NNP B-NP O
, , O O
ACE NNP B-NP O
Inhibitor NNP I-NP O
, , O O
METFORMIN NNP B-NP O
HCL NNP I-NP O
, , O O
SIMVASTATIN NNP B-NP O
, , O O
DRUG NNP B-NP O
ALLERGY NNP I-NP O
, , O O
ALLERGY NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
SOB/Chest NNP I-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
r/o NN B-NP O
MI NNP I-NP O
, , O O
SOB NNP B-NP O
multifactorial JJ B-NP O
deconditioning NN I-NP O
, , O O
pulmon JJ B-NP O
disease NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
, , O O
uncontrolled JJ B-NP O
DM NNP I-NP O
, , O O
Sleep NNP B-NP O
Apnea NNP I-NP O
, , O O
Asthma NNP B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
58 CD O O
yo NNP B-NP O
woman NN I-NP O
multiple NN I-NP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
( ( O O
uncontrolled JJ B-NP O
DM2 NNP I-NP O
10.3 CD O O
HgbAIC NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
lipids NNS B-NP O
) ) O O
, , O O
Asthma NNP B-NP O
, , O O
Sleep NNP B-NP O
Apnea NNP I-NP O
, , O O
with IN B-VP O
1 CD O O
week NN B-NP O
worsening VBG O O
DOE NNP B-NP O
Pt NNP I-NP O
c/o NN I-NP O
DOE NNP I-NP O
only RB O O
when WRB O O
walking VBG O O
up RP O O
an DT B-NP O
incline NN I-NP O
pt NN I-NP O
had VBD B-VP O
one CD O O
episode NN B-NP O
of IN B-VP O
diaphoresis NN B-NP O
with IN B-VP O
this DT B-NP O
SOB NNP I-NP O
but CC O O
denies VBZ O O
any DT B-NP O
cp NN I-NP O
, , O O
shoulder NN B-NP O
pain NN I-NP O
, , O O
backpain NN B-NP O
, , O O
jaw/neck NN B-NP O
pain NN I-NP O
pt JJ O O
denies VBZ O O
any DT B-NP O
n/v/d JJ I-NP O
Pt NNP I-NP O
went VBD B-VP O
to TO O O
PCP NNP B-NP O
and CC O O
due JJ O O
to TO O O
multiple JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
was VBD B-VP O
told VBN O O
to TO O O
come VB O O
to TO O O
ED NNP B-NP O
for IN B-VP O
r/o NN B-NP O
MI NNP I-NP O
pt NN I-NP O
denies VBZ O O
SOB NNP B-NP O
at IN B-VP O
rest NN B-NP O
or CC O O
even RB O O
when WRB O O
walking VBG O O
on IN B-VP O
"flat JJ B-NP O
surface" NN I-NP O
pt NN I-NP O
says VBZ O O
been VBN O O
over IN B-VP O
all DT B-NP O
fatigue NN I-NP O
last JJ B-NP O
week NN I-NP O
also RB O O
known VBN O O
to TO O O
be VB O O
recovering VBG O O
from IN B-VP O
recent JJ B-NP O
renal JJ I-NP O
stone NN I-NP O
Pt NNP I-NP O
admit NN I-NP O
for IN B-VP O
r/o NN B-NP O
MI NNP I-NP O
In IN B-VP O
ED NNP B-NP O
pt NN I-NP O
BP NNP I-NP B-r
BP NNP I-NP B-r
elevated VBD B-VP I-r
elevated JJ O I-r
150-160's/80-90 JJ O O
given VBN O O
IV NNP B-NP B-mo
lopressor NN I-NP B-m
and CC O O
nitro JJ B-NP B-m
paste NN I-NP I-m
pt NN I-NP O
BP NNP I-NP O
stable JJ B-NP O
A/P NNP I-NP O
DOE NNP I-NP O
unlikely RB O O
due JJ O O
to TO O O
cardiac VB O O
problem NN B-NP O
, , O O
symptoms NNS B-NP O
more RBR O O
c/w JJ B-NP O
deconditioning NN I-NP O
in IN B-VP O
obese JJ O O
, , O O
DM NNP B-NP O
women NNS I-NP O
with IN B-VP O
underlying JJ B-NP O
pulmon JJ I-NP O
disease NN I-NP O
CV- NNP I-NP O
cardiac NN I-NP O
enz NN I-NP O
neg JJ B-NP O
x3- JJ I-NP O
ASA NNP I-NP B-m
, , O O
no DT B-NP O
BB NNP I-NP O
secondary JJ B-NP O
Asthma NNP I-NP O
Will NNP I-NP O
need VB O O
cardiac JJ B-NP O
mibi NN I-NP O
with IN B-VP O
adenosine NN B-NP B-m
as IN B-VP O
out RP O O
patient JJ B-NP O
hx NN I-NP O
diasystolic JJ B-NP O
dysfunc NN I-NP O
with IN B-VP O
nl JJ B-NP O
EF NNP I-NP O
Pt NNP I-NP O
on IN B-VP O
telemetry NN B-NP O
with IN B-VP O
no DT B-NP O
abnormalities NNS I-NP O
Serial NNP I-NP O
EKGs NNP I-NP O
unchanged JJ O O
with IN B-VP O
baseline JJ B-NP O
abnl NN I-NP O
poor JJ B-NP O
RWprogression NNP I-NP O
BP NNP I-NP O
initially RB O O
mildly RB O O
elevated VBD B-VP O
stable JJ O O
this DT O O
am VBP O O
can MD O O
rea VB O O
ddress JJ B-NP O
meds NNS I-NP O
as IN B-VP O
an DT B-NP O
outpt JJ I-NP O
Endo- JJ I-NP O
DM NNP I-NP B-r
DM NNP I-NP B-r
cont VBD B-VP O
home NN B-NP B-m
meds NNS I-NP I-m
SSI NNP I-NP B-m
Pulmon- NNP I-NP O
hx NN I-NP O
sleep NN I-NP O
apnea/Asthma NN I-NP O
on IN B-VP O
cpap NN B-NP O
/6lNC NNP I-NP O
( ( O O
while IN B-VP O
in IN B-VP O
hosp NN B-NP O
) ) O O
at IN B-VP O
night NN B-NP O
no DT B-NP O
baseline NN I-NP O
O2 NNP I-NP O
needed VBD B-VP O
Full NNP B-NP O
code NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
call VB O O
your PRP$ O O
doctor NN B-NP O
if IN B-VP O
having VBG O O
chest JJS B-NP O
pain NN I-NP O
, , O O
worsening VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
with IN B-VP O
exertion NN B-NP O
or CC O O
at IN B-VP O
rest JJS O O
, , O O
new JJ O O
onset VBN O O
back/shoulder NN B-NP O
pain NN I-NP O
, , O O
worsening VBG O O
fatigue NN B-NP O
or CC O O
any DT B-NP O
other JJ I-NP O
concerns NNS I-NP O
Please NNP I-NP O
call VB O O
your PRP$ O O
PCP NNP B-NP O
to TO O O
schedule VB O O
out RP O O
patient JJ B-NP O
Cardiac NNP I-NP O
MIBI NNP I-NP O
with IN B-VP O
adenosine JJ B-NP B-m
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GUENIN NNP I-NP O
, , O O
DENVER NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
EM22 NNP B-NP O
) ) O O
11/16/04 CD O O
@ $ O O
12:37 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#293045 VBZ O O
859846912 CD O O
LMC NNP B-NP O
27937230 CD O O
2679773 CD O O
0/20/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/20/2002 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/28/2002 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
WALTS NNP I-NP O
, , O O
MARCELO NNP B-NP O
573-58-18-1 JJ B-NP O
Vi NNP I-NP O
A NNP I-NP O
Ville NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/10/02 CD O O
AT NNP B-NP O
10:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
MCCUTCHAN NNP I-NP O
, , O O
DARRIN NNP B-NP O
JOSH NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
CAPTOPRIL NNP I-NP B-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;95 JJ B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/3/02 CD O O
by IN B-VP O
DIFRONZO NNP B-NP O
, , O O
ALVIN NNP B-NP O
, , O O
MD NNP B-NP O
, , O O
MPH NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
CAPTOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
LEVOXYL NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NITROGLYCERIN NNP I-NP B-m
1/150 CD O B-do
( ( O I-do
0.4 CD O I-do
MG NNP B-NP I-do
) ) O I-do
1 CD O I-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5 NNP I-NP B-f
MIN NNP I-NP O
X NNP I-NP O
3 CD O O
PRN NNP B-NP O
Chest NNP I-NP B-r
Pain NNP I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;[ NNP I-NP O
] NNP I-NP O
Instructions: NNP I-NP O
As IN B-VP O
per IN B-VP O
chest NN B-NP O
pain NN I-NP O
protocol NN I-NP O
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/3/02 CD O O
by IN B-VP O
FITZER NNP B-NP O
, , O O
BRENDON NNP B-NP O
, , O O
MD NNP B-NP O
, , O O
MPH NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
MULTIVITAMIN NNP B-NP B-m
THERAPEUTIC NNP I-NP O
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
23182635 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
previously RB O O
overriden JJ B-NP O
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NITROPATCH NNP I-NP B-m
( ( O I-m
NITROGLYCERIN NNP B-NP I-m
PATCH NNP I-NP I-m
) ) O I-m
0.2 CD O B-do
MG/HR NNP B-NP I-do
TP NNP I-NP B-mo
QHS NNP I-NP B-f
GLYBURIDE NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ISORDIL NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
DINITRATE NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
4 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Sandler NNP I-NP O
11/28/02 CD O O
scheduled VBN O O
, , O O
No DT B-NP O
Known NNP I-NP O
Allergies NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
unstable JJ B-NP O
angina NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CHF NNP B-NP O
exacerbation NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CHF NNP I-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
cad NN B-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
htn NN B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
dm NN B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
gerd NN B-NP O
( ( O O
gastroesophageal JJ B-NP O
reflux NN I-NP O
disease NN I-NP O
) ) O O
hypothyroidism NN B-NP O
( ( O O
hypothyroidism NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
cardiac VBP O O
cath NN B-NP O
and CC O O
stent NN B-NP O
of IN B-VP O
RCA NNP B-NP O
, , O O
4/3/02 CD O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
71 CD O O
y.o NN B-NP O
F NNP I-NP O
w/ NN I-NP O
h/o NN I-NP O
CAD NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
CHF NNP B-NP O
, , O O
and CC O O
DM NNP B-NP O
w/ VBD B-VP O
several JJ B-NP O
recent JJ I-NP O
admissions NNS I-NP O
for IN B-VP O
flash NN B-NP O
pulm NN I-NP O
edema NN I-NP O
, , O O
most RBS O O
recently RB O O
at IN B-VP O
CH NNP B-NP O
1 CD O O
week NN B-NP O
ago RB O O
when WRB O O
she PRP O O
had VBD B-VP O
stent NN B-NP O
placed VBN O O
in IN B-VP O
L NNP B-NP O
renal JJ B-NP O
artery NN I-NP O
( ( O O
cath NN B-NP O
showed VBD B-VP O
30% CD O O
LAD NNP B-NP O
, , O O
60% CD O O
and CC O O
70% CD O O
RCA NNP B-NP O
lesions NNS I-NP O
which WDT O O
were VBD B-VP O
not RB O O
intervened VBN O O
upon IN B-VP O
) ) O O
Pt NNP B-NP O
well RB O O
until IN B-VP O
night NN B-NP O
of IN B-VP O
admission NN B-NP O
, , O O
when WRB O O
she PRP O O
developed VBD B-VP O
SOB NNP B-NP B-r
SOB NNP I-NP B-r
while IN B-VP O
watching VBG O O
TV NN B-NP O
Not RB O O
anginal JJ B-NP O
equivalent NN I-NP O
, , O O
no DT B-NP O
CP NNP I-NP O
Lasted VBD B-VP O
30 CD O O
minutes NNS B-NP O
, , O O
took VBD B-VP O
NTG NNP B-NP B-m
and CC O O
Lasix NNP B-NP B-m
120 CD O B-do
, , O O
called VBN O O
EMS NNP B-NP O
and CC O O
was VBD B-VP O
brought VBN O O
to TO O O
VMH NNP B-NP O
ER NNP I-NP O
In IN B-VP O
ER NNP B-NP O
, , O O
was VBD B-VP O
given VBN O O
ASA NNP B-NP B-m
, , O O
Lopressor NNP B-NP B-m
, , O O
and CC O O
Heparin NNP B-NP B-m
Admission NNP I-NP O
vitals: VBD B-VP O
T NNP B-NP O
98 CD O O
BP NNP B-NP O
119/46 CD O O
HR NNP B-NP O
81 CD O O
O2 NNP B-NP O
sat VBD B-VP O
97% CD O O
Exam NNP B-NP O
notable JJ O O
for: SYM O O
- : O O
m/r/g NN B-NP O
, , O O
decreased VBD B-VP O
BS/dullness NNP B-NP O
at IN B-VP O
R NNP B-NP O
base NN I-NP O
, , O O
guaiac JJ B-NP O
neg NN I-NP O
in IN B-VP O
ER NNP B-NP O
Labs NNP I-NP O
notable JJ O O
for IN B-VP O
Cr NNP B-NP O
2.0 CD O O
, , O O
Hct NNP B-NP O
30.5 CD O O
, , O O
neg JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
CXR NNP I-NP O
with IN B-VP O
bilat JJ B-NP O
pleural JJ I-NP O
effusions NNS I-NP O
EKG NNP I-NP O
w/ VBD B-VP O
downsloping VBG O O
ST NNP B-NP O
depressions NNS I-NP O
in IN B-VP O
II NNP B-NP O
, , O O
III NNP B-NP O
, , O O
F NNP B-NP O
, , O O
I PRP O O
, , O O
L NNP B-NP O
Impression: NNP I-NP O
71F CD O O
w/ NN B-NP O
recurrent NN I-NP O
CHF NNP I-NP O
and CC O O
flash JJ B-NP O
pulm NN I-NP O
edema NN I-NP O
, , O O
possibly RB O O
due JJ O O
to TO O O
coronary JJ B-NP O
artery NN I-NP O
lesions NNS I-NP O
or CC O O
HTN NNP B-NP O
#1 NNP I-NP O
CV- NNP I-NP O
r/o NN I-NP O
MI NNP I-NP O
On IN B-VP O
Heparin NNP B-NP B-m
, , O O
ASA NNP B-NP B-m
, , O O
Plavix NNP B-NP B-m
, , O O
Metoprolol NNP B-NP B-m
, , O O
nitrates VBZ O B-m
, , O O
ACE-I NNP B-NP B-m
, , O O
statin NN B-NP B-m
, , O O
lasix JJ B-NP B-m
Cardiac NNP I-NP O
catheterization NN I-NP O
and CC O O
stent NN B-NP O
placed VBN O O
in IN B-VP O
RCA NNP B-NP O
6/10 CD O O
, , O O
pt NN B-NP O
tolerated VBD B-VP O
procedure NN B-NP O
well RB O O
#2 NNP B-NP O
Pulm NNP I-NP O
- : O O
We PRP O O
continued VBD B-VP O
lasix JJ O B-m
, , O O
PRN NNP B-NP B-f
nebs NN I-NP B-m
for IN B-VP O
wheezing VBG O B-r
Pt NNP B-NP O
was VBD B-VP O
stable JJ O O
throughout IN B-VP O
hospitalization NN B-NP O
#3 NNP I-NP O
Endo NNP I-NP O
- : O O
We PRP O O
checked VBD B-VP O
finger NN B-NP O
sticks NNS I-NP O
and CC O O
covered VBD B-VP O
w/ NNS B-NP O
CZI NNP I-NP O
Continu NNP I-NP O
ed VBZ O O
synthroid JJ O B-m
Once RB O O
pt JJ B-NP O
re-started JJ I-NP O
PO NNP I-NP O
diet NN I-NP O
after IN B-VP O
cardiac JJ B-NP O
cath NN I-NP O
, , O O
we PRP O O
resumed VBD B-VP O
glyburide JJ B-NP B-m
#4 NNP I-NP O
Renal NNP I-NP O
- : O O
increased VBD B-VP O
Cr NNP B-NP O
slightly RB O O
above IN B-VP O
baseline NN B-NP O
Remained VBD B-VP O
stable JJ O O
during IN B-VP O
hospitalization NN B-NP O
#5 NNP I-NP O
F/E/N NNP I-NP O
- : O O
NPO NN B-NP O
in IN B-VP O
anticipation NN B-NP O
of IN B-VP O
cath NN B-NP O
Monitored NNP I-NP O
lytes VBZ O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
1 CD O O
Please NNP B-NP O
f/u NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Lidstone NNP I-NP O
on IN B-VP O
4/25/02 CD O O
, , O O
at IN B-VP O
3:15pm CD O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
F/u NNP B-NP O
with IN B-VP O
Dr NNP B-NP O
Darlin NNP I-NP O
to TO O O
discuss VB O O
results NNS B-NP O
of IN B-VP O
cardiac JJ B-NP O
cath NN I-NP O
, , O O
stenting VBG O O
, , O O
post-cath JJ B-NP O
management NN I-NP O
, , O O
and CC O O
overall JJ B-NP O
management NN I-NP O
of IN B-VP O
CHF NNP B-NP O
and CC O O
flash JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
ORTEA NNP I-NP O
, , O O
ROLANDO NNP B-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
TQ46 NNP B-NP O
) ) O O
7/10/02 CD O O
@ $ O O
10:14 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#293349 VBZ O O
252140420 CD O O
TCLH NNP B-NP O
97727998 CD O O
8788943 CD O O
11/3/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
acute NN B-NP O
on IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/28/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/20/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
DEAL NNP I-NP O
, , O O
ROMAN NNP B-NP O
479-30-32-1 CD O O
Derd NNP B-NP O
T NNP I-NP O
A NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/17/06 CD O O
AT NNP B-NP O
03:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
TOOTHACRE NNP I-NP O
, , O O
SHELBY NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
No NNP I-NP O
CPR NNP I-NP O
, , O O
Other JJ O O
- : O O
withhold JJ B-NP O
CPR NNP I-NP O
for IN B-VP O
sudden JJ B-NP O
death NN I-NP O
DISPOSITION: NNP I-NP O
Rehabilitation NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/2/06 CD O O
by IN B-VP O
KIRSCHBAUM NNP B-NP O
, , O O
JESSIE NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
960263524 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ O O
, , O O
reg JJ B-NP O
home NN I-NP O
meds NNS I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
3/18/06 CD O O
by IN B-VP O
CAPES NNP B-NP O
, , O O
TITUS NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
890243096 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
CALCIUM NNP I-NP B-m
CARBONATE NNP I-NP I-m
( ( O I-m
500 CD O I-m
MG NNP B-NP I-m
ELEMENTAL NNP I-NP I-m
CA++ NNP I-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
IRON NNP I-NP B-m
SULFATE NNP I-NP I-m
( ( O I-m
FERROUS NNP B-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
milk NN I-NP O
and CC O O
antacid JJ B-NP O
FOLATE NNP I-NP B-m
( ( O I-m
FOLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HYDRALAZINE NNP I-NP B-m
HCL NNP I-NP I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;90 NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
Sliding NNP I-NP B-do
Scale NNP I-NP I-do
( ( O B-mo
subcutaneously RB O I-mo
) ) O I-mo
SC NNP B-NP I-mo
AC NNP I-NP I-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
give VB O O
0 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
6 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
ISORDIL NNP B-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
DINITRATE NNP I-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;85 NNP I-NP O
LOPRESSOR NNP I-NP B-m
( ( O I-m
METOPROLOL NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt; JJ O O
100 CD O O
, , O O
hr NN B-NP O
&lt; VBD B-VP O
55 CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
DILANTIN NNP I-NP B-m
( ( O I-m
PHENYTOIN NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/2/06 CD O O
by IN B-VP O
CUNNANE NNP B-NP O
, , O O
RALEIGH NNP B-NP O
I PRP O O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
960263524 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
PHENYTOIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ O O
, , O O
reg JJ B-NP O
home NN I-NP O
meds NNS I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
3/18/06 CD O O
by IN B-VP O
GOICK NNP B-NP O
, , O O
KENNETH NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
890243096 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
PHENYTOIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
PREDNISONE NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
SODIUM NNP I-NP B-m
BICARBONATE NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
Standard NNP B-NP O
Admin NNP I-NP O
Time NNP I-NP O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
10/2/06 CD O O
by IN B-VP O
SOLDAN NNP B-NP O
, , O O
TREVOR NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
PHENYTOIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SULFAMETHOXAZOLE NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ O O
, , O O
reg JJ B-NP O
home NN I-NP O
meds NNS I-NP O
MVI NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVITAMINS NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
3/18/06 CD O O
by IN B-VP O
ARREZOLA NNP B-NP O
, , O O
CLINTON NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
LOVENOX NNP I-NP B-m
( ( O I-m
ENOXAPARIN NNP B-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
SC NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
7/26 CD O O
) ) O O
Instructions: NNP B-NP O
STOP NNP I-NP O
ONCE NNP I-NP O
INR&gt;2.0 NNP I-NP O
GLIPIZIDE NNP I-NP B-m
XL NNP I-NP I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
BACTRIM NNP I-NP B-m
DS NNP I-NP I-m
( ( O I-m
TRIMETHOPRIM/SULFAMETHOXAZOLE NNP B-NP I-m
DOU NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
3x/Week CD O B-f
M-W-F NNP B-NP I-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/2/06 CD O O
by IN B-VP O
KAKEH NNP B-NP O
, , O O
BENTON NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
960263524 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
SULFAMETHOXAZOLE NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ O O
, , O O
reg JJ B-NP O
home NN I-NP O
meds NNS I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
3/18/06 CD O O
by IN B-VP O
HINTON NNP B-NP O
, , O O
PETE NNP B-NP O
K NNP I-NP O
, , O O
M.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
SULFAMETHOXAZOLE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
FLOVENT NNP I-NP B-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE NNP I-NP I-m
) ) O I-m
220 CD O B-do
MCG NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ESOMEPRAZOLE NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DUONEB NNP I-NP B-m
( ( O I-m
ALBUTEROL NNP B-NP I-m
AND NNP I-NP I-m
IPRATROPIUM NNP I-NP I-m
NEBULIZER NNP I-NP I-m
) ) O I-m
3/0.5 CD O B-do
MG NNP B-NP I-do
NEB NNP I-NP B-mo
Q6H NNP I-NP B-f
DARBEPOETIN NNP I-NP B-m
ALFA NNP I-NP I-m
25 CD O B-do
MCG NNP B-NP I-do
SC NNP I-NP B-mo
QWEEK NNP I-NP B-f
Reason NNP I-NP O
for IN B-VP O
ordering: JJ B-NP O
Renal NNP I-NP O
Disease NNP I-NP O
Last JJ B-NP O
known JJ I-NP O
Hgb NNP I-NP O
level NN I-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
order: $ O O
9.2 CD O O
g/dL NN B-NP O
on IN B-VP O
8/25/06 CD O O
at IN B-VP O
HMH NNP B-NP O
Diagnosis: NNP I-NP O
Chronic NNP I-NP O
Renal NNP I-NP O
Failure NNP I-NP O
585 CD O O
Treatment NNP B-NP O
Cycle: NNP I-NP O
Initiation NNP I-NP O
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/17/06 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
reg NN I-NP O
home NN I-NP O
meds NNS I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
NAS NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
ADA NNP I-NP O
1600 CD O O
cals/daycals/dy NN B-NP O
/ NNP I-NP O
Low NNP I-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
/ NNP I-NP O
Renal NNP I-NP O
diet JJ B-NP O
/ NNP I-NP O
LOW NNP I-NP O
POTASSIUM NNP I-NP O
(I) NNP I-NP O
(FDI) NNP I-NP O
ACTIVITY: NNP I-NP O
walking VBG O O
with IN B-VP O
walker NN B-NP O
and CC O O
2L CD O O
O2 NNP B-NP O
with IN B-VP O
assist NN B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Rodney NNP I-NP O
Ahumada NNP I-NP O
6/9 CD O O
@ NNP B-NP O
3:30 CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Gustavo NNP I-NP O
Klecha NNP I-NP O
( ( O O
renal JJ O O
) ) O O
6/30 CD O O
@ $ O O
1:30 CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Pledger NNP I-NP O
( ( O O
cardiology NN B-NP O
) ) O O
7/4/06 CD O O
at IN B-VP O
1pm CD O O
scheduled JJ O O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
7/19/05 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
1 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Rehab NNP B-NP O
facility NN I-NP O
, , O O
then RB O O
Dr NNP B-NP O
Everette NNP I-NP O
Lambrakis NNP I-NP O
ALLERGY: NNP I-NP O
Penicillins NNP I-NP O
, , O O
ACE NNP B-NP O
Inhibitor NNP I-NP O
, , O O
DICLOXACILLIN NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
acute NN I-NP O
on IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
congestive VBP O O
heart NN B-NP O
failure NN I-NP O
, , O O
acute NN B-NP O
on IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
ANEMIA NNP I-NP O
CRI NNP I-NP O
( ( O O
Cr NNP B-NP O
1.7 CD O O
) ) O O
seizures NNS B-NP O
( ( O O
partial JJ B-NP O
seizures NNS I-NP O
) ) O O
dvt NN B-NP O
, , O O
left VBD B-VP O
calf NN B-NP O
( ( O O
deep JJ B-NP O
venous JJ I-NP O
thrombosis NN I-NP O
) ) O O
appendectomy NN B-NP O
( ( O O
appendectomy JJ O O
) ) O O
colon NN B-NP O
adenoma NN I-NP O
( ( O O
colonic JJ B-NP O
polyps NNS I-NP O
) ) O O
TAH NNP B-NP O
( ( O O
hysterectomy NN B-NP O
) ) O O
anemia NN B-NP O
( ( O O
anemia NN B-NP O
) ) O O
PPM VBZ O O
2/29 CD O O
for IN B-VP O
SSS NNP B-NP O
s/p NN I-NP O
MI NNP I-NP O
1997 CD O O
, , O O
9/11 CD O O
with IN B-VP O
stents NNS B-NP O
to TO O O
LAD NNP B-NP O
, , O O
D1 NNP B-NP O
, , O O
LCx NNP B-NP O
severe RB O O
pulmonary JJ B-NP O
sarcoidosis NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
SOB NNP I-NP O
, , O O
Increased VBD B-VP O
Cr NNP B-NP O
*** NNP I-NP O
HPI: NNP I-NP O
Ms NNP I-NP O
Commins NNP I-NP O
is VBZ O O
a DT O O
74 CD O O
yo JJ B-NP O
female NN I-NP O
with IN B-VP O
h/o JJ B-NP O
CAD NNP I-NP O
s/p NN I-NP O
LAD NNP I-NP O
stent NN I-NP O
9/11 CD O O
, , O O
CHF NNP B-NP O
w/ VBD B-VP O
EF NNP B-NP O
50% CD O O
, , O O
and CC O O
CRI NNP B-NP O
w/ VBP O O
Cr NNP B-NP O
( ( O O
1.9-2.4 JJ O O
) ) O O
who WP O O
presents VBZ O O
with IN B-VP O
elevated JJ B-NP O
K NNP I-NP O
and CC O O
Cr NNP B-NP O
and CC O O
increasing VBG O O
SOB NNP B-NP O
Pt NNP I-NP O
reports VBZ O O
1 CD O O
yr NN B-NP O
of IN B-VP O
weight JJ B-NP O
loss NN I-NP O
and CC O O
decreased VBD B-VP O
PO NNP B-NP O
more RBR O O
notable JJ O O
within IN B-VP O
past JJ B-NP O
1-2 JJ I-NP O
wks NN I-NP O
On IN B-VP O
ROS NNP B-NP O
+sweating VBG O O
@ JJ B-NP O
night NN I-NP O
o/w RB O O
negative JJ B-NP O
Pt NNP I-NP O
has VBZ O O
been VBN O O
off RP O O
her PRP$ O O
usual JJ B-NP B-do
dose NN I-NP I-do
of IN B-VP O
lasix JJ O B-m
per IN B-VP O
renal JJ B-NP O
input NN I-NP O
because IN B-VP O
on IN B-VP O
recent JJ B-NP O
admit NN I-NP O
( ( O O
4/10 CD O O
) ) O O
she PRP O O
had VBD B-VP O
elevated VBN O O
Cr NNP B-NP O
thought VBD B-VP O
to TO O O
be VB O O
prerenal JJ O O
, , O O
which WDT O O
is VBZ O O
when WRB O O
lasix NN B-NP B-m
was VBD B-VP O
stopped VBN O O
No RB O O
chest JJ B-NP O
pain NN I-NP O
, , O O
pressure NN B-NP O
or CC O O
palp NN B-NP O
No DT B-NP O
LE NNP I-NP O
edema NN I-NP O
, , O O
no DT B-NP O
PND NNP I-NP O
*** NNP I-NP O
PMH: NNP I-NP O
CHF NNP I-NP O
w/ VBD B-VP O
EF NNP B-NP O
50% CD O O
in IN B-VP O
8/15 CD O O
by IN B-VP O
TTE NNP B-NP O
showing VBG O O
LAE NNP B-NP O
, , O O
mild JJ B-NP O
MR/TR NNP I-NP O
, , O O
HK NNP B-NP O
inf VBP O O
septum NN B-NP O
&amp; NNP I-NP O
posterior NN I-NP O
basal NN I-NP O
, , O O
MI NNP B-NP O
1997 CD O O
, , O O
s/p NN B-NP O
LAD NNP I-NP O
, , O O
D1 NNP B-NP O
, , O O
LCx NNP B-NP O
stents NNS I-NP O
in IN B-VP O
2002 CD O O
, , O O
Anemia NNP B-NP O
, , O O
CRI NNP B-NP O
( ( O O
baseline JJ B-NP O
Cr NNP I-NP O
1.9-2.4 NN I-NP O
) ) O O
, , O O
H/o NNP B-NP O
partial JJ B-NP O
seizures NNS I-NP O
on IN B-VP O
dilantin NN B-NP B-m
, , O O
HTN NNP B-NP O
, , O O
h/o NN B-NP O
DVT NNP I-NP O
L NNP I-NP O
calf NN I-NP O
, , O O
s/p JJ B-NP O
TAH/ NNP I-NP O
appy NN I-NP O
, , O O
H/o NNP B-NP O
cervical JJ B-NP O
CA NNP I-NP O
, , O O
h/o VBD B-VP O
2-3 JJ B-NP O
mm NN I-NP O
polyp NN I-NP O
in IN B-VP O
1993 CD O O
, , O O
SSS NNP B-NP O
s/p VBD B-VP O
DDD NNP B-NP O
pacemaker NN I-NP O
in IN B-VP O
1997 CD O O
, , O O
Sarcoid NNP B-NP O
w/ NN I-NP O
severe JJ B-NP O
restrictive JJ I-NP O
pulmonary JJ I-NP O
dz NN I-NP O
, , O O
NIDDM NNP B-NP O
type NN I-NP O
II NNP I-NP O
, , O O
dyslipidemia NN B-NP O
*** NNP I-NP O
Admit NNP I-NP O
PE: NNP I-NP O
T NNP I-NP O
97.2 CD O O
BP NNP B-NP O
147/66 CD O O
P NNP B-NP O
52 CD O O
R NNP B-NP O
18 CD O O
100% CD O O
RA NNP B-NP O
Gen: NNP I-NP O
Frail NNP I-NP O
appearing VBG O O
elderly JJ B-NP O
female NN I-NP O
HEENT: NNP I-NP O
EOMI NNP I-NP O
, , O O
+ NNP B-NP O
?exopthalmos NNP I-NP O
, , O O
anicteric JJ O O
, , O O
mmm JJ B-NP O
Neck: NNP I-NP O
thyromegaly NN I-NP O
vs NN I-NP O
submandibular JJ B-NP O
fullness NN I-NP O
, , O O
no DT B-NP O
nodules NNS I-NP O
, , O O
non-painful JJ O O
, , O O
no DT B-NP O
cervical JJ I-NP O
LAD NNP I-NP O
Pulm: NNP I-NP O
bilateral JJ B-NP O
crackles NNS I-NP O
to TO O O
apeces NNS B-NP O
CV: NNP I-NP O
RRR NNP I-NP O
, , O O
II/VI NNP B-NP O
HSM NNP I-NP O
@ NNP I-NP O
LLSB NNP I-NP O
, , O O
JVP NNP B-NP O
@ NNP I-NP O
ear VBP O O
Abd: NNP B-NP O
nt NN I-NP O
, , O O
nd RB O O
, , O O
+hyperactive JJ B-NP O
BS NNP I-NP O
, , O O
no DT B-NP O
hsm NN I-NP O
Ext: NNP I-NP O
no DT B-NP O
c/c/e NN I-NP O
, , O O
** NNP B-NP O
EKG: NNP I-NP O
atrial NN I-NP O
paced VBD B-VP O
, , O O
not RB O O
capturing VBG O O
SB NNP B-NP O
@ NNP I-NP O
56 CD O O
, , O O
nl RB O O
axis NN B-NP O
, , O O
nl JJ B-NP O
intervals NNS I-NP O
no DT B-NP O
st-t JJ I-NP O
wave NN I-NP O
changes NNS I-NP O
*** VBP O O
Consults: NNP B-NP O
Renal NNP I-NP O
, , O O
Cards NNP B-NP O
, , O O
EP NNP B-NP O
, , O O
Nutrition NNP B-NP O
, , O O
PT NNP B-NP O
**** NNP I-NP O
Imp: NNP I-NP O
74 CD O O
yo NNP B-NP O
woman NN I-NP O
with IN B-VP O
pulmonary JJ B-NP O
sarcoid NN I-NP O
and CC O O
CHF NNP B-NP O
and CC O O
CRI NNP B-NP O
here RB O O
with IN B-VP O
SOB NNP B-NP O
after IN B-VP O
stopping VBG O O
lasix JJ B-NP B-m
several JJ I-NP O
weeks NNS I-NP O
ago RB O O
Given NNP B-NP O
clinical JJ B-NP O
exam NN I-NP O
and CC O O
CXR NNP B-NP O
it PRP O O
appears VBZ O O
that IN B-VP O
she PRP O O
is VBZ O O
in IN B-VP O
decompensated JJ B-NP O
CHF NNP I-NP O
, , O O
and CC O O
in IN B-VP O
worse JJR B-NP O
renal JJ I-NP O
failure NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
) ) O O
Cardiovascular: NNP B-NP O
She PRP O O
was VBD B-VP O
in IN B-VP O
mildly RB O O
decompensated VBN O O
CHF NNP B-NP O
, , O O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
more RBR O O
aggressive JJ B-NP O
diuresis NN I-NP O
, , O O
starting VBG O O
with IN B-VP O
lasix JJ B-NP B-m
lasix NN I-NP B-m
40 CD O B-do
iv JJ B-NP B-mo
iv JJ I-NP B-mo
BID NNP I-NP B-f
increased VBD B-VP O
to TO O O
80 CD O B-do
bid NN B-NP B-f
on IN B-VP O
HD2 NNP B-NP O
as IN B-VP O
she PRP O O
was VBD B-VP O
not RB O O
meeting VBG O O
her PRP$ O O
diuresis NN B-NP O
goal NN I-NP O
With IN B-VP O
cardiology NN B-NP O
service NN I-NP O
consulting NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
increase NN B-NP O
to TO O O
lasix VB O B-m
drip NN B-NP B-mo
at IN B-VP O
15/hr CD O B-do
on IN B-VP O
HD3 NNP B-NP O
, , O O
with IN B-VP O
i/o JJ B-NP O
goal NN I-NP O
1-2 JJ B-NP O
l NN I-NP O
neg IN B-VP O
She PRP O O
did VBD B-VP O
well RB O O
on IN B-VP O
this DT O O
and CC O O
by IN B-VP O
HD5 NNP B-NP O
was VBD B-VP O
near IN B-VP O
her PRP$ O O
dry JJ B-NP O
weight NN I-NP O
of IN B-VP O
49kg CD O O
and CC O O
her PRP$ O O
drip NN B-NP O
was VBD B-VP O
transitioned VBN O O
back RB O O
to TO O O
PO NNP B-NP B-mo
lasix NN I-NP B-m
She PRP O O
is VBZ O O
no DT O O
on IN B-VP O
lasix NN B-NP B-m
80 CD O B-do
po NN B-NP B-mo
bid NN I-NP B-f
, , O O
which WDT O O
is VBZ O O
felt VBN O O
to TO O O
be VB O O
adequate JJ O O
to TO O O
maintain VB O O
her PRP$ O O
dry JJ B-NP O
weight NN I-NP O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Hydralazine NNP B-NP B-m
, , O O
lopressol NN B-NP B-m
and CC O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
Isordil NNP B-NP B-m
on IN B-VP O
HD3 NNP B-NP O
, , O O
titrated VBD B-VP O
up RB O O
to TO O O
20 CD O B-do
tid NN B-NP B-f
She PRP O O
has VBZ O O
history NN B-NP O
of IN B-VP O
MI NNP B-NP O
with IN B-VP O
stents NNS B-NP O
and CC O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Asa NNP B-NP B-m
, , O O
Plavix NNP B-NP B-m
, , O O
Zocor NNP B-NP B-m
He PRP O O
cardiac VBD B-VP O
enzymes NNS B-NP O
were VBD B-VP O
negative JJ B-NP O
Her NNP I-NP O
BNP NNP I-NP O
fell VBD B-VP O
from IN B-VP O
3500 CD O O
on IN B-VP O
admit NN B-NP O
to TO O O
1500 CD O O
at IN B-VP O
her PRP$ O O
dry JJ B-NP O
wt NN I-NP O
on IN B-VP O
HD6 NNP B-NP O
She PRP O O
was VBD B-VP O
paced VBN O O
intermittent NN B-NP O
( ( O O
pacer NN B-NP O
placed VBN O O
in IN B-VP O
past NN B-NP O
for IN B-VP O
sick JJ B-NP O
sinus NN I-NP O
, , O O
functioning VBG O O
properly RB O O
at IN B-VP O
a DT B-NP O
backup NN I-NP O
rate NN I-NP O
of IN B-VP O
50 CD O O
) ) O O
2 CD O O
) ) O O
Renal: NNP B-NP O
She PRP O O
presented VBD B-VP O
with IN B-VP O
acute NN B-NP O
on IN B-VP O
chronic JJ B-NP O
RF NNP I-NP O
possibly RB O O
due RB O O
to TO O O
poor JJ O O
for IN B-VP O
forward RB O O
flow NN B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
CHF NNP B-NP O
decompensation NN I-NP O
Cr NNP I-NP O
up RB O O
to TO O O
3.6 CD O O
on IN B-VP O
HD3 NNP B-NP O
, , O O
but CC O O
as IN B-VP O
she PRP O O
diuresed VBD B-VP O
, , O O
her PRP$ O O
Cr NNP B-NP O
stabilized VBD B-VP O
Renal NNP B-NP O
consult NN I-NP O
was VBD B-VP O
following VBG O O
and CC O O
recommended JJ B-NP O
diureses NNS I-NP O
, , O O
low JJ B-NP O
K NNP I-NP O
diet NN I-NP O
, , O O
good JJ B-NP O
glucose NN I-NP O
control NN I-NP O
, , O O
and CC O O
withholding VBG O O
ace NN B-NP B-m
inhibitor NN I-NP I-m
She PRP O O
is VBZ O O
discharge NN B-NP O
at IN B-VP O
her PRP$ O O
dry JJ B-NP O
weight NN I-NP O
with IN B-VP O
a DT B-NP O
Cr NNP I-NP O
stable NN I-NP O
at IN B-VP O
3.5 CD O O
She PRP O O
should MD O O
probably RB O O
not RB O O
go VB O O
on IN B-VP O
Ace NNP B-NP O
Inhibitor NNP I-NP O
again RB O O
3 CD O O
) ) O O
FEN- NNP B-NP O
Hyperkalemia NNP I-NP B-r
w/o NN I-NP O
EKG NNP I-NP O
change NN I-NP O
Improved NNP I-NP O
w/ NN I-NP O
lasix NN I-NP B-m
Rec'd NNP I-NP O
Kayexylate NNP I-NP B-m
in IN B-VP O
ED NNP B-NP O
Now RB O O
improved VBZ O O
Follow NNP B-NP O
K/Mg NNP I-NP O
She PRP O O
should MD O O
not RB O O
be VB O O
on IN B-VP O
an DT B-NP O
Ace NNP I-NP O
inhibitor NN I-NP O
or CC O O
a DT O O
K-sparing JJ O O
diuretic JJ O O
4 CD O O
) ) O O
ENDO- JJ B-NP O
glipizide NN I-NP B-m
at IN B-VP O
home NN B-NP O
which WDT O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
HD5 NNP B-NP O
Add NNP I-NP O
insulin NN I-NP B-m
SS NNP I-NP B-do
for IN B-VP O
tight JJ B-NP O
control NN I-NP O
TSH NNP I-NP O
high JJ B-NP O
T4 NNP I-NP O
low NN I-NP O
This DT O O
should MD O O
be VB O O
rechecked VBN O O
as IN B-VP O
an DT B-NP O
outpt NN I-NP O
before IN B-VP O
initiating VBG O O
therapy NN B-NP O
5 CD O O
) ) O O
Heme- NN B-NP O
ON NNP I-NP O
coumadin NN I-NP B-m
for IN B-VP O
history NN B-NP B-r
DVT NNP I-NP I-r
Held NNP I-NP O
on IN B-VP O
HD3 NNP B-NP O
for IN B-VP O
an DT B-NP O
INR NNP I-NP O
3.1 CD O O
and CC O O
was VBD B-VP O
restarted VBN O O
shortly RB O O
after IN B-VP O
, , O O
but CC O O
her PRP$ O O
INR NNP B-NP O
is VBZ O O
1.4 CD O O
She PRP O O
received VBD B-VP O
1.5 CD O B-do
U NNP B-NP I-do
of IN B-VP O
PRBC NNP B-NP B-m
for IN B-VP O
goal NN B-NP O
HCT NNP I-NP O
&gt;30 NNP I-NP O
and CC O O
is VBZ O O
currently RB O O
30.8 CD O O
Her NNP B-NP O
anemia NN I-NP O
is VBZ O O
2/2 CD O O
chronic JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
and CC O O
she PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
darbopoetin NN B-NP B-m
25 CD O B-do
qwk NN B-NP B-f
She PRP O O
developed VBD B-VP O
a DT B-NP B-r
clot NN I-NP I-r
in IN B-VP O
her PRP$ O O
Right NNP B-NP O
external NN I-NP O
jugular NN I-NP O
( ( O O
site NN B-NP O
of IN B-VP O
prior JJ B-NP O
IV NNP I-NP O
) ) O O
and CC O O
was VBD B-VP O
place NN B-NP O
on IN B-VP O
renal JJ B-NP B-do
dose NN I-NP I-do
of IN B-VP O
lovenox NN B-NP B-m
until IN B-VP B-du
her PRP$ O I-du
INR&gt;2 NNP B-NP I-du
Lovenox NNP I-NP B-m
should MD O O
be VB O O
stopped VBN O O
once RB O O
her PRP$ O O
INR NNP B-NP O
is VBZ O O
&gt;2 JJ O O
6 CD O O
) ) O O
Neuro- NN B-NP O
On IN B-VP O
dilantin NN B-NP B-m
for IN B-VP O
history NN B-NP O
of IN B-VP O
partial JJ B-NP B-r
seizures NNS I-NP I-r
7 CD O O
) ) O O
Code- NNP B-NP O
no DT B-NP O
CPR NNP I-NP O
if IN B-VP O
sudden JJ B-NP O
death NN I-NP O
, , O O
but CC O O
intubation/defibrillation NN B-NP O
ok NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
instability NN B-NP O
Dispo: NNP I-NP O
She PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
Wadesdi NNP B-NP O
Ckgart NNP I-NP O
Community NNP I-NP O
Hospital NNP I-NP O
at IN B-VP O
a DT B-NP O
euvolemic JJ I-NP O
state NN I-NP O
with IN B-VP O
a DT B-NP O
dry JJ I-NP O
weight NN I-NP O
of IN B-VP O
49kg CD O O
She PRP O O
should MD O O
continue VB O O
on IN B-VP O
80 CD O B-do
po JJ B-NP B-mo
lasix NN I-NP B-m
bid NN I-NP B-f
unless IN B-VP O
her PRP$ O O
Cr NNP B-NP O
rises VBZ O O
above IN B-VP O
new JJ B-NP O
baseline NN I-NP O
of IN B-VP O
3.5 CD O O
or CC O O
if IN B-VP O
she PRP O O
gains NNS B-NP O
weight VBD B-VP O
or CC O O
shows VBZ O O
signs NNS B-NP O
of IN B-VP O
new JJ B-NP O
overload NN I-NP O
Lovenox NNP I-NP B-m
should MD O O
be VB O O
stopped VBN O O
once RB O O
her PRP$ O O
INR NNP B-NP O
is VBZ O O
&gt; JJ O O
2 CD O O
Coumadin NNP B-NP B-m
dose NN I-NP O
should MD O O
be VB O O
adjusted VBN O O
according VBG O O
to TO O O
INR NNP B-NP O
goal NN I-NP O
2-3 CD O O
She PRP O O
should MD O O
be VB O O
on IN B-VP O
a DT B-NP O
renal JJ I-NP O
diet NN I-NP O
with IN B-VP O
low JJ B-NP O
potassium NN I-NP O
and CC O O
low JJ B-NP O
glucose NN I-NP O
but CC O O
with IN B-VP O
diabetic JJ B-NP O
caloric JJ I-NP O
supplements NNS I-NP O
like IN B-VP O
GLUCERNA NNP B-NP O
She PRP O O
should MD O O
receive VB O O
a DT B-NP O
HOT NNP I-NP O
PACK NNP I-NP O
to TO O O
her PRP$ O O
neck NN B-NP O
2-3x JJ O O
per IN B-VP O
day NN B-NP O
and CC O O
to TO O O
her PRP$ O O
vein NN B-NP O
before IN B-VP O
blood NN B-NP O
draw NN I-NP O
for IN B-VP O
comfort NN B-NP O
She PRP O O
should MD O O
receive VB O O
physical JJ B-NP O
therapy NN I-NP O
daily RB O O
with IN B-VP O
the DT B-NP O
goal NN I-NP O
of IN B-VP O
gait NN B-NP O
stability NN I-NP O
, , O O
home NN B-NP O
safety NN I-NP O
, , O O
and CC O O
good JJ B-NP O
O2 NNP I-NP O
sats NNS I-NP O
on IN B-VP O
2L CD O O
O2 NNP B-NP O
She PRP O O
should MD O O
go VB O O
home NN B-NP O
with IN B-VP O
home NN B-NP O
O2 NNP I-NP B-m
at IN B-VP O
2L CD O B-do
and CC O O
with IN B-VP O
VNA NNP B-NP O
services NNS I-NP O
for IN B-VP O
meds NNS B-NP O
She PRP O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
alone RB O O
and CC O O
it PRP O O
would MD O O
be VB O O
ideal JJ O O
if IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
relative JJ I-NP O
stay NN I-NP O
with IN B-VP O
her PRP$ O O
for IN B-VP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
to TO O O
a DT B-NP O
week NN I-NP O
after IN B-VP O
going VBG O O
home NN B-NP O
resume NN I-NP O
VNA NNP I-NP O
services NNS I-NP O
upon IN B-VP O
dc JJ B-NP O
contact: NN I-NP O
son NN I-NP O
Soulliere NNP I-NP O
in IN B-VP O
Ta NNP B-NP O
Broke NNP I-NP O
Ver NNP I-NP O
O NNP I-NP O
Arb NNP I-NP O
Ca NNP I-NP O
180-226-5150 JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
return VB O O
to TO O O
the DT B-NP O
hospital NN I-NP O
or CC O O
call VB O O
your PRP$ O O
doctor NN B-NP O
if IN B-VP O
you PRP O O
experience VBP O O
worsening VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
fever RB O O
over IN B-VP O
100.5 CD O O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
decreased VBN O O
urine JJ B-NP O
output NN I-NP O
, , O O
weight VBD B-VP O
gain NN B-NP O
over IN B-VP O
5 CD O O
pounds NNS B-NP O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
concerning NN I-NP O
symptoms NNS I-NP O
Please NNP I-NP O
keep VB O O
your PRP$ O O
follow-up JJ B-NP O
appts NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Zari NNP I-NP O
( ( O O
PCP NNP B-NP O
) ) O O
, , O O
Dr NNP B-NP O
Piquette NNP I-NP O
( ( O O
renal JJ O O
) ) O O
, , O O
and CC O O
cardiology NN B-NP O
as IN B-VP O
noted JJ O O
1 CD O O
) ) O O
d/c NN B-NP O
Lovenox NNP I-NP B-m
once RB O O
INR NNP B-NP O
&gt; VBD B-VP O
2 CD O O
2 CD O O
) ) O O
renal NN B-NP O
, , O O
diabetic JJ O O
, , O O
low JJ B-NP O
potassium NN I-NP O
, , O O
low JJ B-NP O
salt NN I-NP O
diet NN I-NP O
with IN B-VP O
glucerna JJ B-NP O
supplements NNS I-NP O
3 CD O O
) ) O O
continue VBP O O
PT NNP B-NP O
for IN B-VP O
goal NN B-NP O
of IN B-VP O
safe JJ B-NP O
ambulation NN I-NP O
, , O O
home NN B-NP O
safety NN I-NP O
, , O O
and CC O O
good JJ B-NP O
O2 NNP I-NP O
sat VBD B-VP O
on IN B-VP O
2L CD O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
COREY NNP I-NP O
, , O O
REYNALDO NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
ND42 NNP B-NP O
) ) O O
8/17/06 CD O O
@ $ O O
03 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#295212 VBZ O O
183042353 CD O O
PMC NNP B-NP O
62412226 CD O O
182679 CD O O
11/28/1991 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/28/1991 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/12/1991 CD O O
DIAGNOSIS: NNP B-NP O
1 CD O O
)CORONARY NNP B-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
2 CD O O
)ADULT NNP B-NP O
ONSET NNP I-NP O
DIABETES NNP I-NP O
MELLITUS NNP I-NP O
3 CD O O
)STATUS NNP B-NP O
POST NNP I-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
BYPASS NNP I-NP O
GRAFTING NNP I-NP O
4 CD O O
)HYPERTENSION NN B-NP O
5 CD O O
)STATUS NN B-NP O
POST NNP I-NP O
TOTAL NNP I-NP O
ABDOMINAL NNP I-NP O
HYSTERECTOMY NNP I-NP O
AND NNP I-NP O
BILATERAL NNP I-NP O
SALPINGO NNP I-NP O
OOPHORECTOMY NNP I-NP O
OPERATION: NNP I-NP O
Reoperation NNP I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Errol NNP I-NP O
Mikhail NNP I-NP O
on IN B-VP O
13 CD O O
of IN B-VP O
July NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
54-year-old JJ I-NP O
black JJ I-NP O
woman NN I-NP O
who WP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
approximately RB O O
two CD O O
years NNS B-NP O
ago RB O O
by IN B-VP O
Dr NNP B-NP O
Micciche NNP I-NP O
who WP O O
had VBD B-VP O
developed VBN O O
recurrent JJ B-NP O
substernal JJ I-NP O
chest NN I-NP O
pain NN I-NP O
approximately RB O O
four CD O O
months NNS B-NP O
after IN B-VP O
her PRP$ O O
bypass NN B-NP O
surgery NN I-NP O
The DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
exercise NN I-NP O
treadmill NN I-NP O
testing VBG O O
which WDT O O
showed VBD B-VP O
non-diagnostic JJ B-NP O
ST NNP I-NP O
segment NN I-NP O
changes NNS I-NP O
However RB O O
, , O O
thallium NN B-NP O
studies NNS I-NP O
revealed VBD B-VP O
decreased JJ B-NP O
perfusion NN I-NP O
to TO O O
the DT B-NP O
apex NN I-NP O
, , O O
superior JJ B-NP O
portion NN I-NP O
of IN B-VP O
the DT B-NP O
septum NN I-NP O
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
anterolateral JJ I-NP O
wall NN I-NP O
There EX O O
was VBD B-VP O
reperfusion NN B-NP O
of IN B-VP O
the DT B-NP O
high JJ I-NP O
septal NN I-NP O
and CC O O
anterolateral JJ B-NP O
wall NN I-NP O
The DT B-NP O
patient NN I-NP O
then RB O O
proceeded VBD B-VP O
to TO O O
cardiac VB O O
catheterization NN B-NP O
which WDT O O
revealed VBD B-VP O
100% CD O O
stenosis NN B-NP O
of IN B-VP O
her PRP$ O O
previous JJ B-NP O
graft NN I-NP O
Additionally RB O O
there EX O O
was VBD B-VP O
100% CD O O
mid JJ B-NP O
stenosis NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
, , O O
80% CD O O
stenosis NN B-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
anterior JJ I-NP O
descending NN I-NP O
, , O O
90% CD O O
mid JJ B-NP O
stenosis NN I-NP O
of IN B-VP O
the DT B-NP O
first JJ I-NP O
diagonal NN I-NP O
, , O O
and CC O O
100% CD O O
stenosis NN B-NP O
of IN B-VP O
the DT B-NP O
circumflex NN I-NP O
after IN B-VP O
the DT B-NP O
first JJ I-NP O
obtuse NN I-NP O
marginal NN I-NP O
There EX O O
was VBD B-VP O
anterior JJ B-NP O
hypokinesis NN I-NP O
as RB O O
well RB O O
as IN B-VP O
apical JJ O O
and CC O O
inferior JJ B-NP O
akinesis NN I-NP O
There EX O O
was VBD B-VP O
severely RB O O
decreased JJ O O
left VBD B-VP O
ventricular JJ B-NP O
function NN I-NP O
The DT B-NP O
pulmonary JJ I-NP O
pressures NNS I-NP O
were VBD B-VP O
fairly RB O O
unremarkable JJ O O
Thus RB O O
, , O O
the DT B-NP O
patient NN I-NP O
presented VBD B-VP O
for IN B-VP O
reop NN B-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
on IN B-VP O
13 CD O O
of IN B-VP O
July NNP B-NP O
Under IN B-VP O
general JJ B-NP O
endotracheal NN I-NP O
anesthesia NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
times NNS B-NP O
three CD O O
was VBD B-VP O
performed VBN O O
The DT B-NP O
right JJ I-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
was VBD B-VP O
grafted VBN O O
to TO O O
the DT B-NP O
first JJ I-NP O
diagonal NN I-NP O
as RB O O
well RB O O
as IN B-VP O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT O O
left VBN O O
anterior JJ B-NP O
descending NN I-NP O
, , O O
the DT B-NP O
old JJ I-NP O
obtuse NN I-NP O
marginal JJ B-NP O
graft NN I-NP O
, , O O
and CC O O
the DT O O
second JJ O O
diagonal JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
dense JJ B-NP O
cardiac JJ I-NP O
adhesions NNS I-NP O
Her PRP$ O O
old JJ B-NP O
right JJ I-NP O
coronary NN I-NP O
artery NN I-NP O
graft NN I-NP O
was VBD B-VP O
occluded VBN O O
and CC O O
the DT B-NP O
old JJ I-NP O
obtuse NN I-NP O
marginal JJ B-NP O
graft NN I-NP O
was VBD B-VP O
tightly RB O O
stenotic JJ O O
at IN B-VP O
the DT B-NP O
origin NN I-NP O
The DT O O
left VBN O O
internal JJ B-NP O
mammary JJ I-NP O
artery NN I-NP O
was VBD B-VP O
subtotally RB O O
occluded VBN O O
distally RB O O
The DT B-NP O
patient NN I-NP O
spontaneously RB O O
defibrillated VBN O O
and CC O O
demonstrated VBN O O
modestly RB O O
decreased VBN O O
left VBD B-VP O
ventricular JJ B-NP O
function NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
stable JJ B-NP O
rhythm NN I-NP O
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
Postoperatively RB O O
the DT B-NP O
patient's NN I-NP O
course NN I-NP O
was VBD B-VP O
thoroughly RB O O
unremarkable JJ O O
The DT B-NP O
patient NN I-NP O
required VBN O O
sodium NN B-NP B-m
Nitroprusside NNP I-NP I-m
in IN B-VP O
the DT B-NP O
immediate JJ I-NP O
postoperative JJ I-NP O
period NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
postoperative JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
successfully RB O O
extubated VBN O O
on IN B-VP O
the DT B-NP O
second JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
and CC O O
her PRP$ O O
mediastinal JJ O O
and CC O O
pleural JJ B-NP O
tubes NNS I-NP O
were VBD B-VP O
also RB O O
pulled VBN O O
without IN B-VP O
significant JJ B-NP O
incident NN I-NP O
The DT B-NP O
patient's NN I-NP O
diuresis NN I-NP O
was VBD B-VP O
initiated VBN O O
and CC O O
tolerated VBN O O
well RB O O
The DT B-NP O
rest NN I-NP O
of IN B-VP O
the DT B-NP O
patient's JJ I-NP O
postoperative JJ I-NP O
course NN I-NP O
was VBD B-VP O
unremarkable JJ O O
She PRP O O
remained VBD B-VP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
without IN B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
arrhythmia NN B-NP O
She PRP O O
was VBD B-VP O
essentially RB O O
afebrile JJ O O
and CC O O
her PRP$ O O
wounds NNS B-NP O
were VBD B-VP O
all DT O O
healing VBG O O
well RB O O
However RB O O
, , O O
on IN B-VP O
chest JJS O O
x-ray JJ O O
it PRP O O
was VBD B-VP O
demonstrated VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
right JJ B-NP O
lower JJR I-NP O
lobe NN I-NP O
collapse NN I-NP O
Because IN B-VP O
of IN B-VP O
her PRP$ O O
afebrile JJ B-NP O
state NN I-NP O
and CC O O
good JJ B-NP O
oxygenation NN I-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
not RB O O
bronch'd VBN O O
in IN B-VP O
order NN B-NP O
to TO O O
re-expand VB O O
her PRP$ O O
right JJ B-NP O
lower JJR I-NP O
lobe NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
dictation NN B-NP O
, , O O
one CD O O
day NN B-NP O
prior RB O O
to TO O O
proposed VBN O O
discharge VB O O
the DT B-NP O
patient's NN I-NP O
chest JJS B-NP O
x-ray NN I-NP O
showed VBD B-VP O
some DT B-NP O
improved JJ I-NP O
aeration NN I-NP O
of IN B-VP O
that DT B-NP O
lower JJR I-NP O
lobe NN I-NP O
Thus NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
will MD O O
likely RB O O
be VB O O
discharged VBN O O
on IN B-VP O
29 CD O O
of IN B-VP O
March NNP B-NP O
DISPOSITION: NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Atenolol NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
baby NN B-NP B-m
aspirin VBD B-VP O
one CD O B-do
po NN B-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Diabinese JJ O B-m
500 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
iron NN B-NP B-m
sulfate NN I-NP O
325 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
tid NN I-NP B-f
, , O O
Colace NNP B-NP B-m
, , O O
Percocet NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
discharged VBN O O
to TO O O
home VB O O
FOLLOW-UP: NNP B-NP O
She PRP O O
will MD O O
follow-up VB O O
with IN B-VP O
Dr NNP B-NP O
Rory NNP I-NP O
Broadnax NNP I-NP O
in IN B-VP O
four CD O O
to TO O O
five CD O O
weeks NNS B-NP O
and CC O O
with IN B-VP O
private JJ B-NP O
medical JJ I-NP O
doctor NN I-NP O
and CC O O
cardiologist NN B-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
also RB O O
have VB O O
visiting VBG O O
nurse JJ O O
come VBN O O
in IN B-VP O
to TO O O
check VB O O
on IN B-VP O
her PRP O O
in IN B-VP O
the DT B-NP O
immediate JJ I-NP O
postoperative JJ I-NP O
period NN I-NP O
XU553/4112 NNP I-NP O
RAMON NNP I-NP O
H NNP I-NP O
LEPEZ NNP I-NP O
, , O O
M.D NNP B-NP O
LM2 NNP I-NP O
D: NNP I-NP O
11/15/91 CD O O
Batch: NNP B-NP O
2629 CD O O
Report: NNP B-NP O
H2454D50 NNP I-NP O
T: NNP I-NP O
9/25/91 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
LEE NNP I-NP O
CATHOLIC NNP I-NP O
, , O O
M.D NNP B-NP O
VS71 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#298021 VBZ O O
977738472 CD O O
CDH NNP B-NP O
18689855 CD O O
8020024 CD O O
7/24/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
angina RB O O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/24/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/30/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
DECICCO NNP I-NP O
, , O O
FAUSTINO NNP B-NP O
541-50-28-4 CD O O
Michigan NNP B-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/9/06 CD O O
AT NNP B-NP O
08:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
CUTLER NNP I-NP O
, , O O
CLAUDIO NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
DUONEB NNP I-NP B-m
( ( O I-m
ALBUTEROL NNP B-NP I-m
AND NNP I-NP I-m
IPRATROPIUM NNP I-NP I-m
NEBULIZER NNP I-NP I-m
) ) O I-m
3/0.5 CD O B-do
MG NNP B-NP I-do
INH NNP I-NP B-mo
Q6H NNP I-NP B-f
ALLOPURINOL NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
AMOXICILLIN NNP I-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
X NNP I-NP B-du
9 CD O I-du
doses NNS B-NP I-du
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
May NNP I-NP O
be VB O O
taken VBN O O
without IN B-VP O
regard NN B-NP O
to TO O O
meals NNS B-NP O
ENTERIC NNP I-NP B-m
COATED NNP I-NP I-m
ASPIRIN NNP I-NP I-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
August NNP I-NP O
ATENOLOL NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PULMICORT NNP I-NP B-m
TURBUHALER NNP I-NP I-m
( ( O I-m
BUDESONIDE NNP B-NP I-m
ORAL NNP I-NP I-m
INHALER NNP I-NP I-m
) ) O I-m
1 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
August NNP I-NP O
Alert NNP I-NP O
overridden: MD O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
10/28/06 CD O O
by IN B-VP O
PINNELL NNP B-NP O
, , O O
JASON NNP B-NP O
E NNP I-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LASIX NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
124703229 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
Sulfa; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NNP B-NP O
home NN I-NP O
medication NN I-NP O
REGLAN NNP I-NP B-m
( ( O I-m
METOCLOPRAMIDE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
RANITIDINE NNP I-NP B-m
HCL NNP I-NP I-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
SENNA NNP I-NP B-m
TABLETS NNP I-NP I-m
( ( O I-m
SENNOSIDES NNP B-NP I-m
) ) O I-m
2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/28/06 CD O O
by IN B-VP O
CRANER NNP B-NP O
, , O O
LUCIEN NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
MULTIVITAMIN NNP B-NP B-m
THERAPEUTIC NNP I-NP O
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
269201277 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MULTIVITAMIN NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVI NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/28/06 CD O O
by IN B-VP O
HAMAR NNP B-NP O
, , O O
ULYSSES NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Please NNP I-NP O
call VB O O
your PRP$ O O
PCP NNP B-NP O
for IN B-VP O
f/u NN B-NP O
appt NN I-NP O
, , O O
ALLERGY: NNP B-NP O
IV NNP I-NP O
Contrast NNP I-NP O
, , O O
IRON NNP B-NP O
ANALOGUES NNP I-NP O
, , O O
Erythromycins NNP B-NP O
, , O O
LEVOFLOXACIN NNP B-NP O
, , O O
Sulfa NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
angina NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
angina VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
ASTHMA/COPD NNP I-NP O
aodm VBZ O O
S/P NNP B-NP O
MI NNP I-NP O
x VBD B-VP O
2 CD O O
S/P NNP B-NP O
V NNP I-NP O
FIB NNP I-NP O
ARREST NNP I-NP O
s/p VBD B-VP O
CABG NNP B-NP O
10/21 CD O O
sleep NN B-NP O
apnea NN I-NP O
obesity NN I-NP O
hypercholesterolemia NN I-NP O
s/p JJ B-NP O
chole NN I-NP O
s/p NN I-NP O
dvt NN I-NP O
-&gt; NNP I-NP O
greenfield VBD B-VP O
aaa JJ B-NP O
repair NN I-NP O
( ( O O
abdominal JJ B-NP O
aortic JJ I-NP O
aneurysm NN I-NP O
) ) O O
diverticular NN B-NP O
abscess NN I-NP O
( ( O O
abscess NN B-NP O
) ) O O
gerd NN B-NP O
( ( O O
gastroesophageal JJ B-NP O
reflux NN I-NP O
disease NN I-NP O
) ) O O
gout NN B-NP O
( ( O O
gout NN B-NP O
) ) O O
dm NN B-NP O
neuropathy JJ O O
( ( O O
neuropathy JJ O O
) ) O O
carpal JJ B-NP O
tunnel NN I-NP O
( ( O O
carpal JJ B-NP O
tunnel NN I-NP O
syndrome NN I-NP O
) ) O O
chf NN B-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
iron NN B-NP O
def NN I-NP O
anemia NN I-NP O
( ( O O
baseline JJ O O
30 CD O O
) ) O O
cri NN B-NP O
( ( O O
1.4 CD O O
to TO O O
2 CD O O
) ) O O
s/p NN B-NP O
sigmoid JJ B-NP O
colectomy NN I-NP O
4/13 CD O O
OSA NNP B-NP O
( ( O O
sleep JJ B-NP O
apnea NN I-NP O
) ) O O
s/p NN B-NP O
R NNP I-NP O
CEA NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
74F CD O O
hx/o NN B-NP O
CAD NNP I-NP O
s/p NN I-NP O
CABG NNP I-NP O
1996 CD O O
, , O O
DMII NNP B-NP O
, , O O
CHF NNP B-NP O
, , O O
hyperlipid NN B-NP O
, , O O
AAA NNP B-NP O
repair NN I-NP O
, , O O
GERD NNP B-NP O
, , O O
hx/o NN B-NP O
DVT NNP I-NP O
s/p VBD B-VP O
Greenfield NNP B-NP O
filter NN I-NP O
, , O O
anemia NN B-NP O
, , O O
who WP O O
p/w VBP O O
CP NNP B-NP O
c VBP O O
typical JJ O O
and CC O O
atypical JJ B-NP O
features NNS I-NP O
after IN B-VP O
recent JJ B-NP O
TKR NNP I-NP O
Pt NNP I-NP O
was VBD B-VP O
recently RB O O
seen VBN O O
by IN B-VP O
Dr NNP B-NP O
Ahlberg NNP I-NP O
and CC O O
sent VBD B-VP O
for IN B-VP O
dobutamine NN B-NP B-m
MIBI NNP I-NP O
to TO O O
risk VB O O
stratify NN B-NP O
in IN B-VP O
prep NN B-NP O
for IN B-VP O
R NNP B-NP O
TKR NNP I-NP O
Had NNP I-NP O
MIBI NNP I-NP O
on IN B-VP O
5/25 CD O O
which WDT O O
showed VBD B-VP O
86% CD O O
MPRH NNP B-NP O
, , O O
no DT B-NP O
clinical JJ I-NP O
ischemia NN I-NP O
, , O O
no DT B-NP O
diagnostic JJ I-NP O
EKG NNP I-NP O
chagnes NNS I-NP O
, , O O
MIBI NNP B-NP O
c VBP O O
small JJ B-NP O
reversible JJ I-NP O
defect NN I-NP O
of IN B-VP O
mod JJ B-NP O
intensity NN I-NP O
in IN B-VP O
mid NN B-NP O
and CC O O
basal NN B-NP O
inferior RB O O
wall PDT O O
This DT O O
was VBD B-VP O
not RB O O
deemed VBN O O
significant JJ O O
and CC O O
pt JJ B-NP O
underwent JJ I-NP O
TKR NNP I-NP O
on IN B-VP O
4/10 CD O O
without IN B-VP O
cardiac JJ B-NP O
complications NNS I-NP O
She PRP O O
was VBD B-VP O
sent VBN O O
to TO O O
rehab VB O O
where WRB O O
she PRP O O
was VBD B-VP O
stable JJ O O
until IN B-VP O
5/22 CD O O
when WRB O O
she PRP O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
Yesterday NN I-NP O
she PRP O O
had VBD B-VP O
3 CD O O
bouts NNS B-NP O
of IN B-VP O
chest JJS B-NP O
pain NN I-NP O
at IN B-VP O
rest NN B-NP O
, , O O
lasting VBG O O
5-10secs JJ O O
at IN B-VP O
a DT B-NP O
time NN I-NP O
, , O O
dull JJ B-NP O
SSCP NNP I-NP O
, , O O
rad NN B-NP O
to TO O O
jaw VB O O
, , O O
non-exertional JJ O O
, , O O
not RB O O
assc JJ B-NP O
c NNS I-NP O
SOB NNP I-NP O
, , O O
N NNP B-NP O
, , O O
V NNP B-NP O
, , O O
D NNP B-NP O
She PRP O O
does VBZ O O
however RB O O
report VB O O
intermittent NN B-NP O
nausea NN I-NP O
and CC O O
vomiting NN B-NP O
since IN B-VP O
her PRP$ O O
surgery NN B-NP O
SHe NNP I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
a DT B-NP O
rule NN I-NP O
out IN B-VP O
and CC O O
possible JJ B-NP O
repeat NN I-NP O
catherization NN I-NP O
She PRP O O
ruled VBD B-VP O
out RP O O
on IN B-VP O
HD#1 NNP B-NP O
and CC O O
it PRP O O
was VBD B-VP O
not RB O O
felt VBN O O
that IN B-VP O
repeat NN B-NP O
stress NN I-NP O
imaging VBG O O
would MD O O
add VB O O
new JJ B-NP O
information NN I-NP O
given VBN O O
her PRP$ O O
recent JJ B-NP O
evaluation NN I-NP O
She PRP O O
refuses VBZ O O
further JJ B-NP O
coronary JJ I-NP O
intervention NN I-NP O
and CC O O
wishes NNS B-NP O
for IN B-VP O
medical JJ B-NP O
treatment NN I-NP O
Discussed VBN O O
c JJ B-NP O
attg NN I-NP O
who WP O O
felt VBD B-VP O
that IN B-VP O
med VBD B-VP O
mgmt NN B-NP O
was VBD B-VP O
appropriate JJ O O
She PRP O O
was VBD B-VP O
additionally RB O O
treated VBN O O
for IN B-VP O
nausea NN B-NP B-r
with IN B-VP O
reglan NN B-NP B-m
A NNP I-NP O
UTI NNP I-NP B-r
was VBD B-VP O
dx'd VBN O O
on IN B-VP O
U/A NNP B-NP O
and CC O O
she PRP O O
was VBD B-VP O
treated VBN O O
c JJ B-NP O
empiric JJ I-NP O
amox NN I-NP B-m
( ( O O
she PRP O O
is VBZ O O
sulfa JJ O O
and CC O O
quinolone JJ B-NP O
allergic NN I-NP O
) ) O O
for IN B-VP B-du
3 CD O I-du
days NNS B-NP I-du
She PRP O O
will MD O O
be VB O O
discharged VBN O O
home NN B-NP O
on IN B-VP O
her PRP$ O O
home NN B-NP B-m
medicines NNS I-NP I-m
including VBG O O
the DT B-NP O
amoxicillin NN I-NP B-m
and CC O O
reglan NN B-NP B-m
as IN B-VP O
discussed VBN O O
above IN B-VP O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
have VBP O O
VNA NNP B-NP O
remove VB O O
staples NNS B-NP O
on IN B-VP O
0/28 CD O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
- : O O
F/u NNP B-NP O
nausea SYM O O
- : O O
F/u NNP B-NP O
Cr NNP I-NP O
, , O O
INR NNP B-NP O
, , O O
HCT NNP B-NP O
- : O O
F/u NNP B-NP O
chest JJS B-NP O
pain NN I-NP O
sxs JJ O O
- : O O
VNA NN B-NP O
to TO O O
remove VB O O
staples NNS B-NP O
from IN B-VP O
knee JJ B-NP O
replacement NN I-NP O
on IN B-VP O
0/28 CD O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BUSUTTIL NNP I-NP O
, , O O
ANTONY NNP B-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
PN293 NNP B-NP O
) ) O O
7/9/06 CD O O
@ $ O O
08:58 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#311514 VBZ O O
157011241 CD O O
SH NNP B-NP O
78994491 CD O O
114569 CD O O
2/5/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/0/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/21/1995 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Patient NNP I-NP O
is VBZ O O
a DT O O
42 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
variegate NN B-NP O
porphyria NNS I-NP O
, , O O
insulin NN B-NP O
dependent NN I-NP O
diabetes NNS I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
, , O O
and CC O O
hypercholesterolemia NN B-NP O
who WP O O
had VBD B-VP O
experienced VBN O O
five CD O O
days NNS B-NP O
of IN B-VP O
confusion NN B-NP O
, , O O
weakness NN B-NP O
, , O O
change NN B-NP O
in IN B-VP O
bowel NN B-NP O
habits NNS I-NP O
, , O O
and CC O O
fatigue NN B-NP O
with IN B-VP O
flashing JJ B-NP O
sensations NNS I-NP O
of IN B-VP O
anxiety NN B-NP O
with IN B-VP O
emotional JJ B-NP O
lability NN I-NP O
Patient NNP I-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
variegate NN B-NP O
porphyria NNS I-NP O
for IN B-VP O
about IN B-VP O
fifteen JJ B-NP O
years NNS I-NP O
, , O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Nigel NNP I-NP O
Wickenhauser NNP I-NP O
, , O O
and CC O O
she PRP O O
had VBD B-VP O
been VBN O O
relatively RB O O
free JJ O O
of IN B-VP O
porphyria NN B-NP O
attacks NNS I-NP O
with IN B-VP O
the DT O O
last JJ O O
major JJ O O
one CD O O
approximately RB O O
twelve CD O O
years NNS B-NP O
ago RB O O
with IN B-VP O
symptoms NNS B-NP O
similar JJ O O
to TO O O
those DT O O
she PRP O O
was VBD B-VP O
experiencing VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
admission NN I-NP O
In IN B-VP O
May NNP B-NP O
1994 CD O O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
mild JJ I-NP O
porphyria NN I-NP O
attack NN I-NP O
which WDT O O
was VBD B-VP O
managed VBN O O
by IN B-VP O
stopping VBG O O
all DT O O
her PRP$ O O
medications NNS B-NP O
She PRP O O
intermittently RB O O
had VBD B-VP O
skin JJ B-NP O
lesions NNS I-NP O
, , O O
especially RB O O
with IN B-VP O
sun JJ B-NP O
exposure NN I-NP O
She PRP O O
had VBD B-VP O
never RB O O
been VBN O O
phlebotomized VBN O O
or CC O O
received VBN O O
other JJ B-NP O
treatments NNS I-NP O
In IN B-VP O
the DT O O
past JJ O O
two CD O B-du
months NNS B-NP I-du
, , O O
she PRP O O
had VBD B-VP O
been VBN O O
taking VBG O O
Ativan NNP B-NP B-m
of IN B-VP O
3-4 JJ B-NP B-do
mg NN I-NP I-do
q.d NN I-NP B-f
for IN B-VP O
anxiety NN B-NP B-r
She PRP O O
stopped VBD B-VP O
taking VBG O O
Ativan NNP B-NP B-m
on IN B-VP O
March NNP B-NP O
, , O O
1995 CD O O
and CC O O
after IN B-VP O
this DT B-NP O
abrupt JJ I-NP O
stopping NN I-NP O
of IN B-VP O
this DT B-NP B-m
medication NN I-NP O
, , O O
she PRP O O
started VBD B-VP O
to TO O O
have VB O O
feelings NNS B-NP O
of IN B-VP O
disorientation NN B-NP O
, , O O
confusion NN B-NP O
, , O O
and CC O O
fatigue NN B-NP O
with IN B-VP O
emotional JJ B-NP O
lability NN I-NP O
She PRP O O
also RB O O
was VBD B-VP O
in IN B-VP O
Idaho NNP B-NP O
with IN B-VP O
extensive JJ B-NP O
sun NN I-NP O
exposure NN I-NP O
in IN B-VP O
the DT O O
last JJ O O
two CD O O
weeks NNS B-NP O
She PRP O O
contacted VBD B-VP O
Dr NNP B-NP O
Furuya NNP I-NP O
who WP O O
advised VBD B-VP O
her PRP O O
to TO O O
increase VB O O
her PRP$ O O
carbohydrate JJ B-NP O
intake NN I-NP O
to TO O O
about IN B-VP O
400 CD O O
grams NNS B-NP O
a DT B-NP O
day NN I-NP O
, , O O
however RB O O
, , O O
her PRP O O
symptoms NNS B-NP O
progressed VBD B-VP O
Two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
she PRP O O
felt VBD B-VP O
weak JJ O O
and CC O O
while IN B-VP O
standing VBG O O
, , O O
her PRP$ O O
legs NNS B-NP O
gave VBD B-VP O
way NN B-NP O
without IN B-VP O
losing VBG O O
consciousness NN B-NP O
She PRP O O
felt VBD B-VP O
weak JJ O O
throughout IN B-VP O
the DT B-NP O
week NN I-NP O
before IN B-VP O
admission NN B-NP O
with IN B-VP O
no DT B-NP O
vertigo NN I-NP O
, , O O
tinnitus NN B-NP O
, , O O
or CC O O
ataxia VB O O
She PRP O O
also RB O O
felt VBD B-VP O
paresthesias NNS B-NP O
of IN B-VP O
the DT B-NP O
hands NNS I-NP O
and CC O O
feet NNS B-NP O
but CC O O
not RB O O
perioral JJ O O
and CC O O
she PRP O O
also RB O O
experienced VBD B-VP O
episodes NNS B-NP O
of IN B-VP O
flushing NN B-NP O
and CC O O
tremulousness NN B-NP O
with IN B-VP O
a DT B-NP O
feeling NN I-NP O
of IN B-VP O
rushing VBG O O
sensation NN B-NP O
in IN B-VP O
the DT B-NP O
chest NN I-NP O
with IN B-VP O
no DT B-NP O
tachycardia NN I-NP O
associated VBN O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
symptomatology NN I-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
fevers NNS I-NP O
with IN B-VP O
the DT B-NP O
sensation NN I-NP O
of IN B-VP O
flushing NN B-NP O
and CC O O
feeling NN B-NP O
of IN B-VP O
burning VBG O O
up RP O O
She PRP O O
had VBD B-VP O
several JJ B-NP O
bouts NNS I-NP O
of IN B-VP O
diarrhea NN B-NP O
intermingled VBN O O
with IN B-VP O
constipation NN B-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
patient NN B-NP O
became VBD B-VP O
confused JJ O O
and CC O O
disoriented VBN O O
while IN B-VP O
driving VBG O O
and CC O O
she PRP O O
came VBD B-VP O
to TO O O
see VB O O
Dr NNP B-NP O
Heyn NNP I-NP O
in IN B-VP O
the DT B-NP O
VVH NNP I-NP O
Clinic NNP I-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
evaluation NN B-NP O
of IN B-VP O
a DT B-NP O
possible JJ I-NP O
porphyria NN I-NP O
attack NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
only JJ I-NP O
new JJ I-NP O
medications NNS I-NP O
that IN B-VP O
she PRP O O
had VBD B-VP O
been VBN O O
taking VBG O O
was VBD B-VP O
chloral JJ B-NP B-m
hydrate NN I-NP I-m
for IN B-VP O
the DT O O
last JJ O O
five CD O B-du
days NNS B-NP I-du
and CC O O
Compazine NNP B-NP B-m
with IN B-VP O
one CD O B-do
dose NN B-NP I-do
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
) ) O O
Insulin NNP B-NP O
dependent NN I-NP O
diabetes VBZ O O
2 CD O O
) ) O O
Coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
PTCA NNP I-NP O
times NNS I-NP O
two CD O O
and CC O O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
anterior JJ I-NP O
descending NN I-NP O
in IN B-VP O
3/21 CD O O
Exercise NN B-NP O
tolerance NN I-NP O
test NN I-NP O
was VBD B-VP O
noted VBN O O
before IN B-VP O
catheterization NN B-NP O
and CC O O
she PRP O O
had VBD B-VP O
a DT B-NP O
catheterization NN I-NP O
in IN B-VP O
7/14 CD O O
for IN B-VP O
angina NN B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
patent NN I-NP O
LIMA NNP I-NP O
graft NN I-NP O
, , O O
60% CD O O
proximal NN B-NP O
left VBD B-VP O
anterior JJ O O
descending VBG O O
lesion NN B-NP O
, , O O
and CC O O
50% CD O O
right JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
stenosis NN I-NP O
3 CD O O
) ) O O
Hypercholesterolemia NNP B-NP O
, , O O
did VBD B-VP O
not RB O O
tolerate VB O O
cholestyramine NN B-NP O
4 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
left VBD B-VP O
ulna JJ B-NP O
entrapment JJ I-NP O
release NN I-NP O
two CD O O
months NNS B-NP O
ago IN B-VP O
5 CD O O
) ) O O
Hypertension NNP B-NP O
6 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
excisional JJ B-NP O
biopsy NN I-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
breast; VBZ O O
the DT B-NP O
pathology NN I-NP O
of IN B-VP O
the DT B-NP O
lesion NN I-NP O
was VBD B-VP O
diabetic JJ B-NP O
mastopathy JJ I-NP O
ALLERGIES: NNP I-NP O
Morphine NNP I-NP O
which WDT O O
gave VBD B-VP O
her PRP O O
a DT B-NP O
rash NN I-NP O
and CC O O
patient NN B-NP O
avoided VBD B-VP O
multiple JJ B-NP O
medications NNS I-NP O
which WDT O O
were VBD B-VP O
known VBN O O
to TO O O
worsen VB O O
porphyria NNS B-NP O
such JJ O O
as IN B-VP O
sulfa NN B-NP O
drugs NNS I-NP O
( ( O O
not RB O O
allgergies NNS B-NP O
) ) O O
CURRENT NNP B-NP O
MEDICATIONS: NNP I-NP O
At IN B-VP O
home NN B-NP O
, , O O
patient JJ O O
took VBD B-VP O
insulin NN B-NP B-m
NPH NNP I-NP I-m
25 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP O
morning NN I-NP O
with IN B-VP O
Regular JJ O B-m
10 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP O
morning NN I-NP O
, , O O
aspirin RB O B-m
81 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Compazine NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
q.6h NN I-NP B-f
p.r.n JJ B-NP I-f
anxiety NN I-NP B-r
of IN B-VP O
which WDT O O
she PRP O O
took VBD B-VP O
only RB O O
one CD O O
dose NN B-NP O
, , O O
and CC O O
chloral JJ B-NP B-m
hydrate NN I-NP O
500 CD O B-do
to TO O I-do
1000 CD O I-do
mg NN B-NP I-do
q.h.s NN I-NP B-f
for IN B-VP B-du
five CD O I-du
days NNS B-NP I-du
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
married VBN O O
for IN B-VP O
fifteen JJ B-NP O
years NNS I-NP O
with IN B-VP O
one CD O O
son NN B-NP O
and CC O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
smoking NN B-NP O
or CC O O
ethanol NN B-NP O
use NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
a DT B-NP O
pale NN I-NP O
and CC O O
anxious JJ B-NP O
white JJ I-NP O
female NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
with IN B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
99.5 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
134/70 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
of IN B-VP O
92 CD O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
of IN B-VP O
18 CD O O
, , O O
and CC O O
O2 NNP B-NP O
saturation NN I-NP O
of IN B-VP O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
HEENT: NNP I-NP O
Examination NNP I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
oropharynx NN B-NP O
with IN B-VP O
upper JJ B-NP O
dentures NNS I-NP O
and CC O O
sclerae NNS B-NP O
were VBD B-VP O
anicteric JJ B-NP O
NECK: NNP I-NP O
Supple NNP I-NP O
with IN B-VP O
no DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
, , O O
no DT B-NP O
lymphadenopathy NN I-NP O
, , O O
and CC O O
thyroid NN B-NP O
was VBD B-VP O
not RB O O
palpable JJ B-NP O
CHEST: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
with IN B-VP O
no DT B-NP O
costovertebral JJ I-NP O
angle NN I-NP O
tenderness NN I-NP O
BREASTS: NNP I-NP O
Examination NNP I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
fully RB O O
healed VBN O O
scar NN B-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
breast NN I-NP O
CARDIOVASCULAR: NNP I-NP O
Examination NNP I-NP O
showed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
and CC O O
2/6 CD O O
systolic JJ O O
murmur RB O O
heard RB O O
best JJS O O
at IN B-VP O
the DT B-NP O
apex NN I-NP O
ABDOMEN: NNP I-NP O
Soft NNP I-NP O
with IN B-VP O
good JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
non-tender NN B-NP O
, , O O
and CC O O
non-distended JJ B-NP O
EXTREMITIES: NNP I-NP O
1+ CD O O
pedal NN B-NP O
pulses NNS I-NP O
bilaterally RB O O
and CC O O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
, , O O
or CC O O
edema VB O O
SKIN: NNP B-NP O
Examination NNP I-NP O
showed VBD B-VP O
a DT B-NP O
blister NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
hand NN I-NP O
fourth JJ O O
and CC O O
fifth JJ B-NP O
digit NN I-NP O
interspace NN I-NP O
and CC O O
healed VBD B-VP O
lesions NNS B-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
hand NN I-NP O
NEUROLOGICAL: NNP I-NP O
Examination NN I-NP O
showed VBD B-VP O
her PRP O O
to TO O O
be VB O O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
three CD O O
with IN B-VP O
a DT B-NP O
normal JJ I-NP O
mental JJ I-NP O
status NN I-NP O
examination NN I-NP O
with IN B-VP O
no DT B-NP O
confusion NN I-NP O
noted VBD B-VP O
Cranial JJ B-NP O
nerves NNS I-NP O
were VBD B-VP O
intact JJ O O
, , O O
motor NN B-NP O
was VBD B-VP O
symmetric JJ O O
of IN B-VP O
3-4/5 JJ O O
on IN B-VP O
all DT B-NP O
muscle NN I-NP O
groups NNS I-NP O
, , O O
sensory JJ B-NP O
examination NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
decrease NN B-NP O
to TO O O
light JJ B-NP O
touch NN I-NP O
in IN B-VP O
the DT B-NP O
distal JJ I-NP O
feet NNS I-NP O
and CC O O
hands NNS B-NP O
, , O O
deep JJ B-NP O
tendon NN I-NP O
reflexes NNS I-NP O
were VBD B-VP O
symmetric JJ O O
and CC O O
1-2+ JJ O O
throughout IN B-VP O
, , O O
and CC O O
coordination NN B-NP O
showed VBD B-VP O
rapid JJ O O
alternating VBG O O
movements NNS B-NP O
and CC O O
finger-to-nose JJ O O
both DT O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Gait NNP I-NP O
was VBD B-VP O
mildly RB O O
wide JJ O O
based VBN O O
with IN B-VP O
normal JJ B-NP O
heel-to-toe JJ I-NP O
walk NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
no DT B-NP O
pronator NN I-NP O
drift NN I-NP O
, , O O
and CC O O
Romberg NNP B-NP O
was VBD B-VP O
positive JJ B-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
admission NN B-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
a DT B-NP O
BUN NNP I-NP O
of IN B-VP O
17 CD O O
, , O O
creatinine NN B-NP O
of IN B-VP O
1.0 CD O O
, , O O
glucose NN B-NP O
was VBD B-VP O
364 CD O O
, , O O
liver JJR B-NP O
function NN I-NP O
tests NNS I-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
7.2 CD O O
, , O O
hematocrit NN B-NP O
was VBD B-VP O
36 CD O O
, , O O
and CC O O
platelet NN B-NP O
count NN I-NP O
was VBD B-VP O
266 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
possible JJ B-NP O
porphyria NN I-NP O
attack NN I-NP O
versus NN I-NP O
Ativan NNP I-NP B-m
withdrawal NN I-NP O
symptoms NNS I-NP O
versus IN B-VP O
anxiety NN B-NP B-r
attack NN I-NP I-r
Neurology NNP I-NP O
consultation NN I-NP O
was VBD B-VP O
obtained VBN O O
who WP O O
felt VBD B-VP O
that IN B-VP O
patient's JJ B-NP O
peripheral JJ I-NP O
neuropathy NN I-NP O
was VBD B-VP O
probably RB O O
secondary JJ O O
to TO O O
longstanding VBG O O
diabetes NNS B-NP O
but CC O O
felt VBD B-VP O
that IN B-VP O
some DT O O
of IN B-VP O
her PRP$ O O
symptomatology NN B-NP O
could MD O O
be VB O O
consistent JJ O O
with IN B-VP O
porphyria JJ B-NP O
Patient NNP I-NP O
was VBD B-VP O
also RB O O
seen VBN O O
by IN B-VP O
Psychiatry NNP B-NP O
who WP O O
felt VBD B-VP O
that IN B-VP O
this DT B-NP O
episode NN I-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
generalized JJ B-NP B-r
anxiety NN I-NP I-r
disorder NN I-NP I-r
separated VBN O O
by IN B-VP O
post NN B-NP O
dysthymia NN I-NP O
and CC O O
suggested VBD B-VP O
phenothiazines NNS B-NP B-m
which WDT O O
are VBP O O
proven VBN O O
to TO O O
be VB O O
safe JJ O O
in IN B-VP O
porphyria NN B-NP O
for IN B-VP O
treatment NN B-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Trilafon NNP B-NP B-m
2 CD O B-do
to TO O I-do
4 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
p.r.n NN I-NP B-f
q.6h NN I-NP O
for IN B-VP O
anxiety NN B-NP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
seen VBN O O
to TO O O
be VB O O
orthostatic JJ O O
which WDT O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
dehydration VB O O
secondary JJ O O
to TO O O
poor JJ B-NP O
p.o NNS I-NP O
intake VBP O O
prior JJ O O
to TO O O
admission VB O O
She PRP O O
was VBD B-VP O
also RB O O
hyperglycemic JJ O O
on IN B-VP O
admission NN B-NP O
which WDT O O
may MD O O
have VB O O
contributed VBN O O
to TO O O
her PRP$ O O
dehydration NN B-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
normal JJ B-NP B-m
saline NN I-NP I-m
boluses NNS I-NP B-mo
and CC O O
her PRP$ O B-r
orthostasis NN B-NP I-r
improved VBD B-VP O
Her NNP B-NP O
Lopressor NNP I-NP B-m
was VBD B-VP O
also RB O O
held VBN O O
with IN B-VP O
this DT B-NP O
episode NN I-NP O
of IN B-VP O
orthostasis NN B-NP O
The DT B-NP O
Watson-Schwartz JJ I-NP O
test NN I-NP O
done VBN O O
by IN B-VP O
Dr NNP B-NP O
Mohar NNP I-NP O
on IN B-VP O
patient JJ O O
very RB O O
early RB O O
in IN B-VP O
the DT B-NP O
admission NN I-NP O
was VBD B-VP O
negative JJ O O
which WDT O O
made VBD B-VP O
an DT B-NP O
acute JJ I-NP O
porphyria NN I-NP O
attack NN I-NP O
very RB O O
unlikely JJ O O
These DT B-NP O
episodes NNS I-NP O
were VBD B-VP O
felt VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
anxiety NN B-NP O
attack NN I-NP O
and CC O O
rapid JJ B-NP O
taper NN I-NP O
of IN B-VP O
Ativan NNP B-NP B-m
which WDT O O
she PRP O O
had VBD B-VP O
been VBN O O
taking VBG O O
at IN B-VP O
moderately RB O O
high JJ B-NP B-do
doses NNS I-NP I-do
for IN B-VP O
the DT O O
last JJ O O
two CD O B-du
months NNS B-NP I-du
Patient NNP I-NP O
also RB O O
developed VBD B-VP O
urinary JJ B-NP B-r
tract NN I-NP I-r
infection NN I-NP I-r
symptoms NNS I-NP I-r
and CC O O
her PRP$ O O
urine JJ B-NP O
culture NN I-NP O
showed VBD B-VP O
greater JJR O O
than IN B-VP O
100 CD O O
, , O O
000 CD O O
colonies NNS B-NP O
of IN B-VP O
E NNP B-NP B-r
coli NNS I-NP I-r
which WDT O O
were VBD B-VP O
pansensitive JJ O O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Keflex NNP B-NP B-m
Keflex NNP I-NP B-m
500 CD O B-do
500 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
p.o NN I-NP B-mo
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
t.i.d NN I-NP B-f
which WDT O O
is VBZ O O
shown VBN O O
to TO O O
be VB O O
safe JJ O O
in IN B-VP O
porphyria JJ B-NP O
DISPOSITION: NNP I-NP O
Patient NNP I-NP O
is VBZ O O
discharged VBN O O
to TO O O
home NN B-NP O
on IN B-VP O
August NNP B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Aspirin NNP I-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
insulin NN B-NP B-m
NPH NNP I-NP I-m
25 CD O B-do
units NNS B-NP O
subcutaneously RB O B-mo
q.a.m RB O B-f
, , O O
insulin NN B-NP B-m
regular JJ O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
q.a.m RB O B-f
, , O O
Trilafon NNP B-NP B-m
2 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.6h NN I-NP B-f
, , O O
and CC O O
Keflex NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d JJ B-NP B-f
FOLLOW-UP: NNP I-NP O
Follow-up NNP I-NP O
will MD O O
be VB O O
with IN B-VP O
Dr NNP B-NP O
Dario NNP I-NP O
Rodriquz NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BERNARD NNP I-NP O
SYPOLT NNP I-NP O
, , O O
M.D NNP B-NP O
UT0 NNP I-NP O
Attending: NNP I-NP O
JASPER NNP I-NP O
E NNP I-NP O
FIDO NNP I-NP O
, , O O
M.D NNP B-NP O
XK1 NNP I-NP O
SR568/7648 NNP I-NP O
Batch: NNP I-NP O
65143 CD O O
Index NNP B-NP O
No NNP I-NP O
ZIBANI61IH NNP I-NP O
D: NNP I-NP O
9/0/95 CD O O
T: NNP B-NP O
1/2/95 CD O O
addendum: VBD B-VP O
Her PRP O O
24 CD O O
hour NN B-NP O
urinary JJ B-NP O
porphobilinogen NN I-NP O
and CC O O
delta-aminolevulinic JJ B-NP O
acid NN I-NP O
were VBD B-VP O
both DT O O
normal JJ O O
, , O O
corroborating VBG O O
the DT B-NP O
Watson NNP I-NP O
Schwartz NNP I-NP O
test NN I-NP O
and CC O O
ruling VBG O O
out RP O O
an DT B-NP O
acute NN I-NP O
porphyric JJ B-NP O
attack NN I-NP O
ch97 NN I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#311829 VBZ O O
650364230 CD O O
TH NNP B-NP O
92473563 CD O O
9014233 CD O O
0/21/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
RENAL NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/19/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/14/2005 CD O O
ATTENDING: NNP B-NP O
SATERFIELD NNP I-NP O
, , O O
JAYSON NNP B-NP O
D NNP I-NP O
MEDICAL NNP I-NP O
SERVICE: NNP I-NP O
Milbrown NNP I-NP O
Ae NNP I-NP O
A NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSES: NNP I-NP O
Acute NNP I-NP O
renal JJ B-NP O
failure NN I-NP O
, , O O
anemia JJ B-NP O
LIST NNP I-NP O
OF NNP I-NP O
PROBLEMS/DIAGNOSES: NNP I-NP O
Hypertension NNP I-NP O
, , O O
family NN B-NP O
history NN I-NP O
of IN B-VP O
CAD NNP B-NP O
, , O O
degenerative JJ B-NP O
joint NN I-NP O
disease NN I-NP O
, , O O
depression NN B-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
pulmonary JJ B-NP O
hypertension NN I-NP O
and CC O O
morbid JJ B-NP O
obesity NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
A NNP I-NP O
60-year-old JJ O O
morbidly RB O O
obese JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
degenerative JJ B-NP O
joint NN I-NP O
disease NN I-NP O
, , O O
and CC O O
recent JJ B-NP O
falls NNS I-NP O
, , O O
now RB O O
in IN B-VP O
rehab NN B-NP O
since IN B-VP O
2/10 CD O O
, , O O
most RBS O O
recently RB O O
at IN B-VP O
Stusem NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
, , O O
who WP O O
presented VBD B-VP O
with IN B-VP O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
found VBN O O
on IN B-VP O
routine JJ B-NP O
labs NN I-NP O
, , O O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
The DT B-NP O
creatinine NN I-NP O
was VBD B-VP O
3.6 CD O O
on IN B-VP O
admission NN B-NP O
up IN B-VP O
from IN B-VP O
1 CD O O
in IN B-VP O
5/13 CD O O
and CC O O
up RB O O
from IN B-VP O
2.2 CD O O
in IN B-VP O
7/24 CD O O
BUN NNP B-NP O
was VBD B-VP O
elevated VBN O O
at IN B-VP O
96 CD O O
Labs NNS B-NP O
were VBD B-VP O
also RB O O
notable JJ O O
for IN B-VP O
hematocrit NN B-NP O
of IN B-VP O
24 CD O O
down IN B-VP O
from IN B-VP O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
44 CD O O
in IN B-VP O
2001 CD O O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
being VBG O O
told VBD B-VP O
that IN B-VP O
she PRP O O
had VBD B-VP O
chronic JJ B-NP O
kidney NN I-NP O
disease NN I-NP O
during IN B-VP O
an DT B-NP O
admission NN I-NP O
to TO O O
SITMH NNP B-NP O
in IN B-VP O
2/10 CD O O
, , O O
attributed VBD B-VP O
to TO O O
heavy VB O O
NSAID NNP B-NP B-m
use NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
degenerative JJ B-NP B-r
joint JJ I-NP I-r
disease NN I-NP I-r
The DT B-NP O
patient NN I-NP O
stopped VBD B-VP O
using VBG O O
NSAIDs NNP B-NP B-m
in IN B-VP O
7/24 CD O O
Prior NNP B-NP O
to TO O O
July NNP B-NP O
, , O O
she PRP O O
reports VBZ O O
decreased VBD B-VP O
p.o NNS B-NP O
intake VB O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
feeling VBG O O
like IN B-VP O
she PRP O O
was VBD B-VP O
retaining VBG O O
fluid NN B-NP O
Today NN I-NP O
, , O O
she PRP O O
complains VBZ O O
of IN B-VP O
diffuse NN B-NP O
swelling VBG O O
and CC O O
increased JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath JJ B-NP O
x2-3 JJ I-NP O
weeks NNS I-NP O
Denies VBZ O O
chest JJS B-NP O
pain NN I-NP O
, , O O
orthopnea NN B-NP O
or CC O O
PND NNP B-NP O
Also RB O O
, , O O
reports NNS B-NP O
dysuria NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
indwelling VBG O O
Foley NNP B-NP O
since IN B-VP O
7/24 CD O O
Denies NNPS B-NP O
fever NN I-NP O
, , O O
chills NNS B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
no DT B-NP O
melena NN I-NP O
or CC O O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
in IN B-VP O
the DT O O
last JJ O O
six CD O O
months NNS B-NP O
but CC O O
reports NNS B-NP O
melena NN I-NP O
and CC O O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
intermittently RB O O
in IN B-VP O
2003 CD O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
colonoscopy NN B-NP O
that WDT O O
was VBD B-VP O
positive JJ O O
for IN B-VP O
diverticula JJ B-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAM: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile JJ O O
with IN B-VP O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
ranging VBG O O
from IN B-VP O
60-90 JJ O O
, , O O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
120-140 JJ O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
of IN B-VP O
18 CD O O
, , O O
she PRP O O
was VBD B-VP O
satting VBG O O
95% CD O O
on IN B-VP O
2-4 JJ B-NP O
liters NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
obese JJ O O
nonmobile RB O O
, , O O
alert NN B-NP O
and CC O O
oriented VBN O O
x3 NN B-NP O
and CC O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Pupils NNP I-NP O
were VBD B-VP O
equal JJ B-NP O
round NN I-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Sclerae NNP I-NP O
were VBD B-VP O
anicteric JJ O O
She PRP O O
had VBD B-VP O
no DT B-NP O
conjunctival JJ I-NP O
pallor NN I-NP O
JVP NNP I-NP O
could MD O O
not RB O O
be VB O O
assessed VBN O O
due JJ O O
to TO O O
body NN B-NP O
habitus VB O O
She PRP O O
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
II/VI NNP I-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
audible JJ O O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
Lungs NNS I-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
crackles NNS B-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
base NN I-NP O
on IN B-VP O
anterior JJ B-NP O
lung NN I-NP O
exam NN I-NP O
, , O O
they PRP O O
were VBD B-VP O
otherwise RB O O
clear JJ B-NP O
Her NNP I-NP O
abdomen NN I-NP O
was VBD B-VP O
obese JJ O O
, , O O
she PRP O O
had VBD B-VP O
positive JJ B-NP O
bowel NN I-NP O
sound VBD B-VP O
It PRP O O
was VBD B-VP O
soft JJ O O
, , O O
nondistended JJ O O
and CC O O
nontender JJ B-NP O
Extremities NNS I-NP O
were VBD B-VP O
warm JJ O O
and CC O O
well RB O O
perfused JJ O O
She PRP O O
had VBD B-VP O
2+ CD O O
pitting VBG O O
edema NN B-NP O
to TO O O
the DT B-NP O
knee NN I-NP O
bilaterally RB O O
Pertinent NNP B-NP O
lab NN I-NP O
results NNS I-NP O
as IN B-VP O
mentioned VBN O O
in IN B-VP O
the DT B-NP O
HPI NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES NNP I-NP O
DURING NNP I-NP O
THE NNP I-NP O
ADMISSION: NNP I-NP O
1/29/05 CD O O
creation NN B-NP O
of IN B-VP O
left JJ B-NP O
arm NN I-NP O
AV NNP I-NP O
fistula; VBD B-VP O
11/20/05 CD O O
EGD NNP B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEM: NNP I-NP O
In IN B-VP O
summary JJ O O
, , O O
this DT O O
is VBZ O O
a DT O O
60-year-old JJ O O
morbidly RB O O
obese JJ B-NP O
woman NN I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
acute NN B-NP O
and CC O O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
and CC O O
anemia NN B-NP O
PROBLEM: NNP I-NP O
1 CD O O
Renal: NNP B-NP O
Renal NNP I-NP O
failure NN I-NP O
initially RB O O
thought VBD B-VP O
to TO O O
be VB O O
secondary JJ O O
to TO O O
prerenal JJ B-NP O
etiology NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
elevated JJ B-NP O
BUN/creatinine NNP I-NP O
ratio NN I-NP O
and CC O O
FENA NNP B-NP O
less JJR O O
than IN B-VP O
1% CD O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
Lasix NNP B-NP B-m
and CC O O
FEBUN NNP B-NP O
of IN B-VP O
19% CD O O
and CC O O
because IN B-VP O
of IN B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
abundant JJ B-NP O
granular JJ I-NP O
casts NNS I-NP O
ATN NNP I-NP O
also RB O O
possibility NN B-NP O
but CC O O
urine JJ B-NP O
sodium NN I-NP O
was VBD B-VP O
29 CD O O
Postrenal NNP B-NP O
etiology NN I-NP O
was VBD B-VP O
ruled VBN O O
out RP O O
with IN B-VP O
a DT B-NP O
renal JJ I-NP O
ultrasound NN I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
hydronephrosis NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
aggressively RB O O
hydrated VBN O O
once RB O O
outside JJ B-NP O
hospital NN I-NP O
records NNS I-NP O
confirmed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
60% CD O O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
initially RB O O
appeared VBD B-VP O
to TO O O
fail VB O O
volume NN B-NP O
challenge NN I-NP O
with IN B-VP O
no DT B-NP O
acute JJ I-NP O
change NN I-NP O
in IN B-VP O
creatinine NN B-NP O
past IN B-VP O
3.2 CD O O
from IN B-VP O
2/16/05 CD O O
to TO O O
7/26/05 CD O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
Vascular NNP B-NP O
Surgery NNP I-NP O
was VBD B-VP O
consulted VBN O O
for IN B-VP O
AV NNP B-NP O
fistula NN I-NP O
placement NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
GFR NNP B-NP O
of IN B-VP O
approximately RB O O
17 CD O O
that WDT O O
was VBD B-VP O
not RB O O
improving VBG O O
AV NNP B-NP O
fistula NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
1/29/05 CD O O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
arm NN I-NP O
without IN B-VP O
complication NN B-NP O
Renal NNP I-NP O
function NN I-NP O
was VBD B-VP O
waxing VBG O O
and CC O O
waning VBG O O
throughout IN B-VP O
hospital JJ B-NP O
course NN I-NP O
with IN B-VP O
creatinine NN B-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
of IN B-VP O
3.1 CD O O
Daily NNP B-NP O
urine JJ B-NP O
output NN I-NP O
usually RB O O
approximately RB O O
600-700 JJ B-NP O
mL NN I-NP O
All DT B-NP O
diuretics NNS I-NP B-m
and CC O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
was VBD B-VP O
held VBN O O
throughout IN B-VP B-du
hospital JJ B-NP O
course NN I-NP O
and CC O O
blood NN B-NP O
pressure NN I-NP O
well RB O O
controlled VBD B-VP O
The DT B-NP O
patient NN I-NP O
should MD O O
not RB O O
be VB O O
restarted VBN O O
on IN B-VP O
these DT B-NP B-m
medications NNS I-NP I-m
because IN B-VP O
it PRP O O
will MD O O
precipitate VB O O
worsening VBG O O
kidney JJ B-NP O
failure NN I-NP O
2 CD O O
GI: NNP B-NP O
Colonoscopy NNP I-NP O
in IN B-VP O
2001/2003 CD O O
notable JJ O O
for IN B-VP O
diverticula JJ B-NP O
Stool NNP I-NP O
was VBD B-VP O
guaiac VBN O O
throughout IN B-VP O
hospital JJ B-NP O
course NN I-NP O
and CC O O
generally RB O O
guaiac JJ B-NP O
positive JJ I-NP O
brown JJ I-NP O
stool NN I-NP O
Hematocrit NNP I-NP O
did VBD B-VP O
not RB O O
bump VB O O
appropriately RB O O
after IN B-VP O
transfusion NN B-NP O
of IN B-VP O
4 CD O O
units NNS B-NP O
It PRP O O
went VBD B-VP O
from IN B-VP O
23.3-30 JJ B-NP O
GI NNP I-NP O
was VBD B-VP O
consulted VBN O O
in IN B-VP O
this DT B-NP O
setting NN I-NP O
and CC O O
plans NNS B-NP O
were VBD B-VP O
made VBN O O
for IN B-VP O
EGD NNP B-NP O
and CC O O
colonoscopy NN B-NP O
to TO O O
look VB O O
for IN B-VP O
a DT B-NP O
source NN I-NP O
of IN B-VP O
GI NNP B-NP O
bleed VBD B-VP O
Both DT B-NP O
procedures NNS I-NP O
were VBD B-VP O
scheduled VBN O O
in IN B-VP O
OR NNP B-NP O
and CC O O
attempted VBN O O
on IN B-VP O
5/3/05 CD O O
EGD NNP B-NP O
successfully RB O O
performed VBD B-VP O
with IN B-VP O
evidence NN B-NP O
of IN B-VP O
gastritis NN B-NP O
, , O O
nonbleeding VBG O O
ulcer NN B-NP O
, , O O
and CC O O
duodenal JJ B-NP O
mass NN I-NP O
with IN B-VP O
gastric JJ B-NP O
heterotopia NN I-NP O
H NNP I-NP O
pylori VBZ O O
stool JJ B-NP O
antigen NN I-NP O
and CC O O
H NNP B-NP O
pylori JJ B-NP O
biopsies NNS I-NP O
negative JJ B-NP O
Patient NNP I-NP O
continued VBD B-VP O
on IN B-VP O
Nexium NNP B-NP B-m
40 CD O B-do
mg JJ B-NP O
daily JJ I-NP B-f
Colonoscopy NNP I-NP O
not RB O O
obtained VBD B-VP O
unable JJ O O
to TO O O
get VB O O
past IN B-VP O
the DT B-NP O
rectum NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
required VBN O O
general JJ B-NP O
anesthesia/ETT NN I-NP O
in IN B-VP O
patient's NN B-NP O
thighs NNS I-NP O
3 CD O O
Cardiovascular/Pump NNP B-NP O
- : O O
ECHO NN B-NP O
with IN B-VP O
EF NNP B-NP O
equal JJ O O
to TO O O
65% CD O O
here RB O O
, , O O
moderate JJ B-NP O
diastolic JJ I-NP O
dysfunction NN I-NP O
and CC O O
moderate JJ B-NP O
pulmonary JJ I-NP O
hypertension NN I-NP O
No NNP I-NP O
rhythm NN I-NP O
or CC O O
ischemia NN B-NP O
issues NNS I-NP O
during IN B-VP O
hospital JJ B-NP O
course NN I-NP O
, , O O
low JJ B-NP O
HDL NNP I-NP O
, , O O
started VBD B-VP O
on IN B-VP O
statin NN B-NP B-m
4 CD O O
Heme/normocytic NNP B-NP O
anemia NN I-NP O
, , O O
likely RB O O
secondary JJ O O
to TO O O
GI NNP B-NP O
bleed NN I-NP O
with IN B-VP O
evidence NN B-NP O
of IN B-VP O
iron NN B-NP O
deficiency NN I-NP O
Iron NNP I-NP O
stores NNS I-NP O
repleted VBD B-VP O
with IN B-VP O
IV NNP B-NP B-mo
iron NN I-NP B-m
, , O O
also RB O O
possible JJ B-NP O
anemia NN I-NP O
in IN B-VP O
setting VBG O O
of IN B-VP O
low JJ B-NP O
EPO NNP I-NP O
EPO NNP I-NP O
level NN I-NP O
checked VBD B-VP O
low JJ O O
and CC O O
normal JJ O O
, , O O
may MD O O
ultimately RB O O
benefit VB O O
from IN B-VP O
Epogen NNP B-NP B-m
On IN B-VP O
Coumadin NNP B-NP B-m
for IN B-VP O
DVT NNP B-NP B-r
prophylaxis/paroxysmal JJ B-NP I-r
a-fib JJ I-NP I-r
prior NN I-NP O
to TO O O
arrival VB O O
Supratherapeutic NNP B-NP O
on IN B-VP O
admission NN B-NP O
, , O O
so RB O O
Coumadin JJ B-NP B-m
held NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
GI NNP B-NP O
bleed NN I-NP O
until IN B-VP B-du
INR NNP B-NP I-du
1.5 CD O I-du
, , O O
then RB O O
patient NN B-NP O
was VBD B-VP O
covered VBN O O
with IN B-VP O
subcutaneous JJ B-NP B-mo
heparin NN I-NP B-m
for IN B-VP O
DVT NNP B-NP B-r
prophylaxis NN I-NP I-r
However RB O O
, , O O
acute JJ B-NP O
drop NN I-NP O
in IN B-VP O
platelets NNS B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
heparin NN B-NP B-m
from IN B-VP O
the DT O O
200s CD O O
to TO O O
the DT O O
30s CD O O
, , O O
so RB O O
heparin JJ O B-m
stopped VBD B-VP O
PF4 NNP B-NP O
antibody NN I-NP O
negative JJ B-NP O
x1 NN I-NP O
and CC O O
borderline NN B-NP O
x1 NNP I-NP O
PF4 NNP I-NP O
antibody NN I-NP O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
but CC O O
all DT B-NP O
heparin JJ I-NP B-m
products NNS I-NP O
including VBG O O
flush NN B-NP O
is VBZ O O
held VBN O O
The DT B-NP O
patient NN I-NP O
restarted VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
after IN B-VP O
EGD NNP B-NP O
at IN B-VP O
12.5 CD O B-do
mg NNS B-NP I-do
a DT B-NP B-f
day NN I-NP I-f
Status NNP I-NP O
post NN I-NP O
three CD O O
doses NNS B-NP O
, , O O
INR NNP B-NP O
was VBD B-VP O
2 CD O O
Target NNP B-NP O
INR NNP I-NP O
is VBZ O O
2-2.5 JJ O O
and CC O O
the DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
followed VBN O O
at IN B-VP O
the DT B-NP O
Tarbripin NNP I-NP O
Of IN B-VP O
Anticoagulation NNP B-NP O
Clinic NNP I-NP O
, , O O
phone NN B-NP O
number NN I-NP O
is VBZ O O
300-135-5841 JJ B-NP O
INRs NNP I-NP O
can MD O O
be VB O O
faxed VBN O O
to TO O O
clinic VB O O
from IN B-VP O
rehab NN B-NP O
and CC O O
adjustments NNS B-NP O
in IN B-VP O
doses NNS B-NP O
can MD O O
be VB O O
made VBN O O
accordingly RB O O
5 CD O O
Endo: NNP B-NP O
TSH NNP I-NP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Hemoglobin NNP I-NP O
A1c NNP I-NP O
5.5 CD O O
, , O O
so RB O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
6 CD O O
ID: NNP B-NP O
UTI/proteus NNP I-NP O
, , O O
levofloxacin VBZ O B-m
renally RB O B-do
dosed VBN O I-do
Repeat NNP B-NP O
urine JJ B-NP O
dirty NN I-NP O
, , O O
so RB O O
p.o JJ B-NP B-mo
Cipro NNP I-NP B-m
started VBD B-VP O
for IN B-VP O
empiric JJ B-NP O
treatment NN I-NP O
of IN B-VP O
UTI NNP B-NP B-r
in IN B-VP O
setting VBG O O
of IN B-VP O
indwelling VBG O O
Foley NNP B-NP O
Two CD O O
days NNS B-NP O
prior RB O O
to TO O O
discharge VB O O
, , O O
the DT B-NP O
patient NN I-NP O
with IN B-VP O
low-grade JJ B-NP O
temp NN I-NP O
to TO O O
max VB O O
100.4 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
unchanged JJ O O
but CC O O
only RB O O
portable JJ B-NP O
chest JJS I-NP O
x-ray NN I-NP O
was VBD B-VP O
obtained VBN O O
due JJ O O
to TO O O
patient's VB O O
immobility NN B-NP O
, , O O
blood NN B-NP O
cultures NNS I-NP O
and CC O O
urine JJ B-NP O
cultures NNS I-NP O
were VBD B-VP O
negative JJ B-NP O
Empirically NNP I-NP O
treating VBG O O
for IN B-VP O
nosocomial JJ B-NP B-r
pneumonia NN I-NP I-r
with IN B-VP O
p.o JJ B-NP B-mo
levo/cefpodox/azithro JJ I-NP B-m
x10 NNP I-NP B-du
days NNS I-NP I-du
, , O O
PICC NNP B-NP O
line NN I-NP O
in IN B-VP O
place NN B-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
However RB O O
, , O O
it PRP O O
should MD O O
be VB O O
discontinued VBN O O
by IN B-VP O
2/22/05 CD O O
to TO O O
prevent VB O O
infection NN B-NP O
7 CD O O
Allergy: NNP B-NP O
Postnasal NNP I-NP O
drip VBZ O O
Rhinorrhea NNP B-NP O
Continued NNP I-NP O
Claritin NNP I-NP B-m
and CC O O
Flonase NNP B-NP B-m
8 CD O O
Psyche: NNP B-NP O
Zoloft NNP I-NP B-m
continued VBD B-VP O
for IN B-VP O
depression NN B-NP B-r
9 CD O O
Pulmonary: NNP B-NP O
Intermittent NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
intermittently RB O O
desaturates VBZ O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
to TO O O
80s CD O O
but CC O O
always RB O O
resolved VBD B-VP O
with IN B-VP O
repositioning NN B-NP O
and CC O O
O2 NNP B-NP O
Likely NNP I-NP O
secondary JJ O O
to TO O O
respiratory VB O O
muscle NN B-NP O
deconditioning VBG O O
and CC O O
to TO O O
restrictive VB O O
lung NN B-NP O
disease NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
morbid NN B-NP O
obesity NN I-NP O
Continuing NNP I-NP O
Flovent NNP I-NP B-m
for IN B-VP O
asthma NN B-NP B-r
and CC O O
albuterol NN B-NP B-m
nebs VBP O I-m
p.r.n NN B-NP B-f
for IN B-VP O
wheezing VBG O B-r
Continue NNP B-NP O
CPAP NNP I-NP O
at IN B-VP O
night NN B-NP O
for IN B-VP O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
10 CD O O
Oncology: NNP B-NP O
History NNP I-NP O
of IN B-VP O
breast NN B-NP O
mass NN I-NP O
last JJ O O
evaluated VBD B-VP O
in IN B-VP O
6/7 CD O O
at IN B-VP O
which WDT O O
time NN B-NP O
the DT B-NP O
risk NN I-NP O
of IN B-VP O
surgery NN B-NP O
would MD O O
determine VB O O
to TO O O
be VB O O
greater JJR O O
than IN B-VP O
the DT B-NP O
possible JJ I-NP O
risk NN I-NP O
of IN B-VP O
breast NN B-NP O
cancer NN I-NP O
Oncology NNP I-NP O
not RB O O
able JJ O O
to TO O O
see VB O O
patient JJ O O
during IN B-VP O
inpatient JJ B-NP O
stay NN I-NP O
but CC O O
will MD O O
schedule VB O O
outpatient JJ B-NP O
followup NN I-NP O
regarding VBG O O
the DT B-NP O
issue NN I-NP O
of IN B-VP O
possible JJ B-NP O
treatment NN I-NP O
with IN B-VP O
tamoxifen JJ O B-m
11 CD O O
FEN: NNP B-NP O
Gentle NNP I-NP O
bowel NN I-NP B-m
regimen NNS I-NP I-m
, , O O
renal JJ B-NP O
diet JJ I-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
KEY NNP I-NP O
FEATURES NNP I-NP O
OF NNP I-NP O
PHYSICAL NNP I-NP O
EXAM NNP I-NP O
AT NNP I-NP O
THE NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
DISCHARGE: NNP I-NP O
Essentially NNP I-NP O
unchanged JJ O O
from IN B-VP O
admission NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Include NNP I-NP O
Tylenol NNP I-NP B-m
650 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.4h NN I-NP B-f
p.r.n NN I-NP I-f
, , O O
albuterol VB O B-m
albuterol JJ B-NP B-m
nebulizer JJ I-NP I-m
nebulizer NN I-NP I-m
2.5 CD O B-do
2.5 CD O B-do
mg NN B-NP O
inhaled VBD B-VP B-mo
inhaled JJ B-NP B-mo
q.6h NN I-NP B-f
q.6h NN I-NP B-f
p.r.n NN I-NP I-f
p.r.n NN I-NP I-f
for IN B-VP O
shortness NN B-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
and CC O O
wheezing NN B-NP B-r
, , O O
ECASA NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
PhosLo NNP B-NP B-m
667 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Catapres VBZ O B-m
0.1 CD O B-do
mg NN B-NP O
per IN B-VP B-f
day NN B-NP I-f
q JJ O I-f
weekly RB O I-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
metoprolol JJ B-NP B-m
tartarate NN I-NP O
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
senna JJ B-NP B-m
tablets NNS I-NP I-m
two CD O B-do
tabs NNS B-NP I-do
p.o VBP O B-mo
b.i.d JJ B-NP B-f
p.r.n NN I-NP O
for IN B-VP O
constipation NN B-NP B-r
, , O O
ocean JJ B-NP B-m
spray NN I-NP I-m
two CD O B-do
sprays NNS B-NP I-do
inhaled VBD B-VP B-mo
q.i.d JJ B-NP B-f
p.r.n NN I-NP O
for IN B-VP O
dry JJ B-NP B-r
nose NN I-NP I-r
, , O O
Coumadin NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m NN I-NP B-f
, , O O
Zoloft NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m NN I-NP B-f
, , O O
azithromycin RB O B-m
250 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
x10 NNP I-NP B-du
days NNS I-NP I-du
, , O O
simvastatin JJ O B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
bedtime NN B-NP I-f
, , O O
doxazosin VBZ O B-m
2 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Norvasc NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Claritin NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Flovent NNP B-NP B-m
110 CD O B-do
mcg NN B-NP I-do
inhaled VBD B-VP B-mo
b.i.d NN B-NP B-f
, , O O
cefpodoxime NN B-NP B-m
proxetil NN I-NP I-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
x10 NNP I-NP B-du
days NNS I-NP I-du
, , O O
Flonase NNP B-NP B-m
one CD O B-do
spray NN B-NP I-do
daily RB O B-f
, , O O
levofloxacin VBD B-VP B-m
250 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.24 NN I-NP B-f
x10 NN I-NP B-du
doses NNS I-NP I-du
, , O O
and CC O O
Nexium NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
DISPOSITION: NNP I-NP O
To TO O O
rehab VB O O
facility NN B-NP O
FOLLOWUP: NNP I-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
patient's NN B-NP O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
, , O O
Dr NNP B-NP O
Gleen NNP I-NP O
, , O O
and CC O O
oncologist NN B-NP O
to TO O O
be VB O O
arranged VBN O O
, , O O
dates NNS B-NP O
of IN B-VP O
appointments NNS B-NP O
will MD O O
be VB O O
forwarded VBN O O
to TO O O
rehab VB O O
facility NN B-NP O
eScription NN I-NP O
document: VBZ O O
3-0977712 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Carlton NNP I-NP O
Ahlstedt NNP I-NP O
M.D NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
LAURION NNP I-NP O
, , O O
ROBERT NNP B-NP O
Attending: NNP I-NP O
GOROVITZ NNP I-NP O
, , O O
EDGAR NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
9670631 CD O O
D: NNP B-NP O
9/20/05 CD O O
T: NNP B-NP O
9/20/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#312736 VBZ O O
877940312 CD O O
NCMH NNP B-NP O
67382759 CD O O
732707 CD O O
6/17/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
AORTIC NNP I-NP O
STENOSIS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/10/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/20/2001 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
74 CD O O
year-old JJ B-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
aortic JJ B-NP O
stenosis NN I-NP O
, , O O
non-insulin JJ B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
hypertension NN B-NP O
and CC O O
hypercholesterolemia NN B-NP O
who WP O O
is VBZ O O
preop NN B-NP O
for IN B-VP O
a DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
and CC O O
aortic JJ B-NP O
valve NN I-NP O
replacement NN I-NP O
to TO O O
be VB O O
admitted VBN O O
on IN B-VP O
July NNP B-NP O
, , O O
2001 CD O O
He PRP O O
has VBZ O O
had VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
which WDT O O
demonstrates VBZ O O
severe JJ B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
with IN B-VP O
mitral JJ B-NP O
annular JJ I-NP O
calcification NN I-NP O
, , O O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
and CC O O
1+ CD O O
aortic JJ B-NP O
insufficiency NN I-NP O
, , O O
also RB O O
mild JJ B-NP O
tricuspid JJ I-NP O
regurgitation NN I-NP O
and CC O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
55% CD O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
non-insulin JJ B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
depression NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
and CC O O
gout NN B-NP O
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
) ) O O
Simvastatin NNP B-NP B-m
2 CD O O
) ) O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
3 CD O O
) ) O O
Allopurinol $ O B-m
300 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP O
day NN I-NP O
4 CD O O
) ) O O
Lasix FW O B-m
40 CD O B-do
mg NN B-NP I-do
three CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
5 CD O O
) ) O O
Captopril NNP B-NP B-m
6 CD O O
) ) O O
Potassium NNP B-NP B-m
replacement NN I-NP I-m
7 CD O O
) ) O O
Multivitamin NNP B-NP B-m
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
His PRP$ O O
examination NN B-NP O
is VBZ O O
unremarkable JJ O O
He PRP O O
has VBZ O O
a DT B-NP O
right JJ I-NP O
carotid NN I-NP O
bruit NN I-NP O
and CC O O
palpable JJ B-NP O
distal JJ I-NP O
pulses NNS I-NP O
CHEST: NNP I-NP O
Clear NNP I-NP O
ABDOMEN: NNP I-NP O
Soft NNP I-NP O
EXTREMITY: NNP I-NP O
No NNP I-NP O
lower JJR B-NP O
extremity NN I-NP O
edema VBP O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
He PRP O O
is VBZ O O
seen VBN O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
Oral NNP B-NP O
Medicine NNP I-NP O
for IN B-VP O
carious JJ B-NP O
teeth NNS I-NP O
since IN B-VP O
he PRP O O
is VBZ O O
preopped VBN O O
for IN B-VP O
aortic JJ B-NP O
valve NN I-NP O
replacement NN I-NP O
and CC O O
he PRP O O
was VBD B-VP O
cleared VBN O O
by IN B-VP O
the DT B-NP O
dentist NN I-NP O
for IN B-VP O
this DT B-NP O
procedure NN I-NP O
He PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
laboratory NN I-NP O
where WRB O O
he PRP O O
underwent JJ B-NP O
coronary JJ I-NP O
arteriography NN I-NP O
on IN B-VP O
June NNP B-NP O
, , O O
2001 CD O O
His PRP$ O O
aortic JJ B-NP O
valve NN I-NP O
area NN I-NP O
had VBD B-VP O
been VBN O O
calculated VBN O O
at IN B-VP O
echocardiogram NN B-NP O
at IN B-VP O
0.7 CD O O
cm NN B-NP O
squared VBD B-VP O
His PRP$ O O
coronary JJ B-NP O
arteriogram NN I-NP O
demonstrated VBD B-VP O
a DT O O
50% CD O O
lesion NN B-NP O
of IN B-VP O
his PRP$ O O
left JJ O O
anterior JJ O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
, , O O
60% CD O O
second JJ B-NP O
diagonal NN I-NP O
and CC O O
a DT O O
60% CD O O
lesion NN B-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
He PRP O O
underwent JJ B-NP O
preop JJ I-NP O
carotid NN I-NP O
ultrasound NN I-NP O
for IN B-VP O
the DT B-NP O
carotid NN I-NP O
bruit NN I-NP O
that WDT O O
was VBD B-VP O
noted VBN O O
and CC O O
he PRP O O
had VBD B-VP O
insignificant JJ B-NP O
carotid NN I-NP O
disease NN I-NP O
by IN B-VP O
doppler NN B-NP O
He PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
July NNP B-NP O
, , O O
2001 CD O O
where WRB O O
he PRP O O
underwent JJ B-NP O
aortic JJ I-NP O
valve NN I-NP O
replacement NN I-NP O
with IN B-VP O
a DT B-NP O
#23 JJ I-NP O
Carpentier-Edwards NNP I-NP O
bioprosthetic JJ B-NP O
valve NN I-NP O
and CC O O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
times NNS B-NP O
two CD O O
with IN B-VP O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT O O
left VBN O O
anterior JJ O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
and CC O O
the DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT O O
posterior JJ O O
descending VBG O O
The DT B-NP O
intraoperative JJ I-NP O
course NN I-NP O
was VBD B-VP O
unremarkable JJ O O
His PRP$ O O
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
only RB O O
by IN B-VP O
mild JJ B-NP O
confusion NN I-NP O
which WDT O O
has VBZ O O
cleared VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
alert JJ O O
and CC O O
oriented VBD B-VP O
He PRP O O
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
to TO O O
rehabilitation VB O O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
) ) O O
Enteric NNP B-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
325 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
day NN I-NP I-f
2 CD O O
) ) O O
Lithium NN B-NP B-m
300 CD O B-do
mg NN B-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
3 CD O O
) ) O O
Potassium NN B-NP B-m
supplementation NN I-NP I-m
20 CD O B-do
mEq NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
4 CD O O
) ) O O
Pravachol VBD B-VP B-m
40 CD O B-do
mg NN B-NP O
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
5 CD O O
) ) O O
Glyburide NNP B-NP B-m
1.25 CD O B-do
mg NN B-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
6 CD O O
) ) O O
Parnate VB O B-m
10 CD O B-do
mg NN B-NP O
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
7 CD O O
) ) O O
Lasix FW O B-m
20 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
FOLLOW-UP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
to TO O O
the DT B-NP O
care NN I-NP O
of IN B-VP O
Dr NNP B-NP O
Kim NNP I-NP O
E NNP I-NP O
Scow NNP I-NP O
, , O O
Cardiovascular NNP B-NP O
Division NNP I-NP O
at IN B-VP O
Hany NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
QUINN NNP I-NP O
WACHSMUTH NNP I-NP O
, , O O
M.D NNP B-NP O
Attending: NNP I-NP O
ERASMO NNP I-NP O
J NNP I-NP O
MURPHREE NNP I-NP O
, , O O
M.D NNP B-NP O
PI3 NNP I-NP O
DT105/7267 NNP I-NP O
Batch: NNP I-NP O
7705 CD O O
Index NNP B-NP O
No NNP I-NP O
HKLJAT69GJ NNP I-NP O
D: NNP I-NP O
8/1/01 CD O O
T: NNP B-NP O
8/1/01 CD O O
CC: NNP B-NP O
LEON NNP I-NP O
M NNP I-NP O
EVERTS NNP I-NP O
, , O O
M.D NNP B-NP O
WL7 NNP I-NP O
BOYD NNP I-NP O
LOVATO NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
Fallsu NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#312933 VBZ O O
441230814 CD O O
SMH NNP B-NP O
75713869 CD O O
8859203 CD O O
4/20/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
CARDIOGENIC NNP I-NP O
SHOCK NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/22/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/24/2007 CD O O
ATTENDING: NNP B-NP O
STIVER NNP I-NP O
, , O O
CALVIN NNP B-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
Coronary NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
BRIEF NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Ms NNP I-NP O
Kolppa NNP I-NP O
was VBD B-VP O
a DT B-NP O
58-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
non-ischemic JJ B-NP O
cardiomyopathy NN I-NP O
and CC O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
15% CD O O
who WP O O
was VBD B-VP O
initially RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Faharb NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Of IN B-VP O
following VBG O O
a DT B-NP O
cardiac JJ I-NP O
arrest NN I-NP O
On IN B-VP O
arrival NN B-NP O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
she PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
recurrent JJ B-NP O
ventricular JJ I-NP O
tachycardia NN I-NP O
and CC O O
was VBD B-VP O
defibrillated VBN O O
She PRP O O
required VBD B-VP O
an DT B-NP O
intraaortic JJ I-NP O
balloon NN I-NP O
pump NN I-NP O
to TO O O
maintain VB O O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
non-ischemic JJ B-NP O
cardiomyopathy NN I-NP O
She PRP O O
has VBZ O O
a DT B-NP O
pacemaker/ICD NN I-NP O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chronic JJ B-NP O
kidney NN I-NP O
disease NN I-NP O
, , O O
deep RB O O
venous JJ B-NP O
thrombosis NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
cerebrovascular JJ B-NP O
accident NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
hypercholesterolemia NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
diabetes NNS B-NP O
, , O O
history NN B-NP O
of IN B-VP O
GI NNP B-NP O
bleed NN I-NP O
and CC O O
history NN B-NP O
of IN B-VP O
chronic JJ B-NP O
hepatitis NN I-NP O
C NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEMS: NNP I-NP O
Ms NNP I-NP O
Rubins NNP I-NP O
had VBD B-VP O
a DT B-NP O
complicated JJ I-NP O
course NN I-NP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
and CC O O
her PRP$ O O
care NN B-NP O
was VBD B-VP O
related VBN O O
primarily RB O O
to TO O O
recurrent VB O O
ventricular JJ B-NP O
tachycardia NN I-NP O
and CC O O
prolonged VBD B-VP O
anoxic JJ B-NP O
injury NN I-NP O
affecting VBG O O
multiple JJ B-NP O
organ JJ I-NP O
systems NNS I-NP O
During IN B-VP B-du
her PRP$ O I-du
hospital JJ B-NP I-du
course NN I-NP I-du
, , O O
she PRP O O
required VBD B-VP O
pressor NN B-NP B-m
medications NNS I-NP I-m
, , O O
an DT B-NP O
intraaortic JJ I-NP O
balloon NN I-NP O
pump NN I-NP O
, , O O
and CC O O
ventilator JJ B-NP O
support NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
noted VBN O O
, , O O
prior RB O O
to TO O O
her PRP$ O O
admission NN B-NP O
, , O O
that IN B-VP O
she PRP O O
would MD O O
never RB O O
want VB O O
to TO O O
be VB O O
dependent JJ O O
upon IN B-VP O
"machines." NNS B-NP O
Due NNP I-NP O
to TO O O
poor JJ B-NP O
neurological JJ I-NP O
status NN I-NP O
and CC O O
poor JJ B-NP O
prognosis NN I-NP O
, , O O
and CC O O
in IN B-VP O
conjunction NN B-NP O
with IN B-VP O
the DT B-NP O
patient's NN I-NP O
previously RB O O
expressed VBN O O
wishes NNS B-NP O
, , O O
medical JJ B-NP O
care NN I-NP O
was VBD B-VP O
withdrawn VBN O O
on IN B-VP O
6/14 CD O O
after IN B-VP O
many JJ B-NP O
discussions NNS I-NP O
with IN B-VP O
family NN B-NP O
The DT B-NP O
patient's NN I-NP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Sangh NNP I-NP O
, , O O
was VBD B-VP O
involved VBN O O
with IN B-VP O
these DT B-NP O
discussions NNS I-NP O
The DT B-NP O
intraaortic JJ I-NP O
balloon NN I-NP O
pump NN I-NP O
was VBD B-VP O
turned VBN O O
off RP O O
Pressure NN B-NP B-m
medications NNS I-NP I-m
were VBD B-VP O
held VBN O O
and CC O O
the DT B-NP O
mechanical JJ I-NP O
ventilator NN I-NP O
was VBD B-VP O
stopped VBN O O
The DT B-NP O
patient NN I-NP O
passed VBD B-VP O
away RB O O
on IN B-VP O
0/14/07 CD O O
shortly RB O O
after IN B-VP O
removal NN B-NP O
of IN B-VP O
mechanical JJ B-NP O
support NN I-NP O
eScription NN I-NP O
document: IN B-VP O
7-5741310 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
SUPPLEE NNP I-NP O
, , O O
GARTH NNP B-NP O
Attending: NNP I-NP O
UHYREK NNP I-NP O
, , O O
PARKER NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
0741981 CD O O
D: NNP B-NP O
0/14/07 CD O O
T: NNP B-NP O
11/28/07 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#327289 VBZ O O
701267368 CD O O
ECH NNP B-NP O
49976759 CD O O
151133 CD O O
7/3/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/29/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/2/1995 CD O O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
care NN B-NP O
on IN B-VP O
the DT B-NP O
Stockvi NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Dilated NNP I-NP O
cardiomyopathy NN I-NP O
with IN B-VP O
associated JJ B-NP O
problems NNS I-NP O
of IN B-VP O
hypertension NN B-NP O
and CC O O
asthma NN B-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
53 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
hypertension NN B-NP O
x NNP I-NP O
eight CD O O
years NNS B-NP O
, , O O
who WP O O
presents VBZ O O
with IN B-VP O
increased JJ B-NP O
dyspnea NN I-NP O
on IN B-VP O
exertion NN B-NP O
and CC O O
admitted VBN O O
for IN B-VP O
left NN B-NP O
and CC O O
right JJ B-NP O
heart NN I-NP O
catheterization NN I-NP O
, , O O
and CC O O
to TO O O
optimize VB O O
blood NN B-NP O
pressure NN I-NP O
control NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
53 CD O O
year NN B-NP O
old JJ B-NP O
Afro-American JJ I-NP O
female NN I-NP O
, , O O
first RB O O
diagnosed VBN O O
with IN B-VP O
hypertension NN B-NP O
in IN B-VP O
1987 CD O O
She PRP O O
presented VBD B-VP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
in IN B-VP O
1987 CD O O
with IN B-VP O
acute JJ B-NP O
atypical JJ I-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
and CC O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
ETT NNP I-NP O
in IN B-VP O
1987 CD O O
demonstrated VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
during IN B-VP O
exercise NN B-NP O
and CC O O
suggestive JJ B-NP O
ST NNP I-NP O
T NNP I-NP O
wave VBP O O
changes NNS B-NP O
in IN B-VP O
the DT B-NP O
inferolateral JJ I-NP O
leads NNS I-NP O
during IN B-VP O
exercise NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
from IN B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
and CC O O
did VBD B-VP O
relatively RB O O
well RB O O
with IN B-VP O
intermittent JJ B-NP O
chest NN I-NP O
pain NN I-NP O
on IN B-VP O
exertion NN B-NP O
Exercise NNP I-NP O
tolerance NN I-NP O
test NN I-NP O
in IN B-VP O
1991 CD O O
demonstrated JJ O O
consistent JJ O O
, , O O
but CC O O
not RB O O
diagnostic JJ O O
of IN B-VP O
ischemia NN B-NP O
No NNP I-NP O
chest NN I-NP O
pain NN I-NP O
Echocardiogram NNP I-NP O
in IN B-VP O
1992 CD O O
demonstrated VBD B-VP O
inferior JJ O O
, , O O
posterior JJ O O
, , O O
and CC O O
apical JJ B-NP O
hyperkinesis NN I-NP O
, , O O
low JJ O O
to TO O O
normal JJ B-NP O
global JJ I-NP O
pattern NN I-NP O
of IN B-VP O
systolic JJ B-NP O
contractile NN I-NP O
function NN I-NP O
, , O O
and CC O O
a DT B-NP O
celionous JJ I-NP O
redundancy NN I-NP O
of IN B-VP O
the DT B-NP O
mitral JJ I-NP O
anterior JJ I-NP O
leaflet NN I-NP O
, , O O
with IN B-VP O
only JJ B-NP O
trace NN I-NP O
mitral JJ B-NP O
regurgitation NN I-NP O
Since IN B-VP O
1992 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
developed VBN O O
severe JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
with IN B-VP O
positive JJ B-NP O
chest NN I-NP O
discomfort NN I-NP O
of IN B-VP O
pin NN B-NP O
and CC O O
needles NNS B-NP O
in IN B-VP O
the DT B-NP O
left NN I-NP O
chest NN I-NP O
, , O O
which WDT O O
radiates VBZ O O
down RP O O
her PRP$ O O
left JJ B-NP O
arm NN I-NP O
She PRP O O
notes VBZ O O
positive JJ B-NP O
paroxysmal JJ I-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
with IN B-VP O
the DT B-NP O
need NN I-NP O
of IN B-VP O
sleeping VBG O O
elevated VBN O O
at IN B-VP O
45 CD O O
degrees NNS B-NP O
at IN B-VP O
some DT B-NP O
times NNS I-NP O
Echocardiogram NNP I-NP O
in IN B-VP O
1994 CD O O
demonstrated VBD B-VP O
moderately RB O O
dilated VBN O O
left JJ B-NP O
ventricle NN I-NP O
with IN B-VP O
severely RB O O
depressed JJ B-NP O
systolic JJ I-NP O
function NN I-NP O
Ejection NNP I-NP O
fraction NN I-NP O
equals NNS I-NP O
26% CD O O
There EX O O
was VBD B-VP O
2+ CD O O
mitral JJ B-NP O
regurgitation NN I-NP O
and CC O O
mild NN B-NP O
left VBD B-VP O
atrial JJ B-NP O
enlargement NN I-NP O
also RB O O
noted VBD B-VP O
Mild NNP B-NP O
tricuspid JJ B-NP O
regurgitation NN I-NP O
with IN B-VP O
pulmonary JJ B-NP O
artery NN I-NP O
pressure NN I-NP O
estimated VBN O O
at IN B-VP O
approximately RB O O
25 CD O O
Due JJ O O
to TO O O
her PRP$ O O
hypertension NN B-NP O
and CC O O
decreased JJ O O
left VBD B-VP O
ventricular JJ B-NP O
function NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
presents VBZ O O
to TO O O
the DT B-NP O
Ton NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
a DT B-NP O
left NN I-NP O
and CC O O
right JJ B-NP O
side NN I-NP O
catheterization NN I-NP O
, , O O
and CC O O
also RB O O
for IN B-VP O
monitoring NN B-NP O
of IN B-VP O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
Her NNP I-NP O
blood NN I-NP O
pressure NN I-NP O
ranged VBD B-VP O
, , O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
, , O O
between IN B-VP O
170 CD O O
to TO O O
180/100 CD O O
to TO O O
110 CD O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
As IN B-VP O
above IN B-VP O
2 CD O O
Asthma NNP B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Beclovent NNP B-NP B-m
4 CD O B-do
puffs NNS B-NP I-do
b.i.d VBD B-VP B-f
2 CD O O
Enalapril NNP B-NP B-m
4 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
3 CD O O
Diltiazem NNP B-NP B-m
360 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
4 CD O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
HABITS: VBP O O
The DT B-NP O
patient NN I-NP O
smokes VBZ O O
one-half JJ O O
per IN B-VP O
day NN B-NP O
to TO O O
one CD O O
pack NN B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
the DT B-NP O
last JJ I-NP O
twenty-five JJ I-NP O
years NNS I-NP O
Alcohol NNP I-NP O
, , O O
occasional JJ B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
mother NN I-NP O
died VBD B-VP O
in IN B-VP O
her PRP$ O O
sleep NN B-NP O
at IN B-VP O
age NN B-NP O
50 CD O O
of IN B-VP O
unknown JJ B-NP O
reasons NNS I-NP O
Her PRP$ O O
father NN B-NP O
died VBD B-VP O
due JJ O O
to TO O O
a DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
accident NN I-NP O
Two CD O O
brothers NNS B-NP O
and CC O O
one CD O O
sister NN B-NP O
all DT O O
died VBD B-VP O
at IN B-VP O
age NN B-NP O
30 CD O O
to TO O O
40 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
know VB O O
cause NN B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
not RB O O
worked VBN O O
since IN B-VP O
1995 CD O O
due JJ O O
to TO O O
what WP O O
she PRP O O
states VBZ O O
as IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
chest NN B-NP O
pain NN I-NP O
She PRP O O
has VBZ O O
three CD O O
daughters NNS B-NP O
, , O O
all DT O O
in IN B-VP O
good JJ B-NP O
health NN I-NP O
, , O O
and CC O O
four CD O O
grandchildren NNS B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
, , O O
this DT O O
is VBZ O O
a DT O O
53 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
, , O O
Afro-American JJ O O
, , O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Vital NNP I-NP O
signs: NN I-NP O
Temperature NNP I-NP O
97.6 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
134/72 CD O O
after IN B-VP O
Hydralazine NNP B-NP B-m
, , O O
heart NN B-NP O
rate NN I-NP O
75 CD O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
of IN B-VP O
12 CD O O
HEENT NNP B-NP O
examination: NN I-NP O
Extraocular NNP I-NP O
movements NNS I-NP O
are VBP O O
intact JJ B-NP O
Pupils NNP I-NP O
are VBP O O
equal JJ O O
, , O O
round NN B-NP O
, , O O
reactive JJ O O
to TO O O
light JJ B-NP O
Nasal NNP I-NP O
oral JJ B-NP O
pharynx NN I-NP O
had VBD B-VP O
no DT B-NP O
discharge NN I-NP O
, , O O
and CC O O
was VBD B-VP O
clear JJ O O
with IN B-VP O
no DT B-NP O
exudates NNS I-NP O
Neck: NNP I-NP O
No NNP I-NP O
adenopathy NN I-NP O
, , O O
no DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
, , O O
no DT B-NP O
thyromegaly NN I-NP O
Carotids NNP I-NP O
are VBP O O
2+ CD O O
with IN B-VP O
no DT B-NP O
bruits NNS I-NP O
Lungs NNP I-NP O
revealed VBD B-VP O
diffuse RB O O
expiratory JJ B-NP O
wheezes NNS I-NP O
, , O O
prolonged VBD B-VP O
expiratory JJ B-NP O
phase NN I-NP O
, , O O
no DT B-NP O
rhonchi NN I-NP O
or CC O O
rales NNS B-NP O
Cardiovascular NNP I-NP O
revealed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
positive JJ B-NP O
S4 NNP I-NP O
, , O O
with IN B-VP O
a DT O O
2/6 CD O O
systolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
apex NN I-NP O
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
obese JJ O O
, , O O
soft JJ O O
, , O O
non-tender JJ O O
, , O O
non-distended JJ O O
, , O O
with IN B-VP O
no DT B-NP O
obvious JJ I-NP O
hepatosplenomegaly NN I-NP O
Extremities NNS I-NP O
revealed VBD B-VP O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
, , O O
or CC O O
edema NN B-NP O
, , O O
and CC O O
no DT B-NP O
bruits NNS I-NP O
Pulses NNS I-NP O
were VBD B-VP O
2+ CD O O
throughout IN B-VP O
Neurological NNP B-NP O
examination: NN I-NP O
Alert NNP I-NP O
and CC O O
oriented VBD B-VP O
x NNP B-NP O
three CD O O
, , O O
nonfocal JJ B-NP O
examination NN I-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
Labs NNP I-NP O
upon IN B-VP O
admission NN B-NP O
revealed VBD B-VP O
an DT B-NP O
SMA-7 NNP I-NP O
of IN B-VP O
143 CD O O
, , O O
4.1 CD O O
, , O O
102 CD O O
, , O O
28 CD O O
, , O O
20 CD O O
, , O O
1.2 CD O O
, , O O
and CC O O
93 CD O O
CBC NNP B-NP O
of IN B-VP O
6.3 CD O O
, , O O
46.1 CD O O
, , O O
and CC O O
280 CD O O
PT NNP B-NP O
and CC O O
PTT NNP B-NP O
of IN B-VP O
12.5 CD O O
and CC O O
28.4 CD O O
ALT NNP B-NP O
of IN B-VP O
14 CD O O
, , O O
AST NNP B-NP O
of IN B-VP O
19 CD O O
, , O O
LDH NNP B-NP O
of IN B-VP O
197 CD O O
, , O O
alkaline JJ B-NP O
phosphatase NN I-NP O
of IN B-VP O
77 CD O O
, , O O
total JJ B-NP O
bilirubin NN I-NP O
of IN B-VP O
.3 NNP B-NP O
, , O O
total JJ B-NP O
protein NN I-NP O
of IN B-VP O
7.9 CD O O
, , O O
albumin NN B-NP O
of IN B-VP O
4.2 CD O O
Globulins NNS B-NP O
of IN B-VP O
3.7 CD O O
, , O O
calcium NN B-NP O
of IN B-VP O
9.4 CD O O
, , O O
phosphate NN B-NP O
of IN B-VP O
4.4 CD O O
, , O O
cholesterol NN B-NP O
of IN B-VP O
210 CD O O
, , O O
and CC O O
triglyceride NN B-NP O
of IN B-VP O
67 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
one CD O O
which WDT O O
demonstrated VBD B-VP O
no DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
disease NN I-NP O
, , O O
right JJ B-NP O
atrium NN I-NP O
pressure NN I-NP O
of IN B-VP O
12 CD O O
, , O O
PA NNP B-NP O
pressure NN I-NP O
of IN B-VP O
56/32 CD O O
with IN B-VP O
a DT B-NP O
mean NN I-NP O
of IN B-VP O
38 CD O O
and CC O O
pulmonary JJ B-NP O
capillary JJ I-NP O
wedge NN I-NP O
pressure NN I-NP O
of IN B-VP O
20 CD O O
Cardiac NNP B-NP O
output NN I-NP O
was VBD B-VP O
5.1 CD O O
, , O O
SVR NNP B-NP O
of IN B-VP O
1459 CD O O
, , O O
and CC O O
PVR NNP B-NP O
of IN B-VP O
282 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
then RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Floor NNP I-NP O
for IN B-VP O
workup NN B-NP O
of IN B-VP O
her PRP$ O O
hypertension NN B-NP O
Urine NNP I-NP O
metanephrine NN I-NP O
and CC O O
urine JJ B-NP O
VMA NNP I-NP O
were VBD B-VP O
sent VBN O O
The DT B-NP O
patient's NN I-NP O
Enalapril NNP I-NP B-m
was VBD B-VP O
discontinued VBN O O
in IN B-VP O
order NN B-NP O
to TO O O
perform VB O O
the DT B-NP O
Captopril NNP I-NP O
Renogram NNP I-NP O
Test NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
Diltiazem NNP B-NP B-m
180 CD O B-do
mg NN B-NP O
q.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
and CC O O
Hydralazine NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
t.i.d VBD B-VP B-f
The DT B-NP O
patient's NN I-NP O
blood NN I-NP O
pressure NN I-NP O
, , O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
three CD O O
, , O O
was VBD B-VP O
130/70 CD O O
and CC O O
well-controlled JJ B-NP O
Her NNP I-NP O
heart NN I-NP O
rate NN I-NP O
was VBD B-VP O
70 CD O O
to TO O O
80 CD O O
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
four CD O O
, , O O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
Captopril NNP I-NP O
Renogram NNP I-NP O
Test NNP I-NP O
which WDT O O
was VBD B-VP O
negative JJ O O
for IN B-VP O
renal JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
Other JJ B-NP O
hypertension NN I-NP O
workup NN I-NP O
Epinephrine NNP I-NP O
, , O O
Dopamine NNP B-NP O
, , O O
Metanephrine NNP B-NP O
, , O O
VMA NNP B-NP O
and CC O O
ANA NNP B-NP O
are VBP O O
still RB O O
pending VBG O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
five CD O O
, , O O
with IN B-VP O
blood NN B-NP O
pressure NN I-NP O
being VBG O O
well-controlled JJ O O
throughout IN B-VP O
her PRP$ O O
hospital JJ B-NP O
visit NN I-NP O
in IN B-VP O
the DT O O
130/70's CD O O
The DT B-NP O
patient's JJ I-NP O
hypertension NN I-NP O
control NN I-NP O
was VBD B-VP O
attributed VBN O O
to TO O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
number NN B-NP O
one CD O O
, , O O
she PRP O O
stopped VBD B-VP O
smoking VBG O O
during IN B-VP O
her PRP$ O O
hospital JJ B-NP O
stay; NN I-NP O
two CD O O
, , O O
she PRP O O
was VBD B-VP O
inactive JJ O O
and CC O O
was VBD B-VP O
on IN B-VP O
bed NN B-NP O
rest; NN I-NP O
and CC O O
three CD O O
, , O O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
strict JJ B-NP O
compliance NN I-NP O
with IN B-VP O
medications NNS B-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Diltiazem NNP B-NP B-m
180 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q.d VBD B-VP B-f
2 CD O O
Enalapril NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q.d VBD B-VP B-f
3 CD O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
b.i.d VBD B-VP B-f
4 CD O O
One CD O B-do
aspirin NN B-NP B-m
per IN B-VP B-f
day NN B-NP I-f
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
stable JJ O O
and CC O O
good JJ B-NP O
condition NN I-NP O
FOLLOW-UP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
have VB O O
follow-up JJ O O
with IN B-VP O
PACKMA NNP B-NP O
TEDET NNP I-NP O
UNIVERSITY NNP I-NP O
OF NNP I-NP O
MEDICAL NNP I-NP O
CENTER NNP I-NP O
on IN B-VP O
Thursday NNP B-NP O
, , O O
May NNP B-NP O
, , O O
1995 CD O O
for IN B-VP O
check NN B-NP O
of IN B-VP O
blood NN B-NP O
pressure NN I-NP O
and CC O O
frequent JJ B-NP O
blood NN I-NP O
follow-up NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Pillon NNP I-NP O
on IN B-VP O
Monday NNP B-NP O
, , O O
July NNP B-NP O
, , O O
1995 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
EMIL NNP I-NP O
LANDING NNP I-NP O
, , O O
M.D NNP B-NP O
Attending: NNP I-NP O
BLAIR NNP I-NP O
AUJLA NNP I-NP O
, , O O
M.D NNP B-NP O
MT83 NNP I-NP O
HO786/2561 NNP I-NP O
Batch: NNP I-NP O
2699 CD O O
Index NNP B-NP O
No NNP I-NP O
A6KVGF44QE NNP I-NP O
D: NNP I-NP O
3/17/95 CD O O
T: NNP B-NP O
0/13/95 CD O O
CC: NNP B-NP O
1 CD O O
MORGAN NNP B-NP O
GROSSEN NNP I-NP O
, , O O
M.D NNP B-NP O
MT83 NNP I-NP O
CARDIOLOGY NNP I-NP O
2 CD O O
BRITT NNP B-NP O
GUDE NNP I-NP O
, , O O
M.D NNP B-NP O
DI49 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#329376 VBZ O O
183820439 CD O O
LHC NNP B-NP O
70360567 CD O O
775030 CD O O
0/19/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
non-cardiac JJ B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/4/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/14/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
CODE NNP I-NP O
, , O O
AUGUSTINE NNP B-NP O
689-97-29-0 CD O O
Waynetpidsran NNP B-NP O
Ri NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
11/1/01 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/1/01 CD O O
by IN B-VP O
FRIEHAUF NNP B-NP O
, , O O
LUTHER NNP B-NP O
G NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
44750239 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
CAPTOPRIL NNP B-NP B-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; NNP I-NP O
100 CD O O
AND NNP B-NP O
CALL NNP I-NP O
HO NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/24/01 CD O O
by IN B-VP O
HOOTMAN NNP B-NP O
, , O O
STUART NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ALDACTONE NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
94240639 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CAPTOPRIL NNP I-NP B-m
&amp; NNP I-NP O
SPIRONOLACTONE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
AWARE NNP I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/24/01 CD O O
by IN B-VP O
POUNDERS NNS B-NP O
, , O O
PHIL NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
CAPTOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
AWARE NNP I-NP O
DIGOXIN NNP I-NP B-m
0.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QOD NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
NIFEREX-150 NNP I-NP B-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O O
3 CD O O
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
ALDACTONE NNP B-NP B-m
( ( O I-m
SPIRONOLACTONE NNP B-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
with IN B-VP O
meals NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
10/24/01 CD O O
by IN B-VP O
STEURY NNP B-NP O
, , O O
JERROD NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
SPIRONOLACTONE NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CAPTOPRIL NNP I-NP B-m
&amp; NNP I-NP O
SPIRONOLACTONE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
AWARE NNP I-NP O
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
6 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
11/1/01 CD O O
by IN B-VP O
JANCZEWSKI NNP B-NP O
, , O O
BRADFORD NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
CARVEDILOL NNP B-NP B-m
3.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
5 CD O B-du
CELEXA NNP B-NP B-m
( ( O I-m
CITALOPRAM NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
Activity NNP I-NP O
- : O O
As IN B-VP O
tolerated JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
After IN B-VP O
Appt NNP B-NP O
with IN B-VP O
local JJ B-NP O
physician NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Denny NNP I-NP O
Wolfard NNP I-NP O
within IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Highbaugh NNP I-NP O
within IN B-VP O
one CD O O
week NN B-NP O
, , O O
ALLERGY: NNP B-NP O
Iv NNP I-NP O
contrast VBD B-VP O
dyes JJ B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
, , O O
R/O NNP B-NP O
MI NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
non-cardiac JJ B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
Chronic NNP I-NP O
AF NNP I-NP O
since IN B-VP O
1/10 CD O O
, , O O
HTN NNP B-NP O
, , O O
BPH NNP B-NP O
, , O O
ventricular JJ B-NP O
pacemaker NN I-NP O
, , O O
h/o NN B-NP O
CHF NNP I-NP O
, , O O
left VBD B-VP O
buttock NN B-NP O
hematoma NN I-NP O
, , O O
S/P NNP B-NP O
TURP NNP I-NP O
, , O O
s/p JJ B-NP O
TV NN I-NP O
, , O O
MV NNP B-NP O
repair NN I-NP O
10/23 CD O O
, , O O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
78 CD O O
yo NN B-NP O
man NN I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
2 CD O O
episodes NNS B-NP O
of IN B-VP O
SSCP NNP B-NP O
Recently NNP I-NP O
had VBD B-VP O
MV NNP B-NP O
and CC O O
TV NNP B-NP O
repair NN I-NP O
with IN B-VP O
SVG NNP B-NP O
to TO O O
OM1 NNP B-NP O
Reported NNP I-NP O
to TO O O
have VB O O
80% CD O O
diag NNS B-NP O
, , O O
70% CD O O
LCX NNP B-NP O
from IN B-VP O
a DT B-NP O
cath NN I-NP O
in IN B-VP O
Ohio NNP B-NP O
in IN B-VP O
10/25 CD O O
Also RB O O
h/o JJ B-NP O
HTN NNP I-NP O
, , O O
DM NNP B-NP O
2 CD O O
( ( O O
diet JJ O O
controlled VBN O O
) ) O O
, , O O
AF NNP B-NP O
, , O O
ventricular JJ B-NP O
pacemaker NN I-NP O
, , O O
ischemic JJ B-NP O
CMP NNP I-NP O
, , O O
EF NNP B-NP O
30% CD O O
CP NNP B-NP O
occurred VBD B-VP O
while IN B-VP O
at IN B-VP O
rest NN B-NP O
, , O O
no DT B-NP O
radiation NN I-NP O
and CC O O
no DT O O
associated VBN O O
symptoms NNS B-NP O
1st CD O O
episode NN B-NP O
was VBD B-VP O
5/25 CD O O
, , O O
resolved VBD B-VP O
spontaneously RB O O
Came NNP B-NP O
to TO O O
ED NNP B-NP O
, , O O
EKG NNP B-NP O
was VBD B-VP O
paced VBN O O
, , O O
CK NNP B-NP O
flat JJ O O
, , O O
TnI NNP B-NP O
elevated VBD B-VP O
at IN B-VP O
0.17 CD O O
, , O O
similar JJ O O
to TO O O
value NN B-NP O
on IN B-VP O
0/12 CD O O
when WRB O O
pt NN B-NP O
came VBD B-VP O
in IN B-VP O
for IN B-VP O
a DT B-NP O
TIA NNP I-NP O
Mr NNP I-NP O
Faiella NNP I-NP O
was VBD B-VP O
sent VBN O O
home NN B-NP O
with IN B-VP O
sl JJ B-NP B-mo
nitro NNS I-NP B-m
Pain NNP I-NP B-r
occurred VBD B-VP O
again RB O O
while IN B-VP O
watching VBG O O
TV NN B-NP O
, , O O
resolved VBD B-VP O
with IN B-VP O
one CD O O
sl NN B-NP B-mo
nitro NN I-NP B-m
Was NNP I-NP O
admitted VBN O O
for IN B-VP O
workup NN B-NP O
of IN B-VP O
possible JJ B-NP O
ischemia NN I-NP O
Currently NNP I-NP O
CP NNP I-NP O
free JJ O O
1 CD O O
CV: NNP B-NP O
Ischemia: NNP I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP O
, , O O
added VBD B-VP O
isordil NN B-NP B-m
to TO O O
regimen VB O O
, , O O
ASA NNP B-NP B-m
Continue NNP I-NP O
carvedilol NN I-NP B-m
, , O O
captopril VBP O B-m
Likely JJ O O
to TO O O
have VB O O
CAD NNP B-NP O
, , O O
Adenosine NNP B-NP O
MIBI NNP I-NP O
revealed VBD B-VP O
fixed VBN O O
inf/lat JJ B-NP O
defect NN I-NP O
, , O O
consistent JJ O O
with IN B-VP O
LCX NNP B-NP O
disease NN I-NP O
No NNP I-NP O
reversible NN I-NP O
defects NNS I-NP O
Since IN B-VP O
chest NN B-NP O
pain NN I-NP O
is VBZ O O
unlikely JJ O O
to TO O O
be VB O O
cardiac JJ O O
in IN B-VP O
origin NN B-NP O
, , O O
will MD O O
stop VB O O
nitrates NNS B-NP B-m
Pt NNP I-NP O
was VBD B-VP O
able JJ O O
to TO O O
amubulate VB O O
w/o JJ B-NP O
SOB NNP I-NP O
or CC O O
CP NNP B-NP O
CHF: NNP I-NP O
euvolemic JJ B-NP O
continue NN I-NP O
lasix NN I-NP B-m
, , O O
aldactone NN B-NP B-m
, , O O
digoxin NN B-NP B-m
2 CD O O
Endo: NNP B-NP O
DM NNP I-NP O
2 CD O O
, , O O
diet NN B-NP O
controlled VBD B-VP O
HbA1C NNP B-NP O
5.8% CD O O
3 CD O O
Renal: NNP B-NP O
baseline NN I-NP O
Cr NNP I-NP O
2.0 CD O O
4 CD O O
Neuro: NNPS B-NP O
recent JJ B-NP O
history NN I-NP O
of IN B-VP O
TIA NNP B-NP B-r
, , O O
on IN B-VP O
coumadin NN B-NP B-m
, , O O
may MD O O
not RB O O
want VB O O
to TO O O
reverse VB O O
anticoagulation NN B-NP O
for IN B-VP O
possibility NN B-NP O
of IN B-VP O
cath NN B-NP O
5 CD O O
Heme: NNP B-NP O
coumadin NN I-NP B-m
was VBD B-VP O
held VBN O O
for IN B-VP O
possible JJ B-NP O
cath NN I-NP O
, , O O
but CC O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
discharge NN B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
You PRP O O
were VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
hospital NN I-NP O
for IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
and CC O O
we PRP O O
have VBP O O
made VBN O O
sure JJ O O
that IN B-VP O
you PRP O O
are VBP O O
not RB O O
and CC O O
did VBD B-VP O
not RB O O
have VB O O
a DT B-NP O
heart NN I-NP O
attack NN I-NP O
We PRP O O
also RB O O
did VBD B-VP O
a DT B-NP O
perfusion NN I-NP O
test NN I-NP O
to TO O O
make VB O O
sure JJ O O
that IN B-VP O
your PRP$ O O
heart NN B-NP O
muscle NN I-NP O
is VBZ O O
receiving VBG O O
adequate JJ B-NP O
amounts NNS I-NP O
of IN B-VP O
blood NN B-NP O
flow NN I-NP O
If IN B-VP O
your PRP$ O O
chest JJS B-NP O
pain NN I-NP O
recurrs NN I-NP O
, , O O
gets VBZ O O
worse JJR O O
, , O O
or CC O O
you PRP O O
become VBP O O
short JJ O O
of IN B-VP O
breath NN B-NP O
, , O O
please VB O O
call VB O O
you PRP O O
cardiologist JJ O O
and CC O O
return NN B-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Make NNP I-NP O
appointment NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Moxness NNP I-NP O
within IN B-VP O
the DT B-NP O
next JJ I-NP O
1-2 JJ I-NP O
weeks NNS I-NP O
VNA: NNP I-NP O
Please NNP I-NP O
oversee VB O O
medications NNS B-NP O
, , O O
check NN B-NP O
vitals NNS I-NP O
, , O O
and CC O O
draw VB O O
PT/INR NNP B-NP O
once RB O O
a DT B-NP O
week NN I-NP O
, , O O
starting VBG O O
Thrusday JJ O O
0/22/01 CD O O
PT: NNP B-NP O
Please NNP I-NP O
help VB O O
Mr NNP B-NP O
Muskett NNP I-NP O
regain NN I-NP O
strength NN I-NP O
, , O O
flexibility NN B-NP O
and CC O O
range NN B-NP O
of IN B-VP O
motion NN B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
NINKE NNP I-NP O
, , O O
GARY NNP B-NP O
H NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
YK88 NNP B-NP O
) ) O O
11/1/01 CD O O
@ $ O O
12 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#333193 VBZ O O
783724033 CD O O
SCMH NNP B-NP O
69750620 CD O O
7272147 CD O O
11/24/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
ischemic JJ B-NP O
foot NN I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/12/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/17/2006 CD O O
ATTENDING: NNP B-NP O
KATO NNP I-NP O
, , O O
WHITNEY NNP B-NP O
CRISTOPHER NNP I-NP O
VASCULAR NNP I-NP O
SURGERY NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Right NNP I-NP O
foot NN I-NP O
gangrene NN I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Right NNP I-NP O
foot NN I-NP O
gangrene NN I-NP O
OTHER NNP I-NP O
MEDICAL NNP I-NP O
ISSUES NNP I-NP O
CONSIDERED NNP I-NP O
AT NNP I-NP O
THIS NNP I-NP O
TIME: NNP I-NP O
Diabetes NNP I-NP O
type VBD B-VP O
2 CD O O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
occlusive JJ I-NP O
disease NN I-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
knee JJ B-NP O
amputation NN I-NP O
, , O O
depression NN B-NP O
, , O O
and CC O O
dementia JJ B-NP O
BRIEF NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PHYSICAL NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
90+-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
multiple JJ B-NP O
medical JJ I-NP O
problems NNS I-NP O
including VBG O O
dementia NN B-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
diabetes VBZ O O
, , O O
and CC O O
PVOD NNP B-NP O
, , O O
who WP O O
presented VBD B-VP O
to TO O O
the DT B-NP O
Trinmo NNP I-NP O
Rybay NNP I-NP O
Bethmorgreene NNP I-NP O
Burgstern NNP I-NP O
Medical NNP I-NP O
University NNP I-NP O
Of IN B-VP O
Medical NNP B-NP O
Center NNP I-NP O
Department NNP I-NP O
on IN B-VP O
5/1/06 CD O O
for IN B-VP O
an DT O O
intermittently RB O O
cold JJ O O
and CC O O
blue JJ B-NP O
foot NN I-NP O
Gangrene NNP I-NP O
was VBD B-VP O
noticed VBN O O
in IN B-VP O
the DT O O
second JJ O O
and CC O O
third JJ B-NP O
right JJ I-NP O
lower JJR I-NP O
extremity NN I-NP O
toes NNS I-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
possible JJ B-NP O
amputation NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
diabetes NNS B-NP O
type JJ O O
2 CD O O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
, , O O
anemia NN B-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
asthma NN B-NP O
, , O O
depression NN B-NP O
, , O O
neurogenic JJ B-NP O
bladder NN I-NP O
, , O O
and CC O O
dementia NN B-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
left VBD B-VP O
above-knee JJ B-NP O
amputation NN I-NP O
in IN B-VP O
4/10 CD O O
, , O O
left VBD B-VP O
superficial JJ B-NP O
femoral JJ I-NP O
artery NN I-NP O
to TO O O
peroneal VB O O
artery JJ B-NP O
bypass NN I-NP O
with IN B-VP O
graft NN B-NP O
on IN B-VP O
3/22 CD O O
, , O O
a DT B-NP O
right JJ I-NP O
hip NN I-NP O
arthroplasty NN I-NP O
in IN B-VP O
7/26 CD O O
, , O O
and CC O O
a DT B-NP O
remote JJ I-NP O
history NN I-NP O
of IN B-VP O
cholecystectomy NN B-NP O
and CC O O
appendectomy JJ B-NP O
HOME NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Trazodone NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
nightly RB O B-f
2 CD O O
Celexa NNP B-NP B-m
20 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
3 CD O O
Lactulose JJ O B-m
30 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
4 CD O O
FiberCon NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
5 CD O O
Hydrochlorothiazide NNP B-NP B-m
25 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
6 CD O O
MVI NNP B-NP B-m
daily RB O B-f
7 CD O O
Synthroid NNP B-NP B-m
25 CD O B-do
mcg VBD B-VP I-do
daily RB O B-f
8 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
9 CD O O
Novolin NNP B-NP B-m
Novolin NNP I-NP B-m
30 CD O B-do
units NNS B-NP I-do
q.a.m RB O B-f
, , O O
7 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
10 CD O O
Novolin NNP B-NP B-m
sliding VBG O B-do
scale JJ O I-do
11 CD O O
Hydrochlorothiazide NNP B-NP B-m
25 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
12 CD O O
Zyprexa NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
nightly RB O B-f
ALLERGIES: NNP B-NP O
She PRP O O
has VBZ O O
an DT B-NP O
allergy NN I-NP O
to TO O O
penicillin VB O O
and CC O O
fluoroquinolones VB O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
She PRP O O
lives VBZ O O
in IN B-VP O
a DT B-NP O
nursing NN I-NP O
home NN I-NP O
She PRP O O
has VBZ O O
not RB O O
been VBN O O
ambulatory VBN O O
at IN B-VP O
baseline NN B-NP O
status NN I-NP O
post NN I-NP O
her PRP$ O O
left JJ B-NP O
AKA NNP I-NP O
She PRP O O
is VBZ O O
wheelchair JJ O O
bound RB O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
bradycardic JJ O O
to TO O O
47 CD O O
, , O O
otherwise RB O O
blood NN B-NP O
pressure NN I-NP O
and CC O O
vital JJ B-NP O
signs NNS I-NP O
were VBD B-VP O
stable JJ O O
In IN B-VP O
general JJ O O
, , O O
she PRP O O
was VBD B-VP O
confused VBN O O
, , O O
alert JJ O O
and CC O O
oriented JJ B-NP O
x0 NN I-NP O
but CC O O
in IN B-VP O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
On IN B-VP O
her PRP$ O O
extremities NNS B-NP O
, , O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
she PRP O O
had VBD B-VP O
an DT B-NP O
above-knee JJ I-NP O
amputation NN I-NP O
with IN B-VP O
stump JJ B-NP O
intact NN I-NP O
without IN B-VP O
ulcers NNS B-NP O
Her PRP$ O O
right JJ B-NP O
foot NN I-NP O
was VBD B-VP O
cool JJ O O
to TO O O
the DT B-NP O
mid JJ I-NP O
foot NN I-NP O
proximally RB O O
There EX O O
was VBD B-VP O
bluish JJ B-NP O
discoloration NN I-NP O
of IN B-VP O
toes NNS B-NP O
one CD O O
, , O O
two CD O O
, , O O
and CC O O
three CD O O
Pulses NNS B-NP O
, , O O
there EX O O
was VBD B-VP O
2+ CD O O
femoral JJ B-NP O
pulses NNS I-NP O
bilaterally RB O O
and CC O O
monophasic JJ B-NP O
PT NNP I-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
The DT B-NP O
DP NNP I-NP O
was VBD B-VP O
not RB O O
dopplerable JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient JJ I-NP O
underwent NN I-NP O
and CC O O
tolerated VBD B-VP O
a DT B-NP O
right JJ I-NP O
AKA NNP I-NP O
on IN B-VP O
7/8/06 CD O O
without IN B-VP O
any DT B-NP O
complications NNS I-NP O
, , O O
and CC O O
after IN B-VP O
recovery NN B-NP O
from IN B-VP O
anesthesia NN B-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
general JJ I-NP O
care NN I-NP O
floor NN I-NP O
Diet NNP I-NP O
was VBD B-VP O
advanced VBN O O
as IN B-VP O
tolerated VBN O O
The DT B-NP B-r
pain NN I-NP I-r
was VBD B-VP O
well RB O O
controlled VBN O O
with IN B-VP O
oral JJ B-NP B-m
pain NN I-NP O
medications NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
Her NNP I-NP O
stump NN I-NP O
wound NN I-NP O
was VBD B-VP O
healing VBG O O
with IN B-VP O
mild JJ B-NP O
erythema NN I-NP O
around IN B-VP O
the DT B-NP O
drainage NN I-NP O
site NN I-NP O
for IN B-VP O
which WDT O O
she PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
perioperative JJ B-NP B-du
ancef NN I-NP B-m
and CC O O
switched VBD B-VP O
to TO O O
one CD O B-du
week NN B-NP I-du
of IN B-VP O
p.o NN B-NP B-mo
linezolid NN I-NP B-m
just RB O O
prior RB O O
to TO O O
discharge VB O O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
the DT B-NP O
discharge NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
afebrile RB O O
with IN B-VP O
vital JJ B-NP O
signs NNS I-NP O
stable JJ O O
and CC O O
the DT B-NP O
wound NN I-NP O
, , O O
clean JJ O O
, , O O
dry JJ O O
and CC O O
intact JJ O O
There EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP O
encountered VBD B-VP O
in IN B-VP O
this DT B-NP O
hospital NN I-NP O
stay NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile RB O O
, , O O
vital JJ B-NP O
signs NNS I-NP O
stable JJ O O
, , O O
with IN B-VP O
the DT B-NP O
right JJ I-NP O
AKA NNP I-NP O
stump NN I-NP O
well RB O O
healed VBN O O
and CC O O
with IN B-VP O
mild JJ B-NP O
erythema NN I-NP O
inferior NN I-NP O
to TO O O
the DT B-NP O
incision NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Tylenol NNP B-NP B-m
Elixir NNP I-NP I-m
1000 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.6h NN I-NP B-f
p.r.n NN I-NP I-f
pain VBP O B-r
2 CD O O
Citalopram NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
4 CD O O
Hydrochlorothiazide NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
5 CD O O
Novolog NNP B-NP B-m
sliding VBG O B-do
scale JJ B-NP I-do
Please NNP I-NP O
see VB O O
the DT B-NP O
discharge NN I-NP O
summary NN I-NP O
for IN B-VP O
the DT B-NP O
scale NN I-NP O
doses VBZ O O
6 CD O O
Lantus NNP B-NP B-m
20 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
q.a.m VBP O B-f
7 CD O O
Lactulose NNP B-NP B-m
30 CD O B-do
mL NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
p.r.n NN I-NP I-f
constipation NN I-NP B-r
8 CD O O
Synthroid NNP B-NP B-m
25 CD O B-do
mcg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
9 CD O O
Linezolid JJ O B-m
600 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.12h NN I-NP B-f
x10 NN I-NP B-du
doses VBZ O I-du
starting VBG O O
today NN B-NP O
, , O O
9/27/06 CD O O
10 CD O O
Zyprexa NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m NN I-NP B-f
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
to TO O O
her PRP$ O O
skilled JJ B-NP O
nursing NN I-NP O
facility NN I-NP O
Plan NN I-NP O
is VBZ O O
for IN B-VP O
her PRP$ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Wynder NNP I-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
and CC O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
ADVANCED NNP I-NP O
DIRECTIVES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
DNR/DNI NNP B-NP O
eScription NN I-NP O
document: VBD B-VP O
4-1720087 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Jesse NNP I-NP O
Cravatta NNP I-NP O
MD NNP I-NP O
Twin NNP I-NP O
Nacomp NNP I-NP O
Blu NNP I-NP O
Health NNP I-NP O
Pring NNP I-NP O
Full NNP I-NP O
Ver NNP I-NP O
Dale NNP I-NP O
A NNP I-NP O
Pit NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BONING NNP I-NP O
, , O O
FREEMAN NNP B-NP O
Attending: NNP I-NP O
VEROEVEN NNP I-NP O
, , O O
KELLEY NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
3032658 CD O O
D: NNP B-NP O
8/27/06 CD O O
T: NNP B-NP O
8/27/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#343900 VBZ O O
543168539 CD O O
CMH NNP B-NP O
07809715 CD O O
970606 CD O O
11/26/1990 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/20/1990 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/4/1990 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
40 CD O O
year NN B-NP O
old JJ O O
, , O O
gravida JJ B-NP O
VI NNP I-NP O
para NN I-NP O
V NNP I-NP O
, , O O
black JJ B-NP O
female NN I-NP O
with IN B-VP O
an DT B-NP O
EDC NNP I-NP O
of IN B-VP O
3/18/90 CD O O
at IN B-VP O
29 CD O O
weeks NNS B-NP O
gestation NN I-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
blood NN B-NP O
sugar NN I-NP O
control NN I-NP O
for IN B-VP O
gestational JJ B-NP O
diabetes NNS I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
fasting JJ I-NP O
blood NN I-NP O
sugar NN I-NP O
of IN B-VP O
150 CD O O
and CC O O
had VBD B-VP O
not RB O O
been VBN O O
by IN B-VP O
an DT B-NP O
endocrinologist NN I-NP O
at IN B-VP O
TMC NNP B-NP O
She PRP O O
had VBD B-VP O
gained VBN O O
approximately RB O O
40 CD O O
pounds NNS B-NP O
to TO O O
date NN B-NP O
during IN B-VP O
this DT B-NP O
pregnancy NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
previous JJ I-NP O
history NN I-NP O
of IN B-VP O
greater JJR O O
than IN B-VP O
eight CD O O
pound NN B-NP O
infants NNS I-NP O
delivered VBN O O
vaginally RB O O
without IN B-VP O
difficulty NN B-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
other JJ I-NP O
complaints NNS I-NP O
during IN B-VP O
this DT B-NP O
pregnancy NN I-NP O
She PRP O O
was VBD B-VP O
seen VBN O O
at IN B-VP O
her PRP$ O O
first JJ B-NP O
prenatal JJ I-NP O
visit NN I-NP O
at IN B-VP O
24 CD O O
weeks NNS B-NP O
She PRP O O
is VBZ O O
RH-negative JJ O O
and CC O O
received VBD B-VP O
RhoGAM NNP B-NP B-m
4/15/90 CD O O
The DT B-NP O
hematocrit NN I-NP O
on IN B-VP O
8/16/90 CD O O
was VBD B-VP O
31.8; CD O O
RPR NNP B-NP O
nonreactive; JJ B-NP O
rubella NN I-NP O
non-immune; JJ B-NP O
Pap NNP I-NP O
negative; NN I-NP O
hepatitis NN I-NP O
negative; JJ B-NP O
OB NNP I-NP O
GLT NNP I-NP O
196 CD O O
She PRP O O
had VBD B-VP O
amniocentesis NN B-NP O
for IN B-VP O
genetic JJ B-NP O
reasons NNS I-NP O
which WDT O O
was VBD B-VP O
46-XY JJ B-NP O
PAST NNP I-NP O
HISTORY: NNP I-NP O
Hyperthyroidism NNP I-NP B-r
, , O O
status NN B-NP O
post NN I-NP O
partial JJ B-NP O
thyroidectomy NN I-NP O
in IN B-VP O
1976 CD O O
, , O O
on IN B-VP O
Synthroid NNP B-NP B-m
0.015 CD O B-do
mg NN B-NP I-do
daily; NN I-NP B-f
endometriosis NN I-NP O
with IN B-VP O
right JJ B-NP O
salpingo-oophorectomy NN I-NP O
in IN B-VP O
1976; CD O O
tonsillectomy NN B-NP O
at IN B-VP O
age NN B-NP O
nine; JJ B-NP O
menarche NN I-NP O
at IN B-VP O
age NN B-NP O
13 CD O O
with IN B-VP O
regular JJ B-NP O
cycles NNS I-NP O
lasting VBG O O
approximately RB O O
three CD O O
days; JJ O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
abnormal JJ B-NP O
Pap NNP I-NP O
smears; NN I-NP O
1972 CD O O
, , O O
spontaneous JJ B-NP O
abortion NN I-NP O
and CC O O
subsequent JJ B-NP O
D&amp;C; NNP I-NP O
1974 CD O O
, , O O
normal JJ B-NP O
spontaneous JJ I-NP O
vaginal JJ I-NP O
delivery NN I-NP O
of IN B-VP O
a DT B-NP O
male NN I-NP O
infant NN I-NP O
, , O O
8 CD O O
pounds NNS B-NP O
11 CD O O
ounces; NN B-NP O
1978 CD O O
, , O O
normal JJ B-NP O
spontaneous JJ I-NP O
vaginal JJ I-NP O
delivery NN I-NP O
of IN B-VP O
a DT B-NP O
male NN I-NP O
infant NN I-NP O
, , O O
nine CD O O
pounds NNS B-NP O
, , O O
with IN B-VP O
jaundice NN B-NP O
neonatally; NN I-NP O
1979 CD O O
, , O O
normal JJ B-NP O
spontaneous JJ I-NP O
vaginal JJ I-NP O
delivery; NN I-NP O
1982 CD O O
, , O O
normal JJ B-NP O
spontaneous JJ I-NP O
vaginal JJ I-NP O
delivery NN I-NP O
, , O O
8+ CD O O
pounds NNS B-NP O
, , O O
no DT B-NP O
complications; NN I-NP O
1984 CD O O
, , O O
normal JJ B-NP O
spontaneous JJ I-NP O
vaginal JJ I-NP O
delivery NN I-NP O
, , O O
six CD O O
pounds NNS B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
has VBZ O O
smoked VBN O O
3-4 JJ B-NP O
packs NNS I-NP O
of IN B-VP O
cigarettes NNS B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
the DT O O
past JJ O O
25 CD O O
years NNS B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Synthroid NNP I-NP B-m
and CC O O
vitamins VBZ O B-m
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Vital NNP I-NP O
signs NNS I-NP O
stable JJ O O
She PRP O O
presented VBD B-VP O
as IN B-VP O
a DT B-NP O
pleasant NN I-NP O
, , O O
obese JJ O O
, , O O
black JJ B-NP O
female NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress VBZ O O
The DT B-NP O
HEENT NNP I-NP O
exam NN I-NP O
was VBD B-VP O
normal JJ O O
The DT B-NP O
neck NN I-NP O
was VBD B-VP O
supple; JJ O O
no DT B-NP O
adenopathy; NN I-NP O
thyroid VBZ O O
full JJ O O
, , O O
scar JJ B-NP O
present NN I-NP O
from IN B-VP O
partial JJ B-NP O
thyroidectomy NN I-NP O
The DT B-NP O
lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
The DT B-NP O
cardiac JJ I-NP O
exam NN I-NP O
revealed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
S1 NNP I-NP O
and CC O O
S2; NNP B-NP O
no DT B-NP O
murmurs NN I-NP O
or CC O O
gallops VBZ O O
The DT B-NP O
breasts NNS I-NP O
were VBD B-VP O
without IN B-VP O
masses NNS B-NP O
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
obese JJ O O
and CC O O
gravid JJ B-NP O
NST NNP I-NP O
was VBD B-VP O
reactive JJ O O
with IN B-VP O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
145 CD O O
The DT B-NP O
cervix NN I-NP O
was VBD B-VP O
long RB O O
, , O O
thick NN B-NP O
and CC O O
closed VBD B-VP O
The DT B-NP O
extremities NNS I-NP O
were VBD B-VP O
without IN B-VP O
edema IN B-VP O
The DT B-NP O
deep JJ I-NP O
tendon NN I-NP O
reflexes NNS I-NP O
were VBD B-VP O
1-2+ JJ B-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
A NNP I-NP O
finger NN I-NP O
stick NN I-NP O
blood NN I-NP O
sugar NN I-NP O
was VBD B-VP O
115 CD O O
with IN B-VP O
her PRP$ O O
last JJ B-NP O
meal NN I-NP O
being VBG O O
at IN B-VP O
noon NN B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
impression NN I-NP O
was VBD B-VP O
29 CD O O
weeks NNS B-NP O
gestation NN I-NP O
with IN B-VP O
gestational JJ B-NP O
diabetes NNS I-NP O
admitted VBD B-VP O
for IN B-VP O
glucose JJ B-NP O
control NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
partial JJ B-NP O
thyroidectomy NN I-NP O
and CC O O
anemia VB O O
The DT B-NP O
plan NN I-NP O
was VBD B-VP O
to TO O O
admit VB O O
her PRP$ O O
and CC O O
check VB O O
q4h JJ B-NP O
blood NN I-NP B-r
sugars NNS I-NP I-r
, , O O
begin VBP O O
an DT B-NP O
ADA NNP I-NP O
diet NN I-NP O
and CC O O
possible JJ B-NP O
insulin NN I-NP B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
endocrinology NN I-NP O
service NN I-NP O
on IN B-VP O
admission NN B-NP O
and CC O O
begun VBN O O
on IN B-VP O
a DT B-NP O
diet JJ I-NP O
Her NNP I-NP O
blood NN I-NP B-r
sugars NNS I-NP I-r
continued VBD B-VP O
to TO O O
be VB O O
high JJ O O
with IN B-VP O
a DT B-NP O
fasting NN I-NP O
in IN B-VP O
the DT B-NP O
120-150 JJ I-NP O
range NN I-NP O
She PRP O O
was VBD B-VP O
begun VBN O O
on IN B-VP O
insulin NN B-NP B-m
and CC O O
was VBD B-VP O
managed VBN O O
by IN B-VP O
the DT B-NP O
endocrinology NN I-NP O
service NN I-NP O
and CC O O
controlled VBN O O
well RB O O
on IN B-VP O
the DT B-NP O
insulin NN I-NP B-m
over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP B-du
days NNS I-NP I-du
Her PRP$ O B-r
fasting JJ B-NP O
blood NN I-NP O
sugar NN I-NP O
came VBD B-VP O
down RB O O
to TO O O
eventually RB O O
100-95 VB O O
on IN B-VP O
9/30/90 CD O O
DISPOSITION: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Insulin NNP I-NP B-m
ten VBD B-VP B-do
units NNS B-NP I-do
of IN B-VP O
regular JJ B-NP O
qAM NN I-NP B-f
and CC O O
16 CD O O
units NNS B-NP O
of IN B-VP O
regular JJ O O
and CC O O
16 CD O B-do
16 CD O B-do
units NNS B-NP I-do
units NNS I-NP I-do
NPH NNP I-NP B-m
qPM NN I-NP B-f
qPM NN I-NP B-f
FOLLOW NNP I-NP O
UP NNP I-NP O
will MD O O
be VB O O
with IN B-VP O
Dr NNP B-NP O
Gorneault NNP I-NP O
of IN B-VP O
the DT B-NP O
endocrinology NN I-NP O
service NN I-NP O
________________________________ NNP I-NP O
TP137/7400 NNP I-NP O
LAWRENCE NNP I-NP O
SHUCK NNP I-NP O
, , O O
M.D NNP B-NP O
FH62 NNP I-NP O
D: NNP I-NP O
1/10/90 CD O O
Batch: NNP B-NP O
3241 CD O O
Report: NNP B-NP O
R0718Y8 NNP I-NP O
T: NNP I-NP O
2/17/90 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
PORFIRIO NNP I-NP O
KRUML NNP I-NP O
, , O O
M.D NNP B-NP O
FH62 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#348094 VBZ O O
765192522 CD O O
EMH NNP B-NP O
79392868 CD O O
6068847 CD O O
8/25/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/1/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/18/2006 CD O O
ATTENDING: NNP B-NP O
WIGDOR NNP I-NP O
, , O O
SHELTON NNP B-NP O
MD NNP I-NP O
DISPOSITION: NNP I-NP O
To TO O O
rehabilitation VB O O
PRINCIPAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
CABG NNP I-NP O
x3/LIMA NNP I-NP O
OTHER NNP I-NP O
DIAGNOSES: NNP I-NP O
Excessive NNP I-NP O
bleeding NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
GI NNP B-NP O
bleeding VBG O O
from IN B-VP O
diverticulosis NN B-NP O
which WDT O O
resulted VBD B-VP O
in IN B-VP O
colectomy NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
myelofibrosis NN B-NP O
followed VBN O O
by IN B-VP O
a DT B-NP O
hematologist JJ I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Royce NNP I-NP O
Meidlinger NNP I-NP O
is VBZ O O
a DT B-NP O
78-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
CAD NNP B-NP O
and CC O O
previous JJ B-NP O
MI NNP I-NP O
, , O O
angioplasty NN B-NP O
in IN B-VP O
1995 CD O O
and CC O O
stent JJ B-NP O
placement NN I-NP O
in IN B-VP O
2001 CD O O
, , O O
complained VBD B-VP O
about IN B-VP O
episodes NNS B-NP O
of IN B-VP O
shortness NN B-NP B-r
of IN B-VP O
breath NN B-NP O
and CC O O
increasing VBG O O
intolerance NN B-NP O
of IN B-VP O
physical JJ B-NP O
activity NN I-NP O
He PRP O O
was VBD B-VP O
using VBG O O
nitroglycerin JJ O B-m
and CC O O
rest NN B-NP O
during IN B-VP B-du
such PDT O I-du
an DT B-NP I-du
episode NN I-NP I-du
with IN B-VP O
obvious JJ B-NP O
success NN I-NP O
His PRP$ O O
cardiac JJ B-NP O
catheterization NN I-NP O
was VBD B-VP O
done VBN O O
at IN B-VP O
WLH NNP B-NP O
which WDT O O
revealed VBD B-VP O
three-vessel JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
with IN B-VP O
EF NNP B-NP O
of IN B-VP O
55% CD O O
He PRP O O
has VBZ O O
a DT B-NP O
permanent JJ I-NP O
pacemaker NN I-NP O
installed VBD B-VP O
4/20 CD O O
due JJ O O
to TO O O
sick VB O O
sinus NN B-NP O
syndrome NN I-NP O
and CC O O
an DT B-NP O
intermittent JJ I-NP O
AV NNP I-NP O
block NN I-NP O
, , O O
second-degree JJ B-NP O
Latest NNP I-NP O
echo NN I-NP O
reported VBD B-VP O
presence NN B-NP O
of IN B-VP O
mild-to-moderate JJ B-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
PREOPERATIVE NNP I-NP O
CARDIAC NNP I-NP O
STATUS: NNP I-NP O
Urgent NNP I-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
critical JJ B-NP O
coronary JJ I-NP O
anatomy/myocardial JJ I-NP O
infarction NN I-NP O
in IN B-VP O
1987 CD O O
requiring VBG O O
hospitalization NN B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
class NN B-NP O
III NNP I-NP O
angina NN I-NP O
There EX O O
has VBZ O O
been VBN O O
recent JJ B-NP O
stable JJ I-NP O
angina NN I-NP O
There EX O O
is VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
class NN B-NP O
II NNP I-NP O
heart NN I-NP O
failure NN I-NP O
Recent NNP I-NP O
signs NNS I-NP O
and CC O O
symptoms NNS B-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
include VBP O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm VBP O O
PREVIOUS NNP B-NP O
CARDIOVASCULAR NNP I-NP O
INTERVENTIONS: NNP I-NP O
4/20 CD O O
off IN B-VP O
pump NN B-NP O
biventricular JJ B-NP O
permanent JJ I-NP O
pacemaker NN I-NP O
PTCAS/atherectomy NNP I-NP O
in IN B-VP O
1995 CD O O
and CC O O
stent NN B-NP O
in IN B-VP O
2001 CD O O
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Colectomy NNP I-NP O
due JJ O O
to TO O O
bleeding VBG O O
from IN B-VP O
diverticulosis NN B-NP O
, , O O
THR NNP B-NP O
, , O O
right JJ B-NP O
inguinal JJ I-NP O
hernia NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
Father NNP I-NP O
with IN B-VP O
MI NNP B-NP O
, , O O
died VBD B-VP O
at IN B-VP O
age NN B-NP O
46 CD O O
from IN B-VP O
MI NNP B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
use IN B-VP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
retired JJ I-NP O
judge NN I-NP O
ALLERGIES: NNP I-NP O
To TO O O
penicillin VB O O
, , O O
which WDT O O
results NNS B-NP O
in IN B-VP O
rash NN B-NP O
and CC O O
heparin JJ B-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
Atenolol NNP I-NP B-m
25 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
allopurinol VBZ O B-m
300 CD O B-do
mg JJ O I-do
daily JJ O B-f
, , O O
and CC O O
Flomax NNP B-NP B-m
0.8 CD O B-do
mg JJ B-NP I-do
daily JJ I-NP B-f
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Height NNP I-NP O
and CC O O
weight VBD B-VP O
6 CD O O
feet NNS B-NP O
and CC O O
76 CD O O
kilos NNS B-NP O
Vital NNP I-NP O
signs: VBD B-VP O
Temperature NNP B-NP O
98 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
65 CD O O
, , O O
BP NNP B-NP O
right VBD B-VP O
arm NN B-NP O
118/60 CD O O
, , O O
left VBD B-VP O
arm NN B-NP O
120/58 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
97% CD O O
room NN B-NP O
air NN I-NP O
HEENT: NNP I-NP O
PERRLA/dentition NNP I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
infection/no JJ B-NP O
carotid NN I-NP O
bruits NNS I-NP O
Chest: NNP I-NP O
No NNP I-NP O
incisions NNS I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm VB O O
All DT B-NP O
distal JJ I-NP O
pulses NNS I-NP O
intact JJ B-NP O
Allen's NNP I-NP O
test: NN I-NP O
Left NNP I-NP O
upper JJ B-NP O
extremity NN I-NP O
normal JJ O O
, , O O
right JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
normal JJ B-NP O
Respiratory: NNP I-NP O
Breath NNP I-NP O
sounds VBZ O O
clear JJ O O
bilaterally RB O O
Abdomen: NNP B-NP O
Laparotomy NNP I-NP O
scar NN I-NP O
, , O O
soft JJ O O
, , O O
no DT B-NP O
masses NNS I-NP O
Extremities: NNP I-NP O
Without IN B-VP O
scarring VBG O O
, , O O
varicosities NNS B-NP O
, , O O
or CC O O
edema VB O O
Neuro: NNP B-NP O
Alert NNP I-NP O
and CC O O
oriented VBN O O
, , O O
no DT B-NP O
focal JJ I-NP O
deficits NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Chemistry: NNP I-NP O
Sodium NNP I-NP O
of IN B-VP O
138 CD O O
, , O O
potassium NN B-NP O
3.9 CD O O
, , O O
chloride RB O O
108 CD O O
, , O O
CO2 NNP B-NP O
24 CD O O
, , O O
BUN NNP B-NP O
19 CD O O
, , O O
creatinine NN B-NP O
1 CD O O
, , O O
glucose RB O O
98 CD O O
, , O O
and CC O O
magnesium NN B-NP O
2.1 CD O O
Hematology: NNP B-NP O
WBC NNP I-NP O
19.78 CD O O
, , O O
hematocrit NN B-NP O
30.4 CD O O
, , O O
hemoglobin NN B-NP O
10.2 CD O O
, , O O
platelets NNS B-NP O
525 CD O O
, , O O
PT NNP B-NP O
17.3 CD O O
, , O O
INR NNP B-NP O
1.4 CD O O
, , O O
PTT NNP B-NP O
51 CD O O
UA NNP B-NP O
was VBD B-VP O
normal JJ B-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
data NNS I-NP O
from IN B-VP O
11/0/05 CD O O
performed VBN O O
at IN B-VP O
HMH NNP B-NP O
showed VBD B-VP O
coronary JJ O O
anatomy RB O O
60% CD O O
distal JJ O O
left VBD B-VP O
main JJ O O
, , O O
60% CD O O
ostial JJ B-NP O
LAD NNP I-NP O
, , O O
70% CD O O
proximal JJ B-NP O
circumflex NN I-NP O
, , O O
80% CD O O
proximal JJ B-NP O
RCA NNP I-NP O
, , O O
60% CD O O
distal JJ B-NP O
RCA NNP I-NP O
, , O O
right JJ B-NP O
dominant JJ I-NP O
circulation NN I-NP O
EKG NNP I-NP O
from IN B-VP O
11/0/05 CD O O
showed VBD B-VP O
paced JJ B-NP O
rhythm NN I-NP O
, , O O
rate NN B-NP O
of IN B-VP O
64 CD O O
Chest JJS B-NP O
x-ray NN I-NP O
from IN B-VP O
11/0/05 CD O O
consistent JJ O O
with IN B-VP O
COPD NNP B-NP O
, , O O
left VBD B-VP O
pacemaker NN B-NP O
permanent NN I-NP O
, , O O
cardiomegaly NN B-NP O
, , O O
thoracic JJ B-NP O
vertebral JJ I-NP O
degeneration NN I-NP O
Patient NNP I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
TCH NNP B-NP O
CSS NNP I-NP O
and CC O O
stabilized VBN O O
for IN B-VP O
surgery NN B-NP O
Date NNP I-NP O
of IN B-VP O
surgery NN B-NP O
2/10/05 CD O O
PREOPERATIVE NNP B-NP O
DIAGNOSIS: NNP I-NP O
CAD NNP I-NP O
PROCEDURE: NNP I-NP O
CABG NNP I-NP O
x3 NNP I-NP O
with IN B-VP O
LIMA NNP B-NP O
to TO O O
LAD NNP B-NP O
, , O O
sequential JJ B-NP O
graft NN I-NP O
, , O O
SVG1 NNP B-NP O
connects VBZ O O
aorta NN B-NP O
to TO O O
VK7 NNP B-NP O
then RB O O
PDA NNP B-NP O
Bypass NNP I-NP O
time NN I-NP O
97 CD O O
minutes NNS B-NP O
Circa NNP I-NP O
arrest NN I-NP O
for IN B-VP O
5 CD O O
minutes NNS B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
unit NN I-NP O
in IN B-VP O
stable JJ B-NP O
fashion NN I-NP O
with IN B-VP O
lines NNS B-NP O
and CC O O
tubes NNS B-NP O
intact JJ B-NP O
ICU NNP I-NP O
PROGRESS NNP I-NP O
EVENT NNP I-NP O
SUMMARY: NNP I-NP O
4/25/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
, , O O
hypotensive JJ B-NP O
low JJ I-NP O
SVR NNP I-NP O
, , O O
vasopressin NN B-NP B-m
started VBD B-VP O
, , O O
rising VBG O O
creatinine NN B-NP O
3/3/05 CD O O
, , O O
postoperative JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
started VBD B-VP O
on IN B-VP O
dopamine NN B-NP B-m
for IN B-VP O
oliguria NN B-NP B-r
and CC O O
rising VBG O O
creatinine NN B-NP O
11/12/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#3 NNP I-NP O
, , O O
creatinine VBP O O
down IN B-VP O
to TO O O
1.4 CD O O
, , O O
episode NN B-NP O
of IN B-VP O
bradycardia JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#4 NNP I-NP O
, , O O
continued VBD B-VP O
on IN B-VP O
dopamine NN B-NP B-m
at IN B-VP O
2 CD O B-do
mcg NN B-NP I-do
, , O O
continued VBD B-VP O
high JJ B-NP O
chest NN I-NP O
tube NN I-NP O
output NN I-NP O
Official NNP I-NP O
echo JJ B-NP O
report NN I-NP O
essentially RB O O
unchanged JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#5 NNP I-NP O
, , O O
weaned VBD B-VP O
off RP O O
dopamine NN B-NP B-m
, , O O
left VBD B-VP O
chest JJS B-NP O
tube NN I-NP O
discontinued VBN O O
, , O O
persistent JJ B-NP O
SVG NNP I-NP O
harvesting VBG O O
site NN B-NP O
bleed VBD B-VP O
Postop NNP B-NP O
day NN I-NP O
#6 NNP I-NP O
, , O O
11/29/05 CD O O
, , O O
no DT B-NP O
significant JJ I-NP O
events NNS I-NP O
, , O O
medial JJ B-NP O
chest NN I-NP O
tubes NNS I-NP O
were VBD B-VP O
discontinued VBN O O
without IN B-VP O
complications NNS B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Step-Down JJ I-NP O
Unit NNP I-NP O
on IN B-VP O
11/29/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#6 NNP I-NP O
SUMMARY NNP I-NP O
BY NNP I-NP O
SYSTEM: NNP I-NP O
Neurologically: NNP I-NP O
Intact NNP I-NP O
Cardiovascular: NNP I-NP O
On IN B-VP O
aspirin NN B-NP B-m
, , O O
has VBZ O O
pacemaker NN B-NP O
for IN B-VP O
sick JJ B-NP B-r
sinus NN I-NP I-r
Battery NNP I-NP O
is VBZ O O
low JJ O O
, , O O
cannot JJ B-NP O
pace NN I-NP O
above IN B-VP O
65 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
with IN B-VP O
plans NNS B-NP O
to TO O O
exchange VB O O
generator NN B-NP O
Pressure NN I-NP O
is VBZ O O
better RBR O O
, , O O
paced VBD B-VP O
externally RB O O
at IN B-VP O
90 CD O O
BPM NNP B-NP O
Respiratory: NNP I-NP O
Saturating NNP I-NP O
well RB O O
on IN B-VP O
2 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
oxygen NN B-NP B-m
delivered VBN O O
by IN B-VP O
nasal JJ B-NP B-mo
cannula NNS I-NP I-mo
so RB O O
was VBD B-VP O
moderate JJ B-NP O
chest NN I-NP O
tube NN I-NP O
output NN I-NP O
Diet: NNP I-NP O
Advanced NNP I-NP O
as IN B-VP O
tolerated VBN O O
Renal: NNP B-NP O
Postop NNP I-NP O
increase NN I-NP O
in IN B-VP O
creatinine JJ O B-r
requiring VBG O O
dopamine NN B-NP B-m
, , O O
creatinine NN B-NP O
now RB O O
down RB O O
to TO O O
1.5 CD O O
P.o NNP B-NP B-mo
Lasix NNP I-NP B-m
started VBD B-VP O
Endocrine: NNP B-NP O
No NNP I-NP O
issues NNS I-NP O
Hematology: NNP I-NP O
Anticoagulation NNP I-NP B-r
with IN B-VP O
aspirin JJ B-NP B-m
ID: NNP I-NP O
Antibiotics NNPS I-NP B-m
are VBP O O
off IN B-VP O
Afebrile NNP B-NP O
Elevated NNP I-NP O
white JJ B-NP O
count NN I-NP O
secondary JJ O O
to TO O O
myelofibrosis VB O O
Transferred NNP B-NP O
to TO O O
Step-Down NNP B-NP O
Unit NNP I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#6 NNP I-NP O
Postop NNP I-NP O
day NN I-NP O
#7 NNP I-NP O
, , O O
8/3/05 CD O O
, , O O
last JJ O O
remaining VBG O O
chest JJS B-NP O
tube NN I-NP O
removed VBD B-VP O
Patient NNP B-NP O
still RB O O
complains VBZ O O
of IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
saturating VBG O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
looked VBD B-VP O
slightly RB O O
wet JJ O O
but CC O O
nothing NN B-NP O
significant JJ O O
noted VBD B-VP O
Echo NNP B-NP O
showed VBD B-VP O
moderate JJ B-NP O
TR NNP I-NP O
No NNP I-NP O
changes NNS I-NP O
from IN B-VP O
prior JJ B-NP O
echos JJ I-NP O
Send NNP I-NP O
troponin NN I-NP B-m
, , O O
BNP NNP B-NP O
to TO O O
help VB O O
rule VB O O
out RP O O
PE NNP B-NP O
per IN B-VP O
cards NNS B-NP O
, , O O
very RB O O
slow JJ O O
to TO O O
ambulate VB O O
, , O O
needs VBZ O O
PT NNP B-NP O
, , O O
probably RB O O
rehab NN B-NP O
, , O O
is VBZ O O
being VBG O O
paced VBN O O
to TO O O
70 CD O O
BPM NNP B-NP O
with IN B-VP O
external JJ B-NP O
V NNP I-NP O
wire NN I-NP O
, , O O
has VBZ O O
internal JJ B-NP O
pacer NN I-NP O
working VBG O O
at IN B-VP O
60 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
but CC O O
needs VBZ O O
battery NN B-NP O
change NN I-NP O
by IN B-VP O
EPS NNP B-NP O
FOLLOW-UP NNP I-NP O
APPOINTMENTS: NNP I-NP O
Dr NNP I-NP O
Clam NNP I-NP O
wants VBZ O O
him PRP O O
on IN B-VP O
low JJ B-NP O
flow NN I-NP O
O2 NNP I-NP O
for IN B-VP O
time NN B-NP O
being VBG O O
1/14/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#8 NNP I-NP O
, , O O
sinus VBD B-VP O
rhythm JJ O O
2 CD O O
liters NNS B-NP O
, , O O
patient NN B-NP O
with IN B-VP O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
DVT's NNP I-NP O
, , O O
right JJ B-NP O
IJ NNP I-NP O
clot NN I-NP O
, , O O
and CC O O
left VBD B-VP O
upper JJ B-NP B-r
extremity NN I-NP I-r
DVT NNP I-NP I-r
as RB O O
well RB O O
, , O O
started VBD B-VP O
on IN B-VP O
argatroban NN B-NP B-m
, , O O
PTT NNP B-NP O
to TO O O
titrate VB O O
the DT B-NP O
goal NN I-NP O
of IN B-VP O
50/70 CD O O
HIT NNP B-NP O
screen NN I-NP O
came VBD B-VP O
back RB O O
positive JJ B-NP O
Hematology NNP I-NP O
, , O O
following VBG O O
recommended VBD B-VP O
vascular JJ B-NP O
consult NN I-NP O
for IN B-VP O
blue JJ B-NP O
fingers NNS I-NP O
and CC O O
toes NNS B-NP O
If IN B-VP O
color NN B-NP O
on IN B-VP O
extremities NNS B-NP O
does VBZ O O
not RB O O
improve VB O O
on IN B-VP O
argatroban NN B-NP B-m
, , O O
will MD O O
get VB O O
vascular JJ O O
to TO O O
see VB O O
So RB O O
far RB O O
color NN B-NP O
in IN B-VP O
right JJ B-NP O
hand NN I-NP O
looks VBZ O O
better RBR O O
Left NNP B-NP O
fingers NNS I-NP O
and CC O O
toes NNS B-NP O
bilaterally RB O O
, , O O
no DT O O
worse JJR O O
, , O O
no DT B-NP O
better JJR I-NP O
Respiratory NN I-NP O
status NN I-NP O
worsens NNS I-NP O
, , O O
consider VB O O
CT NNP B-NP O
angiogram NN I-NP O
with IN B-VP O
contrast NN B-NP O
to TO O O
rule VB O O
out RP O O
PE NNP B-NP O
with IN B-VP O
Mucomyst NNP B-NP B-m
given VBN O O
creatinine NN B-NP O
of IN B-VP O
2.1 CD O O
Blood NNP B-NP O
cultures NNS I-NP O
sent VBD B-VP O
for IN B-VP O
white JJ B-NP O
count NN I-NP O
The DT B-NP O
patient NN I-NP O
with IN B-VP O
left JJ B-NP O
chest NN I-NP O
effusion NN I-NP O
, , O O
will MD O O
get VB O O
chest JJS B-NP O
ultrasound NN I-NP O
once RB O O
stable JJ O O
, , O O
still RB O O
has VBZ O O
wires NNS B-NP O
in IN B-VP O
and CC O O
being VBG O O
externally RB O O
paced VBN O O
at IN B-VP O
70 CD O O
until IN B-VP O
internal JJ B-NP O
PPM NNP I-NP O
can MD O O
have VB O O
battery NN B-NP O
change NN I-NP O
9/15/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#9 NNP I-NP O
, , O O
HIT NNP B-NP O
positive JJ O O
with IN B-VP O
worsening VBG O O
clinical JJ B-NP O
syndrome NN I-NP O
Positive NNP I-NP O
DVT's NNP I-NP O
in IN B-VP O
all DT B-NP O
extremities NNS I-NP O
, , O O
started VBD B-VP O
on IN B-VP O
argatroban NN B-NP B-m
, , O O
transferred VBN O O
to TO O O
ICU NNP B-NP O
for IN B-VP O
further JJ B-NP O
monitoring NN I-NP O
, , O O
intubated VBN O O
in IN B-VP O
early JJ B-NP O
a.m NN I-NP O
for IN B-VP O
respiratory NN B-NP O
distress NN I-NP O
0/4/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#10 NNP I-NP O
, , O O
echo NN B-NP O
obtained VBD B-VP O
RV NNP B-NP O
strain NN I-NP O
, , O O
moderate-to-severe JJ B-NP O
TR NNP I-NP O
Renal NNP I-NP O
ultrasound NN I-NP O
with IN B-VP O
Doppler NNP B-NP O
obtained VBD B-VP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
portal JJ B-NP O
venous JJ I-NP O
vascular JJ I-NP O
thrombosis NN I-NP O
Argatroban NNP I-NP B-m
continued VBD B-VP O
, , O O
persistently RB O O
high JJ B-NP O
minute NN I-NP O
ventilatory NN I-NP O
requirement JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#11 NNP I-NP O
, , O O
transfused VBD B-VP O
2 CD O B-do
units NNS B-NP I-do
packed VBD B-VP B-m
red JJ B-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
with IN B-VP O
improvement NN B-NP O
in IN B-VP O
hematocrit NN B-NP O
, , O O
creatinine NN B-NP O
, , O O
and CC O O
BP NNP B-NP O
after IN B-VP O
second JJ B-NP O
unit NN I-NP O
, , O O
required VBN O O
left VBD B-VP O
femoral JJ B-NP O
CVL NNP I-NP O
placement NN I-NP O
for IN B-VP O
poor JJ B-NP O
peripheral JJ I-NP O
access NN I-NP O
and CC O O
concern NN B-NP O
for IN B-VP O
worsening NN B-NP O
of IN B-VP O
right JJ B-NP O
arm NN I-NP O
swelling NN I-NP O
after IN B-VP O
blood NN B-NP O
administration NN I-NP O
in IN B-VP O
the DT B-NP O
ipsilateral JJ I-NP O
arm NN I-NP O
Postop NNP I-NP O
day NN I-NP O
#12 NNP I-NP O
, , O O
right JJ B-NP O
hand NN I-NP O
cyanosis NN I-NP O
worsening VBG O O
Ortho/plastic/vascular NNP B-NP O
service NN I-NP O
following VBG O O
, , O O
thrombolytic JJ B-NP O
therapy NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
given VBN O O
current JJ B-NP O
anticoagulation NN I-NP O
on IN B-VP O
argatroban NN B-NP B-m
on IN B-VP O
propofol NN B-NP B-m
, , O O
went VBD B-VP O
weaned VBN O O
to TO O O
PSV NNP B-NP O
Total NNP I-NP O
bilirubin NN I-NP O
elevated VBD B-VP O
at IN B-VP O
4.1 CD O O
, , O O
direct JJ B-NP O
bilirubin NN I-NP O
at IN B-VP O
1.5 CD O O
0/18/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#13 NNP I-NP O
, , O O
left VBD B-VP O
hand NN B-NP O
ischemia NN I-NP O
continues VBZ O O
to TO O O
progress VB O O
, , O O
too RB O O
agitated VBN O O
to TO O O
be VB O O
extubated VBN O O
, , O O
continues VBZ O O
to TO O O
be VB O O
therapeutic JJ O O
on IN B-VP O
argatroban JJ B-NP B-m
Microthrombi NNP I-NP O
, , O O
conservative JJ B-NP O
management NN I-NP O
planned VBN O O
Tube NNP B-NP O
feeds NNS I-NP O
started VBD B-VP O
, , O O
bronched VBD B-VP O
moderate JJ B-NP O
amount NN I-NP O
of IN B-VP O
seropurulent JJ B-NP O
secretions NNS I-NP O
Postop NNP I-NP O
day NN I-NP O
#14 NNP I-NP O
, , O O
11/0/05 CD O O
, , O O
left VBD B-VP O
hand NN B-NP O
ischemia NN I-NP O
showed VBD B-VP O
signs NNS B-NP O
of IN B-VP O
demarcation NN B-NP O
, , O O
PTT NNP B-NP O
therapeutic NN I-NP O
on IN B-VP O
argatroban NN B-NP B-m
, , O O
plastic JJ B-NP O
C NNP I-NP O
valve NN I-NP O
patient NN I-NP O
, , O O
suggested VBD B-VP O
conservative JJ B-NP O
therapy NN I-NP O
, , O O
low JJ B-NP O
urine NN I-NP O
output NN I-NP O
which WDT O O
resolved VBD B-VP O
with IN B-VP O
albumin JJ B-NP O
bolus NN I-NP O
, , O O
CK NNP B-NP O
is VBZ O O
trending VBG O O
down RP O O
, , O O
GI NNP B-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
for IN B-VP O
melena NN B-NP O
10/0/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#15 NNP I-NP O
, , O O
increase NN B-NP O
sodium NN I-NP B-m
, , O O
free JJ B-NP O
water NN I-NP O
added VBD B-VP O
, , O O
left VBD B-VP O
hand NN B-NP O
continues VBZ O O
to TO O O
demarcate VB O O
, , O O
argatroban JJ B-NP B-m
dose NN I-NP O
increased VBD B-VP O
to TO O O
get VB O O
PTT NNP B-NP B-r
therapeutic JJ O O
9/4/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#16 NNP I-NP O
, , O O
thick JJ B-NP O
secretions NNS I-NP O
plugged VBD B-VP O
to TO O O
desaturated VBN O O
, , O O
cup JJ B-NP O
leak NN I-NP O
and CC O O
poor JJ B-NP O
TVs NNP I-NP O
, , O O
prompted VBD B-VP O
increasing VBG O O
FIO2 NNP B-NP O
, , O O
temperature NN B-NP O
spike NN I-NP O
, , O O
blood NN B-NP O
glucose RB O O
high JJ O O
, , O O
pancultured VBD B-VP O
for IN B-VP O
question NN B-NP O
of IN B-VP O
sepsis NN B-NP O
4/17/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#17 NNP I-NP O
, , O O
Serratia NNP B-NP O
marcescens VBZ O O
in IN B-VP O
sputum JJ B-NP B-r
culture NN I-NP I-r
, , O O
started VBD B-VP O
on IN B-VP O
ceftazidime NN B-NP B-m
, , O O
awaiting VBG O O
sensitivities NNS B-NP O
, , O O
GI NNP B-NP O
bleed NN I-NP O
, , O O
hematocrit NN B-NP O
dropped VBD B-VP O
from IN B-VP O
28-23 JJ O O
, , O O
2 CD O B-do
units NNS B-NP I-do
packed VBD B-VP B-m
red JJ B-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
given VBN O O
, , O O
NG-tube JJ B-NP O
aspiration NN I-NP O
with IN B-VP O
bilious JJ B-NP O
fluid NN I-NP O
, , O O
presumed VBD B-VP O
lower JJR B-NP O
GI NNP I-NP O
bleed NN I-NP O
, , O O
argatroban NN B-NP B-m
reduced VBD B-VP O
to TO O O
lower VB O O
end NN B-NP O
of IN B-VP O
therapeutic JJ B-NP O
window NN I-NP O
4/25/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#18 NNP I-NP O
, , O O
GI NNP B-NP O
bleed NN I-NP O
continues VBZ O O
, , O O
hematocrit NN B-NP O
dropped VBD B-VP O
having VBG O O
1 CD O O
unit NN B-NP O
transfusion NN I-NP O
, , O O
bilirubin NN B-NP O
increased VBD B-VP O
from IN B-VP O
1.7-3.3 JJ O O
, , O O
echo NN B-NP O
was VBD B-VP O
essentially RB O O
unchanged JJ O O
showing VBG O O
RV NNP B-NP O
strain NN I-NP O
Postop NNP I-NP O
day NN I-NP O
#19 NNP I-NP O
, , O O
persistent JJ B-NP O
respiratory NN I-NP O
alkalosis NN I-NP O
with IN B-VP O
improvement NN B-NP O
of IN B-VP O
blood NN B-NP O
gas NN I-NP O
with IN B-VP O
adequate JJ B-NP O
sedation NN I-NP O
, , O O
decreased VBD B-VP O
minute NN B-NP O
ventilation NN I-NP O
6/29/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#20 NNP I-NP O
, , O O
became VBD B-VP O
hypotensive JJ O O
, , O O
oliguric JJ O O
, , O O
profound JJ B-NP O
metabolic JJ I-NP O
acidosis NN I-NP O
septic JJ O O
, , O O
source NN B-NP O
likely JJ B-NP O
chest NN I-NP O
, , O O
lines NNS B-NP O
rewired VBD B-VP O
, , O O
pressors NNS B-NP O
started VBD B-VP O
, , O O
resedated VBN O O
and CC O O
put VBN O O
on IN B-VP O
a DT B-NP O
rate NN I-NP O
, , O O
also RB O O
further JJ O O
per IN B-VP O
bleeding VBG O O
requiring VBG O O
1 CD O O
unit NN B-NP O
transfusion NN I-NP O
7/4/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#21 NNP I-NP O
, , O O
general JJ B-NP O
surgery NN I-NP O
consult NN I-NP O
, , O O
no DT B-NP O
surgical JJ I-NP O
etiology NN I-NP O
at IN B-VP O
the DT B-NP O
current JJ I-NP O
point NN I-NP O
, , O O
ultrasound NN B-NP O
showed VBD B-VP O
no DT B-NP O
pericholecystic JJ I-NP O
fluid NN I-NP O
, , O O
positively RB O O
distended VBD B-VP O
gallbladder NN B-NP O
, , O O
add VB O O
fluconazole JJ O B-m
and CC O O
Flagyl NNP B-NP B-m
prophylactically RB O O
, , O O
argatroban JJ O B-m
held VBD B-VP O
given VBN O O
profuse NN B-NP B-r
GI NNP I-NP I-r
bleeding VBG O I-r
requiring VBG O O
3 CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
, , O O
hematocrit NN B-NP O
currently RB O O
stable JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#22 NNP I-NP O
, , O O
no DT B-NP O
further JJ I-NP O
GI NNP I-NP O
bleed NN I-NP O
, , O O
argatroban NN B-NP B-m
remains VBZ O O
off RP O O
, , O O
continues VBZ O O
on IN B-VP O
vasopressin NN B-NP B-m
and CC O O
dopamine JJ B-NP B-m
Postop NNP I-NP O
day NN I-NP O
#23 NNP I-NP O
, , O O
no DT B-NP O
GI NNP I-NP O
bleed NN I-NP O
, , O O
off RB O O
vasopressin NN B-NP B-m
, , O O
dopamine NN B-NP B-m
weaned VBD B-VP O
too RB O O
, , O O
left VBD B-VP O
hand NN B-NP O
looks VBZ O O
a DT O O
little JJ O O
better JJR O O
, , O O
trial NN B-NP O
of IN B-VP O
extubation NN B-NP O
, , O O
now RB O O
tachypneic VBZ O O
2/1/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#24 NNP I-NP O
, , O O
extubated VBD B-VP O
, , O O
tolerating VBG O O
BiPAP NNP B-NP O
10/29/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#25 NNP I-NP O
, , O O
tachypneic NN B-NP O
on IN B-VP O
BiPAP NNP B-NP O
, , O O
hypotensive NN B-NP O
, , O O
bolus NN B-NP O
with IN B-VP O
albumin JJ O O
4/7/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#26 NNP I-NP O
, , O O
tolerating VBG O O
facemask NN B-NP O
, , O O
overnight RB O O
started VBD B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
sugars NNS B-NP O
controlled VBD B-VP O
on IN B-VP O
no DT B-NP O
insulin NN I-NP O
and CC O O
possibly RB O O
improving VBG O O
, , O O
we PRP O O
will MD O O
allow VB O O
to TO O O
further JJ B-NP O
demarcate NN I-NP O
for IN B-VP O
further JJ O O
two CD O O
weeks NNS B-NP O
3/0/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#27 NNP I-NP O
, , O O
GI NNP B-NP O
bleed NN I-NP O
, , O O
hematocrit NN B-NP O
stable JJ O O
, , O O
tachypneic JJ O O
, , O O
intolerant NN B-NP O
of IN B-VP O
BiPAP NNP B-NP O
requiring VBG O O
suctioning VBG O O
Postop NNP B-NP O
day NN I-NP O
#28 NNP I-NP O
, , O O
GI NNP B-NP O
bleed NN I-NP O
, , O O
hematocrit NN B-NP O
dropped VBD B-VP O
from IN B-VP O
30-27 JJ O O
, , O O
back RB O O
to TO O O
29 CD O O
appears VBZ O O
stable JJ O O
, , O O
remains VBZ O O
on IN B-VP O
argatroban NN B-NP B-m
, , O O
bronched VBN O O
yesterday NN B-NP O
with IN B-VP O
serous JJ B-NP O
secretions NNS I-NP O
8/11/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#29 NNP I-NP O
, , O O
no DT B-NP O
GI NNP I-NP O
bleeds NNS I-NP O
bleed NN I-NP O
, , O O
transfused VBD B-VP O
1 CD O O
unit NN B-NP O
for IN B-VP O
hematocrit NN B-NP O
of IN B-VP O
26 CD O O
, , O O
intermittent NN B-NP O
problems NNS I-NP O
with IN B-VP O
external JJ B-NP O
pacer NN I-NP O
capture NN I-NP O
and CC O O
internal JJ B-NP O
pacer NN I-NP O
not RB O O
firing VBG O O
, , O O
neurologically RB O O
continues VBZ O O
to TO O O
improve VB O O
10/12/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#30 NNP I-NP O
, , O O
EPS NNP B-NP O
interrogated VBD B-VP O
pacer NN B-NP O
and CC O O
backup NN B-NP O
, , O O
pacing VBG O O
appears VBZ O O
to TO O O
be VB O O
intact JJ O O
, , O O
internal JJ B-NP O
pacer NN I-NP O
set VBN O O
backup NN B-NP O
rate NN I-NP O
at IN B-VP O
65 CD O O
, , O O
currently RB O O
patient JJ B-NP O
overdrive NN I-NP O
paced VBN O O
at IN B-VP O
rate NN B-NP O
of IN B-VP O
100 CD O O
, , O O
external JJ B-NP O
wires NNS I-NP O
working VBG O O
10/30/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#31 NNP I-NP O
, , O O
venous JJ B-NP O
blood NN I-NP O
gas NN I-NP O
overnight VBD B-VP O
revealed VBD B-VP O
pH NN B-NP O
7.28 CD O O
, , O O
BiPAP NNP B-NP O
initiated VBD B-VP O
resulting VBG O O
in IN B-VP O
decreased JJ B-NP O
BP NNP I-NP O
, , O O
held VBD B-VP O
Lasix NNP B-NP B-m
drip NN I-NP B-mo
with IN B-VP O
decreased JJ B-NP O
BP NNP I-NP O
, , O O
patient JJ O O
much RB O O
more JJR O O
alert JJ O O
and CC O O
oriented VBN O O
after IN B-VP O
2 CD O O
hours NNS B-NP O
on IN B-VP O
BiPAP NNP B-NP O
Postop NNP I-NP O
day NN I-NP O
#32 NNP I-NP O
, , O O
right JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
swelling VBG O O
continues VBZ O O
to TO O O
worsen VB O O
, , O O
positive JJ B-NP O
pressure NN I-NP O
mask NN I-NP O
ventilation NN I-NP O
Postop NNP I-NP O
day NN I-NP O
#33 NNP I-NP O
, , O O
more RBR O O
communicative JJ B-NP O
overnight JJ I-NP O
Postop NNP I-NP O
day NN I-NP O
#34 NNP I-NP O
, , O O
more RBR O O
communicative JJ B-NP O
overnight JJ I-NP O
Postop NNP I-NP O
day NN I-NP O
#35 NNP I-NP O
, , O O
increased VBD B-VP O
pacemaker NN B-NP O
threshold NN I-NP O
overnight NN I-NP O
from IN B-VP O
2-7 JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#36 NNP I-NP O
, , O O
2/23/05 CD O O
, , O O
increased VBN O O
pacemaker NN B-NP O
threshold NN I-NP O
overnight NN I-NP O
from IN B-VP O
2-7 JJ O O
6/17/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#36 NNP I-NP O
, , O O
continues VBZ O O
to TO O O
improve VB O O
for IN B-VP O
speech NN B-NP O
and CC O O
swallow NN B-NP O
and CC O O
EP NNP B-NP O
assessment VBD B-VP O
2/4/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#37 NNP I-NP O
, , O O
plans VBZ O O
for IN B-VP O
pacemaker NN B-NP O
battery NN I-NP O
changed VBD B-VP O
, , O O
external JJ B-NP O
wire NN I-NP O
threshold NN I-NP O
at IN B-VP O
7 CD O O
milliamps NNS B-NP O
, , O O
argatroban NN B-NP B-m
, , O O
off RB O O
diuresis NN B-NP O
, , O O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
restarted VBD B-VP O
, , O O
Dobbhoff NNP B-NP O
tube NN I-NP O
pulled VBD B-VP O
out RP O O
by IN B-VP O
patient JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#38 NNP I-NP O
, , O O
had VBD B-VP O
pacing VBG O O
generator NN B-NP O
changed VBD B-VP O
, , O O
off RB O O
argatroban NN B-NP B-m
at IN B-VP O
present JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#39 NNP I-NP O
, , O O
failed VBD B-VP O
video NN B-NP O
swallow NN I-NP O
, , O O
tube NN B-NP O
feed NN I-NP O
to TO O O
continue VB O O
, , O O
argatroban RB O B-m
restarted VBN O O
, , O O
Lopressor NNP B-NP B-m
started VBD B-VP O
, , O O
pacemaker NN B-NP O
working VBG O O
well RB O O
, , O O
wires NNS B-NP O
discontinued VBD B-VP O
0/21/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#40 NNP I-NP O
, , O O
argatroban NN B-NP B-m
dose NN I-NP O
reduced VBN O O
to TO O O
maintain VB O O
PTT NNP B-NP B-r
of IN B-VP O
50 CD O O
Postop NNP B-NP O
day NN I-NP O
#41 NNP I-NP O
, , O O
INR NNP B-NP O
2.3 CD O O
, , O O
will MD O O
check VB O O
INR NNP B-NP O
off IN B-VP O
argatroban NN B-NP B-m
, , O O
large JJ B-NP O
number NN I-NP O
of IN B-VP O
loose JJ B-NP O
stools NNS I-NP O
Postop NNP I-NP O
day NN I-NP O
#42 NNP I-NP O
, , O O
C NNP B-NP O
diff NN I-NP O
pending VBG O O
, , O O
argatroban RB O B-m
restarted VBN O O
Postop NNP B-NP O
day NN I-NP O
#43 NNP I-NP O
, , O O
nausea NN B-NP O
, , O O
no DT B-NP O
vomiting NN I-NP O
yesterday NN I-NP O
, , O O
tube NN B-NP O
feeds NNS I-NP O
turned VBD B-VP O
off RP O O
temporarily RB O O
, , O O
more JJR B-NP O
tachypneic JJ I-NP O
Postop NNP I-NP O
day NN I-NP O
#44 NNP I-NP O
, , O O
GNR NNP B-NP O
from IN B-VP O
A NNP B-NP O
line NN I-NP O
, , O O
sputum NN B-NP O
Gram NNP I-NP O
stain NN I-NP O
, , O O
gram-positive JJ B-NP O
cocci NN I-NP O
, , O O
and CC O O
gram-positive JJ B-NP O
rods NNS I-NP O
, , O O
febrile NN B-NP O
to TO O O
101.8 CD O O
Postop NNP B-NP O
day NN I-NP O
#45 NNP I-NP O
, , O O
A NNP B-NP O
line NN I-NP O
removed VBN O O
, , O O
argatroban VB O B-m
off RP O O
, , O O
sputum JJ B-NP O
culture NN I-NP O
grew VBD B-VP O
Staph NNP B-NP O
aureus NN I-NP O
and CC O O
pseudomonas NN B-NP O
, , O O
afebrile JJ B-NP O
Foley NNP I-NP O
removed VBD B-VP O
, , O O
patient JJ B-NP O
voiding NN I-NP O
, , O O
transferred VBD B-VP O
back RB O O
to TO O O
Step-Down NNP B-NP O
Unit NNP I-NP O
on IN B-VP O
10/5/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#46 NNP I-NP O
, , O O
PTT NNP B-NP O
therapeutic NN I-NP O
on IN B-VP O
argatroban NN B-NP B-m
, , O O
INR NNP B-NP O
tending VBG O O
up RP O O
, , O O
fingers NNS B-NP O
and CC O O
toes NNS B-NP O
still RB O O
discolored VBD B-VP O
, , O O
continue VBP O O
to TO O O
follow VB O O
Foley NNP B-NP O
in IN B-VP O
place NN B-NP O
secondary JJ O O
to TO O O
retention NN B-NP O
, , O O
continues VBZ O O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
continues VBZ O O
on IN B-VP O
triple JJ B-NP B-m
antibiotic JJ I-NP O
therapy NN I-NP O
for IN B-VP O
sputum/blood JJ B-NP B-r
culture NN I-NP I-r
, , O O
rehabilitation NN B-NP O
when WRB O O
ready JJ O O
0/7/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#47 NNP I-NP O
, , O O
V NNP B-NP O
paced/room NN I-NP O
air NN I-NP O
, , O O
family NN B-NP O
meeting NN I-NP O
, , O O
patient NN B-NP O
to TO O O
have VB O O
video NN B-NP O
swallow NN I-NP O
on IN B-VP O
Tuesday NNP B-NP O
, , O O
plastics NNS B-NP O
came VBD B-VP O
up RB O O
today NN B-NP O
, , O O
planned VBD B-VP O
to TO O O
take VB O O
to TO O O
OR NNP B-NP O
next JJ B-NP O
week NN I-NP O
for IN B-VP O
amputation NN B-NP O
of IN B-VP O
left JJ B-NP O
fingers NNS I-NP O
and CC O O
some DT B-NP O
toes NNS I-NP O
, , O O
patient JJ O O
doing VBG O O
much JJ O O
better RBR O O
with IN B-VP O
PT NNP B-NP O
, , O O
goal NN B-NP O
PTT NNP I-NP O
is VBZ O O
50 CD O O
, , O O
argatroban NN B-NP B-m
to TO O O
come VB O O
off RP O O
once RB O O
INR NNP B-NP O
is VBZ O O
over IN B-VP O
2 CD O O
, , O O
starting VBG O O
Flomax NNP B-NP B-m
since IN B-VP O
he PRP O O
had VBD B-VP O
urinary JJ B-NP B-r
retention NN I-NP I-r
and CC O O
Foley NNP B-NP O
had VBD B-VP O
to TO O O
be VB O O
reinserted VBN O O
, , O O
we PRP O O
will MD O O
do VB O O
another DT O O
voiding VBG O O
trial NN B-NP O
48 CD O O
hours NNS B-NP O
Postop NNP I-NP O
day NN I-NP O
#48 NNP I-NP O
, , O O
on IN B-VP O
Flomax NNP B-NP B-m
, , O O
to TO O O
do VB O O
voiding VBG O O
trial NN B-NP O
at IN B-VP O
midnight NN B-NP O
tonight NN I-NP O
, , O O
on IN B-VP O
Coumadin NNP B-NP B-m
and CC O O
argatroban NN B-NP B-m
for IN B-VP O
HIT NNP B-NP B-r
HIT NNP I-NP B-r
, , O O
goal NN B-NP O
PTT NNP I-NP O
is VBZ O O
50-70 JJ O O
, , O O
plans VBZ O O
to TO O O
discontinue VB O O
argatroban NN B-NP B-m
when WRB O O
INR NNP B-NP O
greater JJR O O
than IN B-VP O
2 CD O O
Plastics NNPS B-NP O
most RBS O O
likely JJ O O
to TO O O
take VB O O
to TO O O
OR NNP B-NP O
next JJ B-NP O
week NN I-NP O
for IN B-VP O
removal NN B-NP O
of IN B-VP O
left JJ B-NP O
fingers/hand NN I-NP O
Patient NNP I-NP O
under IN B-VP O
impression NN B-NP O
that IN B-VP O
it PRP O O
is VBZ O O
just RB O O
fingertips NNS B-NP O
, , O O
family NN B-NP O
are VBP O O
aware JJ O O
and CC O O
may MD O O
be VB O O
more JJR O O
once RB O O
Dr NNP B-NP O
Vonseeger NNP I-NP O
makes VBZ O O
final JJ B-NP O
decision NN I-NP O
as IN B-VP O
to TO O O
what WP O O
he PRP O O
will MD O O
do VB O O
, , O O
will MD O O
need VB O O
to TO O O
make VB O O
patient NN B-NP O
aware JJ O O
, , O O
toes NNS B-NP O
are VBP O O
also RB O O
to TO O O
be VB O O
amputated VBN O O
, , O O
most RBS O O
likely RB O O
will MD O O
not RB O O
do VB O O
all DT O O
at IN B-VP O
once RB O O
, , O O
physical JJ B-NP O
therapy NN I-NP O
has VBZ O O
been VBN O O
working VBG O O
with IN B-VP O
him PRP O O
, , O O
very RB O O
happy JJ O O
with IN B-VP O
the DT B-NP O
progress NN I-NP O
he PRP O O
has VBZ O O
been VBN O O
making VBG O O
, , O O
speech NN B-NP O
and CC O O
swallow NN B-NP O
to TO O O
video VB O O
swallow NN B-NP O
on IN B-VP O
Tuesday NNP B-NP O
11/8/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#49 NNP I-NP O
, , O O
V NNP B-NP O
paced VBD B-VP O
room NN B-NP O
air NN I-NP O
, , O O
argatroban NN B-NP B-m
and CC O O
Coumadin NNP B-NP B-m
for IN B-VP O
HIT NNP B-NP B-r
HIT NNP I-NP B-r
, , O O
status NN B-NP O
unchanged JJ O O
, , O O
awaiting VBG O O
plastics NNS B-NP O
input JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#50 NNP I-NP O
, , O O
paced VBD B-VP O
room NN B-NP O
air NN I-NP O
, , O O
plastics NNS B-NP O
talked VBD B-VP O
at IN B-VP O
length NN B-NP O
to TO O O
the DT B-NP O
patient NN I-NP O
to TO O O
take VB O O
him PRP O O
to TO O O
OR NNP B-NP O
later RB O O
this DT B-NP O
week NN I-NP O
, , O O
continue VBP O O
argatroban NN B-NP B-m
, , O O
Coumadin NNP B-NP B-m
held VBD B-VP O
, , O O
PT NNP B-NP O
working VBG O O
closely RB O O
with IN B-VP O
patient NN B-NP O
, , O O
hemodynamically RB O O
stable JJ O O
and CC O O
afebrile JJ O O
, , O O
high JJ B-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
unchanged JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#51 NNP I-NP O
, , O O
V NNP B-NP O
paced VBD B-VP O
room NN B-NP O
air NN I-NP O
, , O O
failed VBD B-VP O
video NN B-NP O
swallow NN I-NP O
, , O O
keep VB O O
n.p.o NN B-NP O
, , O O
patient NN B-NP O
and CC O O
family NN B-NP O
will MD O O
decide VB O O
by IN B-VP O
the DT B-NP O
a.m NN I-NP O
if IN B-VP O
they PRP O O
will MD O O
proceed VB O O
with IN B-VP O
surgery NN B-NP O
on IN B-VP O
Thursday NNP B-NP O
, , O O
wound VBD B-VP O
looking VBG O O
better JJR O O
per IN B-VP O
RN NNP B-NP O
, , O O
otherwise RB O O
status NN B-NP O
quo JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
#52 NNP I-NP O
, , O O
V NNP B-NP O
paced VBD B-VP O
room NN B-NP O
air NN I-NP O
, , O O
patient NN B-NP O
going VBG O O
to TO O O
OR NNP B-NP O
with IN B-VP O
plastics NNS B-NP O
for IN B-VP O
toe NN B-NP O
finger NN I-NP O
amputations/left VBD B-VP O
hand NN B-NP O
debridement NN I-NP O
, , O O
holding VBG O O
tube NN B-NP O
feeds NNS I-NP O
and CC O O
argatroban NN B-NP B-m
after IN B-VP O
midnight NN B-NP O
, , O O
patient NN B-NP O
on IN B-VP O
day NN B-NP O
#9 NNP I-NP O
of IN B-VP O
#14 NNP B-NP O
of IN B-VP O
levofloxacin NN B-NP B-m
for IN B-VP O
EC NNP B-NP B-r
bacteremia NN I-NP I-r
and CC O O
day NN B-NP O
#9 NNP I-NP O
of IN B-VP O
#21 NNP B-NP O
off IN B-VP O
linezolid NN B-NP B-m
for IN B-VP O
pseudomonas JJ B-NP B-r
pneumonia NN I-NP I-r
Postop NNP I-NP O
day NN I-NP O
#53 NNP I-NP O
, , O O
V NNP B-NP O
paced VBD B-VP O
room NN B-NP O
air NN I-NP O
, , O O
went VBD B-VP O
to TO O O
OR NNP B-NP O
today NN I-NP O
, , O O
had VBD B-VP O
complete JJ B-NP O
amputation NN I-NP O
of IN B-VP O
left JJ B-NP O
hand NN I-NP O
and CC O O
most JJS O O
of IN B-VP O
toes NNS B-NP O
bilateral JJ O O
, , O O
toes NNS B-NP O
were VBD B-VP O
left VBN O O
open JJ O O
, , O O
left VBD B-VP O
arm NN B-NP O
was VBD B-VP O
closed VBN O O
with IN B-VP O
a DT B-NP O
large JJ I-NP O
skin NN I-NP O
flap NN I-NP O
, , O O
JP NNP B-NP O
drain NN I-NP O
left VBD B-VP O
in IN B-VP O
place NN B-NP O
at IN B-VP O
left JJ B-NP O
wrist NN I-NP O
, , O O
about RB O O
2 CD O B-do
unit NN B-NP I-do
units NNS I-NP O
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
postop JJ B-NP O
Psych NNP I-NP O
consulted VBD B-VP O
to TO O O
help VB O O
patient NN B-NP O
coping VBG O O
, , O O
they PRP O O
will MD O O
see VB O O
him PRP O O
tomorrow NN B-NP O
, , O O
restarted VBD B-VP O
argatroban NN B-NP B-m
at IN B-VP O
05:00 CD O O
p.m NN B-NP O
, , O O
restarting VBG O O
Coumadin NNP B-NP B-m
Postop NNP I-NP O
day NN I-NP O
#54 NNP I-NP O
, , O O
8/28/05 CD O O
, , O O
plastics NNS B-NP O
following VBG O O
, , O O
patient NN B-NP O
has VBZ O O
JP VBN O O
drain NN B-NP O
in IN B-VP O
wrist NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
hand NN B-NP O
amputation NN I-NP O
, , O O
bilateral JJ B-NP O
toe NN I-NP O
amputation NN I-NP O
, , O O
psych NN B-NP O
consulted VBN O O
for IN B-VP O
further JJ B-NP O
eval NN I-NP O
, , O O
patient NN B-NP O
not RB O O
depressed VBN O O
, , O O
coping VBG O O
well RB O O
, , O O
remains VBZ O O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
followed VBN O O
by IN B-VP O
speech NN B-NP O
and CC O O
swallow NN B-NP O
with IN B-VP O
no DT B-NP O
records NNS I-NP O
for IN B-VP O
p.o NN B-NP O
feeds NNS I-NP O
at IN B-VP O
this DT B-NP O
point NN I-NP O
, , O O
PT NNP B-NP O
following VBG O O
, , O O
will MD O O
continue VB O O
to TO O O
advance VB O O
mobilization NN B-NP O
as IN B-VP O
wounds NNS B-NP O
heal JJ O O
, , O O
stable JJ O O
hemodynamically RB O O
6/13/05 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#55 NNP I-NP O
, , O O
plastics NNS B-NP O
following VBG O O
, , O O
patient JJ O O
remains VBZ O O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
pending VBG O O
speech NN B-NP O
and CC O O
swallow JJ B-NP O
advancement NN I-NP O
, , O O
stable JJ O O
hemodynamically RB O O
, , O O
repeat NN B-NP O
blood NN I-NP O
cultures NNS I-NP O
drawn VBP O O
, , O O
white JJ B-NP O
count NN I-NP O
still RB O O
elevated VBN O O
, , O O
currently RB O O
remaining VBG O O
on IN B-VP O
argatroban NN B-NP B-m
or CC O O
INR NNP B-NP O
subtherapeutic JJ O O
1/25/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#56 NNP I-NP O
, , O O
plastic NN B-NP O
following NN I-NP O
, , O O
removed VBD B-VP O
left JJ B-NP O
wrist NN I-NP O
JP NNP I-NP O
drain NN I-NP O
, , O O
white JJ B-NP O
count NN I-NP O
remains NNS I-NP O
elevated VBD B-VP O
, , O O
remains VBZ O O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
speech NN B-NP O
and CC O O
swallow NN B-NP O
following NN I-NP O
, , O O
PTT NNP B-NP O
therapeutic JJ O O
, , O O
INR NNP B-NP O
not RB O O
yet RB O O
therapeutic JJ O O
, , O O
started VBD B-VP O
low-dose JJ B-NP B-do
Neurontin NNP I-NP B-m
per IN B-VP O
plastics NNS B-NP O
, , O O
stable JJ O O
11/29/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#57 NNP I-NP O
, , O O
white JJ B-NP O
count NN I-NP O
up RP O O
a DT B-NP O
bit NN I-NP O
, , O O
cultures NNS B-NP O
remain VBP O O
negative JJ O O
at IN B-VP O
baseline NN B-NP O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
elevation NN I-NP O
upon IN B-VP O
admit NN B-NP O
, , O O
patient JJ O O
very RB O O
concerned JJ O O
about IN B-VP O
being VBG O O
tube JJ O O
fed VBN O O
, , O O
planned VBN O O
speech NN B-NP O
and CC O O
swallow JJ B-NP O
reevaluation NN I-NP O
scheduled VBN O O
for IN B-VP O
tomorrow NN B-NP O
, , O O
ambulate VBP O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
to TO O O
chair VB O O
with IN B-VP O
lift NN B-NP O
team NN I-NP O
and CC O O
may MD O O
weight VB O O
bear NN B-NP O
with IN B-VP O
PT NNP B-NP O
, , O O
plastics NNS B-NP O
following VBG O O
, , O O
PTT NNP B-NP O
therapeutic NN I-NP O
on IN B-VP O
argatroban JJ O B-m
3/18/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#58 NNP I-NP O
, , O O
V NNP B-NP O
paced VBD B-VP O
via IN B-VP O
internal JJ B-NP O
PPM NNP I-NP O
, , O O
BP NNP B-NP O
stable JJ O O
, , O O
satting VBG O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
with IN B-VP O
PT NNP B-NP O
, , O O
ambulated VBD B-VP O
a DT O O
little JJ O O
, , O O
plastics/vascular JJ B-NP O
following NN I-NP O
, , O O
left VBD B-VP O
upper JJ B-NP O
extremity NN I-NP O
and CC O O
bilateral JJ B-NP O
toe NN I-NP O
amputation NN I-NP O
site NN I-NP O
healing VBG O O
well RB O O
, , O O
argatroban JJ B-NP B-m
argatroban NN I-NP B-m
dose NN I-NP O
increased VBD B-VP O
from IN B-VP O
0.1 CD O B-do
to TO O O
0.2 CD O B-do
, , O O
bridging VBG O O
to TO O O
Coumadin NNP B-NP B-m
, , O O
speech NN B-NP O
and CC O O
swallow JJ B-NP O
reevaluate NN I-NP O
at IN B-VP O
bedside NN B-NP O
, , O O
may MD O O
repeat VB O O
video NN B-NP O
swallow NN I-NP O
study NN I-NP O
later RB O O
this DT B-NP O
week NN I-NP O
as IN B-VP O
patient NN B-NP O
continues VBZ O O
to TO O O
work VB O O
with IN B-VP O
PT NNP B-NP O
and CC O O
increase VB O O
strength NN B-NP O
, , O O
remains VBZ O O
on IN B-VP O
Dobbhoff NNP B-NP O
tube NN I-NP O
feeds NNS I-NP O
, , O O
patient NN B-NP O
has VBZ O O
baseline VBN O O
neutrophilia NNS B-NP O
but CC O O
mildly RB O O
above IN B-VP O
baseline NN B-NP O
, , O O
afebrile RB O O
, , O O
following VBG O O
pancultures NNS B-NP O
including VBG O O
C NNP B-NP O
diff NN I-NP O
for IN B-VP O
loose JJ B-NP O
stools NNS I-NP O
, , O O
dosing VBG O O
Lasix NNP B-NP B-m
for IN B-VP O
reduced JJ B-NP B-r
urine JJ I-NP I-r
output NN I-NP I-r
Foley NNP I-NP O
in IN B-VP O
place NN B-NP O
, , O O
discontinued VBN O O
PCA NNP B-NP O
, , O O
rehabilitation NN B-NP O
screen NN I-NP O
initiated VBD B-VP O
8/25/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#59 NNP I-NP O
, , O O
V NNP B-NP O
paced VBD B-VP O
via IN B-VP O
internal JJ B-NP O
pacemaker NN I-NP O
, , O O
BP NNP B-NP O
stable JJ O O
, , O O
remains VBZ O O
afebrile JJ O O
, , O O
remains VBZ O O
on IN B-VP O
linezolid NN B-NP B-m
for IN B-VP O
EC NNP B-NP B-r
bacteremia NN I-NP I-r
, , O O
chest VB O O
x-ray JJ O O
continues VBZ O O
to TO O O
demonstrate VB O O
persistent JJ B-NP O
opacifications NNS I-NP O
and CC O O
left VBD B-VP O
mid NN B-NP O
, , O O
left VBD B-VP O
lower JJR O O
, , O O
and CC O O
right JJ B-NP O
base NN I-NP O
, , O O
had VBD B-VP O
been VBN O O
on IN B-VP O
levofloxacin JJ B-NP B-m
levofloxacin NN I-NP B-m
1/29/05 CD O B-du
through IN B-VP O
10/29/05 CD O O
and CC O O
8/4/05 CD O B-du
through IN B-VP I-du
3/18/06 CD O I-du
, , O O
satting VBG O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
strictly RB O O
n.p.o JJ O O
, , O O
all DT B-NP O
nutrition NN I-NP O
via IN B-VP O
Dobbhoff NNP B-NP O
, , O O
patient NN B-NP O
has VBZ O O
been VBN O O
working VBG O O
diligently RB O O
with IN B-VP O
PT NNP B-NP O
, , O O
speech NN B-NP O
and CC O O
swallow NN B-NP O
to TO O O
reassess VB O O
again RB O O
Thursday NNP B-NP O
and CC O O
Friday NNP B-NP O
, , O O
remains VBZ O O
on IN B-VP O
argatroban NN B-NP B-m
with IN B-VP O
subtherapeutic JJ B-NP O
INR NNP I-NP O
, , O O
titrating VBG O B-do
Coumadin NNP B-NP B-m
dose NN I-NP O
, , O O
plastics NNS B-NP O
following VBG O O
left JJ B-NP O
hand NN I-NP O
and CC O O
bilateral JJ B-NP O
toe NN I-NP O
amputation NN I-NP O
sites NNS I-NP O
which WDT O O
are VBP O O
clean JJ O O
and CC O O
healing VBG O O
well RB O O
10/28/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#60 NNP I-NP O
, , O O
remains VBZ O O
ventricularly RB O O
paced VBN O O
via IN B-VP O
internal JJ B-NP O
PPM NNP I-NP O
, , O O
BP NNP B-NP O
stable JJ O O
, , O O
ambulated VBD B-VP O
out IN B-VP O
of IN B-VP O
room NN B-NP O
today NN I-NP O
with IN B-VP O
PT NNP B-NP O
, , O O
Speech NNP B-NP O
and CC O O
Swallow NNP B-NP O
Service NNP I-NP O
encouraged VBN O O
by IN B-VP O
recent JJ B-NP O
PT NNP I-NP O
gains NNS I-NP O
, , O O
felt VBD B-VP O
bedside JJ B-NP O
exam NN I-NP O
today NN I-NP O
indicated VBD B-VP O
potential JJ O O
for IN B-VP O
advancement NN B-NP O
, , O O
scheduled VBN O O
for IN B-VP O
repeat NN B-NP O
video NN I-NP O
swallow NN I-NP O
, , O O
remains VBZ O O
strictly RB O O
n.p.o JJ O O
, , O O
fed JJ O O
via IN B-VP O
Dobbhoff NNP B-NP O
, , O O
white JJ B-NP O
count NN I-NP O
at IN B-VP O
preop JJ B-NP O
baseline NN I-NP O
, , O O
afebrile IN B-VP O
completing VBG O O
21 CD O B-du
day NN B-NP O
course NN I-NP O
of IN B-VP O
linezolid JJ O B-m
for IN B-VP O
EC NNP B-NP B-r
bacteremia NN I-NP I-r
, , O O
chest VB O O
x-ray JJ O O
continues VBZ O O
to TO O O
demonstrate VB O O
persistent JJ O O
although IN B-VP O
mildly RB O O
improved VBN O O
opacifications NNS B-NP O
in IN B-VP O
the DT B-NP O
left NN I-NP O
mid NN I-NP O
, , O O
left VBD B-VP O
lower JJR O O
, , O O
and CC O O
right JJ B-NP O
base NN I-NP O
, , O O
has VBZ O O
been VBN O O
on IN B-VP O
levofloxacin NN B-NP B-m
, , O O
saturating VBG O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
urine JJ B-NP O
output NN I-NP O
, , O O
JVD NNP B-NP O
, , O O
and CC O O
chest JJS O O
x-ray JJ O O
improved VBN O O
after IN B-VP O
adding VBG O O
low-dose JJ B-NP B-do
Lasix NNP I-NP B-m
, , O O
remains VBZ O O
on IN B-VP O
argatroban NN B-NP B-m
with IN B-VP O
subtherapeutic JJ B-NP O
INR NNP I-NP O
Plastics NNPS I-NP O
following VBG O O
Postop NNP B-NP O
day NN I-NP O
#61 NNP I-NP O
, , O O
10/2/06 CD O O
, , O O
long RB O O
postop JJ B-NP O
course NN I-NP O
complicated VBN O O
by IN B-VP O
HIT NNP B-NP O
positive JJ O O
, , O O
Speech NNP B-NP O
and CC O O
Swallow NNP B-NP O
Service NNP I-NP O
were VBD B-VP O
encouraged VBN O O
enough RB O O
by IN B-VP O
recent JJ B-NP O
PT NNP I-NP O
gains NNS I-NP O
to TO O O
reassess VB O O
video NN B-NP O
swallow NN I-NP O
but CC O O
again RB O O
was VBD B-VP O
seen VBN O O
to TO O O
aspirate VB O O
with IN B-VP O
all DT B-NP O
consistencies NNS I-NP O
, , O O
keeping VBG O O
strictly RB O O
n.p.o VBN O O
, , O O
all DT B-NP O
nutrition NN I-NP O
and CC O O
meds NNS B-NP O
via IN B-VP O
Dobbhoff NNP B-NP O
NGT NNP I-NP O
, , O O
no DT B-NP O
PEG NNP I-NP O
planned VBD B-VP O
at IN B-VP O
this DT B-NP O
point NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
afebrile JJ O O
, , O O
completing VBG O O
21 CD O B-du
day NN B-NP I-du
course NN I-NP I-du
linezolid NN I-NP B-m
for IN B-VP O
EC NNP B-NP B-r
bacteremia NN I-NP I-r
Chest NNP I-NP O
x-ray NN I-NP O
continues VBZ O O
to TO O O
demonstrate VB O O
persistent JJ O O
although IN B-VP O
improved JJ B-NP O
calcifications NNS I-NP O
in IN B-VP O
the DT B-NP O
left NN I-NP O
mid NN I-NP O
, , O O
left VBD B-VP O
lower JJR O O
, , O O
and CC O O
right JJ B-NP O
base NN I-NP O
0/20/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#62 NNP I-NP O
, , O O
remains VBZ O O
on IN B-VP O
argatroban NN B-NP B-m
drip NN I-NP B-mo
for IN B-VP O
HIT NNP B-NP B-r
, , O O
INR NNP B-NP O
trending VBG O O
up RP O O
, , O O
n.p.o RB O O
tube JJ B-NP O
feeds NNS I-NP O
via IN B-VP O
Dobbhoff NNP B-NP O
, , O O
three CD O B-du
more JJR B-NP I-du
days NNS I-NP I-du
of IN B-VP O
Linezolid NNP B-NP B-m
for IN B-VP O
EC NNP B-NP B-r
bacteremia NN I-NP O
2/29/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
63# CD O O
, , O O
VP NNP B-NP O
room NN I-NP O
air NN I-NP O
, , O O
remains VBZ O O
on IN B-VP O
argatroban NN B-NP B-m
for IN B-VP O
HIT NNP B-NP B-r
, , O O
INR NNP B-NP O
2.5 CD O O
, , O O
rising VBG O O
slowly RB O O
Order NNP B-NP O
for IN B-VP O
portable JJ B-NP O
chest JJ I-NP O
x-ray NN I-NP O
, , O O
20 CD O B-do
20 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
IV NNP I-NP B-mo
IV NNP I-NP B-mo
Lasix NNP I-NP B-m
Lasix NNP I-NP B-m
for IN B-VP O
increased VBN O B-r
increased VBN O B-r
labored VBN O I-r
labored RBR O I-r
breathing VBG O I-r
breathing VBG O I-r
today NN B-NP O
, , O O
weight NN B-NP O
has VBZ O O
been VBN O O
stable JJ O O
past IN B-VP O
few JJ B-NP O
days NNS I-NP O
, , O O
positive JJ O O
on IN B-VP O
I's/O's NNP B-NP O
, , O O
white JJ B-NP O
count NN I-NP O
high JJ O O
but CC O O
at IN B-VP O
baseline JJ O O
secondary JJ O O
to TO O O
his PRP$ O O
history NN B-NP O
of IN B-VP O
myeloproliferative JJ B-NP O
disorder NN I-NP O
, , O O
patient NN B-NP O
remained VBD B-VP O
afebrile JJ O O
8/17/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#64 NNP I-NP O
, , O O
V NNP B-NP O
paced VBD B-VP O
room NN B-NP O
air NN I-NP O
, , O O
decreased VBD B-VP O
argatroban JJ O B-m
4/0/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
#65 NNP I-NP O
, , O O
V NNP B-NP O
paced VBD B-VP O
, , O O
argatroban JJ O B-m
discontinued VBN O O
as IN B-VP O
INR NNP B-NP O
now RB O O
therapeutic JJ O O
, , O O
working VBG O O
with IN B-VP O
PT NNP B-NP O
doing VBG O O
well RB O O
, , O O
patient NN B-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
Cardiac NNP B-NP O
Surgery NNP I-NP O
Service NNP I-NP O
to TO O O
be VB O O
stable JJ O O
to TO O O
discharge VB O O
to TO O O
rehabilitation VB O O
on IN B-VP O
7/24/06 CD O O
with IN B-VP O
the DT O O
following VBG O O
discharge NN B-NP O
instructions NNS I-NP O
DIET: NNP I-NP O
Osmolite NNP I-NP B-m
1.2 CD O O
tube NN B-NP O
feeds NNS I-NP O
at IN B-VP O
80 CD O B-do
cc NN B-NP I-do
an DT B-NP O
hour NN I-NP O
with IN B-VP O
plans NNS B-NP O
to TO O O
advance VB O O
p.o NN B-NP B-mo
as IN B-VP O
swallow JJ B-NP O
function NN I-NP O
improved VBD B-VP O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENTS: NNP I-NP O
Dr NNP I-NP O
Leaird NNP I-NP O
, , O O
282-008-4347 JJ O O
in IN B-VP O
5-6 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Tanaka NNP I-NP O
, , O O
5324-517-0379 JJ O O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Suriel NNP I-NP O
465-337-2375 JJ O O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Peshek NNP I-NP O
OOGMCAGHC NNP I-NP O
Plastics NNS I-NP O
at IN B-VP O
305-235-4279 JJ O O
in IN B-VP O
7-10 JJ B-NP O
days NNS I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
should MD O O
have VB O O
speech NN B-NP O
and CC O O
swallow NN B-NP O
follow VBP O O
up RP O O
while NN B-NP O
at IN B-VP O
rehab NN B-NP O
for IN B-VP O
ongoing VBG O O
evaluation NN B-NP O
of IN B-VP O
swallow JJ B-NP O
function NN I-NP O
He PRP O O
is VBZ O O
going VBG O O
to TO O O
rehabilitation VB O O
with IN B-VP O
Dobbhoff NNP B-NP O
tube NN I-NP O
in IN B-VP O
place NN B-NP O
for IN B-VP O
feeding VBG O O
with IN B-VP O
plans NNS B-NP O
to TO O O
advance VB O O
diet JJ O O
to TO O O
p.o VB O O
intake VB O O
once RB O O
swallow JJ B-NP O
function NN I-NP O
improves VBZ O O
Mr NNP B-NP O
Lesley NNP I-NP O
Cusmano NNP I-NP O
should MD O O
not RB O O
receive VB O O
any DT B-NP O
heparin NN I-NP O
products NNS I-NP O
, , O O
he PRP O O
has VBZ O O
HIT VBN O O
and CC O O
has VBZ O O
required VBN O O
anticoagulation NN B-NP O
therapy/surgical JJ B-NP O
amputation NN I-NP O
as IN B-VP O
a DT B-NP O
result NN I-NP O
TO NNP I-NP O
DO NNP I-NP O
PLAN: NNP I-NP O
Make NNP I-NP O
all DT B-NP O
follow-up JJ I-NP O
appointments NNS I-NP O
, , O O
local JJ B-NP O
wound NN I-NP O
care NN I-NP O
, , O O
wash JJ B-NP O
wounds NNS I-NP O
daily JJ O O
with IN B-VP O
soap NN B-NP O
and CC O O
water NN B-NP O
, , O O
shower JJR B-NP O
patient JJ I-NP O
daily JJ I-NP O
Please NNP I-NP O
follow VB O O
HH NNP B-NP O
Plastic NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
records NNS I-NP O
for IN B-VP O
dressing VBG O O
changes NNS B-NP O
, , O O
bilateral JJ B-NP O
lower JJR I-NP O
extremities NNS I-NP O
and CC O O
left JJ B-NP O
wrist NN I-NP O
Watch NNP I-NP O
wounds VBZ O O
for IN B-VP O
signs NNS B-NP O
of IN B-VP O
infection NN B-NP O
, , O O
redness NN B-NP O
, , O O
swelling VBG O O
, , O O
fever NN B-NP O
, , O O
pain NN B-NP O
, , O O
discharge NN B-NP O
Call NNP I-NP O
PCP/cardiologist NNP I-NP O
or CC O O
JH NNP B-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
at IN B-VP O
282-008-4347 JJ O O
with IN B-VP O
any DT B-NP O
questions NNS I-NP O
or CC O O
Dr NNP B-NP O
Boldenow NNP I-NP O
at IN B-VP O
305-235-4279 JJ O O
with IN B-VP O
any DT B-NP O
questions NNS I-NP O
regarding VBG O O
amputation NN B-NP O
sites NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Tylenol NNP I-NP B-m
325-650 JJ B-NP B-do
mg NN I-NP I-do
PNGT NNP I-NP O
q.4h NN I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
atenolol RB O B-m
12.5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Dulcolax NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
PR NNP I-NP B-mo
daily RB O B-f
p.r.n VBZ O I-f
constipation NN B-NP B-r
, , O O
Chloraseptic NNP B-NP B-m
spray NN I-NP I-m
one CD O B-do
spray NN B-NP I-do
q.2h NN I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP O
instructions NNS I-NP O
for IN B-VP O
throat NN B-NP B-r
pain NN I-NP I-r
due JJ O O
to TO O O
NG NNP B-NP O
tube NN I-NP O
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
p.r.n NN I-NP O
constipation NN I-NP B-r
, , O O
ferrous JJ B-NP B-m
sulfate NN I-NP I-m
300 CD O B-do
mg NN B-NP I-do
PNGT NNP I-NP O
t.i.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP O
PNGT NNP I-NP O
b.i.d NN I-NP B-f
, , O O
gentamicin JJ B-NP B-m
sulfate NN I-NP I-m
two CD O B-do
drops NNS B-NP I-do
OU NNP I-NP B-mo
q.8h NN I-NP B-f
, , O O
regular JJ B-NP B-m
insulin NN I-NP O
sliding VBG O B-do
scale NN B-NP I-do
, , O O
regular JJ B-NP B-m
insulin NN I-NP I-m
8 CD O B-do
units NNS B-NP I-do
subq VBD B-VP B-mo
q.6h NN B-NP B-f
with IN B-VP O
instructions NNS B-NP O
to TO O O
hold VB O O
if IN B-VP O
tube JJ B-NP O
feeds NNS I-NP O
off RP O O
or CC O O
n.p.o RB O O
, , O O
milk NN B-NP B-m
of IN B-VP O
magnesia NN B-NP O
30 CD O B-do
mL JJ B-NP I-do
daily JJ I-NP B-f
p.r.n NN I-NP I-f
constipation NN I-NP B-r
, , O O
nystatin JJ B-NP B-m
suspension NN I-NP I-m
1 CD O B-do
million CD O O
units NNS B-NP O
q.i.d JJ O B-f
swish JJ O O
and CC O O
spit NN B-NP O
, , O O
multivitamin FW O B-m
therapeutic JJ O O
with IN B-VP O
minerals NNS B-NP O
15 CD O B-do
mL NNS B-NP I-do
PNGT NNP I-NP O
daily RB O B-f
, , O O
simvastatin VBD B-VP B-m
20 CD O B-do
mg NN B-NP I-do
PNGT NNP I-NP O
q.h.s NN I-NP B-f
, , O O
Atrovent NNP B-NP B-m
nebulizers VBZ O I-m
0.5 CD O B-do
mg NN B-NP I-do
q.i.d NN I-NP B-f
, , O O
Neurontin NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Ambien NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
q.h.s NN I-NP B-f
p.r.n NN I-NP I-f
insomnia NN I-NP B-r
, , O O
K-Dur NNP B-NP B-m
20 CD O B-do
mEq NN B-NP I-do
PNGT NNP I-NP O
b.i.d NN I-NP B-f
, , O O
Flomax NNP B-NP B-m
0.8 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
miconazole JJ B-NP B-m
nitrate NN I-NP I-m
2% CD O I-m
powder NN B-NP I-m
topical JJ B-NP B-mo
b.i.d NN I-NP B-f
, , O O
Nexium NNP B-NP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Coumadin NNP B-NP B-m
with IN B-VP O
variable JJ B-NP B-do
dosage NN I-NP I-do
to TO O O
be VB O O
determined VBN O O
based VBN O O
on IN B-VP O
INR NNP B-NP O
, , O O
and CC O O
Prochlorperazine NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
PR NNP I-NP B-mo
q.12h NN I-NP B-f
p.r.n NN I-NP O
emesis NN I-NP B-r
eScription NN I-NP O
document: VBZ O O
0-8526852 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Don NNP I-NP O
Lashutva NNP I-NP O
MD NNP I-NP O
DIVISION NNP I-NP O
OF NNP I-NP O
CARDIAC NNP I-NP O
SURGERY NNP I-NP O
Louissi NNP I-NP O
Salt NNP I-NP O
Balt NNP I-NP O
Go NNP I-NP O
E NNP I-NP O
Worce NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
CUMOLETTI NNP I-NP O
, , O O
JOSE NNP B-NP O
BRANDON NNP I-NP O
Attending: NNP I-NP O
HUHTA NNP I-NP O
, , O O
ODIS NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
1341159 CD O O
D: NNP B-NP O
7/24/06 CD O O
T: NNP B-NP O
7/24/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#351554 VBZ O O
889265558 CD O O
TRCHC NNP B-NP O
80689098 CD O O
3425450 CD O O
6/7/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHEST NNP I-NP O
PAIN NNP I-NP O
, , O O
RULE NNP B-NP O
OUT NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/8/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/28/2005 CD O O
ATTENDING: NNP B-NP O
LOBUR NNP I-NP O
, , O O
RENALDO NNP B-NP O
MD NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
with IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
OTHER NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
CAD NNP B-NP O
2 CD O O
Hypertension NNP B-NP O
3 CD O O
Congestive NNP B-NP O
heart NN I-NP O
failure NN I-NP O
4 CD O O
Diabetes VBZ O O
5 CD O O
Hypercholesterolemia NNP B-NP O
6 CD O O
Peripheral NNP B-NP O
vascular JJ B-NP O
disease NN I-NP O
7 CD O O
Smoking NNP B-NP O
history NN I-NP O
8 CD O O
History NN B-NP O
of IN B-VP O
alcohol NN B-NP O
abuse NN I-NP O
9 CD O O
History NNP B-NP O
of IN B-VP O
seizure NN B-NP O
disorder NN I-NP O
10 CD O O
Atrial NNP B-NP O
fibrillation NN I-NP O
with IN B-VP O
rapid JJ B-NP O
ventricular JJ I-NP O
response NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Mauras NNP I-NP O
is VBZ O O
a DT B-NP O
72-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
, , O O
PCI NNP B-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
stable JJ B-NP O
angina NN I-NP O
, , O O
type NN B-NP O
2 CD O O
diabetes NNS B-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
former JJ B-NP O
smoking NN I-NP O
history NN I-NP O
and CC O O
also RB O O
history NN B-NP O
of IN B-VP O
seizure NN B-NP O
disorder NN I-NP O
with IN B-VP O
cataracts NNS B-NP O
and CC O O
recently RB O O
discharged VBD B-VP O
after IN B-VP O
an DT B-NP O
admission NN I-NP O
for IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
with IN B-VP O
rapid JJ B-NP O
ventricular JJ I-NP O
response NN I-NP O
He PRP O O
had VBD B-VP O
occasional JJ B-NP O
anginal JJ I-NP O
symptoms NNS I-NP O
prior RB O O
to TO O O
discharge VB O O
He PRP O O
took VBD B-VP O
about RB O O
two CD O B-do
nitroglycerins NNS B-NP B-m
per IN B-VP B-f
week NN B-NP I-f
Over IN B-VP O
the DT B-NP O
past JJ I-NP O
week NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
escalating VBG O B-r
chest JJS B-NP O
pain NN I-NP O
requiring VBG O O
one CD O B-do
nitroglycerin JJ O B-m
per IN B-VP B-f
day NN B-NP I-f
The DT B-NP O
pain NN I-NP B-r
was VBD B-VP O
relieved VBN O O
by IN B-VP O
rest NN B-NP O
and CC O O
nitroglycerin RB O B-m
One CD O O
week NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
his PRP$ O O
digoxin NN B-NP B-m
was VBD B-VP O
stopped VBN O O
and CC O O
his PRP$ O O
amiodarone NN B-NP B-m
was VBD B-VP O
decreased VBN O O
His PRP$ O O
Plavix NNP B-NP B-m
was VBD B-VP O
stopped VBN O O
and CC O O
his PRP$ O O
Coumadin NNP B-NP B-m
was VBD B-VP O
held VBN O O
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
he PRP O O
had VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
He PRP O O
had VBD B-VP O
two CD O B-do
nitroglycerins NNS B-NP B-m
and CC O O
rested VBN O O
but CC O O
the DT B-NP O
pain NN I-NP O
persisted VBD B-VP O
He PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
ED NNP I-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
he PRP O O
received VBD B-VP O
Lopressor NNP B-NP B-m
, , O O
Enalapril NNP B-NP B-m
, , O O
Lovenox NNP B-NP B-m
treatment NN I-NP O
dose NN I-NP O
and CC O O
a DT B-NP O
Plavix NNP I-NP B-m
load NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Includes NNP I-NP O
CAD NNP I-NP O
, , O O
hypertension NN B-NP O
, , O O
CHF NNP B-NP O
, , O O
diabetes VBZ O O
, , O O
hypercholesterolemia NN B-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
and CC O O
past JJ B-NP O
smoking NN I-NP O
history NN I-NP O
ALLERGIES: NNP I-NP O
To TO O O
penicillin VB O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
past JJ B-NP O
alcohol NN I-NP O
and CC O O
smoking NN B-NP O
history NN I-NP O
He PRP O O
quit VBD B-VP O
alcohol RB O O
25 CD O O
years NNS B-NP O
ago RB O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
afebrile NN B-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
45 CD O O
and CC O O
blood NN B-NP O
pressure NN I-NP O
95/50 CD O O
He PRP O O
had VBD B-VP O
a DT B-NP O
left JJ I-NP O
surgical JJ I-NP O
pupil NN I-NP O
, , O O
left VBD B-VP O
eye NN B-NP O
ptosis NN I-NP O
at IN B-VP O
baseline NN B-NP O
His PRP$ O O
heart NN B-NP O
had VBD B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
rubs NNS B-NP O
or CC O O
gallops VB O O
His PRP$ O O
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
His PRP$ O O
abdomen NNS B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP O
and CC O O
nondistended VBD B-VP O
He PRP O O
had VBD B-VP O
bilateral JJ B-NP O
femoral JJ I-NP O
bruits NNS I-NP O
, , O O
2+ CD O O
distal JJ O O
pulses VBZ O O
No DT B-NP O
pronator NN I-NP O
drift NN I-NP O
LABS: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
hematocrit NN B-NP O
baseline NN I-NP O
at IN B-VP O
30 CD O O
to TO O O
32 CD O O
, , O O
white JJ B-NP O
count NN I-NP O
of IN B-VP O
13 CD O O
His PRP$ O O
troponin NN B-NP O
peaked VBD B-VP O
at IN B-VP O
6.4 CD O O
EKG NNP B-NP O
showed VBD B-VP O
ST NNP B-NP O
depressions NNS I-NP O
in IN B-VP O
V3 NNP B-NP O
through IN B-VP O
V6 NNP B-NP O
that WDT O O
were VBD B-VP O
new JJ B-NP O
Echocardiogram NNP I-NP O
on IN B-VP O
8/11/05 CD O O
showed VBD B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
25 CD O O
to TO O O
30% CD O O
with IN B-VP O
septal JJ B-NP O
akinesis NN I-NP O
lateral JJ O O
and CC O O
posterior JJ B-NP O
hypokinesis NN I-NP O
and CC O O
mild JJ B-NP O
tricuspid JJ I-NP O
regurgitation NN I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
showed VBD B-VP O
mild JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Hospital NNP I-NP O
course NN I-NP O
for IN B-VP O
this DT B-NP O
72-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
non-ST-elevation JJ B-NP O
MI NNP I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
A NNP I-NP O
catheterization NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
1 CD O O
showed VBD B-VP O
four-vessel JJ B-NP O
disease NN I-NP O
No NNP I-NP O
intervention NN I-NP O
was VBD B-VP O
taken VBN O O
at IN B-VP O
that DT B-NP O
point NN I-NP O
, , O O
as IN B-VP O
it PRP O O
was VBD B-VP O
unclear JJ O O
which WDT O O
region NN B-NP O
was VBD B-VP O
the DT B-NP O
culprit NN I-NP O
Afterwards NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
in IN B-VP O
hypotensive JJ B-NP B-r
respiratory NN I-NP I-r
distress NN I-NP I-r
, , O O
likely RB O O
secondary JJ O O
to TO O O
flash VB O O
pulmonary JJ B-NP O
edema NN I-NP O
He PRP O O
received VBD B-VP O
Lasix NNP B-NP B-m
and CC O O
morphine NN B-NP B-m
and CC O O
he PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
nitro JJ I-NP B-m
drip NN I-NP B-mo
with IN B-VP O
improvement NN B-NP O
in IN B-VP O
symptoms NNS B-NP O
He PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
flash JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
and CC O O
in IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
with IN B-VP O
rapid JJ B-NP O
ventricular JJ I-NP O
response NN I-NP O
He PRP O O
was VBD B-VP O
taken VBN O O
back RB O O
to TO O O
the DT B-NP O
catheterization NN I-NP O
lab NN I-NP O
and CC O O
given VBN O O
four CD O O
stents NNS B-NP O
to TO O O
his PRP$ O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
, , O O
OM1 NNP B-NP O
with IN B-VP O
good JJ B-NP O
resolution NN I-NP O
of IN B-VP O
his PRP$ O O
symptoms NNS B-NP O
and CC O O
he PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
CCU NNP I-NP O
afterwards NNS I-NP O
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
3 CD O O
, , O O
he PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
and CC O O
was VBD B-VP O
given VBN O O
an DT B-NP O
amiodarone NN I-NP B-m
load NN I-NP O
given VBN O O
his PRP$ O O
ejection NN B-NP O
fraction NN I-NP O
and CC O O
increased VBD B-VP O
ectopy NN B-NP O
on IN B-VP O
telemetry NN B-NP O
His PRP$ O O
troponin NN B-NP O
had VBD B-VP O
been VBN O O
trended VBN O O
down RB O O
to TO O O
the DT O O
0.2s CD O O
by IN B-VP O
discharge NN B-NP O
His PRP$ O O
beta-blocker NN B-NP B-m
and CC O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
were VBD B-VP O
titrated VBN O B-do
to TO O O
heart NN B-NP O
rate NN I-NP O
and CC O O
blood NN B-NP O
pressure NN I-NP O
Prior NNP I-NP O
to TO O O
anticipated VB O O
discharge NN B-NP O
, , O O
he PRP O O
re-developed VBD B-VP O
flash JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
secondary JJ O O
to TO O O
atrial JJ B-NP O
fibrillation NN I-NP O
with IN B-VP O
rapid JJ B-NP O
ventricular JJ I-NP O
response NN I-NP O
Electrophysiology NNP I-NP O
consult NN I-NP O
evaluated VBD B-VP O
him PRP O O
and CC O O
based VBN O O
on IN B-VP O
his PRP$ O O
prior JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
symptoms NNS I-NP O
, , O O
it PRP O O
was VBD B-VP O
decided VBN O O
to TO O O
place VB O O
a DT B-NP O
dual-chamber JJ I-NP O
pacemaker NN I-NP O
with IN B-VP O
AICD NNP B-NP O
He PRP O O
has VBZ O O
had VBN O O
no DT B-NP O
respiratory NN I-NP O
events NNS I-NP O
since IN B-VP O
that DT B-NP O
placement NN I-NP O
He PRP O O
has VBZ O O
remained VBN O O
in IN B-VP O
atrial JJ B-NP B-r
fibrillation NN I-NP O
and CC O O
was VBD B-VP O
re-loaded VBN O O
with IN B-VP O
digoxin NN B-NP B-m
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
his PRP$ O O
Coumadin NNP B-NP B-m
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
discharge VB O O
and CC O O
was VBD B-VP O
not RB O O
yet RB O O
therapeutic JJ O O
His PRP$ O O
repeat NN B-NP O
echo NN I-NP O
did VBD B-VP O
show VB O O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
55% CD O O
This DT O O
was VBD B-VP O
after IN B-VP O
the DT B-NP O
pacemaker NN I-NP O
was VBD B-VP O
placed VBN O O
2 CD O O
Renal: NNP B-NP O
He PRP O O
has VBZ O O
chronic JJ B-NP B-r
renal JJ I-NP I-r
insufficiency NN I-NP I-r
He PRP O O
was VBD B-VP O
given VBN O O
Mucomyst NNP B-NP B-m
precath NN I-NP B-mo
with IN B-VP O
good JJ B-NP O
effect NN I-NP O
His PRP$ O O
creatinine NN B-NP O
on IN B-VP O
discharge NN B-NP O
was VBD B-VP O
1.1 CD O O
and CC O O
he PRP O O
was VBD B-VP O
making VBG O O
urine JJ O O
3 CD O O
GU: NNP B-NP O
He PRP O O
has VBZ O O
had VBD B-VP O
some DT B-NP O
symptoms NNS I-NP O
of IN B-VP O
urinary JJ B-NP B-r
retention NN I-NP I-r
with IN B-VP O
difficult-to-place NN B-NP O
Foley NNP I-NP O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Flomax NNP B-NP B-m
with IN B-VP O
good JJ B-NP O
effect NN I-NP O
His PRP$ O O
prostate NN B-NP O
was VBD B-VP O
not RB O O
overtly RB O O
large JJ O O
on IN B-VP O
exam IN B-VP O
His PRP$ O O
PSA NNP B-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
4 CD O O
Endocrine: NNP B-NP O
He PRP O O
is VBZ O O
a DT B-NP O
type NN I-NP O
2 CD O O
diabetic JJ O O
His PRP$ O O
home NN B-NP B-do
dose NN I-NP I-do
of IN B-VP O
metformin NN B-NP B-m
was VBD B-VP O
held VBN O O
He PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Lantus NNP B-NP B-m
with IN B-VP O
sliding VBG O B-do
scale JJ B-NP O
insulin NN I-NP B-m
5 CD O O
Hematology: NNP B-NP O
His PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
transiently RB O O
down RB O O
to TO O O
24 CD O O
When WRB O O
transferred VBN O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
CCU NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
given VBN O O
three CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
given VBN O O
his PRP$ O O
history NN B-NP O
of IN B-VP O
CAD NNP B-NP O
Since IN B-VP O
this DT O O
, , O O
his PRP$ O O
hematocrit NN B-NP O
has VBZ O O
been VBN O O
stable JJ O O
in IN B-VP O
the DT B-NP O
30-to-32 JJ I-NP O
range NN I-NP O
An DT B-NP O
abdominal JJ I-NP O
CT NNP I-NP O
did VBD B-VP O
not RB O O
show VB O O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
retroperitoneal NN B-NP O
bleed VB O O
His PRP$ O O
groin NN B-NP O
had VBD B-VP O
only RB O O
a DT O O
very RB O O
small JJ O O
hematoma VB O O
His PRP$ O O
stool NN B-NP O
guaiac NN I-NP O
was VBD B-VP O
only RB O O
trace JJ B-NP O
positive JJ I-NP O
DISPOSITION: NNP I-NP O
He PRP O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
with IN B-VP O
VNA NNP B-NP O
services NNS I-NP O
He PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
PCP NNP B-NP O
on IN B-VP O
4/7/05 CD O O
, , O O
with IN B-VP O
Dr NNP B-NP O
Wicinsky NNP I-NP O
on IN B-VP O
7/8/05 CD O O
, , O O
and CC O O
he PRP O O
should MD O O
have VB O O
his PRP$ O O
INR NNP B-NP O
checked VBD B-VP O
on IN B-VP O
8/4/05 CD O O
or CC O O
7/8/05 CD O O
and CC O O
Coumadin NNP B-NP B-m
adjusted VBD B-VP O
accordingly RB O O
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
His PRP$ O O
physical JJ B-NP O
exam NN I-NP O
on IN B-VP O
discharge NN B-NP O
was VBD B-VP O
largely RB O O
unchanged JJ O O
, , O O
afebrile JJ O O
and CC O O
hemodynamically RB O O
stable JJ O O
He PRP O O
had VBD B-VP O
now RB O O
a DT B-NP O
pacemaker NN I-NP O
placed VBN O O
over IN B-VP O
the DT B-NP O
left JJ I-NP O
chest NN I-NP O
Incision NN I-NP O
looked VBD B-VP O
clean JJ O O
, , O O
slightly RB O O
tender NN B-NP O
to TO O O
palpation NN B-NP O
He PRP O O
had VBD B-VP O
no DT B-NP O
murmurs NNS I-NP O
or CC O O
rubs NNS B-NP O
, , O O
no DT B-NP O
pedal NN I-NP O
edema VBZ O O
His PRP$ O O
chest NN B-NP O
was VBD B-VP O
clear JJ B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Amiodarone NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
2 CD O O
Enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Librium NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
4 CD O O
Colace NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
5 CD O O
Ferrous NNP B-NP B-m
gluconate NN I-NP I-m
324 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
6 CD O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
7 CD O O
Nitroglycerin NNP B-NP B-m
one CD O B-do
tab NN B-NP I-do
p.o NN I-NP B-mo
q.5 NN I-NP B-f
minutes NNS I-NP I-f
p.r.n VBP O I-f
chest JJS B-NP B-r
pain NN I-NP I-r
8 CD O O
Dilantin NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
9 CD O O
Senna NNP B-NP B-m
two CD O B-do
tabs NNS B-NP I-do
p.o VBP O B-mo
b.i.d RB O B-f
10 CD O O
Coumadin NNP B-NP B-m
3 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m VBD B-VP B-f
11 CD O O
Lipitor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
12 CD O O
Flomax NNP B-NP B-m
0.4 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
13 CD O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
14 CD O O
Lantus NNP B-NP B-m
14 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
at IN B-VP B-f
nighttime RB O I-f
15 CD O O
Metformin NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
16 CD O O
Ranitidine NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
17 CD O O
Digoxin NNP B-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
18 CD O O
Enalapril NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
19 CD O O
Atenolol NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
He PRP O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
with IN B-VP O
VNA NNP B-NP O
services NNS I-NP O
FOLLOW-UP: NNP I-NP O
He PRP O O
has VBZ O O
follow-up JJ B-NP O
appointments NNS I-NP O
with IN B-VP O
his PRP$ O O
PCP NNP B-NP O
, , O O
Dr NNP B-NP O
Santos NNP I-NP O
Ciliberto NNP I-NP O
at IN B-VP O
Mira NNP B-NP O
Health NNP I-NP O
on IN B-VP O
11/8/05 CD O O
, , O O
with IN B-VP O
Dr NNP B-NP O
Kelley NNP I-NP O
Hernon NNP I-NP O
of IN B-VP O
Electrophysiology NNP B-NP O
0/7/05 CD O O
at IN B-VP O
3 CD O O
p.m NN B-NP O
and CC O O
Dr NNP B-NP O
Daft NNP I-NP O
9/20/05 CD O O
scheduled VBD B-VP O
He PRP O O
will MD O O
have VB O O
his PRP$ O O
INR NNP B-NP O
drawn NN I-NP O
on IN B-VP O
8/4/05 CD O O
with IN B-VP O
follow-up JJ B-NP O
INRs NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
seven CD O O
days NNS B-NP O
and CC O O
Coumadin NNP B-NP B-m
adjusted VBD B-VP O
accordingly RB O O
eScription JJ O O
document: IN B-VP O
9-8335570 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Mark NNP I-NP O
Lyman NNP I-NP O
Bly NNP I-NP O
MD NNP I-NP O
Pa NNP I-NP O
A NNP I-NP O
Moines NNP I-NP O
OK NNP I-NP O
Xing NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
GEDNEY NNP I-NP O
, , O O
VICTOR NNP B-NP O
Attending: NNP I-NP O
GRANAHAN NNP I-NP O
, , O O
TYSON NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
5879600 CD O O
D: NNP B-NP O
7/8/05 CD O O
T: NNP B-NP O
7/8/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#359997 VBZ O O
046900020 CD O O
RH NNP B-NP O
74123072 CD O O
834335 CD O O
8/20/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/20/1999 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/8/1999 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
64 JJ I-NP O
year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chest NN B-NP O
discomfort NN I-NP O
, , O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
and CC O O
fatigue NN B-NP O
who WP O O
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
grafting NN I-NP O
He PRP O O
had VBD B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
at IN B-VP O
Ryhoagberg NNP B-NP O
Spisus NNP I-NP O
Community NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
1999 CD O O
which WDT O O
demonstrated VBD B-VP O
a DT O O
30% CD O O
tapering VBG O O
lesion NN B-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
main JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
, , O O
70% CD O O
proximal JJ B-NP O
lesion NN I-NP O
of IN B-VP O
the DT O O
left JJ O O
anterior JJ O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
, , O O
80% CD O O
lesion NN B-NP O
distal NN I-NP O
to TO O O
D1 NNP B-NP O
, , O O
100% CD O O
occlusion NN B-NP O
of IN B-VP O
his PRP$ O O
left JJ B-NP O
circumflex NN I-NP O
and CC O O
a DT O O
100% CD O O
occlusion NN B-NP O
of IN B-VP O
his PRP$ O O
right JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
He PRP O O
is VBZ O O
admitted VBN O O
on IN B-VP O
January NNP B-NP O
, , O O
1999 CD O O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Psoriasis NNP I-NP O
and CC O O
polymyalgia NN B-NP O
rheumatica NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
and CC O O
wide JJ B-NP O
eye NN I-NP O
glaucoma VBD B-VP O
His PRP$ O O
echocardiogram NN B-NP O
demonstrated VBD B-VP O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
with IN B-VP O
a DT B-NP O
normal JJ I-NP O
ejection NN I-NP O
fraction NN I-NP O
He PRP O O
has VBZ O O
a DT O O
45 CD O O
year NN B-NP O
history NN I-NP O
of IN B-VP O
smoking VBG O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
) ) O O
Prednisone NN B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
2 CD O O
) ) O O
Lasix FW O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
3 CD O O
) ) O O
Zocor NNP B-NP B-m
40 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
4 CD O O
) ) O O
Atenolol $ O B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
5 CD O O
) ) O O
Nitropatch NNP B-NP B-m
6 CD O O
) ) O O
Enteric NNP B-NP B-m
coated VBD B-VP I-m
aspirin JJ B-NP I-m
p.o JJ I-NP B-mo
q NN I-NP B-f
day NN I-NP I-f
7 CD O O
) ) O O
Timolol NNP B-NP B-m
eye NN I-NP I-m
drops NNS I-NP I-m
to TO O O
his PRP$ O O
left JJ B-NP O
eye NN I-NP O
8 CD O O
) ) O O
Captopril NNP B-NP B-m
18.75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
three CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
9 CD O O
) ) O O
Tagamet VBD B-VP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
10 CD O O
) ) O O
Calcium NN B-NP B-m
supplementation NN I-NP I-m
LABORATORY: NNP I-NP O
Laboratory NNP I-NP O
studies NNS I-NP O
on IN B-VP O
admission NN B-NP O
revealed VBD B-VP O
a DT B-NP O
BUN NNP I-NP O
of IN B-VP O
20 CD O O
, , O O
creatinine NN B-NP O
1.2 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
8.8 CD O O
, , O O
hematocrit NN B-NP O
40.2 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
revealed VBD B-VP O
no DT B-NP O
acute JJ I-NP O
disease NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
On IN B-VP O
March NNP B-NP O
, , O O
1999 CD O O
, , O O
he PRP O O
underwent VBD B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
times NNS B-NP O
three CD O O
with IN B-VP O
a DT B-NP O
left JJ I-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
the DT O O
left VBN O O
anterior JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
, , O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
aorta NN I-NP O
and CC O O
a DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
from IN B-VP O
the DT B-NP O
obtuse NN I-NP O
marginal NN I-NP O
to TO O O
the DT B-NP O
aorta NN I-NP O
His PRP$ O O
intraoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
uncomplicated VBN O O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
one CD O O
, , O O
he PRP O O
was VBD B-VP O
weaned VBN O O
to TO O O
extubation NN B-NP O
and CC O O
he PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
stress JJ B-NP B-do
steroids NNS I-NP B-m
to TO O O
prevent VB O O
steroid JJ B-NP B-r
withdrawal NN I-NP I-r
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
one CD O O
, , O O
he PRP O O
was VBD B-VP O
taken VBN O O
back RB O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
bleeding NN B-NP O
After IN B-VP O
he PRP O O
was VBD B-VP O
extubated VBN O O
, , O O
he PRP O O
was VBD B-VP O
reintubated VBN O O
and CC O O
was VBD B-VP O
returned VBN O O
in IN B-VP O
good JJ O O
and CC O O
stable JJ B-NP O
condition NN I-NP O
to TO O O
the DT B-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
on IN B-VP O
renal JJ B-NP O
Dopamine NNP I-NP B-m
He PRP O O
was VBD B-VP O
again RB O O
extubated JJ O O
and CC O O
was VBD B-VP O
seen VBN O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
the DT B-NP O
Gastrointestinal NNP I-NP O
Service NNP I-NP O
for IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
gastrointestinal JJ B-NP O
bleed NN I-NP O
since IN B-VP O
there EX O O
was VBD B-VP O
a DT B-NP O
clot NN I-NP O
seen VBN O O
on IN B-VP O
the DT B-NP O
transesophageal NN I-NP O
echocardiogram VBZ O O
probe NN B-NP O
at IN B-VP O
its PRP$ O O
withdrawal NN B-NP O
from IN B-VP O
his PRP$ O O
first JJ B-NP O
surgery NN I-NP O
The DT B-NP O
Gastrointestinal NNP I-NP O
Service NNP I-NP O
saw VBD B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
upper JJ I-NP O
gastrointestinal JJ I-NP O
bleed NN I-NP O
and CC O O
he PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
H2 NNP B-NP B-m
blockers NNS I-NP O
He PRP O O
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
step NN I-NP O
down RP O O
unit NN B-NP O
on IN B-VP O
routine JJ B-NP O
postoperative JJ I-NP O
day NN I-NP O
number NN I-NP O
two CD O O
and CC O O
his PRP$ O O
Captopril NNP B-NP B-m
was VBD B-VP O
increased VBN O O
for IN B-VP O
afterload NN B-NP B-r
reduction NN I-NP I-r
His PRP$ O O
course NN B-NP O
improved VBD B-VP O
and CC O O
he PRP O O
was VBD B-VP O
diuresed VBN O O
for IN B-VP O
a DT B-NP O
volume NN I-NP O
overload NN I-NP O
still RB O O
requiring VBG O O
oxygen PRP O B-m
supplementation NN B-NP I-m
on IN B-VP O
two CD O B-do
liters NNS B-NP O
His PRP$ O O
oxygen NN B-NP O
saturation NN I-NP O
was VBD B-VP O
only RB O O
91% CD O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
three CD O O
He PRP O O
continued VBD B-VP O
to TO O O
improve VB O O
and CC O O
continued VBN O O
to TO O O
have VB O O
care NN B-NP O
for IN B-VP O
his PRP$ O O
respiratory NN B-NP O
situation NN I-NP O
with IN B-VP O
continued JJ B-NP O
diuresis NN I-NP O
and CC O O
nebulizer NN B-NP O
treatments NNS I-NP O
and CC O O
ambulation NN B-NP O
He PRP O O
was VBD B-VP O
screened VBN O O
by IN B-VP O
rehabilitation NN B-NP O
and CC O O
awaited JJ B-NP O
rehabilitation NN I-NP O
placement NN I-NP O
He PRP O O
did VBD B-VP O
acquire VB O O
a DT B-NP O
rehabilitation NN I-NP O
bed NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
six CD O O
and CC O O
he PRP O O
is VBZ O O
being VBG O O
transferred VBN O O
to TO O O
rehabilitation VB O O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
) ) O O
Prednisone NN B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
2 CD O O
) ) O O
Enteric NNP B-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
325 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
day NN I-NP I-f
3 CD O O
) ) O O
Zantac VBD B-VP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
4 CD O O
) ) O O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
5 CD O O
) ) O O
Atrovent NNP B-NP B-m
nebulizer $ O I-m
0.5 CD O B-do
mg NN B-NP I-do
four CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
day NN I-NP I-f
6 CD O O
) ) O O
Timolol NNP B-NP B-m
eye NN I-NP I-m
drops VBZ O I-m
0.5% CD O I-m
one CD O B-do
drop NN B-NP I-do
in IN B-VP I-do
both DT B-NP I-do
eyes NNS I-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
7 CD O O
) ) O O
Atenolol $ O B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
8 CD O O
) ) O O
Captopril NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
three CD O B-f
times NNS B-NP O
a DT B-NP O
day NN I-NP O
9 CD O O
) ) O O
Lasix FW O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
10 CD O O
) ) O O
Potassium NN B-NP B-m
SR NNP I-NP I-m
20 CD O B-do
mEq NN B-NP O
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
11 CD O O
) ) O O
Simvastatin NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
12 CD O O
) ) O O
Ibuprofen NNP B-NP B-m
200-800 JJ B-NP B-do
mg NN I-NP I-do
as IN B-VP O
needed VBN O O
for IN B-VP O
pain JJ B-NP B-r
q.4-6h JJ I-NP O
FOLLOW-UP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
the DT B-NP O
care NN I-NP O
of IN B-VP O
Dr NNP B-NP O
Lou NNP I-NP O
Pineault NNP I-NP O
at IN B-VP O
Potmend NNP B-NP O
Rehabilitation NNP I-NP O
Hospital NNP I-NP O
, , O O
Moorlberl NNP B-NP O
Street NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
RENE NNP I-NP O
CASTLEMAN NNP I-NP O
, , O O
M.D NNP B-NP O
Attending: NNP I-NP O
ERIN NNP I-NP O
D NNP I-NP O
CURTISS NNP I-NP O
, , O O
M.D NNP B-NP O
BF88 NNP I-NP O
WX064/8299 NNP I-NP O
Batch: NNP I-NP O
4551 CD O O
Index NNP B-NP O
No NNP I-NP O
XFBG746F4F NNP I-NP O
D: NNP I-NP O
9/19/99 CD O O
T: NNP B-NP O
9/19/99 CD O O
CC: NNP B-NP O
STEPHEN NNP I-NP O
T NNP I-NP O
SHIMANUKI NNP I-NP O
, , O O
M.D NNP B-NP O
MT3 NNP I-NP O
DUSTY NNP I-NP O
BJORGEN NNP I-NP O
, , O O
MD NNP B-NP O
, , O O
ON-TONFORN NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#367173 VBZ O O
435445425 CD O O
HTZMC NNP B-NP O
28920937 CD O O
0445406 CD O O
9/27/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/8/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/3/2006 CD O O
ATTENDING: NNP B-NP O
MANCINELLI NNP I-NP O
, , O O
MAURICE NNP B-NP O
A NNP I-NP O
MD NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
76-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
, , O O
hypertension NN B-NP O
, , O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
MI NNP I-NP O
in IN B-VP O
2000 CD O O
who WP O O
presented VBD B-VP O
with IN B-VP O
an DT B-NP O
ST NNP I-NP O
elevation NN I-NP O
MI NNP I-NP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
on IN B-VP O
0/0/06 CD O O
He PRP O O
was VBD B-VP O
brought VBN O O
to TO O O
Cath VB O O
where WRB O O
he PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
in-stent JJ B-NP O
thrombosis NN I-NP O
in IN B-VP O
his PRP$ O O
LAD NNP B-NP O
which WDT O O
was VBD B-VP O
aspirated VBN O O
and CC O O
bare-metal JJ B-NP O
stent NN I-NP O
was VBD B-VP O
placed VBN O O
in IN B-VP O
his PRP$ O O
LAD NNP B-NP O
and CC O O
another DT B-NP O
stent NN I-NP O
was VBD B-VP O
placed VBN O O
in IN B-VP O
his PRP$ O O
diag-2 NN B-NP O
He PRP O O
had VBD B-VP O
been VBN O O
arrested VBN O O
multiple JJ B-NP O
times NNS I-NP O
in IN B-VP O
V-Tach NNP B-NP O
requiring VBG O O
CPR NNP B-NP O
and CC O O
cardioversion NN B-NP O
In IN B-VP O
the DT B-NP O
Cath NNP I-NP O
Lab NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
given VBN O O
bicarb NN B-NP B-m
, , O O
placed VBN O O
on IN B-VP O
the DT B-NP O
epi NN I-NP B-m
drip NN I-NP B-mo
, , O O
given VBN O O
Lasix NNP B-NP B-m
and CC O O
was VBD B-VP O
intubated VBN O O
He PRP O O
was VBD B-VP O
thought VBN O O
to TO O O
aspirate VB O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
intubation NN B-NP O
secondary JJ O O
to TO O O
vomiting VBG O O
A NNP B-NP O
bedside NN I-NP O
echo NN I-NP O
revealed VBD B-VP O
global JJ B-NP B-r
hypokinesis NN I-NP I-r
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
35% CD O O
He PRP O O
, , O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP O
balloon NN I-NP O
pump NN I-NP O
, , O O
dopamine NN B-NP B-m
16 CD O B-do
, , O O
amio RB O B-m
1 CD O B-do
, , O O
propofol NN B-NP B-m
1 CD O B-do
, , O O
and CC O O
Integrilin NNP B-NP B-m
and CC O O
brought VBD B-VP O
to TO O O
the DT B-NP O
floor NN I-NP O
On IN B-VP O
the DT B-NP O
floor NN I-NP O
, , O O
his PRP$ O O
blood NN B-NP O
pressures NNS I-NP O
were VBD B-VP O
difficult JJ O O
to TO O O
control VB O O
and CC O O
his PRP$ O O
??___?? JJ B-NP O
readings NNS I-NP O
indicated VBD B-VP O
a DT B-NP O
wedge NN I-NP O
pressure NN I-NP O
of IN B-VP O
47 CD O O
His PRP$ O B-r
His PRP$ O B-r
His PRP$ O B-r
His PRP$ O B-r
MAPs NNP B-NP I-r
MAPs NNP I-NP I-r
MAPs NNP I-NP I-r
MAPs NNP I-NP I-r
to TO O O
keep VB O O
them PRP O O
over RP O O
60 CD O O
required VBN O O
max NN B-NP B-do
dopamine NN I-NP B-m
, , O O
max NN B-NP B-do
Levophed NNP I-NP B-m
, , O O
epinephrine NN B-NP B-m
and CC O O
dobutamine VB O B-m
His PRP$ O O
family NN B-NP O
was VBD B-VP O
aware JJ O O
of IN B-VP O
his PRP$ O O
prognosis NN B-NP O
and CC O O
was VBD B-VP O
there RB O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
his PRP$ O O
arrest NN B-NP O
at IN B-VP O
3:30 CD O O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
CPR NNP I-NP O
was VBD B-VP O
initiated VBN O O
, , O O
and CC O O
ACLS NNP B-NP O
was VBD B-VP O
done VBN O O
until IN B-VP O
the DT B-NP O
family NN I-NP O
decided VBD B-VP O
to TO O O
terminate VB O O
the DT B-NP O
ACLS NNP I-NP O
and CC O O
the DT B-NP O
time NN I-NP O
of IN B-VP O
death NN B-NP O
was VBD B-VP O
3:47 CD O O
a.m NN B-NP O
on IN B-VP O
0/0/06 CD O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
exam RB O O
revealed VBD B-VP O
no DT B-NP O
breath NN I-NP O
sounds VBZ O O
, , O O
no DT B-NP O
heart NN I-NP O
sounds VBZ O O
, , O O
and CC O O
nonreactive JJ B-NP O
pupils NNS I-NP O
The DT B-NP O
cause NN I-NP O
of IN B-VP O
death NN B-NP O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
cardiogenic JJ B-NP O
shock NN I-NP O
secondary JJ O O
to TO O O
ST NNP B-NP O
elevation NN I-NP O
MI NNP I-NP O
eScription NN I-NP O
document: VBD B-VP O
1-6435521 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
LADNER NNP I-NP O
, , O O
JASPER NNP B-NP O
Attending: NNP I-NP O
HUXHOLD NNP I-NP O
, , O O
DAREN NNP B-NP O
T NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6785315 CD O O
D: NNP B-NP O
2/22/06 CD O O
T: NNP B-NP O
2/22/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#367177 VBZ O O
063867932 CD O O
CMC NNP B-NP O
69702188 CD O O
9378300 CD O O
3/9/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
hyperglycemia NN I-NP O
, , O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/27/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/14/2005 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
KROPFELDER NNP I-NP O
, , O O
ART NNP B-NP O
378-97-31-8 CD O O
Ge NNP B-NP O
Topemodeport NNP I-NP O
Room: NNP I-NP O
Ver NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/19/05 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
ROBIDEAU NNP I-NP O
, , O O
ROBIN NNP B-NP O
QUINCY NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
LISINOPRIL NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/24/05 CD O O
by IN B-VP O
PAGLIO NNP B-NP O
, , O O
NOAH NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
METFORMIN NNP I-NP B-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LEVOFLOXACIN NNP I-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
X NNP I-NP B-du
1 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
9/14 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-m
products NNS I-NP I-m
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-m
or CC O O
ciprofloxacin NN B-NP B-m
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
LANTUS NNP I-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
20 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
9/14 CD O O
) ) O O
DIET: NNP B-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Hal NNP I-NP O
Marlett NNP I-NP O
, , O O
Tarise NNP B-NP O
Hospital NNP I-NP O
Endocrine NNP I-NP O
and CC O O
Diabetes NNP B-NP O
Clinic NNP I-NP O
, , O O
Notland NNP B-NP O
Ave NNP I-NP O
, , O O
Dar NNP B-NP O
, , O O
Iowa NNP B-NP O
74499 CD O O
7/20/05 CD O O
, , O O
1:00 CD O O
PM NNP B-NP O
scheduled VBN O O
, , O O
Please NNP B-NP O
call VB O O
Kidane NNP B-NP O
at IN B-VP O
CDGH NNP B-NP O
Physician NNP I-NP O
Referral NNP I-NP O
for IN B-VP O
a DT B-NP O
primary JJ I-NP O
care NN I-NP O
physician NN I-NP O
, , O O
1- JJ O O
402-945-7732 JJ O O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
hyperglycemia NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
hyperglycemia NN B-NP O
, , O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
obesity NN I-NP O
( ( O O
obesity NN B-NP O
) ) O O
type NN B-NP O
2 CD O O
DM NNP B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
?OSA NN B-NP O
( ( O O
? . B-VP O
sleep VB O O
apnea NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
Hyperglycemia NNP I-NP O
( ( O O
400s CD O O
) ) O O
, , O O
not RB O O
in IN B-VP O
DKA NNP B-NP O
HPI: NNP I-NP O
31 CD O O
F NNP B-NP O
with IN B-VP O
a DT B-NP O
h/o NN I-NP O
Type NNP I-NP O
2 CD O O
DM NNP B-NP O
( ( O O
diagnosed VBN O O
6 CD O O
years NNS B-NP O
ago RB O O
) ) O O
, , O O
morbid JJ B-NP O
obesity NN I-NP O
, , O O
and CC O O
borderline JJ B-NP O
HTN NNP I-NP O
who WP O O
was VBD B-VP O
referred VBN O O
to TO O O
CH NNP B-NP O
ED NNP I-NP O
after IN B-VP O
being VBG O O
found VBN O O
to TO O O
be VB O O
hyperglylcemic JJ O O
( ( O O
440 CD O O
mg/dl NN B-NP O
) ) O O
at IN B-VP O
Nishing VBG O O
O NNP B-NP O
Chela NNP I-NP O
Center NNP I-NP O
And CC O O
She PRP O O
has VBZ O O
not RB O O
checked VBN O O
her PRP$ O O
blood NN B-NP O
sugar NN I-NP O
or CC O O
taken VBN O O
any DT B-NP O
medications NNS I-NP O
for IN B-VP O
diabetes NNS B-NP O
for IN B-VP O
an DT B-NP O
entire JJ I-NP O
year NN I-NP O
, , O O
secondary JJ O O
to TO O O
being VBG O O
very RB O O
involved VBN O O
with IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
her PRP$ O O
handicapped JJ B-NP O
mother NN I-NP O
( ( O O
who WP O O
passed VBD B-VP O
away RB O O
this DT B-NP O
year NN I-NP O
at IN B-VP O
50 CD O O
years NNS B-NP O
old JJ O O
of IN B-VP O
complications NNS B-NP O
from IN B-VP O
diabetes NNS B-NP O
) ) O O
She PRP O O
has VBZ O O
had VBD B-VP O
symptoms NNS B-NP O
of IN B-VP O
polydipsia NN B-NP O
and CC O O
polyuria NN B-NP O
, , O O
tingling VBG O O
in IN B-VP O
her PRP$ O O
fingers NNS B-NP O
and CC O O
toes NNS B-NP O
, , O O
and CC O O
worsening VBG O O
vision NN B-NP O
Also RB O O
has VBZ O O
had VBN O O
several JJ B-NP O
days NNS I-NP O
of IN B-VP O
UTI NNP B-NP O
symptoms NNS I-NP O
In IN B-VP O
MTCH NNP B-NP O
ED NNP I-NP O
, , O O
her PRP$ O B-r
her PRP$ O B-r
her PRP$ O B-r
blood NN B-NP I-r
blood NN I-NP I-r
blood NN I-NP I-r
sugar NN I-NP I-r
sugar NN I-NP I-r
sugar NN I-NP I-r
remained VBD B-VP O
in IN B-VP O
the DT O O
400s CD O O
despite IN B-VP O
Regular JJ B-NP B-m
insulin NN I-NP I-m
18 CD O B-do
units NNS B-NP I-do
, , O O
Lantus NNP B-NP B-m
20 CD O B-do
units NNS B-NP I-do
, , O O
and CC O O
Novolog NNP B-NP B-m
6 CD O B-do
units NNS B-NP I-do
Admitted VBN O O
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
hyperglycemia NN B-NP O
and CC O O
optimizing VBG O O
her PRP$ O O
diabetes NNS B-NP B-m
medication NN I-NP I-m
regimen NNS I-NP O
-- : O O
PMH: NNP B-NP O
Type NNP I-NP O
2 CD O O
DM NNP B-NP O
- : O O
diagnosed VBD B-VP O
6 CD O O
years NNS B-NP O
ago RB O O
Was NNP B-NP O
previously RB O O
on IN B-VP O
insulin NN B-NP B-m
and CC O O
checking VBG O O
sugars NNS B-NP O
TID NNP I-NP O
No NNP I-NP O
self-FSBG JJ B-NP O
checks NNS I-NP O
or CC O O
diabetes NNS B-NP O
medications NNS I-NP O
for IN B-VP O
1 CD O O
year NN B-NP O
Morbid NNP I-NP O
obesity NN I-NP O
Borderline NNP I-NP O
HTN NNP I-NP O
HOME NNP I-NP O
MEDS: NNP I-NP O
None NNP I-NP O
ALL: NNP I-NP O
None NNP I-NP O
-- : O O
EXAM: NNP B-NP O
T98.1 NNP I-NP O
P84 NNP I-NP O
BP130/57 NNP I-NP O
R18 NNP I-NP O
O2sat96%RA NNP I-NP O
General: NNP I-NP O
Pleasant NNP I-NP O
, , O O
morbidly RB O O
obese JJ B-NP O
woman NN I-NP O
in IN B-VP O
NAD NNP B-NP O
HEENT: NNP I-NP O
EOMI NNP I-NP O
, , O O
PERRL NNP B-NP O
Fundus NNP I-NP O
exam RB O O
limited VBD B-VP O
Dry NNP B-NP O
O/P NNP I-NP O
Neck: NNP I-NP O
Acanthosis NNP I-NP O
nigricans NNS I-NP O
, , O O
no DT B-NP O
LAN NNP I-NP O
CV: NNP I-NP O
RRR NNP I-NP O
, , O O
II/VI NNP B-NP O
HSM NNP I-NP O
@ NNP I-NP O
LLSB NNP I-NP O
No NNP I-NP O
m/r/g NNP I-NP O
Apical NNP I-NP O
auscultation NN I-NP O
limited VBN O O
by IN B-VP O
intervening VBG O O
tissue NN B-NP O
Lungs: NNP I-NP O
CTAB NNP I-NP O
Abdomen: NNP I-NP O
S NNP I-NP O
, , O O
obese JJ O O
, , O O
NT NNP B-NP O
, , O O
ND NNP B-NP O
, , O O
NABS NNP B-NP O
Extremities: NNP I-NP O
No NNP I-NP O
C/C/E NNP I-NP O
No NNP I-NP O
wounds VBZ O O
on IN B-VP O
feet NNS B-NP O
Neuro: NNP I-NP O
Decreased VBD B-VP O
pinprick JJ B-NP O
medial JJ I-NP O
feet NNS I-NP O
b/l NN I-NP O
and CC O O
hands NNS B-NP O
( ( O O
esp JJ B-NP O
ulnar JJ I-NP O
distribution NN I-NP O
) ) O O
-- : O O
CHEM: $ O O
138 CD O O
/ $ O O
4.0 CD O O
/ $ O O
104 CD O O
/ $ O O
29 CD O O
/ $ O O
14 CD O O
/ $ O O
0.9 CD O O
&lt; $ O O
331 CD O O
Anion NNP B-NP O
gap NN I-NP O
5 CD O O
, , O O
pH VBD B-VP O
7.41 CD O O
Blood NNP B-NP O
glucose: NN I-NP O
473 CD O O
, , O O
427 CD O O
, , O O
331 CD O O
, , O O
421 CD O O
CBC: NNP B-NP O
12.2 CD O O
&gt; VBD B-VP O
38.8 CD O O
&lt; JJ O O
428 CD O O
EKG: NNP B-NP O
NSR NNP I-NP O
@96 NNP I-NP O
Normal NNP I-NP O
intervals NNS I-NP O
, , O O
axis RB O O
Deep NNP B-NP O
pathologic NN I-NP O
Q NNP I-NP O
waves VBZ O O
in IN B-VP O
III NNP B-NP O
, , O O
aVF NN B-NP O
that WDT O O
are VBP O O
present JJ O O
in IN B-VP O
EKG NNP B-NP O
from IN B-VP O
2000 CD O O
No NNP B-NP O
ST/T NNP I-NP O
waves VBZ O O
changes NNS B-NP O
suggestive NN I-NP O
of IN B-VP O
ischemia NN B-NP O
************HOSPITAL NNP I-NP O
COURSE************* NNP I-NP O
31 CD O O
F NNP B-NP O
with IN B-VP O
a DT B-NP O
h/o NN I-NP O
Type NNP I-NP O
2 CD O O
DM NNP B-NP O
( ( O O
diagnosed VBN O O
6 CD O O
years NNS B-NP O
ago RB O O
) ) O O
, , O O
morbid JJ B-NP O
obesity NN I-NP O
, , O O
and CC O O
borderline JJ B-NP O
HTN NNP I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
hyperglycemia NN B-NP O
in IN B-VP O
400s CD O O
with IN B-VP O
hyperglycemia NN B-NP O
, , O O
~1 JJ B-NP O
year NN I-NP O
of IN B-VP O
poor JJ B-NP O
diabetes NNS I-NP O
management NN I-NP O
, , O O
symptoms NNS B-NP O
of IN B-VP O
microvascular JJ B-NP O
damage NN I-NP O
, , O O
and CC O O
EKG NNP B-NP O
suggestive NN I-NP O
of IN B-VP O
old JJ B-NP O
inferior JJ I-NP O
MI NNP I-NP O
, , O O
not RB O O
in IN B-VP O
DKA NNP B-NP O
Also RB O O
has VBZ O O
had VBN O O
several JJ B-NP O
days NNS I-NP O
of IN B-VP O
UTI NNP B-NP O
symptoms NNS I-NP O
ENDO: NNP I-NP O
Primary NNP I-NP O
goals NNS I-NP O
of IN B-VP O
admission NN B-NP O
are VBP O O
blood NN B-NP O
glucose JJ B-NP O
&lt;200 NNP I-NP O
mg/dl NN I-NP O
, , O O
diabetes VBZ O O
education NN B-NP O
, , O O
diabetes VBZ O B-m
home NN B-NP I-m
medication NN I-NP I-m
regimen NNS I-NP I-m
/ VBP O O
glucometer NN B-NP O
/ JJ B-NP O
test NN I-NP O
strips NNS I-NP O
, , O O
and CC O O
setting VBG O O
the DT B-NP O
patient NN I-NP O
up RP O O
with IN B-VP O
a DT B-NP O
PCP NNP I-NP O
Check NNP I-NP O
HgA1c NNP I-NP O
Check NNP I-NP O
FSBG NNP I-NP O
QAC NNP I-NP O
Blood NNP I-NP B-r
sugar NN I-NP I-r
was VBD B-VP O
308 CD O O
at IN B-VP O
6 CD O O
pm NN B-NP O
last JJ B-NP O
night NN I-NP O
, , O O
340 CD O O
at IN B-VP O
7 CD O O
am VBP O O
this DT B-NP O
morning NN I-NP O
Increase NNP I-NP O
Lantus NNP I-NP B-m
to TO O O
25 CD O B-do
mg NNS B-NP I-do
SC NNP I-NP B-mo
QD NNP I-NP B-f
Increase NNP I-NP O
Metformin NNP I-NP B-m
to TO O O
1000 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Consult NNP I-NP O
Diabetes NNP I-NP O
teaching VBG O O
program NN B-NP O
in IN B-VP O
AM NNP B-NP O
Set NNP I-NP O
up RP O O
follow-up NN B-NP O
with IN B-VP O
PCP NNP B-NP O
, , O O
+/- JJ B-NP O
ophthalmology NN I-NP O
ISCHEMIA: NNP I-NP O
Admission NNP I-NP O
EKG NNP I-NP O
and CC O O
EKG NNP B-NP O
in IN B-VP O
2000 CD O O
with IN B-VP O
Q-waves NNS B-NP O
in IN B-VP O
III NNP B-NP O
, , O O
F NNP B-NP O
suggesting VBG O O
old JJ B-NP O
inferior JJ I-NP O
infarct NN I-NP O
No NNP I-NP O
CP/SOB NNP I-NP O
Lipid NNP I-NP O
profile: NN I-NP O
Chol NNP I-NP O
160 CD O O
, , O O
Tri NNP B-NP O
187 CD O O
, , O O
HDL NNP B-NP O
38 CD O O
, , O O
LDL NNP B-NP O
94 CD O O
HTN: NNP B-NP B-r
Lisinopril NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ID: NNP I-NP O
UTI NNP I-NP B-r
Levofloxacin NNP I-NP B-m
250 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
x VBD B-VP B-du
2 CD O I-du
doses NNS B-NP I-du
( ( O O
already RB O O
treated VBN O O
for IN B-VP O
2 CD O O
days NNS B-NP O
) ) O O
F/u NNP B-NP O
Urine NNP I-NP O
cultureHEME: NN I-NP O
Microcytic NNP I-NP O
anemia NN I-NP O
, , O O
likely JJ B-NP O
iron NN I-NP O
deficiency NN I-NP O
Fe NNP I-NP O
43 CD O O
, , O O
TIBC NNP B-NP O
300 CD O O
, , O O
Ferr NNP B-NP O
pending VBG O O
F/E/N: NNP B-NP O
KCl NNP I-NP B-m
PO NNP I-NP B-mo
replacement NN I-NP B-do
scale NN I-NP I-do
MgSulfate NNP I-NP B-m
sliding NN I-NP B-do
scale.GI: NN I-NP I-do
Colace NNP I-NP B-m
prn NN I-NP B-f
, , O O
MOM NNP B-NP B-m
prnDISPO: VBP O B-f
Goal NNP B-NP O
blood NN I-NP O
glucose NN I-NP O
is VBZ O O
&lt;200 JJ B-NP O
mg/dl JJ I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
Endocrinologist/Diabetes NNS B-NP O
doctor VBP O O
at IN B-VP O
Thomin NNP B-NP O
Emptroit NNP I-NP O
General NNP I-NP O
Hospital NNP I-NP O
Test NNP I-NP O
fingerstick NN I-NP O
blood NN I-NP O
glucose VBD B-VP O
3 CD O O
times NNS B-NP O
daily JJ O O
( ( O O
including VBG O O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
before IN B-VP O
eating VBG O O
) ) O O
, , O O
and CC O O
keep VB O O
a DT B-NP O
log/record NN I-NP O
of IN B-VP O
the DT B-NP O
values NNS I-NP O
Take VB O O
your PRP$ O O
insulin NN B-NP B-m
and CC O O
metformin NN B-NP B-m
as IN B-VP O
prescribed JJ B-NP O
Decrease NNP I-NP O
your PRP$ O O
intake NN B-NP O
of IN B-VP O
food NN B-NP O
with IN B-VP O
high JJ O O
saturated VBN O O
fat NN B-NP O
and CC O O
cholesterol NN B-NP O
Take VBP O O
a DT B-NP O
30-45 JJ I-NP O
min NN I-NP O
walk NN I-NP O
at IN B-VP O
least JJS O O
5 CD O O
times NNS B-NP O
per IN B-VP O
week NN B-NP O
No RB O O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
CHARLEBOIS NNP I-NP O
, , O O
DWIGHT NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
JS05 NNP B-NP O
) ) O O
9/19/05 CD O O
@ $ O O
02 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#370707 VBZ O O
341782812 CD O O
IMC NNP B-NP O
82129084 CD O O
075826 CD O O
8/27/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/27/1992 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/26/1993 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
53-year-old JJ I-NP O
right NN I-NP O
handed VBN O O
man NN B-NP O
who WP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
neurology NN I-NP O
service NN I-NP O
on IN B-VP O
11/6/92 CD O O
He PRP O O
has VBZ O O
a DT O O
two CD O O
week NN B-NP O
history NN I-NP O
of IN B-VP O
right NN B-NP O
sided VBN O O
slowly RB O O
improving VBG O O
The DT B-NP O
neurology NN I-NP O
service NN I-NP O
felt VBD B-VP O
that IN B-VP O
the DT B-NP O
findings NNS I-NP O
on IN B-VP O
exam NN B-NP O
was VBD B-VP O
most RBS O O
consistent JJ O O
with IN B-VP O
cervical JJ B-NP O
disc NN I-NP O
disease NN I-NP O
and CC O O
they PRP O O
asked VBD B-VP O
neurosurgery NN B-NP O
to TO O O
consult VB O O
In IN B-VP O
brief NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
chief NN I-NP O
complaint NN I-NP O
is VBZ O O
right JJ B-NP O
sided JJ I-NP O
weakness NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
his PRP$ O O
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
approximately RB O O
three CD O O
and CC O O
a DT B-NP O
half JJ I-NP O
weeks NNS I-NP O
prior RB O O
to TO O O
admission NN B-NP O
He PRP O O
noted VBD B-VP O
pain NN B-NP O
in IN B-VP O
his PRP$ O O
right JJ B-NP O
shoulder NN I-NP O
over IN B-VP O
four CD O O
to TO O O
five CD O O
hours NNS B-NP O
, , O O
the DT B-NP O
pain NN I-NP O
increased VBD B-VP O
He PRP O O
also RB O O
noted VBD B-VP O
numbness NN B-NP O
in IN B-VP O
his PRP$ O O
right NN B-NP O
toes VBZ O O
His PRP$ O O
right JJ B-NP O
hand NN I-NP O
was VBD B-VP O
weak JJ O O
as IN B-VP O
well RB O O
and CC O O
he PRP O O
had VBD B-VP O
difficulty NN B-NP O
holding VBG O O
a DT B-NP O
cup NN I-NP O
Conservative NNP I-NP O
management NN I-NP O
failed VBD B-VP O
, , O O
i.e NN B-NP O
, , O O
bedrest IN B-VP O
He PRP O O
came VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
at IN B-VP O
the DT B-NP O
request NN I-NP O
of IN B-VP O
his PRP$ O O
local JJ B-NP O
doctor NN I-NP O
and CC O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
neurology NN I-NP O
service NN I-NP O
While IN B-VP O
here RB O O
, , O O
on IN B-VP O
Decadron NNP B-NP B-m
, , O O
Motrin NNP B-NP B-m
and CC O O
Flexeril NNP B-NP B-m
, , O O
he PRP O O
noted VBD B-VP O
some DT B-NP O
improvement NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
he PRP O O
fell VBD B-VP O
flat JJ O O
on IN B-VP O
his PRP$ O O
face NN B-NP O
first RB O O
on IN B-VP O
3/16/92 CD O O
and CC O O
sustained VBD B-VP O
a DT B-NP O
sprained JJ I-NP O
ankle NN I-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
no DT B-NP O
back NN I-NP O
or CC O O
neck NN B-NP O
pain NN I-NP O
While IN B-VP O
in IN B-VP O
house NN B-NP O
, , O O
he PRP O O
felt VBD B-VP O
that IN B-VP O
he PRP O O
could MD O O
walk VB O O
three CD O O
times NNS B-NP O
around IN B-VP O
the DT B-NP O
Ingnorf NNP I-NP O
At IN B-VP O
that DT B-NP O
point NN I-NP O
, , O O
he PRP O O
experienced VBD B-VP O
weakness NN B-NP O
and CC O O
numbness NN B-NP O
on IN B-VP O
the DT B-NP O
fourth JJ I-NP O
trip NN I-NP O
around IN B-VP O
He PRP O O
has VBZ O O
also RB O O
noted VBN O O
some DT B-NP O
urgency NN I-NP O
since IN B-VP O
the DT B-NP O
onset NN I-NP O
of IN B-VP O
his PRP$ O O
neck NN B-NP O
pain NN I-NP O
He PRP O O
has VBZ O O
normal JJ B-NP O
peroneal JJ I-NP O
sensation NN I-NP O
except IN B-VP O
for IN B-VP O
the DT B-NP O
transient JJ I-NP O
occurrences NNS I-NP O
of IN B-VP O
some DT B-NP O
saddle JJ I-NP O
distribution NN I-NP O
of IN B-VP O
abnormal JJ B-NP O
sensation NN I-NP O
He PRP O O
has VBZ O O
constipation NN B-NP O
which WDT O O
has VBZ O O
now RB O O
improved VBN O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
L4-5 NNP I-NP O
laminectomy NN I-NP O
in IN B-VP O
1970 CD O O
and CC O O
1982 CD O O
In IN B-VP O
1980 CD O O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
perforated JJ I-NP O
ulcer NN I-NP O
In IN B-VP O
1982 CD O O
, , O O
he PRP O O
had VBD B-VP O
surgery NN B-NP O
for IN B-VP O
a DT B-NP O
hiatal JJ I-NP O
hernia NN I-NP O
In IN B-VP O
1983 CD O O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
cholecystectomy NN I-NP O
In IN B-VP O
1984 CD O O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
partial JJ I-NP O
gastrectomy NN I-NP O
and CC O O
colectomy NN B-NP O
for IN B-VP O
swallowing VBG O O
a DT B-NP O
toothpick NN I-NP O
He PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
anxiety NN B-NP O
attacks NNS I-NP O
related VBN O O
to TO O O
highway VB O O
driving VBG O O
He PRP O O
is VBZ O O
a DT B-NP O
past JJ I-NP O
smoker NN I-NP O
, , O O
stopped VBD B-VP O
seven CD O O
years NNS B-NP O
ago RB O O
after IN B-VP O
three CD O O
packs NNS B-NP O
per IN B-VP O
day NN B-NP O
times NNS I-NP O
40 CD O O
years NNS B-NP O
History NNP I-NP O
of IN B-VP O
alcohol NN B-NP O
abuse NN I-NP O
but CC O O
does VBZ O O
not RB O O
drink VB O O
now RB O O
He PRP O O
has VBZ O O
no DT B-NP O
cardiac NN I-NP O
, , O O
respiratory NN B-NP O
or CC O O
GI NNP B-NP O
disturbances NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
admission NN B-NP O
revealed VBD B-VP O
the DT B-NP O
patient NN I-NP O
to TO O O
be VB O O
afebrile JJ B-NP O
Vital JJ I-NP O
signs NNS I-NP O
were VBD B-VP O
stable JJ B-NP O
General NNP I-NP O
exam NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
He PRP O O
had VBD B-VP O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
with IN B-VP O
increased JJ B-NP O
pain NN I-NP O
with IN B-VP O
extension NN B-NP O
of IN B-VP O
his PRP$ O O
neck NN B-NP O
He PRP O O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBN O O
with IN B-VP O
a DT B-NP O
normal JJ I-NP O
mental JJ I-NP O
status NN I-NP O
Speech NNP I-NP O
was VBD B-VP O
fluent JJ O O
with IN B-VP O
no DT B-NP O
dysarthria NN I-NP O
Cranial JJ B-NP O
nerves NNS I-NP O
were VBD B-VP O
entirely RB O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
He PRP O O
had VBD B-VP O
no DT B-NP O
pronator NN I-NP O
drift NN I-NP O
On IN B-VP O
the DT B-NP O
left NN I-NP O
he PRP O O
was VBD B-VP O
5/5 CD O O
throughout IN B-VP O
On IN B-VP O
the DT B-NP O
right NN I-NP O
he PRP O O
had VBD B-VP O
5- JJ B-NP O
strength NN I-NP O
in IN B-VP O
his PRP$ O O
biceps NNS B-NP O
, , O O
triceps NNS B-NP O
, , O O
wrist JJ B-NP O
extensors NNS I-NP O
and CC O O
intrinsics NNS B-NP O
Hip NNP I-NP O
flexors NNS I-NP O
were VBD B-VP O
4/5 CD O O
Knee NNP B-NP O
flexors NNS I-NP O
and CC O O
knee NN B-NP O
extensors NNS I-NP O
were VBD B-VP O
4/5 CD O O
He PRP O O
was VBD B-VP O
essentially RB O O
5/5 CD O O
throughout IN B-VP O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
his PRP$ O O
lower JJR O O
extremities VBZ O O
His PRP$ O O
reflexes NNS B-NP O
were VBD B-VP O
1-2+ JJ O O
in IN B-VP O
his PRP$ O O
upper JJ B-NP O
extremities NNS I-NP O
and CC O O
approximately RB O O
3+ CD O O
at IN B-VP O
the DT B-NP O
knees NNS I-NP O
with IN B-VP O
downgoing NN B-NP O
toes NNS I-NP O
He PRP O O
had VBD B-VP O
3-4 JJ B-NP O
beat NN I-NP O
clonus NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
Coordination NNP I-NP O
was VBD B-VP O
okay VBN O O
bilaterally RB O O
Gait NNP B-NP O
tested VBD B-VP O
revealed VBD B-VP O
a DT B-NP O
tendency NN I-NP O
to TO O O
fall VB O O
with IN B-VP O
decreased JJ B-NP O
ability NN I-NP O
to TO O O
weight VB O O
bear NN B-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
Sensory NNP I-NP O
exam NN I-NP O
revealed VBD B-VP O
decreased JJ B-NP O
sensation NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
hand NN I-NP O
and CC O O
the DT O O
last JJ O O
three CD O O
digits NNS B-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
hand NN I-NP O
He PRP O O
had VBD B-VP O
no DT B-NP O
subjective JJ I-NP O
numbness NN I-NP O
in IN B-VP O
his PRP$ O O
right NN B-NP O
leg NN I-NP O
, , O O
on IN B-VP O
the DT B-NP O
dorsum NN I-NP O
of IN B-VP O
his PRP$ O O
left JJ B-NP O
foot NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
decreased VBN O O
sensation NN B-NP O
with IN B-VP O
a DT B-NP O
cut NN I-NP O
off RP O O
before IN B-VP O
the DT B-NP O
toes NNS I-NP O
MRI NNP I-NP O
was VBD B-VP O
a DT B-NP O
poor JJ I-NP O
quality NN I-NP O
study NN I-NP O
which WDT O O
showed VBD B-VP O
C5-6 NNP B-NP O
and CC O O
C6-7 NNP B-NP O
disc NN I-NP O
bulge NN I-NP O
CAT NNP I-NP O
scan NN I-NP O
showed VBD B-VP O
severe JJ B-NP O
stenosis NN I-NP O
of IN B-VP O
C6-7 NNP B-NP O
with IN B-VP O
osteophyte NN B-NP O
, , O O
moderate JJ B-NP O
stenosis NN I-NP O
at IN B-VP O
C5-6 NNP B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Dr NNP B-NP O
Dubey NNP I-NP O
who WP O O
agreed VBD B-VP O
with IN B-VP O
the DT B-NP O
plan NN I-NP O
for IN B-VP O
C5-6 NNP B-NP O
and CC O O
C6-7 NNP B-NP O
laminectomies NNS I-NP O
He PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
0/8/93 CD O O
Preoperative JJ B-NP O
diagnosis NN I-NP O
with IN B-VP O
cervical JJ B-NP O
stenosis NN I-NP O
with IN B-VP O
myelopathy JJ B-NP O
Postoperative NNP I-NP O
diagnosis NN I-NP O
was VBD B-VP O
the DT O O
same JJ O O
The DT B-NP O
procedure NN I-NP O
was VBD B-VP O
C4-5 NNP B-NP O
, , O O
C5-6 NNP B-NP O
, , O O
C6-7 NNP B-NP O
laminectomy NN I-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
Hemovac NNP I-NP O
placed VBN O O
postoperatively RB O O
The DT O O
estimated VBN O O
blood NN B-NP O
loss NN I-NP O
was VBD B-VP O
less JJR O O
than IN B-VP O
100 CD O O
cc NN B-NP O
Postoperatively RB O O
, , O O
he PRP O O
did VBD B-VP O
very RB O O
well RB O O
He PRP O O
had VBD B-VP O
good JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
strength NN I-NP O
which WDT O O
seemed VBD B-VP O
to TO O O
improve VB O O
He PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
He PRP O O
had VBD B-VP O
a DT O O
slightly RB O O
swollen VBN O O
calf NN B-NP O
and CC O O
had VBD B-VP O
noninvasive JJ B-NP O
vascular JJ I-NP O
studies NNS I-NP O
of IN B-VP O
his PRP$ O O
lower JJR B-NP O
extremities NNS I-NP O
which WDT O O
were VBD B-VP O
negative JJ O O
He PRP O O
did VBD B-VP O
, , O O
however RB O O
, , O O
note VBP O O
some DT O O
shooting VBG O O
pain NN B-NP O
in IN B-VP O
his PRP$ O O
left JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
His PRP$ O O
wound NN B-NP O
was VBD B-VP O
clean JJ O O
and CC O O
healing VBG O O
well RB O O
He PRP O O
was VBD B-VP O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
with IN B-VP O
a DT B-NP O
walker NN I-NP O
The DT B-NP O
plan NN I-NP O
was VBD B-VP O
for IN B-VP O
discharge NN B-NP O
home NN I-NP O
He PRP O O
may MD O O
need VB O O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
his PRP$ O O
lumbar NN B-NP O
spine NN I-NP O
at IN B-VP O
some DT B-NP O
point NN I-NP O
but CC O O
he PRP O O
seems VBZ O O
to TO O O
be VB O O
doing VBG O O
well RB O O
with IN B-VP O
Percocet NNP B-NP B-m
only RB O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
CERVICAL NNP I-NP O
SPONDYLOSIS NNP I-NP O
STATUS NNP I-NP O
POST NNP I-NP O
MULTIPLE NNP I-NP O
LEVEL NNP I-NP O
CERVICAL NNP I-NP O
LAMINECTOMIES NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
LUMBAR NNP I-NP O
DISC NNP I-NP O
DISEASE NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
ALCOHOL NNP I-NP O
AND NNP I-NP O
TOBACCO NNP I-NP O
ABUSE NNP I-NP O
, , O O
NONE NNP B-NP O
CURRENTLY NNP I-NP O
PERFORATED NNP I-NP O
ULCER NNP I-NP O
HIATAL NNP I-NP O
HERNIA NNP I-NP O
STATUS NNP I-NP O
POST NNP I-NP O
CHOLECYSTECTOMY NNP I-NP O
, , O O
GASTRECTOMY NNP B-NP O
AND NNP I-NP O
COLECTOMY NNP I-NP O
ANXIETY NNP I-NP O
ATTACKS NNP I-NP O
DISPOSITION: NNP I-NP O
MEDICATIONS: NNP I-NP O
On IN B-VP O
discharge NN B-NP O
included VBD B-VP O
Colace NNP B-NP B-m
, , O O
klonopin NN B-NP B-m
, , O O
Flexeril NNP B-NP B-m
and CC O O
Percocet NNP B-NP B-m
He PRP O O
will MD O O
follow-up VB O O
with IN B-VP O
Dr NNP B-NP O
Mcnail NNP I-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
Dictated VBD B-VP O
By: NNP B-NP O
ROCCO NNP I-NP O
TANDON NNP I-NP O
, , O O
M.D NNP B-NP O
ZH67 NNP I-NP O
Attending: NNP I-NP O
PEDRO NNP I-NP O
BADOUR NNP I-NP O
, , O O
M.D NNP B-NP O
QY35 NNP I-NP O
VP775/4731 NNP I-NP O
Batch: NNP I-NP O
4920 CD O O
Index NNP B-NP O
No NNP I-NP O
TQZQOXVFE NNP I-NP O
D: NNP I-NP O
6/21/93 CD O O
T: NNP B-NP O
0/16/93 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#403481 VBZ O O
079025012 CD O O
PH NNP B-NP O
73514712 CD O O
2364381 CD O O
9/13/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
OSTEOMYELITIS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/1/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/4/2004 CD O O
ATTENDING: NNP B-NP O
CORTEZ NNP I-NP O
DERICK NNP I-NP O
SADLIER NNP I-NP O
MD NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
4/12/04 CD O O
for IN B-VP O
a DT B-NP O
right JJ I-NP O
plantar NN I-NP O
surface NN I-NP O
neurotrophic JJ O O
ulcer JJ O O
secondary JJ O O
to TO O O
diabetes NNS B-NP O
mellitus IN B-VP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
long-standing JJ I-NP O
history NN I-NP O
of IN B-VP O
peripheral JJ B-NP O
neuropathy NNS I-NP O
and CC O O
slight JJ B-NP O
history NN I-NP O
of IN B-VP O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
This DT O O
has VBZ O O
been VBN O O
treated VBN O O
thus RB O O
far RB O O
by IN B-VP O
podiatric JJ B-NP O
debridements NNS I-NP O
until IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
when WRB O O
the DT B-NP O
patient NN I-NP O
presented VBD B-VP O
low-grade JJ B-NP O
fevers NNS I-NP O
and CC O O
chills VBZ O O
The DT B-NP O
patient NN I-NP O
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
mellitus NNS I-NP O
, , O O
hypertension NN B-NP O
, , O O
distant JJ B-NP O
past NN I-NP O
of IN B-VP O
pancreatitis NN B-NP O
, , O O
gout NN B-NP O
, , O O
neuropathy JJ O O
, , O O
high JJ B-NP O
cholesterol NN I-NP O
, , O O
and CC O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
He PRP O O
has VBZ O O
had VBD B-VP O
a DT O O
left JJ O O
fourth JJ O O
and CC O O
fifth JJ B-NP O
toe NN I-NP O
amputation NN I-NP O
before IN B-VP O
He PRP O O
has VBZ O O
also RB O O
undergone JJ B-NP O
recent JJ I-NP O
eye NN I-NP O
surgery NN I-NP O
of IN B-VP O
unknown JJ B-NP O
origin NN I-NP O
and CC O O
had VBD B-VP O
some DT B-NP O
unknown JJ I-NP O
pancreatic JJ I-NP O
surgery NN I-NP O
in IN B-VP O
1968 CD O O
most JJS O O
likely JJ O O
for IN B-VP O
phlegmon NN B-NP O
or CC O O
some DT B-NP O
sort NN I-NP O
of IN B-VP O
pancreatic JJ B-NP O
condition NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
4/12/04 CD O O
with IN B-VP O
a DT B-NP O
right JJ I-NP O
plantar NN I-NP O
surface NN I-NP O
neurotrophic JJ B-NP O
ulcer NN I-NP O
as RB O O
well RB O O
as IN B-VP O
recent JJ B-NP O
history NN I-NP O
of IN B-VP O
low-grade JJ B-NP O
fevers NNS I-NP O
and CC O O
chills VBZ O O
The DT B-NP O
patient NN I-NP O
notes VBZ O O
that IN B-VP O
the DT B-NP O
ulcer NN I-NP O
came VBD B-VP O
about RB O O
after IN B-VP O
some DT B-NP O
unknown JJ I-NP O
trauma NN I-NP O
to TO O O
the DT B-NP O
foot NN I-NP O
He PRP O O
had VBD B-VP O
been VBN O O
followed VBN O O
by IN B-VP O
podiatrist NN B-NP O
and CC O O
had VBD B-VP O
outpatient VBN O O
MRI NNP B-NP O
revealing VBG O O
osteo NN B-NP O
at IN B-VP O
the DT B-NP O
fifth NN I-NP O
metatarsal NN I-NP O
head NN I-NP O
and CC O O
the DT B-NP O
fourth JJ I-NP O
metatarsal NN I-NP O
shaft NN I-NP O
, , O O
presented VBN O O
to TO O O
the DT B-NP O
Egan NNP I-NP O
Healthcare NNP I-NP O
emergency NN I-NP O
department NN I-NP O
after IN B-VP O
having VBG O O
a DT B-NP O
fever NN I-NP O
of IN B-VP O
101.3 CD O O
degrees NNS B-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
low-grade JJ I-NP O
fever NN I-NP O
of IN B-VP O
99.7 CD O O
degrees NNS B-NP O
, , O O
pulse NN B-NP O
in IN B-VP O
the DT O O
90s CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
16 CD O O
, , O O
and CC O O
blood NN B-NP O
pressure NN I-NP O
144/67 CD O O
He PRP O O
was VBD B-VP O
saturating VBG O O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
MEDICATIONS: NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
were VBD B-VP O
as IN B-VP O
follows: JJ O O
1 CD O O
Lantus NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
2 CD O O
Humalog NNP B-NP B-m
20 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
3 CD O O
Humalog NNP B-NP B-m
sliding VBG O B-do
scale JJ O I-do
4 CD O O
Neurontin NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
5 CD O O
Lisinopril NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
6 CD O O
Allopurinol NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
7 CD O O
Hydrochlorothiazide NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
8 CD O O
Zocor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
9 CD O O
TriCor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
10 CD O O
Atenolol NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
11 CD O O
Eyedrops NNP B-NP B-mo
prednisolone NN I-NP B-m
and CC O O
atropine NN B-NP B-m
12 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
on IN B-VP O
iron NN B-NP B-m
supplementation NN I-NP I-m
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Notable NNP I-NP O
findings NNS I-NP O
and/or VBP O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
clear JJ B-NP O
breath NN I-NP O
sounds NNS I-NP O
and CC O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
On IN B-VP O
cardiac JJ B-NP O
examination NN I-NP O
had VBD B-VP O
a DT B-NP O
slight JJ I-NP O
murmur NN I-NP O
2/6 CD O O
along IN B-VP O
the DT B-NP O
left JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
and CC O O
otherwise RB O O
had VBD B-VP O
a DT B-NP O
obese JJ I-NP O
abdomen NNS I-NP O
The DT B-NP O
extremities NNS I-NP O
and CC O O
back RB O O
revealed VBD B-VP O
no DT B-NP O
abnormalities NNS I-NP O
except IN B-VP O
for IN B-VP O
a DT B-NP O
right JJ I-NP O
foot NN I-NP O
ulcer NN I-NP O
along IN B-VP O
the DT O O
fourth JJ O O
and CC O O
fifth JJ B-NP O
metatarsal NN I-NP O
distal JJ O O
heads VBZ O O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
a DT O O
somewhat RB O O
cyanotic JJ O O
appearing VBG O O
and CC O O
somewhat RB O O
edematous JJ O O
and CC O O
swollen JJ B-NP O
fifth NN I-NP O
right RB O O
toe VBZ O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
decreased VBN O O
sensation NN B-NP O
bilaterally RB O O
in IN B-VP O
the DT B-NP O
feet NNS I-NP O
up IN B-VP O
to TO O O
mid VB O O
shin PDT O O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
a DT B-NP O
known JJ I-NP O
history NN I-NP O
of IN B-VP O
drug NN B-NP O
allergies NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
significant JJ B-NP O
labs NNS I-NP O
were VBD B-VP O
as IN B-VP O
follows VBZ O O
, , O O
his PRP$ O O
potassium NN B-NP O
was VBD B-VP O
4.3 CD O O
, , O O
BUN NNP B-NP O
was VBD B-VP O
38 CD O O
, , O O
creatinine NN B-NP O
was VBD B-VP O
3.2 CD O O
, , O O
and CC O O
his PRP$ O O
blood NN B-NP O
glucose NN I-NP O
was VBD B-VP O
187 CD O O
His PRP$ O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
was VBD B-VP O
12.6 CD O O
and CC O O
hematocrit NN B-NP O
was VBD B-VP O
27.8 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
vascular JJ I-NP O
surgery NN I-NP O
service NN I-NP O
under IN B-VP O
Dr NNP B-NP O
Tosco NNP I-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
vancomycin NN B-NP B-m
, , O O
levofloxacin NN B-NP B-m
, , O O
and CC O O
Flagyl NNP B-NP B-m
He PRP O O
continued VBD B-VP O
to TO O O
have VB O O
low-grade JJ B-NP O
fevers NNS I-NP O
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
the DT O O
next JJ O O
three CD O O
days NNS B-NP O
Finally RB O O
, , O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
3 CD O O
, , O O
had VBD B-VP O
a DT B-NP O
fever NN I-NP O
of IN B-VP O
103.2 CD O O
It PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
would MD O O
need VB O O
to TO O O
undergo VB O O
an DT B-NP O
amputation NN I-NP O
of IN B-VP O
the DT O O
third JJ O O
and CC O O
fourth JJ B-NP O
toe NN I-NP O
as RB O O
well RB O O
as IN B-VP O
metatarsal NN B-NP O
heads NNS I-NP O
to TO O O
remove VB O O
the DT B-NP O
infected JJ I-NP O
bone NN I-NP O
and CC O O
source NN B-NP O
of IN B-VP O
osteomyelitis NN B-NP O
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
3 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
It PRP O O
should MD O O
be VB O O
noted VBN O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
that IN B-VP O
the DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
bumped VBD B-VP O
before IN B-VP O
his PRP$ O O
operation NN B-NP O
from IN B-VP O
a DT B-NP O
BUN NNP I-NP O
of IN B-VP O
39 CD O O
and CC O O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
2.1 CD O O
to TO O O
a DT B-NP O
BUN NNP I-NP O
of IN B-VP O
59 CD O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
3 CD O O
and CC O O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
3.9 CD O O
This DT O O
occurred VBD B-VP O
coincidentally RB O O
the DT B-NP O
day NN I-NP O
after IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
several JJ B-NP O
MRIs NNP I-NP O
of IN B-VP O
is VBZ O O
lower JJR B-NP O
extremities NNS I-NP O
to TO O O
better RBR O O
understand VB O O
the DT B-NP O
vascular JJ I-NP O
supply NN I-NP O
to TO O O
his PRP$ O O
lower JJR B-NP O
extremities NNS I-NP O
Therefore RBR O O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
contrast VBN O B-m
dye JJ O I-m
Although IN B-VP O
, , O O
this DT B-NP O
dye NN I-NP O
was VBD B-VP O
gadolinium NN B-NP B-m
, , O O
which WDT O O
is VBZ O O
sued VBN O O
commonly RB O O
for IN B-VP O
MRA NNP B-NP O
and CC O O
is VBZ O O
not RB O O
usually RB O O
associated VBN O O
with IN B-VP O
any DT O O
soft JJ O O
of IN B-VP O
renal JJ B-NP O
toxicities NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
3 CD O O
for IN B-VP O
a DT O O
right JJ O O
fourth JJ O O
and CC O O
fifth JJ B-NP O
toe NN I-NP O
amputation NN I-NP O
and CC O O
nonhealing JJ B-NP O
ulcer JJ I-NP O
debridement NN I-NP O
Please NNP I-NP O
refer NN I-NP O
to TO O O
the DT B-NP O
operative JJ I-NP O
note NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Guemmer NNP I-NP O
for IN B-VP O
further RB O O
details NNS B-NP O
The DT B-NP O
patient NN I-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
without IN B-VP O
any DT B-NP O
problems NNS I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
control NN I-NP O
was VBD B-VP O
adequate JJ O O
by IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
1 CD O O
However RB O O
on IN B-VP O
postoperative JJ B-NP O
lab NN I-NP O
checkup NN I-NP O
, , O O
it PRP O O
was VBD B-VP O
see VB O O
that IN B-VP O
the DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
bumped VBD B-VP O
to TO O O
4.9 CD O O
with IN B-VP O
a DT B-NP O
BUN NNP I-NP O
of IN B-VP O
61 CD O O
This DT O O
was VBD B-VP O
viewed VBN O O
and CC O O
was VBD B-VP O
monitored VBN O O
by IN B-VP O
serial JJ B-NP O
BUN NNP I-NP O
and CC O O
creatinine NN B-NP O
checks NNS I-NP O
The DT B-NP O
following NN I-NP O
, , O O
BUN NNP B-NP O
and CC O O
creatinine NN B-NP O
came VBD B-VP O
back RB O O
at IN B-VP O
69 CD O O
for IN B-VP O
BUN NNP B-NP O
and CC O O
5.2 CD O O
for IN B-VP O
creatinine NN B-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
continued VBD B-VP O
to TO O O
rise VB O O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
6.5 CD O O
with IN B-VP O
a DT B-NP O
BUN NNP I-NP O
of IN B-VP O
81 CD O O
At IN B-VP O
this DT B-NP O
point NN I-NP O
, , O O
the DT B-NP O
renal JJ I-NP O
service NN I-NP O
was VBD B-VP O
consulted VBN O O
for IN B-VP O
further JJ B-NP O
input NN I-NP O
as RB O O
far RB O O
as IN B-VP O
possible JJ B-NP O
causes NNS I-NP O
of IN B-VP O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
in IN B-VP O
the DT B-NP O
phase NN I-NP O
of IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
and CC O O
postoperative JJ B-NP O
period NN I-NP O
The DT B-NP O
patient's NN I-NP O
vancomycin NN I-NP B-m
level NN I-NP O
came VBD B-VP O
to TO O O
be VB O O
in IN B-VP O
the DT B-NP O
therapeutic JJ I-NP O
range NN I-NP O
of IN B-VP O
30.8 CD O O
FENa NNP B-NP O
was VBD B-VP O
checked VBN O O
which WDT O O
revealed VBD B-VP O
0.74% CD O O
FENa NNP B-NP O
This DT O O
was VBD B-VP O
rechecked VBN O O
and CC O O
revealed VBD B-VP O
a DT B-NP O
FENa NNP I-NP O
of IN B-VP O
0.97% CD O O
both DT O O
, , O O
which WDT O O
indicated VBD B-VP O
prerenal JJ B-NP O
failure NN I-NP O
Renal NNP I-NP O
team NN I-NP O
also RB O O
advised VBD B-VP O
checking VBG O O
for IN B-VP O
other JJ B-NP O
causes NNS I-NP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
anemia NN I-NP O
as RB O O
well RB O O
as IN B-VP O
other JJ B-NP O
causes NNS I-NP O
of IN B-VP O
the DT B-NP O
renal JJ I-NP O
failure NN I-NP O
Labs NNP I-NP O
have VBP O O
been VBN O O
sent VBN O O
and CC O O
some DT O O
are VBP O O
currently RB O O
pending VBG O O
regarding VBG O O
the DT B-NP O
C3-C4 NNP I-NP O
and CC O O
anti-GMB JJ B-NP O
antibodies NNS I-NP O
The DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
continued VBD B-VP O
to TO O O
rise VB O O
despite IN B-VP O
advanced JJ B-NP O
management NN I-NP O
including VBG O O
with IN B-VP O
IV NNP B-NP B-mo
resuscitation NN I-NP B-m
, , O O
fluid NN B-NP O
volume NN I-NP O
boluses NNS I-NP O
, , O O
and CC O O
occasional JJ B-NP O
boluses NNS I-NP O
of IN B-VP O
Lasix NNP B-NP B-m
Eventually NNP I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
BUN NNP I-NP O
and CC O O
creatinine NN B-NP O
rose VBD B-VP O
to TO O O
94 CD O O
and CC O O
8.3 CD O O
by IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
2 CD O O
By IN B-VP O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
, , O O
however RB O O
postoperative JJ B-NP O
day NN I-NP O
3 CD O O
, , O O
the DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
and CC O O
BUN NNP B-NP O
began VBD B-VP O
resolving VBG O O
that IN B-VP O
BUN NNP B-NP O
of IN B-VP O
95 CD O O
and CC O O
a DT B-NP O
creatinine NN I-NP O
7.8 CD O O
However RB O O
, , O O
at IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
began VBD B-VP O
having VBG O O
hypoglycemic JJ B-NP O
episodes NNS I-NP O
in IN B-VP O
response NN B-NP O
to TO O O
the DT B-NP O
Lantus NNP I-NP B-m
dose NN I-NP O
that IN B-VP O
he PRP O O
was VBD B-VP O
getting VBG O O
at IN B-VP O
home NN B-NP O
and CC O O
continue VB O O
to TO O O
get VB O O
here RB O O
in IN B-VP O
hospital NN B-NP O
It PRP O O
was VBD B-VP O
summarized VBN O O
by IN B-VP O
the DT B-NP O
renal JJ I-NP O
team NN I-NP O
as RB O O
well RB O O
as IN B-VP O
by IN B-VP O
the DT B-NP O
surgical JJ I-NP O
service NN I-NP O
and CC O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
may MD O O
have VB O O
not RB O O
been VBN O O
taking VBG O O
his PRP$ O O
medication NN B-NP O
at IN B-VP O
home NN B-NP O
and CC O O
now RB O O
was VBD B-VP O
being VBG O O
his PRP$ O O
medications NNS B-NP O
, , O O
while IN B-VP O
here RB O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
By IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
4 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
have VB O O
dysregulation NN B-NP O
of IN B-VP O
his PRP$ O O
fingerstick JJ B-NP O
blood NN I-NP O
glucoses NNS I-NP O
ranging VBG O O
from IN B-VP O
a DT O O
high JJ O O
of IN B-VP O
367 CD O O
to TO O O
a DT B-NP O
low NN I-NP O
of IN B-VP O
52 CD O O
where WRB O O
she PRP O O
began VBD B-VP O
to TO O O
be VB O O
symptomatic JJ O O
, , O O
somewhat RB O O
somnolent JJ O O
, , O O
and CC O O
groggy VB O O
This DT B-NP O
patient's NN I-NP O
blood NN I-NP O
glucose VB O O
control NN B-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP O
diabetes NNS I-NP O
management NN I-NP O
service NN I-NP O
and CC O O
it PRP O O
was VBD B-VP O
summarized VBN O O
by IN B-VP O
them PRP O O
that IN B-VP O
the DT B-NP O
patient's JJ I-NP O
renal JJ I-NP O
insufficiency NN I-NP O
had VBD B-VP O
a DT B-NP O
significant JJ I-NP O
role NN I-NP O
in IN B-VP O
the DT B-NP O
patient's NN I-NP O
hypoglycemic JJ B-NP O
episodes NNS I-NP O
and CC O O
that IN B-VP O
he PRP O O
ended VBD B-VP O
up RP O O
having VBG O O
insulin NN B-NP O
toxicity NN I-NP O
due JJ O O
to TO O O
poor JJ B-NP O
creatinine JJ I-NP O
clearance NN I-NP O
and CC O O
renal JJ B-NP O
functioning NN I-NP O
level NN I-NP O
It PRP O O
should MD O O
be VB O O
noted VBN O O
that IN B-VP O
in IN B-VP O
light NN B-NP O
of IN B-VP O
this DT B-NP O
patient's JJ I-NP O
postoperative JJ I-NP O
complications NNS I-NP O
of IN B-VP O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
in IN B-VP O
the DT B-NP O
phase NN I-NP O
of IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
and CC O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
never RB O O
required VBD B-VP O
a DT B-NP O
hemodialysis NN I-NP O
because IN B-VP O
the DT B-NP O
potassium NN I-NP O
levels NNS I-NP O
remained VBD B-VP O
stable JJ O O
The DT O O
high JJ O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
reached VBD B-VP O
was VBD B-VP O
5.6 CD O O
of IN B-VP O
potassium NN B-NP B-r
on IN B-VP O
the DT B-NP O
same JJ I-NP O
day NN I-NP O
that IN B-VP O
he PRP O O
had VBD B-VP O
a DT B-NP O
creatine NN I-NP O
of IN B-VP O
8.3 CD O O
, , O O
which WDT O O
was VBD B-VP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
This DT O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
kayexalate NN B-NP B-m
and CC O O
along IN B-VP O
the DT B-NP O
same JJ I-NP O
lines NNS I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
medications NNS I-NP O
were VBD B-VP O
evaluated VBN O O
and CC O O
it PRP O O
was VBD B-VP O
decided VBN O O
to TO O O
decrease VB O O
it PRP O O
to TO O O
b.i.d VB O B-f
dosing NN B-NP O
and CC O O
to TO O O
start VB O O
holding VBG O O
lisinopril NN B-NP B-m
, , O O
Neurontin NNP B-NP B-m
, , O O
and CC O O
vancomycin NN B-NP B-m
for IN B-VP O
their PRP$ O O
possible JJ B-NP O
renal JJ I-NP O
toxic NN I-NP O
effects NNS I-NP O
A DT B-NP O
renal JJ I-NP O
ultrasound NN I-NP O
was VBD B-VP O
obtained VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
as RB O O
well RB O O
as IN B-VP O
Doppler NNP B-NP O
flow NN I-NP O
studies NNS I-NP O
The DT B-NP O
renal JJ I-NP O
ultrasound NN I-NP O
revealed VBD B-VP O
normal JJ B-NP O
parenchyma NN I-NP O
with IN B-VP O
somewhat WP O O
decreased VBD B-VP O
renal JJ B-NP O
indices NNS I-NP O
indicating VBG O O
some DT B-NP O
decreased JJ I-NP O
amount NN I-NP O
of IN B-VP O
blood NN B-NP O
flow NN I-NP O
to TO O O
their PRP$ O O
kidneys NNS B-NP O
At IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
, , O O
an DT B-NP O
MRA NNP I-NP O
of IN B-VP O
the DT B-NP O
renal JJ I-NP O
arteries NNS I-NP O
was VBD B-VP O
obtained VBN O O
which WDT O O
revealed VBD B-VP O
no DT B-NP O
stenosis NN I-NP O
lesions NNS I-NP O
of IN B-VP O
the DT B-NP O
kidneys NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
eventually RB O O
started VBN O O
on IN B-VP O
PhosLo NNP B-NP B-m
and CC O O
Ferrlecit NNP B-NP B-m
as RB O O
well RB O O
as IN B-VP O
Epogen NNP B-NP B-m
10 CD O I-m
10 CD O B-do
, , O I-do
000 CD O I-do
units NNS B-NP I-do
q JJ B-NP B-f
week NN I-NP I-f
at IN B-VP O
the DT B-NP O
recommendation NN I-NP O
of IN B-VP O
the DT B-NP O
renal JJ I-NP O
service NN I-NP O
This DT O O
was VBD B-VP O
continued VBN O O
during IN B-VP O
the DT B-NP O
duration NN I-NP B-du
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
stay NN I-NP O
and CC O O
should MD O O
continue VB O O
in IN B-VP O
the DT B-NP O
postoperative JJ I-NP O
hospitalization NN I-NP O
In IN B-VP O
light NN B-NP O
of IN B-VP O
this DT B-NP O
postoperative JJ I-NP B-r
complications NNS I-NP I-r
, , O O
the DT B-NP O
creatinine NN I-NP O
became VBD B-VP O
stable JJ O O
by IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
3 CD O O
and CC O O
blood NN B-NP B-m
pressure NN I-NP O
medications NNS I-NP O
were VBD B-VP O
restarted VBN O O
at IN B-VP O
previous JJ B-NP O
doses NNS I-NP O
and CC O O
were VBD B-VP O
titrated VBN O O
to TO O O
the DT B-NP O
need NN I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
demonstrated VBN O O
by IN B-VP O
his PRP$ O O
blood NN B-NP B-r
pressure NN I-NP O
control NN I-NP O
This DT O O
was VBD B-VP O
eventually RB O O
attained VBN O O
on IN B-VP O
atenolol NN B-NP B-m
at IN B-VP O
150 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
However RB O O
, , O O
renal JJ B-NP O
service NN I-NP O
recommended VBD B-VP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
be VB O O
given VBN O O
Lopressor NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
This DT O O
seems VBZ O O
to TO O O
have VB O O
controlled VBN O O
the DT B-NP B-r
patient's NN I-NP I-r
blood NN I-NP I-r
pressure NN I-NP I-r
for IN B-VP O
the DT B-NP O
time NN I-NP O
being VBG O O
Physical JJ B-NP O
therapy NN I-NP O
was VBD B-VP O
also RB O O
involved VBN O O
in IN B-VP O
evaluating VBG O O
the DT B-NP O
patient NN I-NP O
and CC O O
assisted VBN O O
in IN B-VP O
the DT B-NP O
management NN I-NP O
of IN B-VP O
this DT B-NP O
patient's NN I-NP O
care NN I-NP O
It PRP O O
should MD O O
also RB O O
be VB O O
noted VBN O O
that IN B-VP O
a DT B-NP O
wax JJ I-NP O
sponge NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
the DT B-NP O
patient's NN I-NP O
right RB O O
open JJ O O
wound IN B-VP O
This DT O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#3 NNP I-NP O
, , O O
5/19/04 CD O O
The DT B-NP O
patient NN I-NP O
seems VBZ O O
to TO O O
be VB O O
tolerating VBG O O
this DT B-NP O
well NN I-NP O
The DT B-NP O
diabetes NNS I-NP O
management NN I-NP O
service NN I-NP O
, , O O
the DT B-NP O
physical JJ I-NP O
therapy NN I-NP O
, , O O
and CC O O
the DT B-NP O
renal JJ I-NP O
teams NNS I-NP O
continued VBD B-VP O
to TO O O
follow VB O O
the DT B-NP O
patient NN I-NP O
closely RB O O
during IN B-VP O
the DT B-NP O
duration NN I-NP O
of IN B-VP O
his PRP$ O O
stay NN B-NP O
until IN B-VP O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT B-NP O
patient's NN I-NP O
postoperative JJ B-NP O
complications NNS I-NP O
and CC O O
issues NNS B-NP O
including VBG O O
blood NN B-NP O
glucose NN I-NP O
control NN I-NP O
as RB O O
well RB O O
as IN B-VP O
renal JJ B-NP O
insufficiency NN I-NP O
were VBD B-VP O
under IN B-VP O
control NN B-NP O
From IN B-VP O
an DT B-NP O
operative JJ I-NP O
standpoint NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
and CC O O
it PRP O O
was VBD B-VP O
decided VBN O O
to TO O O
continue VB O O
the DT B-NP O
patient NN I-NP O
on IN B-VP O
levofloxacin NN B-NP B-m
for IN B-VP B-du
a DT O O
one CD O O
week NN B-NP O
course NN I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
to TO O O
the DT B-NP O
rehab NN I-NP O
facility NN I-NP O
, , O O
which WDT O O
is VBZ O O
the DT O O
Still RB O O
Freedral NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
their PRP$ O O
ability NN B-NP O
to TO O O
care VB O O
for IN B-VP O
wax JJ B-NP O
sponge NN I-NP O
excellently RB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Dr NNP B-NP O
Ulvan NNP I-NP O
in IN B-VP O
the DT B-NP O
renal JJ I-NP O
staff NN I-NP O
and CC O O
by IN B-VP O
the DT B-NP O
diabetes NNS I-NP O
management NN I-NP O
service NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Clint NNP I-NP O
Holets NNP I-NP O
, , O O
pager JJR O O
#050-61 JJ O O
The DT B-NP O
physical JJ I-NP O
examination NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
was VBD B-VP O
unchanged JJ O O
from IN B-VP O
the DT B-NP O
previous JJ I-NP O
few JJ I-NP O
days NNS I-NP O
where WRB O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
to TO O O
have VB O O
adequate JJ B-NP O
Doppler NNP I-NP O
signal NN I-NP O
in IN B-VP O
all DT O O
his PRP$ O O
pedal NN B-NP O
pulses NNS I-NP O
, , O O
DPs NNP B-NP O
as RB O O
well RB O O
as IN B-VP O
PTs NNP B-NP O
and CC O O
a DT O O
faintly RB O O
palpable JJ B-NP O
right JJ I-NP O
DP NNP I-NP O
and CC O O
as RB O O
well RB O O
as IN B-VP O
faintly RB O O
palpable JJ O O
left VBD B-VP O
DP NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications NNS I-NP O
, , O O
Tylenol NNP B-NP B-m
650 CD O B-do
to TO O I-do
1000 CD O I-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.4h NN I-NP B-f
p.r.n NN I-NP I-f
for IN B-VP O
temperature NN B-NP B-r
greater JJR O O
than IN B-VP O
101 CD O O
, , O O
allopurinol RB O B-m
100 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.d NN I-NP B-f
, , O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
81 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
PhosLo NNP B-NP B-m
1334 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.c NN I-NP O
, , O O
please VB O O
give VB O O
with IN B-VP O
meals NNS B-NP O
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Epogen NNP B-NP B-m
10 CD O B-do
, , O I-do
000 CD O I-do
units NNS B-NP I-do
delivered VBN O O
subcuticularly RB O B-mo
q JJ B-NP B-f
week NN I-NP I-f
starting VBG O I-f
on IN B-VP I-f
Monday NNP B-NP I-f
, , O O
already RB O O
given VBN O O
one CD O O
dose JJ B-NP O
intra JJ I-NP O
hospital NN I-NP O
stay NN I-NP O
Please NNP I-NP O
give VB O O
the DT B-NP O
next JJ I-NP O
dose NN I-NP O
on IN B-VP O
0/0/04 CD O O
or CC O O
07 CD O O
, , O O
iron NN B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Percocet NNP B-NP B-m
1 CD O B-do
to TO O O
2 CD O O
tablets NNS B-NP O
p.o JJ B-NP B-mo
q.4h JJ I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
prednisolone NN B-NP B-m
1% CD O I-m
one CD O B-do
drop NN B-NP I-do
in IN B-VP B-mo
the DT B-NP O
effected JJ I-NP O
eye NN I-NP O
b.i.d NN I-NP B-f
, , O O
Zocor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
Neurontin NNP B-NP B-m
300 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
atropine VBP O B-m
1 CD O B-do
mg NN B-NP I-do
one CD O I-do
drop NN B-NP I-do
in IN B-VP B-mo
the DT B-NP I-mo
affected JJ I-NP I-mo
eye NN I-NP I-mo
, , O O
levofloxacin JJ O B-m
250 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
every DT B-NP B-f
morning NN I-NP I-f
starting VBG O O
on IN B-VP O
the DT O O
0/0/04 CD O O
and CC O O
continuing VBG O O
for IN B-VP B-du
one CD O I-du
week NN B-NP I-du
, , O O
Lispro NNP B-NP B-m
6 CD O B-do
units NNS B-NP I-do
subcuticularly RB O B-mo
q.a.c RB O B-f
, , O O
hold VB O O
if IN B-VP O
the DT B-NP O
patient NN I-NP O
is VBZ O O
not RB O O
eating VBG O O
much RB O O
or CC O O
if IN B-VP O
the DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
have VB O O
a DT B-NP O
meal NN I-NP O
sitting VBG O O
right RB O O
in IN B-VP O
front NN B-NP O
of IN B-VP O
him PRP O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
dosage NN B-NP O
and CC O O
also RB O O
Lispro NNP B-NP B-m
Lispro NNP I-NP B-m
Lispro NNP I-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
as IN B-VP O
per IN B-VP O
the DT B-NP O
discharge NN I-NP O
paper NN I-NP O
work NN I-NP O
in IN B-VP O
which WDT O O
the DT B-NP O
patient NN I-NP O
receives VBZ O O
two CD O B-do
units NNS B-NP I-do
if IN B-VP O
the DT B-NP O
blood NN I-NP O
glucose NN I-NP O
is VBZ O O
between IN B-VP O
125 CD O O
to TO O O
150 CD O O
and CC O O
onwards NNS B-NP O
from IN B-VP O
there RB O O
3 CD O B-do
units NNS B-NP I-do
for IN B-VP O
150 CD O O
to TO O O
200 CD O O
, , O O
and CC O O
so RB O O
forth JJ B-NP O
Please NNP I-NP O
also RB O O
give VBP O O
the DT B-NP O
patient NN I-NP O
half PDT O O
his PRP$ O O
sliding VBG O O
scale NN B-NP O
dose NN I-NP O
at IN B-VP O
the DT B-NP O
bedtime NN I-NP O
if IN B-VP O
his PRP$ O O
blood NN B-NP O
glucose NN I-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
200 CD O O
and CC O O
recheck VB O O
his PRP$ O O
blood NN B-NP O
glucose RB O O
1 CD O O
to TO O O
2 CD O O
hours NNS B-NP O
later RB O O
, , O O
TriCor NNP B-NP B-m
54 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Lantus NNP B-NP B-m
25 CD O B-do
units NNS B-NP I-do
subcutaneous JJ B-NP B-mo
q.d NN I-NP B-f
, , O O
and CC O O
DuoNeb NNP B-NP B-m
3/0.5 CD O B-do
mg NN B-NP O
nebulizer NN I-NP B-mo
q.6h NN I-NP B-f
p.r.n NN I-NP I-f
wheezing VBG O B-r
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
be VB O O
followed VBN O O
up RP O O
at IN B-VP O
the DT B-NP O
rehab NN I-NP O
facility NN I-NP O
at IN B-VP O
Ing NNP B-NP O
Mansy NNP I-NP O
General NNP I-NP O
Hospital NNP I-NP O
Please NNP I-NP O
also RB O O
note VBP O O
, , O O
the DT B-NP O
patient NN I-NP O
should MD O O
follow VB O O
up RP O O
with IN B-VP O
the DT B-NP O
renal JJ I-NP O
service NN I-NP O
as IN B-VP O
per IN B-VP O
the DT B-NP O
discharge NN I-NP O
report NN I-NP O
in IN B-VP O
two CD O O
to TO O O
three CD O O
weeks NNS B-NP O
as RB O O
well RB O O
as IN B-VP O
Dr NNP B-NP O
Knaub NNP I-NP O
as IN B-VP O
per IN B-VP O
the DT B-NP O
paper NN I-NP O
work NN I-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
The DT B-NP O
wax JJ I-NP O
sponge NN I-NP O
should MD O O
be VB O O
change NN B-NP O
every DT O O
three CD O O
days NNS B-NP O
and CC O O
please NN B-NP O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Zaxas NNP I-NP O
regarding VBG O O
the DT B-NP O
longevity NN I-NP O
of IN B-VP O
the DT B-NP O
wax NN I-NP O
sponge NN I-NP O
He PRP O O
should MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Amos NNP I-NP O
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
attending NN I-NP O
in IN B-VP O
the DT B-NP O
renal JJ I-NP O
service NN I-NP O
Dr NNP I-NP O
Riech NNP I-NP O
The DT B-NP O
clinic JJ I-NP O
number NN I-NP O
for IN B-VP O
the DT B-NP O
renal JJ I-NP O
service NN I-NP O
is VBZ O O
9057822 CD O O
eScription NN B-NP O
document: NN I-NP O
9-6956226 CD O O
EMSSten NNP B-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
WUERZ NNP I-NP O
, , O O
SANDY NNP B-NP O
Attending: NNP I-NP O
COWAN NNP I-NP O
, , O O
WILBUR NNP B-NP O
MIQUEL NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6436301 CD O O
D: NNP B-NP O
2/12/04 CD O O
T: NNP B-NP O
2/12/04 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#408381 VBZ O O
288978562 CD O O
HSH NNP B-NP O
40164507 CD O O
9863389 CD O O
8/17/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
s/p JJ B-NP O
panniculectomy NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/22/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/17/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
VANDERLOO NNP I-NP O
, , O O
BROOKS NNP B-NP O
940-78-98-8 CD O O
Aro NNP B-NP O
Ryen NNP I-NP O
Wotarg NNP I-NP O
St NNP I-NP O
Service: NNP I-NP O
PLA NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/1/06 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
SNF/rehab NNP I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
JAKIELA NNP I-NP O
, , O O
JEFFERSON NNP B-NP O
LLOYD NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Rehabilitation NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
KEFLEX NNP I-NP B-m
( ( O I-m
CEPHALEXIN NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PEPCID NNP I-NP B-m
( ( O I-m
FAMOTIDINE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DILAUDID NNP I-NP B-m
( ( O I-m
HYDROMORPHONE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
2-4 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/10/06 CD O O
by IN B-VP O
SHOGREN NNP B-NP O
, , O O
DON NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
DILAUDID NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
693815861 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
Morphine; NNP B-NP O
reaction NN I-NP O
is VBZ O O
GI NNP B-NP O
Intolerance NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
watch VB O O
INSULIN NNP B-NP B-m
REGULAR NNP I-NP I-m
HUMAN NNP I-NP I-m
Sliding NNP I-NP O
Scale NNP I-NP O
( ( O B-mo
subcutaneously RB O I-mo
) ) O I-mo
SC NNP B-NP I-mo
Q4H NNP I-NP B-f
Low NNP I-NP O
Scale NNP I-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
less JJR O O
than IN B-VP O
60 CD O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
DO NNP B-NP O
NOT NNP I-NP O
Administer NNP I-NP O
supplemental NN I-NP O
( ( O O
sliding VBG O O
scale NN B-NP O
) ) O O
insulin NN B-NP B-m
insulin NN I-NP B-m
insulin NN I-NP B-m
insulin NN I-NP B-m
insulin NN I-NP B-m
If IN B-VP O
BS NNP B-NP O
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
0 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
1 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
5 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
Call NNP B-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
350 CD O O
Please NNP B-NP O
give VB O O
at IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
and CC O O
in IN B-VP O
addition NN B-NP O
to TO O O
standing VBG O O
mealtime JJ B-NP O
insulin NN I-NP B-m
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
75 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
MAALOX-TABLETS NNP I-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
MILK NNP I-NP B-m
OF NNP I-NP I-m
MAGNESIA NNP I-NP I-m
( ( O I-m
MAGNESIUM NNP B-NP I-m
HYDROXIDE NNP I-NP I-m
) ) O I-m
30 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
METOCLOPRAMIDE NNP I-NP B-m
HCL NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
IV NNP I-NP B-mo
Q8H NNP I-NP B-f
PRN NNP I-NP I-f
Nausea NNP I-NP B-r
QUINAPRIL NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
SIMETHICONE NNP B-NP B-m
SIMETHICONE NNP I-NP B-m
40 CD O B-do
40 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
QID NNP I-NP B-f
QID NNP I-NP B-f
PRN NNP I-NP I-f
PRN NNP I-NP I-f
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
, , O O
Other:gas NNP B-NP B-r
STYKER NNP I-NP B-m
PAIN NNP I-NP I-m
PUMP NNP I-NP I-m
( ( O I-m
BUPIVACAINE NNP B-NP I-m
0.5% CD O I-m
) ) O I-m
400 CD O O
MILLILITERS NNP B-NP O
IV NNP I-NP B-mo
Q24H NNP I-NP B-f
Instructions: NNP I-NP O
Rate NNP I-NP O
= VBD B-VP O
4ml/hr CD O O
Bolus NNP B-NP O
dose JJ B-NP O
= NNP I-NP O
4ml CD O O
Lockout NNP B-NP O
interval NN I-NP O
= VBD B-VP O
60 CD O O
minutes NNS B-NP O
DIET: NNP I-NP O
No NNP I-NP O
Restrictions NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated JJ B-NP O
Lift NNP I-NP O
restrictions: NN I-NP O
Do NNP I-NP O
not RB O O
lift VB O O
greater JJR O O
then RB O O
10 CD O O
pounds NNS B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Donovan NNP I-NP O
Dike NNP I-NP O
446-414-3709 JJ B-NP O
5-7 JJ I-NP O
days NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
Morphine NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
abdominal JJ B-NP O
laxity NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
s/p VBP O O
panniculectomy IN B-VP O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
none NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
0/10/06 CD O O
EADE NNP B-NP O
, , O O
CONNIE NNP B-NP O
EUGENE NNP I-NP O
, , O O
M.D NNP B-NP O
PANNICULECTOMY NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Drain NNP B-NP O
care NN I-NP O
- : O O
monitor/record NN B-NP O
drain NN I-NP O
output NN I-NP O
, , O O
when WRB O O
less JJR O O
than IN B-VP O
30 CD O O
cc NN B-NP O
in IN B-VP O
24 CD O O
hours NNS B-NP O
pt NN I-NP O
may MD O O
call VB O O
for IN B-VP O
appointment NN B-NP O
for IN B-VP O
removal JJ B-NP O
Change NNP I-NP O
drain NN I-NP O
sponges NNS I-NP O
daily RB O O
Strip NNP B-NP O
drains VBZ O O
twice JJ O O
daily RB O O
Wound NNP B-NP O
check NN I-NP O
QD NNP I-NP O
- : O O
DSD NN B-NP O
to TO O O
incision VB O O
if IN B-VP O
spotting JJ B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
56 CD O O
y.o NN B-NP O
morbidly RB O O
obese JJ B-NP O
female NN I-NP O
with IN B-VP O
abdominal JJ B-NP O
skin NN I-NP O
laxity NN I-NP O
2/2 CD O O
massive JJ B-NP O
weight NN I-NP O
loss NN I-NP O
after IN B-VP O
gastric JJ B-NP O
bypass NN I-NP O
, , O O
admitted VBN O O
to TO O O
plastics NNS B-NP O
on IN B-VP O
3/5/05 CD O O
for IN B-VP O
panniculectomy NN B-NP O
pt NN I-NP O
tolerated VBD B-VP O
all DT B-NP O
procedures NNS I-NP O
without IN B-VP O
difficulty NN B-NP O
post-op JJ B-NP O
period NN I-NP O
has VBZ O O
been VBN O O
uneventful JJ O O
at IN B-VP O
discharge NN B-NP O
pt NN I-NP O
is VBZ O O
afebrile JJ O O
with IN B-VP O
stable JJ B-NP O
vitals NNS I-NP O
, , O O
taking VBG O O
po's/voiding VBG O O
q NN B-NP O
shift NN I-NP O
has VBZ O O
ambulated VBN O O
independently RB O O
but CC O O
with IN B-VP O
some DT B-NP O
difficulty NN I-NP O
given VBN O O
body NN B-NP O
habitus NN I-NP O
pain NN I-NP O
generally RB O O
has VBZ O O
been VBN O O
well RB O O
managed VBN O O
Incisions NNS B-NP O
are VBP O O
clean JJ O O
, , O O
dry JJ O O
and CC O O
intact JJ B-NP O
Jp's NNP I-NP O
with IN B-VP O
moderate JJ B-NP O
serosanguinous JJ I-NP O
output NN I-NP O
remain VBP O O
in IN B-VP O
place NN B-NP O
Pt NNP I-NP O
is VBZ O O
discharged VBN O O
to TO O O
rehab VB O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
instructions NNS I-NP O
given VBN O O
Services NNS B-NP O
arranged VBD B-VP O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Continue NNP I-NP O
your PRP$ O O
antibiotics NNS B-NP B-m
as RB O B-du
long RB O I-du
as IN B-VP I-du
you PRP O I-du
have VBP O I-du
drain/s VBN O I-du
in IN B-VP I-du
place NN B-NP I-du
Drain NNP I-NP O
care NN I-NP O
- : O O
monitor/record NN B-NP O
drain NN I-NP O
output NN I-NP O
, , O O
when WRB O O
less JJR O O
than IN B-VP O
30 CD O O
cc NN B-NP O
in IN B-VP O
24 CD O O
hours NNS B-NP O
, , O O
call NN B-NP O
for IN B-VP O
appointment NN B-NP O
for IN B-VP O
removal JJ B-NP O
Change NNP I-NP O
drain NN I-NP O
sponges NNS I-NP O
daily RB O O
Strip NNP B-NP O
drains VBZ O O
twice JJ B-NP O
daily JJ I-NP O
Activity NNP I-NP O
- : O O
sponge NN B-NP O
baths NNS I-NP O
only RB O O
while IN B-VP O
drains NNS B-NP O
are VBP O O
in IN B-VP O
place NN B-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
No NNP B-NP O
lifting VBG O O
more JJR O O
than IN B-VP O
10 CD O O
pounds NNS B-NP O
No DT B-NP O
jogging NN I-NP O
, , O O
swimming NN B-NP O
, , O O
or CC O O
aerobics NNS B-NP O
x JJ B-NP O
4-6 JJ I-NP O
weeks NNS I-NP O
Monitor/return NNP I-NP O
for IN B-VP O
signs NNS B-NP O
of IN B-VP O
infection NN B-NP O
which WDT O O
may MD O O
include: VB O O
increased VBD B-VP O
pain NN B-NP O
, , O O
swelling VBG O O
, , O O
redness NN B-NP O
, , O O
fever NN B-NP O
, , O O
drainage NN B-NP O
, , O O
problems NNS B-NP O
with IN B-VP O
incisions NNS B-NP O
, , O O
or CC O O
other JJ B-NP O
concerns NNS I-NP O
If IN B-VP O
you PRP O O
have VBP O O
any DT B-NP O
questions NNS I-NP O
, , O O
please VB O O
call VB O O
Dr NNP B-NP O
Nicky NNP I-NP O
Yamauchi NNP I-NP O
446-414-3709 CD O O
or CC O O
Benny NNP B-NP O
Demicco NNP I-NP O
NP NNP I-NP O
at IN B-VP O
525 CD O O
503-3214 JJ B-NP O
pager NN I-NP O
92813 CD O O
or CC O O
pager JJR O O
58806 CD O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BORKOSKI NNP I-NP O
, , O O
ALVIN NNP B-NP O
B NNP I-NP O
, , O O
N.P NNP B-NP O
( ( O O
) ) O O
7/1/06 CD O O
@ $ O O
11:28 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#410277 VBZ O O
785289682 CD O O
RM NNP B-NP O
34916218 CD O O
9502354 CD O O
10/16/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
NEW NNP I-NP O
ONSET NNP I-NP O
DIABETES NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/10/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/17/2006 CD O O
ATTENDING: NNP B-NP O
SPIESS NNP I-NP O
, , O O
RAFAEL NNP B-NP O
M.D NNP I-NP O
DIAGNOSIS: NNP I-NP O
New-onset NNP I-NP O
diabetes VBZ O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
A NNP I-NP O
45-year-old JJ B-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
familial JJ B-NP O
cardiomyopathy NN I-NP O
and CC O O
status NN B-NP O
post NN I-NP O
cardiac NN I-NP O
transplant NN I-NP O
in IN B-VP O
2002 CD O O
, , O O
and CC O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
presented VBN O O
with IN B-VP O
greater JJR O O
than IN B-VP O
two CD O O
weeks NNS B-NP O
of IN B-VP O
polyuria NN B-NP O
, , O O
polydipsia NN B-NP O
, , O O
blurry JJ B-NP O
vision NN I-NP O
, , O O
muscle NN B-NP O
cramps NNS I-NP O
, , O O
and CC O O
myalgias NN B-NP O
and CC O O
reported VBD B-VP O
approximately RB O O
a DT B-NP O
15-pound JJ I-NP O
weight NN I-NP O
loss NN I-NP O
over IN B-VP O
three CD O O
weeks NNS B-NP O
with IN B-VP O
decrease NN B-NP O
in IN B-VP O
usual JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
Was NNP I-NP O
seen VBN O O
by IN B-VP O
his PRP$ O O
PCP NN B-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
and CC O O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
fingerstick NN I-NP O
of IN B-VP O
1000 CD O O
The DT B-NP O
patient NN I-NP O
also RB O O
reported VBD B-VP O
sore RB O O
throat NN B-NP O
and CC O O
cough NN B-NP O
times NNS I-NP O
several JJ B-NP O
days NNS I-NP O
, , O O
but CC O O
otherwise RB O O
review NN B-NP O
of IN B-VP O
systems NNS B-NP O
is VBZ O O
negative JJ B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Cardiomyopathy NNP B-NP O
, , O O
status NN B-NP O
post NN I-NP O
transplant NN I-NP O
and CC O O
AICD NNP B-NP O
placement VBD B-VP O
2 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
3 CD O O
Hypothyroidism NNP B-NP O
4 CD O O
Tricuspid NNP B-NP O
regurgitation NN I-NP O
5 CD O O
History NNP B-NP O
of IN B-VP O
pancreatitis NN B-NP O
6 CD O O
Gout NNP B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Calcium NNP I-NP B-m
carbonate NN I-NP I-m
1250 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Cartia NNP B-NP B-m
XT NNP I-NP I-m
300 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
CellCept NNP B-NP B-m
1500 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
colchicine VBP O B-m
0.6 CD O B-do
mg JJ B-NP O
daily JJ I-NP B-f
p.r.n NN I-NP I-f
, , O O
Neoral NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
folate VBP O B-m
1 CD O B-do
mg JJ O I-do
daily JJ O B-f
, , O O
K-dur NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
daily RB O B-f
, , O O
magnesium NN B-NP B-m
oxide RB O I-m
400 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
methotrexate VB O B-m
2.5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Pravastatin NNP B-NP B-m
20 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
prednisone NN B-NP B-m
7 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Rocaltrol NNP B-NP B-m
0.25 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Synthroid NNP B-NP B-m
150 CD O B-do
mcg JJ O I-do
daily RB O B-f
, , O O
Torsemide NNP B-NP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Vitamin NNP B-NP B-m
C NNP I-NP I-m
, , O O
Vitamin NNP B-NP B-m
E NNP I-NP I-m
, , O O
and CC O O
cyclosporin VBZ O B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
ALLERGIES: NNP I-NP O
Penicillin NNP I-NP O
leads VBZ O O
to TO O O
"shaking." VB O O
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
temperature NN B-NP O
98.8 CD O O
Blood NNP B-NP O
pressure NN I-NP O
140/82 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
92 CD O O
, , O O
saturation NN B-NP O
is VBZ O O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
obese JJ O O
, , O O
but CC O O
well RB O O
appearing VBG O O
Weight NNP B-NP O
117.7 CD O O
kilograms NNS B-NP O
Cardiovascular JJ B-NP O
examination: JJ I-NP O
Regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
Soft NNP I-NP O
, , O O
2/6 CD O O
systolic JJ O O
murmur RB O O
heard RB O O
best JJS O O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
No NNP I-NP O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
ADMISSIONS NNP I-NP O
LABORATORIES: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
a DT B-NP O
blood NN I-NP O
glucose NN I-NP O
of IN B-VP O
1064 CD O O
, , O O
creatinine VBP O O
2.2 CD O O
from IN B-VP O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
1.8 CD O O
, , O O
sodium NN B-NP O
130 CD O O
, , O O
potassium NN B-NP O
4.9 CD O O
EKG NNP B-NP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
87 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
, , O O
evidence NN B-NP O
of IN B-VP O
left JJ B-NP O
atrial JJ I-NP O
enlargement NN I-NP O
, , O O
incomplete JJ B-NP O
right JJ I-NP O
bundle-branch NN I-NP O
block NN I-NP O
, , O O
and CC O O
anterior JJ B-NP O
T NNP I-NP O
wave NN I-NP O
changes NNS I-NP O
that WDT O O
are VBP O O
unchanged JJ O O
from IN B-VP O
prior JJ B-NP O
EKGs NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
ISSUE: NNP I-NP O
1 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
with IN B-VP O
new-onset JJ B-NP B-r
new-onset JJ I-NP B-r
diabetes NNS I-NP I-r
diabetes VBZ O I-r
Endocrine NNP B-NP O
service NN I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
controlled VBN O O
with IN B-VP O
a DT B-NP O
combination NN I-NP O
regimen NN I-NP O
of IN B-VP O
Lantus NNP B-NP B-m
, , O O
Novolog NNP B-NP B-m
q VBZ O B-f
q JJ B-NP B-f
a.c NN I-NP I-f
a.c NN I-NP I-f
, , O O
combined VBN O O
with IN B-VP O
a DT B-NP O
Novolog NNP I-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
with IN B-VP O
followup NN B-NP O
with IN B-VP O
Napoleon NNP B-NP O
Mettee NNP I-NP O
, , O O
the DT B-NP O
diabetic JJ I-NP O
teaching NN I-NP O
nurse NN I-NP O
and CC O O
with IN B-VP O
Dr NNP B-NP O
Jonson NNP I-NP O
in IN B-VP O
the DT B-NP O
diabetes NNS I-NP O
clinic JJ O O
and CC O O
with IN B-VP O
VNA NNP B-NP O
services NNS I-NP O
to TO O O
assist VB O O
with IN B-VP O
home NN B-NP O
medications NNS I-NP O
The DT B-NP O
patient NN I-NP O
demonstrated VBD B-VP O
proper JJ B-NP O
understanding NN I-NP O
of IN B-VP O
blood NN B-NP O
glucose JJ B-NP O
testing NN I-NP O
and CC O O
insulin NN B-NP B-m
administration NN I-NP O
prior RB O O
to TO O O
discharge VB O O
2 CD O O
Cardiovascular: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
intravascularly RB O O
dry JJ O O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
aggressively RB O O
hydrated VBN O O
and CC O O
euvolemic JJ B-NP O
prior NN I-NP O
to TO O O
discharge VB O O
3 CD O O
Rheumatology: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
mild VBN O B-r
acute JJ B-NP I-r
gout NN I-NP I-r
flare NN I-NP I-r
during IN B-VP O
admission NN B-NP O
for IN B-VP O
which WDT O O
he PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
colchicine NN B-NP B-m
4 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
with IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
likely JJ B-NP O
transplant NN I-NP O
, , O O
immunosuppression NN B-NP O
medication NN I-NP O
related VBN O O
Baseline NNP B-NP O
creatinine NN I-NP O
is VBZ O O
1.8 CD O O
Creatinine NN B-NP O
at IN B-VP O
admission NN B-NP O
of IN B-VP O
2.2 CD O O
likely RB O O
related VBN O O
to TO O O
prerenal JJ B-NP O
acute JJ I-NP O
renal JJ I-NP O
failure NN I-NP O
Creatinine NNP I-NP O
at IN B-VP O
discharge NN B-NP O
had VBD B-VP O
normalized VBN O O
to TO O O
1.6 CD O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
Vitamin NNP I-NP B-m
C NNP I-NP I-m
500 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Rocaltrol NNP B-NP B-m
0.25 CD O B-do
mcg JJ O O
daily RB O B-f
, , O O
calcium NN B-NP B-m
carbonate NN I-NP I-m
500 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
colchicine VBP O B-m
0.3 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
cyclosporin VBP O B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
folic JJ O B-m
acid VBP O I-m
1 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Synthroid NNP B-NP B-m
150 CD O B-do
mcg JJ O I-do
daily RB O B-f
, , O O
magnesium NN B-NP B-m
oxide RB O I-m
420 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
prednisone NN B-NP B-m
7.5 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
, , O O
Vitamin NNP B-NP B-m
E NNP I-NP I-m
400 CD O B-do
units NNS B-NP I-do
daily RB O B-f
, , O O
Pravachol NNP B-NP B-m
20 CD O B-do
mg NN B-NP O
at IN B-VP B-f
night NN B-NP I-f
, , O O
Cartia NNP B-NP B-m
XT NNP I-NP I-m
that WDT O O
is VBZ O O
diltiazem RB O B-m
extended JJ B-NP I-m
release NN I-NP I-m
300 CD O B-do
300 CD O B-do
mg NNS B-NP I-do
mg JJ O I-do
daily JJ O B-f
daily RB O B-f
, , O O
CellCept NNP B-NP B-m
1500 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Lantus NNP B-NP B-m
insulin NN I-NP I-m
( ( O I-m
Glargine NNP B-NP I-m
) ) O I-m
40 CD O B-do
units NNS B-NP O
subcutaneous JJ B-NP B-mo
q.a.m NN I-NP B-f
, , O O
Novolog NNP B-NP B-m
12 CD O B-do
units NNS B-NP I-do
before IN B-VP B-f
breakfast NN B-NP I-f
, , O O
Novolog NNP B-NP B-m
12 CD O B-do
units NNS B-NP I-do
before IN B-VP B-f
lunch NN B-NP I-f
, , O O
Novolog NNP B-NP B-m
14 CD O B-do
units NNS B-NP I-do
before IN B-VP B-f
dinner NN B-NP I-f
, , O O
and CC O O
Novolog NNP B-NP B-m
Novolog NNP I-NP B-m
Novolog NNP I-NP B-m
Novolog NNP I-NP B-m
Novolog NNP I-NP B-m
Novolog NNP I-NP B-m
sliding VBG O B-do
scale JJ B-NP I-do
q NN I-NP B-f
a.c IN B-VP I-f
The DT O O
sliding VBG O O
scale NN B-NP O
is VBZ O O
as IN B-VP O
follows: NN B-NP O
If IN B-VP O
blood NN B-NP O
sugar NN I-NP O
is VBZ O O
150-200 JJ B-NP O
take NN I-NP O
4 CD O B-do
units NNS B-NP I-do
, , O O
if IN B-VP O
blood NN B-NP O
sugar NN I-NP O
is VBZ O O
201-250 JJ B-NP O
mg NNS I-NP O
take VBP O O
6 CD O B-do
units NNS B-NP I-do
, , O O
if IN B-VP O
blood NN B-NP O
sugar NN I-NP O
is VBZ O O
251-300 JJ B-NP O
take NN I-NP O
8 CD O B-do
units NNS B-NP O
, , O O
if IN B-VP O
blood NN B-NP O
sugar NN I-NP O
is VBZ O O
301-350 JJ B-NP O
take NN I-NP O
10 CD O B-do
units NNS B-NP I-do
, , O O
if IN B-VP O
blood NN B-NP O
sugar NN I-NP O
is VBZ O O
350-400 JJ B-NP O
take NN I-NP O
12 CD O B-do
units NNS B-NP I-do
, , O O
if IN B-VP O
it PRP O O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
instructed VBN O O
to TO O O
call VB O O
his PRP$ O O
doctor NN B-NP O
eScription NN I-NP O
document: VBZ O O
2-8832408 JJ B-NP O
HFFocus NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BRAYE NNP I-NP O
, , O O
DAMION NNP B-NP O
Attending: NNP I-NP O
VIDA NNP I-NP O
, , O O
JUSTIN NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
4581635 CD O O
D: NNP B-NP O
3/25/06 CD O O
T: NNP B-NP O
3/25/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#413813 VBZ O O
965041836 CD O O
EVH NNP B-NP O
94253387 CD O O
7657131 CD O O
6/29/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Chest NNP I-NP O
pressure NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/29/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/7/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
MURPHEY NNP I-NP O
, , O O
CRUZ NNP B-NP O
001-14-30-0 NNP I-NP O
Range NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/25/06 CD O O
AT NNP B-NP O
11:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
HEATLY NNP I-NP O
, , O O
SOLOMON NNP B-NP O
O NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
650 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Headache NNP I-NP B-r
PERSANTINE NNP I-NP B-m
( ( O I-m
DIPYRIDAMOLE NNP B-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATIVAN NNP I-NP B-m
( ( O I-m
LORAZEPAM NNP B-NP I-m
) ) O I-m
3.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
RR&lt;12 NNP I-NP O
or CC O O
oversedation NN B-NP O
ATIVAN NNP I-NP B-m
( ( O I-m
LORAZEPAM NNP B-NP I-m
) ) O I-m
2 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
PRN NNP I-NP I-f
Anxiety NNP I-NP B-r
HOLD NNP I-NP O
IF: NNP I-NP O
RR&lt;12 NNP I-NP O
or CC O O
oversedation NN B-NP O
NTG NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
NITROGLYCERIN NNP B-NP I-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5MIN NNP I-NP B-f
X NNP I-NP B-du
3 CD O I-du
doses NNS B-NP I-du
PRN NNP I-NP I-du
Chest NNP I-NP B-r
Pain NNP I-NP I-r
NITROGLYCERIN NNP I-NP B-m
PASTE NNP I-NP I-m
2% CD O I-m
1 CD O B-do
INCHES NNP B-NP I-do
TP NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;100 NNP I-NP O
and CC O O
call VB O O
HO NNP B-NP O
INDERAL NNP I-NP B-m
( ( O I-m
PROPRANOLOL NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;100 VBD B-VP O
or CC O O
HR&lt;55 NNP B-NP O
and CC O O
call VB O O
HO NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
SUCRALFATE NNP I-NP B-m
1 CD O B-do
GM NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
PAXIL NNP B-NP B-m
( ( O I-m
PAROXETINE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NORVASC NNP I-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;100 NNP I-NP O
and CC O O
call VB O O
HO NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/13/05 CD O O
by IN B-VP O
HERZFELD NNP B-NP O
, , O O
NORBERTO NNP B-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
NORVASC NNP B-NP B-m
PO NNP I-NP B-mo
5 CD O B-do
MG NNP B-NP I-do
QD NNP I-NP B-f
( ( O O
ref JJ O O
# # O O
913242331 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
DILTIAZEM NNP B-NP O
; : O O
reaction NN B-NP O
is VBZ O O
Mental JJ B-NP O
Status NNP I-NP O
Change NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Pt NNP I-NP O
tolerates VBZ O O
IMDUR NNP B-NP B-m
ER NNP I-NP I-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONITRATE NNP I-NP I-m
( ( O I-m
SR NNP B-NP I-m
) ) O I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;100 NNP I-NP O
and CC O O
call VB O O
HO NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
COZAAR NNP B-NP B-m
( ( O I-m
LOSARTAN NNP B-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;100 NNP I-NP O
and CC O O
call VB O O
HO NNP B-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
3 CD O I-du
PROTONIX NNP B-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GLYBURIDE NNP I-NP B-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZETIA NNP I-NP B-m
( ( O I-m
EZETIMIBE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Widowski NNP I-NP O
March NNP I-NP O
at IN B-VP O
3:30 CD O O
PM NNP B-NP O
, , O O
Dr NNP B-NP O
Caris NNP I-NP O
11/10/06 CD O O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
, , O O
Aspirin NNP B-NP O
, , O O
DILTIAZEM NNP B-NP O
, , O O
ATORVASTATIN NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Chest NNP I-NP O
pressure NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Chest NNP B-NP O
pressure NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
htn NN I-NP O
elev NN I-NP O
chol NN I-NP O
bph NN I-NP O
, , O O
s/p JJ B-NP O
turp NN I-NP O
x4 NNP I-NP O
s/p VBZ O O
partial JJ B-NP O
gastrectomy NN I-NP O
IMI NNP I-NP O
'73 POS O O
CAD NNP B-NP O
s/p NN I-NP O
CABG NNP I-NP O
x3 NNP I-NP O
( ( O O
S/P NNP B-NP O
cardiac JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
surgery NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
"Feeling VBG O O
sick" JJ B-NP O
HPI: NNP I-NP O
History NNP I-NP O
was VBD B-VP O
obtained VBN O O
from IN B-VP O
patient NN B-NP O
, , O O
who WP O O
is VBZ O O
a DT B-NP O
poor JJ I-NP O
historian NN I-NP O
He PRP O O
is VBZ O O
an DT O O
83 CD O O
yo NN B-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
CAD NNP B-NP O
s/p NN I-NP O
MI NNP I-NP O
in IN B-VP O
1973 CD O O
, , O O
s/p VBD B-VP O
CABG NNP B-NP O
x3 NNP I-NP O
, , O O
T2DM NNP B-NP O
, , O O
hypertension NN B-NP O
who WP O O
presents VBZ O O
"feeling VBG O O
sick" NN B-NP O
since IN B-VP O
last JJ B-NP O
night NN I-NP O
He PRP O O
states VBZ O O
that IN B-VP O
he PRP O O
took VBD B-VP O
a DT B-NP O
Percocet NNP I-NP B-m
for IN B-VP O
back RB O B-r
pain NN B-NP I-r
and CC O O
that IN B-VP O
after IN B-VP O
that IN B-VP O
he PRP O O
began VBD B-VP O
to TO O O
feel VB O O
numb RB O O
in IN B-VP O
his PRP$ O O
arms NNS B-NP O
and CC O O
legs NNS B-NP O
and CC O O
around IN B-VP O
his PRP$ O O
head NN B-NP O
He PRP O O
also RB O O
had VBD B-VP O
some DT B-NP B-r
chest JJS I-NP O
pressure NN I-NP O
He PRP O O
took VBD B-VP O
some DT B-NP O
SL NNP I-NP B-mo
nitro NN I-NP B-m
and CC O O
doesn't JJ O O
remember VB O O
if IN B-VP O
it PRP O O
helped VBD B-VP O
Says VB O O
it PRP O O
also RB O O
wasn't VBZ O O
relieved VBN O O
by IN B-VP O
positional JJ B-NP O
change NN I-NP O
or CC O O
rest NN B-NP O
He PRP O O
denies VBZ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
He PRP O O
was VBD B-VP O
having VBG O O
some DT B-NP O
nausea NN I-NP O
but CC O O
no DT B-NP O
vomiting NN I-NP O
He PRP O O
does VBZ O O
have VB O O
some DT B-NP O
blurry JJ I-NP O
vision NN I-NP O
at IN B-VP O
baseline NN B-NP O
, , O O
unchanged JJ O O
He PRP O O
awoke VBD B-VP O
this DT B-NP O
morning NN I-NP O
and CC O O
took VBD B-VP O
his PRP$ O O
blood NN B-NP O
pressure NN I-NP O
When WRB O O
he PRP O O
found VBD B-VP O
his PRP$ O O
systolic NN B-NP O
was VBD B-VP O
190 CD O O
, , O O
he PRP O O
called VBD B-VP O
EMS NNP B-NP O
He PRP O O
said VBD B-VP O
he PRP O O
felt VBD B-VP O
dizzy NN B-NP O
, , O O
"like IN B-VP O
I PRP O O
have VBP O O
pressure NN B-NP O
in IN B-VP O
my PRP$ O O
head NN B-NP O
, , O O
" NN B-NP O
and CC O O
could MD O O
not RB O O
describe VB O O
it PRP O O
beyond IN B-VP O
that IN B-VP O
He PRP O O
states VBZ O O
that IN B-VP O
when WRB O O
his PRP$ O O
BP NNP B-NP O
is VBZ O O
elevated VBN O O
his PRP$ O O
head NN B-NP O
feels NNS I-NP O
like IN B-VP O
this DT O O
and CC O O
he PRP O O
gets VBZ O O
flushed VBN O O
in IN B-VP O
the DT B-NP O
face.----- JJ I-NP O
PMH: NNP I-NP O
CAD NNP I-NP O
( ( O O
Donny NNP B-NP O
Lopilato NNP I-NP O
is VBZ O O
outpt JJ B-NP O
cards NNS I-NP O
) ) O O
, , O O
s/p $ O O
3V CD O O
CABG NNP B-NP O
, , O O
s/p NN B-NP O
UGIB NNP I-NP O
and CC O O
partial JJ B-NP O
gastrectomy NN I-NP O
for IN B-VP O
PUD NNP B-NP O
, , O O
chronic JJ O O
back RB O O
pain NN B-NP O
, , O O
s/p NN B-NP O
TURP NNP I-NP O
, , O O
DM NNP B-NP O
------- NNP I-NP O
MEDS:Protonix NNP I-NP B-m
40 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qam NN I-NP B-f
, , O O
Sucralfate NNP B-NP B-m
1g CD O B-do
po NN B-NP B-mo
qid NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd NN I-NP B-f
, , O O
Lescol NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd NN I-NP B-f
, , O O
Cozaar NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd NN I-NP B-f
, , O O
Glyburide NNP B-NP B-m
2.5 CD O B-do
po NN B-NP B-mo
qd NN I-NP B-f
, , O O
Paxil NNP B-NP B-m
10 CD O B-do
mg NN B-NP O
po NN I-NP B-mo
qd NN I-NP B-f
, , O O
Ativan NNP B-NP B-m
2 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qid NN I-NP B-f
, , O O
Norvasc NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd NN I-NP B-f
, , O O
Inderal NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qid NN I-NP B-f
, , O O
Persantine NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
bid NN I-NP B-f
, , O O
Imdur NNP B-NP B-m
SR NNP I-NP I-m
30 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
bid NN I-NP B-f
-------- NNP I-NP O
Exam NNP I-NP O
on IN B-VP O
admit:T NN B-NP O
96.5 CD O O
P: NNP B-NP O
64 CD O O
BP: NNP B-NP O
140/60 CD O O
RR: NNP B-NP O
20 CD O O
O2 NNP B-NP O
Sat: NNP I-NP O
100% CD O O
on IN B-VP O
2L CD O O
No NNP B-NP O
significant JJ B-NP O
findings NNS I-NP O
CN NNP I-NP O
2-12 JJ B-NP O
intact JJ I-NP O
AAOx3 NNP I-NP O
but CC O O
a DT B-NP O
bit NN I-NP O
circular JJ O O
in IN B-VP O
speech NN B-NP O
Labs: NNP I-NP O
cardiac NN I-NP O
enzymes NNS I-NP O
neg RB O O
, , O O
UA NNP B-NP O
clean JJ B-NP O
EKG: NNP I-NP O
A-paced NNP I-NP O
, , O O
unchanged JJ O O
from IN B-VP O
March NNP B-NP O
CXR: NNP I-NP O
no DT B-NP O
acute JJ I-NP O
process NN I-NP O
Stress NNP I-NP O
test NN I-NP O
March NNP I-NP O
2005:A CD O O
small JJ O O
to TO O O
medium VB O O
sized JJ B-NP O
region NN I-NP O
of IN B-VP O
myocardialscar/hibernation NN B-NP O
in IN B-VP O
the DT B-NP O
distribution NN I-NP O
of IN B-VP O
the DT B-NP O
PDA NNP I-NP O
coronary JJ B-NP O
artery NN I-NP O
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
stress NN B-NP O
induced VBN O O
ischemia NN B-NP O
at IN B-VP O
a DT B-NP O
low JJ I-NP O
cardiac JJ I-NP O
workload NN I-NP O
Dobutamine NNP I-NP B-m
MIBI NNP I-NP O
4/9 CD O O
EF NNP B-NP O
48% CD O O
, , O O
no DT B-NP O
reversible JJ I-NP O
ischemia NN I-NP O
, , O O
fixed VBN O O
inferior JJ B-NP O
defect NN I-NP O
( ( O O
old JJ O O
) ) O O
Basoinferolateral NNP B-NP O
wall NN I-NP O
not RB O O
interpretale JJ O O
due JJ O O
to TO O O
bowel VB O O
activity NN B-NP O
When WRB O O
given VBN O O
dobutamine NN B-NP B-m
he PRP O O
went VBD B-VP O
in IN B-VP O
to TO O O
a DT B-NP O
V-paced JJ I-NP O
rhythm--&gt;? JJ I-NP O
paroxysmal JJ I-NP O
Afib NNP I-NP O
Test NNP I-NP O
was VBD B-VP O
submaximal JJ O O
with IN B-VP O
max JJ B-NP O
HR NNP I-NP O
98 CD O O
( ( O O
77% CD O O
predicted VBN O O
) ) O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
1 CD O O
CV: NNP B-NP O
Ischemia: NNP I-NP O
History NNP I-NP O
of IN B-VP O
CAD NNP B-NP B-r
CAD NNP I-NP B-r
CAD NNP I-NP B-r
but CC O O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
ischemia NN B-NP O
at IN B-VP O
present NN B-NP O
Ruled VBN O O
out RP O O
for IN B-VP O
MI NNP B-NP O
with IN B-VP O
3 CD O O
sets NNS B-NP O
of IN B-VP O
cardiac JJ B-NP O
enzymes NNS I-NP O
and CC O O
serial JJ B-NP O
EKGs NNP I-NP O
Continued NNP I-NP O
B-blocker NNP I-NP B-m
, , O O
statin NN B-NP B-m
, , O O
and CC O O
persantine VB O B-m
No NNP B-NP O
ASA NNP I-NP O
since IN B-VP O
history NN B-NP O
of IN B-VP O
GIB NNP B-NP O
with IN B-VP O
it PRP O O
Monitored VBD B-VP O
on IN B-VP O
telemetry NN B-NP O
without IN B-VP O
any DT B-NP O
events NNS I-NP O
Had VBD B-VP O
an DT B-NP O
adenosine JJ I-NP B-m
MIBI NNP I-NP O
on IN B-VP O
2/8/05 CD O O
with IN B-VP O
results NNS B-NP O
as IN B-VP O
above RB O O
Because IN B-VP O
he PRP O O
went VBD B-VP O
into IN B-VP O
brief NN B-NP O
VT NNP I-NP O
, , O O
his PRP$ O O
PM NNP B-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
EP NNP B-NP O
to TO O O
r/o VB O O
pAF JJ B-NP O
EP NNP I-NP O
interoogation NN I-NP O
revealed VBD B-VP O
no DT B-NP O
mode NN I-NP O
shifts VBZ O O
Pt NNP B-NP O
continued VBD B-VP O
to TO O O
do VB O O
well RB O O
post VB O O
MIBI NNP B-NP O
Pump: NNP I-NP O
HTN: NNP I-NP B-r
HTN: NNP I-NP B-r
HTN: NNP I-NP B-r
HTN: NNP I-NP B-r
Continued NNP I-NP O
cozaar NN I-NP B-m
, , O O
ideral JJ O B-m
, , O O
imdur JJ O B-m
, , O O
lasix JJ B-NP B-m
Rhythm: NNP I-NP O
Has NNP I-NP O
pacemaker NN I-NP O
, , O O
no DT B-NP O
change NN I-NP O
on IN B-VP O
EKG NNP B-NP O
Monitored NNP I-NP O
on IN B-VP O
telemetry NN B-NP O
2 CD O O
PULM: NNP B-NP O
No NNP I-NP O
active JJ B-NP O
issues NNS I-NP O
Weaned VBD B-VP O
O2 NNP B-NP B-m
to TO O O
sat&gt;93% VB O B-do
3 CD O O
RENAL: NNP B-NP O
Creatinine NNP I-NP O
at IN B-VP O
baseline NN B-NP O
and CC O O
UA NNP B-NP O
clean VBP O O
Monitored NNP B-NP O
Cr NNP I-NP O
qd NN I-NP O
and CC O O
it PRP O O
remained VBD B-VP O
at IN B-VP O
baseline NN B-NP O
4 CD O O
GI: NNP B-NP O
History NNP I-NP O
of IN B-VP O
GIB NNP B-NP O
and CC O O
partial JJ B-NP O
gastrectomy NN I-NP O
for IN B-VP O
ulcer NN B-NP O
Avoided NNP I-NP O
aspirin NN I-NP O
, , O O
continued VBD B-VP O
PPI NNP B-NP B-m
5 CD O O
ENDO: NNP B-NP O
T2DM NNP I-NP B-r
Held NNP I-NP O
oral JJ B-NP O
hypoglycemic NN I-NP O
while IN B-VP O
in IN B-VP O
house NN B-NP O
Covered VBN O O
with IN B-VP O
SSI NNP B-NP B-m
regular JJ B-NP I-m
qac NN I-NP B-f
6 CD O O
NEURO: NNP B-NP O
"Dizziness" NNP I-NP O
unclear JJ O O
, , O O
does VBZ O O
not RB O O
give VB O O
history NN B-NP O
of IN B-VP O
room NN B-NP O
spinning NN I-NP O
or CC O O
lightheadedness NN B-NP O
It PRP O O
is VBZ O O
probably RB O O
a DT B-NP O
symptom NN I-NP O
of IN B-VP O
his PRP$ O O
hypertension NN B-NP O
since IN B-VP O
he PRP O O
has VBZ O O
had VBN O O
this DT O O
in IN B-VP O
the DT O O
past JJ O O
7 CD O O
FEN: NNP B-NP O
Low-fat NNP I-NP O
, , O O
low JJ B-NP O
salt NN I-NP O
diet JJ B-NP O
No NNP I-NP O
further JJ B-NP O
fluids NNS I-NP O
after IN B-VP O
what WP O O
he PRP O O
got VBD B-VP O
in IN B-VP O
ED NNP B-NP O
Taking NNP I-NP O
good JJ B-NP O
POs NNP I-NP O
8 CD O O
PPX: NNP B-NP O
Sc NNP I-NP B-mo
lovenox NN I-NP B-m
, , O O
PPI NNP B-NP B-m
9 CD O O
DISPO: NNP B-NP O
PT NNP I-NP O
consult NN I-NP O
placed VBD B-VP O
Discharged NNP B-NP O
home NN I-NP O
with IN B-VP O
VNA NNP B-NP O
10 CD O O
Full NNP B-NP O
code NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
call VB O O
physician NN B-NP O
if IN B-VP O
you PRP O O
develop VBP O O
fevers NNS B-NP O
, , O O
chills NNS B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
symptoms NNS I-NP O
you PRP O O
find VBP O O
concerning VBG O O
Please NNP B-NP O
continue VB O O
taking VBG O O
your PRP$ O O
home NN B-NP B-m
medications NNS I-NP I-m
as IN B-VP O
before; NN B-NP O
there EX O O
have VBP O O
been VBN O O
no DT B-NP O
changes NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Satisfactory NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Pacemaker NNP I-NP O
interrogation NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
SLOVINSKY NNP I-NP O
, , O O
JORGE NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
FS29 NNP B-NP O
) ) O O
8/25/06 CD O O
@ $ O O
10 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#416584 VBZ O O
490679245 CD O O
BMC NNP B-NP O
46490049 CD O O
5286761 CD O O
7/18/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/18/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/28/2005 CD O O
ATTENDING: NNP B-NP O
QUINCY NNP I-NP O
BRIDENBAUGH NNP I-NP O
MD NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
Hypoglycemia NNP B-NP O
2 CD O O
Altered NNP B-NP O
mental JJ B-NP O
status NN I-NP O
OTHER NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
Volume NN B-NP O
overload NN I-NP O
likely JJ O O
secondary JJ O O
to TO O O
CHF VB O O
2 CD O O
Possible NNP B-NP O
pneumonia NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for: VBD B-VP O
1 CD O O
Bilateral NNP B-NP O
occipital JJ B-NP O
CVAs NNP I-NP O
2 CD O O
Diabetes NNP B-NP B-r
, , O O
on IN B-VP O
insulin NN B-NP B-m
3 CD O O
Hypertension NNP B-NP O
4 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
5 CD O O
Coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
6 CD O O
Visual NNP B-NP O
impair NN I-NP O
with IN B-VP O
tunnel JJ B-NP O
vision NN I-NP O
7 CD O O
Monoclonal NNP B-NP O
gammopathy NN I-NP O
8 CD O O
Bilateral NNP B-NP O
occipital JJ B-NP O
CVAs NNP I-NP O
9 CD O O
History NNP B-NP O
of IN B-VP O
left JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
thrombophlebitis NN I-NP O
10 CD O O
Microcytic JJ B-NP O
anemia NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
75-year-old JJ I-NP O
woman NN I-NP O
who WP O O
was VBD B-VP O
found VBN O O
at IN B-VP O
home NN B-NP O
with IN B-VP O
altered JJ B-NP O
mental JJ I-NP O
status NN I-NP O
by IN B-VP O
home NN B-NP O
services NNS I-NP O
and CC O O
home NN B-NP O
nursing NN I-NP O
with IN B-VP O
confusion NN B-NP O
Her NNP I-NP O
fingerstick NN I-NP O
was VBD B-VP O
37 CD O O
, , O O
which WDT O O
increased VBD B-VP O
to TO O O
42 CD O O
with IN B-VP O
orange NN B-NP O
juice NN I-NP O
with IN B-VP O
improvement NN B-NP O
of IN B-VP O
her PRP$ O O
mental JJ B-NP O
status NN I-NP O
Her NNP I-NP O
insulin NN I-NP B-m
regimen NN I-NP O
has VBZ O O
been VBN O O
stable JJ O O
for IN B-VP O
quite RB O O
some DT B-NP O
time NN I-NP O
She PRP O O
had VBD B-VP O
taken VBN O O
her PRP$ O O
regular JJ B-NP O
dose NN I-NP O
of IN B-VP O
Novolin NNP B-NP B-m
40 CD O B-do
units NNS B-NP I-do
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
She PRP O O
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
She PRP O O
has VBZ O O
noted VBN O O
increasing VBG O O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
over IN B-VP O
one CD O O
or CC O O
two CD O O
months NNS B-NP O
, , O O
increased VBD B-VP O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
nocturia NN B-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
her PRP$ O O
ambulatory JJ B-NP O
sat NN I-NP O
was VBD B-VP O
91% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Glucose NNP I-NP O
was VBD B-VP O
still RB O O
low JJ O O
and CC O O
on IN B-VP O
chest JJS B-NP O
x-ray NN I-NP O
there EX O O
was VBD B-VP O
evidence NN B-NP O
of IN B-VP O
a DT B-NP O
right JJ I-NP O
pleural JJ I-NP O
effusion NN I-NP O
and CC O O
right JJ B-NP O
lower JJR I-NP O
lobe NN I-NP O
consolidation NN I-NP O
versus IN B-VP O
atelectasis NN B-NP O
She PRP O O
was VBD B-VP O
given VBN O O
Lasix NNP B-NP B-m
, , O O
glucose NN B-NP B-m
, , O O
Levaquin NNP B-NP B-m
, , O O
and CC O O
blood NN B-NP O
cultures NNS I-NP O
were VBD B-VP O
drawn VBN O O
She PRP O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
pneumonia NN B-NP O
She PRP O O
has VBZ O O
an DT B-NP O
allergy NN I-NP O
to TO O O
propoxyphene VB O O
MEDICATIONS: NNP B-NP O
1 CD O O
Lasix NNP B-NP B-m
Lasix NNP I-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
in IN B-VP I-f
the DT B-NP I-f
morning NN I-NP I-f
, , O O
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
in IN B-VP O
the DT B-NP O
evening NN I-NP O
2 CD O O
Atenolol NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
3 CD O O
Lipitor NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
4 CD O O
Amitriptyline NNP B-NP B-m
25 CD O B-do
to TO O I-do
50 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.h.s JJ I-NP B-f
p.r.n NN I-NP I-f
5 CD O O
Multivitamins NNP B-NP B-m
6 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
7 CD O O
Folate NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
8 CD O O
Lisinopril NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d $ O B-f
9 CD O O
Iron NNP B-NP B-m
gluconate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
10 CD O O
Novolin NNP B-NP B-m
34 CD O B-do
to TO O I-do
40 CD O I-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
q.d RB O B-f
11 CD O O
Epogen NN B-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
q JJ B-NP B-f
week NN I-NP I-f
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Father NNP I-NP O
died VBD B-VP O
of IN B-VP O
an DT B-NP O
MI NNP I-NP O
in IN B-VP O
his PRP$ O O
70s CD O O
, , O O
mother JJR O O
died VBD B-VP O
of IN B-VP O
leukemia NN B-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
hematologic NN B-NP O
disorders NNS I-NP O
in IN B-VP O
her PRP$ O O
family NN B-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
thalassemia NN B-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
knows VBZ O O
of IN B-VP O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
She PRP O O
lives VBZ O O
in IN B-VP O
an DT B-NP O
assisted JJ I-NP O
living NN I-NP O
facility NN I-NP O
and CC O O
has VBZ O O
extensive JJ B-NP O
home NN I-NP O
care NN I-NP O
services NNS I-NP O
and CC O O
lives VBZ O O
alone RB O O
She PRP O O
was VBD B-VP O
previously RB O O
a DT B-NP O
nurse NN I-NP O
She PRP O O
has VBZ O O
children NNS B-NP O
who WP O O
live VBP O O
nearby RB O O
PHYSICAL NNP B-NP O
EXAM: NNP I-NP O
Vital NNP I-NP O
signs: VBD B-VP O
Temperature NNP B-NP O
was VBD B-VP O
95.2 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
111/69 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
73 CD O O
, , O O
sating VBG O O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
She PRP O O
was VBD B-VP O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NNP I-NP O
Speech NNP I-NP O
and CC O O
mentation NN B-NP O
were VBD B-VP O
normal JJ B-NP O
No NNP I-NP O
lymphadenopathy NN I-NP O
2/6 CD O O
systolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
base NN I-NP O
radiating NN I-NP O
to TO O O
across IN B-VP O
her PRP$ O O
precordium NN B-NP O
Distant NNP I-NP O
heart NN I-NP O
sounds VBZ O O
Right JJ B-NP O
lower JJR I-NP O
lobe NN I-NP O
with IN B-VP O
decreased JJ B-NP O
breath NN I-NP O
sounds NNS I-NP O
and CC O O
decreased JJ B-NP O
phrenitis NN I-NP O
, , O O
wheezing VBG O O
throughout IN B-VP O
her PRP$ O O
right JJ B-NP O
lung NN I-NP O
Abdomen: NNP I-NP O
Obese NNP I-NP O
, , O O
soft JJ O O
, , O O
nondistended JJ O O
, , O O
nontender NN B-NP O
, , O O
benign JJ B-NP O
Extremities: NNP I-NP O
2 CD O O
to TO O O
3+ CD O O
pitting VBG O O
edema JJ O O
bilateral JJ O O
and CC O O
symmetric JJ B-NP O
Neurologic: NNP I-NP O
She PRP O O
was VBD B-VP O
moving VBG O O
all DT B-NP O
extremities NNS I-NP O
well RB O O
Left NNP B-NP O
eye NN I-NP O
with IN B-VP O
slight JJ B-NP O
lateral JJ I-NP O
deviation NN I-NP O
Extraocular NNP I-NP O
movements NNS I-NP O
intact JJ B-NP O
Pupils NNP I-NP O
equally RB O O
round VBD B-VP O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Evidence NNP I-NP O
of IN B-VP O
an DT B-NP O
old JJ I-NP O
cataract NN I-NP O
ADMISSION NNP I-NP O
DATA: NNP I-NP O
BNP NNP I-NP O
of IN B-VP O
1111 CD O O
, , O O
creatinine NN B-NP O
was VBD B-VP O
2.4 CD O O
which WDT O O
was VBD B-VP O
below IN B-VP O
her PRP$ O O
baseline NN B-NP O
of IN B-VP O
2.6 CD O O
to TO O O
2.8 CD O O
, , O O
white JJ B-NP O
count NN I-NP O
was VBD B-VP O
6.6 CD O O
with IN B-VP O
no DT B-NP O
left NN I-NP O
shift NN I-NP O
, , O O
hematocrit NN B-NP O
was VBD B-VP O
35.7 CD O O
which WDT O O
is VBZ O O
up RP O O
from IN B-VP O
her PRP$ O O
baseline NN B-NP O
of IN B-VP O
27 CD O O
to TO O O
33 CD O O
MCV NNP B-NP O
was VBD B-VP O
67.4 CD O O
which WDT O O
is VBZ O O
stable JJ O O
and CC O O
it PRP O O
has VBZ O O
been VBN O O
in IN B-VP O
this DT B-NP O
range NN I-NP O
and CC O O
she PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
in IN B-VP O
4/27 CD O O
a DT B-NP O
monoclonal JJ I-NP O
gammopathy NN I-NP O
on IN B-VP O
SPEP NNP B-NP O
EKG NNP I-NP O
showed VBD B-VP O
an DT B-NP O
inferoseptal JJ I-NP O
Q NNP I-NP O
wave NN I-NP O
, , O O
poor JJ B-NP O
R NNP I-NP O
wave NN I-NP O
progression NN I-NP O
, , O O
low JJ B-NP O
voltage NN I-NP O
left VBD B-VP O
axis JJ B-NP O
deviation NN I-NP O
Echo NNP I-NP O
in IN B-VP O
4/27 CD O O
showed VBD B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
50 CD O O
to TO O O
55% CD O O
with IN B-VP O
moderate-to-severe JJ B-NP O
MR NNP I-NP O
and CC O O
TR NNP B-NP O
, , O O
septal JJ B-NP O
hypokinesis NN I-NP O
and CC O O
a DT B-NP O
MIBI NNP I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
showed VBD B-VP O
no DT B-NP O
reversible JJ I-NP O
ischemia NN I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
as IN B-VP O
describes NNS B-NP O
above IN B-VP O
UA NNP B-NP O
negative JJ O O
for IN B-VP O
UTI NNP B-NP O
IMPRESSION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
evaluated VBN O O
to TO O O
be VB O O
low JJ B-NP O
likelihood NN I-NP O
for IN B-VP O
having VBG O O
pneumonia NN B-NP O
She PRP O O
was VBD B-VP O
thought VBN O O
to TO O O
more RBR O O
likely JJ O O
have VBP O O
volume NN B-NP O
overload NN I-NP O
secondary JJ O O
to TO O O
CHF NNP B-NP O
Because IN B-VP O
of IN B-VP O
her PRP$ O O
visual JJ B-NP O
problems NNS I-NP O
and CC O O
declining VBG O O
physical JJ B-NP O
condition NN I-NP O
and CC O O
deconditioning NN B-NP O
, , O O
patient's JJ B-NP O
current JJ I-NP O
living NN I-NP O
situation NN I-NP O
and CC O O
arrangements NNS B-NP O
are VBP O O
possibly RB O O
insufficient JJ O O
for IN B-VP O
her PRP$ O O
increasing VBG O O
needs NNS B-NP O
and CC O O
error NN B-NP O
in IN B-VP O
self JJ B-NP O
administration NN I-NP O
of IN B-VP O
medications NNS B-NP O
or CC O O
increasing VBG O O
renal JJ B-NP O
insufficiency NN I-NP O
or CC O O
poor JJ B-NP O
p.o NNS I-NP O
intake VBP O O
may MD O O
have VB O O
precipitated VBN O O
her PRP$ O O
hypoglycemic JJ B-NP O
episode NN I-NP O
and CC O O
altered VBD B-VP O
mental JJ B-NP O
status NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
ID/Pulmonary: NNP I-NP O
Right NNP I-NP O
lower JJR B-NP O
lobe NN I-NP O
pneumonia NN I-NP O
versus NN I-NP O
CHF NNP I-NP O
, , O O
pleural JJ B-NP O
effusion NN I-NP O
This DT O O
was VBD B-VP O
treated VBN O O
initially RB O O
with IN B-VP O
levofloxacin JJ O B-m
although IN B-VP O
it PRP O O
is VBZ O O
unlikely JJ B-NP O
consolidated JJ I-NP O
lobar NN I-NP B-r
pneumonia NN I-NP I-r
because IN B-VP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
good JJ B-NP O
clinical JJ I-NP O
status NN I-NP O
, , O O
lack NN B-NP O
of IN B-VP O
fever NN B-NP O
and CC O O
white JJ B-NP O
count NN I-NP O
and CC O O
lack NN B-NP O
of IN B-VP O
toxicity NN B-NP O
Sputum NNP I-NP O
culture NN I-NP O
and CC O O
gram NN B-NP O
stein NNS I-NP O
were VBD B-VP O
unremarkable JJ B-NP O
Pleural NNP I-NP O
effusion NN I-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
decreased VBD B-VP O
only RB O O
minimally RB O O
with IN B-VP O
diuresis NN B-NP O
of IN B-VP O
1 CD O O
to TO O O
2 CD O O
liters NNS B-NP O
overnight JJ O O
and CC O O
for IN B-VP O
diagnostic JJ O O
and CC O O
therapeutic JJ B-NP O
purposes NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
thoracentesis NN I-NP O
on IN B-VP O
2/11/05 CD O O
and CC O O
had VBD B-VP O
withdraw VBN O O
800 CD O O
cc NN B-NP O
of IN B-VP O
clear JJ B-NP O
yellow JJ I-NP O
fluid NN I-NP O
whose WP$ O O
chemistries NNS B-NP O
and CC O O
cell NN B-NP O
count NN I-NP O
were VBD B-VP O
consistent JJ O O
with IN B-VP O
a DT B-NP O
sterile JJ I-NP O
transudative JJ I-NP O
effusion NN I-NP O
Gram NNP I-NP O
stein NN I-NP O
was VBD B-VP O
negative JJ B-NP O
Cultures NNS I-NP O
are VBP O O
pending VBG O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
and CC O O
a DT B-NP O
chest JJ I-NP O
x-ray NN I-NP O
may MD O O
be VB O O
repeated VBN O O
to TO O O
rule VB O O
out RP O O
underlying VBG O O
pneumonia NN B-NP O
revealed VBN O O
by IN B-VP O
draining VBG O O
of IN B-VP O
the DT B-NP O
effusion NN I-NP O
Urine NNP I-NP O
legionella NN I-NP O
was VBD B-VP O
negative JJ B-NP O
Renal: NNP I-NP O
Chronic NNP I-NP O
renal JJ B-NP O
insufficiency NN I-NP O
Creatinine NNP I-NP O
is VBZ O O
at IN B-VP O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
2.6 CD O O
and CC O O
it PRP O O
decreased VBD B-VP O
significantly RB O O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
possibly RB O O
because IN B-VP O
of IN B-VP O
improved JJ O O
forward RB O O
flow VBP O O
from IN B-VP O
discontinuation NN B-NP O
of IN B-VP O
her PRP$ O O
ACE NNP B-NP B-m
inhibitor NN I-NP O
Endocrinology: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
hypoglycemic JJ B-NP O
diabetes NNS I-NP O
possibly RB O O
secondary JJ O O
to TO O O
infection NN B-NP O
or CC O O
logistical JJ O O
and CC O O
social JJ B-NP O
barriers NNS I-NP O
Her PRP$ O O
NPH NNP B-NP B-m
dose NN I-NP O
was VBD B-VP O
cut VBN O O
to TO O O
20 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
q.d NN B-NP B-f
with IN B-VP O
lispro JJ O B-m
lispro JJ O B-m
lispro FW O B-m
sliding VBG O B-do
sliding VBG O B-do
scale JJ B-NP I-do
scale NN I-NP I-do
q.a.c NN I-NP B-f
and CC O O
q.h.s NN B-NP B-f
which WDT O O
she PRP O O
needed VBD B-VP O
only RB O O
minimally RB O O
about IN B-VP O
5 CD O B-do
units NNS B-NP I-do
a DT B-NP B-f
day NN I-NP I-f
and CC O O
her PRP$ O O
sugars NNS B-NP O
were VBD B-VP O
well RB O O
controlled VBN O O
on IN B-VP O
this DT B-NP O
regimen NN I-NP O
which WDT O O
supports VBZ O O
the DT B-NP O
hypothesis NN I-NP O
that IN B-VP O
her PRP$ O O
NPH NNP B-NP B-m
dose NN I-NP O
of IN B-VP O
34 CD O B-do
units NNS B-NP I-do
a DT B-NP B-f
day NN I-NP I-f
was VBD B-VP O
too RB O O
high JJ O O
beyond IN B-VP O
a DT B-NP O
certain JJ I-NP O
point NN I-NP O
Cardiac: NNP I-NP O
A NNP I-NP O
Pump: NNP I-NP O
The DT B-NP O
patient NN I-NP O
with IN B-VP O
CHF NNP B-NP O
, , O O
known VBN O O
valvular JJ B-NP O
dysfunction NN I-NP O
, , O O
exhibiting VBG O O
pulmonary JJ B-NP O
edema NN I-NP O
, , O O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
and CC O O
orthopnea NN B-NP O
She PRP O O
was VBD B-VP O
initially RB O O
diuresed VBN O O
with IN B-VP O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
and CC O O
it PRP O O
was VBD B-VP O
noted VBN O O
that IN B-VP O
her PRP$ O O
weight NN B-NP O
was VBD B-VP O
up RB O O
10 CD O O
pounds NNS B-NP O
from IN B-VP O
her PRP$ O O
prior JJ B-NP O
admission NN I-NP O
She PRP O O
was VBD B-VP O
transitioned VBN O O
to TO O O
p.o VB O B-mo
Lasix NNP B-NP B-m
after IN B-VP O
diuresing VBG O O
very RB O O
well RB O O
on IN B-VP O
this DT B-NP O
regimen NN I-NP O
She PRP O O
continued VBD B-VP O
her PRP O O
Lipitor NNP B-NP B-m
and CC O O
aspirin NN B-NP B-m
, , O O
atenolol NN B-NP B-m
was VBD B-VP O
changed VBN O O
metoprolol RB O B-m
given VBN O O
her PRP$ O O
renal JJ B-NP B-r
insufficiency NN I-NP I-r
Lisinopril NNP I-NP B-m
was VBD B-VP O
switched VBN O O
to TO O O
captopril VB O B-m
, , O O
then RB O O
discontinued VBD B-VP O
given VBN O O
her PRP$ O O
bumping VBG O O
creatinine NN B-NP O
while IN B-VP O
diuresing VBG O O
on IN B-VP O
the DT B-NP O
ACE NNP I-NP B-m
inhibitor NN I-NP I-m
She PRP O O
was VBD B-VP O
slightly RB O O
hypotensive JJ O O
with IN B-VP O
systolic JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
in IN B-VP O
the DT O O
90s CD O O
to TO O O
100s CD O O
at IN B-VP O
one CD O O
point NN B-NP O
and CC O O
responded VBD B-VP O
to TO O O
a DT B-NP O
bolus NN I-NP O
of IN B-VP O
fluid NN B-NP O
, , O O
decrease NN B-NP O
in IN B-VP O
the DT B-NP O
captopril NN I-NP B-m
and CC O O
holding VBG O O
the DT B-NP O
Lasix NNP I-NP B-m
, , O O
unclear JJ B-NP O
etiology NN I-NP O
, , O O
looks VBZ O O
otherwise RB O O
low JJ B-NP O
Lasix NNP I-NP B-m
Lasix NNP I-NP B-m
was VBD B-VP O
decreased VBN O O
to TO O O
80 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
b.i.d NN I-NP B-f
and CC O O
the DT B-NP O
patient NN I-NP O
should MD O O
have VB O O
daily JJ B-NP O
weights NNS I-NP O
and CC O O
electrolytes VBZ O O
checked VBN O O
and CC O O
repleted VBN O O
to TO O O
ensure VB O O
that IN B-VP O
her PRP$ O O
diuresis NN B-NP O
is VBZ O O
only RB O O
moderate JJ O O
everyday JJ O O
no DT O O
more JJR O O
than IN B-VP O
one CD O O
liter NN B-NP O
a DT B-NP O
day NN I-NP O
but CC O O
is VBZ O O
consistent JJ O O
such JJ O O
that IN B-VP O
she PRP O O
is VBZ O O
able JJ O O
to TO O O
maintain VB O O
her PRP$ O O
electrolytes NNS B-NP O
and CC O O
loose JJ B-NP O
fluid NN I-NP O
overtime NN I-NP O
Heme: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
monoclonal JJ I-NP O
gammopathy NN I-NP O
and CC O O
a DT B-NP O
microcytosis NN I-NP O
which WDT O O
might MD O O
suggest VB O O
thalassemia NN B-NP O
She PRP O O
is VBZ O O
on IN B-VP O
iron NN B-NP B-m
and CC O O
Epogen NNP B-NP B-m
with IN B-VP O
an DT B-NP O
improved JJ I-NP O
hematocrit NN I-NP O
from IN B-VP O
the DT B-NP O
prior JJ I-NP O
admission NN I-NP O
but CC O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
her PRP$ O O
MCV NNP B-NP O
, , O O
which WDT O O
suggests VBZ O O
that IN B-VP O
she PRP O O
has VBZ O O
more JJR O O
than IN B-VP O
renal JJ B-NP O
disease NN I-NP O
causing VBG O O
her PRP$ O O
microcytosis NN B-NP O
Further NNP I-NP O
workup NN I-NP O
of IN B-VP O
her PRP$ O O
monoclonal JJ B-NP O
gammopathy NN I-NP O
will MD O O
be VB O O
deferred VBN O O
to TO O O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician JJ B-NP O
Diabetic NNP I-NP O
diet: NN I-NP O
Low NNP I-NP O
sodium NN I-NP O
, , O O
low JJ B-NP O
fat NN I-NP O
, , O O
low JJ B-NP O
cholesterol NN I-NP O
Prophylaxis: NNP I-NP B-r
Prophylaxis: NNP I-NP B-r
Heparin NNP I-NP B-m
and CC O O
H2 NNP B-NP B-m
blocker NN I-NP I-m
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
screened VBN O O
for IN B-VP O
admission NN B-NP O
to TO O O
Jack NNP B-NP O
Nor NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Of IN B-VP O
where WRB O O
she PRP O O
will MD O O
go VB O O
today NN B-NP O
Her NNP I-NP O
goal NN I-NP O
is VBZ O O
intense JJ B-NP O
physical JJ I-NP O
therapy NN I-NP O
and CC O O
learning VBG O O
greater JJR B-NP O
independence NN I-NP O
in IN B-VP O
her PRP$ O O
daily JJ O O
functioning VBG O O
Her PRP$ O O
pelvic JJ B-NP O
films NNS I-NP O
were VBD B-VP O
negative JJ O O
for IN B-VP O
fracture NN B-NP O
She PRP O O
should MD O O
be VB O O
ambulated VBN O O
t.i.d JJ B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
2 CD O O
Metoprolol NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
3 CD O O
Lipitor NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
4 CD O O
Amitriptyline NNP B-NP B-m
25 CD O B-do
to TO O I-do
50 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.h.s JJ I-NP B-f
p.r.n NN I-NP I-f
5 CD O O
Multivitamins NNP B-NP B-m
6 CD O O
Aspirin325 NNP B-NP B-m
Aspirin325 NNP I-NP B-do
mg NN I-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
7 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
8 CD O O
Lisinopril NNP B-NP B-m
should MD O O
be VB O O
held VBN O O
for IN B-VP O
the DT B-NP O
moment NN I-NP O
9 CD O O
Iron NNP B-NP B-m
gluconate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d VBD B-VP B-f
10 CD O O
NPH NNP B-NP B-m
20 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
q.h.s RB O B-f
11 CD O O
Lispro NNP B-NP B-m
Lispro NNP I-NP B-m
sliding VBG O B-do
sliding VBG O B-do
scale JJ B-NP I-do
scale NN I-NP I-do
q.a.c NN I-NP B-f
and CC O O
q.h.s $ O B-f
12 CD O O
Epogen NNP B-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
q JJ B-NP B-f
week NN I-NP I-f
Ms NNP I-NP O
Mengel NNP I-NP O
should MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Rufener NNP I-NP O
when WRB O O
she PRP O O
is VBZ O O
able JJ O O
to TO O O
within IN B-VP O
the DT B-NP O
next JJ I-NP O
week NN I-NP O
or CC O O
two CD O O
Ellington NNP B-NP O
is VBZ O O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Jarrett NNP B-NP O
Sandlan NNP I-NP O
her PRP$ O O
PCP NNP B-NP O
number NN I-NP O
is VBZ O O
287-274-1873 JJ O O
She PRP O O
should MD O O
b VB O O
switched VBD B-VP O
to TO O O
Toprol NNP B-NP B-m
as IN B-VP O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
tolerates NNS I-NP O
and CC O O
to TO O O
lisinopril VB O B-m
as IN B-VP O
her PRP$ O O
creatinine NN B-NP O
tolerates NNS I-NP O
after IN B-VP O
low-level JJ B-NP O
diuresis NN I-NP O
of IN B-VP O
about IN B-VP O
50 CD O O
cc NN B-NP O
to TO O O
one CD O O
liter NN B-NP O
a DT B-NP O
day NN I-NP O
Studies NNPS I-NP O
pending VBG O O
include VBP O O
cytology NN B-NP O
and CC O O
culture NN B-NP O
of IN B-VP O
pleural JJ B-NP O
fluid NN I-NP O
and CC O O
follow-up JJ B-NP O
chest NN I-NP O
x-ray NN I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
her PRP$ O O
discharge NN B-NP O
Lasix NNP I-NP B-m
dose NN I-NP O
can MD O O
be VB O O
increased VBN O O
as IN B-VP O
needed VBN O O
for IN B-VP O
better JJR B-NP B-r
diuresis NN I-NP I-r
eScription NN I-NP O
document: VBZ O O
2-7752992 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
KUFFEL NNP I-NP O
, , O O
CARLOS NNP B-NP O
Attending: NNP I-NP O
KRESHA NNP I-NP O
, , O O
OTIS NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
5039114 CD O O
D: NNP B-NP O
2/8/05 CD O O
T: NNP B-NP O
2/8/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#417096 VBZ O O
524479939 CD O O
HH NNP B-NP O
47162946 CD O O
1620623 CD O O
6/14/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
chronic JJ B-NP O
diarrhea NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/29/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/17/2005 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
BURGOS NNP I-NP O
, , O O
REGINALD NNP B-NP O
399-26-72-6 CD O O
I PRP O O
Grand NNP B-NP O
Range NNP I-NP O
Ton NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
6/13/05 CD O O
AT NNP B-NP O
01:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KRISHNA NNP I-NP O
, , O O
MAURO NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt; JJ O O
100 CD O O
, , O O
hr NN B-NP O
&lt; VBD B-VP O
60 CD O O
ENALAPRIL NNP B-NP B-m
MALEATE NNP I-NP I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt; $ O O
100 CD O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/7/05 CD O O
by IN B-VP O
ZINGLER NNP B-NP O
, , O O
MOHAMMAD NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
61864355 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/7/05 CD O O
by IN B-VP O
CONNAUGHTON NNP B-NP O
, , O O
DON NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
38155122 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
NIFEDIPINE NNP I-NP B-m
( ( O I-m
EXTENDED NNP B-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
( ( O I-m
NIFEDIPINE NNP B-NP I-m
( ( O I-m
SL NNP B-NP I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt; JJ O O
100 CD O O
, , O O
hr NN B-NP O
&lt; VBD B-VP O
60 CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
ZANTAC NNP I-NP B-m
( ( O I-m
RANITIDINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
METFORMIN NNP I-NP B-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
IMODIUM NNP I-NP B-m
( ( O I-m
LOPERAMIDE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
2-4 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Diarrhea NNP I-NP B-r
PROTONIX NNP I-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
Anti NNP I-NP O
Diarrhea NNP I-NP O
, , O O
Lactose NNP B-NP O
Restricted NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Detillier NNP I-NP O
( ( O O
GI NNP B-NP O
) ) O O
3/5 CD O O
2pm CD O O
3/5 CD O O
2pm CD O O
scheduled VBN O O
, , O O
Colonoscopy NNP B-NP O
6/18 CD O O
9:30am CD O O
6/18 CD O O
9:30am CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Gaboriault NNP I-NP O
( ( O O
PCP NNP B-NP O
) ) O O
0/8 CD O O
1:30pm CD O O
0/8 CD O O
1:30pm CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
CLOPIDOGREL NNP I-NP O
, , O O
Penicillins NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chronic JJ B-NP O
diarrhea NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
chronic VBP O O
diarrhea NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
htn NN I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
hyperchol NN B-NP O
( ( O O
elevated VBN O O
cholesterol NN B-NP O
) ) O O
tobacco NN B-NP O
use NN I-NP O
( ( O O
smoking VBG O O
) ) O O
etoh NN B-NP O
use NN I-NP O
h/o NN I-NP O
+PPD NN I-NP O
'93 NNP I-NP O
( ( O O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
N/A NNP B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
76M CD O O
w NN B-NP O
MMP NNP I-NP O
incl VBZ O O
small JJ B-NP O
cell NN I-NP O
lung NN I-NP O
CA NNP I-NP O
tx'd NN I-NP O
w NN I-NP O
chemo NN I-NP O
and CC O O
XRT NN B-NP O
in IN B-VP O
remission NN B-NP O
X NNP I-NP O
18 CD O O
mo NN B-NP O
p/w NN I-NP O
LLQ NNP I-NP O
+ NNP I-NP O
diarrhea VBZ O O
orignially RB O O
on IN B-VP O
10/28/05 CD O O
, , O O
CT NNP B-NP O
scan JJ B-NP O
w NN I-NP O
diverticulitis NN I-NP O
, , O O
tx'd JJ B-NP O
w NN I-NP O
cipro/flagyl NN I-NP B-m
Diarrhea NNP I-NP O
persisted VBD B-VP O
after IN B-VP O
course NN B-NP O
completed VBN O O
, , O O
PCP NNP B-NP O
gave VBD B-VP O
a DT B-NP O
second JJ I-NP O
course NN I-NP O
, , O O
but CC O O
diarrhea JJ B-NP O
persists NNS I-NP O
Diarrhea NNP I-NP O
is VBZ O O
watery JJ O O
, , O O
sometiems VBZ O O
black/bloody NN B-NP O
, , O O
occurs VBZ O O
throughout IN B-VP O
the DT B-NP O
day NN I-NP O
, , O O
not RB O O
a/w JJ B-NP O
meals NNS I-NP O
No DT B-NP O
cramping/abd NN I-NP O
pain NN I-NP O
, , O O
notes VBZ O O
occasional JJ B-NP O
burning NN I-NP O
in IN B-VP O
stomach NN B-NP O
No NNP I-NP O
recent JJ B-NP O
travels NNS I-NP O
, , O O
no DT B-NP O
h/o NN I-NP O
food NN I-NP O
allergies NNS I-NP O
, , O O
no DT B-NP O
fever/nausea/vomiting/LH NN I-NP O
No RB O O
new JJ B-NP O
meds NNS I-NP O
, , O O
no DT B-NP O
recent JJ I-NP O
weight NN I-NP O
loss NN I-NP O
Appetite NNP I-NP O
good JJ O O
In IN B-VP O
ED NNP B-NP O
, , O O
got VBD B-VP O
protonix RB O B-m
, , O O
guaiac NN B-NP O
was VBD B-VP O
positive JJ B-NP O
ALL: NNP I-NP O
Plavix/PCN NNP I-NP O
gives VBZ O O
GI NNP B-NP O
upset JJ B-NP O
MEDS: NNP I-NP O
ASA NNP I-NP B-m
, , O O
atenolol NN B-NP B-m
, , O O
lipitor NN B-NP B-m
, , O O
enalapril NN B-NP B-m
, , O O
nifedipine JJ B-NP B-m
xl NN I-NP I-m
, , O O
zantac NN B-NP B-m
, , O O
metformin FW O B-m
PE NNP B-NP O
T97.8 NNP I-NP O
HR55 NNP I-NP O
RR20 NNP I-NP O
BP186/92 NNP I-NP O
99% CD O O
RA NNP B-NP O
NAD NNP I-NP O
, , O O
reading VBG O O
paper NN B-NP O
Disconj NNP I-NP O
gaze NN I-NP O
, , O O
L NNP B-NP O
pupil VBP O O
lat JJ B-NP O
dev NN I-NP O
Lungs NNP I-NP O
w NN I-NP O
sl NN I-NP O
wheeze NN I-NP O
CV NNP I-NP O
Dist NNP I-NP O
S1/S2 NNP I-NP O
Abd NNP I-NP O
obese JJ O O
, , O O
+ JJ B-NP O
BS NNP I-NP O
, , O O
S/NT/ND NNP B-NP O
Ext NNP I-NP O
no DT B-NP O
C/C/E NNP I-NP O
Neuro NNP I-NP O
Nonfocal NNP I-NP O
LABS: NNP I-NP O
Lytes NNP I-NP O
WNL NNP I-NP O
, , O O
CBC NNP B-NP O
WNL NNP I-NP O
( ( O O
HCT NNP B-NP O
41.9 CD O O
) ) O O
, , O O
Coags NNP B-NP O
WNL NNP I-NP O
*********************** NNP I-NP O
IMPRESSION: NNP I-NP O
76 CD O O
yo NN B-NP O
M NNP I-NP O
with IN B-VP O
MMP NNP B-NP O
p/w NN I-NP O
chronic NN I-NP O
bloody NN I-NP O
diarrhea VBZ O O
x $ O O
3 CD O O
wks NN B-NP O
, , O O
unclear JJ B-NP O
etiology NN I-NP O
, , O O
? . B-VP O
malabsorption NN B-NP O
, , O O
but CC O O
clinically RB O O
very RB O O
stable JJ O O
, , O O
and CC O O
per IN B-VP O
GI NNP B-NP O
curbside NN I-NP O
, , O O
most JJS O O
of IN B-VP O
the DT B-NP O
work-up NN I-NP O
can MD O O
be VB O O
done VBN O O
as IN B-VP O
outpatient JJ B-NP O
*********************** NNP I-NP O
GI: NNP I-NP O
Chronic NNP I-NP O
diarrhea NN I-NP O
, , O O
possible JJ O O
due JJ O O
to TO O O
malabsorption VB O O
vs JJ B-NP O
infection NN I-NP O
Pt NNP I-NP O
was VBD B-VP O
made VBN O O
NPO NNP B-NP O
on IN B-VP O
night NN B-NP O
of IN B-VP O
admission NN B-NP O
, , O O
and CC O O
had VBD B-VP O
no DT B-NP O
bowel NN I-NP O
movements NNS I-NP O
, , O O
suggesting VBG O O
malabsorption NN B-NP O
as IN B-VP O
a DT B-NP O
possible JJ I-NP O
etiology NN I-NP O
Celiac NNP I-NP O
sprue NN I-NP O
studies NNS I-NP O
are VBP O O
pending VBG O O
Patient NNP B-NP O
was VBD B-VP O
also RB O O
empirically RB O O
put VBN O O
on IN B-VP O
a DT B-NP O
lactose JJ I-NP O
free JJ I-NP O
diet JJ I-NP O
Stool NNP I-NP O
cultures NNS I-NP O
( ( O O
including VBG O O
parasites NNS B-NP O
, , O O
SSYCE NNP B-NP O
, , O O
stool NN B-NP O
osms/lytes NNS I-NP O
) ) O O
were VBD B-VP O
ordered VBN O O
, , O O
but CC O O
could MD O O
not RB O O
be VB O O
sent VBN O O
, , O O
as IN B-VP O
patient NN B-NP O
had VBD B-VP O
no DT B-NP O
stool NN I-NP O
overnight VBD B-VP O
Patient NNP B-NP O
started VBD B-VP O
on IN B-VP O
immodium NN B-NP B-m
as IN B-VP O
diarrhea NN B-NP B-r
not RB O O
thought VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
an DT B-NP O
acute JJ I-NP O
infectious JJ I-NP O
process NN I-NP O
, , O O
with IN B-VP O
low JJ B-NP O
risk NN I-NP O
for IN B-VP O
toxic JJ B-NP O
megacolon NN I-NP O
Patient NNP I-NP O
also RB O O
scheduled VBD B-VP O
for IN B-VP O
an DT B-NP O
outpatient JJ I-NP O
colonoscopy NN I-NP O
Protonix NNP I-NP B-m
for IN B-VP O
heartburn NN B-NP B-r
HEME: NNP I-NP O
HCT NNP I-NP O
stable JJ B-NP O
ID: NNP I-NP O
Hold NNP I-NP O
off RP O O
further JJ B-NP O
abx NN I-NP B-m
at IN B-VP O
this DT B-NP O
point NN I-NP O
, , O O
as IN B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
response NN I-NP O
to TO O O
2 CD O O
course NN B-NP O
of IN B-VP O
cipro/flagyl JJ B-NP B-m
CV: NNP I-NP O
No NNP I-NP O
acute NN I-NP O
issues NNS I-NP O
, , O O
we PRP O O
continued VBD B-VP O
asa/bb/statin/acei/ccb JJ B-NP B-m
ENDO: NNP I-NP O
RISS NNP I-NP B-m
TSH NNP I-NP O
was VBD B-VP O
WNL NNP B-NP O
*********************** NNP I-NP O
DISPO: NNP I-NP O
Will NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Haymans NNPS I-NP O
on IN B-VP O
3/5 CD O O
at IN B-VP O
2pm CD O O
Consider NNP B-NP O
outpatient NN I-NP O
small JJ B-NP O
intestinal JJ I-NP O
biopsy NN I-NP O
, , O O
ERCP NNP B-NP O
Follow NNP I-NP O
up RP O O
on IN B-VP O
celiac NNS B-NP O
sprue JJ B-NP O
studies NNS I-NP O
Patient NNP I-NP O
scheduled VBD B-VP O
for IN B-VP O
an DT B-NP O
outpatient JJ I-NP O
colonoscoyp NN I-NP O
on IN B-VP O
6/18 CD O O
at IN B-VP O
9:30am CD O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
1 CD O O
You PRP O O
are VBP O O
scheduled VBN O O
for IN B-VP O
a DT B-NP O
colonoscopy NN I-NP O
on IN B-VP O
6/18 CD O O
at IN B-VP O
9:30am CD O O
No DT B-NP O
food NN I-NP O
or CC O O
drinks VBZ O O
the DT B-NP O
night NN I-NP O
before IN B-VP O
On IN B-VP O
8/7 CD O O
, , O O
only RB O O
clear JJ B-NP O
liquids NNS I-NP O
Please NNP I-NP O
drink VB O O
Oral NNP B-NP O
Phosphate NNP I-NP B-m
Soda NNP I-NP O
( ( O O
you PRP O O
can MD O O
pick VB O O
up RP O O
over-the-counter JJ O O
at IN B-VP O
any DT B-NP O
pharmacy NN I-NP O
) ) O O
the DT B-NP O
night NN I-NP B-f
before IN B-VP I-f
the DT B-NP I-f
colonoscopy NN I-NP I-f
Pls NNP I-NP O
call VB O O
522-750-9060 JJ O O
for IN B-VP O
more JJR B-NP O
directions NNS I-NP O
2 CD O O
Please NNP B-NP O
do VB O O
not RB O O
take VB O O
any DT B-NP O
dairy NN I-NP O
products NNS I-NP O
3 CD O O
Please NNP B-NP O
resume VB O O
all DT O O
of IN B-VP O
your PRP$ O O
regular JJ B-NP O
medications NNS I-NP O
No DT B-NP O
changes NNS I-NP O
were VBD B-VP O
made VBN O O
If IN B-VP O
the DT B-NP O
list NN I-NP O
above IN B-VP O
does VBZ O O
not RB O O
match VB O O
your PRP$ O O
regular JJ B-NP O
meds NNS I-NP O
, , O O
please VB O O
resume VB O O
your PRP$ O O
regular JJ B-NP O
meds NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Outpatient NNP B-NP O
colonoscopy NN I-NP O
on IN B-VP O
6/18 CD O O
, , O O
follow-up JJ B-NP O
results NNS I-NP O
2 CD O O
Consider NNP B-NP O
outpatient NN I-NP O
small JJ B-NP O
intest NN I-NP O
bx/secretin NN I-NP O
test/ERCP VBZ O O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
SKOUSEN NNP I-NP O
, , O O
HERIBERTO NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
FG35 NNP B-NP O
) ) O O
6/13/05 CD O O
@ $ O O
01:23 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#423034 VBZ O O
227724958 CD O O
RLH NNP B-NP O
53008525 CD O O
669665 CD O O
1/19/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
GANGRENOUS NNP I-NP O
RIGHT NNP I-NP O
FIRST NNP I-NP O
TOE NNP I-NP O
Signed NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/3/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/12/2001 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
STATUS NNP I-NP O
POST NNP I-NP O
RIGHT NNP I-NP O
TIBIAL NNP I-NP O
ARTERIAL NNP I-NP O
BYPASS NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
57 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
who WP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT B-NP O
right JJ I-NP O
femoral JJ I-NP O
posterior JJ I-NP O
tibial JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
in IN B-VP O
1997 CD O O
who WP O O
presented VBD B-VP O
with IN B-VP O
progressive JJ B-NP O
right NN I-NP O
first RB O O
toe VBZ O O
wound NN B-NP O
for IN B-VP O
two CD O O
months NNS B-NP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
fevers NNS I-NP O
or CC O O
chills NNS B-NP O
or CC O O
any DT B-NP O
erythema NN I-NP O
around IN B-VP O
the DT B-NP O
toe NN I-NP O
site NN I-NP O
She PRP O O
also RB O O
denied VBD B-VP O
any DT B-NP O
rest NN I-NP O
pain NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
non JJ B-NP O
insulin NN I-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
hypertension NN B-NP O
, , O O
high JJ B-NP O
cholesterol NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
As IN B-VP O
above NN B-NP O
Also RB O O
is VBZ O O
status NN B-NP O
post NN I-NP O
right RB O O
carotid NN B-NP O
endarterectomy NN I-NP O
in IN B-VP O
'96 CD O O
, , O O
C-section NNP B-NP O
and CC O O
appendectomy NN B-NP O
and CC O O
bilateral JJ B-NP O
cataracts NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Aspirin NNP I-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Pravachol NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
metoprolol FW O B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Glyburide NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Glucophage NNP B-NP B-m
1000 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Vasotec NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
vitamin NN B-NP B-m
B NNP I-NP I-m
multivitamin NN I-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
and CC O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SURGICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
She PRP O O
was VBD B-VP O
afebrile JJ O O
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
She PRP O O
was VBD B-VP O
a DT O O
pleasant JJ O O
, , O O
mildly RB O O
obese JJ B-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
and CC O O
no DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
NECK: NNP I-NP O
Supple NNP I-NP O
CHEST: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
HEART: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
ABDOMEN: NNP I-NP O
Soft NNP I-NP O
, , O O
obese JJ O O
, , O O
non-tender JJ O O
, , O O
nondistended VBD B-VP O
RIGHT NNP B-NP O
LOWER NNP I-NP O
EXTREMITY: NNP I-NP O
Had VBD B-VP O
a DT B-NP O
non JJ I-NP O
healing NN I-NP O
wound NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
great JJ I-NP O
toe NN I-NP O
with IN B-VP O
minimal JJ O O
surrounding VBG O O
erythema NN B-NP O
Pulse NNP I-NP O
examination NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
palpable JJ B-NP O
femoral JJ I-NP O
pulses NNS I-NP O
bilaterally RB O O
and CC O O
Dopplerable JJ B-NP O
DP NNP I-NP O
and CC O O
PT NNP B-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
with IN B-VP O
a DT O O
faintly RB O O
dopplerable JJ B-NP O
posterior JJ I-NP O
tibial JJ I-NP O
pulse NN I-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
and CC O O
no DT B-NP O
dopplerable JJ I-NP O
dorsalis NN I-NP O
pedis NN I-NP O
LABORATORY NNP I-NP O
EXAM: NNP I-NP O
Was NNP I-NP O
significant JJ O O
for IN B-VP O
AVI NNP B-NP O
of IN B-VP O
0.60 CD O O
and CC O O
0.59 CD O O
at IN B-VP O
the DT B-NP O
PT NNP I-NP O
, , O O
and CC O O
PTT NNP B-NP O
respectively RB O O
on IN B-VP O
the DT B-NP O
way NN I-NP O
with IN B-VP O
mildly RB O O
decreased JJ B-NP O
PVRs NNP I-NP O
Her NNP I-NP O
EKG NNP I-NP O
was VBD B-VP O
normal JJ B-NP O
sinus JJ I-NP O
rhythm NN I-NP O
Laboratory NNP I-NP O
exams NNS I-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
vascular JJ I-NP O
surgical JJ I-NP O
service NN I-NP O
and CC O O
placed VBN O O
on IN B-VP O
triple JJ B-NP B-m
antibiotics NNS I-NP I-m
and CC O O
dressing VBG O O
changes NNS B-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
resolution NN I-NP O
of IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
of IN B-VP O
her PRP$ O O
non JJ B-NP O
healing NN I-NP O
ulcer NN I-NP O
and CC O O
as IN B-VP O
a DT B-NP O
result NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
6/30/2001 CD O O
by IN B-VP O
Dr NNP B-NP O
Viteo NNP I-NP O
where WRB O O
she PRP O O
had VBD B-VP O
a DT B-NP O
right JJ I-NP O
femoral JJ I-NP O
tibial JJ I-NP O
bypass NN I-NP O
graft NN I-NP O
and CC O O
first JJ B-NP O
toe NN I-NP O
amputation NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
foot NN I-NP O
Postoperatively RB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
regular JJ I-NP O
hospital NN I-NP O
floor NN I-NP O
She PRP O O
initially RB O O
had VBD B-VP O
a DT B-NP O
PCA NNP I-NP B-m
for IN B-VP O
pain NN B-NP B-r
She PRP O O
began VBD B-VP O
ambulating VBG O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
two CD O O
She PRP O O
has VBZ O O
converted VBN O O
to TO O O
regular JJ B-NP O
diet NN I-NP O
and CC O O
her PRP$ O B-r
pain NN B-NP I-r
was VBD B-VP O
well RB O O
controlled VBN O O
on IN B-VP O
pain NN B-NP B-m
medications NNS I-NP I-m
She PRP O O
was VBD B-VP O
seen VBN O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
the DT B-NP O
cardiology NN I-NP O
service NN I-NP O
and CC O O
made VBD B-VP O
some DT B-NP O
adjustments NNS I-NP O
to TO O O
her PRP$ O O
beta NN B-NP B-m
blockers NNS I-NP I-m
She PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
and CC O O
her PRP$ O O
functional JJ B-NP O
status NN I-NP O
has VBZ O O
improved VBN O O
to TO O O
the DT B-NP O
point NN I-NP O
where WRB O O
the DT B-NP O
day NN I-NP O
before IN B-VP O
discharge NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
able JJ O O
to TO O O
ambulate VB O O
three CD O O
flights NNS B-NP O
of IN B-VP O
stairs NNS B-NP O
without IN B-VP O
difficulty NN B-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
infection NN B-NP O
on IN B-VP O
her PRP$ O O
leg NN B-NP O
wounds NNS I-NP O
and CC O O
she PRP O O
did VBD B-VP O
have VB O O
some DT B-NP O
mild JJ I-NP O
erythema NN I-NP B-r
around IN B-VP O
her PRP$ O O
right JJ B-NP O
great JJ I-NP O
toe NN I-NP O
which WDT O O
was VBD B-VP O
improved VBN O O
after IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
Ancef NNP B-NP B-m
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
three CD O O
This DT B-NP O
erythema NN I-NP O
continued VBD B-VP O
to TO O O
improve VB O O
and CC O O
was VBD B-VP O
much RB O O
improved VBN O O
by IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
and CC O O
home NN B-NP O
physical JJ B-NP O
therapy NN I-NP O
and CC O O
home NN B-NP O
visiting NN I-NP O
nurses NNS I-NP O
DISCHARGE NNP I-NP O
INSTRUCTIONS: NNP I-NP O
Her NNP I-NP O
diet NN I-NP O
is VBZ O O
ADA NNP B-NP O
2100; CD O O
her PRP$ O O
activity NN B-NP O
is VBZ O O
as RB O O
tolerated JJ O O
She PRP O O
is VBZ O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Goldsby NNP I-NP O
on IN B-VP O
Friday NNP B-NP O
, , O O
2/29 CD O O
She PRP O O
should MD O O
call VB O O
to TO O O
schedule VB O O
her PRP$ O O
medications NNS B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Enteric NNP I-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
325 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
d NN I-NP I-f
, , O O
Atenolol NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Atenolol NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
baid NN I-NP O
, , O O
Vasotec NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Glyburide NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Percocet NNP B-NP B-m
one CD O B-do
to TO O I-do
two CD O I-do
tablets NNS B-NP I-do
p.o VBP O B-mo
q RB O B-f
4 CD O I-f
h NN B-NP I-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
vitamin NN B-NP B-m
B NNP I-NP I-m
100 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
multivitamin VB O B-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Pravachol NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
h.s NN I-NP I-f
, , O O
Glucophage NNP B-NP B-m
1000 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
and CC O O
Keflex NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
x NNP I-NP B-du
x VBD B-VP B-du
7 CD O I-du
7 CD O I-du
days NNS B-NP I-du
days NNS I-NP I-du
Dictated VBD B-VP O
By: NNP B-NP O
GERARD NNP I-NP O
OVERDICK NNP I-NP O
, , O O
M.D NNP B-NP O
MQ830 NNP I-NP O
Attending: NNP I-NP O
EDWARD NNP I-NP O
O NNP I-NP O
OWERS NNP I-NP O
, , O O
M.D NNP B-NP O
XY27 NNP I-NP O
MS888/7629 NNP I-NP O
Batch: NNP I-NP O
98881 CD O O
Index NNP B-NP O
No NNP I-NP O
K8RWGI1S99 NNP I-NP O
D: NNP I-NP O
9/17/01 CD O O
T: NNP B-NP O
9/17/01 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#426134 VBZ O O
358237520 CD O O
IOH NNP B-NP O
45549347 CD O O
620218 CD O O
10/16/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/16/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/4/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
HEINZLE NNP I-NP O
, , O O
IAN NNP B-NP O
412-44-02-5 CD O O
Land NNP B-NP O
Jack NNP I-NP O
O NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
10/24/01 CD O O
AT NNP B-NP O
03:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
PHAREL NNP I-NP O
, , O O
ROOSEVELT NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/2/01 CD O O
by IN B-VP O
TRIANO NNP B-NP O
, , O O
ALFREDO NNP B-NP O
, , O O
M.D NNP B-NP O
DEFINITE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
G6PD NNP B-NP O
DEFICIENCY NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
patient NN I-NP O
taking VBG O O
as IN B-VP O
outpt JJ B-NP O
WELLBUTRIN NNP I-NP B-m
( ( O I-m
BUPROPION NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
FESO4 NNP I-NP B-m
( ( O I-m
FERROUS NNP B-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O O
3 CD O O
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
ZOCOR NNP B-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
ZESTRIL NNP B-NP B-m
( ( O I-m
LISINOPRIL NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/24/01 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
PRILOSEC NNP I-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Immediately RB O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Lindsay NNP I-NP O
Wontor NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
Quinine NNP I-NP O
( ( O O
quinine JJ B-NP O
sulfate NN I-NP O
) ) O O
, , O O
Tegretol NNP B-NP O
( ( O O
carbamazepine NN B-NP O
) ) O O
ADMIT NNP B-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
vitilago RB O O
NIDDM NNP B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
depression NN B-NP O
( ( O O
depression NN B-NP O
) ) O O
hypercholesterolemia NN B-NP O
( ( O O
elevated VBN O O
cholesterol NN B-NP O
) ) O O
esophagitis NN B-NP O
CAD NNP I-NP O
2/29 CD O O
, , O O
PTCA NNP B-NP O
htn NN I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
ana NN B-NP O
( ( O O
positive JJ B-NP O
ANA NNP I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
63 CD O O
yo NN B-NP O
male NN I-NP O
, , O O
h/o JJ B-NP O
CAD NNP I-NP O
s/p NN I-NP O
MI NNP I-NP O
x2 NNP I-NP O
, , O O
s/p VBD B-VP O
cath NN B-NP O
11/12 CD O O
which WDT O O
showed VBD B-VP O
100% CD O O
LCfx NNP B-NP O
lesion NN I-NP O
unable JJ O O
to TO O O
be VB O O
stented VBN O O
At IN B-VP O
baseline NN B-NP O
, , O O
has VBZ O O
stable JJ B-NP O
angina NNS I-NP O
with IN B-VP O
exertion NN B-NP O
Has NNP I-NP O
been VBN O O
on IN B-VP O
medical JJ B-NP O
management NN I-NP O
on IN B-VP O
atenolol NN B-NP B-m
, , O O
ace-i JJ O B-m
, , O O
asa JJ O B-m
until IN B-VP B-du
day NN B-NP I-du
of IN B-VP I-du
adm NN B-NP I-du
when WRB O O
he PRP O O
woke VBD B-VP O
up RP O O
with IN B-VP O
L NNP B-NP O
arm NN I-NP O
and CC O O
shoulder NN B-NP B-r
pain NN I-NP I-r
reminiscent NN I-NP O
of IN B-VP O
old JJ B-NP O
MI NNP I-NP O
Tried NNP I-NP O
NTG NNP I-NP B-m
sl NN I-NP B-mo
x3 NN I-NP B-f
without IN B-VP O
full JJ B-NP O
relief NN I-NP O
, , O O
called VBN O O
EMS NNP B-NP O
In IN B-VP O
ED NNP B-NP O
, , O O
EKG NNP B-NP O
without IN B-VP O
significant JJ B-NP O
change NN I-NP O
, , O O
TnI NNP B-NP O
flat NN I-NP O
Started VBD B-VP O
on IN B-VP O
heparin NN B-NP B-m
for IN B-VP O
unstable JJ B-NP B-r
angina NNS I-NP I-r
Continued VBN O O
to TO O O
have VB O O
L NNP B-NP B-r
shoulder VB O O
discomfort NN B-NP O
intermittently RB O O
, , O O
which WDT O O
seemed VBD B-VP O
best RBS O O
relieved VBN O O
by IN B-VP O
tylenol NN B-NP B-m
and CC O O
hot JJ B-NP O
compresses NNS I-NP O
Serial JJ B-NP O
CK's NNP I-NP O
were VBD B-VP O
flat JJ O O
, , O O
and CC O O
while IN B-VP O
in IN B-VP O
hospital NN B-NP O
, , O O
had VBD B-VP O
no DT B-NP O
recurrence NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
He PRP O O
is VBZ O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Tollner NNP I-NP O
, , O O
with IN B-VP O
possibility NN B-NP O
of IN B-VP O
ETT-MIBI NNP B-NP O
as IN B-VP O
outpatient NN B-NP O
to TO O O
better JJR O O
define VB O O
his PRP$ O O
coronary JJ B-NP O
disease NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
) ) O O
Please NNP B-NP O
remember VB O O
to TO O O
take VB O O
the DT O O
increased VBN O O
dose NN B-NP O
of IN B-VP O
zestril $ O B-m
10 CD O B-do
mg NN B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
Take NNP I-NP O
all DT O O
of IN B-VP O
your PRP$ O O
other JJ B-NP O
medicines NNS I-NP B-m
as IN B-VP O
you PRP O O
were VBD B-VP O
before IN B-VP O
2 CD O O
) ) O O
Please NNP B-NP O
make VB O O
a DT B-NP O
follow-up JJ I-NP O
appointment NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Cyrus NNP I-NP O
for IN B-VP O
the DT B-NP O
next JJ I-NP O
week NN I-NP O
or CC O O
two CD O O
3 CD O O
) ) O O
If IN B-VP O
you PRP O O
experience VBP O O
chest JJS B-NP B-r
pain NN I-NP I-r
with IN B-VP O
activity NN B-NP O
, , O O
rest NN B-NP O
, , O O
take VB O O
a DT B-NP O
nitroglycerin NN I-NP B-m
once RB O B-f
every DT O I-f
5 CD O I-f
minutes NNS B-NP I-f
up RB O I-f
to TO O I-f
three CD O I-f
times; NN B-NP I-f
if IN B-VP O
the DT B-NP O
pain NN I-NP O
does VBZ O O
not RB O O
go VB O O
away RB O O
, , O O
call VB O O
911 CD O O
immediately RB O O
If IN B-VP O
you PRP O O
experience VBP O O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
chest JJ B-NP O
pain NN I-NP O
or CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
at IN B-VP O
rest NN B-NP O
, , O O
return NN B-NP O
to TO O O
the DT B-NP O
hospital NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
) ) O O
ETT-MIBI NN B-NP O
as IN B-VP O
outpatient JJ O O
2 CD O O
) ) O O
Check NNP B-NP O
K NNP I-NP O
, , O O
Cr NNP B-NP O
within IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
s/p VBP O O
change NN B-NP O
in IN B-VP O
zestril NN B-NP B-m
dose VBP O O
3 CD O O
) ) O O
Given VBN O O
h/o JJ B-NP O
heartburn NN I-NP O
, , O O
not RB O O
responsive JJ O O
to TO O O
zantac VB O B-m
and CC O O
guaiac VB O O
pos NN B-NP O
stool NN I-NP O
, , O O
should MD O O
have VB O O
referral JJ O O
to TO O O
GI NNP B-NP O
and CC O O
EGD NNP B-NP O
as IN B-VP O
outpatient JJ B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
FODERA NNP I-NP O
, , O O
MYRON NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
AR68 NNP B-NP O
) ) O O
10/24/01 CD O O
@ $ O O
02:12 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#435683 VBZ O O
261209550 CD O O
ICH NNP B-NP O
74936279 CD O O
5609579 CD O O
7/6/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
SEPSIS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/21/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/0/2006 CD O O
ATTENDING: NNP B-NP O
RAMINEZ NNP I-NP O
, , O O
ISRAEL NNP B-NP O
M.D NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Weakness NNP I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
and CC O O
dizziness JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
48-year-old JJ I-NP O
female NN I-NP O
who WP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
on IN B-VP O
6/13/06 CD O O
from IN B-VP O
Nixma NNP B-NP O
County NNP I-NP O
Hospital NNP I-NP O
after IN B-VP O
an DT B-NP O
ICU NNP I-NP O
admission NN I-NP O
for IN B-VP O
pneumonia NN B-NP O
and CC O O
Klonopin NNP B-NP B-m
overdose VBP O O
Two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
here RB O O
, , O O
she PRP O O
experienced VBD B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
at IN B-VP O
rest NN B-NP O
and CC O O
some DT B-NP O
lightheadedness NN I-NP O
At IN B-VP O
baseline NN B-NP O
, , O O
she PRP O O
becomes VBZ O O
dyspneic RB O O
after IN B-VP O
walking VBG O O
20 CD O O
feet NNS B-NP O
secondary JJ O O
to TO O O
obesity NN B-NP O
and CC O O
many JJ B-NP O
years NNS I-NP O
of IN B-VP O
smoking NN B-NP O
She PRP O O
also RB O O
notes VBZ O O
several JJ B-NP O
days NNS I-NP O
of IN B-VP O
headache NN B-NP O
and CC O O
some DT B-NP O
questionable JJ I-NP O
darkening NN I-NP O
in IN B-VP O
her PRP$ O O
visual JJ B-NP O
fields NNS I-NP O
bilaterally RB O O
She PRP O O
admits VBZ O O
that IN B-VP O
her PRP$ O O
p.o NN B-NP O
intake NN I-NP O
has VBZ O O
been VBN O O
rather RB O O
poor JJ O O
since IN B-VP O
coming VBG O O
home RB O O
secondary JJ O O
to TO O O
anorexia VB O O
and CC O O
that IN B-VP O
she PRP O O
has VBZ O O
felt VBN O O
dehydrated VBN O O
On IN B-VP O
review NN B-NP O
of IN B-VP O
systems NNS B-NP O
, , O O
she PRP O O
also RB O O
notes VBZ O O
chronic JJ B-NP O
waxing NN I-NP O
and CC O O
waning VBG O O
erythema NN B-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
lower JJR I-NP O
extremity NN I-NP O
which WDT O O
in IN B-VP O
recent JJ B-NP O
days NNS I-NP O
has VBZ O O
worsened VBN O O
with IN B-VP O
accompanying VBG O O
swelling VBG O O
and CC O O
mild JJ B-NP O
tenderness NN I-NP O
, , O O
although IN B-VP O
her PRP$ O O
son NN B-NP O
says VBZ O O
that IN B-VP O
it PRP O O
has VBZ O O
been VBN O O
worse VBN O O
in IN B-VP O
the DT B-NP O
past NN I-NP O
Also RB O O
, , O O
she PRP O O
has VBZ O O
noted VBN O O
loose JJ B-NP O
stools NNS I-NP O
since IN B-VP O
6/2/06 CD O O
She PRP O O
denies VBZ O O
chest JJS B-NP O
pain NN I-NP O
, , O O
pleurisy NN B-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
blood NN B-NP O
in IN B-VP O
her PRP$ O O
stool NN B-NP O
or CC O O
urine NN B-NP O
, , O O
dysuria NN B-NP O
, , O O
change NN B-NP O
in IN B-VP O
frequency NN B-NP O
, , O O
character NN B-NP O
or CC O O
urination NN B-NP O
, , O O
or CC O O
focal JJ B-NP O
weakness NN I-NP O
No NNP I-NP O
new JJ B-NP O
medications NNS I-NP O
other JJ O O
than IN B-VP O
a DT B-NP O
recent JJ I-NP O
antibiotic JJ I-NP B-m
course NN I-NP O
at IN B-VP O
Dale NNP B-NP O
Skin NNP I-NP O
Sonmu NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
completed VBD B-VP O
there EX O O
for IN B-VP O
pneumonia NN B-NP B-r
She PRP O O
has VBZ O O
not RB O O
taken VBN O O
her PRP$ O O
lisinopril NN B-NP B-m
or CC O O
methadone NN B-NP B-m
in IN B-VP O
the DT O O
last JJ O O
two CD O O
days NNS B-NP O
She PRP O O
has VBZ O O
no DT B-NP O
sick JJ I-NP O
contact NN I-NP O
She PRP O O
saw VBD B-VP O
her PRP O O
PCP NNP B-NP O
on IN B-VP O
0/10/06 CD O O
who WP O O
found VBD B-VP O
her PRP O O
to TO O O
be VB O O
hypotensive JJ O O
and CC O O
hypoxic NN B-NP O
and CC O O
then RB O O
sent VBD B-VP O
her PRP O O
to TO O O
Ma NNP B-NP O
County NNP I-NP O
Hospital NNP I-NP O
ED NNP I-NP O
Her NNP I-NP O
family NN I-NP O
is VBZ O O
not RB O O
clear JJ O O
on IN B-VP O
her PRP$ O O
discharge NN B-NP O
diagnosis NN I-NP O
, , O O
but CC O O
they PRP O O
report VBP O O
that IN B-VP O
her PRP$ O O
kidney NN B-NP O
function NN I-NP O
was VBD B-VP O
abnormal JJ O O
and CC O O
she PRP O O
was VBD B-VP O
dehydrated VBN O O
She PRP O O
was VBD B-VP O
not RB O O
admitted VBN O O
She PRP O O
then RB O O
came VBD B-VP O
to TO O O
the DT B-NP O
ED NNP I-NP O
at IN B-VP O
Town NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
And CC O O
Clinics NNP B-NP O
for IN B-VP O
persistent JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
dizziness NN B-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
her PRP$ O O
vital JJ B-NP O
signs NNS I-NP O
were VBD B-VP O
that IN B-VP O
she PRP O O
was VBD B-VP O
afebrile RB O O
, , O O
her PRP O O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
in IN B-VP O
the DT O O
high JJ O O
60's CD O O
, , O O
her PRP$ O O
heart NN B-NP O
rate NN I-NP O
was VBD B-VP O
110 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
in IN B-VP O
the DT O O
30's CD O O
, , O O
and CC O O
O2 NNP B-NP O
saturations NNS I-NP O
were VBD B-VP O
in IN B-VP O
the DT O O
high JJ O O
80's CD O O
She PRP O O
was VBD B-VP O
given VBN O O
vancomycin NN B-NP B-m
, , O O
Levaquin NNP B-NP B-m
and CC O O
gentamicin NN B-NP B-m
and CC O O
3 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
normal JJ B-NP B-m
saline NN I-NP I-m
She PRP O O
was VBD B-VP O
aggressively RB O O
given VBN O O
fluids NNS B-NP B-m
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Levophed NNP B-NP B-m
for IN B-VP O
blood NN B-NP B-r
pressure NN I-NP O
support NN I-NP O
Her NNP I-NP O
EKG NNP I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
low JJ B-NP O
voltage NN I-NP O
on IN B-VP O
precordial JJ B-NP O
leads NNS I-NP O
and CC O O
borderline NN B-NP O
right RB O O
axis JJ B-NP O
deviation NN I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
showed VBD B-VP O
cardiomegaly JJ O O
, , O O
but CC O O
otherwise RB O O
clear JJ O O
In IN B-VP O
the DT B-NP O
MICU NNP I-NP O
, , O O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
stabilized VBN O O
on IN B-VP O
Levophed NNP B-NP B-m
, , O O
but CC O O
she PRP O O
was VBD B-VP O
also RB O O
noted VBN O O
to TO O O
drop VB O O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
to TO O O
the DT O O
70's CD O O
when WRB O O
initiated VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
BiPAP NNP I-NP O
settings NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
had VBD B-VP O
endocarditis VBN O O
20 CD O O
years NNS B-NP O
ago RB O O
She PRP O O
has VBZ O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
BiPAP NNP I-NP O
, , O O
morbid NN B-NP O
obesity NN I-NP O
, , O O
and CC O O
hypertension NN B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
right JJ I-NP O
ankle NN I-NP O
injury NN I-NP O
more JJR O O
than IN B-VP O
20 CD O O
years NNS B-NP O
ago RB O O
during IN B-VP O
the DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
accident NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
an DT B-NP O
ankle JJ I-NP O
infection NN I-NP O
She PRP O O
has VBZ O O
chronic JJ O B-r
right RB O I-r
lower JJR B-NP I-r
extremity NN I-NP I-r
pain NN I-NP I-r
and CC O O
she PRP O O
is VBZ O O
on IN B-VP O
methadone NN B-NP B-m
She PRP O O
had VBD B-VP O
a DT B-NP O
Klonopin NNP I-NP B-m
overdose NN I-NP O
She PRP O O
had VBD B-VP O
Enterobacter NNP B-NP O
pneumonia NN I-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
cefepime NN B-NP B-m
at IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
questionable JJ O O
the DT B-NP O
vancomycin NN I-NP B-m
She PRP O O
has VBZ O O
a DT B-NP O
questionable JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
COPD NNP B-NP O
with IN B-VP O
her PRP$ O O
extensive JJ B-NP O
smoking NN I-NP O
history NN I-NP O
In IN B-VP O
a DT B-NP O
well NN I-NP O
state NN I-NP O
, , O O
her PRP$ O O
PCO2 NNP B-NP O
was VBD B-VP O
49 CD O O
, , O O
her PRP$ O O
O2 NNP B-NP O
saturation NN I-NP O
is VBZ O O
89% CD O O
, , O O
and CC O O
she PRP O O
has VBZ O O
also RB O O
history NN B-NP O
of IN B-VP O
depression NN B-NP O
MEDICATIONS NNP I-NP O
AT NNP I-NP O
HOME: NNP I-NP O
Lisinopril NNP I-NP B-m
and CC O O
methadone NN B-NP B-m
She PRP O O
is VBZ O O
not RB O O
taking VBG O O
her PRP$ O O
lisinopril NN B-NP B-m
She PRP O O
has VBZ O O
in IN B-VP O
the DT O O
past JJ O O
taken VBN O O
lisinopril NN B-NP B-m
with IN B-VP O
hydrochlorothiazide NN B-NP B-m
ALLERGIES: NNP I-NP O
She PRP O O
is VBZ O O
allergic JJ O O
to TO O O
penicillin VB O O
and CC O O
sulfa VB O O
drugs NNS B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
smoked VBD B-VP O
half PDT O O
a DT B-NP O
pack NN I-NP O
a DT B-NP O
day NN I-NP O
for IN B-VP O
30 CD O O
years NNS B-NP O
No DT B-NP O
alcohol NN I-NP O
for IN B-VP O
three CD O O
years NNS B-NP O
No DT B-NP O
illicit NN I-NP O
drugs NNS I-NP O
She PRP O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
, , O O
but CC O O
does VBZ O O
not RB O O
work VB O O
She PRP O O
is VBZ O O
on IN B-VP O
disability NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
She PRP O O
was VBD B-VP O
afebrile RB O O
, , O O
heart NN B-NP O
rate NN I-NP O
in IN B-VP O
the DT O O
100's CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
130/80 CD O O
, , O O
respiratory NN B-NP O
of IN B-VP O
18 CD O O
, , O O
and CC O O
O2 NNP B-NP O
saturation NN I-NP O
95% CD O O
on IN B-VP O
8 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
oxygen NN B-NP B-m
She PRP O O
was VBD B-VP O
awake JJ O O
and CC O O
alert JJ O O
and CC O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
She PRP O O
is VBZ O O
anicteric JJ O O
, , O O
without IN B-VP O
pallor NN B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
thick JJ I-NP O
neck NN I-NP O
Pulmonary: NNP I-NP O
She PRP O O
had VBD B-VP O
decreased VBN O O
breath NN B-NP O
sounds NNS I-NP O
and CC O O
crackles NNS B-NP O
at IN B-VP O
the DT B-NP O
bases NNS I-NP O
bilaterally RB O O
Cardiovascular: NNP B-NP O
She PRP O O
was VBD B-VP O
tachy JJ O O
, , O O
regular JJ O O
, , O O
but CC O O
distant JJ B-NP O
S4 NNP I-NP O
JVP NNP I-NP O
was VBD B-VP O
difficulty NN B-NP O
to TO O O
ascertain VB O O
secondary JJ O O
to TO O O
neck VB O O
habitus NN B-NP O
Her NNP I-NP O
abdomen NN I-NP O
was VBD B-VP O
obese JJ O O
, , O O
+ JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
nontender NN B-NP O
and CC O O
nondistended JJ B-NP O
Extremities NNS I-NP O
were VBD B-VP O
without IN B-VP O
erythema NN B-NP O
of IN B-VP O
her PRP$ O O
legs NNS B-NP O
, , O O
but CC O O
with IN B-VP O
mild JJ O O
swelling VBG O O
of IN B-VP O
the DT O O
right JJ O O
lower JJR O O
ankle IN B-VP O
The DT B-NP O
ankles NNS I-NP O
were VBD B-VP O
without IN B-VP O
swelling VBG O O
and CC O O
with IN B-VP O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
Neurologically NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
alert JJ O O
and CC O O
oriented JJ O O
, , O O
but CC O O
unfocused VBD B-VP O
in IN B-VP O
conversation NN B-NP O
, , O O
moving VBG O O
all DT O O
her PRP$ O O
extremities NNS B-NP O
Her NNP I-NP O
strength NN I-NP O
was VBD B-VP O
intact JJ B-NP O
LABORATORY NNP I-NP O
STUDIES NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Please NNP I-NP O
see VB O O
LMR NNP B-NP O
ASSESSMENT NNP I-NP O
AND NNP I-NP O
PLAN: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
49-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
recent JJ I-NP O
ICU NNP I-NP O
stay NN I-NP O
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
hypotension NN B-NP O
, , O O
tachycardia NN B-NP O
, , O O
and CC O O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
Presentation NNP I-NP O
was VBD B-VP O
most RBS O O
consistent JJ O O
with IN B-VP O
right JJ B-NP O
pulmonary JJ I-NP O
embolus NN I-NP O
and CC O O
right JJ B-NP O
ventricular NN I-NP O
failure NN I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEM: NNP I-NP O
1 CD O O
Pulmonary/Vascular: NNP B-NP O
There EX O O
was VBD B-VP O
initial JJ B-NP O
concern NN I-NP O
for IN B-VP O
a DT B-NP O
PE NNP I-NP O
given VBN O O
the DT B-NP O
presentation NN I-NP O
of IN B-VP O
severe JJ B-NP O
hypotension NN I-NP O
, , O O
tachycardia NN B-NP O
, , O O
and CC O O
Aa NNP B-NP O
gradient NN I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
infection NN B-NP O
or CC O O
primary JJ B-NP O
cardiac JJ I-NP O
disease NN I-NP O
An DT B-NP O
echo NN I-NP O
showed VBD B-VP O
a DT B-NP O
dilated JJ I-NP O
RV NNP I-NP O
with IN B-VP O
depressed JJ B-NP O
RV NNP I-NP O
function NN I-NP O
suggestive NN I-NP O
of IN B-VP O
PE NNP B-NP O
Her NNP I-NP O
initial JJ B-NP O
PE NNP I-NP O
scan NN I-NP O
was VBD B-VP O
nondiagnostic JJ O O
secondary JJ O O
to TO O O
poorly RB O O
timed VBN O O
contrast NN B-NP O
and CC O O
motion NN B-NP O
of IN B-VP O
the DT B-NP O
patient NN I-NP O
A NNP I-NP O
VQ NNP I-NP O
scan JJ O O
showed VBD B-VP O
intermediate JJ B-NP O
probability NN I-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
heparin NN B-NP B-m
drip NN I-NP B-mo
with IN B-VP O
a DT B-NP O
goal NN I-NP O
of IN B-VP O
60 CD O O
to TO O O
80 CD O O
Her PRP$ O O
second JJ B-NP O
PECT NNP I-NP O
showed VBD B-VP O
a DT B-NP O
small JJ I-NP O
PE NNP I-NP O
to TO O O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
lobe NN I-NP O
, , O O
but CC O O
it PRP O O
was VBD B-VP O
not RB O O
large JJ O O
enough RB O O
to TO O O
explain VB O O
her PRP$ O O
dramatic JJ B-NP O
presentation NN I-NP O
The DT B-NP O
working JJ I-NP O
hypothesis NN I-NP O
is VBZ O O
that IN B-VP O
there EX O O
was VBD B-VP O
a DT B-NP O
significant JJ I-NP O
recanalization NN I-NP O
prior RB O O
to TO O O
this DT B-NP O
repeat NN I-NP O
CT NNP I-NP O
which WDT O O
took VBD B-VP O
place NN B-NP O
two CD O O
days NNS B-NP O
after IN B-VP O
the DT B-NP O
first JJ I-NP O
CT NNP I-NP O
She PRP O O
was VBD B-VP O
initially RB O O
on IN B-VP O
oxygen NN B-NP B-m
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
She PRP O O
was VBD B-VP O
never RB O O
intubated VBN O O
She PRP O O
was VBD B-VP O
on IN B-VP O
face NN B-NP O
mask NN I-NP O
, , O O
and CC O O
upon RB O O
transfer VB O O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
on IN B-VP O
nasal JJ B-NP O
cannula NN I-NP O
4 CD O O
liters NNS B-NP O
Her PRP$ O O
O2 JJ B-NP O
saturations NNS I-NP O
were VBD B-VP O
acceptable JJ B-NP O
in-house NN I-NP O
, , O O
although IN B-VP O
she PRP O O
did VBD B-VP O
desaturate VB O O
to TO O O
90% CD O O
when WRB O O
she PRP O O
took VBD B-VP O
her PRP O O
oxygen NN B-NP B-m
off RP O O
a DT B-NP O
night NN I-NP O
She PRP O O
multiple VBD B-VP O
times NNS B-NP O
refused VBD B-VP O
BiPAP NNP B-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
but CC O O
she PRP O O
will MD O O
go VB O O
back RB O O
on IN B-VP O
it PRP O O
when WRB O O
she PRP O O
returns VBZ O O
home NN B-NP O
2 CD O O
Cardiovascular: NNP B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
mild JJ I-NP O
troponin NN I-NP O
elevation NN I-NP O
on IN B-VP O
admission NN B-NP O
, , O O
likely RB O O
secondary JJ O O
to TO O O
RV VB O O
strain NN B-NP O
She PRP O O
had VBD B-VP O
severe JJ B-NP O
hypotension NN I-NP O
and CC O O
was VBD B-VP O
on IN B-VP O
two CD O O
pressors NNS B-NP O
She PRP O O
was VBD B-VP O
weaned VBN O O
off IN B-VP O
of IN B-VP O
these DT O O
on IN B-VP O
4/15/06 CD O O
, , O O
but CC O O
did VBD B-VP O
have VB O O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
hypotension NN B-NP B-r
when WRB O O
her PRP$ O O
BiPAP NNP B-NP O
was VBD B-VP O
started VBN O O
She PRP O O
was VBD B-VP O
given VBN O O
a DT B-NP O
little JJ I-NP O
bit NN I-NP O
of IN B-VP O
low JJ B-NP B-do
dose JJ I-NP I-do
dobutamine NN I-NP B-m
and CC O O
then RB O O
she PRP O O
was VBD B-VP O
weaned VBN O O
off IN B-VP O
of IN B-VP O
that DT O O
on IN B-VP O
3/6/06 CD O O
Rhythm: NNP B-NP O
She PRP O O
has VBZ O O
no DT B-NP O
active JJ I-NP O
issues NNS I-NP O
We PRP O O
continued VBD B-VP O
to TO O O
hold VB O O
her PRP$ O O
lisinopril NN B-NP B-m
while IN B-VP B-du
in-house NN B-NP I-du
Her NNP I-NP O
blood NN I-NP O
pressures NNS I-NP O
were VBD B-VP O
stable JJ O O
, , O O
but CC O O
not RB O O
high JJ O O
enough RB O O
to TO O O
withstand VB O O
on IN B-VP O
additional JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
lowering VBG O O
medication NN B-NP O
It PRP O O
was VBD B-VP O
discussed VBN O O
with IN B-VP O
her PRP$ O O
PCP NN B-NP O
that IN B-VP O
she PRP O O
perhaps RB O O
will MD O O
need VB O O
this DT B-NP B-m
medication NN I-NP I-m
restarted VBD B-VP O
as IN B-VP O
an DT O O
outpatient JJ O O
She PRP O O
does VBZ O O
have VB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
severe JJ B-NP O
hypertension NN I-NP O
3 CD O O
Renal: NNP B-NP O
As IN B-VP O
she PRP O O
was VBD B-VP O
in IN B-VP O
acute JJ B-NP O
failure NN I-NP O
on IN B-VP O
admission NN B-NP O
with IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
6.9 CD O O
, , O O
it PRP O O
dropped VBD B-VP O
to TO O O
0.5 CD O O
, , O O
most RBS O O
likely JJ O O
this DT O O
was VBD B-VP O
due JJ O O
to TO O O
prerenal JJ B-NP O
azotemia NN I-NP O
and CC O O
decreased VBD B-VP O
renal JJ B-NP O
perfusion NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
hypotension NN B-NP O
Hypoperfusion NNP I-NP O
of IN B-VP O
the DT B-NP O
kidneys NNS I-NP O
in IN B-VP O
setting NN B-NP O
of IN B-VP O
hypovolemia NN B-NP O
and CC O O
right JJ B-NP O
heart NN I-NP O
failure NN I-NP O
resulting VBG O O
in IN B-VP O
decreased JJ O O
left VBD B-VP O
ventricular JJ B-NP O
preload NN I-NP O
Mucomyst NNP I-NP B-m
and CC O O
bicarb NN B-NP B-m
were VBD B-VP O
given VBN O O
prior RB O O
to TO O O
the DT B-NP O
PECTs NNP I-NP O
of IN B-VP O
her PRP$ O O
renal JJ B-NP O
protection NN I-NP O
She PRP O O
did VBD B-VP O
not RB O O
develop VB O O
any DT B-NP O
additional JJ I-NP O
contrast NN I-NP O
nephropathy NN I-NP O
after IN B-VP O
her PRP$ O O
CT NNP B-NP O
scans VBZ O O
Her PRP$ O O
creatinine NN B-NP O
on IN B-VP O
discharge NN B-NP O
was VBD B-VP O
0.6 CD O O
4 CD O O
Endocrine: NNP B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
increase NN I-NP O
in IN B-VP O
her PRP$ O O
cortisol JJ B-NP O
level NN I-NP O
with IN B-VP O
ACTH NNP B-NP O
stimulation NN I-NP O
Her PRP$ O O
fingersticks NNS B-NP O
were VBD B-VP O
monitored VBN O O
while IN B-VP O
she PRP O O
was VBD B-VP O
in-house NN B-NP O
and CC O O
she PRP O O
never RB O O
had VBD B-VP O
any DT B-NP O
need NN I-NP O
for IN B-VP O
supplemental JJ B-NP O
insulin NN I-NP O
5 CD O O
FEN: NNP B-NP O
She PRP O O
was VBD B-VP O
on IN B-VP O
a DT B-NP O
house NN I-NP O
diet JJ O O
6 CD O O
ID: NNP B-NP O
She PRP O O
was VBD B-VP O
empirically RB O O
covered VBN O O
on IN B-VP O
admission NN B-NP O
with IN B-VP O
vancomycin NN B-NP B-m
, , O O
levofloxacin NN B-NP B-m
and CC O O
gentamicin VB O B-m
Her PRP$ O O
antibiotics NNS B-NP B-m
were VBD B-VP O
given VBN O O
again RB O O
on IN B-VP O
10/16/06 CD O O
and CC O O
on IN B-VP O
11/13/06 CD O O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
an DT B-NP O
infection NN I-NP O
found VBD B-VP O
, , O O
no DT B-NP O
fever NN I-NP O
, , O O
normal JJ B-NP O
white JJ I-NP O
count NN I-NP O
, , O O
with IN B-VP O
a DT O O
normal JJ O O
differential JJ O O
, , O O
normal JJ B-NP O
UA NNP I-NP O
, , O O
chest JJS B-NP O
x-ray NN I-NP O
is VBZ O O
without IN B-VP O
infiltrate NN B-NP O
, , O O
and CC O O
antibiotics NNS B-NP B-m
were VBD B-VP O
discontinued VBN O O
on IN B-VP O
4/21/06 CD O O
She PRP O O
continued VBD B-VP O
to TO O O
remain VB O O
afebrile JJ B-NP O
in-house NN I-NP O
without IN B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
infection NN B-NP O
7 CD O O
Urology: NNP B-NP O
She PRP O O
did VBD B-VP O
complain NN B-NP O
of IN B-VP O
bladder NN B-NP O
spasms NNS I-NP O
while IN B-VP O
having VBG O O
the DT B-NP O
Foley NNP I-NP O
in IN B-VP O
place NN B-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Ditropan NNP B-NP B-m
She PRP O O
had VBD B-VP O
multiple JJ B-NP O
negative JJ I-NP O
urinalysis NN I-NP O
and CC O O
urine JJ B-NP O
cultures NNS I-NP O
Once IN B-VP O
the DT B-NP O
Foley NNP I-NP O
was VBD B-VP O
discontinued VBN O O
, , O O
she PRP O O
was VBD B-VP O
able JJ O O
to TO O O
void VB O O
and CC O O
she PRP O O
stopped VBD B-VP O
having VBG O O
bladder NN B-NP O
spasms NNS I-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Monistat NNP B-NP B-m
for IN B-VP O
a DT B-NP B-r
yeast JJ I-NP I-r
infection NN I-NP I-r
8 CD O O
Allergy: NNP B-NP O
She PRP O O
did VBD B-VP O
have VB O O
an DT O O
elevated VBN O O
eosinophilia NN B-NP O
on IN B-VP O
presentation NN B-NP O
and CC O O
it PRP O O
was VBD B-VP O
4% CD O O
on IN B-VP O
admission NN B-NP O
and CC O O
increased VBD B-VP O
to TO O O
8% CD O O
on IN B-VP O
4/21/06 CD O O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
it PRP O O
was VBD B-VP O
7.5 CD O O
There EX O O
is VBZ O O
no DT B-NP O
clinical JJ I-NP O
evidence NN I-NP O
of IN B-VP O
allergy NN B-NP O
, , O O
rheumatic JJ B-NP O
disease NN I-NP O
or CC O O
parasitic JJ B-NP O
infection NN I-NP O
Her NNP I-NP O
obstructive JJ B-NP O
lung NN I-NP O
disease NN I-NP O
may MD O O
be VB O O
of IN B-VP O
an DT B-NP O
asthma NN I-NP O
variant NN I-NP O
, , O O
and CC O O
there EX O O
is VBZ O O
the DT B-NP O
possibility NN I-NP O
she PRP O O
may MD O O
need VB O O
inhaled JJ B-NP B-mo
corticosteroids NNS I-NP B-m
as IN B-VP O
an DT O O
outpatient JJ O O
9 CD O O
Heme: NNP B-NP O
She PRP O O
was VBD B-VP O
on IN B-VP O
unfractionated JJ B-NP B-m
heparin NN I-NP I-m
for IN B-VP O
her PRP$ O B-r
her PRP$ O B-r
presumed NN B-NP I-r
presumed JJ B-NP I-r
PE NNP I-NP I-r
PE NNP I-NP I-r
until IN B-VP B-du
6/15/06 CD O I-du
and CC O O
then RB O O
she PRP O O
was VBD B-VP O
changed VBN O O
to TO O O
Lovenox NNP B-NP B-m
in IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
that DT B-NP O
day NN I-NP O
on IN B-VP O
120 CD O B-do
mg NN B-NP I-do
subq VBD B-VP B-mo
Her NNP B-NP O
weight NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
was VBD B-VP O
157 CD O O
kg NN B-NP O
Her NNP I-NP O
Coumadin NNP I-NP B-m
Coumadin NNP I-NP B-m
, , O O
her PRP$ O O
initially RB O O
given VBN O O
10 CD O O
, , O O
then RB O O
a DT B-NP O
dose NN I-NP O
of IN B-VP O
5 CD O B-do
and CC O O
then RB O O
2 CD O O
dose NN B-NP O
of IN B-VP O
7.5 CD O O
Her NNP B-NP O
INR NNP I-NP O
was VBD B-VP O
therapeutic JJ O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
at IN B-VP O
2.5 CD O O
She PRP O O
will MD O O
continue VB O O
on IN B-VP O
the DT B-NP O
Lovenox NNP I-NP B-m
for IN B-VP B-du
two CD O I-du
additional JJ B-NP I-du
days NNS I-NP I-du
Her PRP$ O O
INR NNP B-NP O
will MD O O
be VB O O
monitored VBN O O
by IN B-VP O
Dr NNP B-NP O
Kid NNP I-NP O
, , O O
her PRP$ O O
PCP NNP B-NP O
10 CD O O
Psych/Addiction: NNP B-NP O
We PRP O O
are VBP O O
continuing VBG O O
her PRP$ O O
methadone NN B-NP B-m
methadone NN I-NP B-m
methadone NN I-NP B-m
It PRP O O
has VBZ O O
been VBN O O
switched VBN O O
from IN B-VP O
20 CD O B-do
20 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
p.o NN I-NP B-mo
p.o JJ O B-mo
daily JJ O B-f
daily RB O B-f
to TO O O
10 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
b.i.d IN B-VP B-f
She PRP O O
was VBD B-VP O
also RB O O
given VBN O O
a DT B-NP O
little JJ I-NP O
bit NN I-NP O
of IN B-VP O
Ativan NNP B-NP B-m
Ativan NNP I-NP B-m
while IN B-VP B-du
while IN B-VP B-du
in-house JJ B-NP I-du
in-house NN I-NP I-du
to TO O O
help VB O O
with IN B-VP O
her PRP$ O B-r
agitation NN B-NP O
and CC O O
anxiety NN B-NP B-r
She PRP O O
was VBD B-VP O
initially RB O O
given VBN O O
a DT B-NP O
little JJ I-NP O
bit NN I-NP O
of IN B-VP O
Haldol NNP B-NP B-m
, , O O
but CC O O
that DT O O
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
8/4/06 CD O O
and CC O O
there EX O O
was VBD B-VP O
no DT B-NP O
additional JJ I-NP O
need NN I-NP O
for IN B-VP O
that DT O O
She PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
central JJ I-NP O
line NN I-NP O
placed VBN O O
on IN B-VP O
4/18/06 CD O O
, , O O
which WDT O O
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
6/15/06 CD O O
without IN B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
line NN I-NP O
infection NN I-NP O
and CC O O
without IN B-VP O
any DT B-NP O
problems NNS I-NP O
She PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Social NNP B-NP O
Work NNP I-NP O
and CC O O
PT NNP B-NP O
The DT B-NP O
patient NN I-NP O
refused VBD B-VP O
to TO O O
go VB O O
to TO O O
any DT B-NP O
sort NN I-NP O
of IN B-VP O
rehab NN B-NP O
or CC O O
nursing NN B-NP O
home NN I-NP O
It PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
return VB O O
home NN B-NP O
with IN B-VP O
skilled JJ B-NP O
nursing NN I-NP O
and CC O O
with IN B-VP O
PT NNP B-NP O
as IN B-VP O
needed VBN O O
eScription NN B-NP O
document: VBZ O O
1-3509519 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MCMAIN NNP I-NP O
, , O O
MITCHELL NNP B-NP O
Attending: NNP I-NP O
MCDUGLE NNP I-NP O
, , O O
VINCENZO NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6997683 CD O O
D: NNP B-NP O
2/21/06 CD O O
T: NNP B-NP O
2/21/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#436461 VBZ O O
819083955 CD O O
LYWCH NNP B-NP O
98905634 CD O O
4508452 CD O O
0/21/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Atypical NNP I-NP O
Angina NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/9/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/9/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
GOMEY NNP I-NP O
, , O O
REGGIE NNP B-NP O
802-36-83-4 CD O O
Jo NNP B-NP O
Morejose NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/14/06 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
GOETTMAN NNP I-NP O
, , O O
NELSON NNP B-NP O
PHIL NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
4/20 CD O O
) ) O O
ATENOLOL $ O B-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;100 NNP I-NP O
or CC O O
HR&lt;50 NNP B-NP O
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
COGENTIN NNP I-NP B-m
( ( O I-m
BENZTROPINE NNP B-NP I-m
MESYLATE NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/14/06 CD O O
by IN B-VP O
SIZELOVE NNP B-NP O
, , O O
RAYMOND NNP B-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
THORAZINE NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
417100958 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
BENZTROPINE NNP I-NP B-m
MESYLATE NNP I-NP I-m
&amp; NNP I-NP O
CHLORPROMAZINE NNP I-NP B-m
HCL NNP I-NP I-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
BENZTROPINE NNP I-NP B-m
MESYLATE NNP I-NP I-m
&amp; NNP I-NP O
CHLORPROMAZINE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
THORAZINE NNP I-NP B-m
( ( O I-m
CHLORPROMAZINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
400 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/14/06 CD O O
by IN B-VP O
BRACAMONTE NNP B-NP O
, , O O
WALLACE NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
BENZTROPINE NNP I-NP B-m
MESYLATE NNP I-NP I-m
&amp; NNP I-NP O
CHLORPROMAZINE NNP I-NP B-m
HCL NNP I-NP I-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
BENZTROPINE NNP I-NP B-m
MESYLATE NNP I-NP I-m
&amp; NNP I-NP O
CHLORPROMAZINE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ECASA NNP I-NP B-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
GLIPIZIDE NNP I-NP B-m
XL NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
SYNTHROID NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;100 NNP I-NP O
METFORMIN NNP I-NP B-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
NPO NNP I-NP O
TRAZODONE NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
PRN NNP I-NP I-f
Insomnia NNP I-NP B-r
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Mike NNP I-NP O
Kalafarski NNP I-NP O
10/1/06 CD O O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Atypical NNP I-NP O
Angina NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Atypical NNP B-NP O
Angina NNP I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
Diabetes NNP I-NP O
Type NNP I-NP O
II NNP I-NP O
HYPOTHYROID NNP I-NP O
HTN NNP I-NP O
schizophrenia NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
NONE NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
pt NN B-NP O
got VBD B-VP O
2 CD O O
sets NNS B-NP O
of IN B-VP O
enzymes NNS B-NP O
and CC O O
they PRP O O
were VBD B-VP O
12 CD O O
hours NNS B-NP O
apart RB O O
and CC O O
both DT O O
were VBD B-VP O
negative JJ B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
70 CD O O
y/o NN B-NP O
with IN B-VP O
known JJ B-NP O
CAD NNP I-NP O
, , O O
DM NNP B-NP O
, , O O
schzioaffective JJ B-NP O
disorder NN I-NP O
p/w NN I-NP O
intermittent NN I-NP O
chest NN I-NP O
pain NN I-NP O
x12 NNP I-NP O
hours NNS I-NP O
Poor NNP I-NP O
historian JJ B-NP O
Reports NNP I-NP O
episode NN I-NP O
of IN B-VP O
Left NNP B-NP O
sided VBD B-VP O
chest JJS B-NP O
pressure NN I-NP O
radiating VBG O O
up RP O O
to TO O O
shoulder/arm VB O O
while IN B-VP O
in IN B-VP O
bed NN B-NP O
lasting JJ B-NP O
couple NN I-NP O
of IN B-VP O
minutes NNS B-NP O
Diaphoresis NNP I-NP O
with IN B-VP O
no DT B-NP O
n/v/fever/cough/SOB NN I-NP O
Had VBD B-VP O
repeat NN B-NP O
episode NN I-NP O
lasting VBG O O
couple NN B-NP O
of IN B-VP O
seconds NNS B-NP O
since IN B-VP O
this DT O O
am VBP O O
No DT B-NP O
similar JJ I-NP O
episodes NNS I-NP O
of IN B-VP O
CP NNP B-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
Had NNP I-NP O
recent JJ B-NP O
cardiac JJ I-NP O
w/u NN I-NP O
and CC O O
MIBI NNP B-NP O
showing VBG O O
mod JJ B-NP O
defect NN I-NP O
at IN B-VP O
the DT B-NP O
circumflex NN I-NP O
but CC O O
decided VBD B-VP O
no DT B-NP O
medical JJ I-NP O
trt NN I-NP O
at IN B-VP O
this DT B-NP O
point NN I-NP O
in IN B-VP O
time NN B-NP O
PMHx: NNP I-NP O
HTN NNP I-NP O
DM NNP I-NP O
CAD NNP I-NP O
s/p VBD B-VP O
MI NNP B-NP O
10/5 CD O O
schziophrenic/depression NN B-NP O
Hypothyroidism NNP I-NP O
ECHO: NNP I-NP O
EF NNP I-NP O
65% CD O O
PET NNP B-NP O
10/5 CD O O
with IN B-VP O
moderate JJ B-NP O
defect NN I-NP O
of IN B-VP O
the DT B-NP O
cx NN I-NP O
but CC O O
did VBD B-VP O
not RB O O
want VB O O
any DT B-NP O
medical JJ I-NP O
trt NN I-NP O
Meds: NNP I-NP O
Metformin NNP I-NP B-m
1000 CD O B-do
BID NNP B-NP B-f
Glipizide NNP I-NP B-m
10 CD O B-do
PO NNP B-NP B-mo
QD NNP I-NP B-f
, , O O
Synthroid NNP B-NP B-m
0.1 CD O B-do
QD NNP B-NP B-f
, , O O
Lisinipril NNP B-NP B-m
20mg CD O B-do
QD NNP B-NP B-f
, , O O
ASA NNP B-NP B-m
81 CD O B-do
QD NNP B-NP B-f
, , O O
Atenolol NNP B-NP B-m
12.5 CD O B-do
QD NNP B-NP B-f
All: NNP I-NP O
NKDA NNP I-NP O
SH:No NNP I-NP O
TOB/no NNP I-NP O
ETOH NNP I-NP O
ETOH NNP I-NP O
FH: NNP I-NP O
CAD NNP I-NP O
of IN B-VP O
mother NN B-NP O
and CC O O
sister NN B-NP O
PExam: NNP I-NP O
T97.7 NNP I-NP O
HR64-85 NNP I-NP O
BP110-165/62-78 NNP I-NP O
RR20 NNP I-NP O
96% CD O O
on IN B-VP O
RA NNP B-NP O
FS NNP I-NP O
89 CD O O
and CC O O
FS NNP B-NP O
149 CD O O
CVD: NNP B-NP O
RRR NNP I-NP O
No NNP I-NP O
M/R/G NNP I-NP O
A/P: NNP I-NP O
70 CD O O
y/o NNS B-NP O
female JJ O O
with IN B-VP O
DM NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
CAD NNP B-NP O
s/p VBD B-VP O
MI NNP B-NP O
10/5 CD O O
, , O O
s/p RB O O
Right NNP B-NP O
hip NN I-NP O
surgery NN I-NP O
came VBD B-VP O
in IN B-VP O
with IN B-VP O
intermittent JJ B-NP O
chest NN I-NP O
pain NN I-NP O
x12 JJ B-NP O
hours NNS I-NP O
likley VBP O O
secondary JJ O O
to TO O O
atypical JJ B-NP O
angina NN I-NP O
CVD: NNP I-NP O
ROMI NNP I-NP O
x2 NNP I-NP O
with IN B-VP O
troponin NN B-NP O
and CC O O
ck NN B-NP O
and CC O O
CKMB NNP B-NP O
nl NN I-NP O
and CC O O
cont NN B-NP O
pt's NN I-NP O
cardiac JJ B-NP B-m
medications NNS I-NP O
for IN B-VP O
BP NNP B-NP B-r
control NN I-NP I-r
and CC O O
ECG NNP B-NP O
early RB O O
R NNP B-NP O
wave VBP O O
but CC O O
no DT B-NP O
ST NNP I-NP O
changes NNS I-NP O
PT NNP I-NP O
denies VBZ O O
any DT B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
SOB NNP B-NP O
No NNP I-NP O
evidence NN I-NP O
of IN B-VP O
active JJ B-NP O
cardiac JJ I-NP O
ishemia NN I-NP O
Known NNP I-NP O
defective JJ B-NP O
circumflex NN I-NP O
artery NN I-NP O
but CC O O
pt NN B-NP O
refused VBD B-VP O
any DT B-NP O
medical JJ I-NP O
intervention NN I-NP O
at IN B-VP O
this DT B-NP O
point NN I-NP O
in IN B-VP O
time NN B-NP O
Would MD O O
like VB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
a DT B-NP O
PCP NNP I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
DM: NNP I-NP O
cont NN I-NP O
pt NN I-NP O
oral JJ B-NP B-mo
hypoglycemics NNS I-NP B-m
Normocytic JJ B-NP O
anemia: NN I-NP O
?anemia NN I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
PCP NNP B-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
, , O O
the DT B-NP O
work NN I-NP O
up RB O O
is VBZ O O
so RB O O
far RB O O
normal JJ B-NP O
PPX: NNP I-NP O
Heparin NNP I-NP B-m
Full NNP I-NP O
Code NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
Call NNP I-NP O
if IN B-VP O
pt NN B-NP O
has VBZ O O
any DT B-NP O
chest JJS I-NP O
discomfort NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
or CC O O
any DT B-NP O
increase NN I-NP O
fatigue NN I-NP O
or CC O O
weakness NN B-NP O
or CC O O
any DT B-NP O
other JJ I-NP O
concerns NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Please NNP B-NP O
go VB O O
to TO O O
your PRP$ O O
follow VB O O
up RP O O
appt RB O O
2 CD O O
Please NNP B-NP O
come VB O O
to TO O O
the DT B-NP O
ER NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
if IN B-VP O
you PRP O O
have VBP O O
any DT B-NP O
recurrent JJ I-NP O
chest NN I-NP O
pain NN I-NP O
or CC O O
any DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
SEREDA NNP I-NP O
, , O O
AHMED NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
UF337 NNP B-NP O
) ) O O
9/14/06 CD O O
@ $ O O
04:38 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#439236 VBZ O O
832383007 CD O O
ICMC NNP B-NP O
89731700 CD O O
826735 CD O O
0/4/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
GERD NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/6/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/18/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
LLOPIS NNP I-NP O
, , O O
EVERETTE NNP B-NP O
086-70-24-3 NNP I-NP O
Tl NNP I-NP O
Room: NNP I-NP O
Leahstock NNP I-NP O
Ra NNP I-NP O
Fay NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
2/19/01 CD O O
AT NNP B-NP O
11:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SOSNOWSKI NNP I-NP O
, , O O
WESLEY NNP B-NP O
NICOLAS NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ASA NNP I-NP B-m
( ( O I-m
ACETYLSALICYLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GEMFIBROZIL NNP I-NP B-m
600 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/4/01 CD O O
by IN B-VP O
REGALADO NNP B-NP O
, , O O
ANDREA NNP B-NP O
G NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ZOCOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
66826896 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
GEMFIBROZIL NNP I-NP B-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
req VBD B-VP O
GLYBURIDE NNP B-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
MAALOX NNP I-NP B-m
PLUS NNP I-NP I-m
EXTRA NNP I-NP I-m
STRENGTH NNP I-NP I-m
15 CD O B-do
ML NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Indigestion NNP I-NP B-r
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/4/01 CD O O
by IN B-VP O
IBACH NNP B-NP O
, , O O
RUBEN NNP B-NP O
T NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
GEMFIBROZIL NNP I-NP B-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
req NN I-NP O
AVANDIA NNP I-NP B-m
( ( O I-m
ROSIGLITAZONE NNP B-NP I-m
) ) O I-m
4 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
OCUFLOX NNP I-NP B-m
( ( O I-m
OFLOXACIN NNP B-NP I-m
0.3% CD O I-m
OPH NNP B-NP I-m
SOLUTION NNP I-NP I-m
) ) O I-m
1 CD O B-do
DROP NNP B-NP I-do
OS NNP I-NP B-mo
QID NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
4 CD O I-du
ATENOLOL NNP B-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
PRILOSEC NNP I-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GLUCOPHAGE NNP I-NP B-m
( ( O I-m
METFORMIN NNP B-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ALTACE NNP I-NP B-m
( ( O I-m
RAMIPRIL NNP B-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/19/01 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
RAMIPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
LOVENOX NNP I-NP B-m
( ( O I-m
ENOXAPARIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
SC NNP I-NP B-mo
Q12H NNP I-NP B-f
X NNP I-NP B-du
14 CD O I-du
Days NNPS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
7/20 CD O O
) ) O O
LOVENOX NNP B-NP B-m
( ( O I-m
ENOXAPARIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
SC NNP I-NP B-mo
QD NNP I-NP B-f
X NNP I-NP B-du
90 CD O I-du
Days NNP B-NP I-du
Starting VBG O O
2 CD O O
WEEKS NNP B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Immediately RB O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Shad NNP I-NP O
Palovick NNP I-NP O
1 CD O O
week NN B-NP O
, , O O
Dr NNP B-NP O
Emmitt NNP I-NP O
Quire NNP I-NP O
0/1/01 CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Procardia NNP I-NP O
( ( O O
nifedipine NN B-NP O
( ( O O
immed JJ B-NP O
release NN I-NP O
) ) O O
) ) O O
, , O O
Isordil NNP B-NP O
, , O O
Benadryl NNP B-NP O
( ( O O
diphenhydramine VB O O
hcl NN B-NP O
) ) O O
ADMIT NNP B-NP O
DIAGNOSIS: NNP I-NP O
abdominal JJ B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
GERD NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CAD NNP I-NP O
, , O O
NIDDM NNP B-NP O
, , O O
Hypercholesterolemia NNP B-NP O
, , O O
h/o NN B-NP O
DVT/PE NNP I-NP O
, , O O
h/o NN B-NP O
RLL NNP I-NP O
pneumonia NN I-NP O
, , O O
GERD NNP B-NP O
, , O O
cva NN B-NP O
( ( O O
cerebrovascular JJ B-NP O
accident NN I-NP O
) ) O O
, , O O
cabg NN B-NP O
( ( O O
cardiac JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
surgery NN I-NP O
) ) O O
pvd NN B-NP O
( ( O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
63 CD O O
year NN B-NP O
old JJ B-NP O
M NNP I-NP O
with IN B-VP O
h/o NN B-NP O
CAD NNP I-NP O
, , O O
MI NNP B-NP O
, , O O
s/p NN B-NP O
CABGx4 NNP I-NP O
, , O O
h/o NN B-NP O
PE NNP I-NP O
, , O O
h/o NN B-NP O
CVA NNP I-NP O
on IN B-VP O
coumadin NN B-NP B-m
, , O O
NIDDM NNP B-NP O
and CC O O
h/o JJ B-NP O
recent JJ I-NP O
pneumonia NN I-NP O
( ( O O
6/14 CD O O
) ) O O
who WP O O
now RB O O
presents VBZ O O
with IN B-VP O
intermittent JJ B-NP O
epigastric JJ I-NP O
pain NN I-NP O
associated VBN O O
with IN B-VP O
nausea NN B-NP O
, , O O
diaphoresis NN B-NP O
and CC O O
SOB NNP B-NP O
x NNP I-NP O
2 CD O O
days NNS B-NP O
which WDT O O
he PRP O O
notes VBZ O O
is VBZ O O
his PRP$ O O
anginal JJ B-NP O
equivalent NN I-NP O
He PRP O O
denied VBD B-VP O
any DT B-NP O
associated JJ I-NP O
CP NNP I-NP O
, , O O
fevers/chills/sweats NNS B-NP O
, , O O
diarrhea/constipation NN B-NP O
Exam NNP I-NP O
was VBD B-VP O
notable JJ O O
only RB O O
for IN B-VP O
mild JJ B-NP O
epigastric JJ I-NP O
tenderness NN I-NP O
Labs NNP I-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
Na NNP B-NP O
133 CD O O
and CC O O
Cr NNP B-NP O
1.7 CD O O
, , O O
negative JJ B-NP O
tropnin NN I-NP O
( ( O O
0.00 CD O O
) ) O O
and CC O O
CK NNP B-NP O
53 CD O O
, , O O
LFTs NNP B-NP O
normal JJ B-NP O
RUQ NNP I-NP O
ultrasound NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
normal JJ B-NP O
gall JJ I-NP O
bladder NN I-NP O
with IN B-VP O
a DT B-NP O
fatty JJ I-NP O
liver NN I-NP O
and CC O O
gallstones NNS B-NP O
and CC O O
no DT B-NP O
sonographic JJ I-NP O
Murphy's NNP I-NP O
ECG NNP I-NP O
showed VBD B-VP O
NSR NNP B-NP O
at IN B-VP O
80 CD O O
with IN B-VP O
flat JJ B-NP O
T NNP I-NP O
in IN B-VP O
I PRP O O
and CC O O
flipped VBD B-VP O
T NNP B-NP O
waves NNS I-NP O
in IN B-VP O
2 CD O O
, , O O
3 CD O O
( ( O O
all DT O O
old JJ O O
) ) O O
and CC O O
new JJ B-NP O
T NNP I-NP O
wave NN I-NP O
inversions NNS I-NP O
V5/V6 NNP I-NP O
V/Q NNP I-NP O
scan NN I-NP O
was VBD B-VP O
intermediate JJ B-NP O
probability NN I-NP O
likely RB O O
secondary JJ O O
to TO O O
recent JJ B-NP O
pne NN I-NP O
umonia NN I-NP O
, , O O
but CC O O
d-dimer JJ O O
800 CD O O
Pt NNP B-NP O
had VBD B-VP O
+LENI's VBN O O
Given VBN O O
his PRP$ O O
history NN B-NP O
of IN B-VP O
CVA NNP B-NP O
on IN B-VP O
anticoagulation NN B-NP B-r
anticoagulation NN I-NP B-r
, , O O
Dr NNP B-NP O
Yuenger NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
reccomended VBN O O
starting VBG O O
the DT B-NP O
patient NN I-NP O
on IN B-VP O
reduced VBN O O
dose JJ B-NP O
lovenox NN I-NP B-m
lovenox NN I-NP B-m
( ( O O
50mg CD O B-do
sc RB O B-mo
bid NN B-NP B-f
x VBZ O B-du
2 CD O I-du
wk NN B-NP I-du
and CC O O
40mg CD O B-do
sc NN B-NP B-mo
x VBD B-VP B-du
3 CD O I-du
mo NN B-NP I-du
) ) O O
Checked VBD B-VP O
heparin JJ B-NP O
level NN I-NP O
( ( O O
0.9 CD O O
) ) O O
so RB O O
reduced JJ B-NP O
dose NN I-NP O
of IN B-VP O
lovenox NN B-NP B-m
to TO O O
lovenox VB O B-m
40mg CD O B-do
sc JJ B-NP B-mo
bid NN I-NP B-f
LENIS NNP I-NP O
to TO O O
be VB O O
repeated VBN O O
in IN B-VP O
3 CD O O
months NNS B-NP O
prior RB O O
to TO O O
d/c VB O O
lovenox JJ B-NP B-m
MI NNP I-NP O
and CC O O
was VBD B-VP O
ruled VBN O O
out RP O O
He PRP O O
underwent JJ O O
adenosine-MIBI JJ O O
which WDT O O
was VBD B-VP O
without IN B-VP O
change NN B-NP O
vs IN B-VP O
his PRP$ O O
dobutamine-MIBI JJ B-NP B-m
'00 NN I-NP O
He PRP O O
was VBD B-VP O
felt VBN O O
to TO O O
have VB O O
mild VBN O O
gastritis/GERD NNS B-NP O
and CC O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
his PRP$ O B-m
regular JJ B-NP I-m
medications NNS I-NP I-m
as RB O O
well RB O O
as IN B-VP O
Prilosec NNP B-NP B-m
20 CD O B-do
BID NNP B-NP B-f
and CC O O
Lovenox NNP B-NP B-m
as IN B-VP O
above IN B-VP O
He PRP O O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
and CC O O
will MD O O
follow-up VB O O
with IN B-VP O
Dr NNP B-NP O
Chadwick NNP I-NP O
Lafone NNP I-NP O
and CC O O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
Please NNP B-NP O
set VBD B-VP O
up RP O O
a DT B-NP O
follow-up JJ I-NP O
appointment NN I-NP O
with IN B-VP O
your PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
within IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
for IN B-VP O
re-assessment NN B-NP O
of IN B-VP O
GI NNP B-NP O
distress NN I-NP O
2 CD O O
Follow-up NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Frank NNP I-NP O
Trigleth NNP I-NP O
within IN B-VP O
1 CD O O
week NN B-NP O
3 CD O O
Take NNP B-NP O
lovenox NN I-NP B-m
as IN B-VP O
directed JJ O O
4 CD O O
Please NNP B-NP O
return NN I-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
with IN B-VP O
worsening VBG O O
symptoms NNS B-NP O
or CC O O
new JJ B-NP O
fevers/chills/sweats NNS I-NP O
, , O O
chest JJS B-NP O
pain NN I-NP O
, , O O
difficulty NN B-NP O
breathing VBG O O
5 CD O O
VNA NNP B-NP O
for IN B-VP O
lovenox JJ B-NP B-m
teaching/compliance NN I-NP O
Medication NNP I-NP O
compliance NN I-NP O
6 CD O O
VNA NNP B-NP O
to TO O O
draw VB O O
serum JJ B-NP O
potassium NN I-NP O
7/21 CD O O
and CC O O
send VB O O
result NN B-NP O
into IN B-VP O
Dr NNP B-NP O
Ambrose NNP I-NP O
Rumple NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Continue NNP B-NP O
home NN I-NP B-m
meds NNS I-NP I-m
2 CD O O
VNA NNP B-NP O
for IN B-VP O
assistance NN B-NP O
with IN B-VP O
Lovenox NNP B-NP B-m
and CC O O
meds NNS B-NP B-m
3 CD O O
Lovenox NNP B-NP B-m
as IN B-VP O
directed JJ O O
4 CD O O
Follow-up JJ B-NP O
LENIS NNP I-NP O
in IN B-VP O
3 CD O O
months NNS B-NP O
before IN B-VP O
d/c JJ O O
lovenox JJ O B-m
5 CD O O
Follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Dean NNP I-NP O
Cooke NNP I-NP O
AND NNP I-NP O
pcp VBZ O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GETTO NNP I-NP O
, , O O
LEO NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
WH9 NNP B-NP O
) ) O O
2/19/01 CD O O
@ $ O O
03 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#439766 VBZ O O
761109598 CD O O
NNMC NNP B-NP O
78121632 CD O O
525450 CD O O
4/5/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
? . B-VP O
MYOCAEDIAL NNP B-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/28/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/16/2001 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Almon NNP I-NP O
is VBZ O O
a DT O O
51 CD O O
year NN B-NP O
old JJ B-NP O
gentleman NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
insulin NN B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus NNS B-NP O
and CC O O
unstable JJ B-NP O
angina NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
doing VBG O O
yard JJ B-NP O
work NN I-NP O
in IN B-VP O
the DT B-NP O
afternoon NN I-NP O
when WRB O O
he PRP O O
experienced VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
nausea NN B-NP O
and CC O O
vomiting VBG O O
along RB O O
with IN B-VP O
chest NN B-NP O
discomfort NN I-NP O
The DT B-NP O
patient NN I-NP O
presented VBD B-VP O
to TO O O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
who WP O O
noted VBD B-VP O
EKG NNP B-NP O
changes NNS I-NP O
with IN B-VP O
ST NNP B-NP O
depressions NNS I-NP O
in IN B-VP O
V3 NNP B-NP O
to TO O O
V6 NNP B-NP O
and CC O O
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
which WDT O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
an DT B-NP O
old JJ I-NP O
T NNP I-NP O
wave NN I-NP O
inversion NN I-NP O
in IN B-VP O
lead NN B-NP O
3 CD O O
which WDT O O
was VBD B-VP O
now RB O O
upright JJ O O
and CC O O
ST NNP B-NP O
depressions NNS I-NP O
that WDT O O
were VBD B-VP O
normalizing VBG O O
CKs NNP B-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
were VBD B-VP O
974 CD O O
, , O O
MB NNP B-NP O
24.3 CD O O
, , O O
Troponin NNP B-NP O
level NN I-NP O
was VBD B-VP O
1.77 CD O O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
aspirin JJ O B-m
5 CD O B-do
mg NN B-NP I-do
of IN B-VP O
intravenous JJ B-NP B-mo
Lopressor NNP I-NP B-m
, , O O
Heparin NNP B-NP B-m
drip NN I-NP B-mo
and CC O O
Adenosine NNP B-NP B-m
MIBI NNP I-NP O
which WDT O O
was VBD B-VP O
performed VBN O O
back RB O O
in IN B-VP O
May NNP B-NP O
of IN B-VP O
1999 CD O O
revealed VBD B-VP O
inferior JJ B-NP O
ischemia NN I-NP O
The DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
2001 CD O O
which WDT O O
revealed VBD B-VP O
the DT B-NP O
following: NN I-NP O
Right NNP I-NP O
dominant NN I-NP O
system NN I-NP O
, , O O
no DT O O
significant JJ O O
left VBD B-VP O
main JJ B-NP O
lesions NNS I-NP O
identified VBN O O
, , O O
left VBD B-VP O
anterior RP O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
with IN B-VP O
a DT B-NP O
discreet NN I-NP O
mid NN I-NP O
65% CD O O
lesion NN B-NP O
, , O O
distal JJ O O
99% CD O O
lesion NN B-NP O
and CC O O
first JJ B-NP O
diagonal JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
with IN B-VP O
a DT O O
proximal JJ O O
discrete JJ O O
70% CD O O
lesion NN B-NP O
, , O O
left VBD B-VP O
circumflex JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
with IN B-VP O
a DT B-NP O
distal NN I-NP O
after IN B-VP O
the DT B-NP O
second JJ I-NP O
obtuse NN I-NP O
marginal JJ O O
discrete JJ O O
60% CD O O
lesion NN B-NP O
, , O O
supplying VBG O O
the DT B-NP O
second JJ I-NP O
obtuse NN I-NP O
marginal JJ B-NP O
First NNP I-NP O
marginal JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
had VBD B-VP O
an DT B-NP O
ostial JJ I-NP O
discrete NN I-NP O
90% CD O O
lesion NN B-NP O
and CC O O
a DT B-NP O
second JJ I-NP O
obtuse NN I-NP O
marginal NN I-NP O
had VBD B-VP O
an DT B-NP O
ostial JJ I-NP O
discrete NN I-NP O
100% CD O O
lesion NN B-NP O
Right NNP I-NP O
coronary NN I-NP O
artery NN I-NP O
had VBD B-VP O
a DT O O
mid JJ O O
discrete JJ O O
95% CD O O
lesion NN B-NP O
supplying VBG O O
the DT B-NP O
right JJ I-NP O
posterior NN I-NP O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
He PRP O O
was VBD B-VP O
also RB O O
noted VBN O O
to TO O O
have VB O O
collateral JJ B-NP O
flow NN I-NP O
from IN B-VP O
left JJ O O
anterior JJ O O
descending VBG O O
artery NN B-NP O
to TO O O
the DT B-NP O
right JJ I-NP O
posterior NN I-NP O
descending VBG O O
artery IN B-VP O
The DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
echocardiogram NN I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
2001 CD O O
which WDT O O
revealed VBD B-VP O
the DT B-NP O
following: NN I-NP O
1 CD O O
There EX O O
was VBD B-VP O
mild JJ O O
concentric JJ O O
left VBD B-VP O
ventricular JJ B-NP O
hypertrophy NN I-NP O
with IN B-VP O
normal JJ B-NP O
cavity NN I-NP O
size NN I-NP O
Left NNP I-NP O
ventricular VBZ O O
systolic JJ B-NP O
function NN I-NP O
is VBZ O O
mildly RB O O
reduced VBN O O
with IN B-VP O
an DT O O
estimated VBN O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
45% CD O O
There EX O O
is VBZ O O
severe JJ B-NP O
hypokinesis NN I-NP O
of IN B-VP O
the DT B-NP O
basal NN I-NP O
and CC O O
mid JJ B-NP O
segments NNS I-NP O
of IN B-VP O
the DT B-NP O
inferior JJ I-NP O
wall NN I-NP O
and CC O O
inferior JJ B-NP O
septum NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
there EX O O
is VBZ O O
severe JJ B-NP O
hypokinesis NN I-NP O
of IN B-VP O
the DT B-NP O
posterior NN I-NP O
wall NN I-NP O
, , O O
apex NN B-NP O
and CC O O
distal JJ O O
anterior RB O O
wall NN B-NP O
THis NNP I-NP O
is VBZ O O
suggestive JJ O O
of IN B-VP O
multiple JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
2 CD O O
The DT B-NP O
right JJ I-NP O
ventricle NN I-NP O
appears VBZ O O
normal JJ O O
in IN B-VP O
size NN B-NP O
and CC O O
systolic JJ B-NP O
function NN I-NP O
3 CD O O
The DT B-NP O
mitral JJ I-NP O
valve NN I-NP O
appears VBZ O O
mildly RB O O
thickened VBD B-VP O
The DT B-NP O
anterior JJ I-NP O
mitral JJ I-NP O
leaflet NN I-NP O
is VBZ O O
mildly RB O O
elongated JJ O O
and CC O O
there EX O O
might MD O O
be VB O O
mild JJ B-NP O
systolic JJ I-NP O
prolapse NN I-NP O
of IN B-VP O
the DT B-NP O
anterior JJ I-NP O
leaflet NN I-NP O
Mild NNP I-NP O
mitral JJ B-NP O
regurgitation NN I-NP O
is VBZ O O
seen VBN O O
4 CD O O
The DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
is VBZ O O
trileaflet VBN O O
and CC O O
appears VBZ O O
mildly RB O O
thickened VBN O O
There EX O O
is VBZ O O
no DT B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
or CC O O
regurgitation NN B-NP O
5 CD O O
The DT B-NP O
tricuspid JJ I-NP O
valve NN I-NP O
appears VBZ O O
structurally RB O O
normal JJ B-NP O
No NNP I-NP O
significant JJ B-NP O
tricuspid JJ I-NP O
regurgitation NN I-NP O
is VBZ O O
seen VBN O O
6 CD O O
There EX O O
is VBZ O O
no DT B-NP O
pericardial JJ I-NP O
effusion NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY/ NNP I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
insulin NN B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
MEDICATIONS: NNP I-NP O
On IN B-VP O
admission NN B-NP O
are VBP O O
Lisinopril NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Zocor NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
vitamin NN B-NP B-m
E NNP I-NP I-m
, , O O
enteric RB O B-m
coated VBD B-VP I-m
aspirin JJ O I-m
325 CD O B-do
mg NN B-NP I-do
every DT B-NP B-f
other JJ I-NP I-f
day NN I-NP I-f
, , O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
Humulin NNP I-NP I-m
Humulin NNP I-NP I-m
insulin NN I-NP I-m
insulin NN I-NP I-m
40 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
and CC O O
10 CD O B-do
in IN B-VP B-f
the DT B-NP I-f
evening NN I-NP I-f
, , O O
regular JJ B-NP B-m
insulin NN I-NP I-m
6 CD O B-do
units NNS B-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
and CC O O
multivitamin VB O B-m
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
Noncontributory NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Mr NNP I-NP O
Bingamon NNP I-NP O
was VBD B-VP O
rushed VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
2001 CD O O
where WRB O O
he PRP O O
underwent VBD B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
x VBD B-VP O
3 CD O O
with IN B-VP O
a DT B-NP O
left JJ I-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
left VB O O
anterior RP O O
descending VBG O O
artery NN B-NP O
, , O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
obtuse NN I-NP O
marginal JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
and CC O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
intermediate JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
intraoperatively RB O O
, , O O
came VBD B-VP O
off RP O O
bypass NN B-NP O
without IN B-VP O
incident NN B-NP O
, , O O
was VBD B-VP O
brought VBN O O
up RP O O
to TO O O
the DT B-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
and CC O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
Postoperatively RB O O
, , O O
Mr NNP B-NP O
Bown NNP I-NP O
did VBD B-VP O
very RB O O
well RB O O
He PRP O O
was VBD B-VP O
extubated VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
one CD O O
and CC O O
transferred VBD B-VP O
to TO O O
the DT B-NP O
step NN I-NP O
down RB O O
unit NN B-NP O
He PRP O O
had VBD B-VP O
an DT B-NP O
unremarkable JJ I-NP O
postoperative JJ I-NP O
course NN I-NP O
until IN B-VP O
the DT B-NP O
night NN I-NP O
prior RB O O
to TO O O
discharge VB O O
when WRB O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
serous JJ B-NP O
drainage NN I-NP O
from IN B-VP O
the DT B-NP O
inferior JJ I-NP O
aspect NN I-NP O
of IN B-VP O
his PRP$ O O
sternal JJ B-NP O
incision NN I-NP O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
no DT B-NP O
sternal JJ I-NP O
click NN I-NP O
and CC O O
his PRP$ O O
white JJ B-NP O
count NN I-NP O
did VBD B-VP O
go VB O O
from IN B-VP O
9.2 CD O O
on IN B-VP O
May NNP B-NP O
to TO O O
11.26 CD O O
on IN B-VP O
February NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
T.max NNP I-NP O
of IN B-VP O
99 CD O O
We PRP O O
did VBD B-VP O
start VB O O
him PRP O O
on IN B-VP O
Keflex NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
four CD O B-f
times NNS B-NP O
a DT B-NP O
day NN I-NP O
for IN B-VP B-du
10 CD O I-du
days NNS B-NP I-du
and CC O O
he PRP O O
will MD O O
have VB O O
a DT B-NP O
follow-up JJ I-NP O
white JJ I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
2001 CD O O
which WDT O O
shall MD O O
be VB O O
called VBN O O
into IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician JJ B-NP O
Mr NNP I-NP O
Piotrowski NNP I-NP O
other JJ B-NP O
labs NN I-NP O
for IN B-VP O
February NNP B-NP O
, , O O
2001 CD O O
are VBP O O
as IN B-VP O
follows: NNS B-NP O
Glucose NNP I-NP O
291 CD O O
, , O O
BUN NNP B-NP O
20 CD O O
, , O O
creatinine NN B-NP O
of IN B-VP O
0.9 CD O O
, , O O
sodium NN B-NP O
136 CD O O
, , O O
potassium NN B-NP O
5 CD O O
, , O O
chloride NN B-NP O
of IN B-VP O
97 CD O O
, , O O
CO2 NNP B-NP O
of IN B-VP O
31 CD O O
, , O O
magnesium NN B-NP O
of IN B-VP O
1.5 CD O O
WBC NNP B-NP O
was VBD B-VP O
11.26 CD O O
, , O O
hemoglobin NN B-NP O
9.2 CD O O
, , O O
hematocrit NN B-NP O
28.2 CD O O
, , O O
platelets NNS B-NP O
438 CD O O
PT NNP B-NP O
was VBD B-VP O
12.7 CD O O
, , O O
PT/INR NNP B-NP O
of IN B-VP O
1.1 CD O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
For IN B-VP O
Mr NNP B-NP O
Eide NNP I-NP O
are VBP O O
as IN B-VP O
follows: JJ B-NP O
Enteric NNP I-NP B-m
coated VBD B-VP O
aspirin RB O O
325 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
ibuprofen RB O B-m
200 CD O B-do
to TO O I-do
800 CD O I-do
mg NN B-NP I-do
every DT O B-f
4 CD O I-f
to TO O I-f
6 CD O I-f
h NN B-NP I-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
Humulin NNP I-NP I-m
Humulin NNP I-NP I-m
insulin NN I-NP I-m
insulin NN I-NP I-m
44 CD O B-do
units NNS B-NP O
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
, , O O
14 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
evening NN I-NP I-f
, , O O
regular JJ B-NP B-m
insulin NN I-NP I-m
6 CD O B-do
units NNS B-NP O
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
potassium NN B-NP B-m
chloride NN I-NP I-m
20 CD O B-do
mEq NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Zocor NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
once RB O B-f
in IN B-VP I-f
the DT B-NP I-f
evening NN I-NP I-f
, , O O
Atenolol NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Lisinopril NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Keflex NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
four CD O B-f
times NNS B-NP O
a DT B-NP O
day NN I-NP O
for IN B-VP B-du
10 CD O I-du
days NNS B-NP I-du
for IN B-VP O
his PRP$ O B-r
superficial JJ B-NP I-r
sternal JJ I-NP I-r
wound NN I-NP I-r
infection NN I-NP I-r
and CC O O
torsemide VB O B-m
60 CD O B-do
mg NN B-NP I-do
twice RB O B-f
a DT B-NP I-f
day NN I-NP I-f
DISPOSITION: NNP I-NP O
Mr NNP I-NP O
Geronimo NNP I-NP O
will MD O O
be VB O O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
He PRP O O
will MD O O
follow-up VB O O
with IN B-VP O
Dr NNP B-NP O
Vern NNP I-NP O
Meehan NNP I-NP O
in IN B-VP O
six CD O O
weeks NNS B-NP O
, , O O
Dr NNP B-NP O
Tyrone NNP I-NP O
Younis NNP I-NP O
in IN B-VP O
two CD O O
weeks NNS B-NP O
and CC O O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
, , O O
Dr NNP B-NP O
Waldie NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
He PRP O O
is VBZ O O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MICHALE NNP I-NP O
SCHMIEL NNP I-NP O
, , O O
P.A NNP B-NP O
Attending: NNP I-NP O
CARROLL NNP I-NP O
F NNP I-NP O
YABLONSKY NNP I-NP O
, , O O
M.D NNP B-NP O
BF88 NNP I-NP O
QI057/9707 NNP I-NP O
Batch: NNP I-NP O
04367 CD O O
Index NNP B-NP O
No NNP I-NP O
D9XLM86A6X NNP I-NP O
D: NNP I-NP O
3/1/01 CD O O
T: NNP B-NP O
7/18/01 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#442126 VBZ O O
840157437 CD O O
CBZMC NNP B-NP O
29175143 CD O O
019871 CD O O
10/23/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/30/1999 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/27/1999 CD O O
FINAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
70 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
type NN B-NP O
II NNP I-NP O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
and CC O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
who WP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT B-NP O
PTCA/stent NN I-NP O
of IN B-VP O
obtuse NN B-NP O
marginal JJ O O
1 CD O O
in IN B-VP O
August NNP B-NP O
of IN B-VP O
1990 CD O O
which WDT O O
restenosed VBD B-VP O
and CC O O
required JJ B-NP O
rotablation NN I-NP O
and CC O O
restenting NN B-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1998 CD O O
who WP O O
presents VBZ O O
now RB O O
with IN B-VP O
unstable JJ O O
angina VBP O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
increasing VBG O O
chest JJS B-NP O
pain NN I-NP O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
month NN I-NP O
progressing VBG O O
to TO O O
pain VB O O
at IN B-VP O
rest NN B-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
department NN I-NP O
with IN B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
230/90 CD O O
The DT B-NP B-r
patient's NN I-NP I-r
blood NN I-NP I-r
pressure NN I-NP I-r
was VBD B-VP O
controlled VBN O O
with IN B-VP O
IV NNP B-NP B-mo
Lopressor NNP I-NP B-m
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
rule NN B-NP O
out IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
The DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
2/25/99 CD O O
which WDT O O
revealed VBD B-VP O
the DT B-NP O
following: NN I-NP O
A NNP I-NP O
stent JJ B-NP O
restenosis NN I-NP O
of IN B-VP O
left JJ B-NP O
circumflex JJ I-NP O
artery NN I-NP O
, , O O
a DT O O
60 CD O O
percent NN B-NP O
left VBD B-VP O
anterior JJ O O
descending VBG O O
artery JJ B-NP O
stenosis NN I-NP O
, , O O
a DT O O
70 CD O O
percent NN B-NP O
diagonal JJ B-NP O
ostial JJ I-NP O
stenosis NN I-NP O
, , O O
a DT O O
40 CD O O
percent NN B-NP O
ostial JJ B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
stenosis NN I-NP O
, , O O
and CC O O
95 CD O O
percent NN B-NP O
ostial JJ O O
posterior JJ O O
descending VBG O O
artery JJ B-NP O
stenosis NN I-NP O
No NNP I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
was VBD B-VP O
noted VBN O O
and CC O O
ejection JJ B-NP O
fraction NN I-NP O
was VBD B-VP O
approximately RB O O
50 CD O O
percent NN B-NP O
calculated VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
subsequently RB O O
scheduled VBN O O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
Hypertension NNP I-NP O
Congestive NNP I-NP O
heart NN I-NP O
failure NN I-NP O
Type NNP I-NP B-r
II NNP I-NP O
diabetes VBZ O O
mellitus FW O O
requiring VBG O O
insulin JJ B-NP B-m
Peripheral NNP I-NP O
vascular NN I-NP O
disease NN I-NP O
Gastroesophageal NNP I-NP O
reflux VBZ O O
disease NN B-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Left NNP I-NP O
lower JJR B-NP O
extremity NN I-NP O
revascularization NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Spanish-speaking NNP I-NP O
female JJ B-NP O
HEENT: NNP I-NP O
Unremarkable NNP I-NP O
Carotid NNP I-NP O
pulses VBZ O O
1 CD O O
plus CC O O
bilaterally RB O O
with IN B-VP O
no DT B-NP O
bruits NNS I-NP O
Lungs NNS I-NP O
clear VBP O O
to TO O O
auscultation VB O O
bilaterally RB O O
Heart: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
No NNP I-NP O
murmurs NN I-NP O
Abdomen: NNP I-NP O
Soft NNP I-NP O
, , O O
nontender NN B-NP O
, , O O
nondistended VBD B-VP O
Firm NN B-NP O
to TO O O
palpation NN B-NP O
in IN B-VP O
both DT B-NP O
lower JJR I-NP O
quadrants NNS I-NP O
in IN B-VP O
area NN B-NP O
of IN B-VP O
lower JJR B-NP O
midline NN I-NP O
scar NN I-NP O
Extremities: NNP I-NP O
Tenderness NNP I-NP O
to TO O O
palpation NN B-NP O
in IN B-VP O
bilateral JJ B-NP O
lower JJR I-NP O
extremities NNS I-NP O
which WDT O O
was VBD B-VP O
diffuse NN B-NP O
and CC O O
nonspecific JJ B-NP O
Peripheral NNP I-NP O
pulses NNS I-NP O
revealed VBD B-VP O
1 CD O O
plus CC O O
dorsalis JJ B-NP O
pedis NN I-NP O
pulse NN I-NP O
and CC O O
1 CD O O
plus CC O O
posterior JJ B-NP O
tibial JJ I-NP O
pulse NN I-NP O
on IN B-VP O
right JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
and CC O O
2 CD O O
plus CC O O
dorsalis JJ B-NP O
pedis NN I-NP O
pulse NN I-NP O
and CC O O
2 CD O O
plus CC O O
posterior JJ B-NP O
tibial JJ I-NP O
pulse NN I-NP O
on IN B-VP O
left NNS B-NP O
lower JJR B-NP O
extremity NN I-NP O
with IN B-VP O
1 CD O O
plus CC O O
edema VB O O
bilaterally RB O O
Neurologic: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
conscious JJ O O
and CC O O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
three CD O O
with IN B-VP O
no DT B-NP O
deficits NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Sodium NNP I-NP O
140 CD O O
, , O O
potassium NN B-NP O
4.7 CD O O
, , O O
BUN NNP B-NP O
18 CD O O
, , O O
creatinine NN B-NP O
1.0 CD O O
, , O O
glucose VBD B-VP O
205 CD O O
WBC NNP B-NP O
12 CD O O
, , O O
hematocrit NN B-NP O
37 CD O O
, , O O
INR NNP B-NP O
0.1 CD O O
ECG NNP B-NP O
revealed VBD B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
nonspecific JJ B-NP O
ST-T NNP I-NP O
wave NN I-NP O
changes NNS I-NP O
MEDICATIONS: NNP I-NP O
Aspirin NNP I-NP B-m
325 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Atenolol NNP B-NP B-m
125 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Captopril NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Colace NNP B-NP B-m
, , O O
Axid NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Amlodipine NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Imdur NNP B-NP B-m
120 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
and CC O O
insulin NN B-NP B-m
NPH NNP I-NP I-m
22 CD O B-do
units NNS B-NP I-do
q.a.m RB O B-f
and CC O O
regular JJ O O
10 CD O B-do
units NNS B-NP I-do
q.a.m JJ B-NP B-f
ALLERGIES: NNP I-NP O
Penicillin- NNP I-NP O
rash NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
On IN B-VP O
1/30/99 CD O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
and CC O O
underwent NN B-NP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
times NNS I-NP O
three CD O O
with IN B-VP O
a DT B-NP O
left JJ I-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
the DT O O
left VBN O O
anterior JJ O O
descending VBG O O
artery NN B-NP O
and CC O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
obtuse VB O O
marginal JJ O O
and CC O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
posterior VB O O
descending VBG O O
artery RB O O
After IN B-VP O
surgery NN B-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 VBD B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
extubated VBN O O
without IN B-VP O
incident NN B-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#2 VBD B-VP O
the DT B-NP O
patient NN I-NP O
experienced VBD B-VP O
a DT B-NP O
period NN I-NP O
of IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
with IN B-VP O
a DT B-NP O
rapid JJ I-NP O
ventricular JJ I-NP O
response NN I-NP O
and CC O O
rates NNS B-NP O
in IN B-VP O
the DT O O
150s CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
IV NNP B-NP B-mo
Lopressor NNP I-NP B-m
and CC O O
Diltiazem NNP B-NP B-m
drip NN I-NP O
at IN B-VP O
10 CD O B-do
mg/hr FW O I-do
The DT B-NP O
patient NN I-NP O
subsequently RB O O
converted VBD B-VP O
spontaneously RB O O
to TO O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
Postoperatively RB O O
the DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
experience VB O O
hypertension NN B-NP B-r
hypertension NN I-NP B-r
with IN B-VP O
systolic JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
ranging VBG O O
from IN B-VP O
160s CD O O
to TO O O
190s CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
back RB O O
on IN B-VP O
Lopressor NNP B-NP B-m
and CC O O
Captopril NNP B-NP B-m
and CC O O
gradually RB O O
increased VBD B-VP O
to TO O O
preoperative JJ B-NP O
doses NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
started VBN O O
back RP O O
on IN B-VP O
Amlodipine NNP B-NP B-m
for IN B-VP O
further JJ B-NP B-r
blood NN I-NP O
pressure NN I-NP O
control VB O O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
experience VB O O
brief JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
with IN B-VP O
spontaneous JJ B-NP O
conversion NN I-NP O
to TO O O
normal JJ B-NP O
sinus NN I-NP O
rhythm VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
followed VBN O O
by IN B-VP O
her PRP$ O O
cardiologist NN B-NP O
postoperatively RB O O
, , O O
Dr NNP B-NP O
Grunow NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
anticoagulation NN B-NP B-r
with IN B-VP O
Coumadin NNP B-NP B-m
The DT B-NP O
patient's NN I-NP O
atrial JJ B-NP O
fibrillation NN I-NP O
continued VBD B-VP O
to TO O O
decrease VB O O
in IN B-VP O
frequency NN B-NP O
and CC O O
duration NN B-NP O
and CC O O
, , O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
for IN B-VP O
greater JJR O O
than IN B-VP O
24 CD O O
hours NNS B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
service NN I-NP O
and CC O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
benefit VB O O
from IN B-VP O
rehabilitation NN B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
scheduled VBN O O
to TO O O
be VB O O
discharged VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#8 NNP I-NP O
to TO O O
rehabilitation VB O O
facility NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
with IN B-VP O
all DT B-NP O
wounds NNS I-NP O
clean JJ O O
and CC O O
dry JJ O O
On IN B-VP O
day NN B-NP O
of IN B-VP O
discharge NN B-NP O
her PRP$ O O
sodium NN B-NP O
is VBZ O O
137 CD O O
, , O O
potassium NN B-NP O
3.9 CD O O
, , O O
BUN NNP B-NP O
16 CD O O
, , O O
creatinine NN B-NP O
0.9 CD O O
, , O O
glucose VBD B-VP O
163 CD O O
WBC NNP B-NP O
16.7 CD O O
, , O O
hematocrit NN B-NP O
31 CD O O
, , O O
platelet NN B-NP O
count NN I-NP O
340 CD O O
, , O O
INR NNP B-NP O
2.3 CD O O
DISPOSITION: NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Atenolol NNP I-NP B-m
125 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Captopril NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
insulin NN B-NP O
22 CD O B-do
units NNS B-NP I-do
NPH NNP I-NP O
subcu NN I-NP B-mo
q.a.m NN I-NP B-f
and CC O O
10 CD O B-do
units NNS B-NP I-do
regular JJ B-NP O
subcu NN I-NP B-mo
q.a.m NN I-NP B-f
, , O O
CZI NNP B-NP B-m
regular JJ B-NP I-m
insulin NN I-NP I-m
sliding VBG O B-do
scale NN B-NP O
, , O O
Percocet NNP B-NP B-m
1 CD O B-do
to TO O I-do
2 CD O I-do
tablets NNS B-NP I-do
p.o VBP O B-mo
q3 SYM O B-f
- : O I-f
4h CD O I-f
p.r.n NN B-NP I-f
pain NN I-NP B-r
, , O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Coumadin NNP B-NP B-m
dosed VBD B-VP O
to TO O O
INR NNP B-NP O
of IN B-VP O
2 CD O O
to TO O O
2.5 CD O O
, , O O
and CC O O
Amlodipine NNP B-NP B-m
5 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.d NN I-NP B-f
FOLLOWUP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
follow-up JJ O O
in IN B-VP O
six CD O O
weeks NNS B-NP O
with IN B-VP O
cardiac JJ B-NP O
surgeon NN I-NP O
, , O O
Dr NNP B-NP O
Standrew NNP I-NP O
, , O O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Birdsong NNP I-NP O
, , O O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
, , O O
and CC O O
with IN B-VP O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Shelko NNP I-NP O
, , O O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
the DT B-NP O
Faithhugh NNP I-NP O
Lowe NNP I-NP O
County NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MARCEL NNP I-NP O
SHABOT NNP I-NP O
, , O O
P.A NNP B-NP O
Attending: NNP I-NP O
DOYLE NNP I-NP O
S NNP I-NP O
VARAKUTA NNP I-NP O
, , O O
M.D NNP B-NP O
HK45 NNP I-NP O
RY675/7835 NNP I-NP O
Batch: NNP I-NP O
3215 CD O O
Index NNP B-NP O
No NNP I-NP O
AFKJ4311BM NNP I-NP O
D: NNP I-NP O
9/19/99 CD O O
T: NNP B-NP O
9/19/99 CD O O
UZ5 NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#449738 VBZ O O
789989806 CD O O
HMC NNP B-NP O
20775881 CD O O
9405886 CD O O
7/0/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/10/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/1/2005 CD O O
ATTENDING: NNP B-NP O
KEMERER NNP I-NP O
, , O O
DEAN NNP B-NP O
OMAR NNP I-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
Cardiology NNP I-NP O
Usoslee NNP I-NP O
Avenue NNP I-NP O
, , O O
Ri NNP B-NP O
Dar NNP I-NP O
Cincogarlstock NNP I-NP O
, , O O
22451 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
Acute NNP I-NP O
renal JJ B-NP O
failure NN I-NP O
PROBLEMS NNP I-NP O
AND NNP I-NP O
DIAGNOSIS: NNP I-NP O
Ischemic NNP I-NP O
cardiomyopathy NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus VBP O O
with IN B-VP O
neuropathy JJ O O
, , O O
hypercholesterolemia NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
polyarticular JJ B-NP O
gout NN I-NP O
, , O O
elevated VBD B-VP O
CK NNP B-NP O
, , O O
and CC O O
osteoarthritis NN B-NP O
left VBD B-VP O
hip JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Sheumaker NNP I-NP O
is VBZ O O
a DT B-NP O
65-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
known VBN O O
cardiomyopathy NN B-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
osteoarthritis NN B-NP O
, , O O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus NNS I-NP O
, , O O
who WP O O
presented VBD B-VP O
with IN B-VP O
a DT O O
1 CD O O
week NN B-NP O
of IN B-VP O
progressive JJ B-NP O
fatigue NN I-NP O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
In IN B-VP O
the DT O O
prior JJ O O
2 CD O B-du
weeks NNS B-NP I-du
, , O O
he PRP O O
had VBD B-VP O
been VBN O O
started VBN O O
on IN B-VP O
hydrochlorothiazide NN B-NP B-m
He PRP O O
had VBD B-VP O
been VBN O O
nauseated VBN O O
and CC O O
vomiting VBG O O
as IN B-VP O
a DT B-NP O
result NN I-NP O
of IN B-VP O
Percocet NNP B-NP B-m
taken VBN O O
for IN B-VP O
his PRP$ O B-r
left JJ B-NP I-r
hip NN I-NP I-r
pain NN I-NP I-r
with IN B-VP O
resulting VBG O O
decreased VBN O O
p.o NNS B-NP O
intake VB O O
He PRP O O
was VBD B-VP O
evaluated VBN O O
in IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
clinic NN I-NP O
and CC O O
felt VBD B-VP O
to TO O O
be VB O O
in IN B-VP O
decompensated JJ B-NP O
heart NN I-NP O
failure NN I-NP O
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
dehydrated VBN O O
and CC O O
found VBN O O
to TO O O
be VB O O
in IN B-VP O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
hyperkalemic JJ O O
, , O O
and CC O O
uremic JJ O O
He PRP O O
complained VBD B-VP O
of IN B-VP O
joint JJ B-NP O
soreness NN I-NP O
, , O O
particularly RB O O
in IN B-VP O
his PRP$ O O
third JJ B-NP O
proximal JJ I-NP O
interphalangeal NN I-NP O
joints NNS I-NP O
bilaterally RB O O
His PRP$ O O
BUN NNP B-NP O
and CC O O
creatinine NN B-NP O
were VBD B-VP O
182 CD O O
and CC O O
4.8 CD O O
respectively RB O O
His PRP$ O O
potassium NN B-NP O
6.4 CD O O
, , O O
his PRP$ O O
sodium NN B-NP O
128 CD O O
, , O O
and CC O O
his PRP$ O O
CPK NN B-NP O
1356 CD O O
, , O O
and CC O O
his PRP$ O O
uric JJ B-NP O
acid NN I-NP O
level NN I-NP O
11.6 CD O O
Issues NNP B-NP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
included VBD B-VP O
hyperkalemia NN B-NP O
, , O O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
secondary JJ O O
to TO O O
dehydration NN B-NP O
, , O O
polyarticular JJ B-NP O
joint NN I-NP O
soreness NN I-NP O
and CC O O
left VBD B-VP O
hip NN B-NP O
pain NN I-NP O
For IN B-VP O
his PRP$ O B-r
his PRP$ O B-r
his PRP$ O B-r
his PRP$ O B-r
hyperkalemia NN B-NP I-r
hyperkalemia NN I-NP I-r
hyperkalemia NN I-NP I-r
hyperkalemia NN I-NP I-r
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
calcium NN B-NP B-m
, , O O
gluconate NN B-NP B-m
, , O O
insulin NN B-NP B-m
, , O O
Kayexalate NNP B-NP B-m
and CC O O
his PRP$ O O
potassium NN B-NP O
level NN I-NP O
returned VBD B-VP O
to TO O O
normal JJ B-NP O
levels NNS I-NP O
by IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 VB O O
For IN B-VP O
his PRP$ O B-r
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
hydrated VBN O O
gently RB O O
with IN B-VP O
60 CD O B-do
cc NNS B-NP I-do
of IN B-VP O
normal JJ O B-m
saline VBP O O
The DT B-NP O
renal JJ I-NP O
service NN I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
assisted VBN O O
with IN B-VP O
management NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
urinating JJ B-NP O
Renal NNP I-NP O
ultrasound NN I-NP O
was VBD B-VP O
normal JJ B-NP O
Renal NNP I-NP O
function NN I-NP O
returned VBD B-VP O
to TO O O
baseline VB O O
and CC O O
his PRP$ O O
creatinine NN B-NP O
at IN B-VP O
discharge NN B-NP O
was VBD B-VP O
1.4 CD O O
His PRP$ O O
baseline NN B-NP O
is VBZ O O
1.6 CD O O
With IN B-VP O
correction NN B-NP O
of IN B-VP O
his PRP$ O O
renal JJ B-NP O
function NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
regained VBD B-VP O
strength NN B-NP O
For IN B-VP O
his PRP$ O O
joint NN B-NP O
symptoms NNS I-NP O
, , O O
Rheumatology NNP B-NP O
was VBD B-VP O
consulted VBN O O
who WP O O
performed VBD B-VP O
arthrocentesis NN B-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
knee NN I-NP O
and CC O O
diagnosed VBD B-VP O
polyarticular NN B-NP O
gout NN I-NP O
No NNP I-NP O
treatment NN I-NP O
was VBD B-VP O
initiated VBN O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
impaired JJ B-NP O
renal JJ I-NP O
function NN I-NP O
and CC O O
a DT B-NP O
concern NN I-NP O
for IN B-VP O
fluid NN B-NP O
retention NN I-NP O
He PRP O O
has VBZ O O
a DT B-NP O
followup JJ I-NP O
appointment NN I-NP O
with IN B-VP O
Rheumatology NNP B-NP O
in IN B-VP O
July NNP B-NP O
2005 CD O O
For IN B-VP O
his PRP$ O O
hip NN B-NP O
pain NN I-NP O
, , O O
his PRP$ O O
orthopedist NN B-NP O
, , O O
Dr NNP B-NP O
Schuchmann NNP I-NP O
, , O O
evaluated VBD B-VP O
him PRP O O
for IN B-VP O
possible JJ B-NP O
future JJ I-NP O
hip NN I-NP O
surgery NN I-NP O
Neurology NNP I-NP O
was VBD B-VP O
consulted VBN O O
regarding VBG O O
atrophy NN B-NP O
of IN B-VP O
thenar NN B-NP O
muscles NNS I-NP O
and CC O O
elevated VBN O O
CPK NNP B-NP O
They PRP O O
did VBD B-VP O
not RB O O
feel VB O O
a DT B-NP O
secure NN I-NP O
diagnosis NN I-NP O
could MD O O
be VB O O
made VBN O O
and CC O O
recommended VBN O O
following VBG O O
daily JJ B-NP O
CPK NNP I-NP O
, , O O
which WDT O O
trended VBD B-VP O
down RB O O
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
hospitalization NN B-NP O
Followup NNP I-NP O
appointment NN I-NP O
in IN B-VP O
Neurology NNP B-NP O
was VBD B-VP O
scheduled VBN O O
to TO O O
discuss VB O O
essential JJ B-NP O
tremor NN I-NP O
and CC O O
further JJ O O
investigate VB O O
the DT B-NP O
muscle NN I-NP O
wasting VBG O O
with IN B-VP O
nerve NN B-NP O
conduction NN I-NP O
studies NNS I-NP O
and CC O O
EMG NNP B-NP O
if IN B-VP O
necessary JJ O O
based VBN O O
on IN B-VP O
CPK NNP B-NP O
levels NNS I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
which WDT O O
showed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
40 CD O O
to TO O O
45% CD O O
, , O O
no DT B-NP O
pericardial JJ I-NP O
effusion NN I-NP O
, , O O
and CC O O
hypokinesis NN B-NP O
of IN B-VP O
the DT B-NP O
mid NN I-NP O
and CC O O
distal JJ B-NP O
septum NN I-NP O
, , O O
mid NN B-NP O
and CC O O
distal JJ B-NP O
inferior NN I-NP O
wall NN I-NP O
and CC O O
decreased VBD B-VP O
global JJ B-NP O
right NN I-NP O
ventricular NN I-NP O
function NN I-NP O
The DT B-NP O
patent NN I-NP O
foramen NNS I-NP O
ovale NN I-NP O
was VBD B-VP O
visualized VBN O O
At IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile RB O O
, , O O
hemodynamically RB O O
stable JJ O O
, , O O
euvolemic JJ O O
, , O O
ambulating VBG O O
, , O O
and CC O O
saturating VBG O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
and CC O O
on IN B-VP O
a DT B-NP O
stable JJ I-NP O
medical JJ I-NP O
regimen NNS I-NP O
He PRP O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
VNA NNP B-NP O
at IN B-VP O
home NN B-NP O
starting VBG O O
February NNP B-NP O
, , O O
2005 CD O O
, , O O
for IN B-VP O
INR NNP B-NP O
checks NNS I-NP O
Followup NNP I-NP O
appointments NNS I-NP O
for IN B-VP O
Cardiology NNP B-NP O
, , O O
Neurology NNP B-NP O
, , O O
and CC O O
Rheumatology NNP B-NP O
were VBD B-VP O
put VBN O O
in IN B-VP O
place NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
asked VBN O O
to TO O O
contact VB O O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
to TO O O
schedule VB O O
a DT B-NP O
followup JJ I-NP O
appointment NN I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile JJ O O
and CC O O
hemodynamically RB O O
stable JJ B-NP O
eScription NN I-NP O
document: VBZ O O
6-5164249 JJ B-NP O
SSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
PIERMONT NNP I-NP O
, , O O
FLOYD NNP B-NP O
Attending: NNP I-NP O
SULESKI NNP I-NP O
, , O O
CHADWICK NNP B-NP O
ANTONIO NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
0550727 CD O O
D: NNP B-NP O
8/24/05 CD O O
T: NNP B-NP O
8/24/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#451911 VBZ O O
610002579 CD O O
OHMC NNP B-NP O
73726819 CD O O
6004894 CD O O
4/11/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHF NNP I-NP O
EXACERBATION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/17/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/21/2006 CD O O
ATTENDING: NNP B-NP O
DEMARTINO NNP I-NP O
, , O O
HARRIS NNP B-NP O
MD NNP I-NP O
DISCHARGE NNP I-NP O
DISPOSITION: NNP I-NP O
To TO O O
Rehabilitation NNP B-NP O
Hospital NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Enteric-coated NNP I-NP B-m
aspirin VBZ O I-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
amiodarone RB O B-m
200 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
insulin JJ B-NP B-m
insulin NN I-NP B-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
7 CD O B-do
units NNS B-NP I-do
q.a.m RB O B-f
and CC O O
3 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
subcutaneously RB O B-mo
subcutaneously RB O B-mo
, , O O
Atrovent NNP B-NP B-m
HFA NNP I-NP I-m
inhaler NN I-NP I-m
2 CD O B-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
q.i.d JJ B-NP B-f
p.r.n NN I-NP I-f
for IN B-VP O
wheezing VBG O B-r
, , O O
magnesium NN B-NP B-m
gluconate NN I-NP I-m
sliding VBG O B-do
scale JJ O O
p.o JJ O B-mo
daily JJ O B-f
, , O O
oxycodone JJ B-NP B-m
5-10 JJ I-NP B-do
mg NN I-NP I-do
p.o NN I-NP B-mo
q VBD B-VP B-f
4h CD O I-f
p.r.n NN B-NP I-f
pain NN I-NP B-r
, , O O
senna JJ B-NP B-m
tablets NNS I-NP I-m
one CD O B-do
to TO O I-do
two CD O I-do
tablets NNS B-NP I-do
p.o VBP O B-mo
b.i.d JJ B-NP B-f
p.r.n NN I-NP I-f
constipation NN I-NP B-r
, , O O
spironolactone NN B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Coumadin NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
every DT B-NP B-f
other JJ I-NP O
day NN I-NP O
, , O O
multivitamin CC O B-m
therapeutic JJ O I-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
daily RB O B-f
, , O O
Zocor NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
torsemide RB O B-m
100 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
OxyContin NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Cozaar NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Remeron NNP B-NP B-m
7.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
and CC O O
aspartate JJ B-NP B-m
insulin NN I-NP I-m
sliding VBG O B-do
scale JJ B-NP I-do
DISCHARGE NNP I-NP O
DIET: NNP I-NP O
Discharge NNP I-NP O
diet NN I-NP O
is VBZ O O
2 CD O O
liters NNS B-NP O
fluid JJ B-NP O
restrict JJ I-NP O
Liberal NNP I-NP O
house NN I-NP O
diet JJ B-NP O
ADMISSION NNP I-NP O
DIAGNOSIS: NNP I-NP O
Foot NNP I-NP O
infection NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Decompensated NNP I-NP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
bilateral JJ B-NP O
knee NN I-NP O
amputation NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
BKA NNP I-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Not RB O O
applicable JJ B-NP O
FOLLOW-UP JJ I-NP O
APPOINTMENTS: NNP I-NP O
Please NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Ricardo NNP I-NP O
Dzierzanowski NNP I-NP O
, , O O
at IN B-VP O
Pipe NNP B-NP O
Shanm NNP I-NP O
Hasb NNP I-NP O
Nota NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
within IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
Please NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
primary JJ B-NP O
cardiologist NN I-NP O
, , O O
Dr NNP B-NP O
Edwin NNP I-NP O
Mellor NNP I-NP O
within IN B-VP O
one CD O O
month NN B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Shortness NNP I-NP O
of IN B-VP O
breath JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
A NNP I-NP O
73-year-old JJ B-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
, , O O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
, , O O
valvular JJ B-NP O
heart NN I-NP O
disease NN I-NP O
, , O O
known VBN O O
EF NNP B-NP O
of IN B-VP O
15-20% JJ O O
as IN B-VP O
of IN B-VP O
6/25 CD O O
, , O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Rose-le NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
from IN B-VP O
No NNP B-NP O
Memorial NNP I-NP O
with IN B-VP O
signs NNS B-NP O
and CC O O
symptoms NNS B-NP O
of IN B-VP O
decompensated JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
and CC O O
acute NN B-NP O
on IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
On IN B-VP O
11/0/06 CD O O
, , O O
he PRP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
a DT B-NP O
large JJ I-NP O
left JJ I-NP O
foot NN I-NP O
toe NN I-NP O
ulcer NN I-NP O
that WDT O O
was VBD B-VP O
nonhealing VBG O O
Multiple JJ B-NP O
surgeries NNS I-NP O
were VBD B-VP O
performed VBN O O
with IN B-VP O
persistent JJ O O
nonhealing VBG O O
wounds: NN B-NP O
Left NNP I-NP O
great JJ B-NP O
toe JJ I-NP O
amputation NN I-NP O
on IN B-VP O
6/10/06 CD O O
, , O O
which WDT O O
failed VBD B-VP O
to TO O O
heal VB O O
despite IN B-VP O
SFA NNP B-NP O
to TO O O
perineal VB O O
artery RB O O
bypassing VBG O O
the DT B-NP O
composite JJ I-NP O
vein NN I-NP O
Had VBD B-VP O
a DT B-NP O
short JJ I-NP O
CICU NNP I-NP O
stay NN I-NP O
for IN B-VP O
hypotension NN B-NP B-r
postoperatively RB O O
, , O O
maintained VBD B-VP O
on IN B-VP O
dobutamine NN B-NP B-m
On IN B-VP O
0/9/06 CD O O
underwent JJ B-NP O
debridement NN I-NP O
of IN B-VP O
left JJ B-NP O
medial JJ I-NP O
ulcer NN I-NP O
On IN B-VP O
10/12/06 CD O O
transmetatarsal JJ B-NP O
amputation NN I-NP O
, , O O
on IN B-VP O
7/3/06 CD O O
, , O O
debridement NN B-NP O
of IN B-VP O
transmetatarsal JJ B-NP O
amputation NN I-NP O
On IN B-VP O
11/29/06 CD O O
received VBD B-VP O
a DT O O
left VBN O O
below IN B-VP O
the DT B-NP O
knee NN I-NP O
amputation NN I-NP O
His PRP$ O O
renal JJ B-NP O
function NN I-NP O
had VBD B-VP O
been VBN O O
normal JJ O O
prior RB O O
to TO O O
the DT B-NP O
final JJ I-NP O
surgery NN I-NP O
until IN B-VP O
6/21/06 CD O O
to TO O O
3/25/06 CD O O
when WRB O O
his PRP$ O O
creatinine NN B-NP O
rose VBD B-VP O
from IN B-VP O
1.3 CD O O
to TO O O
2.2 CD O O
He PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
acute VB O O
rehabilitation NN B-NP O
and CC O O
was VBD B-VP O
there RB O O
noted VBN O O
to TO O O
have VB O O
this DT B-NP O
acute JJ I-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
prerenal JJ B-NP O
azotemia NN I-NP O
, , O O
but CC O O
his PRP$ O O
creatinine NN B-NP O
at IN B-VP O
this DT B-NP O
point NN I-NP O
had VBD B-VP O
not RB O O
changed VBN O O
much RB O O
from IN B-VP O
2.2 CD O O
to TO O O
2.5 CD O O
during IN B-VP O
his PRP$ O O
stay NN B-NP O
Diuretics NNPS I-NP O
were VBD B-VP O
held VBN O O
at IN B-VP O
rehabilitation NN B-NP O
facility NN I-NP O
until IN B-VP O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
He PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
increased VBN O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
Patient NNP I-NP O
denies VBZ O O
any DT B-NP O
other JJ I-NP O
symptoms NNS I-NP O
up IN B-VP O
to TO O O
that DT B-NP O
point NN I-NP O
except IN B-VP O
occasional JJ B-NP O
lightheadedness NN I-NP O
, , O O
depressed VBD B-VP O
mood NN B-NP O
, , O O
and CC O O
lack NN B-NP O
of IN B-VP O
motivation NN B-NP O
No NNP I-NP O
orthopnea NN I-NP O
, , O O
uses VBZ O O
1 CD O O
pillow NN B-NP O
regularly RB O O
, , O O
denies VBZ O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
and CC O O
denies VBZ O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
but CC O O
very RB O O
limited JJ B-NP O
movement NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
, , O O
GERD NNP B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
MI NNP I-NP O
in IN B-VP O
1996 CD O O
, , O O
received VBD B-VP O
a DT B-NP O
CABG NNP I-NP O
in IN B-VP O
0/26 CD O O
with IN B-VP O
a DT B-NP O
LIMA NNP I-NP O
to TO O O
LAD NNP B-NP O
, , O O
SVG NNP B-NP O
to TO O O
PDA NNP B-NP O
, , O O
SVG NNP B-NP O
to TO O O
OM1 NNP B-NP O
, , O O
and CC O O
mitral JJ B-NP O
valve NN I-NP O
annuloplasty NN I-NP O
Diabetes NNP I-NP O
mellitus NN I-NP O
, , O O
insulin-dependent JJ O O
, , O O
status NN B-NP O
post NN I-NP O
bilateral JJ O O
below IN B-VP O
the DT B-NP O
knee NN I-NP O
amputation NN I-NP O
, , O O
likely RB O O
from IN B-VP O
diabetes NNS B-NP O
related JJ B-NP O
foot NN I-NP O
ulcers NNS I-NP O
, , O O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
and CC O O
atrial JJ B-NP O
flutter NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
sick JJ B-NP O
sinus NN I-NP O
syndrome NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
second-degree JJ B-NP O
heart NN I-NP O
block NN I-NP O
, , O O
AICD NNP B-NP O
placed VBD B-VP O
2/10 CD O O
complicated VBN O O
by IN B-VP O
hematoma JJ B-NP O
History NNP I-NP O
of IN B-VP O
admissions NNS B-NP O
for IN B-VP O
hyponatremia NN B-NP O
Status NNP I-NP O
post NN I-NP O
left VBD B-VP O
SFA NNP B-NP O
to TO O O
perineal VB O O
artery JJ B-NP O
bypass NN I-NP O
to TO O O
incompetent VB O O
pain NN B-NP O
in IN B-VP O
0/2 CD O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Amiodarone NNP I-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
Atrovent NNP I-NP B-m
one CD O B-do
to TO O I-do
two CD O I-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
q.i.d JJ B-NP B-f
p.r.n NN I-NP I-f
for IN B-VP O
wheezing VBG O B-r
, , O O
Celexa NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Coumadin NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP O
p.o JJ O B-mo
daily RB O B-f
, , O O
Diovan NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Lantus NNP B-NP B-m
25 CD O B-do
units NNS B-NP I-do
every DT B-NP B-f
day NN I-NP I-f
subcutaneous JJ O B-mo
, , O O
Lasix NNP B-NP B-m
160 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Lipitor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
therapeutic JJ B-NP B-m
multivitamin NN I-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
daily RB O B-f
, , O O
solsite JJ B-NP B-m
topical JJ I-NP B-mo
IMPRESSION: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
a DT B-NP O
73-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
severe JJ B-NP O
cardiomyopathy NN I-NP O
and CC O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
15% CD O O
admitted VBN O O
for IN B-VP O
decompensated JJ B-NP O
heart NN I-NP O
failure NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
his PRP$ O O
diuretics NNS B-NP O
being VBG O O
held VBN O O
due JJ O O
to TO O O
an DT B-NP O
acute JJ I-NP O
renal JJ I-NP O
failure NN I-NP O
Review NNP I-NP O
of IN B-VP O
chart NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
showed VBD B-VP O
renal JJ B-NP O
failure NN I-NP O
is VBZ O O
actually RB O O
present JJ O O
since IN B-VP O
the DT B-NP O
perioperative JJ I-NP O
period NN I-NP O
of IN B-VP O
his PRP$ O O
BKA NNP B-NP O
After IN B-VP O
being VBG O O
admitted VBN O O
to TO O O
the DT B-NP O
cardiology NN I-NP O
service NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
diuresed VBN O O
successfully RB O O
to TO O O
his PRP$ O O
dry JJ B-NP O
weight NN I-NP O
, , O O
with IN B-VP O
a DT B-NP O
significant JJ I-NP O
improvement NN I-NP O
in IN B-VP O
his PRP$ O O
oxygen NN B-NP O
saturation NN I-NP O
, , O O
his PRP$ O O
creatinine NN B-NP O
, , O O
and CC O O
venous JJ B-NP O
congestion NN I-NP O
Other JJ B-NP O
active JJ I-NP O
issues NNS I-NP O
he PRP O O
was VBD B-VP O
treated VBN O O
for IN B-VP O
include NN B-NP O
urinary JJ B-NP O
tract JJ I-NP O
infection NN I-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
acute NN B-NP O
on IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
depression NN B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS: NNP I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
Ischemia: NNP I-NP O
Known NNP I-NP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
x3 NNP I-NP O
, , O O
admitted VBD B-VP O
with IN B-VP O
troponin NN B-NP O
elevation NN I-NP O
likely RB O O
due JJ O O
to TO O O
demand VB O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
heart NN B-NP O
failure NN I-NP O
for IN B-VP O
having VBG O O
his PRP$ O O
diuretics NNS B-NP O
held VBD B-VP O
This DT O O
was VBD B-VP O
noted VBN O O
to TO O O
trend NN B-NP O
down RP O O
post-diuresis NN B-NP O
We PRP O O
continued VBD B-VP O
aspirin JJ B-NP B-m
Initially NNP I-NP O
, , O O
we PRP O O
held VBD B-VP O
his PRP$ O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
given VBN O O
history NN B-NP O
of IN B-VP O
cough NN B-NP O
and CC O O
his PRP$ O O
ARF NNP B-NP O
, , O O
and CC O O
ultimately RB O O
restarted VBD B-VP O
the DT B-NP O
patient NN I-NP O
on IN B-VP O
ARB NNP B-NP B-m
, , O O
after IN B-VP O
his PRP$ O O
creatinine NN B-NP O
had VBD B-VP O
normalized VBN O O
Statins NNP B-NP O
had VBD B-VP O
been VBN O O
held VBN O O
until IN B-VP O
we PRP O O
were VBD B-VP O
certain JJ O O
his PRP$ O O
liver JJ B-NP O
function NN I-NP O
tests NNS I-NP O
were VBD B-VP O
decreasing VBG O O
2 CD O O
Cardiovascular JJ B-NP O
pump: NN I-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
in IN B-VP O
floor NN B-NP O
volume NN I-NP O
overload NN I-NP O
on IN B-VP O
presentation NN B-NP O
, , O O
maintained VBD B-VP O
on IN B-VP O
2 CD O O
grams NNS B-NP O
salt JJ O O
daily RB O O
, , O O
2 CD O O
liters NNS B-NP O
fluid JJ B-NP O
restriction NN I-NP O
diet NN I-NP O
with IN B-VP O
1-2 JJ B-NP O
liters NNS I-NP O
per IN B-VP O
day NN B-NP O
goal NN I-NP O
diuresis NN I-NP O
attained VBN O O
by IN B-VP O
using VBG O O
100 CD O B-do
mg JJ B-NP I-do
IV NNP I-NP B-mo
torsemide NN I-NP B-m
b.i.d NN I-NP B-f
with IN B-VP O
the DT B-NP O
addition NN I-NP O
of IN B-VP O
25 CD O B-do
mg NN B-NP I-do
of IN B-VP O
hydrochlorothiazide NN B-NP B-m
b.i.d NN I-NP B-f
30 CD O O
minutes NNS B-NP O
prior RB O O
to TO O O
each DT B-NP O
torsemide NN I-NP B-m
dose NN I-NP O
, , O O
an DT B-NP O
average NN I-NP O
of IN B-VP O
two CD O O
liter NN B-NP O
fluid NN I-NP O
negative JJ B-NP O
Diuresis NNP I-NP O
was VBD B-VP O
affected VBN O O
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
a DT B-NP O
week NN I-NP O
, , O O
and CC O O
his PRP$ O O
status NN B-NP O
gradually RB O O
improved VBD B-VP O
Spironolactone NNP B-NP B-m
was VBD B-VP O
initially RB O O
held VBN O O
due JJ O O
to TO O O
high JJ B-NP O
K NNP I-NP O
but CC O O
was VBD B-VP O
re-added VBN O O
on IN B-VP O
1/30/06 CD O O
His PRP$ O O
jugular NN B-NP O
venous JJ B-NP O
distention NN I-NP O
dropped VBD B-VP O
from IN B-VP O
initial JJ B-NP O
presentation NN I-NP O
above IN B-VP O
the DT B-NP O
earlobes NNS I-NP O
at IN B-VP O
a DT B-NP O
30-degree JJ I-NP O
angle NN I-NP O
to TO O O
a DT B-NP O
JVP NNP I-NP O
of IN B-VP O
6-7 JJ B-NP O
cm NN I-NP O
at IN B-VP O
30 CD O O
degree JJ B-NP O
angle NN I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
Two CD O O
days NNS B-NP O
prior RB O O
to TO O O
discharge VB O O
, , O O
his PRP$ O O
creatinine NN B-NP O
began VBD B-VP O
to TO O O
rise VB O O
, , O O
suggesting VBG O O
prerenal JJ B-NP O
azotemia NN I-NP O
secondary JJ O O
to TO O O
over IN B-VP O
diuresis NN B-NP B-r
and CC O O
when WRB O O
his PRP$ O O
torsemide NN B-NP B-m
was VBD B-VP O
reduced VBN O O
to TO O O
100 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
hydrochlorothiazide NN B-NP B-m
was VBD B-VP O
dropped VBN O O
from IN B-VP O
his PRP$ O O
regimen NNS B-NP O
, , O O
patient's FW O O
creatinine NN B-NP O
began VBD B-VP O
to TO O O
drop VB O O
again RB O O
, , O O
and CC O O
patient NN B-NP O
was VBD B-VP O
able JJ O O
to TO O O
maintain VB O O
even RB O O
Ins NNP B-NP O
and CC O O
Outs NNP B-NP O
of IN B-VP O
fluid NN B-NP O
for IN B-VP O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
discharge VB O O
3 CD O O
Cardiovascular NNP B-NP O
rhythm: NN I-NP O
Patient NNP I-NP O
is VBZ O O
ventricularly RB O O
paced VBN O O
on IN B-VP O
symmetry NN B-NP O
for IN B-VP O
duration NN B-NP O
of IN B-VP O
hospitalization NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP B-r
atrial JJ I-NP B-r
fibrillation NN I-NP O
on IN B-VP O
Coumadin NNP B-NP B-m
, , O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
amiodarone NN B-NP B-m
during IN B-VP B-du
this DT B-NP O
hospitalization NN I-NP O
4 CD O O
Pulmonary: NNP B-NP O
The DT B-NP O
patient NN I-NP O
with IN B-VP O
initial JJ B-NP O
O2 NNP I-NP O
dependence NN I-NP O
Continued NNP I-NP O
inhaled VBD B-VP B-mo
ipratropium VB O B-m
his PRP$ O O
home NN B-NP O
medication NN I-NP O
After IN B-VP O
diuresis NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
able JJ O O
to TO O O
achieve VB O O
oxygen NN B-NP O
saturation NN I-NP O
of IN B-VP O
100% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
5 CD O O
Renal: NNP B-NP O
Initial NNP I-NP O
acute NN I-NP O
on IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
thought VBD B-VP O
secondary JJ O O
to TO O O
volume NN B-NP O
overload NN I-NP O
and CC O O
forward RB O O
flow NN B-NP O
in IN B-VP O
the DT B-NP O
context NN I-NP O
of IN B-VP O
decompensated JJ B-NP O
congestive JJ I-NP O
heart NN I-NP O
failure NN I-NP O
His PRP$ O O
renal JJ B-NP O
function NN I-NP O
improved VBD B-VP O
, , O O
as IN B-VP O
he PRP O O
was VBD B-VP O
diuresed VBN O O
and CC O O
his PRP$ O O
heart NN B-NP O
likely RB O O
moved VBD B-VP O
to TO O O
more RBR O O
useful JJ B-NP O
part NN I-NP O
of IN B-VP O
the DT O O
starling VBG O O
curve NN B-NP O
Renal NNP I-NP O
ultrasound NN I-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
hydronephrosis NN B-NP O
as IN B-VP O
was VBD B-VP O
test NN B-NP O
for IN B-VP O
urine NN B-NP O
eosinophils NNS I-NP O
Hyponatremia NNP I-NP O
was VBD B-VP O
likely JJ O O
due JJ O O
to TO O O
heart NN B-NP O
failure NN I-NP O
improved VBN O O
with IN B-VP O
diuresis NN B-NP O
6 CD O O
Heme: NNP B-NP O
The DT B-NP O
patient NN I-NP O
maintained VBD B-VP O
on IN B-VP O
Coumadin NNP B-NP B-m
with IN B-VP O
an DT B-NP O
INR NNP I-NP O
goal NN I-NP O
of IN B-VP O
2-3 JJ O O
In IN B-VP O
order NN B-NP O
to TO O O
achieve VB O O
this DT B-NP O
goal NN I-NP O
, , O O
his PRP$ O O
Coumadin NNP B-NP B-m
dose NN I-NP O
was VBD B-VP O
adjusted VBN O O
to TO O O
mg VB O O
p.o NN B-NP B-mo
every DT B-NP B-f
other JJ I-NP I-f
day NN I-NP I-f
He PRP O O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
chemo NN B-NP O
and CC O O
Coumadin NNP B-NP B-m
service NN I-NP O
after IN B-VP O
discharge NN B-NP O
with IN B-VP O
weekly JJ B-NP O
tests NNS I-NP O
to TO O O
make VB O O
sure JJ O O
that IN B-VP O
his PRP$ O O
INR NNP B-NP O
is VBZ O O
maintained VBN O O
within IN B-VP O
this DT B-NP O
range NN I-NP O
7 CD O O
Endocrine NNP B-NP O
Diabetes NNP I-NP B-r
Diabetes NNP I-NP B-r
mellitus NN I-NP I-r
mellitus NN I-NP I-r
, , O O
insulin-dependent JJ O O
, , O O
covered VBN O O
on IN B-VP O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
q.a.m NN I-NP B-f
and CC O O
q.p.m NN B-NP B-f
with IN B-VP O
aspartate JJ O B-m
sliding VBG O B-do
scale NN B-NP I-do
for IN B-VP B-du
duration NN B-NP O
of IN B-VP O
hospitalization NN B-NP O
8 CD O O
Psych: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
Celexa NNP B-NP B-m
per IN B-VP O
PCP NNP B-NP O
for IN B-VP O
likely JJ B-NP B-r
depressive JJ I-NP I-r
mood NN I-NP I-r
response NN I-NP O
to TO O O
recent JJ B-NP O
bilateral JJ I-NP O
knee NN I-NP O
amputation NN I-NP O
It PRP O O
is VBZ O O
what WP O O
is VBZ O O
quite RB O O
possible JJ O O
that IN B-VP O
patient's JJ B-NP O
depression NN I-NP O
precedes VBZ O O
the DT B-NP O
bilateral JJ I-NP O
knee NN I-NP O
amputation NN I-NP O
and CC O O
informs NNS B-NP O
much RB O O
of IN B-VP O
his PRP$ O O
overall JJ B-NP O
care NN I-NP O
The DT B-NP O
patient's NN I-NP O
PCP NNP I-NP O
, , O O
Dr NNP B-NP O
Micheal NNP I-NP O
L NNP I-NP O
Davirro NNP I-NP O
, , O O
aware NN B-NP O
of IN B-VP O
the DT B-NP O
situation NN I-NP O
and CC O O
managing NN B-NP O
as IN B-VP O
outpatient NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
seen VBN O O
by IN B-VP O
the DT B-NP O
inpatient JJ I-NP O
psychiatry NN I-NP O
consultation NN I-NP O
, , O O
and CC O O
started VBD B-VP O
on IN B-VP O
Remeron NNP B-NP B-m
7.5 CD O B-do
7.5 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
p.o JJ O B-mo
daily RB O B-f
in IN B-VP O
place NN B-NP O
of IN B-VP O
Celexa NNP B-NP B-m
He PRP O O
is VBZ O O
discharged VBN O O
on IN B-VP O
this DT B-NP B-m
medication NN I-NP I-m
The DT B-NP O
patient NN I-NP O
is VBZ O O
status NN B-NP O
post NN I-NP O
one CD O O
fall NN B-NP O
from IN B-VP O
the DT B-NP O
bed NN I-NP O
during IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
Head NNP I-NP O
CT NNP I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
bleed NN B-NP O
or CC O O
trauma NN B-NP O
to TO O O
the DT B-NP O
head NN I-NP O
to TO O O
head VB O O
Examination NNP B-NP O
of IN B-VP O
back RB O O
and CC O O
extremities NNS B-NP O
reveals VBZ O O
no DT B-NP O
focal JJ I-NP O
tenderness NN I-NP O
or CC O O
ecchymoses VBZ O O
9 CD O O
Infectious JJ B-NP O
disease NN I-NP O
The DT B-NP O
patient NN I-NP O
initially RB O O
treated VBD B-VP O
for IN B-VP O
urinary JJ B-NP B-r
tract NN I-NP I-r
infection NN I-NP I-r
with IN B-VP O
uncomplicated JJ B-NP O
course NN I-NP O
with IN B-VP O
ciprofloxacin JJ O B-m
10 CD O O
Wound: NNP B-NP O
Wound NNP I-NP O
care NN I-NP O
nurse NN I-NP O
consulted VBN O O
for IN B-VP O
BKA NNP B-NP O
wound NN I-NP O
and CC O O
small JJ B-NP O
decubitus NN I-NP O
on IN B-VP O
his PRP$ O O
back NN B-NP O
, , O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
DuoDERM NNP B-NP B-m
, , O O
BKA NNP B-NP O
site NN I-NP O
healing VBG O O
well RB O O
11 CD O O
Fluids NNS B-NP O
, , O O
electrolytes NNS B-NP O
and CC O O
nutrition: VBZ O O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
on IN B-VP O
cardiac NN B-NP O
, , O O
2000 CD O O
calorie NN B-NP O
diabetic JJ B-NP O
diet NN I-NP O
, , O O
however RB O O
, , O O
as IN B-VP O
it PRP O O
became VBD B-VP O
apparent JJ O O
that IN B-VP O
he PRP O O
was VBD B-VP O
severely RB O O
malnourished VBN O O
, , O O
his PRP$ O O
diet NN B-NP O
was VBD B-VP O
liberalized VBN O O
to TO O O
allow VB O O
for IN B-VP O
nutritional JJ B-NP O
supplementation NN I-NP O
12 CD O O
PPX: NNP B-NP O
The DT B-NP O
patient NN I-NP O
maintained VBD B-VP O
on IN B-VP O
subcutaneous JJ B-NP B-mo
subcutaneous JJ I-NP B-mo
heparin NN I-NP B-m
heparin NN I-NP B-m
and CC O O
Nexium NNP B-NP B-m
Nexium NNP I-NP B-m
as IN B-VP O
DVT NNP B-NP O
and CC O O
GI NNP B-NP B-r
GI NNP I-NP B-r
prophylaxis NN I-NP I-r
prophylaxis NN I-NP I-r
during IN B-VP B-du
this DT B-NP I-du
hospitalization NN I-NP I-du
13 CD O O
Code NNP B-NP O
status NN I-NP O
, , O O
full JJ B-NP O
code NN I-NP O
TO NNP I-NP O
DO NNP I-NP O
PLAN NNP I-NP O
1 CD O O
Discharge NNP B-NP O
the DT B-NP O
patient NN I-NP O
to TO O O
rehab VB O O
on IN B-VP O
current JJ B-NP O
regimen NNS I-NP O
Patient NNP I-NP O
has VBZ O O
been VBN O O
working VBG O O
with IN B-VP O
PT NNP B-NP O
and CC O O
OT NNP B-NP O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
and CC O O
appears VBZ O O
well RB O O
positioned VBN O O
to TO O O
take VB O O
advantage NN B-NP O
of IN B-VP O
rehabilitation NN B-NP O
facilities NNS I-NP O
services NNS I-NP O
2 CD O O
Maintain NNP B-NP O
new JJ B-NP O
prescription NN I-NP O
of IN B-VP O
Remeron NNP B-NP B-m
, , O O
follow VB O O
up RP O O
with IN B-VP O
psychiatry NN B-NP O
to TO O O
assess VB O O
depressive JJ B-NP B-r
disorder/adjustment NN I-NP I-r
disorder NN I-NP I-r
3 CD O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
off RP O O
beta-blocker NN B-NP B-m
PCP NNP I-NP O
may MD O O
choose VB O O
to TO O O
start VB O O
beta-blocker NN B-NP B-m
at IN B-VP O
a DT O B-do
low-dose JJ O I-do
in IN B-VP O
the DT B-NP O
outpatient NN I-NP O
setting VBG O O
4 CD O O
Fasciculations NNS B-NP O
noted VBD B-VP O
during IN B-VP O
hospitalization NN B-NP O
fine JJ B-NP O
fasciculations NNS I-NP O
at IN B-VP O
hands NNS B-NP O
in IN B-VP O
Surga NNP B-NP O
Hospital NNP I-NP O
Maybe RB O O
secondary JJ O O
to TO O O
malnutrition NN B-NP O
and CC O O
diaries NNS B-NP O
is VBZ O O
, , O O
but CC O O
may MD O O
merit VB O O
further JJ B-NP O
workup NN I-NP O
in IN B-VP O
an DT B-NP O
outpatient JJ I-NP O
context NN I-NP O
5 CD O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
rising VBG O O
alkaline NN B-NP O
phosphatase NN I-NP O
during IN B-VP O
hospitalization NN B-NP O
, , O O
CT NNP B-NP O
of IN B-VP O
chest JJS O O
incidentally RB O O
showed VBD B-VP O
gallstone JJ B-NP O
present NN I-NP O
within IN B-VP O
the DT B-NP O
gallbladder NN I-NP O
, , O O
follow VB O O
up RP O O
LFTs NNP B-NP O
in IN B-VP O
the DT B-NP O
outpatient NN I-NP O
context NN I-NP O
and CC O O
possible JJ B-NP O
right JJ I-NP O
upper NN I-NP O
quadrant NN I-NP O
ultrasound NN I-NP O
may MD O O
merit VB O O
consideration NN B-NP O
and CC O O
further JJ B-NP O
outpatient NN I-NP O
workup NN I-NP O
of IN B-VP O
this DT B-NP O
patient NN I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Coumadin NNP B-NP O
clinic JJ O O
given VBN O O
goal NN B-NP O
INR NNP I-NP O
of IN B-VP O
2.0-3.0 JJ O O
The DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
and CC O O
BUN NNP B-NP O
should MD O O
be VB O O
checked VBN O O
along IN B-VP O
with IN B-VP O
electrolytes NNS B-NP O
to TO O O
make VB O O
sure JJ B-NP O
patient NN I-NP O
is VBZ O O
doing VBG O O
well RB O O
on IN B-VP O
current JJ B-NP O
maintenance NN I-NP O
diuretic JJ B-NP O
schedule NN I-NP O
of IN B-VP O
100 CD O B-do
mg NNS B-NP I-do
torsemide JJ O B-m
p.o JJ O B-mo
daily JJ O B-f
and CC O O
spironolactone JJ B-NP B-m
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
Discharged NNP I-NP O
to TO O O
rehabilitation VB O O
eScription NN B-NP O
document: IN B-VP O
2-3432980 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Noe NNP I-NP O
W NNP I-NP O
Mcgoldrick NNP I-NP O
M.D NNP I-NP O
Ton NNP I-NP O
CC: NNP I-NP O
Keneth NNP I-NP O
Bartuska NNP I-NP O
M.D NNP I-NP O
NUTRISOCHI NNP I-NP O
ZIE-BRI NNP I-NP O
MEMORIAL NNP I-NP O
Jose NNP I-NP O
Mi NNP I-NP O
Ant NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
DOULANI NNP I-NP O
, , O O
DEVIN NNP B-NP O
Attending: NNP I-NP O
LEEDER NNP I-NP O
, , O O
BRENDON NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
7465299 CD O O
D: NNP B-NP O
7/14/06 CD O O
T: NNP B-NP O
7/14/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#451973 VBZ O O
036050725 CD O O
WR NNP B-NP O
53380160 CD O O
093316 CD O O
1/3/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/21/1997 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/12/1997 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
SIGNIFICANT NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
CORONARY NNP B-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
2 CD O O
HYPERCHOLESTEROLEMIA NNP B-NP O
3 CD O O
HYPERTENSION NNP B-NP O
4 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
WITH NNP I-NP O
FLASH NNP I-NP O
PULMONARY NNP I-NP O
EDEMA NNP I-NP O
5 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
DEPRESSION NNP I-NP O
6 CD O O
GLAUCOMA NNP B-NP O
7 CD O O
NON-INSULIN-DEPENDENT NNP B-NP O
DIABETES NNP I-NP O
MELLITUS NNP I-NP O
8 CD O O
MITRAL NNP B-NP O
REGURGITATION NNP I-NP O
9 CD O O
CHRONIC NNP B-NP O
RENAL NNP I-NP O
INSUFFICIENCY NNP I-NP O
10 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
BREAST NNP I-NP O
CANCER NNP I-NP O
STATUS NNP I-NP O
POST NNP I-NP O
LEFT NNP I-NP O
MASTECTOMY NNP I-NP O
AND NNP I-NP O
TAMOXIFEN NNP I-NP B-m
TREATMENT NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
69-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
known JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
CRF NNP B-NP O
, , O O
and CC O O
history NN B-NP O
of IN B-VP O
flash JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
, , O O
recently RB O O
admitted VBN O O
to TO O O
Darnbo NNP B-NP O
Hospital NNP I-NP O
on IN B-VP O
7/29/97 CD O O
after IN B-VP O
sudden JJ B-NP O
onset NN I-NP O
of IN B-VP O
shortness NN B-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
unrelieved VBN O O
by IN B-VP O
one CD O B-do
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
This DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
awakened VBD B-VP O
her PRP O O
from IN B-VP O
sleep NN B-NP O
Her NNP I-NP O
blood NN I-NP O
pressure NN I-NP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
was VBD B-VP O
230/110 CD O O
without IN B-VP O
EKG NNP B-NP O
changes NNS I-NP O
She PRP O O
responded VBD B-VP O
well RB O O
to TO O O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
and CC O O
IV NNP B-NP B-mo
nitroglycerin RB O B-m
, , O O
saturating VBG O O
at IN B-VP O
99% CD O O
on IN B-VP O
100% CD O O
nonrebreather CC O O
mask JJ B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
pulmonary JJ B-NP O
edema NN I-NP O
Her NNP I-NP B-r
blood NN I-NP I-r
pressure NN I-NP I-r
was VBD B-VP O
stabilized VBN O O
on IN B-VP O
IV NNP B-NP B-mo
nitroglycerin NN I-NP B-m
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
her PRP$ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
She PRP O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
recently RB O O
admitted VBD B-VP O
one CD O O
month NN B-NP O
ago RB O O
to TO O O
Stonemep NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
flash JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
Echo NNP I-NP O
on IN B-VP O
admission NN B-NP O
showed VBD B-VP O
30% CD O O
ejection NN B-NP O
fraction NN I-NP O
with IN B-VP O
anteroapical JJ O O
and CC O O
posterobasal JJ B-NP O
hypokinesis NN I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
in IN B-VP O
March NNP B-NP O
1997 CD O O
showed VBD B-VP O
a DT O O
90% CD O O
proximal JJ B-NP O
RCA NNP I-NP O
lesion NN I-NP O
and CC O O
diffuse NN B-NP O
distal JJ B-NP O
LAD NNP I-NP O
disease NN I-NP O
During IN B-VP O
vigorous JJ B-NP O
rehydration NN I-NP O
following VBG O O
that IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
, , O O
she PRP O O
developed VBD B-VP O
recurrent JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
requiring VBG O O
intubation NN B-NP O
from IN B-VP O
which WDT O O
she PRP O O
was VBD B-VP O
weaned VBN O O
following VBG O O
diuresis NN B-NP O
Because IN B-VP O
her PRP$ O O
pulmonary JJ B-NP O
edema NN I-NP O
was VBD B-VP O
believed VBN O O
to TO O O
be VB O O
ischemia RB O O
related VBN O O
, , O O
she PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Ha NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
RCA NNP B-NP O
angioplasty NN I-NP O
On IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
she PRP O O
denies VBZ O O
any DT B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
or CC O O
dizziness NN B-NP O
She PRP O O
has VBZ O O
three CD O O
pillow NN B-NP O
orthopnea NN I-NP O
, , O O
ankle NN B-NP O
edema NN I-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
paroxysmal JJ I-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
with IN B-VP O
the DT B-NP O
exception NN I-NP O
of IN B-VP O
her PRP$ O O
current JJ B-NP O
presentation NN I-NP O
The DT B-NP O
patient's NN I-NP O
coronary JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
include VBP O O
diabetes NNS B-NP O
mellitus NNS I-NP O
, , O O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
post NN B-NP O
menopausal NN I-NP O
status NN I-NP O
without IN B-VP O
hormone NN B-NP O
replacement NN I-NP O
therapy NN I-NP O
, , O O
and CC O O
history NN B-NP O
of IN B-VP O
tobacco NN B-NP O
use IN B-VP O
Her PRP$ O O
exercise NN B-NP O
tolerance NN I-NP O
is VBZ O O
such JJ O O
that IN B-VP O
she PRP O O
develops VBZ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
with IN B-VP O
walking VBG O O
one CD O O
block NN B-NP O
or CC O O
one CD O O
flight NN B-NP O
of IN B-VP O
stairs NNS B-NP O
She PRP O O
reports VBZ O O
having VBG O O
to TO O O
sit VB O O
down RP O O
at IN B-VP O
every DT B-NP O
other JJ I-NP O
bench NN I-NP O
in IN B-VP O
the DT B-NP O
mall NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Hypercholesterolemia NNP B-NP O
Total NNP I-NP O
cholesterol NN I-NP O
266 CD O O
down RB O O
to TO O O
193 CD O O
2 CD O O
Hypertension NN B-NP O
3 CD O O
Breast NNP B-NP O
cancer NN I-NP O
status NN I-NP O
post NN I-NP O
left VBD B-VP O
mastectomy JJ O O
seven CD O O
years NNS B-NP O
ago RB O O
and CC O O
status NN B-NP O
post NN I-NP O
five CD O B-du
years NNS B-NP I-du
of IN B-VP O
Tamoxifen NNP B-NP B-m
therapy NN I-NP O
She PRP O O
has VBZ O O
had VBN O O
no DT B-NP O
other JJ I-NP O
chemo NN I-NP O
or CC O O
radiation NN B-NP O
treatment NN I-NP O
4 CD O O
Depression NNP B-NP O
5 CD O O
Hypercalcemia NNP B-NP O
( ( O O
no DT O O
alkalized VBN O O
syndrome NN B-NP O
) ) O O
1/11 CD O O
6 CD O O
History NN B-NP O
of IN B-VP O
recurrent NN B-NP O
pneumonia NN I-NP O
7 CD O O
History NNP B-NP O
of IN B-VP O
diverticulitis NN B-NP O
8 CD O O
Glaucoma NNP B-NP O
9 CD O O
Non-insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus VBP O O
diagnosed VBN O O
one CD O O
year NN B-NP O
ago RB O O
, , O O
diet VB O O
controlled VBD B-VP O
10 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
pyelonephritis NN B-NP O
at IN B-VP O
age NN B-NP O
three CD O O
11 CD O O
Mitral NNP B-NP O
regurgitation NN I-NP O
12 CD O O
Status NNP B-NP O
post NN I-NP O
total JJ B-NP O
abdominal JJ I-NP O
hysterectomy NN I-NP O
, , O O
bilateral JJ B-NP O
salpingo-oophorectomy NN I-NP O
at IN B-VP O
age NN B-NP O
40 CD O O
, , O O
hormone CD O O
replacement NN B-NP O
therapy NN I-NP O
for IN B-VP O
five CD O O
years NNS B-NP O
which WDT O O
was VBD B-VP O
then RB O O
discontinued VBN O O
secondary JJ O O
to TO O O
her PRP$ O O
breast NN B-NP O
cancer NN I-NP O
13 CD O O
Status NNP B-NP O
post NN I-NP O
bilateral JJ B-NP O
knee NN I-NP O
replacement NN I-NP O
TRANSFER NNP I-NP O
MEDICATIONS: NNP I-NP O
Lopressor NNP I-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
started VBD B-VP O
three CD O B-du
weeks NNS B-NP O
ago RB O O
, , O O
Axid NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
enteric RB O B-m
coated VBD B-VP O
aspirin JJ O O
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
, , O O
Isordil NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
, , O O
hydralazine VBP O B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
, , O O
Timoptic JJ O B-m
0.25% CD O O
one CD O B-do
GTT NNP B-NP I-do
OU NNP I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Serax NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
p.r.n NN I-NP I-f
insomnia NN I-NP B-r
, , O O
and CC O O
IV NNP B-NP B-mo
heparin NN I-NP B-m
at IN B-VP O
1 CD O B-do
, , O I-do
300 CD O I-do
units NNS B-NP I-do
per IN B-VP B-f
hour NN B-NP I-f
ALLERGIES: NNP I-NP O
Tagamet NNP I-NP O
causes VBZ O O
a DT B-NP O
rash NN I-NP O
and CC O O
adhesive JJ B-NP O
tape NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
She PRP O O
quit VBD B-VP O
17 CD O O
years NNS B-NP O
ago RB O O
She PRP O O
uses VBZ O O
no DT B-NP O
alcohol NN I-NP O
and CC O O
no DT B-NP O
IV NNP I-NP O
drug NN I-NP O
use NN I-NP O
She PRP O O
lives VBZ O O
with IN B-VP O
her PRP$ O O
husband NN B-NP O
in IN B-VP O
Lau NNP B-NP O
and CC O O
has VBZ O O
six CD O O
children NNS B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Her NNP I-NP O
father NN I-NP O
died VBD B-VP O
of IN B-VP O
stomach NN B-NP O
cancer NN I-NP O
Mother NNP I-NP O
, , O O
two CD O O
aunts NNS B-NP O
, , O O
and CC O O
sister RB O O
have VBP O O
history NN B-NP O
of IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
at IN B-VP O
ages NNS B-NP O
greater JJR O O
than IN B-VP O
60 CD O O
REVIEW NNP B-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
following VBG O O
her PRP$ O O
weight NN B-NP O
since IN B-VP O
her PRP$ O O
last JJ B-NP O
discharge NN I-NP O
( ( O O
pulmonary JJ B-NP O
edema NN I-NP O
) ) O O
She PRP O O
reports VBZ O O
a DT B-NP O
weight JJ I-NP O
loss NN I-NP O
from IN B-VP O
177 CD O O
to TO O O
175 CD O O
lb NN B-NP O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
couple NN I-NP O
of IN B-VP O
days NNS B-NP O
She PRP O O
reports VBZ O O
a DT O O
12 CD O O
lb JJ B-NP O
weight JJ I-NP O
loss NN I-NP O
in IN B-VP O
the DT B-NP O
last JJ I-NP O
month NN I-NP O
She PRP O O
has VBZ O O
no DT B-NP O
complaints NNS I-NP O
of IN B-VP O
dysuria NN B-NP O
or CC O O
cough JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
pleasant JJ I-NP O
female NN I-NP O
, , O O
resting VBG O O
comfortably RB O O
in IN B-VP O
bed NN B-NP O
Her PRP$ O O
temperature NN B-NP O
was VBD B-VP O
98.5 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
156/68 CD O O
, , O O
pulse RB O O
78 CD O O
, , O O
respirations NNS B-NP O
20 CD O O
, , O O
and CC O O
95% CD O O
on IN B-VP O
two CD O O
liters NNS B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
JVD NNP I-NP O
Carotids NNP I-NP O
were VBD B-VP O
1+ CD O O
without IN B-VP O
bruits NNS B-NP O
, , O O
no DT B-NP O
thyromegaly NN I-NP O
, , O O
and CC O O
no DT B-NP O
lymphadenopathy JJ I-NP O
Lungs NNS I-NP O
revealed VBD B-VP O
right JJ B-NP O
basilar NN I-NP O
crackles NNS I-NP O
She PRP O O
was VBD B-VP O
using VBG O O
accessory JJ B-NP O
muscles NNS I-NP O
for IN B-VP O
respirations NNS B-NP O
Heart NNP I-NP O
revealed VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
II-III/VI JJ I-NP O
systolic JJ I-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
LSB NNP I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
III/VI NNP I-NP O
holosystolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
apex NN I-NP O
radiating VBG O O
to TO O O
the DT B-NP O
axilla NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
S3 NNP I-NP O
or CC O O
S4 NNP B-NP O
Her NNP I-NP O
abdomen NN I-NP O
was VBD B-VP O
slightly RB O O
distended VBN O O
with IN B-VP O
no DT B-NP O
hepatosplenomegaly NN I-NP O
She PRP O O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
She PRP O O
had VBD B-VP O
2+ CD O O
femoral JJ B-NP O
pulses NNS I-NP O
bilaterally RB O O
without IN B-VP O
bruits NNS B-NP O
and CC O O
2+ CD O O
DP NNP B-NP O
pulses NNS I-NP O
bilaterally RB O O
There EX O O
was VBD B-VP O
no DT O O
ankle JJ O O
edema RB O O
Neurological JJ B-NP O
examination NN I-NP O
was VBD B-VP O
grossly RB O O
intact JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
BUN NNP I-NP O
was VBD B-VP O
59 CD O O
, , O O
creatinine NN B-NP O
3.9 CD O O
, , O O
hematocrit NN B-NP O
28.9 CD O O
, , O O
and CC O O
MCV NNP B-NP O
82.3 CD O O
Magnesium NNP B-NP O
was VBD B-VP O
2.4 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
from IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
pulmonary JJ B-NP O
edema NN I-NP O
EKG NNP I-NP O
revealed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
81 CD O O
, , O O
normal JJ B-NP O
axis NN I-NP O
and CC O O
intervals NNS B-NP O
( ( O O
QT NNP B-NP O
slightly RB O O
increased VBD B-VP O
at IN B-VP O
0.46 CD O O
) ) O O
, , O O
LVH NNP B-NP O
, , O O
LAE NNP B-NP O
There EX O O
was VBD B-VP O
T NNP B-NP O
flattening VBG O O
in IN B-VP O
AVL NNP B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
acute JJ I-NP O
ST NNP I-NP O
or CC O O
T NNP B-NP O
wave VBP O O
changes NNS B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
CONGESTIVE NNP B-NP O
HEART NNP I-NP O
FAILURE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
much RB O O
improved VBN O O
after IN B-VP O
successful JJ B-NP O
diuresis NN I-NP O
with IN B-VP O
improvement NN B-NP O
of IN B-VP O
her PRP$ O O
pulmonary JJ B-NP O
examination NN I-NP O
and CC O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
right NN B-NP O
sided VBN O O
failure NN B-NP O
She PRP O O
was VBD B-VP O
saturating VBG O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Care NNP I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
diurese JJ O O
slowly RB O O
in IN B-VP O
order NN B-NP O
to TO O O
present VB O O
a DT B-NP O
prerenal JJ I-NP O
insult NN I-NP O
She PRP O O
remained VBD B-VP O
symptom JJ O O
free JJ O O
for IN B-VP O
the DT B-NP O
duration NN I-NP O
of IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
2 CD O O
CORONARY NNP B-NP O
ARTERY NNP I-NP O
DISEASE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
ever RB O O
having VBG O O
had VBD B-VP O
any DT B-NP O
chest JJS I-NP O
pain NN I-NP O
, , O O
but CC O O
had VBD B-VP O
known VBN O O
anatomy NN B-NP O
with IN B-VP O
single JJ B-NP O
vessel NN I-NP O
disease NN I-NP O
( ( O O
RCA NNP B-NP O
) ) O O
Her PRP$ O O
history NN B-NP O
is VBZ O O
suggestive JJ O O
of IN B-VP O
possible JJ B-NP O
silent JJ I-NP O
ischemia NN I-NP O
consistent NN I-NP O
with IN B-VP O
her PRP$ O O
diabetic JJ B-NP O
status NN I-NP O
Her NNP I-NP O
anginal JJ B-NP O
equivalent NN I-NP O
appears VBZ O O
to TO O O
be VB O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
The DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
11/4/97 CD O O
with IN B-VP O
PTCA NNP B-NP O
plus CC O O
stent JJ B-NP O
placement NN I-NP O
to TO O O
her PRP$ O O
RCA NNP B-NP O
with IN B-VP O
a DT B-NP O
good JJ I-NP O
result NN I-NP O
She PRP O O
is VBZ O O
on IN B-VP O
Ticlid NNP B-NP B-m
for IN B-VP B-du
two CD O I-du
weeks NNS B-NP I-du
Her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
well RB O O
controlled VBN O O
in IN B-VP O
her PRP$ O O
target NN B-NP O
range NN I-NP O
of IN B-VP O
140-160 JJ B-NP O
systolic JJ I-NP B-r
systolic JJ I-NP B-r
systolic JJ I-NP B-r
blood NN I-NP O
pressure NN I-NP O
on IN B-VP O
hydralazine NN B-NP B-m
, , O O
Lasix NNP B-NP B-m
, , O O
and CC O O
Lopressor NNP B-NP B-m
The DT B-NP O
day NN I-NP O
following VBG O O
cardiac JJ B-NP O
catheterization NN I-NP O
, , O O
her PRP$ O O
hematocrit NN B-NP O
and CC O O
creatinine NN B-NP O
remained VBD B-VP O
stable JJ O O
at IN B-VP O
30.9 CD O O
and CC O O
3.7 CD O O
, , O O
respectively RB O O
On IN B-VP O
0/9/97 CD O O
, , O O
her PRP$ O O
creatinine NN B-NP O
increased VBD B-VP O
to TO O O
4.2 CD O O
This DT B-NP O
increase NN I-NP O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
prerenal JJ B-NP O
insult NN I-NP O
in IN B-VP O
addition NN B-NP O
to TO O O
possible JJ O O
dinephropathy JJ O O
She PRP O O
was VBD B-VP O
hydrated VBN O O
gently RB O O
and CC O O
her PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
watched VBN O O
for IN B-VP O
the DT O O
next JJ O O
two CD O O
days NNS B-NP O
, , O O
stabilizing VBG O O
in IN B-VP O
the DT O O
4.4 CD O O
to TO O O
4.5 CD O O
range NN B-NP O
3 CD O O
CHRONIC NNP B-NP O
RENAL NNP I-NP O
INSUFFICIENCY: NNP I-NP O
Etiology NNP I-NP O
was VBD B-VP O
unknown JJ O O
, , O O
possibly RB O O
secondary JJ O O
to TO O O
diabetes VB O O
mellitus NN B-NP O
or CC O O
hypertensive JJ O O
nephropathy JJ O O
She PRP O O
has VBZ O O
history NN B-NP O
of IN B-VP O
creatinine NN B-NP O
rises NNS I-NP O
to TO O O
high JJ O O
3s CD O O
and CC O O
4s CD O O
during IN B-VP O
recent JJ B-NP O
hospitalizations NNS I-NP O
Hospital NNP I-NP O
course NN I-NP O
is VBZ O O
as IN B-VP O
described VBN O O
above IN B-VP O
In IN B-VP O
addition NN B-NP O
, , O O
Axid NNP B-NP B-m
was VBD B-VP O
changed VBN O O
to TO O O
renal VB O B-do
dosing NN B-NP I-do
( ( O O
q.day JJ O B-f
) ) O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
for IN B-VP O
a DT B-NP O
urinary JJ I-NP O
tract NN I-NP O
infection NN I-NP O
In IN B-VP O
reviewing VBG O O
the DT B-NP O
hospital NN I-NP O
records NNS I-NP O
, , O O
there EX O O
is VBZ O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
previous JJ B-NP O
work NN I-NP O
up RB O O
for IN B-VP O
renal JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
This DT B-NP O
patient NN I-NP O
with IN B-VP O
history NN B-NP O
and CC O O
physical JJ O O
to TO O O
control VB O O
blood NN B-NP O
pressures NNS I-NP O
and CC O O
flash JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
hypertension NN B-NP O
may MD O O
benefit VB O O
from IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
possible JJ B-NP O
renal JJ I-NP O
artery NN I-NP O
stenosis NN I-NP O
This DT B-NP O
work NN I-NP O
up RB O O
was VBD B-VP O
deferred VBN O O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
due JJ O O
to TO O O
management NN B-NP O
of IN B-VP O
acute NN B-NP O
issues NNS I-NP O
4 CD O O
DIABETES NNP B-NP O
MELLITUS: NNP I-NP O
This DT O O
was VBD B-VP O
stable JJ O O
, , O O
diet JJ O O
controlled VBD B-VP O
5 CD O O
ANEMIA: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
worked VBN O O
up RP O O
for IN B-VP O
her PRP$ O O
baseline NN B-NP O
low JJ B-NP O
hematocrit NN I-NP O
, , O O
found VBN O O
to TO O O
have VB O O
an DT B-NP B-r
iron NN I-NP I-r
deficiency NN I-NP I-r
anemia NN I-NP I-r
treated VBN O O
with IN B-VP O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
Given NNP I-NP O
her PRP$ O O
underlying JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
there EX O O
may MD O O
also RB O O
be VB O O
a DT O O
renally RB O O
driven JJ B-NP O
component NN I-NP O
to TO O O
her PRP$ O B-r
anemia NN B-NP I-r
and CC O O
she PRP O O
may MD O O
benefit VB O O
from IN B-VP O
Epogen NNP B-NP B-m
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Andre NNP I-NP O
Smithe NNP I-NP O
, , O O
her PRP$ O O
cardiologist NN B-NP O
, , O O
in IN B-VP O
two CD O O
weeks NNS B-NP O
, , O O
and CC O O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
based VBN O O
on IN B-VP O
previously RB O O
scheduled VBN O O
appointment NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Enteric NNP I-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
325 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.day NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
, , O O
hydralazine VBP O B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
, , O O
Isordil NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
nitroglycerin RB O B-m
1/150 CD O I-m
one CD O B-do
tablet NN B-NP I-do
sublingual JJ B-NP B-mo
q NN I-NP B-f
5 CD O O
minutes NNS B-NP O
times NNS I-NP O
three CD O O
p.r.n NN B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
, , O O
Timoptic NNP B-NP B-m
0.25% CD O I-m
one CD O B-do
drop NN B-NP I-do
OU NNP I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Axid NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
, , O O
and CC O O
Ticlid NNP B-NP B-m
250 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
for IN B-VP B-du
two CD O O
weeks NNS B-NP O
Also RB O O
, , O O
Niferex NNP B-NP B-m
tablet VBD B-VP I-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
DISCHARGE NNP I-NP O
INSTRUCTIONS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
have VB O O
her PRP$ O O
CBC NNP B-NP O
checked VBN O O
at IN B-VP O
two CD O O
weeks NNS B-NP O
and CC O O
four CD O B-du
weeks NNS B-NP I-du
given VBN O O
her PRP$ O O
Ticlid NNP B-NP B-m
therapy NN I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
LOUIS NNP I-NP O
LIEBOLD NNP I-NP O
, , O O
M.D NNP B-NP O
GS15 NNP I-NP O
Attending: NNP I-NP O
REFUGIO NNP I-NP O
J NNP I-NP O
HASSELL NNP I-NP O
, , O O
M.D NNP B-NP O
HA40 NNP I-NP O
MR501/7465 NNP I-NP O
Batch: NNP I-NP O
37548 CD O O
Index NNP B-NP O
No NNP I-NP O
O1EZ468S7B NNP I-NP O
D: NNP I-NP O
2/5/97 CD O O
T: NNP B-NP O
10/24/97 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#456469 VBZ O O
608189475 CD O O
BMH NNP B-NP O
63257078 CD O O
0048321 CD O O
1/21/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/24/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/8/2006 CD O O
Date NNP B-NP O
of IN B-VP O
Admission: NNP B-NP O
7/24/2006 CD O O
ATTENDING: NNP B-NP O
LUY NNP I-NP O
, , O O
GENE NNP B-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
discharge NN I-NP O
summary JJ B-NP O
addendum NN I-NP O
to TO O O
the DT O O
previously RB O O
dictated VBN O O
note NN B-NP O
by IN B-VP O
Neville NNP B-NP O
Mastenbrook NNP I-NP O
, , O O
dictated VBD B-VP O
on IN B-VP O
7/20/06 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
Mr NNP I-NP O
Timbers NNP I-NP O
had VBD B-VP O
been VBN O O
prepared VBN O O
for IN B-VP O
discharge NN B-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
five CD O O
, , O O
10/28/06 CD O O
, , O O
however RB O O
, , O O
was VBD B-VP O
noted VBN O O
to TO O O
complain VB O O
of IN B-VP O
left JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
tenderness NN I-NP O
and CC O O
erythema JJ B-NP O
White NNP I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
8.9 CD O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
afebrile IN B-VP O
He PRP O O
otherwise RB O O
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
with IN B-VP O
stable JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
and CC O O
creatinine NN B-NP O
of IN B-VP O
1.1 CD O O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
6 CD O O
, , O O
7/9/06 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
count NN I-NP O
was VBD B-VP O
increased VBN O O
at IN B-VP O
11.7 CD O O
with IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
increasingly RB O O
erythematous JJ O O
and CC O O
tender NN B-NP O
SVG NNP I-NP O
tract NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
contain VB O O
only RB O O
minimal JJ B-NP O
fluid NN I-NP O
Negative NNP I-NP O
Homans' NNP I-NP O
sign NN I-NP O
was VBD B-VP O
observed VBN O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
demonstrating VBG O O
no DT B-NP O
calf NN I-NP O
tenderness NN I-NP O
on IN B-VP O
palpation NN B-NP O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
remain VB O O
afebrile IN B-VP O
A DT B-NP O
course NN I-NP O
of IN B-VP O
Keflex NNP B-NP B-m
was VBD B-VP O
commenced VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
seven CD O O
, , O O
with IN B-VP O
the DT B-NP O
patient's JJ I-NP O
white JJ I-NP O
count NN I-NP O
increasing VBG O O
to TO O O
12.1 CD O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
now RB O O
demonstrating VBG O O
continued VBN O O
increase NN B-NP O
in IN B-VP O
erythema NN B-NP O
and CC O O
warmth NN B-NP O
along IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
at IN B-VP O
SVG NNP B-NP O
harvest JJS B-NP O
site NN I-NP O
incision NN I-NP O
, , O O
particularly RB O O
distal JJ O O
to TO O O
the DT B-NP O
knee NN I-NP O
Additionally NNP I-NP O
, , O O
of IN B-VP O
note NN B-NP O
, , O O
Mr NNP B-NP O
Hovenga NNP I-NP O
's POS O O
Toprol NNP B-NP B-m
was VBD B-VP O
increased VBN O O
to TO O O
150 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
with IN B-VP O
an DT O O
extra JJ O O
2 CD O B-do
mg NN B-NP I-do
of IN B-VP O
magnesium NN B-NP B-m
administered VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
seven CD O O
for IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
in IN B-VP O
the DT O O
high JJ O O
90s CD O O
with IN B-VP O
blood NN B-NP B-r
pressure NN I-NP I-r
mildly RB O O
hypertensive JJ O O
, , O O
additionally RB O O
with IN B-VP O
frequent JJ B-NP O
PVCs NNP I-NP O
noted VBD B-VP O
on IN B-VP O
telemetry NN B-NP O
Mr NNP I-NP O
Notarnicola NNP I-NP O
continued VBD B-VP O
to TO O O
ambulate VB O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
and CC O O
remained VBD B-VP O
afebrile JJ B-NP O
Leukocytosis NNP I-NP O
was VBD B-VP O
additionally RB O O
worked VBN O O
up RP O O
with IN B-VP O
urinalysis NN B-NP O
and CC O O
chest JJS B-NP O
X-Ray NN I-NP O
, , O O
which WDT O O
subsequently RB O O
demonstrated VBD B-VP O
no DT B-NP O
infection NN I-NP O
or CC O O
infiltrate VB O O
Mr NNP B-NP O
Sermersheim NNP I-NP O
is VBZ O O
discharged VBN O O
to TO O O
rehabilitation VB O O
today NN B-NP O
, , O O
postoperative JJ B-NP O
day NN I-NP O
eight CD O O
, , O O
having VBG O O
recovered VBN O O
well RB O O
following VBG O O
his PRP$ O O
elective JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
procedure NN I-NP O
, , O O
hemodynamically RB O O
stable JJ O O
with IN B-VP O
left JJ B-NP B-r
lower JJR I-NP O
extremity NN I-NP O
erythema NN I-NP O
and CC O O
tenderness NN B-NP O
significantly RB O O
improved VBD B-VP O
24 CD O O
hours NNS B-NP O
following VBG O O
initiation NN B-NP O
of IN B-VP O
Keflex NNP B-NP B-m
course NN I-NP O
White NNP I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
has VBZ O O
improved VBN O O
to TO O O
11.2 CD O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
remaining VBG O O
afebrile JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
day NN B-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
pleasant JJ I-NP O
male NN I-NP O
, , O O
appearing VBG O O
younger JJR O O
than IN B-VP O
stated VBN O O
age NN B-NP O
, , O O
alert NN B-NP O
and CC O O
oriented VBN O O
x3 NN B-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Vital NNP I-NP O
signs NNS I-NP O
are VBP O O
as IN B-VP O
follows: JJ B-NP O
temperature NN I-NP O
99.5 CD O O
degrees NNS B-NP O
Fahrenheit NNP I-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
80 CD O O
, , O O
sinus NN B-NP O
rhythm NN I-NP O
, , O O
blood NN B-NP O
pressure NN I-NP O
118/60 CD O O
, , O O
and CC O O
oxygen NN B-NP O
saturation NN I-NP O
100% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Today's NNP I-NP O
weight NN I-NP O
listed VBD B-VP O
as IN B-VP O
0.7 CD O O
kilograms NNS B-NP O
above IN B-VP O
his PRP$ O O
preoperative JJ B-NP O
weight NN I-NP O
( ( O O
preoperative JJ B-NP O
weight NN I-NP O
listed VBN O O
as IN B-VP O
87.3 CD O O
kilograms NNS B-NP O
) ) O O
HEENT: VBP O O
no DT B-NP O
carotid NN I-NP O
bruits VBZ O O
or CC O O
JVD NNP B-NP O
is VBZ O O
appreciated VBN O O
Pulmonary: NNP B-NP O
lungs NNS I-NP O
are VBP O O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
with IN B-VP O
slightly RB O O
diminished VBN O O
breath NN B-NP O
sounds NNS I-NP O
at IN B-VP O
left JJ B-NP O
base NN I-NP O
Coronary: NNP I-NP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
, , O O
or CC O O
gallops NNS B-NP O
are VBP O O
appreciated VBN O O
Abdomen: NNP B-NP O
slightly RB O O
distended VBD B-VP O
, , O O
mildly RB O O
obese JJ O O
, , O O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities: NNP B-NP O
trace NN I-NP O
bilateral JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
Skin: NNP I-NP O
midline NN I-NP O
sternotomy NN I-NP O
incision NN I-NP O
, , O O
well RB O O
approximated VBN O O
and CC O O
healing VBG O O
well RB O O
, , O O
with IN B-VP O
no DT B-NP O
erythema NN I-NP O
or CC O O
drainage VB O O
present JJ B-NP O
No NNP I-NP O
sternal NN I-NP O
click NN I-NP O
is VBZ O O
elicited VBN O O
on IN B-VP O
examination NN B-NP O
Left NNP I-NP O
lower JJR B-NP O
extremity NN I-NP O
thigh NN I-NP O
is VBZ O O
ecchymotic JJ O O
and CC O O
tender NN B-NP O
, , O O
no DT B-NP O
drainage NN I-NP O
present NN I-NP O
from IN B-VP O
proximal JJ B-NP O
SVG NNP I-NP O
harvest JJS B-NP O
site NN I-NP O
incision NN I-NP O
Left NNP I-NP O
lower JJR B-NP O
extremity NN I-NP O
distal NN I-NP O
to TO O O
SVG NNP B-NP O
incision NN I-NP O
and CC O O
knee NN B-NP O
erythematous JJ O O
although IN B-VP O
improved VBN O O
from IN B-VP O
prior JJ B-NP O
examinations NNS I-NP O
with IN B-VP O
decreased JJ B-NP O
erythema NN I-NP O
, , O O
warmth NN B-NP O
, , O O
and CC O O
tenderness NN B-NP O
along IN B-VP O
prior JJ B-NP O
SVG NNP I-NP O
tract NN I-NP O
No NNP I-NP O
calf NN I-NP O
tenderness NN I-NP O
is VBZ O O
present JJ O O
2+ CD O O
pulses NNS B-NP O
at IN B-VP O
all DT B-NP O
extremities NNS I-NP O
bilaterally RB O O
Neuro: NNP B-NP O
intact JJ O O
, , O O
nonfocal JJ B-NP O
examination NN I-NP O
LAB NNP I-NP O
VALUES NNP I-NP O
ON NNP I-NP O
DAY NNP I-NP O
OF NNP I-NP O
DISCHARGE: NNP I-NP O
( ( O O
8/1/06 CD O O
) ) O O
Sodium NN B-NP O
135 CD O O
, , O O
Potassium NNP B-NP O
4.1 CD O O
, , O O
BUN NNP B-NP O
33 CD O O
, , O O
Creatinine NNP B-NP O
1.5 CD O O
, , O O
Glucose NNP B-NP O
79 CD O O
, , O O
Calcium NNP B-NP O
9.0 CD O O
, , O O
Magnesium NNP B-NP O
1.6 CD O O
( ( O O
replaced VBN O O
) ) O O
, , O O
White NNP B-NP O
Blood NNP I-NP O
Cell NNP I-NP O
Count NNP I-NP O
11.2 CD O O
, , O O
Hematocrit NNP B-NP O
28.0 CD O O
, , O O
Platelet NNP B-NP O
Count: NNP I-NP O
380 CD O O
, , O O
000 CD O O
Microbiology: NNP B-NP O
negative JJ O O
for IN B-VP O
VRE NNP B-NP O
and CC O O
MRSA NNP B-NP O
and CC O O
routine JJ B-NP O
screening NN I-NP O
sent VBD B-VP O
on IN B-VP O
8/15/06 CD O O
Sputum JJ B-NP O
culture NN I-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
growth NN B-NP O
( ( O O
sent JJ O O
7/9/06 CD O O
) ) O O
Repeat NNP B-NP O
sputum NN I-NP O
and CC O O
urine JJ B-NP O
cultures NNS I-NP O
negative JJ O O
for IN B-VP O
growth NN B-NP O
( ( O O
sent JJ O O
1/22/06 CD O O
) ) O O
DIAGNOSTIC NNP B-NP O
IMAGING: NNP I-NP O
Chest NNP I-NP O
x-ray JJ B-NP O
PA NNP I-NP O
and CC O O
lateral JJ B-NP O
view NN I-NP O
obtained VBN O O
day NN B-NP O
prior RB O O
to TO O O
discharge VB O O
, , O O
1/22/06 CD O O
, , O O
demonstrates VBZ O O
bilateral JJ B-NP O
small JJ I-NP O
pleural JJ I-NP O
effusions NNS I-NP O
, , O O
no DT B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
present NN I-NP O
, , O O
and CC O O
calcified VBD B-VP O
granuloma NN B-NP O
present NN I-NP O
left VBD B-VP O
upper JJ B-NP O
lobe NN I-NP O
unchanged JJ O O
from IN B-VP O
prior JJ B-NP O
postoperative NN I-NP O
and CC O O
preoperative JJ B-NP O
films NNS I-NP O
, , O O
no DT B-NP O
pneumothorax NN I-NP O
or CC O O
infiltrate VB O O
present JJ B-NP O
Stable JJ I-NP O
cardiomediastinal JJ I-NP O
silhouette NN I-NP O
and CC O O
no DT B-NP O
infiltrate JJ I-NP O
present JJ I-NP O
DISPOSITION: NNP I-NP O
Mr NNP I-NP O
Neth NNP I-NP O
is VBZ O O
discharged VBN O O
to TO O O
rehabilitation VB O O
today NN B-NP O
having VBG O O
recovered VBN O O
well RB O O
following VBG O O
his PRP$ O O
elective JJ B-NP O
CABG NNP I-NP O
procedure NN I-NP O
Mr NNP I-NP O
Marcusen NNP I-NP O
is VBZ O O
discharged VBN O O
to TO O O
rehabilitation VB O O
today NN B-NP O
, , O O
postoperative JJ B-NP O
day NN I-NP O
eight CD O O
, , O O
hemodynamically RB O O
stable JJ O O
, , O O
to TO O O
continue VB O O
a DT B-NP O
course NN I-NP O
of IN B-VP O
Keflex NNP B-NP B-m
for IN B-VP O
left VBD B-VP B-r
lower JJR B-NP I-r
extremity NN I-NP I-r
erythema NN I-NP I-r
and CC O O
additionally RB O O
to TO O O
continue VB O O
one CD O B-du
week NN B-NP O
of IN B-VP O
diuresis NN B-NP O
in IN B-VP O
the DT B-NP O
form NN I-NP O
of IN B-VP O
low JJ B-NP B-do
dose JJ I-NP I-do
Lasix NNP I-NP B-m
for IN B-VP O
mild JJ B-NP B-r
persistent JJ I-NP O
postoperative JJ I-NP O
pulmonary JJ I-NP O
effusions NNS I-NP O
Mr NNP I-NP O
Brannigan NNP I-NP O
has VBZ O O
been VBN O O
instructed VBN O O
to TO O O
shower VB O O
and CC O O
monitor VB O O
incisions NNS B-NP O
for IN B-VP O
signs NNS B-NP O
of IN B-VP O
increasing VBG O O
infection NN B-NP O
such JJ O O
as IN B-VP O
fever NN B-NP O
, , O O
drainage NN B-NP O
, , O O
worsening VBG O O
pain NN B-NP O
or CC O O
increase NN B-NP O
in IN B-VP O
redness NN B-NP O
He PRP O O
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
for IN B-VP O
continued JJ B-NP O
evaluation NN I-NP O
and CC O O
management NN B-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
dyslipidemia NN B-NP O
, , O O
obesity NN B-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
and CC O O
uncontrolled VBD B-VP O
Type NNP B-NP O
II NNP I-NP O
diabetes VBZ O O
mellitus FW O O
Additionally RB O O
, , O O
the DT B-NP O
patient NN I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
cardiologist NN B-NP O
for IN B-VP O
continued JJ B-NP O
evaluation NN I-NP O
and CC O O
management NN B-NP O
of IN B-VP O
blood NN B-NP O
pressure NN I-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
, , O O
heart NN B-NP O
rhythm NN I-NP O
, , O O
lipid JJ B-NP O
levels NNS I-NP O
, , O O
and CC O O
for IN B-VP O
possible JJ B-NP O
future JJ I-NP O
adjustment NN I-NP O
in IN B-VP O
medication NN B-NP B-m
Mr NNP I-NP O
Connin NNP I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
cardiac NN B-NP O
surgeon NN I-NP O
, , O O
Dr NNP B-NP O
Quinn NNP I-NP O
Dalio NNP I-NP O
, , O O
in IN B-VP O
six CD O O
to TO O O
eight CD O O
weeks NNS B-NP O
Additionally RB O O
, , O O
he PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Octavio NNP I-NP O
Wulffraat NNP I-NP O
, , O O
in IN B-VP O
two CD O O
to TO O O
four CD O O
weeks NNS B-NP O
and CC O O
with IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Barrett NNP I-NP O
Mittleman NNP I-NP O
, , O O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Include NNP I-NP O
the DT B-NP O
following JJ I-NP O
Tylenol NNP I-NP B-m
Tylenol NNP I-NP B-m
325 CD O B-do
325 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
p.o NN I-NP B-mo
p.o NN I-NP B-mo
q.6h NN I-NP B-f
q.6h NN I-NP B-f
p.r.n NN I-NP I-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
for IN B-VP O
temperature NN B-NP B-r
greater JJR O O
than IN B-VP O
101 CD O O
degrees NNS B-NP O
Fahrenheit NNP I-NP O
, , O O
amlodipine VBP O B-m
5 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
atorvastatin VBD B-VP B-m
10 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
captopril VBD B-VP B-m
6.25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Keflex NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
times NNS I-NP B-du
total JJ O I-du
of IN B-VP I-du
seven CD O I-du
days NNS B-NP I-du
, , O O
last JJ B-NP O
dose NN I-NP O
on IN B-VP O
9/15/06 CD O O
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
p.r.n NN I-NP I-f
constipation NN I-NP B-r
, , O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
x7 NNP I-NP B-du
days NNS I-NP I-du
, , O O
hydrochlorothiazide JJ O B-m
12.5 CD O B-do
mg JJ O I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
NovoLog NNP B-NP B-m
3 CD O B-do
units NNS B-NP I-do
subcu JJ B-NP B-mo
AC NNP I-NP B-f
, , O O
Lantus NNP B-NP B-m
24 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
q RB O B-f
10 CD O I-f
p.m NN B-NP I-f
, , O O
hold VBP O O
if IN B-VP O
n.p.o NNS B-NP O
, , O O
potassium NN B-NP B-m
slow JJ B-NP I-m
release NN I-NP I-m
20 CD O B-do
mEq NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
x7 NNP I-NP B-du
days NNS I-NP I-du
, , O O
Toprol-XL JJ O B-m
150 CD O B-do
mg JJ O I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
oxycodone RB O B-m
5 CD O B-do
to TO O I-do
10 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.4h JJ I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
Ambien NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
nightly RB O B-f
p.r.n VBZ O I-f
insomnia NN B-NP B-r
, , O O
NovoLog NNP B-NP B-m
6 CD O B-do
units NNS B-NP I-do
subcu VBP O B-mo
with IN B-VP B-f
breakfast NN B-NP O
, , O O
hold VBP O O
if IN B-VP O
n.p.o NNS B-NP O
, , O O
NovoLog NNP B-NP B-m
4 CD O B-do
units NNS B-NP I-do
subcu VBN O B-mo
with IN B-VP B-f
lunch NN B-NP I-f
, , O O
hold VBP O O
if IN B-VP O
n.p.o NNS B-NP O
, , O O
NovoLog NNP B-NP B-m
4 CD O B-do
units NNS B-NP I-do
subcu VBN O B-mo
with IN B-VP B-f
dinner NN B-NP I-f
, , O O
hold VBP O O
if IN B-VP O
n.p.o NNS B-NP O
, , O O
NovoLog NNP B-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
sliding VBG O B-do
scale JJ B-NP I-do
subcu NN I-NP B-mo
AC NNP I-NP B-f
, , O O
blood NN B-NP B-r
sugar NN I-NP I-r
less JJR O O
than IN B-VP O
125 CD O O
, , O O
give VBP O O
0 CD O B-do
units NNS B-NP O
subcu RB O B-mo
, , O O
blood NN B-NP B-r
sugar NN I-NP I-r
125 CD O O
to TO O O
150 CD O O
, , O O
give VBP O O
2 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
blood NN B-NP B-r
sugar NN I-NP O
151 CD O O
to TO O O
200 CD O O
, , O O
give VBP O O
3 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
blood NN B-NP B-r
sugar NN I-NP I-r
201 CD O O
to TO O O
250 CD O O
, , O O
give VBP O O
4 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
blood NN B-NP B-r
sugar NN I-NP I-r
251 CD O O
to TO O O
300 CD O O
, , O O
give VBP O O
6 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
blood NN B-NP B-r
sugar NN I-NP I-r
301 CD O O
to TO O O
350 CD O O
, , O O
give VBP O O
8 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
if IN B-VP O
blood NN B-NP O
sugar NN I-NP O
351 CD O O
to TO O O
400 CD O O
, , O O
give VBP O O
10 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
call VB O O
physician NN B-NP O
if IN B-VP O
blood NN B-NP O
sugar NN I-NP O
greater JJR O O
than IN B-VP O
400 CD O O
, , O O
NovoLog NNP B-NP B-m
sliding VBG O B-do
scale JJ B-NP I-do
subcu NN I-NP B-mo
q.h.s NN I-NP B-f
Please NNP I-NP O
recheck VB O O
fingerstick NN B-NP O
in IN B-VP O
1 CD O O
hour NN B-NP O
if IN B-VP O
administering VBG O O
NovoLog NNP B-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
at IN B-VP B-f
at IN B-VP B-f
at IN B-VP B-f
at IN B-VP B-f
at IN B-VP B-f
bedtime NN B-NP I-f
bedtime NN I-NP I-f
bedtime NN I-NP I-f
bedtime NN I-NP I-f
bedtime NN I-NP I-f
, , O O
if IN B-VP O
blood NN B-NP O
sugar NN I-NP O
less JJR O O
than IN B-VP O
200 CD O O
, , O O
give VBP O O
0 CD O B-do
units NNS B-NP I-do
subcu JJ B-NP B-mo
subcu NN I-NP B-mo
, , O O
if IN B-VP O
blood NN B-NP O
sugar NN I-NP O
201 CD O O
to TO O O
250 CD O O
, , O O
give VBP O O
2 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
blood NN B-NP O
sugar NN I-NP O
251 CD O O
to TO O O
300 CD O O
, , O O
give VBP O O
3 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
blood NN B-NP O
sugar NN I-NP O
301 CD O O
to TO O O
350 CD O O
, , O O
give VBP O O
4 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
blood NN B-NP O
sugar NN I-NP O
351 CD O O
to TO O O
400 CD O O
, , O O
give VBP O O
5 CD O O
units NNS B-NP O
subcu RB O O
, , O O
blood NN B-NP O
sugar NN I-NP O
greater JJR O O
than IN B-VP O
400 CD O O
, , O O
call NN B-NP O
physician JJ B-NP O
Mr NNP I-NP O
Forde NNP I-NP O
has VBZ O O
recovered VBN O O
very RB O O
well RB O O
following VBG O O
his PRP$ O O
elective JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
procedure NN I-NP O
and CC O O
is VBZ O O
anticipated VBN O O
to TO O O
continue VB O O
to TO O O
make VB O O
excellent JJ B-NP O
recovery NN I-NP O
with IN B-VP O
continued JJ B-NP O
close JJ I-NP O
followup NN I-NP O
with IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
and CC O O
cardiologist NN B-NP O
Thank NNP I-NP O
you PRP O O
for IN B-VP O
referring VBG O O
this DT B-NP O
patient NN I-NP O
to TO O O
our PRP$ O O
service NN B-NP O
Please NNP I-NP O
do VB O O
not RB O O
hesitate VB O O
to TO O O
call VB O O
with IN B-VP O
further JJ B-NP O
questions NNS I-NP O
or CC O O
concerns NNS B-NP O
eScription NN I-NP O
document: IN B-VP O
5-8522470 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Jasper NNP I-NP O
Rojo NNP I-NP O
MD NNP I-NP O
DIVISION NNP I-NP O
OF NNP I-NP O
CARDIAC NNP I-NP O
SURGERY NNP I-NP O
Reve NNP I-NP O
U NNP I-NP O
Rill NNP I-NP O
Di NNP I-NP O
CC: NNP I-NP O
Max NNP I-NP O
Lattig NNP I-NP O
MD NNP I-NP O
Porteju NNP I-NP O
Surn NNP I-NP O
Anra NNP I-NP O
Hospital NNP I-NP O
A NNP I-NP O
Rance NNP I-NP O
En NNP I-NP O
CC: NNP I-NP O
Emil NNP I-NP O
Dee NNP I-NP O
Spatafora NNP I-NP O
MD NNP I-NP O
Terbsa NNP I-NP O
Hireve NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
CHAPDELAINE NNP I-NP O
, , O O
ALFRED NNP B-NP O
Attending: NNP I-NP O
KANETA NNP I-NP O
, , O O
RUSTY NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6108486 CD O O
D: NNP B-NP O
8/1/06 CD O O
T: NNP B-NP O
1/30/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#457094 VBZ O O
356821645 CD O O
TSH NNP B-NP O
20926128 CD O O
8585430 CD O O
4/3/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/3/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/29/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
PADGET NNP I-NP O
, , O O
CHRISTOPER NNP B-NP O
A NNP I-NP O
434-60-76-2 JJ B-NP O
Bernand NNP I-NP O
Terfordpeocasterl NNP I-NP O
Ca NNP I-NP O
Room: NNP I-NP O
Virg NNP I-NP O
Hamlene NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
0/10/05 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
CIDRE NNP I-NP O
, , O O
CALVIN NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
No NNP I-NP O
CPR NNP I-NP O
, , O O
No NNP B-NP O
defib NN I-NP O
, , O O
No DT B-NP O
intubation NN I-NP O
DISPOSITION: NNP I-NP O
Assisted NNP I-NP O
living VBG O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
ECOTRIN NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
FERRO-SEQUELS NNP I-NP B-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PRAVACHOL NNP I-NP B-m
( ( O I-m
PRAVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
NORVASC NNP B-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
IMDUR NNP B-NP B-m
ER NNP I-NP I-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONITRATE NNP I-NP I-m
( ( O I-m
SR NNP B-NP I-m
) ) O I-m
) ) O I-m
120 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
PILOCARPINE VBD B-VP B-m
2% CD O I-m
1 CD O B-do
DROP NNP B-NP I-do
OU NNP I-NP B-mo
BID NNP I-NP B-f
BACTRIM NNP I-NP B-m
DS NNP I-NP I-m
( ( O I-m
TRIMETHOPRIM/SULFAMETHOXAZOLE NNP B-NP I-m
DOU NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
X NNP I-NP B-du
12 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
10/19 CD O O
) ) O O
Instructions: NNP B-NP O
started VBD B-VP O
on IN B-VP O
4/14 CD O O
, , O O
continue VBP O O
until IN B-VP O
10/25 CD O O
AM NNP B-NP O
CLOBETASOL NNP I-NP B-m
PROPIONATE NNP I-NP I-m
0.05% CD O I-m
CREAM NNP B-NP I-m
TP NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
please VB O O
apply VB O O
to TO O O
affected JJ B-NP O
areas NNS I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
ALLEGRA NNP B-NP B-m
( ( O I-m
FEXOFENADINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/20/05 CD O O
by IN B-VP O
HADESTY NNP B-NP O
, , O O
MARSHALL NNP B-NP O
NED NNP I-NP O
GERARD NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ALLEGRA NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
483093734 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
DIPHENHYDRAMINE NNP B-NP O
; : O O
reaction NN B-NP O
is VBZ O O
agitation JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
takes VBZ O O
at IN B-VP O
home NN B-NP O
ALPHAGAN NNP I-NP B-m
( ( O I-m
BRIMONIDINE NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
1 CD O B-do
DROP NNP B-NP I-do
OU NNP I-NP B-mo
BID NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
CALCIUM NNP I-NP B-m
CARBONATE NNP I-NP I-m
1 CD O B-do
, , O I-do
500 CD O I-do
MG NNP B-NP I-do
( ( O O
600 CD O O
MG NNP B-NP O
ELEM NNP I-NP O
CA NNP I-NP O
)/ NNP I-NP O
VIT NNP I-NP B-m
D NNP I-NP I-m
200 CD O B-do
IU NNP B-NP O
1 CD O O
TAB NNP B-NP O
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZETIA NNP I-NP B-m
( ( O I-m
EZETIMIBE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
METFORMIN NNP I-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ACIPHEX NNP I-NP B-m
( ( O I-m
RABEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Root NNP I-NP O
in IN B-VP O
March NNP B-NP O
scheduled VBD B-VP O
, , O O
ALLERGY: NNP B-NP O
epinephrine VBP O O
eye NN B-NP O
drops NNS I-NP O
, , O O
LEVOFLOXACIN NNP B-NP O
, , O O
IV NNP B-NP O
Contrast NNP I-NP O
, , O O
DIPHENHYDRAMINE NNP B-NP O
, , O O
Penicillins NNP B-NP O
, , O O
BACITRICIN NNP B-NP O
OINTMENT NNP I-NP O
, , O O
OXYBUTININ NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
'93LIMA-LAD;SVGs-PDA CD O O
, , O O
D1 NNP B-NP O
, , O O
OM1 NNP B-NP O
?USA NNP I-NP O
glaucoma NN I-NP O
esophageal NN I-NP O
spasm NN I-NP O
NIDDM NNP I-NP O
, , O O
diet JJ O O
controlled VBD B-VP O
fibrocystic JJ B-NP O
mastitis NN I-NP O
peripheral JJ B-NP O
neuropathy JJ I-NP O
OA NNP I-NP O
, , O O
DJD NNP B-NP O
h/o VBD B-VP O
duodenal JJ B-NP O
ulcer JJ I-NP O
lumbar NN I-NP O
spinal JJ B-NP O
stenosis NN I-NP O
HTN NNP I-NP O
hypercholesterolemia NN I-NP O
s/p NN I-NP O
carpal JJ B-NP O
tunnel NN I-NP O
release NN I-NP O
hyponatremia NN I-NP O
( ( O O
hyponatremia NN B-NP O
) ) O O
MI NNP B-NP O
( ( O O
myocardial JJ B-NP O
infarction NN I-NP O
) ) O O
?cauda NN B-NP O
equina JJ B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
ADMIT: NNP I-NP O
substernal JJ B-NP O
CP NNP I-NP O
HPI: NNP I-NP O
83yoF CD O O
w/ NN B-NP O
CAD NNP I-NP O
s/p VBD B-VP O
4 CD O O
vessel NN B-NP O
CABG NNP I-NP O
1993 CD O O
s/p NN B-NP O
L NNP I-NP O
main JJ O O
and CC O O
diagonal JJ B-NP O
PTCA NNP I-NP O
w/ NN I-NP O
cypher NN I-NP O
stent NN I-NP O
0/4 CD O O
followed VBN O O
by IN B-VP O
bare NN B-NP O
metal NN I-NP O
stent NN I-NP O
in IN B-VP O
diagonal JJ O O
for IN B-VP O
recurrent NN B-NP O
CP NNP I-NP O
, , O O
p/w JJ B-NP O
substernal JJ I-NP O
epigastric NN I-NP O
pain NN I-NP O
Has NNP I-NP O
had VBD B-VP O
multiple VBN O O
admissions NNS B-NP O
for IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
last JJ O O
in IN B-VP O
4/30 CD O O
w/ NN B-NP O
MIBI NNP I-NP O
that WDT O O
was VBD B-VP O
improved VBN O O
from IN B-VP O
prior RB O O
Woke NNP B-NP O
up RB O O
at IN B-VP O
5am CD O O
w/ JJ B-NP O
substernal JJ I-NP B-r
epigastric NN I-NP I-r
pain NN I-NP I-r
, , O O
unclear JJ O O
if IN B-VP O
angina NNS B-NP O
or CC O O
esophageal JJ B-NP O
spasm NN I-NP O
Took NNP I-NP O
maalox NN I-NP B-m
and CC O O
3 CD O B-do
ntg JJ B-NP B-m
w/ NN I-NP O
pain NN I-NP B-r
relief NN I-NP O
Then RB O O
CP NNP B-NP O
radiated VBD B-VP O
to TO O O
left VB O O
arm NN B-NP O
which WDT O O
is VBZ O O
more RBR O O
typical JJ O O
of IN B-VP O
anginal JJ B-NP O
pain NN I-NP O
Called VBN O O
elkca NN B-NP O
rospi NN I-NP O
valley NN I-NP O
hospital NN I-NP O
and CC O O
came VBD B-VP O
in IN B-VP O
Had NNP B-NP O
some DT B-NP O
vague JJ I-NP B-r
symptoms NNS I-NP I-r
in IN B-VP O
ED NNP B-NP O
that WDT O O
responded VBD B-VP O
to TO O O
nitro VB O B-m
, , O O
BP NNP B-NP O
dropped VBD B-VP O
140s CD O O
to TO O O
90s CD O O
but CC O O
came VBD B-VP O
right RB O O
back RB O O
up IN B-VP O
First NNP B-NP O
set VBD B-VP O
neg RB O O
EKG NNP B-NP O
no DT B-NP O
changes NNS I-NP O
PE NNP I-NP O
unremarkable JJ B-NP O
*********************** NNP I-NP O
PMH: NNP I-NP O
CAD NNP I-NP O
s/p VBD B-VP O
4v CD O O
CABG NNP B-NP O
s/p NN I-NP O
Lmain NNP I-NP O
and CC O O
diagonal JJ B-NP O
cypher NN I-NP O
stent NN I-NP O
and CC O O
diagonal JJ B-NP O
BMT NNP I-NP O
0/4 CD O O
, , O O
htn NN B-NP O
, , O O
hyperchol NN B-NP O
, , O O
fibrocystic JJ B-NP O
mastitis NN I-NP O
, , O O
h/o NN B-NP O
type NN I-NP O
IV NNP I-NP O
RTADM NNP I-NP O
, , O O
eophageal NN B-NP O
spasm NN I-NP O
, , O O
glaucoma NN B-NP O
, , O O
peripheral JJ B-NP O
neuropathy NN I-NP O
, , O O
OA NNP B-NP O
, , O O
DJD NNP B-NP O
, , O O
h/o VBD B-VP O
duodenal JJ B-NP O
ulcer NN I-NP O
, , O O
lumbar JJ B-NP O
spinal JJ I-NP O
stenosis NN I-NP O
, , O O
s/p NN B-NP O
carpal JJ B-NP O
tunnel NN I-NP O
releaseplease NN I-NP O
see VBP O O
problem NN B-NP O
list NN I-NP O
*********************** NNP I-NP O
Cardiac NNP I-NP O
studies NNS I-NP O
-Cath VBP O O
0/4 CD O O
LM NNP B-NP O
stent JJ B-NP O
patent NN I-NP O
LAD NNP I-NP O
100% CD O O
lesion NN B-NP O
w/ NN I-NP O
patent NN I-NP O
LIMA NNP I-NP O
diagonal JJ O O
80% CD O O
lesion NN B-NP O
w/ NN I-NP O
cypher NN I-NP O
stent NN I-NP O
, , O O
another DT B-NP O
bare NN I-NP O
metal NN I-NP O
stent NN I-NP O
placed VBD B-VP O
distally RB O O
, , O O
LCx NNP B-NP O
100% CD O O
RCA NNP B-NP O
100% CD O O
w/ JJ B-NP O
patent NN I-NP O
SVG-&gt;RAMUS NNP I-NP O
, , O O
LIMA-&gt;LAD NNP B-NP O
, , O O
SVG-&gt;D2 NNP B-NP O
, , O O
SVG-&gt;PDA NNP B-NP O
-MIBI NNP I-NP O
4/30 CD O O
mod NN B-NP O
sized VBN O O
severe JJ B-NP O
perfusion NN I-NP O
defect NN I-NP O
in IN B-VP O
LCx/OM! NNP B-NP O
territory NN I-NP O
throughout IN B-VP O
inferolateral JJ O O
and CC O O
basal JJ B-NP O
inferior JJ I-NP O
wall NN I-NP O
w/ NN I-NP O
mild JJ B-NP O
reversibility NN I-NP O
, , O O
improved VBN O O
since IN B-VP O
3/24 CD O O
************************ JJ B-NP O
ADMISSION NNP I-NP O
MEDS: NNP I-NP O
lisinopril VBD B-VP B-m
20mg CD O B-do
daily RB O B-f
, , O O
calcium NN B-NP B-m
600+D CD O I-m
daily RB O B-f
, , O O
isosorbide JJ O B-m
120mg CD O B-do
daily RB O B-f
, , O O
metformin VBD B-VP B-m
250mg CD O B-do
bid NN B-NP B-f
, , O O
allegra VBP O B-m
60mg CD O B-do
daily RB O B-f
, , O O
asa JJ O B-m
325mg CD O B-do
daily RB O B-f
, , O O
alphagam JJ B-NP B-m
gtts NN I-NP I-m
bid NN I-NP B-f
, , O O
pilocarpine VBP O B-m
2% CD O I-m
bid NN B-NP B-f
, , O O
clobetizol NN B-NP B-m
cream NN I-NP I-m
0.5mg CD O B-do
bid NN B-NP B-f
, , O O
pravachol NN B-NP B-m
80mg CD O B-do
qhs NN B-NP B-f
, , O O
zetia NN B-NP B-m
10mg CD O B-do
qhs NN B-NP B-f
, , O O
norvasc RB O B-m
5mg CD O B-do
daily JJ O B-f
, , O O
atenolol JJ O B-m
50mg CD O B-do
daily RB O B-f
, , O O
ferrex JJ O B-m
1/day CD O B-f
, , O O
acephex RB O B-m
20mg CD O B-do
daily JJ O B-f
, , O O
plavix JJ O B-m
75mg CD O B-do
qhs NN B-NP B-f
, , O O
ntg JJ B-NP B-m
prn NN I-NP B-f
ALLERGIES: NNP I-NP O
epi NN I-NP O
eyedrops NNS I-NP O
, , O O
IV NNP B-NP O
contrast NN I-NP O
, , O O
levo NN B-NP O
, , O O
penicillin NN B-NP O
, , O O
bacitracin JJ B-NP O
ointment NN I-NP O
, , O O
oxybutinin JJ B-NP O
SH: NNP I-NP O
lives VBZ O O
at IN B-VP O
Ran NNP B-NP O
O NNP I-NP O
assisted VBD B-VP O
living VBG O O
HCP NNP B-NP O
is VBZ O O
niece JJ B-NP O
Lucio NNP I-NP O
Fritzman NNP I-NP O
638 CD O O
826 CD O O
7097 CD O O
no DT B-NP O
tob/etoh/ivdu NN I-NP O
************************* VBZ O O
ADMISSION NNP B-NP O
PE: NNP I-NP O
VS NNP I-NP O
afeb VBD B-VP O
61 CD O O
146/67 CD O O
16 CD O O
100%2L CD O O
HEENT: NNP B-NP O
anicteric NN I-NP O
, , O O
eomi NN B-NP O
, , O O
surgical JJ B-NP O
pupils NNS I-NP O
b/l NN I-NP O
, , O O
op JJ B-NP O
clear JJ I-NP O
NECK: NNP I-NP O
supple NN I-NP O
, , O O
carotid VBP O O
2+ CD O O
w/o JJ B-NP O
bruits NNS I-NP O
, , O O
no DT B-NP O
lan NN I-NP O
, , O O
jvp NN B-NP O
7 CD O O
LUNGS: NNP B-NP O
ctab NN I-NP O
, , O O
occ JJ B-NP O
wheezes NNS I-NP O
CV: NNP I-NP O
rr NN I-NP O
, , O O
nl JJ B-NP O
s1 NN I-NP O
s2 NN I-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
ABD: NNP I-NP O
nl NN I-NP O
bs NN I-NP O
, , O O
soft JJ O O
, , O O
mild JJ B-NP O
tender NN I-NP O
in IN B-VP O
LLQ NNP B-NP O
to TO O O
deep VB O O
palpation NN B-NP O
, , O O
no DT B-NP O
masses NNS I-NP O
, , O O
no DT B-NP O
hsm NN I-NP O
EXT: NNP I-NP O
trace NN I-NP O
edema NN I-NP O
, , O O
warm JJ O O
, , O O
dp/pt JJ O O
1+ CD O O
b/l NN B-NP O
SKIN: NNP I-NP O
diffuse RB O O
erythematous JJ B-NP O
nodular JJ I-NP O
skin NN I-NP O
lesions NNS I-NP O
left VBD B-VP O
elbow JJ B-NP O
w/ JJ I-NP O
abrasion NN I-NP O
NEURO: NNP I-NP O
a&amp;ox3 NN I-NP O
, , O O
moves VBZ O O
all DT B-NP O
extremities NNS I-NP O
************************* NNP I-NP O
LABS/STUDIES NNP I-NP O
--labs NNP I-NP O
on IN B-VP O
admission: NN B-NP O
Ca NNP I-NP O
10.9 CD O O
--cardiac NNP B-NP O
enzymes NNS I-NP O
x VBP O O
3 CD O O
neg JJ O O
--UA $ O O
1+ CD O O
LE NNP B-NP O
, , O O
neg JJ O O
nitrite RB O O
, , O O
10-15 JJ B-NP O
WBC NNP I-NP O
, , O O
4+ CD O O
bact NN B-NP O
--UCx NNP I-NP O
&gt;100 NNP I-NP O
, , O O
000 CD O O
enteric JJ B-NP O
gram NN I-NP O
neg NN I-NP O
rods NNS I-NP O
, , O O
mucoid NN B-NP O
, , O O
sens VBZ O O
pnding VBG O O
--EKG NNP B-NP O
sinus NN I-NP O
@55 NNP I-NP O
, , O O
LAD NNP B-NP O
, , O O
TWI NNP B-NP O
III NNP I-NP O
( ( O O
new JJ O O
) ) O O
, , O O
TW NNP B-NP O
flattening VBG O O
I/avF NNP B-NP O
( ( O O
old JJ O O
) ) O O
, , O O
V5-V6 JJ B-NP O
lateral JJ I-NP O
flattening NN I-NP O
( ( O O
old JJ O O
) ) O O
no DT B-NP O
ST NNP I-NP O
changes NNS I-NP O
, , O O
poor JJ B-NP O
RWP NNP I-NP O
--CXR NNP I-NP O
( ( O O
portable JJ B-NP O
): NN I-NP O
clear JJ B-NP O
************************* NNP I-NP O
A/P NNP I-NP O
CV: NNP I-NP O
--ischemia: NNP I-NP O
Given NNP I-NP O
cardiac JJ B-NP O
history NN I-NP O
patient NN I-NP O
admitted VBN O O
for IN B-VP O
r/o NN B-NP O
MI NNP I-NP O
, , O O
although IN B-VP O
from IN B-VP O
story NN B-NP O
discomfort NN I-NP O
could MD O O
also RB O O
have VB O O
been VBN O O
2/2 CD O O
esophageal JJ B-NP O
spasm NN I-NP O
Patient NNP I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP O
w/ VBD B-VP O
3 CD O O
sets NNS B-NP O
of IN B-VP O
neg JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
and CC O O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
Did NNP I-NP O
not RB O O
have VB O O
recurrence NN B-NP O
of IN B-VP O
her PRP$ O O
chest JJS B-NP O
discomfort NN I-NP O
or CC O O
left VBD B-VP O
arm RP O O
tingling NN B-NP O
at IN B-VP O
rest NN B-NP O
or CC O O
with IN B-VP O
ambulation NN B-NP O
On IN B-VP O
good JJ B-NP O
cardiac JJ I-NP O
regimen NNS I-NP O
, , O O
and CC O O
continued VBD B-VP O
on IN B-VP O
ASA NNP B-NP B-m
, , O O
plavix NN B-NP B-m
, , O O
BB NNP B-NP B-m
, , O O
ACE NNP B-NP B-m
, , O O
statin NN B-NP B-m
, , O O
zetia NN B-NP B-m
lipid JJ B-NP O
panel NN I-NP O
good JJ B-NP O
w/ NN I-NP O
total JJ B-NP O
chol NN I-NP O
163 CD O O
and CC O O
ldl $ O O
86 CD O O
hdl NN B-NP O
43 CD O O
uptitrated JJ B-NP O
ACE NNP I-NP B-m
to TO O O
optimize VB O O
BP NNP B-NP B-r
, , O O
increased VBD B-VP O
to TO O O
30mg CD O B-do
daily JJ B-NP B-f
w/ NNS I-NP O
improved VBN O O
BP NNP B-NP O
w/ JJ B-NP O
SBP NNP I-NP O
in IN B-VP O
110s CD O O
--pump: JJ O O
no DT B-NP O
e/o JJ I-NP O
overload NN I-NP O
cont NN I-NP O
on IN B-VP O
home NN B-NP O
BP NNP I-NP B-m
meds VBZ O I-m
--rhythm: NNP B-NP O
tele NN I-NP O
w/out NN I-NP O
events NNS I-NP O
GI: NNP I-NP O
h/o NN I-NP O
esophageal NN I-NP B-r
spasm NN I-NP I-r
, , O O
cont NN B-NP O
PPI NNP I-NP B-m
likely JJ B-NP O
source NN I-NP O
of IN B-VP O
chest NN B-NP O
discomfort NN I-NP O
NEURO: NNP I-NP O
left VBD B-VP O
arm RP O O
tingling NN B-NP O
did VBD B-VP O
not RB O O
recur VB O O
but CC O O
if IN B-VP O
recurs NNS B-NP O
in IN B-VP O
the DT B-NP O
future NN I-NP O
may MD O O
consider VB O O
carotid NN B-NP O
ultrasound NN I-NP O
or CC O O
neck NN B-NP O
imaging VBG O O
HEME: NNP B-NP O
h/o NN I-NP O
Fed NNP I-NP B-r
anemia NN I-NP I-r
, , O O
cont NN B-NP O
iron NN I-NP B-m
Hct NNP I-NP O
stable JJ O O
in IN B-VP O
low JJ O O
30s CD O O
, , O O
32.6 CD O O
at IN B-VP O
d/c NN B-NP O
ENDO: NNP I-NP O
on IN B-VP O
lantus NN B-NP B-m
, , O O
novolog JJ B-NP B-m
prandial NN I-NP O
, , O O
and CC O O
novolog RB O B-m
sliding VBG O B-do
scale NN B-NP I-do
here RB O O
, , O O
restarted VBN O O
on IN B-VP O
home NN B-NP O
metformin NN I-NP B-m
at IN B-VP O
d/c JJ B-NP O
ID: NNP I-NP O
UTI NNP I-NP O
Started VBD B-VP O
on IN B-VP O
Bactrim NNP B-NP B-m
for IN B-VP B-du
7 CD O I-du
day NN B-NP I-du
course NN I-NP I-du
DERM: NNP I-NP O
cont NN I-NP O
steroid NN I-NP B-m
ointment NN I-NP I-m
HEENT: NNP I-NP O
cont NN I-NP O
eyedrops VBZ O B-m
FEN: NNP B-NP O
cardiac NN I-NP O
, , O O
diabetic JJ B-NP O
diet NN I-NP O
watch NN I-NP O
Ca NNP I-NP O
PPx: NNP I-NP O
lovenox NN I-NP B-m
, , O O
PPI NNP B-NP B-m
CODE: NNP I-NP O
DNR/DNI NNP I-NP O
----- NNP I-NP O
> NNP I-NP O
HCP NNP I-NP O
niece RB O O
Andrea NNP B-NP O
Cocanougher NNP I-NP O
139 CD O O
049 CD O O
2689 CD O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
*Please NNP I-NP O
call VB O O
our PRP$ O O
Dr NNP B-NP O
or CC O O
return VB O O
to TO O O
the DT B-NP O
ED NNP I-NP O
if IN B-VP O
you PRP O O
have VBP O O
any DT B-NP O
more JJR I-NP O
episodes NNS I-NP O
of IN B-VP O
chest JJS B-NP O
discomfort NN I-NP O
*Your NN I-NP O
lisinopril NN I-NP B-m
lisinopril NN I-NP B-m
has VBZ O O
been VBN O O
increased VBN O O
to TO O O
30mg CD O B-do
daily RB O B-f
You PRP O O
have VBP O O
been VBN O O
started VBN O O
on IN B-VP O
Bactrim NNP B-NP B-m
for IN B-VP B-du
7 CD O I-du
days NNS B-NP I-du
for IN B-VP O
a DT B-NP B-r
urinary JJ I-NP I-r
tract NN I-NP I-r
infection NN I-NP I-r
All DT B-NP O
other JJ I-NP B-m
medications NNS I-NP O
are VBP O O
the DT B-NP O
same JJ I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
*monitor NNP I-NP O
BP NNP I-NP O
w/ POS O O
uptitration NN B-NP O
of IN B-VP O
ACE NNP B-NP B-m
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
SCHRENK NNP I-NP O
, , O O
ALLAN NNP B-NP O
HIRAM NNP I-NP O
JAE NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
DL79 NNP B-NP O
) ) O O
0/10/05 CD O O
@ $ O O
11 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#471540 VBZ O O
342590615 CD O O
CCHO NNP B-NP O
47454253 CD O O
0272677 CD O O
3/14/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
s/p JJ B-NP O
mechanical JJ I-NP O
fall NN I-NP O
, , O O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/5/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/20/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
HEMRICH NNP I-NP O
, , O O
NOBLE NNP B-NP O
223-66-98-9 JJ B-NP O
Por NNP I-NP O
Olu NNP I-NP O
Naeans NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
10/2/06 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BOLSTAD NNP I-NP O
, , O O
CLEMENTE NNP B-NP O
ARMAND NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Rehabilitation NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
TYLENOL NNP I-NP B-m
( ( O I-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
ACETAMINOPHEN NNP I-NP I-m
) ) O I-m
) ) O I-m
650 CD O B-do
650 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
, , O O
Headache NNP B-NP B-r
AMIODARONE NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/2/06 CD O O
by IN B-VP O
GREINKE NNP B-NP O
, , O O
LAMONT NNP B-NP O
M NNP I-NP O
, , O O
PA NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
901447890 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/29/06 CD O O
by IN B-VP O
RELYEA NNP B-NP O
, , O O
ROCKY NNP B-NP O
B NNP I-NP O
, , O O
PA NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
766358178 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitor NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/11/06 CD O O
by IN B-VP O
RODGERS NNP B-NP O
, , O O
CLARENCE NNP B-NP O
CARMINE NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
699369105 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/11/06 CD O O
by IN B-VP O
PETRONE NNP B-NP O
, , O O
EDDY NNP B-NP O
DALTON NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
275187370 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/11/06 CD O O
by IN B-VP O
FRANDEEN NNP B-NP O
, , O O
FRANKIE NNP B-NP O
PETER NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
451868012 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/30/06 CD O O
by IN B-VP O
MONNERJAHN NNP B-NP O
, , O O
VANCE NNP B-NP O
, , O O
PA-C NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
582207144 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitor NN I-NP O
INR NNP I-NP O
NATURAL NNP I-NP B-m
TEARS NNP I-NP I-m
( ( O I-m
ARTIFICIAL NNP B-NP I-m
TEARS NNP I-NP I-m
) ) O I-m
2 CD O B-do
DROP NNP B-NP I-do
OU NNP I-NP B-mo
BID NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PLAQUENIL NNP I-NP B-m
SULFATE NNP I-NP I-m
( ( O I-m
HYDROXYCHLOROQUINE NNP B-NP I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
ISORDIL NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
DINITRATE NNP I-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt;110 NNP I-NP O
LISINOPRIL NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt;110 NNP I-NP O
MILK NNP I-NP B-m
OF NNP I-NP I-m
MAGNESIA NNP I-NP I-m
( ( O I-m
MAGNESIUM NNP B-NP I-m
HYDROXIDE NNP I-NP I-m
) ) O I-m
30 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
Standard NNP B-NP O
Admin NNP I-NP O
Time NNP I-NP O
) ) O O
Instructions: NNP B-NP O
Pt NNP I-NP O
takes VBZ O O
coumadin VBP O B-m
2.5 CD O B-do
mg/ NNS B-NP I-do
5mg CD O I-do
once RB O B-f
daily JJ O I-f
, , O O
alternating JJ B-NP O
days NNS I-NP O
( ( O O
5mg CD O O
3d/wk; CD O O
2.5mg CD O O
4d/wk CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
10/2/06 CD O O
by IN B-VP O
DANCY NNP B-NP O
, , O O
GERARD NNP B-NP O
E NNP I-NP O
, , O O
PA NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
NORVASC NNP I-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt;110 NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
NEURONTIN NNP B-NP B-m
( ( O I-m
GABAPENTIN NNP B-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
MAALOX-TABLETS NNP I-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
DULCOLAX NNP I-NP B-m
RECTAL NNP I-NP I-m
( ( O I-m
BISACODYL NNP B-NP I-m
RECTAL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PR NNP I-NP B-mo
DAILY NNP I-NP B-f
PRN NNP I-NP O
Constipation NNP I-NP B-r
CLOTRIMAZOLE NNP I-NP B-m
1% CD O I-m
TOPICAL NNP B-NP I-m
TOPICAL NNP I-NP B-mo
TP NNP I-NP I-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
apply VBP O O
to TO O O
feet NNS B-NP O
bilat JJ B-NP O
GLYBURIDE NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/2/06 CD O O
by IN B-VP O
: : O O
on IN B-VP O
order NN B-NP O
for IN B-VP O
GLYBURIDE NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
086901876 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
Sulfa; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
takes VBZ O O
regularly RB O O
at IN B-VP O
baseline NN B-NP O
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
February NNP I-NP O
Instructions: NNP I-NP O
Of IN B-VP O
note: JJ B-NP O
pt NN I-NP O
was VBD B-VP O
on IN B-VP O
40 CD O O
daily JJ O O
at IN B-VP O
baseline NN B-NP O
yet RB O O
was VBD B-VP O
held VBN O O
during IN B-VP O
admission NN B-NP O
for IN B-VP O
renal JJ B-NP O
insuff NN I-NP O
, , O O
since IN B-VP O
renal JJ B-NP O
fx NN I-NP O
corrected VBD B-VP O
pt NN B-NP O
restarted VBN O O
on IN B-VP O
lasix NN B-NP B-m
20 CD O B-do
qd NN B-NP B-f
on IN B-VP O
d/c NN B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/2/06 CD O O
by IN B-VP O
: : O O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LASIX NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
684783802 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
Sulfa; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitored VBD B-VP O
DIET: NNP B-NP O
House NNP I-NP O
/ NNP I-NP O
NAS NNP I-NP O
/ NNP I-NP O
Carbohydrate NNP I-NP O
Controlled NNP I-NP O
/ NNP I-NP O
Low NNP I-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
per IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
recs NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Mcnichol NNP I-NP O
( ( O O
MH NNP B-NP O
MD NNP I-NP O
) ) O O
724-105-6354 CD O O
2/10 CD O O
@ NN B-NP O
8:30am CD O O
, , O O
Dr NNP B-NP O
Jacob NNP I-NP O
Hainer NNP I-NP O
in IN B-VP O
SONMEN'S NNP B-NP O
COMMUNITY NNP I-NP O
MEMORIAL NNP I-NP O
HOSPITAL NNP I-NP O
( ( O O
Dr NNP B-NP O
Krag NNP I-NP O
is VBZ O O
away RB O O
) ) O O
291-538-5457 JJ O O
2/10 CD O O
@ JJ O O
9:15 CD O O
, , O O
psych NN B-NP O
will MD O O
call VB O O
the DT B-NP O
patient NN I-NP O
within IN B-VP O
24-48hrs JJ O O
780-484-6591 JJ O O
, , O O
Dr NNP B-NP O
Harty NNP I-NP O
- : O O
in IN B-VP O
the DT B-NP O
arthritis NN I-NP O
center NN I-NP O
Cean NNP I-NP O
Rockca NNP I-NP O
506-776-0600 JJ O O
0/8 CD O O
@ JJ O O
3:30 CD O O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
9/11/06 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
3 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Stanko NNP I-NP O
( ( O O
PCP NNP B-NP O
) ) O O
ALLERGY: NNP B-NP O
QUININE NNP I-NP O
, , O O
Aspirin NNP B-NP O
, , O O
Sulfa NNP B-NP O
, , O O
Penicillins NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
s/p VBD B-VP O
mech JJ B-NP O
fall NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
s/p VBD B-VP O
mechanical JJ B-NP O
fall NN I-NP O
, , O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
, , O O
CHF NNP B-NP O
, , O O
s/p NN B-NP O
St NNP I-NP O
Jude NNP I-NP O
MVR NNP I-NP O
for IN B-VP O
MS NNP B-NP O
, , O O
Hx NNP B-NP O
AFib/flutter NNP I-NP O
, , O O
s/p NN B-NP O
IMI NNP I-NP O
, , O O
NIDDM NNP B-NP O
, , O O
gout NN B-NP O
Hx NNP I-NP O
DVT NNP I-NP O
'70 NNP I-NP O
, , O O
s/p NN B-NP O
appy JJ O O
, , O O
s/p JJ B-NP O
umbilical JJ I-NP O
hernia NN I-NP O
repair NN I-NP O
, , O O
s/p JJ B-NP O
sigmoidectomy NN I-NP O
for IN B-VP O
diverticulitis NN B-NP O
s/p NN I-NP O
L NNP I-NP O
hip NN I-NP O
# # O O
'95 CD O O
, , O O
PE NNP B-NP O
, , O O
heart NN B-NP O
block NN I-NP O
( ( O O
third JJ O O
degree VBP O O
heart NN B-NP O
block NN I-NP O
) ) O O
, , O O
s/p JJ B-NP O
DDD NNP I-NP O
pacer NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
fall NN I-NP O
--- NNP I-NP O
HPI: NNP I-NP O
83 CD O O
year NN B-NP O
old JJ B-NP O
F NNP I-NP O
with IN B-VP O
hx JJ B-NP O
CAD NNP I-NP O
s/p NN I-NP O
MI NNP I-NP O
, , O O
CHF NNP B-NP O
, , O O
Afib/aflutter NNP B-NP O
, , O O
heart NN B-NP O
block NN I-NP O
s/p NN I-NP O
pacer NN I-NP O
, , O O
s/p JJ B-NP O
St NNP I-NP O
Judes NNP I-NP O
MVR NNP I-NP O
, , O O
NIDDM NNP B-NP O
, , O O
hx NN B-NP O
PE NNP I-NP O
, , O O
hx NN B-NP O
L NNP I-NP O
hip NN I-NP O
fx NN I-NP O
s/p NN I-NP O
screws NNS I-NP O
since IN B-VP O
removed VBN O O
who WP O O
presents VBZ O O
with IN B-VP O
fall NN B-NP O
She PRP O O
was VBD B-VP O
reportedly RB O O
trying VBG O O
to TO O O
open VB O O
her PRP$ O O
closet NN B-NP O
door NN I-NP O
when WRB O O
she PRP O O
was VBD B-VP O
suprised VBN O O
to TO O O
realize VB O O
the DT B-NP O
door NN I-NP O
was VBD B-VP O
already RB O O
ajar JJ O O
and CC O O
this DT O O
resulted VBD B-VP O
in IN B-VP O
her PRP$ O O
falling VBG O O
into IN B-VP O
the DT B-NP O
closet NN I-NP O
She PRP O O
could MD O O
not RB O O
get VB O O
up RP O O
She PRP O O
reported VBD B-VP O
that IN B-VP O
she PRP O O
hit VBD B-VP O
her PRP O O
"whole JJ B-NP O
body" NN I-NP O
when WRB O O
she PRP O O
fell VBD B-VP O
She PRP O O
lay VBD B-VP O
there EX O O
through IN B-VP O
the DT B-NP O
entire JJ I-NP O
night NN I-NP O
The DT B-NP O
following JJ I-NP O
day NN I-NP O
she PRP O O
was VBD B-VP O
able JJ O O
to TO O O
crawl VB O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
closet NN I-NP O
Her NNP I-NP O
son NN I-NP O
was VBD B-VP O
concerned VBN O O
when WRB O O
she PRP O O
didn't VBD B-VP O
answer VB O O
the DT B-NP O
phone NN I-NP O
and CC O O
called VBD B-VP O
the DT B-NP O
police NN I-NP O
who WP O O
found VBD B-VP O
her PRP O O
lying VBG O O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
She PRP O O
complained VBD B-VP O
on IN B-VP O
admission NN B-NP O
of IN B-VP O
L NNP B-NP O
shoulder NN I-NP O
pain NN I-NP O
, , O O
bilat JJ B-NP O
Knee NNP I-NP O
pain NN I-NP O
, , O O
and CC O O
L NNP B-NP O
pubic/pelvis VBP O O
pain NN B-NP O
ROS NNP I-NP O
otherwise RB O O
negative JJ O O
for IN B-VP O
syncope NN B-NP O
, , O O
LOC NNP B-NP O
, , O O
CP NNP B-NP O
, , O O
SOB NNP B-NP O
, , O O
F/C NNP B-NP O
, , O O
cough NN B-NP O
, , O O
diarrhea NN B-NP O
, , O O
vomiting VBG O O
In IN B-VP O
ED: NNP B-NP O
Pt NNP I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
troponin JJ B-NP O
leak NN I-NP O
of IN B-VP O
0.23 CD O O
Her PRP$ O O
films NNS B-NP O
were VBD B-VP O
negative JJ O O
except IN B-VP O
pelvis NN B-NP O
XRY NNP I-NP O
which WDT O O
showed VBD B-VP O
question NN B-NP O
of IN B-VP O
pubic JJ B-NP O
ramus JJ I-NP O
fracture NN I-NP O
--- NNP I-NP O
Data: NNP I-NP O
EKG: NNP I-NP O
Prolonged NNP I-NP O
QT NNP I-NP O
interval NN I-NP O
, , O O
otherwise RB O O
unchanged JJ B-NP O
CXR: NNP I-NP O
neg NN I-NP O
for IN B-VP O
acute JJ B-NP O
cardiopulm NN I-NP O
dz NN I-NP O
Head NNP I-NP O
CT: NNP I-NP O
neg JJ B-NP O
Cspine NNP I-NP O
CT: NNP I-NP O
neg MD O O
L NNP B-NP O
shoulder VB O O
film: JJ B-NP O
neg JJ I-NP O
Bilat NNP I-NP O
knee NN I-NP O
film: NN I-NP O
neg JJ B-NP O
Pelvis NNP I-NP O
XRY: NNP I-NP O
?pubic NNP I-NP O
ramus VBZ O O
fracture NN B-NP O
Labs: NNP I-NP O
*Na NNP I-NP O
146 CD O O
, , O O
*CK NN B-NP O
3320 CD O O
, , O O
*CKMB VBD B-VP O
12.9 CD O O
, , O O
*Trop FW O O
0.23--&gt;0.10 JJ B-NP O
*AST NN I-NP O
107 CD O O
Cr: NNP B-NP O
1.2-&gt;1.6 JJ B-NP O
--- NNP I-NP O
Medications NNP I-NP O
on IN B-VP O
Admission: NNP B-NP O
Amiodarone NNP I-NP B-m
100 CD O B-do
QD NNP B-NP B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
bid NN B-NP B-f
, , O O
lasix VBZ O B-m
40mg CD O B-do
QD NNP B-NP B-f
, , O O
Glyburide NNP B-NP B-m
5mg CD O B-do
bid NN B-NP B-f
, , O O
Plaquenil NNP B-NP B-m
200mg CD O B-do
bid NN B-NP B-f
, , O O
Isordil NNP B-NP B-m
20mg CD O B-do
tid NN B-NP B-f
, , O O
Lisinopril NNP B-NP B-m
20mg CD O B-do
QD NNP B-NP B-f
, , O O
Coumadin NNP B-NP B-m
Coumadin NNP I-NP B-m
5mg CD O B-do
3dys/week CD O B-f
, , O O
2.5mg CD O B-do
4dys/week CD O B-f
, , O O
Norvasc NNP B-NP B-m
10mg CD O B-do
QD NNP B-NP B-f
, , O O
Neurontin NNP B-NP B-m
300mg CD O B-do
TID NNP B-NP B-f
--- NNP I-NP O
ALL: NNP I-NP O
Quinine-hypotension NNP I-NP O
&amp; NNP I-NP O
syncope NN I-NP O
, , O O
PCN-rash NNP B-NP O
, , O O
Sulfa NNP B-NP O
, , O O
Asa-rash NNP B-NP O
--- NNP I-NP O
PMH: NNP I-NP O
See NNP I-NP O
list NN I-NP O
--- NNP I-NP O
Exam NNP I-NP O
on IN B-VP O
Admit: NNP B-NP O
T NNP I-NP O
98.5 CD O O
, , O O
HR NNP B-NP O
60-64 CD O O
, , O O
RR NNP B-NP O
16-18 CD O O
, , O O
BP NNP B-NP O
149-155/58-81 CD O O
, , O O
O2 NNP B-NP O
99% CD O O
on IN B-VP O
2L CD O O
GEN: NNP B-NP O
NAD NNP I-NP O
, , O O
of IN B-VP O
stated VBN O O
age NN B-NP O
HEENT: NNP I-NP O
L NNP I-NP O
eye NN I-NP O
not RB O O
opening VBG O O
all PDT O O
the DT B-NP O
way NN I-NP O
L NNP I-NP O
eye NN I-NP O
slightly RB O O
tender VBZ O O
to TO O O
palpation VB O O
, , O O
EOMI NNP B-NP O
, , O O
PERRLA NNP B-NP O
B NNP I-NP O
, , O O
Dry NNP B-NP O
MM NNP I-NP O
NECK: NNP I-NP O
no DT B-NP O
LAD NNP I-NP O
, , O O
No NNP B-NP O
JVD NNP I-NP O
LUNGS: NNP I-NP O
CTA NNP I-NP O
B NNP I-NP O
HEART: NNP I-NP O
RRR NNP I-NP O
nrml MD O O
S1 NNP B-NP O
, , O O
mechanical JJ B-NP O
S2 NNP I-NP O
ABD: NNP I-NP O
soft JJ O O
, , O O
NT NNP B-NP O
, , O O
ND NNP B-NP O
EXT: NNP I-NP O
L NNP I-NP O
shoulder NN I-NP O
pain NN I-NP O
to TO O O
palpation NN B-NP O
and CC O O
with IN B-VP O
extension JJ B-NP O
Hyperkeratosis NNP I-NP O
of IN B-VP O
LE NNP B-NP O
to TO O O
below VB O O
knees NNS B-NP O
bilaterally RB O O
L NNP B-NP O
pelvis NN I-NP O
tender NN I-NP O
to TO O O
palpation VB O O
L NNP B-NP O
leg NN I-NP O
SAR NNP I-NP O
limited VBN O O
by IN B-VP O
pain NN B-NP O
in IN B-VP O
L NNP B-NP O
pubic JJ B-NP O
area NN I-NP O
Strength NNP I-NP O
5/5 CD O O
otherwise RB O O
No DT B-NP O
cyanosis NN I-NP O
--- NNP I-NP O
Hospital NNP I-NP O
Course: NNP I-NP O
1 CD O O
) ) O O
ORTHO: IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
s/p JJ B-NP O
fall NN I-NP O
with IN B-VP O
concern NN B-NP O
for IN B-VP O
pelvic JJ B-NP O
fracture NN I-NP O
from IN B-VP O
XRY NNP B-NP O
Shoulder NNP I-NP O
, , O O
hip NN B-NP O
, , O O
pelvic JJ B-NP O
films NNS I-NP O
negative JJ O O
for IN B-VP O
fx NN B-NP O
or CC O O
dislocation NN B-NP O
except IN B-VP O
abnl NN B-NP O
finding VBG O O
R NNP B-NP O
pelvic JJ B-NP O
ramus NN I-NP O
Unable JJ O O
to TO O O
perform VB O O
MRI NNP B-NP O
2/2 CD O O
valve NN B-NP O
and CC O O
pacer NN B-NP O
CT NNP I-NP O
pelvis NN I-NP O
negative NN I-NP O
for IN B-VP O
pelvic JJ B-NP O
fx NN I-NP O
Pain NNP I-NP B-r
controlled VBD B-VP O
with IN B-VP O
APAP NNP B-NP B-m
prn NN I-NP B-f
PT NNP I-NP O
consult NN I-NP O
obtained VBD B-VP O
3/21 CD O O
and CC O O
to TO O O
follow VB O O
daily RB O O
at IN B-VP O
rehab NN B-NP O
--- NNP I-NP O
2 CD O O
) ) O O
GYN: NNP B-NP O
CT NNP I-NP O
pelvis NN I-NP O
did VBD B-VP O
show VB O O
R NNP B-NP O
adnexal JJ B-NP O
cyst NN I-NP O
on IN B-VP O
prelim NN B-NP O
read NN I-NP O
which WDT O O
will MD O O
need VB O O
further JJ B-NP O
characterization NN I-NP O
by IN B-VP O
US NNP B-NP O
and CC O O
outpt RB O O
follow VB O O
up RP O O
--- RB O O
3 CD O O
) ) O O
CV: NNP B-NP O
She PRP O O
has VBZ O O
extensive JJ B-NP O
cardiac JJ I-NP O
history NN I-NP O
as IN B-VP O
above IN B-VP O
Her NNP B-NP O
fall NN I-NP O
is VBZ O O
not RB O O
likely JJ O O
related VBN O O
to TO O O
cardiac JJ B-NP O
issue NN I-NP O
as IN B-VP O
it PRP O O
appears VBZ O O
mechanical JJ O O
, , O O
no DT B-NP O
syncope NN I-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
etc FW O O
ISCHEMIA: NNP B-NP O
NSTEMI NNP I-NP O
w/ VBD B-VP O
small JJ B-NP O
TnI NNP I-NP O
leak NN I-NP O
, , O O
likely JJ B-NP O
demand NN I-NP O
related VBN O O
in IN B-VP O
setting NN B-NP O
of IN B-VP O
hypovolemia NN B-NP O
, , O O
fall NN B-NP O
Enzymes NNP I-NP O
trended VBD B-VP O
down RP O O
PUMP: NNP B-NP O
Dry NNP I-NP O
on IN B-VP O
admission NN B-NP O
Rehydrated VBN O O
with IN B-VP O
IVF NNP B-NP B-m
, , O O
po's NN B-NP O
encouraged VBD B-VP O
Euvolemic NNP B-NP O
by IN B-VP O
1/2 CD O O
JVP NNP B-NP O
up RB O O
to TO O O
12cm CD O O
, , O O
but CC O O
difficult JJ O O
to TO O O
gauge VB O O
volume NN B-NP O
status NN I-NP O
2/2 CD O O
TR NNP B-NP O
To TO O O
recommence VB O O
lasix NN B-NP B-m
at IN B-VP O
half PDT O B-do
dose JJ O I-do
1/28 CD O O
PCP NNP B-NP O
to TO O O
monitor VB O O
and CC O O
titrate VB O O
back RB O O
to TO O O
40 CD O O
mg NNS B-NP O
daily JJ O O
baseline VBP O O
dose JJ O O
if IN B-VP O
tolerated VBN O O
IVF NNP B-NP O
d/c'd NN I-NP O
RHYTHM: NNP I-NP O
She PRP O O
has VBZ O O
prolonged VBN O O
QT NNP B-NP O
on IN B-VP O
admission NN B-NP O
, , O O
on IN B-VP O
telemetry NN B-NP O
Unclear NNP I-NP O
etiology NN I-NP O
?starvation NN I-NP O
Monitored NNP I-NP O
on IN B-VP O
tele NN B-NP O
until IN B-VP O
ROMI NNP B-NP O
Avoided NNP I-NP O
drugs NNS I-NP O
that WDT O O
confound VBP O O
Resolved VBN O O
to TO O O
QTc NNP B-NP O
in IN B-VP O
low JJ O O
500s CD O O
DDD NNP B-NP O
pacer NN I-NP O
functioning VBG O O
with IN B-VP O
V-pacing NNP B-NP O
at IN B-VP O
60bpm CD O O
--- $ O O
4 CD O O
)ENDO: NNP B-NP O
Holding NNP I-NP O
Glypizide NNP I-NP B-m
while IN B-VP B-du
in IN B-VP I-du
house NN B-NP I-du
Novolog NNP I-NP B-m
sliding VBG O B-do
scale JJ O I-do
Starting VBG O O
low JJ B-NP O
dose JJ I-NP O
NPH NNP I-NP B-m
6 CD O B-do
units NNS B-NP I-do
BID NNP I-NP B-f
on IN B-VP O
1/2 CD O O
Monitored NNP B-NP O
FS NNP I-NP O
daily RB O O
and CC O O
adjusted VBN O O
scale NN B-NP O
prn NN I-NP O
--- NNP I-NP O
5 CD O O
) ) O O
HEME: NNP B-NP O
She PRP O O
is VBZ O O
on IN B-VP O
Coumadin NNP B-NP B-m
for IN B-VP O
St NNP B-NP O
Judes NNP I-NP O
Valve NNP I-NP O
, , O O
afib/flutter NN B-NP O
and CC O O
hx NN B-NP O
PEs NNP I-NP O
She PRP O O
did VBD B-VP O
not RB O O
take VB O O
coumadin NN B-NP O
the DT O O
last JJ O O
two CD O O
nights NNS B-NP O
before IN B-VP O
admission NN B-NP O
because IN B-VP O
of IN B-VP O
lying VBG O O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
s/p NN I-NP O
fall NN I-NP O
Her NNP I-NP O
INR NNP I-NP O
was VBD B-VP O
subtherapeutic JJ O O
on IN B-VP O
admission NN B-NP O
Bridged NNP I-NP O
w/ NN I-NP O
lovenox NN I-NP B-m
and CC O O
INR NNP B-NP O
therapeutic JJ O O
1/2 CD O O
and CC O O
restarted VBN O O
on IN B-VP O
home NN B-NP B-m
regimen NNS I-NP I-m
of IN B-VP O
5/2.5mg CD O B-do
5/2.5mg CD O B-do
variable JJ B-NP I-do
dose JJ I-NP I-do
***Needs NNS I-NP O
to TO O O
be VB O O
dosed VBN O O
daily RB O O
because IN B-VP O
of IN B-VP O
variable JJ B-NP O
dose JJ I-NP O
--- NNP I-NP O
6 CD O O
) ) O O
FEN: NNP B-NP O
of IN B-VP O
note NN B-NP O
pt NN I-NP O
on IN B-VP O
80mg CD O B-do
lasix JJ O B-m
daily RB O B-f
at IN B-VP O
home NN B-NP O
yet RB O O
dry JJ O O
on IN B-VP O
admission NN B-NP O
with IN B-VP O
worsening VBG O O
renal JJ B-NP O
fx NN I-NP O
, , O O
thus RB O O
lasix JJ O B-m
held VBD B-VP O
Restarted VBN O O
on IN B-VP O
lasix NN B-NP B-m
20 CD O B-do
qd NN B-NP B-f
on IN B-VP O
day NN B-NP O
of IN B-VP O
d/c NN B-NP O
- : O O
to TO O O
be VB O O
monitored VBN O O
by IN B-VP O
PCP NNP B-NP O
--- NNP I-NP O
7 CD O O
) ) O O
PPX NNP B-NP O
Lovenox/coumadin NNP I-NP B-m
--- NNP I-NP O
FULL NNP I-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
VNA NNP B-NP O
to TO O O
draw VB O O
INR NNP B-NP O
Q3 NNP I-NP O
days NNS I-NP O
and CC O O
call VB O O
PCP NNP B-NP O
with IN B-VP O
result NN B-NP O
for IN B-VP O
coumadin NN B-NP B-m
dosing VBG O O
management/adjustments NNS B-NP O
2 CD O O
PCP NNP B-NP O
to TO O O
follow-up NN B-NP O
with IN B-VP O
HgA1C NNP B-NP O
and CC O O
manage VB O O
DM NNP B-NP O
medications NNS I-NP O
Recommend NNP I-NP O
pt NN I-NP O
be VB O O
started VBN O O
on IN B-VP O
STATIN NNP B-NP B-m
and CC O O
LFTs NNP B-NP O
followed VBD B-VP O
3 CD O O
Physical NNP B-NP O
Therapy NNP I-NP O
to TO O O
follow VB O O
daily RB O O
at IN B-VP O
rehab NN B-NP O
for IN B-VP O
strength/conditioning/ JJ B-NP O
ambulatory/ JJ I-NP O
safety NN I-NP O
needs NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
ROCKAFELLOW NNP I-NP O
, , O O
CARMEN NNP B-NP O
B NNP I-NP O
, , O O
PA NNP B-NP O
( ( O O
NM87 NNP B-NP O
) ) O O
10/2/06 CD O O
@ $ O O
11:11 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#471570 VBZ O O
837820887 CD O O
SMMC NNP B-NP O
73429706 CD O O
888579 CD O O
0/22/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
RENAL NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/7/1998 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/19/1998 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
RIGHT NNP I-NP O
GROIN NNP I-NP O
ABSCESS NNP I-NP O
PROBLEM NNP I-NP O
LIST: NNP I-NP O
( ( O O
1 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
renal JJ B-NP O
transplantation NN I-NP O
, , O O
living VBG O O
related VBN O O
donor NN B-NP O
May NNP I-NP O
1997 CD O O
, , O O
( ( O O
2 CD O O
) ) O O
hypertension NN B-NP O
, , O O
( ( O O
3 CD O O
) ) O O
insulin-dependent NN B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
( ( O O
4 CD O O
) ) O O
pulmonary JJ B-NP O
hypertension NN I-NP O
, , O O
( ( O O
5 CD O O
) ) O O
hyperthyroidism NN B-NP O
, , O O
( ( O O
6 CD O O
) ) O O
hyperparathyroidism NN B-NP O
, , O O
( ( O O
7 CD O O
) ) O O
hypertriglyceridemia NN B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
42-year-old JJ I-NP O
white JJ I-NP O
man NN I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
complaints NNS B-NP O
of IN B-VP O
fever NN B-NP O
to TO O O
103 CD O O
and CC O O
chills NNS B-NP O
, , O O
a DT B-NP O
productive JJ I-NP O
cough NN I-NP O
and CC O O
groin NN B-NP O
pain NN I-NP O
lasting JJ O O
three CD O O
days NNS B-NP O
At IN B-VP O
age NN B-NP O
three CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
diagnosed VBN O O
with IN B-VP O
Wilms' NNP B-NP O
tumor NN I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
resected VBN O O
and CC O O
subsequently RB O O
treated VBN O O
with IN B-VP O
wide JJ B-NP O
field NN I-NP O
radiation NN I-NP O
The DT B-NP O
patient NN I-NP O
, , O O
thereafter RB O O
developed VBD B-VP O
radiation-induced JJ B-NP O
tyroid NN I-NP O
cancer NN I-NP O
, , O O
at IN B-VP O
which WDT O O
time NN B-NP O
he PRP O O
underwent JJ B-NP O
subtotal JJ I-NP O
thyroidectomy NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
developed VBD B-VP O
radiation NN B-NP O
nephritis NN I-NP O
in IN B-VP O
his PRP$ O O
remaining VBG O O
right JJ B-NP O
kidney NN I-NP O
and CC O O
pulmonary JJ B-NP O
fibrosis NN I-NP O
In IN B-VP O
May NNP B-NP O
of IN B-VP O
1997 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
living NN I-NP O
related VBN O O
donor JJ B-NP O
renal JJ I-NP O
transplantation NN I-NP O
for IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
at IN B-VP O
that DT B-NP O
point NN I-NP O
CMV NNP I-NP O
antigen NN I-NP O
negative NN I-NP O
, , O O
however RB O O
, , O O
the DT B-NP O
donor NN I-NP O
kidney NN I-NP O
was VBD B-VP O
CMV NNP B-NP O
antigen NN I-NP O
positive JJ O O
The DT B-NP O
patient JJ I-NP O
underwent NN I-NP O
an DT B-NP O
uncomplicated JJ I-NP O
transplantation NN I-NP O
, , O O
however RB O O
, , O O
the DT B-NP O
postoperative JJ I-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
cytomegalovirus NN B-NP B-r
infection NN I-NP I-r
, , O O
presenting VBG O O
with IN B-VP O
diarrhea NN B-NP O
and CC O O
requiring VBG O O
hospitalization NN B-NP O
in IN B-VP O
February NNP B-NP O
1997 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
ganciclovir NN B-NP B-m
and CC O O
subsequently RB O O
maintained VBN O O
on IN B-VP O
Cytovene NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
healthy JJ O O
until IN B-VP O
November NNP B-NP O
1997 CD O O
, , O O
at IN B-VP O
which WDT O O
time NN B-NP O
he PRP O O
was VBD B-VP O
again RB O O
admitted VBN O O
for IN B-VP O
a DT B-NP O
recrudescence NN I-NP O
of IN B-VP O
his PRP$ O O
cytomegalovirus NN B-NP O
infection NN I-NP O
In IN B-VP O
November NNP B-NP O
1997 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
a DT B-NP O
three-day JJ I-NP O
history NN I-NP O
of IN B-VP O
fever NN B-NP O
to TO O O
approximately RB O O
105 CD O O
, , O O
anorexia NN B-NP O
, , O O
dry JJ B-NP O
cough NN I-NP B-r
, , O O
fatigue NN B-NP B-r
, , O O
headache NN B-NP B-r
, , O O
dizziness NN B-NP B-r
, , O O
sweats NNS B-NP B-r
, , O O
nausea NN B-NP O
and CC O O
dyspnea NN B-NP B-r
on IN B-VP O
exertion NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
, , O O
at IN B-VP O
that DT B-NP O
point NN I-NP O
, , O O
treated VBN O O
with IN B-VP O
ganciclovir JJ B-NP B-m
ganciclovir NN I-NP B-m
ganciclovir NN I-NP B-m
ganciclovir NN I-NP B-m
ganciclovir NN I-NP B-m
ganciclovir NN I-NP B-m
ganciclovir NN I-NP B-m
, , O O
however RB O O
his PRP$ O O
fevers NNS B-NP O
persisted VBD B-VP O
and CC O O
he PRP O O
was VBD B-VP O
discharged VBN O O
after IN B-VP O
five CD O B-du
five CD O B-du
five CD O B-du
five CD O B-du
five CD O B-du
five CD O B-du
five CD O B-du
days NNS B-NP I-du
days NNS I-NP I-du
days NNS I-NP I-du
days NNS I-NP I-du
days NNS I-NP I-du
days NNS I-NP I-du
days NNS I-NP I-du
of IN B-VP O
therapy NN B-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
CMV NNP I-NP O
antigen NN I-NP O
test NN I-NP O
was VBD B-VP O
negative JJ O O
, , O O
however RB O O
, , O O
his PRP$ O O
shell NN B-NP O
vial JJ B-NP O
cultures NNS I-NP O
, , O O
both DT O O
returned VBD B-VP O
as IN B-VP O
positive JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
ganciclovir NN B-NP B-m
therapy NN I-NP O
in IN B-VP O
the DT B-NP O
post NN I-NP O
hospital NN I-NP O
course NN I-NP O
until IN B-VP B-du
May NNP B-NP I-du
, , O I-du
1997 CD O I-du
, , O O
at IN B-VP O
which WDT O O
time NN B-NP O
his PRP$ O O
peripherally RB O O
inserted VBN O O
catheter NN B-NP O
was VBD B-VP O
removed VBN O O
Subsequently RB O O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
healthy JJ O O
for IN B-VP O
approximately RB O O
four CD O O
weeks NNS B-NP O
, , O O
then RB O O
on IN B-VP O
November NNP B-NP O
, , O O
1998 CD O O
, , O O
he PRP O O
noted VBD B-VP O
a DT B-NP O
groin JJ I-NP O
lump NN I-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
From IN B-VP O
November NNP B-NP O
, , O O
1998 CD O O
, , O O
he PRP O O
noted VBD B-VP O
feeling VBG O O
worse NN B-NP O
with IN B-VP O
fevers NNS B-NP O
and CC O O
chills NNS B-NP O
, , O O
and CC O O
a DT B-NP O
productive JJ I-NP O
cough NN I-NP O
beginning NN I-NP O
on IN B-VP O
July NNP B-NP O
, , O O
1998 CD O O
The DT B-NP O
patient's NN I-NP O
groin NN I-NP O
lump NN I-NP O
, , O O
subsequently RB O O
, , O O
became VBD B-VP O
painful JJ O O
, , O O
and CC O O
he PRP O O
passed VBD B-VP O
several JJ B-NP O
loose JJ I-NP O
bowel NN I-NP O
movements NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
( ( O O
1 CD O O
) ) O O
Wilms' NNP B-NP O
tumor NN I-NP O
, , O O
( ( O O
2 CD O O
) ) O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
nephrectomy JJ O O
with IN B-VP O
wide JJ B-NP O
field NN I-NP O
radiation NN I-NP O
therapy NN I-NP O
, , O O
( ( O O
3 CD O O
) ) O O
NCH NNP B-NP O
renal JJ B-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
living NN I-NP O
related VBN O O
donor JJ B-NP O
renal JJ I-NP O
transplant NN I-NP O
from IN B-VP O
father NN B-NP O
in IN B-VP O
May NNP B-NP O
1997 CD O O
, , O O
( ( O O
4 CD O O
) ) O O
hypertension NN B-NP O
, , O O
( ( O O
5 CD O O
) ) O O
insulin-dependent NN B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
( ( O O
6 CD O O
) ) O O
pulmonary JJ B-NP O
hypertension NN I-NP O
, , O O
( ( O O
7 CD O O
) ) O O
hyperthyroid NN B-NP O
, , O O
( ( O O
8 CD O O
) ) O O
hyperparathyroid NN B-NP O
, , O O
( ( O O
9 CD O O
) ) O O
hypertriglyceridemia NN B-NP O
, , O O
( ( O O
10 CD O O
) ) O O
gout NN B-NP O
, , O O
( ( O O
11 CD O O
) ) O O
CMV NNP B-NP O
infection NN I-NP O
in IN B-VP O
February NNP B-NP O
1997 CD O O
and CC O O
November NNP B-NP O
1997 CD O O
, , O O
( ( O O
12 CD O O
) ) O O
history NN B-NP O
of IN B-VP O
perirectal JJ B-NP O
abscess NN I-NP O
, , O O
( ( O O
13 CD O O
) ) O O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
spontaneously RB O O
converted VBN O O
in IN B-VP O
March NNP B-NP O
1998 CD O O
ALLERGIES: NNP B-NP O
NO NNP I-NP O
KNOWN NNP I-NP O
DRUG NNP I-NP O
ALLERGIES NNP I-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
Synthroid NNP I-NP B-m
150 CD O B-do
mcg NN B-NP I-do
q.d NN I-NP B-f
, , O O
NPH NNP B-NP B-m
insulin VBZ O I-m
14 CD O B-do
units NNS B-NP O
q.a.m RB O B-f
, , O O
regular JJ B-NP B-m
insulin NN I-NP I-m
p.r.n NN I-NP B-f
, , O O
nadolol RB O B-m
80 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Prednisone NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Neoral NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
CellCept NNP B-NP B-m
1 CD O B-do
g NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Axid NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
p.r.n NN I-NP B-f
, , O O
Coumadin NNP B-NP B-m
4 CD O B-do
mg NN B-NP I-do
q.d JJ B-NP B-f
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
at IN B-VP O
home NN B-NP O
with IN B-VP O
his PRP$ O O
wife NN B-NP O
and CC O O
has VBZ O O
four CD O O
children NNS B-NP O
He PRP O O
denies VBZ O O
alcohol NN B-NP O
or CC O O
tobacco NN B-NP O
use VBP O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
cancer NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
pleasant JJ O O
, , O O
but CC O O
ill-appearing JJ B-NP O
man NN I-NP O
in IN B-VP O
some DT B-NP O
respiratory NN I-NP O
distress NN I-NP O
, , O O
lying VBG O O
in IN B-VP O
bed NN B-NP O
Temperature NN I-NP O
is VBZ O O
103 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
70 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
160/80 CD O O
, , O O
respirations NNS B-NP O
26 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
90% CD O O
on IN B-VP O
4 CD O B-do
L NNP B-NP I-do
oxygen NN I-NP B-m
HEENT NNP I-NP O
examination NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
cushingoid JJ B-NP O
facies NNS I-NP O
and CC O O
flushing NN B-NP O
was VBD B-VP O
evident JJ B-NP O
No NNP I-NP O
lymphadenopathy NN I-NP O
The DT B-NP O
neck NN I-NP O
was VBD B-VP O
supple JJ O O
, , O O
mucous JJ B-NP O
membranes NNS I-NP O
moist NN I-NP O
and CC O O
sclera NN B-NP O
were VBD B-VP O
anicteric JJ B-NP O
Chest NNP I-NP O
examination NN I-NP O
revealed VBD B-VP O
crackles NNS B-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
to TO O O
half DT B-NP O
way NN I-NP O
up RP O O
Heart NNP B-NP O
examination NN I-NP O
revealed VBD B-VP O
a DT B-NP O
noisy JJ I-NP O
precordium NN I-NP O
with IN B-VP O
a DT B-NP O
prominent JJ I-NP O
T2 NNP I-NP O
and CC O O
a DT O O
2/6 CD O O
systolic JJ B-NP O
ejection NN I-NP O
murmur VBD B-VP O
Abdominal NNP B-NP O
examination NN I-NP O
was VBD B-VP O
negative JJ B-NP O
Extremity NNP I-NP O
examination NN I-NP O
revealed VBD B-VP O
some DT B-NP O
slight JJ I-NP O
swelling NN I-NP O
of IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremities NNS I-NP O
Cutaneous NNP I-NP O
examination NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
evidence NN B-NP O
of IN B-VP O
thin JJ B-NP O
subcutaneous JJ I-NP O
tissues NNS I-NP O
and CC O O
development NN B-NP O
of IN B-VP O
a DT B-NP O
buffalo JJ I-NP O
hump NN I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
White NNP I-NP O
count NN I-NP O
of IN B-VP O
11.3 CD O O
with IN B-VP O
46 CD O O
polys NNS B-NP O
, , O O
36 CD O O
lymphocytes NNS B-NP O
and CC O O
7 CD O O
bands NNS B-NP O
, , O O
hematocrit NN B-NP O
was VBD B-VP O
32.4 CD O O
and CC O O
platelets NNS B-NP O
were VBD B-VP O
143 CD O O
, , O O
000 CD O O
Coagulation NNP B-NP O
studies NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
prothrombin JJ I-NP O
time NN I-NP O
of IN B-VP O
15.8 CD O O
and CC O O
an DT B-NP O
INR NNP I-NP O
of IN B-VP O
1.8 CD O O
Electrolytes NNS B-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
blood NN B-NP O
urea JJ B-NP O
nitrogen NN I-NP O
was VBD B-VP O
39 CD O O
, , O O
creatinine NN B-NP O
was VBD B-VP O
2.5 CD O O
, , O O
glucose NN B-NP O
was VBD B-VP O
85 CD O O
, , O O
calcium NN B-NP O
10.2 CD O O
Liver NNP B-NP O
function NN I-NP O
tests NNS I-NP O
revealed VBD B-VP O
an DT B-NP O
alkaline JJ I-NP O
phosphatase NN I-NP O
of IN B-VP O
342 CD O O
, , O O
total JJ B-NP O
protein NN I-NP O
was VBD B-VP O
7.9 CD O O
with IN B-VP O
an DT B-NP O
albumin NN I-NP O
of IN B-VP O
3.9 CD O O
Cholesterol NNP B-NP O
was VBD B-VP O
194 CD O O
, , O O
triglycerides NNS B-NP O
were VBD B-VP O
249 CD O O
Cyclosporine NNP B-NP O
level NN I-NP O
was VBD B-VP O
303 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
1 CD O O
INFECTIOUS NNP B-NP O
DISEASES: NNP I-NP O
Surgery NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
the DT B-NP O
right JJ I-NP O
groin NN I-NP O
abscess NN I-NP O
was VBD B-VP O
drained VBN O O
and CC O O
a DT B-NP O
wick NN I-NP O
was VBD B-VP O
inserted VBN O O
This DT B-NP O
wound NN I-NP O
was VBD B-VP O
dressed VBN O O
and CC O O
continued VBN O O
care NN B-NP O
was VBD B-VP O
preformed VBN O O
by IN B-VP O
nursing VBG O O
staff NN B-NP O
Blood NNP I-NP O
cultures NNS I-NP O
on IN B-VP O
admission NN B-NP O
revealed VBD B-VP O
no DT B-NP O
growth NN I-NP O
and CC O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
two CD O O
revealed VBD B-VP O
no DT B-NP O
growth NN I-NP O
Wound NNP I-NP O
cultures VBZ O O
revealed VBN O O
few JJ B-NP O
coagulase NN I-NP O
, , O O
negative JJ B-NP O
staph NN I-NP O
Antibiotics NNS I-NP B-m
were VBD B-VP O
initiated VBN O O
, , O O
first JJ B-NP O
vancomycin NN I-NP B-m
, , O O
gentamicin NN B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
were VBD B-VP O
initiated VBN O O
, , O O
however RB O O
gentamycin NN B-NP B-m
was VBD B-VP O
subsequently RB O O
discontinued VBN O O
and CC O O
ceftazidime NN B-NP B-m
was VBD B-VP O
initiated VBN O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
one CD O O
fever NN B-NP O
spike NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
one CD O O
to TO O O
101.9 CD O O
The DT B-NP O
patient NN I-NP O
subsequently RB O O
had VBD B-VP O
no DT B-NP O
fever NN I-NP O
spikes NNS I-NP O
, , O O
however RB O O
, , O O
on IN B-VP O
hospital NN B-NP O
day NN I-NP O
three CD O O
Levaquin NNP B-NP B-m
was VBD B-VP O
initiated VBN O O
and CC O O
intravenous JJ B-NP B-mo
antibiotics NNS I-NP B-m
were VBD B-VP O
continued VBN O O
until IN B-VP B-du
hospital JJ B-NP I-du
day NN I-NP I-du
four CD O I-du
At IN B-VP O
that DT B-NP O
point NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
afebrile RB O O
for IN B-VP O
48 CD O O
hours NNS B-NP O
and CC O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
switch VB O O
the DT B-NP O
patient NN I-NP O
to TO O O
oral JJ B-NP B-mo
antibiotics NNS I-NP B-m
, , O O
including VBG O O
Levaquin NNP B-NP B-m
and CC O O
Augmentin NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
defervesce VB O O
, , O O
his PRP$ O O
breathing VBG O O
improved VBN O O
, , O O
the DT B-NP O
pain NN I-NP O
in IN B-VP O
his PRP$ O O
right JJ B-NP O
groin NN I-NP O
improved VBD B-VP O
, , O O
dressing VBG O O
changes NNS B-NP O
were VBD B-VP O
continued VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
remained VBD B-VP O
afebrile JJ O O
for IN B-VP O
more JJR O O
than IN B-VP O
24 CD O O
hours NNS B-NP O
after IN B-VP O
initiating VBG O O
oral JJ B-NP B-mo
antibiotics NNS I-NP B-m
2 CD O O
CARDIOVASCULAR: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP B-r
hypertension NN I-NP B-r
and CC O O
has VBZ O O
been VBN O O
maintained VBN O O
on IN B-VP O
nadolol JJ B-NP B-m
nadolol NN I-NP B-m
, , O O
recently RB O O
requiring VBG O O
a DT O O
doubling VBG O O
in IN B-VP O
his PRP$ O O
dose NN B-NP O
from IN B-VP O
40 CD O B-do
mg NNS B-NP I-do
q.d RB O B-f
to TO O O
80 CD O B-do
mg NNS B-NP I-do
q.d RB O B-f
He PRP O O
was VBD B-VP O
admitted VBN O O
and CC O O
placed VBN O O
on IN B-VP O
80 CD O B-do
mg JJ B-NP I-do
q.d NN I-NP B-f
of IN B-VP O
nadolol NN B-NP B-m
, , O O
however RB O O
, , O O
his PRP$ O B-r
blood NN B-NP I-r
pressures NNS I-NP I-r
continued VBD B-VP O
to TO O O
run VB O O
up RB O O
to TO O O
170 CD O O
systolic NN B-NP O
and CC O O
up RB O O
to TO O O
110 CD O O
diastolic NN B-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
initiate VB O O
a DT B-NP O
second JJ I-NP O
antihypertensive JJ I-NP B-m
medication NN I-NP I-m
and CC O O
nifedipine JJ B-NP B-m
XL NNP I-NP I-m
was VBD B-VP O
chosen VBN O O
He PRP O O
was VBD B-VP O
maintained VBN O O
for IN B-VP B-du
for IN B-VP B-du
two CD O I-du
two CD O I-du
days NNS B-NP I-du
days NNS I-NP I-du
at IN B-VP O
30 CD O B-do
30 CD O B-do
mg NN B-NP O
on IN B-VP O
this DT B-NP B-m
medication NN I-NP I-m
and CC O O
his PRP$ O B-r
blood NN B-NP I-r
pressures NNS I-NP I-r
subsequently RB O O
stabilized VBN O O
at IN B-VP O
130/80 CD O O
The DT B-NP O
patient NN I-NP O
also RB O O
carries VBZ O O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
pulmonary JJ B-NP O
hypertension NN I-NP O
, , O O
presumed VBN O O
from IN B-VP O
the DT B-NP O
February NNP I-NP O
1997 CD O O
, , O O
results NNS B-NP O
of IN B-VP O
his PRP$ O O
echocardiogram NN B-NP O
These DT B-NP O
results NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
pressure NN I-NP O
gradient NN I-NP O
in IN B-VP O
the DT B-NP O
pulmonary JJ I-NP O
arterial NN I-NP O
system NN I-NP O
, , O O
and CC O O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
a DT B-NP O
subsequent JJ I-NP O
echocardiogram NN I-NP O
was VBD B-VP O
obtained VBN O O
to TO O O
assess VB O O
left JJ B-NP O
ventricular JJ I-NP O
function NN I-NP O
and CC O O
his PRP$ O O
pulmonary JJ B-NP O
vascular NN I-NP O
status NN I-NP O
The DT B-NP O
results NNS I-NP O
of IN B-VP O
this DT B-NP O
study NN I-NP O
revealed VBD B-VP O
2+ CD O O
tricuspid JJ B-NP O
regurgitation NN I-NP O
and CC O O
1+ CD O O
mitral JJ B-NP O
regurgitation NN I-NP O
, , O O
unchanged JJ O O
from IN B-VP O
prior JJ B-NP O
studies NNS I-NP O
and CC O O
a DT B-NP O
pulmonary JJ I-NP O
arterial JJ I-NP O
pressure NN I-NP O
of IN B-VP O
approximately RB O O
45 CD O O
mmHg NN B-NP O
, , O O
also RB O O
not RB O O
notably RB O O
changed VBD B-VP O
3 CD O O
PULMONARY: NNP B-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
reported VBD B-VP O
a DT B-NP O
productive JJ I-NP O
cough NN I-NP O
, , O O
in IN B-VP O
addition NN B-NP O
to TO O O
difficulty VB O O
breathing VBG O O
This DT O O
was VBD B-VP O
evaluated VBN O O
with IN B-VP O
a DT B-NP O
chest NN I-NP O
radiogram NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
possibility NN B-NP O
of IN B-VP O
a DT B-NP O
right NN I-NP O
sided VBD B-VP O
pulmonary JJ B-NP O
process NN I-NP O
, , O O
corroborated VBN O O
on IN B-VP O
examination NN B-NP O
by IN B-VP O
evidence NN B-NP O
of IN B-VP O
crackles NNS B-NP O
half DT B-NP O
way NN I-NP O
up RP O O
The DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
rule VB O O
the DT B-NP O
patient NN I-NP O
out RP O O
for IN B-VP O
another DT B-NP O
flare NN I-NP O
of IN B-VP O
his PRP$ O O
CMV NNP B-NP O
infection NN I-NP O
Studies NNP I-NP O
for IN B-VP O
CMV NNP B-NP O
antigen NN I-NP O
and CC O O
CMV NNP B-NP O
from IN B-VP O
the DT B-NP O
buffy NN I-NP O
coat NN I-NP O
were VBD B-VP O
sent VBN O O
and CC O O
the DT B-NP O
final JJ I-NP O
results NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
positive JJ I-NP O
CMV NNP I-NP O
antigen NN I-NP O
, , O O
but CC O O
a DT B-NP O
negative JJ I-NP O
buffy NN I-NP O
coat NN I-NP O
The DT B-NP O
patient's NN I-NP O
pulmonary JJ B-NP O
status NN I-NP O
improved VBN O O
on IN B-VP O
oxygen NN B-NP B-m
and CC O O
on IN B-VP O
intravenous JJ B-NP B-mo
antibiotics NNS I-NP B-m
A DT B-NP O
induced JJ I-NP O
sputum NN I-NP O
sample NN I-NP O
was VBD B-VP O
obtained VBN O O
and CC O O
studies NNS B-NP O
were VBD B-VP O
sent VBN O O
for IN B-VP O
atypical JJ B-NP O
organisms NNS I-NP O
including VBG O O
CPT NNP B-NP O
, , O O
fungi NN B-NP O
, , O O
in IN B-VP O
addition NN B-NP O
to TO O O
bacteria VB O O
All PDT O O
these DT B-NP O
studies NNS I-NP O
were VBD B-VP O
negative JJ O O
In IN B-VP O
addition NN B-NP O
, , O O
Legionella NNP B-NP O
antigen NN I-NP O
was VBD B-VP O
also RB O O
negative JJ B-NP O
Prior NNP I-NP O
to TO O O
discharge VB O O
, , O O
the DT B-NP O
patient's NN I-NP O
pulmonary JJ B-NP O
status NN I-NP O
had VBD B-VP O
returned VBN O O
to TO O O
baseline VB O O
and CC O O
had VBD B-VP O
entirely RB O O
resolved VBN O O
4 CD O O
GASTROINTESTINAL: NNP B-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
reported VBD B-VP O
multiple JJ B-NP O
loose JJ I-NP O
bowel NN I-NP O
movements NNS I-NP O
However RB O O
, , O O
in IN B-VP O
his PRP$ O O
hospital NN B-NP O
course NN I-NP O
this DT O O
did VBD B-VP O
not RB O O
continue VB O O
to TO O O
be VB O O
an DT B-NP O
issue NN I-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
regained VBD B-VP O
his PRP$ O O
appetite NN B-NP O
during IN B-VP O
the DT B-NP O
hospital JJ I-NP O
course NN I-NP O
5 CD O O
HEMATOLOGIC: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
anticoagulation NN B-NP B-m
for IN B-VP O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
at IN B-VP O
4 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
with IN B-VP O
an DT B-NP O
INR NNP I-NP O
remaining VBG O O
in IN B-VP O
his PRP$ O O
goal NN B-NP O
parameters NNS I-NP O
, , O O
which WDT O O
were VBD B-VP O
set VBN O O
at IN B-VP O
1.6-2.0 JJ O O
The DT B-NP O
patient NN I-NP O
however RB O O
, , O O
has VBZ O O
recently RB O O
spontaneously RB O O
converted VBN O O
to TO O O
sinus VB O O
rhythm NN B-NP O
and CC O O
throughout IN B-VP O
his PRP$ O O
hospital NN B-NP O
course NN I-NP O
remained VBD B-VP O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
with IN B-VP O
continuous JJ O O
monitoring VBG O O
6 CD O O
RENAL: NNP B-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient's JJ I-NP O
creatinine NN I-NP O
level NN I-NP O
was VBD B-VP O
2.5 CD O O
and CC O O
remained VBD B-VP O
stable JJ O O
throughout IN B-VP O
his PRP$ O O
hospital NN B-NP O
course NN I-NP O
His PRP$ O O
cyclosporine JJ B-NP B-m
level NN I-NP O
was VBD B-VP O
303 CD O O
on IN B-VP O
admission NN B-NP O
, , O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
four CD O O
, , O O
a DT B-NP O
level NN I-NP O
of IN B-VP O
700 CD O O
was VBD B-VP O
obtained VBN O O
, , O O
however RB O O
, , O O
this DT O O
determined VBN O O
from IN B-VP O
a DT B-NP O
history NN I-NP O
that IN B-VP O
this DT B-NP O
level NN I-NP O
had VBD B-VP O
been VBN O O
drawn VBN O O
shortly RB O O
after IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
taken VBN O O
the DT B-NP O
cyclosporine NN I-NP B-m
During IN B-VP O
his PRP$ O O
hospital JJ B-NP O
course NN I-NP O
, , O O
vancomycin NN B-NP B-m
levels NNS I-NP O
were VBD B-VP O
followed VBN O O
These DT B-NP O
levels NNS I-NP O
reached VBD B-VP O
a DT B-NP O
maximum NN I-NP O
of IN B-VP O
19.8 CD O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
four CD O O
, , O O
at IN B-VP O
which WDT O O
time NN B-NP O
intravenous JJ B-NP B-mo
antibiotics NNS I-NP B-m
were VBD B-VP O
discontinued VBN O O
7 CD O O
ENDOCRINE NNP B-NP O
The DT B-NP O
patient NN I-NP O
carries VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
multiple JJ B-NP O
endocrine JJ I-NP O
issues NNS I-NP O
including VBG O O
hypercalcemia NN B-NP O
and CC O O
hyperparathyroidism NN B-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
hyperthyroidism NN B-NP B-r
on IN B-VP O
thyroid JJ B-NP B-m
replacement NN I-NP O
therapy NN I-NP O
following VBG O O
subtotal JJ B-NP O
thyroidectomy NN I-NP O
, , O O
and CC O O
possibility NN B-NP O
of IN B-VP O
mineral JJ B-NP O
corticoid NN I-NP O
deficiency NN I-NP O
The DT B-NP O
Endocrine NNP I-NP O
Team NNP I-NP O
was VBD B-VP O
consulted VBN O O
Thyroid NNP B-NP O
studies NNS I-NP O
and CC O O
parathyroid JJ B-NP O
studies NNS I-NP O
were VBD B-VP O
sent VBN O O
and CC O O
revealed VBD B-VP O
a DT B-NP O
TSH NNP I-NP O
of IN B-VP O
0.02 CD O O
, , O O
a DT B-NP O
T4 NNP I-NP O
of IN B-VP O
6.0 CD O O
, , O O
a DT B-NP O
THPR NNP I-NP O
of IN B-VP O
1.47 CD O O
On IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
parathyroid NN I-NP O
1 CD O O
, , O O
25 CD O O
vitamin NN B-NP O
D NNP I-NP O
and CC O O
25 CD O O
vitamin NN B-NP O
D NNP I-NP O
were VBD B-VP O
still RB O O
pending VBG O O
The DT B-NP O
Endocrine NNP I-NP O
Team NNP I-NP O
recommended VBD B-VP O
decreasing VBG O O
his PRP$ O O
Synthroid NNP B-NP B-m
dose NN I-NP O
to TO O O
a DT B-NP O
level NN I-NP O
of IN B-VP O
125 CD O B-do
mcg JJ O I-do
daily RB O B-f
In IN B-VP O
addition NN B-NP O
, , O O
they PRP O O
recommended VBD B-VP O
a DT B-NP O
bone NN I-NP O
densitometry NN I-NP O
study NN I-NP O
for IN B-VP O
evaluation NN B-NP O
of IN B-VP O
his PRP$ O O
bone NN B-NP O
mass NN I-NP O
following VBG O O
chronic JJ B-NP O
maintenance NN I-NP O
on IN B-VP O
the DT B-NP O
steroid JJ I-NP B-m
therapy NN I-NP O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hyperparathyroidism NN B-NP O
The DT B-NP O
team NN I-NP O
thought VBD B-VP O
that IN B-VP O
the DT B-NP O
patient's NN I-NP O
previous JJ B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP O
mineral JJ I-NP O
corticoid NN I-NP O
deficiency NN I-NP O
was VBD B-VP O
likely JJ O O
due JJ O O
to TO O O
his PRP$ O O
prior JJ B-NP O
Cozaar NNP I-NP B-m
therapy NN I-NP O
They PRP O O
did VBD B-VP O
not RB O O
fell VBD B-VP O
it PRP O O
was VBD B-VP O
necessary JJ O O
at IN B-VP O
this DT B-NP O
point NN I-NP O
to TO O O
preform VB O O
a DT B-NP O
cortizone NN I-NP B-m
stimulation NN I-NP O
study NN I-NP O
or CC O O
to TO O O
further RB O O
assess VB O O
this DT B-NP O
possibility NN I-NP O
of IN B-VP O
a DT B-NP O
mineral JJ I-NP O
corticoid NN I-NP O
deficiency NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Augmentin NNP I-NP B-m
250/125 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Levaquin NNP B-NP B-m
250 CD O B-do
mg NN B-NP O
q.d NN I-NP B-f
, , O O
CellCept NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Neoral NNP B-NP B-m
100 CD O B-do
mg NN B-NP O
b.i.d NN I-NP B-f
, , O O
Prednisone NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Synthroid NNP B-NP B-m
125 CD O B-do
mcg NN B-NP I-do
q.d NN I-NP B-f
, , O O
INP NNP B-NP B-m
insulin VBZ O O
14 CD O B-do
units NNS B-NP I-do
subcu JJ B-NP B-mo
q.a.m NN I-NP B-f
, , O O
regular JJ B-NP B-m
insulin NN I-NP I-m
subcu NN I-NP B-mo
p.r.n NN I-NP B-f
, , O O
Axid NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
nadolol RB O B-m
80 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
nifedipine JJ B-NP B-m
XL NNP I-NP I-m
30 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
Coumadin NNP B-NP B-m
4 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
, , O O
iron NN B-NP B-m
sulfate NN I-NP I-m
300 CD O B-do
mg NN B-NP I-do
q.d JJ B-NP B-f
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Stable NNP I-NP O
DISPOSITION: NNP I-NP O
To TO O O
home VB O O
FOLLOW-UP: NNP B-NP O
1 CD O O
Bone NNP B-NP O
densitometry NN I-NP O
July NNP I-NP O
, , O O
1998 CD O O
2 CD O O
Dr NNP B-NP O
Clinton NNP I-NP O
Ardizone NNP I-NP O
January NNP I-NP O
, , O O
1998 CD O O
3 CD O O
Dr NNP B-NP O
Win NNP I-NP O
in IN B-VP O
March NNP B-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MOHAMMAD NNP I-NP O
CLEARK NNP I-NP O
, , O O
M.D NNP B-NP O
Attending: NNP I-NP O
FABIAN NNP I-NP O
V NNP I-NP O
POMPONI NNP I-NP O
, , O O
M.D NNP B-NP O
MK1 NNP I-NP O
XA067/4603 NNP I-NP O
Batch: NNP I-NP O
59411 CD O O
Index NNP B-NP O
No NNP I-NP O
Y9BVVA9CXG NNP I-NP O
D: NNP I-NP O
0/18/98 CD O O
T: NNP B-NP O
0/18/98 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#472947 VBZ O O
965041836 CD O O
RTH NNP B-NP O
94253387 CD O O
5833170 CD O O
1/7/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Viral NNP I-NP O
syndrome NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/7/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/16/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
REDFEARN NNP I-NP O
, , O O
SHAUN NNP B-NP O
001-14-30-0 NNP I-NP O
Lake NNP I-NP O
Woodcho NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
5/18/05 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SCHEINER NNP I-NP O
, , O O
WILLIAMS NNP B-NP O
MAYNARD NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
650 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Headache NNP I-NP B-r
CEPACOL NNP I-NP B-m
1-2 JJ B-NP B-do
LOZENGE NNP I-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Other:sore NNP I-NP B-r
throat NN I-NP I-r
VITAMIN NNP I-NP B-m
B12 NNP I-NP I-m
( ( O I-m
CYANOCOBALAMIN NNP B-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MCG NNP B-NP I-do
IM NNP I-NP B-mo
QD NNP I-NP B-f
X NNP I-NP B-du
3 CD O I-du
doses NNS B-NP I-du
DIPYRIDAMOLE NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ISORDIL NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
DINITRATE NNP I-NP I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
ATIVAN NNP I-NP B-m
( ( O I-m
LORAZEPAM NNP B-NP I-m
) ) O I-m
3.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
PRN NNP I-NP I-f
Insomnia NNP I-NP B-r
INDERAL NNP I-NP B-m
( ( O I-m
PROPRANOLOL NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
NORVASC NNP I-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
NITROGLYCERIN NNP B-NP B-m
0.2% CD O B-do
TOPICAL NNP B-NP B-mo
TP NNP I-NP I-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
1 CD O O
inch NN B-NP O
, , O O
ZETIA NNP B-NP B-m
( ( O I-m
EZETIMIBE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
AZITHROMYCIN NNP I-NP B-m
500 CD O I-m
MG NNP B-NP I-m
PACK NNP I-NP I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
X NNP I-NP B-du
4 CD O I-du
doses NNS B-NP I-du
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
5/18/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LORAZEPAM NNP I-NP B-m
&amp; NNP I-NP O
AZITHROMYCIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMLODIPINE NNP I-NP B-m
BESYLATE NNP I-NP I-m
&amp; NNP I-NP O
CALCIUM NNP I-NP B-m
PHOSPHATE NNP I-NP I-m
, , O O
ORAL NNP B-NP B-mo
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
DIET: NNP I-NP O
No NNP I-NP O
Restrictions NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Tatlock NNP I-NP O
within IN B-VP O
2 CD O O
wks NNS B-NP O
, , O O
Dr NNP B-NP O
Ausherman NNP I-NP O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
, , O O
Aspirin NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Viral NNP I-NP O
syndrome NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Viral NNP B-NP O
syndrome NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
htn NN I-NP O
elev NN I-NP O
chol NN I-NP O
bph NN I-NP O
, , O O
s/p JJ B-NP O
turp NN I-NP O
x4 NNP I-NP O
s/p VBZ O O
partial JJ B-NP O
gastrectomy NN I-NP O
IMI NNP I-NP O
'73 POS O O
CAD NNP B-NP O
s/p NN I-NP O
CABG NNP I-NP O
x3 NNP I-NP O
( ( O O
S/P NNP B-NP O
cardiac JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
surgery NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
Sore NNP I-NP O
throat NN I-NP O
, , O O
cough NN B-NP O
, , O O
weakness NN B-NP O
--------------- NNP I-NP O
DDX: NNP I-NP O
83yo CD O O
man NN B-NP O
w/ NN I-NP O
ho NN I-NP O
CAD NNP I-NP O
, , O O
IMI NNP B-NP O
, , O O
CABG NNP B-NP O
( ( O O
2000 CD O O
) ) O O
, , O O
HTN NNP B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
stable JJ B-NP O
angina NN I-NP O
, , O O
recently RB O O
d/c'd VBZ O O
from IN B-VP O
BDBH NNP B-NP O
10/7 CD O O
after IN B-VP O
being VBG O O
r/o'd NN B-NP O
for IN B-VP O
MI NNP B-NP O
with IN B-VP O
negative JJ B-NP O
MIBI NNP I-NP O
p/w NN I-NP O
2 CD O O
days NNS B-NP O
viral JJ B-NP O
syndrome JJ I-NP O
w NN I-NP O
sore NN I-NP O
throat NN I-NP O
, , O O
cough NN B-NP O
, , O O
weakness NN B-NP O
, , O O
sweats NNS B-NP O
--------------- VBP O O
HPI: NNP B-NP O
Pt NNP I-NP O
came VBD B-VP O
to TO O O
BMC NNP B-NP O
ED NNP I-NP O
with IN B-VP O
2 CD O O
days NNS B-NP O
weakness NN I-NP O
, , O O
fatigue NN B-NP O
, , O O
diziness NN B-NP O
, , O O
sore NN B-NP O
throat NN I-NP O
and CC O O
cough NN B-NP O
No NNP I-NP O
CP NNP I-NP O
, , O O
SOB NNP B-NP O
Appetite NNP I-NP O
ok NN I-NP O
, , O O
drinking VBG O O
plenty NN B-NP O
of IN B-VP O
fluids NNS B-NP O
No NNP I-NP O
weight NN I-NP O
loss NN I-NP O
Has NNP I-NP O
several JJ B-NP O
month NN I-NP O
h/o VBD B-VP O
weight JJ B-NP O
loss NN I-NP O
In IN B-VP O
ED NNP B-NP O
, , O O
given VBN O O
500 CD O B-do
azithro IN B-VP B-m
He PRP O O
was VBD B-VP O
observed VBN O O
O/N NNP B-NP O
and CC O O
then RB O O
admitted VBD B-VP O
to TO O O
medicine VB O O
because IN B-VP O
of IN B-VP O
FTT NNP B-NP O
Of IN B-VP O
note NN B-NP O
, , O O
pt NN B-NP O
c/o NN I-NP O
very RB O O
depressed JJ B-NP O
mood NN I-NP O
Had VBD B-VP O
a DT B-NP O
break NN I-NP O
in IN B-VP O
at IN B-VP O
his PRP$ O O
apartment NN B-NP O
10/7 CD O O
, , O O
everythign NN B-NP O
stolen VBN O O
Son NNP B-NP O
also RB O O
recently RB O O
dx'd VBZ O O
with IN B-VP O
metastatic JJ B-NP O
prostate NN I-NP O
ca MD O O
---------------- VB O O
STATUS: NNP B-NP O
Afebrile NNP I-NP O
( ( O O
though IN B-VP O
101.9 CD O O
O/N NNP B-NP O
in IN B-VP O
ED NNP B-NP O
) ) O O
VSS NNP B-NP O
, , O O
NAD NNP B-NP O
, , O O
no DT B-NP O
cough NN I-NP O
CTAB NNP I-NP O
, , O O
RRR NNP B-NP O
, , O O
normal JJ B-NP O
S1/S2 NNP I-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
Abd NNP B-NP O
benign NN I-NP O
, , O O
no DT B-NP O
edema NN I-NP O
AOx3 NNP I-NP O
- : O O
EKG:A-paced JJ O O
at IN B-VP O
69 CD O O
, , O O
IMI NNP B-NP O
, , O O
normal JJ B-NP O
axis NN I-NP O
, , O O
no DT B-NP O
acute NN I-NP O
iscmeic NN I-NP O
changes NNS I-NP O
---------------- VBP O O
STUDIES: NNP B-NP O
- : O O
MIBI NNP B-NP O
( ( O O
10/5 CD O O
): NNP B-NP O
EF NNP I-NP O
45% CD O O
, , O O
noted VBD B-VP O
to TO O O
have VB O O
multiple JJ B-NP O
pulmonary JJ I-NP O
nodules NNS I-NP O
- : O O
CXR NNP B-NP O
( ( O O
2/14 CD O O
): RB O O
negative JJ O O
- : O O
CT NN B-NP O
Chest NNP I-NP O
( ( O O
0/17 CD O O
): RB O O
several JJ B-NP O
pulmonary JJ I-NP O
nodules NNS I-NP O
in IN B-VP O
RUL NNP B-NP O
inferiorly RB O O
, , O O
largest JJS O O
0.6cm CD O O
Also RB O O
tiny JJ B-NP O
nodules NNS I-NP O
in IN B-VP O
upper JJ B-NP O
lobes NNS I-NP O
bilaterally RB O O
, , O O
2-3mm JJ B-NP O
Several NNP I-NP O
small JJ B-NP O
nodes NNS I-NP O
in IN B-VP O
mediastinum NN B-NP O
No NNP I-NP O
LAD NNP I-NP O
C/W NNP I-NP O
inflammatory NN I-NP O
changes NNS I-NP O
, , O O
including VBG O O
possible JJ B-NP O
TB NN I-NP O
or CC O O
atypical JJ B-NP O
mycobacterium NN I-NP O
---------------- NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEMS: NNP I-NP O
---------------- NNP I-NP O
1 CD O O
) ) O O
ID NNP B-NP O
- : O O
No DT B-NP O
significant JJ I-NP O
fever NN I-NP O
or CC O O
WBC NNP B-NP O
Symptoms NNP I-NP O
were VBD B-VP O
already RB O O
improved VBN O O
on IN B-VP O
admission; NN B-NP O
no DT B-NP O
cough NN I-NP O
Pt NNP I-NP O
was VBD B-VP O
observed VBN O O
O/N NNP B-NP O
with IN B-VP O
IVF NNP B-NP B-m
Improved NNP I-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
Will MD O O
be VB O O
D/C'd NNP B-NP O
on IN B-VP O
azithromycin NN B-NP B-m
x $ O B-du
5 CD O I-du
days NNS B-NP I-du
---------------- RB O O
2 CD O O
) ) O O
PULMONARY NNP B-NP O
NODULES: NNP I-NP O
Had NNP I-NP O
been VBN O O
seen VBN O O
on IN B-VP O
prior JJ B-NP O
MIBI NNP I-NP O
CT NNP I-NP O
c/w NN I-NP O
pulmonary JJ O O
nodules VBZ O O
No DT B-NP O
clinical JJ I-NP O
signs NNS I-NP O
of IN B-VP O
TB NNP B-NP O
, , O O
but CC O O
did VBD B-VP O
have VB O O
night NN B-NP O
sweats NNS I-NP O
for IN B-VP O
several JJ B-NP O
months NNS I-NP O
Will MD O O
f/u VB O O
with IN B-VP O
Dr NNP B-NP O
Muether NNP I-NP O
as IN B-VP O
outpatient NN B-NP O
for IN B-VP O
w/u NN B-NP O
----------------- NNP I-NP O
3 CD O O
) ) O O
HEME: NNP B-NP O
Given NNP I-NP O
anemia NN I-NP O
, , O O
iron NN B-NP O
studies NNS I-NP O
, , O O
B12 NNP B-NP O
, , O O
folate NN B-NP O
sent VBD B-VP O
Got NNP B-NP O
B12 NNP I-NP B-m
1000ug CD O B-do
IM NNP B-NP B-mo
x VBD B-VP B-f
1 CD O I-f
Pt NNP B-NP O
refuses VBZ O O
all DT B-NP O
VNA NNP I-NP O
services NNS I-NP O
, , O O
so RB O O
patient JJ O O
was VBD B-VP O
instructed VBN O O
to TO O O
f/u VB O O
with IN B-VP O
doctors NNS B-NP O
office NN I-NP O
to TO O O
get VB O O
injectiosn NN B-NP O
for IN B-VP O
2 CD O O
more JJR B-NP O
days NNS I-NP O
, , O O
then RB O O
monthly RB O O
Likely JJ O O
2/2 CD O O
gastrectomy NN B-NP O
----------------- NNP I-NP O
4 CD O O
) ) O O
DEPRESSION: NNP B-NP O
Pt NNP I-NP O
seems VBZ O O
severely RB O O
depressed VBN O O
, , O O
admits VBZ O O
to TO O O
depressed VB O O
mood NN B-NP O
patient JJ B-NP O
declines NNS I-NP O
psych RB O O
consult VBP O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
--------------- VBZ O O
FULL NNP B-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
call VB O O
your PRP$ O O
doctor NN B-NP O
if IN B-VP O
you PRP O O
continue VBP O O
to TO O O
feel VB O O
unwell RB O O
, , O O
or CC O O
return NN B-NP O
to TO O O
the DT O O
hosptial JJ O O
If IN B-VP O
you PRP O O
would MD O O
like VB O O
to TO O O
receive VB O O
your PRP$ O O
B12 NNP B-NP B-m
injections NNS I-NP B-mo
, , O O
please NN B-NP O
go VB O O
to TO O O
the DT B-NP O
doctors NNS I-NP O
office NN I-NP O
on IN B-VP O
Thursday NNP B-NP O
and CC O O
Friday NNP B-NP O
to TO O O
receive VB O O
the DT B-NP O
injections NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
- : O O
continue NN B-NP O
azithro VBZ O B-m
x $ O B-du
4 CD O I-du
days NNS B-NP I-du
- : O O
B12 NNP B-NP B-m
1000ug CD O B-do
QD NNP B-NP B-f
for IN B-VP B-du
2 CD O I-du
more JJR B-NP I-du
days NNS I-NP I-du
, , O O
the DT B-NP O
qmonth JJ I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
SMELSER NNP I-NP O
, , O O
KOREY NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
RJ68 NNP B-NP O
) ) O O
5/18/05 CD O O
@ $ O O
05 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#483034 VBZ O O
590977812 CD O O
FFACH NNP B-NP O
63114914 CD O O
1131190 CD O O
5/13/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/30/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
ATTENDING: NNP I-NP O
ZOGG NNP I-NP O
, , O O
RAYMOND NNP B-NP O
RANDALL NNP I-NP O
MD NNP I-NP O
DISCHARGE NNP I-NP O
DATE: NNP I-NP O
Presumed NNP I-NP O
to TO O O
be VB O O
5/1/05 CD O O
PRIMARY NNP B-NP O
ONCOLOGIST: NNP I-NP O
Antoine NNP I-NP O
Petchulis NNP I-NP O
, , O O
M.D NNP B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Pain NNP I-NP O
secondary JJ O O
to TO O O
a DT B-NP O
lytic JJ I-NP O
lesion NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
Recurrent NNP I-NP O
lymphoma NN I-NP O
, , O O
pulmonary JJ B-NP O
dysfunction NN I-NP O
secondary JJ O O
to TO O O
chemotherapy VB O B-m
and CC O O
obesity JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
In IN B-VP O
brief NN B-NP O
, , O O
this DT O O
is VBZ O O
a DT B-NP O
57-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
follicular JJ B-NP O
lymphoma NN I-NP O
diagnosed VBD B-VP O
approximately RB O O
eight CD O O
years NNS B-NP O
ago RB O O
who WP O O
has VBZ O O
been VBN O O
treated VBN O O
in IN B-VP O
the DT O O
past JJ O O
with IN B-VP O
CVP NNP B-NP B-m
and CC O O
CHOP/Rituxan NNP B-NP B-m
She PRP O O
underwent VBD B-VP O
high-dose JJ B-NP O
chemotherapy NN I-NP O
and CC O O
autologous JJ B-NP O
stem NN I-NP O
cell NN I-NP O
rescue NN I-NP O
in IN B-VP O
10/6 CD O O
Her PRP$ O O
transplant NN B-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
worsening VBG O O
of IN B-VP O
her PRP$ O O
baseline NN B-NP O
impaired JJ B-NP O
lung NN I-NP O
function NN I-NP O
, , O O
and CC O O
she PRP O O
has VBZ O O
been VBN O O
oxygen VBN O O
dependent JJ O O
since IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transplant NN B-NP O
In IN B-VP O
3/24 CD O O
, , O O
she PRP O O
began VBD B-VP O
to TO O O
have VB O O
back RB O O
pain NN B-NP O
and CC O O
eventually RB O O
was VBD B-VP O
shown VBN O O
to TO O O
have VB O O
recurrent NN B-NP O
or CC O O
increasing VBG O O
disease NN B-NP O
in IN B-VP O
the DT B-NP O
retroperitoneum NN I-NP O
by IN B-VP O
abdominal JJ B-NP O
CT NNP I-NP O
( ( O O
paraaortic JJ O O
at IN B-VP O
the DT B-NP O
level NN I-NP O
of IN B-VP O
L2 NNP B-NP O
) ) O O
The DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
pursue VB O O
radiation NN B-NP O
therapy NN I-NP O
to TO O O
this DT B-NP O
area NN I-NP O
, , O O
which WDT O O
she PRP O O
completed VBD B-VP O
on IN B-VP O
4/7/05 CD O O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
complaints NNS B-NP O
of IN B-VP O
pain NN B-NP O
in IN B-VP O
the DT B-NP O
mid NN I-NP O
lower RBR O O
back RB O O
radiating VBG O O
in IN B-VP O
a DT B-NP O
band-like JJ I-NP O
distribution NN I-NP O
around IN B-VP O
the DT B-NP O
waist NN I-NP O
to TO O O
the DT B-NP O
abdomen NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
into IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
and CC O O
buttock NN B-NP O
area NN I-NP O
The DT B-NP O
pain NN I-NP O
also RB O O
radiated VBD B-VP O
into IN B-VP O
the DT B-NP O
right JJ I-NP O
thigh NN I-NP O
with IN B-VP O
movement NN B-NP O
for IN B-VP O
weightbearing VBG O O
The DT B-NP O
patient NN I-NP O
reports VBZ O O
the DT B-NP O
pain NN I-NP O
was VBD B-VP O
occasionally RB O O
associated VBN O O
with IN B-VP O
numbness NN B-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
lateral JJ I-NP O
thigh NN I-NP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
radiation NN I-NP O
of IN B-VP O
the DT B-NP O
pain NN I-NP O
to TO O O
below IN B-VP O
the DT B-NP O
knee NN I-NP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
numbness NN I-NP O
in IN B-VP O
the DT B-NP O
lower JJR I-NP O
legs NN I-NP O
, , O O
back RB O O
or CC O O
saddle JJ B-NP O
area NN I-NP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
change NN I-NP O
in IN B-VP O
bowel NN B-NP O
or CC O O
bladder NN B-NP O
function NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
fluoroscopic VBN O O
LP NNP B-NP O
on IN B-VP O
10/19/05 CD O O
with IN B-VP O
a DT B-NP O
glucose NN I-NP O
of IN B-VP O
69 CD O O
, , O O
a DT B-NP O
total JJ I-NP O
protein NN I-NP O
of IN B-VP O
49.3 CD O O
, , O O
and CC O O
cytology NN B-NP O
which WDT O O
was VBD B-VP O
negative JJ B-NP O
Plain NNP I-NP O
films NNS I-NP O
of IN B-VP O
her PRP$ O O
hip NN B-NP O
showed VBD B-VP O
enthesopathy NN B-NP O
of IN B-VP O
the DT B-NP O
superior JJ I-NP O
pelvis NN I-NP O
bilaterally RB O O
, , O O
lower JJR B-NP O
lumbar NN I-NP O
spine NN I-NP O
degeneration NN I-NP O
, , O O
and CC O O
sclerotic JJ B-NP O
focus NN I-NP O
in IN B-VP O
the DT B-NP O
proximal JJ I-NP O
region NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
femur NN I-NP O
MRI NNP I-NP O
of IN B-VP O
the DT B-NP O
lumbar NN I-NP O
spine NN I-NP O
on IN B-VP O
4/7/05 CD O O
showed VBD B-VP O
an DT B-NP O
irregular JJ I-NP O
soft JJ I-NP O
tissue NN I-NP O
mass NN I-NP O
within IN B-VP O
the DT B-NP O
retroperitoneum NN I-NP O
centered VBD B-VP O
anterior RB O O
to TO O O
the DT B-NP O
spine NN I-NP O
at IN B-VP O
the DT B-NP O
level NN I-NP O
of IN B-VP O
L2 NNP B-NP O
, , O O
position NN B-NP O
posterior NN I-NP O
to TO O O
the DT B-NP O
IVC NNP I-NP O
and CC O O
right JJ B-NP O
lateral JJ I-NP O
aorta NN I-NP O
measuring VBG O O
4.5 CD O O
x JJ O O
2.7 CD O O
x JJ O O
3.4 CD O O
cm; NN B-NP O
there EX O O
is VBZ O O
a DT B-NP O
lesion NN I-NP O
involving VBG O O
the DT B-NP O
anterior JJ I-NP O
superior JJ I-NP O
aspect NN I-NP O
to TO O O
the DT B-NP O
L2 NNP I-NP O
vertebral JJ B-NP O
body NN I-NP O
continuous JJ O O
with IN B-VP O
the DT B-NP O
anterior JJ I-NP O
paraspinal JJ I-NP O
mass NN I-NP O
with IN B-VP O
wedging NN B-NP O
and CC O O
probable JJ B-NP O
pathologic JJ I-NP O
compression NN I-NP O
fracture NN I-NP O
No NNP I-NP O
epidural JJ B-NP O
mass NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Recurrent NNP B-NP O
lymphoma NN I-NP O
2 CD O O
Pulmonary NNP B-NP O
function NN I-NP O
thought VBD B-VP O
to TO O O
be VB O O
due JJ O O
in IN B-VP O
part NN B-NP O
to TO O O
BCNU NNP B-NP B-m
chemotherapy NN I-NP O
, , O O
currently RB O O
on IN B-VP O
5 CD O B-do
liters NNS B-NP I-do
home VBP O O
O2 NNP B-NP B-m
3 CD O O
Status NNP B-NP O
post NN I-NP O
cholecystectomy NN I-NP O
4 CD O O
Obesity NNP B-NP O
MEDICATIONS NNP I-NP O
AT NNP I-NP O
THE NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Prednisone NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
2 CD O O
Imuran NNP B-NP B-m
Imuran NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m NN I-NP B-f
, , O O
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m VBD B-VP B-f
3 CD O O
Coumadin NNP B-NP B-m
6 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s VBD B-VP B-f
4 CD O O
Lasix NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
5 CD O O
Potassium NNP B-NP B-m
t.i.d NN I-NP B-f
6 CD O O
Folic NNP B-NP B-m
acid VBD B-VP I-m
7 CD O O
Multivitamin NNP B-NP B-m
8 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
9 CD O O
MiraLax NNP B-NP B-m
10 CD O O
Paxil NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
11 CD O O
MS-Contin JJ O B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
12 CD O O
Flexeril NNP B-NP B-m
one CD O B-do
tab NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
ALLERGIES: NNP I-NP O
Sulfa NNP I-NP O
, , O O
latex VBD B-VP O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Father NNP I-NP O
died VBD B-VP O
at IN B-VP O
the DT B-NP O
age NN I-NP O
of IN B-VP O
50 CD O O
from IN B-VP O
a DT B-NP O
brain NN I-NP O
tumor NN I-NP O
Mother NNP I-NP O
was VBD B-VP O
diagnosed VBN O O
with IN B-VP O
uterine JJ B-NP O
cancer NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
and CC O O
diabetes VBZ O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
with IN B-VP O
her PRP$ O O
husband NN B-NP O
in IN B-VP O
Holl NNP B-NP O
Cho NNP I-NP O
Shing NNP I-NP O
She PRP O O
denies VBZ O O
tobacco NN B-NP O
and CC O O
alcohol NN B-NP O
She PRP O O
has VBZ O O
four CD O O
grown JJ B-NP O
children NNS I-NP O
PHYSICAL JJ B-NP O
EXAMINATION NNP I-NP O
AT NNP I-NP O
THE NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
ADMISSION: NNP I-NP O
Vitals: NNP I-NP O
Temperature NNP I-NP O
97.6 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
91 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
140/90 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
22 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
97% CD O O
on IN B-VP O
5 CD O O
liters NNS B-NP O
In IN B-VP O
general JJ O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NN I-NP O
with IN B-VP O
difficulty NN B-NP O
standing VBG O O
secondary JJ O O
to TO O O
pain VB O O
and CC O O
habitus VB O O
HEENT: NNP B-NP O
Pupils NNP I-NP O
were VBD B-VP O
equally RB O O
round JJ O O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Normal NNP I-NP O
sclerae NN I-NP O
, , O O
normal JJ B-NP O
conjunctivae NN I-NP O
Extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
Moist NNP I-NP O
mucous JJ B-NP O
membranes NNS I-NP O
and CC O O
clear JJ B-NP O
oropharynx NN I-NP O
Neck: NNP I-NP O
No NNP I-NP O
lymphadenopathy NN I-NP O
, , O O
no DT B-NP O
thyromegaly NN I-NP O
Pulmonary: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
with IN B-VP O
some DT B-NP O
wheeze NN I-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
base NN I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
, , O O
or CC O O
gallops NNS B-NP O
Abdomen: NNP I-NP O
Morbid NNP I-NP O
obesity NN I-NP O
, , O O
nontender NN B-NP O
, , O O
normoactive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
no DT B-NP O
hepatosplenomegaly NN I-NP O
Back: NNP I-NP O
Mild NNP I-NP O
paraspinal JJ B-NP O
tenderness NN I-NP O
bilaterally RB O O
Extremities: NNP B-NP O
Bilateral NNP I-NP O
lower JJR B-NP O
extremity NN I-NP O
edema VBP O O
Neuro: NNP B-NP O
2/5 CD O O
hip NN B-NP O
flexion NN I-NP O
and CC O O
knee VB O O
extension NN B-NP O
and CC O O
flexion NN B-NP O
on IN B-VP O
the DT B-NP O
right; NN I-NP O
5/5 CD O O
hip NN B-NP O
flexion NN I-NP O
and CC O O
knee VB O O
extension NN B-NP O
and CC O O
flexion NN B-NP O
on IN B-VP O
the DT B-NP O
right; NN I-NP O
5/5 CD O O
hip NN B-NP O
flexion NN I-NP O
and CC O O
knee VB O O
extension NN B-NP O
and CC O O
flexion NN B-NP O
on IN B-VP O
the DT B-NP O
left; JJ I-NP O
distal JJ I-NP O
neuropathy JJ I-NP O
LABORATORY NNP I-NP O
STUDIES: NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
white JJ B-NP O
cell NN I-NP O
count NN I-NP O
9.8 CD O O
, , O O
hematocrit NN B-NP O
35.5 CD O O
, , O O
platelets NNS B-NP O
249 CD O O
INR NNP B-NP O
2.1 CD O O
, , O O
PTT NNP B-NP O
45.8 CD O O
BMP NNP B-NP O
showed VBD B-VP O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
139 CD O O
, , O O
potassium NN B-NP O
4.2 CD O O
, , O O
chloride RB O O
99 CD O O
, , O O
bicarbonate NN B-NP O
36 CD O O
, , O O
BUN NNP B-NP O
19 CD O O
, , O O
creatinine NN B-NP O
0.6 CD O O
, , O O
glucose VBD B-VP O
126 CD O O
LFTs NNP B-NP O
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
UA NNP I-NP O
showed VBD B-VP O
2+ CD O O
bacteria NNS B-NP O
but CC O O
no DT B-NP O
white JJ I-NP O
cells NNS I-NP O
In IN B-VP O
general JJ O O
, , O O
this DT O O
is VBZ O O
a DT B-NP O
57-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
follicular JJ B-NP O
lymphoma NN I-NP O
who WP O O
presented VBD B-VP O
for IN B-VP O
workup NN B-NP O
of IN B-VP O
lower JJR B-NP O
back NN I-NP O
pain NN I-NP O
recurring VBG O O
status NN B-NP O
post NN I-NP O
XRT NN I-NP O
to TO O O
the DT B-NP O
lumbar NN I-NP O
spine NN I-NP O
region NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
Oncology: NNP B-NP O
CT NNP I-NP O
of IN B-VP O
the DT B-NP O
thoracic NN I-NP O
, , O O
lumbar NN B-NP O
, , O O
and CC O O
sacral JJ B-NP O
spine NN I-NP O
on IN B-VP O
2/10/05 CD O O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
cord NN B-NP O
compression NN I-NP O
but CC O O
did VBD B-VP O
show VB O O
a DT B-NP O
compression NN I-NP O
fracture NN I-NP O
at IN B-VP O
L2 NNP B-NP O
IR NNP I-NP O
was VBD B-VP O
consulted VBN O O
on IN B-VP O
11/24/05 CD O O
regarding VBG O O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
kyphoplasty NN B-NP O
to TO O O
this DT B-NP O
area; NN I-NP O
however RB O O
, , O O
they PRP O O
deferred VBD B-VP O
further RBR O O
treatment NN B-NP O
, , O O
as IN B-VP O
the DT B-NP O
pain NN I-NP O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
hip VB O O
pathology NN B-NP O
rather RB O O
than IN B-VP O
lumbar VB O O
spine JJ B-NP O
pathology NN I-NP O
CT NNP I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
on IN B-VP O
11/24/05 CD O O
showed VBD B-VP O
a DT B-NP O
lytic JJ I-NP O
lesion NN I-NP O
in IN B-VP O
the DT B-NP O
posterior JJ I-NP O
acetabulum NN I-NP O
with IN B-VP O
an DT B-NP O
associated JJ I-NP O
fracture NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
Orthopedic NNP B-NP O
Oncology NNP I-NP O
as RB O O
well RB O O
as IN B-VP O
Radiation NNP B-NP O
Oncology NNP I-NP O
Dr NNP I-NP O
Cestia NNP I-NP O
with IN B-VP O
Orthopedic NNP B-NP O
Oncology NNP I-NP O
deferred VBD B-VP O
any DT B-NP O
surgical JJ I-NP O
intervention NN I-NP O
until IN B-VP O
the DT B-NP O
completion NN I-NP O
of IN B-VP O
radiation NN B-NP O
therapy IN B-VP O
The DT B-NP O
patient NN I-NP O
started VBD B-VP O
radiation NN B-NP O
therapy NN I-NP O
to TO O O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
on IN B-VP O
5/18/05 CD O O
The DT B-NP O
contact NN I-NP O
in IN B-VP O
Radiation NNP B-NP O
Oncology NNP I-NP O
is VBZ O O
Britt NNP B-NP O
L NNP I-NP O
Redden NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
pager NN B-NP O
number NN I-NP O
93376 CD O O
The DT B-NP O
plan NN I-NP O
is VBZ O O
for IN B-VP O
the DT B-NP O
patient NN I-NP O
to TO O O
complete VB O O
a DT B-NP O
course NN I-NP O
of IN B-VP O
18 CD O O
treatments NNS B-NP O
of IN B-VP O
radiation NN B-NP O
to TO O O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
then RB O O
have VB O O
a DT B-NP O
repeat NN I-NP O
CT NNP I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
in IN B-VP O
one CD O O
month's NN B-NP O
time NN I-NP O
and CC O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Saralegui NNP I-NP O
She PRP O O
has VBZ O O
an DT B-NP O
appointment NN I-NP O
to TO O O
meet VB O O
with IN B-VP O
Dr NNP B-NP O
Strief NNP I-NP O
on IN B-VP O
6/13/05 CD O O
at IN B-VP O
2:45 CD O O
p.m NN B-NP O
Per NNP I-NP O
recommendations NNS I-NP O
of IN B-VP O
Orthopedic NNP B-NP O
Oncology NNP I-NP O
and CC O O
Physical NNP B-NP O
Therapy NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
be VB O O
touched VBN O O
down RP O O
weightbearing VBG O O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
leg NN I-NP O
( ( O O
toes IN B-VP O
only RB O O
) ) O O
and CC O O
full JJ B-NP O
weightbearing NN I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
leg NN I-NP O
It PRP O O
is VBZ O O
expected VBN O O
that IN B-VP O
she PRP O O
should MD O O
be VB O O
able JJ O O
to TO O O
undergo VB O O
physical JJ B-NP O
therapy NN I-NP O
with IN B-VP O
the DT B-NP O
use NN I-NP O
of IN B-VP O
a DT B-NP O
walker NN I-NP O
She PRP O O
should MD O O
be VB O O
kept VBN O O
on IN B-VP O
posterior JJ B-NP O
hip NN I-NP O
precaution NN I-NP O
with IN B-VP O
limitation NN B-NP O
of IN B-VP O
hip NN B-NP O
flexion NN I-NP O
and CC O O
internal JJ B-NP O
rotation NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
2 CD O O
Pain: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Pain NNP I-NP O
Service NNP I-NP O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
Her NNP I-NP O
current JJ B-NP O
pain NN I-NP B-m
pain NN I-NP B-r
regimen NNS I-NP I-m
includes VBZ O O
methadone NN B-NP B-m
5 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Neurontin NNP B-NP B-m
Neurontin NNP I-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
and CC O O
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.8 NN I-NP O
a.m NN I-NP O
and CC O O
q NN B-NP O
noon NN I-NP O
, , O O
MSIR NNP B-NP B-m
MSIR NNP I-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
as RB O O
well RB O O
as IN B-VP O
15-30 JJ B-NP B-do
mg NN I-NP I-do
q.2h NN I-NP B-f
as IN B-VP I-f
needed VBN O I-f
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
started VBN O O
on IN B-VP O
Decadron NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m NN I-NP B-f
given VBN O O
her PRP$ O O
initial JJ B-NP O
concern NN I-NP O
for IN B-VP O
spinal JJ B-NP B-r
cord NN I-NP O
compression NN I-NP O
She PRP O O
has VBZ O O
been VBN O O
tapering VBG O O
off IN B-VP O
of IN B-VP O
the DT B-NP O
Decadron NNP I-NP B-m
and CC O O
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
4 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.a.m NN I-NP B-f
with IN B-VP O
taper NN B-NP O
as IN B-VP O
listed VBN O O
in IN B-VP O
the DT B-NP O
discharge NN I-NP O
instructions NNS I-NP O
Once IN B-VP O
the DT B-NP O
patient NN I-NP O
has VBZ O O
completed VBN O O
Decadron NNP B-NP B-m
2 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m NN I-NP B-f
x3 NN I-NP B-du
doses NNS I-NP I-du
, , O O
she PRP O O
should MD O O
then RB O O
be VB O O
started VBN O O
on IN B-VP O
prednisone NN B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
per IN B-VP O
her PRP$ O O
home NN B-NP O
dosing NN I-NP O
for IN B-VP O
pulmonary JJ B-NP B-r
disease NN I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
receive JJ B-NP O
pamidronate NN I-NP B-m
90 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
x1 NNP I-NP B-f
during IN B-VP B-du
this DT B-NP O
hospitalization NN I-NP O
3 CD O O
ID: NNP B-NP O
UA NNP I-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
more RBR O O
or CC O O
less RBR O O
benign JJ O O
, , O O
and CC O O
urine JJ B-NP O
culture NN I-NP O
remained VBD B-VP O
negative JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile JJ O O
throughout IN B-VP O
her PRP$ O O
hospitalization NN B-NP O
She PRP O O
was VBD B-VP O
given VBN O O
a DT B-NP B-du
five-day JJ I-NP I-du
course NN I-NP I-du
of IN B-VP O
acyclovir JJ O B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
five CD O B-f
times NNS B-NP I-f
per IN B-VP I-f
day NN B-NP I-f
for IN B-VP O
concern NN B-NP O
of IN B-VP O
recurrent NN B-NP O
genital JJ B-NP B-r
herpes NNS I-NP I-r
Given VBN O O
continued VBD B-VP O
complaints NNS B-NP O
of IN B-VP O
vaginal JJ B-NP O
itching NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
fluconazole JJ O B-m
150 CD O B-do
mg NN B-NP I-do
x1 NN I-NP B-du
on IN B-VP O
9/29/05 CD O O
to TO O O
treat VB O O
a DT B-NP B-r
presumed JJ I-NP I-r
yeast NN I-NP I-r
infection NN I-NP I-r
4 CD O O
GI: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
constipation NN B-NP O
secondary NN I-NP O
to TO O O
use VB O O
of IN B-VP O
pain NN B-NP O
medication NN I-NP O
She PRP O O
has VBZ O O
been VBN O O
having VBG O O
good JJ B-NP O
bowel NN I-NP O
movement NN I-NP O
on IN B-VP O
MiraLax NNP B-NP B-m
, , O O
Senna NNP B-NP B-m
, , O O
Colace NNP B-NP B-m
She PRP O O
has VBZ O O
also RB O O
writing VBG O O
for IN B-VP O
Dulcolax NNP B-NP B-m
p.r.n NN I-NP B-f
for IN B-VP O
constipation NN B-NP B-r
5 CD O O
Heme: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
Coumadin NNP B-NP B-m
given VBN O O
a DT B-NP O
recent JJ I-NP O
history NN I-NP O
of IN B-VP O
DVT NNP B-NP B-r
She PRP O O
had VBD B-VP O
an DT B-NP O
INR NNP I-NP O
of IN B-VP O
3.7 CD O O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
so IN B-VP O
her PRP$ O O
dosing NN B-NP O
was VBD B-VP O
reduced VBN O O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
Her NNP I-NP O
INR NNP I-NP O
has VBZ O O
been VBN O O
stable JJ O O
and CC O O
is VBZ O O
at IN B-VP O
2.3 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
on IN B-VP O
dosing NN B-NP O
of IN B-VP O
4.5 CD O O
mg NNS B-NP O
p.o JJ O O
q.h.s RB O O
6 CD O O
Pulmonary: NNP B-NP O
As NNP I-NP O
mentioned VBD B-VP O
above IN B-VP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
pulmonary JJ I-NP B-r
dysfunction NN I-NP O
with IN B-VP O
a DT B-NP O
home NN I-NP O
O2 NNP I-NP B-m
requirement NN I-NP O
of IN B-VP O
5 CD O B-do
liters NNS B-NP I-do
She PRP O O
has VBZ O O
been VBN O O
stable JJ O O
on IN B-VP O
this DT B-NP O
home NN I-NP O
O2 NNP I-NP B-m
requirement NN I-NP O
throughout IN B-VP B-du
this DT B-NP O
hospitalization NN I-NP O
She PRP O O
does VBZ O O
require VB O O
CPAP NNP B-NP O
at IN B-VP O
night NN B-NP O
for IN B-VP O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
7 CD O O
Cardiovascular: NNP B-NP O
No NNP I-NP O
known JJ B-NP O
history NN I-NP O
of IN B-VP O
cardiovascular JJ B-NP O
disease NN I-NP O
Echo NNP I-NP O
on IN B-VP O
11/28/04 CD O O
showed VBD B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
55% CD O O
8 CD O O
Endo: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
a DT O O
sliding VBG O B-do
scale NN B-NP I-do
of IN B-VP O
regular JJ B-NP B-m
insulin NN I-NP I-m
while IN B-VP O
on IN B-VP O
Decadron NNP B-NP B-m
It PRP O O
is VBZ O O
intended VBN O O
that IN B-VP O
this DT O O
should MD O O
be VB O O
stopped VBN O O
when WRB O O
the DT B-NP O
Decadron NNP I-NP B-m
taper NN I-NP O
has VBZ O O
finished VBN O O
9 CD O O
Fluids NNP B-NP O
, , O O
Electrolytes NNP B-NP O
, , O O
Nutrition: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
some DT B-NP B-r
hypocalcemia NN I-NP O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Tums NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
with IN B-VP O
good JJ B-NP O
response NN I-NP O
She PRP O O
was VBD B-VP O
also RB O O
given VBN O O
pamidronate NN B-NP B-m
x1 NN I-NP B-f
as IN B-VP O
listed VBN O O
above IN B-VP O
CODE: NNP B-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
being VBG O O
discharged VBN O O
to TO O O
the DT B-NP O
Ensers NNS I-NP O
1 CD O O
for IN B-VP O
further JJ B-NP O
rehabilitation NN I-NP O
She PRP O O
has VBZ O O
a DT B-NP O
lytic JJ I-NP O
lesion NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
with IN B-VP O
evidence NN B-NP O
of IN B-VP O
fracture NN B-NP O
Per NNP I-NP O
recommendations NNS I-NP O
of IN B-VP O
Orthopedic NNP B-NP O
Oncology NNP I-NP O
as RB O O
well RB O O
as IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
, , O O
please VB O O
limit NN B-NP O
right RB O O
leg VBZ O O
to TO O O
touchdown VB O O
weightbearing VBG O O
only RB O O
The DT B-NP O
patient NN I-NP O
should MD O O
be VB O O
full JJ O O
weightbearing VBG O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
leg NN I-NP O
with IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
involving VBG O O
use NN B-NP O
of IN B-VP O
a DT B-NP O
walker NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
stable JJ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
She PRP O O
should MD O O
continue VB O O
with IN B-VP O
her PRP$ O O
radiation NN B-NP O
therapy NN I-NP O
to TO O O
completion NN B-NP O
and CC O O
then RB O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Kelvin NNP I-NP O
Lang NNP I-NP O
, , O O
in IN B-VP O
Orthopedic NNP B-NP O
Oncology NNP I-NP O
on IN B-VP O
6/13/05 CD O O
MEDICATIONS NNP B-NP O
AT NNP I-NP O
THE NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
DISCHARGE: NNP I-NP O
Include NNP I-NP O
, , O O
Imuran NNP B-NP B-m
Imuran NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m NN I-NP B-f
, , O O
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m.; NN I-NP B-f
Dulcolax NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
p.r.n NN I-NP I-f
for IN B-VP O
constipation; NN B-NP B-r
calcium NN I-NP B-m
carbonate NN I-NP I-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d.; NN I-NP B-f
Flexeril NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d.; NN I-NP B-f
dexamethasone NN I-NP B-m
dexamethasone NN I-NP B-m
4 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
x2 NN I-NP B-du
doses NNS I-NP I-du
then RB O O
2 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
x3 NN I-NP B-du
doses NNS I-NP I-du
then RB O O
start VB O O
prednisone NN B-NP B-m
10 CD O B-do
mg NN B-NP O
p.o JJ B-NP B-mo
daily JJ I-NP B-f
Colace NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
, , O O
Regular JJ B-NP B-m
Insulin NNP I-NP I-m
sliding VBG O B-do
scale NN B-NP I-do
, , O O
methadone NN B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Sennosides NNP B-NP B-m
two CD O B-do
tables NNS B-NP I-do
p.o VBP O B-mo
b.i.d NN B-NP B-f
, , O O
Coumadin NNP B-NP B-m
4.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m NN I-NP B-f
, , O O
MSIR NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
MSIR NNP B-NP B-m
50-30 JJ B-NP B-do
mg NN I-NP I-do
p.o NN I-NP B-mo
q.2h NN I-NP B-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
, , O O
Paxil NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Mepron NNP B-NP B-m
750 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Neurontin NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
Neurontin NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.8 NN I-NP O
a.m NN I-NP O
and CC O O
q NN B-NP O
noon NN I-NP O
, , O O
MiraLax NNP B-NP B-m
17 CD O B-do
g NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
eScription NN I-NP O
document: VBZ O O
6-6674736 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Chadwick NNP I-NP O
Kaua NNP I-NP O
MD NNP I-NP O
Chocollmiho NNP I-NP O
Valedelp NNP I-NP O
CC: NNP I-NP O
Melvin NNP I-NP O
Norris NNP I-NP O
Bernacki NNP I-NP O
MD NNP I-NP O
Arl NNP I-NP O
Wayne NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
WEINZINGER NNP I-NP O
, , O O
DONTE NNP B-NP O
Attending: NNP I-NP O
WAUTERS NNP I-NP O
, , O O
GAYLE NNP B-NP O
KENDALL NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
4360670 CD O O
D: NNP B-NP O
5/1/05 CD O O
T: NNP B-NP O
5/1/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#496398 VBZ O O
079220999 CD O O
SHH NNP B-NP O
92547244 CD O O
5799826 CD O O
5/29/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
dizziness NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/29/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/17/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
CORKILL NNP I-NP O
, , O O
MICKEY NNP B-NP O
625-13-08-7 CD O O
Rhamcastaleah NNP B-NP O
Nono NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/0/04 CD O O
AT NNP B-NP O
06:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
DEWYSE NNP I-NP O
, , O O
KENDALL NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
STAT NNP I-NP O
( ( O O
0/17 CD O O
) ) O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/6/04 CD O O
by IN B-VP O
LAHUE NNP B-NP O
, , O O
HENRY NNP B-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ASPIRIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
aware NN I-NP O
, , O O
pt NN B-NP O
on IN B-VP O
this DT B-NP O
regimen NN I-NP O
at IN B-VP O
home NN B-NP O
AMIODARONE NNP I-NP B-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/6/04 CD O O
by IN B-VP O
DYMENT NNP B-NP O
, , O O
ISAAC NNP B-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
aware JJ B-NP O
pt NN I-NP O
on IN B-VP O
this DT B-NP O
regimen NN I-NP O
at IN B-VP O
home NN B-NP O
DIGOXIN NNP I-NP B-m
0.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/6/04 CD O O
by IN B-VP O
MURIE NNP B-NP O
, , O O
ELLIOTT NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
AMIODARONE NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
75986840 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
aware JJ B-NP O
pt NN I-NP O
on IN B-VP O
this DT B-NP O
regimen NN I-NP O
at IN B-VP O
home NN B-NP O
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
120 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
NPH NNP I-NP B-m
HUMULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
( ( O I-m
INSULIN NNP B-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
47 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
REGULAR NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
Sliding NNP I-NP B-do
Scale NNP I-NP I-do
( ( O B-mo
subcutaneously RB O I-mo
) ) O I-mo
SC NNP B-NP I-mo
AC+HS NNP I-NP B-f
If IN B-VP O
BS NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
give VB O O
0 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
6 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
MILK NNP B-NP B-m
OF NNP I-NP I-m
MAGNESIA NNP I-NP I-m
( ( O I-m
MAGNESIUM NNP B-NP I-m
HYDROXIDE NNP I-NP I-m
) ) O I-m
30 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
2 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
NOW NNP I-NP O
, , O O
Within NNP B-NP O
Hour NNP I-NP O
of IN B-VP O
Pharmacy NNP B-NP O
Approval NNP I-NP O
( ( O O
0/17 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/6/04 CD O O
by IN B-VP O
PALEN NNP B-NP O
, , O O
EVERETTE NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ACETYLSALICYLIC NNP B-NP B-m
ACID NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
44957141 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ASPIRIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
aware NN I-NP O
, , O O
pt NN B-NP O
on IN B-VP O
this DT B-NP O
regimen NN I-NP O
at IN B-VP O
home NN B-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/6/04 CD O O
by IN B-VP O
LOTERBAUER NNP B-NP O
, , O O
PORTER NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
AMIODARONE NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
75986840 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
aware JJ B-NP O
pt NN I-NP O
on IN B-VP O
this DT B-NP O
regimen NN I-NP O
at IN B-VP O
home NN B-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/23/04 CD O O
by IN B-VP O
ODONALD NNP B-NP O
, , O O
EMANUEL NNP B-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
aware JJ B-NP O
SIMVASTATIN NNP I-NP B-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Starting NNP I-NP O
STAT NNP I-NP O
( ( O O
4/13 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/23/04 CD O O
by IN B-VP O
KIDWELL NNP B-NP O
, , O O
RICHIE NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
55008411 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
MD NNP I-NP O
aware JJ B-NP O
NORVASC NNP I-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
95 CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
IMDUR NNP B-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONIT.( NNP I-NP I-m
SR NNP I-NP I-m
) ) O I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
40 CD O B-do
MEQ NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
potassium NN I-NP O
&gt; VBZ O O
4.5 CD O O
As IN B-VP O
per NN B-NP O
ICH NNP I-NP O
Potassium NNP I-NP O
Chloride NNP I-NP O
Policy: NNP I-NP O
each DT O O
20 CD O O
mEq NNS B-NP O
dose VB O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4 CD O O
oz NNS B-NP O
of IN B-VP O
fluid NN B-NP O
COZAAR NNP I-NP B-m
( ( O I-m
LOSARTAN NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Starting NNP I-NP O
STAT NNP I-NP O
( ( O O
4/13 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBZ O O
95 CD O O
Number NNP B-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
3 CD O I-du
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
STAT NNP I-NP O
( ( O O
0/17 CD O O
) ) O O
NEXIUM NNP B-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
50 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/0/04 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
2 CD O O
gm NN B-NP O
Na NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/day NN B-NP O
/ NNP I-NP O
Low NNP I-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Kirkconnell NNP I-NP O
( ( O O
cardiology VB O O
521-540-0293 NNS B-NP O
) ) O O
at IN B-VP O
11:00am CD O O
9/22/04 CD O O
, , O O
Dr NNP B-NP O
Mccaffrey NNP I-NP O
( ( O O
PCP NNP B-NP O
221-764-2384 CD O O
) ) O O
at IN B-VP O
10:45am CD O O
5/8/04 CD O O
, , O O
Dr NNP B-NP O
Ziebol NNP I-NP O
( ( O O
endocrinology IN B-VP O
091-018-1923 NN B-NP O
) ) O O
at IN B-VP O
3:00pm CD O O
10/11/04 CD O O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
9/22/04 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
7 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Mac NNP I-NP O
Strogen NNP I-NP O
ALLERGY: NNP I-NP O
Cephalosporins NNP I-NP O
, , O O
ERYTHROMYCIN NNP B-NP O
, , O O
Penicillins NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
dizziness NN I-NP O
, , O O
ataxia NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
dizziness NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
s/p RB O O
right RB O O
CEA NNP B-NP O
LBBB NNP I-NP O
on IN B-VP O
EKG NNP B-NP O
hypertension NN I-NP O
diabetes VBZ O O
EF NNP B-NP O
25-30% JJ B-NP O
CHF NNP I-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
Ischemic NNP B-NP O
Cardiomyopathy NNP I-NP O
( ( O O
cardiomyopathy NN B-NP O
) ) O O
Atrial NNP B-NP O
Fibrillation NNP I-NP O
( ( O O
atrial JJ B-NP O
fibrillation NN I-NP O
) ) O O
, , O O
symptomatic JJ B-NP O
bradycardia NN I-NP O
s/p NN I-NP O
AICD/pacer NNP I-NP O
placement NN I-NP O
, , O O
?TIA JJ B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Chest NNP B-NP O
PA NNP I-NP O
and CC O O
Lateral NNP B-NP O
AICD NNP I-NP O
Interrogation NNP I-NP O
( ( O O
Dr NNP B-NP O
Kurt NNP I-NP O
Morring NNP I-NP O
) ) O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Ms NNP I-NP O
Galabeas NNP I-NP O
is VBZ O O
a DT O O
71F JJ O O
with IN B-VP O
DM NNP B-NP O
, , O O
CAD NNP B-NP O
, , O O
s/p VBD B-VP O
3vCABG CD O O
, , O O
s/p NN B-NP O
RCA NNP I-NP O
stent NN I-NP O
in IN B-VP O
1/2 CD O O
, , O O
CHF( NNP B-NP O
EF=45% NNP I-NP O
in IN B-VP O
1/2 CD O O
) ) O O
, , O O
h/o JJ B-NP O
bradycardia NN I-NP O
now RB O O
with IN B-VP O
AICD/Pacer NNP B-NP O
, , O O
s/p JJ B-NP O
R-CEA NNP I-NP O
, , O O
s/p NN B-NP O
? . B-VP O
TIA NNP B-NP O
, , O O
who WP O O
presents VBZ O O
with IN B-VP O
dizziness NN B-NP O
, , O O
ataxia JJ O O
x FW O O
24H CD O O
Pt NNP B-NP O
denies NNS I-NP O
CP NNP I-NP O
, , O O
SOB NNP B-NP O
, , O O
palpitations NNS B-NP O
Pt NNP I-NP O
denies VBZ O O
melana; FW O O
BRBPR NNP B-NP O
NO NNP I-NP O
new JJ B-NP O
meds NNS I-NP O
, , O O
no DT B-NP O
N/V/F/C NNP I-NP O
This DT O O
is VBZ O O
unlike IN B-VP O
anything NN B-NP O
she PRP O O
has VBZ O O
had VBN O O
in IN B-VP O
the DT B-NP O
past NN I-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
labs NNS B-NP O
were VBD B-VP O
all DT O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
While IN B-VP O
on IN B-VP O
a DT B-NP O
monitor NN I-NP O
she PRP O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
bradycardia NN B-NP O
to TO O O
the DT O O
40s CD O O
Dr NNP B-NP O
Hilmer NNP I-NP O
of IN B-VP O
the DT B-NP O
EP NNP I-NP O
service NN I-NP O
interogated VBD B-VP O
the DT B-NP O
device NN I-NP O
and CC O O
indicated VBD B-VP O
that IN B-VP O
it PRP O O
was VBD B-VP O
working VBG O O
properly RB O O
with IN B-VP O
no DT B-NP O
arrhythmias JJ I-NP O
Telemetry NN I-NP O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
also RB O O
did VBD B-VP O
not RB O O
record VB O O
the DT B-NP O
bradycardic JJ I-NP O
episode NN I-NP O
, , O O
suggesting VBG O O
that IN B-VP O
perhaps RB O O
it PRP O O
was VBD B-VP O
an DT B-NP O
artifact JJ I-NP O
Pt's NNP I-NP O
toxicology NN I-NP O
screen NN I-NP O
was VBD B-VP O
negative JJ B-NP O
Her NNP I-NP O
vitals NNS I-NP O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
w NN I-NP O
ere RB O O
98.0 CD O O
, , O O
55 CD O O
, , O O
176/60 CD O O
, , O O
18 CD O O
, , O O
98%RA CD O O
No NNP B-NP O
dysmetria; NN I-NP O
no RB O O
dysdiadocokinesia; JJ O O
negativ RB O O
e VBP O O
Romberg's NNP B-NP O
sign NN I-NP O
Hospital NNP I-NP O
Course: NNP I-NP O
1 CD O O
CV: NNP B-NP O
pt NN I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI; NNP B-NP O
24H CD O O
telemetry NN B-NP O
showed VBD B-VP O
no DT B-NP O
arrhythmias JJ I-NP O
Pt's NNP I-NP O
BB NNP I-NP B-m
BB NNP I-NP B-m
was VBD B-VP O
held VBN O O
while IN B-VP O
in IN B-VP O
house NN B-NP O
because IN B-VP O
of IN B-VP O
worry NN B-NP O
about IN B-VP O
bradyarrhythmia NN B-NP B-r
, , O O
hypotension NN B-NP B-r
Continued VBD B-VP O
antihypertensive JJ B-NP B-m
antihypertensive JJ I-NP B-r
antihypertensive JJ I-NP B-r
antihypertensive JJ I-NP B-r
antihypertensive JJ I-NP B-r
antihypertensive JJ I-NP B-r
antihypertensive NN I-NP B-r
and CC O O
CAD NNP B-NP B-r
CAD NNP I-NP B-r
CAD NNP I-NP B-r
CAD NNP I-NP B-r
CAD NNP I-NP B-r
CAD NNP I-NP B-r
treatment NN I-NP O
with IN B-VP O
with IN B-VP O
Cozaar NNP B-NP B-m
Cozaar NNP I-NP B-m
, , O O
Lasix NNP B-NP B-m
Lasix NNP I-NP B-m
, , O O
Norvasc NNP B-NP B-m
Norvasc NNP I-NP B-m
, , O O
Isosorbide NNP B-NP B-m
Isosorbide NNP I-NP B-m
, , O O
Digoxin NNP B-NP B-m
Digoxin NNP I-NP B-m
, , O O
Amiodarone NNP B-NP B-m
Amiodarone NNP I-NP B-m
Pt NNP I-NP O
is VBZ O O
also RB O O
on IN B-VP O
Coumadin NNP B-NP B-m
, , O O
Plavix NNP B-NP B-m
, , O O
and CC O O
ASA NNP B-NP B-m
, , O O
which WDT O O
was VBD B-VP O
continued VBN O O
in IN B-VP O
house NN B-NP O
Pt NNP I-NP O
was VBD B-VP O
discussed VBN O O
w/ JJ B-NP O
pt's NN I-NP O
cardiologist NN I-NP O
, , O O
Dr NNP B-NP O
Kallio NNP I-NP O
who WP O O
indicated VBD B-VP O
this DT O O
was VBD B-VP O
not RB O O
a DT B-NP O
new JJ I-NP O
complaint NN I-NP O
in IN B-VP O
the DT B-NP O
patient NN I-NP O
and CC O O
also RB O O
that IN B-VP O
she PRP O O
has VBZ O O
been VBN O O
non-compliant JJ O O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
PT NNP I-NP O
was VBD B-VP O
on IN B-VP O
Coreg NNP B-NP B-m
but CC O O
this DT O O
was VBD B-VP O
held VBN O O
prior RB O O
to TO O O
admit VB O O
for IN B-VP O
low JJ B-NP O
BP's NNP I-NP O
Pt NNP I-NP O
was VBD B-VP O
hypertensive JJ B-NP B-r
w/ NN I-NP O
SB NNP I-NP O
P NNP I-NP O
150's CD O O
while IN B-VP O
inpt NNS B-NP O
but CC O O
we PRP O O
will MD O O
d/c VB O O
pt VB O O
off RP O O
Coreg NNP B-NP B-m
and CC O O
defer VB O O
to TO O O
Dr NNP B-NP O
Doniel NNP I-NP O
for IN B-VP O
reinstitution NN B-NP O
of IN B-VP O
beta NN B-NP O
blockade NN I-NP O
2 CD O O
NEURO: NNP B-NP O
pt's NN I-NP O
neuro NN I-NP O
exam NN I-NP O
was VBD B-VP O
normal JJ O O
with IN B-VP O
no DT B-NP O
focal JJ I-NP O
signs NNS I-NP O
, , O O
and CC O O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
cerebellar JJ B-NP O
dysfunction NN I-NP O
Nevertheless NNP I-NP O
given VBN O O
her PRP$ O O
significant JJ B-NP O
vascular JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
there RB O O
was VBD B-VP O
concern NN B-NP O
for IN B-VP O
vertebral-basilar JJ B-NP O
insufficiency NN I-NP O
MRI/MRA NNP I-NP O
was VBD B-VP O
not RB O O
possible JJ O O
given VBN O O
pt's JJ B-NP O
AICD/pacer NNP I-NP O
Upon NNP I-NP O
discussion NN I-NP O
w/ NN I-NP O
team NN I-NP O
CT/CTA NNP I-NP O
were VBD B-VP O
deferred VBN O O
given VBN O O
pt's JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
and CC O O
risk NN B-NP O
of IN B-VP O
contrast NN B-NP O
nephropathy NN I-NP O
coupled VBN O O
with IN B-VP O
our PRP$ O O
feeling NN B-NP O
that IN B-VP O
any DT B-NP O
findings NNS I-NP O
would MD O O
not RB O O
change VB O O
pt JJ B-NP O
management NN I-NP O
This DT O O
will MD O O
be VB O O
discussed VBN O O
with IN B-VP O
pt's NN B-NP O
PCP NNP I-NP O
, , O O
Dr NNP B-NP O
Benedict NNP I-NP O
Wichern NNP I-NP O
3 CD O O
ENDO: NNP B-NP O
pt NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
home NN B-NP O
insulin NN I-NP B-m
regimen NNS I-NP I-m
with IN B-VP O
coverage NN B-NP O
with IN B-VP O
insulin NN B-NP B-m
sliding VBG O B-do
scale JJ B-NP I-do
Pt NNP I-NP O
was VBD B-VP O
found VBN O O
have VBP O O
a DT B-NP O
TSH NNP I-NP O
of IN B-VP O
158 CD O O
FT4 NNP B-NP O
1.8 CD O O
, , O O
FT3 NNP B-NP O
56 CD O O
Upon NNP B-NP O
discussion NN I-NP O
w/ NN I-NP O
pt NN I-NP O
, , O O
she PRP O O
revealed VBD B-VP O
that IN B-VP O
she PRP O O
had VBD B-VP O
previously RB O O
been VBN O O
diagnosed VBN O O
and CC O O
begun VBN O O
on IN B-VP O
replacement NN B-NP O
but CC O O
did VBD B-VP O
not RB O O
know VB O O
what WP O O
it PRP O O
was VBD B-VP O
for IN B-VP O
and CC O O
subsequently RB O O
stopped VBD B-VP O
it PRP O O
on IN B-VP O
her PRP O O
own JJ B-NP O
Pt NNP I-NP O
started VBD B-VP O
on IN B-VP O
synthroid NN B-NP B-m
to TO O O
be VB O O
f/u JJ B-NP O
w/endocrine NN I-NP O
This DT O O
may MD O O
be VB O O
the DT B-NP O
etiology NN I-NP O
of IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
4 CD O O
Prophylaxis: NNP B-NP O
Nexium; NNP I-NP B-m
pt NN I-NP O
was VBD B-VP O
already RB O O
anticoagulated VBN O O
with IN B-VP O
ASA NNP B-NP B-m
, , O O
plavix NN B-NP B-m
and CC O O
Coumadin NNP B-NP B-m
5 CD O O
Disp: NNP B-NP O
Pt NNP I-NP O
to TO O O
follow-up JJ B-NP O
w/ NN I-NP O
Dr NNP I-NP O
Kishaba NNP I-NP O
for IN B-VP O
managment NN B-NP O
of IN B-VP O
CHF/BP NNP B-NP O
, , O O
and CC O O
with IN B-VP O
Dr NNP B-NP O
Blagg NNP I-NP O
for IN B-VP O
f/u NN B-NP O
of IN B-VP O
potential JJ B-NP O
neurovascular JJ I-NP O
etiology NN I-NP O
of IN B-VP O
symptoms NNS B-NP O
Pt NNP I-NP O
to TO O O
f/u VB O O
with IN B-VP O
endocrinology NN B-NP O
for IN B-VP O
managment NN B-NP O
of IN B-VP O
hypothyroidism NN B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
continue NN B-NP O
levothyroxine NN I-NP B-m
for IN B-VP O
hypothyroidism NN B-NP B-r
f/u NN I-NP O
endo NN I-NP O
for IN B-VP O
management NN B-NP O
2 CD O O
f/u NN B-NP O
w/ NN I-NP O
Dr NNP I-NP O
Schryer NNP I-NP O
for IN B-VP O
possible JJ B-NP O
reinstitution NN I-NP O
of IN B-VP O
beta NN B-NP O
blockade NN I-NP O
and CC O O
CHF/BP NNP B-NP O
management NN I-NP O
3 CD O O
f/u NN B-NP O
Dr NNP I-NP O
Hackborn NNP I-NP O
for IN B-VP O
w/u JJ B-NP O
potential JJ I-NP O
vertebral-basilar JJ I-NP O
insufficieny NN I-NP O
with IN B-VP O
recognition NN B-NP O
of IN B-VP O
risk NN B-NP O
of IN B-VP O
iv JJ B-NP O
contrast NN I-NP O
nephropathy JJ B-NP O
vs JJ I-NP O
utility NN I-NP O
of IN B-VP O
information NN B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
CRAMM NNP I-NP O
, , O O
ALAN NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
JX65 NNP B-NP O
) ) O O
9/0/04 CD O O
@ $ O O
06:12 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#497131 VBZ O O
089633078 CD O O
SMC NNP B-NP O
47778883 CD O O
4598548 CD O O
1/12/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
back RB O O
pain NN B-NP O
, , O O
UTI NNP B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/9/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/12/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
EADDY NNP I-NP O
, , O O
DEAN NNP B-NP O
708-09-45-0 CD O O
Tl NNP B-NP O
I PRP O O
Service: NNP B-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
3/15/05 CD O O
AT NNP B-NP O
12:30 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
ekg NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
RULLMAN NNP I-NP O
, , O O
JARRETT NNP B-NP O
Q NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
J.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/28 CD O O
) ) O O
Instructions: NNP B-NP O
FOR NNP I-NP O
YOUR NNP I-NP B-r
HEART NNP I-NP I-r
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/4/05 CD O O
by IN B-VP O
DAGDAG NNP B-NP O
, , O O
DION NNP B-NP O
EMMETT NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ACETYLSALICYLIC NNP B-NP B-m
ACID NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
262695316 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
IBUPROFEN; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Hives NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
CIPROFLOXACIN NNP I-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q12H NNP I-NP B-f
X NNP I-NP B-du
5 CD O I-du
Days NNPS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
5/28 CD O O
) ) O O
Instructions: NNP B-NP O
FINISH NNP I-NP O
ANTIBIOTICS NNP I-NP B-m
TO NNP I-NP O
TREAT NNP I-NP O
YOUR NNP I-NP B-r
URINARY NNP I-NP O
TRACT NNP I-NP O
INFECTION NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-m
products NNS I-NP I-m
a DT B-NP B-f
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-m
or CC O O
ciprofloxacin NN B-NP B-m
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/28 CD O O
) ) O O
Instructions: NNP B-NP O
STOOL NNP I-NP B-r
SOFTNER NNP I-NP I-r
FOLATE NNP I-NP B-m
( ( O I-m
FOLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GLIPIZIDE NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q12H NNP I-NP B-f
Starting NNP I-NP O
AT NNP I-NP O
9:00 CD O O
PM NNP B-NP O
ON NNP I-NP O
0/16 CD O O
( ( O O
5/28 CD O O
) ) O O
Instructions: NNP B-NP O
for IN B-VP O
your PRP$ O B-r
diabetes NNS B-NP I-r
LISINOPRIL VBP O B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q12H NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/4/05 CD O O
by IN B-VP O
BOWERY NNP B-NP O
, , O O
TOM NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
876350117 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/4/05 CD O O
by IN B-VP O
FULBRIGHT NNP B-NP O
, , O O
JEWELL NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IV NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
739034101 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/4/05 CD O O
by IN B-VP O
ANADIO NNP B-NP O
, , O O
SHAWN NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
898030992 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/4/05 CD O O
by IN B-VP O
RANDLES NNP B-NP O
, , O O
COLEMAN NNP B-NP O
KELLEY NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
K-LOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
887251597 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/4/05 CD O O
by IN B-VP O
KLINGLESMITH NNP B-NP O
, , O O
EFREN NNP B-NP O
O NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ O O
NIFEREX-150 JJ O B-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
MVI NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVITAMINS NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/4/05 CD O O
by IN B-VP O
CAPPAERT NNP B-NP O
, , O O
BASIL NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
requires VBZ O O
TOPROL NNP B-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q24H NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
3 CD O O
AMBIEN NNP B-NP B-m
( ( O I-m
ZOLPIDEM NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
PRN NNP I-NP I-f
Insomnia NNP I-NP B-r
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
KCL NNP B-NP B-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
20 CD O B-do
MEQ NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
As IN B-VP O
per IN B-VP O
WRH NNP B-NP O
Potassium NNP I-NP B-m
Chloride NNP I-NP I-m
Policy: NNP I-NP O
each DT O O
20 CD O B-do
mEq NNS B-NP I-do
dose VB O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4 CD O O
oz NNS B-NP O
of IN B-VP O
fluid NN B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/4/05 CD O O
by IN B-VP O
WAYT NNP B-NP O
, , O O
FERDINAND NNP B-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LISINOPRIL NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
700978620 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/28 CD O O
) ) O O
Instructions: NNP B-NP O
for IN B-VP O
your PRP$ O B-r
cholesterol NN B-NP I-r
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/4/05 CD O O
by IN B-VP O
HALSELL NNP B-NP O
, , O O
FIDEL NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
MVI NNP B-NP B-m
THERAPEUTIC NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
537040946 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
&amp; NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
requires VBZ O O
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
3/28 CD O O
) ) O O
Instructions: NN B-NP O
to TO O O
prevent VB O O
blood NN B-NP B-r
clots NNS I-NP I-r
CANDESARTAN NNP I-NP B-m
16 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/28 CD O O
) ) O O
Instructions: NNP B-NP O
for IN B-VP O
your PRP$ O B-r
blood NN B-NP I-r
pressure NN I-NP I-r
ADVAIR NNP I-NP B-m
DISKUS NNP I-NP I-m
250/50 CD O I-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE/ NNP I-NP I-m
) ) O I-m
1 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/28 CD O O
) ) O O
Instructions: NNP B-NP O
for IN B-VP O
your PRP$ O B-r
breathing NN B-NP I-r
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
FOR NNP I-NP O
LEG NNP I-NP B-r
SWELLING NNP I-NP I-r
OXYCONTIN NNP I-NP B-m
( ( O I-m
OXYCODONE NNP B-NP I-m
CONTROLLED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
45 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q12H NNP I-NP B-f
Starting NNP I-NP O
AT NNP I-NP O
5:00 CD O O
PM NNP B-NP O
ON NNP I-NP O
10/9/05 CD O O
( ( O O
5/28 CD O O
) ) O O
Instructions: NNP B-NP O
for IN B-VP O
pain NN B-NP B-r
PERCOCET NNP I-NP B-m
PERCOCET NNP I-NP B-m
1 CD O B-do
1 CD O B-do
TAB NNP B-NP I-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
Q4-6 NNP I-NP B-f
Q4-6 NNP I-NP B-f
hours NNS I-NP I-f
hours NNS I-NP I-f
PRN NNP I-NP I-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Instructions: NNP I-NP O
for IN B-VP O
breakthrough NN B-NP B-r
pain NN I-NP I-r
not RB O O
managed VBN O O
by IN B-VP O
oxycontin JJ B-NP B-m
ALBUTEROL NNP I-NP B-m
INHALER NNP I-NP I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
PRN NNP I-NP I-f
Wheezing NNP I-NP B-r
Instructions: NNP I-NP O
for IN B-VP O
your PRP$ O O
breathing VBG O O
ALBUTEROL NNP B-NP B-m
NEBULIZER NNP I-NP I-m
2.5 CD O B-do
MG NNP B-NP I-do
NEB NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Wheezing NNP I-NP B-r
Instructions: NNP I-NP O
for IN B-VP O
your PRP$ O O
breathing NN B-NP O
METAMUCIL NNP I-NP B-m
SUGAR NNP I-NP I-m
FREE NNP I-NP I-m
( ( O I-m
PSYLLIUM NNP B-NP I-m
( ( O I-m
METAMUCIL NNP B-NP I-m
) ) O I-m
SU NNP B-NP I-m
) ) O I-m
1-2 CD O B-do
PACKET NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5MIN NNP I-NP B-f
X NNP I-NP O
3 CD O O
doses NNS B-NP O
PRN NNP I-NP O
Chest NNP I-NP B-r
Pain NNP I-NP I-r
Instructions: NNP I-NP O
if IN B-VP O
pain NN B-NP B-r
is VBZ O O
not RB O O
relieved VBN O O
by IN B-VP O
nitro NN B-NP B-m
, , O O
call VB O O
911 CD O O
DIET: NNP B-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Brentkii NNP I-NP O
Hospital NNP I-NP O
office NN I-NP O
will MD O O
call VB O O
you PRP O O
If IN B-VP O
you PRP O O
do VBP O O
not RB O O
hear VB O O
from IN B-VP O
the DT B-NP O
office NN I-NP O
, , O O
call: VBP O O
701-815-0965 CD O O
, , O O
Dr NNP B-NP O
Kleinke NNP I-NP O
, , O O
Renal NNP B-NP O
10/16 CD O O
at IN B-VP O
3PM CD O O
scheduled JJ O O
, , O O
Dr NNP B-NP O
Romine NNP I-NP O
, , O O
Cardiology NNP B-NP O
2/7 CD O O
at IN B-VP O
12:30 CD O O
PM NNP B-NP O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Erythromycins NNP I-NP O
, , O O
Penicillins NNP B-NP O
, , O O
CLINDAMYCIN NNP B-NP O
, , O O
IBUPROFEN NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
nephrolithiasis NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
back RB O O
pain NN B-NP O
, , O O
UTI NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
h/o JJ B-NP O
IMI NNP I-NP O
Non-cardiac NNP I-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
Lumbosacral NNP B-NP O
disc VBZ O O
dz NN B-NP O
Chronic NNP I-NP O
pain NN I-NP O
syndrome NN I-NP O
Migraines NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
Anxiety NNP B-NP O
Depression NNP I-NP O
ALLERG:PCN NNP I-NP O
, , O O
Erythro NNP B-NP O
, , O O
Tetracy NNP B-NP O
S/P NNP I-NP O
PTCA NNP I-NP O
3/18 CD O O
FOR NNP B-NP O
OCC NNP I-NP O
RCA NNP I-NP O
POSITIVE NNP I-NP O
ETT/MIBI NNP I-NP O
93: CD O O
ANT/LAT NNP B-NP O
WALL NNP I-NP O
ISCHEMIA NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
CT NNP B-NP O
abd VBP O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
59F CD O O
w/ NN B-NP O
CAD NNP I-NP O
recently RB O O
RCA/OM1 NNP B-NP O
stent NN I-NP O
admitted VBD B-VP O
with IN B-VP O
nephrolithiasis NN B-NP O
for IN B-VP O
pain NN B-NP O
control NN I-NP O
HPI: NNP I-NP O
hx NN I-NP O
chronic NN I-NP B-r
pain NN I-NP I-r
syndrome NN I-NP I-r
on IN B-VP O
percocet NN B-NP B-m
and CC O O
morphine NN B-NP B-m
( ( O O
also RB O O
for IN B-VP O
OA NNP B-NP O
) ) O O
, , O O
who WP O O
recently RB O O
had VBD B-VP O
R NNP B-NP O
heart NN I-NP O
cath NN I-NP O
and CC O O
PCI NNP B-NP O
1 CD O O
wks NN B-NP O
ago RB O O
During IN B-VP O
that DT B-NP O
admission NN I-NP O
, , O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
hematuria NNS B-NP O
--&gt; NNP I-NP O
renal JJ B-NP O
f/u NN I-NP O
C/O NNP I-NP O
L NNP I-NP O
flank VBD B-VP O
pain NN B-NP O
x JJ O O
2 CD O O
days NNS B-NP O
, , O O
planned VBN O O
for IN B-VP O
CT NNP B-NP O
In IN B-VP O
Cards NNP B-NP O
clinic NN I-NP O
on IN B-VP O
DOA NNP B-NP O
, , O O
noted VBD B-VP O
poor JJ B-NP O
pain NN I-NP O
control NN I-NP O
admitted VBN O O
by IN B-VP O
ED NNP B-NP O
for IN B-VP O
pain NN B-NP O
control NN I-NP O
Got NNP I-NP O
ASA NNP I-NP B-m
, , O O
no DT B-NP O
IVF NNP I-NP O
morphine NN I-NP O
PMH: NNP I-NP O
chronic NN I-NP O
pain NN I-NP O
syndrome NN I-NP O
, , O O
FM NNP B-NP O
on IN B-VP O
mscontin NN B-NP B-m
tid NN I-NP B-f
CHF NNP I-NP O
, , O O
diastolic JJ B-NP O
dysfunction NN I-NP O
OSA NNP I-NP O
, , O O
CPAP NNP B-NP O
HTN NNP I-NP O
, , O O
CAD NNP B-NP O
, , O O
chol NN B-NP O
, , O O
mult NN B-NP O
MI NNP I-NP O
, , O O
stent NN B-NP O
x VBD B-VP O
3 CD O O
1 CD O O
wk NN B-NP O
---------- NNP I-NP O
EVENTS: NNP I-NP O
in IN B-VP O
ED NNP B-NP O
OBS NNP I-NP O
appeared VBD B-VP O
comfortable JJ O O
on IN B-VP O
dilaudid NN B-NP B-m
and CC O O
morphine NN B-NP B-m
---------- NNP I-NP O
STATUS: NNP I-NP O
resumed VBD B-VP O
on IN B-VP O
home NN B-NP O
pain NN I-NP O
regimen NNS I-NP O
, , O O
required VBD B-VP O
additional JJ O O
25 CD O B-do
mg NN B-NP I-do
oxycodone NN I-NP B-m
overnight VBD B-VP B-du
--------- JJ B-NP O
STUDIES: NNP I-NP O
I- NNP I-NP O
CT NNP I-NP O
showed: VBD B-VP O
kidney NNP B-NP O
stones NNS I-NP O
on IN B-VP O
R NNP B-NP O
, , O O
by IN B-VP O
CT NNP B-NP O
ureter NN I-NP O
in IN B-VP O
ED NNP B-NP O
, , O O
no DT B-NP O
hydro NN I-NP O
stones NNS I-NP O
are VBP O O
old JJ O O
, , O O
not RB O O
clear JJ O O
that IN B-VP O
this DT O O
is VBZ O O
causing VBG O O
her PRP$ O O
current JJ B-NP O
pain NN I-NP O
-------- NNP I-NP O
IMP: NNP I-NP O
59F CD O O
with IN B-VP O
CAD NNP B-NP O
and CC O O
recent JJ B-NP O
PCI NNP I-NP O
now RB O O
with IN B-VP O
nephrolithiasis NN B-NP O
and CC O O
pain NN B-NP O
control NN I-NP O
problems NNS I-NP O
PLAN: NNP I-NP O
1 CD O O
CV: NNP B-NP O
gave VBD B-VP O
lasix JJ B-NP B-m
lasix NN I-NP B-m
to TO O O
increase VB O O
filtration NN B-NP B-r
and CC O O
UOP NNP B-NP B-r
, , O O
while IN B-VP O
increasing VBG O O
IVF NNP B-NP B-m
to TO O O
keep VB O O
up RP O O
w/ JJ B-NP O
euvolemic JJ I-NP B-r
state NN I-NP I-r
- : O O
cont NN B-NP O
outpt JJ B-NP O
regimen NNS I-NP O
- : O O
asa NN B-NP B-m
, , O O
statin NN B-NP B-m
, , O O
bb NN B-NP B-m
, , O O
acei RB O B-m
2 CD O O
GU/RENAL: NNP B-NP O
increase NN I-NP O
UOP NNP I-NP B-r
UOP NNP I-NP B-r
w/ NN I-NP O
IVF NNP I-NP B-m
and CC O O
Lasix NNP B-NP B-m
3 CD O O
ID: NNP B-NP O
does VBZ O O
not RB O O
appear VB O O
to TO O O
have VB O O
systemic JJ B-NP O
infection NN I-NP O
Inflammation NNP I-NP B-r
of IN B-VP O
ureter JJ B-NP O
tx NN I-NP O
UTI NNP I-NP O
( ( O O
UA+ NNP B-NP O
) ) O O
with IN B-VP O
cipro JJ O B-m
250 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
x VBZ O B-du
7 CD O O
days NNS B-NP O
Started VBD B-VP O
1/16 CD O O
, , O O
ending VBG O O
2/12 CD O O
4 CD O O
FEN: NNP B-NP O
Diabetic NNP I-NP O
, , O O
low JJ B-NP O
salt NN I-NP O
, , O O
low JJ B-NP O
fat/cholesterol NN I-NP O
diet JJ O O
5 CD O O
Pain NNP B-NP B-r
Pain NNP I-NP B-r
Pain NNP I-NP B-r
control VB O I-r
control NN B-NP I-r
control NN I-NP I-r
with IN B-VP O
home NN B-NP O
regimen NNS I-NP O
of IN B-VP O
MScontin NNP B-NP B-m
and CC O O
oxycodone RB O B-m
Switched VBD B-VP O
to TO O O
45 CD O B-do
mg NN B-NP I-do
oxycontin NN I-NP B-m
PO NNP I-NP B-mo
q12h NN I-NP B-f
instead RB O O
of IN B-VP O
MS NNP B-NP B-m
contin NN I-NP I-m
upon RB O O
discharge NN B-NP O
as IN B-VP O
patient JJ O O
requiring VBG O O
frequent JJ B-NP O
PRN NNP I-NP O
for IN B-VP O
breakthrough NN B-NP O
Of IN B-VP O
note NN B-NP O
, , O O
back RB O O
pain NN B-NP O
crosses NNS I-NP O
lumbosacrum VBP O O
, , O O
radiates VBZ O O
down RP O O
legs NNS B-NP O
bilaterally RB O O
, , O O
and CC O O
to TO O O
groin VB O O
bilaterally RB O O
This DT B-NP O
distribution NN I-NP O
is VBZ O O
consistent JJ O O
with IN B-VP O
a DT O O
more RBR O O
mucskuloskeletal JJ B-NP O
etiology NN I-NP O
of IN B-VP O
pain NN B-NP O
, , O O
rather RB O O
than IN B-VP O
R-sided JJ B-NP O
nephrolithiasis JJ I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
You PRP O O
must MD O O
continue VB O O
your PRP$ O B-m
medications NNS B-NP I-m
, , O O
especially RB O O
aspirin JJ O B-m
and CC O O
plavix NN B-NP B-m
to TO O O
protect VB O O
your PRP$ O B-r
your PRP$ O B-r
stent JJ B-NP I-r
stent NN I-NP I-r
Continue NNP I-NP O
the DT B-NP O
Ciprrfloxacin NNP I-NP B-m
for IN B-VP O
your PRP$ O B-r
UTI NNP B-NP I-r
Follow NNP I-NP O
up RP O O
with IN B-VP O
your PRP$ O O
doctors NNS B-NP O
or CC O O
call VB O O
to TO O O
reschedule VB O O
the DT B-NP O
appointments NNS I-NP O
Call VB O O
your PRP$ O O
doctor NN B-NP O
or CC O O
return NN B-NP O
to TO O O
the DT B-NP O
ER NNP I-NP O
if IN B-VP O
you PRP O O
have VBP O O
fever VBN O O
, , O O
chills NNS B-NP O
, , O O
sweats NNS B-NP O
, , O O
worsening VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
problems NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
Follow-up NNP B-NP O
U/A NNP I-NP O
2 CD O O
Consider NNP B-NP O
CT NNP I-NP O
scan NN I-NP O
to TO O O
R/O NNP B-NP O
renal JJ B-NP O
CA NNP I-NP O
given VBN O O
hx NN B-NP O
of IN B-VP O
microscopic NN B-NP O
hematuria NN I-NP O
3 CD O O
Consider NNP B-NP O
cystoscopy NN I-NP O
to TO O O
R/O NNP B-NP O
bladder NN I-NP O
CA NNP I-NP O
given VBN O O
above IN B-VP O
4 CD O O
Med NNP B-NP O
check NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
HEMBRE NNP I-NP O
, , O O
MARCELINO NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
PS482 NNP B-NP O
) ) O O
3/15/05 CD O O
@ $ O O
01 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#497321 VBZ O O
078554939 CD O O
LRH NNP B-NP O
62413233 CD O O
7368393 CD O O
6/24/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
INCACERATED NNP I-NP O
HERNIA NNP I-NP O
, , O O
SEPSIS NNP B-NP O
, , O O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/26/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/25/2007 CD O O
ATTENDING: NNP B-NP O
CELLAR NNP I-NP O
, , O O
DONN NNP B-NP O
WILL NNP I-NP O
M.D NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Include NNP I-NP O
Tylenol NNP I-NP B-m
325 CD O B-do
to TO O I-do
650 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.4 JJ I-NP B-f
h NN I-NP O
p.r.n NN I-NP O
pain NN I-NP B-r
, , O O
DuoNeb NNP B-NP B-m
3/0.5 CD O B-do
mg NN B-NP I-do
q.6 NN I-NP B-f
h NN I-NP I-f
p.r.n NN I-NP I-f
, , O O
amiodarone VBP O B-m
amiodarone RB O B-m
400 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
b.i.d NN I-NP B-f
for IN B-VP B-du
six CD O I-du
more JJR B-NP I-du
days NNS I-NP I-du
and CC O O
then RB O O
400 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
hold NN B-NP O
for IN B-VP O
systolic JJ O O
less JJR O O
than IN B-VP O
90 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
less JJR O O
than IN B-VP O
55 CD O O
, , O O
econazole JJ B-NP B-m
nitrate JJ I-NP O
topical JJ I-NP B-mo
daily NN I-NP B-f
, , O O
heparin JJ O B-m
5000 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
q.12 JJ B-NP B-f
h NN I-NP I-f
, , O O
Regular NNP B-NP B-m
Insulin NNP I-NP I-m
sliding VBG O B-do
scale NN B-NP I-do
subcutaneously RB O B-mo
q.6 JJ B-NP B-f
h NN I-NP I-f
, , O O
Imodium NNP B-NP B-m
A-D NNP I-NP I-m
2 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
metoclopramide RB O B-m
10 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.i.d NN I-NP B-f
, , O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.6 NN I-NP B-f
h NN I-NP I-f
, , O O
hold NN B-NP O
for IN B-VP O
systolic JJ O O
less JJR O O
than IN B-VP O
90 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
less JJR O O
than IN B-VP O
55 CD O O
, , O O
omeprazole VBD B-VP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
oxycodone RB O B-m
1 CD O O
mg NNS B-NP O
per IN B-VP O
1 CD O O
mL JJ B-NP O
solution NN I-NP O
for IN B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
5 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.4 JJ I-NP B-f
h NN I-NP I-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
Carafate NNP B-NP B-m
1 CD O B-do
gm NN B-NP O
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
, , O O
and CC O O
Ambien NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
nightly RB O B-f
DIET: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
currently RB O O
on IN B-VP O
a DT B-NP O
house NN I-NP O
diet JJ B-NP O
TPN NNP I-NP B-m
was VBD B-VP O
d/c'ed VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
ACTIVITY: NNP I-NP O
He PRP O O
may MD O O
walk VB O O
as IN B-VP O
tolerated JJ B-NP O
ADMISSION NNP I-NP O
DIAGNOSIS: NNP I-NP O
Incarcerated NNP I-NP O
chronic JJ B-NP O
ventral JJ I-NP O
hernia NN I-NP O
status NN I-NP O
post NN I-NP O
sigmoid NN I-NP O
colectomy NN I-NP O
, , O O
colostomy NN B-NP O
, , O O
and CC O O
Hartmann's NNP B-NP O
operation NN I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Galla NNP I-NP O
in IN B-VP O
two CD O O
weeks NNS B-NP O
and CC O O
Dr NNP B-NP O
Caracciolo NNP I-NP O
who WP O O
is VBZ O O
the DT O O
attending VBG O O
in IN B-VP O
two CD O O
weeks NNS B-NP O
He PRP O O
should MD O O
also RB O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Smutzler NNP I-NP O
, , O O
cardiology NN B-NP O
in IN B-VP O
2 CD O O
months NNS B-NP O
, , O O
and CC O O
Dr NNP B-NP O
Parramore NNP I-NP O
, , O O
GI NNP B-NP O
in IN B-VP O
2-4 JJ B-NP O
weeks NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
72-year-old JJ I-NP O
male NN I-NP O
admitted VBN O O
for IN B-VP O
an DT B-NP O
incarcerated JJ I-NP O
chronic JJ I-NP O
ventral JJ I-NP O
hernia NN I-NP O
, , O O
postoperative JJ B-NP O
day NN I-NP O
6 CD O O
, , O O
status NN B-NP O
post NN I-NP O
sigmoid NN I-NP O
colectomy NN I-NP O
, , O O
colostomy NN B-NP O
, , O O
and CC O O
Hartmann's NNP B-NP O
operation NN I-NP O
Hospital NNP I-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
postoperative JJ B-NP O
acute NN I-NP O
respiratory NN I-NP O
failure NN I-NP O
, , O O
respiratory JJ B-NP O
acidosis NN I-NP O
with IN B-VP O
metabolic JJ B-NP O
acidosis NN I-NP O
, , O O
pleural JJ B-NP O
effusion NN I-NP O
, , O O
hypokalemia NN B-NP O
, , O O
myocardial JJ B-NP O
infarction NN I-NP O
, , O O
thrombocytopenia NN B-NP O
, , O O
and CC O O
delirium NN B-NP O
He PRP O O
has VBZ O O
a DT O O
known VBN O O
history NN B-NP O
of IN B-VP O
penile NN B-NP O
cancer NN I-NP O
status NN I-NP O
post NN I-NP O
penectomy NN I-NP O
complicated VBN O O
by IN B-VP O
perineal NN B-NP O
urethrocutaneous JJ B-NP O
fistula NN I-NP O
, , O O
chronic JJ B-NP O
anemia NN I-NP O
requiring VBG O O
transfusions NNS B-NP O
, , O O
non-insulin-dependant JJ B-NP O
diabetes NNS I-NP O
, , O O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
obesity NN B-NP O
, , O O
and CC O O
recurrent NN B-NP O
UTIs NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
suprapubic JJ I-NP O
catheter NN I-NP O
placed VBN O O
by IN B-VP O
Urology NNP B-NP O
His PRP$ O O
postoperative JJ B-NP O
course NN I-NP O
otherwise NN I-NP O
was VBD B-VP O
alright RB O O
He PRP O O
started VBD B-VP O
having VBG O O
atrial JJ B-NP O
fibrillation NN I-NP O
on IN B-VP O
10/30/07 CD O O
, , O O
initially RB O O
remained VBD B-VP O
stable JJ O O
with IN B-VP O
normal JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
He PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
10/30/07 CD O O
, , O O
wherein NN B-NP O
he PRP O O
developed VBD B-VP O
rapid JJ B-NP O
ventricular JJ I-NP O
response NN I-NP O
to TO O O
120 CD O O
On IN B-VP O
11/21/07 CD O O
, , O O
he PRP O O
began VBD B-VP O
hypotensive JJ O O
with IN B-VP O
systolics NNS B-NP O
of IN B-VP O
70 CD O O
Cardiology NNP B-NP O
was VBD B-VP O
consulted VBN O O
He PRP O O
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
Lopressor NNP B-NP B-m
and CC O O
diltiazem VB O B-m
drip NN B-NP B-mo
He PRP O O
remained VBD B-VP O
hypotensive JJ O O
despite IN B-VP O
IV JJ B-NP O
boluses NNS I-NP O
He PRP O O
was VBD B-VP O
switched VBN O O
to TO O O
amiodarone VB O B-m
mode NN B-NP O
and CC O O
drip NN B-NP B-mo
, , O O
but CC O O
again RB O O
he PRP O O
became VBD B-VP O
hypotensive JJ O O
Therefore IN B-VP O
he PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
unit NN I-NP O
and CC O O
given VBN O O
a DT B-NP O
digoxin NN I-NP B-m
load NN I-NP O
and CC O O
was VBD B-VP O
transferred VBN O O
for IN B-VP O
a DT B-NP O
possible JJ I-NP O
electrocardioversion NN I-NP O
He PRP O O
remained VBD B-VP O
asymptomatic JJ O O
throughout IN B-VP O
the DT B-NP O
day NN I-NP O
with IN B-VP O
low JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
In IN B-VP O
the DT B-NP O
ICU NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
again RB O O
started JJ O O
and CC O O
maintained VBD B-VP O
on IN B-VP O
amiodarone NN B-NP B-m
IV NNP I-NP B-mo
He PRP O O
tolerated VBD B-VP O
it PRP O O
without IN B-VP O
a DT B-NP O
problem NN I-NP O
He PRP O O
did VBD B-VP O
have VB O O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
from IN B-VP O
his PRP$ O O
NG NNP B-NP O
tube NN I-NP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
and CC O O
GI NNP B-NP O
was VBD B-VP O
consulted VBN O O
They PRP O O
felt VBD B-VP O
given VBN O O
that IN B-VP O
his PRP$ O O
hematocrits NNS B-NP B-r
have VBP O O
stabilized VBN O O
after IN B-VP O
two CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
cells NNS I-NP I-m
, , O O
he PRP O O
did VBD B-VP O
not RB O O
need VB O O
to TO O O
be VB O O
urgently RB O O
scoped VBN O O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Pepcid NNP B-NP B-m
IV NNP I-NP B-mo
and CC O O
a DT B-NP O
Nexium NNP I-NP B-m
drip NN I-NP B-mo
, , O O
and CC O O
had VBD B-VP O
hematocrit VBN O O
measured VBN O O
q.6 RBR O O
h NN B-NP O
, , O O
which WDT O O
remains VBZ O O
normal JJ O O
He PRP O O
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
these DT B-NP B-m
medications NNS I-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
TPN NNP B-NP B-m
after IN B-VP O
a DT B-NP O
PICC NNP I-NP O
line NN I-NP O
was VBD B-VP O
placed VBN O O
and CC O O
continued VBN O O
to TO O O
do VB O O
well RB O O
He PRP O O
was VBD B-VP O
scoped VBN O O
by IN B-VP O
GI NNP B-NP O
on IN B-VP O
6/20/07 CD O O
, , O O
which WDT O O
showed VBD B-VP O
diffuse IN B-VP O
gastritis NN B-NP O
thought VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
the DT B-NP O
NG NNP I-NP O
tube NN I-NP O
, , O O
and CC O O
two CD O O
ulcers NNS B-NP O
turned VBD B-VP O
out RP O O
bleeding JJ B-NP O
Postprocedure NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Carafate NNP B-NP B-m
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
Nexium NNP B-NP B-m
p.o NN I-NP B-mo
after IN B-VP O
he PRP O O
was VBD B-VP O
taking VBG O O
a DT B-NP O
diet NN I-NP O
Again NNP I-NP O
, , O O
his PRP$ O O
PICC NNP B-NP O
line NN I-NP O
was VBD B-VP O
safe JJ O O
on IN B-VP O
11/8/07 CD O O
and CC O O
he PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
TPN NNP B-NP B-m
on IN B-VP O
8/25/07 CD O O
The DT B-NP O
NG NNP I-NP O
tube NN I-NP O
was VBD B-VP O
removed VBN O O
on IN B-VP O
6/20/07 CD O O
and CC O O
his PRP$ O O
diet NN B-NP O
has VBZ O O
been VBN O O
slowly RB O O
advanced JJ O O
He PRP O O
is VBZ O O
being VBG O O
discharged VBN O O
on IN B-VP O
TPN NNP B-NP B-m
as IN B-VP O
his PRP$ O O
total JJ B-NP O
caloric JJ I-NP O
needs NNS I-NP O
are VBP O O
still RB O O
not RB O O
being VBG O O
met VBN O O
by IN B-VP O
p.o JJ B-NP O
nutrition NN I-NP O
and CC O O
he PRP O O
is VBZ O O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
on IN B-VP O
discharge NN B-NP O
He PRP O O
was VBD B-VP O
not RB O O
anti-coagulated JJ O O
for IN B-VP O
his PRP$ O O
Atrial JJ B-NP O
Fibrillation NNP I-NP O
due NN I-NP O
to TO O O
his PRP$ O O
risk NN B-NP O
of IN B-VP O
GI NNP B-NP O
bleeding NN I-NP O
, , O O
as IN B-VP O
decided VBN O O
by IN B-VP O
GI NNP B-NP O
eScription NN I-NP O
document: VBD B-VP O
5-6745409 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
VOCK NNP I-NP O
, , O O
RODOLFO NNP B-NP O
Attending: NNP I-NP O
REGINALDO NNP I-NP O
, , O O
EARLE NNP B-NP O
CHANCE NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6112785 CD O O
D: NNP B-NP O
8/26/07 CD O O
T: NNP B-NP O
8/26/07 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#498500 VBZ O O
407488014 CD O O
VEHH NNP B-NP O
39523841 CD O O
3178895 CD O O
3/17/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
Pancreatitis NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/17/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/1/2003 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
EMILE NNP I-NP O
, , O O
DARON NNP B-NP O
493-31-10-1 CD O O
Ert NNP B-NP O
Deownside NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
4/15/03 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SALEHI NNP I-NP O
, , O O
ALVIN NNP B-NP O
H NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
AMITRIPTYLINE NNP I-NP B-m
HCL NNP I-NP I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
PREMARIN NNP I-NP B-m
( ( O I-m
CONJUGATED NNP B-NP I-m
ESTROGENS NNP I-NP I-m
) ) O I-m
0.625 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
FLEXERIL NNP I-NP B-m
( ( O I-m
CYCLOBENZAPRINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/10/03 CD O O
by IN B-VP O
NICKLESS NNP B-NP O
, , O O
JAMES NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
FLEXERIL NNP B-NP B-m
PO NNP I-NP B-mo
10 CD O B-do
MG NNP B-NP I-do
TID NNP I-NP B-f
( ( O O
ref JJ O O
# # O O
75816429 CD O O
) ) O O
DEFINITE NNP B-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
MUSCLE NNP B-NP O
RELAXANTS NNP I-NP O
, , O O
SKELETAL NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
meds NNS I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
4 CD O O
COLACE NNP B-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
FLUOXETINE NNP I-NP B-m
( ( O I-m
FLUOXETINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GEMFIBROZIL NNP I-NP B-m
600 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/03 CD O O
by IN B-VP O
HOKKANEN NNP B-NP O
, , O O
WALTER NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
GEMFIBROZIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
GEMFIBROZIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
NPH NNP I-NP B-m
HUMULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
( ( O I-m
INSULIN NNP B-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
10 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/19 CD O O
) ) O O
NPH NNP B-NP B-m
HUMULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
( ( O I-m
INSULIN NNP B-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
50 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QHS NNP I-NP B-f
LORAZEPAM NNP I-NP B-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
AMLODIPINE NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
TOPROL NNP B-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
10 CD O O
IRBESARTAN NNP B-NP B-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
LASIX NNP B-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/03 CD O O
by IN B-VP O
: : O O
POSSIBLE NNP B-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
SULFA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/03 CD O O
by IN B-VP O
: : O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
GEMFIBROZIL NNP I-NP B-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
GEMFIBROZIL NNP I-NP B-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
Adv NNP I-NP O
as IN B-VP O
tol NN B-NP O
/ IN B-VP O
ADA NNP B-NP O
1800 CD O O
cals/day NN B-NP O
/ VB O O
Very RB O O
low JJ B-NP O
fat NN I-NP O
( ( O O
20gms/day CD O O
) ) O O
ACTIVITY: NNP B-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Bouy NNP I-NP O
, , O O
vascular JJ B-NP O
surgery NN I-NP O
, , O O
U NNP B-NP O
Daylis NNP I-NP O
Ont NNP I-NP O
, , O O
12:50 CD O O
pm NN B-NP O
, , O O
you PRP O O
need VBP O O
to TO O O
ask VB O O
Dr NNP B-NP O
Master NNP I-NP O
for IN B-VP O
a DT O O
referral JJ O O
for IN B-VP O
this DT B-NP O
appointment NN I-NP O
1/14/03 CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Blaine NNP I-NP O
Wehrley NNP I-NP O
, , O O
11:30 CD O O
AM NNP B-NP O
5/14/03 CD O O
scheduled VBN O O
, , O O
MRI/A NNP B-NP O
of IN B-VP O
abdomen NNS B-NP O
, , O O
SHS NNP B-NP O
Re NNP I-NP O
Na NNP I-NP O
, , O O
New NNP B-NP O
Hampshire NNP I-NP O
59460 CD O O
, , O O
11:20 CD O O
AM NNP B-NP O
, , O O
please NN B-NP O
arrive JJ O O
30 CD O O
min NN B-NP O
prior RB O O
to TO O O
appt VB O O
and CC O O
have VB O O
only RB O O
clear JJ B-NP O
liquids NNS I-NP O
that IN B-VP O
morning NN B-NP O
0/9/03 CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Amoxicillin NNP I-NP O
, , O O
Sulfa NNP B-NP O
, , O O
Ciprofloxacin NNP B-NP O
, , O O
Orphenadrine NNP B-NP O
citrate NN I-NP O
, , O O
Angiotensin NNP B-NP O
converting VBG O O
enzyme JJ B-NP O
inhibitor NN I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Pancreatitis NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Pancreatitis NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
?CARDIOMYOPATHY NNP I-NP O
EF=39% NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
SEVERE NNP B-NP O
HYPERCHOL/HYPER NNP I-NP O
TG NNP I-NP O
POORLY NNP I-NP O
CONTROLLED NNP I-NP O
DM NNP I-NP O
S/P NNP I-NP O
CHOLE/APPY/TAH NNP I-NP O
DIFFUSE NNP I-NP O
ABDOMINAL NNP I-NP O
PAIN NNP I-NP O
ALLG: NNP I-NP O
SULFA/AMOXICILLIN NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
64-year-old JJ O O
with IN B-VP O
known JJ B-NP O
CAD NNP I-NP O
, , O O
atherosclerotic JJ B-NP O
peripheral JJ I-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
and CC O O
type $ O O
2 CD O O
diabetes NNS B-NP O
presented VBN O O
with IN B-VP O
back JJ B-NP O
pain NN I-NP O
She PRP O O
describes VBZ O O
a DT B-NP O
sudden JJ I-NP O
onset NN I-NP O
of IN B-VP O
8/10 CD O O
stabbing VBG O O
back RB O O
pain RB O O
4 CD O O
days NNS B-NP O
ago RB O O
without IN B-VP O
a DT B-NP O
clear JJ I-NP O
precipitant NN I-NP O
The DT B-NP O
pain NN I-NP B-r
was VBD B-VP O
non JJ B-NP O
raditating NN I-NP O
and CC O O
partially RB O O
releived VBN O O
with IN B-VP O
analgesics.She NNS B-NP B-m
denied VBD B-VP O
any DT B-NP O
bowel NN I-NP O
or CC O O
bladder NN B-NP O
incontinence NN I-NP O
or CC O O
saddle JJ B-NP O
anesthes NNS I-NP O
ia VBP O O
She PRP O O
denied VBD B-VP O
any DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
or CC O O
diarrhea VB O O
She PRP O O
does VBZ O O
however RB O O
complain VB O O
of IN B-VP O
some DT B-NP O
urinary JJ I-NP O
frequency NN I-NP O
( ( O O
on IN B-VP O
lasix NN B-NP B-m
) ) O O
in IN B-VP O
the DT B-NP O
last JJ I-NP O
few JJ I-NP O
days NNS I-NP O
with IN B-VP O
out RP O O
any DT B-NP O
dysuria NN I-NP O
or CC O O
urgency NN B-NP O
Of IN B-VP O
note NN B-NP O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
month NN I-NP O
she PRP O O
has VBZ O O
had VBD B-VP O
increasing VBG O O
had VBD B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
however RB O O
she PRP O O
denies VBZ O O
any DT B-NP O
orthopnea NN I-NP O
or CC O O
PND VB O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
long RB O O
standing VBG O O
pedal NN B-NP O
edema NN I-NP O
and CC O O
has VBZ O O
increasing VBG O O
abdominal JJ B-NP O
distension NN I-NP O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
month NN I-NP O
but CC O O
has VBZ O O
not RB O O
noticed VBN O O
any DT B-NP O
change NN I-NP O
in IN B-VP O
her PRP$ O O
weight NN B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
CAD NNP B-NP O
and CC O O
her PRP$ O O
angina JJ B-NP O
equivalent NN I-NP O
is VBZ O O
jaw JJ B-NP O
pain.However NN I-NP O
in IN B-VP O
the DT O O
last JJ O O
6 CD O O
months NNS B-NP O
she PRP O O
has VBZ O O
had VBN O O
intermittent NN B-NP O
left VBN O O
sided VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
that WDT O O
radiates VBZ O O
to TO O O
her PRP$ O O
left JJ B-NP O
arm NN I-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
an DT B-NP O
aortic JJ I-NP O
dissection NN I-NP O
, , O O
MI NNP B-NP O
and CC O O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
D-Dimer NNP I-NP O
However RB O O
lipase NN B-NP O
levels NNS I-NP O
have VBP O O
been VBN O O
elevated VBN O O
with IN B-VP O
norm JJ B-NP O
al NN I-NP O
LFTs NNP I-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
pancreatitis NN B-NP O
Hospital NNP I-NP O
course: VBD B-VP O
1.GI- JJ B-NP O
S/P NNP I-NP O
cholecystectomy NN I-NP O
Her PRP$ O O
lipase NN B-NP O
was VBD B-VP O
mildly RB O O
elevated VBN O O
on IN B-VP O
admission NN B-NP O
to TO O O
200 CD O O
, , O O
fell VBD B-VP O
to TO O O
60 CD O O
with IN B-VP O
NPO NNP B-NP O
and CC O O
IVF NNP B-NP B-m
However RB O O
, , O O
MRA NNP B-NP O
read VBP O O
with IN B-VP O
radiology NN B-NP O
2/11 CD O O
shows NNS B-NP O
diffuse VBP O O
atherosclerotic JJ B-NP O
disease NN I-NP O
including VBG O O
stenosis NN B-NP O
of IN B-VP O
celiac JJ B-NP O
artery NN I-NP O
, , O O
vascular JJ B-NP O
surgery NN I-NP O
was VBD B-VP O
consulted VBN O O
for IN B-VP O
concer NN B-NP O
about IN B-VP O
mesenteric JJ B-NP O
ischemia NN I-NP O
They PRP O O
do VBP O O
not RB O O
think VB O O
she PRP O O
is VBZ O O
having VBG O O
symptoms NNS B-NP O
of IN B-VP O
ischemia NN B-NP O
, , O O
would MD O O
like VB O O
abdominal JJ B-NP O
MRA NNP I-NP O
to TO O O
further VB O O
assess JJ B-NP O
abdominal JJ I-NP O
vasculature NN I-NP O
Triglycerides NNP I-NP B-r
very RB O O
high JJ O O
, , O O
could MD O O
be VB O O
cause NN B-NP O
of IN B-VP O
her PRP$ O O
pancreatitis NN B-NP O
, , O O
starting VBG O O
gemfibrozil JJ B-NP B-m
LDL NNP I-NP O
was VBD B-VP O
151 CD O O
2.Cardivascular- JJ B-NP O
Ischemia-On NNP I-NP O
a DT B-NP O
beta NN I-NP B-m
blocker NN I-NP I-m
, , O O
statin NN B-NP B-m
, , O O
ARB NNP B-NP B-m
, , O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
an DT B-NP O
MI NNP I-NP O
, , O O
but CC O O
has VBZ O O
6 CD O O
month NN B-NP O
history NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
Adenosine NNP I-NP O
MIBI NNP I-NP O
negative JJ B-NP O
Started NNP I-NP O
gemfibrozil VBD B-VP B-m
Pump-We NNP B-NP O
changed VBD B-VP O
atenolol NN B-NP B-m
to TO O O
toprol VB O B-m
XL NNP B-NP I-m
and CC O O
amlodipine JJ B-NP B-m
3.Endocrine- NN I-NP O
Has NNP I-NP O
had VBD B-VP O
poor JJ B-NP B-r
poor JJ I-NP B-r
glucose JJ I-NP I-r
glucose JJ I-NP I-r
control NN I-NP I-r
control NN I-NP I-r
HbA1c NNP I-NP O
13 CD O O
We PRP O O
continued VBD B-VP O
NPH NNP B-NP B-m
qhs NN I-NP B-f
and CC O O
started VBD B-VP O
AM NNP B-NP B-f
NPH NNP I-NP B-m
as IN B-VP O
well RB O O
4.Renal-Chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
Cr NNP B-NP O
stable JJ O O
5 CD O O
ID NNP B-NP O
- : O O
Patient NN B-NP O
c/o NN I-NP O
urinary JJ B-NP O
frequency NN I-NP O
U/A NNP I-NP O
negative JJ B-NP O
6.Psych-On JJ I-NP O
amitryptilline NN I-NP B-m
and CC O O
fluoxetine JJ B-NP B-m
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
take VB O O
all DT B-NP O
medications NNS I-NP O
as IN B-VP O
described VBN O O
You PRP O O
will MD O O
need VB O O
to TO O O
follow VB O O
a DT B-NP O
low JJ I-NP O
fat NN I-NP O
and CC O O
low JJ B-NP O
carbohydrate NN I-NP O
diet NN I-NP O
to TO O O
control VB O O
your PRP$ O O
cholesterol NN B-NP O
and CC O O
diabetes VBZ O O
Please NNP B-NP O
take VB O O
insulin NN B-NP B-m
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
as RB O I-f
well RB O I-f
as IN B-VP I-f
the DT B-NP I-f
night NN I-NP I-f
, , O O
check VB O O
your PRP$ O O
fingersticks NNS B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
and CC O O
record VB O O
them PRP O O
Please NNP B-NP O
see VB O O
Dr NNP B-NP O
Colleen NNP I-NP O
on IN B-VP O
10/2 CD O O
and CC O O
ask VB O O
him PRP O O
to TO O O
help VB O O
with IN B-VP O
your PRP$ O O
insulin NN B-NP B-m
regimen NNS I-NP I-m
Please NNP I-NP O
go VB O O
to TO O O
your PRP$ O O
MRI NNP B-NP O
appointment NN I-NP O
0/12 CD O O
and CC O O
see VB O O
Dr NNP B-NP O
Cicerchia NNP I-NP O
4/8 CD O O
Call NNP B-NP O
your PRP$ O O
doctor NN B-NP O
or CC O O
go VB O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
if IN B-VP O
you PRP O O
develop VBP O O
severe JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
or CC O O
abdominal JJ B-NP O
pain NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
HUNEYCUTT NNP I-NP O
, , O O
IRVING NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
VS38 NNP B-NP O
) ) O O
4/15/03 CD O O
@ $ O O
02:03 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#499301 VBZ O O
697377829 CD O O
JC NNP B-NP O
38527267 CD O O
8331308 CD O O
10/26/2007 CD O O
12:00:00 CD O O
AM NNP B-NP O
ABDOMINAL NNP I-NP O
PAIN; NNP I-NP O
RENAL NNP I-NP O
FAILURE NNP I-NP O
, , O O
PULIMONARY NNP B-NP O
EDEMA NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/13/2007 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/16/2007 CD O O
ATTENDING: NNP B-NP O
ARBOLEDA NNP I-NP O
, , O O
CORNELL NNP B-NP O
MD NNP I-NP O
ADMISSION NNP I-NP O
DIAGNOSIS: NNP I-NP O
Abdominal NNP I-NP O
pain NN I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Pneumonia NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
An DT B-NP O
86-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
, , O O
diastolic JJ B-NP O
CHF NNP I-NP O
, , O O
rheumatic JJ B-NP O
heart NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
mitral JJ B-NP O
valve NN I-NP O
replacement NN I-NP O
and CC O O
tricuspid JJ B-NP O
repair NN I-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
, , O O
prior JJ B-NP O
small-bowel JJ I-NP O
obstruction NN I-NP O
and CC O O
GI NNP B-NP O
bleeding NN I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
sudden JJ B-NP O
onset NN I-NP O
of IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
approximately RB O O
one CD O O
day NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
which WDT O O
became VBD B-VP O
progressively RB O O
worse JJR O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
nausea NN B-NP O
and CC O O
vomiting NN B-NP O
at IN B-VP O
home NN B-NP O
with IN B-VP O
green/yellow JJ B-NP O
fluid NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
suspected VBN O O
to TO O O
have VB O O
an DT B-NP O
aspiration NN I-NP O
event NN I-NP O
per IN B-VP O
the DT B-NP O
patient's NN I-NP O
daughter NN I-NP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
fever RB O O
or CC O O
chills VB O O
Denies NNPS B-NP O
dysuria NN I-NP O
Denies NNP I-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
cough NN B-NP O
No DT B-NP O
recent JJ I-NP O
antibiotics NNS I-NP O
No DT B-NP O
sick JJ I-NP O
contacts NNS I-NP O
EMERGENCY NNP I-NP O
DEPARTMENT NNP I-NP O
COURSE: NNP I-NP O
Temperature NNP I-NP O
97.5 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
74 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
183/65 CD O O
improved VBN O O
to TO O O
128/56 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
16 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
subsequently RB O O
decreased VBN O O
to TO O O
92% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
and CC O O
improved VBN O O
to TO O O
96% CD O O
on IN B-VP O
2 CD O O
L NNP B-NP O
nasal JJ B-NP O
cannula NN I-NP O
On IN B-VP O
exam NN B-NP O
, , O O
patient NN B-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
positive JJ B-NP O
jugular NN I-NP O
venous JJ B-NP O
distension NN I-NP O
, , O O
3/6 CD O O
systolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
, , O O
right JJ B-NP O
lower JJR I-NP O
quadrant JJ I-NP O
tenderness NN I-NP O
to TO O O
palpation NN B-NP O
, , O O
abdomen NNS B-NP O
soft JJ O O
and CC O O
without IN B-VP O
rebound NN B-NP O
tenderness NN I-NP O
A DT B-NP O
chest JJ I-NP O
x-ray NN I-NP O
was VBD B-VP O
performed VBN O O
and CC O O
a DT B-NP O
right JJ I-NP O
lower JJR I-NP O
lobe NN I-NP O
infiltrate NN I-NP O
and CC O O
moderate JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
was VBD B-VP O
noted VBN O O
A NNP B-NP O
KUB NNP I-NP O
was VBD B-VP O
also RB O O
performed VBN O O
, , O O
which WDT O O
did VBD B-VP O
not RB O O
show VB O O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
obstruction NN B-NP O
An DT B-NP O
abdominal JJ I-NP O
CT NNP I-NP O
demonstrated VBD B-VP O
mild JJ O O
diffuse IN B-VP O
small JJ B-NP O
bowel NN I-NP O
thickening VBG O O
concerning VBG O O
for IN B-VP O
infection NN B-NP O
versus NN I-NP O
ischemia VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
ceftriaxone NN B-NP B-m
, , O O
azithromycin NN B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
IV NNP I-NP B-mo
as RB O O
well RB O O
as IN B-VP O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
x1 NNP I-NP B-du
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Hypertension NNP I-NP O
, , O O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
on IN B-VP O
Coumadin NNP B-NP B-m
, , O O
rheumatic JJ B-NP O
heart NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
bioprosthetic JJ B-NP O
mitral JJ I-NP O
valve NN I-NP O
replacement NN I-NP O
and CC O O
tricuspid JJ B-NP O
valve NN I-NP O
repair NN I-NP O
( ( O O
2000 CD O O
) ) O O
, , O O
mild JJ B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
, , O O
diastolic JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
with IN B-VP O
baseline NN B-NP O
creatinine=2.6 NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
small-bowel JJ B-NP O
obstruction NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
GI NNP B-NP O
bleed NN I-NP O
( ( O O
No-jack NNP B-NP O
Hospital NNP I-NP O
admission NN I-NP O
in IN B-VP O
3/28 CD O O
with IN B-VP O
capsule NN B-NP O
study NN I-NP O
demonstrating VBG O O
small JJ B-NP O
bowel NN I-NP O
lymphangiectasias NN I-NP O
and CC O O
angiectasis NN B-NP O
, , O O
colonoscopy NN B-NP O
demonstrating VBG O O
sessile JJ B-NP O
polyps NNS I-NP O
and CC O O
diverticulitis NN B-NP O
, , O O
questionable JJ B-NP O
history NN I-NP O
of IN B-VP O
mesenteric JJ B-NP O
ischemia NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
right RB O O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
CVA NNP I-NP O
at IN B-VP O
age NN B-NP O
55 CD O O
, , O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
MI NNP B-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Renagel NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
with IN B-VP B-f
dinner NN B-NP I-f
2 CD O O
Diovan NNP B-NP B-m
120 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
3 CD O O
Procrit NNP B-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subcutaneous JJ B-NP B-mo
q JJ I-NP B-f
week NN I-NP I-f
4 CD O O
Norvasc NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
5 CD O O
Norvasc NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
6 CD O O
Imdur NNP B-NP B-m
30 CD O B-do
mg NN B-NP I-do
twice RB O B-f
daily RB O I-f
7 CD O O
NovoLog NNP B-NP B-m
4/4/5 CD O B-do
plus CC O O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP B-m
8 CD O O
Lantus NNP B-NP B-m
8 CD O B-do
units NNS B-NP I-do
nightly RB O B-f
9 CD O O
Nexium NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
twice RB O B-f
daily RB O I-f
10 CD O O
Coumadin NNP B-NP B-m
4 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m VBD B-VP B-f
11 CD O O
Caltrate NNP B-NP B-m
plus CC O I-m
D NNP B-NP I-m
one CD O B-do
tab NN B-NP I-do
twice RB O B-f
daily RB O I-f
12 CD O O
Iron NNP B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
twice RB O B-f
daily RB O I-f
13 CD O O
Lasix NNP B-NP B-m
Lasix NNP I-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m NN I-NP B-f
plus CC O O
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m NN I-NP B-f
ALLERGIES: NNP I-NP O
Codeine NNP I-NP O
and CC O O
Benadryl NNP B-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
96.6 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
62 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
108/60 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
20 CD O O
and CC O O
oxygen JJ B-NP O
saturation NN I-NP O
95% CD O O
on IN B-VP O
2 CD O O
l NN B-NP O
Chest NNP I-NP O
with IN B-VP O
bilateral JJ B-NP O
dullness NN I-NP O
and CC O O
right JJ B-NP O
basilar NN I-NP O
rales NNS I-NP O
Positive NNP I-NP O
egophony NN I-NP O
at IN B-VP O
right JJ B-NP O
base NN I-NP O
Heart NNP I-NP O
with IN B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
and CC O O
a DT O O
3/6 CD O O
systolic JJ B-NP O
mid NN I-NP O
peaking VBG O O
murmur NN B-NP O
at IN B-VP O
left JJ B-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
heard NN I-NP O
throughout IN B-VP O
Normal NNP B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
Abdomen NNP I-NP O
is VBZ O O
soft JJ O O
, , O O
nontender NN B-NP O
and CC O O
nondistended VBD B-VP O
Positive NNP B-NP O
bowel NN I-NP O
sounds VBZ O O
Guaiac NNP B-NP O
negative JJ B-NP O
ADMISSION NNP I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Sodium NNP I-NP O
141 CD O O
, , O O
potassium NN B-NP O
4.5 CD O O
, , O O
chloride RB O O
101 CD O O
, , O O
bicarbonate NN B-NP O
25 CD O O
, , O O
BUN NNP B-NP O
111 CD O O
, , O O
creatinine NN B-NP O
2.7 CD O O
and CC O O
glucose VB O O
206 CD O O
WBC NNP B-NP O
6.29 CD O O
, , O O
hematocrit NN B-NP O
37.7 CD O O
( ( O O
38.5 CD O O
at IN B-VP O
last JJ B-NP O
check NN I-NP O
) ) O O
, , O O
platelets VBZ O O
260 CD O O
, , O O
000 CD O O
, , O O
INR NNP B-NP O
2.8 CD O O
LFTs NNP B-NP O
normal JJ O O
, , O O
amylase JJ O O
80 CD O O
, , O O
lipase NN B-NP O
18 CD O O
, , O O
total JJ B-NP O
bilirubin NN I-NP O
0.8 CD O O
, , O O
albumin RB O O
3.7 CD O O
, , O O
lactate VBP O O
1.7 CD O O
Urinalysis NNP B-NP O
1+ CD O O
protein NN B-NP O
, , O O
WBC NNP B-NP O
2 CD O O
, , O O
RBC NNP B-NP O
0 CD O O
STUDIES: NNP B-NP O
1 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
( ( O O
5/30/07 CD O O
): NNP B-NP O
Cardiomegaly NNP I-NP O
, , O O
mediastinal JJ B-NP O
wires NNS I-NP O
, , O O
positive JJ B-NP O
cephalization NN I-NP O
and CC O O
Kerley NNP B-NP O
B NNP I-NP O
lines NNS I-NP O
consistent NN I-NP O
with IN B-VP O
moderate JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
, , O O
right JJ B-NP O
lower JJR I-NP O
lobe NN I-NP O
opacification NN I-NP O
2 CD O O
KUB NNP B-NP O
( ( O O
5/30/07 CD O O
): NNP B-NP O
Nonspecific NNP I-NP O
gas NN I-NP O
pattern NN I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
obstruction NN B-NP O
or CC O O
free JJ B-NP O
air NN I-NP O
Calcified NNP I-NP O
aorta NN I-NP O
and CC O O
iliac JJ O O
3 CD O O
CT NNP B-NP O
abdomen NNS I-NP O
( ( O O
2/17/070 CD O O
: : O O
1bilateral CD O O
infiltrates NNS B-NP O
consistent JJ O O
with IN B-VP O
pneumonia NN B-NP O
, , O O
questionable JJ O O
mild JJ O O
diffuse IN B-VP O
small-bowel JJ B-NP O
thickening NN I-NP O
, , O O
no DT B-NP O
appendicitis NN I-NP O
, , O O
no DT B-NP O
obstruction NN I-NP O
, , O O
no DT B-NP O
perforation NN I-NP O
, , O O
positive JJ B-NP O
gallstones NNS I-NP O
, , O O
positive JJ B-NP O
gallbladder NN I-NP O
distension NN I-NP O
without IN B-VP O
wall NN B-NP O
thickening NN I-NP O
or CC O O
pericholecystic JJ B-NP O
fluid NN I-NP O
4 CD O O
EKG NNP B-NP O
( ( O O
5/30/07 CD O O
): NNP B-NP O
Atrial NNP I-NP O
fibrillation NN I-NP O
at IN B-VP O
71 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
, , O O
pseudonormalized VBD B-VP O
CONSULTING NNP B-NP O
SERVICES: NNP I-NP O
1 CD O O
Gastroenterology NNP B-NP O
2 CD O O
Surgery NNP B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEM: NNP I-NP O
1 CD O O
Abdominal NNP B-NP O
pain: NN I-NP O
Unclear NNP I-NP O
etiology NN I-NP O
of IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
on IN B-VP O
presentation NN B-NP O
, , O O
but CC O O
given VBN O O
history NN B-NP O
of IN B-VP O
mesenteric JJ B-NP O
ischemia NN I-NP O
and CC O O
questionable JJ B-NP O
small-bowel JJ I-NP O
thickening NN I-NP O
on IN B-VP O
CT NNP B-NP O
, , O O
the DT B-NP O
initial JJ I-NP O
concern NN I-NP O
GI NNP I-NP O
and CC O O
Surgical NNP B-NP O
Services NNPS I-NP O
were VBD B-VP O
consulted VBN O O
and CC O O
followed VBD B-VP O
the DT B-NP O
patient NN I-NP O
over IN B-VP O
Hospital NNP B-NP O
day NN I-NP O
#1 NNP I-NP O
Serial NNP I-NP O
CBC NNP I-NP O
, , O O
lactate NN B-NP O
and CC O O
anion NN B-NP O
gaps NNS I-NP O
were VBD B-VP O
followed VBN O O
and CC O O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemia NN B-NP O
By IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
, , O O
the DT B-NP O
patient's JJ I-NP O
abdominal JJ I-NP O
pain NN I-NP O
had VBD B-VP O
fully RB O O
resolved VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
initiated VBN O O
on IN B-VP O
clears NNS B-NP O
By IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
hospital NN B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
tolerating VBG O O
a DT O O
regular JJ O O
diet JJ O O
Although IN B-VP O
no DT B-NP O
clear JJ I-NP O
diagnosis NN I-NP O
could MD O O
be VB O O
made VBN O O
, , O O
the DT B-NP O
rapid JJ I-NP O
resolution NN I-NP O
of IN B-VP O
the DT B-NP O
patient's JJ I-NP O
abdominal JJ I-NP O
pain NN I-NP O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
most RBS O O
consistent JJ O O
with IN B-VP O
viral JJ B-NP O
enteritis NN I-NP O
Given NNP I-NP O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
atherosclerosis NN B-NP O
, , O O
further JJ B-NP O
imaging NN I-NP O
of IN B-VP O
the DT B-NP O
abdominal JJ I-NP O
vessels NNS I-NP O
by IN B-VP O
MRA NNP B-NP O
during IN B-VP O
followup NN B-NP O
was VBD B-VP O
recommended VBN O O
by IN B-VP O
the DT B-NP O
GI NNP I-NP O
Service NNP I-NP O
2 CD O O
Pneumonia: NNP B-NP O
Bilateral NNP I-NP O
infiltrates VBZ O O
consistent JJ O O
with IN B-VP O
aspiration NN B-NP B-r
aspiration NN I-NP B-r
aspiration NN I-NP B-r
aspiration NN I-NP B-r
aspiration NN I-NP B-r
pneumonia IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
initially RB O O
treated VBN O O
empirically RB O O
with IN B-VP O
ceftriaxone NN B-NP B-m
, , O O
azithromycin NN B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
IV NNP I-NP B-mo
, , O O
which WDT O O
was VBD B-VP O
switched VBN O O
to TO O O
cefpodoxime VB O B-m
plus CC O O
Flagyl NNP B-NP B-m
p.o NN I-NP B-mo
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 VBD B-VP O
The DT B-NP O
patient NN I-NP O
became VBD B-VP O
febrile JJ B-NP B-r
febrile NN I-NP B-r
on IN B-VP O
HD#4 NNP B-NP O
( ( O O
11/22/07 CD O O
) ) O O
up RB O O
to TO O O
101.9 CD O O
and CC O O
as IN B-VP O
such JJ O O
was VBD B-VP O
switched VBN O O
back RB O O
to TO O O
ceftriaxone NN B-NP B-m
, , O O
Flagyl NNP B-NP B-m
and CC O O
azithromycin VB O B-m
IV NNP B-NP B-mo
after IN B-VP O
which WDT O O
the DT B-NP O
patient NN I-NP O
remained VBD B-VP O
afebrile JJ O O
throughout IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
her PRP$ O O
admission NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
2/11/07 CD O O
with IN B-VP O
instructions NNS B-NP O
to TO O O
complete VB O O
an DT O B-du
an DT O B-du
an DT O B-du
additional JJ O I-du
additional JJ O I-du
additional JJ O I-du
six CD O I-du
six CD O I-du
six CD O I-du
days NNS B-NP I-du
days NNS I-NP I-du
days NNS I-NP I-du
of IN B-VP O
cefpodoxime NN B-NP B-m
, , O O
Flagyl NNP B-NP B-m
and CC O O
azithromycin JJ B-NP B-m
p.o NN I-NP B-mo
p.o NN I-NP B-mo
for IN B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
14 CD O O
days NNS B-NP O
of IN B-VP O
antibiotic JJ B-NP O
therapy NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
given VBN O O
lactobacillus CC O B-m
as IN B-VP O
a DT B-NP B-r
probiotic JJ I-NP O
agent NN I-NP O
3 CD O O
Hypoxemia: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
to TO O O
have VB O O
a DT B-NP O
mild JJ I-NP O
oxygen NN I-NP O
requirement NN I-NP O
with IN B-VP O
an DT B-NP O
oxygen NN I-NP O
saturation NN I-NP O
of IN B-VP O
92% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
which WDT O O
improved VBD B-VP O
to TO O O
97% CD O O
on IN B-VP O
2 CD O O
L NNP B-NP O
nasal NN I-NP O
cannula VBZ O O
The DT B-NP O
differential JJ I-NP O
diagnosis NN I-NP O
for IN B-VP O
the DT B-NP O
patient's NN I-NP O
hypoxemia NN I-NP O
included VBD B-VP O
pulmonary JJ B-NP O
edema NN I-NP O
( ( O O
seen VBN O O
on IN B-VP O
chest JJS B-NP O
x-ray NN I-NP O
) ) O O
and CC O O
pneumonia VBZ O B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
40 CD O B-do
mg JJ B-NP I-do
IV NNP I-NP B-mo
Lasix NNP I-NP B-m
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
and CC O O
was VBD B-VP O
treated VBN O O
for IN B-VP O
pneumonia NN B-NP O
as IN B-VP O
above IN B-VP O
On IN B-VP O
Hospital NNP B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
at IN B-VP O
rest NN B-NP O
room NN I-NP O
air NN I-NP O
oxygen IN B-VP O
saturation NN B-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
95-97% JJ O O
, , O O
but CC O O
decreased VBD B-VP O
to TO O O
85% CD O O
with IN B-VP O
ambulation NN B-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
still RB O O
thought VBN O O
to TO O O
be VB O O
mildly RB O O
hypervolemic JJ O O
and CC O O
was VBD B-VP O
gently RB O O
diuresed VBN O O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
room NN I-NP O
air NN I-NP O
saturation NN I-NP O
of IN B-VP O
100% CD O O
at IN B-VP O
rest NN B-NP O
and CC O O
95% CD O O
with IN B-VP O
ambulation NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
continue VB O O
gentle JJ B-NP O
oral JJ I-NP O
diuresis NN I-NP O
at IN B-VP O
home NN B-NP O
and CC O O
VNA NNP B-NP O
services NNS I-NP O
were VBD B-VP O
arranged VBN O O
to TO O O
monitor VB O O
her PRP$ O O
oxygen NN B-NP O
saturations NNS I-NP O
and CC O O
daily JJ B-NP O
weight NN I-NP O
4 CD O O
Anemia: NNP B-NP O
History NNP I-NP O
of IN B-VP O
GI NNP B-NP O
bleeding NN I-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
The DT B-NP O
patient's NN I-NP O
hematocrit NN I-NP O
was VBD B-VP O
stable JJ O O
at IN B-VP O
baseline JJ O O
33-36 JJ O O
throughout IN B-VP O
her PRP$ O O
hospital JJ B-NP O
admission NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
on IN B-VP O
admission NN B-NP O
An DT B-NP O
active JJ I-NP O
type NN I-NP O
and CC O O
screen NN B-NP O
was VBD B-VP O
maintained VBN O O
throughout IN B-VP O
admission NN B-NP O
No NNP I-NP O
evidence NN I-NP O
of IN B-VP O
GI NNP B-NP O
bleeding VBG O O
throughout IN B-VP O
hospitalization NN B-NP O
The DT B-NP O
patient's NN I-NP O
hematocrit NN I-NP O
was VBD B-VP O
37.7 CD O O
on IN B-VP O
admission NN B-NP O
and CC O O
33.5 CD O O
at IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
her PRP$ O O
weekly JJ B-NP B-f
Procrit NN I-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subcutaneous JJ B-NP B-mo
injection NN I-NP I-mo
on IN B-VP O
2/11/07 CD O O
prior JJ O O
to TO O O
discharge VB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
resume VB O O
iron NN B-NP B-m
supplementation NN I-NP I-m
after IN B-VP O
discharge NN B-NP O
5 CD O O
CHF: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
admission NN I-NP O
chest JJS B-NP O
x-ray NN I-NP O
was VBD B-VP O
suggestive JJ O O
of IN B-VP O
pulmonary JJ B-NP O
edema NN I-NP O
, , O O
possibly RB O O
secondary JJ O O
to TO O O
elevated VB O O
blood NN B-NP O
pressure NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
versus NN I-NP O
insufficient JJ B-NP O
diuresis NN I-NP O
at IN B-VP O
home NN B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
acute JJ B-NP O
ischemia NN I-NP O
on IN B-VP O
EKG NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
gently RB O O
diuresed VBN O O
during IN B-VP O
her PRP$ O O
admission NN B-NP O
The DT B-NP O
patient's NN I-NP O
dry JJ B-NP O
weight NN I-NP O
is VBZ O O
57 CD O O
kg NN B-NP O
The DT B-NP O
patient's NN I-NP O
weight NN I-NP O
at IN B-VP O
discharge NN B-NP O
was VBD B-VP O
61 CD O O
kg JJ B-NP O
Repeat NNP I-NP O
chest JJS B-NP O
x-ray NN I-NP O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
discharge NN B-NP O
still RB O O
showed VBD B-VP O
evidence NN B-NP O
of IN B-VP O
pulmonary JJ B-NP O
congestion NN I-NP O
and CC O O
interstitial JJ B-NP O
edema NN I-NP O
As IN B-VP O
such JJ O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
still RB O O
mildly RB O O
hypervolemic JJ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
her PRP$ O O
discharge NN B-NP O
and CC O O
was VBD B-VP O
instructed VBN O O
to TO O O
continue VB O O
gentle JJ B-NP B-r
gentle JJ I-NP B-r
gentle JJ I-NP B-r
diuresis NN I-NP O
at IN B-VP O
home NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
Lasix NNP B-NP B-m
Lasix NNP I-NP B-m
Lasix NNP I-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
daily RB O I-f
, , O O
which WDT O O
is VBZ O O
a DT B-NP O
slight JJ I-NP O
increase NN I-NP O
from IN B-VP O
her PRP$ O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
80 CD O B-do
mg NNS B-NP O
q.a.m RB O B-f
and CC O O
40 CD O B-do
mg NN B-NP I-do
q.p.m VBD B-VP B-f
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
measure VB O O
her PRP$ O O
weights NNS B-NP O
daily RB O O
and CC O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Michele NNP I-NP O
, , O O
for IN B-VP O
further JJ B-NP O
titration NN I-NP O
of IN B-VP O
her PRP$ O O
diuretic JJ B-NP O
dose NN I-NP O
6 CD O O
Hypertension: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
elevated VBN O O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
up RB O O
to TO O O
183/65 CD O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
and CC O O
improved VBN O O
over IN B-VP O
several JJ B-NP O
hours NNS I-NP O
to TO O O
the DT B-NP O
110-120s/60s-70s NNS I-NP O
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
the DT O B-r
the DT B-NP B-r
patient's NN I-NP I-r
patient's NN I-NP I-r
blood NN I-NP I-r
blood NN I-NP I-r
pressure NN I-NP I-r
pressure NN I-NP I-r
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
slightly RB O O
elevated VBN O O
from IN B-VP O
130s-150s/70s JJ O O
As IN B-VP O
such JJ O O
, , O O
the DT B-NP O
patient's NN I-NP O
valsartan NN I-NP B-m
and CC O O
Norvasc NNP B-NP B-m
were VBD B-VP O
restarted VBN O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 VBD B-VP O
The DT B-NP O
patient's NN I-NP O
Imdur NNP I-NP B-m
was VBD B-VP O
restarted VBN O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#4 VBD B-VP O
The DT B-NP O
patient's NN I-NP O
blood NN I-NP O
pressure NN I-NP O
remained VBD B-VP O
well RB O O
controlled VBN O O
during IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
her PRP$ O O
admission NN B-NP O
ranging VBG O O
from IN B-VP O
100-122/46-71 JJ O O
on IN B-VP O
her PRP$ O O
home NN B-NP B-m
regimen NNS I-NP I-m
7 CD O O
Atrial NNP B-NP O
fibrillation: NN I-NP O
With IN B-VP O
pseudoregularization NN B-NP O
The DT B-NP O
patient's NN I-NP O
rate NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
well RB O O
controlled VBN O O
The DT B-NP O
patient's NN I-NP O
Coumadin NNP I-NP B-m
was VBD B-VP O
held VBN O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
a DT B-NP O
supratherapeutic JJ I-NP O
INR NNP I-NP O
likely RB O O
secondary JJ O O
to TO O O
concurrent VB O O
antibiotic JJ B-NP B-m
use NN I-NP O
The DT B-NP O
patient's NN I-NP O
INR NNP I-NP O
trended VBD B-VP O
down RB O O
to TO O O
2.1 CD O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#4 NN I-NP O
and CC O O
she PRP O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
a DT O B-do
reduced VBN O I-do
dose NN B-NP I-do
of IN B-VP O
Coumadin NNP B-NP B-m
The DT B-NP O
patient's NN I-NP O
INR NNP I-NP O
was VBD B-VP O
2.7 CD O O
on IN B-VP O
the DT B-NP O
a.m NN I-NP O
of IN B-VP O
discharge NN B-NP O
on IN B-VP O
Coumadin NNP B-NP B-m
1 CD O B-do
mg NNS B-NP I-do
nightly RB O B-f
while IN B-VP B-du
still RB O O
on IN B-VP O
antibiotics NNS B-NP B-m
as IN B-VP O
above IN B-VP O
VNA NNP B-NP O
Services NNPS I-NP O
were VBD B-VP O
arranged VBN O O
to TO O O
measure VB O O
her PRP$ O O
INR NNP B-NP O
on IN B-VP O
3/14/07 CD O O
and CC O O
to TO O O
send VB O O
the DT B-NP O
results NNS I-NP O
to TO O O
the DT B-NP O
WSMH NNP I-NP O
Coumadin NNP I-NP O
Clinic NNP I-NP O
, , O O
300-135-5841 JJ O O
7 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency: NN I-NP O
The DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
at IN B-VP O
baseline JJ O O
2.7 CD O O
on IN B-VP O
admission NN B-NP O
and CC O O
slightly RB O O
increased VBD B-VP O
creatinine NN B-NP O
to TO O O
3.2 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
In IN B-VP O
contrast NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
BUN NNP I-NP O
was VBD B-VP O
83 CD O O
at IN B-VP O
discharge NN B-NP O
, , O O
down RB O O
from IN B-VP O
111 CD O O
on IN B-VP O
admission NN B-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
show VB O O
evidence NN B-NP O
of IN B-VP O
contraction NN B-NP O
alkalosis NN I-NP O
with IN B-VP O
bicarbonate=22 NN B-NP O
on IN B-VP O
a.m NN B-NP O
of IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient's NN I-NP O
BUN NNP I-NP O
, , O O
creatinine NN B-NP O
and CC O O
bicarbonate NN B-NP O
were VBD B-VP O
to TO O O
be VB O O
rechecked VBN O O
on IN B-VP O
3/14/07 CD O O
with IN B-VP O
the DT B-NP O
results NNS I-NP O
sent VBD B-VP O
to TO O O
Dr NNP B-NP O
Banana NNP I-NP O
( ( O O
Cardiology NNP B-NP O
) ) O O
and CC O O
Dr NNP B-NP O
Bechman NNP I-NP O
( ( O O
nephrology NN B-NP O
) ) O O
for IN B-VP O
further JJ B-NP O
titration NN I-NP O
of IN B-VP O
her PRP$ O O
medications NNS B-NP O
as IN B-VP O
needed JJ O O
8 CD O O
Diabetes: NNP B-NP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
initially RB O O
continued VBN O O
on IN B-VP O
home NN B-NP B-do
dose NN I-NP I-do
Lantus NNP I-NP B-m
and CC O O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP B-m
Standing VBG O O
NovoLog NNP B-NP B-m
insulin NN I-NP I-m
q.a.c NN I-NP B-f
was VBD B-VP O
reinitiated VBN O O
as IN B-VP O
the DT B-NP O
patient's NN I-NP O
p.o NN I-NP O
intake NN I-NP O
improved VBD B-VP O
The DT B-NP O
patient's NN I-NP O
Lantus NNP I-NP B-m
dose NN I-NP O
was VBD B-VP O
titrated VBN O B-do
up RP O I-do
to TO O O
improve VB O O
glucose JJ B-NP B-r
control NN I-NP O
during IN B-VP O
admission NN B-NP O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
experienced VBD B-VP O
intermittent JJ B-NP O
hypoglycemia NN I-NP O
at IN B-VP O
increased JJ B-NP B-do
doses NNS I-NP I-do
of IN B-VP O
Lantus NNP B-NP B-m
Lantus NNP I-NP B-m
and CC O O
was VBD B-VP O
returned VBN O O
to TO O O
her PRP$ O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
8 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
nightly RB O B-f
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
returned VBN O O
to TO O O
her PRP$ O O
home NN B-NP O
insulin NN I-NP B-m
regimen NNS I-NP O
of IN B-VP O
Lantus NNP B-NP B-m
8 CD O B-do
units NNS B-NP I-do
nightly RB O B-f
plus CC O O
NovoLog NNP B-NP B-m
NovoLog NNP I-NP B-m
NovoLog NNP I-NP B-m
4 CD O B-do
units NNS B-NP I-do
with IN B-VP B-f
breakfast NN B-NP O
, , O O
4 CD O B-do
units NNS B-NP I-do
with IN B-VP B-f
lunch NN B-NP I-f
and CC O O
5 CD O B-do
units NNS B-NP I-do
with IN B-VP B-f
dinner NN B-NP I-f
plus CC O O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
continue VB O O
to TO O O
monitor VB O O
her PRP$ O O
blood NN B-NP O
glucose NN I-NP O
with IN B-VP O
meals NNS B-NP O
PROPHYLAXIS: NNP I-NP O
TEDs/Coumadin NNP I-NP B-m
, , O O
PPI NNP B-NP B-m
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
CONTACT: NNP I-NP O
Florencio NNP I-NP O
Kisto NNP I-NP O
, , O O
daughter/healthcare NN B-NP O
proxy NN I-NP O
, , O O
cell NN B-NP O
618-098-0834 CD O O
, , O O
home NN B-NP O
649-549-0700 JJ B-NP O
DISCHARGE NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Vital NNP I-NP O
signs: NN I-NP O
Afebrile NNP I-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
65 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
122/46 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
96% CD O O
room NN B-NP O
air NN I-NP O
General: NNP I-NP O
Breathing NNP I-NP O
comfortably RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Chest: NNP I-NP O
Bilateral NNP I-NP O
BASILAR NNP I-NP O
Rales NNP I-NP O
right RB O O
greater JJR O O
than IN B-VP O
left VBD B-VP O
Heart: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
3/6 CD O O
mid NN B-NP O
peaking VBG O O
murmur NN B-NP O
at IN B-VP O
left JJ B-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
heard NN I-NP O
throughout IN B-VP O
, , O O
external JJ B-NP O
jugular NN I-NP O
venous JJ B-NP O
distention NN I-NP O
Abdomen: NNP I-NP O
Soft NNP I-NP O
, , O O
nontender NN B-NP O
and CC O O
nondistended VBD B-VP O
Positive NNP B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities: NNP B-NP O
Trace NNP I-NP O
bilateral JJ B-NP O
pedal NN I-NP O
edema NN I-NP O
, , O O
positive JJ B-NP O
pigmentation NN I-NP O
changes NNS I-NP O
of IN B-VP O
shins NNS B-NP O
consistent JJ O O
with IN B-VP O
venous JJ B-NP O
stasis NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Norvasc NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.a.m VBD B-VP B-f
2 CD O O
Norvasc NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
3 CD O O
Azithromycin NNP B-NP B-m
250 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
x6 NN I-NP B-du
doses VBZ O I-du
4 CD O O
Caltrate NNP B-NP B-m
600 CD O I-m
plus CC O I-m
D NNP B-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o VB O B-mo
twice RB O B-f
daily RB O I-f
5 CD O O
Cefpodoxime NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
x6 NN I-NP B-du
doses VBZ O I-du
6 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
daily RB O I-f
as IN B-VP I-f
needed VBN O I-f
, , O O
constipation NN B-NP B-r
7 CD O O
Procrit NNP B-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subcutaneous JJ B-NP B-mo
q JJ I-NP B-f
week NN I-NP I-f
8 CD O O
Nexium NN B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
9 CD O O
Ferrous JJ B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
10 CD O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
twice RB O B-f
daily RB O I-f
11 CD O O
NovoLog NNP B-NP B-m
sliding VBG O B-do
scale JJ O I-do
subcutaneous JJ O B-mo
with IN B-VP B-f
meals NNS B-NP I-f
12 CD O O
NovoLog NNP B-NP B-m
NovoLog NNP I-NP B-m
4 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
subcutaneous JJ O B-mo
with IN B-VP O
breakfast NN B-NP O
and CC O O
with IN B-VP O
lunch NN B-NP O
, , O O
5 CD O B-do
units NNS B-NP I-do
with IN B-VP B-f
dinner NN B-NP I-f
13 CD O O
Insulin NNP B-NP B-m
, , O O
glargine NN B-NP B-m
8 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
daily JJ O B-f
14 CD O O
Isosorbide NNP B-NP B-m
mononitrate NN I-NP I-m
30 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
daily RB O I-f
15 CD O O
Lactobacillus NNP B-NP B-m
two CD O B-do
tablets NNS B-NP I-do
p.o VBP O B-mo
three CD O B-f
times NNS B-NP I-f
daily JJ B-NP I-f
x25 NNP I-NP B-du
doses VBZ O I-du
16 CD O O
Flagyl NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.8 NN I-NP B-f
h NN I-NP I-f
x19 NNP I-NP B-du
doses VBZ O I-du
17 CD O O
Senna NNP B-NP B-m
tablets NNS I-NP I-m
one CD O B-do
tablet NN B-NP I-do
p.o VB O B-mo
twice RB O B-f
daily RB O I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
constipation NN B-NP B-r
18 CD O O
Sevelamer NNP B-NP B-m
400 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m VBD B-VP B-f
19 CD O O
Diovan NNP B-NP B-m
120 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
20 CD O O
Coumadin NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.p.m NN I-NP B-f
( ( O O
levels NNS B-NP O
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
the DT B-NP O
HCVMC NNP I-NP O
Coumadin NNP I-NP O
Clinic NNP I-NP O
) ) O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
eScription NN I-NP O
document: VBD B-VP O
6-7041125 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MILANI NNP I-NP O
, , O O
HARLAND NNP B-NP O
Attending: NNP I-NP O
NALDER NNP I-NP O
, , O O
MATHEW NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
5063364 CD O O
D: NNP B-NP O
4/26/07 CD O O
T: NNP B-NP O
4/26/07 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#505217 VBZ O O
275113133 CD O O
HNOH NNP B-NP O
67641761 CD O O
146738 CD O O
6/11/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/16/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/25/1995 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
RULE NNP I-NP O
OUT NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
NONINSULIN NNP I-NP O
DEPENDENT NNP I-NP O
DIABETES NNP I-NP O
2 CD O O
RIGHT NNP B-NP O
GREAT NNP I-NP O
TOE NNP I-NP O
ULCERATION NNP I-NP O
WITH NNP I-NP O
LYMPHANGITIS NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
55 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
noninsulin JJ B-NP O
dependent JJ I-NP O
diabetes NNS I-NP O
mellitus VBP O O
, , O O
a DT B-NP O
significant JJ I-NP O
heavy JJ I-NP O
smoking NN I-NP O
history NN I-NP O
, , O O
and CC O O
he PRP O O
has VBZ O O
a DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
cardiac JJ B-NP O
disease NN I-NP O
who WP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
and CC O O
worsening VBG O O
right RB O O
great JJ B-NP O
toe JJ I-NP O
ulceration NN I-NP O
with IN B-VP O
lymphangitis NN B-NP O
In IN B-VP O
March NNP B-NP O
, , O O
Mr NNP B-NP O
Shroyer NNP I-NP O
stubbed VBD B-VP O
his PRP$ O O
right JJ B-NP O
great JJ I-NP O
toe NN I-NP O
and CC O O
subsequently RB O O
developed JJ B-NP O
ulceration NN I-NP O
He PRP O O
was VBD B-VP O
first RB O O
seen VBN O O
for IN B-VP O
this DT B-NP O
ulceration NN I-NP O
when WRB O O
it PRP O O
began VBD B-VP O
to TO O O
have VB O O
serosanguineous JJ B-NP O
fluid NN I-NP O
leakage NN I-NP O
Over IN B-VP O
the DT B-NP O
past JJ I-NP O
month NN I-NP O
he PRP O O
has VBZ O O
received VBN O O
several JJ B-NP O
debridements NNS I-NP O
and CC O O
completed VBD B-VP O
a DT B-NP B-du
course NN I-NP I-du
of IN B-VP O
Cipro NNP B-NP B-m
yesterday NN I-NP O
A NNP I-NP O
few JJ B-NP O
days NNS I-NP O
prior RB O O
to TO O O
admission VB O O
he PRP O O
began VBD B-VP O
to TO O O
have VB O O
left-sided JJ B-NP O
chest NN I-NP O
pressure NN I-NP O
on IN B-VP O
exertion NN B-NP O
with IN B-VP O
the DT B-NP O
pain NN I-NP O
resolving VBG O O
with IN B-VP O
rest NN B-NP O
The DT B-NP O
episode NN I-NP O
lasted VBD B-VP O
30 CD O O
seconds NNS B-NP O
to TO O O
two CD O O
minutes NNS B-NP O
and CC O O
were VBD B-VP O
accompanied VBN O O
by IN B-VP O
posterior JJ B-NP O
neck NN I-NP O
pain NN I-NP O
and CC O O
dizziness NN B-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
he PRP O O
developed VBD B-VP O
chills NNS B-NP O
with IN B-VP O
rigors NNS B-NP O
, , O O
nausea NN B-NP O
and CC O O
vomiting NN B-NP O
of IN B-VP O
food NN B-NP O
without IN B-VP O
blood NN B-NP O
He PRP O O
has VBZ O O
had VBN O O
2-3 JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
soaking VBG O O
night NN B-NP O
sweats NNS I-NP O
in IN B-VP O
the DT O O
past JJ O O
two CD O O
weeks NNS B-NP O
For IN B-VP O
the DT O O
past JJ O O
two CD O O
days NNS B-NP O
he PRP O O
has VBZ O O
noted VBN O O
redness NN B-NP O
and CC O O
swelling NN B-NP O
of IN B-VP O
his PRP$ O O
right JJ B-NP O
foot NN I-NP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
palpitations NNS B-NP O
, , O O
weight JJ B-NP O
loss NN I-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
diarrhea NN B-NP O
, , O O
melena NN B-NP O
, , O O
or CC O O
hematochezia VB O O
An DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1995 CD O O
, , O O
was VBD B-VP O
limited VBN O O
by IN B-VP O
back RB O O
pain NN B-NP O
, , O O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
in IN B-VP O
the DT O O
220 CD O O
range NN B-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
in IN B-VP O
150 CD O O
range NN B-NP O
, , O O
and CC O O
frequent JJ B-NP O
premature NN I-NP O
ventricular JJ B-NP O
beats NNS I-NP O
, , O O
but CC O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
negative JJ O O
for IN B-VP O
ischemia NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
at IN B-VP O
VRBCMH NNP B-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
and CC O O
was VBD B-VP O
given VBN O O
a DT B-NP B-du
dose NN I-NP I-du
of IN B-VP O
oxacillin NN B-NP B-m
and CC O O
sent VBD B-VP O
to TO O O
the DT O O
the DT B-NP O
Sidecrestso NNP I-NP O
Community NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
IV NNP B-NP B-mo
antibiotics NNS I-NP B-m
and CC O O
work-up JJ B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
( ( O O
1 CD O O
) ) O O
Back NNP B-NP O
trauma NN I-NP O
with IN B-VP O
sciatica NN B-NP O
following VBG O O
back RB O O
surgery NN B-NP O
( ( O O
2 CD O O
) ) O O
Noninsulin NNP B-NP O
dependent NN I-NP O
diabetes NNS I-NP O
( ( O O
3 CD O O
) ) O O
Peripheral NNP B-NP O
neuropathy NN I-NP O
( ( O O
4 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
colon NN I-NP O
carcinoma NN I-NP O
with IN B-VP O
resection NN B-NP O
in IN B-VP O
1981 CD O O
( ( O O
5 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
appendectomy NN I-NP O
( ( O O
6 CD O O
) ) O O
Hearing NNP B-NP O
loss NN I-NP O
in IN B-VP O
his PRP$ O O
left JJ B-NP O
ear JJ I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Tylenol NNP I-NP B-m
#3 NNP I-NP I-m
and CC O O
glyburide RB O B-m
10 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
day NN I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
&amp; NNP I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT O O
40 CD O O
year NN B-NP O
history NN I-NP O
of IN B-VP O
smoking VBG O O
four CD O O
packs NNS B-NP O
per IN B-VP O
day NN B-NP O
, , O O
currently RB O O
smoking VBG O O
1-1/2 JJ B-NP O
packs NNS I-NP O
per IN B-VP O
day NN B-NP O
No NNP I-NP O
alcohol NN I-NP O
use NN I-NP O
No NNP I-NP O
IV NNP I-NP O
drugs NNS I-NP O
He PRP O O
is VBZ O O
a DT B-NP O
retired JJ I-NP O
shift NN I-NP O
chief NN I-NP O
for IN B-VP O
a DT B-NP O
local JJ I-NP O
prison NN I-NP O
on IN B-VP O
disability NN B-NP O
due JJ O O
to TO O O
back VB O O
pain NN B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
married JJ O O
and CC O O
lives VBZ O O
with IN B-VP O
his PRP$ O O
wife NN B-NP O
and CC O O
a DT O O
two CD O O
year NN B-NP O
old JJ B-NP O
son NN I-NP O
He PRP O O
is VBZ O O
active JJ O O
around IN B-VP O
the DT B-NP O
house NN I-NP O
and CC O O
does VBZ O O
seasonal JJ B-NP O
work NN I-NP O
with IN B-VP O
plant NN B-NP O
care NN I-NP O
He PRP O O
has VBZ O O
two CD O O
adult NN B-NP O
children NNS I-NP O
He PRP O O
has VBZ O O
a DT B-NP O
brother NN I-NP O
who WP O O
died VBD B-VP O
of IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
at IN B-VP O
the DT B-NP O
age NN I-NP O
of IN B-VP O
48 CD O O
A NNP B-NP O
cousin NN I-NP O
died VBD B-VP O
of IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
in IN B-VP O
his PRP$ O O
mid NN B-NP O
40s CD O O
A NNP B-NP O
sister NN I-NP O
died NN I-NP O
of IN B-VP O
breast NN B-NP O
cancer NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
100.6 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
130/80 CD O O
, , O O
and CC O O
pulse RB O O
68 CD O O
NECK: NNP B-NP O
No NNP I-NP O
jugular NN I-NP O
venous JJ B-NP O
distention NN I-NP O
, , O O
no DT B-NP O
bruits NNS I-NP O
, , O O
no DT B-NP O
masses NNS I-NP O
, , O O
no DT B-NP O
lymphadenopathy JJ I-NP O
LUNGS: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation NN B-NP O
and CC O O
percussion NN B-NP O
CARDIAC: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
Normal NNP I-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
A NNP I-NP O
1/6 CD O O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left NN I-NP O
lower RBR O O
sternal JJ B-NP O
base NN I-NP O
No NNP I-NP O
changes NNS I-NP O
with IN B-VP O
maneuvers NNS B-NP O
No DT B-NP O
radiation NN I-NP O
No RB O O
S3 NNP B-NP O
or CC O O
S4 NNP B-NP O
auscultated VBD B-VP O
ABDOMEN: NNP B-NP O
Benign NNP I-NP O
EXTREMITIES: NNP I-NP O
Trigger NNP I-NP O
finger NN I-NP O
of IN B-VP O
the DT O O
left JJ O O
fourth JJ O O
digit VB O O
A DT O O
1 CD O O
cm NN B-NP O
deep JJ B-NP O
ulcer NN I-NP O
with IN B-VP O
surrounding VBG O O
collar JJ O O
callous JJ O O
at IN B-VP O
the DT B-NP O
tip NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
great JJ I-NP O
toe NN I-NP O
with IN B-VP O
erythema PDT O O
The DT B-NP O
ulcer JJ I-NP O
base NN I-NP O
is VBZ O O
red JJ O O
, , O O
nonpurulent JJ O O
, , O O
and CC O O
there EX O O
is VBZ O O
trace JJ B-NP O
edema NN I-NP O
NEURO: NNP I-NP O
Left VBD B-VP O
ear JJ O O
with IN B-VP O
decreased JJ B-NP O
hearing NN I-NP O
compared VBN O O
to TO O O
the DT B-NP O
right JJ I-NP O
Cranial NNP I-NP O
nerves NNS I-NP O
II-XII NNP I-NP O
otherwise RB O O
grossly RB O O
intact JJ O O
No DT B-NP O
sensation NN I-NP O
to TO O O
touch VB O O
below IN B-VP O
the DT B-NP O
knees NNS I-NP O
DTRs NNP I-NP O
are VBP O O
2+ CD O O
and CC O O
bilaterally RB O O
symmetric JJ O O
in IN B-VP O
the DT B-NP O
upper JJ I-NP O
extremities NNS I-NP O
DTRs NNP I-NP O
are VBP O O
zero CD O O
in IN B-VP O
the DT B-NP O
right NN I-NP O
and CC O O
left VBD B-VP O
lower JJR B-NP O
extremities NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Sodium NNP I-NP O
135 CD O O
, , O O
potassium NN B-NP O
4.0 CD O O
, , O O
chloride RB O O
98 CD O O
, , O O
bicarb NN B-NP O
22 CD O O
, , O O
BUN NNP B-NP O
16 CD O O
, , O O
creatinine NN B-NP O
1.3 CD O O
, , O O
and CC O O
glucose VB O O
304 CD O O
White NNP B-NP O
count NN I-NP O
16.14 CD O O
, , O O
25 CD O O
bands NNS B-NP O
, , O O
68 CD O O
polys NN B-NP O
, , O O
and CC O O
2 CD O O
lymphs NN B-NP O
Hematocrit NNP I-NP O
43.2 CD O O
and CC O O
platelet NN B-NP O
count NN I-NP O
was VBD B-VP O
180 CD O O
CK NNP B-NP O
is VBZ O O
486 CD O O
, , O O
MB NNP B-NP O
5.1 CD O O
PT/PTT NNP B-NP O
11.6 CD O O
and CC O O
27.6 CD O O
INR NNP B-NP O
0.9 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Right JJ B-NP O
foot NN I-NP O
x-ray NN I-NP O
shows NNS I-NP O
soft JJ B-NP O
tissue NN I-NP O
swelling VBG O O
in IN B-VP O
the DT B-NP O
first JJ I-NP O
toe NN I-NP O
No NNP I-NP O
bony NN I-NP O
changes NNS I-NP O
EKG NNP I-NP O
on IN B-VP O
admission NN B-NP O
showed VBD B-VP O
no DT B-NP O
ischemic JJ I-NP O
changes NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
and CC O O
was VBD B-VP O
treated VBN O O
for IN B-VP O
right RB O B-r
right JJ O B-r
right RB O B-r
toe NN B-NP I-r
toe NN I-NP I-r
toe NN I-NP I-r
cellulitis NN I-NP I-r
cellulitis NN I-NP I-r
cellulitis NN I-NP I-r
with IN B-VP O
IV NNP B-NP B-mo
IV NNP I-NP B-mo
IV NNP I-NP B-mo
antibiotics NNS I-NP B-m
of IN B-VP O
gentamicin NN B-NP B-m
and CC O O
Clindamycin NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
placed VBN O O
on IN B-VP O
atenolol JJ B-NP B-m
atenolol NN I-NP B-m
with IN B-VP O
the DT B-NP O
dose NN I-NP O
increased VBD B-VP O
to TO O O
75 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
day NN I-NP I-f
On IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
switched VBN O O
from IN B-VP O
Nitropaste NNP B-NP B-m
to TO O O
Isordil NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d IN B-VP B-f
The DT B-NP O
patient's NN I-NP O
glyburide NN I-NP B-m
glyburide NN I-NP B-m
was VBD B-VP O
also RB O O
increased VBN O O
to TO O O
20 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
day NN I-NP I-f
The DT B-NP O
patient NN I-NP O
underwent NN I-NP O
MIBI NNP I-NP O
which WDT O O
showed VBD B-VP O
a DT O O
large JJ O O
fixed VBN O O
posterior JJ B-NP O
lesion NN I-NP O
with IN B-VP O
peri-infarct JJ B-NP O
ischemia NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
medically RB O O
stable JJ O O
and CC O O
capable JJ O O
of IN B-VP O
being VBG O O
managed VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
He PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
on IN B-VP O
2/5/95 CD O O
MEDICATIONS: NNP B-NP O
On IN B-VP O
discharge NN B-NP O
included VBD B-VP O
atenolol NN B-NP B-m
, , O O
75 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
aspirin NN B-NP B-m
, , O O
325 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Glyburide NNP B-NP B-m
, , O O
20 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
, , O O
Tylenol NNP B-NP B-m
#3 NNP I-NP I-m
, , O O
two CD O B-do
tablets NNS B-NP I-do
po VBP O B-mo
x JJ O B-f
one CD O I-f
p.r.n NN B-NP I-f
for IN B-VP O
pain NN B-NP O
, , O O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
, , O O
p.r.n VBP O B-f
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr NNP B-NP O
Netti NNP I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
and CC O O
with IN B-VP O
Dr NNP B-NP O
Frasso NNP I-NP O
of IN B-VP O
AMH NNP B-NP O
Cardiology NNP I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
Dictated NNP I-NP O
By: NNP I-NP O
EDWARDO NNP I-NP O
J NNP I-NP O
KNORI NNP I-NP O
, , O O
M.D NNP B-NP O
IF98 NNP I-NP O
Attending: NNP I-NP O
LUTHER NNP I-NP O
C NNP I-NP O
YAMAKI NNP I-NP O
, , O O
M.D NNP B-NP O
JW06 NNP I-NP O
YN997/9798 NNP I-NP O
Batch: NNP I-NP O
91184 CD O O
Index NNP B-NP O
No NNP I-NP O
UURKGW1LHR NNP I-NP O
D: NNP I-NP O
8/1/95 CD O O
T: NNP B-NP O
8/1/95 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#506934 VBZ O O
222107294 CD O O
TSMC NNP B-NP O
86070162 CD O O
7180054 CD O O
5/29/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
HO NNP I-NP O
evaluation NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/8/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/27/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
ORBIN NNP I-NP O
, , O O
EARLE NNP B-NP O
B NNP I-NP O
460-45-53-2 JJ B-NP O
Bend NNP I-NP O
Uxcallcon NNP I-NP O
Service: NNP I-NP O
GGI NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/15/06 CD O O
AT NNP B-NP O
09:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BLANDO NNP I-NP O
, , O O
BRUCE NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ALBUTEROL NNP I-NP B-m
ALBUTEROL NNP I-NP B-m
INHALER NNP I-NP I-m
INHALER NNP I-NP I-m
2 CD O B-do
2 CD O B-do
PUFF NNP B-NP I-do
PUFF NNP I-NP I-do
INH NNP I-NP B-mo
INH NNP I-NP B-mo
QID NNP I-NP B-f
QID NNP I-NP B-f
PRN NNP I-NP O
Shortness NNP I-NP B-r
of IN B-VP I-r
Breath NNP B-NP I-r
, , O O
Wheezing NNP B-NP B-r
LANTUS NNP I-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
60 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
10/21 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
npo JJ B-NP O
ROXICET NNP I-NP B-m
ORAL NNP I-NP I-m
SOLUTION NNP I-NP I-m
( ( O I-m
OXYCODONE+APAP NNP B-NP I-m
LIQUID NNP I-NP I-m
) ) O I-m
5-10 JJ B-NP B-do
MILLILITERS NNP I-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
ZANTAC NNP I-NP B-m
SYRUP NNP I-NP I-m
( ( O I-m
RANITIDINE NNP B-NP I-m
HCL NNP I-NP I-m
SYRUP NNP I-NP I-m
) ) O I-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ACTIGALL NNP I-NP B-m
( ( O I-m
URSODIOL NNP B-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
if IN B-VP O
gallbladder NN B-NP O
still RB O O
in- JJ B-NP O
start NN I-NP O
taking VBG O O
2 CD O O
weeks NNS B-NP O
after IN B-VP O
discharge NN B-NP O
LEVAQUIN NNP I-NP B-m
( ( O I-m
LEVOFLOXACIN NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP O
products NNS I-NP O
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-m
or CC O O
ciprofloxacin NN B-NP B-m
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
Alert NNP I-NP O
overridden: MD O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
9/15/06 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
PROCHLORPERAZINE NNP I-NP B-m
&amp; NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
DIET: NNP I-NP O
stage NN I-NP O
II NNP I-NP O
bypass NN I-NP O
diet JJ B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Please NNP I-NP O
call VB O O
Dr NNP B-NP O
Machesky NNP I-NP O
immediately RB O O
to TO O O
schedule VB O O
follow-up JJ B-NP O
appiontment NN I-NP O
, , O O
Please NNP B-NP O
follow-up NN I-NP O
with IN B-VP O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
for IN B-VP O
blood NN B-NP O
sugar NN I-NP O
check NN I-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
morbid NN I-NP O
obesity NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
HO NNP B-NP O
evaluation NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
none NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
laparoscopic VBD B-VP O
roux-en-y JJ B-NP O
gastric JJ I-NP O
bypass NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Patient NNP I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Toott NNP I-NP O
Hospital NNP I-NP O
surgery NN I-NP O
service NN I-NP O
after IN B-VP O
undergoing VBG O O
LRYGB NNP B-NP O
No NNP I-NP O
concerning VBG O O
intraoperative JJ B-NP O
events NNS I-NP O
occurred; JJ B-NP O
please NN I-NP O
see VB O O
dictated JJ B-NP O
operative JJ I-NP O
note NN I-NP O
for IN B-VP O
details NNS B-NP O
Patient NNP I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
from IN B-VP O
the DT B-NP O
PACU NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
Patient NNP I-NP O
had VBD B-VP O
adequate JJ B-NP O
pain NN I-NP O
control NN I-NP O
and CC O O
no DT B-NP O
issues NNS I-NP O
overnight VBD B-VP O
into IN B-VP O
POD1 NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
UGI NNP I-NP O
on IN B-VP O
POD1 NNP B-NP O
that WDT O O
was VBD B-VP O
negative JJ O O
for IN B-VP O
obstruction NN B-NP O
or CC O O
leak NN B-NP O
, , O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
Stage NN I-NP O
I PRP O O
diet VBP O O
which WDT O O
was VBD B-VP O
tolerated VBN O O
well RB O O
The DT B-NP O
following JJ I-NP O
day NN I-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
Stage NNP I-NP O
II NNP I-NP O
diet VBD B-VP O
that DT O O
was VBD B-VP O
tolerated VBN O O
as RB O O
well RB O O
, , O O
but CC O O
patient JJ O O
initially RB O O
struggled VBN O O
to TO O O
have VB O O
adequate JJ B-NP O
intake NN I-NP O
Incision NNP I-NP O
erytematous JJ O O
, , O O
with IN B-VP O
serous JJ B-NP O
discharge NN I-NP O
by IN B-VP O
POD NNP B-NP O
2 CD O O
requiring VBG O O
multiple NNS B-NP O
but CC O O
decreasing VBG O O
dressing NN B-NP O
changes NNS I-NP O
Continued VBD B-VP O
dressing VBG O O
wound NN B-NP O
, , O O
DSD NNP B-NP O
with IN B-VP O
improvement NN B-NP O
Sugars NNP I-NP O
remained VBD B-VP O
high JJ O O
in IN B-VP O
200's CD O O
during IN B-VP O
admission NN B-NP O
Pt NNP I-NP O
seen VBN O O
by IN B-VP O
Endocrine NNP B-NP O
service NN I-NP O
and CC O O
sugars NNS B-NP O
finally RB O O
improving VBG O O
with IN B-VP O
lantus JJ O B-m
60 CD O B-do
sc NN B-NP B-mo
hs NN I-NP B-f
She PRP O O
also RB O O
had VBD B-VP O
some DT B-NP O
difficulties NNS I-NP O
with IN B-VP O
urination NN B-NP O
on IN B-VP O
POD4 NNP B-NP O
and CC O O
required VBD B-VP O
a DT B-NP O
foley JJ I-NP O
catheter NN I-NP O
for IN B-VP O
about IN B-VP O
a DT B-NP O
day NN I-NP O
Her NNP I-NP O
foley NN I-NP O
was VBD B-VP O
d/c'd VBN O O
the DT B-NP O
AM NNP I-NP O
before IN B-VP O
she PRP O O
was VBD B-VP O
d/c'd NN B-NP O
and CC O O
she PRP O O
urinated VBD B-VP O
without IN B-VP O
incident JJ B-NP O
Patient NNP I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
UTI NNP I-NP O
at IN B-VP O
discharge NN B-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
three CD O B-du
day NN B-NP I-du
course NN I-NP I-du
of IN B-VP O
levaquin JJ B-NP B-m
Remainder NNP I-NP O
of IN B-VP O
hospital JJ B-NP O
course NN I-NP O
unremarkable JJ O O
, , O O
and CC O O
the DT B-NP O
pateint NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
, , O O
tolerating VBG O O
stage NN B-NP O
II NNP I-NP O
diet RB O O
well RB O O
, , O O
ambulating VBG O O
, , O O
voiding VBG O O
independently RB O O
, , O O
and CC O O
with IN B-VP O
adequate JJ B-NP O
pain NN I-NP O
control NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
explicit JJ B-NP O
instructions NNS I-NP O
to TO O O
follow-up NN B-NP O
in IN B-VP O
clinic NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Truglia NNP I-NP O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
Pt NNP I-NP O
sent VBD B-VP O
home NN B-NP O
with IN B-VP O
VNA NNP B-NP O
for IN B-VP O
wound NN B-NP O
checks NNS I-NP O
and CC O O
close JJ B-NP O
sugar NN I-NP O
control NN I-NP O
with IN B-VP O
instructions NNS B-NP O
to TO O O
f/u VB O O
with IN B-VP O
Leland NNP B-NP O
Bredeson NNP I-NP O
by IN B-VP O
phone NN B-NP O
and CC O O
record NN B-NP O
fingersticks NNS I-NP O
She PRP O O
should MD O O
f/u VB O O
with IN B-VP O
her PRP O O
PCP NNP B-NP O
if IN B-VP O
she PRP O O
has VBZ O O
further JJ B-NP O
probelms NNS I-NP O
with IN B-VP O
urination JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
-You NNP I-NP O
may MD O O
shower VB O O
, , O O
but CC O O
do VBP O O
not RB O O
bathe VB O O
, , O O
swim VB O O
or CC O O
otherwise VB O O
immerse JJ O O
your PRP$ O O
incision NN B-NP O
-Do IN B-VP O
not RB O O
lift VB O O
anything NN B-NP O
heavier JJR O O
than IN B-VP O
a DT B-NP O
phone NN I-NP O
book NN I-NP O
-Do NNP I-NP O
not RB O O
drive VB O O
or CC O O
drink VB O O
alcohol NN B-NP O
while IN B-VP O
taking VBG O O
narcotic JJ B-NP B-m
pain NN I-NP I-m
medication NN I-NP I-m
-Resume IN B-VP O
all DT O O
of IN B-VP O
your PRP$ O B-m
home NN B-NP I-m
medications NNS I-NP I-m
-If VBP O O
you PRP O O
have VBP O O
fevers NNS B-NP O
&gt; VBP O O
101.5 CD O O
F NNP B-NP O
, , O O
vomiting VBG O O
, , O O
or CC O O
increased VBD B-VP O
redness NN B-NP O
, , O O
swelling VBG O O
, , O O
or CC O O
discharge NN B-NP O
from IN B-VP O
your PRP$ O O
incision NN B-NP O
, , O O
call VB O O
your PRP$ O O
doctor NN B-NP O
or CC O O
go VB O O
to TO O O
the DT B-NP O
nearest JJS I-NP O
emergency NN I-NP O
room NN I-NP O
-VNA: NNP I-NP O
please NN I-NP O
check VB O O
blood NN B-NP O
sugar NN I-NP O
daily RB O O
and CC O O
call VB O O
results NNS B-NP O
into IN B-VP O
MD NNP B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
LEMME NNP I-NP O
, , O O
CRISTOBAL NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
XU023 NNP B-NP O
) ) O O
9/15/06 CD O O
@ $ O O
10 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#508921 VBZ O O
515984806 CD O O
JMH NNP B-NP O
10446912 CD O O
917465 CD O O
5/1/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
Infected NNP I-NP O
R NNP I-NP O
THR NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/1/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/15/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
FOSSELMAN NNP I-NP O
, , O O
JONAS NNP B-NP O
G NNP I-NP O
312-34-40-6 JJ B-NP O
Dier NNP I-NP O
Drive NNP I-NP O
, , O O
Villevo NNP B-NP O
Ttawi NNP I-NP O
Tlloa NNP I-NP O
Belle NNP I-NP O
, , O O
North NNP B-NP O
Dakota NNP I-NP O
03596 CD O O
Service: NNP B-NP O
ORT NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
6/6/01 CD O O
AT NNP B-NP O
03:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Eval NNP I-NP O
by IN B-VP O
Cardiology NNP B-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BRINIUS NNP I-NP O
, , O O
MIKEL NNP B-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
650 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
headache NN I-NP B-r
VENTOLIN NNP I-NP B-m
( ( O I-m
ALBUTEROL NNP B-NP I-m
INHALER NNP I-NP I-m
) ) O I-m
1-2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
PRN NNP I-NP O
sob/wheeze NN I-NP B-r
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
CEFTRIAXONE NNP I-NP B-m
2 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
IV NNP I-NP B-mo
QD NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
2 CD O I-du
COLACE NNP B-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ENALAPRIL NNP I-NP B-m
( ( O I-m
ENALAPRIL NNP B-NP I-m
MALEATE NNP I-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PERCOCET NNP I-NP B-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
pain NN I-NP B-r
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
ISOSORBIDE NNP B-NP B-m
MONONITRATE NNP I-NP I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
Number NNP B-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
15 CD O O
NEXIUM NNP B-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
No NNP I-NP O
Restrictions NNP I-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
after IN B-VP O
eval NN B-NP O
by IN B-VP O
Dr NNP B-NP O
Ashurst NNP I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Lobato NNP I-NP O
9/24/01 CD O O
, , O O
VH NNP B-NP O
pre-admit NN I-NP O
for IN B-VP O
OR NNP B-NP O
I&amp;D/removal NNP I-NP O
hardware NN I-NP O
9/24/01 CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Shellfish NNP I-NP O
, , O O
Morphine NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Infected NNP I-NP O
R NNP I-NP O
THR NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Infected VBD B-VP O
R NNP B-NP O
THR NNP I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
hodgkins VBZ O O
lymphoma FW O O
( ( O O
Hodgkins NNP B-NP O
disease NN I-NP O
) ) O O
Asthma NNP B-NP O
( ( O O
asthma NN B-NP O
) ) O O
R NNP B-NP O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
( ( O O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
) ) O O
septic JJ B-NP O
joint NN I-NP O
( ( O O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
) ) O O
non NN B-NP O
Q NNP I-NP O
wave VBP O O
MI; NNP B-NP O
Extensive NNP I-NP O
CAD NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
CT-guided NNP I-NP O
aspiration NN I-NP O
R NNP I-NP O
hip NN I-NP O
per IN B-VP O
Radiology NNP B-NP O
4/1/01 CD O O
OTHER NNP B-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
IV NNP B-NP B-mo
Abx NNP I-NP B-m
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Admitted NNP I-NP O
from IN B-VP O
office NN B-NP O
4/1/01 CD O O
for IN B-VP O
infected VBN O O
L NNP B-NP O
THR NNP I-NP O
Aspiration NNP I-NP B-r
demonstrated VBD B-VP O
purulent JJ B-NP O
material NN I-NP O
Started VBD B-VP O
on IN B-VP O
Ceftriaxone NNP B-NP B-m
per IN B-VP O
ID NNP B-NP O
consult NN I-NP O
recs NN I-NP O
MIC NNP I-NP O
to TO O O
both DT B-NP O
PCN NNP I-NP B-m
and CC O O
Ceftriaxone NNP B-NP B-m
pending VBG O O
MRI NNP B-NP O
of IN B-VP O
pelvis NN B-NP O
completed VBN O O
10/10/01 CD O O
as IN B-VP O
pre-op JJ B-NP O
eval NN I-NP O
TU NNP I-NP O
Cardiology NNP I-NP O
was VBD B-VP O
consulted VBN O O
for IN B-VP O
pre-op JJ B-NP O
clearance NN I-NP O
given VBN O O
extensive JJ B-NP O
H/O NNP I-NP O
cardiomyopathy NN I-NP O
and CC O O
unstentable JJ B-NP O
CAD NNP I-NP O
per IN B-VP O
last JJ B-NP O
cardiac JJ I-NP O
cath NN I-NP O
8/7 CD O O
On IN B-VP O
further JJ B-NP O
d/w NN I-NP O
PT NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
adament JJ O O
about IN B-VP O
being VBG O O
allowed VBN O O
to TO O O
be VB O O
D/C NNP B-NP O
home NN I-NP O
on IN B-VP O
Abx NNP B-NP B-m
for IN B-VP O
August NNP B-NP O
holiday NN I-NP O
Given NNP I-NP O
that IN B-VP O
his PRP$ O O
clinical JJ B-NP O
picture NN I-NP O
was VBD B-VP O
much RB O O
improved VBN O O
on IN B-VP O
antibiotics NNS B-NP B-m
, , O O
both DT B-NP O
Dr NNP I-NP O
Salkeld NNP I-NP O
and CC O O
ID NNP B-NP O
MD NNP I-NP O
agreed VBD B-VP O
to TO O O
this DT O O
on IN B-VP O
provision NN B-NP O
that IN B-VP O
he PRP O O
return VB O O
immediately RB O O
for IN B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
progressing VBG O O
infection NN B-NP O
His PRP$ O O
R NNP B-NP O
hip NN I-NP O
pain NN I-NP O
and CC O O
exam NN B-NP O
were VBD B-VP O
much RB O O
improved VBN O O
by IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
Will NNP I-NP O
plan NN I-NP O
for IN B-VP O
IV NNP B-NP B-mo
lon NN I-NP O
line NN I-NP O
to TO O O
be VB O O
placed VBN O O
prior RB O O
to TO O O
D/C NNP B-NP O
for IN B-VP O
home NN B-NP B-do
dosing NN I-NP I-do
of IN B-VP O
QD NNP B-NP B-f
Ceftriaxone NNP I-NP B-m
ID NNP I-NP O
to TO O O
be VB O O
re-consulted JJ O O
on IN B-VP O
admission NN B-NP O
post-op NN I-NP O
10/5 CD O O
for IN B-VP O
re-eval NN B-NP O
of IN B-VP O
abx JJ B-NP B-m
choice NN I-NP O
By IN B-VP O
that DT B-NP O
time NN I-NP O
it PRP O O
is VBZ O O
presumed VBN O O
that IN B-VP O
the DT B-NP O
MIC NNP I-NP O
for IN B-VP O
PCN/CTX NNP B-NP B-m
will MD O O
be VB O O
available JJ O O
for IN B-VP O
ascertation NN B-NP O
of IN B-VP O
proper JJ B-NP O
long-term JJ I-NP O
Abx NNP I-NP B-m
care NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Return NNP I-NP O
immediately RB O O
for IN B-VP O
increasing VBG O O
temps/shaking VBG O O
chills/pain NN B-NP O
at IN B-VP O
R NNP B-NP O
hip NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
D/C NNP B-NP O
home NN I-NP O
with IN B-VP O
services NNS B-NP O
for IN B-VP O
QD NNP B-NP B-f
CTX NNP I-NP B-m
dosing VBG O O
2 CD O O
IV NNP B-NP O
long JJ B-NP O
line NN I-NP O
placement NN I-NP O
3 CD O O
Re-admission NN B-NP O
for IN B-VP O
removal NN B-NP O
of IN B-VP O
infected JJ B-NP O
hardware NN I-NP O
and CC O O
spacer NN B-NP O
placement NN I-NP O
9/24/01 CD O O
4 CD O O
IV NNP B-NP B-mo
Ceftriaxone NNP I-NP B-m
per IN B-VP O
VNA NNP B-NP O
2 CD O B-do
Gr NNP B-NP I-do
IV NNP I-NP O
QD NNP I-NP B-f
for IN B-VP O
10/9/01 CD O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BURKHARDT NNP I-NP O
, , O O
GIL NNP B-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
JT50 NNP B-NP O
) ) O O
6/6/01 CD O O
@ $ O O
09:20 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#523663 VBZ O O
022965881 CD O O
CCHO NNP B-NP O
06363622 CD O O
5189032 CD O O
9/9/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/9/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/30/2005 CD O O
ATTENDING: NNP B-NP O
MANCHE NNP I-NP O
, , O O
EARLE NNP B-NP O
MD NNP I-NP O
ADMISSION NNP I-NP O
DIAGNOSIS: NNP I-NP O
Dyspnea NNP I-NP O
on IN B-VP O
exertion NN B-NP O
DISCHARGE NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
CHF NNP B-NP O
2 CD O O
Stage NNP B-NP O
IV NNP I-NP O
esophageal JJ B-NP O
cancer NN I-NP O
PRESENTING NNP I-NP O
SYMPTOMS: NNP I-NP O
Mr NNP I-NP O
Kanaan NNP I-NP O
is VBZ O O
a DT B-NP O
68-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
stage NN B-NP O
IV NNP I-NP O
esophageal NN I-NP O
cancer NN I-NP O
who WP O O
was VBD B-VP O
two CD O O
weeks NNS B-NP O
status NN I-NP O
post VBD B-VP O
his PRP$ O O
third JJ B-NP O
cycle NN I-NP O
of IN B-VP O
chemotherapy NN B-NP O
for IN B-VP O
his PRP$ O O
cancer NN B-NP O
He PRP O O
also RB O O
had VBD B-VP O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
with IN B-VP O
a DT B-NP O
known JJ I-NP O
ejection NN I-NP O
of IN B-VP O
20% CD O O
and CC O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
in IN B-VP O
1993 CD O O
He PRP O O
presented VBD B-VP O
with IN B-VP O
progressive JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
over IN B-VP O
the DT O O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
He PRP O O
denied VBD B-VP O
any DT B-NP O
fever NN I-NP O
However RB O O
, , O O
he PRP O O
did VBD B-VP O
note VB O O
increase NN B-NP O
in IN B-VP O
his PRP$ O O
weight NN B-NP O
and CC O O
increased VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
week NN I-NP O
He PRP O O
has VBZ O O
three-pillow JJ B-NP O
orthopnea NN I-NP O
at IN B-VP O
baseline NN B-NP O
, , O O
but CC O O
has VBZ O O
been VBN O O
sleeping VBG O O
both DT O O
upright JJ O O
for IN B-VP O
the DT O O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission VB O O
Two CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
walking VBG O O
in IN B-VP O
the DT B-NP O
mall NN I-NP O
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
accomplish VB O O
all DT O O
of IN B-VP O
his PRP$ O O
ADLs NNP B-NP O
without IN B-VP O
difficulty NN B-NP O
On IN B-VP O
admission NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
unable JJ O O
to TO O O
walk VB O O
more JJR O O
than IN B-VP O
20 CD O O
feet NNS B-NP O
without IN B-VP O
becoming VBG O O
severely RB O O
dyspneic IN B-VP O
He PRP O O
does VBZ O O
describe VB O O
having VBG O O
diminished VBN O O
appetite JJ O O
, , O O
increased JJ B-NP O
fatigue NN I-NP O
, , O O
and CC O O
three CD O O
days NNS B-NP O
of IN B-VP O
copious JJ B-NP O
watery NN I-NP O
stool NN I-NP O
, , O O
possibly RB O O
related VBN O O
to TO O O
his PRP$ O O
chemotherapy NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
pneumonia RB O O
two CD O O
weeks NNS B-NP O
ago RB O O
treated VBD B-VP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
, , O O
esophageal JJ B-NP O
cancer NN I-NP O
stage NN I-NP O
IV NNP I-NP O
status NN I-NP O
post NN I-NP O
chemo NN I-NP O
x3 NN I-NP O
cycles NNS I-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
, , O O
COPD NNP B-NP O
, , O O
atrial JJ B-NP O
fibrillation NN I-NP O
status NN I-NP O
post NN I-NP O
pacemaker NN I-NP O
and CC O O
AICD NNP B-NP O
placement NN I-NP O
, , O O
gout NN B-NP O
, , O O
pulmonary JJ B-NP O
vasculitis NN I-NP O
, , O O
and CC O O
also RB O O
CAD NNP B-NP O
OUTPATIENT NNP I-NP O
MEDICATIONS: NNP I-NP O
Include NNP I-NP O
amiodarone NN I-NP B-m
, , O O
digoxin NN B-NP B-m
, , O O
colchicine NN B-NP B-m
, , O O
Atrovent NNP B-NP B-m
, , O O
lisinopril NN B-NP B-m
, , O O
spironolactone NN B-NP B-m
, , O O
torsemide NN B-NP B-m
, , O O
Ativan NNP B-NP B-m
, , O O
Zocor NNP B-NP B-m
, , O O
and CC O O
Prilosec NNP B-NP B-m
ALLERGIES: NNP I-NP O
He PRP O O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
He PRP O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
and CC O O
denies NNS B-NP O
alcohol VBP O O
use JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
afebrile JJ O O
with IN B-VP O
the DT B-NP O
temperature NN I-NP O
of IN B-VP O
95.8 CD O O
His PRP$ O O
heart NN B-NP O
rate NN I-NP O
was VBD B-VP O
in IN B-VP O
the DT O O
90s CD O O
His PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
90/60 CD O O
breathing NN B-NP O
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
22 CD O O
His PRP$ O O
room NN B-NP O
air NN I-NP O
oxygenation NN I-NP O
was VBD B-VP O
82% CD O O
, , O O
but CC O O
increased VBD B-VP O
to TO O O
98% CD O O
on IN B-VP O
3 CD O O
liters NNS B-NP O
nasal JJ B-NP O
cannula NN I-NP O
He PRP O O
was VBD B-VP O
slightly RB O O
uncomfortable JJ O O
sitting VBG O O
straight VBD B-VP O
up RP O O
in IN B-VP O
bed NN B-NP O
and CC O O
visibly RB O O
tachypnic VB O O
His PRP$ O O
lung NN B-NP O
exam NN I-NP O
demonstrated VBD B-VP O
bilateral JJ B-NP O
scattered JJ I-NP O
wheezes NNS I-NP O
throughout IN B-VP O
the DT B-NP O
lung NN I-NP O
fields NNS I-NP O
and CC O O
bibasilar JJ B-NP O
crackles NNS I-NP O
His PRP$ O O
JVP NNP B-NP O
was VBD B-VP O
approximately RB O O
15 CD O O
cm JJ B-NP O
Heart NNP I-NP O
exam NN I-NP O
reveled VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
prominent JJ B-NP O
S3 NNP I-NP O
Abdominal NNP I-NP O
exam NN I-NP O
was VBD B-VP O
nontender JJR O O
His PRP$ O O
extremities NNS B-NP O
had VBD B-VP O
2+ CD O O
pitting VBG O O
edema NN B-NP O
to TO O O
the DT B-NP O
knees NNS I-NP O
PERTINENT NNP I-NP O
LABS: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1.7 CD O O
, , O O
which WDT O O
is VBZ O O
at IN B-VP O
his PRP$ O O
baseline NN B-NP O
and CC O O
BUN NNP B-NP O
of IN B-VP O
46 CD O O
His PRP$ O O
BNP NNP B-NP O
was VBD B-VP O
2960 CD O O
, , O O
CK NNP B-NP O
48 CD O O
, , O O
CK-MB NNP B-NP O
1.0 CD O O
, , O O
and CC O O
troponin $ O O
0.1 CD O O
Hematocrit NNP B-NP O
44.5 CD O O
, , O O
white JJ B-NP O
count NN I-NP O
7.8 CD O O
, , O O
and CC O O
D-dimer NNP B-NP O
was VBD B-VP O
150 CD O O
His PRP$ O O
INR NNP B-NP O
was VBD B-VP O
1.3 CD O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
palliative JJ I-NP O
esophageal NN I-NP O
stent NN I-NP O
placed VBD B-VP O
on IN B-VP O
2/8/05 CD O O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS: NNP I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
exam NN B-NP O
and CC O O
labs JJ B-NP O
findings NNS I-NP O
consistent JJ O O
with IN B-VP O
decompensated JJ B-NP O
heart NN I-NP O
failure NN I-NP O
For IN B-VP O
this DT O O
, , O O
he PRP O O
had VBD B-VP O
a DT O O
known VBN O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
20% CD O O
While IN B-VP O
he PRP O O
was VBD B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
strict JJ B-NP O
I's NNP I-NP O
and CC O O
O's NNP B-NP O
and CC O O
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
Lasix NNP B-NP B-m
and CC O O
torsemide VB O B-m
His PRP$ O O
diureses NNS B-NP O
was VBD B-VP O
somewhat RB O O
limited JJ O O
by IN B-VP O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
with IN B-VP O
a DT B-NP O
range NN I-NP O
of IN B-VP O
85 CD O O
to TO O O
110 CD O O
during IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
On IN B-VP O
discharge NN B-NP O
, , O O
his PRP$ O O
weight NN B-NP O
was VBD B-VP O
down RB O O
to TO O O
82.1 CD O O
kg NNS B-NP O
and CC O O
was VBD B-VP O
down RB O O
from IN B-VP O
87.5 CD O O
on IN B-VP O
admission NN B-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
have VB O O
slight VBN O O
leak NN B-NP O
in IN B-VP O
his PRP$ O O
troponin NN B-NP O
of IN B-VP O
0.1 CD O O
on IN B-VP O
admission NN B-NP O
, , O O
but CC O O
his PRP$ O O
EKG NNP B-NP O
was VBD B-VP O
unchanged JJ O O
and CC O O
his PRP$ O O
enzymes NNS B-NP O
x3 VBP O O
were VBD B-VP O
negative JJ O O
except IN B-VP O
for IN B-VP O
the DT B-NP O
troponin NN I-NP O
, , O O
which WDT O O
did VBD B-VP O
not RB O O
trend NN B-NP O
to TO O O
higher JJR O O
His PRP$ O O
cardiac JJ B-NP O
medical JJ I-NP O
regimen NN I-NP O
was VBD B-VP O
maximized VBN O O
with IN B-VP O
an DT B-NP O
ACE NNP I-NP B-m
inhibitor NN I-NP I-m
or CC O O
statin NN B-NP B-m
and CC O O
baby NN B-NP B-m
aspirin NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
him PRP O O
He PRP O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
on IN B-VP O
torsemide JJ O B-m
100 CD O B-do
mg JJ O I-do
daily RB O B-f
in IN B-VP O
addition NN B-NP O
to TO O O
his PRP$ O O
spironolactone NN B-NP B-m
dose VBD B-VP O
2 CD O O
Pulmonary: NNP B-NP O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
Atrovent JJ B-NP B-m
nebulizers NNS I-NP I-m
in-house VBP O O
to TO O O
help VB O O
with IN B-VP O
his PRP$ O O
shortness NN B-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
His PRP$ O O
primary JJ B-NP O
etiology NN I-NP O
, , O O
however RB O O
, , O O
was VBD B-VP O
pulmonary JJ O O
edema RB O O
secondary JJ O O
to TO O O
decompensated VB O O
heart NN B-NP O
failure NN I-NP O
His PRP$ O B-r
His PRP$ O B-r
His PRP$ O B-r
diuresis NN B-NP I-r
diuresis NN I-NP I-r
diuresis NN I-NP I-r
goal NN I-NP O
of IN B-VP O
1.5 CD O O
liter NN B-NP O
a DT B-NP O
day NN I-NP O
was VBD B-VP O
achieved VBN O O
with IN B-VP O
the DT B-NP O
combination NN I-NP O
of IN B-VP O
dopamine NN B-NP B-m
, , O O
nesiritide RB O B-m
, , O O
and CC O O
Lasix NNP B-NP B-m
drips NNS I-NP B-mo
He PRP O O
was VBD B-VP O
most RBS O O
responsive JJ O O
to TO O O
combination NN B-NP O
of IN B-VP O
nesiritide JJ O B-m
and CC O O
dopamine NN B-NP B-m
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
room NN I-NP O
air NN I-NP O
saturations NNS I-NP O
were VBD B-VP O
94% CD O O
with IN B-VP O
ambulatory JJ B-NP O
saturations NNS I-NP O
of IN B-VP O
86% CD O O
He PRP O O
was VBD B-VP O
therefore RB O O
discharged JJ B-NP O
home NN I-NP O
with IN B-VP O
oxygen NN B-NP B-m
to TO O O
use VB O O
overnight JJ O B-du
and CC O O
when WRB O O
symptomatic JJ O O
3 CD O O
Gastrointestinal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
diarrhea NN B-NP O
that WDT O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
related VBN O O
to TO O O
his PRP$ O O
chemotherapy NN B-NP O
, , O O
which WDT O O
has VBZ O O
been VBN O O
completed VBN O O
two CD O O
weeks NNS B-NP O
earlier RBR O O
Stool NNP B-NP O
was VBD B-VP O
sent VBN O O
out RP O O
for IN B-VP O
C NNP B-NP O
difficile NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
negative JJ O O
His PRP$ O O
colchicine NN B-NP B-m
was VBD B-VP O
initially RB O O
held VBN O O
because IN B-VP O
of IN B-VP O
his PRP$ O O
diarrhea NN B-NP O
, , O O
but CC O O
the DT B-NP O
patient NN I-NP O
then RB O O
developed VBD B-VP O
a DT B-NP O
flare NN I-NP O
of IN B-VP O
his PRP$ O O
gout NN B-NP O
in IN B-VP O
his PRP$ O O
right JJ B-NP O
great JJ I-NP O
toe JJ I-NP O
Colchicine NNP I-NP B-m
was VBD B-VP O
resumed VBN O O
to TO O O
treat VB O O
this DT O O
with IN B-VP O
good JJ B-NP O
results NNS I-NP O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
palliative JJ B-NP O
stent NN I-NP O
to TO O O
his PRP$ O O
esophagus NN B-NP O
on IN B-VP O
2/8/05 CD O O
that WDT O O
is VBZ O O
placed VBN O O
by IN B-VP O
Dr NNP B-NP O
Cap NNP I-NP O
without IN B-VP O
complications NNS B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
plans NNS B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
is VBZ O O
outpatient JJ B-NP O
oncologist NN I-NP O
for IN B-VP O
ongoing VBG O O
care NN B-NP O
of IN B-VP O
his PRP$ O O
esophageal NN B-NP O
cancer NN I-NP O
after IN B-VP O
discharge NN B-NP O
4 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
was VBD B-VP O
1.7 CD O O
His PRP$ O O
baseline NN B-NP O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
was VBD B-VP O
with IN B-VP O
the DT B-NP O
creatinine NN I-NP O
of IN B-VP O
approximately RB O O
1.3 CD O O
to TO O O
1.5 CD O O
At IN B-VP O
discharge NN B-NP O
, , O O
his PRP$ O O
creatinine NN B-NP O
was VBD B-VP O
1.6 CD O O
, , O O
which WDT O O
has VBZ O O
been VBN O O
stable JJ O O
throughout IN B-VP O
his PRP$ O O
entire JJ B-NP O
stay NN I-NP O
He PRP O O
briefly VBZ O O
required VBN O O
having VBG O O
a DT B-NP O
Foley NNP I-NP O
catheter NN I-NP O
placed VBD B-VP O
on IN B-VP O
8/28/05 CD O O
because IN B-VP O
of IN B-VP O
urinary JJ B-NP O
retention NN I-NP O
, , O O
but CC O O
it PRP O O
was VBD B-VP O
removed VBN O O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
without IN B-VP O
difficulty NN B-NP O
and CC O O
did VBD B-VP O
not RB O O
have VB O O
problems NNS B-NP O
with IN B-VP O
voiding VBG O O
prior RB O O
to TO O O
discharge VB O O
5 CD O O
Hematology: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
DVT NNP B-NP B-r
prophylaxis NN I-NP I-r
with IN B-VP O
Lovenox NNP B-NP B-m
He PRP O O
did VBD B-VP O
exhibit VB O O
some DT B-NP O
right JJ I-NP O
leg NN I-NP O
edema RB O O
more RBR O O
pronounced JJ O O
than IN B-VP O
his PRP$ O O
left JJ B-NP O
leg NN I-NP O
edema NN I-NP O
, , O O
but CC O O
this DT O O
is VBZ O O
felt VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
his PRP$ O O
gout NN B-NP O
in IN B-VP O
his PRP$ O O
right JJ O O
great JJ O O
toe IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
and CC O O
PT NNP B-NP O
was VBD B-VP O
arranged VBN O O
to TO O O
go VB O O
and CC O O
do VB O O
a DT B-NP O
home NN I-NP O
safety NN I-NP O
evaluation NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
vital JJ B-NP O
signs NNS I-NP O
were VBD B-VP O
stable JJ O O
He PRP O O
was VBD B-VP O
resting VBG O O
comfortably RB O O
in IN B-VP O
bed NN B-NP O
Crackles NNS I-NP O
in IN B-VP O
his PRP$ O O
lungs NNS B-NP O
were VBD B-VP O
notably RB O O
diminished VBN O O
from IN B-VP O
admission NN B-NP O
He PRP O O
no RB O O
longer RBR O O
was VBD B-VP O
tachypnic JJ O O
His PRP$ O O
heart NN B-NP O
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
, , O O
occasional JJ B-NP O
S3 NNP I-NP O
No NNP I-NP O
murmurs FW O O
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender VB O O
His PRP$ O O
extremities NNS B-NP O
had VBD B-VP O
trace NN B-NP O
pitting VBG O O
edema JJ B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Amiodarone NNP B-NP B-m
300 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
2 CD O O
Colchicine NNP B-NP B-m
0.6 CD O B-do
mg NN B-NP I-do
every DT B-NP B-f
other JJ I-NP I-f
day NN I-NP I-f
3 CD O O
Digoxin NNP B-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
every DT B-NP B-f
other JJ I-NP I-f
day NN I-NP I-f
4 CD O O
Ferrous NNP B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg JJ O I-do
daily RB O B-f
5 CD O O
Lisinopril NNP B-NP B-m
5 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
6 CD O O
Ativan NNP B-NP B-m
0.5 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
7 CD O O
Spironolactone NNP B-NP B-m
12.5 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
8 CD O O
Trazodone CD O B-m
50 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
night NN B-NP I-f
9 CD O O
Multivitamins NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
daily RB O B-f
10 CD O O
Torsemide NNP B-NP B-m
100 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
11 CD O O
Prilosec NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
12 CD O O
Simvastatin NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
night NN B-NP I-f
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
He PRP O O
had VBD B-VP O
instructions NNS B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
, , O O
Dr NNP B-NP O
Keltt NNP I-NP O
in IN B-VP O
one CD O O
weeks' NN B-NP O
time NN I-NP O
eScription NN I-NP O
document: IN B-VP O
1-0883572 JJ B-NP O
EMS NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
RENEAU NNP I-NP O
, , O O
DEVON NNP B-NP O
Attending: NNP I-NP O
SASHINGTON NNP I-NP O
, , O O
KENT NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
7154601 CD O O
D: NNP B-NP O
7/3/05 CD O O
T: NNP B-NP O
7/3/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#544162 VBZ O O
044020768 CD O O
SHMC NNP B-NP O
29970772 CD O O
006624 CD O O
8/0/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
SYNCOPE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/13/2002 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/9/2002 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
SYNCOPE NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
SYNCOPE NNP B-NP O
2 CD O O
ORTHOSTATIC NNP B-NP O
HYPOTENSION NNP I-NP O
3 CD O O
ISCHEMIC NNP B-NP O
CARDIOMYOPATHY NNP I-NP O
4 CD O O
DIABETES NNP B-NP O
MELLITUS NNP I-NP O
5 CD O O
CORONARY NNP B-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
62-year-old JJ I-NP O
white JJ I-NP O
male NN I-NP O
with IN B-VP O
insulin JJ B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
and CC O O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
who WP O O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
syncope NN B-NP O
He PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
in IN B-VP O
1979 CD O O
and CC O O
1985 CD O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
in IN B-VP O
1987 CD O O
with IN B-VP O
a DT B-NP O
LIMA NNP I-NP O
to TO O O
LAD NNP B-NP O
, , O O
SVG NNP B-NP O
to TO O O
RCA NNP B-NP O
, , O O
SVG NNP B-NP O
to TO O O
OMB NNP B-NP O
Over IN B-VP O
the DT B-NP O
past JJ I-NP O
ten NN I-NP O
years NNS I-NP O
he PRP O O
has VBZ O O
complained VBN O O
of IN B-VP O
increasing VBG O O
CHF NNP B-NP O
symptoms NNS I-NP O
including VBG O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
fatigue NN B-NP O
, , O O
chest NN B-NP O
tightness NN I-NP O
and CC O O
has VBZ O O
had VBN O O
multiple JJ B-NP O
admits NNS I-NP O
for IN B-VP O
exacerbations NNS B-NP O
, , O O
the DT O O
most RBS O O
recent JJ O O
from IN B-VP O
June NNP B-NP O
to TO O O
January NNP B-NP O
, , O O
2001 CD O O
for IN B-VP O
progressive JJ B-NP O
fatigue NN I-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
a DT B-NP O
right JJ I-NP O
heart NN I-NP O
catheterization NN I-NP O
revealed VBD B-VP O
high JJ B-NP O
filling NN I-NP O
pressures NNS I-NP O
and CC O O
he PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
Angiography NNP I-NP O
revealed VBD B-VP O
occluded VBN O O
SVGs NNP B-NP O
and CC O O
a DT B-NP O
patent NN I-NP O
LIMA NNP I-NP O
Dobutamine NNP I-NP B-m
radionuclide NN I-NP O
study NN I-NP O
revealed VBD B-VP O
inferior JJ O O
and CC O O
inferolateral JJ B-NP O
infarct NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
revascularization NN B-NP O
Evaluation NNP I-NP O
for IN B-VP O
heart NN B-NP O
transplant NN I-NP O
found VBD B-VP O
cirrhosis NN B-NP O
by IN B-VP O
liver NN B-NP O
spleen NN I-NP O
scan JJ O O
which WDT O O
ruled VBD B-VP O
out RP O O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
transplant NN B-NP O
He PRP O O
reported VBD B-VP O
light-headedness JJ O O
and CC O O
dizziness NN B-NP O
and CC O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Electrophysiology NNP I-NP O
Service NNP I-NP O
who WP O O
performed VBD B-VP O
an DT B-NP O
EP NNP I-NP O
study NN I-NP O
which WDT O O
was VBD B-VP O
negative JJ O O
for IN B-VP O
provokable JJ B-NP O
VT NNP I-NP O
and CC O O
since IN B-VP O
he PRP O O
is VBZ O O
not RB O O
a DT B-NP O
transplant JJ I-NP O
candidate NN I-NP O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
empiric JJ B-NP O
ICD NNP I-NP O
placement NN I-NP O
would MD O O
not RB O O
be VB O O
in IN B-VP O
his PRP$ O O
best JJS B-NP O
interest NN I-NP O
His PRP$ O O
light-headedness JJ O O
and CC O O
presyncope NN B-NP O
worsened VBD B-VP O
His PRP$ O O
captopril NN B-NP B-m
captopril NN I-NP B-m
dose NN I-NP O
was VBD B-VP O
reduced VBN O O
from IN B-VP O
37.5 CD O B-do
mg NNS B-NP I-do
to TO O O
25 CD O B-do
mg NNS B-NP I-do
t.i.d JJ B-NP B-f
t.i.d NN I-NP B-f
with IN B-VP O
marked JJ B-NP O
improvement NN I-NP O
in IN B-VP O
his PRP$ O O
energy NN B-NP O
and CC O O
less JJR B-NP O
dizziness NN I-NP O
Over IN B-VP O
the DT B-NP O
past JJ I-NP O
weeks NNS I-NP O
his PRP$ O O
dizziness NN B-NP O
and CC O O
light-headedness NN B-NP O
recurred NN I-NP O
and CC O O
worsened VBD B-VP O
with IN B-VP O
episodes NNS B-NP O
of IN B-VP O
presyncope NN B-NP O
and CC O O
frank JJ B-NP O
syncope NN I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
he PRP O O
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
a DT B-NP O
clinic JJ I-NP O
appointment NN I-NP O
On IN B-VP O
arrival NN B-NP O
he PRP O O
felt VBD B-VP O
dizzy JJ O O
and CC O O
"crumpled" JJ O O
with IN B-VP O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
and CC O O
therefore NN B-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Ischemic NNP I-NP O
cardiomyopathy NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
15% CD O O
to TO O O
20% CD O O
in IN B-VP O
February NNP B-NP O
of IN B-VP O
2001 CD O O
, , O O
status NN B-NP O
post NN I-NP O
anterior JJ B-NP O
MI NNP I-NP O
in IN B-VP O
1980 CD O O
and CC O O
1986 CD O O
, , O O
three CD O O
vessel NN B-NP O
CABG NNP I-NP O
in IN B-VP O
1987 CD O O
with IN B-VP O
LIMA NNP B-NP O
to TO O O
LAD NNP B-NP O
, , O O
SVG NNP B-NP O
to TO O O
OM NNP B-NP O
and CC O O
SVG NNP B-NP O
to TO O O
PDA NNP B-NP O
, , O O
type NN B-NP O
2 CD O O
diabetes NNS B-NP O
mellitus RB O O
, , O O
insulin JJ B-NP O
dependent NN I-NP O
, , O O
hypothyroidism NN B-NP O
, , O O
nephrolithiasis NN B-NP O
, , O O
gallstones NNS B-NP O
, , O O
cardiac JJ B-NP O
cirrhosis NN I-NP O
which WDT O O
is VBZ O O
mild JJ O O
and CC O O
was VBD B-VP O
diagnosed VBN O O
in IN B-VP O
February NNP B-NP O
2001 CD O O
by IN B-VP O
abdominal JJ B-NP O
ultrasound NN I-NP O
and CC O O
liver NN B-NP O
scan JJ O O
, , O O
IBS NNP B-NP O
, , O O
psoriasis NN B-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
Captopril NNP I-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Isordil NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Lipitor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
NPH NNP B-NP B-m
insulin VBZ O O
65 CD O B-do
units NNS B-NP I-do
subcu JJ B-NP B-mo
b.i.d NN I-NP B-f
, , O O
Xanax NNP B-NP B-m
p.r.n NN I-NP B-f
, , O O
torsemide RB O B-m
120 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.a.m NN I-NP B-f
, , O O
torsemide RB O B-m
80 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
q.p.m RB O B-f
, , O O
digoxin VBZ O B-m
0.125 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Synthroid NNP B-NP B-m
250 CD O B-do
mcg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Prozac NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Vital NNP I-NP O
signs: VBD B-VP O
Lying VBG O O
blood NN B-NP O
pressure NN I-NP O
94/58 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
70 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Sitting VBG O O
blood NN B-NP O
pressure NN I-NP O
78/54 CD O O
Patient NNP B-NP O
could MD O O
not RB O O
stand VB O O
secondary JJ O O
to TO O O
light-headedness JJ O O
to TO O O
complete VB O O
orthostatic JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
Afebrile NNP I-NP O
General: NNP I-NP O
Appearing NNP I-NP O
comfortable JJ O O
in IN B-VP O
a DT B-NP O
supine JJ I-NP O
position NN I-NP O
No NNP I-NP O
acute NN I-NP O
distress NN I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
Normal NNP I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
No NNP I-NP O
S3 NNP I-NP O
JVP NNP I-NP O
approximately RB O O
5 CD O O
cm NN B-NP O
A NNP I-NP O
II/VI NNP I-NP O
holosystolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
apex JJ B-NP O
Lungs: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
Abdomen: NNP B-NP O
Soft NNP I-NP O
, , O O
non-tender NN B-NP O
, , O O
nondistended VBD B-VP O
No DT B-NP O
hepatosplenomegaly NN I-NP O
Extremities: NNP I-NP O
No NNP I-NP O
edema NN I-NP O
ADMISSION NNP I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Sodium NNP I-NP O
128 CD O O
, , O O
potassium NN B-NP O
4.2 CD O O
, , O O
chloride RB O O
91 CD O O
, , O O
bicarbonate NN B-NP O
22 CD O O
, , O O
BUN NNP B-NP O
64 CD O O
, , O O
creatinine NN B-NP O
2.6 CD O O
, , O O
glucose VBD B-VP O
348 CD O O
White NNP B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
17.9 CD O O
, , O O
hematocrit NN B-NP O
37.6 CD O O
, , O O
platelets NNS B-NP O
286 CD O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
62-year-old JJ I-NP O
white JJ I-NP O
male NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
insulin NN B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
and CC O O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
and CC O O
probably RB O O
cardiac JJ B-NP O
cirrhosis NN I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
presyncope NN B-NP O
and CC O O
syncope VB O O
The DT B-NP O
arrhythmia NN I-NP O
was VBD B-VP O
considered VBN O O
possible JJ O O
and CC O O
there EX O O
has VBZ O O
been VBN O O
none RB O O
documented VBN O O
and CC O O
he PRP O O
was VBD B-VP O
not RB O O
inducible JJ O O
two CD O O
years NNS B-NP O
prior RB O O
to TO O O
admission VB O O
Given NNP B-NP O
his PRP$ O O
orthostatic JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
his PRP$ O O
volume NN B-NP O
status NN I-NP O
and CC O O
medications NNS B-NP O
were VBD B-VP O
responsible JJ O O
for IN B-VP O
his PRP$ O O
symptoms NNS B-NP O
In IN B-VP O
addition NN B-NP O
his PRP$ O O
elevated JJ B-NP O
BUN NNP I-NP O
and CC O O
creatinine NN B-NP O
were VBD B-VP O
consistent JJ O O
with IN B-VP O
volume NN B-NP O
depletion NN I-NP O
He PRP O O
improved VBD B-VP O
off RP O O
diuretics NNS B-NP B-m
, , O O
nitrates NNS B-NP B-m
and CC O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
as RB O O
well RB O O
as IN B-VP O
liberalization NN B-NP O
of IN B-VP O
his PRP$ O O
diet JJ O O
regarding VBG O O
salt NN B-NP O
and CC O O
fluid JJ B-NP O
intake NN I-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
arrhythmias NN I-NP O
noted VBD B-VP O
on IN B-VP O
his PRP$ O O
telemetry NN B-NP O
monitor NN I-NP O
An DT B-NP O
endocrine NN I-NP O
consult NN I-NP O
was VBD B-VP O
called VBN O O
to TO O O
evaluate VB O O
for IN B-VP O
possible JJ B-NP O
contribution NN I-NP O
of IN B-VP O
autonomic JJ B-NP O
insufficiency NN I-NP O
secondary JJ O O
to TO O O
his PRP$ O O
diabetes NNS B-NP O
mellitus VBP O O
They PRP O O
recommended VBD B-VP O
decreasing VBG O O
his PRP$ O O
Synthroid NNP B-NP B-m
dose NN I-NP O
due JJ O O
to TO O O
a DT B-NP O
suppressed JJ I-NP O
TSH NN I-NP O
as RB O O
well RB O O
as IN B-VP O
more RBR O O
aggressive JJ B-NP O
blood NN I-NP O
sugar NN I-NP O
control NN I-NP O
, , O O
however RB O O
, , O O
they PRP O O
were VBD B-VP O
unable JJ O O
to TO O O
document VB O O
orthostatic JJ B-NP O
hypotension NN I-NP O
and CC O O
felt VBD B-VP O
that IN B-VP O
his PRP$ O O
episodes NNS B-NP O
of IN B-VP O
presyncope NN B-NP O
and CC O O
syncope NN B-NP O
were VBD B-VP O
related VBN O O
to TO O O
his PRP$ O O
volume NN B-NP O
status NN I-NP O
and CC O O
medications NNS B-NP O
rather RB O O
than IN B-VP O
autonomic JJ B-NP O
insufficiency NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
To TO O O
be VB O O
dictated VBN O O
on IN B-VP O
the DT B-NP O
actual JJ I-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Satisfactory NNP I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
with IN B-VP O
services NNS B-NP O
FOLLOW-UP: NNP I-NP O
Primary NNP I-NP O
care NN I-NP O
provider NN I-NP O
and CC O O
cardiologist NN B-NP O
, , O O
Dr NNP B-NP O
Edgar NNP I-NP O
Der NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
JEFFERSON NNP I-NP O
PARIDO NNP I-NP O
, , O O
M.D NNP B-NP O
PC23 NNP I-NP O
Attending: NNP I-NP O
OMER NNP I-NP O
A NNP I-NP O
CALICO NNP I-NP O
, , O O
M.D NNP B-NP O
YS72 NNP I-NP O
LI346/023810 NNP I-NP O
Batch: NNP I-NP O
6827 CD O O
Index NNP B-NP O
No NNP I-NP O
G7HNXU3HHX NNP I-NP O
D: NNP I-NP O
7/18/02 CD O O
T: NNP B-NP O
7/18/02 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#549067 VBZ O O
384866461 CD O O
WVHO NNP B-NP O
24092986 CD O O
3081628 CD O O
7/13/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/7/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/24/2004 CD O O
ATTENDING: NNP B-NP O
DUDLEY NNP I-NP O
SPERL NNP I-NP O
MD NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
66-year-old JJ I-NP O
female NN I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
one CD O O
day NN B-NP O
of IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
She PRP O O
was VBD B-VP O
constipated VBN O O
for IN B-VP O
seven CD O O
days NNS B-NP O
and CC O O
presented VBN O O
with IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
on IN B-VP O
0/5/04 CD O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
, , O O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
on IN B-VP O
Coumadin NNP B-NP B-m
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
high JJ B-NP O
cholesterol NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
gallstones NNS B-NP O
and CC O O
diverticuli VB O O
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Nonsignificant NNP I-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
Avandia NNP I-NP B-m
4 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
lisinopril VBZ O B-m
20 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Hytrin NNP B-NP B-m
one CD O B-do
q.h.s NN B-NP B-f
, , O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
x1 NN I-NP B-f
, , O O
spironolactone NN B-NP B-m
25 CD O B-do
mg NN B-NP I-do
x3 NN I-NP B-f
, , O O
atenolol RB O B-m
50 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Lipitor NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
x1 NN I-NP B-f
, , O O
Flovent NNP B-NP B-m
, , O O
Bextra NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
x1 NN I-NP B-f
, , O O
Nexium NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
x1 NN I-NP B-f
, , O O
Humulin NNP B-NP B-m
22 CD O B-do
units NNS B-NP I-do
q.a.m RB O B-f
, , O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
, , O O
and CC O O
baby NN B-NP B-m
aspirin VBP O I-m
81 CD O B-do
mg NN B-NP I-do
For IN B-VP O
this DT B-NP O
reason NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
ED NNP I-NP O
and CC O O
the DT B-NP O
chest JJS I-NP O
x-ray NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
showed VBD B-VP O
free JJ B-NP O
air NN I-NP O
below IN B-VP O
the DT B-NP O
diaphragm NN I-NP O
The DT B-NP O
KUB NNP I-NP O
showed VBD B-VP O
dilated VBN O O
small JJ B-NP O
bowel NN I-NP O
and CC O O
the DT B-NP O
abdominal JJ I-NP O
CT NNP I-NP O
showed VBD B-VP O
multiple JJ B-NP O
free JJ I-NP O
air NN I-NP O
For IN B-VP O
this DT B-NP O
reason NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
OR NNP I-NP O
on IN B-VP O
0/5/04 CD O O
, , O O
the DT B-NP O
same JJ I-NP O
day NN I-NP O
and CC O O
she PRP O O
underwent JJ B-NP O
exploratory JJ I-NP O
laparotomy NN I-NP O
and CC O O
appendectomy NN B-NP O
as RB O O
well RB O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
diagnosed VBN O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
of IN B-VP O
perforated JJ O O
appendicitis IN B-VP O
The DT B-NP O
surgery NN I-NP O
was VBD B-VP O
uncomplicated VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
afterwards NNS I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
SICU NNP I-NP O
Please NNP I-NP O
refer VB O O
to TO O O
the DT B-NP O
interim JJ I-NP O
dictation NN I-NP O
for IN B-VP O
the DT B-NP O
patient NN I-NP O
for IN B-VP O
the DT B-NP O
SICU NNP I-NP O
course NN I-NP O
In IN B-VP O
the DT B-NP O
SICU NNP I-NP O
, , O O
mainly RB O O
she PRP O O
had VBD B-VP O
three CD O O
problems NNS B-NP O
and CC O O
for IN B-VP O
this DT B-NP O
reason NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
kept VBN O O
in IN B-VP O
the DT B-NP O
unit NN I-NP O
She PRP O O
had VBD B-VP O
rapid JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
, , O O
oliguria NN B-NP O
, , O O
and CC O O
confusion NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
back RB O O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
3/20/04 CD O O
on IN B-VP O
no DT B-NP O
antibiotics NNS I-NP O
and CC O O
was VBD B-VP O
stable JJ O O
with IN B-VP O
NG NNP B-NP O
tube NN I-NP O
in IN B-VP O
place NN B-NP O
and CC O O
through IN B-VP O
this DT B-NP O
NG NNP I-NP O
tube NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
fed VBN O O
The DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
speech NN I-NP O
and CC O O
swallow JJ B-NP O
evaluation NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
and CC O O
the DT B-NP O
Speech NNP I-NP O
&amp; NNP I-NP O
Swallow NNP I-NP O
cleared VBD B-VP O
her PRP$ O O
for IN B-VP O
mechanical JJ B-NP O
soft JJ I-NP O
diet NN I-NP O
and CC O O
the DT B-NP O
NG NNP I-NP O
tube NN I-NP O
was VBD B-VP O
discontinued VBN O O
The DT B-NP O
postoperative JJ I-NP O
course NN I-NP O
mainly RB O O
has VBZ O O
been VBN O O
characterized VBN O O
by IN B-VP O
slow JJ B-NP O
recovery NN I-NP O
and CC O O
decrease NN B-NP O
in IN B-VP O
mental JJ B-NP O
confusion NN I-NP O
, , O O
for IN B-VP O
presence NN B-NP O
of IN B-VP O
flatus NN B-NP O
, , O O
bowel NN B-NP O
movement NN I-NP O
and CC O O
advanced VBD B-VP O
diet NNS B-NP O
to TO O O
mechanical JJ O O
soft JJ O O
diet VBZ O O
The DT B-NP O
patient NN I-NP O
also RB O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
9 CD O O
, , O O
and CC O O
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
13 CD O O
, , O O
she PRP O O
was VBD B-VP O
started VBN O O
also RB O O
on IN B-VP O
baby NN B-NP B-m
aspirin IN B-VP I-m
The DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
, , O O
she PRP O O
is VBZ O O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NN I-NP O
Respiratory: NNP I-NP O
She PRP O O
is VBZ O O
clear JJ O O
in IN B-VP O
both DT B-NP O
lungs NNS I-NP O
She PRP O O
is VBZ O O
saturating VBG O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
92% CD O O
during IN B-VP O
the DT B-NP O
day NN I-NP O
However RB O O
during IN B-VP O
the DT B-NP O
night NN I-NP O
and CC O O
most RBS O O
likely JJ O O
due JJ O O
to TO O O
her PRP$ O O
position NN B-NP O
in IN B-VP O
the DT B-NP O
bed NN I-NP O
, , O O
she PRP O O
requires VBZ O O
sometimes RB O O
oxygen JJ O B-m
2 CD O B-do
liters NNS B-NP I-do
nasal JJ B-NP B-mo
cannula NN I-NP I-mo
for IN B-VP O
saturation NN B-NP O
97% CD O O
Cardiac: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
in IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
, , O O
stable JJ B-NP O
condition NN I-NP O
Heart NNP I-NP O
rate NN I-NP O
is VBZ O O
controlled VBN O O
at IN B-VP O
93 CD O O
She PRP O O
is VBZ O O
on IN B-VP O
atenolol JJ O B-m
50 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
GI: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
mechanical JJ O O
soft JJ O O
diet VBZ O O
The DT B-NP O
abdomen NNS I-NP O
is VBZ O O
nonpainful JJ B-NP O
Nondistended NNP I-NP O
Bowels NNP I-NP O
sounds NNS I-NP O
are VBP O O
present JJ O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
already RB O O
bowel VBN O O
movement NN B-NP O
and CC O O
she PRP O O
is VBZ O O
passing VBG O O
flatus NN B-NP O
because IN B-VP O
she PRP O O
had VBD B-VP O
in IN B-VP O
the DT O O
last JJ O O
two CD O O
days NNS B-NP O
three CD O O
bowel NN B-NP O
movements NNS I-NP O
in IN B-VP O
one CD O O
day NN B-NP O
C NNP I-NP O
diff NN I-NP O
and CC O O
leucocytes NNS B-NP O
were VBD B-VP O
sent VBN O O
that WDT O O
are VBP O O
so RB O O
far RB O O
negative JJ B-NP O
GU: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
back RB O O
on IN B-VP O
home NN B-NP O
Lasix NNP I-NP B-m
80 CD O B-do
mg NN B-NP I-do
x1 NNP I-NP B-f
plus CC O O
spironolactone JJ O B-m
25 CD O B-do
mg NN B-NP I-do
b.i.d VBD B-VP B-f
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
voiding VBG O O
fine JJ O O
and CC O O
with IN B-VP O
no DT B-NP O
problem NN I-NP O
in IN B-VP O
urinating NN B-NP O
and CC O O
the DT B-NP O
Foley NNP I-NP O
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#12 NNP I-NP O
ID: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
no DT B-NP O
antibiotics NNS I-NP O
Heme: VBP O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
back RB O O
on IN B-VP O
Coumadin NNP B-NP B-m
and CC O O
her PRP$ O O
INR NNP B-NP O
is VBZ O O
3.5 CD O O
She PRP O O
received VBD B-VP O
yesterday NN B-NP O
a DT B-NP O
dose NN I-NP O
of IN B-VP O
Coumadin NNP B-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
She PRP O O
is VBZ O O
back RB O O
on IN B-VP O
baby NN B-NP B-m
aspirin NN I-NP I-m
also RB O O
at IN B-VP O
81 CD O B-do
mg NN B-NP O
She PRP O O
is VBZ O O
also RB O O
on IN B-VP O
subcutaneous JJ B-NP B-mo
heparin NN I-NP B-m
b.i.d NN I-NP B-f
as IN B-VP O
prophylaxis NN B-NP O
for IN B-VP O
DVT NNP B-NP B-r
and CC O O
she PRP O O
is VBZ O O
also RB O O
on IN B-VP O
pneumo JJ B-NP O
boots NNS I-NP O
The DT B-NP O
recent JJ I-NP O
labs NN I-NP O
on IN B-VP O
discharge NN B-NP O
are VBP O O
glucose JJ O O
100 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
6 CD O O
, , O O
creatinine NN B-NP O
0.8 CD O O
, , O O
sodium NN B-NP O
144 CD O O
, , O O
potassium NN B-NP O
3.3 CD O O
She PRP O O
received VBD B-VP O
a DT B-NP O
dose NN I-NP O
of IN B-VP O
20 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
potassium NN I-NP B-m
today NN I-NP O
Chloride NNP I-NP O
is VBZ O O
104 CD O O
, , O O
CO2 NNP B-NP O
32 CD O O
, , O O
anion NN B-NP O
gap NN I-NP O
8 CD O O
, , O O
calcium NN B-NP O
8 CD O O
, , O O
magnesium NN B-NP O
1.8 CD O O
PTT NNP B-NP O
34.7 CD O O
, , O O
PTT NNP B-NP O
6.3 CD O O
, , O O
INR NNP B-NP O
is VBZ O O
3.5 CD O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
with IN B-VP O
the DT O O
following VBG O O
medications: NN B-NP O
Flovent NNP I-NP B-m
220 CD O B-do
, , O O
INH NNP B-NP B-mo
x2 NNP I-NP B-f
, , O O
Pepcid NNP B-NP B-m
p.o VBZ O B-mo
20 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
subcutaneous JJ B-NP B-mo
heparin NN I-NP B-m
5000 CD O B-do
units NNS B-NP O
b.i.d RB O B-f
, , O O
atenolol VBZ O B-m
50 CD O B-do
x2 NN B-NP B-f
She PRP O O
is VBZ O O
on IN B-VP O
Seroquel NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
x1 NNP I-NP B-f
p.o NN I-NP B-mo
, , O O
insulin NN B-NP B-m
scale NN I-NP B-do
, , O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
spironolactone NN B-NP B-m
25 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Simvastatin NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
x1 NN I-NP B-f
, , O O
baby NN B-NP B-m
aspirin VBD B-VP I-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
p.r.n NN I-NP B-f
She PRP O O
is VBZ O O
on IN B-VP O
albuterol NN B-NP B-m
at IN B-VP O
2.5 CD O B-do
mg NN B-NP I-do
q.12h NN I-NP B-f
and CC O O
she PRP O O
is VBZ O O
on IN B-VP O
Zofran NNP B-NP B-m
for IN B-VP O
nausea NN B-NP B-r
She PRP O O
is VBZ O O
on IN B-VP O
no DT B-NP O
pain NN I-NP O
medication NN I-NP O
and CC O O
she PRP O O
does VBZ O O
not RB O O
have VB O O
any DT O O
pain VB O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
and CC O O
she PRP O O
will MD O O
need VB O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Ulysses NNP I-NP O
Gunnett NNP I-NP O
in IN B-VP O
three CD O O
weeks NNS B-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
also RB O O
will MD O O
need VB O O
to TO O O
restart VB O O
her PRP$ O O
Humulin NNP B-NP B-m
dose NN I-NP O
for IN B-VP O
glucose JJ B-NP B-r
control NN I-NP I-r
and CC O O
the DT B-NP O
patient NN I-NP O
will MD O O
need VB O O
to TO O O
have VB O O
anticoagulation NN B-NP B-r
and CC O O
therefore RB O O
begin VB O O
Coumadin NNP B-NP B-m
for IN B-VP O
INR NNP B-NP O
range NN I-NP O
between IN B-VP O
2 CD O O
and CC O O
3 CD O O
eScription NN B-NP O
document: NN I-NP O
8-3090492 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
RADEN NNP I-NP O
, , O O
WILBERT NNP B-NP O
Attending: NNP I-NP O
BRANTINGHAM NNP I-NP O
, , O O
QUINTON NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
9642896 CD O O
D: NNP B-NP O
5/24/04 CD O O
T: NNP B-NP O
5/24/04 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#553121 VBZ O O
253394750 CD O O
R NNP B-NP O
76252492 CD O O
3915170 CD O O
0/3/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
? . B-VP O
MYOCARDIAL NNP B-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/25/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/23/2006 CD O O
ATTENDING: NNP B-NP O
PUSSER NNP I-NP O
, , O O
ROLLAND NNP B-NP O
M.D NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Chest NNP I-NP O
and CC O O
left VBD B-VP O
arm NN B-NP O
pain NN I-NP O
, , O O
and CC O O
left VBD B-VP O
arm NN B-NP O
paresthesias NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
47-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
, , O O
which WDT O O
includes VBZ O O
HIV NNP B-NP O
positive JJ O O
, , O O
hepatitis JJ B-NP O
C NNP I-NP O
positive JJ O O
, , O O
seizures NNS B-NP O
, , O O
and CC O O
neuropathy JJ O O
, , O O
who WP O O
presented VBD B-VP O
complaining NN B-NP O
of IN B-VP O
left JJ B-NP O
hand NN I-NP O
paresthesias NN I-NP O
followed VBN O O
by IN B-VP O
left JJ B-NP O
hand NN I-NP O
pain NN I-NP O
that IN B-VP O
marches NNS B-NP O
proximally RB O O
up IN B-VP O
her PRP$ O O
left JJ B-NP O
arm NN I-NP O
and CC O O
affecting VBG O O
her PRP$ O O
left JJ B-NP O
shoulder NN I-NP O
and CC O O
chest NN B-NP O
Along IN B-VP O
with IN B-VP O
these DT B-NP O
symptoms NNS I-NP O
, , O O
she PRP O O
has VBZ O O
associated VBN O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
lightheadedness NN B-NP O
, , O O
diaphoresis NN B-NP O
, , O O
and CC O O
nausea VBZ O O
The DT B-NP O
patient NN I-NP O
notes VBZ O O
that IN B-VP O
these DT B-NP O
symptoms NNS I-NP O
have VBP O O
been VBN O O
occurring VBG O O
approximately RB O O
five CD O O
times NNS B-NP O
per IN B-VP O
week NN B-NP O
over IN B-VP O
the DT O O
past JJ O O
two CD O O
months NNS B-NP O
She PRP O O
has VBZ O O
notified VBN O O
her PRP$ O O
PCP NNP B-NP O
of IN B-VP O
these DT B-NP O
events NNS I-NP O
, , O O
however RB O O
, , O O
the DT B-NP O
etiology NN I-NP O
has VBZ O O
never RB O O
been VBN O O
identified VBN O O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
states VBZ O O
that IN B-VP O
these DT B-NP O
symptoms NNS I-NP O
have VBP O O
increased VBN O O
in IN B-VP O
frequency NN B-NP O
since IN B-VP O
having VBG O O
two CD O O
syncopal JJ B-NP O
events NNS I-NP O
, , O O
which WDT O O
occurred VBD B-VP O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
Regarding NNP I-NP O
syncope NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
recalls VBZ O O
her PRP$ O O
first JJ B-NP O
loss NN I-NP O
of IN B-VP O
consciousness JJ B-NP O
episode NN I-NP O
occurring VBG O O
three CD O O
days NNS B-NP O
ago RB O O
in IN B-VP O
her PRP$ O O
bedroom NN B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
antecedent NN I-NP O
symptoms VBZ O O
She PRP O O
came VBD B-VP O
back RB O O
to TO O O
consciousness NN B-NP O
while IN B-VP O
on IN B-VP O
the DT B-NP O
ground NN I-NP O
, , O O
called VBN O O
out RP O O
for IN B-VP O
help NN B-NP O
and CC O O
her PRP$ O O
daughter NN B-NP O
came VBD B-VP O
immediately RB O O
There EX O O
was VBD B-VP O
no DT B-NP O
witnessed JJ I-NP O
seizure NN I-NP O
activity NN I-NP O
, , O O
no DT B-NP O
postictal JJ I-NP O
confusion NN I-NP O
, , O O
no DT B-NP O
tongue NN I-NP O
trauma NN I-NP O
nor CC O O
was VBD B-VP O
there EX O O
any DT B-NP O
incontinence NN I-NP O
A NNP I-NP O
second JJ B-NP O
episode NN I-NP O
of IN B-VP O
syncope NN B-NP O
occurred VBD B-VP O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
arrival VB O O
while IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
standing VBG O O
in IN B-VP O
the DT B-NP O
bathroom NN I-NP O
There EX O O
was VBD B-VP O
some DT O O
preceding VBG O O
lightheadedness RBR O O
this DT B-NP O
time NN I-NP O
The DT B-NP O
post-event JJ I-NP O
characteristics NNS I-NP O
were VBD B-VP O
the DT B-NP O
same JJ I-NP O
Again NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
by IN B-VP O
her PRP$ O O
son NN B-NP O
when WRB O O
she PRP O O
called VBD B-VP O
out RP O O
for IN B-VP O
help NN B-NP O
The DT B-NP O
patient NN I-NP O
denies VBZ O O
prior JJ B-NP O
history NN I-NP O
of IN B-VP O
syncopal JJ B-NP O
events NNS I-NP O
, , O O
however RB O O
, , O O
she PRP O O
does VBZ O O
have VB O O
a DT B-NP O
lifelong JJ I-NP O
history NN I-NP O
of IN B-VP O
seizures NNS B-NP O
and CC O O
has VBZ O O
not RB O O
been VBN O O
taking VBG O O
her PRP$ O O
Keppra NNP B-NP B-m
for IN B-VP B-du
approximately RB O I-du
a DT B-NP I-du
year NN I-NP I-du
, , O O
as IN B-VP O
her PRP$ O O
prescription NN B-NP O
has VBZ O O
ran VBN O O
out RP O O
and CC O O
she PRP O O
has VBZ O O
failed VBN O O
to TO O O
keep VB O O
follow-up JJ B-NP O
appointments NNS I-NP O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
neurologist NN I-NP O
, , O O
Dr NNP B-NP O
Loock NNP I-NP O
Both NNP I-NP O
the DT B-NP O
patient NN I-NP O
and CC O O
her PRP$ O O
daughter NN B-NP O
note NN I-NP O
that IN B-VP O
she PRP O O
usually RB O O
has VBZ O O
postictal JJ B-NP O
confusion NN I-NP O
and CC O O
that IN B-VP O
these DT B-NP O
syncopal JJ I-NP O
events NNS I-NP O
did VBD B-VP O
not RB O O
fit VB O O
that IN B-VP O
description NN B-NP O
Furthermore NNP I-NP O
, , O O
these DT B-NP O
episodes NNS I-NP O
did VBD B-VP O
not RB O O
feel VB O O
like IN B-VP O
her PRP$ O O
occasional JJ B-NP O
hypoglycemic JJ I-NP O
episodes NNS I-NP O
Unfortunately RB O O
, , O O
the DT B-NP O
patient's NN I-NP O
blood NN I-NP O
sugars NNS I-NP O
were VBD B-VP O
not RB O O
obtained VBN O O
during IN B-VP O
these DT B-NP O
syncopal JJ I-NP O
events NNS I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
recently RB O O
started VBD B-VP O
Flexeril NNP B-NP B-m
to TO O O
treat VB O O
chronic JJ O B-r
low JJ O O
back RB O O
pain NN B-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
admits VBZ O O
stable JJ B-NP O
three-pillow JJ I-NP O
orthopnea NN I-NP O
, , O O
but CC O O
new JJ B-NP O
paroxysmal JJ I-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
no DT B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
, , O O
weight JJ B-NP O
loss NN I-NP O
or CC O O
increased VBN O O
abdominal JJ B-NP O
girth NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
stable JJ B-NP O
four-block JJ I-NP O
ambulation NN I-NP O
limited VBN O O
by IN B-VP O
dyspnea NN B-NP O
She PRP O O
has VBZ O O
had VBN O O
notable JJ B-NP O
weight JJ I-NP O
loss NN I-NP O
as IN B-VP O
she PRP O O
has VBZ O O
decreased VBN O O
in IN B-VP O
dress NN B-NP O
size NN I-NP O
from IN B-VP O
18-14 CD O O
over IN B-VP O
the DT O O
past JJ O O
nine CD O O
months NNS B-NP O
She PRP O O
denies VBZ O O
fevers NNS B-NP O
or CC O O
chills NNS B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
HIV NNP I-NP O
positive JJ O O
, , O O
drug-seeking JJ B-NP O
behavior NN I-NP O
, , O O
parotitis NN B-NP O
, , O O
migraine NN B-NP O
headaches NNS I-NP O
, , O O
anxiety NN B-NP O
and CC O O
panic NN B-NP O
, , O O
depression NN B-NP O
, , O O
hepatitis NN B-NP O
C NNP I-NP O
, , O O
seizures VBZ O O
, , O O
neuropathy JJ O O
, , O O
pancreatitis NN B-NP O
, , O O
abnormal JJ B-NP O
Pap NNP I-NP O
smear NN I-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
cerebral JJ B-NP O
aneurysm NN I-NP O
, , O O
herpes VBZ O O
simplex JJ B-NP O
type NN I-NP O
1 CD O O
, , O O
and CC O O
chronic JJ O O
low JJ O O
back RB O O
pain NN B-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
Flexeril NNP I-NP B-m
5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
clonazepam VBD B-VP B-m
1 CD O B-do
mg NN B-NP I-do
q.i.d NN I-NP B-f
, , O O
Truvada NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
daily RB O B-f
, , O O
Norvir NNP B-NP B-m
1400 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
glyburide JJ B-NP B-m
glyburide NN I-NP B-m
5 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
and CC O O
2.5 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
, , O O
Lomotil NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
q.i.d NN I-NP B-f
p.r.n NN I-NP I-f
, , O O
methadone NN B-NP B-m
150 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Zofran NNP B-NP B-m
4 CD O B-do
mg JJ B-NP I-do
daily JJ I-NP B-f
p.r.n NN I-NP I-f
, , O O
Percocet NNP B-NP B-m
325 CD O B-do
mg/5 NN B-NP I-do
mg NN I-NP I-do
tablets VBZ O I-do
one CD O I-do
tablet NN B-NP I-do
q.6 NN I-NP B-f
h NN I-NP I-f
p.r.n NN I-NP I-f
, , O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Zoloft NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
, , O O
and CC O O
trazodone RB O B-m
100 CD O B-do
mg NNS B-NP I-do
nightly RB O B-f
ALLERGIES: NNP B-NP O
Compazine NNP I-NP O
, , O O
Bactrim NNP B-NP O
, , O O
didanosine NN B-NP O
, , O O
gabapentin NN B-NP O
, , O O
cephalosporins NNS B-NP O
, , O O
penicillin NN B-NP O
, , O O
clindamycin NN B-NP O
, , O O
stavudine NN B-NP O
, , O O
Tylenol NNP B-NP O
No.3 NNP I-NP O
, , O O
levofloxacin NN B-NP O
, , O O
clindamycin NN B-NP O
, , O O
tetanus NN B-NP O
, , O O
IV NNP B-NP O
contrast NN I-NP O
, , O O
ibuprofen NN B-NP O
, , O O
abacavir NN B-NP O
and CC O O
ritonavir VB O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
from IN B-VP O
Reve NNP B-NP O
Abilester NNP I-NP O
She PRP O O
is VBZ O O
living VBG O O
with IN B-VP O
her PRP$ O O
daughter NN B-NP O
and CC O O
son NN B-NP O
No NNP I-NP O
prior RB O O
tobacco NN B-NP O
or CC O O
smoking NN B-NP O
history NN I-NP O
She PRP O O
has VBZ O O
a DT B-NP O
prior JJ I-NP O
history NN I-NP O
of IN B-VP O
drinking NN B-NP O
alcohol NN I-NP O
and CC O O
IV NNP B-NP O
drug NN I-NP O
use NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Negative NNP I-NP O
for IN B-VP O
early RB O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
Her NNP I-NP O
father NN I-NP O
had VBD B-VP O
an DT B-NP O
MI NNP I-NP O
at IN B-VP O
age NN B-NP O
74 CD O O
Her NNP B-NP O
mother NN I-NP O
had VBD B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
at IN B-VP O
age NN B-NP O
76 CD O O
ADMISSION NNP B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
97.8 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
172/80 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
82 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
20 CD O O
, , O O
and CC O O
saturating VBG O O
100% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
This DT O O
is VBZ O O
a DT B-NP O
middle-aged JJ I-NP O
woman NN I-NP O
appearing VBG O O
older JJR O O
than IN B-VP O
stated VBN O O
age NN B-NP O
, , O O
complaining NN B-NP O
of IN B-VP O
left JJ B-NP O
hand NN I-NP O
pain NN I-NP O
, , O O
but CC O O
otherwise RB O O
appears VBZ O O
comfortable JJ O O
She PRP O O
has VBZ O O
a DT B-NP O
disconjugate NN I-NP O
gaze NN I-NP O
, , O O
has VBZ O O
only RB O O
light JJ B-NP O
vision NN I-NP O
in IN B-VP O
her PRP$ O O
left JJ B-NP O
eye NN I-NP O
Sclerae NNP I-NP O
are VBP O O
anicteric JJ B-NP O
Oropharynx NNP I-NP O
is VBZ O O
benign JJ O O
She PRP O O
had VBD B-VP O
no DT B-NP O
oral JJ I-NP O
ulcers NNS I-NP O
or CC O O
thrush NN B-NP O
Neck NN I-NP O
is VBZ O O
supple JJ O O
, , O O
without IN B-VP O
cervical JJ B-NP O
lymphadenopathy NN I-NP O
, , O O
no DT B-NP O
JVD NNP I-NP O
, , O O
and CC O O
no DT B-NP O
carotid NN I-NP O
bruits VBZ O O
Lungs NNS B-NP O
are VBP O O
clear JJ O O
to TO O O
auscultation VB O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
or CC O O
gallops NNS B-NP O
Abdomen NNP I-NP O
was VBD B-VP O
obese JJ O O
, , O O
soft JJ O O
, , O O
nondistended JJ O O
, , O O
and CC O O
nontender NN B-NP O
with IN B-VP O
questionable JJ B-NP O
splenic JJ I-NP O
fullness NN I-NP O
, , O O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
or CC O O
edema VB O O
She PRP O O
had VBD B-VP O
a DT O O
4 CD O O
x NN B-NP O
4 CD O O
ecchymosis NN B-NP O
on IN B-VP O
her PRP$ O O
left JJ B-NP O
shoulder NN I-NP O
and CC O O
a DT O O
2 CD O O
x NN B-NP O
2 CD O O
scab NN B-NP O
over IN B-VP O
her PRP$ O O
left JJ B-NP O
elbow NN I-NP O
The DT B-NP O
soft JJ I-NP O
tissue NN I-NP O
extending VBG O O
from IN B-VP O
the DT B-NP O
left JJ I-NP O
shoulder NN I-NP O
to TO O O
left VB O O
elbow NN B-NP O
was VBD B-VP O
tender NN B-NP O
to TO O O
palpation NN B-NP O
as IN B-VP O
was VBD B-VP O
the DT B-NP O
left NN I-NP O
chest NN I-NP O
She PRP O O
had VBD B-VP O
decreased VBN O O
sensation NN B-NP O
of IN B-VP O
bilateral JJ B-NP O
lower JJR I-NP O
extremities NNS I-NP O
and CC O O
left VBD B-VP O
Aside NNP B-NP O
from IN B-VP O
a DT B-NP O
disconjugate NN I-NP O
gaze NN I-NP O
, , O O
cranial JJ B-NP O
nerves NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
Motor NNP I-NP O
exam NN I-NP O
was VBD B-VP O
intact JJ B-NP O
Gait NNP I-NP O
was VBD B-VP O
slightly RB O O
wide-based JJ O O
, , O O
but CC O O
sufficient JJ O O
without IN B-VP O
cane NN B-NP O
Negative NNP I-NP O
Romberg NNP I-NP O
, , O O
negative JJ B-NP O
pronator NN I-NP O
drift NN I-NP O
, , O O
and CC O O
no DT B-NP O
dysmetria NN I-NP O
on IN B-VP O
finger-to-nose JJ B-NP O
bilateral NN I-NP O
, , O O
and CC O O
deep JJ B-NP O
tendon NN I-NP O
reflexes NNS I-NP O
were VBD B-VP O
2+ CD O O
throughout IN B-VP O
ADMISSION NNP B-NP O
LABORATORY NNP I-NP O
VALUES: NNP I-NP O
Sodium NNP I-NP O
138 CD O O
, , O O
potassium NN B-NP O
3.9 CD O O
, , O O
chloride RB O O
103 CD O O
, , O O
CO2 NNP B-NP O
28 CD O O
, , O O
BUN NNP B-NP O
13 CD O O
, , O O
creatinine NN B-NP O
0.7 CD O O
, , O O
glucose RB O O
179 CD O O
, , O O
calcium NN B-NP O
9.2 CD O O
, , O O
magnesium NN B-NP O
1.6 CD O O
, , O O
ALT NNP B-NP O
35 CD O O
, , O O
AST NNP B-NP O
34 CD O O
, , O O
alkaline JJ B-NP O
phosphatase NN I-NP O
57 CD O O
, , O O
CK NNP B-NP O
51 CD O O
, , O O
CK-MB NNP B-NP O
1.4 CD O O
, , O O
troponin NN B-NP O
less JJR O O
than IN B-VP O
assay NN B-NP O
, , O O
white JJ B-NP O
count NN I-NP O
of IN B-VP O
3.35 CD O O
, , O O
hemoglobin NN B-NP O
12.6 CD O O
, , O O
hematocrit NN B-NP O
36.7 CD O O
, , O O
PT NNP B-NP O
14.4 CD O O
, , O O
INR NNP B-NP O
1.1 CD O O
, , O O
and CC O O
PTT NNP B-NP O
29.5 CD O O
ADMISSION NNP B-NP O
DATA: NNP I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
EKG NNP I-NP O
was VBD B-VP O
normal JJ B-NP O
sinus JJ I-NP O
rhythm NN I-NP O
without IN B-VP O
ischemic JJ B-NP O
change NN I-NP O
CAT NNP I-NP O
scan NN I-NP O
of IN B-VP O
the DT B-NP O
head NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
Left VBN O O
shoulder NN B-NP O
and CC O O
arm NN B-NP O
plain NN I-NP O
films NNS I-NP O
were VBD B-VP O
negative JJ O O
for IN B-VP O
fracture NN B-NP O
or CC O O
dislocation NN B-NP O
IMPRESSION: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
47-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
HIV NNP B-NP O
, , O O
diabetes VBZ O O
, , O O
questionable JJ B-NP O
cerebral JJ I-NP O
aneurysm NN I-NP O
, , O O
and CC O O
seizure NN B-NP O
disorder NN I-NP O
( ( O O
not RB O O
taking VBG O O
Keppra NNP B-NP B-m
for IN B-VP B-du
the DT B-NP I-du
past JJ I-NP I-du
year NN I-NP I-du
) ) O O
, , O O
who WP O O
recently RB O O
had VBD B-VP O
two CD O O
syncopal JJ B-NP O
events NNS I-NP O
without IN B-VP O
prodrome NN B-NP O
and CC O O
without IN B-VP O
postictal JJ B-NP O
state NN I-NP O
( ( O O
thus RB O O
unlikely RB O O
a DT B-NP O
seizure NN I-NP O
in IN B-VP O
etiology NN B-NP O
) ) O O
, , O O
who WP O O
presented VBD B-VP O
for IN B-VP O
evaluation NN B-NP O
of IN B-VP O
left JJ B-NP O
arm NN I-NP O
paresthesias NN I-NP O
and CC O O
chest NN B-NP O
pain NN I-NP O
, , O O
with IN B-VP O
associated JJ B-NP O
diaphoresis NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
nausea NN B-NP O
, , O O
which WDT O O
has VBZ O O
been VBN O O
intermittently RB O O
occurring VBG O O
over IN B-VP O
the DT O O
past JJ O O
two CD O O
months NNS B-NP O
During IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
frequent JJ B-NP O
recurrences NNS I-NP O
of IN B-VP O
her PRP$ O O
left JJ B-NP O
arm NN I-NP O
and CC O O
chest NN B-NP O
pain NN I-NP O
symptoms NNS I-NP O
, , O O
which WDT O O
were VBD B-VP O
related VBN O O
to TO O O
syncopal JJ B-NP O
events NNS I-NP O
Thus RB O O
, , O O
the DT B-NP O
medical JJ I-NP O
team NN I-NP O
does VBZ O O
not RB O O
think VB O O
that IN B-VP O
these DT O O
two CD O O
issues NNS B-NP O
are VBP O O
related VBN O O
The DT B-NP O
patient NN I-NP O
underwent NN I-NP O
an DT B-NP O
extensive JJ I-NP O
syncopal JJ I-NP O
evaluation NN I-NP O
, , O O
however RB O O
, , O O
the DT B-NP O
etiology NN I-NP O
was VBD B-VP O
never RB O O
identified VBN O O
The DT B-NP O
etiology NN I-NP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
left VBD B-VP O
arm NN B-NP O
and CC O O
chest NN B-NP O
symptoms NNS I-NP O
and CC O O
syndromes NNS B-NP O
also RB O O
was VBD B-VP O
not RB O O
identified VBN O O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
however RB O O
, , O O
the DT B-NP O
medical JJ I-NP O
team NN I-NP O
suspects VBZ O O
it PRP O O
may MD O O
be VB O O
related VBN O O
to TO O O
a DT B-NP O
cervical JJ I-NP O
spinous JJ I-NP O
process NN I-NP O
, , O O
potentially RB O O
arthritis NN B-NP O
, , O O
disc JJ B-NP O
herniation NN I-NP O
or CC O O
nerve NN B-NP O
root NN I-NP O
impingement JJ B-NP O
Please NNP I-NP O
see VB O O
below IN B-VP O
for IN B-VP O
more JJR B-NP O
details NNS I-NP O
The DT B-NP O
remainder NN I-NP O
of IN B-VP O
the DT B-NP O
dictation NN I-NP O
will MD O O
be VB O O
divided VBN O O
into IN B-VP O
system: JJ O O
1 CD O O
Cardiovascular: NNP B-NP O
The DT B-NP O
patient NN I-NP O
underwent NN I-NP O
an DT B-NP O
extensive JJ I-NP O
cardiovascular JJ I-NP O
evaluation NN I-NP O
, , O O
all DT O O
of IN B-VP O
which WDT O O
was VBD B-VP O
negative JJ O O
a DT B-NP O
Pump: NNP I-NP O
Given NNP I-NP O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
HIV NNP B-NP O
and CC O O
taking VBG O O
antiretroviral JJ O O
, , O O
there EX O O
was VBD B-VP O
a DT B-NP O
concern NN I-NP O
about IN B-VP O
associated VBN O O
cardiomyopathy JJ B-NP O
Echocardiogram NNP I-NP O
that WDT O O
was VBD B-VP O
performed VBN O O
was VBD B-VP O
completely RB O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
exhibit VB O O
signs NNS B-NP O
of IN B-VP O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
or CC O O
orthopnea NN B-NP O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
Dyspnea NNP I-NP O
on IN B-VP O
exertion NN B-NP O
could MD O O
be VB O O
related VBN O O
to TO O O
decondition NN B-NP O
b NN I-NP O
Rhythm: NNP I-NP O
The DT B-NP O
patient's JJ I-NP O
telemetry NN I-NP O
history NN I-NP O
on IN B-VP O
2/23/2006 CD O O
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
nonsustained JJ I-NP O
5-beat JJ I-NP O
run NN I-NP O
of IN B-VP O
wide JJ B-NP O
complex JJ I-NP O
tachycardia NN I-NP O
with IN B-VP O
rates NNS B-NP O
in IN B-VP O
the DT O O
150's CD O O
This DT O O
was VBD B-VP O
immediately RB O O
followed VBN O O
by IN B-VP O
a DT B-NP O
nonsustained JJ I-NP O
4-beat JJ I-NP O
run NN I-NP O
of IN B-VP O
narrow JJ B-NP O
complex JJ I-NP O
tachycardia NN I-NP O
Cardiology NNP I-NP O
consult NN I-NP O
was VBD B-VP O
placed VBN O O
to TO O O
review VB O O
the DT B-NP O
telemetry NN I-NP O
strip NN I-NP O
and CC O O
to TO O O
assess VB O O
for IN B-VP O
referral JJ O O
to TO O O
EP NNP B-NP O
Service NNP I-NP O
for IN B-VP O
potential JJ B-NP O
AICD NNP I-NP O
Given NNP I-NP O
the DT B-NP O
negative JJ I-NP O
echocardiogram NN I-NP O
, , O O
the DT B-NP O
Card NNP I-NP O
Service NNP I-NP O
wanted VBD B-VP O
to TO O O
rule VB O O
out IN B-VP O
ischemia-induced JJ B-NP O
arrhythmia NN I-NP O
, , O O
so IN B-VP O
a DT B-NP O
MIBI NNP I-NP O
was VBD B-VP O
performed VBN O O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
low-dose JJ B-NP B-do
beta-blocker NN I-NP B-m
and CC O O
aspirin VB O B-m
The DT B-NP O
adenosine NN I-NP O
MIBI NNP I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
The DT B-NP O
telemetry NN I-NP O
strip NN I-NP O
was VBD B-VP O
reviewed VBN O O
by IN B-VP O
the DT B-NP O
EP NNP I-NP O
Service NNP I-NP O
and CC O O
diagnosed VBD B-VP O
the DT B-NP O
patient NN I-NP O
with IN B-VP O
nonsustained JJ B-NP O
SVT NNP I-NP O
with IN B-VP O
aberrancy NN B-NP O
The DT B-NP O
Card NNP I-NP O
Service NNP I-NP O
then RB O O
advised VBD B-VP O
that IN B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
need NN I-NP O
for IN B-VP O
AICD NNP B-NP O
They PRP O O
stated VBD B-VP O
that IN B-VP O
if IN B-VP O
tolerated VBN O O
, , O O
the DT B-NP O
beta-blocker NN I-NP B-m
could MD O O
be VB O O
continued VBN O O
and CC O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
should MD O O
be VB O O
set VBN O O
up RP O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
for IN B-VP O
a DT B-NP O
loop JJ I-NP O
recorder NN I-NP O
This DT O O
will MD O O
be VB O O
coordinated VBN O O
through IN B-VP O
the DT B-NP O
patient's JJ I-NP O
PCP NNP I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
after IN B-VP O
starting VBG O O
metoprolol JJ O B-m
12.5 CD O B-do
b.i.d NN B-NP B-f
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
occasional JJ B-NP O
bradycardia NN I-NP O
to TO O O
the DT O O
high JJ O O
40's CD O O
Thus RB O O
, , O O
it PRP O O
was VBD B-VP O
determined VBN O O
that IN B-VP O
this DT B-NP B-m
medication NN I-NP I-m
should MD O O
be VB O O
discontinued VBN O O
as IN B-VP O
it PRP O O
may MD O O
be VB O O
impairing VBG O O
the DT B-NP O
patient's NN I-NP O
exercise NN I-NP O
tolerance NN I-NP O
c NN I-NP O
Ischemia: NNP I-NP O
Coronary NNP I-NP O
disease NN I-NP O
risk NN I-NP O
factors NNS I-NP O
include VBP O O
diabetes NNS B-NP O
and CC O O
family NN B-NP O
history NN I-NP O
She PRP O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
, , O O
had VBD B-VP O
no DT B-NP O
ischemic JJ I-NP O
change NN I-NP O
on IN B-VP O
her PRP$ O O
EKG NNP B-NP O
, , O O
and CC O O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
MIBI NNP I-NP O
No NNP I-NP O
further RB O O
workup NN B-NP O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
was VBD B-VP O
indicated VBN O O
A NNP B-NP O
lipid JJ B-NP O
panel NN I-NP O
was VBD B-VP O
completely RB O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
and CC O O
suggesting VBG O O
treatment NN B-NP O
was VBD B-VP O
not RB O O
indicated VBN O O
d NN B-NP O
Miscellaneous: NNP I-NP O
On IN B-VP O
8/12/2006 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
evaluated VBN O O
for IN B-VP O
one CD O O
of IN B-VP O
her PRP$ O O
left JJ B-NP O
arm NN I-NP O
and CC O O
chest NN B-NP O
pain NN I-NP O
events NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
diaphoretic JJ O O
and CC O O
complained VBD B-VP O
of IN B-VP O
nausea NN B-NP O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
The DT B-NP O
symptoms NNS I-NP O
occurred VBD B-VP O
while IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
lying VBG O O
in IN B-VP O
bed NN B-NP O
Upon IN B-VP O
arrival NN B-NP O
by IN B-VP O
the DT B-NP O
team NN I-NP O
, , O O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
90/56 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
was VBD B-VP O
56 CD O O
, , O O
she PRP O O
had VBD B-VP O
poor JJ B-NP O
pallor NN I-NP O
, , O O
was VBD B-VP O
diaphoretic JJ O O
, , O O
and CC O O
described VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
radiating VBG O O
up RP O O
and CC O O
down IN B-VP O
her PRP$ O O
arm NN B-NP O
EKG NN I-NP O
in IN B-VP O
telemetry NN B-NP O
during IN B-VP O
the DT B-NP O
event NN I-NP O
was VBD B-VP O
normal JJ B-NP O
sinus JJ I-NP O
rhythm NN I-NP O
with IN B-VP O
any DT B-NP O
acute JJ I-NP O
ST NNP I-NP O
or CC O O
T-wave NNP B-NP O
changes VBZ O O
The DT B-NP O
event NN I-NP O
spontaneously RB O O
resolved VBN O O
in IN B-VP O
less JJR O O
than IN B-VP O
15 CD O O
minutes NNS B-NP O
without IN B-VP O
medical JJ B-NP O
intervention NN I-NP O
2 CD O O
Neuro: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
convulsive JJ B-NP B-r
seizures NNS I-NP I-r
and CC O O
has VBZ O O
been VBN O O
noncompliant JJ O O
with IN B-VP O
Keppra NNP B-NP B-m
for IN B-VP B-du
the DT O I-du
past JJ O I-du
12 CD O I-du
months NNS B-NP I-du
because IN B-VP O
she PRP O O
failed VBD B-VP O
to TO O O
keep VB O O
neuro JJ B-NP O
appointment NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Sconiers NNP I-NP O
and CC O O
has VBZ O O
been VBN O O
unable JJ O O
to TO O O
obtain VB O O
refills NNS B-NP O
Per IN B-VP O
the DT B-NP O
patient NN I-NP O
, , O O
her PRP$ O O
recent JJ B-NP O
syncopal JJ I-NP O
events NNS I-NP O
were VBD B-VP O
without IN B-VP O
prodrome NN B-NP O
and CC O O
without IN B-VP O
postictal JJ B-NP O
state NN I-NP O
Thus NNP I-NP O
, , O O
were VBD B-VP O
unlikely JJ B-NP O
prior JJ I-NP O
seizures NNS I-NP O
and CC O O
unlikely JJ B-NP O
seizure NN I-NP O
in IN B-VP O
focus NN B-NP O
An DT B-NP O
EEG NNP I-NP O
was VBD B-VP O
performed VBN O O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
and CC O O
demonstrated VBD B-VP O
no DT O O
definite JJ O O
focal JJ O O
or CC O O
epileptiform JJ B-NP O
features NNS I-NP O
Keppra NNP I-NP B-m
Keppra NNP I-NP B-m
Keppra NNP I-NP B-m
was VBD B-VP O
restarted VBN O O
at IN B-VP O
250 CD O B-do
mg NNS B-NP I-do
b.i.d NN I-NP B-f
with IN B-VP O
a DT B-NP O
goal NN I-NP O
to TO O O
increase VB O O
to TO O O
500 CD O B-do
mg NNS B-NP I-do
b.i.d RB O B-f
after IN B-VP O
7 CD O B-du
days NNS B-NP I-du
and CC O O
to TO O O
750 CD O B-do
mg NN B-NP I-do
after IN B-VP O
another DT B-NP O
week NN I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
cerebral JJ B-NP O
aneurysm NN I-NP O
, , O O
diagnosed VBN O O
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
facility NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
never RB O O
confirmed VBN O O
by IN B-VP O
Tonfay NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
imaging VBG O O
MRI NNP B-NP O
of IN B-VP O
the DT B-NP O
brain NN I-NP O
and CC O O
MRA NNP B-NP O
of IN B-VP O
the DT B-NP O
head NN I-NP O
and CC O O
neck NN B-NP O
obtained VBD B-VP O
this DT B-NP O
admission NN I-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
hemorrhage NN B-NP O
, , O O
mass NN B-NP O
, , O O
edema NN B-NP O
, , O O
hydrocephalus NN B-NP O
, , O O
infarction NN B-NP O
, , O O
and CC O O
negative JJ O O
for IN B-VP O
abnormal JJ B-NP O
enhancement NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
aneurysm JJ I-NP O
high-flow JJ I-NP O
AVM NNP I-NP O
or CC O O
stenosis NN B-NP O
found VBN O O
, , O O
and CC O O
MRA NNP B-NP O
of IN B-VP O
the DT B-NP O
neck NN I-NP O
had VBD B-VP O
no DT B-NP O
significant JJ I-NP O
abnormality NN I-NP O
The DT B-NP O
patient's JJ I-NP O
neurologist NN I-NP O
, , O O
Dr NNP B-NP O
Klez NNP I-NP O
, , O O
was VBD B-VP O
aware JJ O O
of IN B-VP O
this DT B-NP O
admission NN I-NP O
A DT B-NP O
follow-up JJ I-NP O
appointment NN I-NP O
has VBZ O O
been VBN O O
made VBN O O
3 CD O O
Endocrine: NNP B-NP O
History NNP I-NP O
of IN B-VP O
diabetes NNS B-NP O
type JJ B-NP O
II NNP I-NP O
, , O O
hemoglobin JJ B-NP O
A1c NNP I-NP O
of IN B-VP O
6.1 CD O O
, , O O
reflects VBZ O O
excellent JJ B-NP O
outpatient JJ I-NP O
glycemic JJ I-NP O
control NN I-NP O
, , O O
however RB O O
, , O O
the DT B-NP O
patient NN I-NP O
reports NNS I-NP O
becoming VBG O O
diaphoretic JJ O O
with IN B-VP O
normal JJ B-NP O
glycemic JJ I-NP O
levels NNS I-NP O
between IN B-VP O
80 CD O O
and CC O O
100 CD O O
Given NNP B-NP O
recent JJ B-NP O
weight NN I-NP O
loss NN I-NP O
without IN B-VP O
glyburide NN B-NP B-m
dose NN I-NP O
adjustment NN I-NP O
, , O O
the DT B-NP O
medical JJ I-NP O
team NN I-NP O
decreased VBD B-VP O
glyburide JJ B-NP B-m
glyburide NN I-NP B-m
to TO O O
2.5 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
for IN B-VP O
the DT B-NP O
patient NN I-NP O
to TO O O
begin VB O O
upon IN B-VP O
discharge NN B-NP O
During IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
the DT O O
all DT B-NP O
oral JJ I-NP O
agents NNS I-NP O
were VBD B-VP O
held VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
the DT B-NP O
Ryo NNP I-NP O
Hospital NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
insulin NN I-NP B-m
protocol NN I-NP O
4 CD O O
Infectious NNP B-NP O
disease: VBD B-VP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
HIV NNP B-NP O
positive JJ O O
, , O O
CD4 NNP B-NP O
count NN I-NP O
on IN B-VP O
1/21/2006 CD O O
was VBD B-VP O
217 CD O O
The DT B-NP O
viral JJ I-NP O
load NN I-NP O
was VBD B-VP O
less JJR O O
than IN B-VP O
assay VB O O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
on IN B-VP O
Truvada NNP B-NP B-m
and CC O O
Lexiva NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
complained VBD B-VP O
of IN B-VP O
dysuria NN B-NP O
on IN B-VP O
2/6/2006 CD O O
Urinalysis NN B-NP O
was VBD B-VP O
ordered VBN O O
, , O O
but CC O O
symptoms NNS B-NP O
resolved VBD B-VP O
before IN B-VP O
specimen NNS B-NP O
could MD O O
be VB O O
sent VBN O O
the DT B-NP O
lab NN I-NP O
5 CD O O
Pain: NNP B-NP O
History NNP I-NP O
of IN B-VP O
chronic JJ B-NP B-r
pain NN I-NP I-r
and CC O O
lumbar NN B-NP B-r
spine NN I-NP I-r
herniations VBZ O I-r
The DT B-NP O
methadone NN I-NP B-m
methadone NN I-NP B-m
dose NN I-NP O
of IN B-VP O
155 CD O B-do
155 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
was VBD B-VP O
confirmed VBN O O
with IN B-VP O
the DT B-NP O
outpatient NN I-NP O
clinic NN I-NP O
No NNP I-NP O
additional JJ B-NP O
regular NN I-NP O
narcotics NNS I-NP O
were VBD B-VP O
given VBN O O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
6 CD O O
Heme: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
chronic VBN O O
pancytopenia NN B-NP O
She PRP O O
has VBZ O O
a DT B-NP O
normocytic JJ I-NP O
normochromic JJ I-NP O
anemia NN I-NP O
with IN B-VP O
normal JJ B-NP O
iron NN I-NP O
studies NNS I-NP O
, , O O
B12 NNP B-NP B-m
and CC O O
folate NN B-NP B-m
, , O O
and CC O O
a DT B-NP O
low JJ I-NP O
reticulocyte NN I-NP O
index NN I-NP O
consistent JJ O O
with IN B-VP O
anemia NN B-NP O
of IN B-VP O
chronic JJ B-NP O
disease NN I-NP O
, , O O
likely RB O O
from IN B-VP O
HIV NNP B-NP O
immunosuppression NN I-NP O
7 CD O O
Miscellaneous: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
screened VBN O O
by IN B-VP O
the DT B-NP O
Physical NNP I-NP O
Therapy NNP I-NP O
Service NNP I-NP O
who WP O O
recommended VBD B-VP O
a DT B-NP O
home NN I-NP O
safety NN I-NP O
evaluation NN I-NP O
This DT O O
will MD O O
be VB O O
coordinated VBN O O
to TO O O
the DT B-NP O
Tlandgilb NNP I-NP O
O NNP I-NP O
Visiting NNP I-NP O
Nurses NNP I-NP O
Association NNP I-NP O
Given NNP I-NP O
the DT B-NP O
liability NN I-NP O
and CC O O
predictability NN B-NP O
of IN B-VP O
events NNS B-NP O
, , O O
the DT B-NP O
team NN I-NP O
implemented VBD B-VP O
a DT B-NP O
24-hour JJ I-NP O
urine JJ I-NP O
collection NN I-NP O
to TO O O
assess VB O O
for IN B-VP O
pheochromocytoma NN B-NP O
The DT B-NP O
results NNS I-NP O
of IN B-VP O
the DT B-NP O
studies NNS I-NP O
are VBP O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
discharge NN I-NP O
The DT B-NP O
patient NN I-NP O
may MD O O
have VB O O
autonomic JJ B-NP O
dysregulation NN I-NP O
as IN B-VP O
part NN B-NP O
of IN B-VP O
her PRP$ O O
diabetes NNS B-NP O
Alternatively RB O O
, , O O
the DT B-NP O
medical JJ I-NP O
team NN I-NP O
speculates VBZ O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
may MD O O
have VB O O
cervical JJ B-NP O
spinal JJ I-NP O
arthritis NN I-NP O
, , O O
lumbar JJ B-NP O
herniation NN I-NP O
or CC O O
nerve NN B-NP O
root NN I-NP O
impingement NN I-NP O
contributing VBG O O
to TO O O
these DT B-NP O
symptoms NNS I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
states VBZ O O
that IN B-VP O
these DT B-NP O
episodes NNS I-NP O
had VBD B-VP O
occurred VBN O O
more RBR O O
frequently RB O O
inpatient JJ O O
and CC O O
they PRP O O
were VBD B-VP O
at IN B-VP O
home NN B-NP O
It PRP O O
was VBD B-VP O
until IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
that IN B-VP O
it PRP O O
was VBD B-VP O
noted VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
not RB O O
receiving VBG O O
her PRP$ O O
Klonopin NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
q.i.d NN I-NP B-f
as IN B-VP O
she PRP O O
had VBD B-VP O
prior RB O O
to TO O O
admission NN B-NP O
In IN B-VP O
fact NN B-NP O
, , O O
she PRP O O
has VBZ O O
only RB O O
received VBN O O
three CD O B-do
doses NNS B-NP I-do
of IN B-VP O
Klonopin NNP B-NP B-m
over IN B-VP B-du
a DT B-NP I-du
six-day JJ I-NP I-du
period NN I-NP I-du
It PRP O O
is VBZ O O
unclear JJ O O
what WP O O
role NN B-NP O
anxiety NN I-NP O
is VBZ O O
playing VBG O O
into IN B-VP O
these DT B-NP O
events NNS I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
stated VBD B-VP O
that IN B-VP O
she PRP O O
was VBD B-VP O
making VBG O O
arrangements NNS B-NP O
to TO O O
see VB O O
an DT B-NP O
orthopedic JJ I-NP O
specialist NN I-NP O
at IN B-VP O
Laly NNP B-NP O
County NNP I-NP O
Health NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
of IN B-VP O
her PRP$ O O
cervical JJ B-NP O
spine NN I-NP O
FINAL NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
Syncope NNP B-NP O
, , O O
not RB O O
otherwise RB O O
specified VBN O O
2 CD O O
Left NNP B-NP O
arm NN I-NP O
pain/left NN I-NP O
chest NN I-NP O
pain/left NN I-NP O
arm NN I-NP O
paresthesias NN I-NP O
( ( O O
not RB O O
otherwise RB O O
specified VBN O O
) ) O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
Ecotrin NNP I-NP B-m
81 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
clonazepam VBD B-VP B-m
1 CD O B-do
mg NN B-NP I-do
q.6 NN I-NP B-f
h NN I-NP I-f
p.r.n NN I-NP I-f
, , O O
Imodium NNP B-NP B-m
one CD O B-do
to TO O O
two CD O O
tablets NNS B-NP O
q.i.d VBP O B-f
p.r.n NN B-NP I-f
for IN B-VP O
diarrhea NN B-NP B-r
, , O O
Truvada NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
p.o NN I-NP B-mo
daily RB O B-f
, , O O
Lexiva NNP B-NP B-m
1400 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
glyburide RB O B-m
2.5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Keppra NNP B-NP B-m
Keppra NNP I-NP B-m
500 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
for IN B-VP B-du
14 CD O I-du
doses NNS B-NP I-du
and CC O O
then RB O O
750 CD O B-do
mg NNS B-NP I-do
b.i.d RBR O B-f
indefinitely RB O B-du
, , O O
methadone PRP O B-m
155 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Zoloft NNP B-NP B-m
300 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
trazodone NN B-NP B-m
100 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
bedtime NN B-NP I-f
p.r.n NN I-NP I-f
, , O O
and CC O O
Zofran NNP B-NP B-m
4 CD O B-do
mg JJ B-NP I-do
daily JJ I-NP B-f
p.r.n NN I-NP I-f
for IN B-VP O
nausea NN B-NP B-r
MEDICAL NNP I-NP O
FOLLOW NNP I-NP O
UP: NNP I-NP O
On IN B-VP O
2/25/2006 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
scheduled VBN O O
to TO O O
see VB O O
her PRP$ O O
PCP NNP B-NP O
, , O O
Dr NNP B-NP O
Les NNP I-NP O
Orosco NNP I-NP O
On IN B-VP O
7/10/2006 CD O O
, , O O
she PRP O O
is VBZ O O
scheduled VBN O O
to TO O O
see VB O O
her PRP$ O O
psychiatrist NN B-NP O
, , O O
Dr NNP B-NP O
Damien NNP I-NP O
Scherzer NNP I-NP O
On IN B-VP O
9/18/2006 CD O O
, , O O
she PRP O O
is VBZ O O
scheduled VBN O O
to TO O O
see VB O O
her PRP$ O O
Infectious JJ B-NP O
Disease NNP I-NP O
, , O O
Dr NNP B-NP O
Marion NNP I-NP O
Callais NNP I-NP O
On IN B-VP O
0/14/2006 CD O O
, , O O
she PRP O O
is VBZ O O
scheduled VBN O O
to TO O O
see VB O O
her PRP$ O O
neurologist NN B-NP O
, , O O
Dr NNP B-NP O
Shane NNP I-NP O
Bemberry NNP I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
going VBG O O
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
the DT B-NP O
Na NNP I-NP O
Riventtortonlis NNP I-NP O
Jo NNP I-NP O
VNA NNP I-NP O
who WP O O
will MD O O
do VB O O
a DT B-NP O
medication NN I-NP O
reconciliation NN I-NP O
and CC O O
home NN B-NP O
safety NN I-NP O
evaluation NN I-NP O
SPECIFIC NNP I-NP O
INSTRUCTIONS: NNP I-NP O
1 CD O O
Take NNP B-NP O
medications NNS I-NP O
as IN B-VP O
listed VBN O O
, , O O
clarify VB O O
discrepancies NNS B-NP O
with IN B-VP O
your PRP$ O O
PCP NNP B-NP O
This DT O O
means VBZ O O
stop JJ O O
taking VBG O O
Flexeril NNP B-NP B-m
, , O O
____ NNP B-NP O
glyburide NN I-NP B-m
has VBZ O O
been VBN O O
changed VBN O O
to TO O O
2.5 CD O B-do
mg NN B-NP I-do
, , O O
and CC O O
low-dose JJ B-NP B-do
aspirin NN I-NP B-m
has VBZ O O
been VBN O O
started VBN O O
2 CD O O
If IN B-VP O
you PRP O O
faint VBP O O
again RB O O
, , O O
you PRP O O
should MD O O
return VB O O
to TO O O
the DT B-NP O
ER NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
3 CD O O
If IN B-VP O
your PRP$ O O
chest JJS B-NP O
pain NN I-NP O
symptoms NNS I-NP O
recur NN I-NP O
and CC O O
persist NN B-NP O
longer JJR O O
than IN B-VP O
the DT B-NP O
typical JJ I-NP O
course NN I-NP O
, , O O
call VB O O
your PRP$ O O
PCP NNP B-NP O
and/or NN I-NP O
return NN I-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
4 CD O O
Make NNP B-NP O
an DT B-NP O
appointment NN I-NP O
with IN B-VP O
the DT B-NP O
Smill NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
to TO O O
evaluate VB O O
the DT B-NP O
cause NN I-NP O
of IN B-VP O
her PRP$ O O
left JJ B-NP O
arm NN I-NP O
symptoms NNS I-NP O
5 CD O O
Check NNP B-NP O
your PRP$ O O
blood NN B-NP O
sugars NNS I-NP O
before IN B-VP O
meals NNS B-NP O
and CC O O
at IN B-VP O
bedtime NN B-NP O
, , O O
record NN B-NP O
and CC O O
bring VB O O
your PRP$ O O
results NNS B-NP O
to TO O O
your PRP$ O O
follow-up JJ B-NP O
appointment NN I-NP O
SPECIFIC NNP I-NP O
INSTRUCTIONS NNP I-NP O
FOR IN B-VP O
THE NNP B-NP O
PCP: NNP I-NP O
1 CD O O
Please NNP B-NP O
arrange NN I-NP O
for IN B-VP O
a DT B-NP O
loop JJ I-NP O
monitor NN I-NP O
2 CD O O
Follow NNP B-NP O
up RB O O
on IN B-VP O
a DT B-NP O
24-hour JJ I-NP O
urine JJ I-NP O
studies NNS I-NP O
assessing VBG O O
for IN B-VP O
pheochromocytoma NN B-NP O
3 CD O O
Adjust NNP B-NP O
the DT B-NP O
patient's NN I-NP O
diabetes VBZ O O
management NN B-NP O
as IN B-VP O
needed VBN O O
eScription NN B-NP O
document: VBZ O O
1-2481939 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MARTYN NNP I-NP O
, , O O
BRUNO NNP B-NP O
Attending: NNP I-NP O
TOTI NNP I-NP O
, , O O
JEREMY NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
1865427 CD O O
D: NNP B-NP O
9/4/06 CD O O
T: NNP B-NP O
9/4/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#555996 VBZ O O
708486546 CD O O
WRH NNP B-NP O
96067621 CD O O
9079561 CD O O
5/13/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
same JJ B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/13/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/13/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
COLAFRANCESCO NNP I-NP O
, , O O
VANCE NNP B-NP O
J NNP I-NP O
324-27-48-7 JJ B-NP O
Inero NNP I-NP O
Lane NNP I-NP O
Room: NNP I-NP O
Ster NNP I-NP O
Mar NNP I-NP O
1 CD O O
Service: NNP B-NP O
URO NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/20/05 CD O O
AT NNP B-NP O
11:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
ISHERWOOD NNP I-NP O
, , O O
REYES NNP B-NP O
GAVIN NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
CAPSAICIN NNP I-NP B-m
0.025 CD O I-m
% NN B-NP I-m
TP NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
apply VB O O
to TO O O
legs VB O O
LASIX NNP B-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
MICRONASE NNP I-NP B-m
( ( O I-m
GLYBURIDE NNP B-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
L-THYROXINE NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
50 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/3/05 CD O O
by IN B-VP O
MURRI NNP B-NP O
, , O O
CRISTOPHER NNP B-NP O
STEPHEN NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
DIGOXIN NNP I-NP B-m
&amp; NNP I-NP O
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
home NN I-NP O
PYRIDIUM NNP I-NP B-m
( ( O I-m
PHENAZOPYRIDINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
PRN NNP I-NP O
Other:bladder/stent NNP I-NP O
pain NN I-NP B-r
PROBENECID NNP I-NP B-m
1 CD O B-do
, , O I-do
500 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
COZAAR NNP I-NP B-m
( ( O I-m
LOSARTAN NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt;100 NNP B-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
FLOMAX NNP B-NP B-m
( ( O I-m
TAMSULOSIN NNP B-NP I-m
) ) O I-m
0.4 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
BACTRIM NNP I-NP B-m
DS NNP I-NP I-m
( ( O I-m
TRIMETHOPRIM/SULFAMETHOXAZOLE NNP B-NP I-m
DOU NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
Q24H NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Lyvers NNP I-NP O
at IN B-VP O
865-655-3733 JJ B-NP O
Please NNP I-NP O
call NN I-NP O
office NN I-NP O
for IN B-VP O
follow-up JJ B-NP O
appointment NN I-NP O
, , O O
ALLERGY: NNP B-NP O
Aspirin NNP I-NP O
, , O O
Morphine NNP B-NP O
, , O O
ALLOPURINOL NNP B-NP O
, , O O
ALENDRONATE NNP B-NP O
, , O O
FOSINOPRIL NNP B-NP O
, , O O
Codeine NNP B-NP O
, , O O
CARBAMAZEPINE NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
nephrolithiasis NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
same JJ B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
DM NNP I-NP O
, , O O
gout NN B-NP O
, , O O
OA NNP B-NP O
, , O O
Afib NNP B-NP O
, , O O
Diverticulitis NNP B-NP O
, , O O
nephrolithiasis NN B-NP O
, , O O
CRI NNP B-NP O
, , O O
sleep JJ B-NP O
apnea NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
cystoscopy NN I-NP O
, , O O
L NNP B-NP O
ureteroscopy NN I-NP O
, , O O
L NNP B-NP O
retrograde VBD B-VP O
pyelogram NN B-NP O
, , O O
Laser NNP B-NP O
lithotripsy NN I-NP O
and CC O O
L NNP B-NP O
stent JJ B-NP O
placement NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
79 CD O O
yoM NN B-NP O
with IN B-VP O
a DT O O
1 CD O O
cm NN B-NP O
L NNP I-NP O
renal VBZ O O
stone NN B-NP O
that WDT O O
was VBD B-VP O
stable JJ O O
for IN B-VP O
years NNS B-NP O
but CC O O
caused VBD B-VP O
left VBN O O
hip NN B-NP O
and CC O O
flank NN B-NP O
pain NN I-NP O
with IN B-VP O
nausea NN B-NP O
and CC O O
vomiting VBG O O
Patient NNP B-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
OCMC NNP B-NP O
on IN B-VP O
8/9/05 CD O O
With IN B-VP O
hx NN B-NP O
of IN B-VP O
Afib NNP B-NP B-r
, , O O
patient's JJ B-NP O
cardiologist NN I-NP O
Dr NNP I-NP O
Cannizzo NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
coumadin NN B-NP B-m
was VBD B-VP O
helf PRP O O
for IN B-VP O
operation NN B-NP O
It PRP O O
was VBD B-VP O
orginally RB O O
planned VBN O O
to TO O O
reverse VB O O
INR NNP B-NP B-r
with IN B-VP O
FFP NNP B-NP B-m
but CC O O
patient JJ O O
felt VBD B-VP O
throat NN B-NP O
tightness NN I-NP O
after IN B-VP O
5 CD O O
min NN B-NP O
of IN B-VP O
FFP NNP B-NP B-m
transfusion NN I-NP B-mo
and CC O O
FFP NNP B-NP B-m
was VBD B-VP O
stopped VBN O O
Patient NNP B-NP O
underwent JJ B-NP O
laser NN I-NP O
lithotripsy NN I-NP O
and CC O O
stent JJ B-NP O
placement NN I-NP O
on IN B-VP O
8/0/50 CD O O
and CC O O
he PRP O O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
Immediate NNP B-NP O
post-op NN I-NP O
, , O O
patient NN B-NP O
had VBD B-VP O
frequent JJ B-NP O
PVC NNP I-NP O
but CC O O
cardiac JJ B-NP O
enzyme NN I-NP O
was VBD B-VP O
negative JJ B-NP O
Foley NNP I-NP O
was VBD B-VP O
removed VBN O O
on IN B-VP O
POD1 NNP B-NP O
midnight NN I-NP O
and CC O O
patient NN B-NP O
voided VBD B-VP O
without IN B-VP O
difficulties NNS B-NP O
with IN B-VP O
post NN B-NP O
void NN I-NP O
residue JJ O O
120 CD O O
cc NN B-NP O
Patient NNP I-NP O
was VBD B-VP O
noticed VBN O O
to TO O O
have VB O O
an DT B-NP O
enlarged JJ I-NP O
prostate NN I-NP O
during IN B-VP O
procedure NN B-NP O
and CC O O
need NN B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Domebo NNP I-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
On IN B-VP O
POD2 NNP B-NP O
, , O O
patient NN B-NP O
tolerated VBD B-VP O
regular JJ B-NP O
diet NN I-NP O
, , O O
and CC O O
was VBD B-VP O
ready JJ O O
to TO O O
be VB O O
discharged VBN O O
home NN B-NP O
with IN B-VP O
Bactrim NNP B-NP B-m
and CC O O
low JJ B-NP B-do
dose NN I-NP I-do
Coumadin NNP I-NP B-m
He PRP O O
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O O
PCP NNP B-NP O
for IN B-VP O
INR NNP B-NP O
check NN I-NP O
and CC O O
Coumadin NNP B-NP B-m
dose VBP O O
adjustment JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
start VB O O
taking VBG O O
Coumadin NNP B-NP B-m
at IN B-VP O
3 CD O B-do
mg NN B-NP I-do
for IN B-VP O
tonight NN B-NP B-du
and CC O I-du
tomorrow NN B-NP I-du
night NN I-NP I-du
and CC O O
resume VB O O
your PRP$ O O
regular JJ B-NP O
coumadine NN I-NP B-m
dose NN I-NP O
schedule NN I-NP O
Call NNP I-NP O
your PRP$ O O
Coumadin NNP B-NP B-m
clinic NN I-NP O
on IN B-VP O
Monday NNP B-NP O
for IN B-VP O
follow VBP O O
up RP O O
regarding VBG O O
to TO O O
blood VB O O
check NN B-NP O
and CC O O
coumadin JJ B-NP B-m
dosage NN I-NP O
adjustment NN I-NP O
No NNP I-NP O
lifting VBG O O
more JJR O O
that IN B-VP O
10 CD O O
lbs JJ B-NP O
No NNP I-NP O
driving VBG O O
while IN B-VP O
on IN B-VP O
narcotics NNS B-NP B-m
Please NNP I-NP O
call NN I-NP O
for IN B-VP O
fever NN B-NP O
&gt; NN I-NP O
101.5 CD O O
, , O O
unable JJ O O
to TO O O
urinate VB O O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
any DT B-NP O
other JJ I-NP O
concerning NN I-NP O
symptoms NNS I-NP O
Call NNP I-NP O
Urology NNP I-NP O
office NN I-NP O
865-655-3733 NN I-NP O
for IN B-VP O
appointment NN B-NP O
and CC O O
questions NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
JEZ NNP I-NP O
, , O O
JAMEY NNP B-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
PI87 NNP B-NP O
) ) O O
9/20/05 CD O O
@ $ O O
12 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#560453 VBZ O O
748470127 CD O O
CBMC NNP B-NP O
32700120 CD O O
8249855 CD O O
1/30/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
RIGHT NNP I-NP O
KNEE NNP I-NP O
EFFUSION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/27/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/21/2005 CD O O
ATTENDING: NNP B-NP O
REDWINE NNP I-NP O
, , O O
KENNY NNP B-NP O
M.D NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
Knee NNP B-NP O
pain NN I-NP O
2 CD O O
Chronic NNP B-NP O
venous JJ B-NP O
stasis NN I-NP O
3 CD O O
Lithium NNP B-NP O
toxicity NN I-NP O
4 CD O O
Obesity NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
50-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
, , O O
obesity NN B-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
schizophrenia NN I-NP O
and CC O O
bipolar JJ B-NP O
disorder NN I-NP O
, , O O
presents NNS B-NP O
with IN B-VP O
right JJ B-NP O
knee NN I-NP O
swelling VBG O O
, , O O
redness NN B-NP O
and CC O O
pain NN B-NP O
for IN B-VP O
one CD O O
week NN B-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
alone RB O O
at IN B-VP O
home NN B-NP O
and CC O O
has VBZ O O
two CD O O
brothers NNS B-NP O
who WP O O
periodically RB O O
check VBP O O
in IN B-VP O
on IN B-VP O
her PRP$ O O
She PRP O O
was VBD B-VP O
visited VBN O O
by IN B-VP O
her PRP$ O O
brother NN B-NP O
yesterday NN I-NP O
and CC O O
found VBD B-VP O
that IN B-VP O
her PRP$ O O
right JJ B-NP O
knee NN I-NP O
had VBD B-VP O
been VBN O O
swollen VBN O O
red JJ O O
and CC O O
tender NN B-NP O
for IN B-VP O
about IN B-VP O
a DT B-NP O
week NN I-NP O
After IN B-VP O
he PRP O O
noted VBD B-VP O
this DT O O
, , O O
he PRP O O
brought VBD B-VP O
her PRP O O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
The DT B-NP O
patient NN I-NP O
states VBZ O O
that IN B-VP O
the DT B-NP O
leg NN I-NP O
has VBZ O O
made VBN O O
it PRP O O
impossible JJ O O
for IN B-VP O
her PRP$ O O
to TO O O
ambulate VB O O
She PRP O O
denies VBZ O O
trauma NN B-NP O
to TO O O
the DT B-NP O
area NN I-NP O
recently RB O O
She PRP O O
also RB O O
denies VBZ O O
fevers NNS B-NP O
, , O O
chills NNS B-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
chest JJS B-NP O
pain NN I-NP O
There EX O O
is VBZ O O
no DT B-NP O
nausea NN I-NP O
, , O O
vomiting VBG O O
, , O O
constipation NN B-NP O
or CC O O
diarrhea NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Ovarian NNP B-NP O
cystadenofibroma NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
TAH-BSO NNP I-NP O
in IN B-VP O
1/24 CD O O
2 CD O O
Obesity NN B-NP O
3 CD O O
Hypertension NNP B-NP O
4 CD O O
Diabetes VBZ O O
5 CD O O
Hyperlipidemia NNP B-NP O
6 CD O O
Schizophrenia NNP B-NP O
7 CD O O
Bipolar NNP B-NP O
disorder NN I-NP O
8 CD O O
Obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
on IN B-VP O
home NN B-NP O
BiPAP NNP I-NP O
9 CD O O
History NNP B-NP O
of IN B-VP O
laparoscopy NN B-NP O
for IN B-VP O
infertility NN B-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Lisinopril NNP B-NP B-m
10 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
2 CD O O
Lipitor NNP B-NP B-m
40 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
3 CD O O
Klonopin NNP B-NP B-m
4 CD O O
MetroGel NNP B-NP B-m
p.o NN I-NP B-mo
at IN B-VP B-f
bedtime JJ O I-f
5 CD O O
Lithium NNP B-NP B-m
900 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
bedtime JJ O I-f
6 CD O O
Acebutolol NNP B-NP B-m
200 CD O B-do
mg VBD B-VP I-do
daily RB O B-f
7 CD O O
Risperdal NNP B-NP B-m
0.5 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
bedtime JJ B-NP I-f
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
at IN B-VP O
home NN B-NP O
alone RB O O
She PRP O O
smokes VBZ O O
tobacco NN B-NP O
, , O O
but CC O O
denies VBZ O O
ethanol FW O O
She PRP O O
does VBZ O O
drink VB O O
several JJ B-NP O
bottles NNS I-NP O
of IN B-VP O
soda JJ O O
per IN B-VP O
day NN B-NP O
Her PRP$ O O
brother NN B-NP O
, , O O
Willard NNP B-NP O
Kloock NNP I-NP O
, , O O
did VBD B-VP O
involve VB O O
in IN B-VP O
her PRP O O
care; VB O O
his PRP$ O O
phone NN B-NP O
number NN I-NP O
is VBZ O O
427-986-1973 JJ O O
, , O O
he PRP O O
can MD O O
also RB O O
be VB O O
reached VBN O O
at IN B-VP O
243-754-1828 JJ B-NP O
Her NNP I-NP O
other JJ B-NP O
brother NN I-NP O
, , O O
Merrill NNP B-NP O
Luersen NNP I-NP O
, , O O
is VBZ O O
also RB O O
involved VBN O O
in IN B-VP O
her PRP$ O O
care NN B-NP O
and CC O O
can MD O O
be VB O O
reached VBN O O
at IN B-VP O
938-506-7946 JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
97.5 CD O O
, , O O
pulse RB O O
42 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
107/58 CD O O
, , O O
respirations NNS B-NP O
20 CD O O
, , O O
and CC O O
oxygen NN B-NP O
saturation NN I-NP O
97% CD O O
In IN B-VP O
general JJ O O
, , O O
this DT O O
is VBZ O O
an DT B-NP O
obese JJ I-NP O
female NN I-NP O
, , O O
she PRP O O
is VBZ O O
Spanish-speaking VBG O O
mostly RB O O
She PRP O O
appears VBZ O O
unkempt JJ O O
and CC O O
in IN B-VP O
discomfort NN B-NP O
somewhat RB O O
because IN B-VP O
of IN B-VP O
her PRP$ O O
right JJ B-NP O
knee NN I-NP O
pain NN I-NP O
She PRP O O
is VBZ O O
no DT B-NP O
acute JJ I-NP O
distress NN I-NP O
Cardiovascular NNP I-NP O
exam NN I-NP O
shows NNS I-NP O
bradycardia VBP O O
, , O O
with IN B-VP O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
and CC O O
2/6 CD O O
systolic JJ B-NP O
ejection NN I-NP O
murmur FW O O
heard NN B-NP O
best JJS O O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
Her NNP I-NP O
chest NN I-NP O
exam NN I-NP O
showed VBD B-VP O
some DT O O
low JJ O O
soft JJ O O
rumbling VBG O O
sounds NNS B-NP O
with IN B-VP O
inspiration NN B-NP O
and CC O O
expiration NN B-NP O
, , O O
otherwise RB O O
, , O O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
Abdomen NNP B-NP O
was VBD B-VP O
distended VBN O O
and CC O O
obese JJ O O
There EX O O
are VBP O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
and CC O O
no DT B-NP O
palpable JJ I-NP O
liver NN I-NP O
and CC O O
spleen JJ B-NP O
Extremity NNP I-NP O
exam NN I-NP O
showed VBD B-VP O
uncut JJ B-NP O
nails NNS I-NP O
on IN B-VP O
upper JJ O O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
bilaterally RB O O
Her PRP$ O O
right JJ B-NP O
leg NN I-NP O
was VBD B-VP O
greater JJR O O
in IN B-VP O
size NN B-NP O
than IN B-VP O
her PRP$ O O
left NN B-NP O
, , O O
however RB O O
, , O O
both DT O O
show VBP O O
significant JJ B-NP O
2-3+ JJ I-NP O
pitting NN I-NP O
edema NN I-NP O
On IN B-VP O
the DT B-NP O
right JJ I-NP O
ankle NN I-NP O
area NN I-NP O
, , O O
there EX O O
appears VBZ O O
to TO O O
be VB O O
chronic JJ B-NP O
venous JJ I-NP O
stasis NN I-NP O
changes NNS I-NP O
with IN B-VP O
hyperpigmented JJ B-NP O
patch NN I-NP O
on IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremity NN I-NP O
There EX O O
are VBP O O
less JJR B-NP O
chronic JJ I-NP O
venous JJ I-NP O
stasis NN I-NP O
changes NNS I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
There EX O O
was VBD B-VP O
some DT B-NP O
mild JJ I-NP O
erythema NN I-NP O
around IN B-VP O
the DT B-NP O
right JJ I-NP O
knee NN I-NP O
This DT B-NP O
area NN I-NP O
of IN B-VP O
redness NN B-NP O
was VBD B-VP O
poorly RB O O
demarcated VBN O O
and CC O O
mildly RB O O
blanching VBG O O
There EX O O
was VBD B-VP O
painful JJ B-NP O
passive JJ I-NP O
motion NN I-NP O
on IN B-VP O
her PRP$ O O
right JJ B-NP O
knee NN I-NP O
Neuro NNP I-NP O
exam NN I-NP O
was VBD B-VP O
grossly RB O O
intact JJ O O
and CC O O
nonfocal JJ O O
She PRP O O
did VBD B-VP O
have VB O O
a DT B-NP O
coarse JJ I-NP O
tremor NN I-NP O
in IN B-VP O
her PRP$ O O
upper JJ O O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
when WRB O O
asked VBD B-VP O
to TO O O
use VB O O
these DT B-NP O
extremities NNS I-NP O
for IN B-VP O
motion NN B-NP O
DIAGNOSTIC NNP I-NP O
DATA: NNP I-NP O
Electrolytes NNP I-NP O
were VBD B-VP O
significant JJ O O
for IN B-VP O
a DT B-NP O
potassium NN I-NP O
of IN B-VP O
5.8 CD O O
and CC O O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1.6 CD O O
that WDT O O
was VBD B-VP O
raised VBN O O
from IN B-VP O
previous JJ B-NP O
creatinine NN I-NP O
in IN B-VP O
2004 CD O O
of IN B-VP O
1.0 CD O O
Her PRP$ O O
liver NN B-NP O
enzymes NNS I-NP O
were VBD B-VP O
unremarkable JJ B-NP O
Her NNP I-NP O
hematocrit NN I-NP O
was VBD B-VP O
45.5 CD O O
A NNP B-NP O
UA NNP I-NP O
done VBN O O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
bland NN B-NP O
, , O O
however RB O O
, , O O
urine JJ B-NP O
cultures NNS I-NP O
grew VBD B-VP O
greater JJR O O
than IN B-VP O
a DT O O
1000 CD O O
CFU/mL NNP B-NP O
of IN B-VP O
coag-negative JJ B-NP O
Staphylococcus NNP I-NP O
Her NNP I-NP O
right NN I-NP O
knee NN I-NP O
film NN I-NP O
showed VBD B-VP O
mild JJ B-NP O
effusion NN I-NP O
, , O O
no DT B-NP O
fracture NN I-NP O
This DT B-NP O
effusion NN I-NP O
was VBD B-VP O
tapped VBN O O
and CC O O
showed VBD B-VP O
20 CD O O
white JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
810 CD O O
red JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
Of IN B-VP O
the DT B-NP O
white JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
21% CD O O
were VBD B-VP O
PMNs NNP B-NP O
and CC O O
75% CD O O
were VBD B-VP O
lymphocytes NNS B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
crystals NNS I-NP O
seen VBN O O
There EX O O
were VBD B-VP O
no DT O O
organisms JJ O O
seen VBN O O
ASSESSMENT: NNP B-NP O
Ms NNP I-NP O
Fought NNP I-NP O
is VBZ O O
a DT B-NP O
50-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
bipolar JJ B-NP O
disorder NN I-NP O
, , O O
schizophrenia NN B-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
and CC O O
diabetes NNS B-NP O
, , O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
one CD O O
week NN B-NP O
of IN B-VP O
worsening VBG O O
right JJ B-NP O
knee NN I-NP O
redness NN I-NP O
, , O O
swelling VBG O O
and CC O O
pain NN B-NP O
causing NN I-NP O
immobility NN I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEM/PROBLEM: NNP I-NP O
1 CD O O
Leg NNP B-NP O
swelling: VBD B-VP O
The DT B-NP O
differential JJ I-NP O
diagnosis NN I-NP O
that WDT O O
was VBD B-VP O
considered VBN O O
for IN B-VP O
her PRP$ O O
leg NN B-NP O
swelling VBG O O
included VBD B-VP O
deep JJ B-NP O
venous JJ I-NP O
thrombosis NN I-NP O
versus NN I-NP O
cellulitis NN I-NP O
versus IN B-VP O
septic JJ B-NP O
joints NNS I-NP O
versus VBP O O
gout NN B-NP O
versus NN I-NP O
chronic JJ B-NP O
lymphedema NN I-NP O
with IN B-VP O
an DT B-NP O
acute NN I-NP O
worsening VBG O O
Infectious JJ B-NP O
causes NNS I-NP O
were VBD B-VP O
considered VBN O O
less RBR O O
likely JJ O O
given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
the DT B-NP O
patient's JJ I-NP O
white JJ I-NP O
count NN I-NP O
was VBD B-VP O
not RB O O
significantly RB O O
elevated VBN O O
, , O O
( ( O O
it PRP O O
was VBD B-VP O
10.5 CD O O
with IN B-VP O
75% CD O O
polys NN B-NP O
, , O O
and CC O O
80% CD O O
lymphs NN B-NP O
) ) O O
, , O O
and CC O O
in IN B-VP O
fact NN B-NP O
that IN B-VP O
she PRP O O
has VBZ O O
not RB O O
had VBN O O
any DT O O
fever RB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
empirically RB O O
, , O O
however RB O O
, , O O
as IN B-VP O
this DT B-NP O
diagnosis NN I-NP O
was VBD B-VP O
unable JJ O O
to TO O O
be VB O O
ruled VBN O O
out RP O O
initially RB O O
with IN B-VP O
vancomycin NN B-NP B-m
and CC O O
Unasyn NNP B-NP B-m
and CC O O
then RB O O
with IN B-VP O
levofloxacin PDT O B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
therapeutic JJ B-NP B-do
therapeutic JJ I-NP B-do
doses NNS I-NP I-do
doses NNS I-NP I-do
of IN B-VP O
heparin NN B-NP B-m
heparin NN I-NP B-m
because IN B-VP O
of IN B-VP O
the DT B-NP O
concern NN I-NP O
of IN B-VP O
pain NN B-NP B-r
and CC O O
swelling VBG O B-r
asymmetrically RB O O
of IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremities NNS I-NP O
This DT O O
continued VBN O O
until IN B-VP O
lower JJR B-NP O
extremity NN I-NP O
Doppler NNP I-NP O
studies NNS I-NP O
showed VBD B-VP O
no DT B-NP O
deep JJ I-NP O
venous JJ I-NP O
thrombosis NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
femoral NN I-NP O
or CC O O
left VBD B-VP O
popliteal JJ B-NP O
veins NNS I-NP O
Uric JJ B-NP O
acid NN I-NP O
levels NNS I-NP O
were VBD B-VP O
checked VBN O O
and CC O O
shown VBN O O
to TO O O
be VB O O
elevated VBN O O
at IN B-VP O
8.6 CD O O
and CC O O
again RB O O
at IN B-VP O
8.0 CD O O
These DT B-NP O
values NNS I-NP O
suggest VBP O O
that IN B-VP O
gout NN B-NP O
may MD O O
be VB O O
involved VBN O O
in IN B-VP O
this DT B-NP O
problem NN I-NP O
, , O O
however RB O O
, , O O
there EX O O
are VBP O O
no DT B-NP O
crystals NNS I-NP O
and CC O O
the DT B-NP O
synovial JJ I-NP O
fluid NN I-NP O
making VBG O O
this DT B-NP O
diagnosis NN I-NP O
also RB O O
less RBR O O
likely RB O O
Over IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
, , O O
the DT B-NP O
swelling NN I-NP O
, , O O
tenderness NN B-NP O
and CC O O
redness NN B-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
knee NN I-NP O
decreased VBD B-VP O
significantly RB O O
However RB O O
, , O O
the DT B-NP O
patient's NN I-NP O
left VBD B-VP O
knee NN B-NP O
began VBD B-VP O
to TO O O
cause VB O O
her PRP$ O O
significant JJ B-NP O
pain NN I-NP O
, , O O
requiring VBG O O
oxycodone NN B-NP B-m
, , O O
Tylenol NNP B-NP B-m
and CC O O
lidocaine JJ B-NP B-m
patch NN I-NP I-m
Because IN B-VP O
of IN B-VP O
concerning VBG O O
renal JJ B-NP O
function NN I-NP O
with IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1.6 CD O O
from IN B-VP O
1.0 CD O O
, , O O
NSAIDs NNP B-NP B-m
were VBD B-VP O
held VBN O O
initially RB O O
, , O O
however RB O O
, , O O
her PRP O O
creatinine NN B-NP O
trended VBD B-VP O
down RB O O
to TO O O
1.2 CD O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
and CC O O
so RB O O
she PRP O O
will MD O O
be VB O O
discharged VBN O O
with IN B-VP O
NSAIDs NNP B-NP B-m
, , O O
which WDT O O
are VBP O O
expected VBN O O
to TO O O
help VB O O
her PRP$ O B-r
musculoskeletal JJ B-NP I-r
pain NN I-NP I-r
While IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
she PRP O O
received VBD B-VP O
Physical JJ B-NP O
Therapy NNP I-NP O
who WP O O
evaluated VBD B-VP O
the DT B-NP O
patient NN I-NP O
and CC O O
suggested VBD B-VP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
benefit VB O O
from IN B-VP O
continued JJ B-NP O
direct JJ I-NP O
physical JJ I-NP O
therapy NN I-NP O
to TO O O
address VB O O
functional JJ B-NP O
mobility NN I-NP O
retraining VBG O O
Short-terms JJ B-NP O
goals NNS I-NP O
included VBD B-VP O
ambulate JJ O O
50 CD O O
feet NNS B-NP O
with IN B-VP O
minimal JJ B-NP O
assistance NN I-NP O
with IN B-VP O
restrictive JJ B-NP O
device NN I-NP O
, , O O
and CC O O
to TO O O
tolerate VB O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
to TO O O
chair VB O O
for IN B-VP O
30 CD O O
minutes NNS B-NP O
with IN B-VP O
reports NNS B-NP O
of IN B-VP O
fatigue JJ O O
2 CD O O
Lithium NN B-NP O
toxicity: NN I-NP O
Because IN B-VP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
coarse NN I-NP O
tremor NN I-NP O
, , O O
bradycardia NN B-NP O
, , O O
hypotension NN B-NP O
, , O O
and CC O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
she PRP O O
was VBD B-VP O
taking VBG O O
lithium NN B-NP B-m
, , O O
encouraged VBD B-VP O
her PRP O O
lithium NN B-NP B-m
level NN I-NP O
to TO O O
be VB O O
checked VBN O O
which WDT O O
came VBD B-VP O
back RB O O
elevated VBN O O
at IN B-VP O
2.7 CD O O
, , O O
( ( O O
normal JJ B-NP O
levels NNS I-NP O
between IN B-VP O
0.5 CD O O
and CC O O
1.3 CD O O
) ) O O
This DT B-NP O
level NN I-NP O
was VBD B-VP O
concerning VBG O O
because IN B-VP O
lithium NN B-NP O
has VBZ O O
a DT O O
very RB O O
narrow JJ B-NP O
therapeutic JJ I-NP O
window NN I-NP O
Her NNP I-NP O
lithium NN I-NP B-m
was VBD B-VP O
held VBN O O
and CC O O
she PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
IV NNP B-NP B-mo
fluids NNS I-NP B-m
, , O O
which WDT O O
allowed VBD B-VP O
her PRP$ O O
creatinine NN B-NP O
to TO O O
decrease VB O O
It PRP O O
was VBD B-VP O
thought VBN O O
that IN B-VP O
she PRP O O
was VBD B-VP O
also RB O O
somewhat RB O O
dehydrated VBD B-VP O
on IN B-VP O
presentation NN B-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
Her NNP I-NP O
lithium NN I-NP O
toxicity NN I-NP O
could MD O O
in IN B-VP O
part NN B-NP O
explain NN I-NP O
for IN B-VP O
her PRP$ O O
bradycardia NN B-NP O
and CC O O
hypotension NN B-NP O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
hypokalemia NN B-NP O
and CC O O
renal JJ B-NP O
failure NN I-NP O
A NNP I-NP O
psych NN I-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
to TO O O
address VB O O
the DT B-NP O
question NN I-NP O
of IN B-VP O
when WRB O O
and CC O O
how WRB O O
to TO O O
restart VB O O
the DT B-NP O
lithium NN I-NP B-m
The DT B-NP O
psych NN I-NP O
consultant NN I-NP O
suggested VBD B-VP O
to TO O O
check VB O O
lithium NN B-NP B-m
levels NNS I-NP O
daily RB O O
until IN B-VP O
they PRP O O
fell VBD B-VP O
below IN B-VP O
0.5 CD O O
and CC O O
then RB O O
should MD O O
restart VB O O
the DT B-NP O
lithium NN I-NP B-m
at IN B-VP O
300 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
bedtime NN B-NP I-f
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
her PRP$ O O
lithium JJ B-NP B-m
level NN I-NP O
was VBD B-VP O
at IN B-VP O
1.12 CD O O
This DT B-NP O
level NN I-NP O
should MD O O
be VB O O
checked VBN O O
at IN B-VP O
the DT B-NP O
nursing NN I-NP O
facility NN I-NP O
and CC O O
lithium NN B-NP B-m
should MD O O
be VB O O
restarted VBN O O
at IN B-VP O
300 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
bedtime NN B-NP I-f
when WRB O O
the DT B-NP O
level NN I-NP O
is VBZ O O
0.5 CD O O
or CC O O
below IN B-VP O
3 CD O O
Cardiovascular: NNP B-NP O
From IN B-VP O
a DT B-NP O
pump NN I-NP O
standpoint NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
hypovolemic JJ O O
and CC O O
hypotensive JJ O O
on IN B-VP O
presentation NN B-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
She PRP O O
responded VBD B-VP O
well RB O O
to TO O O
normal JJ B-NP B-m
saline JJ I-NP I-m
fluid NN I-NP I-m
boluses NNS I-NP I-m
and CC O O
given VBN O O
a DT B-NP O
total NN I-NP O
of IN B-VP O
3 CD O B-do
liters NNS B-NP I-do
over IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
From IN B-VP O
a DT B-NP O
rhythm NN I-NP O
standpoint NN I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
bradycardia NN I-NP O
was VBD B-VP O
resolved VBN O O
of IN B-VP O
either DT O O
over IN B-VP O
beta NN B-NP B-m
blockade NN I-NP I-m
or CC O O
lithium NN B-NP O
toxicity NN I-NP O
Her NNP I-NP O
beta-blocker NN I-NP B-m
was VBD B-VP O
held VBN O O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
lithium NN B-NP B-m
and CC O O
her PRP$ O O
heart NN B-NP O
rate NN I-NP O
improved VBN O O
to TO O O
the DT O O
50 CD O O
and CC O O
60s CD O O
We PRP O O
would MD O O
recommend VB O O
holding VBG O O
the DT B-NP O
beta-blocker NN I-NP B-m
until IN B-VP B-du
follow VB O O
up RP O O
at IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician's NN I-NP O
office NN I-NP O
for IN B-VP O
her PRP$ O O
next JJ B-NP O
appointment NN I-NP O
From IN B-VP O
an DT B-NP O
ischemia NN I-NP O
standpoint NN I-NP O
, , O O
EKG NNP B-NP O
was VBD B-VP O
performed VBN O O
which WDT O O
was VBD B-VP O
a DT B-NP O
poor JJ I-NP O
study NN I-NP O
that WDT O O
showed VBD B-VP O
perhaps RB O O
some DT B-NP O
T-wave JJ I-NP O
inversions NNS I-NP O
in IN B-VP O
aVL NN B-NP O
However RB O O
, , O O
ACS NNP B-NP O
is VBZ O O
unlikely JJ O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
chest NN I-NP O
pain NN I-NP O
4 CD O O
Renal: NNP B-NP O
Acute NNP I-NP O
renal JJ B-NP O
failure NN I-NP O
on IN B-VP O
presentation NN B-NP O
with IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1.6 CD O O
and CC O O
1.0 CD O O
is VBZ O O
likely JJ B-NP O
prerenal JJ I-NP O
versus NN I-NP O
lithium NN I-NP O
toxicity NN I-NP O
versus IN B-VP O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
these DT B-NP O
A NNP I-NP O
creatinine NN I-NP O
improved VBN O O
to TO O O
1.2 CD O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
5 CD O O
Endocrinology: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
according VBG O O
to TO O O
her PRP$ O O
medical JJ B-NP O
records NNS I-NP O
Her PRP$ O O
glucose NN B-NP O
while IN B-VP O
admitted VBN O O
here RB O O
was VBD B-VP O
in IN B-VP O
between IN B-VP O
90 CD O O
and CC O O
132 CD O O
These DT O O
were VBD B-VP O
random RB O O
glucose JJ B-NP O
draws NNS I-NP O
Hemoglobin NNP I-NP O
A1c NNP I-NP O
was VBD B-VP O
checked VBN O O
which WDT O O
came VBD B-VP O
back RB O O
at IN B-VP O
6.2 CD O O
At IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
diabetes NNS B-NP O
may MD O O
or CC O O
may MD O O
not RB O O
be VB O O
an DT B-NP O
appropriate JJ I-NP O
diagnosis NN I-NP O
for IN B-VP O
her PRP$ O O
and CC O O
she PRP O O
should MD O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
with IN B-VP O
a DT O O
fasting VBG O O
blood NN B-NP O
glucose JJ B-NP O
test NN I-NP O
6 CD O O
Infectious NNP B-NP O
disease: NN I-NP O
On IN B-VP O
initial JJ B-NP O
presentation NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
hypotension NN B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
bradycardia NN B-NP O
and CC O O
beta NN B-NP B-m
blockade NN I-NP O
with IN B-VP O
decreased JJ B-NP O
volume NN I-NP O
status NN I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
concern NN I-NP O
initially RB O O
that IN B-VP O
this DT O O
may MD O O
be VB O O
cellulitis NN B-NP O
and CC O O
she PRP O O
was VBD B-VP O
covered VBN O O
broadly RB O O
with IN B-VP O
Unasyn NNP B-NP B-m
and CC O O
vancomycin NN B-NP B-m
However RB O O
, , O O
as IN B-VP O
she PRP O O
improved VBD B-VP O
, , O O
and CC O O
the DT B-NP O
redness NN I-NP O
and CC O O
swelling VBG O O
decreased VBN O O
, , O O
she PRP O O
was VBD B-VP O
switched VBN O O
to TO O O
levofloxacin VB O B-m
and CC O O
committed VBN O O
to TO O O
complete VB O O
a DT B-NP B-du
seven-day JJ I-NP I-du
course NN I-NP I-du
She PRP O O
will MD O O
complete VB O O
six CD O B-du
more JJR B-NP I-du
days NNS I-NP I-du
after IN B-VP O
discharge NN B-NP O
from IN B-VP O
the DT B-NP O
hospital NN I-NP O
of IN B-VP O
levofloxacin $ O B-m
7 CD O O
Deconditioning: NNP B-NP O
As NNP I-NP O
mentioned VBD B-VP O
above IN B-VP O
, , O O
Physical NNP B-NP O
Therapy NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
will MD O O
go VB O O
to TO O O
nursing VBG O O
facility NN B-NP O
for IN B-VP O
a DT B-NP O
temporary JJ I-NP O
rehabilitation NN I-NP O
Upon NNP I-NP O
discharge NN I-NP O
to TO O O
her PRP$ O O
home NN B-NP O
from IN B-VP O
rehab NN B-NP O
, , O O
home NN B-NP O
safety NN I-NP O
evaluation NN I-NP O
should MD O O
take VB O O
place NN B-NP O
to TO O O
make VB O O
sure JJ O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
is VBZ O O
okay JJ O O
to TO O O
go VB O O
back RB O O
home NN B-NP O
and CC O O
can MD O O
give VB O O
the DT B-NP O
services NNS I-NP O
that IN B-VP O
she PRP O O
needs VBZ O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
Tylenol NNP B-NP B-m
650 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.4h NN I-NP B-f
p.r.n NN I-NP I-f
pain VBP O B-r
2 CD O O
Klonopin NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
bedtime JJ O I-f
3 CD O O
Oxycodone NN B-NP B-m
5 CD O B-do
mg NN B-NP I-do
to TO O I-do
10 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.4h JJ I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
please NN B-NP O
hold VB O O
if IN B-VP O
respiration NN B-NP O
rate NN I-NP O
is VBZ O O
less JJR O O
than IN B-VP O
12 CD O O
4 CD O O
Risperdal NNP B-NP B-m
0.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
bedtime JJ O I-f
5 CD O O
Levofloxacin NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
for IN B-VP B-du
six CD O I-du
days NNS B-NP I-du
after IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
from IN B-VP O
Wilgeimante NNP B-NP O
Eycis NNP I-NP O
Health NNP I-NP O
on IN B-VP O
0/19/05 CD O O
6 CD O O
Ibuprofen NNP B-NP B-m
600 CD O B-do
mg NN B-NP I-do
q.6h NN I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
DISCHARGE NNP I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
to TO O O
a DT B-NP O
nursing NN I-NP O
facility NN I-NP O
Please NNP I-NP O
draw VB O O
blood NN B-NP O
for IN B-VP O
lithium JJ B-NP O
level NN I-NP O
checks NNS I-NP O
daily RB O O
until IN B-VP O
it PRP O O
is VBZ O O
below IN B-VP O
0.5 CD O O
, , O O
at IN B-VP O
which WDT O O
time NN B-NP O
, , O O
she PRP O O
should MD O O
be VB O O
restarted VBN O O
on IN B-VP O
lithium NN B-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
bedtime NN B-NP I-f
She PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Aurelio NNP I-NP O
Gilberto NNP I-NP O
Hencheck NNP I-NP O
at IN B-VP O
Li NNP B-NP O
County NNP I-NP O
Hospital NNP I-NP O
, , O O
phone NN B-NP O
number NN I-NP O
is VBZ O O
156-903-7650 JJ B-NP O
A NNP I-NP O
message NN I-NP O
was VBD B-VP O
left VBN O O
in IN B-VP O
the DT B-NP O
voice NN I-NP O
mail NN I-NP O
of IN B-VP O
her PRP$ O O
physician's JJ B-NP O
office NN I-NP O
to TO O O
schedule VB O O
her PRP$ O O
an DT B-NP O
appointment NN I-NP O
and CC O O
to TO O O
contact VB O O
her PRP$ O O
brother NN B-NP O
, , O O
Oren NNP B-NP O
Dad NNP I-NP O
, , O O
at IN B-VP O
phone NN B-NP O
number NN I-NP O
427-986-1973 CD O O
or CC O O
683-173-8613 JJ O O
, , O O
or CC O O
Daren NNP B-NP O
Perella NNP I-NP O
at IN B-VP O
990-786-9092 CD O O
to TO O O
inform VB O O
them PRP O O
at IN B-VP O
when WRB O O
the DT B-NP O
appointment NN I-NP O
will MD O O
be VB O O
It PRP O O
was VBD B-VP O
requested VBN O O
that IN B-VP O
she PRP O O
be VB O O
seen VBN O O
within IN B-VP O
two CD O O
to TO O O
three CD O O
weeks NNS B-NP O
eScription NN I-NP O
document: IN B-VP O
3-9332178 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Colby NNP I-NP O
Kopan NNP I-NP O
M.D NNP I-NP O
Comho NNP I-NP O
Street NNP I-NP O
, , O O
Sas NNP B-NP O
Co NNP I-NP O
Lareox NNP I-NP O
, , O O
Utah NNP B-NP O
34863 CD O O
Ana NNP B-NP O
CC: NNP I-NP O
Raul NNP I-NP O
Nagelschmidt NNP I-NP O
MD NNP I-NP O
Lem NNP I-NP O
Ca NNP I-NP O
Chi NNP I-NP O
Son NNP I-NP O
Oak NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
BEKER NNP I-NP O
, , O O
ANIBAL NNP B-NP O
Attending: NNP I-NP O
BEIL NNP I-NP O
, , O O
LYMAN NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
1150769 CD O O
D: NNP B-NP O
6/17/05 CD O O
T: NNP B-NP O
6/17/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#565443 VBZ O O
982004989 CD O O
C NNP B-NP O
70419019 CD O O
9147032 CD O O
0/7/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
hypertensive JJ B-NP O
encephalopathy NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/7/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/20/2003 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
CHOW NNP I-NP O
, , O O
MIKEL NNP B-NP O
R NNP I-NP O
943-98-90-2 CD O O
Co NNP B-NP O
Stobelle NNP I-NP O
Ey NNP I-NP O
Service: NNP I-NP O
NEU NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
7/9/03 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
STAIRES NNP I-NP O
, , O O
KIRBY NNP B-NP O
SANDY NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
2/11 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
SBP&lt;120 NNP I-NP O
, , O O
HR&lt;55 NNP B-NP O
ATORVASTATIN NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HYDROCHLOROTHIAZIDE NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
AMLODIPINE NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
FOLATE NNP B-NP B-m
( ( O I-m
FOLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
4 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
PCP NNP I-NP O
Dr NNP I-NP O
Burdzel NNP I-NP O
3-4 JJ B-NP O
weeks NNS I-NP O
, , O O
carotid VBP O O
ultrasound JJ O O
4/12/03 CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Losartan NNP I-NP O
, , O O
Perfume NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
stroke VBD B-VP O
PRINCIPAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
hypertensive VBP O O
encephalopathy JJ B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HYPERCHOLESTEROLEMIA NNP I-NP O
HTN NNP I-NP O
DEPRESSION NNP I-NP O
CAD NNP I-NP O
s/p VBD B-VP O
MI NNP B-NP O
'84 NNP I-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
, , O O
recurrent JJ O O
left VBD B-VP O
Bell's NNP B-NP O
palsy NN I-NP O
, , O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
allergic NN B-NP O
rhinitis NN I-NP O
( ( O O
allergic JJ B-NP O
rhinitis NN I-NP O
) ) O O
, , O O
history NN B-NP O
of IN B-VP O
TIA NNP B-NP O
vs FW O O
stroke NN B-NP O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
CT NNP B-NP O
head NN I-NP O
without IN B-VP O
contrast NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
59 CD O O
year-old JJ B-NP O
right-handed JJ I-NP O
woman NN I-NP O
admitted VBD B-VP O
for IN B-VP O
suspected VBN O O
acute JJ O O
stroke VBD B-VP O
Her NNP B-NP O
PMH NNP I-NP O
includes VBZ O O
HTN NNP B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
prior JJ B-NP O
TIA NNP I-NP O
vs NN I-NP O
stroke VBD B-VP O
3/23 CD O O
( ( O O
manifest RBS O O
as IN B-VP O
slurred JJ B-NP O
speech NN I-NP O
, , O O
left VBD B-VP O
arm NN B-NP O
and CC O O
leg NN B-NP O
weakness NN I-NP O
) ) O O
prior RB O O
myocardial JJ B-NP O
infarction NN I-NP O
( ( O O
1984 CD O O
) ) O O
, , O O
and CC O O
history NN B-NP O
of IN B-VP O
left JJ B-NP O
Bell's NNP I-NP O
palsy NN I-NP O
x VBD B-VP O
3 CD O O
with IN B-VP O
chronic JJ B-NP O
weakness NN I-NP O
of IN B-VP O
facial JJ B-NP O
expression NN I-NP O
muscles NNS I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
possible JJ I-NP O
patent NN I-NP O
foramen NNS I-NP O
ovale VBP O O
with IN B-VP O
agitated JJ B-NP O
saline NN I-NP O
contrast NN I-NP O
passage NN I-NP O
on IN B-VP O
valsalva NN B-NP O
maneuver NN I-NP O
TTE NNP I-NP O
when WRB O O
she PRP O O
was VBD B-VP O
admitted VBN O O
7/21 CD O O
for IN B-VP O
stroke NN B-NP O
work-up NN I-NP O
Recently RB O O
, , O O
this DT B-NP O
woman NN I-NP O
has VBZ O O
had VBN O O
2-weeks CD O O
of IN B-VP O
general JJ B-NP O
fatigue NN I-NP O
, , O O
exertional JJ B-NP O
dys NN I-NP O
pnea NN I-NP O
, , O O
frequent JJ B-NP O
headaches NNS I-NP O
, , O O
and CC O O
intermittent NN B-NP O
blurred VBN O O
vision NN B-NP O
while IN B-VP O
driving VBG O O
followed VBN O O
by IN B-VP O
a DT B-NP O
2-3 JJ I-NP O
second JJ I-NP O
episode NN I-NP O
of IN B-VP O
binocular JJ B-NP O
visual JJ I-NP O
loss NN I-NP O
7/17/03 CD O O
Notably RB O O
, , O O
she PRP O O
ran VBD B-VP O
out IN B-VP O
of IN B-VP O
amlodipine NN B-NP B-m
and CC O O
reports NNS B-NP O
obtaining VBG O O
a DT B-NP O
level NN I-NP O
of IN B-VP O
240/150 CD O O
on IN B-VP O
self-monitoring JJ O O
One CD O O
day NN B-NP O
prior RB O O
to TO O O
admission VB O O
she PRP O O
saw VBD B-VP O
her PRP O O
PCP NNP B-NP O
who WP O O
noted VBD B-VP O
hypertension NN B-NP O
and CC O O
referred VBD B-VP O
her PRP O O
to TO O O
an DT B-NP O
ophthalmologist NN I-NP O
, , O O
who WP O O
obtained VBD B-VP O
a DT B-NP O
normal JJ I-NP O
exam NN I-NP O
by IN B-VP O
report NN B-NP O
She PRP O O
awoke VBD B-VP O
this DT B-NP O
morning NN I-NP O
with IN B-VP O
a DT O O
more RBR O O
severe JJ B-NP O
right JJ I-NP O
frontal NN I-NP O
headache NN I-NP O
with IN B-VP O
pain NN B-NP O
radiating VBG O O
to TO O O
the DT B-NP O
right JJ I-NP O
shoulder NN I-NP O
She PRP O O
also RB O O
experienced VBD B-VP O
a DT B-NP O
problem NN I-NP O
with IN B-VP O
gait NN B-NP O
, , O O
leaning VBG O O
to TO O O
the DT B-NP O
right NN I-NP O
Her NNP I-NP O
husband NN I-NP O
phoned VBD B-VP O
EMS NNP B-NP O
because IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
severe JJ I-NP O
headache NN I-NP O
and CC O O
seemed VBD B-VP O
"confused." NNS B-NP O
At IN B-VP O
present JJ O O
, , O O
the DT B-NP O
patient NN I-NP O
denies VBZ O O
headache NN B-NP O
and CC O O
confusion NN B-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
diplopia NN B-NP O
, , O O
vertigo NN B-NP O
, , O O
dysphagia NN B-NP O
, , O O
and CC O O
dysarthria VBZ O O
She PRP O O
denies VBZ O O
recent JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
but CC O O
has VBZ O O
had VBN O O
orthopnea VBN O O
PMHx: NNP B-NP O
hypertension NN I-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
prior JJ B-NP O
TIA NNP I-NP O
versus NN I-NP O
stroke NN I-NP O
, , O O
prior JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
( ( O O
1984 CD O O
) ) O O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
recurrent NN B-NP O
left VBD B-VP O
Bell's NNP B-NP O
palsy NN I-NP O
, , O O
allergic JJ B-NP O
rhinitis NN I-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
( ( O O
baseline JJ B-NP O
creatinine NN I-NP O
around IN B-VP O
1.5 CD O O
) ) O O
Meds: NNP B-NP O
ASA NNP I-NP B-m
81 CD O B-do
, , O O
HCTZ NNP B-NP B-m
, , O O
atenolol NN B-NP B-m
, , O O
amlodipine NN B-NP B-m
, , O O
atorvastatin NN B-NP B-m
, , O O
loratadine NN B-NP B-m
, , O O
PRN NNP B-NP B-f
albuterol NN I-NP B-m
All: NNP I-NP O
iodinated VBD B-VP O
contrast NN B-NP O
, , O O
losartan JJ B-NP O
VS: NNP I-NP O
T NNP I-NP O
97.2 CD O O
HR NNP B-NP O
57 CD O O
BP NNP B-NP O
150/90 CD O O
GEN NNP B-NP O
obese JJ B-NP O
woman NN I-NP O
, , O O
comfortable JJ B-NP O
HEENT NNP I-NP O
sclerae NN I-NP O
anicteric NN I-NP O
, , O O
oral JJ B-NP O
mucosa NN I-NP O
moist NN I-NP O
NECK: NNP I-NP O
no DT B-NP O
bruits NNS I-NP O
HEART NNP I-NP O
mild NN I-NP O
bradycardia NN I-NP O
, , O O
regular JJ B-NP O
rhythm NN I-NP O
, , O O
II/VI NNP B-NP O
SEM NNP I-NP O
at IN B-VP O
USB NNP B-NP O
ABD NNP I-NP O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
nondistended VBD B-VP O
EXT: NNP B-NP O
no DT B-NP O
cyanosis NN I-NP O
, , O O
clubbing VBG O O
, , O O
or CC O O
edema; VB O O
radial JJ O O
and CC O O
dorsalis JJ B-NP O
pedis NN I-NP O
pulses VBZ O O
2+ CD O O
NEURO: NNP B-NP O
MS NNP I-NP O
significant JJ O O
for IN B-VP O
no DT B-NP O
deficits NNS I-NP O
on IN B-VP O
orientation NN B-NP O
, , O O
attention NN B-NP O
, , O O
langua JJ B-NP O
ge NN I-NP O
, , O O
memory NN B-NP O
, , O O
and CC O O
praxis NN B-NP O
CN NNP I-NP O
exam NN I-NP O
significant JJ O O
for IN B-VP O
right JJ B-NP O
hypertropic NN I-NP O
skew NN I-NP O
, , O O
left VBD B-VP O
facial JJ B-NP O
droop NN I-NP O
, , O O
mostly RB O O
lower JJR B-NP O
face NN I-NP O
but CC O O
with IN B-VP O
weak JJ B-NP O
eyebrow NN I-NP O
raise NN I-NP O
as RB O O
well RB O O
Motor NNP B-NP O
exam NN I-NP O
with IN B-VP O
normal JJ B-NP O
tone NN I-NP O
, , O O
no DT B-NP O
pronator NN I-NP O
drift NN I-NP O
, , O O
strength NN B-NP O
5/5 CD O O
in IN B-VP O
all DT B-NP O
muscle NN I-NP O
groups NNS I-NP O
in IN B-VP O
upper JJ O O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
Coordination NNP I-NP O
exam NN I-NP O
with IN B-VP O
slightly RB O O
slowed VBN O O
fine JJ B-NP O
finger NN I-NP O
movements NNS I-NP O
, , O O
right JJ B-NP O
hand NN I-NP O
, , O O
normal JJ B-NP O
performance NN I-NP O
on IN B-VP O
finger-nose-finger NN B-NP O
and CC O O
heel-knee-shin NN B-NP O
, , O O
sensory JJ B-NP O
exam NN I-NP O
without IN B-VP O
deficits NNS B-NP O
in IN B-VP O
light JJ B-NP O
touch NN I-NP O
, , O O
temperature NN B-NP O
, , O O
vibratory JJ B-NP O
sensation NN I-NP O
, , O O
reflexes VBZ O O
2 CD O O
throughout IN B-VP O
except IN B-VP O
for IN B-VP O
1 CD O O
in IN B-VP O
the DT B-NP O
ankles NNS I-NP O
, , O O
toes NNS B-NP O
downgoing VBG O O
bilaterally RB O O
GAIT NNP B-NP O
slightly RB O O
wided VBD B-VP O
based VBN O O
but CC O O
stable JJ B-NP O
gait NN I-NP O
with IN B-VP O
upright JJ B-NP O
posture NN I-NP O
, , O O
normal JJ B-NP O
arm-swing JJ I-NP O
No NNP I-NP O
difficulty NN I-NP O
with IN B-VP O
heel NN B-NP O
, , O O
or CC O O
toe NN B-NP O
walk VBP O O
Falls NNP B-NP O
to TO O O
left VB O O
on IN B-VP O
tandem JJ B-NP O
gait NN I-NP O
Non-contrast NNP I-NP O
head NN I-NP O
CT NNP I-NP O
negative JJ O O
for IN B-VP O
evidence NN B-NP O
of IN B-VP O
stroke NN B-NP O
or CC O O
hemorrhage NN B-NP O
Hospital NNP I-NP O
course: VBD B-VP O
the DT B-NP O
pt NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
hypertension NN B-NP O
and CC O O
recent JJ B-NP O
headaches NNS I-NP O
, , O O
visual JJ B-NP O
changes NNS I-NP O
( ( O O
blurred JJ B-NP O
vision NN I-NP O
) ) O O
, , O O
change NN B-NP O
in IN B-VP O
gait NN B-NP O
( ( O O
inability NN B-NP O
to TO O O
walk VB O O
in IN B-VP O
heels NNS B-NP O
) ) O O
, , O O
and CC O O
recent JJ B-NP O
confusion NN I-NP O
Neurologic NNP I-NP O
exam NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
right JJ B-NP O
hypertropic NN I-NP O
skew NN I-NP O
without IN B-VP O
diplopia NN B-NP O
, , O O
left VBD B-VP O
facial JJ B-NP O
weakness NN I-NP O
that WDT O O
is VBZ O O
old JJ O O
per IN B-VP O
pt NN B-NP O
and CC O O
LMR NNP B-NP O
notes NNS I-NP O
, , O O
mild JJ B-NP O
slowing NN I-NP O
of IN B-VP O
right JJ B-NP O
fine JJ I-NP O
finger NN I-NP O
movements NNS I-NP O
, , O O
and CC O O
tendency NN B-NP O
to TO O O
fall VB O O
towards IN B-VP O
the DT B-NP O
left NN I-NP O
on IN B-VP O
tandem JJ B-NP O
gait NN I-NP O
These DT B-NP O
findings NNS I-NP O
do VBP O O
not RB O O
localize VB O O
well RB O O
and CC O O
the DT B-NP O
differential JJ I-NP O
diagnosis NN I-NP O
was VBD B-VP O
felt VBN O O
to TO O O
include VB O O
cerebral JJ B-NP O
ischemia/infarction NN I-NP O
and CC O O
hypertensive JJ B-NP O
encephalopathy NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
recent JJ B-NP O
poorly-controlled JJ I-NP O
hypertension NN I-NP O
as RB O O
well RB O O
as IN B-VP O
symptoms NNS B-NP O
of IN B-VP O
possible JJ B-NP O
heart NN I-NP O
failure NN I-NP O
including VBG O O
exertional JJ B-NP O
dyspnea NN I-NP O
and CC O O
orthopnea VB O O
An DT B-NP O
MRI NNP I-NP O
was VBD B-VP O
ordered VBN O O
to TO O O
evaluate VB O O
for IN B-VP O
possible JJ B-NP O
stroke NN I-NP O
or CC O O
hypertensive JJ B-NP O
encephalopathy NN I-NP O
Unfortunately RB O O
, , O O
the DT B-NP O
pt NN I-NP O
was VBD B-VP O
not RB O O
able JJ O O
to TO O O
tolerate VB O O
the DT B-NP O
procedure NN I-NP O
, , O O
citing VBG O O
claustrophobia NN B-NP O
from IN B-VP O
a DT B-NP O
traumatic JJ I-NP O
childhood NN I-NP O
experience NN I-NP O
as IN B-VP O
a DT B-NP O
prohibitive JJ I-NP O
factor NN I-NP O
Her PRP$ O O
atenolol NN B-NP B-m
was VBD B-VP O
continued VBN O O
and CC O O
she PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
aspirin NN B-NP B-m
aspirin NN I-NP B-m
325 CD O B-do
325 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
qd NN I-NP B-f
qd NN I-NP B-f
for IN B-VP O
stroke NN B-NP B-r
and CC O O
heart NN B-NP B-r
prophylaxis VBP O I-r
Her PRP$ O O
blood NN B-NP O
pressures NNS I-NP O
remained VBD B-VP O
well-controlled JJ O O
throughout IN B-VP O
admission NN B-NP O
and CC O O
she PRP O O
remained VBD B-VP O
asymptomatic JJ O O
, , O O
without IN B-VP O
recurrent NN B-NP O
headache NN I-NP O
, , O O
confusion NN B-NP O
, , O O
and CC O O
weakness NN B-NP O
Her NNP I-NP O
fine NN I-NP O
finger NN I-NP O
movements NNS I-NP O
with IN B-VP O
the DT B-NP O
right JJ I-NP O
hand NN I-NP O
were VBD B-VP O
improved VBN O O
by IN B-VP O
hospital JJ B-NP O
day NN I-NP O
2 CD O O
She PRP O O
continued VBD B-VP O
to TO O O
have VB O O
difficulty NN B-NP O
with IN B-VP O
tandem JJ B-NP O
gait NN I-NP O
, , O O
falling VBG O O
to TO O O
the DT B-NP O
left NN I-NP O
Her NNP I-NP O
lipid NN I-NP O
profile NN I-NP O
revealed VBD B-VP O
elevated JJ B-NP O
total JJ I-NP O
cholesterol NN I-NP O
and CC O O
LDL NNP B-NP O
Her NNP I-NP O
homocysteine NN I-NP O
level NN I-NP O
was VBD B-VP O
slightly RB O O
elevated VBN O O
at IN B-VP O
14 CD O O
She PRP O O
was VBD B-VP O
instructed VBN O O
to TO O O
raise VB O O
her PRP$ O O
dose NN B-NP O
of IN B-VP O
atorvastatin NN B-NP B-m
as RB O O
well RB O O
as IN B-VP O
supplement NN B-NP O
her PRP$ O O
diet JJ O O
with IN B-VP O
folic JJ B-NP B-m
acid NN I-NP I-m
She PRP O O
has VBZ O O
an DT B-NP O
outpt JJ I-NP O
appointment NN I-NP O
for IN B-VP O
carotid JJ B-NP O
non-invasive JJ I-NP O
studies NNS I-NP O
4/0/03 CD O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Fair NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
The DT B-NP O
pt NN I-NP O
should MD O O
take VB O O
a DT B-NP O
full JJ I-NP O
dose NN I-NP O
of IN B-VP O
aspirin NN B-NP B-m
( ( O O
325 CD O B-do
mg NN B-NP I-do
) ) O O
She PRP O O
should MD O O
take VB O O
folate NN B-NP B-m
supplementation NN I-NP I-m
She PRP O O
should MD O O
also RB O O
discuss VB O O
raising VBG O O
her PRP$ O O
dose NN B-NP O
of IN B-VP O
atorvastatin NN B-NP B-m
atorvastatin NN I-NP B-m
( ( O I-m
( ( O I-m
Lipitor NNP B-NP I-m
Lipitor NNP I-NP I-m
) ) O I-m
) ) O I-m
with IN B-VP O
her PRP$ O O
PCP NNP B-NP O
, , O O
because IN B-VP O
her PRP$ O O
cholesterol NN B-NP B-r
and CC O O
LDL NNP B-NP B-r
were VBD B-VP O
elevated VBN O O
this DT B-NP O
admission NN I-NP O
No RB O O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
LIDDER NNP I-NP O
, , O O
LENARD NNP B-NP O
JEFFERSON NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
FR22 NNP B-NP O
) ) O O
7/9/03 CD O O
@ $ O O
05 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#565922 VBZ O O
784638933 CD O O
ABOHS NNP B-NP O
85258264 CD O O
595041 CD O O
8/13/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
CEREBRO NNP I-NP O
VASCULAR NNP I-NP O
ACCIDENT NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/23/1998 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/7/1998 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
LEFT NNP I-NP O
SUBCORTICAL NNP I-NP O
STROKE NNP I-NP O
PROBLEM NNP I-NP O
LIST: NNP I-NP O
1 CD O O
) ) O O
DIABETES NNPS B-NP O
MELLITUS NNP I-NP O
2 CD O O
) ) O O
MULTINODULAR NNP B-NP O
GOITER NNP I-NP O
3 CD O O
) ) O O
HYPERTENSION NNP B-NP O
4 CD O O
) ) O O
ANEMIA NNP B-NP O
, , O O
SICKLE NNP B-NP O
CELL NNP I-NP O
TRAIT NNP I-NP O
5 CD O O
) ) O O
STATUS NNP B-NP O
POST NNP I-NP O
TOTAL NNP I-NP O
ABDOMINAL NNP I-NP O
HYSTERECTOMY NNP I-NP O
, , O O
CERVICAL NNP B-NP O
DYSPLASIA NNP I-NP O
6 CD O O
) ) O O
BURSITIS NNP B-NP O
AND NNP I-NP O
MULTIPLE NNP I-NP O
SITES NNP I-NP O
OF NNP I-NP O
ARTHRITIS NNP I-NP O
7 CD O O
) ) O O
HISTORY NN B-NP O
OF NNP I-NP O
PHYSICAL NNP I-NP O
ABUSE NNP I-NP O
8 CD O O
) ) O O
VITILIGO NNP B-NP O
9 CD O O
) ) O O
HEMORRHOIDS NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Approximately RB O O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
presentation NN B-NP O
, , O O
while IN B-VP O
preparing VBG O O
to TO O O
return VB O O
to TO O O
bed VB O O
, , O O
the DT B-NP O
patient NN I-NP O
noted VBD B-VP O
decrease NN B-NP O
feeling NN I-NP O
in IN B-VP O
her PRP$ O O
right JJ B-NP O
leg NN I-NP O
and CC O O
right JJ B-NP O
arm NN I-NP O
clumsiness NN I-NP O
She PRP O O
returned VBD B-VP O
to TO O O
bed NN B-NP O
and CC O O
remained VBD B-VP O
there EX O O
all DT B-NP O
day NN I-NP O
long IN B-VP O
She PRP O O
fell VBD B-VP O
onto IN B-VP O
her PRP$ O O
bottom JJ O O
secondary JJ O O
to TO O O
unsteadiness VB O O
She PRP O O
has VBZ O O
remained VBN O O
on IN B-VP O
the DT B-NP O
couch NN I-NP O
, , O O
except IN B-VP O
to TO O O
get VB O O
water NN B-NP O
since IN B-VP O
one CD O O
day NN B-NP O
prior RB O O
to TO O O
admission VB O O
She PRP O O
was VBD B-VP O
unable JJ O O
to TO O O
stand VB O O
up RP O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
This DT B-NP O
event NN I-NP O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
different JJ O O
from IN B-VP O
her PRP$ O O
usual JJ B-NP O
paralysis NN I-NP O
( ( O O
she PRP O O
had VBD B-VP O
had VBN O O
similar JJ B-NP O
symptoms NNS I-NP O
of IN B-VP O
this DT B-NP O
before NN I-NP O
and CC O O
had VBD B-VP O
waited VBN O O
for IN B-VP O
it PRP O O
to TO O O
resolve VB O O
) ) O O
, , O O
except IN B-VP O
that IN B-VP O
this DT B-NP O
event NN I-NP O
had VBD B-VP O
lasted VBN O O
greater JJR O O
than IN B-VP O
24 CD O O
hours NNS B-NP O
and CC O O
she PRP O O
also RB O O
began VBD B-VP O
to TO O O
notice VB O O
dysarthria NN B-NP O
She PRP O O
had VBD B-VP O
not RB O O
taken VBN O O
insulin NN B-NP B-m
for IN B-VP B-du
several JJ B-NP I-du
days NNS I-NP I-du
, , O O
but CC O O
has VBZ O O
had VBN O O
decreased VBN O O
p.o NNS B-NP O
intake VBP O O
secondary JJ O O
to TO O O
her PRP$ O O
inability NN B-NP O
to TO O O
move VB O O
Of IN B-VP O
note NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
difficulty NN B-NP O
swallowing VBG O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
vomiting VBG O O
or CC O O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
No NNP I-NP O
seizure NN I-NP O
activity NN I-NP O
No NNP I-NP O
head NN I-NP O
or CC O O
neck NN B-NP O
trauma NN I-NP O
No NNP I-NP O
vertigo NN I-NP O
or CC O O
tenderness NN B-NP O
No DT B-NP O
recent JJ I-NP O
change NN I-NP O
in IN B-VP O
medications NNS B-NP O
No DT B-NP O
chest NN I-NP O
pain NN I-NP O
or CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
no DT B-NP O
photophobia NN I-NP O
or CC O O
neck NN B-NP O
stiffness NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
History NNP I-NP O
of IN B-VP O
diabetes NNS B-NP O
mellitus NNS I-NP O
, , O O
multinodular JJ B-NP O
goiter NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
anemia NN B-NP O
and CC O O
sickle NN B-NP O
cell NN I-NP O
trait NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
total JJ B-NP O
abdominal JJ I-NP O
hysterectomy NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
cervical JJ B-NP O
dysplasia NN I-NP O
, , O O
bursitis NN B-NP O
and CC O O
multiple JJ B-NP O
musculoskeletal JJ I-NP O
complaints NNS I-NP O
, , O O
just RB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
physical JJ B-NP O
abuse NN I-NP O
and CC O O
vitiligo NN B-NP O
, , O O
hemorrhoids NNS B-NP O
MEDICATIONS: NNP I-NP O
Hydrochlorothiazide NNP I-NP B-m
12.5 CD O B-do
milligrams NNS B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Norvasc NNP B-NP B-m
5 CD O B-do
milligrams NNS B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Taxol NNP B-NP B-m
28 CD O B-do
milligrams NNS B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Premarin NNP B-NP B-m
0.625 CD O B-do
milligrams NNS B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
, , O O
Trazodone NNP B-NP B-m
, , O O
insulin NN B-NP O
12 CD O B-do
units NNS B-NP I-do
of IN B-VP O
regular JJ O B-m
and CC O O
50 CD O B-do
units NNS B-NP I-do
of IN B-VP O
NPH NNP B-NP B-m
in IN B-VP B-f
in IN B-VP B-f
the DT O I-f
the DT B-NP I-f
morning NN I-NP I-f
morning NN I-NP I-f
and CC O O
14 CD O B-do
units NNS B-NP I-do
of IN B-VP O
regular JJ O B-m
and CC O O
10 CD O B-do
units NNS B-NP I-do
of IN B-VP O
NPH NNP B-NP B-m
in IN B-VP B-f
in IN B-VP B-f
the DT O I-f
the DT B-NP I-f
evening NN I-NP I-f
evening NN I-NP I-f
She PRP O O
had VBD B-VP O
also RB O O
been VBN O O
taking VBG O O
Ansaid NNP B-NP B-m
100 CD O B-do
milligrams NNS B-NP I-do
p.o VBP O B-mo
b.i.d JJ B-NP B-f
p.r.n NN I-NP I-f
joint NN I-NP B-r
pain NN I-NP O
She PRP O O
is VBZ O O
also RB O O
reportedly RB O O
taking VBG O O
a DT B-NP O
baby NN I-NP B-m
aspirin RB O I-m
81 CD O B-do
milligrams NNS B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
disability NN B-NP O
She PRP O O
lives VBZ O O
alone RB O O
as IN B-VP O
a DT B-NP O
widow NN I-NP O
No DT B-NP O
clear JJ I-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
or CC O O
ethanol NN B-NP O
use NN I-NP O
She PRP O O
has VBZ O O
two CD O O
children NNS B-NP O
She PRP O O
is VBZ O O
independent JJ O O
with IN B-VP O
ADLs NNP B-NP O
and CC O O
mobility NNP B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Familial NNP I-NP O
intermittent NN I-NP O
paralytic JJ B-NP O
syndrome JJ I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
was VBD B-VP O
97.1 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
110 CD O O
, , O O
respirations NNS B-NP O
20 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
130/70 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
100% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Glucose NNP I-NP O
is VBZ O O
388 CD O O
Mental JJ B-NP O
status NN I-NP O
examination: VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
three CD O O
following VBG O O
three CD O O
step NN B-NP O
command NN I-NP O
across IN B-VP O
the DT B-NP O
midline NN I-NP O
No NNP I-NP O
apraxia RB O O
Positive NNP B-NP O
dysarthria NN I-NP O
Repetition NNP I-NP O
intact JJ B-NP O
Memory NNP I-NP O
3/3 CD O O
immediately RB O O
and CC O O
3/3 CD O O
at IN B-VP O
5 CD O O
minutes NNS B-NP O
Cranial JJ B-NP O
nerves: JJ I-NP O
Pupils NNP I-NP O
3-2 CD O O
bilaterally RB O O
Right JJ B-NP O
central JJ I-NP O
facial JJ I-NP O
paralysis NN I-NP O
No NNP I-NP O
pallor NN I-NP O
or CC O O
droop NN B-NP O
Decreased VBN O O
sensation NN B-NP O
to TO O O
light JJ B-NP O
touch NN I-NP O
, , O O
pinprick NN B-NP O
and CC O O
temperature NN B-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
Tears NNP I-NP O
well RB O O
bilaterally RB O O
She PRP O O
cannot VBZ O O
shrug JJ O O
her PRP$ O O
right JJ B-NP O
shoulder NN I-NP O
Motor NNP I-NP O
and CC O O
tone NN B-NP O
flaccid NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
Strength: NNP I-NP O
Right NNP I-NP O
hemiplegia NN I-NP O
( ( O O
can MD O O
only RB O O
wiggle VB O O
toes NNS B-NP O
) ) O O
, , O O
left VBD B-VP O
strength NN B-NP O
4-5/5 JJ O O
( ( O O
poor JJ B-NP O
effort NN I-NP O
) ) O O
Deep NNP B-NP O
tendon NN I-NP O
reflexes NNS I-NP O
are VBP O O
2+ CD O O
at IN B-VP O
the DT B-NP O
biceps NNS I-NP O
, , O O
1+ CD O O
at IN B-VP O
the DT B-NP O
knees NNS I-NP O
, , O O
0-1 NN B-NP O
at IN B-VP O
the DT B-NP O
ankle NN I-NP O
with IN B-VP O
an DT B-NP O
upgoing JJ I-NP O
right NN I-NP O
toe NN I-NP O
Sensation: NNP I-NP O
Decreased VBD B-VP O
sensation NN B-NP O
to TO O O
light JJ B-NP O
touch NN I-NP O
, , O O
pinprick NN B-NP O
and CC O O
vibration NN B-NP O
Temperature NN I-NP O
on IN B-VP O
the DT O O
right JJ O O
including VBG O O
trunk NN B-NP O
Gait NNP I-NP O
not RB O O
assessed VBD B-VP O
HEENT: NNP B-NP O
Atraumatic NNP I-NP O
Neck NNP I-NP O
supple JJ B-NP O
Lungs NNP I-NP O
clear NN I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
Cardiovascular: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
Abdomen: NNP I-NP O
Soft NNP I-NP O
and CC O O
nontender RB O O
Positive NNP B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities: NNP B-NP O
No NNP I-NP O
edema NN I-NP O
EKG: NNP I-NP O
Sinus NNP I-NP O
tachycardia NN I-NP O
at IN B-VP O
104 CD O O
per IN B-VP O
report NN B-NP O
when WRB O O
compared VBN O O
with IN B-VP O
EKG NNP B-NP O
of IN B-VP O
March NNP B-NP O
, , O O
no DT B-NP O
significant JJ I-NP O
change NN I-NP O
Chest NNP I-NP O
x-ray: NN I-NP O
No NNP I-NP O
evidence NN I-NP O
of IN B-VP O
active JJ B-NP O
cardiopulmonary JJ I-NP O
disease NN I-NP O
CT NNP I-NP O
scan NN I-NP O
of IN B-VP O
the DT B-NP O
head NN I-NP O
on IN B-VP O
10/6/98 CD O O
showed VBD B-VP O
low JJ B-NP O
density NN I-NP O
area NN I-NP O
present NN I-NP O
in IN B-VP O
the DT B-NP O
posterior JJ I-NP O
limb NN I-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
intracapsular JJ B-NP O
capsule NN I-NP O
consistent NN I-NP O
with IN B-VP O
an DT B-NP O
infarct JJ I-NP O
Otherwise NNP I-NP O
, , O O
no DT B-NP O
significant JJ I-NP O
abnormality NN I-NP O
was VBD B-VP O
seen VBN O O
Mild NNP B-NP O
age NN I-NP O
appropriate JJ B-NP O
involutional JJ I-NP O
changes NNS I-NP O
were VBD B-VP O
present JJ B-NP O
LABORATORY: NNP I-NP O
Showed VBD B-VP O
a DT B-NP O
glucose NN I-NP O
of IN B-VP O
353 CD O O
, , O O
sodium NN B-NP O
138 CD O O
, , O O
potassium NN B-NP O
4.9 CD O O
, , O O
chloride RB O O
98 CD O O
, , O O
CO2 NNP B-NP O
28 CD O O
, , O O
BUN NNP B-NP O
33 CD O O
, , O O
creatinine NN B-NP O
1.1 CD O O
, , O O
calcium NN B-NP O
10.3 CD O O
, , O O
magnesium NN B-NP O
2.0 CD O O
, , O O
troponin VBD B-VP O
0.09 CD O O
White NNP B-NP O
count NN I-NP O
8.4 CD O O
, , O O
hematocrit NN B-NP O
39.8 CD O O
, , O O
platelet NN B-NP O
count NN I-NP O
367 CD O O
, , O O
000 CD O O
PT NNP B-NP O
12.1 CD O O
, , O O
PTT NNP B-NP O
19.5 CD O O
INR NNP B-NP O
1.0 CD O O
ASSESSMENT NNP B-NP O
AND NNP I-NP O
PLAN: NNP I-NP O
Ms NNP I-NP O
Lofstrom NNP I-NP O
is VBZ O O
a DT B-NP O
57-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
multinodular JJ B-NP O
goiter NN I-NP O
, , O O
arthritis NN B-NP O
and CC O O
questionable JJ B-NP O
recurrent NN I-NP O
bouts NNS I-NP O
of IN B-VP O
generalized JJ B-NP O
weakness NN I-NP O
who WP O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
new JJ B-NP O
onset NN I-NP O
of IN B-VP O
right NN B-NP O
sided VBN O O
weakness NN B-NP O
( ( O O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
) ) O O
, , O O
right JJ B-NP O
leg NN I-NP O
numbness NN I-NP O
and CC O O
weakness NN B-NP O
, , O O
right JJ B-NP O
arm NN I-NP O
clumsiness NN I-NP O
followed VBN O O
by IN B-VP O
dysarthria NNS B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS: NNP I-NP O
1 CD O O
NEUROLOGY: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
felt VBN O O
to TO O O
have VB O O
a DT B-NP O
probable JJ I-NP O
subcortical JJ I-NP O
stroke NN I-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
hemisphere NN I-NP O
with IN B-VP O
preservation NN B-NP O
of IN B-VP O
the DT B-NP O
speech NN I-NP O
processing NN I-NP O
abilities NNS I-NP O
with IN B-VP O
dense JJ B-NP O
motor NN I-NP O
and CC O O
sensory JJ B-NP O
involvement NN I-NP O
This DT O O
was VBD B-VP O
felt VBN O O
to TO O O
potentially RB O O
represent VB O O
an DT B-NP O
MCA NNP I-NP O
branch NN I-NP O
occlusion NN I-NP O
with IN B-VP O
increased JJ B-NP O
edema NN I-NP O
versus IN B-VP O
a DT B-NP O
large JJ I-NP O
lacuna NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
given VBN O O
her PRP$ O O
history NN B-NP O
, , O O
the DT B-NP O
team NN I-NP O
was VBD B-VP O
unable JJ O O
to TO O O
rule VB O O
out RP O O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
an DT B-NP O
embolic JJ I-NP O
event NN I-NP O
Therefore NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
and CC O O
ruled VBN O O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
Her PRP$ O O
CKs NNP B-NP O
were VBD B-VP O
25 CD O O
, , O O
37 CD O O
, , O O
37 CD O O
and CC O O
32 CD O O
She PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP O
cardiac JJ I-NP O
monitor NN I-NP O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
arrhythmia NN B-NP O
she PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
subcu NN B-NP B-mo
heparin NN I-NP B-m
and CC O O
started VBD B-VP O
on IN B-VP O
full JJ B-NP O
dose NN I-NP O
aspirin IN B-VP B-m
325 CD O B-do
milligrams NNS B-NP I-do
p.o VBP O B-mo
q.d NN B-NP B-f
In IN B-VP O
order NN B-NP O
to TO O O
further RBR O O
work VB O O
up RP O O
the DT B-NP O
etiology NN I-NP O
for IN B-VP O
stroke NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
done VBN O O
which WDT O O
revealed VBD B-VP O
evidence NN B-NP O
of IN B-VP O
concentric JJ B-NP O
LVH NNP I-NP O
with IN B-VP O
preserved VBN O O
systolic JJ B-NP O
function NN I-NP O
, , O O
calculated VBN O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
55% CD O O
Other JJ O O
than IN B-VP O
nonspecific JJ B-NP O
septal JJ I-NP O
abnormality NN I-NP O
, , O O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
regional JJ B-NP O
wall NN I-NP O
motion NN I-NP O
dysfunction NN I-NP O
There EX O O
were VBD B-VP O
early JJ B-NP O
changes NNS I-NP O
of IN B-VP O
mitral JJ B-NP O
annular JJ I-NP O
calcification NN I-NP O
present NN I-NP O
, , O O
some DT O O
increased VBN O O
excursion NN B-NP O
of IN B-VP O
the DT B-NP O
mitral JJ I-NP O
leaflet NN I-NP O
, , O O
but CC O O
this DT O O
is VBZ O O
associated VBN O O
with IN B-VP O
only RB O O
trivial JJ B-NP O
regurgitation NN I-NP O
Trileaflet NNP I-NP O
aortic JJ B-NP O
valve NN I-NP O
without IN B-VP O
dysfunction NN B-NP O
One CD O O
plus CC O O
tricuspid JJ B-NP O
regurgitation NN I-NP O
Peak NNP I-NP O
doppler NN I-NP O
flow NN I-NP O
velocity NN I-NP O
across IN B-VP O
the DT B-NP O
tricuspid JJ I-NP O
valve NN I-NP O
reached VBD B-VP O
2.5 CD O O
meters NNS B-NP O
per IN B-VP O
second JJ O O
consistent JJ O O
with IN B-VP O
normal JJ B-NP O
right JJ I-NP O
heart NN I-NP O
systolic JJ B-NP O
pressures NNS I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
effusion NN B-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
carotid NN I-NP O
noninvasive JJ B-NP O
studies NNS I-NP O
which WDT O O
revealed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
hemodynamically RB O O
significant JJ B-NP O
disease NN I-NP O
in IN B-VP O
either DT B-NP O
carotid JJ I-NP O
artery NN I-NP O
with IN B-VP O
those DT B-NP O
arteries NNS I-NP O
having VBG O O
minimal JJ B-NP O
plaque NN I-NP O
and CC O O
1-25% JJ B-NP O
stenosis NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
MRI/MRA NNP I-NP O
to TO O O
further VB O O
evaluate VB O O
potential JJ B-NP O
lesions NNS I-NP O
On IN B-VP O
MRI NNP B-NP O
there EX O O
was VBD B-VP O
a DT B-NP O
focal JJ I-NP O
area NN I-NP O
of IN B-VP O
increased VBN O O
T2 NNP B-NP O
signal NN I-NP O
in IN B-VP O
the DT B-NP O
posterior JJ I-NP O
limb NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
internal JJ I-NP O
capsule NN I-NP O
, , O O
close VB O O
the DT B-NP O
genu NN I-NP O
This DT B-NP O
area NN I-NP O
demonstrated VBD B-VP O
restricted JJ B-NP O
diffusion NN I-NP O
on IN B-VP O
EPI NNP B-NP O
diffusion NN I-NP O
, , O O
weighted VBD B-VP O
sequence NN B-NP O
A NNP I-NP O
similar JJ B-NP O
smaller JJR I-NP O
area NN I-NP O
of IN B-VP O
signal JJ B-NP O
abnormality NN I-NP O
was VBD B-VP O
noted VBN O O
in IN B-VP O
the DT B-NP O
left NN I-NP O
globus NN I-NP O
pallidus NN I-NP O
adjacent NN I-NP O
to TO O O
the DT O O
left VBN O O
internal JJ B-NP O
capsule NN I-NP O
abnormality NN I-NP O
These DT B-NP O
areas NNS I-NP O
represent VBP O O
subacute JJ B-NP O
infarctions NNS I-NP O
The DT B-NP O
ventricles NNS I-NP O
and CC O O
sulci NNS B-NP O
were VBD B-VP O
minimally RB O O
prominent JJ O O
, , O O
consistent JJ O O
with IN B-VP O
the DT B-NP O
patient's NN I-NP O
age NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
other JJ I-NP O
signal JJ I-NP O
abnormality NN I-NP O
noted VBD B-VP O
Major NNP B-NP O
vascular JJ B-NP O
flow NN I-NP O
voids NNS I-NP O
were VBD B-VP O
normal JJ O O
There EX O O
was VBD B-VP O
no DT B-NP O
mass NN I-NP O
or CC O O
mass NN B-NP O
effect NN I-NP O
Three NNP I-NP O
D NNP I-NP O
, , O O
TOF NNP B-NP O
MRN NNP I-NP O
angiogram NN I-NP O
on IN B-VP O
the DT B-NP O
circle NN I-NP O
of IN B-VP O
Willis NNP B-NP O
and CC O O
its PRP$ O O
major JJ B-NP O
tributaries NNS I-NP O
did VBD B-VP O
not RB O O
demonstrate VB O O
any DT B-NP O
abnormality NN I-NP O
Incidental NNP I-NP O
note NN I-NP O
was VBD B-VP O
made VBN O O
of IN B-VP O
a DT O O
dominant JJ O O
right JJ O O
vertebral JJ O O
artery IN B-VP O
The DT B-NP O
formal JJ I-NP O
impression NN I-NP O
revealed VBD B-VP O
subacute JJ B-NP O
infarcts NNS I-NP O
involving VBG O O
the DT B-NP O
posterior JJ I-NP O
limb NN I-NP O
of IN B-VP O
the DT B-NP O
internal JJ I-NP O
capsule NN I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
left NN I-NP O
globus NN I-NP O
pallidus NN I-NP O
Unremarkable NNP I-NP O
MR NNP I-NP O
angiogram NN I-NP O
on IN B-VP O
the DT B-NP O
circle NN I-NP O
of IN B-VP O
Willis NNP B-NP O
In IN B-VP O
addition NN B-NP O
, , O O
given VBN O O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
polymyalgias NN B-NP O
, , O O
an DT B-NP O
ESR NNP I-NP O
and CC O O
C-reactive JJ B-NP O
protein NN I-NP O
were VBD B-VP O
obtained VBN O O
The DT B-NP O
ESR NNP I-NP O
was VBD B-VP O
46 CD O O
The DT B-NP O
C-reactive JJ I-NP O
protein NN I-NP O
was VBD B-VP O
1.13 CD O O
The DT B-NP O
stroke NN I-NP O
service NN I-NP O
was VBD B-VP O
asked VBN O O
to TO O O
comment VB O O
on IN B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
a DT B-NP O
vasculitic JJ I-NP O
process NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
primary JJ B-NP O
rheumatologist NN I-NP O
was VBD B-VP O
consulted VBN O O
as RB O O
well RB O O
The DT B-NP O
patient's NN I-NP O
primary JJ B-NP O
rheumatologist NN I-NP O
felt VBD B-VP O
that IN B-VP O
the DT B-NP O
patient's NN I-NP O
stroke NN I-NP O
was VBD B-VP O
most RBS O O
likely JJ O O
due JJ O O
to TO O O
small JJ B-NP O
vessel JJ I-NP O
disease NN I-NP O
associated VBN O O
with IN B-VP O
diabetes NNS B-NP O
and CC O O
hypertension NN B-NP O
He PRP O O
felt VBD B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
a DT B-NP O
vasculitis NN I-NP O
He PRP O O
therefore RB O O
suggested VBD B-VP O
to TO O O
continue VB O O
aspirin NN B-NP B-m
, , O O
but CC O O
in IN B-VP O
higher JJR B-NP B-do
doses NNS I-NP I-do
to TO O O
alleviate VB O O
her PRP$ O B-r
left JJ B-NP I-r
shoulder NN I-NP I-r
pain VBP O I-r
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
feel VB O O
that IN B-VP O
she PRP O O
had VBD B-VP O
any DT B-NP O
vasculitic JJ I-NP O
process NN I-NP O
They PRP O O
therefore RB O O
recommended VBD B-VP O
continuing VBG O O
aspirin RB O B-m
325 CD O B-do
milligrams NNS B-NP I-do
p.o JJ B-NP B-mo
q.d NN I-NP B-f
, , O O
checking VBG O O
a DT B-NP O
serum NN I-NP O
homocystine NN I-NP O
which WDT O O
remains VBZ O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
, , O O
reviewing VBG O O
her PRP$ O O
carotid NN B-NP O
studies NNS I-NP O
( ( O O
mentioned VBN O O
above IN B-VP O
) ) O O
, , O O
and CC O O
continue VB O O
with IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
occupational JJ B-NP O
therapy NN I-NP O
and CC O O
speech NN B-NP O
therapy NN I-NP O
PT NNP I-NP O
and CC O O
OT NNP B-NP O
were VBD B-VP O
consulted VBN O O
as RB O O
well RB O O
as IN B-VP O
Speech NNP B-NP O
Therapy NNP I-NP O
In IN B-VP O
addition NN B-NP O
to TO O O
continuing VBG O O
the DT B-NP O
patient NN I-NP O
on IN B-VP O
aspirin NN B-NP B-m
, , O O
continuing VBG O O
subcu JJ B-NP B-mo
heparin NN I-NP B-m
while IN B-VP B-du
the DT B-NP I-du
patient NN I-NP I-du
was VBD B-VP I-du
immobile JJ O I-du
, , O O
the DT B-NP O
patient's NN I-NP O
antihypertensives NNS I-NP B-m
were VBD B-VP O
held VBN O O
in IN B-VP O
order NN B-NP O
to TO O O
maintain VB O O
a DT B-NP O
systolic JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
between IN B-VP O
140-160 JJ O O
and CC O O
a DT B-NP O
diastolic JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
between IN B-VP O
85-90 JJ O O
for IN B-VP O
the DT B-NP O
first JJ I-NP O
ten JJ I-NP O
days NNS I-NP O
following VBG O O
her PRP$ O O
stroke NN B-NP O
For IN B-VP O
the DT B-NP O
first JJ I-NP O
few JJ I-NP O
days NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
kept VBN O O
in IN B-VP O
a DT B-NP O
lying JJ I-NP O
position NN I-NP O
as RB O O
much JJ O O
as IN B-VP O
possible JJ O O
and CC O O
her PRP$ O O
activity NN B-NP O
level NN I-NP O
was VBD B-VP O
gradually RB O O
increased VBN O O
to TO O O
the DT B-NP O
point NN I-NP O
where WRB O O
she PRP O O
was VBD B-VP O
participating VBG O O
in IN B-VP O
full JJ B-NP O
PT/OT NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
Norvasc NNP I-NP B-m
continued VBD B-VP O
to TO O O
be VB O O
held VBN O O
with IN B-VP O
excellent JJ B-NP O
control NN I-NP O
of IN B-VP O
her PRP$ O B-r
blood NN B-NP I-r
pressure NN I-NP I-r
between IN B-VP O
systolic NN B-NP O
of IN B-VP O
140-160 JJ O O
It PRP O O
should MD O O
not RB O O
be VB O O
reinitiated VBN O O
until IN B-VP O
roughly RB O O
ten JJ B-NP O
days NNS I-NP O
after IN B-VP O
her PRP$ O O
stroke VBD B-VP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
relatively RB O O
poor JJ B-NP O
return NN I-NP O
of IN B-VP O
function NN B-NP O
during IN B-VP O
her PRP$ O O
hospital NN B-NP O
stay NN I-NP O
, , O O
but CC O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
a DT B-NP O
good JJ I-NP O
candidate NN I-NP O
for IN B-VP O
potential JJ B-NP O
rehabilitation NN I-NP O
Therefore RB O O
when WRB O O
her PRP$ O O
medical JJ B-NP O
issues NNS I-NP O
were VBD B-VP O
stable JJ O O
, , O O
she PRP O O
was VBD B-VP O
considered VBN O O
ready JJ O O
for IN B-VP O
transfer NN B-NP O
to TO O O
a DT B-NP O
rehabilitation NN I-NP O
facility NN I-NP O
in IN B-VP O
an DT B-NP O
attempt NN I-NP O
to TO O O
further RB O O
improve VB O O
her PRP$ O O
neurologic JJ B-NP O
function NN I-NP O
As IN B-VP O
noted JJ O O
previously RB O O
, , O O
the DT B-NP O
patient's NN I-NP O
antihypertensives NNS I-NP B-m
should MD O O
be VB O O
reinitiated VBN O O
gradually RB O O
with IN B-VP O
a DT B-NP O
goal NN I-NP O
systolic JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
between IN B-VP O
140-160 JJ O O
with IN B-VP O
a DT B-NP O
diastolic JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
85-90 JJ O O
to TO O O
be VB O O
initiated VBN O O
roughly RB O O
ten JJ B-NP O
days NNS I-NP O
from IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
her PRP$ O O
stroke NN B-NP O
( ( O O
presented VBN O O
on IN B-VP O
10/6/98 CD O O
) ) O O
As IN B-VP O
noted VBN O O
by IN B-VP O
the DT B-NP O
work NN I-NP O
up RB O O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
an DT B-NP O
embolic JJ I-NP O
source NN I-NP O
for IN B-VP O
her PRP$ O O
stroke NN B-NP O
and CC O O
her PRP$ O O
carotid NN B-NP O
studies NNS I-NP O
were VBD B-VP O
unremarkable JJ O O
2 CD O O
RHEUMATOLOGIC: NNP B-NP O
As IN B-VP O
noted VBN O O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
long JJ I-NP O
history NN I-NP O
of IN B-VP O
diffuse NN B-NP O
arthritic JJ B-NP O
complaints NNS I-NP O
She PRP O O
had VBD B-VP O
her PRP O O
sed JJ B-NP O
rate NN I-NP O
and CC O O
C-reactive JJ B-NP O
protein NN I-NP O
checked VBD B-VP O
Rheumatology NNP B-NP O
was VBD B-VP O
consulted VBN O O
who WP O O
felt VBD B-VP O
that IN B-VP O
her PRP$ O O
stroke NN B-NP O
was VBD B-VP O
not RB O O
consistent JJ O O
with IN B-VP O
a DT B-NP O
vascular JJ I-NP O
process NN I-NP O
They PRP O O
did VBD B-VP O
recommend VB O O
checking VBG O O
a DT B-NP O
urinalysis NN I-NP O
to TO O O
check VB O O
for IN B-VP O
red JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
and CC O O
casts VBZ O O
Her PRP$ O O
urinalysis NN B-NP O
showed VBD B-VP O
no DT B-NP O
protein NN I-NP O
, , O O
no DT B-NP O
blood NN I-NP O
, , O O
0-2 JJ B-NP O
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
, , O O
no DT B-NP O
casts NNS I-NP O
Only RB O O
other JJ B-NP O
recommendation NN I-NP O
was VBD B-VP O
to TO O O
continue VB O O
aspirin NN B-NP B-m
and CC O O
consider VB O O
higher JJR B-NP B-do
doses NNS I-NP I-do
to TO O O
alleviate VB O O
left JJ B-NP B-r
shoulder NN I-NP I-r
pain NN I-NP I-r
In IN B-VP O
addition NN B-NP O
, , O O
recommended VBD B-VP O
avoiding VBG O O
nonsteroidals NNS B-NP O
while IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
on IN B-VP O
aspirin JJ O B-m
3 CD O O
ENDOCRINE: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-r
diabetes NNS I-NP B-r
mellitus VBP O I-r
mellitus NN B-NP I-r
and CC O O
had VBD B-VP O
not RB O O
taken VBN O O
her PRP$ O O
insulin NN B-NP B-m
for IN B-VP B-du
several JJ B-NP I-du
days NNS I-NP I-du
prior RB O O
to TO O O
admission VB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
her PRP$ O O
regular JJ B-NP B-m
insulin NN I-NP I-m
schedule NN I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT O O
sliding VBG O B-do
scale NN B-NP I-do
The DT B-NP O
patient's NN I-NP O
blood NN I-NP O
sugar NN I-NP O
has VBZ O O
ranged VBN O O
from IN B-VP O
the DT O O
150 CD O O
to TO O O
the DT O O
high JJ O O
200s CD O O
As IN B-VP O
the DT B-NP O
patient's NN I-NP O
diet JJ B-NP O
returns NNS I-NP O
to TO O O
baseline VB O O
, , O O
she PRP O O
may MD O O
require VB O O
adjustments NNS B-NP O
of IN B-VP O
her PRP$ O O
NPH NNP B-NP B-m
and CC O O
regular JJ B-NP B-m
insulin NN I-NP I-m
doses NNS I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
Premarin NNP I-NP B-m
was VBD B-VP O
held VBN O O
during IN B-VP B-du
this DT B-NP I-du
admission NN I-NP I-du
and CC O O
further JJ B-NP O
therapy NN I-NP O
should MD O O
be VB O O
decided VBN O O
by IN B-VP O
the DT B-NP O
patient's NN I-NP O
follow VBP O O
up RB O O
neurologist RB O O
4 CD O O
FLUIDS NNP B-NP O
, , O O
ELECTROLYTES NNP B-NP O
AND NNP I-NP O
NUTRITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
initially RB O O
appeared VBD B-VP O
somewhat RB O O
dehydrated VBN O O
on IN B-VP O
admission NN B-NP O
and CC O O
was VBD B-VP O
therefore RB O O
rehydrated VBN O O
with IN B-VP O
IV NNP B-NP B-mo
fluids NNS I-NP B-m
She PRP O O
had VBD B-VP O
good JJ B-NP O
resolution NN I-NP O
and CC O O
returned VBN O O
to TO O O
baseline NN B-NP O
of IN B-VP O
her PRP$ O O
BUN NNP B-NP O
and CC O O
creatinine VB O O
She PRP O O
was VBD B-VP O
eating VBG O O
well RB O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
Close NNP I-NP O
observation NN I-NP O
was VBD B-VP O
paid VBN O O
to TO O O
her PRP$ O O
electrolytes NNS B-NP O
including VBG O O
her PRP$ O O
potassium NN B-NP O
Her PRP$ O O
electrolytes NNS B-NP O
should MD O O
be VB O O
periodically RB O O
monitored VBN O O
at IN B-VP O
least JJS O O
once RB O O
a DT B-NP O
week NN I-NP O
at IN B-VP O
rehabilitation NN B-NP O
She PRP O O
does VBZ O O
have VB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hyperkalemia NN B-NP O
and CC O O
should MD O O
be VB O O
watched VBN O O
carefully RB O O
for IN B-VP O
this DT O O
5 CD O O
SOCIAL NNP B-NP O
WORK: NNP I-NP O
The DT B-NP O
patient NN I-NP O
initially RB O O
made VBD B-VP O
a DT B-NP O
comment NN I-NP O
to TO O O
the DT B-NP O
Medical NNP I-NP O
Team NN I-NP O
that IN B-VP O
she PRP O O
had VBD B-VP O
been VBN O O
abused VBN O O
by IN B-VP O
her PRP$ O O
husband NN B-NP O
The DT B-NP O
social JJ I-NP O
worker NN I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
asked VBN O O
to TO O O
see VB O O
her PRP$ O O
regarding VBG O O
this DT B-NP O
issue NN I-NP O
of IN B-VP O
spouse NN B-NP O
abuse IN B-VP O
It PRP O O
is VBZ O O
true JJ O O
that IN B-VP O
her PRP$ O O
husband NN B-NP O
had VBD B-VP O
hit VBN O O
her PRP O O
in IN B-VP O
the DT B-NP O
forehead NN I-NP O
with IN B-VP O
a DT B-NP O
baseball NN I-NP O
bat NN I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
He PRP O O
died VBD B-VP O
several JJ B-NP O
years NNS I-NP O
ago RB O O
and CC O O
no DT B-NP O
further JJ I-NP O
abuse NN I-NP O
history NN I-NP O
could MD O O
be VB O O
elicited VBN O O
since IN B-VP O
his PRP$ O O
death NN B-NP O
She PRP O O
currently RB O O
has VBZ O O
two CD O O
supportive JJ B-NP O
children NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
considered VBN O O
stable JJ O O
and CC O O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
a DT B-NP O
rehabilitation NN I-NP O
facility NN I-NP O
When WRB O O
the DT B-NP O
date NN I-NP O
of IN B-VP O
her PRP$ O O
transfer NN B-NP O
is VBZ O O
made VBN O O
available JJ O O
, , O O
her PRP$ O O
discharge NN B-NP O
medications NNS I-NP O
will MD O O
be VB O O
dictated VBN O O
along IN B-VP O
with IN B-VP O
follow JJ O O
up RP O O
Dictated NNP B-NP O
By: NNP I-NP O
RODGER NNP I-NP O
FALIS NNP I-NP O
, , O O
M.D NNP B-NP O
JL81 NNP I-NP O
Attending: NNP I-NP O
JUAN NNP I-NP O
AMISANO NNP I-NP O
, , O O
M.D NNP B-NP O
RW2 NNP I-NP O
CK149/6034 NNP I-NP O
Batch: NNP I-NP O
5491 CD O O
Index NNP B-NP O
No NNP I-NP O
PGONI565Z NNP I-NP O
D: NNP I-NP O
3/29/98 CD O O
T: NNP B-NP O
6/16/98 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#569323 VBZ O O
185076505 CD O O
BMC NNP B-NP O
25759757 CD O O
6146391 CD O O
1/20/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHRONIC NNP I-NP O
OBSTRUCTIVE NNP I-NP O
PULMONARY NNP I-NP O
DISEASE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/30/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/7/2005 CD O O
ATTENDING: NNP B-NP O
REOPELL NNP I-NP O
, , O O
ROLF NNP B-NP O
M.D NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
This DT O O
is VBZ O O
the DT B-NP O
diagnosis NN I-NP O
responsible JJ O O
for IN B-VP O
causing VBG O O
the DT B-NP O
admission NN I-NP O
is VBZ O O
sinus JJ B-NP O
arrest NN I-NP O
with IN B-VP O
apnea JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
71-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
nonischemic JJ O O
dilated VBN O O
cardiomyopathy NN B-NP O
( ( O O
EF NNP B-NP O
of IN B-VP O
55% CD O O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
although IN B-VP O
prior JJ B-NP O
admission NN I-NP O
indicating VBG O O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
35% CD O O
) ) O O
, , O O
diabetes VBZ O O
, , O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
, , O O
obesity NN B-NP O
hypoventilation NN I-NP O
syndrome NN I-NP O
, , O O
atrial JJ B-NP O
flutter NN I-NP O
status NN I-NP O
post NN I-NP O
ablation NN I-NP O
On IN B-VP O
7/28/05 CD O O
, , O O
he PRP O O
presented VBD B-VP O
with IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
witnessed JJ I-NP O
apneic NN I-NP O
episode VB O O
His PRP$ O O
recent JJ B-NP O
history NN I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
having VBG O O
stopped VBD B-VP O
his PRP$ O O
Lasix NNP B-NP B-m
dose NN I-NP O
one CD O O
week NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
due JJ O O
to TO O O
increased VBN O O
frustration NN B-NP O
with IN B-VP O
incontinence NN B-NP O
Since IN B-VP O
then RB O O
, , O O
he PRP O O
has VBZ O O
had VBD B-VP O
increasing VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
orthopnea NN B-NP O
, , O O
bilateral JJ B-NP O
lower JJR I-NP O
edema NN I-NP O
, , O O
and CC O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
to TO O O
the DT B-NP O
point NN I-NP O
of IN B-VP O
symptoms NNS B-NP O
upon IN B-VP O
walking VBG O O
10 CD O O
feet NNS B-NP O
In IN B-VP O
the DT B-NP O
Centsshealt NNP I-NP O
Careman NNP I-NP O
Inerist NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Emergency NNP I-NP O
Department NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
saturating VBG O O
91% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
and CC O O
99% CD O O
on IN B-VP O
a DT O O
nonrebreather DT O O
An DT B-NP O
ABG NNP I-NP O
showed VBD B-VP O
a DT B-NP O
pH NN I-NP O
of IN B-VP O
7.31 CD O O
and CC O O
a DT B-NP O
PCO2 NNP I-NP O
of IN B-VP O
55; CD O O
he PRP O O
was VBD B-VP O
tried VBN O O
on IN B-VP O
BiPAP NNP B-NP O
without IN B-VP O
improvement NN B-NP O
in IN B-VP O
either CC O O
PCO2 NNP B-NP O
or CC O O
PO2 NNP B-NP O
While IN B-VP O
being VBG O O
interviewed VBN O O
by IN B-VP O
the DT B-NP O
medical JJ I-NP O
residents NNS I-NP O
, , O O
he PRP O O
was VBD B-VP O
seen VBN O O
to TO O O
have VB O O
a DT B-NP O
30-second JJ I-NP O
apneic NN I-NP O
episode NN I-NP O
with IN B-VP O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
and CC O O
cyanosis; VB O O
his PRP$ O O
sensorium NN B-NP O
quickly RB O O
returned VBD B-VP O
after IN B-VP O
this DT B-NP O
event NN I-NP O
, , O O
although IN B-VP O
he PRP O O
retained VBD B-VP O
no DT B-NP O
memory NN I-NP O
of IN B-VP O
this DT B-NP O
occurrence NN I-NP O
He PRP O O
received VBD B-VP O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
x1 NN I-NP B-du
, , O O
Solu-Medrol NNP B-NP B-m
, , O O
and CC O O
DuoNebs NNP B-NP B-m
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
CCU NNP I-NP O
initially RB O O
with IN B-VP O
CHF/apnea/sinus NNP B-NP O
arrest NN I-NP O
, , O O
and CC O O
subsequently RB O O
transferred VBN O O
to TO O O
the DT B-NP O
hospital NN I-NP O
floor NN I-NP O
when WRB O O
he PRP O O
was VBD B-VP O
stable JJ B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Congestive NNP B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
nonischemic JJ O O
dilated VBD B-VP O
cardiomyopathy JJ O O
, , O O
8/21 CD O O
echo NN B-NP O
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
35% CD O O
and CC O O
global JJ O O
left VBD B-VP O
ventricular JJ B-NP O
hypokinesis; NN I-NP O
2/10 CD O O
echo NN B-NP O
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
55% CD O O
, , O O
without IN B-VP O
hypokinesis NN B-NP O
2 CD O O
Atrial NNP B-NP O
flutter NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
ablation NN I-NP O
( ( O O
2003 CD O O
) ) O O
3 CD O O
Atrial JJ B-NP O
fibrillation NN I-NP O
4 CD O O
Hyperostosis NNP B-NP O
frontalis VBD B-VP O
5 CD O O
Complex NNP B-NP O
renal JJ B-NP O
cyst NN I-NP O
versus NN I-NP O
angiomyolipoma NN I-NP O
, , O O
resected VBD B-VP O
via IN B-VP O
laparoscopy NN B-NP O
in IN B-VP O
6/9 CD O O
6 CD O O
Morbid NNP B-NP O
obesity NN I-NP O
with IN B-VP O
obesity NN B-NP O
hypoventilation NN I-NP O
syndrome VBD B-VP O
7 CD O O
Obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
8 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
( ( O O
baseline JJ B-NP O
creatinine NN I-NP O
2 CD O O
) ) O O
MEDICATIONS: NNP B-NP O
1 CD O O
Allopurinol NNP B-NP B-m
2 CD O O
Iron NNP B-NP B-m
3 CD O O
Lisinopril NNP B-NP B-m
4 CD O O
Toprol-XL NNP B-NP B-m
5 CD O O
Coumadin NNP B-NP B-m
( ( O O
discontinued VBN O O
on IN B-VP O
2/4/05 CD O O
) ) O O
6 CD O O
Albuterol NNP B-NP B-m
inhaler NN I-NP I-m
p.r.n NN I-NP B-f
7 CD O O
Aspirin NNP B-NP B-m
8 CD O O
Flomax NNP B-NP B-m
9 CD O O
Hytrin NNP B-NP B-m
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
alone RB O O
at IN B-VP O
Rys NNP B-NP O
Ville NNP I-NP O
Santster NNP I-NP O
He PRP O O
is VBZ O O
a DT B-NP O
retired JJ I-NP O
Burg NNP I-NP O
Bovalle NNP I-NP O
Ge NNP I-NP O
employee NN I-NP O
He PRP O O
is VBZ O O
an DT B-NP O
ex-smoker NN I-NP O
, , O O
quit NN B-NP O
in IN B-VP O
the DT B-NP O
1960s NNS I-NP O
He PRP O O
is VBZ O O
a DT B-NP O
heavy JJ I-NP O
drinker NN I-NP O
in IN B-VP O
his PRP$ O O
20s CD O O
, , O O
but CC O O
now RB O O
he PRP O O
rarely RB O O
drinks VBZ O O
alcohol NN B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Gastric NNP I-NP O
cancer NN I-NP O
in IN B-VP O
his PRP$ O O
father NN B-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
of IN B-VP O
96 CD O O
, , O O
pulse NN B-NP O
of IN B-VP O
53 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
of IN B-VP O
125/65 CD O O
, , O O
and CC O O
saturating VBG O O
94% CD O O
on IN B-VP O
2 CD O O
liters NNS B-NP O
by IN B-VP O
nasal JJ B-NP O
cannula NN I-NP O
In IN B-VP O
general JJ O O
, , O O
alert JJ O O
and CC O O
oriented VBN O O
, , O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
HEENT: NNP I-NP O
Pupils NNP I-NP O
are VBP O O
equally RB O O
round JJ O O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
, , O O
sclerae EX O O
are VBP O O
anicteric JJ O O
, , O O
moist JJ B-NP O
mucous JJ I-NP O
membranes NNS I-NP O
Cardiovascular NNP I-NP O
exam: VBD B-VP O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
although IN B-VP O
JVP NNP B-NP O
difficult JJ O O
to TO O O
assess VB O O
due JJ O O
to TO O O
body NN B-NP O
habitus NN I-NP O
Lung NNP I-NP O
exam: VBD B-VP O
Clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
, , O O
no DT B-NP O
wheezes NN I-NP O
or CC O O
crackles NNS B-NP O
Abdomen: NNP I-NP O
Obese NNP I-NP O
, , O O
soft JJ O O
and CC O O
nontender JJ O O
, , O O
normal JJ B-NP O
abdominal JJ I-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities: NNP B-NP O
2+ CD O O
edema NN B-NP O
LABORATORY NNP I-NP O
STUDIES NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
creatinine NN B-NP O
of IN B-VP O
2.3 CD O O
( ( O O
at IN B-VP O
baseline NN B-NP O
) ) O O
, , O O
BNP NNP B-NP O
of IN B-VP O
500 CD O O
His PRP$ O O
admission NN B-NP O
EKG: NNP I-NP O
Sinus NNP I-NP O
rhythm NN I-NP O
with IN B-VP O
occasional JJ B-NP O
bradycardia NN I-NP O
to TO O O
the DT O O
40s CD O O
, , O O
no DT B-NP O
ST NNP I-NP O
changes NNS I-NP O
SUMMARY NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
ISSUE: NNP I-NP O
Assessment NNP I-NP O
and CC O O
Plan: NNP B-NP O
A NNP I-NP O
71-year-old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
obesity NN B-NP O
hypoventilation NN I-NP O
syndrome NN I-NP O
, , O O
restrictive JJ B-NP O
lung NN I-NP O
disease NN I-NP O
, , O O
diabetes VBZ O O
, , O O
nonischemic JJ O O
dilated VBD B-VP O
cardiomyopathy JJ O O
with IN B-VP O
a DT B-NP O
preserved JJ I-NP O
EF NNP I-NP O
, , O O
who WP O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
sinus NN B-NP O
arrest NN I-NP O
, , O O
ultimately RB O O
treated VBN O O
with IN B-VP O
diuresis NN B-NP O
and CC O O
a DT B-NP O
pacemaker NN I-NP O
placement NN I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
Ischemia: NNP I-NP O
No NNP I-NP O
active JJ B-NP O
issues NNS I-NP O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
Pump: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
nonischemic JJ O O
dilated VBD B-VP O
cardiomyopathy JJ O O
with IN B-VP O
a DT B-NP O
preserved JJ I-NP O
EF NNP I-NP O
, , O O
( ( O O
an DT B-NP O
echo NN I-NP O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
revealed VBD B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
55% CD O O
without IN B-VP O
hypokinesis NN B-NP O
, , O O
although IN B-VP O
prior JJ B-NP O
echo NN I-NP O
in IN B-VP O
2003 CD O O
showed VBD B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
35% CD O O
with IN B-VP O
global JJ O O
left VBD B-VP O
ventricular JJ B-NP O
hypokinesis NN I-NP O
) ) O O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
signs NNS B-NP O
and CC O O
symptoms NNS B-NP O
of IN B-VP O
volume NN B-NP O
overload NN I-NP O
in IN B-VP O
a DT B-NP O
setting NN I-NP O
of IN B-VP O
having VBG O O
not RB O O
taken VBN O O
his PRP$ O O
Lasix NNP B-NP B-m
for IN B-VP B-du
about RB O I-du
a DT B-NP I-du
week NN I-NP I-du
He PRP O O
was VBD B-VP O
admitted VBN O O
initially RB O O
to TO O O
the DT B-NP O
CCU NNP I-NP O
, , O O
and CC O O
subsequently RB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
with IN B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
of IN B-VP O
approximately RB O O
10 CD O O
kg NNS B-NP O
since IN B-VP O
admission NN B-NP O
( ( O O
including VBG O O
diuresis NN B-NP O
with IN B-VP O
ultrafiltration NN B-NP O
in IN B-VP O
the DT B-NP O
CCU NNP I-NP O
) ) O O
Following VBG O O
transfer NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
switched VBN O O
to TO O O
Lasix NNP B-NP B-m
diuresis NN I-NP B-r
, , O O
which WDT O O
was VBD B-VP O
titrated VBN O O
down RB O O
gradually RB O O
to TO O O
40 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
, , O O
( ( O O
cautioned VBN O O
with IN B-VP O
administration NN B-NP O
giving VBG O O
a DT B-NP O
rise NN I-NP O
in IN B-VP O
creatinine NN B-NP O
) ) O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
maintained VBN O O
on IN B-VP O
captopril NN B-NP B-m
, , O O
which WDT O O
was VBD B-VP O
up RB O O
titrated VBN O O
to TO O O
25 CD O B-do
mg NNS B-NP I-do
t.i.d NN I-NP B-f
( ( O O
held VBN O O
at IN B-VP O
one CD O O
point NN B-NP O
due JJ O O
to TO O O
the DT B-NP O
rise NN I-NP O
in IN B-VP O
the DT B-NP O
creatinine NN I-NP O
) ) O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
titrated VBN O O
up RP O O
on IN B-VP O
metoprolol NNS B-NP B-m
to TO O O
25 CD O B-do
mg NNS B-NP I-do
b.i.d JJ B-NP B-f
Rhythm: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
followed VBN O O
by IN B-VP O
the DT B-NP O
Electrophysiology NNP I-NP O
Service NNP I-NP O
In IN B-VP O
the DT B-NP O
CCU NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
sinus VBN O O
arrest NN B-NP O
of IN B-VP O
8-9 JJ B-NP O
seconds NNS I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
apnea NN B-NP O
Following VBG O O
transfer NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
sinus VBN O O
arrest NN B-NP O
of IN B-VP O
4 CD O O
seconds NNS B-NP O
, , O O
again RB O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
apnea NN B-NP O
His PRP$ O O
last JJ B-NP O
such JJ I-NP O
episode NN I-NP O
was VBD B-VP O
on IN B-VP O
3/29/05 CD O O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP O
fibrillation/flutter NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
ablation NN I-NP O
On IN B-VP O
0/5/05 CD O O
, , O O
he PRP O O
underwent JJ B-NP O
pacemaker NN I-NP O
placement NN I-NP O
through IN B-VP O
cephalic JJ B-NP O
veins NNS I-NP O
, , O O
which WDT O O
he PRP O O
tolerated VBD B-VP O
well RB O O
2 CD O O
Pulmonary: NNP B-NP O
The DT B-NP O
patient NN I-NP O
, , O O
as IN B-VP O
noted VBN O O
above IN B-VP O
, , O O
had VBD B-VP O
several JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
apnea NN B-NP O
, , O O
some DT O O
of IN B-VP O
which WDT O O
were VBD B-VP O
associated VBN O O
with IN B-VP O
sinus JJ B-NP O
arrest NN I-NP O
Following VBG O O
diuresis NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
apnea NN I-NP O
episodes VBZ O O
improved VBD B-VP O
He PRP O O
was VBD B-VP O
recommended VBN O O
for IN B-VP O
formal JJ B-NP O
sleep NN I-NP O
study NN I-NP O
as IN B-VP O
an DT O O
outpatient JJ O O
3 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
a DT B-NP O
creatinine NN I-NP O
roughly RB O O
around IN B-VP O
baseline NN B-NP O
( ( O O
2 CD O O
) ) O O
, , O O
which WDT O O
rose VBD B-VP O
briskly NNS B-NP O
during IN B-VP O
his PRP$ O O
hospitalization NN B-NP O
to TO O O
a DT B-NP O
peak NN I-NP O
of IN B-VP O
3.2 CD O O
on IN B-VP O
0/5/05 CD O O
His PRP$ O O
FENa NN B-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
6-8%; JJ O O
a DT B-NP O
repeat NN I-NP O
FENa NNP I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
his PRP$ O O
peak NN B-NP O
serum NN I-NP O
creatinine NN I-NP O
of IN B-VP O
3.2 CD O O
and CC O O
following VBG O O
10 CD O O
kg NNS B-NP O
of IN B-VP O
diuresis NN B-NP O
was VBD B-VP O
1.86% CD O O
His PRP$ O O
urine NN B-NP O
eosinophils NNS I-NP O
were VBD B-VP O
negative JJ O O
His PRP$ O O
UA NN B-NP O
showed VBD B-VP O
evidence NN B-NP O
of IN B-VP O
a DT B-NP O
UTI NNP I-NP O
plus CC O O
triple JJ B-NP O
phosphate NN I-NP O
crystals; NN I-NP O
urine JJ B-NP O
culture NN I-NP O
showed VBD B-VP O
greater JJR O O
than IN B-VP O
100 CD O O
, , O O
000 CD O O
colonies NNS B-NP O
of IN B-VP O
mixed JJ B-NP O
morphology NN I-NP O
It PRP O O
was VBD B-VP O
thought VBN O O
that IN B-VP O
the DT B-NP O
rise NN I-NP O
in IN B-VP O
the DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
was VBD B-VP O
likely JJ O O
due JJ O O
to TO O O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
intravascular JJ B-NP O
depletion NN I-NP O
and CC O O
possibly RB O O
UTI NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
antibiotics NNS B-NP B-m
following VBG O O
his PRP$ O O
pacemaker NN B-NP O
placement NN I-NP O
, , O O
which WDT O O
would MD O O
be VB O O
expected VBN O O
to TO O O
cover VB O O
GU NNP B-NP O
microbial JJ B-NP O
flora NNS I-NP O
and CC O O
SNHU NNP B-NP O
microbes VBD B-VP O
4 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-r
and CC O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
a DT B-NP O
Regular JJ I-NP B-m
Insulin NNP I-NP I-m
sliding VBG O B-do
scale JJ O I-do
5 CD O O
ID: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
expected VBN O O
to TO O O
having VBG O O
an DT B-NP O
UTI NNP I-NP O
as IN B-VP O
noted VBN O O
above IN B-VP O
Following VBG O O
his PRP$ O O
pacemaker NN B-NP O
placement NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
cefazolin NN B-NP B-m
while IN B-VP B-du
in-house NN B-NP I-du
, , O O
followed VBN O O
by IN B-VP O
Keflex NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
should MD O O
stay VB O O
on IN B-VP O
Keflex NNP B-NP B-m
for IN B-VP B-du
four CD O I-du
days NNS B-NP I-du
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Albuterol NNP B-NP B-m
inhaler NN I-NP I-m
two CD O B-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
q.i.d JJ B-NP B-f
p.r.n NN I-NP I-f
wheezing VBG O B-r
2 CD O O
Allopurinol NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Captopril NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
4 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
5 CD O O
Ferrous NNP B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
6 CD O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
7 CD O O
Heparin NNP B-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subcutaneous JJ O B-mo
t.i.d JJ O B-f
8 CD O O
Regular JJ B-NP B-m
Insulin NNP I-NP I-m
sliding VBG O B-do
scale JJ B-NP I-do
subcutaneous JJ I-NP B-mo
q.a.c NN I-NP B-f
9 CD O O
Lopressor NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
10 CD O O
Oxycodone NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
to TO O I-do
10 CD O I-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.6h JJ I-NP B-f
p.r.n NN I-NP I-f
11 CD O O
Keflex NNP B-NP B-m
250 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
x12 NN I-NP B-du
doses NNS I-NP I-du
, , O O
starting VBG O O
on IN B-VP O
7/7/05 CD O O
12 CD O O
Flomax NNP B-NP B-m
0.4 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
13 CD O O
Nexium NN B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
eScription NN I-NP O
document: VBZ O O
4-8315924 JJ B-NP O
EMSFocus NNP I-NP O
transcriptionists NNS I-NP O
Dictated VBD B-VP O
By: NNP B-NP O
DUBIEL NNP I-NP O
, , O O
SCOT NNP B-NP O
Attending: NNP I-NP O
MCGARITY NNP I-NP O
, , O O
LINCOLN NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
5034522 CD O O
D: NNP B-NP O
7/7/05 CD O O
T: NNP B-NP O
7/7/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#573300 VBZ O O
219990133 CD O O
MHAMC NNP B-NP O
03057354 CD O O
9559708 CD O O
3/24/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
AORTIC NNP I-NP O
STENOSIS NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/17/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/23/2006 CD O O
ATTENDING: NNP B-NP O
FAVORITE NNP I-NP O
, , O O
HIPOLITO NNP B-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
DISPOSITION: NNP I-NP O
To TO O O
rehabilitation VB O O
PRINCIPAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
AVR NNP I-NP O
with IN B-VP O
a DT O O
25 CD O O
CE NNP B-NP O
Magna NNP I-NP O
valve NN I-NP O
and CC O O
CABG NNP B-NP O
x2/LIMA NNP I-NP O
OTHER NNP I-NP O
DIAGNOSES: NNP I-NP O
Diabetes NNP I-NP O
mellitus NNP I-NP O
type NN I-NP O
II NNP I-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
arthritis NN B-NP O
, , O O
and CC O O
increasing VBG O O
forgetfulness JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Esbenshade NNP I-NP O
is VBZ O O
a DT B-NP O
70-year-old JJ I-NP O
Caucasian JJ I-NP O
male NN I-NP O
with IN B-VP O
CAD NNP B-NP O
, , O O
stented VBD B-VP O
five CD O O
years NNS B-NP O
ago RB O O
, , O O
known VBN O O
as IN B-VP O
calcific JJ B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
with IN B-VP O
progression NN B-NP O
of IN B-VP O
exertional JJ B-NP O
dyspnea NN I-NP O
He PRP O O
has VBZ O O
chronic JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
He PRP O O
is VBZ O O
planned VBN O O
for IN B-VP O
catheter NN B-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
, , O O
AVR NNP B-NP O
and CC O O
possible JJ B-NP O
CABG NNP I-NP O
PREOPERATIVE NNP I-NP O
CARDIAC NNP I-NP O
STATUS: NNP I-NP O
Elective NNP I-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
critical JJ B-NP O
coronary JJ I-NP O
anatomy/valve NN I-NP O
dysfunction NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
class NN B-NP O
II NNP I-NP O
angina NN I-NP O
There EX O O
has VBZ O O
been VBN O O
no DT B-NP O
recent JJ I-NP O
angina NN I-NP O
There EX O O
is VBZ O O
history NN B-NP O
of IN B-VP O
class NN B-NP O
III NNP I-NP O
heart NN I-NP O
failure NN I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
in IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
history NN B-NP O
of IN B-VP O
Afib/flutter NNP B-NP B-r
treated VBD B-VP O
with IN B-VP O
drugs/beta-blocker NN B-NP B-m
PREVIOUS NNP I-NP O
CARDIOVASCULAR NNP I-NP O
INTERVENTIONS: NNP I-NP O
PTCA/atherectomy NNP I-NP O
in IN B-VP O
1996 CD O O
and CC O O
1997 CD O O
Stent NN B-NP O
in IN B-VP O
1996 CD O O
and CC O O
1997 CD O O
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Right NNP I-NP O
ACL NNP I-NP O
repair NN I-NP O
, , O O
appendectomy NN B-NP O
, , O O
benign JJ B-NP O
breast NN I-NP O
mass NN I-NP O
excision NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
CAD NNP B-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
History NNP I-NP O
of IN B-VP O
tobacco NN B-NP O
150-pack-year JJ B-NP O
cigarette NN I-NP O
smoking VBG O O
history NN B-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PREOP NNP I-NP O
MEDICATIONS: NNP I-NP O
Toprol NNP I-NP B-m
Toprol NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
and CC O O
25 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
, , O O
Coumadin NNP B-NP B-m
, , O O
Lasix NNP B-NP B-m
20 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
atorvastatin VBD B-VP B-m
20 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Neurontin NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
metformin NN B-NP B-m
1000 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
and CC O O
glipizide RB O B-m
2.5 CD O B-do
mg NNS B-NP I-do
b.i.d JJ B-NP B-f
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Height NNP I-NP O
and CC O O
weight VBD B-VP O
5 CD O O
feet NNS B-NP O
10 CD O O
inches NNS B-NP O
, , O O
108 CD O O
kilos NN B-NP O
Vital NNP I-NP O
Signs: NNP I-NP O
Temperature NNP I-NP O
96.4 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
75 CD O O
, , O O
BP NNP B-NP O
right VBD B-VP O
arm NN B-NP O
127/62 CD O O
, , O O
left VBD B-VP O
arm NN B-NP O
110/75 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
HEENT: NNP I-NP O
PERRLA/dentition NNP I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
infection/no JJ B-NP O
carotid NN I-NP O
bruits/edentulous JJ B-NP O
Chest: NNP I-NP O
No NNP I-NP O
incisions NNS I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
rhythm NN I-NP O
and CC O O
systolic JJ B-NP O
murmur NN I-NP O
All NNP I-NP O
distal JJ B-NP O
pulses NNS I-NP O
intact JJ O O
with IN B-VP O
the DT B-NP O
exception NN I-NP O
of IN B-VP O
the DT B-NP O
right NN I-NP O
dorsalis NN I-NP O
pedis NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
present JJ O O
by IN B-VP O
Doppler NNP B-NP O
only RB O O
and CC O O
posterior JJ B-NP O
tibial JJ I-NP O
pulses NNS I-NP O
were VBD B-VP O
present JJ O O
by IN B-VP O
Doppler NNP B-NP O
bilaterally RB O O
Allen's NNP B-NP O
test NN I-NP O
left VBD B-VP O
upper JJ B-NP O
extremity NN I-NP O
normal JJ O O
, , O O
right JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
normal JJ B-NP O
Respiratory: NNP I-NP O
Breath NNP I-NP O
sounds VBZ O O
clear JJ O O
bilaterally RB O O
Abdomen: NNP B-NP O
No NNP I-NP O
incisions NNS I-NP O
, , O O
soft JJ O O
, , O O
no DT B-NP O
masses NNS I-NP O
Extremities: NNP I-NP O
Thread NNP I-NP O
veins NNS I-NP O
Minor NNP I-NP O
varicosities NNS I-NP O
Larger NNP I-NP O
varicosities NNS I-NP O
right RB O O
thigh VBP O O
Neuro: NNP B-NP O
Alert NNP I-NP O
and CC O O
oriented VBN O O
, , O O
no DT B-NP O
focal JJ I-NP O
deficits NNS I-NP O
PREOPERATIVE NNP I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Chemistries: NNP I-NP O
Sodium NNP I-NP O
138 CD O O
, , O O
potassium NN B-NP O
4.5 CD O O
, , O O
chloride RB O O
102 CD O O
, , O O
CO2 NNP B-NP O
of IN B-VP O
26 CD O O
, , O O
BUN NNP B-NP O
20 CD O O
, , O O
creatinine NN B-NP O
1 CD O O
, , O O
glucose VBD B-VP O
170 CD O O
Hematology: NNP B-NP O
WBC NNP I-NP O
8.25 CD O O
, , O O
hematocrit NN B-NP O
42.6 CD O O
, , O O
hemoglobin NN B-NP O
14.7 CD O O
, , O O
platelets NNS B-NP O
300 CD O O
, , O O
PT NNP B-NP O
18.2 CD O O
, , O O
INR NNP B-NP O
1.5 CD O O
, , O O
PTT NNP B-NP O
45.9 CD O O
UA NNP B-NP O
was VBD B-VP O
normal JJ B-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
data NNS I-NP O
from IN B-VP O
7/20/06 CD O O
performed VBN O O
at IN B-VP O
SH NNP B-NP O
showed VBD B-VP O
coronary JJ O O
anatomy RB O O
80% CD O O
proximal JJ B-NP O
RCA NNP I-NP O
stenosis NN I-NP O
, , O O
80% CD O O
mid NN B-NP O
RCA NNP I-NP O
, , O O
80% CD O O
distal JJ B-NP O
RCA NNP I-NP O
, , O O
50% CD O O
proximal JJ B-NP O
LAD NNP I-NP O
Echo NNP I-NP O
from IN B-VP O
10/29/05 CD O O
showed VBD B-VP O
45% CD O O
ejection NN B-NP O
fraction NN I-NP O
, , O O
aortic JJ B-NP O
stenosis NN I-NP O
, , O O
mean JJ B-NP O
gradient NN I-NP O
33 CD O O
mmHg NN B-NP O
, , O O
peak JJ B-NP O
gradient NN I-NP O
51 CD O O
, , O O
and CC O O
calculated VBD B-VP O
valve NNS B-NP O
area NN I-NP O
1 CD O O
cm2 NN B-NP O
, , O O
mild JJ B-NP O
aortic JJ I-NP O
insufficiency NN I-NP O
, , O O
moderate JJ B-NP O
mitral JJ I-NP O
insufficiency NN I-NP O
, , O O
trivial JJ B-NP O
tricuspid JJ I-NP O
insufficiency NN I-NP O
, , O O
aortic JJ B-NP O
root NN I-NP O
4.4 CD O O
cm NN B-NP O
EKG NNP I-NP O
from IN B-VP O
9/10/06 CD O O
showed VBD B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
rate NN I-NP O
of IN B-VP O
97 CD O O
, , O O
inverted VBN O O
T NNP B-NP O
waves NNS I-NP O
in IN B-VP O
leads NNS B-NP O
AVR NNP I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
from IN B-VP O
9/10/06 CD O O
was VBD B-VP O
normal JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
CSS NNP B-NP O
and CC O O
stabilized VBN O O
for IN B-VP O
surgery NN B-NP O
DATE NNP I-NP O
OF NNP I-NP O
SURGERY: NNP I-NP O
9/13/06 CD O O
PREOPERATIVE NNP B-NP O
DIAGNOSIS: NNP I-NP O
CAD NNP I-NP O
, , O O
AS NNP B-NP O
, , O O
and CC O O
Afib NNP B-NP O
PROCEDURE: NNP I-NP O
AVR NNP I-NP O
with IN B-VP O
a DT O O
25 CD O O
CE NNP B-NP O
magna NN I-NP O
valve NN I-NP O
, , O O
CABG NNP B-NP O
x2 NNP I-NP O
with IN B-VP O
LIMA NNP B-NP O
to TO O O
LAD NNP B-NP O
and CC O O
SVG1 NNP B-NP O
to TO O O
PDA NNP B-NP O
, , O O
pulmonary JJ B-NP O
vein NN I-NP O
isolation NN I-NP O
, , O O
and CC O O
left VBD B-VP O
atrial JJ B-NP O
appendage NN I-NP O
resection NN I-NP O
BYPASS NNP I-NP O
TIME: NNP I-NP O
171 CD O O
minutes NNS B-NP O
CROSSCLAMP NNP I-NP O
TIME: NNP I-NP O
107 CD O O
minutes NNS B-NP O
??__04:13___?? JJ B-NP O
antegrade/retrograde JJ I-NP O
cardioplegia NN I-NP O
Patient NNP I-NP O
is VBZ O O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
, , O O
rate NN B-NP O
of IN B-VP O
80 CD O O
at IN B-VP O
end NN B-NP O
of IN B-VP O
case NN B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
unit NN I-NP O
in IN B-VP O
stable JJ B-NP O
fashion NN I-NP O
with IN B-VP O
lines NNS B-NP O
and CC O O
tubes NNS B-NP O
intact JJ O O
10/28/06 CD O O
, , O O
postop JJ B-NP O
day NN I-NP O
1 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
slow JJ O O
to TO O O
ambulate VB O O
Postop NNP B-NP O
day NN I-NP O
2 CD O O
, , O O
responded VBD B-VP O
to TO O O
gentle VB O O
diuresis NN B-NP O
Meds NNP I-NP O
changed VBD B-VP O
to TO O O
p.o VB O O
Postop NNP B-NP O
day NN I-NP O
3 CD O O
, , O O
chest NN B-NP O
tubes NNS I-NP O
and CC O O
wires NNS B-NP O
were VBD B-VP O
discontinued VBN O O
Somnolence NNP B-NP O
resolved VBD B-VP O
Fluid NNP B-NP O
overloaded VBD B-VP O
Loss NNP B-NP O
of IN B-VP O
secretions NNS B-NP O
Able NNP I-NP O
to TO O O
clear VB O O
up RP O O
Postop NNP B-NP O
day NN I-NP O
4 CD O O
, , O O
failed VBD B-VP O
speech NN B-NP O
and CC O O
swallow JJ B-NP O
Wires NNP I-NP O
discontinued VBN O O
Hemodynamically NNP B-NP O
stable JJ O O
in IN B-VP O
Afib NNP B-NP O
since IN B-VP O
evening VBG O O
Rate NNP B-NP O
controlled VBD B-VP O
Diuresing NNP B-NP O
well RB O O
Transferred NNP B-NP O
to TO O O
Step-Down NNP B-NP O
Unit NNP I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
4 CD O O
SUMMARY NNP B-NP O
BY NNP I-NP O
SYSTEM: NNP I-NP O
Neurologic: NNP I-NP O
Mildly NNP I-NP O
confused VBD B-VP O
immediately RB O O
postoperative JJ O O
, , O O
now RB O O
resolved VBN O O
, , O O
neurologically RB O O
intact JJ B-NP O
Cardiovascular: NNP I-NP O
Cardiac NNP I-NP O
meds: NN I-NP O
Aspirin NNP I-NP B-m
, , O O
Lopressor NNP B-NP B-m
, , O O
and CC O O
Coumadin NNP B-NP B-m
Hemodynamically NNP I-NP O
stable JJ O O
on IN B-VP O
Lopressor NNP B-NP B-m
, , O O
now RB O O
back RB O O
in IN B-VP O
Afib NNP B-NP O
, , O O
stable JJ B-NP O
rate NN I-NP O
of IN B-VP O
90s CD O O
, , O O
respiratory NN B-NP O
ventilated VBD B-VP O
greater JJR O O
than IN B-VP O
24 CD O O
hours NNS B-NP O
postoperatively RB O O
Extubated VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
1 CD O O
without IN B-VP O
complication NN B-NP O
Currently NNP I-NP O
on IN B-VP O
5 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
O2 NNP B-NP B-m
and CC O O
some DT B-NP O
pulmonary JJ I-NP B-r
edema NN I-NP O
, , O O
improving VBG O O
with IN B-VP O
Lasix NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
t.i.d NN I-NP B-f
and CC O O
diuresis NN B-NP O
GI: NNP I-NP O
Failed VBD B-VP O
speech NN B-NP O
and CC O O
swallow JJ B-NP O
Bedside NNP I-NP O
Dobhoff NNP I-NP O
placed VBD B-VP O
Started NNP B-NP O
on IN B-VP O
Osmolite NNP B-NP B-m
tube NN I-NP B-mo
feeds NNS I-NP I-mo
at IN B-VP O
20 CD O B-do
mL FW O I-do
an DT B-NP B-f
hour NN I-NP I-f
Awaiting VBG O O
nutrition NN B-NP O
input NN I-NP O
for IN B-VP O
goals NNS B-NP O
Needs NNP I-NP O
video NN I-NP O
swallow NN I-NP O
to TO O O
assess VB O O
swallow JJ B-NP O
function NN I-NP O
Renal: NNP I-NP O
Appropriately NNP I-NP O
diuresing NN I-NP O
, , O O
maintaining VBG O O
1.5 CD O O
liters NNS B-NP O
negative JJ O O
until IN B-VP O
preop JJ B-NP O
weight NN I-NP O
Endocrine: NNP I-NP O
Stable NNP I-NP O
on IN B-VP O
CVI NNP B-NP O
Hematology: NNP I-NP O
Anticoagulation NNP I-NP O
Coumadin NNP I-NP B-m
and CC O O
aspirin NN B-NP B-m
for IN B-VP O
atrial JJ B-NP B-r
atrial JJ I-NP B-r
fibrillation NN I-NP I-r
fibrillation NN I-NP I-r
ID: NNP I-NP O
No NNP I-NP O
issues NNS I-NP O
Prophylactic NNP I-NP O
antibiotics NNS I-NP B-m
for IN B-VP O
chest JJS B-NP B-r
tubes NNS I-NP I-r
In IN B-VP O
step-down JJ B-NP O
unit NN I-NP O
proceeded VBD B-VP O
to TO O O
progress VB O O
well RB O O
Postop NNP B-NP O
day NN I-NP O
4 CD O O
strict JJ O O
n.p.o FW O O
per IN B-VP O
speech NN B-NP O
and CC O O
swallow NN B-NP O
for IN B-VP O
aspiration NN B-NP O
with IN B-VP O
all DT B-NP O
consistencies NNS I-NP O
, , O O
currently RB O O
on IN B-VP O
sitter NN B-NP O
Postop NNP I-NP O
day NN I-NP O
#5 NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
self NN I-NP O
discontinued VBD B-VP O
the DT B-NP O
Dobbhoff NNP I-NP O
feeding NN I-NP O
tube NN I-NP O
twice RB O O
last JJ B-NP O
night NN I-NP O
requiring VBG O O
meds NNS B-NP B-m
IV NNP I-NP B-mo
today NN I-NP O
until IN B-VP B-du
tube NN B-NP I-du
replaced VBD B-VP I-du
and CC O I-du
KUB NNP B-NP I-du
confirmed VBD B-VP I-du
tip NN B-NP I-du
this DT B-NP O
afternoon NN I-NP O
Dobbhoff NNP I-NP O
currently RB O O
okay VBZ O O
to TO O O
use VB O O
We PRP O O
will MD O O
resume VB O O
tube JJ B-NP O
feeds NNS I-NP O
Heart NNP I-NP O
rate NN I-NP O
elevated VBD B-VP O
to TO O O
90s-130s CD O O
and CC O O
also RB O O
run VB O O
of IN B-VP O
VT NNP B-NP O
, , O O
which WDT O O
was VBD B-VP O
asymptomatic JJ B-NP O
Rechecking NNP I-NP O
electrolytes NNS I-NP O
, , O O
BP NNP B-NP O
stable JJ B-NP O
Preop NNP I-NP O
EF NNP I-NP O
of IN B-VP O
45% CD O O
Ordered NNP B-NP O
echo NN I-NP O
to TO O O
assess VB O O
postop JJ B-NP O
EF NNP I-NP O
given VBN O O
run NN B-NP O
of IN B-VP O
VT NNP B-NP O
, , O O
which WDT O O
was VBD B-VP O
9 CD O O
beats NNS B-NP O
Normal NNP I-NP O
a.m NN I-NP O
electrolytes VBZ O O
Remains VBZ O O
on IN B-VP O
3 CD O B-do
liters NNS B-NP O
of IN B-VP O
O2 NNP B-NP B-m
, , O O
diuresing VBG O O
well RB O O
Speech NNP B-NP O
and CC O O
swallow VB O O
will MD O O
reassess VB O O
next JJ B-NP O
week NN I-NP O
Strict NNP I-NP O
n.p.o NN I-NP O
for IN B-VP O
history NN B-NP O
of IN B-VP O
aspiration NN B-NP O
Afebrile NNP I-NP O
White NNP I-NP O
count NN I-NP O
improved VBD B-VP O
to TO O O
10.9 CD O O
, , O O
remains VBZ O O
on IN B-VP O
sitter NN B-NP O
for IN B-VP O
mild JJ B-NP O
confusion NN I-NP O
Plan NN I-NP O
rehabilitation NN I-NP O
when WRB O O
ready JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
6 CD O O
, , O O
chronic JJ B-NP O
Afib NNP I-NP B-r
, , O O
rate NN B-NP O
has VBZ O O
been VBN O O
difficult JJ O O
to TO O O
control VB O O
, , O O
patient NN B-NP O
was VBD B-VP O
on IN B-VP O
Lopressor NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d JJ B-NP B-f
postop NN I-NP O
via IN B-VP O
Dobbhoff NNP B-NP O
tube NN I-NP O
Patient NNP I-NP O
has VBZ O O
self VBN O O
discontinued VBN O O
Dobbhoff NNP B-NP O
several JJ B-NP O
times NNS I-NP O
and CC O O
is VBZ O O
quite RB O O
sensitive JJ O O
to TO O O
missed VBN O O
dose NN B-NP O
of IN B-VP O
oral JJ B-NP B-mo
Lopressor NNP I-NP B-m
so IN B-VP O
dosing VBG O O
IV NNP B-NP B-mo
Lopressor NNP I-NP B-m
currently RB O O
Heart NNP B-NP O
rate NN I-NP O
is VBZ O O
still RB O O
a DT B-NP O
bit NN I-NP O
elevated VBN O O
at IN B-VP O
100-120s JJ O O
, , O O
BP NNP B-NP O
stable JJ B-NP O
Mental NNP I-NP O
status NN I-NP O
improved VBD B-VP O
off RP O O
sitter NN B-NP O
Remains VBZ O O
on IN B-VP O
1.5 CD O B-do
liters NNS B-NP O
of IN B-VP O
O2 NNP B-NP B-m
junky NN I-NP O
cough NN I-NP O
, , O O
unable JJ O O
to TO O O
produce VB O O
sputum NN B-NP O
Afebrile NNP I-NP O
White NNP I-NP O
count NN I-NP O
stable NN I-NP O
at IN B-VP O
10.4 CD O O
Chest NNP B-NP O
x-ray JJ B-NP O
looks NNS I-NP O
okay IN B-VP O
No DT B-NP O
echo NN I-NP O
ordered VBD B-VP O
for IN B-VP O
her PRP$ O O
fellow JJ B-NP O
Repeat NNP I-NP O
electrolytes VBZ O B-m
Titrate NNP B-NP B-do
beta-blocker NN I-NP B-m
We PRP O O
will MD O O
reorder VB O O
echo NN B-NP O
if IN B-VP O
VT NNP B-NP O
recurs VBP O O
PT NNP B-NP O
consult NN I-NP O
placed VBD B-VP O
Postop NNP B-NP O
day NN I-NP O
7 CD O O
, , O O
past JJ B-NP O
video NN I-NP O
swallow NN I-NP O
exempted VBD B-VP O
Dobbhoff NNP B-NP O
out RP O O
on IN B-VP O
sitter NN B-NP O
because IN B-VP O
he PRP O O
is VBZ O O
having VBG O O
suicidal JJ B-NP O
ideations NNS I-NP O
He PRP O O
has VBZ O O
been VBN O O
quite RB O O
hyperglycemic JJ O O
with IN B-VP O
blood NN B-NP O
sugar NN I-NP O
in IN B-VP O
350 CD O O
range NN B-NP O
EMS NNP I-NP O
following VBG O O
Screening VBG O O
for IN B-VP O
rehabilitation NN B-NP O
Postop NNP I-NP O
day NN I-NP O
#8 NNP I-NP O
, , O O
running VBG O O
a DT B-NP O
bit NN I-NP O
fast JJ O O
in IN B-VP O
Afib NNP B-NP B-r
Increase NNP I-NP O
Lopressor NNP I-NP B-m
Mood NNP I-NP O
has VBZ O O
improved VBN O O
Will NNP B-NP O
most RBS O O
likely JJ O O
be VB O O
able JJ O O
to TO O O
discontinue VB O O
sitter RB O O
soon RB O O
Screen NNP B-NP O
for IN B-VP O
rehabilitation NN B-NP O
Postop NNP I-NP O
day NN I-NP O
#9 NNP I-NP O
in IN B-VP O
Afib NNP B-NP O
running VBG O O
between IN B-VP O
90-100 NNP B-NP O
, , O O
had VBD B-VP O
been VBN O O
on IN B-VP O
a DT B-NP O
sitter NN I-NP O
up RB O O
until IN B-VP O
this DT B-NP O
a.m NN I-NP O
for IN B-VP O
suicidal JJ B-NP O
ideation NN I-NP O
a DT B-NP O
couple NN I-NP O
of IN B-VP O
days NNS B-NP O
ago IN B-VP O
eating VBG O O
well RB O O
Screening VBG O O
for IN B-VP O
rehab JJ B-NP O
Postop NNP I-NP O
day NN I-NP O
10 CD O O
, , O O
rate NN B-NP O
controlled VBD B-VP O
Afib/room NNP B-NP O
air NN I-NP O
Patient NNP I-NP O
followed VBN O O
by IN B-VP O
psych NN B-NP O
for IN B-VP O
postoperative JJ B-NP B-r
confusion/possible JJ I-NP O
suicidal JJ I-NP O
ideation NN I-NP O
Patient NNP I-NP O
stable NN I-NP O
on IN B-VP O
Celexa NNP B-NP B-m
Patient's NNP I-NP O
UA NNP I-NP O
from IN B-VP O
10/5/06 CD O O
with IN B-VP O
probable JJ B-NP B-r
enterogram-negative JJ I-NP I-r
rods NNS I-NP I-r
Started VBD B-VP O
Cipro NNP B-NP B-m
x3 NNP I-NP B-du
days NNS I-NP I-du
Continue NNP I-NP O
rehabilitation NN I-NP O
screen NN I-NP O
Postop NNP I-NP O
day NN I-NP O
11 CD O O
, , O O
Afib NNP B-NP O
, , O O
rate NN B-NP O
controlled/room NN I-NP O
air NN I-NP O
Patient's NNP I-NP O
chest VBD B-VP O
x-ray NN B-NP O
with IN B-VP O
no DT B-NP O
edema NN I-NP O
, , O O
slight JJ O O
left VBD B-VP O
middle JJ B-NP O
lobe NN I-NP O
atelectasis NN I-NP O
Neurologically NNP I-NP O
stable JJ O O
and CC O O
Celexa NNP B-NP B-m
ordered VBD B-VP O
per IN B-VP O
psych NN B-NP B-r
Awaiting NNP I-NP O
rehabilitation NN I-NP O
bed VBD B-VP O
Postop NNP B-NP O
day NN I-NP O
12 CD O O
Afib/room NNP B-NP O
air NN I-NP O
doing VBG O O
well RB O O
with IN B-VP O
blood NN B-NP O
pressure NN I-NP O
Seen NNP I-NP O
by IN B-VP O
psych NN B-NP O
and CC O O
recommend NN B-NP O
follow VBP O O
up RP O O
with IN B-VP O
them PRP O O
post VBP O O
DC NNP B-NP O
for IN B-VP O
memory NN B-NP O
studies NNS I-NP O
No NNP I-NP O
new JJ B-NP O
??__?? NNP I-NP O
Ready NNP I-NP O
for IN B-VP O
rehabilitation NN B-NP O
Just NNP I-NP O
waiting VBG O O
for IN B-VP O
acceptance NN B-NP O
and CC O O
bed VBD B-VP O
Postop NNP B-NP O
day NN I-NP O
13 CD O O
, , O O
rate NN B-NP O
controlled VBD B-VP O
Afib/room NNP B-NP O
air NN I-NP O
Patient NNP I-NP O
waiting VBG O O
for IN B-VP O
rehab NN B-NP O
bed NN I-NP O
On IN B-VP O
Coumadin NNP B-NP B-m
for IN B-VP O
Afib NNP B-NP B-r
, , O O
followed VBN O O
by IN B-VP O
psych NN B-NP O
for IN B-VP O
confusion/delirium NN B-NP O
and CC O O
note NN B-NP O
by IN B-VP O
them PRP O O
that IN B-VP O
they PRP O O
would MD O O
like VB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
him PRP O O
when WRB O O
he PRP O O
is VBZ O O
discontinued VBN O O
Postop NNP B-NP O
day NN I-NP O
14 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
Cardiac NNP B-NP O
Surgery NNP I-NP O
Service NNP I-NP O
to TO O O
be VB O O
stable JJ O O
to TO O O
discharge VB O O
to TO O O
rehabilitation VB O O
with IN B-VP O
the DT O O
following VBG O O
discharge NN B-NP O
instructions: JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
, , O O
low-cholesterol NN B-NP O
, , O O
low-saturated JJ B-NP O
fat NN I-NP O
, , O O
ADA NNP B-NP O
2100 CD O O
calories NNS B-NP O
per IN B-VP O
day NN B-NP O
FOLLOW-UP NNP I-NP O
APPOINTMENTS: NNP I-NP O
Dr NNP I-NP O
Bueti NNP I-NP O
, , O O
282-008-4347 JJ O O
in IN B-VP O
5-6 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Happ NNP I-NP O
759-428-0145 JJ O O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
and CC O O
Dr NNP B-NP O
Hignite NNP I-NP O
384-136-0303 CD O O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Per NNP I-NP O
BH NNP I-NP O
psychiatry NN I-NP O
department NN I-NP O
they PRP O O
would MD O O
recommend VB O O
follow VB O O
up RP O O
as IN B-VP O
outpatient NN B-NP O
for IN B-VP O
continued JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
forgetfullness/mental JJ B-NP O
status NN I-NP O
TO NNP I-NP O
DO NNP I-NP O
PLAN: NNP I-NP O
Make NNP I-NP O
all DT B-NP O
follow-up JJ I-NP O
appointments NNS I-NP O
, , O O
local JJ B-NP O
wound NN I-NP O
care NN I-NP O
, , O O
wash JJ B-NP O
wounds NNS I-NP O
daily JJ O O
with IN B-VP O
soap NN B-NP O
and CC O O
water NN B-NP O
, , O O
shower JJR O O
patient JJ O O
daily RB O O
, , O O
keep VB O O
legs NNS B-NP O
elevated VBN O O
while IN B-VP O
sitting/in JJ B-NP O
bed NNS I-NP O
Watch VBP O O
all DT B-NP O
wounds NNS I-NP O
for IN B-VP O
signs NNS B-NP O
of IN B-VP O
infection NN B-NP O
, , O O
redness NN B-NP O
, , O O
swelling VBG O O
, , O O
fever NN B-NP O
, , O O
pain NN B-NP O
, , O O
discharge NN B-NP O
, , O O
call VB O O
PCP/cardiologist NNP B-NP O
or CC O O
Anle NNP B-NP O
Health NNP I-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
at IN B-VP O
282-008-4347 JJ O O
with IN B-VP O
any DT B-NP O
questions NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Acetaminophen NNP I-NP B-m
Acetaminophen NNP I-NP B-m
325-650 JJ B-NP B-do
325-650 JJ I-NP B-do
mg NN I-NP I-do
mg NN I-NP I-do
q NN I-NP B-f
q VBD B-VP B-f
4h CD O I-f
4h CD O I-f
p.r.n NN B-NP I-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
or CC O O
temperature NN B-NP B-r
greater JJR O O
than IN B-VP O
101 CD O O
, , O O
DuoNeb NNP B-NP B-m
q VBZ O B-f
6h CD O I-f
p.r.n NN B-NP I-f
wheezing NN I-NP B-r
, , O O
enteric-coated JJ B-NP B-m
aspirin NN I-NP O
81 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Dulcolax NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
PR NNP I-NP B-mo
daily RB O B-f
p.r.n VBZ O I-f
constipation NN B-NP B-r
, , O O
Celexa NNP B-NP B-m
10 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Nexium NNP B-NP B-m
20 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Lasix NNP B-NP B-m
20 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
for IN B-VP B-du
5 CD O I-du
days NNS B-NP I-du
, , O O
Neurontin NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
, , O O
Robitussin NNP B-NP B-m
10 CD O B-do
mL NN B-NP I-do
q NN I-NP B-f
6h CD O I-f
p.r.n NN B-NP I-f
cough NN I-NP B-r
, , O O
NovoLog NNP B-NP B-m
NovoLog NNP I-NP B-m
insulin NN I-NP I-m
insulin NN I-NP I-m
on IN B-VP O
sliding VBG O B-do
sliding VBG O B-do
scale JJ B-NP I-do
scale NN I-NP I-do
q.a.c NN I-NP B-f
and CC O O
at IN B-VP B-f
bedtime NN B-NP I-f
, , O O
NovoLog NNP B-NP B-m
insulin VBZ O I-m
14 CD O B-do
units NNS B-NP I-do
subq VBN O B-mo
with IN B-VP B-f
lunch NN B-NP O
and CC O O
supper NN B-NP O
, , O O
NovoLog NNP B-NP B-m
insulin VBZ O I-m
22 CD O B-do
units NNS B-NP I-do
subq VBP O B-mo
with IN B-VP B-f
breakfast NN B-NP I-f
, , O O
Lantus NNP B-NP B-m
insulin VBZ O O
42 CD O B-do
units NNS B-NP I-do
subq VBP O B-mo
at IN B-VP B-f
10 CD O I-f
p.m NN B-NP I-f
, , O O
Atrovent NNP B-NP B-m
nebulizers NNS I-NP I-m
q.i.d RB O B-f
, , O O
K-Dur NNP B-NP B-m
10 CD O B-do
mEq NNS B-NP I-do
daily RB O B-f
for IN B-VP B-du
five CD O I-du
days NNS B-NP I-du
, , O O
Toprol-XL JJ O B-m
200 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
miconazole JJ B-NP B-m
nitrate NN I-NP I-m
powder NN I-NP I-m
topical JJ B-NP B-mo
b.i.d NN I-NP B-f
, , O O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
simvastatin VBD B-VP B-m
40 CD O B-do
mg NN B-NP I-do
at IN B-VP B-f
bedtime NN B-NP I-f
, , O O
multivitamin CC O B-m
therapeutic JJ O I-m
one CD O B-do
tab NN B-NP I-do
daily RB O B-f
, , O O
Coumadin NNP B-NP B-m
with IN B-VP O
variable JJ B-NP B-do
dosage NN I-NP I-do
to TO O O
be VB O O
determined VBN O O
based VBN O O
on IN B-VP O
INR NNP B-NP O
, , O O
and CC O O
Boudreaux's NNP B-NP B-m
Butt NNP I-NP I-m
Paste NNP I-NP I-m
topical JJ B-NP B-mo
apply NN I-NP I-mo
to TO O I-mo
effected VBN O I-mo
areas NNS B-NP I-mo
eScription VBP O O
document: JJ B-NP O
1-2683254 JJ I-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
PAULSEN NNP I-NP O
, , O O
JUDE NNP B-NP O
BILLIE NNP I-NP O
Attending: NNP I-NP O
CROMPTON NNP I-NP O
, , O O
DOMINIQUE NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
0797664 CD O O
D: NNP B-NP O
9/11/06 CD O O
T: NNP B-NP O
9/11/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#578984 VBZ O O
131265124 CD O O
LHC NNP B-NP O
06281860 CD O O
5110719 CD O O
9/22/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
PULMONARY NNP I-NP O
EMBOLISM NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/8/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/8/2005 CD O O
ATTENDING: NNP B-NP O
EDMUNDO NNP I-NP O
STEVIE NNP I-NP O
BEDOKA NNP I-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
on IN B-VP O
the DT B-NP O
cardiac JJ I-NP O
surgical JJ I-NP O
service NN I-NP O
under IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
Dr NNP B-NP O
Kyle NNP I-NP O
Lennington NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Heldman NNP I-NP O
is VBZ O O
a DT B-NP O
69-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
end-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
on IN B-VP O
hemodialysis NN B-NP O
He PRP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
CABG NNP I-NP O
x1 NNP I-NP O
and CC O O
aortic JJ B-NP O
valve NN I-NP O
replacement NN I-NP O
in IN B-VP O
February NNP B-NP O
2004 CD O O
He PRP O O
presented VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
with IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
was VBD B-VP O
taken VBN O O
that IN B-VP O
revealed VBD B-VP O
pulmonary JJ B-NP O
edema NN I-NP O
Stated VBD B-VP O
he PRP O O
had VBD B-VP O
been VBN O O
complaining VBG O O
of IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
over IN B-VP O
the DT B-NP O
month NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
with IN B-VP O
no DT B-NP O
dyspnea NN I-NP O
on IN B-VP O
exertion NN B-NP O
or CC O O
chest JJS B-NP O
pain NN I-NP O
While IN B-VP O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
, , O O
he PRP O O
had VBD B-VP O
respiratory JJ B-NP O
distress NN I-NP O
with IN B-VP O
O2 NNP B-NP O
oxygen NN I-NP O
saturations NNS I-NP O
69% CD O O
An DT B-NP O
echocardiogram NN I-NP O
was VBD B-VP O
done VBN O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
It PRP O O
was VBD B-VP O
significant JJ O O
for IN B-VP O
showing VBG O O
evidence NN B-NP O
of IN B-VP O
a DT B-NP O
dehiscence NN I-NP O
of IN B-VP O
the DT B-NP O
bioprosthetic JJ I-NP O
aortic JJ I-NP O
valve NN I-NP O
with IN B-VP O
prolapse NN B-NP O
into IN B-VP O
the DT O O
left JJ O O
ventricular JJ O O
outflow IN B-VP O
tract NN B-NP O
It PRP O O
was VBD B-VP O
noted VBN O O
that IN B-VP O
there EX O O
is VBZ O O
at IN B-VP O
least JJS B-NP O
moderate JJ I-NP O
perivalvular JJ I-NP O
aortic JJ I-NP O
regurgitation NN I-NP O
It PRP O O
also RB O O
noted VBD B-VP O
mitral JJ B-NP O
valve NN I-NP O
had VBD B-VP O
moderate JJ O O
to TO O O
severe VB O O
mitral JJ B-NP O
regurgitation NN I-NP O
As IN B-VP O
stated VBN O O
previously RB O O
, , O O
he PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
surgical JJ I-NP O
service NN I-NP O
for IN B-VP O
repair/replacement NN B-NP O
of IN B-VP O
his PRP$ O O
aortic JJ O O
and CC O O
mitral JJ B-NP O
valves NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Includes NNP I-NP O
hypertension NN I-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
renal JJ B-NP O
failure NN I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
gout NN B-NP O
, , O O
GERD NNP B-NP O
, , O O
closed VBD B-VP O
angle NN B-NP O
glaucoma NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
colonic JJ B-NP O
lymphoma NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Right NNP I-NP O
arm NN I-NP O
AV NNP I-NP O
fistula NN I-NP O
that WDT O O
was VBD B-VP O
originally RB O O
placed VBN O O
in IN B-VP O
the DT B-NP O
year NN I-NP O
2000 CD O O
and CC O O
revised VBN O O
in IN B-VP O
2001 CD O O
, , O O
2002 CD O O
, , O O
and CC O O
2003 CD O O
A NNP B-NP O
right JJ B-NP O
brachiocephalic NN I-NP O
stent NN I-NP O
was VBD B-VP O
also RB O O
placed VBN O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
use NN I-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PREOPERATIVE NNP I-NP O
MEDICATIONS: NNP I-NP O
Labetalol NNP I-NP B-m
, , O O
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
amlodipine VBP O B-m
10 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
lisinopril NN B-NP B-m
, , O O
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
day NN I-NP B-f
, , O O
Zocor NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
PhosLo NNP B-NP B-m
1334 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
a.c JJ B-NP B-f
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Vital NNP I-NP O
signs NNS I-NP O
, , O O
temperature NN B-NP O
95.8 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
74 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
arm NN I-NP O
134/62 CD O O
HEENT NNP B-NP O
, , O O
dentition NN B-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
infection NN B-NP O
, , O O
no DT B-NP O
carotid NN I-NP O
bruit NN I-NP O
Cardiovascular NNP I-NP O
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm VB O O
Peripheral NNP B-NP O
pulses NNS I-NP O
are VBP O O
the DT O O
following JJ O O
, , O O
peripheral JJ B-NP O
pulses NNS I-NP O
are VBP O O
2+the CD O O
carotid NNS B-NP O
, , O O
radial JJ O O
, , O O
and CC O O
femoral JJ O O
The DT B-NP O
dorsalis NN I-NP O
pedis NN I-NP O
and CC O O
posterior JJ B-NP O
tibial NN I-NP O
are VBP O O
each DT O O
present JJ O O
by IN B-VP O
Doppler NNP B-NP O
bilaterally RB O O
Respiratory NNP B-NP O
rales NNS I-NP O
present JJ O O
bilaterally RB O O
Neuro NNP B-NP O
, , O O
cool JJ B-NP O
extremities NNS I-NP O
with IN B-VP O
monophasic JJ B-NP O
pulse JJ I-NP O
PREOPERATIVE NNP I-NP O
LABS: NNP I-NP O
Sodium NNP I-NP O
141 CD O O
, , O O
potassium NN B-NP O
4.4 CD O O
, , O O
chloride RB O O
102 CD O O
Carbon NNP B-NP O
dioxide NN I-NP O
29 CD O O
, , O O
BUN NNP B-NP O
26 CD O O
, , O O
creatinine NN B-NP O
5.8 CD O O
, , O O
glucose RB O O
195 CD O O
, , O O
magnesium NN B-NP O
1.9 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
6.11 CD O O
, , O O
hematocrit NN B-NP O
28 CD O O
, , O O
hemoglobin NN B-NP O
9.5 CD O O
, , O O
and CC O O
platelets NNS B-NP O
98 CD O O
, , O O
000 CD O O
PT NNP B-NP O
14.8 CD O O
, , O O
INR NNP B-NP O
1.1 CD O O
, , O O
PTT NNP B-NP O
42.2 CD O O
Arterial NNP B-NP O
blood NN I-NP O
gas NN I-NP O
showed VBD B-VP O
pO2 NN B-NP O
of IN B-VP O
64 CD O O
, , O O
pH NN B-NP O
7.38 CD O O
, , O O
PCO2 NNP B-NP O
of IN B-VP O
52 CD O O
and CC O O
the DT B-NP O
base NN I-NP O
excess NN I-NP O
of IN B-VP O
4 CD O O
Cardiac NNP B-NP O
catheterization NN I-NP O
data NNS I-NP O
on IN B-VP O
1/3/04 CD O O
, , O O
coronary JJ B-NP O
anatomy NN I-NP O
, , O O
10% CD O O
proximal JJ B-NP O
LAD NNP I-NP O
, , O O
5% CD O O
proximal JJ B-NP O
circumflex NN I-NP O
, , O O
85% CD O O
mid NN B-NP O
RCA NNP I-NP O
with IN B-VP O
a DT B-NP O
codominant JJ I-NP O
circulation NN I-NP O
ECG NNP I-NP O
on IN B-VP O
10/0/05 CD O O
shows NNS B-NP O
first-degree JJ B-NP O
AV NNP I-NP O
block NN I-NP O
with IN B-VP O
left JJ B-NP O
anterior JJ I-NP O
hemiblock NN I-NP O
with IN B-VP O
inverted JJ B-NP O
Ts NNP I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
on IN B-VP O
10/24/05 CD O O
consistent JJ O O
with IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
Brachiocephalic NNP I-NP O
and CC O O
right JJ B-NP O
subclavian JJ I-NP O
stents NNS I-NP O
were VBD B-VP O
in IN B-VP O
place NN B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BRIEF NNP I-NP O
OPERATIVE NNP I-NP O
NOTE: NNP I-NP O
Date NNP I-NP O
of IN B-VP O
surgery NN B-NP O
, , O O
2/13/05 CD O O
PREOPERATIVE NNP B-NP O
DIAGNOSIS: NNP I-NP O
See NNP I-NP O
magna NN I-NP O
valve VBD B-VP O
three CD O O
months NNS B-NP O
prior RB O O
EPL NNP B-NP O
on IN B-VP O
echo NN B-NP O
showed VBD B-VP O
grossly RB O O
mobile JJ O O
on IN B-VP O
the DT B-NP O
stable JJ I-NP O
aortic JJ I-NP O
valve NN I-NP O
prosthesis NN I-NP O
moderate NN I-NP O
, , O O
MR NNP B-NP O
No NNP I-NP O
vegetations NNS I-NP O
PROCEDURE: NNP I-NP O
Reoperation NNP I-NP O
of IN B-VP O
ascending VBG O O
aortic JJ B-NP O
dissection NN I-NP O
, , O O
aortic JJ B-NP O
valve NN I-NP O
replacement NN I-NP O
, , O O
#24 NNP B-NP O
homograph NN I-NP O
, , O O
MVP NNP B-NP O
with IN B-VP O
Alfieri NNP B-NP O
suture NN I-NP O
BYPASS NNP I-NP O
TIME: NNP I-NP O
355 CD O O
minutes NNS B-NP O
, , O O
CROSSCLAMP NNP B-NP O
TIME: NNP I-NP O
265 CD O O
minutes NNS B-NP O
One CD O O
ventricular NN B-NP O
wire NN I-NP O
, , O O
one CD O O
pericardial NN B-NP O
tube NN I-NP O
, , O O
one CD O O
retrosternal NN B-NP O
tube NN I-NP O
, , O O
two CD O O
left VBD B-VP O
pleural JJ B-NP O
tubes NNS I-NP O
and CC O O
two CD O O
right JJ B-NP O
pleural JJ I-NP O
tubes NNS I-NP O
were VBD B-VP O
placed VBN O O
FINDINGS: NNP B-NP O
Dense NNP I-NP O
inflammatory NN I-NP O
edematous JJ B-NP O
scar NN I-NP O
tissue NN I-NP O
throughout IN B-VP O
pericardium NN B-NP O
, , O O
especially RB O O
periaortic JJ B-NP O
Right NNP I-NP O
axillary JJ B-NP O
cannulation NN I-NP O
with IN B-VP O
6 CD O O
mm NNS B-NP O
Hemashield NNP I-NP O
side RB O O
Percutaneous NNP B-NP O
right JJ B-NP O
CF NNP I-NP O
decannulation NN I-NP O
Uneventful NNP I-NP O
re-sternotomy JJ B-NP O
Previous NNP I-NP O
SVG NNP I-NP O
PDA NNP I-NP O
injured VBD B-VP O
during IN B-VP O
dissection NN B-NP O
, , O O
repaired VBN O O
with IN B-VP O
interrupted JJ B-NP O
7-0 JJ I-NP O
Prolene NNP I-NP O
Aortic NNP I-NP O
valve NN I-NP O
prosthesis NN I-NP O
dehisced VBD B-VP O
3/4 CD O O
of IN B-VP O
circumference NN B-NP O
with IN B-VP O
question NN B-NP O
of IN B-VP O
an DT B-NP O
abscess JJ I-NP O
cavity NN I-NP O
near IN B-VP O
LCC/RCC NNP B-NP O
junction NN I-NP O
Debridement NNP I-NP O
, , O O
the DT B-NP O
annulus NN I-NP O
is VBZ O O
of IN B-VP O
extensive JJ B-NP O
inflammatory NN I-NP O
tissue NN I-NP O
Previous NNP I-NP O
Dacron NNP I-NP O
aortic JJ B-NP O
root NN I-NP O
patch NN I-NP O
removed VBD B-VP O
due JJ O O
to TO O O
pocket NN B-NP O
of IN B-VP O
pus NN B-NP O
on IN B-VP O
the DT B-NP O
anterior JJ I-NP O
aspect NN I-NP O
No NNP I-NP O
24 CD O O
allograft NN B-NP O
placed VBN O O
with IN B-VP O
double JJ B-NP O
layer NN I-NP O
proximal JJ B-NP O
suture NN I-NP O
line NN I-NP O
SVG NNP I-NP O
and CC O O
both DT B-NP O
coronary JJ I-NP O
arteries NNS I-NP O
implanted VBN O O
as IN B-VP O
buttons NNS B-NP O
Distal NNP I-NP O
suture NN I-NP O
line NN I-NP O
continuous JJ B-NP O
4-0 JJ I-NP O
Prolene NNP I-NP O
Transaortic NNP I-NP O
and CC O O
mitral JJ B-NP O
valves NNS I-NP O
replaced VBD B-VP O
After IN B-VP O
the DT B-NP O
operation NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
His PRP$ O O
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
the DT B-NP O
following: NN I-NP O
1 CD O O
Infectious NNP B-NP O
disease: NN I-NP O
Although IN B-VP O
, , O O
Mr NNP B-NP O
Ownbey NNP I-NP O
had VBD B-VP O
multiple JJ B-NP O
blood NN I-NP O
cultures NNS I-NP O
, , O O
sent VBD B-VP O
, , O O
they PRP O O
all DT O O
proved VBD B-VP O
to TO O O
be VB O O
negative JJ O O
as IN B-VP O
of IN B-VP O
the DT B-NP O
date NN I-NP O
of IN B-VP O
discharge NN B-NP O
Although IN B-VP O
Mr NNP B-NP O
Cavitt NNP I-NP O
was VBD B-VP O
never RB O O
felt VBN O O
to TO O O
be VB O O
bacteremic JJ O O
, , O O
the DT B-NP O
cultures NNS I-NP O
that WDT O O
were VBD B-VP O
sent VBN O O
from IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
were VBD B-VP O
of IN B-VP O
the DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
prosthesis NN I-NP O
This DT O O
never RB O O
showed VBD B-VP O
the DT B-NP O
organisms NNS I-NP O
identified VBN O O
on IN B-VP O
Gram NNP B-NP O
stain NN I-NP O
and CC O O
MSSA NNP B-NP O
stain VBP O O
However RB O O
, , O O
the DT B-NP O
infectious JJ I-NP O
disease NN I-NP O
physicians NNS I-NP O
were VBD B-VP O
consulted VBN O O
and CC O O
felt VBD B-VP O
that IN B-VP O
Mr NNP B-NP O
Sanjurjo NNP I-NP O
should MD O O
be VB O O
on IN B-VP O
vancomycin NN B-NP B-m
, , O O
rifampin NN B-NP B-m
, , O O
and CC O O
gentamicin NN B-NP B-m
As IN B-VP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
Mr NNP B-NP O
Bersamin NNP I-NP O
has VBZ O O
finished VBN O O
his PRP$ O O
regimen NNS B-NP O
of IN B-VP O
gentamicin NN B-NP B-m
and CC O O
will MD O O
continue VB O O
to TO O O
be VB O O
on IN B-VP O
both DT B-NP O
vancomycin NN I-NP B-m
and CC O O
rifampin NN B-NP B-m
until IN B-VP B-du
until IN B-VP B-du
1/3/04 CD O O
The DT B-NP O
rifampin NN I-NP B-m
he PRP O O
will MD O O
take VB O O
orally RB O B-mo
and CC O O
the DT B-NP O
vancomycin NN I-NP B-m
he PRP O O
will MD O O
get VB O O
after IN B-VP O
dialysis NN B-NP O
three CD O B-f
times NNS B-NP I-f
a DT B-NP I-f
week NN I-NP I-f
While IN B-VP O
an DT B-NP O
inpatient NN I-NP O
, , O O
Mr NNP B-NP O
Rakus NNP I-NP O
never RB O O
had VBD B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
leukocytosis NN B-NP O
or CC O O
bacteremia NN B-NP O
2 CD O O
Cardiovascular: NNP B-NP O
Ms NNP I-NP O
Johe NNP I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
first-degree JJ I-NP O
AV NNP I-NP O
block NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#7 NNP I-NP O
with IN B-VP O
a DT B-NP O
PR NNP I-NP O
interval NN I-NP O
of IN B-VP O
0.35 CD O O
Up NNP B-NP O
into IN B-VP O
this DT B-NP O
point NN I-NP O
he PRP O O
had VBD B-VP O
been VBN O O
receiving VBG O O
labetalol NN B-NP B-m
This DT O O
was VBD B-VP O
held VBN O O
and CC O O
the DT B-NP O
electrophysiology NN I-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
The DT B-NP O
electrophysiology NN I-NP O
service NN I-NP O
saw VBD B-VP O
the DT B-NP O
patient NN I-NP O
agreed VBD B-VP O
to TO O O
be VB O O
an DT B-NP O
excellent JJ I-NP O
candidate NN I-NP O
for IN B-VP O
permanent JJ B-NP O
pacemaker NN I-NP O
Initially NNP I-NP O
they PRP O O
attempted VBD B-VP O
to TO O O
gain VB O O
access NN B-NP O
to TO O O
the DT B-NP O
right NN I-NP O
brachiocephalic/subclavian NN I-NP O
However RB O O
, , O O
this DT O O
proved VBD B-VP O
to TO O O
be VB O O
difficult JJ O O
and CC O O
ultimately RB O O
obtain VB O O
access NN B-NP O
through IN B-VP O
the DT B-NP O
left JJ I-NP O
iliac NN I-NP O
His PRP$ O O
permanent JJ B-NP O
pacemaker NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
1/29/05 CD O O
and CC O O
was VBD B-VP O
interrogated VBN O O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
and CC O O
felt VBD B-VP O
to TO O O
be VB O O
functioning VBG O O
appropriately RB O O
He PRP O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
his PRP$ O O
labetalol NN B-NP B-m
and CC O O
as IN B-VP O
of IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
has VBZ O O
had VBN O O
no DT B-NP O
symptoms NNS I-NP O
Other JJ O O
than IN B-VP O
the DT B-NP O
above NN I-NP O
, , O O
Ms NNP B-NP O
Dingman NNP I-NP O
was VBD B-VP O
weaned VBN O O
from IN B-VP O
his PRP$ O O
oxygen NN B-NP O
requirement NN I-NP O
, , O O
mobilized VBN O O
rapidly RB O O
following VBG O O
surgery NN B-NP O
All DT B-NP O
epicardial JJ I-NP O
pacing NN I-NP O
wires NNS I-NP O
and CC O O
chest JJS B-NP O
tubes NNS I-NP O
were VBD B-VP O
removed VBN O O
without IN B-VP O
complication NN B-NP O
He PRP O O
will MD O O
be VB O O
discharged VBN O O
home NN B-NP O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications NNS I-NP O
aspirin VBP O B-m
325 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
hydralazine PRP O B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
, , O O
labetalol100 JJ B-NP B-m
mg NN I-NP O
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
lisinopril VBZ O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
oxycodone RB O B-m
5 CD O B-do
mg NNS B-NP I-do
p.o RB O B-mo
6 CD O B-f
hours NNS B-NP I-f
p.r.n RB O I-f
pain VBP O B-r
, , O O
rifampin VBP O B-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.8h NN I-NP B-f
, , O O
vancomycin NN B-NP B-m
for IN B-VP O
which WDT O O
he PRP O O
will MD O O
receive VB O O
following VBG O O
dialysis NN B-NP O
until IN B-VP B-du
5/14/05 CD O I-du
, , O O
Zocor NNP B-NP B-m
40 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
, , O O
losartan VBZ O B-m
100 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
Mr NNP I-NP O
Llanez NNP I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Owston NNP I-NP O
, , O O
cardiac JJ B-NP O
surgeon NN I-NP O
, , O O
in IN B-VP O
six CD O O
weeks NNS B-NP O
, , O O
and CC O O
Dr NNP B-NP O
Geister NNP I-NP O
, , O O
cardiologist NN B-NP O
, , O O
in IN B-VP O
three CD O O
to TO O O
four CD O O
weeks NNS B-NP O
, , O O
Dr NNP B-NP O
Kmiecik NNP I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
and CC O O
Dr NNP B-NP O
Vaught NNP I-NP O
, , O O
cardiologist NN B-NP O
, , O O
in IN B-VP O
two CD O O
weeks NNS B-NP O
eScription NN I-NP O
document: IN B-VP O
3-6323131 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
ORTMAN NNP I-NP O
, , O O
HUMBERTO NNP B-NP O
Attending: NNP I-NP O
ANENE NNP I-NP O
, , O O
WARREN NNP B-NP O
NICK NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
7068367 CD O O
D: NNP B-NP O
11/16/05 CD O O
T: NNP B-NP O
11/16/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#579754 VBZ O O
252140420 CD O O
ACMH NNP B-NP O
97727998 CD O O
271243 CD O O
10/27/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
UNSTABLE NNP I-NP O
ANGINA NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/27/1997 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/25/1997 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
OTHER NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
SARCOIDOSIS NNP B-NP O
2 CD O O
HYPERTENSION NNP B-NP O
3 CD O O
NON-INSULIN-DEPENDENT NNP B-NP O
DIABETES NNP I-NP O
MELLITUS NNP I-NP O
4 CD O O
STATUS NNP B-NP O
POST NNP I-NP O
PACEMAKER NNP I-NP O
PLACEMENT NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
65-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
non-insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
and CC O O
with IN B-VP O
no DT B-NP O
known JJ I-NP O
hx NN I-NP O
of IN B-VP O
CAD NNP B-NP O
admitted VBD B-VP O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
She PRP O O
has VBZ O O
had VBD B-VP O
several JJ B-NP O
days NNS I-NP O
of IN B-VP O
exertional JJ B-NP O
chest NN I-NP O
pain NN I-NP O
characterized VBN O O
by IN B-VP O
substernal JJ B-NP O
burning NN I-NP O
pain NN I-NP O
which WDT O O
, , O O
at IN B-VP O
times NNS B-NP O
, , O O
radiates VBZ O O
to TO O O
the DT B-NP O
left NN I-NP O
shoulder NN I-NP O
It PRP O O
is VBZ O O
sometimes RB O O
accompanied VBN O O
by IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
without IN B-VP O
nausea NN B-NP O
and CC O O
occasional JJ B-NP O
diaphoresis NN I-NP O
She PRP O O
was VBD B-VP O
seen VBN O O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
with IN B-VP O
chest JJS B-NP O
pain NN I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
1997 CD O O
, , O O
with IN B-VP O
negative JJ B-NP O
troponins NNS I-NP O
and CC O O
negative JJ B-NP O
cardiac NN I-NP O
enzymes VBZ O O
An DT B-NP O
exercise NN I-NP O
treadmill NN I-NP O
test NN I-NP O
on IN B-VP O
May NNP B-NP O
, , O O
1997 CD O O
, , O O
for IN B-VP O
three CD O O
minutes NNS B-NP O
revealed VBD B-VP O
a DT B-NP O
maximal JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
127 CD O O
and CC O O
maximal JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
134/80 CD O O
She PRP O O
experienced VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
with IN B-VP O
1 CD O O
millimeter NN B-NP O
of IN B-VP O
ST NNP B-NP O
depression NN I-NP O
in IN B-VP O
V5 NNP B-NP O
and CC O O
T-wave NNP B-NP O
inversions NNS I-NP O
in IN B-VP O
V4-V6 NNP B-NP O
This DT B-NP O
study NN I-NP O
was VBD B-VP O
interpreted VBN O O
as IN B-VP O
consistent NN B-NP O
with IN B-VP O
, , O O
but CC O O
not RB O O
diagnostic JJ B-NP O
ischemia NN I-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
aspirin NN B-NP B-m
and CC O O
atenolol NN B-NP B-m
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
walking VBG O O
to TO O O
catch VB O O
a DT B-NP O
bus NN I-NP O
and CC O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
burning VBG O O
lasting VBG O O
less JJR O O
than IN B-VP O
10 CD O O
minutes NNS B-NP O
with IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
but CC O O
no DT B-NP O
nausea NN I-NP O
, , O O
vomiting VBG O O
, , O O
or CC O O
diaphoresis NN B-NP O
She PRP O O
came VBD B-VP O
by IN B-VP O
cab NN B-NP O
to TO O O
Rirel NNP B-NP O
Carleo NNP I-NP O
And CC O O
for IN B-VP O
her PRP$ O O
scheduled VBN O O
exercise NN B-NP O
ett/mibi NN I-NP O
test NN I-NP O
study NN I-NP O
and CC O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
T NNP B-NP O
wave VB O O
inversions NNS B-NP O
in IN B-VP O
II NNP B-NP O
, , O O
III NNP B-NP O
, , O O
F NNP B-NP O
, , O O
and CC O O
V3-V6 NNP B-NP O
On IN B-VP O
arrival NN B-NP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
pain JJ O O
free JJ O O
She PRP O O
denied VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
and CC O O
had VBD B-VP O
mild VBN O O
orthopnea NN B-NP O
which WDT O O
was VBD B-VP O
unchanged JJ O O
She PRP O O
denied VBD B-VP O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
, , O O
and CC O O
stools NNS B-NP O
were VBD B-VP O
black JJ O O
secondary JJ O O
to TO O O
iron VB O B-m
supplementation NN B-NP I-m
Hematocrit NNP I-NP O
on IN B-VP O
June NNP B-NP O
, , O O
1997 CD O O
, , O O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
29.3 CD O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
been VBN O O
iron VBN O B-m
supplements NNS B-NP I-m
since IN B-VP O
that DT B-NP O
time NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
colonic JJ B-NP O
polyps NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
) ) O O
Significant NN B-NP O
for IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
sarcoidosis NN B-NP O
Her NNP I-NP O
last JJ B-NP O
pulmonary JJ I-NP O
test NN I-NP O
was VBD B-VP O
in IN B-VP O
May NNP B-NP O
1995 CD O O
which WDT O O
showed VBD B-VP O
an DT B-NP O
FEV NNP I-NP O
1 CD O O
of IN B-VP O
1.61 CD O O
, , O O
72% CD O O
of IN B-VP O
predicted; NN B-NP O
FEV NNP I-NP O
1 CD O O
ratio NN B-NP O
to TO O O
FVC NNP B-NP O
was VBD B-VP O
80 CD O O
or CC O O
102% CD O O
of IN B-VP O
predicted VBN O O
FVC NNP B-NP O
was VBD B-VP O
2.01 CD O O
or CC O O
72% CD O O
of IN B-VP O
predicted VBN O O
In IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
she PRP O O
has VBZ O O
been VBN O O
treated VBN O O
with IN B-VP O
prednisone NN B-NP B-m
and CC O O
now RB O O
uses VBZ O O
Ventolin NNP B-NP B-m
inhalers NNS I-NP I-m
p.r.n VBP O B-f
2 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
seizure NN B-NP O
disorder NN I-NP O
3 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
pacemaker NN I-NP O
placement NN I-NP O
in IN B-VP O
March NNP B-NP O
1996 CD O O
for IN B-VP O
tachycardia JJ B-NP O
bradycardia NN I-NP O
syndrome NN I-NP O
4 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
appendectomy RB O O
5 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
total JJ B-NP O
abdominal JJ I-NP O
hysterectomy NN I-NP O
for IN B-VP O
cervical JJ B-NP O
cancer NN I-NP O
6 CD O O
) ) O O
Adult NNP B-NP O
onset MD O O
diabetes VBZ O O
mellitus NNS B-NP O
, , O O
diet-controlled JJ O O
7 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
left JJ B-NP O
calf NN I-NP O
deep JJ B-NP O
vein NN I-NP O
thrombosis NN I-NP O
in IN B-VP O
1993 CD O O
8 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
colonic JJ B-NP O
polyps NNS I-NP O
with IN B-VP O
a DT B-NP O
colonic JJ I-NP O
adenoma NN I-NP O
diagnosed VBN O O
in IN B-VP O
1993 CD O O
MEDICATIONS NNP B-NP O
AT NNP I-NP O
THE NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
ADMISSION: NNP I-NP O
Linsinopril NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
q.d.; NN I-NP B-f
Pravachol NNP I-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.h.s.; NN I-NP B-f
aspirin VBD B-VP B-m
325 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
day; NN I-NP I-f
atenolol VBD B-VP B-m
0.5 CD O B-do
mg NN B-NP I-do
b.i.d.; NN I-NP B-f
Dilantin NNP I-NP B-m
200 CD O B-do
mg NN B-NP I-do
b.i.d.; NN I-NP B-f
Ventolin NNP I-NP B-m
inhaler NN I-NP I-m
p.r.n.; NN I-NP B-f
ferrous JJ B-NP B-m
gluconate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
ALLERGIES: NNP I-NP O
Penicillin NNP I-NP O
and CC O O
erythromycin RB O O
, , O O
gives VBZ O O
rash JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
She PRP O O
was VBD B-VP O
a DT B-NP O
pleasant JJ I-NP O
female NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Vital NNP I-NP O
signs NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
97.9; CD O O
heart NN B-NP O
rate NN I-NP O
78; CD O O
blood NN B-NP O
pressure NN I-NP O
120/70; CD O O
respiratory NN B-NP O
rate NN I-NP O
19 CD O O
Saturation NNP B-NP O
was VBD B-VP O
99% CD O O
on IN B-VP O
two CD O O
liters NNS B-NP O
Head VBP O O
, , O O
eyes NNS B-NP O
, , O O
nose RB O O
, , O O
and CC O O
throat NN B-NP O
examination: NN I-NP O
Pupils NNP I-NP O
were VBD B-VP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Extraocular JJ I-NP O
movements NNS I-NP O
intact JJ B-NP O
Oropharynx NNP I-NP O
was VBD B-VP O
clear JJ O O
and CC O O
edentulous JJ B-NP O
Jugular NNP I-NP O
venous JJ B-NP O
pressure NN I-NP O
was VBD B-VP O
8 CD O O
centimeters NNS B-NP O
No NNP I-NP O
lymphadenopathy JJ B-NP O
Carotids NNP I-NP O
were VBD B-VP O
2+ CD O O
bilaterally RB O O
, , O O
no DT B-NP O
bruits NNS I-NP O
Lungs: NNP I-NP O
Diffuse NNP I-NP O
, , O O
dry JJ O O
rales VBZ O O
No DT B-NP O
wheezes JJ I-NP O
Cardiac: NNP I-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
S4 NNP I-NP O
present JJ O O
1/6 CD O O
systolic JJ O O
murmur FW O O
heard NN B-NP O
at IN B-VP O
upper JJ O O
left VBD B-VP O
sternal JJ B-NP O
border NN I-NP O
Abdomen: NNP I-NP O
Cholecystectomy NNP I-NP O
scar NN I-NP O
Infraumbilical NNP I-NP O
midline NN I-NP O
scar NN I-NP O
No NNP I-NP O
masses VBZ O O
No DT B-NP O
hepatosplenomegaly JJ I-NP O
Positive NNP I-NP O
bowel NN I-NP O
sounds VBZ O O
Rectal: NNP B-NP O
Guaiac NNP I-NP O
negative JJ O O
per IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
Extremities: NNP I-NP O
Femoral NNP I-NP O
pulses NNS I-NP O
were VBD B-VP O
2+ CD O O
bilaterally RB O O
No NNP B-NP O
bruits VBZ O O
No DT B-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
Dorsalis NNP I-NP O
pedis NN I-NP O
and CC O O
posterior JJ B-NP O
tibialis NN I-NP O
pulses NNS I-NP O
were VBD B-VP O
2+ CD O O
bilaterally RB O O
Nonfocal JJ B-NP O
neurological JJ I-NP O
examination NN I-NP O
No NNP I-NP O
motor NN I-NP O
or CC O O
sensory JJ B-NP O
deficits NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Chest NNP I-NP O
x-ray: JJ B-NP O
Bilateral NNP I-NP O
parenchymal NN I-NP O
opacities NNS I-NP O
, , O O
most JJS O O
prominent JJ O O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
lung NN I-NP O
fields NNS I-NP O
Stable JJ O O
and CC O O
consistent JJ O O
with IN B-VP O
previous JJ B-NP O
examinations NNS I-NP O
from IN B-VP O
March NNP B-NP O
, , O O
1997 CD O O
, , O O
consistent JJ O O
with IN B-VP O
chronic JJ B-NP O
sarcoidosis NN I-NP O
Pacer NNP I-NP O
wires NNS I-NP O
were VBD B-VP O
in IN B-VP O
good JJ B-NP O
position NN I-NP O
Electrocardiogram NNP I-NP O
on IN B-VP O
admission NN B-NP O
, , O O
May NNP B-NP O
, , O O
1997 CD O O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
, , O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
66 CD O O
T-wave JJ B-NP O
inversion NN I-NP O
in IN B-VP O
I PRP O O
, , O O
T-wave JJ B-NP O
inversion NN I-NP O
in IN B-VP O
II NNP B-NP O
and CC O O
AVF NNP B-NP O
, , O O
biphasic JJ B-NP O
T-waves NNS I-NP O
in IN B-VP O
V2 NNP B-NP O
, , O O
and CC O O
T-wave NNP B-NP O
inversions NNS I-NP O
in IN B-VP O
V3-V6 NNP B-NP O
Slightly NNP I-NP O
pronounced VBD B-VP O
when WRB O O
compared VBN O O
with IN B-VP O
previous JJ B-NP O
electrocardiogram NNS I-NP O
Sodium VBP O O
143; CD O O
potassium NN B-NP O
5.1; CD O O
chloride NN B-NP O
108; CD O O
bicarbonate NN B-NP O
23; CD O O
BUN NNP B-NP O
36; CD O O
creatinine NN B-NP O
1.8; CD O O
glucose JJ O O
255 CD O O
White NNP B-NP O
count NN I-NP O
6700; CD O O
hematocrit NN B-NP O
30.9; CD O O
platelets NNS B-NP O
143 CD O O
, , O O
000; CD O O
MCV NNP B-NP O
85.1 CD O O
Prothrombin NNP B-NP O
time NN I-NP O
was VBD B-VP O
11.4 CD O O
Partial NNP B-NP O
thromboplastin NN I-NP O
time NN I-NP O
was VBD B-VP O
25.2 CD O O
INR NNP B-NP O
was VBD B-VP O
0.9 CD O O
CK NNP B-NP O
was VBD B-VP O
79 CD O O
Troponin NNP B-NP O
0.0 CD O O
Dilantin: NNP B-NP O
Less NNP I-NP O
than IN B-VP O
assay VBP O O
Hematocrit NNP B-NP O
on IN B-VP O
June NNP B-NP O
, , O O
1997 CD O O
, , O O
was VBD B-VP O
29.3 CD O O
Cholesterol NNP B-NP O
total NN I-NP O
was VBD B-VP O
258; CD O O
LDH NNP B-NP O
43; CD O O
LDL NNP B-NP O
166 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
Ms NNP I-NP O
Talburt NNP I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
a DT B-NP O
rule NN I-NP O
out IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
protocol NN I-NP O
and CC O O
underwent JJ B-NP O
serial JJ I-NP O
electrocardiograms NN I-NP O
and CC O O
her PRP$ O O
enzymes NNS B-NP O
were VBD B-VP O
studied VBN O O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Nitrol NNP B-NP B-m
paste NN I-NP I-m
Aspirin NNP I-NP B-m
, , O O
linsinopril NN B-NP B-m
, , O O
and CC O O
atenolol RB O B-m
, , O O
were VBD B-VP O
continued VBN O O
Given NNP B-NP O
her PRP$ O O
low JJ B-NP O
hematocrit NN I-NP O
as IN B-VP O
a DT B-NP O
possible JJ I-NP O
etiology NN I-NP O
for IN B-VP O
her PRP$ O B-r
ischemia NN B-NP I-r
, , O O
she PRP O O
was VBD B-VP O
transfused VBN O O
with IN B-VP O
one CD O B-do
unit NN B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
cells NNS I-NP I-m
Stools NNP I-NP O
were VBD B-VP O
guaiac JJ B-NP O
neg NN I-NP O
and CC O O
anemia NN B-NP O
workup NN I-NP O
was VBD B-VP O
initiated VBN O O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
albuterol NN B-NP B-m
inhale NN I-NP I-m
and CC O O
nebulizers NNS B-NP B-m
p.r.n VBP O B-f
p.r.n NN B-NP B-f
On IN B-VP O
February NNP B-NP O
, , O O
1997 CD O O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
cardiac NN I-NP O
catheterization NN I-NP O
which WDT O O
showed VBD B-VP O
a DT O O
70% CD O O
residual JJ B-NP O
osteal JJ I-NP O
diagonal JJ I-NP O
stenosis NN I-NP O
, , O O
0% CD O O
left VBD B-VP O
anterior JJ O O
descending VBG O O
stenosis NN B-NP O
A DT B-NP O
stent NN I-NP O
was VBD B-VP O
placed VBN O O
in IN B-VP O
the DT B-NP O
diagonal JJ I-NP O
artery NN I-NP O
with IN B-VP O
0% CD O O
residual JJ B-NP O
stenosis NN I-NP O
Later NNP I-NP O
than IN B-VP O
evening VBG O O
, , O O
the DT B-NP O
patient NN I-NP O
began VBD B-VP O
to TO O O
complain VB O O
of IN B-VP O
severe JJ O O
left VBN O O
arm NN B-NP O
pain NN I-NP O
radiating VBG O O
to TO O O
her PRP$ O O
left JJ B-NP O
chest NN I-NP O
Her PRP$ O O
electrocardiogram NN B-NP O
changes NNS I-NP O
showed VBD B-VP O
ST NNP B-NP O
elevation NN I-NP O
in IN B-VP O
VI NNP B-NP O
and CC O O
VII NNP B-NP O
, , O O
and CC O O
T-wave NNP B-NP O
more RBR O O
inverted JJ O O
in IN B-VP O
VIV NNP B-NP O
She PRP O O
received VBD B-VP O
morphine NN B-NP B-m
and CC O O
was VBD B-VP O
already RB O O
on IN B-VP O
a DT B-NP O
nitroglycerin JJ I-NP B-m
drip NN I-NP B-mo
, , O O
and CC O O
she PRP O O
was VBD B-VP O
taken VBN O O
back RB O O
to TO O O
the DT B-NP O
catheterization NN I-NP O
laboratory NN I-NP O
Her NNP I-NP O
spectral NN I-NP O
study NN I-NP O
on IN B-VP O
February NNP B-NP O
, , O O
1997 CD O O
, , O O
revealed VBD B-VP O
a DT O O
90% CD O O
mid NN B-NP O
left VBD B-VP O
anterior JJ B-NP O
descending NN I-NP O
and CC O O
95% CD O O
VI NNP B-NP O
, , O O
and CC O O
her PRP$ O O
left JJ B-NP O
anterior JJ I-NP O
descending NN I-NP O
was VBD B-VP O
stented VBN O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
Following VBG O O
her PRP O O
two CD O O
cardiac JJ B-NP O
catheterizations NNS I-NP O
, , O O
she PRP O O
experienced VBD B-VP O
intermittent JJ B-NP O
atypical JJ I-NP O
chest NN I-NP O
which WDT O O
was VBD B-VP O
transient NN B-NP O
in IN B-VP O
nature NN B-NP O
without IN B-VP O
sustaining VBG O O
any DT B-NP O
electrocardiogram JJ I-NP O
changes NNS I-NP O
Her PRP$ O O
cardiac JJ B-NP O
enzymes NNS I-NP O
were VBD B-VP O
significant JJ O O
for IN B-VP O
a DT B-NP O
CK NNP I-NP O
of IN B-VP O
409 CD O O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
fraction NN I-NP O
o RB O O
21 CD O O
On IN B-VP O
March NNP B-NP O
, , O O
1997 CD O O
, , O O
it PRP O O
was VBD B-VP O
noted VBN O O
that IN B-VP O
her PRP$ O O
creatinine NN B-NP O
had VBD B-VP O
risen VBN O O
to TO O O
3.1 CD O O
, , O O
elevated VBN O O
from IN B-VP O
a DT B-NP O
level NN I-NP O
of IN B-VP O
1.9 CD O O
before IN B-VP O
the DT B-NP O
catheterization NN I-NP O
and CC O O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
radial JJ B-NP O
contrast NN I-NP O
induced VBD B-VP O
nephrotoxicity NN B-NP O
was VBD B-VP O
made VBN O O
Her NNP B-NP O
creatinine NN I-NP O
rose VBD B-VP O
and CC O O
rose VBD B-VP O
to TO O O
a DT B-NP O
peak JJ I-NP O
level NN I-NP O
of IN B-VP O
5.1 CD O O
on IN B-VP O
March NNP B-NP O
, , O O
1997 CD O O
, , O O
and CC O O
then RB O O
began VBD B-VP O
to TO O O
decrease VB O O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
it PRP O O
was VBD B-VP O
down RB O O
to TO O O
2.2 CD O O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
have VB O O
excellent JJ B-NP O
urine NN I-NP O
output NN I-NP O
throughout IN B-VP O
the DT B-NP O
rise NN I-NP O
in IN B-VP O
her PRP$ O O
creatinine NN B-NP O
and CC O O
was VBD B-VP O
normal JJ O O
by IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
Her NNP I-NP O
laboratories NNS I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
were VBD B-VP O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
141; CD O O
potassium NN B-NP O
4.8; CD O O
chloride NN B-NP O
106; CD O O
bicarbonate NN B-NP O
20; CD O O
BUN NNP B-NP O
31; CD O O
creatinine NN B-NP O
2.2; CD O O
glucose JJ O O
90 CD O O
White NNP B-NP O
count NN I-NP O
6900; CD O O
hematocrit NN B-NP O
33.9; CD O O
platelets NNS B-NP O
were VBD B-VP O
203 CD O O
, , O O
000 CD O O
She PRP O O
had VBD B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
and CC O O
ED NNP B-NP O
study NN I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
1997 CD O O
, , O O
which WDT O O
showed VBD B-VP O
an DT O O
essentially RB O O
negative JJ B-NP O
exercise NN I-NP O
treadmill NN I-NP O
test NN I-NP O
and CC O O
was VBD B-VP O
a DT B-NP O
suboptimal JJ I-NP O
study NN I-NP O
She PRP O O
exercised VBD B-VP O
for IN B-VP O
approximately RB O O
five CD O O
minutes NNS B-NP O
on IN B-VP O
submaximal JJ B-NP O
exercise NN I-NP O
treadmill NN I-NP O
test NN I-NP O
protocol NN I-NP O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemia NN B-NP O
, , O O
but CC O O
low JJ B-NP O
exercise NN I-NP O
tolerance NN I-NP O
Her NNP I-NP O
medications NNS I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
included: NN I-NP O
Ticlid NNP I-NP B-m
250 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
albuterol NN I-NP B-m
inhaler NN I-NP I-m
2 CD O B-do
puffs NNS B-NP I-do
q.i.d RB O B-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
shortness NN B-NP B-r
of IN B-VP I-r
breath; JJ B-NP I-r
enteric-coated JJ I-NP B-m
aspirin NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d.; NN I-NP B-f
atenolol VBD B-VP B-m
37.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
nitroglycerin RB O B-m
1/150 CD O I-m
sublingual JJ O B-mo
one CD O B-do
tablet NN B-NP O
q NN I-NP B-f
5 CD O I-f
minutes NNS B-NP I-f
times NNS I-NP I-f
three CD O I-f
for IN B-VP O
chest NN B-NP B-r
pain; NN I-NP I-r
and CC O O
Dilantin NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
She PRP O O
is VBZ O O
scheduled VBN O O
to TO O O
followup VB O O
with IN B-VP O
Dr NNP B-NP O
Doug NNP I-NP O
Millis NNP I-NP O
in IN B-VP O
her PRP$ O O
office NN B-NP O
in IN B-VP O
one CD O O
week NN B-NP O
and CC O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
cardiology NN B-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
CLEVELAND NNP I-NP O
PRINCEVALLE NNP I-NP O
, , O O
M.D NNP B-NP O
IP95 NNP I-NP O
Attending: NNP I-NP O
COLEMAN NNP I-NP O
HOYLAND NNP I-NP O
, , O O
M.D NNP B-NP O
XF78 NNP I-NP O
GC702/3343 NNP I-NP O
Batch: NNP I-NP O
29248 CD O O
Index NNP B-NP O
No NNP I-NP O
DPIXVYL69 NNP I-NP O
D: NNP I-NP O
10/28/97 CD O O
T: NNP B-NP O
10/12/97 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#589139 VBZ O O
624364932 CD O O
THS NNP B-NP O
28965512 CD O O
029873 CD O O
11/28/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
SYNCOPE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/16/1997 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/20/1997 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
SYNCOPE NNP I-NP O
SIGNIFICANT NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
IDIOPATHIC NNP B-NP O
CARDIOMYOPATHY NNP I-NP O
2 CD O O
ATYPICAL NNP B-NP O
CHEST NNP I-NP O
PAIN NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
64-year-old JJ I-NP O
woman NN I-NP O
who WP O O
has VBZ O O
lived VBN O O
in IN B-VP O
Tall NNP B-NP O
Dis NNP I-NP O
Thou NNP I-NP O
since IN B-VP O
1993 CD O O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
and CC O O
has VBZ O O
a DT B-NP O
baseline NN I-NP O
EKG NNP I-NP O
with IN B-VP O
an DT B-NP O
intraventricular JJ I-NP O
conduction NN I-NP O
delay NN I-NP O
, , O O
QRS NNP B-NP O
interval NN I-NP O
of IN B-VP O
0.10 CD O O
Her PRP$ O O
cardiac JJ B-NP O
history NN I-NP O
includes: NN I-NP O
In IN B-VP O
February NNP B-NP O
1988 CD O O
, , O O
she PRP O O
underwent VBD B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
for IN B-VP O
chest NN B-NP O
pain NN I-NP O
The DT B-NP O
patient NN I-NP O
went VBD B-VP O
7 CD O O
minutes NNS B-NP O
35 CD O O
seconds NNS B-NP O
and CC O O
had VBD B-VP O
a DT B-NP O
maximum JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
100 CD O O
, , O O
maximum JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
not RB O O
recorded VBN O O
She PRP O O
developed VBD B-VP O
a DT B-NP O
left NN I-NP O
bundle NN I-NP O
branch NN I-NP O
block NN I-NP O
with IN B-VP O
exercise NN B-NP O
A NNP I-NP O
thallium NN I-NP O
scan NN I-NP O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemia NN B-NP O
In IN B-VP O
July NNP B-NP O
1992 CD O O
, , O O
she PRP O O
had VBD B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
for IN B-VP O
chest NN B-NP O
pain NN I-NP O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
She PRP O O
went VBD B-VP O
9 CD O O
minutes NNS B-NP O
0 CD O O
seconds NNS B-NP O
and CC O O
had VBD B-VP O
a DT B-NP O
maximum JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
167 CD O O
with IN B-VP O
maximum JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
138/60 CD O O
She PRP O O
developed VBD B-VP O
angina RB O O
during IN B-VP O
the DT B-NP O
test NN I-NP O
The DT B-NP O
SPECT NNP I-NP O
scan NN I-NP O
showed VBD B-VP O
a DT O O
moderate JJ O O
fixed VBN O O
defect NN B-NP O
in IN B-VP O
the DT B-NP O
apicolateral JJ I-NP O
wall NN I-NP O
In IN B-VP O
8/21 CD O O
, , O O
she PRP O O
had VBD B-VP O
an DT B-NP O
EKG NNP I-NP O
done VBN O O
which WDT O O
showed VBD B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
a DT B-NP O
QRS NNP I-NP O
interval NN I-NP O
of IN B-VP O
0.10 CD O O
and CC O O
moderate JJ B-NP O
LVH NNP I-NP O
In IN B-VP O
1995 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
states VBZ O O
that IN B-VP O
she PRP O O
had VBD B-VP O
a DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
in IN B-VP O
Auriend NNP B-NP O
Road NNP I-NP O
, , O O
Kane NNP B-NP O
Cho NNP I-NP O
, , O O
Mississippi NNP B-NP O
13286 CD O O
which WDT O O
showed VBD B-VP O
no DT B-NP O
coronary JJ I-NP O
disease NN I-NP O
, , O O
although IN B-VP O
she PRP O O
was VBD B-VP O
told VBN O O
that IN B-VP O
she PRP O O
had VBD B-VP O
a DT O O
cardiomyopathy JJ O O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
feeling VBG O O
well RB O O
until IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
without IN B-VP O
any DT B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
or CC O O
orthopnea NN B-NP O
in IN B-VP O
the DT B-NP O
recent JJ I-NP O
past NN I-NP O
On IN B-VP O
the DT B-NP O
afternoon NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
at IN B-VP O
about IN B-VP O
2 CD O O
o'clock NN B-NP O
in IN B-VP O
the DT B-NP O
afternoon NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
watching VBG O O
television NN B-NP O
She PRP O O
arose VBD B-VP O
from IN B-VP O
the DT B-NP O
couch NN I-NP O
and CC O O
went VBD B-VP O
to TO O O
the DT B-NP O
kitchen NN I-NP O
to TO O O
get VB O O
a DT B-NP O
cup NN I-NP O
of IN B-VP O
coffee NN B-NP O
She PRP O O
recalls VBZ O O
filling VBG O O
her PRP$ O O
cup NN B-NP O
with IN B-VP O
water NN B-NP O
, , O O
then RB O O
recalls VBZ O O
nothing NN B-NP O
else RB O O
until IN B-VP O
she PRP O O
awoke VBD B-VP O
with IN B-VP O
her PRP$ O O
grandchildren NNS B-NP O
lying VBG O O
on IN B-VP O
half NN B-NP O
of IN B-VP O
her PRP$ O O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
and CC O O
crying VBG O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
oriented VBN O O
upon IN B-VP O
awakening VBG O O
and CC O O
recognized VBD B-VP O
her PRP$ O O
grandchildren NN B-NP O
immediately RB O O
She PRP O O
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP O
incontinence NN I-NP O
or CC O O
tongue NN B-NP O
biting NN I-NP O
She PRP O O
denied VBD B-VP O
muscle NN B-NP O
aches NNS I-NP O
, , O O
somnolence NN B-NP O
, , O O
confusion NN B-NP O
, , O O
or CC O O
weakness NN B-NP O
She PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
couch NN I-NP O
to TO O O
sit VB O O
down RP O O
and CC O O
had VBD B-VP O
nausea NN B-NP O
and CC O O
vomiting VBG O O
about IN B-VP O
five CD O O
minutes NNS B-NP O
after IN B-VP O
her PRP$ O O
syncopal JJ B-NP O
episode NN I-NP O
She PRP O O
also RB O O
noted VBD B-VP O
a DT B-NP O
bump NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
of IN B-VP O
her PRP$ O O
head NN B-NP O
and CC O O
subsequently RB O O
developed VBD B-VP O
a DT B-NP O
headache NN I-NP O
She PRP O O
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP O
neurologic JJ I-NP O
symptoms NNS I-NP O
, , O O
denied VBD B-VP O
any DT B-NP O
chest JJS I-NP O
pain NN I-NP O
or CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
She PRP O O
was VBD B-VP O
diaphoretic JJ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
that IN B-VP O
she PRP O O
was VBD B-VP O
sitting VBG O O
on IN B-VP O
the DT B-NP O
cough NN I-NP O
, , O O
nauseous JJ O O
and CC O O
vomiting VBG O O
afterwards NNS B-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
palpitations NNS I-NP O
and CC O O
she PRP O O
had VBD B-VP O
no DT B-NP O
presyncopal JJ I-NP O
sensation NN I-NP O
or CC O O
dizziness NN B-NP O
at IN B-VP O
any DT B-NP O
time NN I-NP O
She PRP O O
does VBZ O O
report VB O O
having VBG O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
palpitations NNS B-NP O
in IN B-VP O
the DT O O
past JJ O O
, , O O
but CC O O
none NN B-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
fevers NNS I-NP O
, , O O
chills NNS B-NP O
, , O O
or CC O O
other JJ B-NP O
sick JJ I-NP O
contacts NNS I-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
prior JJ I-NP O
history NN I-NP O
of IN B-VP O
syncope NN B-NP O
or CC O O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
She PRP O O
had VBD B-VP O
no DT B-NP O
history NN I-NP O
of IN B-VP O
seizures NNS B-NP O
or CC O O
transient JJ B-NP O
neurologic NN I-NP O
symptoms NNS I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
does VBZ O O
report VB O O
that IN B-VP O
she PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
The DT B-NP O
last JJ I-NP O
time NN I-NP O
was VBD B-VP O
more JJR O O
than IN B-VP O
a DT B-NP O
year NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
She PRP O O
has VBZ O O
no DT B-NP O
paroxysmal JJ I-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
no DT B-NP O
pedal NN I-NP O
edema NN I-NP O
, , O O
no DT B-NP O
orthopnea NN I-NP O
, , O O
and CC O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
exercise NN B-NP O
tolerance NN I-NP O
recently RB O O
She PRP O O
climbs VBZ O O
stairs NNS B-NP O
without IN B-VP O
any DT B-NP O
problems NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Hypertension NNP B-NP O
2 CD O O
Chest NNP B-NP O
pain NN I-NP O
, , O O
last JJ B-NP O
episode NN I-NP O
approximately RB O O
one CD O O
year NN B-NP O
prior RB O O
to TO O O
admission VB O O
3 CD O O
Palpitations NNS B-NP O
4 CD O O
Question NN B-NP O
of IN B-VP O
cardiomyopathy NN B-NP O
, , O O
diagnosed VBN O O
by IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
in IN B-VP O
Sa NNP B-NP O
in IN B-VP O
1995 CD O O
ADMISSION NNP B-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Vasotec NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day RB O B-f
2 CD O O
Digoxin NNP B-NP B-m
0.25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day RB O B-f
3 CD O O
Lasix NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.day NN I-NP B-f
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Negative NNP I-NP O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
stroke NN B-NP O
, , O O
diabetes VBZ O O
mellitus NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
and CC O O
sudden JJ B-NP O
death NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
smoke VB O O
, , O O
does VBZ O O
not RB O O
drink VB O O
alcohol NN B-NP O
, , O O
and CC O O
does VBZ O O
not RB O O
use VB O O
IV NNP B-NP O
drugs NNS I-NP O
She PRP O O
lives VBZ O O
with IN B-VP O
her PRP$ O O
daughter NN B-NP O
in IN B-VP O
Co NNP B-NP O
Ville NNP I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
of IN B-VP O
year NN B-NP O
She PRP O O
works VBZ O O
in IN B-VP O
an DT B-NP O
outreach NN I-NP O
program NN I-NP O
as IN B-VP O
a DT B-NP O
nurse NN I-NP O
She PRP O O
came VBD B-VP O
from IN B-VP O
Ige NNP B-NP O
Pkwy NNP I-NP O
, , O O
Norfsta NNP B-NP O
Olk NNP I-NP O
Mer NNP I-NP O
, , O O
New NNP B-NP O
Hampshire NNP I-NP O
25909 CD O O
where WRB O O
she PRP O O
has VBZ O O
been VBN O O
since IN B-VP O
1993 CD O O
Prior NNP B-NP O
to TO O O
that DT B-NP O
time NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
living VBG O O
in IN B-VP O
Birhamstonro NNP B-NP O
and CC O O
receiving VBG O O
medical JJ B-NP O
care NN I-NP O
at IN B-VP O
the DT B-NP O
Cla NNP I-NP O
Du NNP I-NP O
Rencein NNP I-NP O
Hospital NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Vital NNP I-NP O
signs NNS I-NP O
included VBD B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
130/70 CD O O
, , O O
pulse RB O O
62 CD O O
( ( O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
200/100 CD O O
when WRB O O
initially RB O O
seen VBN O O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
) ) O O
She PRP O O
was VBD B-VP O
an DT B-NP O
elderly JJ I-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Her PRP$ O O
HEENT NNP B-NP O
examination NN I-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
having VBG O O
poor JJ B-NP O
dentition NN I-NP O
Her NNP I-NP O
JVP NNP I-NP O
was VBD B-VP O
at IN B-VP O
8 CD O O
cm NN B-NP O
Her PRP$ O O
chest NN B-NP O
was VBD B-VP O
clear JJ B-NP O
Her NNP I-NP O
cardiovascular NN I-NP O
examination NN I-NP O
revealed VBD B-VP O
an DT B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
and CC O O
intermittent JJ B-NP O
S3 NNP I-NP O
, , O O
no DT B-NP O
murmurs NNS I-NP O
, , O O
with IN B-VP O
regular JJ B-NP O
rate NN I-NP O
Her PRP$ O O
abdomen NNS B-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender VB O O
Her PRP$ O O
extremities NNS B-NP O
were VBD B-VP O
warm JJ O O
without IN B-VP O
any DT B-NP O
cyanosis NN I-NP O
, , O O
clubbing VBG O O
, , O O
or CC O O
edema VB O O
Neurological JJ B-NP O
examination NN I-NP O
was VBD B-VP O
unremarkable JJ B-NP O
Her NNP I-NP O
mental NN I-NP O
status NN I-NP O
was VBD B-VP O
entirely RB O O
intact JJ B-NP O
Cranial NNP I-NP O
nerve NN I-NP O
examination NN I-NP O
was VBD B-VP O
grossly RB O O
intact JJ B-NP O
Her NNP I-NP O
reflexes NNS I-NP O
were VBD B-VP O
2+ CD O O
throughout IN B-VP O
and CC O O
her PRP$ O O
toes NNS B-NP O
did VBD B-VP O
not RB O O
respond VB O O
to TO O O
the DT B-NP O
Babinski NNP I-NP O
stimulation NN I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
CK NNP I-NP O
of IN B-VP O
119 CD O O
, , O O
magnesium NN B-NP O
2.2 CD O O
Her NNP B-NP O
digoxin NN I-NP O
level NN I-NP O
was VBD B-VP O
0.7 CD O O
Troponin NNP B-NP O
I PRP O O
was VBD B-VP O
0 CD O O
Electrolytes NNPS B-NP O
were VBD B-VP O
entirely RB O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
as IN B-VP O
were VBD B-VP O
BUN NNP B-NP O
and CC O O
creatinine JJ B-NP O
White NNP I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
was VBD B-VP O
10.3 CD O O
, , O O
hematocrit NN B-NP O
36.5 CD O O
, , O O
and CC O O
platelet NN B-NP O
count NN I-NP O
298 CD O O
Urinalysis NNP B-NP O
revealed VBD B-VP O
0-1 JJ B-NP O
white JJ I-NP O
cells NNS I-NP O
, , O O
0-1 JJ B-NP O
red JJ I-NP O
cells NNS I-NP O
, , O O
1+ CD O O
bacteria NNS B-NP O
, , O O
and CC O O
1+ CD O O
epithelial JJ B-NP O
cells NNS I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
revealed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
or CC O O
infiltrate NN B-NP O
EKG NNP I-NP O
, , O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
93 CD O O
with IN B-VP O
intervals NNS B-NP O
of IN B-VP O
0.183 CD O O
, , O O
0.15 CD O O
, , O O
and CC O O
0.417 CD O O
She PRP O O
had VBD B-VP O
a DT O O
left VBN O O
bundle NN B-NP O
branch NN I-NP O
block NN I-NP O
which WDT O O
was VBD B-VP O
new JJ O O
since IN B-VP O
her PRP$ O O
1993 CD O O
EKG NNP B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
work NN B-NP O
up RB O O
of IN B-VP O
her PRP$ O O
syncopal JJ B-NP O
episode NN I-NP O
By IN B-VP O
hospital JJ B-NP O
day NN I-NP O
one CD O O
, , O O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
rule NN I-NP O
out IN B-VP O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
Her PRP$ O O
enzymes NNS B-NP O
were VBD B-VP O
flat JJ O O
and CC O O
her PRP$ O O
EKG NNP B-NP O
showed VBD B-VP O
no DT B-NP O
changes NNS I-NP O
consistent VBP O O
with IN B-VP O
acute JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
underwent VBD B-VP O
an DT B-NP O
echocardiogram NN I-NP O
which WDT O O
revealed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
30%-35% JJ O O
She PRP O O
also RB O O
had VBD B-VP O
anterolateral JJ B-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities NNS I-NP O
On IN B-VP O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
underwent VBD B-VP O
a DT B-NP O
right NN I-NP O
sided VBN O O
heart NN B-NP O
catheterization NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
that IN B-VP O
her PRP$ O O
coronary JJ B-NP O
arteries NNS I-NP O
were VBD B-VP O
completely RB O O
clean JJ O O
She PRP O O
underwent VBD B-VP O
an DT B-NP O
EP NNP I-NP O
study NN I-NP O
which WDT O O
was VBD B-VP O
entirely RB O O
normal JJ O O
On IN B-VP O
the DT B-NP O
following JJ I-NP O
hospital NN I-NP O
day NN I-NP O
, , O O
she PRP O O
underwent VBD B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
, , O O
and CC O O
no DT B-NP O
arrhythmias NN I-NP O
were VBD B-VP O
triggered VBN O O
by IN B-VP O
her PRP$ O O
exercise NN B-NP O
Carotid NNP I-NP O
noninvasive JJ B-NP O
studies NNS I-NP O
revealed VBD B-VP O
minimal JJ B-NP O
disease NN I-NP O
bilaterally RB O O
, , O O
and CC O O
the DT B-NP O
neurology NN I-NP O
service NN I-NP O
was VBD B-VP O
consulted VBN O O
The DT B-NP O
patient NN I-NP O
also RB O O
underwent VBD B-VP O
a DT B-NP O
tilt NN I-NP O
table NN I-NP O
study NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
entirely RB O O
normal JJ O O
, , O O
with IN B-VP O
no DT B-NP O
suggestion NN I-NP O
of IN B-VP O
a DT B-NP O
vasovagal JJ I-NP O
response NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
had VBN O O
no DT B-NP O
further JJ I-NP O
symptoms NNS I-NP O
and CC O O
no DT B-NP O
further JJ I-NP O
episodes NNS I-NP O
of IN B-VP O
syncope NN B-NP O
while IN B-VP O
in IN B-VP O
hospital NN B-NP O
Her PRP$ O O
Holter NNP B-NP O
monitor NN I-NP O
results NNS I-NP O
are VBP O O
pending VBG O O
The DT B-NP O
feeling NN I-NP O
is VBZ O O
that IN B-VP O
her PRP$ O O
syncopal JJ B-NP O
event NN I-NP O
was VBD B-VP O
most RBS O O
likely JJ B-NP O
cardiac NN I-NP O
related VBN O O
, , O O
probably RB O O
related VBN O O
to TO O O
a DT B-NP O
tachycardic JJ I-NP O
arrhythmia NN I-NP O
However RB O O
, , O O
her PRP O O
neurologic JJ B-NP O
work NN I-NP O
up RB O O
is VBZ O O
still RB O O
underway JJ O O
She PRP O O
is VBZ O O
to TO O O
have VB O O
an DT B-NP O
MRI/MRA NNP I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
and CC O O
to TO O O
follow VB O O
up RP O O
in IN B-VP O
DISPAN NNP B-NP O
NI NNP I-NP O
TI NNP I-NP O
HOSPITAL NNP I-NP O
clinic NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
with IN B-VP O
Dr NNP B-NP O
Triche NNP I-NP O
for IN B-VP O
further JJ B-NP O
discussion NN I-NP O
as IN B-VP O
to TO O O
whether IN B-VP O
AICD NNP B-NP O
placement NN I-NP O
might MD O O
be VB O O
in IN B-VP O
order NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Enteric NNP B-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
325 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
q.day RB O B-f
2 CD O O
Digoxin NNP B-NP B-m
0.25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day RB O B-f
3 CD O O
Vasotec JJ O B-m
15 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day RB O B-f
4 CD O O
Lasix NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day RB O B-f
5 CD O O
Atenolol NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.day NN I-NP B-f
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
to TO O O
follow VB O O
up RP O O
in IN B-VP O
I PRP O O
MINVIC NNP B-NP O
MEDICAL NNP I-NP O
CENTER NNP I-NP O
clinic NN I-NP O
with IN B-VP O
me PRP O O
( ( O O
Leo NNP B-NP O
Paponetti NNP I-NP O
) ) O O
on IN B-VP O
7/20/97 CD O O
She PRP O O
will MD O O
have VB O O
an DT B-NP O
MRA/MRI NNP I-NP O
of IN B-VP O
her PRP$ O O
brain NN B-NP O
scheduled VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
will MD O O
be VB O O
set VBN O O
up RP O O
with IN B-VP O
an DT B-NP O
ECG NNP I-NP O
loop NN I-NP O
recorder NN I-NP O
for IN B-VP O
further JJ B-NP O
monitoring NN I-NP O
of IN B-VP O
events NNS B-NP O
at IN B-VP O
home NN B-NP O
Dictated NNP I-NP O
By: NNP I-NP O
CHADWICK NNP I-NP O
METTA NNP I-NP O
, , O O
M.D NNP B-NP O
ZW08 NNP I-NP O
Attending: NNP I-NP O
STANTON NNP I-NP O
H NNP I-NP O
OTHMAN NNP I-NP O
, , O O
M.D NNP B-NP O
JP51 NNP I-NP O
LM638/0391 NNP I-NP O
Batch: NNP I-NP O
42029 CD O O
Index NNP B-NP O
No NNP I-NP O
A4XU7G90HE NNP I-NP O
D: NNP I-NP O
2/2/97 CD O O
T: NNP B-NP O
0/3/97 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#595688 VBZ O O
641097022 CD O O
ELSUOMC NNP B-NP O
53507186 CD O O
541876 CD O O
11/16/1994 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/18/1994 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/17/1994 CD O O
PRINCIPLE NNP B-NP O
DIAGNOSIS: NNP I-NP O
HYPOTENSIVE NNP I-NP O
EPISODE NNP I-NP O
SIGNIFICANT NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
End NNP B-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
on IN B-VP O
chronic JJ B-NP O
hemodialysis NN I-NP O
2 CD O O
Mild NNP B-NP O
mental JJ B-NP O
retardation NN I-NP O
3 CD O O
Movement NNP B-NP O
disorder NN I-NP O
( ( O O
tics NNS B-NP O
) ) O O
4 CD O O
Status NNP B-NP O
post NN I-NP O
parathyroidectomy NN I-NP O
5 CD O O
Partial NNP B-NP O
thyroidectomy VBD B-VP O
6 CD O O
Status NNP B-NP O
post NN I-NP O
partial JJ B-NP O
gastrectomy NN I-NP O
for IN B-VP O
peptic JJ B-NP O
ulcer JJ I-NP O
disease NN I-NP O
7 CD O O
History NNP B-NP O
of IN B-VP O
MRSA NNP B-NP O
from IN B-VP O
wound NN B-NP O
in IN B-VP O
1988 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
46-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
end NN B-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
on IN B-VP O
chronic JJ B-NP O
hemodialysis NN I-NP O
who WP O O
was VBD B-VP O
admitted VBN O O
status NN B-NP O
post NN I-NP O
fall NN I-NP O
and CC O O
seizure NN B-NP O
The DT B-NP O
patient's JJ I-NP O
end NN I-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
is VBZ O O
thought VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
hypertension NN B-NP O
, , O O
although IN B-VP O
he PRP O O
has VBZ O O
never RB O O
had VBD B-VP O
a DT B-NP O
renal JJ I-NP O
biopsy NN I-NP O
He PRP O O
has VBZ O O
been VBN O O
on IN B-VP O
hemodialysis NN B-NP O
since IN B-VP O
1987 CD O O
, , O O
having VBG O O
dialysis NN B-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
week NN I-NP O
His PRP$ O O
dry JJ B-NP O
weight NN I-NP O
is VBZ O O
about RB O O
85 CD O O
to TO O O
86 CD O O
kilos VB O O
His PRP$ O O
dialysis NN B-NP O
has VBZ O O
been VBN O O
complicated VBN O O
by IN B-VP O
multiple JJ B-NP O
episodes NNS I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
of IN B-VP O
hypotension NN B-NP O
and CC O O
seizure NN B-NP O
activity NN I-NP O
occurring VBG O O
after IN B-VP O
dialysis NN B-NP O
These DT B-NP O
episodes NNS I-NP O
occur VBP O O
about IN B-VP O
once RB O O
a DT B-NP O
month NN I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
came VBD B-VP O
home NN B-NP O
from IN B-VP O
routine JJ B-NP O
hemodialysis NN I-NP O
where WRB O O
he PRP O O
was VBD B-VP O
ultrafiltered JJ O O
5.5 CD O O
kilograms NNS B-NP O
of IN B-VP O
fluid NN B-NP O
and CC O O
his PRP$ O O
final JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
after IN B-VP O
dialysis NN B-NP O
was VBD B-VP O
100/60 CD O O
At IN B-VP O
noon NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
went VBD B-VP O
home NN B-NP O
, , O O
ate JJ B-NP O
lunch NN I-NP O
and CC O O
went VBD B-VP O
up RB O O
to TO O O
his PRP$ O O
room NN B-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
he PRP O O
complained VBD B-VP O
of IN B-VP O
feeling VBG O O
dizzy NN B-NP O
and CC O O
sitting VBG O O
on IN B-VP O
the DT B-NP O
edge NN I-NP O
of IN B-VP O
the DT B-NP O
bed NN I-NP O
told VBD B-VP O
his PRP$ O O
uncle NN B-NP O
that IN B-VP O
he PRP O O
was VBD B-VP O
not RB O O
feeling VBG O O
well RB O O
and CC O O
then RB O O
slumped VBD B-VP O
onto IN B-VP O
the DT B-NP O
floor NN I-NP O
He PRP O O
does VBZ O O
not RB O O
believe VB O O
that IN B-VP O
he PRP O O
hurt VBD B-VP O
himself PRP O O
, , O O
i.e RB O O
, , O O
did VBD B-VP O
not RB O O
hurt VB O O
his PRP$ O O
head NN B-NP O
, , O O
although IN B-VP O
he PRP O O
did VBD B-VP O
complain NN B-NP O
of IN B-VP O
some DT B-NP O
right JJ I-NP O
foot NN I-NP O
pain NN I-NP O
He PRP O O
was VBD B-VP O
still RB O O
conscious JJ O O
as IN B-VP O
his PRP$ O O
uncle NN B-NP O
lifted VBD B-VP O
him PRP O O
back RB O O
to TO O O
bed NN B-NP O
and CC O O
then RB O O
an DT B-NP O
ambulance NN I-NP O
was VBD B-VP O
called VBN O O
After IN B-VP O
a DT B-NP O
few JJ I-NP O
minutes NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
lost VBD B-VP O
consciousness NN B-NP O
, , O O
rolling VBG O O
his PRP$ O O
eyes NNS B-NP O
back RP O O
with IN B-VP O
some DT B-NP O
facial JJ I-NP O
twitching NN I-NP O
bilaterally RB O O
and CC O O
tongue JJ B-NP O
retraction NN I-NP O
This DT B-NP O
episode NN I-NP O
lasted VBD B-VP O
about IN B-VP O
five CD O O
minutes NNS B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
tongue NN I-NP O
biting NN I-NP O
, , O O
no DT B-NP O
urinary JJ I-NP O
incontinence NN I-NP O
or CC O O
bowel NN B-NP O
incontinence NN I-NP O
The DT B-NP O
patient NN I-NP O
gained VBD B-VP O
full JJ B-NP O
recovery NN I-NP O
of IN B-VP O
his PRP$ O O
alertness NN B-NP O
upon IN B-VP O
waking VBG O O
up RP O O
but CC O O
was VBD B-VP O
a DT B-NP O
bit NN I-NP O
diaphoretic JJ O O
His PRP$ O O
aunt NN B-NP O
checked VBD B-VP O
his PRP$ O O
vital JJ B-NP O
signs NNS I-NP O
which WDT O O
were VBD B-VP O
blood NN B-NP O
pressure NN I-NP O
70/40 CD O O
, , O O
pulse RB O O
79 CD O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
also RB O O
complained VBN O O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
for IN B-VP O
a DT B-NP O
few JJ I-NP O
minutes NNS I-NP O
prior RB O O
to TO O O
his PRP$ O O
episode NN B-NP O
When WRB O O
the DT B-NP O
EMTs NNP I-NP O
arrived VBD B-VP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
three CD O O
, , O O
cold NN B-NP O
and CC O O
clammy NN B-NP O
, , O O
temperature NN B-NP O
98.6 CD O O
, , O O
pulse RB O O
89 CD O O
, , O O
respirations NNS B-NP O
26 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
82/60 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
and CC O O
was VBD B-VP O
orthostatic JJ O O
by IN B-VP O
blood NN B-NP B-r
pressure NN I-NP I-r
( ( O O
10 CD O O
points NNS B-NP O
) ) O O
from IN B-VP O
lying VBG O O
to TO O O
sitting VBG O O
He PRP O O
was VBD B-VP O
given VBN O O
500 CD O B-do
ccs NN B-NP I-do
of IN B-VP O
normal JJ B-NP B-m
saline NN I-NP I-m
and CC O O
was VBD B-VP O
no RB O O
longer RBR O O
orthostatic JJ O O
, , O O
comfortably RB O O
sitting VBG O O
up RP O O
in IN B-VP O
the DT B-NP O
bed NN I-NP O
At IN B-VP O
about IN B-VP O
9:00 CD O O
p.m NN B-NP O
he PRP O O
complained VBD B-VP O
of IN B-VP O
feeling VBG O O
dizzy JJ O O
and CC O O
became VBD B-VP O
diaphoretic JJ O O
while IN B-VP O
trying VBG O O
to TO O O
stand VB O O
up RP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
again RB O O
brought VBN O O
into IN B-VP O
bed NN B-NP O
He PRP O O
became VBD B-VP O
unresponsive JJ O O
for IN B-VP O
one CD O O
minute NN B-NP O
with IN B-VP O
his PRP$ O O
eyes NNS B-NP O
rolled VBD B-VP O
up RP O O
and CC O O
some DT B-NP O
bilateral JJ I-NP O
face NN I-NP O
twitching VBG O O
This DT B-NP O
episode NN I-NP O
only RB O O
lasted VBD B-VP O
about IN B-VP O
one CD O O
minute NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
observation NN B-NP O
Past NNP I-NP O
medical JJ B-NP O
history NN I-NP O
reveals VBZ O O
the DT B-NP O
following: NN I-NP O
1 CD O O
) ) O O
Mild NNP B-NP O
mental JJ B-NP O
retardation NN I-NP O
since IN B-VP O
about IN B-VP O
10 CD O O
years NNS B-NP O
ago RB O O
2 CD O O
) ) O O
Movement NN B-NP B-r
disorder NN I-NP I-r
( ( O O
tics NNS B-NP O
) ) O O
on IN B-VP O
Stelazine NNP B-NP B-m
3 CD O O
) ) O O
End NN B-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
thought VBD B-VP O
to TO O O
be VB O O
secondary JJ O O
to TO O O
hypertension VB O O
4 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
parathyroidectomy NN I-NP O
for IN B-VP O
secondary JJ B-NP O
hyperparathyroidism NN I-NP O
5 CD O O
) ) O O
Partial NNP B-NP O
thyroidectomy NN I-NP O
for IN B-VP O
goiter NN B-NP O
incidentally RB O O
found VBN O O
at IN B-VP O
surgery NN B-NP O
6 CD O O
) ) O O
Status NNP B-NP O
post NN I-NP O
partial JJ B-NP O
gastrectomy NN I-NP O
for IN B-VP O
peptic JJ B-NP O
ulcer JJ I-NP O
disease NN I-NP O
in IN B-VP O
the DT O O
1960's CD O O
7 CD O O
) ) O O
History NN B-NP O
of IN B-VP O
MRSA NNP B-NP O
from IN B-VP O
wound NN B-NP O
in IN B-VP O
1988 CD O O
8 CD O O
) ) O O
Hepatitis NN B-NP O
B NNP I-NP O
surface NN I-NP O
antibody NN I-NP O
positive JJ O O
and CC O O
hepatitis JJ B-NP O
C NNP I-NP O
virus NN I-NP O
positive JJ B-NP O
Medications NNS I-NP O
on IN B-VP O
admission: JJ B-NP O
Calcium NNP I-NP B-m
carbonate NN I-NP O
, , O O
1250 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
tid; NN I-NP B-f
nephrocaps NNS I-NP B-m
, , O O
1 CD O B-do
PO NNP B-NP B-mo
qd; NN I-NP B-f
DHT NNP I-NP B-m
, , O O
0.2 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
qd; NN I-NP B-f
Stelazine NNP I-NP B-m
, , O O
2 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
tid NN I-NP B-f
There EX O O
are VBP O O
no DT B-NP O
known JJ I-NP O
allergies NNS I-NP O
Social NNP I-NP O
history: VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
a DT B-NP O
former JJ I-NP O
smoker NN I-NP O
and CC O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
alcohol NN B-NP O
abuse NN I-NP O
but CC O O
no DT B-NP O
IV NNP I-NP O
drug NN I-NP O
use NN I-NP O
He PRP O O
lives VBZ O O
with IN B-VP O
his PRP$ O O
aunt NN B-NP O
and CC O O
uncle NN B-NP O
and CC O O
is VBZ O O
mildly RB O O
retarded JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
, , O O
vital JJ B-NP O
signs NNS I-NP O
showed VBD B-VP O
a DT O O
lying VBG O O
blood NN B-NP O
pressure NN I-NP O
of IN B-VP O
96/60 CD O O
, , O O
pulse RB O O
80 CD O O
, , O O
sitting VBG O O
up RP O O
blood NN B-NP O
pressure NN I-NP O
104/70 CD O O
, , O O
pulse RB O O
96 CD O O
, , O O
temperature NN B-NP O
97.5 CD O O
, , O O
O2 NNP B-NP O
sat VBD B-VP O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
a DT O O
well RB O O
nourished VBN O O
, , O O
black JJ B-NP O
male NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
HEENT NNP I-NP O
exam NN I-NP O
was VBD B-VP O
unremarkable JJ B-NP O
Neck NNP I-NP O
showed VBD B-VP O
JVD NNP B-NP O
of IN B-VP O
4 CD O O
cms NN B-NP O
No NNP I-NP O
lymphadenopathy NN I-NP O
Chest NNP I-NP O
was VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O O
Heart NNP B-NP O
revealed VBD B-VP O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
, , O O
normal JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT O O
1/6 CD O O
systolic JJ B-NP O
murmur NN I-NP O
best JJS B-NP O
heard NN I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
No NNP I-NP O
CVA NNP I-NP O
tenderness NN I-NP O
Abdomen NNP I-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
no DT B-NP O
masses NNS I-NP O
Bowel NNP I-NP O
sounds NNS I-NP O
were VBD B-VP O
positive JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
with IN B-VP O
brown JJ B-NP O
stool NN I-NP O
Extremities NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
tender NN I-NP O
, , O O
edematous JJ B-NP O
dorsal NN I-NP O
aspect NN I-NP O
of IN B-VP O
right JJ B-NP O
foot NN I-NP O
, , O O
with IN B-VP O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
at IN B-VP O
the DT B-NP O
ankle NN I-NP O
joint NN I-NP O
Left NNP I-NP O
extremity NN I-NP O
benign NN I-NP O
Neuro NNP I-NP O
exam NN I-NP O
was VBD B-VP O
grossly RB O O
nonfocal JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
sodium NN B-NP O
142 CD O O
, , O O
potassium NN B-NP O
4.8 CD O O
, , O O
chloride RB O O
94 CD O O
, , O O
bicarb NN B-NP O
32 CD O O
, , O O
BUN NNP B-NP O
38 CD O O
, , O O
creatinine NN B-NP O
8.6 CD O O
, , O O
glucose VBD B-VP O
168 CD O O
A NNP B-NP O
CBC NNP I-NP O
revealed VBD B-VP O
white JJ B-NP O
count NN I-NP O
of IN B-VP O
8.82 CD O O
, , O O
hematocrit NN B-NP O
35 CD O O
, , O O
platelets NNS B-NP O
246 CD O O
Calcium NNP B-NP O
was VBD B-VP O
9.7 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
revealed VBD B-VP O
mild JJ B-NP O
pulmonary JJ I-NP O
vascular JJ I-NP O
redistribution NN I-NP O
with IN B-VP O
no DT B-NP O
significant JJ I-NP O
CHF NNP I-NP O
and CC O O
no DT B-NP O
infiltrates NNS I-NP O
Ankle VBP O O
x-rays NNS B-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
revealed VBD B-VP O
no DT B-NP O
fracture NN I-NP O
or CC O O
dislocation NN B-NP O
EKG NNP I-NP O
revealed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
76 CD O O
, , O O
axis RB O O
2 CD O O
degrees NNS B-NP O
, , O O
some DT O O
1 CD O O
mm NNS B-NP O
ST NNP I-NP O
elevations NNS I-NP O
in IN B-VP O
I PRP O O
and CC O O
AVL NNP B-NP O
, , O O
T-waves NNP B-NP O
flat NN I-NP O
in IN B-VP O
lead JJ B-NP O
III NNP I-NP O
The DT B-NP O
slight JJ I-NP O
elevations NNS I-NP O
in IN B-VP O
ST NNP B-NP O
were VBD B-VP O
consistent JJ O O
with IN B-VP O
EKG NNP B-NP O
on IN B-VP O
1/2/94 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
observed VBN O O
overnight JJ O O
and CC O O
put VB O O
on IN B-VP O
an DT B-NP O
oral JJ I-NP O
renal JJ I-NP O
diet NN I-NP O
, , O O
checking VBG O O
orthostatics NNS B-NP O
frequently RB O O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
asymptomatic JJ O O
throughout IN B-VP O
his PRP$ O O
hospital NN B-NP O
course NN I-NP O
and CC O O
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
with IN B-VP O
no DT B-NP O
orthostasis NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP O
renal JJ I-NP O
service NN I-NP O
who WP O O
assessed VBD B-VP O
that IN B-VP O
this DT B-NP O
episode NN I-NP O
was VBD B-VP O
most RBS O O
likely JJ O O
secondary JJ O O
to TO O O
the DT B-NP O
extensive JJ I-NP O
fluid NN I-NP O
removal NN I-NP O
from IN B-VP O
dialysis NN B-NP O
leading VBG O O
to TO O O
a DT B-NP O
low JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
they PRP O O
noted VBD B-VP O
that IN B-VP O
seizures NNS B-NP O
and CC O O
orthostasis NN B-NP O
are VBP O O
often RB O O
seen VBN O O
status NN B-NP O
post NN I-NP O
dialysis NN I-NP O
in IN B-VP O
some DT B-NP O
patients NNS I-NP O
They PRP O O
recommended VBD B-VP O
no DT B-NP O
further JJ I-NP O
work NN I-NP O
up RB O O
of IN B-VP O
this DT B-NP O
seizure NN I-NP O
episode NN I-NP O
and CC O O
recommended VBD B-VP O
no DT B-NP O
prophylaxis NN I-NP O
with IN B-VP O
an DT O O
antiepileptic JJ O O
The DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
dialysis NN I-NP O
again RB O O
on IN B-VP O
1/25/94 CD O O
per IN B-VP O
schedule NN B-NP O
After IN B-VP O
this DT B-NP O
dialysis NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
asymptomatic JJ O O
, , O O
not RB O O
orthostatic JJ O O
and CC O O
did VBD B-VP O
not RB O O
complain VB O O
of IN B-VP O
any DT B-NP O
light JJ I-NP O
headedness NN I-NP O
As IN B-VP O
the DT B-NP O
patient NN I-NP O
complained VBD B-VP O
of IN B-VP O
right JJ B-NP O
foot NN I-NP O
pain NN I-NP O
, , O O
right JJ B-NP O
foot NN I-NP O
films NNS I-NP O
were VBD B-VP O
obtained VBN O O
which WDT O O
revealed VBD B-VP O
nondisplaced JJ B-NP O
fractures NNS I-NP O
of IN B-VP O
the DT O O
second JJ O O
, , O O
third JJ O O
, , O O
fourth JJ O O
and CC O O
fifth JJ B-NP O
metatarsal NN I-NP O
bones NNS I-NP O
Orthopaedic NNP I-NP O
service NN I-NP O
was VBD B-VP O
consulted VBN O O
who WP O O
put VBD B-VP O
the DT B-NP O
patient NN I-NP O
in IN B-VP O
a DT B-NP O
bivalve NN I-NP O
cast NN I-NP O
with IN B-VP O
a DT B-NP O
toe NN I-NP O
plate NN I-NP O
Physical NNP I-NP O
therapy NN I-NP O
was VBD B-VP O
consulted VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
allowed VBN O O
to TO O O
sit VB O O
in IN B-VP O
a DT B-NP O
chair NN I-NP O
and CC O O
engage NN B-NP O
in IN B-VP O
nonweight JJ B-NP O
bearing NN I-NP O
activities NNS I-NP O
His PRP$ O O
foot NN B-NP O
was VBD B-VP O
elevated VBN O O
on IN B-VP O
three CD O O
pillows NNS B-NP O
for IN B-VP O
72 CD O O
hours NNS B-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
and CC O O
now RB O O
awaits VBZ O O
placement NN B-NP O
into IN B-VP O
a DT B-NP O
skilled JJ I-NP O
nursing NN I-NP O
facility NN I-NP O
for IN B-VP O
rehabilitation NN B-NP O
, , O O
given VBN O O
his PRP$ O O
casted JJ B-NP O
right NN I-NP O
lower RBR O O
leg NN B-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
his PRP$ O O
medications NNS B-NP O
from IN B-VP O
admission NN B-NP O
which WDT O O
include: VBZ O O
1 CD O O
) ) O O
Nephrocaps NNP B-NP B-m
, , O O
1 CD O B-do
PO NNP B-NP B-mo
qd RB O B-f
2 CD O O
) ) O O
Calcium NN B-NP B-m
carbonate NN I-NP I-m
, , O O
1250 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
tid VBZ O B-f
3 CD O O
) ) O O
DHT NNP B-NP B-m
, , O O
0.2 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
qd RB O B-f
4 CD O O
) ) O O
Stelazine NNP B-NP B-m
, , O O
2 CD O B-do
mg NN B-NP I-do
PO NNP I-NP B-mo
tid VBZ O B-f
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
seen VBN O O
again RB O O
in IN B-VP O
orthopaedics NNS B-NP O
clinic JJ O O
on IN B-VP O
Friday NNP B-NP O
, , O O
7/17/94 CD O O
at IN B-VP O
9:15 CD O O
a.m IN B-VP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
to TO O O
a DT B-NP O
rehab/skilled JJ I-NP O
nursing NN I-NP O
facility NN I-NP O
per IN B-VP O
wishes NNS B-NP O
of IN B-VP O
patient NN B-NP O
, , O O
family NN B-NP O
and CC O O
per IN B-VP O
recommendation NN B-NP O
of IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MAXIMO NNP I-NP O
RAUH NNP I-NP O
, , O O
M.D NNP B-NP O
Attending: NNP I-NP O
LUIS NNP I-NP O
B NNP I-NP O
DEPUGH NNP I-NP O
, , O O
M.D NNP B-NP O
NO72 NNP I-NP O
BJ379/1337 NNP I-NP O
Batch: NNP I-NP O
039 CD O O
Index NNP B-NP O
No NNP I-NP O
YQSP379ZHV NNP I-NP O
D: NNP I-NP O
9/17/94 CD O O
T: NNP B-NP O
9/17/94 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#597307 VBZ O O
077894674 CD O O
ZH NNP B-NP O
13194350 CD O O
2481419 CD O O
11/14/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Pulmonary NNP I-NP O
hypertension NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/20/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/13/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
BRUSTER NNP I-NP O
, , O O
RANDAL NNP B-NP O
B NNP I-NP O
338-46-12-6 JJ B-NP O
Sas NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
1/12/06 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
FITCH NNP I-NP O
, , O O
ERNIE NNP B-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
CALTRATE NNP I-NP B-m
600 CD O I-m
+ NNP B-NP I-m
D NNP I-NP I-m
( ( O I-m
CALCIUM NNP B-NP I-m
CARBONATE NNP I-NP I-m
1 CD O I-m
, , O I-m
500 CD O I-m
MG NNP B-NP I-m
( ( O I-m
) ) O I-m
2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
7/22 CD O O
) ) O O
Instructions: NNP B-NP O
please NN I-NP O
give VB O O
before IN B-VP O
1st CD O O
meal NN B-NP O
of IN B-VP O
day NN B-NP O
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
INSULIN NNP I-NP B-m
70/30 CD O I-m
HUMAN NNP B-NP I-m
40 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
BID NNP I-NP B-f
IMDUR NNP I-NP B-m
ER NNP I-NP I-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONITRATE NNP I-NP I-m
( ( O I-m
SR NNP B-NP I-m
) ) O I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
LABETALOL NNP B-NP B-m
HCL NNP I-NP I-m
400 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q8H NNP I-NP B-f
Starting NNP I-NP O
Tonight NNP I-NP O
( ( O O
2/22 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
LEVOXYL NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
112 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/26 CD O O
) ) O O
Instructions: NNP B-NP O
to TO O O
start VB O O
as IN B-VP O
outpatient JJ B-NP O
OXYCODONE NNP I-NP B-m
5-10 JJ B-NP B-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/11/06 CD O O
by IN B-VP O
PISELLI NNP B-NP O
, , O O
TRISTAN NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
OXYCODONE NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
931753288 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
Codeine; NNP B-NP O
reaction NN I-NP O
is VBZ O O
NAUSEA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
states NNS I-NP O
takes VBZ O O
at IN B-VP O
home NN B-NP O
ALDACTONE NNP I-NP B-m
( ( O I-m
SPIRONOLACTONE NNP B-NP I-m
) ) O I-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
with IN B-VP O
meals NNS B-NP O
DIOVAN NNP I-NP B-m
( ( O I-m
VALSARTAN NNP B-NP I-m
) ) O I-m
160 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Not RB O O
Applicable NNP B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Tyler NNP I-NP O
Brabston NNP I-NP O
, , O O
456-9721 JJ B-NP O
November NNP I-NP O
, , O O
2006 CD O O
@ NN B-NP O
9AM CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Statz NNP I-NP O
( ( O O
PCP NNP B-NP O
) ) O O
as IN B-VP O
previously RB O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
AMOXICILLIN NNP I-NP O
, , O O
Codeine NNP B-NP O
, , O O
LISINOPRIL NNP B-NP O
, , O O
NUTS NNP B-NP O
AND NNP I-NP O
STRAWBERRIES NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Pulmonary NNP B-NP O
hypertension NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
S/P NNP I-NP O
R NNP I-NP O
CEA NNP I-NP O
ON NNP I-NP O
6/10 CD O O
DM NNP B-NP O
SINCE NNP I-NP O
1980 CD O O
S.P NNP B-NP O
L NNP I-NP O
CAD NNP I-NP O
w VBD B-VP O
cardiac JJ B-NP O
catheterization; NN I-NP O
2005 CD O O
and CC O O
2006 CD O O
with IN B-VP O
stent JJ B-NP O
placement NN I-NP O
in IN B-VP O
the DT B-NP O
LCX NNP I-NP O
, , O O
LAD NNP B-NP O
, , O O
RCA NNP B-NP O
THR NNP I-NP O
S/P NNP I-NP O
L NNP I-NP O
TIBIAL NNP I-NP O
FRACTURE NNP I-NP O
HTN NNP I-NP O
S/P NNP I-NP O
PTCA NNP I-NP O
6/28 CD O O
RCA NNP B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
L NNP I-NP O
heart NN I-NP O
cardiac NN I-NP O
catheterization NN I-NP O
, , O O
which WDT O O
showed VBD B-VP O
no DT B-NP O
change NN I-NP O
from IN B-VP O
prior JJ B-NP O
studies NNS I-NP O
R NNP I-NP O
heart NN I-NP O
cardiac NN I-NP O
catheterization: NN I-NP O
pulmonary JJ B-NP O
hypertension NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
HPI: NNP I-NP O
77 CD O O
yo NNP B-NP O
woman NN I-NP O
with IN B-VP O
known VBN O O
CAD NNP B-NP O
( ( O O
s/p JJ O O
4 CD O O
stents NNS B-NP O
to TO O O
LCX/LAD/RCA VB O O
on IN B-VP O
two CD O O
separate JJ B-NP O
occasions NNS I-NP O
) ) O O
presents NNS B-NP O
w/ VBP O O
the DT B-NP O
sudden JJ I-NP O
onset NN I-NP O
of IN B-VP O
severe JJ B-NP O
sharp JJ I-NP O
chest NN I-NP O
pain NN I-NP O
at IN B-VP O
4AM CD O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
which WDT O O
awoke VBD B-VP O
her PRP O O
from IN B-VP O
sleep NN B-NP O
Severe NNP I-NP O
, , O O
L NNP B-NP O
sided VBD B-VP O
, , O O
worse JJR B-NP O
w JJ I-NP O
inspiration NN I-NP O
&amp; NNP I-NP O
a/b VBZ O O
nausea NN B-NP O
&amp; NNP I-NP O
diaphoresis; VBZ O O
no DT B-NP O
SOB NNP I-NP O
Pain NNP I-NP O
not RB O O
initially RB O O
relieved VBN O O
by IN B-VP O
nitro RB O B-m
Presented VBN O O
to TO O O
ED NNP B-NP O
where WRB O O
EKG NNP B-NP O
was VBD B-VP O
without IN B-VP O
changes NNS B-NP O
and CC O O
enzymes NNS B-NP O
neg RB O O
but CC O O
D NNP B-NP O
Dimer NNP I-NP O
elevated VBD B-VP O
at IN B-VP O
801 CD O O
Cont'd NNP B-NP O
to TO O O
c/o VB O O
chest JJS B-NP O
pain; NN I-NP O
heparin NN I-NP B-m
initiated VBN O O
, , O O
along IN B-VP O
w/ JJ B-NP O
ASA/Plavix NNP I-NP B-m
( ( O O
home NN B-NP B-do
dose NN I-NP I-do
); NNP I-NP O
found VBD B-VP O
to TO O O
have VB O O
HTN NNP B-NP O
at IN B-VP O
SBP NNP B-NP O
235 CD O O
b/l NN B-NP O
arms; NN I-NP O
In IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
hydralazine NN B-NP B-m
, , O O
SL NNP B-NP B-mo
nitro RB O B-m
, , O O
nitro JJ B-NP B-m
drip NN I-NP B-mo
and CC O O
then RB O O
pain VB O O
free; RB O O
given VBN O O
lopressor NN B-NP B-m
25 CD O B-do
Admit NNP B-NP O
for IN B-VP O
w/u NN B-NP O
of IN B-VP O
pain NN B-NP O
***** NNP I-NP O
PMHx: NNP I-NP O
IDDM NNP I-NP O
, , O O
diastolic JJ B-NP O
CHF NNP I-NP O
, , O O
hypothyroidism NN B-NP O
, , O O
s/p NN B-NP O
RCEA NNP I-NP O
, , O O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
Cards NNP I-NP O
HX: NNP I-NP O
0/4 CD O O
cath NN B-NP O
w NN I-NP O
stents NNS I-NP O
to TO O O
LAD/LCX VB O O
7/21 CD O O
cath NN B-NP O
w NN I-NP O
stents NNS I-NP O
x VBP O O
2 CD O O
to TO O O
RCA NNP B-NP O
Echo NNP I-NP O
data: NN I-NP O
known VBN O O
EF NNP B-NP O
55% CD O O
in IN B-VP O
'03 CD O O
***** JJ B-NP O
ALL: NNP I-NP O
PEANUTS NNP I-NP O
&amp; NNP I-NP O
STRAWBERRIES NNP I-NP O
***** NNP I-NP O
PE NNP I-NP O
on IN B-VP O
ADMIT: NNP B-NP O
NAD NNP I-NP O
, , O O
BP NNP B-NP O
142/56 CD O O
on IN B-VP O
nitro NN B-NP B-m
, , O O
RR NNP B-NP O
18 CD O O
, , O O
96% CD O O
on IN B-VP O
2L CD O O
, , O O
70 CD O O
, , O O
afeb; VBZ O O
no DT B-NP O
bruit; NN I-NP O
JVP NNP I-NP O
8cm; CD O O
rrr NN B-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
, , O O
bibasilar JJ B-NP O
crackles NNS I-NP O
, , O O
reproducible JJ B-NP O
sharp JJ I-NP O
pain NN I-NP O
abd NN I-NP O
nl NN I-NP O
alert NN I-NP O
, , O O
oriented VBD B-VP O
x JJ O O
3 CD O O
tho NN B-NP O
sometimes RB O O
requires VBZ O O
repeating VBG O O
Nonfocal NNP B-NP O
***** NNP I-NP O
**Labs: NNP I-NP O
Cr NNP I-NP O
1.8 CD O O
( ( O O
b/l NN B-NP O
) ) O O
Hct $ O O
34.4 CD O O
( ( O O
b/l NN B-NP O
) ) O O
D NNP B-NP O
Dimer NNP I-NP O
871 CD O O
CK NNP B-NP O
, , O O
MB NNP B-NP O
fraction NN I-NP O
, , O O
TNI NNP B-NP O
&lt;assay NNP I-NP O
three CD O O
times NNS B-NP O
**CXR: JJ B-NP O
cardiomegaly NN I-NP O
, , O O
no DT B-NP O
pulm NN I-NP O
edema VBZ O O
**V/Q NNP B-NP O
scan: NN I-NP O
intermediate NN I-NP O
prob NN I-NP O
**lenis NNP I-NP O
- : O O
neg NN B-NP O
**PE NN I-NP O
protocol NN I-NP O
chest NN I-NP O
CT: NNP I-NP O
neg NN I-NP O
for IN B-VP O
PE NNP B-NP O
Ground NNP I-NP O
glass NN I-NP O
diffusely RB O O
+LAD JJ B-NP O
Pulm NNP I-NP O
nodule NN I-NP O
, , O O
will MD O O
need VB O O
repeat NN B-NP O
for IN B-VP O
f/u NN B-NP O
in IN B-VP O
6-12 JJ B-NP O
months NNS I-NP O
***** IN B-VP O
Discharge NNP B-NP O
Exam: NNP I-NP O
BP NNP I-NP O
systolic JJ O O
130s CD O O
, , O O
rare JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
occ'l JJ B-NP O
crackles NNS I-NP O
at IN B-VP O
bases NNS B-NP O
which WDT O O
clear VBP O O
w IN B-VP O
coughing; NN B-NP O
alert NN I-NP O
, , O O
oriented VBD B-VP O
x JJ O O
3 CD O O
, , O O
somewhat RB O O
anxious JJ B-NP O
otw NN I-NP O
at IN B-VP O
baseline NN B-NP O
***** NNP I-NP O
A/P: NNP I-NP O
77F CD O O
w NN B-NP O
ho NN I-NP O
CAD NNP I-NP O
p/w NN I-NP O
chest NN I-NP O
pain NN I-NP O
of IN B-VP O
sudden JJ B-NP O
onset: NN I-NP O
Original NNP I-NP O
ddx NN I-NP O
includes VBZ O O
acs/usa/PE/hypertensive JJ B-NP O
urgency NN I-NP O
or CC O O
emergency/msk/chf VB O O
Given VBN O O
the DT B-NP O
excellenet NN I-NP O
response NN I-NP O
to TO O O
heparin VB O B-m
and CC O O
a DT B-NP O
negative JJ I-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
, , O O
and CC O O
the DT B-NP O
continuoation NN I-NP O
of IN B-VP O
pain NN B-NP O
despite IN B-VP O
control NN B-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
the DT B-NP O
cardiac JJ I-NP O
team NN I-NP O
felt VBD B-VP O
that IN B-VP O
the DT O O
most RBS O O
likely JJ B-NP O
diagnosis NN I-NP O
was VBD B-VP O
a DT B-NP B-r
pulmonary JJ I-NP I-r
embolism NN I-NP I-r
However RB O O
, , O O
had VBD B-VP O
neg VBN O O
lenis NN B-NP O
and CC O O
PE NNP B-NP O
CT NNP I-NP O
, , O O
so RB O O
unlikely JJ B-NP O
PE NNP I-NP O
She PRP O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
with IN B-VP O
follow JJ O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Sollitto NNP I-NP O
and CC O O
with IN B-VP O
her PRP$ O O
usual JJ B-NP O
PCP NNP I-NP O
Will NNP I-NP O
need VBP O O
monitoring NN B-NP O
of IN B-VP O
lytes NNS B-NP O
and CC O O
Cr NNP B-NP O
given VBN O O
possibility NN B-NP O
of IN B-VP O
contrast NN B-NP O
induced VBN O O
nephropathy JJ O O
in IN B-VP O
setting VBG O O
of IN B-VP O
underlying VBG O O
elev JJ B-NP O
Cr NNP I-NP O
**CV: NNP I-NP O
( ( O O
i JJ O O
): VBP O O
Chest JJS B-NP O
pain NN I-NP O
was VBD B-VP O
initially RB O O
concerning VBG O O
for IN B-VP O
ischemic JJ B-NP O
pain; NN I-NP O
however RB O O
, , O O
cardiac JJ B-NP O
catheterization NN I-NP O
was VBD B-VP O
unchanged JJ O O
from IN B-VP O
prior JJ B-NP O
cath NN I-NP O
She PRP O O
will MD O O
continue VB O O
asa/plavix/BB/statin; VB O B-m
she PRP O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP O
w VBP O O
serial JJ B-NP O
enzymes NNS I-NP O
and CC O O
ekgs VB O O
Given NNP B-NP O
an DT O O
intermediate JJ O O
to TO O O
high JJ B-NP O
probability NN I-NP O
story NN I-NP O
and CC O O
an DT B-NP O
intermediate JJ I-NP O
V-Q JJ I-NP O
scan NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
heparin NN B-NP B-m
and CC O O
PE NNP B-NP O
protocol VBP O O
CT NNP B-NP O
of IN B-VP O
chest NN B-NP O
was VBD B-VP O
obtained VBN O O
, , O O
which WDT O O
was VBD B-VP O
neg NN B-NP O
for IN B-VP O
PE NNP B-NP O
but CC O O
showed VBD B-VP O
a DT B-NP O
pulmonary JJ I-NP O
nodule; NN I-NP O
she PRP O O
will MD O O
need VB O O
repeat NN B-NP O
CT NNP I-NP O
for IN B-VP O
nodule NN B-NP O
f/u NN I-NP O
in IN B-VP O
6-12 JJ B-NP O
months NNS I-NP O
Excellent JJ B-NP O
oxygentation NN I-NP O
, , O O
stable JJ B-NP O
walking NN I-NP O
and CC O O
nearly RB O O
pain RB O O
free JJ O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
( ( O O
r JJ O O
): VBZ O O
no DT B-NP O
active JJ I-NP O
issues NNS I-NP O
, , O O
telemetry NN B-NP O
monitoring NN I-NP O
was VBD B-VP O
nl JJ O O
( ( O O
p JJ B-NP O
): NNP I-NP O
HTN NNP I-NP O
, , O O
w NN B-NP O
ss NN I-NP O
, , O O
uptitrated JJ B-NP B-do
labetalol NN I-NP B-m
for IN B-VP O
BP NNP B-NP B-r
**PULM: NNP I-NP O
PE NNP I-NP O
intermediate JJ B-NP O
pretest NN I-NP O
prob NN I-NP O
- : O O
elev NN B-NP O
d JJ B-NP O
dimer NN I-NP O
but CC O O
no DT B-NP O
ekg NN I-NP O
changes NNS I-NP O
, , O O
no DT B-NP O
o2 NN I-NP O
req NN I-NP O
, , O O
no DT O O
known VBN O O
ca MD O O
, , O O
no DT B-NP O
obvious JJ I-NP O
dvt NN I-NP O
risks NNS I-NP O
lenis RBR O O
negative JJ O O
, , O O
PE NNP B-NP O
CT NNP I-NP O
neg NN I-NP O
, , O O
so RB O O
PE NNP B-NP O
considered VBD B-VP O
unlikely JJ O O
, , O O
will MD O O
not RB O O
anticoagulate VB O O
Pulm NNP B-NP O
nodule NN I-NP O
on IN B-VP O
CT NNP B-NP O
, , O O
will MD O O
need VB O O
6-12 JJ B-NP O
month NN I-NP O
f/u JJ B-NP O
scan NN I-NP O
Of IN B-VP O
importance NN B-NP O
however RB O O
, , O O
has VBZ O O
pulm VBN O O
hypertension NN B-NP O
that WDT O O
is VBZ O O
new JJ O O
on IN B-VP O
R NNP B-NP O
heart NN I-NP O
cath NN I-NP O
and CC O O
given VBN O O
no DT B-NP O
other JJ I-NP O
explanation NN I-NP O
for IN B-VP O
sudden JJ B-NP O
pressure NN I-NP O
changes NNS I-NP O
( ( O O
impressively RB O O
higher JJR O O
since IN B-VP O
last JJ B-NP O
cath NN I-NP O
) ) O O
, , O O
may MD O O
have VB O O
primary JJ B-NP O
pulm NN I-NP O
HTN NNP I-NP O
Given NNP I-NP O
ground NN I-NP O
glass NN I-NP O
in IN B-VP O
lungs NNS B-NP O
and CC O O
pulm NN B-NP O
nodule NN I-NP O
, , O O
should MD O O
have VB O O
outpt VBN O O
pulm JJ B-NP O
eval NN I-NP O
for IN B-VP O
pulm NN B-NP O
parenchymal JJ B-NP O
disease NN I-NP O
in IN B-VP O
near JJ B-NP O
future NN I-NP O
**endo: NNP I-NP O
DM NNP I-NP O
on IN B-VP O
70/30 CD O O
at IN B-VP O
home NN B-NP O
Poor NNP I-NP O
control NN I-NP O
given VBN O O
HbA1c NNP B-NP O
elev NN I-NP O
and CC O O
high JJ B-NP O
finger NN I-NP O
sticks NNS I-NP O
in IN B-VP O
house NN B-NP O
Chgd NNP I-NP O
to TO O O
nph VB O B-m
and CC O O
short VB O O
acting VBG O O
pre-meal JJ B-NP B-f
insulin NN I-NP O
for IN B-VP O
tight JJ B-NP B-r
control NN I-NP I-r
Pt NNP I-NP O
agreed VBD B-VP O
to TO O O
incr VB O O
freq NN B-NP O
of IN B-VP O
SC NNP B-NP B-mo
insulin NN I-NP B-m
for IN B-VP O
tight JJ B-NP B-r
control NN I-NP I-r
, , O O
still RB O O
high JJ B-NP O
sugera NN I-NP O
in IN B-VP O
house NN B-NP O
Wanted VBD B-VP O
to TO O O
send VB O O
with IN B-VP O
NPH NNP B-NP B-m
and CC O O
short JJ O O
acting VBG O O
pre-meal JJ B-NP B-f
regimen NNS I-NP O
but CC O O
pt NNS B-NP O
refused VBD B-VP O
to TO O O
change VB O O
home NN B-NP O
regimen NNS I-NP O
despite IN B-VP O
repeated JJ B-NP O
explanations NNS I-NP O
of IN B-VP O
value NN B-NP O
of IN B-VP O
tighter JJR B-NP O
control NN I-NP O
Agreed VBD B-VP O
that IN B-VP O
she PRP O O
would MD O O
return VB O O
to TO O O
home VB O O
regimen NNS B-NP O
of IN B-VP O
70/30 CD O O
and CC O O
f/u JJ B-NP O
ASAP NNP I-NP O
with IN B-VP O
Dr NNP B-NP O
Douglas NNP I-NP O
Tippett NNP I-NP O
of IN B-VP O
Endocrinology NNP B-NP O
to TO O O
optimize VB O O
insulin NN B-NP B-m
regimen; NN I-NP I-m
also RB O O
should MD O O
f/u VB O O
with IN B-VP O
outpt JJ B-NP O
pcp NN I-NP O
for IN B-VP O
titration NN B-NP O
H/o NNP I-NP O
hypothyroidism NN I-NP O
TSH NNP I-NP O
elevated; NN I-NP O
gave VBD B-VP O
script NN B-NP O
for IN B-VP O
112 CD O B-do
mcg NN B-NP I-do
of IN B-VP O
levoxyl NN B-NP B-m
( ( O O
an DT B-NP O
increase NN I-NP O
) ) O O
and CC O O
contacted VBD B-VP O
her PRP$ O O
o/p JJ B-NP O
endocrinologist NN I-NP O
for IN B-VP O
follow VB O O
up RP O O
**MSK: NNP B-NP O
arthritis: IN B-VP O
oxycodone NN B-NP B-m
and CC O O
tylenol NN B-NP B-m
prn NN I-NP B-f
**FEN NNP I-NP O
mag/k/calcium NN I-NP B-m
**ppx: NNP I-NP O
heparin NN I-NP B-m
while IN B-VP B-du
in IN B-VP I-du
house NN B-NP I-du
**Code NN I-NP O
status: CC O O
FULL NNP B-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Work NNP I-NP O
with IN B-VP O
your PRP$ O O
VNA NNP B-NP O
for IN B-VP O
aggressive JJ B-NP O
diabetes NNS I-NP O
management NN I-NP O
Please NNP I-NP O
assess RB O O
blood VBD B-VP B-r
sugars NNS B-NP I-r
and CC O O
titrate JJ B-NP B-do
insulin NN I-NP B-m
as IN B-VP O
per IN B-VP O
your PRP$ O O
doctor NN B-NP O
Please NNP I-NP O
assess RB O O
blood NN B-NP O
pressures NNS I-NP O
as IN B-VP O
well RB O O
Check VB O O
your PRP$ O O
electrolytes NNS B-NP O
with IN B-VP O
VNA NNP B-NP O
in IN B-VP O
1 CD O O
week NN B-NP O
Continue NNP I-NP O
diabetes VBZ O O
teaching VBG O O
thank VB O O
you PRP O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Check NNP I-NP O
Cr NNP I-NP O
, , O O
lytes VBZ O O
in IN B-VP O
1 CD O O
week NN B-NP O
by IN B-VP O
VNA NNP B-NP O
given VBN O O
contrast NN B-NP O
load NN I-NP O
and CC O O
risk NN B-NP O
of IN B-VP O
nephropathy JJ B-NP O
Pulmonary NNP I-NP O
consult NN I-NP O
to TO O O
eval VB O O
for IN B-VP O
primary JJ B-NP O
pulm JJ I-NP O
disease NN I-NP O
Repeat NNP I-NP O
chest JJS B-NP O
CT NNP I-NP O
6-12 JJ B-NP O
months NNS I-NP O
to TO O O
f/u VB O O
nodule.Titrate JJ B-NP O
insulin NN I-NP B-m
by IN B-VP O
finger NN B-NP O
sticks NNS I-NP O
at IN B-VP O
PCP NNP B-NP O
Monitor NNP I-NP O
BP NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
RIEKERT NNP I-NP O
, , O O
NEWTON NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
PS482 NNP B-NP O
) ) O O
6/14/06 CD O O
@ $ O O
07:23 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#600921 VBZ O O
787502532 CD O O
BRH NNP B-NP O
92648184 CD O O
361994 CD O O
3/0/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/13/1992 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/2/1992 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
72 CD O O
year NN B-NP O
old JJ B-NP O
black JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
angina NN B-NP O
, , O O
adult NN B-NP O
onset NN I-NP O
diabetes NNS I-NP O
, , O O
admitted VBN O O
after IN B-VP O
a DT B-NP O
syncopal JJ I-NP O
event NN I-NP O
She PRP O O
has VBZ O O
a DT O O
known VBN O O
history NN B-NP O
of IN B-VP O
syncope NN B-NP O
which WDT O O
dates VBZ O O
as IN B-VP O
far RB O O
back RB O O
as IN B-VP O
the DT B-NP O
late JJ I-NP O
1960s NNS I-NP O
In IN B-VP O
1970 CD O O
she PRP O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
with IN B-VP O
30 CD O O
seconds NNS B-NP O
of IN B-VP O
generalized JJ B-NP O
tonic JJ I-NP O
convulsions NNS I-NP O
witnessed VBN O O
by IN B-VP O
her PRP$ O O
daughter NN B-NP O
An DT B-NP O
EEG NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
showed VBD B-VP O
diffuse IN B-VP O
theta NN B-NP O
waves NNS I-NP O
but CC O O
was VBD B-VP O
nonfocal JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Dilantin NNP B-NP B-m
for IN B-VP B-du
less JJR O I-du
than IN B-VP I-du
a DT B-NP I-du
year NN I-NP I-du
In IN B-VP O
1972 CD O O
she PRP O O
had VBD B-VP O
another DT B-NP O
episode NN I-NP O
of IN B-VP O
syncope NN B-NP O
associated VBN O O
with IN B-VP O
hyperventilation NN B-NP O
In IN B-VP O
1983 CD O O
she PRP O O
had VBD B-VP O
yet RB O O
another DT B-NP O
episode NN I-NP O
of IN B-VP O
syncope NN B-NP O
and CC O O
a DT O O
24 CD O O
hour NN B-NP O
Holter NNP I-NP O
started VBD B-VP O
after IN B-VP O
the DT B-NP O
event NN I-NP O
showed VBD B-VP O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
that WDT O O
went VBD B-VP O
as RB O O
low JJ O O
as IN B-VP O
38 CD O O
but CC O O
was VBD B-VP O
not RB O O
associated VBN O O
with IN B-VP O
any DT B-NP O
symptoms NNS I-NP O
In IN B-VP O
1987 CD O O
she PRP O O
had VBD B-VP O
a DT B-NP O
vasovagal JJ I-NP O
event NN I-NP O
which WDT O O
was VBD B-VP O
later RB O O
aggravated VBN O O
when WRB O O
her PRP$ O O
neighbor NN B-NP O
gave VBD B-VP O
her PRP O O
a DT B-NP O
nitroglycerin JJ I-NP B-m
tablet NN I-NP I-m
Throughout IN B-VP O
this DT B-NP O
time NN I-NP O
she PRP O O
has VBZ O O
had VBN O O
multiple VBN O O
other JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
syncope NN B-NP O
Her NNP I-NP O
last JJ B-NP O
episode NN I-NP O
was VBD B-VP O
in IN B-VP O
1989 CD O O
, , O O
when WRB O O
she PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiology NNP I-NP O
Team NNP I-NP O
for IN B-VP O
workup NN B-NP O
Her NNP I-NP O
EKG NNP I-NP O
was VBD B-VP O
unremarkable JJ O O
, , O O
24 CD O O
hour NN B-NP O
Holter NNP I-NP O
was VBD B-VP O
normal JJ O O
, , O O
an DT B-NP O
echocardiogram NN I-NP O
was VBD B-VP O
normal JJ O O
, , O O
and CC O O
she PRP O O
underwent VBD B-VP O
an DT B-NP O
exercise NN I-NP O
stress NN I-NP O
test NN I-NP O
which WDT O O
did VBD B-VP O
not RB O O
show VB O O
ischemic JJ B-NP O
changes NNS I-NP O
In IN B-VP O
March NNP B-NP O
of IN B-VP O
1992 CD O O
, , O O
she PRP O O
had VBD B-VP O
carotid NN B-NP O
ultrasounds NNS I-NP O
for IN B-VP O
symptoms NNS B-NP O
of IN B-VP O
right JJ B-NP O
hand NN I-NP O
and CC O O
leg NN B-NP O
numbness NN I-NP O
They PRP O O
did VBD B-VP O
not RB O O
show VB O O
significant JJ B-NP O
stenosis NN I-NP O
In IN B-VP O
March NNP B-NP O
of IN B-VP O
1992 CD O O
, , O O
she PRP O O
was VBD B-VP O
admitted VBN O O
and CC O O
ruled VBN O O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Isordil NNP B-NP B-m
and CC O O
Lopressor NNP B-NP B-m
empirically RB O O
but CC O O
these DT O O
were VBD B-VP O
later RB O O
discontinued VBN O O
In IN B-VP O
February NNP B-NP O
of IN B-VP O
1992 CD O O
she PRP O O
had VBD B-VP O
a DT B-NP O
clinic JJ I-NP O
visit NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Ed NNP I-NP O
Ville NNP I-NP O
who WP O O
is VBZ O O
her PRP$ O O
CALL NNP B-NP O
MEDICAL NNP I-NP O
CENTER NNP I-NP O
doctor NN I-NP O
The DT B-NP O
patient NN I-NP O
indicates VBZ O O
that IN B-VP O
she PRP O O
has VBZ O O
stable JJ B-NP O
exertional JJ I-NP O
angina NN I-NP O
without IN B-VP O
limitation NN B-NP O
of IN B-VP O
daily JJ B-NP O
activity NN I-NP O
, , O O
chest NN B-NP B-r
pain NN I-NP I-r
is VBZ O O
relieved VBN O O
with IN B-VP O
nitroglycerin NN B-NP B-m
and CC O O
her PRP$ O O
most RBS O O
recent JJ B-NP O
episode NN I-NP O
was VBD B-VP O
last JJ B-NP O
week NN I-NP O
She PRP O O
has VBZ O O
also RB O O
been VBN O O
on IN B-VP O
a DT B-NP B-do
stable JJ I-NP I-do
dose NN I-NP I-do
of IN B-VP O
Micronase NNP B-NP B-m
for IN B-VP B-du
the DT B-NP I-du
last JJ I-NP I-du
couple NN I-NP I-du
of IN B-VP I-du
years NNS B-NP I-du
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
awoke NN I-NP O
and CC O O
felt VBD B-VP O
fine JJ O O
, , O O
and CC O O
was VBD B-VP O
getting VBG O O
ready JJ O O
to TO O O
have VB O O
coffee NN B-NP O
with IN B-VP O
her PRP$ O O
friends NNS B-NP O
upstairs IN B-VP O
She PRP O O
was VBD B-VP O
reaching VBG O O
for IN B-VP O
something NN B-NP O
across IN B-VP O
the DT B-NP O
table NN I-NP O
and CC O O
suddenly RB O O
felt VBD B-VP O
a DT B-NP O
sharp JJ I-NP O
pain NN I-NP O
in IN B-VP O
her PRP$ O O
back NN B-NP O
and CC O O
fell VBD B-VP O
unconscious JJ O O
into IN B-VP O
the DT B-NP O
chair NN I-NP O
Estimated NNP I-NP O
loss NN I-NP O
of IN B-VP O
consciousness NN B-NP O
was VBD B-VP O
6-7 JJ B-NP O
minutes NNS I-NP O
She PRP O O
awoke VBD B-VP O
confused JJ O O
, , O O
did VBD B-VP O
not RB O O
know VB O O
her PRP$ O O
name NN B-NP O
and CC O O
had VBD B-VP O
a DT B-NP O
little JJ I-NP O
bit NN I-NP O
of IN B-VP O
difficulty NN B-NP O
seeing VBG O O
It PRP O O
was VBD B-VP O
unclear JJ O O
by IN B-VP O
her PRP$ O O
history NN B-NP O
whether IN B-VP O
her PRP$ O O
vision NN B-NP O
was VBD B-VP O
blurry NN B-NP O
or CC O O
whether IN B-VP O
she PRP O O
felt VBD B-VP O
that IN B-VP O
there EX O O
was VBD B-VP O
a DT O O
shade JJ O O
across IN B-VP O
her PRP$ O O
eyes NNS B-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
double JJ I-NP O
vision NN I-NP O
Prior NNP I-NP O
to TO O O
this DT B-NP O
event NN I-NP O
she PRP O O
did VBD B-VP O
not RB O O
experience VB O O
any DT B-NP O
prodrome NN I-NP O
or CC O O
aura NN B-NP O
She PRP O O
also RB O O
denied VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
or CC O O
palpitations NNS B-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
loss NN I-NP O
of IN B-VP O
bladder NN B-NP O
or CC O O
bowel NN B-NP O
function NN I-NP O
during IN B-VP O
the DT B-NP O
event NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
orange NN B-NP O
juice NN I-NP O
after IN B-VP O
the DT B-NP O
episode NN I-NP O
and CC O O
gradually RB O O
she PRP O O
regained VBD B-VP O
awareness NN B-NP O
of IN B-VP O
her PRP$ O O
surroundings NNS B-NP O
Her NNP I-NP O
vital JJ B-NP O
signs NNS I-NP O
were VBD B-VP O
stable JJ O O
She PRP O O
was VBD B-VP O
brought VBN O O
to TO O O
Tia NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
upper JJ B-NP O
extremity NN I-NP O
twitching NN I-NP O
by IN B-VP O
report NN B-NP O
from IN B-VP O
observers NNS B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Hypertension NNP I-NP O
dating VBG O O
at IN B-VP O
least JJS O O
10 CD O O
years NNS B-NP O
back RB O O
and CC O O
is VBZ O O
presently RB O O
not RB O O
requiring VBG O O
any DT B-NP O
treatment NN I-NP O
She PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
, , O O
as IN B-VP O
mentioned VBN O O
, , O O
of IN B-VP O
recurrent NN B-NP O
syncopal JJ B-NP O
events NNS I-NP O
She PRP O O
was VBD B-VP O
diagnosed VBN O O
a DT B-NP O
couple NN I-NP O
of IN B-VP O
years NNS B-NP O
ago RB O O
with IN B-VP O
adult NN B-NP B-r
onset VBN O O
diabetes NNS B-NP O
and CC O O
has VBZ O O
been VBN O O
on IN B-VP O
a DT B-NP B-do
stable JJ I-NP I-do
dose NN I-NP I-do
of IN B-VP O
Micronase NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
multiple JJ B-NP O
colonic JJ I-NP O
polyps NNS I-NP O
and CC O O
in IN B-VP O
1983 CD O O
underwent NN B-NP O
a DT B-NP O
left JJ I-NP O
hemicolectomy NN I-NP O
for IN B-VP O
multiple JJ B-NP O
polyps NNS I-NP O
In IN B-VP O
1988 CD O O
she PRP O O
underwent VBD B-VP O
an DT B-NP O
ileal JJ I-NP O
resection NN I-NP O
for IN B-VP O
large JJ B-NP O
inflammatory JJ I-NP O
polyps NNS I-NP O
leading VBG O O
to TO O O
a DT B-NP O
small JJ I-NP O
bowel NN I-NP O
obstruction NN I-NP O
She PRP O O
has VBZ O O
had VBD B-VP O
a DT B-NP O
cholecystectomy NN I-NP O
and CC O O
an DT B-NP O
appendectomy NN I-NP O
in IN B-VP O
the DT O O
distant JJ O O
past IN B-VP O
The DT B-NP O
patient NN I-NP O
also RB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
glaucoma NN B-NP O
In IN B-VP O
1973 CD O O
and CC O O
1976 CD O O
she PRP O O
had VBD B-VP O
a DT B-NP O
right JJ I-NP O
lower JJR I-NP O
extremity NN I-NP O
DVT NNP I-NP O
, , O O
etiology NN B-NP O
was VBD B-VP O
unclear JJ O O
The DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
smoke VB O O
, , O O
drink VB O O
or CC O O
use VB O O
any DT B-NP O
drugs NNS I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
include VBP O O
aspirin JJ O B-m
one CD O B-do
tablet NN B-NP I-do
q NN I-NP B-f
d NN I-NP I-f
, , O O
Questran NNP B-NP B-m
one CD O B-do
pack NN B-NP I-do
q NN I-NP B-f
d NN I-NP I-f
, , O O
Micronase NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Betaxolol NNP B-NP B-m
eye NN I-NP I-m
drops NNS I-NP I-m
bid VBD B-VP B-f
to TO O B-mo
each DT B-NP I-mo
eye NN I-NP I-mo
, , O O
Pilocarpine NNP B-NP B-m
eye NN I-NP I-m
drops NNS I-NP I-m
tid VBP O B-f
to TO O B-mo
each DT B-NP I-mo
eye NN I-NP I-mo
, , O O
eye NN B-NP O
drops NNS I-NP O
bid VBD B-VP O
to TO O O
each DT B-NP O
eye NN I-NP O
The DT B-NP O
patient JJ I-NP O
receives NNS I-NP O
monthly JJ B-NP B-f
Vitamin NNP I-NP B-m
B12 NNP I-NP O
injections NNS I-NP B-mo
She PRP O O
also RB O O
takes VBZ O O
nitroglycerin NN B-NP B-m
with IN B-VP O
chest NN B-NP B-r
pain NN I-NP I-r
FAMILY NNP I-NP O
HISTORY NNP I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
a DT B-NP O
brother NN I-NP O
who WP O O
suffered VBD B-VP O
a DT B-NP O
stroke NN I-NP O
at IN B-VP O
the DT B-NP O
age NN I-NP O
of IN B-VP O
74 CD O O
There EX O O
is VBZ O O
also RB O O
a DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
heart NN B-NP O
attacks VBZ O O
No DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
gastrointestinal JJ B-NP O
cancer NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
separated VBN O O
and CC O O
lives NNS B-NP O
by IN B-VP O
herself PRP O O
in IN B-VP O
Hutmill NNP B-NP O
Rd NNP I-NP O
, , O O
Bock NNP B-NP O
Tonlake NNP I-NP O
Son NNP I-NP O
, , O O
North NNP B-NP O
Dakota NNP I-NP O
32472 CD O O
She PRP O O
has VBZ O O
eight CD O O
children NNS B-NP O
with IN B-VP O
many JJ B-NP O
grandchildren NNS I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS NNP I-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
episodes NNS B-NP O
of IN B-VP O
sweats NNS B-NP O
and CC O O
nervousness NN B-NP O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
week NN I-NP O
which WDT O O
she PRP O O
describes VBZ O O
as IN B-VP O
being VBG O O
similar JJ O O
to TO O O
the DT B-NP O
hot JJ I-NP O
flashes NNS I-NP O
of IN B-VP O
menopause NN B-NP O
which WDT O O
she PRP O O
had VBD B-VP O
at IN B-VP O
age NN B-NP O
49 CD O O
These DT B-NP O
episodes NNS I-NP O
are VBP O O
occurring VBG O O
a DT B-NP O
few JJ I-NP O
times NNS I-NP O
a DT B-NP O
day NN I-NP O
but CC O O
do VBP O O
not RB O O
in IN B-VP O
any DT B-NP O
way NN I-NP O
coincide NN I-NP O
with IN B-VP O
her PRP$ O O
syncopal JJ B-NP O
events NNS I-NP O
She PRP O O
is VBZ O O
also RB O O
complaining VBG O O
of IN B-VP O
right JJ B-NP O
hand NN I-NP O
and CC O O
foot NN B-NP O
numbness NN I-NP O
which WDT O O
have VBP O O
increased VBN O O
in IN B-VP O
frequency NN B-NP O
The DT B-NP O
numbness NN I-NP O
occasionally RB O O
wakes VBZ O O
her PRP O O
up RP O O
at IN B-VP O
night NN B-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
motor NN I-NP O
weakness NN I-NP O
whatsoever RB O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
She PRP O O
is VBZ O O
an DT O O
elderly JJ O O
, , O O
mildly RB O O
obese JJ B-NP O
female NN I-NP O
, , O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
She PRP O O
was VBD B-VP O
afebrile RB O O
, , O O
with IN B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
126/70 CD O O
, , O O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
60 CD O O
, , O O
and CC O O
a DT B-NP O
respiratory JJ I-NP O
rate NN I-NP O
of IN B-VP O
18 CD O O
HEENT NNP B-NP O
exam NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
pinpoint JJ B-NP O
constriction NN I-NP O
of IN B-VP O
her PRP$ O O
pupils NNS B-NP O
secondary JJ O O
to TO O O
her PRP$ O O
glaucoma NN B-NP B-m
eyedrops VBZ O I-m
Her PRP$ O O
pupils NNS B-NP O
were VBD B-VP O
reactive JJ B-NP O
Her NNP I-NP O
throat NN I-NP O
was VBD B-VP O
benign JJ O O
She PRP O O
had VBD B-VP O
dentures NNS B-NP O
Her NNP I-NP O
neck NN I-NP O
was VBD B-VP O
supple JJ O O
, , O O
without IN B-VP O
lymphadenopathy JJ O O
or CC O O
thyromegaly JJ B-NP O
Chest NNP I-NP O
exam NN I-NP O
revealed VBD B-VP O
bibasilar JJ O O
, , O O
coarse JJ B-NP O
crackles NNS I-NP O
On IN B-VP O
cardiac JJ B-NP O
exam NN I-NP O
she PRP O O
had VBD B-VP O
no DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
distention NN I-NP O
, , O O
and CC O O
carotids NNS B-NP O
were VBD B-VP O
normal JJ O O
without IN B-VP O
bruits NNS B-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
, , O O
and CC O O
an DT B-NP O
occasional JJ I-NP O
S4 NNP I-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
murmurs JJ I-NP O
Abdominal NNP I-NP O
exam NN I-NP O
was VBD B-VP O
benign JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
guaiac JJ B-NP O
negative JJ I-NP O
Extremities NNS I-NP O
were VBD B-VP O
without IN B-VP O
edema NN B-NP O
and CC O O
there EX O O
was VBD B-VP O
no DT B-NP O
calf NN I-NP O
tenderness VBD B-VP O
The DT B-NP O
neurologic JJ I-NP O
exam NN I-NP O
was VBD B-VP O
entirely RB O O
nonfocal JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Includes VBZ O O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
143 CD O O
, , O O
potassium NN B-NP O
of IN B-VP O
4.3 CD O O
, , O O
chloride NN B-NP O
of IN B-VP O
109 CD O O
, , O O
bicarbonate NN B-NP O
of IN B-VP O
20 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
21; CD O O
creatinine NN B-NP O
was VBD B-VP O
1.0 CD O O
The DT B-NP O
glucose NN I-NP O
was VBD B-VP O
160 CD O O
Her NNP B-NP O
calcium NN I-NP O
and CC O O
phosphate NN B-NP O
were VBD B-VP O
normal JJ B-NP O
Her NNP I-NP O
hematocrit NN I-NP O
was VBD B-VP O
43.4 CD O O
, , O O
her PRP$ O O
white JJ B-NP O
count NN I-NP O
6.45 CD O O
with IN B-VP O
a DT O O
normal JJ O O
differential JJ O O
Her PRP$ O O
coagulation NN B-NP O
factors NNS I-NP O
were VBD B-VP O
normal JJ B-NP O
Her NNP I-NP O
liver NN I-NP O
function NN I-NP O
tests NNS I-NP O
were VBD B-VP O
normal JJ B-NP O
A NNP I-NP O
chest NN I-NP O
X NN I-NP O
ray NN I-NP O
showed VBD B-VP O
a DT B-NP O
calcific JJ I-NP O
aorta NN I-NP O
but CC O O
was VBD B-VP O
otherwise RB O O
clear JJ B-NP O
C NNP I-NP O
spine NN I-NP O
X NNP I-NP O
ray NN I-NP O
and CC O O
head NN B-NP O
CT NNP I-NP O
on IN B-VP O
admission NN B-NP O
were VBD B-VP O
also RB O O
negative JJ O O
The DT B-NP O
EKG NNP I-NP O
showed VBD B-VP O
no DT B-NP O
changes NNS I-NP O
from IN B-VP O
her PRP$ O O
baseline JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP O
cardiac JJ I-NP O
monitor NN I-NP O
, , O O
and CC O O
her PRP$ O O
Micronase NNP B-NP B-m
was VBD B-VP O
held VBN O O
In IN B-VP O
fact NN B-NP O
, , O O
her PRP$ O O
fingerstick NN B-NP O
glucose NN I-NP O
went VBD B-VP O
as RB O O
low JJ O O
as IN B-VP O
80 CD O O
that IN B-VP O
evening VBG O O
On IN B-VP O
day NN B-NP O
two CD O O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
syncopal JJ B-NP O
event NN I-NP O
while IN B-VP O
in IN B-VP O
house NN B-NP O
She PRP O O
was VBD B-VP O
apparently RB O O
walking VBG O O
about RB O O
after IN B-VP O
having VBG O O
washed VBD B-VP O
her PRP O O
face NN B-NP O
and CC O O
was VBD B-VP O
reaching VBG O O
to TO O O
pull VB O O
the DT B-NP O
curtain NN I-NP O
when WRB O O
she PRP O O
began VBD B-VP O
feeling VBG O O
lightheaded VBD B-VP O
She PRP O O
told VBD B-VP O
the DT B-NP O
nurse NN I-NP O
immediately RB O O
, , O O
who WP O O
tried VBD B-VP O
to TO O O
get VB O O
her PRP O O
on IN B-VP O
the DT B-NP O
bed NN I-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
collapsed VBD B-VP O
on IN B-VP O
the DT B-NP O
bed NN I-NP O
, , O O
was VBD B-VP O
limp VBN O O
and CC O O
lost VBN O O
consciousness NN B-NP O
for IN B-VP O
about IN B-VP O
3-5 JJ B-NP O
minutes NNS I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
systolic JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
200/105 CD O O
and CC O O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
90 CD O O
There EX O O
were VBD B-VP O
no DT B-NP O
changes NNS I-NP O
on IN B-VP O
the DT B-NP O
cardiac JJ I-NP O
monitor NN I-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
maintain VB O O
a DT B-NP O
strong JJ I-NP O
pulse NN I-NP O
at IN B-VP O
all DT B-NP O
times NNS I-NP O
She PRP O O
was VBD B-VP O
given VBN O O
Nitro NNP B-NP B-m
Paste NNP I-NP I-m
and CC O O
1 CD O B-do
amp NN B-NP I-do
of IN B-VP O
D50 NNP B-NP B-m
Fingerstick NNP I-NP O
glucose NN I-NP O
was VBD B-VP O
then RB O O
noted VBN O O
to TO O O
be VB O O
232 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
witnessed VBN O O
to TO O O
have VB O O
mild JJ B-NP O
twitching NN I-NP O
of IN B-VP O
her PRP$ O O
jaw NN B-NP O
and CC O O
eyelids NNS B-NP O
and CC O O
after IN B-VP O
five CD O O
minutes NNS B-NP O
, , O O
she PRP O O
opened VBD B-VP O
her PRP O O
eyes NNS B-NP O
but CC O O
was VBD B-VP O
not RB O O
able JJ O O
to TO O O
respond VB O O
When WRB O O
asked VBN O O
to TO O O
give VB O O
her PRP O O
name NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
not RB O O
able JJ O O
to TO O O
answer VB O O
The DT B-NP O
confusion NN I-NP O
subsided VBD B-VP O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
couple NN I-NP O
of IN B-VP O
minutes NNS B-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
able JJ O O
to TO O O
respond VB O O
and CC O O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBN O O
However RB O O
, , O O
she PRP O O
had VBD B-VP O
no DT B-NP O
recollection NN I-NP O
of IN B-VP O
the DT B-NP O
event NN I-NP O
Further NNP I-NP O
workup NN I-NP O
included VBD B-VP O
a DT B-NP O
head NN I-NP O
MRI NNP I-NP O
, , O O
MR NNP B-NP O
angiogram NN I-NP O
of IN B-VP O
her PRP$ O O
vertebrobasilar JJ B-NP O
circulation NN I-NP O
, , O O
a DT B-NP O
sleep NN I-NP O
deprived VBN O O
EEG NNP B-NP O
, , O O
a DT B-NP O
cardiac JJ I-NP O
echo NN I-NP O
, , O O
and CC O O
a DT O O
24 CD O O
hour NN B-NP O
Holter NNP I-NP O
All NNP I-NP O
of IN B-VP O
the DT B-NP O
above NN I-NP O
were VBD B-VP O
negative JJ O O
We PRP O O
also RB O O
applied VBD B-VP O
carotid JJ B-NP O
sinus JJ I-NP O
stimulation NN I-NP O
and CC O O
she PRP O O
showed VBD B-VP O
no DT B-NP O
change NN I-NP O
in IN B-VP O
heart NN B-NP O
rate NN I-NP O
to TO O O
either DT B-NP O
side NN I-NP O
The DT B-NP O
etiology NN I-NP O
of IN B-VP O
her PRP$ O O
syncopal JJ B-NP O
event NN I-NP O
is VBZ O O
not RB O O
completely RB O O
clear JJ O O
It PRP O O
appears VBZ O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
does VBZ O O
have VB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
a DT B-NP O
witnessed JJ I-NP O
seizure NN I-NP O
but CC O O
also RB O O
has VBZ O O
had VBN O O
syncopal JJ B-NP O
events NNS I-NP O
consistent JJ O O
with IN B-VP O
either DT B-NP O
bradycardia NN I-NP O
or CC O O
a DT B-NP O
vasovagal JJ I-NP O
event NN I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
to TO O O
home VB O O
with IN B-VP O
plans NNS B-NP O
for IN B-VP O
a DT B-NP O
repeat NN I-NP O
24 CD O O
hour NN B-NP O
Holter NNP I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
FOLLOW NNP I-NP O
UP: NNP I-NP O
She PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Danilo NNP I-NP O
Mcquaid NNP I-NP O
in IN B-VP O
the DT B-NP O
THERPLEA NNP I-NP O
HOSPITAL NNP I-NP O
Clinic NNP I-NP O
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Stable NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
include VBP O O
aspirin JJ O B-m
one CD O B-do
tablet NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Questran NNP B-NP B-m
one CD O B-do
package NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Pilocarpine NNP B-NP B-m
eye NN I-NP O
drops NNS I-NP O
tid VBP O B-f
per IN B-VP B-mo
eye NN B-NP I-mo
, , O O
Betaxolol NNP B-NP B-m
eye NN I-NP I-m
drops NNS I-NP I-m
bid VBP O B-f
per IN B-VP B-mo
eye NN B-NP I-mo
, , O O
eye NN B-NP O
drops NNS I-NP O
bid VBP O O
per IN B-VP O
eye NN B-NP O
, , O O
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
prn NN I-NP B-f
chest NN I-NP B-r
pain NN I-NP I-r
, , O O
Naprosyn NNP B-NP B-m
375 CD O B-do
mg NN B-NP I-do
tid NN I-NP B-f
prn NN I-NP I-f
DISCHARGE NNP I-NP O
DIAGNOSIS: NNP I-NP O
SYNCOPE NNP I-NP O
OTHER NNP I-NP O
DIAGNOSES: NNP I-NP O
BORDERLINE NNP I-NP O
TYPE NNP I-NP O
II NNP I-NP O
DIABETES NNP I-NP O
, , O O
STABLE NNP B-NP O
EXERTIONAL NNP I-NP O
ANGINA NNP I-NP O
, , O O
AND NNP B-NP O
GLAUCOMA NNP I-NP O
IQ732/2070 NNP I-NP O
CHUCK NNP I-NP O
VONDRASEK NNP I-NP O
, , O O
M.D NNP B-NP O
TN3 NNP I-NP O
D: NNP I-NP O
5/8/92 CD O O
Batch: NNP B-NP O
8886 CD O O
Report: NNP B-NP O
W5608N6 NNP I-NP O
T: NNP I-NP O
8/0/92 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
GRUNER NNP I-NP O
, , O O
MAURO NNP B-NP O
RUPERT NNP I-NP O
KRAIG NNP I-NP O
cc: VBD B-VP O
1 CD O O
HARRIS NNP B-NP O
LEMBRICK NNP I-NP O
, , O O
M.D./DEPT NNP B-NP O
OF NNP I-NP O
MED NNP I-NP O
2 CD O O
ELBERT NNP B-NP O
STREJAN NNP I-NP O
, , O O
M.D./DEPT NNP B-NP O
OF NNP I-NP O
MED NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#603643 VBZ O O
168640048 CD O O
CHCC NNP B-NP O
77575346 CD O O
4523497 CD O O
0/20/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Diabetes NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/5/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/21/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
POUPARD NNP I-NP O
, , O O
RUBEN NNP B-NP O
ELIAS NNP I-NP O
414-48-72-5 JJ B-NP O
Hiypendwau NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
11/1/05 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
LILJEBERG NNP I-NP O
, , O O
PHILIP NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
INSULIN NNP I-NP B-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
40 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/1 CD O O
) ) O O
INSULIN NNP B-NP B-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
40 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QPM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/1 CD O O
) ) O O
INSULIN NNP B-NP B-m
REGULAR NNP I-NP I-m
HUMAN NNP I-NP I-m
15 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
6/1 CD O O
) ) O O
Instructions: NNP B-NP O
can MD O O
give VB O O
with IN B-VP O
am VBP O B-f
dose NN B-NP O
of IN B-VP O
nph JJ B-NP B-m
GLUCOMETER NNP I-NP O
1 CD O O
EA NNP B-NP O
SC NNP I-NP O
x1 NNP I-NP O
INSULIN NNP I-NP B-m
REGULAR NNP I-NP I-m
HUMAN NNP I-NP I-m
20 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QPM NNP I-NP B-f
INSULIN NNP I-NP B-m
REGULAR NNP I-NP I-m
HUMAN NNP I-NP I-m
10 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
AC NNP I-NP B-f
Instructions: NNP I-NP O
Take VB O O
if IN B-VP O
pre-lunch JJ B-NP O
FS NNP I-NP O
&gt; NNP I-NP O
180 CD O O
METFORMIN NNP B-NP B-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Kohout NNP I-NP O
( ( O O
new JJ B-NP O
PCP NNP I-NP O
) ) O O
9/13/05 CD O O
@ $ O O
2:50pm CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Lackner NNP I-NP O
( ( O O
Endocrine NNP B-NP O
) ) O O
10/13/05 CD O O
@ $ O O
7:30pm CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Diabetic NNP I-NP O
Ketoacidosis NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Diabetes VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
Diabetes NNP I-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
23 CD O O
yo NN B-NP O
M NNP I-NP O
w/ NN I-NP O
morbid NN I-NP O
obesity NN I-NP O
p/w VBP O O
1 CD O O
wk NN B-NP O
of IN B-VP O
polyuria NN B-NP O
and CC O O
polydypsia NN B-NP O
and CC O O
3 CD O O
days NNS B-NP O
of IN B-VP O
nausea NN B-NP O
and CC O O
vomiting VBG O O
Mr NNP B-NP O
Longo NNP I-NP O
was VBD B-VP O
in IN B-VP O
his PRP$ O O
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
one CD O O
week NN B-NP O
ago RB O O
when WRB O O
he PRP O O
started VBD B-VP O
to TO O O
have VB O O
a DT B-NP O
decreased JJ I-NP O
apetitie NN I-NP O
, , O O
polyuria NN B-NP O
and CC O O
polydypsia NN B-NP O
He PRP O O
would MD O O
wake VB O O
up RP O O
every DT O O
2hours CD O O
at IN B-VP O
night NN B-NP O
to TO O O
urinate VB O O
He PRP O O
was VBD B-VP O
drinking VBG O O
vitamin JJ B-NP O
water NN I-NP O
and CC O O
Gatorade NNP B-NP O
to TO O O
keep VB O O
from IN B-VP O
being VBG O O
too RB O O
dehydrated VBN O O
He PRP O O
denies VBZ O O
any DT B-NP O
URI NNP I-NP O
symptoms NNS I-NP O
, , O O
cough NN B-NP O
, , O O
SOB NNP B-NP O
, , O O
dysuria NN B-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
or CC O O
diarrhea NN B-NP O
during IN B-VP O
the DT B-NP O
past JJ I-NP O
couple NN I-NP O
of IN B-VP O
weeks NNS B-NP O
He PRP O O
does VBZ O O
however RB O O
complain VB O O
of IN B-VP O
some DT B-NP O
DOE NNP I-NP O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
week NN I-NP O
3 CD O O
days NNS B-NP O
ago RB O O
, , O O
he PRP O O
developed VBD B-VP O
morning NN B-NP O
nausea NN I-NP O
and CC O O
vomiting VBG O O
The DT B-NP O
vomit NN I-NP O
was VBD B-VP O
nonbilious JJ O O
, , O O
nonbloody JJ B-NP O
vomit NN I-NP O
and CC O O
no DT B-NP O
associated JJ I-NP O
abdominal JJ I-NP O
pain NN I-NP O
or CC O O
diarrhea NN B-NP O
He PRP O O
denies VBZ O O
any DT B-NP O
HA NNP I-NP O
, , O O
visual JJ B-NP O
changes NNS I-NP O
, , O O
changes NNS B-NP O
in IN B-VP O
mental JJ B-NP O
status NN I-NP O
or CC O O
dizziness NN B-NP O
He PRP O O
also RB O O
denies VBZ O O
sick JJ B-NP O
contacts NNS I-NP O
He PRP O O
has VBZ O O
not RB O O
had VBN O O
any DT B-NP O
change NN I-NP O
in IN B-VP O
weight NN B-NP O
PMH: NNP I-NP O
Morbid NNP I-NP O
obesity NN I-NP O
MEDICATIONS: NNP I-NP O
Pepcid NNP I-NP B-m
AC NNP I-NP I-m
QHS NNP I-NP B-f
ALLERGIES: NNP I-NP O
NKDA NNP I-NP O
SH: NNP I-NP O
Marital NNP I-NP O
Status: NNP I-NP O
not RB O O
married VBD B-VP O
Lives NNS B-NP O
with IN B-VP O
girlfriend NN B-NP O
Not RB O O
working VBG O O
TOB NNP B-NP O
negative; JJ B-NP O
ETOH NNP I-NP O
negative; NN I-NP O
ILLICITS NNP I-NP O
negative JJ B-NP O
FH: NNP I-NP O
Maternal NNP I-NP O
grandmother NN I-NP O
with IN B-VP O
DM/Htn NNP B-NP O
ROS: NNP I-NP O
See NNP I-NP O
HPI NNP I-NP O
for IN B-VP O
pertinent JJ B-NP O
positives NNS I-NP O
PHYSICAL NNP I-NP O
EXAM NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
VS: NNP I-NP O
T NNP I-NP O
97.5 CD O O
, , O O
HR NNP B-NP O
103 CD O O
, , O O
BP NNP B-NP O
110/60 CD O O
, , O O
RR NNP B-NP O
20 CD O O
, , O O
O2sat NNP B-NP O
96%RA CD O O
GENERAL: NNP B-NP O
Morbidly NNP I-NP O
obese JJ B-NP O
young JJ I-NP O
man NN I-NP O
, , O O
lying VBG O O
in IN B-VP O
bed NN B-NP O
, , O O
comfortable JJ B-NP O
NAD NNP I-NP O
HEENT: NNP I-NP O
NCAT NNP I-NP O
, , O O
sclera NN B-NP O
anicteric; RB O O
mucous JJ B-NP O
membranes NNS I-NP O
are VBP O O
dry JJ O O
, , O O
OP NNP B-NP O
without IN B-VP O
erythema NN B-NP O
or CC O O
thrush NN B-NP O
Fundi NNP I-NP O
with IN B-VP O
clear JJ B-NP O
margins NNS I-NP O
CHEST:CTAB NNP I-NP O
CV: NNP I-NP O
RRR NNP I-NP O
, , O O
audible JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
2+ CD O O
and CC O O
symmetric JJ B-NP O
radial NN I-NP O
, , O O
2+ CD O O
and CC O O
symmetric JJ B-NP O
pedal NN I-NP O
pulses VBZ O O
ABD: NNP B-NP O
Positive NNP I-NP O
bowel NN I-NP O
sounds VBZ O O
Obese JJ B-NP O
abdomen NNS I-NP O
Nontender NNP I-NP O
, , O O
non-distended JJ B-NP O
Hepatic NNP I-NP O
margin NN I-NP O
, , O O
soft JJ O O
, , O O
palpable JJ O O
just RB O O
under IN B-VP O
the DT B-NP O
costal JJ I-NP O
margin NN I-NP O
NEURO: NNP I-NP O
AOx3 NNP I-NP O
CNII-XII NNP I-NP O
intact JJ B-NP O
Strenght: NNP I-NP O
UE NNP I-NP O
5/5 CD O O
, , O O
LE NNP B-NP O
5/5 CD O O
bilaterally RB O O
Sensation NNP B-NP O
intact JJ O O
to TO O O
light JJ B-NP O
touch NN I-NP O
and CC O O
temperature NN B-NP O
Reflexes NNP I-NP O
1+ CD O O
brachial NN B-NP O
, , O O
brachioradialis NN B-NP O
and CC O O
patellar JJ B-NP O
DATA: NNP I-NP O
Chemistry NNP I-NP O
On IN B-VP O
admission: NN B-NP O
Chem7: NNP I-NP O
131/4/92/22/11/1.1/440 CD O O
ABG: NNP B-NP O
PO2 NNP I-NP O
82 CD O O
, , O O
PH NNP B-NP O
7.39 CD O O
, , O O
PCO2 NNP B-NP O
35 CD O O
TP NNP B-NP O
8.5 CD O O
, , O O
Alb NNP B-NP O
4.8 CD O O
, , O O
AST NNP B-NP O
42 CD O O
, , O O
ALT NNP B-NP O
76 CD O O
, , O O
Bt NNP B-NP O
0.5 CD O O
, , O O
Alk NNP B-NP O
80 CD O O
UA: NNP B-NP O
pH5 NN I-NP O
, , O O
3+ CD O O
gluc NN B-NP O
, , O O
2+ CD O O
ketones NNS B-NP O
, , O O
neg JJ B-NP O
bili NN I-NP O
, , O O
1+ CD O O
blood NN B-NP O
, , O O
neg JJ B-NP O
Leuks NNP I-NP O
, , O O
neg JJ B-NP O
nitrite JJ I-NP O
RADIOLOGY: NNP I-NP O
Chest NNP I-NP O
Xray: NNP I-NP O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
an DT B-NP O
acute JJ I-NP O
cardiopulm NN I-NP O
process NN I-NP O
EKG: NNP I-NP O
HR NNP I-NP O
100bpm CD O O
, , O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
, , O O
normal JJ B-NP O
PR NNP I-NP O
, , O O
QRS NNP B-NP O
and CC O O
QT NNP B-NP O
intervals VBZ O O
No DT B-NP O
ST-T JJ I-NP O
wave NN I-NP O
abnormalities NNS I-NP O
J-point NNP I-NP O
elevations NNS I-NP O
in IN B-VP O
v2-v6 JJ B-NP O
ASSESSMENT/HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
23 CD O O
yo NN B-NP O
M NNP I-NP O
w/ NN I-NP O
morbid NN I-NP O
obesity NN I-NP O
who WP O O
p/w VBZ O O
polyuria NN B-NP O
, , O O
polydypsia NN B-NP O
, , O O
nausea NN B-NP O
and CC O O
vomiting VBG O O
Given NNP B-NP O
presentation NN I-NP O
and CC O O
lab NN B-NP O
values NNS I-NP O
, , O O
patient NN B-NP O
is VBZ O O
in IN B-VP O
diabetic JJ B-NP O
ketoacidosis: NN I-NP O
BS&gt;200 NNP I-NP O
, , O O
ketonuria NN B-NP O
, , O O
pH&lt;7.4 VBP O O
1 CD O O
DKA: NNP B-NP O
New NNP I-NP O
diagnosis NN I-NP O
of IN B-VP O
diabetes NNS B-NP O
Unclear IN B-VP O
what WP O O
the DT B-NP O
trigger NN I-NP O
was VBD B-VP O
for IN B-VP O
the DT B-NP O
DKA NNP I-NP O
- : O O
no DT B-NP O
signs/symptoms NNS I-NP O
of IN B-VP O
infection NN B-NP O
No NNP I-NP O
h/o NN I-NP O
of IN B-VP O
stress NN B-NP O
in IN B-VP O
recent JJ B-NP O
weeks NNS I-NP O
a DT B-NP O
Corrected NNP I-NP O
hyperglycemia NN I-NP B-r
and CC O O
acidosis NN B-NP B-r
with IN B-VP O
insulin NN B-NP B-m
insulin NN I-NP B-m
- : O O
anion NN B-NP O
gap NN I-NP O
resolved VBN O O
by IN B-VP O
HD#2 NNP B-NP O
b NN I-NP O
Repleted NNP I-NP O
volume NN I-NP O
and CC O O
electrolytes: JJ B-NP O
whole JJ I-NP O
body NN I-NP O
potassium NN I-NP O
depleted VBD B-VP O
- : O O
started VBN O O
NS NNP B-NP O
w/ VBD B-VP O
20mEQ CD O B-do
of IN B-VP O
KCl NNP B-NP B-m
` `` O O
give VB O O
2L CD O O
of IN B-VP O
fluid NN B-NP O
in IN B-VP O
total JJ O O
Until IN B-VP B-du
gap NN B-NP O
normalized VBN O O
and CC O O
potassium JJ O O
became VBD B-VP O
stable JJ O O
at IN B-VP O
4 CD O O
c.Blood NN B-NP O
sugars NNS I-NP O
were VBD B-VP O
erratic JJ O O
during IN B-VP O
entire JJ B-NP O
Hospital NNP I-NP O
stay NN I-NP O
Difficult NNP I-NP O
to TO O O
control VB O O
on IN B-VP O
high JJ B-NP B-do
high JJ I-NP B-do
levels NNS I-NP I-do
levels NNS I-NP I-do
of IN B-VP O
NPH NNP B-NP B-m
and CC O O
regular JJ O B-m
alone RB O O
Adequate NNP B-NP O
control NN I-NP O
to TO O O
BS NNP B-NP O
= NNP I-NP O
200s CD O O
achieved VBD B-VP O
with: NN B-NP O
Metformin NNP I-NP B-m
500mg CD O B-do
bid; NN B-NP B-f
AM NNP I-NP B-f
AM NNP I-NP B-f
-- : O O
NPH NNP B-NP B-m
40u CD O B-do
, , O O
reg VBD B-VP B-m
15u; CD O B-do
lunch NN B-NP B-f
-- : O O
Reg NNP B-NP B-m
10u CD O B-do
if IN B-VP O
BS&gt;180; NNP B-NP O
PM NNP I-NP B-f
PM NNP I-NP B-f
NPH NNP I-NP B-m
40u CD O B-do
, , O O
reg VBD B-VP B-m
20u CD O B-do
Endocrine NNP B-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
agreed VBN O O
with IN B-VP O
plan NN B-NP O
Antibodies NNS I-NP O
for IN B-VP O
?typeI JJ B-NP O
DM NNP I-NP O
sent VBD B-VP O
F/U NNP B-NP O
with IN B-VP O
endocrine NN B-NP O
scheduled VBN O O
d.Patient NN B-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP O
diabetic JJ I-NP O
diet NN I-NP O
, , O O
received VBD B-VP O
a DT B-NP O
nutrition NN I-NP O
consult NN I-NP O
with IN B-VP O
diabetes NNS B-NP O
education NN I-NP O
He PRP O O
also RB O O
received VBD B-VP O
education NN B-NP O
on IN B-VP O
finger NN B-NP O
sticks NNS I-NP O
and CC O O
insulin JJ B-NP B-m
administration NN I-NP O
The DT B-NP O
importance NN I-NP O
of IN B-VP O
health NN B-NP O
care NN I-NP O
and CC O O
compliance NN B-NP O
was VBD B-VP O
asserted VBN O O
Regular JJ B-NP O
exercise NN I-NP O
and CC O O
only RB O O
3 CD O O
meals NNS B-NP O
a DT B-NP O
day NN I-NP O
w/ POS O O
limitation NN B-NP O
of IN B-VP O
snacks NNS B-NP O
was VBD B-VP O
encouraged VBN O O
e RB O O
Follow NNP B-NP O
up RP O O
appointments NNS B-NP O
w/ IN B-VP O
Dr NNP B-NP O
Duewall NNP I-NP O
and CC O O
Endocrine NNP B-NP O
were VBD B-VP O
obtained VBN O O
-------------------- NNP B-NP O
FULL NNP I-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
-Be NNP I-NP O
sure NN I-NP O
to TO O O
continue VB O O
compliance NN B-NP O
with IN B-VP O
a DT B-NP O
diabetic JJ I-NP O
diet NN I-NP O
-- : O O
3 CD O O
meals NNS B-NP O
a DT B-NP O
day NN I-NP O
=Take VB O O
your PRP$ O O
insulin NN B-NP B-m
at IN B-VP O
the DT B-NP O
designated JJ I-NP O
times NNS I-NP O
-Take VBP O O
Metformin NNP B-NP B-m
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
-Continue NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
-Be NNP I-NP O
aware NN I-NP O
of IN B-VP O
potential JJ B-NP O
low JJ I-NP O
blood NN I-NP O
sugar NN I-NP O
levels NNS I-NP O
and CC O O
symptoms NNS B-NP O
-Folow VBP O O
up RP O O
with IN B-VP O
your PRP$ O O
PCP NNP B-NP O
Dr NNP I-NP O
Benett NNP I-NP O
in IN B-VP O
May NNP B-NP O
-Follow VB O O
up RP O O
with IN B-VP O
Endocrine NNP B-NP O
clinic NN I-NP O
-- : O O
Dr NNP B-NP O
Rataczak NNP I-NP O
-- : O O
on IN B-VP O
February NNP B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
-Diabetic NNP I-NP O
insulin NN I-NP B-m
regimen: NN I-NP O
QAM: NNP I-NP B-f
QAM: NNP I-NP B-f
40u CD O B-do
NPH NNP B-NP B-m
, , O O
15u CD O B-do
reg NN B-NP B-m
@noon: VBD B-VP B-f
10u CD O B-do
reg NN B-NP B-m
if IN B-VP O
BS&gt;180 NNP B-NP O
QPM: NNP I-NP B-f
QPM: NNP I-NP B-f
40u CD O B-do
NPH NNP B-NP B-m
, , O O
20u CD O B-do
reg NN B-NP B-m
Metformin NNP I-NP B-m
500mg CD O B-do
bid NN B-NP B-f
-Patient NN I-NP O
to TO O O
attempt VB O O
3meals CD O O
a DT B-NP O
day NN I-NP O
of IN B-VP O
diabetic JJ B-NP O
diet; NN I-NP O
check NN I-NP O
BS NNP I-NP O
qid; NN I-NP O
administer RB O O
insulin NN B-NP B-m
as IN B-VP O
recommended; NN B-NP O
have VBP O O
regular JJ B-NP O
exercise NN I-NP O
-F/U NN I-NP O
w/ NN I-NP O
PCP NNP I-NP O
and CC O O
Endocrine NNP B-NP O
at IN B-VP O
designated VBN O O
appointments NNS B-NP O
No RB O O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
PADAMADAN NNP I-NP O
, , O O
WILLIAMS NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
AM13 NNP B-NP O
) ) O O
11/1/05 CD O O
@ $ O O
11 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#610966 VBZ O O
329859652 CD O O
VGMUOHC NNP B-NP O
45873980 CD O O
8127980 CD O O
10/18/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
RULE NNP I-NP O
OUT NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/26/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/24/2005 CD O O
ATTENDING: NNP B-NP O
BRAMLETT NNP I-NP O
, , O O
BENNETT NNP B-NP O
MD NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Abdominal NNP I-NP O
pain NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
56-year-old JJ I-NP O
female NN I-NP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
Internal NNP I-NP O
Medicine NNP I-NP O
Service NNP I-NP O
for IN B-VP O
acute JJ B-NP O
cholecystitis NN I-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
abdominal JJ B-NP O
pain NN I-NP O
for IN B-VP O
five CD O O
days NNS B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
originally RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Internal NNP I-NP O
Medicine NNP I-NP O
Service NNP I-NP O
where WRB O O
she PRP O O
received VBD B-VP O
a DT B-NP O
cardiac JJ I-NP O
rule NN I-NP O
out IN B-VP O
A NNP B-NP O
CT NNP I-NP O
scan NN I-NP O
was VBD B-VP O
obtained VBN O O
on IN B-VP O
4/26/2005 CD O O
, , O O
which WDT O O
showed VBD B-VP O
an DT B-NP O
inflamed JJ I-NP O
gallbladder NN I-NP O
, , O O
which WDT O O
corresponded VBD B-VP O
to TO O O
patient's VB O O
ongoing VBG O O
right JJ B-NP O
upper JJ I-NP O
quadrant NN I-NP O
pain NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Hypertension NNP B-NP O
2 CD O O
Hypercholesterolemia NNP B-NP O
3 CD O O
Diabetes NNP B-NP O
mellitus VBD B-VP O
type JJ O O
2 CD O O
( ( O O
untreated VBN O O
) ) O O
OUTPATIENT NNP B-NP O
MEDICATIONS: NNP I-NP O
Atenolol NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
hydrochlorothiazide RB O B-m
25 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Nexium NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Vitals: NNP I-NP O
98.4 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
101 CD O O
, , O O
pulse RB O O
82 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
92/60 CD O O
, , O O
respirations NNS B-NP O
20 CD O O
, , O O
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Appearance: NNP I-NP O
Comfortable NNP I-NP O
, , O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Cardiovascular: NNP I-NP O
Regular NNP I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
No NNP I-NP O
gallops NN I-NP O
, , O O
rubs NN B-NP O
or CC O O
murmurs NNS B-NP O
Pulmonary: NNP I-NP O
Clear NNP I-NP O
to TO O O
auscultation VB O O
bilaterally RB O O
No NNP B-NP O
wheezes NN I-NP O
or CC O O
crackles NNS B-NP O
Abdomen: NNP I-NP O
Soft NNP I-NP O
, , O O
mildly RB O O
distended VBD B-VP O
, , O O
right JJ B-NP O
upper NN I-NP O
quadrant NN I-NP O
tenderness NN I-NP O
with IN B-VP O
guarding NN B-NP O
, , O O
positive JJ B-NP O
Murphy's NNP I-NP O
, , O O
no DT B-NP O
rebound NN I-NP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
no DT B-NP O
peritoneal JJ I-NP O
signs NNS I-NP O
Extremities: NNP I-NP O
No NNP I-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
or CC O O
edema NN B-NP O
Rectal: NNP I-NP O
Guaiac NNP I-NP O
negative JJ O O
, , O O
no DT B-NP O
masses NNS I-NP O
IMAGING: NNP I-NP O
CT NNP I-NP O
of IN B-VP O
the DT B-NP O
abdomen NNS I-NP O
, , O O
distended VBD B-VP O
gallbladder NN B-NP O
with IN B-VP O
gallbladder NN B-NP O
wall NN I-NP O
thickening NN I-NP O
, , O O
pericholecystic JJ B-NP O
fluid NN I-NP O
, , O O
bile JJ B-NP O
duct NN I-NP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
Acute NNP B-NP O
cholecystitis: VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
8/21/2005 CD O O
for IN B-VP O
open JJ B-NP O
cholecystectomy NN I-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
moved VBN O O
to TO O O
the DT B-NP O
general JJ I-NP O
surgical JJ I-NP O
floor NN I-NP O
and CC O O
continued VBD B-VP O
to TO O O
recover VB O O
without IN B-VP O
complication NN B-NP O
By IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#6 NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
and CC O O
ambulatory NN B-NP O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
developed VBD B-VP O
productive JJ B-NP O
cough NN I-NP O
and CC O O
a DT B-NP O
chest JJ I-NP O
x-ray NN I-NP O
was VBD B-VP O
obtained VBN O O
, , O O
which WDT O O
failed VBD B-VP O
to TO O O
show VB O O
any DT B-NP O
infiltrate NN I-NP O
and CC O O
she PRP O O
remained VBD B-VP O
afebrile JJ O O
throughout IN B-VP O
her PRP$ O O
hospital NN B-NP O
stay NN I-NP O
She PRP O O
was VBD B-VP O
discharged VBN O O
with IN B-VP O
Robitussin NNP B-NP B-m
A-C NNP I-NP I-m
and CC O O
instruction NN B-NP O
to TO O O
call VB O O
or CC O O
return VB O O
to TO O O
the DT B-NP O
hospital NN I-NP O
if IN B-VP O
she PRP O O
developed VBD B-VP O
worsening VBG O O
cough NN B-NP O
, , O O
fever NN B-NP O
, , O O
vomiting VBG O O
or CC O O
had VBD B-VP O
any DT B-NP O
other JJ I-NP O
concerns NNS I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
instructed VBN O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Sagaser NNP I-NP O
for IN B-VP O
staple JJ B-NP O
removal NN I-NP O
and CC O O
wound NN B-NP O
check NN I-NP O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Aspirin NNP I-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
atenolol VBZ O B-m
50 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
hydrochlorothiazide RB O B-m
25 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Lipitor NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ B-NP B-mo
daily JJ I-NP B-f
DISCHARGE NNP I-NP O
RECOMMENDATIONS NNP I-NP O
AND NNP I-NP O
FOLLOWUP: NNP I-NP O
1 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Store NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
for IN B-VP O
wound NN B-NP O
check NN I-NP O
and CC O O
staple NN B-NP O
removal NN I-NP O
2 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
instructed VBN O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
An DT B-NP O
appointment NN I-NP O
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
Dr NNP B-NP O
Dee NNP I-NP O
Vanosdol NNP I-NP O
on IN B-VP O
7/1/2005 CD O O
at IN B-VP O
11:30 CD O O
a.m IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
notified VBN O O
that IN B-VP O
she PRP O O
likely RB O O
has VBZ O O
untreated VBN O B-r
diabetes NNS B-NP I-r
and CC O O
needs NNS B-NP O
to TO O O
be VB O O
started VBN O O
on IN B-VP O
new JJ B-NP B-m
medications NNS I-NP O
eScription VBP O O
document: JJ B-NP O
4-5659606 JJ I-NP O
RFFocus NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
MARCINEK NNP I-NP O
, , O O
IRVING NNP B-NP O
Attending: NNP I-NP O
BEHL NNP I-NP O
, , O O
JORDON NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
4543867 CD O O
D: NNP B-NP O
8/28/05 CD O O
T: NNP B-NP O
8/28/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#613230 VBZ O O
570681541 CD O O
FHC NNP B-NP O
61247160 CD O O
235280 CD O O
1/27/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
chf NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/27/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/18/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
CZAPLINSKI NNP I-NP O
, , O O
LOGAN NNP B-NP O
833-08-42-8 CD O O
Ster NNP B-NP O
Ville NNP I-NP O
Perv NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
0/16/01 CD O O
AT NNP B-NP O
10:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
GREANY NNP I-NP O
, , O O
QUINTON NNP B-NP O
NORBERT NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ASA NNP I-NP B-m
( ( O I-m
ACETYLSALICYLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/10/01 CD O O
by IN B-VP O
LLANES NNP B-NP O
, , O O
GARLAND NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
98904908 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
ALLOPURINOL NNP B-NP B-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIGOXIN NNP I-NP B-m
0.25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
FOLIC NNP I-NP B-m
ACID NNP I-NP I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ATIVAN NNP I-NP B-m
ATIVAN NNP I-NP B-m
( ( O I-m
( ( O I-m
LORAZEPAM NNP B-NP I-m
LORAZEPAM NNP I-NP I-m
) ) O I-m
) ) O I-m
1 CD O B-do
1 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
BID NNP I-NP B-f
BID NNP I-NP B-f
PRN NNP I-NP I-f
PRN NNP I-NP I-f
anxiety NN I-NP B-r
or CC O O
insomnia NN B-NP B-r
LOPRESSOR NNP I-NP B-m
( ( O I-m
METOPROLOL NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;90 NN I-NP O
, , O O
hr&lt;55 JJ B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
THIAMINE NNP I-NP B-m
( ( O I-m
THIAMINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
10/10/01 CD O O
by IN B-VP O
PECCIA NNP B-NP O
, , O O
IAN NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
INSULIN NNP B-NP B-m
70/30 CD O I-m
( ( O I-m
HUMAN NNP B-NP I-m
) ) O I-m
30 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
fsg&lt;60 JJ B-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
IMDUR NNP B-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONIT.( NNP I-NP I-m
SR NNP I-NP I-m
) ) O I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;90 JJ B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
KCL NNP B-NP B-m
SLOW NNP I-NP I-m
REL NNP I-NP I-m
20 CD O B-do
MEQ NNP B-NP I-do
X NNP I-NP B-du
1 CD O I-du
PO NNP B-NP B-mo
BID NNP I-NP B-f
As IN B-VP O
per IN B-VP O
LGRH NNP B-NP O
Potassium NNP I-NP O
Chloride NNP I-NP O
Policy: NNP I-NP O
each DT O O
20 CD O O
mEq NNS B-NP O
dose VB O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4 CD O O
oz NNS B-NP O
of IN B-VP O
fluid NN B-NP O
ALLEGRA NNP I-NP B-m
( ( O I-m
FEXOFENADINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
LEVOFLOXACIN NNP B-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
7/21 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/10/01 CD O O
by IN B-VP O
KAZEE NNP B-NP O
, , O O
KENT NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
98904908 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
monitor VB O O
AVAPRO NNP B-NP B-m
( ( O I-m
IRBESARTAN NNP B-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;90 VBD B-VP O
Number NNP B-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
5 CD O I-du
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/16/01 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
known VBN O O
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
Activity NNP I-NP O
- : O O
As IN B-VP O
tolerated JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
After IN B-VP O
Appt NNP B-NP O
with IN B-VP O
local JJ B-NP O
physician NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Gaines NNP I-NP O
1 CD O O
weeks NNS B-NP O
, , O O
Dr NNP B-NP O
Shorr NNP I-NP O
0/2/01 CD O O
scheduled VBN O O
, , O O
No DT B-NP O
Known NNP I-NP O
Allergies NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chf NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
chf VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
RECURRENT NNP I-NP O
VT/VFIB NNP I-NP O
CAD NNP I-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
s/p NN B-NP O
MI NNP I-NP O
( ( O O
S/P NNP B-NP O
myocardial NNP I-NP O
infarction NN I-NP O
) ) O O
s/p NN B-NP O
CABG NNP I-NP O
x4 NNP I-NP O
( ( O O
S/P NNP B-NP O
cardiac JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
surgery NN I-NP O
) ) O O
s/p NN B-NP O
AICD NNP I-NP O
( ( O O
S/P NNP B-NP O
implanted VBD B-VP O
cardiac JJ B-NP O
defibrillator NN I-NP O
) ) O O
s/p VBD B-VP O
sternal JJ B-NP O
wound NN I-NP O
infection NN I-NP O
( ( O O
S/P NNP B-NP O
wound IN B-VP O
infection NN B-NP O
) ) O O
s/p NN B-NP O
sternum NN I-NP O
resection NN I-NP O
IDDM NNP I-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
chronic NN B-NP O
anemia NN I-NP O
( ( O O
anemia NN B-NP O
) ) O O
atrial JJ B-NP O
fibrillation NN I-NP O
( ( O O
atrial JJ B-NP O
fibrillation NN I-NP O
) ) O O
dyslipidemia NN B-NP O
( ( O O
dyslipidemia NN B-NP O
) ) O O
?amiodarone NN B-NP O
toxicity NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
60 CD O O
yo NN B-NP O
M NNP I-NP O
w/ischemic JJ B-NP O
CMP NNP I-NP O
and CC O O
AFib NNP B-NP B-r
dx VBP O I-r
5 CD O O
weeks NNS B-NP O
ago RB O O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
coumadin NN B-NP B-m
then RB O O
, , O O
and CC O O
last JJ B-NP O
Tues NNP I-NP O
, , O O
was VBD B-VP O
cardioverted VBN O O
( ( O O
via IN B-VP O
the DT B-NP O
AICD NNP I-NP O
) ) O O
Later NNP B-NP O
that WDT O O
night NN B-NP O
, , O O
he PRP O O
developed VBD B-VP O
SOB NNP B-NP O
, , O O
this DT O O
became VBD B-VP O
severe JJ O O
and CC O O
assoc JJ B-NP O
w/ NN I-NP O
fever NN I-NP O
to TO O O
102.4 CD O O
yesterday NN B-NP O
Today NNP I-NP O
, , O O
went VBD B-VP O
to TO O O
local JJ B-NP O
ED NNP I-NP O
( ( O O
in IN B-VP O
RI NNP B-NP O
) ) O O
Got NNP B-NP O
lasix NN I-NP B-m
and CC O O
Rocephin NNP B-NP B-m
( ( O O
due JJ O O
to TO O O
bibasilar JJ B-NP B-r
infiltrates NNS I-NP I-r
on IN B-VP O
CXR NNP B-NP O
) ) O O
WBC NNP B-NP O
elevated VBD B-VP O
at IN B-VP O
12.2 CD O O
, , O O
Bcx's NNP B-NP O
pending VBG O O
Pt NNP B-NP O
was VBD B-VP O
sent VBN O O
to TO O O
LMH NNP B-NP O
at IN B-VP O
his PRP$ O O
request NN B-NP O
Here RB O O
, , O O
low JJ B-NP O
grade NN I-NP O
fever; NN I-NP O
requires VBZ O O
FM NNP B-NP B-mo
O2; NNP I-NP B-m
vitals NNS I-NP O
stable; VBD B-VP O
mild-mod JJ B-NP O
fluid NN I-NP O
overload NN I-NP O
Will NNP I-NP O
treat VB O O
empirically RB O O
with IN B-VP O
levofloxacin NN B-NP B-m
( ( O O
?aspiration NN B-NP O
, , O O
?comm NNP B-NP B-r
acq VBZ O O
PNA NNP B-NP O
) ) O O
Will NNP B-NP O
diurese JJ O O
( ( O O
well RB O O
perfused VBN O O
) ) O O
and CC O O
finally RB O O
will MD O O
need VB O O
to TO O O
assess VB O O
underlying JJ B-NP O
rhythm NN I-NP O
( ( O O
not RB O O
all DT B-NP O
beats NNS I-NP O
paced VBD B-VP O
, , O O
need VBP O O
to TO O O
see VB O O
if IN B-VP O
back RB O O
in IN B-VP O
AFib NNP B-NP O
) ) O O
Repeat NNP B-NP O
CXR NNP I-NP O
and CC O O
F/U NNP B-NP O
on IN B-VP O
cx's NN B-NP O
from IN B-VP O
SNESUHC NNP B-NP O
2/3 CD O O
cx's NN B-NP O
from IN B-VP O
SMH NNP B-NP O
NGTD NNP I-NP O
CXR NNP I-NP O
showed VBD B-VP O
interval JJ B-NP O
improvement NN I-NP O
from IN B-VP O
past JJ B-NP O
films NNS I-NP O
has VBZ O O
bilateral JJ B-NP O
small JJ I-NP O
effusions NNS I-NP O
that WDT O O
are VBP O O
stable JJ O O
and CC O O
? . B-VP O
aspiration NN B-NP O
in IN B-VP O
right JJ B-NP O
base NN I-NP O
, , O O
but CC O O
overall JJ B-NP O
interval JJ I-NP O
improvement NN I-NP O
BCxs NNP I-NP O
from IN B-VP O
LWMH NNP B-NP O
are VBP O O
neg VBN O O
at IN B-VP O
3 CD O O
days NNS B-NP O
and CC O O
ECHO NNP B-NP O
is VBZ O O
pending VBG O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
discharged VBN O O
on IN B-VP O
po NN B-NP B-mo
diuretics NNS I-NP B-m
and CC O O
14 CD O B-du
day NN B-NP I-du
course NN I-NP I-du
of IN B-VP O
levoflox NN B-NP B-m
sating VBG O O
well RB O O
on IN B-VP O
RA NNP B-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Patient NNP I-NP O
should MD O O
seek VB O O
immediate VB O O
medical JJ B-NP O
attention NN I-NP O
if IN B-VP O
he PRP O O
develops VBZ O O
chest JJS B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
lightheadedness NN B-NP O
, , O O
fever NN B-NP O
, , O O
chills NNS B-NP O
, , O O
palpitations NNS B-NP O
, , O O
or CC O O
falls VBZ O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
SWEERE NNP I-NP O
, , O O
DANE NNP B-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
NU37 NNP B-NP O
) ) O O
0/16/01 CD O O
@ $ O O
09 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#614396 VBZ O O
263375915 CD O O
CEMC NNP B-NP O
08942951 CD O O
5123692 CD O O
5/18/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
, , O O
UTI NNP B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/20/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/28/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
TEWA NNP I-NP O
, , O O
GERMAN NNP B-NP O
M NNP I-NP O
924-52-39-1 CD O O
NE NNP B-NP O
Profortment NNP I-NP O
O NNP I-NP O
Lona NNP I-NP O
Fay NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
3/21/05 CD O O
AT NNP B-NP O
06:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
POSER NNP I-NP O
, , O O
ROBIN NNP B-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ALLOPURINOL NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
FERROUS NNP I-NP B-m
SULFATE NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
milk NN I-NP O
and CC O O
antacid JJ B-NP O
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
8/27 CD O O
) ) O O
HYDRALAZINE NNP B-NP B-m
HCL NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
below IN B-VP O
90 CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
ISORDIL NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
DINITRATE NNP I-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
below IN B-VP O
90 CD O O
LISINOPRIL NNP B-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
below IN B-VP O
90 CD O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/12/05 CD O O
by IN B-VP O
WROBLESKI NNP B-NP O
, , O O
JULIO NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.S.C NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
03030471 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
noted VBD B-VP O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/12/05 CD O O
by IN B-VP O
ALTONEN NNP B-NP O
, , O O
EDUARDO NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.S.C NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
01642329 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
noted VBD B-VP O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/29/05 CD O O
by IN B-VP O
BAGWELL NNP B-NP O
, , O O
TYSON NNP B-NP O
H NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.S.C NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
91907761 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
noted VBD B-VP O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/29/05 CD O O
by IN B-VP O
BIALEK NNP B-NP O
, , O O
CYRUS NNP B-NP O
O NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.S.C NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
15927551 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
noted VBD B-VP O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/29/05 CD O O
by IN B-VP O
HERT NNP B-NP O
, , O O
LEIGH NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.S.C NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IV NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
78178294 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
noted VBN O O
LIPITOR NNP B-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PROTONIX NNP I-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
LEVAQUIN NNP I-NP B-m
( ( O I-m
LEVOFLOXACIN NNP B-NP I-m
) ) O I-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-m
products NNS I-NP O
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-m
or CC O O
ciprofloxacin NN B-NP B-m
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
Fluid NNP I-NP O
restriction: VBD B-VP O
2 CD O O
liters NNS B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Haworth NNP I-NP O
( ( O O
in IN B-VP O
for IN B-VP O
Dr NNP B-NP O
Soulek NNP I-NP O
) ) O O
, , O O
888-079-9738 JJ O O
0/7/05 CD O O
, , O O
11:30a CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CHF NNP B-NP O
exacerbation NN I-NP O
, , O O
UTI NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
, , O O
obesity NN B-NP O
, , O O
anemia NN B-NP O
, , O O
OA NNP B-NP O
, , O O
gout NN B-NP O
, , O O
GERD NNP B-NP O
, , O O
CRI NNP B-NP O
, , O O
CAD NNP B-NP O
, , O O
hyperlipidemia NN B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
, , O O
9/4/05 CD O O
; : O O
Echocardiogram NNP B-NP O
, , O O
9/4/05 CD O O
OTHER NNP B-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
Dyspnea NNP I-NP O
HPI: NNP I-NP O
74 CD O O
yo NN B-NP O
AAF NNP I-NP O
h/o NN I-NP O
NYHF NNP I-NP O
III NNP I-NP O
CHF NNP I-NP O
( ( O O
EF NNP B-NP O
45% CD O O
) ) O O
, , O O
PHT NNP B-NP O
, , O O
HTN-CMP NNP B-NP O
, , O O
p/w NN B-NP O
worsening VBG O O
fatigue NN B-NP O
, , O O
DOE NNP B-NP O
and CC O O
orthopnea NN B-NP O
over IN B-VP O
3-4 JJ B-NP O
w JJ I-NP O
Pt NNP I-NP O
presented VBD B-VP O
to TO O O
clinic VB O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
admit NN B-NP O
and CC O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
acute JJ B-NP O
decompensation NN I-NP O
Pt NNP I-NP O
claims VBZ O O
compliance NN B-NP O
to TO O O
diet VB O O
but CC O O
there EX O O
is VBZ O O
some DT B-NP O
question NN I-NP O
from IN B-VP O
the DT B-NP O
ED NNP I-NP O
of IN B-VP O
dietary JJ B-NP O
indiscretion NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
pt NN B-NP O
reports NNS I-NP O
not RB O O
being VBG O O
able JJ O O
to TO O O
get VB O O
dose NN B-NP O
of IN B-VP O
procrit NN B-NP O
x $ O O
3 CD O O
mo NN B-NP O
, , O O
due JJ O O
to TO O O
inconvenience VB O O
in IN B-VP O
aquiring VBG O O
it PRP O O
Pt NNP B-NP O
does VBZ O O
not RB O O
require VB O O
home NN B-NP O
O2 NNP I-NP O
Denies NNP I-NP O
CP NNP I-NP O
, , O O
SOB NNP B-NP O
at IN B-VP O
rest NN B-NP O
, , O O
PND NNP B-NP O
, , O O
palpitations NNS B-NP O
, , O O
or CC O O
dizziness NN B-NP O
No RB O O
cough NN B-NP O
, , O O
fever NN B-NP O
, , O O
or CC O O
sick JJ B-NP O
contacts NNS I-NP O
Echo VBP O O
5/28 CD O O
nl JJ B-NP O
septal JJ I-NP O
chamber NN I-NP O
size NN I-NP O
, , O O
mildly RB O O
enlarged VBD B-VP O
aL JJ B-NP O
atrium NN I-NP O
, , O O
mild JJ B-NP O
LVH NNP I-NP O
, , O O
1+ CD O O
MR NNP B-NP O
, , O O
mod NN B-NP O
TR NNP I-NP O
PE NNP I-NP O
on IN B-VP O
admit: NN B-NP O
VS NNP I-NP O
98.9 CD O O
96 CD O O
136/88 CD O O
100% CD O O
RA NNP B-NP O
NECK: NNP I-NP O
JVP NNP I-NP O
to TO O O
jaw VB O O
angle JJ B-NP O
w/ NN I-NP O
pulsatile NN I-NP O
v NN I-NP O
wave VBP O O
No DT B-NP O
bruits NNS I-NP O
CV: NNP I-NP O
RRR NNP I-NP O
, , O O
+s3 NNP B-NP O
, , O O
? . B-VP O
systolic JJ B-NP O
murmur NN I-NP O
at IN B-VP O
LSB NNP B-NP O
, , O O
increased VBD B-VP O
but CC O O
non RB O O
displaced VBD B-VP O
pmi JJ B-NP O
LUNGS: NNP I-NP O
Crackles NNP I-NP O
to TO O O
2/3 CD O O
of IN B-VP O
lung NN B-NP O
B NNP I-NP O
EXT: NNP I-NP O
Warm NNP I-NP O
, , O O
2+ CD O O
DP NNP B-NP O
pulse NN I-NP O
B NNP I-NP O
1+ CD O O
pitting VBG O O
edema RB O O
2/3 CD O O
to TO O O
B NNP B-NP O
knees NNS I-NP O
Labs NNP I-NP O
on IN B-VP O
admit: NN B-NP O
Cr NNP I-NP O
2 CD O O
, , O O
Trop NNP B-NP O
0.24 CD O O
, , O O
CK NNP B-NP O
27 CD O O
, , O O
MB NNP B-NP O
0.6 CD O O
CXR: NNP B-NP O
increased VBD B-VP O
heart NN B-NP O
border NN I-NP O
, , O O
B NNP B-NP O
effusion NN I-NP O
BNP NNP I-NP O
2329 CD O O
UA NNP B-NP O
6-10 JJ B-NP O
wbc NN I-NP O
, , O O
2+ CD O O
bact NN B-NP O
EKG NNP I-NP O
no DT B-NP O
changes NNS I-NP O
, , O O
baseline NN B-NP O
diffuse NN I-NP O
flattened VBD B-VP O
TW NNP B-NP O
**************HOSPITAL NNP I-NP O
COURSE********************* NNP I-NP O
CV: NNP I-NP O
( ( O O
P NNP B-NP O
) ) O O
NYHA NNP B-NP O
III NNP I-NP O
CHF NNP I-NP O
( ( O O
EF NNP B-NP O
45% CD O O
) ) O O
in IN B-VP O
acute JJ B-NP O
decompensation NN I-NP O
Strict NNP I-NP O
I&amp;Os NNP I-NP O
, , O O
fluid JJ B-NP O
restriction NN I-NP O
Diurese NNP I-NP O
aggressively RB O O
w/ VBD B-VP O
lasix JJ O B-m
100 CD O B-do
bid NN B-NP B-f
, , O O
replete JJ B-NP O
lytes NNS I-NP O
, , O O
keeping VBG O O
in IN B-VP O
mind NN B-NP O
CRI NNP I-NP O
Cont NNP I-NP O
BB NNP I-NP B-m
, , O O
ACEI NNP B-NP B-m
Added NNP I-NP O
hydralazine/isordil NN I-NP B-m
on IN B-VP O
HD3 NNP B-NP O
Repeat NNP I-NP O
Echo NNP I-NP O
on IN B-VP O
HD3 NNP B-NP O
showed VBD B-VP O
decreased JJ B-NP O
EF NNP I-NP O
30-35% NNP I-NP O
( ( O O
I PRP O O
) ) O O
CAD NNP B-NP O
, , O O
hyperlipidemia: NN B-NP B-r
hyperlipidemia: NN I-NP B-r
hyperlipidemia: NN I-NP B-r
hyperlipidemia: NN I-NP B-r
BB NNP I-NP B-m
, , O O
ACEI NNP B-NP B-m
, , O O
statin NN B-NP B-m
, , O O
ASA NNP B-NP B-m
Lipids NNP I-NP O
nl RB O O
Suspected VBD B-VP O
ischemic JJ B-NP O
etiology NN I-NP O
to TO O O
worsening VBG O O
CHF NNP B-NP O
, , O O
given VBN O O
decreased VBD B-VP O
EF NNP B-NP O
on IN B-VP O
echo NN B-NP O
Did NNP I-NP O
cath NN I-NP O
on IN B-VP O
Na NNP B-NP O
Worth NNP I-NP O
Salt NNP I-NP O
however RB O O
w/o VBD B-VP O
lesions NNS B-NP O
( ( O O
although IN B-VP O
confirming VBG O O
PHT NNP B-NP O
) ) O O
( ( O O
R NNP B-NP O
) ) O O
No NNP B-NP O
issues NNS I-NP O
RENAL: NNP I-NP O
CRI NNP I-NP B-r
w/ NN I-NP I-r
anemia NN I-NP I-r
Given NNP I-NP O
mucomyst VBZ O B-m
post FW O O
cath NN B-NP O
HEME: NNP I-NP O
Anemia NNP I-NP B-r
Anemia NNP I-NP B-r
- : O O
Given NNP B-NP O
aranesp NN I-NP B-m
, , O O
FeSO4 NNP B-NP B-m
HTN: NNP I-NP O
BB NNP I-NP B-m
, , O O
ACEI NNP B-NP B-m
ID: NNP I-NP O
UTI NNP I-NP O
, , O O
E NNP B-NP O
coli VBP O O
in IN B-VP O
Ucx NNP B-NP O
, , O O
sensitivities VBZ O O
pending VBG O O
Empirically NNP B-NP O
tx JJ B-NP O
w/ NN I-NP O
Keflex NNP I-NP B-m
, , O O
changed VBD B-VP O
empirically RB O O
on IN B-VP O
HD4 NNP B-NP O
to TO O O
levo VB O B-m
ENDO: NNP B-NP O
R/o'd NNP I-NP O
Hyperthyroidism NNP I-NP O
w/ VBD B-VP O
nl JJ B-NP O
TSH NNP I-NP O
RHEUM: NNP I-NP O
Gout NNP I-NP B-r
- : O O
allopurinol JJ B-NP B-m
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Satisfactory NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
LOUKS NNP I-NP O
, , O O
CLAYTON NNP B-NP O
T NNP I-NP O
C NNP I-NP O
( ( O O
UW22 NNP B-NP O
) ) O O
3/21/05 CD O O
@ $ O O
05 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#633499 VBZ O O
753455514 CD O O
GWH NNP B-NP O
15453858 CD O O
5156068 CD O O
5/8/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
CAD NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/18/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/24/2003 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
GOODNESS NNP I-NP O
, , O O
GREGORY NNP B-NP O
079-03-97-6 NNP I-NP O
Sachua NNP I-NP O
Oaks NNP I-NP O
De NNP I-NP O
Service: NNP I-NP O
RNM NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
4/7/03 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Home NNP I-NP O
services NNS I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KOS NNP I-NP O
, , O O
GENE NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
7.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
b/p&lt;100 VBZ O O
systolic JJ B-NP O
Instructions: NNP I-NP O
Hold NNP I-NP O
on IN B-VP O
the DT B-NP O
mornings NNS I-NP O
of IN B-VP O
dialysis NN B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/4/03 CD O O
by IN B-VP O
: : O O
DEFINITE NNP B-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
ACE NNP B-NP O
INHIBITORS NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
K NNP I-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/4/03 CD O O
by IN B-VP O
HIRSCHY NNP B-NP O
, , O O
EDGAR NNP B-NP O
, , O O
M.D NNP B-NP O
DEFINITE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
ACE NNP B-NP O
INHIBITORS NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Monitoring NNP I-NP O
K NNP I-NP O
Previous NNP I-NP O
override IN B-VP O
reason: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/29/03 CD O O
by IN B-VP O
GOONEN NNP B-NP O
, , O O
WILL NNP B-NP O
, , O O
M.D NNP B-NP O
DEFINITE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
ACE NNP B-NP O
INHIBITORS NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Pt NNP I-NP O
needs VBZ O O
for IN B-VP O
his PRP$ O O
heart NN B-NP O
Is VBZ O O
on IN B-VP O
HD NNP B-NP O
, , O O
will MD O O
monitor VB O O
his PRP$ O O
K NNP B-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/29/03 CD O O
by IN B-VP O
MAZA NNP B-NP O
, , O O
RUSTY NNP B-NP O
, , O O
M.D NNP B-NP O
DEFINITE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
ACE NNP B-NP O
INHIBITORS NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
on IN B-VP O
dialysis NN B-NP O
, , O O
will MD O O
monitor VB O O
K NNP B-NP O
needs VBZ O O
ACE NNP B-NP B-m
for IN B-VP O
heart NN B-NP B-r
NPH NNP I-NP B-m
HUMULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
( ( O I-m
INSULIN NNP B-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
2 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
NPH NNP I-NP B-m
HUMULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
( ( O I-m
INSULIN NNP B-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
3 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QPM NNP I-NP B-f
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O O
3 CD O O
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
IMDUR NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONIT.( NNP I-NP I-m
SR NNP I-NP I-m
) ) O I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Instructions: NNP I-NP O
Hold NNP I-NP O
on IN B-VP O
the DT B-NP O
mornings NNS I-NP O
of IN B-VP O
dialysis NN B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
NEPHROCAPS NNP B-NP B-m
( ( O I-m
NEPHRO-VIT NNP B-NP I-m
RX NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2000 CD O O
cals/day NN B-NP O
/ NNP I-NP O
Low NNP I-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
/ NNP I-NP O
Renal NNP I-NP O
diet JJ B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Renal NNP I-NP O
Doctor NNP I-NP O
MWF NNP I-NP O
, , O O
Dr NNP B-NP O
Handrick NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Donkle NNP I-NP O
, , O O
cardiology NN B-NP O
2 CD O O
weeks NNS B-NP O
, , O O
ALLERGY: NNP B-NP O
Lisinopril NNP I-NP O
, , O O
Zocor NNP B-NP O
( ( O O
hmg JJ B-NP O
coa NN I-NP O
reductase NN I-NP O
inhibitors NNS I-NP O
) ) O O
ADMIT VBP O O
DIAGNOSIS: NNP B-NP O
hypercalcemia NN I-NP O
, , O O
hyperkalemia NN B-NP O
CHF NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CAD NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
1 CD O O
NIDDM NNP B-NP O
2 CD O O
AI/AS NNP B-NP O
, , O O
bicuspid JJ B-NP O
aortic JJ I-NP O
valve NN I-NP O
, , O O
LVH NNP B-NP O
3 CD O O
HTN NNP B-NP O
4 CD O O
s/p NN B-NP O
thyroglossal NN I-NP O
duct NN I-NP O
cyst NN I-NP O
excision NN I-NP O
5 CD O O
h/o NN B-NP O
noncompliance NN I-NP O
with IN B-VP O
meds NNS B-NP O
cad NNS I-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
ESRD NNP B-NP O
ON NNP I-NP O
HD NNP I-NP O
( ( O O
end JJ B-NP O
stage NN I-NP O
renal JJ B-NP O
disease NN I-NP O
) ) O O
CHF NNP B-NP O
, , O O
unclear JJ B-NP O
etiology NN I-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
hyperlipidemia NN B-NP O
( ( O O
hyperlipidemia NN B-NP O
) ) O O
h/o NN B-NP O
syphilis NN I-NP O
( ( O O
H/O NNP B-NP O
syphilis NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Routine NNP B-NP O
Hemodialysis NNP I-NP O
Right NNP I-NP O
heart NN I-NP O
catheterization NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
56M CD O O
with IN B-VP O
SOB NNP B-NP O
admitted VBD B-VP O
on IN B-VP O
4/22 CD O O
Hx NNP B-NP O
of IN B-VP O
ESRD NNP B-NP O
on IN B-VP O
HD NNP B-NP O
, , O O
CHF NNP B-NP O
with IN B-VP O
EF NNP B-NP O
of IN B-VP O
25% CD O O
, , O O
DM NNP B-NP O
, , O O
HTN NNP B-NP O
Pt NNP I-NP O
became VBD B-VP O
acutely RB O O
sob VBN O O
on IN B-VP O
8/7 CD O O
at IN B-VP O
rest NN B-NP O
, , O O
but CC O O
then RB O O
states VBZ O O
sob NN B-NP O
for IN B-VP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
No DT B-NP O
cp NN I-NP O
, , O O
occasional JJ B-NP O
epigastric JJ I-NP O
burning NN I-NP O
+PND NN I-NP O
, , O O
sleeps NNS B-NP O
on IN B-VP O
1 CD O O
pillow NN B-NP O
, , O O
no DT B-NP O
LE NNP I-NP O
edema NN I-NP O
CV NNP I-NP O
March NNP I-NP O
Cath NNP I-NP O
90% CD O O
LAD NNP B-NP O
, , O O
80% CD O O
Ramus NNP B-NP O
, , O O
80% CD O O
LCx NNP B-NP O
EF NNP I-NP O
25% CD O O
No NNP B-NP O
chest NN I-NP O
pain NN I-NP O
complaints NNS I-NP O
+Troponin VBP O O
likely JJ B-NP O
due JJ I-NP O
due JJ I-NP O
demand NN I-NP O
ischemia NN I-NP O
from IN B-VP O
volume NN B-NP O
overload NN I-NP O
Pt NNP I-NP O
on IN B-VP O
ASA NNP B-NP B-m
, , O O
Lopressor NNP B-NP B-m
which WDT O O
was VBD B-VP O
increased VBN O O
over IN B-VP O
2 CD O O
days NNS B-NP O
, , O O
Nitrates NNP B-NP B-m
, , O O
and CC O O
ACE-inh NNP B-NP B-m
Pt NNP I-NP O
will MD O O
maximize VB O O
medical JJ B-NP O
management NN I-NP O
of IN B-VP O
CV NNP B-NP O
status NN I-NP O
, , O O
and CC O O
dialysis NN B-NP O
done VBN O O
0/20 CD O O
Cardiology NNP B-NP O
Consult NNP I-NP O
0/20 CD O O
for IN B-VP O
Troponin NNP B-NP O
rising VBG O O
to TO O O
2.9 CD O O
?if NNS B-NP O
CABG NNP I-NP O
candidate NN I-NP O
, , O O
cards NNS B-NP O
suggesting VBG O O
med VBD B-VP O
mgt NNS B-NP O
Increased VBD B-VP O
the DT B-NP O
lopressor NN I-NP B-m
with IN B-VP O
goal NN B-NP O
b/p NN I-NP O
&lt;130 NNP I-NP O
Troponin NNP I-NP O
max VBD B-VP O
2.99 CD O O
on IN B-VP O
0/20 CD O O
RHcath NN B-NP O
after IN B-VP O
dialysis NN B-NP O
3/24 CD O O
showed VBD B-VP O
increased VBN O O
filling NN B-NP O
pressures NNS I-NP O
and CC O O
adenosine JJ B-NP O
mibi NN I-NP O
on IN B-VP O
9/10 CD O O
showed VBD B-VP O
minimal JJ B-NP B-r
ischemia NN I-NP I-r
of IN B-VP O
inferior-lateral JJ B-NP O
wall NN I-NP O
and CC O O
?defect NN B-NP O
in IN B-VP O
anterior JJ B-NP O
wall NN I-NP O
Will NNP I-NP O
switch VB O O
to TO O O
Toprol NNP B-NP B-m
XL NNP I-NP I-m
200 CD O B-do
QD NNP B-NP B-f
7/24 CD O O
p NN B-NP O
HD NNP I-NP O
6/10 CD O O
12 CD O O
beats NNS B-NP O
, , O O
and CC O O
3/24 CD O O
7 CD O O
beats NNS B-NP O
VT NNP I-NP O
follow VBP O O
lytes NNS B-NP O
, , O O
will MD O O
hold VB O O
off RP O O
on IN B-VP O
further JJ B-NP O
intervention NN I-NP O
for IN B-VP O
now RB O O
per IN B-VP O
cardiology NN B-NP O
( ( O O
fellow JJ B-NP O
#07724 NN I-NP O
) ) O O
BNP NNP B-NP O
after IN B-VP O
dialysis NN B-NP O
&gt;assay NNP I-NP O
FEN NNP I-NP O
) ) O O
Hypercalcemia NNP B-NP O
15 CD O O
on IN B-VP O
admission NN B-NP O
Pt NNP I-NP O
recieving VBG O O
50mg CD O B-do
of IN B-VP O
Calcitonin NNP B-NP B-m
SC NNP I-NP B-mo
PTH NNP I-NP O
pending VBG O O
, , O O
SPEP NNP B-NP O
pending VBG O O
May NNP B-NP O
also RB O O
be VB O O
related VBN O O
to TO O O
Phos NNP B-NP O
Lo NNP I-NP O
or CC O O
tert JJ B-NP O
Hyper NNP I-NP O
pth NN I-NP O
Hyperkalemia NNP I-NP B-r
Hyperkalemia NNP I-NP B-r
without IN B-VP O
T NNP B-NP O
wave VBP O O
peaking VBG O O
Kayexelate NNP B-NP B-m
given VBN O O
with IN B-VP O
Lactulose NNP B-NP B-m
with IN B-VP O
good JJ B-NP O
results NNS I-NP O
Repeat NNP I-NP O
K NNP I-NP O
improving VBG O O
, , O O
dialysis NN B-NP O
MWF NNP I-NP O
PULM NNP I-NP O
) ) O O
SOB NNP B-NP O
with IN B-VP O
hypoxia NN B-NP O
on IN B-VP O
admission NN B-NP O
from IN B-VP O
CHF NNP B-NP O
No NNP I-NP O
clear JJ B-NP O
infiltrates NNS I-NP O
Doing VBG O O
well RB O O
on IN B-VP O
NC NNP B-NP O
O2 NNP I-NP B-m
On IN B-VP O
review NN B-NP O
of IN B-VP O
Cxr NNP B-NP O
there EX O O
is VBZ O O
?consolidation NN B-NP O
LLL NNP I-NP O
If IN B-VP O
spikes NNS B-NP O
then RB O O
culture NN B-NP O
and CC O O
add VB O O
pna JJ B-NP O
coverage NN I-NP O
GI NNP I-NP O
) ) O O
Constipation NNP B-NP O
likely RB O O
related VBD B-VP O
to TO O O
hypercalcemia VB O O
Pt NNP B-NP O
on IN B-VP O
agressive JJ B-NP O
bowel NN I-NP O
regimen NNS I-NP O
RENAL NNP I-NP O
) ) O O
ESRD NNP B-NP O
on IN B-VP O
HD NNP B-NP O
Dialysis NNP I-NP O
per IN B-VP O
Renal NNP B-NP O
team NN I-NP O
Pt NNP I-NP O
did VBD B-VP O
recieve VB O O
Vit NNP B-NP B-m
D NNP I-NP I-m
recently RB O O
which WDT O O
may MD O O
also RB O O
have VB O O
con NN B-NP O
tributed VBN O O
to TO O O
hypercalcemia VB O O
ENDO NNP B-NP O
) ) O O
Pt NNP B-NP O
put VBD B-VP O
on IN B-VP O
decreased JJ B-NP O
NPH NNP I-NP B-m
regimen NNS I-NP O
bs NN I-NP O
of IN B-VP O
56 CD O O
on IN B-VP O
4/22 CD O O
, , O O
pt NN B-NP O
given VBN O O
D50x1 NNP B-NP B-m
and CC O O
NPH NNP B-NP B-m
decreased VBD B-VP O
further RBR O O
Will NNP B-NP O
try VB O O
to TO O O
maintain VB O O
tight JJ B-NP O
glycemic NNS I-NP O
control NN I-NP O
ADA NNP I-NP O
diet NN I-NP O
Last JJ B-NP O
A1C NNP I-NP O
8.3 CD O O
in IN B-VP O
10/19 CD O O
HEME NNP B-NP O
) ) O O
Hct NNP B-NP O
high JJ O O
normal JJ O O
, , O O
?intravascularly JJ B-NP O
dry NN I-NP O
, , O O
but CC O O
CHF NNP B-NP O
on IN B-VP O
exam NN B-NP O
and CC O O
CXR NNP B-NP O
TP NNP I-NP O
increased VBD B-VP O
with IN B-VP O
nl JJ B-NP O
albumin NN I-NP O
SPEP NNP I-NP O
and CC O O
UPEP NNP B-NP O
pending NN I-NP O
, , O O
pt NN B-NP O
did VBD B-VP O
have VB O O
increased VBN O O
gamma NN B-NP O
on IN B-VP O
spep NN B-NP O
in IN B-VP O
10/19 CD O O
, , O O
but CC O O
no DT B-NP O
monoclonal JJ I-NP O
spike NN I-NP O
Also RB O O
hx CD O O
of IN B-VP O
a-phospholipid JJ B-NP O
ab NN I-NP O
, , O O
but CC O O
no DT B-NP O
hx NN I-NP O
of IN B-VP O
clotting VBG O O
??? NNP B-NP O
)Ant NNP I-NP O
mediastinal JJ B-NP O
mass NN I-NP O
, , O O
stable JJ O O
in IN B-VP O
appearance NN B-NP O
on IN B-VP O
CXR NNP B-NP O
Will NNP I-NP O
need VB O O
f/u RB O O
as IN B-VP O
outpatient JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Call NNP I-NP O
your PRP$ O O
doctor NN B-NP O
for IN B-VP O
any DT B-NP O
chest NN I-NP O
pains NNS I-NP O
, , O O
dizziness NN B-NP O
, , O O
trouble NN B-NP O
breathing NN I-NP O
, , O O
fevers NNS B-NP O
&gt;100.4 VBP O O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
concerns NNS I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Follow NNP I-NP O
up RB O O
chest RB O O
CT NNP B-NP O
Check NNP I-NP O
SPEP NNP I-NP O
, , O O
PTH NNP B-NP O
labs VBZ O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MCMEEN NNP I-NP O
, , O O
MARTY NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
WP104 NNP B-NP O
) ) O O
4/7/03 CD O O
@ $ O O
01:22 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#634712 VBZ O O
342590615 CD O O
LCH NNP B-NP O
47454253 CD O O
230530 CD O O
9/1/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
Syncope NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/26/2000 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/20/2000 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
KOMLOS NNP I-NP O
, , O O
COLEMAN NNP B-NP O
223-66-98-9 CD O O
Rieville NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/4 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
DELFELDER NNP I-NP O
, , O O
MILLARD NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
) ) O I-m
650-1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
pain VBP O B-r
AMIODARONE NNP B-NP B-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/28 CD O O
by IN B-VP O
KNIGHTSTEP NNP B-NP O
, , O O
HAYDEN NNP B-NP O
S NNP I-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
03417627 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
SCRUDATO NNP B-NP O
, , O O
DWAYNE NNP B-NP O
MYLES NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
VARIABLE NNP I-NP O
( ( O O
ref JJ O O
# # O O
01479158 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
RECHEL NNP B-NP O
, , O O
JOSH NNP B-NP O
AVERY NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
FURNAS NNP B-NP O
, , O O
CLAUD NNP B-NP O
PHIL NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates/monitored VBN O O
COLACE NNP B-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
MCWHINNEY NNP B-NP O
, , O O
VALENTINE NNP B-NP O
BUCK NNP I-NP O
, , O O
M.D NNP B-NP O
POSSIBLE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
SULFA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
GOLA NNP B-NP O
, , O O
TODD NNP B-NP O
AARON NNP I-NP O
, , O O
M.D NNP B-NP O
POSSIBLE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
SULFA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
QUAIN NNP B-NP O
, , O O
ETHAN NNP B-NP O
CURT NNP I-NP O
, , O O
M.D NNP B-NP O
POSSIBLE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
SULFA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
MICRONASE NNP I-NP B-m
( ( O I-m
GLYBURIDE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
FARUG NNP B-NP O
, , O O
CHAUNCEY NNP B-NP O
STANFORD NNP I-NP O
, , O O
M.D NNP B-NP O
POSSIBLE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
SULFA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
GERETY NNP B-NP O
, , O O
LINWOOD NNP B-NP O
KAREEM NNP I-NP O
, , O O
M.D NNP B-NP O
POSSIBLE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
SULFA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
TESSITORE NNP B-NP O
, , O O
ALDEN NNP B-NP O
GUY NNP I-NP O
, , O O
M.D NNP B-NP O
POSSIBLE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
SULFA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
PLAQUENIL NNP I-NP B-m
( ( O I-m
HYDROXYCHLOROQUINE NNP B-NP I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
with IN B-VP O
meals NNS B-NP O
ISORDIL NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
DINITRATE NNP I-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt;90 NNP B-NP O
LISINOPRIL NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt;100 NNP B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
SIWEK NNP B-NP O
, , O O
ASHLEY NNP B-NP O
KENNITH NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
SCALE NNP I-NP O
QD NNP I-NP B-f
( ( O O
ref JJ O O
# # O O
65848216 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
ALKIRE NNP B-NP O
, , O O
EUSEBIO NNP B-NP O
LYLE NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
Override NNP I-NP O
Notice NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
KUPRES NNP B-NP O
, , O O
OSWALDO NNP B-NP O
DEVIN NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
65848216 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitored VBN O O
LOPRESSOR NNP B-NP B-m
( ( O I-m
METOPROLOL NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt;100 NNP B-NP O
HR NNP I-NP O
60 CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
SIEBERT NNP B-NP O
, , O O
DOUGLAS NNP B-NP O
GERALD NNP I-NP O
, , O O
M.D NNP B-NP O
DEFINITE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
BETA-BLOCKERS NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/17 CD O O
by IN B-VP O
CENTANO NNP B-NP O
, , O O
LEVI NNP B-NP O
CLAUD NNP I-NP O
, , O O
M.D NNP B-NP O
DEFINITE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
BETA-BLOCKERS NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitored VBD B-VP O
NITROGLYCERIN NNP B-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O O
3 CD O O
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
COUMADIN NNP B-NP B-m
COUMADIN NNP I-NP B-m
( ( O I-m
( ( O I-m
WARFARIN NNP B-NP I-m
WARFARIN NNP I-NP I-m
SODIUM NNP I-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
) ) O I-m
EVEN NNP B-NP O
days: $ O O
5 CD O B-do
MG NNP B-NP I-do
qTTHSat; NN I-NP B-f
ODD NNP I-NP O
days: VBZ O O
2.5 CD O B-do
MG NNP B-NP I-do
qMWF NN I-NP B-f
PO NNP I-NP B-mo
PO NNP I-NP B-mo
QD NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
6/1 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
INR NNP I-NP O
&gt;3.0 NNP I-NP O
and CC O O
call VB O O
primary JJ B-NP O
doctor NN I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
0/28 CD O O
by IN B-VP O
MCCLISH NNP B-NP O
, , O O
ZACK NNP B-NP O
R NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
NORVASC NNP I-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt;100 NNP B-NP O
LOVENOX NNP I-NP B-m
( ( O I-m
ENOXAPARIN NNP B-NP I-m
) ) O I-m
70 CD O B-do
MG NNP B-NP I-do
SC NNP I-NP B-mo
Q12H NNP I-NP B-f
X NNP I-NP B-du
4 CD O I-du
Days NNPS B-NP I-du
Starting VBG O O
Today NNP B-NP O
( ( O O
6/1 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
INR NNP I-NP O
is VBZ O O
2-3 JJ B-NP O
Instructions: NNP I-NP O
Please NNP I-NP O
give VB O O
first RB O O
dose JJ B-NP O
today NN I-NP O
and CC O O
provide VB O O
teaching VBG O O
Would MD O O
have VB O O
her PRP$ O O
visiting VBG O O
nurse JJ O O
give VBP O O
the DT B-NP O
injections NNS I-NP O
if IN B-VP O
INR NNP B-NP O
is VBZ O O
not RB O O
2-3 JJ B-NP O
DIET: NNP I-NP O
No NNP I-NP O
Restrictions NNP I-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Not RB O O
Applicable NNP B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Wilber NNP I-NP O
Tussing NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
patient NN B-NP O
to TO O O
call VB O O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
, , O O
Dr NNP B-NP O
Heriberto NNP I-NP O
Mertins NNP I-NP O
, , O O
Cardiology NNP B-NP O
2-3 JJ B-NP O
weeks NNS I-NP O
, , O O
patient NN B-NP O
to TO O O
call VB O O
for IN B-VP O
appointment NN B-NP O
, , O O
ALLERGY: NNP B-NP O
Sotalol NNP I-NP O
, , O O
Procainamide NNP B-NP O
, , O O
Aspirin NNP B-NP O
, , O O
Penicillins NNP B-NP O
, , O O
Sulfa NNP B-NP O
, , O O
Quinaglute NNP B-NP O
, , O O
Asa NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Syncope NNP I-NP O
, , O O
R/O NNP B-NP O
MI NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Syncope NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
*** VBZ O O
0/28 CD O O
*** NN B-NP O
10/16 CD O O
78F CD O O
w/ NN B-NP O
HTN NNP I-NP O
, , O O
PAFon NNP B-NP O
amiodarone NN I-NP B-m
, , O O
MS NNP B-NP O
s/p VBZ O O
MVR NNP B-NP B-r
on IN B-VP O
coumadin NN B-NP B-m
, , O O
?CAD/IMI NN B-NP O
with IN B-VP O
clean JJ B-NP O
coronaries NNS I-NP O
on IN B-VP O
cath NN B-NP O
'91 CD O O
, , O O
h/o NN B-NP O
CHF NNP I-NP O
, , O O
now RB O O
presenting VBG O O
with IN B-VP O
2 CD O O
episodes NNS B-NP O
of IN B-VP O
?syncope NN B-NP O
First NNP I-NP O
episode NN I-NP O
while IN B-VP O
sitting VBG O O
, , O O
?LOC NNP B-NP O
, , O O
second JJ B-NP O
episode NN I-NP O
while IN B-VP O
leaning VBG O O
over RP O O
, , O O
likely JJ O O
no DT B-NP O
LOC NNP I-NP O
, , O O
both DT B-NP O
episodes NNS I-NP O
without IN B-VP O
pre- JJ O O
or CC O O
post-syncopal JJ B-NP O
SOB/palpitations/lightheadedness/confusion NN I-NP O
or CC O O
other JJ B-NP O
sx NN I-NP O
In IN B-VP O
ED NNP B-NP O
had VBD B-VP O
Lleg/armpain NNP B-NP O
and CC O O
HA NNP B-NP O
Had NNP I-NP O
negative JJ B-NP O
Head NNP I-NP O
CT NNP I-NP O
, , O O
neg JJ B-NP O
Lextremity NNP I-NP O
films NNS I-NP O
Meds NNP I-NP O
noteable JJ O O
for IN B-VP O
extensive JJ B-NP O
cardiac JJ I-NP B-m
regimen NNS I-NP I-m
including VBG O O
lopressor NN B-NP B-m
, , O O
coumadin NN B-NP B-m
, , O O
amio NN B-NP B-m
, , O O
norvasc RB O B-m
, , O O
lisinopril NN B-NP B-m
, , O O
lasix NN B-NP B-m
, , O O
isordil NN B-NP B-m
CXR NNP I-NP O
showed VBD B-VP O
mild JJ B-NP O
CHF NNP I-NP O
?Lbase NNP I-NP O
effusion NN I-NP O
ECHO NNP I-NP O
29 CD O O
of IN B-VP O
July NNP B-NP O
EF65% NNP I-NP O
, , O O
EKG NNP B-NP O
old JJ B-NP O
inferior JJ I-NP O
MI NNP I-NP O
changes/primary NN I-NP O
AVblock NNP I-NP O
Noted VBD B-VP O
bradycardia NN B-NP O
to TO O O
30s CD O O
while IN B-VP O
asleep NN B-NP O
on IN B-VP O
night NN B-NP O
of IN B-VP O
admission NN B-NP O
CV: NNP I-NP O
unclear JJ B-NP O
etiology NN I-NP O
of IN B-VP O
syncopal JJ B-NP O
episodes NNS I-NP O
but CC O O
CV NNP B-NP O
likely RB O O
given VBN O O
her PRP$ O O
history NN B-NP O
Will NNP I-NP O
call VB O O
Cards NNP B-NP O
consult NN I-NP O
in IN B-VP O
a.m JJ B-NP O
Important NNP I-NP O
to TO O O
assess VB O O
specific JJ B-NP O
etiology NN I-NP O
given VBN O O
need VBP O O
for IN B-VP O
coumadin NN B-NP B-m
for IN B-VP O
MVR NNP B-NP B-r
versus NN I-NP O
fall NN I-NP O
risk NN I-NP O
with IN B-VP O
the DT B-NP O
syncopal JJ I-NP O
episodes.Orthostatics NNS I-NP O
negative JJ B-NP O
Cardiology NNP I-NP O
consulted VBD B-VP O
, , O O
and CC O O
recommended VBD B-VP O
an DT B-NP O
event NN I-NP O
monitor NN I-NP O
to TO O O
assess VB O O
for IN B-VP O
specific JJ B-NP O
rhythms NN I-NP O
while IN B-VP O
she PRP O O
is VBZ O O
symptomatic JJ O O
Over IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
one CD O O
episode NN B-NP O
of IN B-VP O
near-syncope JJ O O
similar JJ O O
to TO O O
her PRP$ O O
weekend NN B-NP O
symptoms NNS I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
typical JJ I-NP O
rhythm NN I-NP O
noted VBD B-VP O
on IN B-VP O
telemetry NN B-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
Cardiology NNP I-NP O
recommended VBD B-VP O
monitoring NN B-NP O
HR NNP I-NP O
and CC O O
BP NNP B-NP O
and CC O O
consider VB O O
d/c'ing VBG O O
Lopressor NNP B-NP B-m
if IN B-VP O
it PRP O O
is VBZ O O
excessively RB O O
low JJ O O
and CC O O
correlating VBG O O
with IN B-VP O
symptoms NNS B-NP O
Would MD O O
follow VB O O
up RP O O
on IN B-VP O
event NN B-NP O
monitor NN I-NP O
to TO O O
determine VB O O
need NN B-NP O
for IN B-VP O
further JJ B-NP O
intervention NN I-NP O
Neuro: NNP I-NP O
Head NNP I-NP O
MR NNP I-NP O
negative; RB O O
ruled VBD B-VP O
out RP O O
intracranial JJ B-NP O
ischemia/bleed NN I-NP O
Heme: NNP I-NP O
INR NNP I-NP O
4.3 CD O O
on IN B-VP O
admission NN B-NP O
and CC O O
restarted VBN O O
after IN B-VP O
holding VBG O O
for IN B-VP O
one CD O O
day NN B-NP O
Restarted VBD B-VP O
coumadin NN B-NP B-m
at IN B-VP O
usual JJ B-NP O
home NN I-NP B-do
dosing NN I-NP I-do
On IN B-VP O
3/28 CD O O
INR NNP B-NP O
was VBD B-VP O
2.1 CD O O
so RB O O
arranged VBN O O
for IN B-VP B-du
4days CD O I-du
of IN B-VP O
Lovenox NNP B-NP B-m
to TO O O
be VB O O
given VBN O O
if IN B-VP O
INR NNP B-NP O
is VBZ O O
not RB O O
therapeutic JJ B-NP O
Follow NNP I-NP O
up RP O O
plan: NN B-NP O
Event NNP I-NP O
monitor NN I-NP O
to TO O O
be VB O O
ordered VBN O O
Patient NNP B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Bergerson NNP I-NP O
and CC O O
Dr NNP B-NP O
Gamma NNP I-NP O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
Visiting VBG O O
nurse NN B-NP O
to TO O O
do VB O O
home NN B-NP O
safety NN I-NP O
eval NN I-NP O
, , O O
and CC O O
monitor NN B-NP O
INR/administer NNP I-NP O
Lovenox NNP I-NP B-m
if IN B-VP O
needed VBN O O
, , O O
and CC O O
check VB O O
BP/HR/symptoms NNP B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
For IN B-VP O
visiting VBG O O
nurse: JJ B-NP O
Please NNP I-NP O
draw VB O O
blood NN B-NP O
qd NN I-NP O
for IN B-VP O
5 CD O O
days NNS B-NP O
to TO O O
check VB O O
INR NNP B-NP O
If IN B-VP O
it PRP O O
is VBZ O O
less JJR O O
than IN B-VP O
2 CD O O
please NN B-NP O
give VB O O
the DT B-NP O
Lovenox NNP I-NP B-m
injections NNS I-NP B-mo
for IN B-VP O
the DT B-NP O
day NN I-NP O
If IN B-VP O
it PRP O O
remains VBZ O O
in IN B-VP O
2-3 JJ B-NP O
range NN I-NP O
, , O O
just RB O O
continue VB O O
the DT B-NP O
regular JJ I-NP B-do
Coumadin NNP I-NP B-m
dosing VBG O O
Please NNP B-NP O
check VB O O
BP NNP B-NP O
and CC O O
heart NN B-NP O
rate NN I-NP O
and CC O O
call VB O O
primary JJ B-NP O
doctor NN I-NP O
Dr NNP I-NP O
Mickles NNP I-NP O
if IN B-VP O
it PRP O O
is VBZ O O
excessively RB O O
low JJ O O
or CC O O
high JJ O O
and CC O O
patient JJ O O
is VBZ O O
complaining VBG O O
of IN B-VP O
symptoms NNS B-NP O
Please NNP I-NP O
ensure VB O O
she PRP O O
is VBZ O O
wearing VBG O O
her PRP$ O O
event NN B-NP O
monitor NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
DRIEVER NNP I-NP O
, , O O
LOGAN NNP B-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
HJ06 NNP B-NP O
) ) O O
9/4 CD O O
@ $ O O
01 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#640167 VBZ O O
349403045 CD O O
VTH NNP B-NP O
15063553 CD O O
5309751 CD O O
0/2/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
research NN I-NP O
study NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/3/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/1/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
WEINGARTEN NNP I-NP O
, , O O
LAVERNE NNP B-NP O
721-51-59-9 CD O O
Bock NNP B-NP O
Pit NNP I-NP O
Magaford NNP I-NP O
Hfortro NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
5/10/04 CD O O
AT NNP B-NP O
08:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
completion NN I-NP O
of IN B-VP O
study NN B-NP O
protocol NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
GAWRONSKI NNP I-NP O
, , O O
KELLEY NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
study NN I-NP O
diet JJ B-NP O
ACTIVITY: NNP I-NP O
activity NN I-NP O
as IN B-VP O
tolerated JJ B-NP O
NO NNP I-NP O
FOLLOW NNP I-NP O
APPOINTMRNT NNP I-NP O
REQUIRED NNP I-NP O
No NNP I-NP O
Known NNP I-NP O
Allergies NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
research NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
research NN B-NP O
study NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
dm NN I-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
htn NN B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
sleep NN B-NP O
apnea NN I-NP O
( ( O O
sleep JJ B-NP O
apnea NN I-NP O
) ) O O
gout NN B-NP O
( ( O O
gout NN B-NP O
) ) O O
depression NN B-NP O
( ( O O
depression NN B-NP O
) ) O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
left VBD B-VP O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
n/a FW O O
OTHER NNP B-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
as IN B-VP O
per IN B-VP O
study NN B-NP O
protocol NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
pt NN I-NP O
admitted VBD B-VP O
for IN B-VP O
research NN B-NP O
study NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
CICHONSKI NNP I-NP O
, , O O
BOB NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
QH06 NNP B-NP O
) ) O O
5/10/04 CD O O
@ $ O O
03 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#647217 VBZ O O
593111043 CD O O
PSUH NNP B-NP O
01580237 CD O O
763408 CD O O
1/0/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
UNSTABLE NNP I-NP O
ANGINA NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/8/2002 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/5/2002 CD O O
CHIEF NNP B-NP O
COMPLAINT: NNP I-NP O
CHEST NNP I-NP O
PAIN NNP I-NP O
, , O O
SHORTNESS NNP B-NP O
OF NNP I-NP O
BREATH NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
65-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
HTN NNP B-NP O
, , O O
IPF NNP B-NP O
and CC O O
some DT B-NP O
CAD NNP I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
the DT B-NP O
first JJ I-NP O
episode NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
and CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
The DT B-NP O
patient NN I-NP O
first RB O O
experienced VBD B-VP O
a DT B-NP O
sudden JJ I-NP O
onset NN I-NP O
of IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pressure NN I-NP O
and CC O O
severe JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
five CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
which WDT O O
resolved VBD B-VP O
in IN B-VP O
one CD O O
hour NN B-NP O
but CC O O
continued VBD B-VP O
to TO O O
have VB O O
some DT B-NP O
substernal JJ I-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
with IN B-VP O
even RB O O
mild JJ B-NP O
exertion NN I-NP O
, , O O
i.e NN B-NP O
, , O O
crossing VBG O O
the DT B-NP O
room NN I-NP O
This DT O O
occurred VBD B-VP O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
The DT B-NP O
patient NN I-NP O
described VBD B-VP O
the DT B-NP O
substernal JJ I-NP O
chest NN I-NP O
pressure NN I-NP O
as IN B-VP O
being VBG O O
like IN B-VP O
hit VBN O O
in IN B-VP O
the DT B-NP O
chest NN I-NP O
and CC O O
this DT O O
lasted VBN O O
about IN B-VP O
fifteen JJ B-NP O
minutes NNS I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
have VB O O
some DT B-NP O
nausea NN I-NP O
and CC O O
vomiting NN B-NP O
associated VBN O O
with IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
and CC O O
was VBD B-VP O
most RBS O O
comfortable JJ O O
sitting VBG O O
up RP O O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
continue VB O O
to TO O O
have VB O O
increased VBN O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
at IN B-VP O
rest NN B-NP O
and CC O O
worsened VBD B-VP O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
with IN B-VP O
around IN B-VP O
two CD O O
episodes NNS B-NP O
per IN B-VP O
day NN B-NP O
of IN B-VP O
severe JJ B-NP O
chest NN I-NP O
pressure/dyspnea/pain NN I-NP O
that WDT O O
required VBD B-VP O
her PRP O O
to TO O O
remain VB O O
still RB O O
over IN B-VP O
the DT O O
next JJ O O
five CD O O
days NNS B-NP O
She PRP O O
also RB O O
noted VBD B-VP O
diaphoresis NN B-NP O
with IN B-VP O
all PDT O O
those DT O O
episodes IN B-VP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
fever NN I-NP O
, , O O
chills NNS B-NP O
, , O O
URI NNP B-NP O
symptoms NNS I-NP O
, , O O
cough NN B-NP O
, , O O
change NN B-NP O
in IN B-VP O
bowel NN B-NP O
movements NNS I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
complain NN B-NP O
of IN B-VP O
some DT B-NP O
bilateral JJ I-NP O
foot NN I-NP O
edema RB O O
1-2 JJ B-NP O
weeks NNS I-NP O
prior RB O O
to TO O O
admission VB O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
stable JJ B-NP O
two-pillow JJ I-NP O
orthopnea NN I-NP O
and CC O O
notes VBZ O O
no DT B-NP O
weight NN I-NP O
gain NN I-NP O
or CC O O
loss NN B-NP O
, , O O
but CC O O
notes NNS B-NP O
decreased VBD B-VP O
exercise NN B-NP O
tolerance NN I-NP O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
month NN I-NP O
The DT B-NP O
patient NN I-NP O
presented VBD B-VP O
to TO O O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician JJ B-NP O
today NN I-NP O
secondary JJ O O
to TO O O
continued JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
and CC O O
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
where WRB O O
electrocardiogram NN B-NP O
revealed VBD B-VP O
some DT B-NP O
ST NNP I-NP O
depressions NNS I-NP O
anterolaterally RB O O
with IN B-VP O
a DT B-NP O
troponin NN I-NP O
leak NN I-NP O
with IN B-VP O
a DT B-NP O
troponin JJ I-NP O
level NN I-NP O
of IN B-VP O
0.19 CD O O
and CC O O
was VBD B-VP O
thus RB O O
admitted VBN O O
to TO O O
the DT B-NP O
cardiology NN I-NP O
Memp NNP I-NP O
Mont NNP I-NP O
service NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Insulin-dependent NNP I-NP O
diabetes VBZ O O
mellitus JJ O O
x $ O O
30 CD O O
years NNS B-NP O
, , O O
hypertension NN B-NP O
, , O O
IPF NNP B-NP B-r
IPF NNP I-NP B-r
diagnosed VBD B-VP O
in IN B-VP O
1986 CD O O
treated VBD B-VP O
with IN B-VP O
digoxin NN B-NP B-m
and CC O O
prednisone NN B-NP B-m
, , O O
osteoarthritis NN B-NP O
, , O O
obesity NN B-NP O
, , O O
pneumonia NN B-NP O
, , O O
colonic JJ B-NP O
polyps NNS I-NP O
with IN B-VP O
guaiac-positive JJ B-NP O
stool NN I-NP O
, , O O
TKR NNP B-NP O
on IN B-VP O
9/24 CD O O
, , O O
cholecystectomy NN B-NP O
, , O O
Bell's NNP B-NP O
palsy VBZ O O
x $ O O
20 CD O O
years NNS B-NP O
, , O O
LBP NNP B-NP O
, , O O
right JJ B-NP O
cataracts NNS I-NP O
, , O O
catheterization NN B-NP O
in IN B-VP O
1998 CD O O
showed VBD B-VP O
a DT B-NP O
LAD NNP I-NP O
lesion NN I-NP O
of IN B-VP O
40% CD O O
and CC O O
a DT B-NP O
circ JJ I-NP O
lesion NN I-NP O
of IN B-VP O
30% CD O O
, , O O
RCA NNP B-NP O
lesion NN I-NP O
of IN B-VP O
30% CD O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Captopril NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
b.i.d.; NN I-NP B-f
Lasix NNP I-NP B-m
40 CD O B-do
mg NN B-NP I-do
q.d.; NN I-NP B-f
Lopid NNP I-NP B-m
600 CD O B-do
mg NN B-NP I-do
b.i.d.; NN I-NP B-f
Axid NNP I-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d.; NN I-NP B-f
insulin NN I-NP B-m
insulin NN I-NP B-m
70/30 CD O I-m
70/30 CD O I-m
90 CD O B-do
q NN B-NP B-f
a.m NN I-NP I-f
and CC O O
40 CD O B-do
q NN B-NP B-f
p.m.; NN I-NP I-f
atenolol VBD B-VP B-m
50 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
ALLERGIES: NNP I-NP O
IV NNP I-NP O
contrast NN I-NP O
, , O O
patient JJ O O
gets VBZ O O
hives NNS B-NP O
Bactrim NNP I-NP O
, , O O
also RB O O
hives VBZ O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Father NNP I-NP O
died VBD B-VP O
of IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
at IN B-VP O
age NN B-NP O
81 CD O O
, , O O
brother JJR O O
died VBD B-VP O
of IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
at IN B-VP O
age NN B-NP O
38 CD O O
, , O O
mother JJR O O
died VBD B-VP O
of IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
at IN B-VP O
age NN B-NP O
73 CD O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
A NNP I-NP O
housekeeper NN I-NP O
, , O O
lives VBZ O O
with IN B-VP O
her PRP$ O O
granddaughter NN B-NP O
, , O O
has VBZ O O
a DT B-NP O
boyfriend JJ I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
VITAL NNP I-NP O
SIGNS: NNP I-NP O
Temperature NNP I-NP O
98.4 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
65 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
20 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
142/64 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
99% CD O O
on IN B-VP O
three CD O O
liters NNS B-NP O
of IN B-VP O
O2 NNP B-NP O
GENERAL: NNP I-NP O
Lying NNP I-NP O
in IN B-VP O
bed NN B-NP O
, , O O
labored VBD B-VP O
breathing VBG O O
HEENT: NNP B-NP O
NC/AT NNP I-NP O
EOMI NNP I-NP O
, , O O
PERRLA NNP B-NP O
NECK: NNP I-NP O
JVP NNP I-NP O
around IN B-VP O
8 CD O O
cm NN B-NP O
, , O O
no DT B-NP O
carotid NN I-NP O
bruits VBZ O O
PULMONARY: NNP B-NP O
Dry NNP I-NP O
, , O O
fine JJ B-NP O
crackles NNS I-NP O
one-third NN I-NP O
of IN B-VP O
the DT B-NP O
way NN I-NP O
up RP O O
bilaterally RB O O
No NNP B-NP O
wheezes NN I-NP O
, , O O
no DT B-NP O
focal JJ I-NP O
dullness NN I-NP O
CARDIOVASCULAR: NNP I-NP O
Distant NNP I-NP O
heart NN I-NP O
sounds VBZ O O
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1S2 NNP I-NP O
, , O O
no DT B-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
or CC O O
gallops NNS B-NP O
ABDOMEN: NNP I-NP O
Obese NNP I-NP O
, , O O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
EXTREMITIES: NNP B-NP O
Trace NNP I-NP O
pedal NN I-NP O
edema NN I-NP O
NEURO: NNP I-NP O
Alert NNP I-NP O
and CC O O
oriented VBD B-VP O
x $ O O
3 CD O O
DTRs NNP B-NP O
2+ CD O O
Sensation NNP B-NP O
intact JJ O O
distally RB O O
LABORATORY NNP B-NP O
DATA: NNP I-NP O
White NNP I-NP O
count NN I-NP O
8.44 CD O O
, , O O
hematocrit NN B-NP O
34.2 CD O O
platelets NNS B-NP O
408 CD O O
, , O O
sodium NN B-NP O
138 CD O O
, , O O
potassium NN B-NP O
5.6 CD O O
, , O O
chloride/bicarb NN B-NP O
109/19 CD O O
, , O O
BUN/creatinine NNP B-NP O
20/1.1 CD O O
, , O O
glucose RB O O
249 CD O O
, , O O
ALT NNP B-NP O
13 CD O O
, , O O
AST NNP B-NP O
16 CD O O
, , O O
CK NNP B-NP O
68 CD O O
, , O O
alk VBP O O
phos JJ O O
119 CD O O
, , O O
TP NNP B-NP O
7.4 CD O O
, , O O
albumin RB O O
4.2 CD O O
, , O O
CA NNP B-NP O
9.2 CD O O
, , O O
TB NNP B-NP O
0.4 CD O O
, , O O
troponin NN B-NP O
0.19 CD O O
, , O O
INR NNP B-NP O
1.1 CD O O
, , O O
D-dimer NNP B-NP O
573 CD O O
, , O O
PTT NNP B-NP O
29.3 CD O O
Electrocardiogram NNP B-NP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
67 CD O O
, , O O
LAD NNP B-NP O
, , O O
LDH NNP B-NP O
, , O O
RBBB NNP B-NP O
, , O O
ST NNP B-NP O
depressions VBZ O O
V3-V6 NNP B-NP O
, , O O
0.5 CD O O
mm NN B-NP O
in IN B-VP O
2 CD O O
and CC O O
3 CD O O
Echo NNP B-NP O
5/4/01: CD O O
Ejection NNP B-NP O
fraction NN I-NP O
55-60% CD O O
, , O O
no DT B-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities NNS I-NP O
, , O O
trace NN B-NP O
AI NNP I-NP O
, , O O
trace NN B-NP O
MR NNP I-NP O
, , O O
mild JJ B-NP O
TR NNP I-NP O
1/17 CD O O
adenosine NN B-NP O
MIBI: NNP I-NP O
No NNP I-NP O
symptoms NNS I-NP O
, , O O
1 CD O O
mm NN B-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
1 CD O O
, , O O
2 CD O O
and CC O O
V4-V6 JJ B-NP O
Chest NNP I-NP O
x-ray: NN I-NP O
Positive NNP I-NP O
for IN B-VP O
mild JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
, , O O
retrocardial JJ B-NP O
infiltrate NN I-NP O
and CC O O
left VBD B-VP O
effusion NN B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
65-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
diabetes VBZ O O
, , O O
IPF NNP B-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
five CD O O
days NNS B-NP O
of IN B-VP O
chest JJ B-NP O
pain/SOB NN I-NP O
beginning VBG O O
with IN B-VP O
sudden JJ B-NP O
onset NN I-NP O
five CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
and CC O O
had VBD B-VP O
EKG NNP B-NP O
changes NNS I-NP O
consistent VBP O O
with IN B-VP O
a DT B-NP O
non-Q-wave JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
anterolaterally RB O O
Of IN B-VP O
note NN B-NP O
her PRP$ O O
troponin NN B-NP O
was VBD B-VP O
0.19 CD O O
The DT B-NP O
differential JJ I-NP O
diagnosis NN I-NP O
included VBD B-VP O
unstable JJ B-NP O
angina NN I-NP O
and CC O O
PE NNP B-NP O
with IN B-VP O
worsening VBG O O
IPF NNP B-NP O
superimposed VBN O O
on IN B-VP O
heart NN B-NP O
disease NN I-NP O
From IN B-VP O
a DT B-NP O
cardiovascular JJ I-NP O
standpoint NN I-NP O
the DT B-NP O
patient NN I-NP O
has VBZ O O
known VBN O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
with IN B-VP O
EKG NNP B-NP O
changes NNS I-NP O
which WDT O O
is VBZ O O
likely JJ B-NP O
status NN I-NP O
post NN I-NP O
non-Q-wave JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
with IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
continued JJ O O
unstable JJ O O
angina IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
initially RB O O
put VBN O O
on IN B-VP O
aspirin NN B-NP B-m
, , O O
Lopressor NNP B-NP B-m
37.5 CD O B-do
t.i.d NN B-NP B-f
, , O O
heparin NN B-NP B-m
, , O O
oxygen NN B-NP B-m
and CC O O
hooked VBD B-VP O
up RB O O
to TO O O
a DT B-NP O
cardiac JJ I-NP O
monitor NN I-NP O
and CC O O
EKG NNP B-NP O
q.d NN I-NP O
and CC O O
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
enzymes RB O O
The DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
which WDT O O
revealed VBD B-VP O
LAD NNP B-NP O
ostial JJ O O
90% CD O O
, , O O
proximal JJ O O
80% CD O O
, , O O
diag VBP O O
ostial JJ O O
90% CD O O
, , O O
left VBD B-VP O
circ NN B-NP O
90% CD O O
, , O O
80% CD O O
lesions NNS B-NP O
, , O O
marginal JJ O O
1 CD O O
, , O O
TUB NNP B-NP O
90% CD O O
, , O O
RCA NNP B-NP O
50% CD O O
The DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
PTCA NNP I-NP O
and CC O O
stent JJ B-NP O
x NN I-NP O
2 CD O O
with IN B-VP O
good JJ B-NP O
results NNS I-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
free JJ O O
and CC O O
had VBD B-VP O
no DT B-NP O
chest JJS I-NP O
pain NN I-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
i.e NN B-NP O
, , O O
with IN B-VP O
ambulation NN B-NP O
The DT B-NP O
echo NN I-NP O
showed VBD B-VP O
preserved JJ O O
left VBD B-VP O
ventricular JJ B-NP O
function NN I-NP O
with IN B-VP O
a DT B-NP O
good JJ I-NP O
ejection NN I-NP O
fraction NN I-NP O
The DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
55% CD O O
There EX O O
was VBD B-VP O
no DT B-NP O
discrete JJ I-NP O
evidence NN I-NP O
of IN B-VP O
wall NN B-NP O
motion NN I-NP O
abnormality NN I-NP O
although IN B-VP O
the DT O O
inferior JJ O O
and CC O O
posterior JJ B-NP O
segments NNS I-NP O
were VBD B-VP O
not RB O O
well RB O O
visualized IN B-VP O
There EX O O
was VBD B-VP O
left VBN O O
ventricular JJ B-NP O
hypertrophy NN I-NP O
There EX O O
was VBD B-VP O
stromal JJ B-NP O
mild JJ I-NP O
right JJ I-NP O
ventricular NN I-NP O
hypertrophy NN I-NP O
and CC O O
overall JJ B-NP O
right JJ I-NP O
heart NN I-NP O
function NN I-NP O
appeared VBD B-VP O
to TO O O
be VB O O
preserved VBN O O
There EX O O
was VBD B-VP O
trivial JJ O O
to TO O O
1+ CD O O
tricuspid JJ B-NP O
regurgitation NN I-NP O
with IN B-VP O
right JJ B-NP O
heart NN I-NP O
pressures NNS I-NP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
There EX O O
was VBD B-VP O
thickened VBN O O
aortic JJ B-NP O
leaflets NNS I-NP O
with IN B-VP O
trivial JJ B-NP O
central JJ I-NP O
insufficiency NN I-NP O
and CC O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
outflow JJ I-NP O
tract NN I-NP O
obstruction NN I-NP O
There EX O O
was VBD B-VP O
similar JJ B-NP O
mild JJ I-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
with IN B-VP O
the DT B-NP O
elliptic JJ I-NP O
ring NN I-NP O
, , O O
the DT B-NP O
left JJ I-NP O
atrial JJ I-NP O
size NN I-NP O
was VBD B-VP O
slightly RB O O
increased VBN O O
and CC O O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP O
effusion NN I-NP O
From IN B-VP O
a DT B-NP O
pulmonary JJ I-NP O
standpoint NN I-NP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
LENIs NNP B-NP O
which WDT O O
were VBD B-VP O
negative JJ O O
for IN B-VP O
a DT B-NP O
deep JJ I-NP O
venous JJ I-NP O
thrombosis NN I-NP O
PFCs NNP I-NP O
revealed VBD B-VP O
a DT B-NP O
restrictive JJ I-NP O
physiology NN I-NP O
and CC O O
poor JJ B-NP O
diffusion NN I-NP O
consistent NN I-NP O
with IN B-VP O
IPF NNP B-NP O
The DT B-NP O
FEV1 NNP I-NP O
was VBD B-VP O
69% CD O O
predicted VBN O O
, , O O
TLC NNP B-NP O
was VBD B-VP O
63% CD O O
predicted VBN O O
, , O O
with IN B-VP O
a DT B-NP O
DLCO NNP I-NP O
of IN B-VP O
56% CD O O
predicted VBD B-VP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
have VB O O
a DT B-NP B-r
retrocardiac JJ I-NP I-r
infiltrate NN I-NP I-r
on IN B-VP O
chest JJ B-NP O
x-ray NN I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
levofloxacin JJ O B-m
500 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
for IN B-VP B-du
fourteen JJ B-NP O
days NNS I-NP O
From IN B-VP O
a DT B-NP O
GI NNP I-NP O
perspective NN I-NP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
colonic JJ B-NP O
polyps NNS I-NP O
but CC O O
tolerated VBD B-VP O
the DT B-NP O
aspirin NN I-NP B-m
and CC O O
was VBD B-VP O
put VBN O O
on IN B-VP O
Nexium NNP B-NP B-m
prophylaxis VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
hypokalemic JJ O B-r
on IN B-VP O
10/23 CD O O
with IN B-VP O
a DT B-NP O
curious JJ I-NP O
whitening NN I-NP O
on IN B-VP O
EKG NNP B-NP O
and CC O O
peak JJ B-NP O
T NNP I-NP O
waves VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
insulin NN B-NP B-m
, , O O
given VBN O O
calcium NN B-NP B-m
and CC O O
treated VBN O O
with IN B-VP O
Kayexalate NNP B-NP B-m
x NNP I-NP B-du
3 CD O I-du
and CC O O
the DT B-NP O
hypokalemia NN I-NP O
quickly RB O O
resolved VBD B-VP O
The DT B-NP O
origin NN I-NP O
of IN B-VP O
the DT B-NP O
hypokalemia NN I-NP O
was VBD B-VP O
unclear JJ O O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
have VB O O
an DT B-NP O
elevated JJ I-NP O
potassium NN I-NP O
with IN B-VP O
a DT B-NP O
low JJ I-NP O
bicarb NN I-NP O
which WDT O O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
a DT B-NP O
type NN I-NP O
4 CD O O
RTA NNP B-NP O
and CC O O
also RB O O
had VBD B-VP O
hypoglycemia NN B-NP B-r
which WDT O O
was VBD B-VP O
then RB O O
treated VBN O O
with IN B-VP O
prednisone NN B-NP B-m
overnight NN I-NP B-du
for IN B-VP O
IV NNP B-NP O
contrast NN I-NP O
dye NN I-NP O
allergy IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
on IN B-VP O
Captopril NNP B-NP B-m
which WDT O O
was VBD B-VP O
discontinued VBN O O
secondary JJ O O
to TO O O
her PRP$ O O
renal JJ B-NP O
issues NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ASA NNP I-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o.q.d.; NN I-NP B-mo
atenolol VBD B-VP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
Lasix NNP I-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o.q.d.; NN I-NP B-mo
Lopid NNP I-NP B-m
600 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
nitroglycerin RB O B-m
1/150 CD O I-m
one CD O B-do
tab NN B-NP I-do
q VBZ O O
5 CD O O
minutes NNS B-NP O
x VBP O B-du
3 CD O I-du
p.r.n JJ B-NP O
chest NN I-NP B-r
pain; NN I-NP I-r
Zocor NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s.; NN I-NP B-f
Norvasc NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o.q.d.; NN I-NP B-mo
xalatan NNP I-NP B-m
one CD O B-do
drop NN B-NP I-do
OU NNP I-NP B-mo
q.h.s.; NN I-NP B-f
Alphagan NNP I-NP B-m
one CD O B-do
drop NN B-NP I-do
OU NNP I-NP B-mo
b.i.d.; NN I-NP B-f
levofloxacin VBD B-VP B-m
500 CD O B-do
mg NN B-NP O
p.o.q.d.; NN I-NP B-mo
clopidogrel NN I-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o.q.d.; NN I-NP B-mo
insulin NN I-NP B-m
insulin NN I-NP B-m
70/30 CD O I-m
70/30 CD O I-m
90 CD O B-do
units NNS B-NP I-do
q RB O B-f
a.m RB O O
, , O O
40 CD O B-do
units NNS B-NP I-do
q RB O B-f
p.m VBP O I-f
subcu; JJ B-NP B-mo
Axid NNP I-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
Dictated NNP I-NP O
By: NNP I-NP O
GARTH NNP I-NP O
KILLE NNP I-NP O
, , O O
M.D NNP B-NP O
RX628 NNP I-NP O
Attending: NNP I-NP O
NORMAND NNP I-NP O
PERRUZZA NNP I-NP O
, , O O
M.D NNP B-NP O
DG98 NNP I-NP O
LX446/691450 NNP I-NP O
Batch: NNP I-NP O
19985 CD O O
Index NNP B-NP O
No NNP I-NP O
FEAYNM1BTQ NNP I-NP O
D: NNP I-NP O
8/29/02 CD O O
T: NNP B-NP O
8/29/02 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#650471 VBZ O O
100417558 CD O O
CHO NNP B-NP O
71347001 CD O O
261218 CD O O
9/3/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
ANGINA NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/17/2000 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/11/2000 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
SIGNIFICANT NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
CORONARY NNP B-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
2 CD O O
HYPERCHOLESTEROLEMIA NNP B-NP O
3 CD O O
HYPERTENSION NNP B-NP O
4 CD O O
ANEMIA NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Ms NNP I-NP O
Christin NNP I-NP O
is VBZ O O
an DT O O
80 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
who WP O O
presents VBZ O O
to TO O O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
She PRP O O
states VBZ O O
the DT B-NP O
night NN I-NP O
prior RB O O
to TO O O
admission VB O O
she PRP O O
felt VBD B-VP O
some DT B-NP O
shortness NN I-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
and CC O O
tightness NN B-NP O
in IN B-VP O
her PRP$ O O
chest NN B-NP O
upon IN B-VP O
laying VBG O O
down RP O O
She PRP O O
took VBD B-VP O
one CD O B-do
sublingual JJ B-NP B-mo
Nitroglycerin NNP I-NP B-m
without IN B-VP O
relief NN B-NP O
Thirty NNP I-NP O
minutes NNS I-NP O
later RB O O
took VBD B-VP O
another DT B-NP O
sublingual JJ I-NP B-mo
Nitroglycerin NNP I-NP B-m
, , O O
again RB O O
without IN B-VP O
relief NN B-NP O
Shortness NNP I-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
was VBD B-VP O
accompanied VBN O O
with IN B-VP O
increasing VBG O O
feeling NN B-NP O
of IN B-VP O
chest NN B-NP O
tightness NN I-NP O
rated VBD B-VP O
approximately RB O O
8/10 CD O O
Took NNP B-NP O
a DT B-NP O
third JJ I-NP O
Nitroglycerin NNP I-NP B-m
without IN B-VP O
relief NN B-NP O
and CC O O
felt VBD B-VP O
her PRP$ O O
breathing NN B-NP O
became VBD B-VP O
wheezy JJ O O
She PRP O O
then RB O O
drove VBD B-VP O
herself PRP O O
to TO O O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
for IN B-VP O
evaluation NN B-NP O
She PRP O O
was VBD B-VP O
there RB O O
treated VBN O O
with IN B-VP O
intravenous JJ B-NP B-mo
Lasix NNP I-NP B-m
, , O O
morphine NN B-NP B-m
and CC O O
Nitroglycerin NNP B-NP B-m
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
her PRP$ O B-r
her PRP$ O B-r
pain NN B-NP I-r
pain NN I-NP I-r
EKG NNP I-NP O
at IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
showed VBD B-VP O
anterolateral JJ B-NP O
ST NNP I-NP O
depression NN I-NP O
and CC O O
her PRP$ O O
enzymes NNS B-NP O
were VBD B-VP O
negative JJ B-NP O
ruling NN I-NP O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
She PRP O O
has VBZ O O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
of IN B-VP O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
and CC O O
age NN B-NP O
Her PRP$ O O
cardiac JJ B-NP O
symptomatology NN I-NP O
began VBD B-VP O
in IN B-VP O
the DT B-NP O
fall NN I-NP O
of IN B-VP O
1999 CD O O
when WRB O O
she PRP O O
began VBD B-VP O
to TO O O
experience VB O O
chest JJS B-NP O
discomfort NN I-NP O
with IN B-VP O
exertion NN B-NP O
and CC O O
rest NN B-NP O
Evaluation NN I-NP O
by IN B-VP O
Dr NNP B-NP O
Jose NNP I-NP O
Esparza NNP I-NP O
showed VBD B-VP O
high JJ B-NP O
cholesterol NN I-NP O
with IN B-VP O
an DT B-NP O
LDL NNP I-NP O
141 CD O O
, , O O
EKG NNP B-NP O
with IN B-VP O
LVH NNP B-NP O
and CC O O
nonspecific JJ B-NP O
T NNP I-NP O
wave NN I-NP O
flattening VBG O O
A NNP B-NP O
Thallium NNP I-NP O
stress NN I-NP O
test NN I-NP O
in IN B-VP O
November NNP B-NP O
of IN B-VP O
1999 CD O O
was VBD B-VP O
three CD O O
minutes NNS B-NP O
, , O O
fifty-two JJ B-NP O
seconds NNS I-NP O
duration NN I-NP O
, , O O
stopped VBD B-VP O
secondary JJ O O
to TO O O
shortness VB O O
of IN B-VP O
breath NN B-NP O
, , O O
and CC O O
there EX O O
were VBD B-VP O
inferolateral JJ B-NP O
ST NNP I-NP O
depressions NNS I-NP O
with IN B-VP O
inferior JJ B-NP O
apical JJ I-NP O
ischemia NN I-NP O
on IN B-VP O
imaging VBG O O
She PRP O O
had VBD B-VP O
her PRP O O
symptoms NNS B-NP O
managed VBD B-VP O
medically RB O O
with IN B-VP O
cholesterol NN B-NP O
lowering NN I-NP O
and CC O O
antihypertensive JJ B-NP O
therapy NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
angina NN B-NP O
, , O O
Paget's NNP B-NP O
disease NN I-NP O
, , O O
anemia NN B-NP O
, , O O
osteoarthritis FW O O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Noncontributory NNP I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
She PRP O O
is VBZ O O
widowed VBN O O
, , O O
she PRP O O
lives VBZ O O
alone RB O O
Has NNP B-NP O
many JJ B-NP O
friends NNS I-NP O
and CC O O
support NN B-NP O
in IN B-VP O
the DT B-NP O
area NN I-NP O
Owns NNP I-NP O
her PRP$ O O
own JJ B-NP O
store NN I-NP O
No NNP I-NP O
tobacco NN I-NP O
, , O O
no DT B-NP O
alcohol NN I-NP O
, , O O
no DT B-NP O
drug NN I-NP O
use NN I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Positive NNP I-NP O
for IN B-VP O
orthopnea NN B-NP O
increasing VBG O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
month NN I-NP O
No NNP I-NP O
palpitations VBZ O O
No DT B-NP O
claudication NN I-NP O
No RB O O
lower JJR B-NP O
extremity NN I-NP O
edema VBZ O O
No NNP B-NP O
syncope NN I-NP O
No NNP I-NP O
melena NN I-NP O
, , O O
diarrhea NN B-NP O
, , O O
hemoptysis NN B-NP O
or CC O O
bright JJ B-NP O
red JJ I-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
ADMISSION NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
VITAL NNP I-NP O
SIGNS NNP I-NP O
- : O O
She PRP O O
is VBZ O O
afebrile JJ O O
at IN B-VP O
98.3 CD O O
degrees NNS B-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
52 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
160/68 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
GENERAL NNP I-NP O
- : O O
She PRP O O
is VBZ O O
a DT O O
petite JJ O O
, , O O
elderly JJ B-NP O
woman NN I-NP O
sitting VBG O O
in IN B-VP O
bed NN B-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
HEENT NNP I-NP O
- : O O
Pupils NNS B-NP O
are VBP O O
equally RB O O
round JJ O O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Oropharynx NNP I-NP O
is VBZ O O
clear JJ B-NP O
NECK NNP I-NP O
- : O O
JV NNP B-NP O
pressure NN I-NP O
approximately RB O O
6 CD O O
cm NN B-NP O
of IN B-VP O
water NN B-NP O
, , O O
2+ CD O O
carotids NNS B-NP O
, , O O
no DT B-NP O
bruits NNS I-NP O
LUNGS NNP I-NP O
- : O O
Crackles NNS B-NP O
bilaterally RB O O
at IN B-VP O
the DT B-NP O
bases NNS I-NP O
, , O O
no DT O O
wheezing VBG O O
HEART: NNP B-NP O
Distant NNP I-NP O
heart NN I-NP O
sounds VBZ O O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
Soft NNP I-NP O
grade VBD B-VP O
I/VI NNP B-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur VBZ O O
No DT B-NP O
gallop NN I-NP O
ABDOMEN NNP I-NP O
- : O O
Soft JJ O O
, , O O
non-tender JJ O O
, , O O
nondistended JJ B-NP O
Normal NNP I-NP O
bowel NN I-NP O
sounds VBZ O O
No DT B-NP O
masses NNS I-NP O
, , O O
guarding VBG O O
or CC O O
rebound VB O O
EXTREMITIES: NNP B-NP O
Warm NNP I-NP O
No NNP I-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
or CC O O
edema NN B-NP O
, , O O
1+ CD O O
dorsalis NN B-NP O
pedis NN I-NP O
pulses VBZ O O
bilaterally RB O O
NEURO: NNP B-NP O
Nonfocal NNP I-NP O
ADMISSION NNP I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
140 CD O O
, , O O
potassium NN B-NP O
of IN B-VP O
4.4 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
40 CD O O
, , O O
creatinine NN B-NP O
of IN B-VP O
1.6 CD O O
CK NNP B-NP O
of IN B-VP O
459 CD O O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
of IN B-VP O
28.7 CD O O
White NNP B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
8 CD O O
, , O O
000 CD O O
, , O O
hematocrit NN B-NP O
26.9 CD O O
, , O O
platelet NN B-NP O
count NN I-NP O
238 CD O O
Urinalysis NN B-NP O
was VBD B-VP O
negative JJ B-NP O
EKG NNP I-NP O
on IN B-VP O
admission NN B-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
60 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
with IN B-VP O
ST NNP B-NP O
segment NN I-NP O
depression NN I-NP O
V4 NNP I-NP O
through IN B-VP O
V6 NNP B-NP O
approximately RB O O
1 CD O O
mm NNS B-NP O
and CC O O
approximately RB O O
1 CD O O
mm NNS B-NP O
ST NNP I-NP O
depression NN I-NP O
in IN B-VP O
lead JJ B-NP O
II NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Ms NNP I-NP O
Dison NNP I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
Ster NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
of IN B-VP O
her PRP$ O O
angina NN B-NP O
after IN B-VP O
ruling VBG O O
out RP O O
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
however RB O O
, , O O
on IN B-VP O
presentation NN B-NP O
her PRP$ O O
laboratory NN B-NP O
values NNS I-NP O
were VBD B-VP O
consistent JJ O O
with IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
and CC O O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
is VBZ O O
summarized VBN O O
as IN B-VP O
follows VBZ O O
1 CD O O
CARDIOVASCULAR: NNP B-NP O
Ms NNP I-NP O
Berish NNP I-NP O
ruled VBD B-VP O
in IN B-VP O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
with IN B-VP O
a DT B-NP O
peak JJ I-NP O
CK NNP I-NP O
of IN B-VP O
459 CD O O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
of IN B-VP O
28.7 CD O O
This DT O O
decreased VBN O O
to TO O O
328 CD O O
with IN B-VP O
an DT B-NP O
MB NNP I-NP O
of IN B-VP O
15.4 CD O O
the DT B-NP O
following JJ I-NP O
morning NN I-NP O
Her PRP$ O O
troponin NN B-NP O
was VBD B-VP O
15 CD O O
She PRP O O
, , O O
however RB O O
, , O O
remained VBD B-VP O
asymptomatic JJ O O
and CC O O
pain NN B-NP O
free JJ O O
throughout IN B-VP O
her PRP$ O O
hospitalization NN B-NP O
She PRP O O
underwent JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
May NNP B-NP O
, , O O
2000 CD O O
which WDT O O
showed VBD B-VP O
an DT B-NP O
okay NN I-NP O
left VBD B-VP O
main JJ O O
, , O O
LAD NNP B-NP O
with IN B-VP O
proximal JJ O O
90% CD O O
stenosis NN B-NP O
, , O O
which WDT O O
underwent JJ B-NP O
PTCA NNP I-NP O
and CC O O
stenting VBG O O
with IN B-VP O
good JJ B-NP O
result NN I-NP O
, , O O
an DT O O
osteal JJ O O
D-1 JJ O O
80% CD O O
lesion NN B-NP O
which WDT O O
underwent JJ B-NP O
PTCA NNP I-NP O
with IN B-VP O
good JJ B-NP O
result NN I-NP O
, , O O
a DT O O
totally RB O O
occluded JJ B-NP O
proximal NN I-NP O
left VBD B-VP O
circumflex JJ O O
and CC O O
a DT B-NP O
right JJ I-NP O
coronary NN I-NP O
with IN B-VP O
a DT O O
proximal JJ O O
30% CD O O
to TO O O
40% CD O O
stenosis NN B-NP O
She PRP O O
tolerated VBD B-VP O
this DT B-NP O
procedure NN I-NP O
well RB O O
and CC O O
without IN B-VP O
complications NNS B-NP O
Her NNP I-NP O
medical JJ B-NP O
regimen NN I-NP O
was VBD B-VP O
altered VBN O O
to TO O O
include VB O O
beta NN B-NP B-m
blockade NN I-NP I-m
, , O O
ACE NNP B-NP B-m
inhibition NN I-NP I-m
and CC O O
antihypertensives NNS B-NP B-m
and CC O O
ischemics NNS B-NP B-m
, , O O
as IN B-VP O
outlined VBN O O
below IN B-VP O
Of IN B-VP O
note NN B-NP O
, , O O
left VBD B-VP O
ventriculogram NN B-NP O
on IN B-VP O
her PRP$ O O
catheterization NN B-NP O
showed VBD B-VP O
anterior JJ B-NP O
hypokinesis NN I-NP O
with IN B-VP O
3+ CD O O
mitral JJ B-NP O
regurgitation NN I-NP O
2 CD O O
ANEMIA: NNP B-NP O
Ms NNP I-NP O
Flewellen NNP I-NP O
has VBZ O O
a DT O O
known VBN O O
normochromic JJ O O
, , O O
normocytic JJ B-NP O
anemia NN I-NP O
which WDT O O
was VBD B-VP O
worked VBN O O
up RP O O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
She PRP O O
had VBD B-VP O
a DT B-NP O
hematocrit NN I-NP B-r
of IN B-VP O
26.9 CD O O
on IN B-VP O
admission NN B-NP O
for IN B-VP O
which WDT O O
she PRP O O
was VBD B-VP O
transfused VBN O O
one CD O B-do
unit NN B-NP O
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
Her PRP$ O O
workup NN B-NP O
showed VBD B-VP O
an DT B-NP O
iron NN I-NP O
of IN B-VP O
74 CD O O
, , O O
a DT B-NP O
TIBC NNP I-NP O
of IN B-VP O
244 CD O O
, , O O
a DT B-NP O
ferritin NN I-NP O
of IN B-VP O
224 CD O O
, , O O
B-12 NNP B-NP O
of IN B-VP O
241 CD O O
( ( O O
borderline VB O O
low NN B-NP O
) ) O O
Folate NNP B-NP O
and CC O O
Epogen NNP B-NP O
levels NNS I-NP O
were VBD B-VP O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
She PRP O O
also RB O O
had VBD B-VP O
a DT B-NP O
TSH NNP I-NP O
which WDT O O
was VBD B-VP O
normal JJ O O
at IN B-VP O
2.86 CD O O
, , O O
reticulocyte NN B-NP O
count NN I-NP O
of IN B-VP O
3% CD O O
and CC O O
a DT O O
pending VBG O O
serum NN B-NP O
protein NN I-NP O
electrophoresis NN I-NP O
She PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Hematology NNP I-NP O
Consult NNP I-NP O
Service NNP I-NP O
and CC O O
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
follow-up NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Esteves NNS I-NP O
in IN B-VP O
the DT B-NP O
Hematology NNP I-NP O
Clinic NNP I-NP O
Her NNP I-NP O
hematocrit NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
was VBD B-VP O
30 CD O O
Ms NNP B-NP O
Bottoni NNP I-NP O
was VBD B-VP O
stable JJ O O
for IN B-VP O
discharge NN B-NP O
on IN B-VP O
February NNP B-NP O
, , O O
2000 CD O O
Follow-up NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Porter NNP I-NP O
Luckenbaugh NNP I-NP O
in IN B-VP O
SH NNP B-NP O
Cardiovascular NNP I-NP O
Group NNP I-NP O
on IN B-VP O
January NNP B-NP O
at IN B-VP O
1:00 CD O O
p.m NN B-NP O
and CC O O
with IN B-VP O
Dr NNP B-NP O
Sammy NNP I-NP O
Kleindienst NNP I-NP O
in IN B-VP O
the DT B-NP O
Greenetons NNP I-NP O
Opi NNP I-NP O
Hospital NNP I-NP O
Hematology NNP I-NP O
Clinic NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Aspirin NNP I-NP B-m
81 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
iron NN B-NP B-m
300 CD O B-do
mg NN B-NP I-do
three CD O B-f
times NNS B-NP O
a DT B-NP O
day NN I-NP O
, , O O
Hydrochlorothiazide NNP B-NP B-m
25 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Lisinopril NNP B-NP B-m
5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
multivitamin PRP O B-m
one CD O B-do
daily RB O B-f
, , O O
Relafen NNP B-NP B-m
500 CD O B-do
mg NN B-NP O
orally RB O B-mo
a DT B-NP B-f
day NN I-NP I-f
, , O O
Imdur NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
orally RB O B-mo
a DT B-NP B-f
day NN I-NP I-f
, , O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NNS B-NP I-do
daily RB O B-f
for IN B-VP B-du
29 CD O O
days NNS B-NP O
, , O O
Lipitor NNP B-NP B-m
40 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Atenolol NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
orally RB O B-mo
a DT B-NP B-f
day NN I-NP I-f
, , O O
magnesium NN B-NP B-m
oxide RB O I-m
420 CD O B-do
mg JJ O I-do
daily RB O B-f
Dictated NNP B-NP O
By: NNP I-NP O
CLINTON NNP I-NP O
DARVILLE NNP I-NP O
, , O O
M.D NNP B-NP O
BE00 NNP I-NP O
Attending: NNP I-NP O
ARNULFO NNP I-NP O
L NNP I-NP O
BASNETT NNP I-NP O
, , O O
M.D NNP B-NP O
EG9 NNP I-NP O
XQ978/3171 NNP I-NP O
Batch: NNP I-NP O
60071 CD O O
Index NNP B-NP O
No NNP I-NP O
W7NX6M31MH NNP I-NP O
D: NNP I-NP O
4/8 CD O O
T: NNP B-NP O
4/8 CD O O
CC: NNP B-NP O
1 CD O O
ANTIONE NNP B-NP O
R NNP I-NP O
SULENTIC NNP I-NP O
, , O O
M.D NNP B-NP O
EG9 NNP I-NP O
2 CD O O
VITO NNP B-NP O
B NNP I-NP O
LADO NNP I-NP O
, , O O
M.D NNP B-NP O
NY6 NNP I-NP O
3 CD O O
FOREST NNP B-NP O
G NNP I-NP O
NICODEMUS NNP I-NP O
, , O O
M.D NNP B-NP O
WZ6 NNP I-NP O
4 CD O O
DR NNP B-NP O
OHRT NNP I-NP O
, , O O
Ster NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#652612 VBZ O O
148900251 CD O O
EMHAHS NNP B-NP O
69939492 CD O O
0604964 CD O O
1/3/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/17/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
altered VBD B-VP O
mental JJ B-NP O
status NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Patient NNP I-NP O
is VBZ O O
a DT B-NP O
73-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
prior JJ B-NP O
delirious JJ I-NP O
episodes NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chronic JJ B-NP O
diarrhea NN I-NP O
who WP O O
, , O O
on IN B-VP O
the DT B-NP O
night NN I-NP O
before IN B-VP O
admission NN B-NP O
, , O O
was VBD B-VP O
noted VBN O O
to TO O O
no DT O O
longer RBR O O
recognize VB O O
people NNS B-NP O
at IN B-VP O
home NN B-NP O
and CC O O
to TO O O
be VB O O
confused VBN O O
about IN B-VP O
his PRP$ O O
location NN B-NP O
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
had VBN O O
intractable JJ B-NP O
explosive JJ I-NP O
diarrhea NN I-NP O
He PRP O O
does VBZ O O
have VB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chronic JJ B-NP O
diarrhea NN I-NP O
but CC O O
the DT B-NP O
diarrhea NN I-NP O
on IN B-VP O
the DT B-NP O
date NN I-NP O
of IN B-VP O
admission NN B-NP O
was VBD B-VP O
significantly RB O O
more RBR O O
severe JJ O O
than IN B-VP O
usual JJ B-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
denied VBD B-VP O
any DT B-NP O
chest JJS I-NP O
pain NN I-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
, , O O
or CC O O
decrease NN B-NP O
in IN B-VP O
his PRP$ O O
p.o NN B-NP O
intake NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
50% CD O O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
five CD O O
vessel NN B-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
in IN B-VP O
March NNP B-NP O
2002 CD O O
, , O O
myelodysplastic JJ B-NP O
syndrome NN I-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
gastrointestinal JJ B-NP O
bleed NN I-NP O
status NN I-NP O
post NN I-NP O
right RB O O
colectomy NN B-NP O
, , O O
prostate NN B-NP O
cancer NN I-NP O
status NN I-NP O
post NN I-NP O
transurethral JJ B-NP O
resection NN I-NP O
of IN B-VP O
the DT B-NP O
prostate NN I-NP O
, , O O
and CC O O
macular JJ B-NP O
degeneration NN I-NP O
CURRENT NNP I-NP O
MEDICATIONS: NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
included VBD B-VP O
opium JJ B-NP B-m
tincture NN I-NP O
, , O O
aspirin NN B-NP B-m
, , O O
Lomotil NNP B-NP B-m
, , O O
Lasix NNP B-NP B-m
, , O O
Ditropan NNP B-NP B-m
, , O O
Lopid NNP B-NP B-m
, , O O
Zocor NNP B-NP B-m
, , O O
Atapryl NNP B-NP B-m
, , O O
and CC O O
iron VB O B-m
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
patient NN B-NP O
was VBD B-VP O
afebrile RB O O
, , O O
his PRP$ O O
heart NN B-NP O
rate NN I-NP O
was VBD B-VP O
60 CD O O
, , O O
his PRP$ O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
145/68 CD O O
, , O O
and CC O O
he PRP O O
was VBD B-VP O
saturating VBG O O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
His PRP$ O O
physical JJ B-NP O
examination NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
pressure NN I-NP O
at IN B-VP O
5 CD O O
cm NN B-NP O
, , O O
moist VBP O O
mucous JJ B-NP O
membranes NNS I-NP O
, , O O
and CC O O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
nondistended VBD B-VP O
abdominal JJ B-NP O
examination NN I-NP O
On IN B-VP O
rectal JJ B-NP O
examination NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
guaiac JJ B-NP O
positive JJ I-NP O
brown JJ I-NP O
stool NN I-NP O
LABORATORY NNP I-NP O
EXAMINATION: NNP I-NP O
Head NNP I-NP O
CT NNP I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
any DT B-NP O
acute JJ I-NP O
change NN I-NP O
, , O O
chest JJS B-NP O
x-ray NN I-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
pneumonia NN B-NP O
, , O O
and CC O O
the DT B-NP O
patient's NN I-NP O
EKG NNP I-NP O
was VBD B-VP O
reviewed VBN O O
and CC O O
shown VBN O O
to TO O O
be VB O O
without IN B-VP O
change NN B-NP O
from IN B-VP O
prior JJ B-NP O
studies NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
Neurological NNP B-NP O
- : O O
The DT B-NP O
patient's JJ I-NP O
mental JJ I-NP O
status NN I-NP O
improved VBD B-VP O
quickly RB O O
on IN B-VP O
admission NN B-NP O
As IN B-VP O
noted VBN O O
above IN B-VP O
, , O O
his PRP$ O O
head NN B-NP O
CT NNP I-NP O
was VBD B-VP O
negative JJ O O
It PRP O O
was VBD B-VP O
thought VBN O O
that IN B-VP O
his PRP$ O O
mental JJ B-NP O
status NN I-NP O
changes NNS I-NP O
were VBD B-VP O
likely JJ O O
secondary JJ O O
to TO O O
dehydration NN B-NP O
and CC O O
were VBD B-VP O
resolved VBN O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
2 CD O O
Pulmonary NNP B-NP O
- : O O
During IN B-VP O
resuscitation NN B-NP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
dehydration NN I-NP O
, , O O
he PRP O O
developed VBD B-VP O
an DT B-NP O
O2 NNP I-NP O
requirement NN I-NP O
although IN B-VP O
chest JJ B-NP O
x-ray NN I-NP O
did VBD B-VP O
not RB O O
show VB O O
any DT B-NP O
evidence NN I-NP O
for IN B-VP O
fluid NN B-NP O
overload NN I-NP O
or CC O O
infiltrates VBZ O O
Occasional JJ B-NP O
wheezes NNS I-NP B-r
were VBD B-VP O
appreciated VBN O O
on IN B-VP O
examination NN B-NP O
and CC O O
the DT B-NP O
patient's NN I-NP O
symptoms NNS I-NP O
improved VBN O O
significantly RB O O
with IN B-VP O
occasional JJ B-NP B-f
nebulizer NN I-NP B-mo
treatments NNS I-NP O
of IN B-VP O
Albuterol NNP B-NP B-m
and CC O O
Atrovent NNP B-NP B-m
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
oxygenating VBG O O
well RB O O
3 CD O O
Cardiovascular JJ O O
- : O O
There EX O O
were VBD B-VP O
no DT B-NP O
acute JJ I-NP O
cardiac JJ I-NP O
issues NNS I-NP O
during IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
Patient's NNP I-NP O
losartan NN I-NP B-m
was VBD B-VP O
held VBN O O
at IN B-VP O
admission NN B-NP O
given VBN O O
his PRP$ O O
acute JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
but CC O O
other JJ B-NP O
outpatient JJ I-NP B-m
medications NNS I-NP I-m
were VBD B-VP O
continued VBN O O
4 CD O O
Hematology NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
MDS NNP B-NP O
and CC O O
was VBD B-VP O
a DT B-NP O
patient NN I-NP O
of IN B-VP O
Dr NNP B-NP O
Boivin NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
hematocrit NN I-NP O
dropped VBD B-VP O
10 CD O O
points NNS B-NP O
but CC O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
likely RB O O
due JJ O O
to TO O O
hydration NN B-NP O
Since IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
hematocrit NN I-NP O
has VBZ O O
remained VBN O O
stable JJ O O
at IN B-VP O
35 CD O O
5 CD O O
Infectious JJ B-NP O
disease NN I-NP O
- : O O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
blood NN I-NP O
cultures NNS I-NP O
, , O O
urine JJ B-NP O
cultures NNS I-NP O
, , O O
and CC O O
stool NN B-NP O
cultures NNS I-NP O
were VBD B-VP O
all DT B-NP O
negative JJ I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
2003 CD O O
was VBD B-VP O
clear JJ O O
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT O O
most RBS O O
likely JJ B-NP O
etiology NN I-NP O
of IN B-VP O
his PRP$ O O
acute JJ B-NP O
worsening NN I-NP O
of IN B-VP O
his PRP$ O O
diarrhea NN B-NP O
was VBD B-VP O
viral JJ B-NP O
gastroenteritis NN I-NP O
He PRP O O
also RB O O
did VBD B-VP O
receive VB O O
a DT O B-du
a DT B-NP B-du
7-day JJ I-NP O
course NN I-NP O
of IN B-VP O
levofloxacin NN B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
for IN B-VP O
empiric JJ B-NP B-r
empiric JJ I-NP B-r
abdominal JJ I-NP I-r
abdominal JJ I-NP I-r
coverage NN I-NP I-r
coverage NN I-NP I-r
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
afebrile JJ O O
since IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
his PRP$ O O
antibiotics NNS B-NP B-m
6 CD O O
Gastrointestinal NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
status NN B-NP O
post NN I-NP O
right RB O O
hemicolectomy NN B-NP O
He PRP O O
has VBZ O O
a DT B-NP O
long JJ I-NP O
history NN I-NP O
of IN B-VP O
diarrhea NN B-NP O
and CC O O
presented VBN O O
to TO O O
this DT B-NP O
admission NN I-NP O
with IN B-VP O
explosive JJ B-NP B-r
explosive JJ I-NP B-r
diarrhea NN I-NP I-r
diarrhea NN I-NP I-r
and CC O O
guaiac JJ B-NP B-r
guaiac NN I-NP B-r
positive JJ B-NP O
brown JJ I-NP O
stool NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
Kaopectate NNP B-NP B-m
Kaopectate NNP I-NP B-m
and CC O O
Lomotil NNP B-NP B-m
Lomotil NNP I-NP B-m
were VBD B-VP O
started VBN O O
On IN B-VP O
August NNP B-NP O
, , O O
2003 CD O O
, , O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
increased VBN O O
distention NN B-NP O
but CC O O
a DT B-NP O
KUB NNP I-NP O
was VBD B-VP O
negative JJ O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
for IN B-VP O
partial JJ B-NP O
obstruction NN I-NP O
or CC O O
impaction NN B-NP O
There EX O O
were VBD B-VP O
concerns NNS B-NP O
that IN B-VP O
the DT B-NP O
patient's JJ I-NP O
abdominal JJ I-NP O
symptoms NNS I-NP O
might MD O O
be VB O O
secondary JJ O O
to TO O O
ischemia VB O O
so RB O O
an DT B-NP O
MRI NNP I-NP O
was VBD B-VP O
obtained VBN O O
which WDT O O
showed VBD B-VP O
proximal JJ B-NP O
disease NN I-NP O
in IN B-VP O
the DT B-NP O
SMA NNP I-NP O
, , O O
IMA NNP B-NP O
, , O O
and CC O O
celiac NN B-NP O
but CC O O
overall JJ O O
with IN B-VP O
good JJ B-NP O
distal NN I-NP O
flow NN I-NP O
An DT B-NP O
abdominal JJ I-NP O
CT NNP I-NP O
was VBD B-VP O
obtained VBN O O
which WDT O O
showed VBD B-VP O
a DT B-NP O
thick JJ I-NP O
small JJ I-NP O
bowel NN I-NP O
and CC O O
dilated VBD B-VP O
gallbladder NN B-NP O
with IN B-VP O
stranding VBG O O
but CC O O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
ischemia JJ B-NP O
Gastrointestinal NNP I-NP O
consultation NN I-NP O
was VBD B-VP O
obtained VBN O O
and CC O O
on IN B-VP O
June NNP B-NP O
, , O O
2003 CD O O
, , O O
and CC O O
esophagogastroduodenoscopy NN B-NP O
was VBD B-VP O
performed VBN O O
which WDT O O
revealed VBD B-VP O
grade NN B-NP B-r
IV NNP I-NP O
gastritis NN I-NP O
As IN B-VP O
a DT B-NP O
result NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
Nexium NN B-NP B-m
40 CD O B-do
b.i.d NN B-NP B-f
7 CD O O
Renal NNP B-NP O
- : O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
The DT B-NP O
entire JJ I-NP O
hospitalization NN I-NP O
, , O O
his PRP$ O O
BUN NNP B-NP O
was VBD B-VP O
in IN B-VP O
the DT B-NP O
fifties NNS I-NP O
with IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
2.2 CD O O
His PRP$ O O
FENA NNP B-NP O
was VBD B-VP O
less JJR O O
than IN B-VP O
0.1% CD O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
extremely RB O O
intervascularly JJ O O
dry JJ O O
With IN B-VP O
gentle JJ B-NP O
hydration NN I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
eventually RB O O
improved VBN O O
to TO O O
1.9 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Included NNP I-NP O
esophagogastroduodenoscopy NN I-NP O
revealing VBG O O
gastritis NN B-NP O
as IN B-VP O
discussed VBN O O
above IN B-VP O
DISPOSITION: NNP B-NP O
Diet NNP I-NP O
includes VBZ O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
on IN B-VP O
a DT B-NP O
full JJ I-NP O
p.o NN I-NP O
diet NN I-NP O
He PRP O O
was VBD B-VP O
also RB O O
instructed VBN O O
to TO O O
supplement VB O O
his PRP$ O O
diet NN B-NP O
with IN B-VP O
high JJ B-NP O
nutrition NN I-NP O
Boost NNP I-NP O
shakes VBZ O O
Nutrition NNP B-NP O
followed VBD B-VP O
the DT B-NP O
patient NN I-NP O
closely RB O O
during IN B-VP O
the DT B-NP O
admission NN I-NP O
and CC O O
thought VBD B-VP O
that IN B-VP O
he PRP O O
would MD O O
need VB O O
close RB O O
follow-up JJ O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
for IN B-VP O
his PRP$ O O
nutrition NN B-NP O
status NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Will MD O O
be VB O O
dictated VBN O O
in IN B-VP O
an DT B-NP O
Addendum NNP I-NP O
to TO O O
this DT B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
FOLLOW-UP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
follow-up VB O O
with IN B-VP O
Dr NNP B-NP O
Venzor NNP I-NP O
following VBG O O
discharge NN B-NP O
Dictated NNP I-NP O
By: NNP I-NP O
LUCIO NNP I-NP O
MAN NNP I-NP O
GRAMS NNP I-NP O
, , O O
M.D NNP B-NP O
VM675 NNP I-NP O
Attending: NNP I-NP O
ERASMO NNP I-NP O
N NNP I-NP O
MATHUR NNP I-NP O
, , O O
M.D NNP B-NP O
NI4 NNP I-NP O
OG097/562852 NNP I-NP O
Batch: NNP I-NP O
0836 CD O O
Index NNP B-NP O
No NNP I-NP O
OUHR0Y5GN5 NNP I-NP O
D: NNP I-NP O
3/28/03 CD O O
T: NNP B-NP O
3/28/03 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#654297 VBZ O O
242524874 CD O O
LMH NNP B-NP O
52961901 CD O O
969014 CD O O
2/18/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
RULE NNP I-NP O
OUT NNP I-NP O
MYOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/18/1999 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/0/1999 CD O O
IDENTIFICATION: NNP B-NP O
A NNP I-NP O
73-year-old JJ B-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
extensive JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
diabetes VBZ O O
, , O O
hypertension NN B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
and CC O O
smoking NN B-NP O
, , O O
who WP O O
presents VBZ O O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
and CC O O
is VBZ O O
admitted VBN O O
for IN B-VP O
rule NN B-NP O
out IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Boyles NNP I-NP O
has VBZ O O
a DT B-NP O
long JJ I-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
with IN B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
in IN B-VP O
1989 CD O O
, , O O
left VBD B-VP O
internal JJ B-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
the DT O O
left VBN O O
anterior JJ O O
descending VBG O O
artery NN B-NP O
, , O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT O O
diagonal JJ O O
one CD O O
, , O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
posterior JJ I-NP O
descending NN I-NP O
artery NN I-NP O
, , O O
and CC O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
obtuse NN I-NP O
marginal JJ B-NP O
artery NN I-NP O
three CD O O
In IN B-VP O
1992 CD O O
he PRP O O
had VBD B-VP O
unstable JJ B-NP O
angina NN I-NP O
, , O O
and CC O O
catheterization NN B-NP O
showed VBD B-VP O
that IN B-VP O
the DT B-NP O
distal JJ I-NP O
grafts NNS I-NP O
were VBD B-VP O
totally RB O O
occluded VBN O O
He PRP O O
had VBD B-VP O
a DT B-NP O
redo JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
with IN B-VP O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
posterior JJ I-NP O
descending NN I-NP O
artery NN I-NP O
and CC O O
the DT B-NP O
left NN I-NP O
circumflex NN I-NP O
, , O O
his PRP$ O O
postoperative JJ B-NP O
course NN I-NP O
being VBG O O
complicated VBN O O
by IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
In IN B-VP O
1996 CD O O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
non-Q JJ I-NP O
wave NN I-NP O
myocardial JJ B-NP O
infarction NN I-NP O
with IN B-VP O
a DT B-NP O
percutaneous JJ I-NP O
transluminal JJ I-NP O
coronary JJ I-NP O
angioplasty NN I-NP O
of IN B-VP O
the DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
diagonal JJ I-NP O
one NN I-NP O
, , O O
and CC O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
posterior JJ I-NP O
descending NN I-NP O
artery NN I-NP O
In IN B-VP O
1997 CD O O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
repeat NN I-NP O
percutaneous JJ B-NP O
transluminal JJ I-NP O
coronary JJ I-NP O
angioplasty NN I-NP O
with IN B-VP O
an DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
diagonal JJ I-NP O
one NN I-NP O
, , O O
and CC O O
an DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
posterior JJ I-NP O
descending NN I-NP O
artery NN I-NP O
Most RBS O O
recently RB O O
he PRP O O
was VBD B-VP O
admitted VBN O O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
1999 CD O O
with IN B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
mibi NN I-NP O
, , O O
for IN B-VP O
which WDT O O
exercise NN B-NP O
for IN B-VP O
four CD O O
minutes NNS B-NP O
and CC O O
seven CD O O
seconds NNS B-NP O
he PRP O O
had VBD B-VP O
inferolateral JJ B-NP O
ischemia NN I-NP O
Echocardiogram NNP I-NP O
showed VBD B-VP O
an DT B-NP O
left JJ I-NP O
ventricular JJ I-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
50 CD O O
percent NN B-NP O
, , O O
anterior JJ B-NP O
inferior JJ I-NP O
posterior JJ I-NP O
hypokinesis NN I-NP O
, , O O
1 CD O O
to TO O O
2+ CD O O
mitral JJ B-NP O
regurgitation NN I-NP O
, , O O
pulmonary JJ B-NP O
artery NN I-NP O
systolic JJ B-NP O
pressure NN I-NP O
of IN B-VP O
42.0 CD O O
millimeters NNS B-NP O
of IN B-VP O
mercury NN B-NP O
plus CC O O
right JJ B-NP O
atrial JJ I-NP O
pressure NN I-NP O
of IN B-VP O
6 CD O O
Catheterization NN B-NP O
showed VBD B-VP O
100 CD O O
percent JJ B-NP O
occlusion NN I-NP O
of IN B-VP O
his PRP$ O O
saphenous JJ B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT O O
diagonal JJ O O
one CD O O
, , O O
which WDT O O
was VBD B-VP O
stented VBN O O
His PRP$ O O
right JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
and CC O O
diagonal JJ O O
one CD O O
were VBD B-VP O
totally RB O O
occluded VBN O O
His PRP$ O O
left JJ O O
anterior JJ O O
descending VBG O O
artery NN B-NP O
was VBD B-VP O
95 CD O O
percent NN B-NP O
His PRP$ O O
left JJ B-NP O
circumflex NN I-NP O
was VBD B-VP O
clear JJ O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
he PRP O O
was VBD B-VP O
randomized VBN O O
to TO O O
the DT B-NP O
Airssylv NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
trial NN I-NP O
At IN B-VP O
baseline NN B-NP O
, , O O
Mr NNP B-NP O
Dodwell NNP I-NP O
denies VBZ O O
exertional JJ B-NP O
chest NN I-NP O
pain NN I-NP O
or CC O O
any DT B-NP O
angina NN I-NP O
He PRP O O
does VBZ O O
get VB O O
short JJ O O
of IN B-VP O
breath NN B-NP O
with IN B-VP O
one CD O O
flight NN B-NP O
of IN B-VP O
stairs NNS B-NP O
, , O O
or CC O O
going VBG O O
uphill JJ O O
for IN B-VP O
one CD O O
block NN B-NP O
He PRP O O
gets VBZ O O
claudication NN B-NP O
after IN B-VP O
walking VBG O O
three CD O O
house NN B-NP O
lots NNS I-NP O
He PRP O O
was VBD B-VP O
in IN B-VP O
his PRP$ O O
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
one CD O O
day NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
he PRP O O
noted VBD B-VP O
the DT B-NP O
onset NN I-NP O
of IN B-VP O
4/10 CD O O
aching VBG O O
chest NN B-NP O
, , O O
shoulder NN B-NP O
, , O O
and CC O O
left VBD B-VP O
arm NN B-NP O
pain NN I-NP O
while IN B-VP O
watching VBG O O
television NN B-NP O
, , O O
and CC O O
it PRP O O
was VBD B-VP O
associated VBN O O
with IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
He PRP O O
sat VBD B-VP O
still RB O O
, , O O
waited VBD B-VP O
for IN B-VP O
it PRP O O
to TO O O
dissipate VB O O
At IN B-VP O
7:00 CD O O
p.m NN B-NP O
, , O O
he PRP O O
took VBD B-VP O
one CD O B-do
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
with IN B-VP O
a DT B-NP O
decrease NN I-NP O
of IN B-VP O
pain NN B-NP B-r
At IN B-VP O
11:00 CD O O
p.m NN B-NP O
, , O O
he PRP O O
took VBD B-VP O
one CD O B-do
sublingual JJ B-NP B-mo
nitroglycerin NN I-NP B-m
and CC O O
went VBD B-VP O
to TO O O
sleep VB O O
before IN B-VP O
noting VBG O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
the DT B-NP O
pain NN I-NP B-r
He PRP O O
was VBD B-VP O
driving VBG O O
to TO O O
his PRP$ O O
appointment NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Stolberg NNP I-NP O
, , O O
his PRP$ O O
primary JJ B-NP O
cardiologist NN I-NP O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
with IN B-VP O
the DT B-NP O
return NN I-NP O
of IN B-VP O
the DT B-NP O
chest JJS I-NP O
pain NN I-NP O
for IN B-VP O
one CD O O
to TO O O
two CD O O
minutes NNS B-NP O
and CC O O
it PRP O O
was VBD B-VP O
gone VBN O O
spontaneously RB O O
At IN B-VP O
Dr NNP B-NP O
Boulanger NNP I-NP O
office NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
new JJ B-NP O
lateral JJ I-NP O
T NNP I-NP O
wave NN I-NP O
inversions NNS I-NP O
and CC O O
was VBD B-VP O
sent VBN O O
down RB O O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
for IN B-VP O
admission NN B-NP O
Mr NNP I-NP O
Demik NNP I-NP O
denies VBZ O O
any DT B-NP O
associated JJ I-NP O
nausea NN I-NP O
, , O O
vomiting VBG O O
, , O O
diaphoresis NN B-NP O
, , O O
exertional JJ O O
or CC O O
pleuritic JJ B-NP O
chest NN I-NP O
pain NN I-NP O
currently RB O O
, , O O
fever RB O O
, , O O
chills NNS B-NP O
, , O O
or CC O O
cough NN B-NP O
He PRP O O
does VBZ O O
report VB O O
stable VB O O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
, , O O
but CC O O
denies VBZ O O
orthopnea NN B-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
or CC O O
palpitations NNS B-NP O
He PRP O O
has VBZ O O
poor JJ B-NP O
exercise NN I-NP O
tolerance NN I-NP O
His PRP$ O O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
include VBP O O
the DT B-NP O
following: JJ I-NP O
Age NNP I-NP O
, , O O
diabetes VBZ O O
, , O O
hypertension NN B-NP O
, , O O
cholesterol NN B-NP O
, , O O
smoking NN B-NP O
, , O O
and CC O O
family NN B-NP O
history NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
His PRP$ O O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
as IN B-VP O
follows: JJ O O
1 CD O O
Hypertension NNP B-NP O
2 CD O O
Diabetes VBZ O O
with IN B-VP O
fingersticks NNS B-NP O
of IN B-VP O
120 CD O O
to TO O O
160 CD O O
at IN B-VP O
home NN B-NP O
3 CD O O
Hypercholesterolemia NNP B-NP O
, , O O
his PRP$ O O
last JJ B-NP O
panel NN I-NP O
in IN B-VP O
November NNP B-NP O
of IN B-VP O
1999 CD O O
with IN B-VP O
cholesterol NN B-NP O
of IN B-VP O
164 CD O O
, , O O
HDL NNP B-NP O
of IN B-VP O
31 CD O O
, , O O
LDL NNP B-NP O
of IN B-VP O
93 CD O O
4 CD O O
Atrial JJ B-NP O
fibrillation NN I-NP O
5 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
6 CD O O
Benign NNP B-NP O
prostatic JJ B-NP O
hypertrophy NN I-NP O
7 CD O O
Peripheral NNP B-NP O
vascular JJ B-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
carotid NN I-NP O
endarterectomies NNS I-NP O
bilaterally RB O O
8 CD O O
Status NNP B-NP O
post NN I-NP O
cholecystectomy NN I-NP O
and CC O O
inguinal JJ B-NP O
hernia NN I-NP O
repair NN I-NP O
ALLERGIES: NNP I-NP O
His PRP$ O O
allergies NNS B-NP O
include VBP O O
Quinaglute NNP B-NP O
, , O O
lisinopril NN B-NP O
, , O O
and CC O O
verapamil NN B-NP O
He PRP O O
thinks VBZ O O
they PRP O O
cause VBP O O
gastrointestinal JJ B-NP O
upset JJ I-NP O
MEDICATIONS: NNP I-NP O
His PRP$ O O
medications NNS B-NP O
include VBP O O
the DT O O
following: JJ O O
1 CD O O
Coumadin NNP B-NP B-m
5 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
2 CD O O
Atenolol NNP B-NP B-m
25 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
3 CD O O
Mitozalone NNP B-NP B-m
5 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
4 CD O O
Lasix NNP B-NP B-m
160 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
5 CD O O
Atorvastatin NNP B-NP B-m
20 CD O B-do
milligrams NNS B-NP I-do
q.h.s RB O B-f
6 CD O O
K-Dur JJ O B-m
60 CD O B-do
mEq NN B-NP I-do
q.d NN I-NP B-f
7 CD O O
Rezulin NNP B-NP B-m
400 CD O B-do
q.d NN B-NP B-f
8 CD O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
34 CD O B-do
q.a.m NN B-NP B-f
, , O O
10 CD O B-do
q.p.m NN B-NP B-f
, , O O
regular JJ B-NP B-m
insulin NN I-NP I-m
4 CD O B-do
q.p.m NN B-NP B-f
9 CD O O
Finasteride NNP B-NP B-m
5 CD O B-do
q.d NN B-NP B-f
10 CD O O
Colchicine NNP B-NP B-m
0.6 CD O B-do
milligrams NNS B-NP I-do
p.r.n VBP O B-f
11 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
12 CD O O
Restoril NNP B-NP B-m
30 CD O B-do
milligrams NNS B-NP I-do
p.r.n VBP O B-f
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
He PRP O O
occasionally RB O O
drinks VBZ O O
alcohol NN B-NP O
He PRP O O
has VBZ O O
a DT O O
120 CD O O
pack NN B-NP O
year NN I-NP O
smoking VBG O O
history NN B-NP O
, , O O
quit NN B-NP O
in IN B-VP O
1989 CD O O
He PRP O O
is VBZ O O
a DT B-NP O
retired JJ I-NP O
machinist NN I-NP O
and CC O O
lives VBZ O O
with IN B-VP O
his PRP$ O O
wife NN B-NP O
of IN B-VP O
53 CD O O
years NNS B-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
His PRP$ O O
father NN B-NP O
died VBD B-VP O
of IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
at IN B-VP O
77 CD O O
His PRP$ O O
sister NN B-NP O
had VBD B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
at IN B-VP O
70 CD O O
He PRP O O
has VBZ O O
many JJ O O
brother RB O O
, , O O
one CD O O
of IN B-VP O
whom WP O O
is VBZ O O
71 CD O O
who WP O O
had VBD B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
at IN B-VP O
44 CD O O
, , O O
and CC O O
one CD O O
who WP O O
had VBD B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
at IN B-VP O
70 CD O O
PHYSICAL NNP B-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
in IN B-VP O
general JJ O O
, , O O
he PRP O O
is VBZ O O
a DT B-NP O
pleasant JJ I-NP O
elderly JJ I-NP O
man NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
His PRP$ O O
vital JJ B-NP O
signs NNS I-NP O
, , O O
his PRP$ O O
heart NN B-NP O
rate NN I-NP O
was VBD B-VP O
96 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
174/64 CD O O
, , O O
saturating VBG O O
95 CD O O
percent NN B-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
He PRP O O
had VBD B-VP O
carotid VBN O O
bruits NNS B-NP O
bilaterally RB O O
His PRP$ O O
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
His PRP$ O O
jugular JJ B-NP O
venous JJ I-NP O
pressure NN I-NP O
was VBD B-VP O
less JJR O O
than IN B-VP O
5.0 CD O O
centimeters NNS B-NP O
His PRP$ O O
PMI NNP B-NP O
was VBD B-VP O
nonpalpable JJ O O
He PRP O O
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
with IN B-VP O
a DT O O
1/6 CD O O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
without IN B-VP O
radiation NN B-NP O
Extremities NNS I-NP O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
left JJ I-NP O
femoral JJ I-NP O
thrill NN I-NP O
and CC O O
bilateral JJ B-NP O
femoral JJ I-NP O
bruits NNS I-NP O
He PRP O O
had VBD B-VP O
1+ CD O O
dorsalis NNS B-NP O
pedis JJ B-NP O
pulses NNS I-NP O
bilaterally RB O O
His PRP$ O O
extremities NNS B-NP O
were VBD B-VP O
warm JJ O O
without IN B-VP O
edema VBG O O
His PRP$ O O
neurologic JJ B-NP O
examination NN I-NP O
was VBD B-VP O
non-focal JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
His PRP$ O O
labs NN B-NP O
on IN B-VP O
admission NN B-NP O
were VBD B-VP O
significant JJ O O
for IN B-VP O
a DT B-NP O
BUN NNP I-NP O
and CC O O
creatinine NN B-NP O
of IN B-VP O
49 CD O O
and CC O O
1.3 CD O O
, , O O
hematocrit NN B-NP O
of IN B-VP O
40.5 CD O O
His PRP$ O O
urinalysis NN B-NP O
was VBD B-VP O
normal JJ B-NP O
Electrocardiogram NNP I-NP O
shows NNS I-NP O
sinus VBP O O
bradycardia NN B-NP O
at IN B-VP O
53 CD O O
, , O O
left VBD B-VP O
axis JJ B-NP O
deviation NN I-NP O
, , O O
right JJ B-NP O
bundle NN I-NP O
branch NN I-NP O
block NN I-NP O
, , O O
no DT B-NP O
hypertrophy NN I-NP O
, , O O
no DT B-NP O
Q NNP I-NP O
, , O O
new JJ B-NP O
T NNP I-NP O
wave NN I-NP O
inversion NN I-NP O
in IN B-VP O
V4 NNP B-NP O
through IN B-VP O
V6 NNP B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
was VBD B-VP O
clear JJ O O
His PRP$ O O
Troponin NNP B-NP O
was VBD B-VP O
0.45 CD O O
, , O O
CK NNP B-NP O
was VBD B-VP O
197 CD O O
, , O O
his PRP$ O O
myoglobin NN B-NP O
was VBD B-VP O
159 CD O O
, , O O
his PRP$ O O
INR NNP B-NP O
was VBD B-VP O
1.5 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
In IN B-VP O
summary JJ O O
, , O O
this DT O O
is VBZ O O
a DT B-NP O
73-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
extensive JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
who WP O O
presents VBZ O O
with IN B-VP O
one CD O O
day NN B-NP O
of IN B-VP O
his PRP$ O O
typical JJ B-NP O
anginal JJ I-NP O
pain NN I-NP O
, , O O
multiple JJ B-NP O
bruits NNS I-NP O
, , O O
new JJ B-NP O
lateral JJ I-NP O
T NNP I-NP O
wave NN I-NP O
inversions NNS I-NP O
, , O O
admitted VBN O O
for IN B-VP O
a DT B-NP O
rule NN I-NP O
out IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
His PRP$ O O
hospital NN B-NP O
course NN I-NP O
by IN B-VP O
issue: JJ O O
1 CD O O
Cardiovascular: NNP B-NP O
Mr NNP I-NP O
Jinkerson NNP I-NP O
was VBD B-VP O
catheterized VBN O O
on IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
and CC O O
he PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
the DT B-NP O
following NN I-NP O
He PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
saphenous JJ I-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
diagonal JJ I-NP O
one NN I-NP O
was VBD B-VP O
100 CD O O
percent NN B-NP O
occluded VBD B-VP O
Saphenous NNP B-NP O
vein NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
posterior JJ I-NP O
descending NN I-NP O
artery NN I-NP O
was VBD B-VP O
open JJ O O
His PRP$ O O
left JJ O O
main JJ O O
was VBD B-VP O
30 CD O O
percent NN B-NP O
occluded VBD B-VP O
His PRP$ O O
left JJ O O
anterior JJ O O
descending VBG O O
artery NN B-NP O
was VBD B-VP O
99 CD O O
percent NN B-NP O
occluded VBD B-VP O
His PRP$ O O
diagonal JJ B-NP O
one NN I-NP O
was VBD B-VP O
100 CD O O
percent NN B-NP O
occluded VBD B-VP O
His PRP$ O O
left JJ B-NP O
circumflex NN I-NP O
was VBD B-VP O
80 CD O O
percent NN B-NP O
occluded VBD B-VP O
His PRP$ O O
left NN B-NP O
subclavian NN I-NP O
which WDT O O
was VBD B-VP O
supplying VBG O O
his PRP$ O O
left JJ B-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
was VBD B-VP O
100 CD O O
percent NN B-NP O
occluded VBD B-VP O
He PRP O O
was VBD B-VP O
taken VBN O O
back RB O O
to TO O O
the DT B-NP O
Catheterization NNP I-NP O
Laboratory NNP I-NP O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
with IN B-VP O
Dr NNP B-NP O
Devincenzo NNP I-NP O
who WP O O
performed VBD B-VP O
a DT B-NP O
left JJ I-NP O
subclavian JJ I-NP O
artery NN I-NP O
stent NN I-NP O
and CC O O
also RB O O
a DT B-NP O
left JJ I-NP O
brachial JJ I-NP O
artery NN I-NP O
angioplasty NN I-NP O
Mr NNP I-NP O
Maheu NNP I-NP O
tolerated VBD B-VP O
this DT B-NP O
procedure NN I-NP O
well RB O O
He PRP O O
had VBD B-VP O
no DT B-NP O
return NN I-NP O
of IN B-VP O
his PRP$ O O
chest NN B-NP O
pain NN I-NP O
after IN B-VP O
the DT B-NP O
procedure NN I-NP O
, , O O
and CC O O
his PRP$ O O
pulses NNS B-NP O
remained VBD B-VP O
normal JJ O O
, , O O
he PRP O O
had VBD B-VP O
no DT B-NP O
groin NN I-NP O
hematoma NN I-NP O
He PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
Plavix NNP B-NP B-m
He PRP O O
also RB O O
continued VBD B-VP O
his PRP$ O O
aspirin NN B-NP B-m
, , O O
and CC O O
his PRP$ O O
Coumadin NNP B-NP B-m
was VBD B-VP O
restarted VBN O O
after IN B-VP O
the DT B-NP O
heparin NN I-NP B-m
and CC O O
intravenous JJ B-NP B-mo
TNG NNP I-NP B-m
which WDT O O
were VBD B-VP O
originally RB O O
put VBN O O
on IN B-VP O
board NN B-NP O
to TO O O
prevent VB O O
arterial JJ B-NP O
spasm NN I-NP O
after IN B-VP O
the DT B-NP O
procedure NN I-NP O
, , O O
were VBD B-VP O
discontinued VBN O O
His PRP$ O O
next JJ B-NP O
cardiovascular JJ I-NP O
issue NN I-NP O
was VBD B-VP O
his PRP$ O O
blood NN B-NP O
pressure NN I-NP O
He PRP O O
was VBD B-VP O
originally RB O O
on IN B-VP O
atenolol JJ O B-m
25 CD O B-do
milligrams NNS B-NP O
q.d RB O B-f
, , O O
we PRP O O
added VBD B-VP O
back RB O O
Cozaar NNP B-NP B-m
25 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
which WDT O O
he PRP O O
had VBD B-VP O
been VBN O O
on IN B-VP O
before IN B-VP O
admission NN B-NP O
and CC O O
had VBD B-VP O
been VBN O O
stopped VBN O O
a DT B-NP O
month NN I-NP O
prior RB O O
because IN B-VP O
he PRP O O
had VBD B-VP O
low JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
with IN B-VP O
a DT B-NP O
systolic NN I-NP O
in IN B-VP O
the DT O O
80s CD O O
However RB O O
, , O O
his PRP$ O O
first JJ B-NP O
day NN I-NP O
here RB O O
, , O O
his PRP$ O O
systolic JJ B-NP O
pressure NN I-NP O
was VBD B-VP O
120 CD O O
to TO O O
130 CD O O
, , O O
and CC O O
restarted VBD B-VP O
it PRP O O
He PRP O O
had VBD B-VP O
no DT B-NP O
problems NNS I-NP O
with IN B-VP O
that DT O O
His PRP$ O O
blood NN B-NP O
pressure NN I-NP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
after IN B-VP O
admission NN B-NP O
was VBD B-VP O
in IN B-VP O
the DT O O
150 CD O O
to TO O O
160 CD O O
systolic NN B-NP O
over IN B-VP O
70 CD O O
, , O O
and CC O O
amlodipine NN B-NP B-m
was VBD B-VP O
added VBN O O
to TO O O
his PRP$ O O
regimen NNS B-NP O
He PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
outpatient JJ B-NP O
doses NNS I-NP O
of IN B-VP O
Lasix NNP B-NP B-m
160 CD O B-do
milligrams NNS B-NP I-do
q.a.m RB O B-f
and CC O O
mitozalone RB O B-m
5 CD O B-do
q.d NN B-NP B-f
He PRP O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
2 CD O O
Renal: NNP B-NP O
After IN B-VP O
the DT B-NP O
first JJ I-NP O
catheterization NN I-NP O
, , O O
Mr NNP B-NP O
Ong NNP I-NP O
creatinine NN I-NP O
went VBD B-VP O
from IN B-VP O
1.3 CD O O
to TO O O
1.8 CD O O
However RB O O
, , O O
it PRP O O
went VBD B-VP O
back RB O O
to TO O O
1.3 CD O O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
After IN B-VP O
the DT B-NP O
second JJ I-NP O
catheterization NN I-NP O
it PRP O O
went VBD B-VP O
up RB O O
to TO O O
a DT B-NP O
peak NN I-NP O
of IN B-VP O
4.3 CD O O
However RB O O
, , O O
his PRP$ O O
urine JJ B-NP O
output NN I-NP O
remained VBD B-VP O
at IN B-VP O
100 CD O O
to TO O O
150 CD O O
cc NNS B-NP O
an DT B-NP O
hour NN I-NP O
with IN B-VP O
Lasix NNP B-NP B-m
Lasix NNP I-NP B-m
100 CD O B-do
milligrams NNS B-NP I-do
intravenous JJ B-NP B-mo
p.r.n NNS I-NP B-f
, , O O
in IN B-VP O
addition NN B-NP O
to TO O O
his PRP$ O O
morning NN B-NP O
dose NN I-NP O
of IN B-VP O
160 CD O B-do
milligrams NNS B-NP I-do
q.a.m RB O B-f
, , O O
and CC O O
he PRP O O
was VBD B-VP O
given VBN O O
normal JJ B-NP O
saline NN I-NP O
intravenous JJ B-NP B-mo
fluids NNS I-NP O
to TO O O
equalize VB O O
his PRP$ O O
ins NNS B-NP O
and CC O O
outs NNS B-NP O
He PRP O O
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP O
signs NNS I-NP O
of IN B-VP O
cholesterol NN B-NP O
emboli NN I-NP O
, , O O
no DT B-NP O
levator NN I-NP O
reticularis NN I-NP O
, , O O
no DT B-NP O
eosinophilia NN I-NP O
, , O O
no DT B-NP O
blue NN I-NP O
toes VBZ O O
3 CD O O
Fluids NNP B-NP O
, , O O
Electrolytes NNP B-NP O
, , O O
Nutrition: NNP B-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
low JJ I-NP O
potassium NN I-NP O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
with IN B-VP O
a DT B-NP O
potassium NN I-NP O
of IN B-VP O
2.7 CD O O
because IN B-VP O
he PRP O O
had VBD B-VP O
missed VBN O O
his PRP$ O O
outpatient JJ B-NP O
K-Dur NNP I-NP B-m
of IN B-VP O
60 CD O B-do
mEq NNS B-NP I-do
q.d RB O B-f
He PRP O O
had VBD B-VP O
no DT B-NP O
symptoms NNS I-NP O
, , O O
he PRP O O
had VBD B-VP O
no DT B-NP O
electrocardiogram NN I-NP O
changes VBZ O O
He PRP O O
was VBD B-VP O
repleted VBN O O
throughout IN B-VP O
admission NN B-NP O
and CC O O
was VBD B-VP O
kept VBN O O
on IN B-VP O
his PRP$ O B-do
outpatient NN B-NP I-do
dose NN I-NP I-do
of IN B-VP O
K-Dur NNP B-NP B-m
and CC O O
had VBD B-VP O
no DT B-NP O
problems NNS I-NP O
further RBR O O
with IN B-VP O
potassium NN B-NP O
In IN B-VP O
addition NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
a DT O B-do
standing VBG O O
dose NN B-NP O
of IN B-VP O
magnesium NN B-NP B-m
because IN B-VP O
his PRP$ O B-r
magnesium NN B-NP I-r
was VBD B-VP O
routinely RB O O
low JJ O O
throughout IN B-VP O
admission NN B-NP O
, , O O
on IN B-VP O
the DT B-NP O
order NN I-NP O
of IN B-VP O
1.5 CD O O
to TO O O
1.8 CD O O
4 CD O O
Hematology: NNP B-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
after IN B-VP O
his PRP$ O O
catheterization NN B-NP O
, , O O
his PRP$ O O
hematocrit NN B-NP O
dropped VBD B-VP O
from IN B-VP O
33.0 CD O O
to TO O O
28.0 CD O O
He PRP O O
was VBD B-VP O
transfused VBN O O
two CD O O
units NNS B-NP O
with IN B-VP O
an DT B-NP O
appropriate JJ I-NP O
bump NN I-NP O
back RB O O
to TO O O
33.0 CD O O
He PRP O O
tolerated VBD B-VP O
this DT O O
without IN B-VP O
any DT B-NP O
problems NNS I-NP O
5 CD O O
Diabetes: NNP B-NP B-r
Diabetes: NNP I-NP B-r
He PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
his PRP$ O O
outpatient JJ B-NP O
regimen NNS I-NP O
of IN B-VP O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
30/10 CD O O
and CC O O
4 CD O B-do
regular JJ B-NP I-do
q.p.m NN I-NP B-f
, , O O
and CC O O
Rezulin NNP B-NP B-m
His PRP$ O O
blood NN B-NP O
sugars NNS I-NP O
were VBD B-VP O
maintained VBN O O
throughout IN B-VP O
admission NN B-NP O
6 CD O O
Genitourinary: NNP B-NP O
He PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
his PRP$ O O
finasteride NN B-NP B-m
for IN B-VP O
benign JJ B-NP B-r
prostatic JJ I-NP O
hypertrophy NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
biopsy NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
which WDT O O
had VBD B-VP O
shown VBN O O
chronic JJ B-NP B-r
prostatitis NN I-NP I-r
His PRP$ O O
outpatient JJ B-NP O
urologist NN I-NP O
had VBD B-VP O
recommended VBN O O
ciprofloxacin RB O B-m
500 CD O B-do
milligrams NNS B-NP I-do
b.i.d VBP O B-f
for IN B-VP B-du
thirty NN B-NP O
days NNS I-NP O
Since IN B-VP O
the DT B-NP O
hospital NN I-NP O
does VBZ O O
not RB O O
carry VB O O
ciprofloxacin NN B-NP B-m
, , O O
we PRP O O
put VBD B-VP O
him PRP O O
on IN B-VP O
Levofloxacin NNP B-NP B-m
500 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
He PRP O O
had VBD B-VP O
no DT B-NP O
return NN I-NP O
of IN B-VP O
those DT B-NP O
symptoms NNS I-NP O
7 CD O O
Musculoskeletal: NNP B-NP O
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
four CD O O
, , O O
he PRP O O
developed VBD B-VP O
excruciating VBG O O
point NN B-NP O
tenderness NN I-NP O
in IN B-VP O
the DT B-NP O
medial JJ I-NP O
aspect NN I-NP O
of IN B-VP O
his PRP$ O O
right JJ B-NP O
knee NN I-NP O
The DT B-NP O
knee NN I-NP O
did VBD B-VP O
not RB O O
appear VB O O
swollen NN B-NP O
or CC O O
red JJ O O
, , O O
and CC O O
he PRP O O
had VBD B-VP O
no DT B-NP O
source NN I-NP O
of IN B-VP O
trauma NN B-NP O
However RB O O
, , O O
it PRP O O
was VBD B-VP O
thought VBN O O
it PRP O O
might MD O O
be VB O O
a DT B-NP O
recrudescence NN I-NP O
of IN B-VP O
his PRP$ O O
gout NN B-NP O
The DT B-NP O
next JJ I-NP O
day NN I-NP O
it PRP O O
was VBD B-VP O
more RBR O O
warm JJ O O
and CC O O
slightly RB O O
swollen JJ B-NP O
Colchicine NNP I-NP B-m
helped VBD B-VP O
somewhat RB O O
, , O O
and CC O O
he PRP O O
was VBD B-VP O
then RB O O
put VBN O O
on IN B-VP O
a DT B-NP O
prednisone NN I-NP B-m
taper NN I-NP O
starting VBG O O
at IN B-VP O
40 CD O B-do
milligrams NNS B-NP I-do
and CC O O
tolerated VBD B-VP O
this DT B-NP O
well NN I-NP O
DISPOSITION: NNP I-NP O
He PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
1999 CD O O
He PRP O O
has VBZ O O
follow-up JJ B-NP O
appointments NNS I-NP O
with IN B-VP O
his PRP$ O O
primary JJ B-NP O
doctor NN I-NP O
, , O O
Dr NNP B-NP O
Eslinger NNP I-NP O
, , O O
on IN B-VP O
November NNP B-NP O
, , O O
2000 CD O O
, , O O
his PRP$ O O
primary JJ B-NP O
cardiologist NN I-NP O
, , O O
Dr NNP B-NP O
Edd NNP I-NP O
, , O O
on IN B-VP O
March NNP B-NP O
, , O O
1999 CD O O
, , O O
and CC O O
Dr NNP B-NP O
Notowich NNP I-NP O
who WP O O
performed VBD B-VP O
the DT B-NP O
procedure NN I-NP O
on IN B-VP O
the DT B-NP O
subclavian JJ I-NP O
artery NN I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
2000 CD O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
His PRP$ O O
medications NNS B-NP O
on IN B-VP O
discharge NN B-NP O
are VBP O O
the DT O O
following: JJ O O
1 CD O O
Cozaar NNP B-NP B-m
25 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
2 CD O O
Restoril NNP B-NP B-m
30 CD O B-do
milligrams NNS B-NP O
q.d JJ B-NP B-f
q.h.s JJ I-NP I-f
p.r.n NN I-NP I-f
3 CD O O
Nitroglycerin NNP B-NP B-m
0.4 CD O B-do
milligrams NNS B-NP I-do
p.r.n VBP O O
chest JJS B-NP B-r
pain NN I-NP I-r
, , O O
sublingual JJ O B-mo
, , O O
may MD O O
repeat VB O O
times NNS B-NP O
three CD O O
q.5 NN B-NP O
minutes NNS I-NP O
4 CD O O
Regular JJ B-NP B-m
insulin NN I-NP I-m
4 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
, , O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
34 CD O B-do
units NNS B-NP I-do
q.a.m RB O B-f
10 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
5 CD O O
Rezulin NNP B-NP B-m
400 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
6 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
7 CD O O
Coumadin NNP B-NP B-m
5 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
8 CD O O
Clopidogrel NNP B-NP B-m
75 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
9 CD O O
Magnesium NNP B-NP B-m
oxide RB O I-m
280 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
10 CD O O
Colchicine NNP B-NP B-m
0.6 CD O B-do
milligrams NNS B-NP O
p.r.n VBP O B-f
11 CD O O
K-Dur JJ O B-m
60 CD O B-do
mEq NN B-NP I-do
q.d NN I-NP B-f
12 CD O O
Lasix NNP B-NP B-m
160 CD O B-do
milligrams NNS B-NP O
q.d RB O B-f
13 CD O O
Mitozalone NNP B-NP B-m
5 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
14 CD O O
Atenolol NNP B-NP B-m
25 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
15 CD O O
Atorvastatin NNP B-NP B-m
20 CD O B-do
milligrams NNS B-NP I-do
q.h.s RB O B-f
16 CD O O
Finasteride NNP B-NP B-m
5 CD O B-do
milligrams NNS B-NP I-do
q.d RB O B-f
17 CD O O
Ciprofloxacin NNP B-NP B-m
500 CD O B-do
milligrams NNS B-NP I-do
b.i.d RB O B-f
Dictated NNP B-NP O
By: NNP I-NP O
BEAU NNP I-NP O
GROOMES NNP I-NP O
, , O O
M.D NNP B-NP O
ZT84 NNP I-NP O
Attending: NNP I-NP O
KRIS NNP I-NP O
N NNP I-NP O
DEASE NNP I-NP O
, , O O
M.D NNP B-NP O
VI5 NNP I-NP O
NF166/9758 NNP I-NP O
Batch: NNP I-NP O
68854 CD O O
Index NNP B-NP O
No NNP I-NP O
S4CL2C19K0 NNP I-NP O
D: NNP I-NP O
8/23/99 CD O O
T: NNP B-NP O
7/24/99 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#655922 VBZ O O
060262714 CD O O
SMC NNP B-NP O
34620616 CD O O
6090030 CD O O
3/4/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
unstable JJ B-NP O
angina NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/8/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/25/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
DILEO NNP I-NP O
, , O O
DOUGLASS NNP B-NP O
W NNP I-NP O
004-09-86-5 JJ B-NP O
O53 NNP I-NP O
Room: NNP I-NP O
00E-984 JJ B-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
11/23/04 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
ambulatory NN I-NP O
O2 NNP I-NP O
sat VBD B-VP O
&gt;90% NNP B-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KLOKE NNP I-NP O
, , O O
BRADLEY NNP B-NP O
RICHIE NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ENTERIC NNP I-NP B-m
COATED NNP I-NP I-m
ASA NNP I-NP I-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/10/04 CD O O
by IN B-VP O
PHELP NNP B-NP O
, , O O
RYAN NNP B-NP O
KENNETH NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ENTERIC NNP B-NP B-m
COATED NNP I-NP I-m
ASA NNP I-NP I-m
PO NNP I-NP B-mo
325 CD O B-do
MG NNP B-NP I-do
QD NNP I-NP B-f
( ( O O
ref JJ O O
# # O O
49885688 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
NSAIDs; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/18/04 CD O O
by IN B-VP O
PUCIO NNP B-NP O
, , O O
JERROLD NNP B-NP O
GERMAN NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ENTERIC NNP B-NP B-m
COATED NNP I-NP I-m
ASA NNP I-NP I-m
PO NNP I-NP B-mo
325 CD O B-do
MG NNP B-NP I-do
QD NNP I-NP B-f
( ( O O
ref JJ O O
# # O O
90327323 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
NSAIDs; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
has VBZ O O
tolerated VBN O O
Previous NNP B-NP O
override IN B-VP O
reason: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/24/04 CD O O
by IN B-VP O
SWENK NNP B-NP O
, , O O
RILEY NNP B-NP O
RICKY NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ECASA NNP B-NP B-m
PO NNP I-NP B-mo
325 CD O B-do
MG NNP B-NP I-do
QD NNP I-NP B-f
( ( O O
ref JJ O O
# # O O
57541802 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
POSSIBLE NNP I-NP O
allergy NN I-NP O
to TO O O
NSAIDs; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
patient NN I-NP O
takes VBZ O O
at IN B-VP O
home NN B-NP O
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
36 CD O B-do
UNITS NNP B-NP I-do
QAM; NNP I-NP B-f
QAM; NNP I-NP B-f
40 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
SC NNP I-NP B-mo
36 CD O B-do
UNITS NNP B-NP I-do
QAM NNP I-NP O
40 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
NEURONTIN NNP I-NP B-m
( ( O I-m
GABAPENTIN NNP B-NP I-m
) ) O I-m
600 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZETIA NNP I-NP B-m
( ( O I-m
EZETIMIBE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HYDROCHLOROTHIAZIDE NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
PREVACID NNP I-NP B-m
( ( O I-m
LANSOPRAZOLE NNP B-NP I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GLUCOPHAGE NNP I-NP B-m
( ( O I-m
METFORMIN NNP B-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
IBUPROFEN NNP I-NP B-m
600-800 JJ B-NP B-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/23/04 CD O O
by IN B-VP O
: : O O
on IN B-VP O
order NN B-NP O
for IN B-VP O
IBUPROFEN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
20352570 CD O O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
PROBABLE NNP I-NP O
allergy NN I-NP O
to TO O O
NSAIDs; NNP B-NP O
reaction NN I-NP O
is VBZ O O
Unknown JJ B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Patient NNP I-NP O
has VBZ O O
tolerated VBN O O
in IN B-VP O
past JJ B-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
11/23/04 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
CLOPIDOGREL NNP I-NP B-m
BISULFATE NNP I-NP I-m
&amp; NNP I-NP O
IBUPROFEN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
Monitoring NNP I-NP O
HCT NNP I-NP O
ATENOLOL NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Instructions: NNP I-NP O
take VB O O
1/2 CD O O
your PRP$ O O
regular JJ B-NP O
home NN I-NP O
dose NN I-NP O
until IN B-VP O
you PRP O O
see VBP O O
your PRP$ O O
cardiologist/PCP JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Brechbiel NNP I-NP O
his PRP$ O O
office NN B-NP O
will MD O O
call VB O O
you PRP O O
re: JJ B-NP O
appointment NN I-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
, , O O
Dr NNP B-NP O
Damms NNP I-NP O
's POS O O
office NN B-NP O
is VBZ O O
setting VBG O O
up RP O O
right JJ B-NP O
leg NN I-NP O
ultrasound NN I-NP O
for IN B-VP O
2-4 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY: NNP B-NP O
SIMVASTATIN NNP I-NP O
, , O O
NSAIDs NNP B-NP O
, , O O
SHELLFISH NNP B-NP O
, , O O
Codeine NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
unstable JJ B-NP O
angina NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
unstable JJ B-NP O
angina NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
diabetes NNS I-NP O
( ( O O
diabetes NNS B-NP O
mellitus VBP O O
) ) O O
s/p FW O O
stent JJ B-NP O
placement NN I-NP O
( ( O O
S/P NNP B-NP O
angioplasty RB O O
) ) O O
high JJ B-NP O
cholesterol NN I-NP O
( ( O O
elevated VBN O O
cholesterol NN B-NP O
) ) O O
htn NN B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
fibromyalgia NN B-NP O
( ( O O
fibromyalgia NN B-NP O
) ) O O
gallstones NNS B-NP O
( ( O O
biliary JJ B-NP O
stones NNS I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
6/18/04 CD O O
Cardiac NNP B-NP O
cath NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
64 CD O O
y/o NN B-NP O
F NNP I-NP O
w/ NN I-NP O
DM NNP I-NP O
, , O O
CAD NNP B-NP O
s/p VBD B-VP O
OM1 NNP B-NP O
stent NN I-NP O
'99 NN I-NP O
, , O O
w/ RB O O
1 CD O O
month NN B-NP O
h/o NN I-NP O
worsened VBD B-VP O
exertional JJ B-NP O
angina NN I-NP O
( ( O O
jaw JJ B-NP O
tightness NN I-NP O
) ) O O
, , O O
and CC O O
2 CD O O
day NN B-NP O
h/o VBD B-VP O
worsening VBG O O
intermittent JJ B-NP O
jaw NN I-NP O
pain NN I-NP O
, , O O
SOB NNP B-NP O
, , O O
presented VBD B-VP O
after IN B-VP O
2nd CD O O
episode NN B-NP O
of IN B-VP O
pain NN B-NP O
at IN B-VP O
rest NN B-NP O
to TO O O
G NNP B-NP O
ED NNP I-NP O
Initial NNP I-NP O
enzymes NNS I-NP O
were VBD B-VP O
negative JJ O O
, , O O
patient NN B-NP O
was VBD B-VP O
heparinized VBN O O
for IN B-VP O
EKG NNP B-NP O
changes NNS I-NP O
and CC O O
transferred VBD B-VP O
to TO O O
PMBMC NNP B-NP O
ED NNP I-NP O
where WRB O O
B-set NNP B-NP O
TnI NNP I-NP O
positive; NN I-NP O
TWI NNP I-NP O
in IN B-VP O
anterior JJ B-NP O
leads NNS I-NP O
Cath NNP I-NP O
results NNS I-NP O
below IN B-VP O
Initial NNP B-NP O
exam SYM O O
- : O O
BP NNP B-NP O
140s CD O O
, , O O
HR NNP B-NP O
50s CD O O
, , O O
afebrile RB O O
, , O O
soft JJ B-NP O
systolic JJ I-NP O
murmur NN I-NP O
, , O O
clear JJ B-NP O
lungs NNS I-NP O
EKG- NNP I-NP O
NSR NNP I-NP O
, , O O
TWI NNP B-NP O
in IN B-VP O
anterior JJ B-NP O
leads NNS I-NP O
, , O O
Troponin NNP B-NP O
0.67 CD O O
, , O O
MB NNP B-NP O
7.4 CD O O
, , O O
CK NNP B-NP O
303 CD O O
, , O O
CK NNP B-NP O
303 CD O O
HCT NNP B-NP O
39.1 CD O O
PMHx: NNP B-NP O
DM NNP I-NP O
, , O O
CAD NNP B-NP O
s/p VBD B-VP O
Om1 NNP B-NP O
stent NN I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
HTN NNP B-NP O
, , O O
fibromyalgia NN B-NP O
, , O O
s/p NN B-NP O
CCY NNP I-NP O
, , O O
spinal JJ B-NP O
stenosis NN I-NP O
, , O O
obesity NN B-NP O
, , O O
s/p JJ B-NP O
TAH NNP I-NP O
**Hospital NNP I-NP O
Course** NNP I-NP O
CV/HEME: NNP I-NP O
Patient NNP I-NP O
underwent JJ B-NP O
cardiac JJ I-NP O
cath NN I-NP O
on IN B-VP O
6/18/04 CD O O
- : O O
LAD NN B-NP O
90% CD O O
lesion NN B-NP O
and CC O O
OM2 NNP B-NP O
99% CD O O
lesion NN B-NP O
both DT O O
successfully RB O O
stented VBN O O
with IN B-VP O
cypher NN B-NP O
Remaining VBG O O
100% CD O O
PDA NNP B-NP O
Following NNP I-NP O
cath NN I-NP O
, , O O
patient NN B-NP O
had VBD B-VP O
bradycardia VBN O O
to TO O O
20-30's JJ O O
in IN B-VP O
setting VBG O O
of IN B-VP O
femoral JJ B-NP O
hematoma NN I-NP O
BP NNP I-NP B-r
initially RB O O
measured VBD B-VP O
in IN B-VP O
60s CD O O
, , O O
thought VBN O O
to TO O O
be VB O O
vagal JJ O O
2/2 CD O O
femoral JJ B-NP O
hematoma NN I-NP O
Received NNP I-NP O
atropine NN I-NP B-m
x NNP I-NP B-du
1 CD O I-du
and CC O O
Fem NNP B-NP O
stop NN I-NP O
placed VBD B-VP O
over IN B-VP O
cath NN B-NP O
site NN I-NP O
for IN B-VP O
compression NN B-NP O
- : O O
BP NNP B-NP O
dropped VBD B-VP O
again RB O O
with IN B-VP O
bradycardia- NN B-NP O
transferred VBN O O
to TO O O
CCU NNP B-NP O
and CC O O
briefly NN B-NP O
on IN B-VP O
dopamine NN B-NP B-m
CT NNP I-NP O
ruled VBD B-VP O
out RP O O
retroperitoneal JJ B-NP O
bleed NN I-NP O
Hct NNP I-NP O
stable JJ B-NP O
Transferred NNP I-NP O
back RB O O
to TO O O
floor NN B-NP O
within IN B-VP O
24 CD O O
hours NNS B-NP O
Patient NNP I-NP O
also RB O O
noted VBD B-VP O
occasional JJ B-NP O
mild JJ I-NP O
abdominal JJ I-NP O
discomfort NN I-NP O
, , O O
but CC O O
had VBD B-VP O
negative JJ B-NP O
LFTs NNP I-NP O
and CC O O
lipase NN B-NP O
She PRP O O
also RB O O
noted VBD B-VP O
right JJ B-NP O
calf NN I-NP O
pain NN I-NP O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
below-the JJ I-NP O
knee NN I-NP O
right JJ B-NP O
tibial JJ I-NP O
vein NN I-NP O
DVT NNP I-NP O
, , O O
was VBD B-VP O
not RB O O
anticoagulated VBN O O
for IN B-VP O
this DT B-NP O
below-the JJ I-NP O
knee NN I-NP O
clot NN I-NP O
because IN B-VP O
of IN B-VP O
low JJ B-NP O
risk NN I-NP O
of IN B-VP O
embolization NN B-NP O
and CC O O
he PRP O O
r VB O O
recent JJ B-NP O
HCT NNP I-NP B-r
drop/hematoma NN I-NP I-r
LENI NNP I-NP B-m
was VBD B-VP O
repeated VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
discharge NN B-NP O
and CC O O
showed VBD B-VP O
no DT B-NP O
progression NN I-NP O
One CD O O
the DT O O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
her PRP$ O B-r
HCT NNP B-NP I-r
dropped VBD B-VP O
from IN B-VP O
32 CD O O
to TO O O
26 CD O O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
trandfused VBN O B-mo
2 CD O B-do
U NNP B-NP I-do
PRBC NNP I-NP B-m
w/HCT VBD B-VP O
bump NN B-NP O
to TO O O
34.1 CD O O
Repeat NNP B-NP O
CT NNP I-NP O
showed VBD B-VP O
shrinkage NN B-NP O
of IN B-VP O
hematoma NN B-NP O
, , O O
so IN B-VP O
pt JJ O O
is VBZ O O
being VBG O O
discharged VBN O O
with IN B-VP O
plans NNS B-NP O
to TO O O
have VB O O
PCP NNP B-NP O
recheck VB O O
HCT NNP B-NP O
at IN B-VP O
home NN B-NP O
in IN B-VP O
2 CD O O
days NNS B-NP O
MSK: NNP I-NP O
Patient NNP I-NP O
complained VBD B-VP O
of IN B-VP O
left JJ B-NP O
knee NN I-NP O
pain NN I-NP O
after IN B-VP O
fall NN B-NP O
one CD O O
week NN B-NP O
prior RB O O
X-ray NNP B-NP O
shoed VBD B-VP O
only RB O O
osteoarthritis RB O O
, , O O
although IN B-VP O
knee NN B-NP O
was VBD B-VP O
somewhat RB O O
warm JJ O O
There EX O O
was VBD B-VP O
no DT B-NP O
clear JJ I-NP O
effusion NN I-NP O
, , O O
so RB O O
patient JJ O O
is VBZ O O
being VBG O O
given VBN O O
ibuprofen NNS B-NP B-m
PRN NNP I-NP B-f
for IN B-VP O
now RB O O
______ VBZ O O
Anti-ischemic JJ B-NP B-m
regimen NNS I-NP I-m
at IN B-VP O
discharge: NN B-NP O
ASA NNP I-NP B-m
, , O O
Plavix NNP B-NP B-m
, , O O
Atenolol NNP B-NP B-m
, , O O
Lisinopril NNP B-NP B-m
( ( O O
no DT B-NP O
Statin NNP I-NP B-m
because IN B-VP O
of IN B-VP O
muscle NN B-NP O
pain NN I-NP O
hx NN I-NP O
) ) O O
Will NNP B-NP O
continue VBP O O
home NN B-NP O
diabetic JJ B-NP B-m
regimen NNS I-NP O
and CC O O
followup NN B-NP O
with IN B-VP O
PCP/cardiology NNP B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
You PRP O O
should MD O O
return VB O O
to TO O O
the DT B-NP O
hospital NN I-NP O
or CC O O
call VB O O
your PRP$ O O
doctor NN B-NP O
if IN B-VP O
you PRP O O
have VBP O O
chest VBN O O
pain NN B-NP O
or CC O O
difficulty NN B-NP O
breathing VBG O O
Dr NNP B-NP O
Estrello NNP I-NP O
's POS O O
office NN B-NP O
will MD O O
send VB O O
someone NN B-NP O
to TO O O
your PRP$ O O
home NN B-NP O
on IN B-VP O
Sunday NNP B-NP O
3/6 CD O O
to TO O O
draw VB O O
your PRP$ O O
blood NN B-NP O
levels NNS I-NP O
Your VBP O O
hematocrit NN B-NP O
on IN B-VP O
discharge NN B-NP O
today NN I-NP O
is VBZ O O
34.1 CD O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
You PRP O O
should MD O O
have VB O O
a DT B-NP O
repeat NN I-NP O
right JJ B-NP O
leg NN I-NP O
ultrasound JJ B-NP O
test NN I-NP O
( ( O O
"LENI" NN B-NP O
) ) O O
to TO O O
follow VB O O
the DT B-NP O
small JJ I-NP O
blood NN I-NP O
clot NN I-NP O
in IN B-VP O
your PRP$ O O
leg NN B-NP O
You PRP O O
will MD O O
need VB O O
to TO O O
schedule VB O O
this DT B-NP O
test NN I-NP O
to TO O O
occur VB O O
in IN B-VP O
the DT B-NP O
next JJ I-NP O
3-4 JJ I-NP O
weeks NNS I-NP O
through IN B-VP O
Dr NNP B-NP O
Gino NNP I-NP O
Onisick NNP I-NP O
office NN I-NP O
No RB O O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MILLISOR NNP I-NP O
, , O O
JERE NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.S NNP B-NP O
( ( O O
XD73 NNP B-NP O
) ) O O
11/23/04 CD O O
@ $ O O
05 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#658896 VBZ O O
521830719 CD O O
BH NNP B-NP O
27567873 CD O O
628764 CD O O
10/27/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/25/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/26/1995 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
RIGHT NNP I-NP O
BREAST NNP I-NP O
ABSCESS NNP I-NP O
SIGNIFICANT NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
) ) O O
OBESITY NNP B-NP O
2 CD O O
) ) O O
DEPRESSION NNP B-NP O
3 CD O O
) ) O O
HYPERTENSION NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
57 JJ I-NP O
year-old JJ I-NP O
woman NN I-NP O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Haggard NNP I-NP O
in IN B-VP O
the DT B-NP O
IWAKE NNP I-NP O
HEALTHCARE NNP I-NP O
Clinic NNP I-NP O
for IN B-VP O
problems NNS B-NP O
related VBN O O
to TO O O
obesity NN B-NP O
, , O O
depression NN B-NP O
and CC O O
poorly RB O O
controlled VBN O O
hypertension NN B-NP O
In IN B-VP O
February NNP B-NP O
of IN B-VP O
1994 CD O O
, , O O
she PRP O O
complained VBD B-VP O
of IN B-VP O
right JJ B-NP O
breast NN I-NP O
tenderness NN I-NP O
with IN B-VP O
a DT B-NP O
palpable JJ I-NP O
nodule NN I-NP O
A DT B-NP O
mammogram NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
revealed VBD B-VP O
mildly RB O O
dense JJ B-NP O
parenchyma NN I-NP O
and CC O O
no DT B-NP O
calcium NN I-NP O
and CC O O
an DT B-NP O
ultrasound NN I-NP O
revealed VBD B-VP O
4 CD O O
mm NN B-NP O
hypoechoic NN I-NP O
nodule NN I-NP O
compatible JJ B-NP O
duct NN I-NP O
obstruction NN I-NP O
with IN B-VP O
debris NN B-NP O
Her PRP$ O O
symptoms NNS B-NP O
of IN B-VP O
right JJ B-NP O
breast NN I-NP O
tenderness NN I-NP O
waxed VBD B-VP O
and CC O O
waned VBD B-VP O
and CC O O
follow-up JJ B-NP O
ultrasound NN I-NP O
in IN B-VP O
May NNP B-NP O
of IN B-VP O
1994 CD O O
revealed VBD B-VP O
a DT O O
1 CD O O
X NN B-NP O
0.5 CD O O
cm JJ B-NP O
mass NN I-NP O
unchanged JJ O O
from IN B-VP O
the DT O O
previous JJ O O
ultrasound IN B-VP O
She PRP O O
was VBD B-VP O
advise RB O O
to TO O O
return VB O O
in IN B-VP O
three CD O O
months NNS B-NP O
for IN B-VP O
repeat NN B-NP O
ultrasound NN I-NP O
and CC O O
aspiration NN B-NP O
In IN B-VP O
March NNP B-NP O
of IN B-VP O
1995 CD O O
, , O O
she PRP O O
had VBD B-VP O
a DT B-NP O
palpable JJ I-NP O
indurated JJ I-NP O
area NN I-NP O
at IN B-VP O
12:00 CD O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
breast NN I-NP O
She PRP O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Dr NNP B-NP O
Noguchi NNP I-NP O
in IN B-VP O
the DT B-NP O
Surgery NNP I-NP O
Clinic NNP I-NP O
and CC O O
scheduled VBN O O
for IN B-VP O
a DT B-NP O
right JJ I-NP O
breast NN I-NP O
biopsy NN I-NP O
, , O O
but CC O O
because IN B-VP O
of IN B-VP O
persistent JJ B-NP O
hypertension NN I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
, , O O
she PRP O O
is VBZ O O
now RB O O
admitted VBN O O
for IN B-VP O
blood NN B-NP O
pressure NN I-NP O
control NN I-NP O
prior RB O O
to TO O O
the DT B-NP O
breast NN I-NP O
biopsy NN I-NP O
on IN B-VP O
November NNP B-NP O
, , O O
1995 CD O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
1 CD O O
) ) O O
Hypertension NN B-NP O
, , O O
2 CD O O
) ) O O
Obesity NN B-NP O
, , O O
3 CD O O
) ) O O
Tobacco NN B-NP O
use NN I-NP O
, , O O
4 CD O O
) ) O O
Depression NNP B-NP O
, , O O
5 CD O O
) ) O O
Uterine NNP B-NP O
leiomyoma NN I-NP O
, , O O
6 CD O O
) ) O O
Polymyalgia NNP B-NP O
rheumatica NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
) ) O O
Lisinopril FW O B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
2 CD O O
) ) O O
Diltiazem NNP B-NP B-m
240 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
six CD O O
children NNS B-NP O
She PRP O O
is VBZ O O
divorced VBN O O
She PRP O O
has VBZ O O
a DT O O
40 CD O O
pack NN B-NP O
year NN I-NP O
history NN I-NP O
of IN B-VP O
smoking NN B-NP O
and CC O O
denies VBZ O O
alcohol NN B-NP O
abuse IN B-VP O
FAMILY NNP B-NP O
HISTORY: NNP I-NP O
Positive NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
and CC O O
cerebral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
an DT B-NP O
obese JJ I-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Vital NNP I-NP O
signs: VBD B-VP O
Blood NNP B-NP O
pressure NN I-NP O
170/110 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
80 CD O O
Her NNP B-NP O
pupils NNS I-NP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Discs NNP I-NP O
are VBP O O
sharp JJ O O
and CC O O
there EX O O
are VBP O O
narrowed JJ B-NP O
vessels NNS I-NP O
on IN B-VP O
fundoscopic NN B-NP O
examination NN I-NP O
She PRP O O
has VBZ O O
no DT B-NP O
lymphadenopathy NN I-NP O
and CC O O
no DT B-NP O
bruits NNS I-NP O
Her PRP$ O O
lungs NNS B-NP O
are VBP O O
clear JJ O O
to TO O O
auscultation VB O O
Her NNP B-NP O
right NN I-NP O
breast NN I-NP O
shows NNS I-NP O
indurated VBD B-VP O
2 CD O O
X NNP B-NP O
3 CD O O
cm JJ B-NP O
mass NN I-NP O
just RB O O
above IN B-VP O
the DT B-NP O
right JJ I-NP O
nipple NN I-NP O
, , O O
with IN B-VP O
an DT O O
overlying VBG O O
erythema NN B-NP O
which WDT O O
is VBZ O O
moderately RB O O
tender JJ B-NP O
Her NNP I-NP O
cardiac NN I-NP O
examination NN I-NP O
reveals VBZ O O
a DT B-NP O
normal JJ I-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
and CC O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT O O
two CD O O
out IN B-VP O
of IN B-VP O
six CD O O
systolic JJ B-NP O
ejection NN I-NP O
murmur FW O O
heard NN B-NP O
best JJS O O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
Her PRP$ O O
abdomen NNS B-NP O
is VBZ O O
obese JJ O O
with IN B-VP O
a DT B-NP O
midline NN I-NP O
scar NN I-NP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
and CC O O
no DT B-NP O
hepatosplenomegaly NN I-NP O
Her PRP$ O O
extremities NNS B-NP O
revealed VBD B-VP O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
or CC O O
edema NN B-NP O
and CC O O
she PRP O O
has VBZ O O
diminished VBN O O
peripheral JJ B-NP O
pulses NNS I-NP O
Her PRP$ O O
neurological JJ B-NP O
examination NN I-NP O
is VBZ O O
grossly RB O O
intact JJ B-NP O
LABORATORY: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
her PRP$ O O
EKG NNP B-NP O
shows VBZ O O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
without IN B-VP O
any DT B-NP O
ischemic JJ I-NP O
changes NNS I-NP O
, , O O
unchanged JJ O O
from IN B-VP O
EKG NNP B-NP O
in IN B-VP O
July NNP B-NP O
of IN B-VP O
1992 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
General NNP I-NP O
Medical NNP I-NP O
Service NNP I-NP O
and CC O O
given VBN O O
more RBR O O
aggressive JJ B-NP O
hypertensive JJ I-NP O
medications NNS I-NP O
including VBG O O
increasing VBG O O
her PRP$ O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
to TO O O
Lisinopril NNP B-NP B-m
40 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
and CC O O
discontinuing VBG O O
her PRP$ O O
Diltiazem NNP B-NP B-m
and CC O O
started VBD B-VP O
on IN B-VP O
Hydrochlorothiazide NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ O B-f
daily JJ O I-f
and CC O O
starting VBG O O
Beta NNP B-NP B-m
blocker NN I-NP I-m
Lopressor NNP I-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
and CC O O
increasing VBG O O
as RB O O
tolerated VBN O O
according VBG O O
to TO O O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
She PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
surgery VB O O
on IN B-VP O
November NNP B-NP O
, , O O
1995 CD O O
The DT B-NP O
right JJ I-NP O
breast NN I-NP O
abscess NN I-NP O
was VBD B-VP O
drained VBN O O
without IN B-VP O
incident NN B-NP O
Post NNP I-NP O
surgery NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
IV NNP B-NP B-mo
antibiotics NNS I-NP B-m
which WDT O O
included VBD B-VP O
Ancef NNP B-NP B-m
1 CD O B-do
gram NN B-NP O
IV NNP I-NP B-mo
q RB O B-f
8h CD O I-f
Other JJ B-NP O
notable JJ I-NP O
events NNS I-NP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
included VBD B-VP O
a DT B-NP O
Psychiatry NNP I-NP O
consult NN I-NP O
who WP O O
suggested VBD B-VP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
major JJ B-NP O
depression NN I-NP O
and CC O O
recommended VBD B-VP O
ruling NN B-NP O
organic JJ B-NP O
brain NN I-NP O
disease NN I-NP O
A NNP I-NP O
polysonography NN I-NP O
was VBD B-VP O
done VBN O O
for IN B-VP O
monitoring NN B-NP O
of IN B-VP O
sleep JJ B-NP O
apnea NN I-NP O
and CC O O
an DT B-NP O
MMTI NNP I-NP O
for IN B-VP O
further JJ B-NP O
diagnostic JJ I-NP O
evaluation NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
uneventful JJ I-NP O
postoperative JJ I-NP O
course NN I-NP O
with IN B-VP O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
remaining VBG O O
moderately RB O O
elevated VBN O O
and CC O O
resolution NN B-NP O
of IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
of IN B-VP O
right JJ B-NP O
breast NN I-NP O
tenderness NN I-NP O
which WDT O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
the DT B-NP O
Zonhend NNP I-NP O
Manggu NNP I-NP O
Community NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Surgical NNP I-NP O
Service NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
on IN B-VP O
Keflex NNP B-NP B-m
and CC O O
Cephradine NNP B-NP B-m
with IN B-VP O
follow-up NN B-NP O
in IN B-VP O
the DT B-NP O
TLET NNP I-NP O
HOSPITAL NNP I-NP O
Clinic NNP I-NP O
with IN B-VP O
Dr NNP B-NP O
Mcgowan NNP I-NP O
and CC O O
in IN B-VP O
a DT B-NP O
Hmotmed NNP I-NP O
Dell NNP I-NP O
An DT B-NP O
Community NNP I-NP O
Hospital NNP I-NP O
Medical NNP I-NP O
Service NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
) ) O O
Enteric NNP B-NP B-m
coated VBD B-VP I-m
aspirin RB O I-m
325 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
day NN I-NP I-f
2 CD O O
) ) O O
Colace NN B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
3 CD O O
) ) O O
Hydrochlorothiazide $ O B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q VBD B-VP B-f
daily RB O I-f
4 CD O O
) ) O O
Lisinopril FW O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q VBD B-VP B-f
daily RB O I-f
5 CD O O
) ) O O
Tylox NNP B-NP B-m
1-2 JJ B-NP B-do
capsules NNS I-NP I-do
p.o VBP O B-mo
q JJ B-NP B-f
4-6h JJ I-NP I-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
6 CD O O
) ) O O
Atenolol $ O B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q VBD B-VP B-f
daily RB O I-f
7 CD O O
) ) O O
Cephradine NN B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
times NNS I-NP B-du
five CD O I-du
days NNS B-NP I-du
Dictated VBN O O
By: NNP B-NP O
BURL NNP I-NP O
G NNP I-NP O
NORLUND NNP I-NP O
, , O O
M.D NNP B-NP O
/D.PHIL NNP I-NP O
ZT7 NNP I-NP O
Attending: NNP I-NP O
EDMUNDO NNP I-NP O
Z NNP I-NP O
VARGO NNP I-NP O
, , O O
M.D NNP B-NP O
OT63 NNP I-NP O
XK927/4459 NNP I-NP O
Batch: NNP I-NP O
37149 CD O O
Index NNP B-NP O
No NNP I-NP O
LSCARH4YI NNP I-NP O
D: NNP I-NP O
10/14/96 CD O O
T: NNP B-NP O
5/17/96 CD O O
CC: NNP B-NP O
LENARD NNP I-NP O
A NNP I-NP O
PLUMLEE NNP I-NP O
, , O O
M.D NNP B-NP O
TV63 NNP I-NP O
WILBURN NNP I-NP O
I PRP O O
UXA NNP B-NP O
, , O O
M.D NNP B-NP O
KO36 NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#661928 VBZ O O
457962568 CD O O
OMC NNP B-NP O
15325194 CD O O
7149373 CD O O
5/5/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
chf JJ B-NP O
exacerbation NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/8/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/1/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
EVANKO NNP I-NP O
, , O O
BENEDICT NNP B-NP O
205-94-27-9 CD O O
Dalemilci NNP B-NP O
Lake NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/4/06 CD O O
AT NNP B-NP O
11:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
RHATIGAN NNP I-NP O
, , O O
WENDELL NNP B-NP O
E NNP I-NP O
E NNP I-NP O
M NNP I-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
ATORVASTATIN NNP I-NP B-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
COREG NNP I-NP B-m
( ( O I-m
CARVEDILOL NNP B-NP I-m
) ) O I-m
3.125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;90 NNP I-NP O
or CC O O
P&lt;55 NNP B-NP O
Instructions: NNP I-NP O
if IN B-VP O
held VBN O O
, , O O
please VB O O
call VB O O
HO NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
6 CD O O
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
March NNP I-NP O
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
70/30 CD O I-m
70/30 CD O I-m
70/30 CD O I-m
70/30 CD O I-m
HUMAN NNP B-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
HUMAN NNP I-NP I-m
50 CD O B-do
UNITS NNP B-NP I-do
QAM; NNP I-NP B-f
35 CD O B-do
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
SC NNP I-NP B-mo
50 CD O B-do
UNITS NNP B-NP I-do
QAM NNP I-NP B-f
35 CD O B-do
35 CD O I-f
UNITS NNP B-NP I-do
QPM NNP I-NP B-f
IMDUR NNP I-NP B-m
ER NNP I-NP I-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONITRATE NNP I-NP I-m
( ( O I-m
SR NNP B-NP I-m
) ) O I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
March NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
LISINOPRIL NNP B-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; NNP I-NP O
90 CD O O
and CC O O
call VB O O
HO NNP B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/06 CD O O
by IN B-VP O
REICKS NNP B-NP O
, , O O
JACQUES NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SPIRONOLACTONE NNP I-NP B-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitor NN I-NP O
METAMUCIL NNP I-NP B-m
SUGAR NNP I-NP I-m
FREE NNP I-NP I-m
( ( O I-m
PSYLLIUM NNP B-NP I-m
( ( O I-m
METAMUCIL NNP B-NP I-m
) ) O I-m
SU NNP B-NP I-m
) ) O I-m
1 CD O B-do
PACKET NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
SPIRONOLACTONE NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;90 NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
with IN B-VP O
meals NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/06 CD O O
by IN B-VP O
VAZZANA NNP B-NP O
, , O O
JAN NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
LISINOPRIL NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
166373866 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SPIRONOLACTONE NNP I-NP B-m
&amp; NNP I-NP O
LISINOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitor NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/15/06 CD O O
by IN B-VP O
SOLARSKI NNP B-NP O
, , O O
ERICH NNP B-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
040984307 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
SPIRONOLACTONE NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitored VBD B-VP O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/16/06 CD O O
by IN B-VP O
SCHWISOW NNP B-NP O
, , O O
CHUNG NNP B-NP O
P NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
POTASSIUM NNP B-NP B-m
CHLORIDE NNP I-NP I-m
IMMED NNP I-NP I-m
REL NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
573534645 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
SPIRONOLACTONE NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitor NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/16/06 CD O O
by IN B-VP O
TROTZ NNP B-NP O
, , O O
HEATH NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
CAPTOPRIL NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
244774599 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SPIRONOLACTONE NNP I-NP B-m
&amp; NNP I-NP O
CAPTOPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
Sliding NNP I-NP B-do
Scale NNP I-NP I-do
( ( O B-mo
subcutaneously RB O I-mo
) ) O I-mo
SC NNP B-NP I-mo
AC NNP I-NP B-f
If IN B-VP O
BS NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
give VB O O
0 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
6 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
DIET: NNP B-NP O
Fluid NNP I-NP O
restriction NN I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
cardiology NN I-NP O
dr NN I-NP O
lelonek VBD B-VP O
714.815.2497 CD O O
1-4 JJ B-NP O
weeks NNS I-NP O
, , O O
pcp NN B-NP O
dr NN I-NP O
hoyt NN I-NP O
shimek VBD B-VP O
556-913-5202 JJ O O
2 CD O O
weeks NNS B-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chf NN I-NP O
, , O O
unstable JJ B-NP O
angina NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
chf VBP O O
exacerbation NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
chf JJ B-NP O
exacerbation NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
echo VBP O O
10/7 CD O O
-with JJ B-NP O
EF NNP I-NP O
20-25% CD O O
, , O O
wall DT B-NP O
motion NN I-NP O
abnl NN I-NP O
, , O O
dil NN B-NP O
ivc NN I-NP O
, , O O
tr NN B-NP O
, , O O
mr JJ B-NP O
evidence NN I-NP O
of IN B-VP O
atrial JJ B-NP O
septal JJ I-NP O
defect NN I-NP O
noted VBD B-VP O
Mibi/PET-CT NNP B-NP O
6/1 CD O O
test NN B-NP O
results NNS I-NP O
are VBP O O
abnormal JJ O O
and CC O O
c/w VBZ O O
the DT B-NP O
following: NN I-NP O
1 CD O O
A NNP B-NP O
medium NN I-NP O
sized JJ B-NP O
region NN I-NP O
of IN B-VP O
myocardial JJ B-NP O
scar NN I-NP O
without IN B-VP O
residual JJ B-NP O
ischemia NN I-NP O
or CC O O
viability NN B-NP O
in IN B-VP O
the DT B-NP O
distribution NN I-NP O
of IN B-VP O
the DT B-NP O
mid-LAD JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
2 CD O O
A NNP B-NP O
small JJ B-NP O
region NN I-NP O
of IN B-VP O
myocardial JJ B-NP O
scar NN I-NP O
without IN B-VP O
residual JJ B-NP O
ischemia NN I-NP O
or CC O O
viability NN B-NP O
in IN B-VP O
the DT B-NP O
distribution NN I-NP O
of IN B-VP O
the DT B-NP O
PDA NNP I-NP O
coronary JJ B-NP O
artery NN I-NP O
3 CD O O
Moderate NNP B-NP O
global JJ B-NP O
LV NNP I-NP O
systolic JJ B-NP O
dysfunction NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC- NNP I-NP O
sent VBD B-VP O
in IN B-VP O
by IN B-VP O
pcp NN B-NP O
for IN B-VP O
chest JJ B-NP O
pressure NN I-NP O
HPI-66yo NNP I-NP O
M NNP I-NP O
spanish JJ B-NP O
speaking NN I-NP O
from IN B-VP O
O NNP B-NP O
Ankament NNP I-NP O
Ta NNP I-NP O
1/10 CD O O
had VBD B-VP O
labs VBN O O
drawn VBN O O
at IN B-VP O
frelawn NN B-NP O
dinghung NN I-NP O
ant VBP O O
hospital NN B-NP O
11/17 CD O O
saw NN B-NP O
pcp NN I-NP O
, , O O
reported VBD B-VP O
sig.cardiac JJ B-NP O
hx NN I-NP O
and CC O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
months NNS I-NP O
has VBZ O O
had VBD B-VP O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
chest JJ B-NP O
pressure NN I-NP O
, , O O
nonradiating VBG O O
, , O O
initially RB O O
sx VB O O
on IN B-VP O
exertion NN B-NP O
, , O O
most RBS O O
recently RB O O
at IN B-VP O
rest NN B-NP O
On IN B-VP O
sunday NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
lying VBG O O
on IN B-VP O
couch NN B-NP O
when WRB O O
the DT B-NP B-r
sx NN I-NP I-r
started VBD B-VP O
, , O O
took VBD B-VP O
two CD O B-do
nitro NN B-NP B-m
with IN B-VP O
good JJ B-NP O
resolution NN I-NP O
no DT B-NP O
sob NN I-NP O
, , O O
no DT B-NP O
n/v/diaphoresis/fevers NNS I-NP O
he PRP O O
has VBZ O O
also RB O O
noted VBN O O
worsening VBG O O
LE NNP B-NP O
edema NN I-NP O
and CC O O
weight JJ B-NP O
gain NN I-NP O
of IN B-VP O
30lbs CD O O
over IN B-VP O
this DT B-NP O
time NN I-NP O
period NN I-NP O
He PRP O O
admits VBZ O O
to TO O O
missing VBG O O
his PRP$ O O
meds NNS B-NP B-m
and CC O O
to TO O O
eating VBG O O
a DT B-NP O
lot NN I-NP O
of IN B-VP O
salt NN B-NP O
He PRP O O
was VBD B-VP O
worked VBN O O
up RP O O
at IN B-VP O
A NNP B-NP O
in IN B-VP O
Tonusni NNP B-NP O
for IN B-VP O
several JJ B-NP O
months NNS I-NP O
to TO O O
try VB O O
and CC O O
determine VB O O
how WRB O O
to TO O O
best VB O O
treat NN B-NP O
his PRP$ O O
cardiac JJ B-NP O
disease NN I-NP O
Per NNP I-NP O
the DT B-NP O
pt NN I-NP O
, , O O
they PRP O O
said VBD B-VP O
they PRP O O
couldn't VBP O O
do VB O O
anything NN B-NP O
for IN B-VP O
him PRP O O
In IN B-VP O
ED NNP B-NP O
, , O O
afebrile JJ B-NP O
hr NN I-NP O
60s CD O O
, , O O
BP NNP B-NP O
110s CD O O
sat VBD B-VP O
100%RA CD O O
Tx NNP B-NP O
with IN B-VP O
lasix JJ O B-m
80iiv CD O B-do
, , O O
asa RB O B-m
325 CD O B-do
, , O O
coreg NN B-NP B-m
6.25 CD O B-do
, , O O
inuslin NN B-NP B-m
8u CD O B-do
OU NNP B-NP O
1500 CD O O
CXR NNP B-NP O
c/w NN I-NP O
pulm NN I-NP O
edema NN I-NP O
Exam NNP I-NP O
Gen- NNP I-NP O
resting VBG O O
comfortably RB O O
in IN B-VP O
bed NN B-NP O
, , O O
no DT B-NP O
c/o JJ I-NP O
HEENT- NNP I-NP O
jvp NN I-NP O
to TO O O
jaw VB O O
Pulm- NNP B-NP O
b/l NN I-NP O
crackles NNS I-NP O
at IN B-VP O
bases NNS B-NP O
Abd- NNP I-NP O
soft JJ O O
, , O O
NT NNP B-NP O
, , O O
ND NNP B-NP O
Ext- NNP I-NP O
c/o NN I-NP O
rt NN I-NP O
foot NN I-NP O
pain NN I-NP O
, , O O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
trauma NN B-NP O
slight JJ B-NP O
edema NN I-NP O
, , O O
b/l NN B-NP O
, , O O
c/o NN B-NP O
ttp NN I-NP O
along IN B-VP O
top NN B-NP O
of IN B-VP O
left JJ B-NP O
DPs NNP I-NP O
not RB O O
palpable JJ B-NP O
Home NNP I-NP O
meds NNS I-NP O
plavix75 VBP O B-m
asa81 JJ B-NP B-m
carnitidine NN I-NP B-m
( ( O O
? . B-VP O
) ) O O
150 CD O B-do
bid NN B-NP B-f
imdur NN I-NP B-m
30 CD O B-do
digitek NN B-NP B-m
0.125 CD O B-do
lasix NN B-NP B-m
80 CD O B-do
coreg NN B-NP B-m
6.25 CD O B-do
spironolactone NN B-NP B-m
50 CD O B-do
insulin NN B-NP B-m
insulin NN I-NP B-m
70/30 CD O I-m
70/30 CD O I-m
50qam CD O B-do
, , O O
35 CD O B-do
qpm NN B-NP B-f
NKDA NNP I-NP O
PMH NNP I-NP O
mi NN I-NP O
x3 NNP I-NP O
( ( O O
1993 CD O O
) ) O O
- : O O
? . B-VP O
cath NN B-NP O
, , O O
?inoperable JJ O O
, , O O
knows VBZ O O
he PRP O O
has VBZ O O
3v CD O O
dz NN B-NP O
htn NN I-NP O
chf NN I-NP O
gerd NN I-NP O
dm NN I-NP O
Shx NNP I-NP O
from IN B-VP O
U NNP B-NP O
Salosra NNP I-NP O
Scot NNP I-NP O
exsmoker NN I-NP O
quit VBD B-VP O
5y CD O O
pta NN B-NP O
no DT B-NP O
etoh NN I-NP O
, , O O
no DT B-NP O
ivdu NN I-NP O
FHx NNP I-NP O
brother NN I-NP O
died VBD B-VP O
of IN B-VP O
MI NNP B-NP O
10/22 CD O O
in IN B-VP O
50s CD O O
parents NNS B-NP O
died VBD B-VP O
of IN B-VP O
CAD NNP B-NP O
in IN B-VP O
70s/80s CD O O
htn NN B-NP O
, , O O
dm JJ B-NP O
studies NNS I-NP O
cxr VBP O O
6/10 CD O O
cardiomegaly NN B-NP O
, , O O
increased VBD B-VP O
interstitial JJ B-NP O
marking NN I-NP O
c/w NN I-NP O
pulm NN I-NP O
edema VBD B-VP O
ekg- JJ O O
nsr JJ O O
1 CD O O
degree NN B-NP O
avblock NN I-NP O
, , O O
nl JJ B-NP O
axis NN I-NP O
, , O O
q NN B-NP O
in IN B-VP O
v1-v3 NN B-NP O
, , O O
poor JJ B-NP O
r NN I-NP O
waves NNS I-NP O
in IN B-VP O
v4-v5 NN B-NP O
, , O O
T NNP B-NP O
inversion NN I-NP O
3 CD O O
, , O O
avf NN B-NP O
, , O O
biphasic JJ B-NP O
Ts NNP I-NP O
and CC O O
mild JJ B-NP O
depression NN I-NP O
( ( O O
&lt;0.5mm NN B-NP O
) ) O O
in IN B-VP O
v5 NN B-NP O
echo VBP O O
10/7 CD O O
-with JJ B-NP O
EF NNP I-NP O
20-25% CD O O
, , O O
wall DT B-NP O
motion NN I-NP O
abnl NN I-NP O
, , O O
dil NN B-NP O
ivc NN I-NP O
, , O O
tr NN B-NP O
, , O O
mr JJ B-NP O
evidence NN I-NP O
of IN B-VP O
ASD NNP B-NP O
seen VBN O O
Mibi NNP B-NP O
6/1 CD O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
reversible JJ B-NP O
ischemia NN I-NP O
assessment NN I-NP O
and CC O O
plan NN B-NP O
66yo CD O O
with IN B-VP O
cad/mi NN B-NP O
, , O O
dm NN B-NP O
, , O O
chf NN B-NP O
, , O O
admitted VBN O O
for IN B-VP O
chf JJ B-NP O
exacerbation NN I-NP O
and CC O O
r/o VB O O
MI NNP B-NP O
1.CV- JJ B-NP O
a. NN I-NP O
ischemia- JJ B-NP O
sig NN I-NP O
cad NN I-NP O
with IN B-VP O
hx NN B-NP O
of IN B-VP O
chest JJ B-NP O
presure NN I-NP O
at IN B-VP O
rest NN B-NP O
, , O O
ce VBP O O
-x2 JJ B-NP O
ekg NN I-NP O
abnl NN I-NP O
w/o NN I-NP O
priors NNS I-NP O
, , O O
concerning VBG O O
for IN B-VP O
unstable JJ B-NP B-r
angina NN I-NP I-r
given VBN O O
asa NNS B-NP B-m
, , O O
carvedilol NN B-NP B-m
( ( O O
changed VBN O O
to TO O O
lisinopril VB O B-m
5/26 CD O O
) ) O O
, , O O
lipitor NN B-NP B-m
, , O O
plavix NN B-NP B-m
and CC O O
started VBD B-VP O
on IN B-VP O
lovenox NN B-NP B-m
100 CD O B-do
sq NN B-NP B-mo
Lovenox NNP I-NP B-m
was VBD B-VP O
stopped VBN O O
when WRB O O
ce JJ O O
neg RB O O
x3 VBP O O
on IN B-VP O
10/7 CD O O
Lipid JJ B-NP O
panel NN I-NP O
ok NN I-NP O
, , O O
continue VBP O O
on IN B-VP O
lipitor NN B-NP B-m
80 CD O B-do
Has NNP B-NP O
been VBN O O
CP NNP B-NP O
free JJ O O
since IN B-VP O
Sunday NNP B-NP O
Stressed VBD B-VP O
on IN B-VP O
5/26 CD O O
, , O O
results NNS B-NP O
show VBP O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
reversible JJ B-NP O
ischemia NN I-NP O
and CC O O
pt NN B-NP O
has VBZ O O
had VBN O O
no DT B-NP O
CP NNP I-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
b.pump SYM O O
- : O O
chf NN B-NP O
exacerbation NN I-NP O
, , O O
likely RB O O
2/2 CD O O
not RB O O
taking VBG O O
meds NNS B-NP O
and CC O O
poor JJ B-NP O
diet JJ I-NP O
control NN I-NP O
will MD O O
txc VB O O
with IN B-VP O
lasix JJ O B-m
40iv CD O B-do
bid NN B-NP B-f
, , O O
goals NNS B-NP O
-1liter/day VBP O O
pt JJ O O
already RB O O
improving- JJ B-NP O
good JJ I-NP O
diuresis NN I-NP O
with IN B-VP O
lasix JJ O B-m
40iv CD O B-do
continue VBP O O
home NN B-NP O
spironolactone NN I-NP B-m
, , O O
restarted VBN O O
on IN B-VP O
home NN B-NP O
imdur NN I-NP B-m
ACEi NNP I-NP B-m
ACEi NNP I-NP B-m
started VBD B-VP O
and CC O O
increased VBD B-VP O
to TO O O
10mg CD O B-do
qd NNS B-NP B-f
fluid RB O O
restricted VBD B-VP O
to TO O O
2L CD O O
echo NNS B-NP O
10/7 CD O O
with IN B-VP O
EF NNP B-NP O
20-25% CD O O
, , O O
wall DT B-NP O
motion NN I-NP O
abnl NN I-NP O
, , O O
dil NN B-NP O
ivc NN I-NP O
, , O O
tr NN B-NP O
, , O O
mr NN B-NP O
Patient NNP I-NP O
has VBZ O O
diuresed VBN O O
well RB O O
during IN B-VP O
his PRP$ O O
time NN B-NP O
in IN B-VP O
house NN B-NP O
with IN B-VP O
a DT B-NP O
weight NN I-NP O
on IN B-VP O
dc NN B-NP O
of IN B-VP O
82 CD O O
kg.Continue NN B-NP O
on IN B-VP O
lasix JJ O B-m
80po CD O B-do
daily JJ B-NP B-f
c. NNS I-NP O
rhythm- JJ B-NP O
sinus NN I-NP O
, , O O
on IN B-VP O
tele NNS B-NP O
long JJ B-NP O
Pr NNP I-NP O
interval NN I-NP O
noted VBD B-VP O
, , O O
dig NN B-NP O
stopped VBD B-VP O
to TO O O
avoid VB O O
any DT B-NP O
additional JJ I-NP O
PR NNP I-NP O
prolongation NN I-NP O
may MD O O
need VB O O
EP NNP B-NP O
workup NN I-NP O
in IN B-VP O
the DT B-NP O
future JJ I-NP O
2.pulm- JJ I-NP O
cardiogenic JJ I-NP O
pulm NN I-NP O
edema NN I-NP O
, , O O
imprving VBG O O
sat VBD B-VP O
stable JJ O O
on IN B-VP O
RA NNP B-NP O
continue VBP O O
diuresis NN B-NP O
On IN B-VP O
room NN B-NP O
air NN I-NP O
throughout IN B-VP O
his PRP$ O O
time NN B-NP O
in IN B-VP O
house NN B-NP O
, , O O
appears VBZ O O
very RB O O
comfortable JJ O O
3. CD O O
GI- JJ B-NP O
mild JJ I-NP O
transaminitis- NNS I-NP O
decreased VBN O O
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
his PRP$ O O
time NN B-NP O
here RB O O
and CC O O
normal JJ B-NP O
AST/ALT/Tbili NNP I-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
discharge NN B-NP O
Alk NNP I-NP O
phos NN I-NP O
contiues NNS I-NP O
to TO O O
be VB O O
elevated VBN O O
at IN B-VP O
175 CD O O
Will NNP B-NP O
need VBP O O
pcp NNS B-NP O
follow VB O O
up RP O O
evaluation NN B-NP O
, , O O
but CC O O
no DT B-NP O
abdominal JJ I-NP O
complaints NNS I-NP O
4.Heme- JJ O O
on IN B-VP O
lovenox NN B-NP O
for IN B-VP B-m
UA NNP B-NP O
, , O B-r
transitioned VBD B-VP O
to TO O O
SC NNP B-NP O
DVT NNP I-NP O
ppx NN I-NP O
dosing VBG O O
on IN B-VP O
10/7 CD O O
, , O O
on IN B-VP O
plavix NN B-NP B-m
for IN B-VP O
? . B-VP O
stent NN B-NP B-r
Will NNP I-NP O
continue VBP O O
on IN B-VP O
plavix NN B-NP B-m
and CC O O
asa NN B-NP B-m
as IN B-VP O
outpt JJ B-NP O
5.endo- JJ I-NP O
nph NN I-NP O
18 CD O B-m
18 CD O B-m
18 CD O B-m
bid NN B-NP B-do
for IN B-VP B-f
now RB O O
( ( O O
inc NN B-NP O
from IN B-VP O
home NN B-NP O
10 CD O O
) ) O B-do
, , O O
6u CD O O
ac NN B-NP B-do
and CC O B-mo
ss NN B-NP O
hgb NN I-NP O
a1c IN B-VP O
10.4- JJ O O
indicating VBG O O
need NN B-NP O
for IN B-VP O
tighter JJR B-NP B-r
tighter NN I-NP B-r
tighter NN I-NP B-r
glucose VBP O I-r
glucose JJ B-NP I-r
glucose JJ I-NP I-r
control NN I-NP I-r
control NN I-NP I-r
control NN I-NP I-r
He PRP O O
will MD O O
go VB O O
home NN B-NP O
on IN B-VP O
an DT O B-do
increased VBN O I-do
dose NN B-NP I-do
on IN B-VP O
NPH NNP B-NP B-m
and CC O O
advised VBD B-VP O
to TO O O
keep VB O O
tight JJ B-NP O
control NN I-NP O
over IN B-VP O
his PRP$ O B-r
blood NN B-NP O
sugar NN I-NP O
6.msk- JJ B-NP O
c/o NN I-NP O
left VBD B-VP O
foot NN B-NP O
pain NN I-NP O
, , O O
unclear JJ B-NP O
source NN I-NP O
xray NNP I-NP O
final JJ B-NP O
read NN I-NP O
shows NNS I-NP O
degenerative VBP O O
changes NNS B-NP O
able JJ O O
to TO O O
doppler VB O O
DPs NNP B-NP O
? . B-VP O
claudication? NN B-NP O
Patient NNP I-NP O
is VBZ O O
pain JJ O O
free JJ O O
now RB O O
7.fen- JJ B-NP O
ada NN I-NP O
, , O O
cardiac JJ B-NP O
diet NN I-NP O
Lytes NNP I-NP O
repleted VBD B-VP O
while IN B-VP O
in IN B-VP O
house NN B-NP O
, , O O
all DT O O
normal JJ O O
on IN B-VP O
discharge NN B-NP O
8.Patient CD O O
is VBZ O O
staible JJ O O
for IN B-VP O
discharge NN B-NP O
home NN I-NP O
He PRP O O
will MD O O
need VB O O
to TO O O
followup VB O O
with IN B-VP O
cardiology NN B-NP O
as IN B-VP O
an DT B-NP O
outpt JJ I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
take VBP O O
all DT O O
your PRP$ O B-m
medications NNS B-NP B-m
medications NNS I-NP I-m
as IN B-VP O
directed JJ O O
2 CD O O
Weigh NNP B-NP O
yourself PRP O O
daily RB O O
, , O O
if IN B-VP O
you PRP O O
start VBP O O
to TO O O
gain VB O O
weight NN B-NP O
( ( O O
even RB O O
5 CD O O
pounds NNS B-NP O
) ) O O
, , O O
you PRP O O
need VBP O O
to TO O O
contact VB O O
your PRP$ O O
doctor NN B-NP O
about IN B-VP O
increasing VBG O O
your PRP$ O O
lasix NN B-NP B-m
dose VBD B-VP O
3 CD O O
Follow NNP B-NP O
up RB O O
with IN B-VP O
cardiology NN B-NP O
as IN B-VP O
directed JJ O O
4 CD O O
check NN B-NP O
you PRP O O
blood VBP O B-r
sugars NNS B-NP I-r
in IN B-VP O
the DT B-NP O
morning NN I-NP O
and CC O O
with IN B-VP O
meals NNS B-NP O
adjust VBP O O
your PRP$ O O
insulin NN B-NP B-m
as IN B-VP B-f
needed VBN O I-f
dr NN B-NP O
erick NN I-NP O
bedaw NN I-NP O
at IN B-VP O
carlekadl JJ B-NP O
rine JJ I-NP O
calccal JJ I-NP O
memorial JJ I-NP O
hospital NN I-NP O
of IN B-VP O
county NN B-NP O
will MD O O
be VB O O
following VBG O O
his PRP$ O O
blood NN B-NP O
sugars NNS I-NP O
5 CD O O
get VBP O O
a DT B-NP O
recheck NN I-NP O
of IN B-VP O
your PRP$ O O
lfts NNS B-NP O
as IN B-VP O
an DT B-NP O
outpt NN I-NP O
, , O O
your PRP$ O O
Alk NNP B-NP O
Phos NNP I-NP O
and CC O O
GGT NNP B-NP O
were VBD B-VP O
elevated VBN O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
take VBP O O
all DT O O
your PRP$ O B-m
medications NNS B-NP B-m
medications NNS I-NP I-m
as IN B-VP O
directed JJ O O
2 CD O O
Weigh NNP B-NP O
yourself PRP O O
daily RB O O
, , O O
if IN B-VP O
you PRP O O
start VBP O O
to TO O O
gain VB O O
weight NN B-NP O
( ( O O
even RB O O
5 CD O O
pounds NNS B-NP O
) ) O O
, , O O
you PRP O O
need VBP O O
to TO O O
contact VB O O
your PRP$ O O
doctor NN B-NP O
about IN B-VP O
increasing VBG O O
your PRP$ O O
lasix NN B-NP B-m
dose VBD B-VP B-do
3 CD O O
Follow NNP B-NP O
up RB O O
with IN B-VP O
cardiology NN B-NP O
as IN B-VP O
directed JJ B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
DONNA NNP I-NP O
, , O O
EMMANUEL NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
( ( O O
YH225 NNP B-NP O
) ) O O
8/4/06 CD O O
@ $ O O
12:54 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#681606 VBZ O O
765120422 CD O O
COH NNP B-NP O
85296554 CD O O
3810112 CD O O
9/8/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
asthma JJ B-NP O
exacerbation NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/24/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
0/12/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
RUMBLE NNP I-NP O
, , O O
LUPE NNP B-NP O
646-77-20-0 CD O O
Washington NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
5/1/06 CD O O
AT NNP B-NP O
01:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KOETS NNP I-NP O
, , O O
LEN NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ALBUTEROL NNP I-NP B-m
INHALER NNP I-NP I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
ALBUTEROL NNP I-NP B-m
ALBUTEROL NNP I-NP B-m
NEBULIZER NNP I-NP I-m
NEBULIZER NNP I-NP I-m
2.5 CD O B-do
2.5 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
NEB NNP I-NP B-mo
NEB NNP I-NP B-mo
Q4H NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
5/12 CD O O
) ) O O
PRN NNP B-NP O
Shortness NNP I-NP B-r
of IN B-VP I-r
Breath NNP B-NP I-r
, , O O
Wheezing NNP B-NP B-r
ADVAIR NNP I-NP B-m
DISKUS NNP I-NP I-m
500/50 CD O I-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE/ NNP I-NP I-m
) ) O I-m
1 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
COMBIVENT NNP I-NP B-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
AND NNP I-NP I-m
ALBUTEROL NNP I-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
TID NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/10/06 CD O O
by IN B-VP O
SICKEL NNP B-NP O
, , O O
SON NNP B-NP O
ORVILLE NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
108524680 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
SINGULAIR NNP I-NP B-m
( ( O I-m
MONTELUKAST NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
PREDNISONE NNP I-NP B-m
Taper NNP I-NP I-m
Taper NNP I-NP I-m
Taper NNP I-NP I-m
Taper NNP I-NP I-m
Taper NNP I-NP I-m
Taper NNP I-NP I-m
Taper NNP I-NP I-m
Taper NNP I-NP I-m
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP B-mo
Give NNP I-NP O
60 CD O B-do
60 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
q NN I-NP B-f
q VBD B-VP B-f
24 CD O I-f
24 CD O I-f
h NN B-NP I-f
h NN I-NP I-f
X NNP I-NP B-du
X NNP I-NP I-f
2 CD O I-du
2 CD O I-f
dose( NN B-NP I-du
dose( NN I-NP I-f
s NN I-NP I-du
s NN I-NP I-f
) ) O I-du
) ) O I-f
, , O O
then RB O O
Give VB O O
50 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
3 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
40 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
3 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
30 CD O B-do
30 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
q NN I-NP B-f
q VBD B-VP B-f
24 CD O I-f
24 CD O I-f
h NN B-NP I-f
h NN I-NP I-f
X NNP I-NP B-du
X NNP I-NP I-f
X NNP I-NP B-du
3 CD O I-du
3 CD O I-f
3 CD O I-du
dose( NN B-NP I-du
dose( NN I-NP I-du
s NN I-NP I-du
s NN I-NP I-du
) ) O I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
20 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
3 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Give VB O O
10 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
24 CD O I-f
h NN B-NP I-f
X NNP I-NP B-du
2 CD O I-du
dose( NN B-NP I-du
s NN I-NP I-du
) ) O I-du
, , O O
then RB O O
Starting VBG O O
IN NNP B-NP O
AM NNP I-NP O
( ( O O
7/21 CD O O
) ) O O
DIET: NNP B-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Activity NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Please NNP I-NP O
arrange NN I-NP O
to TO O O
see VB O O
Dr NNP B-NP O
Minium NNP I-NP O
by IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
week NN I-NP O
, , O O
ALLERGY: NNP B-NP O
AMOX./CLAV.ACID NNP I-NP O
250/125 CD O O
, , O O
Codeine NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Asthma NNP I-NP O
exacerbation NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
asthma VBP O O
exacerbation NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
asthma NN I-NP O
( ( O O
asthma NN B-NP O
) ) O O
HTN NNP B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
HTN NNP B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
hyperglycemia NN B-NP O
on IN B-VP O
steriods NNS B-NP O
( ( O O
elevated VBN O O
glucose RB O O
) ) O O
hirsutism NN B-NP O
( ( O O
hirsutism NN B-NP O
) ) O O
spinal JJ B-NP O
stenosis NN I-NP O
( ( O O
spinal JJ B-NP O
stenosis NN I-NP O
) ) O O
LBP NNP B-NP O
( ( O O
low JJ O O
back RB O O
pain NN B-NP O
) ) O O
chiari NN B-NP O
malformation NN I-NP O
spinal JJ B-NP O
syrinx NN I-NP O
C3-T2 NNP I-NP O
( ( O O
8 CD O O
) ) O O
OPERATIONS NN B-NP O
AND CC O O
PROCEDURES: NNP B-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
42 CD O O
yo NN B-NP O
F NNP I-NP O
w/ NN I-NP O
h/o NN I-NP O
asthma NN I-NP O
p/w NN I-NP O
SOB NNP I-NP O
in IN B-VP O
setting NN B-NP O
of IN B-VP O
recent JJ B-NP O
asthma NN I-NP O
flare NN I-NP O
****************** NNP I-NP O
Pt NNP I-NP O
was VBD B-VP O
in IN B-VP O
her PRP$ O O
USOH NNP B-NP O
until IN B-VP O
1wk CD O O
PTA NNS B-NP O
when WRB O O
experienced VBN O O
URI NNP B-NP O
sx NN I-NP O
, , O O
productive JJ B-NP O
cough NN I-NP O
and CC O O
low JJ B-NP O
grade NN I-NP O
fevers NNS I-NP O
Seen NNP I-NP O
at IN B-VP O
Tasleyka NNP B-NP O
Medical NNP I-NP O
where WRB O O
rx'd NN B-NP O
with IN B-VP O
nebs NNS B-NP B-m
, , O O
steroids NNS B-NP B-m
and CC O O
d/c'd NN B-NP O
on IN B-VP O
pred JJ O B-m
taper IN B-VP O
starting VBG O O
at IN B-VP O
40mg CD O B-do
qd NN B-NP B-f
Pt NNP I-NP O
was VBD B-VP O
told VBN O O
that IN B-VP O
her PRP$ O O
CXR NNP B-NP O
was VBD B-VP O
c/w JJ B-NP O
PNA NNP I-NP O
Also RB O O
rx'd VBD B-VP O
Z-pack NNP B-NP B-m
which WDT O O
she PRP O O
has VBZ O O
completed VBN O O
Cough NNP B-NP O
and CC O O
URI NNP B-NP O
sx NNS I-NP O
have VBP O O
improved VBN O O
but CC O O
she PRP O O
has VBZ O O
had VBN O O
persistent JJ B-NP O
DOE NNP I-NP O
Peak NNP I-NP O
flow NN I-NP O
has VBZ O O
been VBN O O
150 CD O O
, , O O
decreased VBN O O
from IN B-VP O
baseline NN B-NP O
of IN B-VP O
300-350 JJ B-NP O
Seen NNP I-NP O
in IN B-VP O
TNH NNP B-NP O
urgent JJ B-NP O
care NN I-NP O
today NN I-NP O
where WRB O O
reportedly RB O O
she PRP O O
was VBD B-VP O
hypertensive JJ O O
and CC O O
O2 NNP B-NP O
sat VBD B-VP O
94-95% CD O O
on IN B-VP O
RA NNP B-NP O
, , O O
referred VBD B-VP O
to TO O O
OAKMA NNP B-NP O
VALLEY NNP I-NP O
HOSPITAL NNP I-NP O
for IN B-VP O
asthma NN B-NP O
flare NN I-NP O
refractory NN I-NP O
to TO O O
current JJ B-NP O
treatment NN I-NP O
No NNP I-NP O
CP NNP I-NP O
, , O O
HA NNP B-NP O
or CC O O
focal JJ B-NP O
neurological JJ I-NP O
deficits NNS I-NP O
Pt NNP I-NP O
c/o NN I-NP O
+increased VBD B-VP O
LE NNP B-NP O
edema NN I-NP O
L&gt;R NNP I-NP O
, , O O
+orthopnea NNP B-NP O
, , O O
and CC O O
+PND VBZ O O
No DT B-NP O
sick JJ I-NP O
contacts NNS I-NP O
**** VBP O O
ED: NNP B-NP O
97.4 CD O O
p126 NN B-NP O
181/95 CD O O
30 CD O O
94% CD O O
RA NNP B-NP O
, , O O
CXR NNP B-NP O
and CC O O
EKG NNP B-NP O
performed VBD B-VP O
, , O O
rx'd VB O O
prednisone NN B-NP B-m
60mg CD O B-do
x1 NN B-NP B-f
, , O O
nebs JJ B-NP B-mo
************** NNP I-NP O
PMH: NNP I-NP O
Asthma NNP I-NP B-r
- : O O
no DT B-NP O
h/o JJ I-NP O
intubation NN I-NP O
, , O O
multiple JJ B-NP O
admissions NNS I-NP O
and CC O O
courses NNS B-NP O
of IN B-VP O
steroids NNS B-NP B-m
, , O O
HTN NNP B-NP O
, , O O
Obesity NNP B-NP O
, , O O
Hyperlipidemia NNP B-NP O
, , O O
Hyperglycemia NNP B-NP O
- : O O
when WRB O O
on IN B-VP O
steroids NNS B-NP B-m
, , O O
Hirsutism NNP B-NP O
, , O O
Chiari NNP B-NP O
Malformation NNP I-NP O
- : O O
s/p NN B-NP O
decompression NN I-NP O
, , O O
Spinal NNP B-NP O
Stenosis NNP I-NP O
, , O O
Spinal NNP B-NP O
Syrinx NNP I-NP O
- : O O
C3-T2 JJ O O
, , O O
Low NNP B-NP B-r
back RB O I-r
pain VBP O I-r
- : O O
s/p NN B-NP O
multiple JJ B-NP O
epidural JJ I-NP B-mo
steroid NN I-NP B-m
injections NNS I-NP O
************* VBP O O
MEDS: NNP B-NP O
prednisone NN I-NP B-m
30mg CD O B-do
qd NN B-NP B-f
( ( O O
taper NN B-NP O
) ) O O
, , O O
advair NN B-NP B-m
, , O O
albuterol NN B-NP B-m
, , O O
combivent NN B-NP B-m
, , O O
singulair NN B-NP B-m
, , O O
lisinopril JJ B-NP B-m
*********** NNP I-NP O
EXAM: NNP I-NP O
Afeb NNP I-NP O
p104 VBD B-VP O
199/104 CD O O
rr25 NN B-NP O
96% CD O O
2L CD O O
Pt NNP B-NP O
appeared VBD B-VP O
in IN B-VP O
mild JJ B-NP O
respiratory NN I-NP O
distress NN I-NP O
, , O O
sitting VBG O O
up RP O O
reading VBG O O
a DT B-NP O
book NN I-NP O
, , O O
very RB O O
pleasant JJ B-NP O
obese JJ I-NP O
woman NN I-NP O
HEENT: NNP I-NP O
JVP NNP I-NP O
not RB O O
elevated VBD B-VP O
LUNGS: NNP B-NP O
prolonged VBD B-VP O
expiratory JJ B-NP O
phase NN I-NP O
CVS: NNP I-NP O
rrr NN I-NP O
, , O O
nl JJ B-NP O
S1S2 NNP I-NP O
, , O O
no DT B-NP O
m/g/r NN I-NP O
ABD: NNP I-NP O
obese NN I-NP O
, , O O
BS+ NNP B-NP O
, , O O
NT/ND NNP B-NP O
EXT: NNP I-NP O
TR NNP I-NP O
to TO O O
1+ CD O O
edema NN B-NP O
to TO O O
mid VB O O
calf NN B-NP O
bilat NN I-NP O
, , O O
L&gt;R NNP B-NP O
*************** NNP I-NP O
LABS: NNP I-NP O
WBC NNP I-NP O
14 CD O O
STUDIES: NNP B-NP O
EKG: NNP I-NP O
sinus VBD B-VP O
tach $ O O
104 CD O O
CXR( NNP B-NP O
: : O O
linear JJ B-NP O
opacity NN I-NP O
in IN B-VP O
RLL NNP B-NP O
most JJS O O
c/w VBP O O
platelike JJ B-NP O
atelectasis NN I-NP O
but CC O O
cannot NN B-NP O
r/o NN I-NP O
resolving VBG O O
or CC O O
new JJ B-NP O
PNA NNP I-NP O
*************** NNP I-NP O
HOSITAL NNP I-NP O
COURSE: NNP I-NP O
42 CD O O
yo NN B-NP O
F NNP I-NP O
w/ NN I-NP O
asthma NN I-NP O
and CC O O
tobacco NN B-NP O
use NN I-NP O
presents NNS I-NP O
with IN B-VP O
asthma/COPD JJ B-NP O
flare NN I-NP O
refractory NN I-NP O
to TO O O
initial JJ B-NP O
treatment NN I-NP O
* NNP I-NP O
PULM: NNP I-NP O
SOB NNP I-NP O
most RBS O O
likely JJ O O
2/2 CD O O
reactive JJ B-NP O
airway NN I-NP O
disease NN I-NP O
Substantial NNP I-NP O
smoking VBG O O
history NN B-NP O
raises VBZ O O
question NN B-NP O
of IN B-VP O
COPD NNP B-NP O
as IN B-VP O
contributor NN B-NP O
or CC O O
dominant JJ B-NP O
factor NN I-NP O
in IN B-VP O
her PRP$ O O
pulmonary JJ B-NP O
disease NN I-NP O
Pt NNP I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
duonebs JJ B-NP B-m
q4h NN I-NP B-f
with IN B-VP O
Albuterol NNP B-NP B-m
q2h VBP O B-f
prn NN B-NP I-f
Pt NNP I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
advair NN B-NP B-m
, , O O
singulair NN B-NP B-m
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Prednisone NNP B-NP B-m
60 CD O B-do
daily RB O B-f
for IN B-VP B-du
4 CD O I-du
days NNS B-NP I-du
and CC O O
then RB O O
slowy VB O O
tapered VBD B-VP O
No DT B-NP O
abx NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
as IN B-VP O
she PRP O O
just RB O O
completed VBD B-VP O
course NN B-NP O
WBC NNP I-NP O
elevation NN I-NP O
likely RB O O
2/2 CD O O
steroids NNS B-NP B-m
At IN B-VP O
D/C NNP B-NP O
, , O O
peak NN B-NP O
flow NN I-NP O
had VBD B-VP O
improved VBN O O
to TO O O
250 CD O O
and CC O O
ambulating VBG O O
O2 NNP B-NP O
sat NN I-NP O
was VBD B-VP O
92-94% JJ B-NP O
Pt's NNP I-NP O
breathing NN I-NP O
had VBD B-VP O
significantly RB O O
improved VBN O O
Smoking NNP B-NP B-r
cessation NN I-NP I-r
encouraged VBD B-VP O
Pt NNP B-NP O
was VBD B-VP O
interested JJ O O
in IN B-VP O
trying VBG O O
nicotine JJ B-NP B-m
patch NN I-NP I-m
* NNP I-NP O
CV: NNP I-NP O
PUMP: NNP I-NP O
HTN: NNP I-NP O
Lisinopril NNP I-NP B-m
Lisinopril NNP I-NP B-m
was VBD B-VP O
increased VBN O O
to TO O O
20mg CD O B-do
daily RB O B-f
due JJ O O
to TO O O
hypertension VB O B-r
hypertension NN B-NP B-r
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
end-organ JJ B-NP O
damage NN I-NP O
in IN B-VP O
w/u JJ B-NP O
UA NNP I-NP O
neg NN I-NP O
for IN B-VP O
proteinuria NN B-NP O
* NNP I-NP O
PPX: NNP I-NP O
lovenox NN I-NP B-m
CODE: NNP I-NP O
full JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
1 CD O O
) ) O O
Continue NNP B-NP O
all DT O O
of IN B-VP O
your PRP$ O O
home NN B-NP B-m
medications NNS I-NP I-m
Your VBP O O
lisinopril JJ B-NP B-m
lisinopril NN I-NP B-m
was VBD B-VP O
increased VBN O O
to TO O O
20mg CD O B-do
daily RB O B-f
2 CD O O
) ) O O
Take VB O O
prednisone NN B-NP B-m
prednisone NN I-NP B-m
prednisone NN I-NP B-m
prednisone NN I-NP B-m
prednisone NN I-NP B-m
prednisone NN I-NP B-m
60mg CD O B-do
daily NN B-NP B-f
for IN B-VP B-du
2 CD O I-du
days NNS B-NP I-du
( ( O O
starting VBG O O
tomorrow NN B-NP O
) ) O O
, , O O
then RB O O
50mg CD O B-do
daily JJ O B-f
x RB O B-du
3days CD O I-du
, , O O
then RB O O
40mg CD O B-do
daily JJ B-NP B-f
x3 NNP I-NP B-du
days NNS I-NP I-du
, , O O
then RB O O
30mg CD O B-do
daily JJ O B-f
x RB O B-du
3days CD O I-du
, , O O
then RB O O
20mg CD O B-do
daily JJ B-NP B-f
x3 NNP I-NP B-du
days NNS I-NP I-du
, , O O
and CC O O
then RB O O
10mg CD O B-do
daily JJ B-NP B-f
x2 NNP I-NP B-du
days NNS I-NP I-du
and CC O O
stop VB O O
3 CD O O
) ) O O
Please NNP B-NP O
arrnge NN I-NP O
to TO O O
see VB O O
Dr NNP B-NP O
Portune NNP I-NP O
by IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
week NN I-NP O
She PRP O O
will MD O O
advise VB O O
you PRP O O
of IN B-VP O
any DT B-NP O
change NN I-NP O
in IN B-VP O
your PRP$ O O
prednisone NN B-NP B-m
taper IN B-VP O
4 CD O O
) ) O O
Call VB O O
Dr NNP B-NP O
Schmatz NNP I-NP O
or CC O O
come VBN O O
back RB O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
if IN B-VP O
you PRP O O
experience VBP O O
worsening VBG O O
of IN B-VP O
your PRP$ O O
breathing NN B-NP O
or CC O O
fever VB O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
** NNP I-NP O
Dr NNP I-NP O
Tremmel NNP I-NP O
** NNP I-NP O
Please NNP I-NP O
taper VB O O
prednisone NN B-NP B-m
as IN B-VP O
tolerated VBN O O
by IN B-VP O
patient JJ B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
DANIELS NNP I-NP O
, , O O
BOB NNP B-NP O
T NNP I-NP O
( ( O O
GN51 NNP B-NP O
) ) O O
5/1/06 CD O O
@ $ O O
12:40 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#683679 VBZ O O
315194766 CD O O
TH NNP B-NP O
10418500 CD O O
1689655 CD O O
1/27/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHF NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/24/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/25/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SWARR NNP I-NP O
, , O O
BLAKE NNP B-NP O
R NNP I-NP O
752-23-91-8 JJ B-NP O
Ma NNP I-NP O
Service: NNP I-NP O
RNM NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/27/06 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
SWEEDEN NNP I-NP O
, , O O
JOHNATHON NNP B-NP O
PERCY NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ASPIRIN NNP I-NP B-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Instructions: NNP I-NP O
At IN B-VP O
12 CD O O
noon NN B-NP O
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Instructions: NNP I-NP O
take VB O O
at IN B-VP O
noon RB O O
COLESTIPOL NNP B-NP B-m
HYDROCHLORIDE NNP I-NP I-m
10 CD O B-do
GM NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Instructions: NNP I-NP O
At IN B-VP O
6PM CD O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
before IN B-VP O
meals NNS B-NP O
Monitor NNP I-NP O
fat VBD B-VP O
soluble JJ B-NP O
vitamins NNS I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
5 CD O B-du
INSULIN NNP B-NP B-m
GLARGINE NNP I-NP I-m
14 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
DAILY NNP I-NP B-f
HUMALOG NNP I-NP B-m
HUMALOG NNP I-NP B-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
( ( O I-m
( ( O I-m
INSULIN NNP B-NP I-m
INSULIN NNP I-NP I-m
LISPRO NNP I-NP I-m
LISPRO NNP I-NP I-m
) ) O I-m
) ) O I-m
Sliding VBG O B-do
Sliding VBG O B-do
Scale NNP B-NP I-do
Scale NNP I-NP I-do
( ( O O
subcutaneous JJ O B-mo
subcutaneous JJ O B-mo
) ) O I-mo
) ) O I-mo
SC NNP B-NP I-mo
SC NNP I-NP I-mo
AC NNP I-NP B-f
Instructions: NNP I-NP O
pt NN I-NP O
takes VBZ O O
his PRP$ O O
own JJ B-NP O
scale NN I-NP O
Low NNP I-NP O
Scale NNP I-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
less JJR O O
than IN B-VP O
60 CD O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
DO NNP B-NP O
NOT NNP I-NP O
Administer NNP I-NP O
supplemental NN I-NP O
( ( O O
sliding VBG O O
scale NN B-NP O
) ) O O
insulin NN B-NP O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
0 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
1 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
2 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
3 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
4 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
5 CD O O
units NNS B-NP O
subcutaneously RB O O
Call NNP B-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
350 CD O O
Please NNP B-NP O
give VB O O
at IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
and CC O O
in IN B-VP O
addition NN B-NP O
to TO O O
standing VBG O O
mealtime JJ B-NP O
insulin NN I-NP O
IMDUR NNP I-NP B-m
ER NNP I-NP I-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONITRATE NNP I-NP I-m
( ( O I-m
SR NNP B-NP I-m
) ) O I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;100 NN I-NP O
, , O O
please NN B-NP O
hold VB O O
prior JJ O O
to TO O O
dialysis VB O O
Instructions: NNP B-NP O
12 CD O O
noon NN B-NP O
, , O O
unless IN B-VP O
patient NN B-NP O
is VBZ O O
at IN B-VP O
dialysis NN B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
KLOR-CON NNP B-NP B-m
( ( O I-m
KCL NNP B-NP I-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
20 CD O B-do
MEQ NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
As IN B-VP O
per IN B-VP O
IMC NNP B-NP O
Potassium NNP I-NP B-m
Chloride NNP I-NP I-m
Policy: NNP I-NP O
each DT O O
20 CD O B-do
mEq NNS B-NP I-do
dose VB O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4 CD O O
oz NNS B-NP O
of IN B-VP O
fluid NN B-NP O
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;100 VBD B-VP O
or CC O O
hr&lt;60 NN B-NP O
and CC O O
notify VB O O
HO NNP B-NP O
if IN B-VP O
holding VBG O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
5 CD O O
FLOMAX NNP B-NP B-m
( ( O I-m
TAMSULOSIN NNP B-NP I-m
) ) O I-m
0.4 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Instructions: NNP I-NP O
At IN B-VP O
12 CD O O
noon NN B-NP O
TORSEMIDE NNP I-NP B-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;100 NN I-NP O
and CC O O
notify VB O O
HO NNP B-NP O
if IN B-VP O
holding VBG O O
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
2 CD O O
gm NN B-NP O
Na NNP I-NP O
/ VBZ O O
2 CD O O
gram NN B-NP O
K+ NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
LH NNP I-NP O
dialysis NN I-NP O
unit NN I-NP O
Monday NNP I-NP O
6/30 CD O O
10:30am CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
, , O O
LISINOPRIL NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CHF NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CHF NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
ESRD NNP I-NP O
, , O O
PVD NNP B-NP O
, , O O
CAD NNP B-NP O
s/p VBD B-VP O
3MIs CD O O
3vCABG CD O O
, , O O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
25% CD O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
4/10 CD O O
placement NN B-NP O
of IN B-VP O
tunneled JJ B-NP O
catheter NN I-NP O
in IN B-VP O
RIJ NNP B-NP O
1/19 CD O O
Hemodialysis NNP B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
admitted VBD B-VP O
for IN B-VP O
HD NNP B-NP O
initiation NN I-NP O
****** NNP I-NP O
HPI: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
54 JJ I-NP O
yo NN I-NP O
male NN I-NP O
with IN B-VP O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
with IN B-VP O
EF NNP B-NP O
25% CD O O
, , O O
severe JJ B-NP O
pulmonary JJ I-NP O
HTN NNP I-NP O
, , O O
and CC O O
chronic JJ B-NP O
kidney NN I-NP O
disease NN I-NP O
bl VBD B-VP O
Cr NNP B-NP O
2.5 CD O O
who WP O O
was VBD B-VP O
admitted VBN O O
3 CD O O
weeks NNS B-NP O
ago RB O O
to TO O O
MSCH NNP B-NP O
for IN B-VP O
CHF NNP B-NP O
and CC O O
diuresis NN B-NP O
He PRP O O
was VBD B-VP O
begun VBN O O
on IN B-VP O
metolazone NN B-NP B-m
on IN B-VP O
as IN B-VP B-f
needed JJ B-NP I-f
basis NN I-NP O
for IN B-VP O
weight NN B-NP O
, , O O
but CC O O
presented VBD B-VP O
to TO O O
ED NNP B-NP O
with IN B-VP O
Cr NNP B-NP O
5.1 CD O O
and CC O O
looking VBG O O
dehydrated VBD B-VP O
He PRP O O
was VBD B-VP O
volume NN B-NP O
resuscitated VBN O O
with IN B-VP O
creatinine NN B-NP O
decreasing VBG O O
to TO O O
3.9 CD O O
Metolazone NNP B-NP B-m
was VBD B-VP O
held VBN O O
on IN B-VP O
d/c NN B-NP O
with IN B-VP O
Cr NNP B-NP O
dec NN I-NP O
to TO O O
3.4 CD O O
, , O O
but CC O O
pt RB O O
appeared VBD B-VP O
at IN B-VP O
renal JJ B-NP O
clinic NN I-NP O
on IN B-VP O
2/3 CD O O
with IN B-VP O
extreme JJ B-NP O
SOB NNP I-NP O
and CC O O
inability NN B-NP O
to TO O O
sleep VB O O
at IN B-VP O
night NN B-NP O
Pt NNP I-NP O
has VBZ O O
DOE NNP B-NP O
+orthopnea NNP I-NP O
, , O O
sleeps VBZ O O
in IN B-VP O
chair NN B-NP O
Denies NNP I-NP O
any DT B-NP O
CP NNP I-NP O
or CC O O
dizziness NN B-NP O
BUN/Cr NNP I-NP O
102/3.3 CD O O
Due NNP B-NP O
to TO O O
the DT B-NP O
pt's NN I-NP O
difficult JJ O O
to TO O O
control VB O O
volume NN B-NP O
status NN I-NP O
, , O O
pt JJ B-NP O
underwent JJ I-NP O
14-french JJ I-NP O
double JJ I-NP O
IJ NNP I-NP O
TC NNP I-NP O
placement NN I-NP O
today NN I-NP O
in IN B-VP O
IR NNP B-NP O
Presently NNP I-NP O
, , O O
he PRP O O
is VBZ O O
complaining VBG O O
of IN B-VP O
soreness NN B-NP O
at IN B-VP O
the DT B-NP O
R NNP I-NP O
tunnel NN I-NP O
catheter NN I-NP O
site NN I-NP O
Denies NNPS I-NP O
CP NNP I-NP O
but CC O O
has VBZ O O
some DT B-NP O
SOB NNP I-NP O
Planned VBD B-VP O
for IN B-VP O
HD NNP B-NP O
tomorrow NN I-NP O
AM NNP I-NP O
****** NNP I-NP O
PMH: NNP I-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
3v CD O O
CABG NNP B-NP O
1996; CD O O
PVD NNP B-NP O
s/p NN I-NP O
R NNP I-NP O
AKA NNP I-NP O
s/p JJ B-NP O
bilateral JJ I-NP O
femoral-popliteal NN I-NP O
and CC O O
bypass NN B-NP O
graft; NN I-NP O
DM NNP I-NP O
type NN I-NP O
1 CD O O
x NN B-NP O
44 CD O O
yrs NN B-NP O
, , O O
c/b JJ B-NP O
diabetic JJ I-NP O
nephropathy NN I-NP O
, , O O
diabetic JJ B-NP O
retinopathy NN I-NP O
, , O O
and CC O O
diabetic JJ B-NP O
neuropathy; NN I-NP O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
with IN B-VP O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
25% CD O O
to TO O O
30% CD O O
, , O O
severe JJ B-NP O
pulmonary JJ I-NP O
hypertension NN I-NP O
, , O O
BPH NNP B-NP O
, , O O
lactose JJ B-NP O
intolerance NN I-NP O
, , O O
COPD NNP B-NP O
, , O O
Right NNP B-NP O
hydronephrosis NN I-NP O
secondary JJ O O
to TO O O
a DT B-NP O
right JJ I-NP O
ureteral JJ I-NP O
stricture NN I-NP O
Bilateral NNP I-NP O
renal JJ B-NP O
artery NN I-NP O
stenosis NN I-NP O
****** NNP I-NP O
ALLERGIES: NNP I-NP O
penicillin NN I-NP O
causes VBZ O O
rash JJ B-NP O
****** JJ I-NP O
Medications NNS I-NP O
at IN B-VP O
home: NN B-NP O
Aspirin NNP I-NP B-m
81 CD O B-do
qd NN B-NP B-f
, , O O
torsemide RB O B-m
150 CD O B-do
qd NN B-NP B-f
, , O O
lipitor NN B-NP B-m
10 CD O B-do
, , O O
imdur NN B-NP B-m
ER NNP I-NP I-m
60 CD O B-do
, , O O
zemplar JJ O B-m
1mg CD O B-do
daily RB O B-f
, , O O
klorcon NN B-NP B-m
slow JJ B-NP I-m
release NN I-NP I-m
20 CD O B-do
mEq JJ O I-do
daily RB O B-f
, , O O
Flomax NNP B-NP B-m
0.4 CD O B-do
qd NN B-NP B-f
, , O O
colestipol VBP O B-m
1g CD O B-do
qd NN B-NP B-f
, , O O
toprol-XL JJ O B-m
50 CD O B-do
qhs NN B-NP B-f
, , O O
lantus VBZ O B-m
14 CD O B-do
unit NN B-NP I-do
sc NN I-NP B-mo
, , O O
humalog NN B-NP B-m
scale NN I-NP O
, , O O
metolazone RB O B-m
5mg CD O B-do
as IN B-VP B-f
needed VBN O O
****** NN B-NP O
ADMISSION NNP I-NP O
EXAM: NNP I-NP O
VS NNP I-NP O
T NNP I-NP O
95.5 CD O O
, , O O
HR NNP B-NP O
64 CD O O
, , O O
BP NNP B-NP O
100/56 CD O O
, , O O
RR NNP B-NP O
18 CD O O
, , O O
O2sat NNP B-NP O
99% CD O O
RA NNP B-NP O
Gen: NNP I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
sitting VBG O O
at IN B-VP O
45 CD O O
degrees NNS B-NP O
HEENT: NNP I-NP O
PERRL NNP I-NP O
3mm CD O O
pupils NNS B-NP O
Arcus NNP I-NP O
senilus CC O O
EOMI NNP B-NP O
O/p NNP I-NP O
clear JJ B-NP O
No NNP I-NP O
LAD NNP I-NP O
Tenderness NNP I-NP O
at IN B-VP O
R NNP B-NP O
tunnel NN I-NP O
cath NN I-NP O
site NN I-NP O
o/w IN B-VP O
dressing VBG O O
c/d/i NN B-NP O
Chest: NNP I-NP O
bilateral JJ B-NP O
base NN I-NP O
crackles NNS I-NP O
Decreased VBN O O
BS NNP B-NP O
to TO O O
= VB O O
way NN B-NP O
up IN B-VP O
CV: NNP B-NP O
RRR NNP I-NP O
S1 NNP I-NP O
and CC O O
widely RB O O
split VBD B-VP O
S2 NNP B-NP O
3/6 CD O O
harsh NN B-NP O
SEM NNP I-NP O
loudest JJS O O
in IN B-VP O
pulmonic JJ B-NP O
area NN I-NP O
+RV NNS I-NP O
heave VBP O O
JVP NNP B-NP O
&gt; $ O O
15cm CD O O
( ( O O
to TO O O
jaw VB O O
standing VBG O O
up RP O O
) ) O O
Abd: NNP B-NP O
soft JJ B-NP O
nontender NN I-NP O
+BS NNP I-NP O
Ext: NNP I-NP O
R NNP I-NP O
above IN B-VP O
the DT B-NP O
knee NN I-NP O
amputation NN I-NP O
2+ CD O O
pitting VBG O O
edema NN B-NP O
in IN B-VP O
left JJ B-NP O
leg NN I-NP O
No NNP I-NP O
ulcers NNS I-NP O
in IN B-VP O
left JJ B-NP O
foot NN I-NP O
0-1+ JJ B-NP O
DP NNP I-NP O
pulses VBZ O O
Neuro: NNP B-NP O
AO NNP I-NP O
x VBD B-VP O
3 CD O O
CN2-12 JJ B-NP O
intact JJ I-NP O
Motor NNP I-NP O
strength NN I-NP O
grossly RB O O
intact JJ B-NP O
Sensation NNP I-NP O
intact NN I-NP O
except IN B-VP O
decreased VBN O O
in IN B-VP O
left JJ B-NP O
foot NN I-NP O
****** NNP I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
0/16 CD O O
Na NNP B-NP O
137 CD O O
, , O O
K NNP B-NP O
3.3 CD O O
, , O O
Cl NNP B-NP O
97 CD O O
, , O O
CO2 NNP B-NP O
29 CD O O
, , O O
BUN NNP B-NP O
102 CD O O
, , O O
Cr NNP B-NP O
3.3 CD O O
, , O O
Glc NNP B-NP O
293 CD O O
4/13 CD O O
AST NNP B-NP O
20 CD O O
, , O O
ALT NNP B-NP O
17 CD O O
, , O O
ALKP NNP B-NP O
118 CD O O
, , O O
TB NNP B-NP O
1.0 CD O O
4/13 CD O O
WBC NNP B-NP O
7.4 CD O O
, , O O
HCT NNP B-NP O
34.3 CD O O
, , O O
PLT NNP B-NP O
211 CD O O
7/14 CD O O
PT NNP B-NP O
14.4 CD O O
, , O O
PTT NNP B-NP O
33.7 CD O O
, , O O
INR NNP B-NP O
1.1 CD O O
2/2/06 CD O O
: : O O
UA NNP B-NP O
neg MD O O
****** VB O O
MAJOR NNP B-NP O
STUDIES: NNP I-NP O
ECG NNP I-NP O
4/5/06 CD O O
: : O O
NSR NN B-NP O
68 CD O O
, , O O
LAD NNP B-NP O
, , O O
biatrial JJ B-NP O
enlargement NN I-NP O
, , O O
QRS NNP B-NP O
196 CD O O
, , O O
BBB NNP B-NP O
V4-V6 NNP I-NP O
Q NNP I-NP O
waves NNS I-NP O
and CC O O
Tw NNP B-NP O
inv VBP O O
V5-V6 NNP B-NP O
vs NN I-NP O
prior RB O O
study NN B-NP O
on IN B-VP O
11/11 CD O O
unchanged JJ B-NP O
PA/lateral NNP I-NP O
CXR NNP I-NP O
0/23/06 CD O O
: : O O
Interval NN B-NP O
worsening VBG O O
pulmonary JJ B-NP O
edema NN I-NP O
Persistent NNP I-NP O
small JJ B-NP O
bilateral JJ I-NP O
pleural JJ I-NP O
effusions NNS I-NP O
TTE VBP O O
6/28 CD O O
Overall JJ B-NP O
LVEF NNP I-NP O
20% CD O O
Global NNP B-NP O
hypokinesis NN I-NP O
with IN B-VP O
regional JJ B-NP O
variation NN I-NP O
Global NNP I-NP O
RVSF NNP I-NP O
reduced VBD B-VP O
Severe NNP B-NP O
LAE NNP I-NP O
RAE NNP I-NP O
Trace NNP I-NP O
AR NNP I-NP O
Mod NNP I-NP O
MR NNP I-NP O
Mild NNP I-NP O
-mod NNP I-NP O
TR NNP I-NP O
Mild NNP I-NP O
PR NNP I-NP O
******** NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEM: NNP I-NP O
In IN B-VP O
summary JJ O O
, , O O
this DT O O
is VBZ O O
a DT B-NP O
54yo JJ I-NP O
man NN I-NP O
with IN B-VP O
CKD NNP B-NP O
and CC O O
poorly RB O O
controlled VBD B-VP O
volume NN B-NP O
status NN I-NP O
2/2 CD O O
diuresis NN B-NP O
limited VBN O O
by IN B-VP O
azotemia NN B-NP O
admitted VBN O O
for IN B-VP O
tunnel NN B-NP O
catheter NN I-NP O
placement NN I-NP O
and CC O O
initiation NN B-NP O
of IN B-VP O
HD NNP B-NP O
*Renal: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
volume NN B-NP O
overloaded VBN O O
by IN B-VP O
exam NN B-NP O
He PRP O O
underwent JJ B-NP O
TC NNP I-NP O
without IN B-VP O
complications NNS B-NP O
on IN B-VP O
4/10 CD O O
The DT B-NP O
patient NN I-NP O
underwent NN I-NP O
first JJ B-NP O
hemodialysis NN I-NP O
on IN B-VP O
1/19 CD O O
with IN B-VP O
improvement NN B-NP O
of IN B-VP O
volume NN B-NP O
status NN I-NP O
( ( O O
decreased JJ B-NP O
crackles NNS I-NP O
, , O O
decreased VBD B-VP O
JVP NNP B-NP O
, , O O
less JJR B-NP O
edema NN I-NP O
On IN B-VP O
discharge NN B-NP O
, , O O
we PRP O O
have VBP O O
held VBN O O
zemplar JJ O B-m
and CC O O
metolazone NN B-NP B-m
, , O O
and CC O O
told VBD B-VP O
pt NN B-NP O
to TO O O
continue VB O O
his PRP$ O O
home NN B-NP B-m
medications NNS I-NP I-m
otherwise RB O O
( ( O O
see VB O O
todo/plan NN B-NP O
) ) O O
The DT B-NP O
pt NN I-NP O
is VBZ O O
to TO O O
return VB O O
Monday NNP B-NP O
for IN B-VP O
his PRP$ O O
second JJ B-NP O
dialysis NN I-NP O
run VB O O
*Code NNP B-NP O
status: NN I-NP O
Presently NNP I-NP O
, , O O
full JJ B-NP O
code NN I-NP O
He PRP O O
does VBZ O O
not RB O O
have VB O O
formal JJ B-NP O
HCP NNP I-NP O
but CC O O
we PRP O O
have VBP O O
discussed VBN O O
the DT B-NP O
importance NN I-NP O
of IN B-VP O
arranging VBG O O
for IN B-VP O
one CD O O
********* NN B-NP O
Discharge NNP I-NP O
meds: NNS I-NP O
take VBP O O
all DT B-NP O
medications NNS I-NP O
as IN B-VP O
at IN B-VP O
home NN B-NP O
with IN B-VP O
the DT O O
following VBG O O
changes: NN B-NP O
1.Hold CD O O
zemplar JJ O O
2.Hold CD O O
metolazone NN B-NP O
3.Take CD O O
Torsemide NNP B-NP O
and CC O B-m
Klor-Con NNP B-NP O
as IN B-VP B-m
per IN B-VP O
your PRP$ O O
normal JJ B-NP O
routine JJ I-NP O
Do NNP I-NP O
not RB O O
take VB O O
Torsemide NN B-NP B-m
on IN B-VP O
Monday NNP B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
take VB O O
all DT B-NP O
medications NNS I-NP O
as IN B-VP O
at IN B-VP O
home NN B-NP O
with IN B-VP O
the DT O O
following VBG O O
changes: NN B-NP O
1 CD O O
Hold NNP B-NP O
zemplar NN I-NP B-m
2 CD O O
Hold NNP B-NP O
metolazone NN I-NP B-m
3 CD O O
Take NNP B-NP O
Torsemide NNP I-NP B-m
and CC O O
Klor-Con NNP B-NP B-m
as IN B-VP O
per IN B-VP O
your PRP$ O O
normal JJ B-NP O
routine JJ I-NP O
Do NNP I-NP O
not RB O O
take VB O O
Torsemide NN B-NP B-m
on IN B-VP O
Monday NNP B-NP O
4 CD O O
Your NNP B-NP O
dialysis NN I-NP O
appointment NN I-NP O
is VBZ O O
on IN B-VP O
Monday NNP B-NP O
6/30 CD O O
at IN B-VP O
10:30am CD O O
at IN B-VP O
the DT B-NP O
Lankewoo NNP I-NP O
Valley NNP I-NP O
Hospital NNP I-NP O
dialysis NN I-NP O
unit NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
CLACK NNP I-NP O
, , O O
KERMIT NNP B-NP O
O NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
KC06 NNP B-NP O
) ) O O
8/27/06 CD O O
@ $ O O
01:26 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#686140 VBZ O O
028440356 CD O O
VMH NNP B-NP O
34902422 CD O O
2806858 CD O O
2/1/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
s/p JJ B-NP O
ICD NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/15/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/27/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
COOPERWOOD NNP I-NP O
, , O O
GLEN NNP B-NP O
334-73-41-9 CD O O
Ny NNP B-NP O
Villea NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
6/11/05 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
ZANIS NNP I-NP O
, , O O
CLEO NNP B-NP O
BERNIE NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/24/05 CD O O
by IN B-VP O
ZACHMANN NNP B-NP O
, , O O
JONATHON NNP B-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ASPIRIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
needs NNS I-NP O
both DT B-NP O
INSULIN NNP I-NP B-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
10 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
BID NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
OXYCODONE NNP I-NP B-m
5-10 JJ B-NP B-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
ROUTINE NNP I-NP O
, , O O
20:00 CD O O
( ( O O
Standard NNP B-NP O
Admin NNP I-NP O
Time NNP I-NP O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/24/05 CD O O
by IN B-VP O
KRUIS NNP B-NP O
, , O O
MAJOR NNP B-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
TRICOR NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
76717119 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
FENOFIBRATE NNP I-NP B-m
, , O O
MICRONIZED NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
INR NNP I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/24/05 CD O O
by IN B-VP O
BICE NNP B-NP O
, , O O
DALTON NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ACETYLSALICYLIC NNP B-NP B-m
ACID NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
02538787 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ASPIRIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
needs NNS I-NP O
both DT B-NP O
KEFLEX NNP I-NP B-m
KEFLEX NNP I-NP B-m
( ( O I-m
( ( O I-m
CEPHALEXIN NNP B-NP I-m
CEPHALEXIN NNP I-NP I-m
) ) O I-m
) ) O I-m
250 CD O B-do
250 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
QID NNP I-NP B-f
QID NNP I-NP B-f
X NNP I-NP B-du
12 CD O I-du
doses NNS B-NP I-du
Starting VBG O O
when WRB O O
IV NNP B-NP B-mo
ANTIBIOTICS NNP I-NP B-m
END NNP I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
20 CD O I-du
TOPROL NNP B-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
2 CD O I-du
TRICOR NNP B-NP B-m
( ( O I-m
FENOFIBRATE NNP B-NP I-m
) ) O I-m
145 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/24/05 CD O O
by IN B-VP O
DEPPEN NNP B-NP O
, , O O
VINCENT NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
FENOFIBRATE NNP I-NP B-m
, , O O
MICRONIZED NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
INR NNP I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
2 CD O I-du
PRILOSEC NNP B-NP B-m
( ( O I-m
OMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
No NNP I-NP O
heavy JJ B-NP O
lifting NN I-NP O
and CC O O
do VB O O
not RB O O
lift VB O O
L NNP B-NP O
elbow FW O O
above IN B-VP O
L NNP B-NP O
shoulder NN I-NP O
x VBD B-VP O
1 CD O O
month NN B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Vuckovich NNP I-NP O
June NNP I-NP O
10:40am CD O O
scheduled VBN O O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
2/1/05 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT B-NP O
4-7 JJ I-NP O
days NNS I-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
PCP NNP B-NP O
ALLERGY: NNP I-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
s/p VBD B-VP O
ICD NNP B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
s/p VBP O O
ICD NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CHF NNP I-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
CAD NNP B-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
s/p NN B-NP O
CABG NNP I-NP O
( ( O O
S/P NNP B-NP O
cardiac JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
surgery NN I-NP O
) ) O O
dm NN B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
htn NN B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
hyperchol NN B-NP O
( ( O O
elevated VBN O O
cholesterol NN B-NP O
) ) O O
cri NN B-NP O
( ( O O
chronic JJ B-NP O
renal JJ I-NP O
dysfunction NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
s/p VBP O O
dual JJ B-NP O
chamber NN I-NP O
ICD NNP I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
69 CD O O
y/o NN B-NP O
man NN I-NP O
with IN B-VP O
ischemic JJ B-NP O
CMP NNP I-NP O
( ( O O
EF NNP B-NP O
25-30% CD O O
) ) O O
, , O O
recent JJ B-NP O
admit NN I-NP O
for IN B-VP O
atrial JJ B-NP O
flutter NN I-NP O
, , O O
s/p JJ B-NP O
ablation NN I-NP O
, , O O
and CC O O
NSVT NNP B-NP O
Primary NNP I-NP O
prevention NN I-NP O
ICD NNP I-NP O
placed VBD B-VP O
without IN B-VP O
complicaiton NN B-NP O
Had NNP I-NP O
short JJ B-NP O
runs NNS I-NP O
of IN B-VP O
AF NNP B-NP O
during IN B-VP O
procedure NN B-NP O
For IN B-VP O
coumadin NN B-NP B-m
, , O O
baby NN B-NP B-m
ASA NNP I-NP I-m
Also RB O O
h/o VBD B-VP O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
CRI NNP B-NP O
, , O O
CHF NNP B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Continue NNP I-NP O
coumadin VBD B-VP B-m
5mg CD O B-do
each DT B-NP B-f
night NN I-NP I-f
Have VBP O O
your PRP$ O O
INR/coumadin NNP B-NP O
level NN I-NP O
checked VBD B-VP O
on IN B-VP O
Monday NNP B-NP O
, , O O
March NNP B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
WEALER NNP I-NP O
, , O O
ROYAL NNP B-NP O
R NNP I-NP O
, , O O
PA-C NNP B-NP O
( ( O O
NY43 NNP B-NP O
) ) O O
6/11/05 CD O O
@ $ O O
10 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#689300 VBZ O O
717528703 CD O O
MHH NNP B-NP O
11030451 CD O O
5310269 CD O O
2/14/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Non NNP I-NP O
cardiac JJ B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/12/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/13/2005 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
BEBEE NNP I-NP O
, , O O
MITCHEL NNP B-NP O
900-43-64-1 CD O O
Xandnew NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/29/05 CD O O
AT NNP B-NP O
06:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
DEAVERS NNP I-NP O
, , O O
TEDDY NNP B-NP O
N NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
SYNTHROID NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
( ( O I-m
SUST NNP B-NP I-m
REL NNP I-NP I-m
) ) O I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
DIET: NNP I-NP O
No NNP I-NP O
Restrictions NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Decambra NNP I-NP O
1-2 JJ B-NP O
wks NN I-NP O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Sulfa NNP I-NP O
, , O O
Cephalosporins NNP B-NP O
, , O O
IV NNP B-NP O
Contrast NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Atypical NNP I-NP O
chest NN I-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Non NNP B-NP O
cardiac JJ B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
, , O O
obesity NN B-NP O
, , O O
seasonal JJ B-NP O
allergies NNS I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
adenosine NN I-NP O
MIBI NNP I-NP O
-&gt;negative NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
atypical JJ B-NP O
CP NNP I-NP O
HPI:76F NNP I-NP O
with IN B-VP O
hyperlipidemia NN B-NP O
, , O O
HTN NNP B-NP O
admitted VBD B-VP O
after IN B-VP O
4hrs CD O O
burning VBG O B-r
epigastric JJ B-NP O
pain NN I-NP O
( ( O O
resolved VBN O O
with IN B-VP O
opiates NNS B-NP B-m
in IN B-VP O
ED NNP B-NP O
) ) O O
EKG NNP B-NP O
no DT B-NP O
changes NNS I-NP O
, , O O
negative JJ B-NP O
cardiac JJ I-NP O
markers NNS I-NP O
x3 VBP O O
but CC O O
nondiagnostic JJ B-NP O
ETT NNP I-NP O
so RB O O
admitted VBD B-VP O
for IN B-VP O
adenosine JJ B-NP O
MIBI NNP I-NP O
in IN B-VP O
AM NNP B-NP O
Pain NNP I-NP O
described VBD B-VP O
as IN B-VP O
substernal JJ B-NP O
burning NN I-NP O
and CC O O
pressure NN B-NP O
which WDT O O
began VBD B-VP O
after IN B-VP O
pt NN B-NP O
had VBD B-VP O
eaten VBN O O
hotdog JJ B-NP O
wine NN I-NP O
and CC O O
potato NN B-NP O
salad NN I-NP O
and CC O O
gone VBN O O
to TO O O
sleep VB O O
in IN B-VP O
recliner NN B-NP O
chair NN I-NP O
PMH:hyperlipidemia/HTN/hypothyroidism NNP I-NP O
Meds:toprol NNP I-NP O
xl VBD B-VP O
50/lipitor CD O O
10/synthroid CD O O
100 CD O O
ALL:PCNs NNP B-NP O
, , O O
sulfa NN B-NP O
, , O O
iodine JJ B-NP O
EXAM: NNP I-NP O
96.6 CD O O
57 CD O O
102/75 CD O O
16 CD O O
98%RA CD O O
obese JJ O O
, , O O
NAD NNP B-NP O
JVP NNP I-NP O
flat JJ O O
, , O O
CTA NNP B-NP O
, , O O
RRR NNP B-NP O
( ( O O
slow JJ O O
) ) O O
, , O O
no DT B-NP O
edema NN I-NP O
Labs:cardiac NNP I-NP O
markers NNS I-NP O
neg VBP O O
x3 NNP B-NP O
EKG:SB NNP I-NP O
no DT B-NP O
TW/ST NNP I-NP O
changes NNS I-NP O
CXR:negative NNP I-NP O
ABD NNP I-NP O
CT:negative NNP I-NP O
except IN B-VP O
for IN B-VP O
3 CD O O
cm NN B-NP O
LN NNP I-NP O
in IN B-VP O
mesentery NN B-NP O
? . B-VP O
etiology NN B-NP O
-&gt;recommended VBD B-VP O
follow VB O O
up RP O O
CT NNP B-NP O
in IN B-VP O
3 CD O O
months NNS B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
Atypical NNP I-NP O
CP-&gt;admitted NNP I-NP O
for IN B-VP O
adenosine NN B-NP O
MIBI NNP I-NP O
after IN B-VP O
non JJ B-NP O
diagnostic JJ I-NP O
ETT NNP I-NP O
Adenosine NNP I-NP O
MIBI NNP I-NP O
was VBD B-VP O
negative JJ B-NP O
ISCH:low NNP I-NP O
suspicion NN I-NP O
given VBN O O
history NN B-NP O
and CC O O
normal JJ B-NP O
EKG NNP I-NP O
and CC O O
cardiac JJ B-NP O
markers NNS I-NP O
Adenosine VBP O O
MIBI NNP B-NP O
was VBD B-VP O
negative JJ B-NP O
RR:no NNP I-NP O
arrhythmias NN I-NP O
on IN B-VP O
telemetry NN B-NP O
Endo:continued NNP I-NP O
home NN I-NP O
synthroid NN I-NP B-m
FOLLOW NNP I-NP O
UP:Pt NNP I-NP O
had VBD B-VP O
an DT B-NP O
abdominal JJ I-NP O
CT NNP I-NP O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
which WDT O O
did VBD B-VP O
not RB O O
elucidate VB O O
an DT B-NP O
etiology NN I-NP O
of IN B-VP O
her PRP$ O O
abdominal JJ B-NP O
pain NN I-NP O
but CC O O
did VBD B-VP O
show VB O O
a DT O O
3 CD O O
cm NN B-NP O
mesenteric JJ B-NP O
lymph NN I-NP O
node IN B-VP O
She PRP O O
should MD O O
have VB O O
a DT B-NP O
repeat NN I-NP O
CT NNP I-NP O
in IN B-VP O
3 CD O O
months NNS B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
The DT B-NP O
stress JJ I-NP O
test NN I-NP O
of IN B-VP O
your PRP$ O O
heart NN B-NP O
was VBD B-VP O
negative JJ B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
You PRP O O
need VBP O O
to TO O O
have VB O O
a DT B-NP O
repeat NN I-NP O
abdominal JJ B-NP O
CAT NNP I-NP O
scan NN I-NP O
in IN B-VP O
3 CD O O
months NNS B-NP O
or CC O O
so RB O O
No RB O O
dictated JJ B-NP O
summary NN I-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
HIX NNP I-NP O
, , O O
GROVER NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
IP14 NNP B-NP O
) ) O O
9/29/05 CD O O
@ $ O O
05 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#691620 VBZ O O
649480096 CD O O
VMC NNP B-NP O
04502391 CD O O
9678698 CD O O
7/10/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Atypical NNP I-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/14/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/24/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
WITTIE NNP I-NP O
, , O O
DEWEY NNP B-NP O
857-68-84-4 CD O O
Kna NNP B-NP O
Street NNP I-NP O
, , O O
Beau NNP B-NP O
Cam NNP I-NP O
Rie NNP I-NP O
, , O O
Arkansas NNP B-NP O
57131 CD O O
Service: NNP B-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
10/5/06 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
GROTHEN NNP I-NP O
, , O O
ALPHONSO NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
AMITRIPTYLINE NNP I-NP B-m
HCL NNP I-NP I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
ENTERIC NNP I-NP B-m
COATED NNP I-NP I-m
ASPIRIN NNP I-NP I-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
ATENOLOL NNP I-NP B-m
ATENOLOL NNP I-NP B-m
ATENOLOL NNP I-NP B-m
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
QAM; NNP I-NP B-f
25 CD O B-do
MG NNP B-NP I-do
QPM NNP I-NP B-f
PO NNP I-NP B-mo
50 CD O B-do
MG NNP B-NP I-do
QAM NNP I-NP B-f
25 CD O B-do
MG NNP B-NP I-do
QPM NNP I-NP B-f
CALTRATE NNP I-NP B-m
600 CD O I-m
+ NNP B-NP I-m
D NNP I-NP I-m
( ( O I-m
CALCIUM NNP B-NP I-m
CARBONATE NNP I-NP I-m
1 CD O I-m
, , O I-m
500 CD O I-m
MG NNP B-NP I-m
( ( O I-m
) ) O I-m
2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
FLUOXETINE NNP I-NP B-m
HCL NNP I-NP I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
o MD O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/18/06 CD O O
by IN B-VP O
LIEFER NNP B-NP O
, , O O
STACEY NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
985891392 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
METFORMIN NNP I-NP B-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
AVADIA NNP I-NP B-m
8 CD O B-do
UNIT NNP B-NP I-do
DAILY NNP I-NP B-f
GLYBURIDE NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
4 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Please NNP I-NP O
scedule VBD B-VP O
an DT B-NP O
appointment NN I-NP O
with IN B-VP O
your PRP$ O O
primary JJ B-NP O
care NN I-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Atypical NNP B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
NIDDM NNP B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
sleep NN B-NP O
apnea NN I-NP O
( ( O O
sleep JJ B-NP O
apnea NN I-NP O
) ) O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
ETT NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
Atypical NNP I-NP O
Chest NNP I-NP O
pain NN I-NP O
**** NNP I-NP O
HPI: NNP I-NP O
54 CD O O
hispanic JJ B-NP O
woman NN I-NP O
with IN B-VP O
morbid NN B-NP O
obesity NN I-NP O
, , O O
HTN NNP B-NP O
, , O O
NIDDM NNP B-NP O
, , O O
sleep JJ B-NP O
apnea NN I-NP O
on IN B-VP O
CPAP NNP B-NP O
, , O O
who WP O O
presented VBD B-VP O
with IN B-VP O
one CD O O
week NN B-NP O
history NN I-NP O
of IN B-VP O
intermittent NN B-NP B-r
left VBD B-VP O
arm JJ B-NP O
pain NN I-NP O
while IN B-VP O
washing VBG O O
dishes NNS B-NP O
, , O O
lasting VBG O O
15 CD O O
minutes NNS B-NP O
, , O O
sometimes RB O O
radiating VBG O O
to TO O O
her PRP$ O O
left JJ B-NP O
chest NN I-NP O
, , O O
positional JJ O O
, , O O
no DT O O
associated VBN O O
with IN B-VP O
SOB NNP B-NP O
, , O O
N/V/D NNP B-NP O
Responds NNP I-NP O
to TO O O
SL NNP B-NP B-mo
NTG NNP I-NP B-m
( ( O O
however RB O O
within IN B-VP O
5-10min JJ O O
) ) O O
She PRP O O
has VBZ O O
history NN B-NP O
of IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
last JJ B-NP O
ETT NNP I-NP O
1998 CD O O
, , O O
walked VBD B-VP O
3min CD O O
, , O O
HR-128 NNP B-NP O
, , O O
non JJ B-NP O
ischemic JJ I-NP O
Cardiac NNP I-NP O
risk NN I-NP O
factors: NN I-NP O
Age NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
Obesity NNP B-NP O
, , O O
FH NNP B-NP O
In IN B-VP O
ED NNP B-NP O
pain NN I-NP O
free JJ O O
, , O O
no DT B-NP O
changes NNS I-NP O
in IN B-VP O
EKG NNP B-NP O
, , O O
first RB O O
set VBN O O
of IN B-VP O
cardiac JJ B-NP O
enzymes NNS I-NP O
is VBZ O O
negative JJ B-NP O
Received NNP I-NP O
ASA NNP I-NP B-m
, , O O
Heparin NNP B-NP B-m
gtt NN I-NP B-mo
started VBD B-VP O
**** NNP B-NP O
PMH: NNP I-NP O
1 CD O O
NIDDM NNP B-NP O
2 CD O O
HTN NNP B-NP O
3 CD O O
Morbid NNP B-NP O
obesity NN I-NP O
4 CD O O
OSA NNP B-NP O
-&gt;Home NNP I-NP O
CPAP NNP I-NP O
5 CD O O
Chronic NNP B-NP O
back RB O O
pain VBP O O
**** JJ B-NP O
Home NNP I-NP O
meds: NN I-NP O
Atenolol NNP I-NP B-m
50AM/25PM CD O B-do
, , O O
Avadia NNP B-NP B-m
8 CD O B-do
, , O O
Fluoxetine NNP B-NP B-m
20 CD O B-do
, , O O
Metformin NNP B-NP B-m
1gm CD O B-do
BID NNP B-NP B-f
, , O O
Glyburide NNP B-NP B-m
10BID CD O B-do
, , O O
Lisinopril NNP B-NP B-m
20 CD O B-do
, , O O
CaCO3 NNP B-NP B-m
1200QD CD O B-do
, , O O
Amitriptyline NNP B-NP B-m
50QHS CD O B-do
**** NNP B-NP O
Exam: NNP I-NP O
T- NNP I-NP O
98.6 CD O O
HR-86R NNP B-NP O
, , O O
BP-117/55 NNP B-NP O
, , O O
RA-18 NNP B-NP O
, , O O
97%RA CD O O
General: NNP B-NP O
Obese NNP I-NP O
, , O O
NAD NNP B-NP O
HEENT:MMM NNP I-NP O
, , O O
PEEEL NNP B-NP O
CV: NNP I-NP O
Flat NNP I-NP O
JVP NNP I-NP O
, , O O
RRR NNP B-NP O
, , O O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
, , O O
no DT B-NP O
MRG NNP I-NP O
Lungs: NNP I-NP O
CTA NNP I-NP O
B/L NNP I-NP O
Abdomen: NNP I-NP O
soft JJ O O
, , O O
NTND NNP B-NP O
, , O O
+BS NNP B-NP O
Ext: NNP I-NP O
Warm NNP I-NP O
, , O O
no DT B-NP O
edema NN I-NP O
**** NNP I-NP O
Hospital NNP I-NP O
course: VBD B-VP O
54F CD O O
with IN B-VP O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
admitted VBD B-VP O
with IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
ACS NNP B-NP O
*CV: NNP I-NP O
( ( O O
I PRP O O
) ) O O
Completed VBD B-VP O
ROMI NNP B-NP O
, , O O
ETT NNP B-NP O
walked VBD B-VP O
for IN B-VP O
2 CD O O
minutes NNS B-NP O
and CC O O
33 CD O O
sec NN B-NP O
, , O O
75% CD O O
MPHR NNP B-NP O
, , O O
stopped VBD B-VP O
due JJ O O
to TO O O
fatigue VB O O
, , O O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
Can NNP I-NP O
continue VBP O O
home NN B-NP O
ASA NNP I-NP B-m
, , O O
BB NNP B-NP B-m
, , O O
Risk NNP B-NP O
stratification: VBP O O
Lipid NNP B-NP O
profile NN I-NP O
, , O O
A1C NNP B-NP O
are VBP O O
pending VBG O O
( ( O O
P NNP B-NP O
) ) O O
ETT NNP B-NP O
in IN B-VP O
ED NNP B-NP O
with IN B-VP O
EF-55% NNP B-NP O
, , O O
not RB O O
in IN B-VP O
failure NN B-NP O
, , O O
htn NN B-NP B-r
htn NN I-NP B-r
controlled VBN O O
with IN B-VP O
BB NNP B-NP B-m
, , O O
ACEI NNP B-NP B-m
( ( O O
R NNP B-NP O
) ) O O
No NNP B-NP O
events NNS I-NP O
*Endo: RB O O
RISS NNP B-NP B-m
, , O O
return NN B-NP O
to TO O O
home NN B-NP B-m
meds NNS I-NP I-m
, , O O
A1C NNP B-NP O
pending VBG O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
1 CD O O
You PRP O O
did VBD B-VP O
not RB O O
have VB O O
heart NN B-NP O
attack!! VBZ O O
2 CD O O
Continue NNP B-NP O
all DT O O
your PRP$ O B-m
medications NNS B-NP I-m
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
follow VBP O O
up RB O O
A1C NNP B-NP O
, , O O
lipid JJ B-NP O
profile NN I-NP O
2 CD O O
Weight NNP B-NP O
reduction NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
GOSHEN NNP I-NP O
, , O O
TUAN NNP B-NP O
, , O O
M.D NNP B-NP O
( ( O O
HO91 NNP B-NP O
) ) O O
10/5/06 CD O O
@ $ O O
12:00 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#698005 VBZ O O
585164725 CD O O
FH NNP B-NP O
16469218 CD O O
7093317 CD O O
4/0/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
MITRAL NNP I-NP O
REGURGITATION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/6/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/6/2003 CD O O
Date NNP B-NP O
of IN B-VP O
Discharge: NNP B-NP O
10/6/2003 CD O O
ATTENDING: NNP B-NP O
EUSEBIO NNP I-NP O
HENDLER NNP I-NP O
MD NNP I-NP O
PRIMARY NNP I-NP O
DIAGNOSIS: NNP I-NP O
Mitral NNP I-NP O
valve POS O O
regurgitation NN B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
26-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
Hodgkin's NNP B-NP O
lymphoma NN I-NP O
requiring VBG O O
chemotherapy NN B-NP O
and CC O O
radiation NN B-NP O
therapy NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
splenectomy NN B-NP O
, , O O
asthma NN B-NP O
, , O O
and CC O O
history NN B-NP O
of IN B-VP O
tobacco NN B-NP O
use NN I-NP O
, , O O
who WP O O
presents VBZ O O
to TO O O
our PRP$ O O
service NN B-NP O
with IN B-VP O
symptoms NNS B-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
including VBG O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
lower JJR B-NP O
extremity NN I-NP O
bilateral JJ B-NP O
edema NN I-NP O
, , O O
and CC O O
decrease NN B-NP O
exercise NN I-NP O
tolerance NN I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
2/17/03 CD O O
, , O O
she PRP O O
underwent JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
clean JJ B-NP O
coronary JJ I-NP O
arteries NNS I-NP O
On IN B-VP O
November NNP B-NP O
, , O O
2003 CD O O
, , O O
she PRP O O
then RB O O
underwent VBD B-VP O
an DT B-NP O
elective JJ I-NP O
mitral NN I-NP O
valvuloplasty NN I-NP O
, , O O
26 CD O O
Carpentier-Edwards JJ B-NP O
pericardial NN I-NP O
, , O O
with IN B-VP O
size NN B-NP O
26 CD O O
Cosgrove-Edwards JJ B-NP O
ring NN I-NP O
and CC O O
vegectomy NN B-NP O
In IN B-VP O
the DT B-NP O
immediate JJ I-NP O
postoperative JJ I-NP O
period NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
initially RB O O
requiring VBG O O
0.5 CD O B-do
of IN B-VP O
epinephrine NN B-NP B-m
to TO O O
maintain VB O O
proper JJ B-NP B-r
pressure NN I-NP I-r
Epinephrine NNP I-NP B-m
was VBD B-VP O
weaned VBN O O
to TO O O
off VB O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 IN B-VP O
She PRP O O
was VBD B-VP O
extubated VBN O O
in IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
surgery NN B-NP O
and CC O O
epinephrine NN B-NP B-m
was VBD B-VP O
subsequently RB O O
weaned VBN O O
to TO O O
off VB O O
Gentle NNP B-NP O
diuresis NN I-NP O
was VBD B-VP O
begun VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
as RB O O
well RB O O
as IN B-VP O
low JJ B-NP B-do
dose NN I-NP I-do
beta NN I-NP B-m
blocker NN I-NP I-m
, , O O
which WDT O O
she PRP O O
tolerated VBD B-VP O
well RB O O
She PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Step NNP I-NP O
Down NNP I-NP O
Unit NNP I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 NNP I-NP O
, , O O
where WRB O O
diuresis NN B-NP O
was VBD B-VP O
increased VBN O O
Baby NNP B-NP B-m
aspirin NN I-NP I-m
was VBD B-VP O
begun VBN O O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
make VB O O
excellent JJ B-NP O
cardiovascular JJ I-NP O
progress NN I-NP O
On IN B-VP O
February NNP B-NP O
, , O O
2003 CD O O
, , O O
she PRP O O
began VBD B-VP O
to TO O O
complain VB O O
of IN B-VP O
some DT B-NP O
persistent JJ I-NP O
numbness NN I-NP O
and CC O O
tingling NN B-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
, , O O
which WDT O O
she PRP O O
felt VBD B-VP O
to TO O O
be VB O O
interrupting VBG O O
her PRP$ O O
attempts NNS B-NP O
to TO O O
stand VB O O
and CC O O
maintain VB O O
balance NN B-NP O
For IN B-VP O
further JJ B-NP O
treatment NN I-NP O
, , O O
a DT B-NP O
Neurology NNP I-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
Per NNP B-NP O
Neurology NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
no DT B-NP O
weakness NN I-NP O
at IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
leg NN I-NP O
and CC O O
foot NN B-NP O
, , O O
although IN B-VP O
when WRB O O
pressure NN B-NP O
was VBD B-VP O
exerted VBN O O
on IN B-VP O
the DT B-NP O
foot NN I-NP O
, , O O
she PRP O O
reported VBD B-VP O
an DT B-NP O
uncomfortable JJ I-NP O
tingling NN I-NP O
throughout IN B-VP O
the DT B-NP O
leg NN I-NP O
She PRP O O
reported VBD B-VP O
no DT B-NP O
back NN I-NP O
pain NN I-NP O
and CC O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
bowel NN B-NP O
or CC O O
bladder VB O O
control NN B-NP O
Sensory NNP I-NP O
examination NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
intact JJ O O
, , O O
however RB O O
, , O O
soft JJ B-NP O
touch NN I-NP O
and CC O O
pin JJ B-NP O
sensation NN I-NP O
tested VBN O O
in IN B-VP O
the DT B-NP O
lateral JJ I-NP O
leg NN I-NP O
below IN B-VP O
the DT B-NP O
knee NN I-NP O
caused VBD B-VP O
a DT B-NP O
spreading NN I-NP O
tingling VBG O O
sensation NN B-NP O
throughout IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
Per NNP I-NP O
Neurology NNP I-NP O
recommendations NNS I-NP O
, , O O
Neurontin NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
was VBD B-VP O
begun VBN O O
and CC O O
it PRP O O
was VBD B-VP O
recommended VBN O O
that IN B-VP O
she PRP O O
follow VBD B-VP O
up RB O O
with IN B-VP O
the DT B-NP O
Department NNP I-NP O
of IN B-VP O
Neurology NNP B-NP O
following VBG O O
discharge NN B-NP O
if IN B-VP O
the DT B-NP O
tingling NN I-NP O
sensation NN I-NP O
has VBZ O O
not RB O O
improved VBN O O
With IN B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
able JJ O O
to TO O O
regain VB O O
her PRP$ O O
postoperative JJ B-NP O
weight NN I-NP O
and CC O O
by IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
was VBD B-VP O
1.7 CD O O
kilograms NNS B-NP O
below IN B-VP O
her PRP$ O O
preoperative JJ B-NP O
weight NN I-NP O
She PRP O O
has VBZ O O
made VBN O O
excellent JJ B-NP O
cardiovascular JJ I-NP O
progress NN I-NP O
following VBG O O
this DT B-NP O
surgery NN I-NP O
and CC O O
is VBZ O O
anticipated VBN O O
to TO O O
continue VB O O
her PRP$ O O
rehabilitation NN B-NP O
at IN B-VP O
home NN B-NP O
with IN B-VP O
VNA NNP B-NP O
System NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
an DT B-NP O
obese JJ I-NP O
young JJ I-NP O
woman NN I-NP O
alert NN I-NP O
and CC O O
oriented VBD B-VP O
x $ O O
3 CD O O
HEENT: NNP B-NP O
No NNP I-NP O
carotid NN I-NP O
bruits NNS I-NP O
or CC O O
JVD NNP B-NP O
present JJ B-NP O
Pulmonary: NNP I-NP O
Lungs NNP I-NP O
are VBP O O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
Coronary: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
Normal NNP I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
No NNP I-NP O
murmurs NN I-NP O
, , O O
rubs NN B-NP O
, , O O
or CC O O
gallops NNS B-NP O
appreciated VBN O O
Abdomen: NNP B-NP O
Obese NNP I-NP O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
Positive NNP B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities: NNP B-NP O
2+ CD O O
pulses NNS B-NP O
at IN B-VP O
all DT B-NP O
extremities NNS I-NP O
bilaterally RB O O
Trace NNP B-NP O
edema NN I-NP O
at IN B-VP O
the DT B-NP O
bilateral JJ I-NP O
lower JJR I-NP O
extremities NNS I-NP O
to TO O O
mid VB O O
calf JJ B-NP O
Skin: NNP I-NP O
Midline NNP I-NP O
sternotomy NN I-NP O
incision NN I-NP O
well RB O O
approximated VBN O O
, , O O
healing VBG O O
well RB O O
No NNP B-NP O
areas NNS I-NP O
of IN B-VP O
erythema NN B-NP O
or CC O O
drainage NN B-NP O
noted JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
sodium NN B-NP O
141 CD O O
, , O O
potassium NN B-NP O
4.2 CD O O
, , O O
BUN NNP B-NP O
17 CD O O
, , O O
creatinine NN B-NP O
1.0 CD O O
, , O O
calcium NN B-NP O
8.9 CD O O
, , O O
magnesium NN B-NP O
2.6 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
11.3 CD O O
, , O O
hematocrit NN B-NP O
33.5 CD O O
, , O O
platelets NNS B-NP O
361 CD O O
, , O O
and CC O O
INR NNP B-NP O
1.0 CD O O
PROCEDURES: NNP B-NP O
On IN B-VP O
7/27/2003 CD O O
, , O O
elective JJ B-NP O
mitral JJ I-NP O
valvuloplasty NN I-NP O
, , O O
26 CD O O
Cosgrove-Edwards NNS B-NP O
ring VBG O O
with IN B-VP O
vegectomy NN B-NP O
, , O O
small JJ B-NP O
sterile JJ I-NP O
vegetations NNS I-NP O
on IN B-VP O
A2 NNP B-NP O
and CC O O
P2 NNP B-NP O
debrided VBD B-VP O
, , O O
and CC O O
found VBN O O
by IN B-VP O
lab NN B-NP O
testing VBG O O
to TO O O
be VB O O
sterile JJ B-NP O
vegetations NNS I-NP O
Cross NNP I-NP O
clamp NN I-NP O
times NNS I-NP O
were VBD B-VP O
confirmed VBN O O
by IN B-VP O
Gram NNP B-NP O
stain NN I-NP O
as IN B-VP O
sterile JJ O O
and CC O O
debrided VBD B-VP O
intraoperatively RB O O
Please NNP B-NP O
refer VB O O
to TO O O
operative JJ B-NP O
note NN I-NP O
for IN B-VP O
details NNS B-NP O
CONSULT: NNP I-NP O
Consulted NNP I-NP O
Department NNP I-NP O
of IN B-VP O
Neurology NNP B-NP O
with IN B-VP O
followup JJ B-NP O
recommendations NNS I-NP O
implemented VBN O O
during IN B-VP O
this DT B-NP O
patient's NN I-NP O
stay NN I-NP O
DISPOSITION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
discharged VBN O O
today NN B-NP O
to TO O O
her PRP$ O O
home NN B-NP O
with IN B-VP O
VNA NNP B-NP O
assistance NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Enteric-coated NNP I-NP B-m
aspirin VBZ O I-m
81 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
x $ O B-du
7 CD O I-du
days NNS B-NP I-du
, , O O
Lasix NNP B-NP B-m
60 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
ibuprofen JJ O B-m
800 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.8h NN I-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
, , O O
Lopressor NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Atrovent NNP B-NP B-m
nebulizer RB O I-m
0.5 CD O B-do
mg NNS B-NP I-do
nebulized VBN O B-mo
q.i.d RB O B-f
, , O O
Neurontin NNP B-NP B-m
300 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
, , O O
K-Dur NNP B-NP B-m
30 CD O B-do
mEq NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
to TO O O
be VB O O
discontinued VBN O O
or CC O O
decreased VBN O O
if IN B-VP O
Lasix NNP B-NP B-m
dose NN I-NP O
is VBZ O O
changed VBN O O
, , O O
and CC O O
Flovent NNP B-NP B-m
44 CD O B-do
mcg/inh NN B-NP I-do
b.i.d VBD B-VP B-f
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
instructed VBN O O
to TO O O
call VB O O
to TO O O
schedule VB O O
follow VB O O
up RP O O
appointments NNS B-NP O
with IN B-VP O
Cogang NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
Department NNP I-NP O
of IN B-VP O
Cardiac NNP B-NP O
Surgery NNP I-NP O
, , O O
Dr NNP B-NP O
Elbert NNP I-NP O
Reitzes NNP I-NP O
, , O O
within IN B-VP O
6-8 JJ B-NP O
weeks NNS I-NP O
following VBG O O
discharge NN B-NP O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Keith NNP I-NP O
Lapusnak NNP I-NP O
in IN B-VP O
approximately RB O O
1-2 JJ B-NP O
weeks NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
with IN B-VP O
her PRP$ O O
Cardiologist NNP B-NP O
, , O O
Dr NNP B-NP O
Wilbur NNP I-NP O
Nuzzo NNP I-NP O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
She PRP O O
will MD O O
call VB O O
on IN B-VP O
recommendation NN B-NP O
from IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
to TO O O
schedule NN B-NP O
follow VB O O
up RP O O
appointment NN B-NP O
with IN B-VP O
Tor's NNP B-NP O
Community NNP I-NP O
Hospital NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Department NNP I-NP O
of IN B-VP O
Neurology NNP B-NP O
should MD O O
her PRP$ O O
left VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
tingling VBG O O
not RB O O
resolve VB O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
she PRP O O
would MD O O
be VB O O
advised VBN O O
to TO O O
pursue VB O O
EMG NNP B-NP O
testing VBG O O
for IN B-VP O
further JJ B-NP O
workup NN I-NP O
of IN B-VP O
dysasthesia NN B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
made VBN O O
excellent JJ B-NP O
progress NN I-NP O
following VBG O O
her PRP$ O O
mitral JJ B-NP O
valvuloplasty NN I-NP O
surgery NN I-NP O
and CC O O
is VBZ O O
anticipated VBN O O
that IN B-VP O
she PRP O O
will MD O O
return VB O O
to TO O O
her PRP$ O O
full JJ B-NP O
preoperative JJ I-NP O
level NN I-NP O
of IN B-VP O
independent JJ O O
functioning VBG O O
with IN B-VP O
continued JJ B-NP O
cardiovascular JJ I-NP O
rehabilitation NN I-NP O
and CC O O
VNA NNP B-NP O
assistance NN I-NP O
Please NNP I-NP O
call VB O O
if IN B-VP O
further JJ B-NP O
questions NNS I-NP O
or CC O O
concerns NNS B-NP O
Thank NNP I-NP O
you PRP O O
for IN B-VP O
referring VBG O O
this DT B-NP O
patient NN I-NP O
to TO O O
our PRP$ O O
service NN B-NP O
eScription NN I-NP O
document: VBZ O O
6-9587956 JJ B-NP O
ISSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Alvaro NNP I-NP O
Claud NNP I-NP O
M.D NNP I-NP O
ELT NNP I-NP O
GP1 NNP I-NP O
, , O O
Sleyapa NNP B-NP O
Hospital NNP I-NP O
Gene NNP I-NP O
Osta NNP I-NP O
Ford NNP I-NP O
, , O O
RI NNP B-NP O
West NNP I-NP O
Hampmo NNP I-NP O
Nor NNP I-NP O
CC: NNP I-NP O
Roberto NNP I-NP O
Mellecker NNP I-NP O
MD NNP I-NP O
DIVISION NNP I-NP O
OF NNP I-NP O
CARDIAC NNP I-NP O
SURGERY NNP I-NP O
I PRP O O
Ni NNP B-NP O
Son NNP I-NP O
Ton NNP I-NP O
Ha NNP I-NP O
Napro NNP I-NP O
CC: NNP I-NP O
Jonah NNP I-NP O
Debiasi NNP I-NP O
M.D NNP I-NP O
DEP NNP I-NP O
DWARDAIN NNP I-NP O
MEDICAL NNP I-NP O
CENTER NNP I-NP O
Naca NNP I-NP O
Scond NNP I-NP O
Paul NNP I-NP O
Den NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
KIZZIE NNP I-NP O
, , O O
ROBERTO NNP B-NP O
Attending: NNP I-NP O
OLIVIO NNP I-NP O
, , O O
LEWIS NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
1644899 CD O O
D: NNP B-NP O
6/14/03 CD O O
T: NNP B-NP O
0/29/03 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#698248 VBZ O O
694272750 CD O O
EGH NNP B-NP O
55957670 CD O O
6256055 CD O O
6/14/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHF NNP I-NP O
flare NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/26/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/4/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
LEBEL NNP I-NP O
, , O O
LUCIEN NNP B-NP O
889-75-18-3 CD O O
O NNP B-NP O
Westhend NNP I-NP O
Gle NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
2/17/05 CD O O
AT NNP B-NP O
01:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
TAKAI NNP I-NP O
, , O O
AARON NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/1/05 CD O O
by IN B-VP O
LEGER NNP B-NP O
, , O O
GROVER NNP B-NP O
G NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
90193915 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
mda NN I-NP O
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
July NNP I-NP O
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
November NNP I-NP O
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBD B-VP O
&lt; $ O O
100 CD O O
NPH NNP B-NP B-m
INSULIN NNP I-NP I-m
HUMAN NNP I-NP I-m
( ( O I-m
INSULIN NNP B-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
60 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
July NNP I-NP O
NPH NNP I-NP B-m
INSULIN NNP I-NP I-m
HUMAN NNP I-NP I-m
( ( O I-m
INSULIN NNP B-NP I-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
) ) O I-m
60 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QPM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
November NNP I-NP O
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting VBG O O
NOW NNP B-NP O
November NNP I-NP O
Instructions: NNP I-NP O
Take NNP I-NP O
every DT B-NP O
Monday NNP I-NP O
, , O O
Wed NNP B-NP O
, , O O
Fri NNP B-NP O
, , O O
Sat NNP B-NP O
, , O O
Sun NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/1/05 CD O O
by IN B-VP O
PALLA NNP B-NP O
, , O O
REYES NNP B-NP O
H NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
SIMVASTATIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
13797611 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
mda VBP O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
7/1/05 CD O O
by IN B-VP O
IZZO NNP B-NP O
, , O O
ROCKY NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ASPIRIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
mda NN I-NP O
PAXIL NNP I-NP B-m
( ( O I-m
PAROXETINE NNP B-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
SEROQUEL NNP I-NP B-m
( ( O I-m
QUETIAPINE NNP B-NP I-m
) ) O I-m
800 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
4 CD O I-du
DEPAKOTE NNP B-NP B-m
ER NNP I-NP I-m
( ( O I-m
DIVALPROEX NNP B-NP I-m
SODIUM NNP I-NP I-m
ER NNP I-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/1/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ATORVASTATIN NNP I-NP B-m
CALCIUM NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
mda NN I-NP O
PROTONIX NNP I-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dorsey NNP I-NP O
Deases NNP I-NP O
November NNP I-NP O
2:30 CD O O
PM NNP B-NP O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Lavern NNP I-NP O
Bringhurst NNP I-NP O
February NNP I-NP O
scheduled VBD B-VP O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
0/4/05 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
7 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Lesley NNP I-NP O
Bertling NNP I-NP O
ALLERGY: NNP I-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Aflutter NNP I-NP O
with IN B-VP O
RVR NNP B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
CHF NNP B-NP O
flare NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CAD NNP I-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
s/p NN B-NP O
MI NNP I-NP O
2000 CD O O
( ( O O
S/P NNP B-NP O
myocardial NNP I-NP O
infarction NN I-NP O
) ) O O
PE NNP B-NP O
( ( O O
pulmonary JJ B-NP O
embolism NN I-NP O
) ) O O
Schizophrenia NNP B-NP O
( ( O O
schizophrenia NN B-NP O
) ) O O
gut NN B-NP O
malrotation NN I-NP O
( ( O O
3 CD O O
) ) O O
Atrial NNP B-NP O
fibrillation NN I-NP O
( ( O O
atrial JJ B-NP O
fibrillation NN I-NP O
) ) O O
IDDM NNP B-NP O
( ( O O
diabetes VBZ O O
mellitus VBP O O
type JJ O O
2 CD O O
) ) O O
HTN NNP B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
dysfunctional JJ B-NP O
uterine JJ I-NP O
bleeding NN I-NP O
( ( O O
dysfunctional JJ B-NP O
uterine NN I-NP O
bleeding NN I-NP O
) ) O O
uterine NN B-NP O
fibroid NN I-NP O
( ( O O
uterine JJ B-NP O
fibroids NNS I-NP O
) ) O O
h/o VBP O O
rheumatic JJ B-NP O
fever NN I-NP O
( ( O O
H/O NNP B-NP O
rheumatic JJ B-NP O
fever NN I-NP O
) ) O O
s/p VBD B-VP O
c-section NN B-NP O
x2 NN I-NP O
( ( O O
S/P NNP B-NP O
cesarean VBP O O
section NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
CXR NNP B-NP O
- : O O
clear JJ B-NP O
EKG NNP I-NP O
- : O O
Aflutter NNP B-NP O
Lower NNP I-NP O
Extremity NNP I-NP O
Vascular NNP I-NP O
Ultrasound NNP I-NP O
- : O O
negative JJ O O
for IN B-VP O
DVT NNP B-NP O
bilaterally RB O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
--- NNP I-NP O
ID: NNP I-NP O
52 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
--- NNP I-NP O
CC: NNP I-NP O
SOB NNP I-NP O
, , O O
weight VBD B-VP O
gain NN B-NP O
--- NN I-NP O
DX: NNP I-NP O
CHF NNP I-NP O
HPI: NNP I-NP O
52 CD O O
yr NN B-NP O
old JJ B-NP O
woman NN I-NP O
w/ VBZ O O
a DT B-NP O
h/o NN I-NP O
of IN B-VP O
rheumatic JJ B-NP O
heart NN I-NP O
disease NN I-NP O
, , O O
CHF NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
Type NNP B-NP B-r
2 CD O I-r
DM NNP B-NP I-r
on IN B-VP O
insulin NN B-NP B-m
, , O O
CAD NNP B-NP O
, , O O
s/p NN B-NP O
MI NNP I-NP O
2000 CD O O
, , O O
and CC O O
A NNP B-NP O
fib/flutter NN I-NP O
, , O O
who WP O O
presents VBZ O O
with IN B-VP O
2 CD O O
days NNS B-NP O
of IN B-VP O
increasing VBG O O
SOB NNP B-NP O
and CC O O
weight VBD B-VP O
gain NN B-NP O
Per NNP I-NP O
patient NN I-NP O
- : O O
came VBD B-VP O
in IN B-VP O
to TO O O
ED NNP B-NP O
because IN B-VP O
CHF NNP B-NP O
nurse RB O O
noted VBD B-VP O
weight JJ B-NP O
gain NN I-NP O
Pt NNP I-NP O
also RB O O
describes VBZ O O
2 CD O O
days NNS B-NP O
of IN B-VP O
swelling VBG O O
in IN B-VP O
her PRP$ O O
legs NNS B-NP O
and CC O O
an DT O O
increasing VBG O O
SOB NNP B-NP O
Pt NNP I-NP O
had VBD B-VP O
to TO O O
sleep VB O O
with IN B-VP O
3 CD O O
pillows NNS B-NP O
, , O O
rather RB O O
than IN B-VP O
her PRP$ O O
usual JJ O O
2 CD O O
1 CD O O
day NN B-NP O
PTA NNP I-NP O
patient NN I-NP O
developed VBD B-VP O
pain NN B-NP O
in IN B-VP O
her PRP$ O O
L NNP B-NP O
lower JJR B-NP O
leg NN I-NP O
, , O O
described VBN O O
as IN B-VP O
a DT B-NP O
"knot NN I-NP O
in IN B-VP O
her PRP$ O O
calf." JJ B-NP O
Day NNP I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
patient JJ B-NP O
weight NN I-NP O
was VBD B-VP O
noticed VBN O O
to TO O O
be VB O O
+10 JJ B-NP O
lbs NN I-NP O
and CC O O
she PRP O O
was VBD B-VP O
recommended VBN O O
to TO O O
come VB O O
to TO O O
the DT B-NP O
ED NNP I-NP O
Patient NNP I-NP O
has VBZ O O
+orthopnea VBN O O
, , O O
PND NNP B-NP O
, , O O
fatigue NN B-NP O
At IN B-VP O
baseline JJ B-NP O
patient NN I-NP O
becomes NNS I-NP O
SOB NNP I-NP O
when WRB O O
climbing VBG O O
2 CD O O
stairs NNS B-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
palpitations NNS I-NP O
, , O O
cp NN B-NP O
, , O O
n/v/d JJ B-NP O
Admits NNP I-NP O
auditory NN I-NP O
and CC O O
visual JJ B-NP O
hallucinations NNS I-NP O
( ( O O
men NNS B-NP O
and CC O O
women NNS B-NP O
crawling VBG O O
on IN B-VP O
the DT B-NP O
wall NN I-NP O
saying VBG O O
things NNS B-NP O
about IN B-VP O
me PRP O O
) ) O O
PMH: NNP B-NP O
Htn NNP I-NP O
, , O O
CAD NNP B-NP O
s/p VBZ O O
MI NNP B-NP O
2000 CD O O
, , O O
Rheumatic NNP B-NP O
Fever NNP I-NP O
c VBP O O
valve NN B-NP O
dz NN I-NP O
, , O O
CHF NNP B-NP O
, , O O
IDDM NNP B-NP O
, , O O
Depression NNP B-NP O
, , O O
Schizophrenia NNP B-NP O
, , O O
Afib/flutter NNP B-NP O
, , O O
Fibroids NNP B-NP O
, , O O
Dysfunctional NNP B-NP O
Uterine NNP I-NP O
Bleeding NNP I-NP O
, , O O
h/o NN B-NP O
PE NNP I-NP O
, , O O
h/o NN B-NP O
domestic JJ B-NP O
violence NN I-NP O
--- NNP I-NP O
EVENTS: NNP I-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
EKG NNP B-NP O
showed VBD B-VP O
the DT B-NP O
patient NN I-NP O
to TO O O
be VB O O
in IN B-VP O
A DT B-NP B-r
flutter NN I-NP O
with IN B-VP O
HR NNP B-NP O
in IN B-VP O
the DT O O
110s CD O O
She PRP O O
was VBD B-VP O
given VBN O O
25 CD O B-do
mg JJ B-NP I-do
PO NNP I-NP B-mo
Lopressor NNP I-NP B-m
x NNP I-NP B-du
2 CD O I-du
, , O O
which WDT O O
brought VBD B-VP O
her PRP O O
HR NNP B-NP O
down RB O O
to TO O O
the DT O O
80s CD O O
Patient NNP B-NP O
described VBD B-VP O
a DT B-NP O
period NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
which WDT O O
lasted VBD B-VP O
for IN B-VP O
seconds NNS B-NP O
The DT B-NP O
pain NN I-NP O
was VBD B-VP O
described VBN O O
as IN B-VP O
sharp JJ O O
, , O O
midline NN B-NP O
, , O O
and CC O O
pleuritic JJ O O
10/17 CD O O
- : O O
no DT B-NP O
O/N NNP I-NP O
events NNS I-NP O
0/12 CD O O
- : O O
no DT B-NP O
O/N NNP I-NP O
events NNS I-NP O
--- VBP O O
STATUS: NNP B-NP O
VS: NNP I-NP O
T: NNP I-NP O
97.1 CD O O
, , O O
HR NNP B-NP O
80 CD O O
, , O O
BP NNP B-NP O
106/67 CD O O
, , O O
RR NNP B-NP O
18 CD O O
, , O O
O2sat NNP B-NP O
98% CD O O
on IN B-VP O
RA NNP B-NP O
GEN: NNP I-NP O
breathing NN I-NP O
comfortably RB O O
, , O O
NAD NNP B-NP O
NECK: NNP I-NP O
JVP NNP I-NP O
flat JJ B-NP O
PULM: NNP I-NP O
CTAB NNP I-NP O
CV: NNP I-NP O
NL NNP I-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
No NNP I-NP O
MRG's NNP I-NP O
ABD: NNP I-NP O
obese JJ B-NP O
soft JJ I-NP O
NT NNP I-NP O
mild NN I-NP O
distention NN I-NP O
+BS VBZ O O
No DT B-NP O
masses NNS I-NP O
or CC O O
bruits NNS B-NP O
EXT: NNP I-NP O
DP NNP I-NP O
and CC O O
TP NNP B-NP O
2+ CD O O
, , O O
1+ CD O O
pitting VBG O O
edema NN B-NP O
bilaterally RB O O
Left NNP B-NP O
calf NN I-NP O
, , O O
ankle JJ B-NP O
tender NN I-NP O
anteriorly RB O O
and CC O O
posteriorly RB O O
+ JJ B-NP O
Homan's NNP I-NP O
sign NN I-NP O
--- NNP I-NP O
STUDIES/TESTS: NNP I-NP O
8/4/05 CD O O
CXR: NNP B-NP O
mild JJ B-NP O
kyphosis NN I-NP O
, , O O
no DT B-NP O
effusion NN I-NP O
, , O O
moderate JJ B-NP O
cardiomegaly NN I-NP O
no DT B-NP O
change NN I-NP O
since IN B-VP O
6/15/05 CD O O
8 CD O O
EKG: NNP B-NP O
HR NNP I-NP O
118 CD O O
, , O O
A NNP B-NP O
flutter RB O O
Previous NNP B-NP O
EKG NNP I-NP O
( ( O O
9/24/05 CD O O
) ) O O
showed VBD B-VP O
A DT B-NP O
fib NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
changed VBN O O
from IN B-VP O
a DT B-NP O
previous JJ I-NP O
A NNP I-NP O
flutter NN I-NP O
0/12 CD O O
- : O O
Bilat NNP B-NP O
Lenis NNP I-NP O
- : O O
neg NN B-NP O
for IN B-VP O
DVT NNP B-NP O
--- NNP I-NP O
PROBLEM NNP I-NP O
LIST: NNP I-NP O
1 CD O O
) ) O O
Pulm NNP B-NP O
- : O O
Currently RB O O
treating VBG O O
this DT O O
as IN B-VP O
a DT B-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
- : O O
etiology NN B-NP O
likely JJ B-NP O
diet JJ I-NP O
non-compliance JJ I-NP O
Very NNP I-NP O
mild NN I-NP O
BLE NNP I-NP O
edema NN I-NP O
, , O O
inc JJ B-NP O
abd NN I-NP O
girth NN I-NP O
and CC O O
wt JJ B-NP O
gain NN I-NP O
Ischemia NNP I-NP O
ruled VBD B-VP O
out RP O O
2 CD O O
) ) O O
CV NNP B-NP O
- : O O
I: NNP B-NP O
ruled VBD B-VP O
out RP O O
with IN B-VP O
enzymes NNS B-NP O
x3 VBP O O
Continue NNP B-NP O
ASA NNP I-NP B-m
, , O O
Metop NNP B-NP B-m
, , O O
Statin NNP B-NP B-m
, , O O
ACE NNP B-NP B-m
P NNP I-NP I-m
- : O O
CHF NN B-NP O
, , O O
likely RB O O
minor JJ B-NP O
flare NN I-NP O
2/2 CD O O
diet JJ B-NP O
non-compliance JJ I-NP O
Continue NNP I-NP O
Lasix NNP I-NP B-m
R: NNP I-NP O
pt NN I-NP O
appears VBZ O O
to TO O O
have VB O O
history NN B-NP O
of IN B-VP O
Afib/flutter NNP B-NP O
, , O O
unclear JJ O O
if IN B-VP O
goes VBZ O O
in IN B-VP O
and CC O O
out IN B-VP O
, , O O
but CC O O
pt VBP O O
states NNS B-NP O
always RB O O
in IN B-VP O
Afib NNP B-NP B-r
Rate NNP I-NP B-r
Rate NNP I-NP B-r
control NN I-NP I-r
control NN I-NP I-r
with IN B-VP O
BB NNP B-NP B-m
BB NNP I-NP B-m
, , O O
coumadin SYM O B-m
- : O O
last JJ B-NP O
INR NNP I-NP O
2.8 CD O O
3 CD O O
) ) O O
Endo NNP B-NP O
- : O O
h/o NN B-NP O
DM NNP I-NP O
- : O O
FS NNP B-NP O
high VBP O O
on IN B-VP O
HD1 NNP B-NP O
, , O O
now RB O O
140s CD O O
-150s NNS B-NP O
after IN B-VP O
increased VBN O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
dose VBD B-VP O
to TO O O
60 CD O B-do
60 CD O B-do
QAM NNP B-NP B-f
QAM NNP I-NP B-f
and CC O I-f
QPM NNP B-NP I-f
- : O O
cont NN B-NP O
RISS NNP I-NP B-m
4 CD O O
) ) O O
Psych NNP B-NP O
- : O O
h/o NN B-NP O
schizophrenia NN I-NP O
, , O O
with IN B-VP O
active JJ B-NP O
aud NN I-NP O
and CC O O
vis NN B-NP O
hallucinations NNS I-NP O
( ( O O
chronic JJ O O
, , O O
for IN B-VP O
years NNS B-NP O
) ) O O
ALso NNP B-NP O
, , O O
was VBD B-VP O
issue NN B-NP O
of IN B-VP O
domestic JJ B-NP O
violence NN I-NP O
from IN B-VP O
first JJ B-NP O
husband NN I-NP O
but CC O O
per IN B-VP O
social JJ B-NP O
work NN I-NP O
- : O O
this DT O O
appears VBZ O O
to TO O O
be VB O O
remote JJ B-NP O
SW NNP I-NP O
spoke VBD B-VP O
with IN B-VP O
patient NN B-NP O
in IN B-VP O
ED NNP B-NP O
No NNP I-NP O
psych NN I-NP O
consult NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
as IN B-VP O
psych JJ B-NP O
issues NNS I-NP O
appear VBP O O
to TO O O
be VB O O
at IN B-VP O
baseline JJ B-NP O
Social NNP I-NP O
Work NNP I-NP O
is VBZ O O
seeing VBG O O
patient JJ O O
regarding VBG O O
getting VBG O O
her PRP$ O O
section NN B-NP O
8 CD O O
housing NN B-NP O
5 CD O O
) ) O O
FEN NNP B-NP O
- : O O
Monitor NN B-NP O
Lytes VBZ O O
, , O O
replace VB O O
Mg NNP B-NP O
, , O O
K NNP B-NP O
as IN B-VP O
needed VBN O O
6 CD O O
) ) O O
Ppx NNP B-NP O
- : O O
on IN B-VP O
Coumadin NNP B-NP B-m
7 CD O O
) ) O O
CODE NNP B-NP O
- : O O
Full NNP B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
Sol NNP B-NP O
Kragt NNP I-NP O
, , O O
the DT B-NP O
CHF NNP I-NP O
nurse NN I-NP O
it PRP O O
is VBZ O O
very RB O O
important JJ O O
that IN B-VP O
you PRP O O
maintain VBP O O
your PRP$ O O
careful JJ B-NP O
low JJ I-NP O
salt NN I-NP O
diet NN I-NP O
and CC O O
do VBP O O
not RB O O
drink VB O O
too RB O O
many JJ B-NP O
fluids NNS I-NP O
Otherwise VBP O O
you PRP O O
will MD O O
end VB O O
up RP O O
back RB O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
Continue NNP I-NP O
to TO O O
measure VB O O
your PRP$ O O
daily JJ B-NP O
weights NNS I-NP O
Be VB O O
very RB O O
strict JJ O O
about IN B-VP O
taking VBG O O
your PRP$ O O
insulin NN B-NP B-m
Seek NNP I-NP O
medical JJ B-NP O
attention NN I-NP O
if IN B-VP O
you PRP O O
develop VBP O O
worsening VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
lightheadedness NN B-NP O
, , O O
dizziness NN B-NP O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
concerning NN I-NP O
symptoms NNS I-NP O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
SCHEFFEL NNP I-NP O
, , O O
SHANE NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
GI832 NNP B-NP O
) ) O O
2/17/05 CD O O
@ $ O O
10:56 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#699364 VBZ O O
048372102 CD O O
VSTMC NNP B-NP O
63794588 CD O O
4661987 CD O O
0/23/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/16/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/25/2005 CD O O
ATTENDING: NNP B-NP O
VANDERBIE NNP I-NP O
, , O O
SEBASTIAN NNP B-NP O
J NNP I-NP O
MD NNP I-NP O
, , O O
PHD NNP B-NP O
ADDENDUM NNP I-NP O
Please NNP I-NP O
note VB O O
this DT O O
is VBZ O O
an DT B-NP O
addendum NN I-NP O
to TO O O
the DT O O
previously RB O O
dictated VBN O O
discharge NN B-NP O
summary JJ B-NP O
#2200332 NNP I-NP O
INTERIM NNP I-NP O
HISTORY: NNP I-NP O
In IN B-VP O
the DT B-NP O
interim NN I-NP O
, , O O
since IN B-VP O
the DT O O
previously RB O O
dictated VBN O O
discharge NN B-NP O
summary NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
continued VBN O O
to TO O O
progress VB O O
from IN B-VP O
a DT B-NP O
cardiac JJ I-NP O
standpoint NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
His PRP$ O O
hospital NN B-NP O
course NN I-NP O
by IN B-VP O
system NN B-NP O
from IN B-VP O
9/24/05 CD O O
through IN B-VP O
the DT B-NP O
date NN I-NP O
of IN B-VP O
discharge NN B-NP O
is VBZ O O
as IN B-VP O
follows: JJ O O
1 CD O O
Ischemia: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
continued VBN O O
to TO O O
remain VB O O
stable JJ O O
from IN B-VP O
an DT B-NP O
ischemia NN I-NP O
standpoint NN I-NP O
He PRP O O
continues VBZ O O
on IN B-VP O
aspirin NN B-NP B-m
and CC O O
statin VB O B-m
A DT B-NP O
beta-blocker NN I-NP B-m
has VBZ O O
been VBN O O
added VBN O O
back RB O O
to TO O O
his PRP$ O O
regimen NNS B-NP O
and CC O O
was VBD B-VP O
titrated VBN O B-do
to TO O O
a DT B-NP O
dose NN I-NP O
of IN B-VP O
Lopressor NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d IN B-VP B-f
The DT B-NP O
patient NN I-NP O
has VBZ O O
not RB O O
been VBN O O
started VBN O O
on IN B-VP O
an DT B-NP O
ACE NNP I-NP O
inhibitor NN I-NP O
secondary NN I-NP O
to TO O O
his PRP$ O O
elevated JJ B-NP O
creatinine NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
He PRP O O
has VBZ O O
had VBN O O
no DT B-NP O
further JJ I-NP O
episodes NNS I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
2 CD O O
Pump: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
regimen NN I-NP O
was VBD B-VP O
titrated VBN O O
The DT B-NP O
patient NN I-NP O
continues VBZ O O
on IN B-VP O
Isordil NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
and CC O O
hydralazine NN B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
for IN B-VP O
after IN B-VP O
load NN B-NP O
reduction NN I-NP O
He PRP O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
a DT B-NP O
low-dose JJ I-NP O
beta-blocker NN I-NP B-m
beta-blocker NN I-NP B-m
at IN B-VP O
12.5 CD O B-do
12.5 CD O B-do
mg NN B-NP I-do
mg NN I-NP I-do
p.o NN I-NP B-mo
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
as RB O O
well RB O O
as IN B-VP O
digoxin NN B-NP B-m
at IN B-VP O
0.125 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.o.d VBD B-VP B-f
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
aggressively RB O O
diuresed VBN O O
with IN B-VP O
intravenous JJ B-NP B-mo
Lasix NNP I-NP B-m
and CC O O
Zaroxolyn NNP B-NP B-m
followed VBN O O
by IN B-VP O
conversion NN B-NP O
to TO O O
oral JJ B-NP B-mo
diuresis NN I-NP O
with IN B-VP O
torsemide NN B-NP B-m
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Rayford NNP I-NP O
Hogenmiller NNP I-NP O
in IN B-VP O
the DT B-NP O
Clevesa NNP I-NP O
Irvca NNP I-NP O
Sideenandri NNP I-NP O
as RB O O
well RB O O
as IN B-VP O
by IN B-VP O
the DT B-NP O
CHF NNP I-NP O
Service NNP I-NP O
at IN B-VP O
Sher-ship NNP B-NP O
Rimark's NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
nearing VBG O O
euvolemia JJ O O
with IN B-VP O
estimated VBN O O
dry JJ B-NP O
weight NN I-NP O
of IN B-VP O
approximately RB O O
76 CD O O
to TO O O
77 CD O O
kg NNS B-NP O
3 CD O O
Rhythm: NNP B-NP O
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
have VB O O
atrial JJ B-NP O
flutter NN I-NP O
with IN B-VP O
a DT B-NP O
block NN I-NP O
His PRP$ O O
heart NN B-NP O
rate NN I-NP O
remained VBD B-VP O
in IN B-VP O
the DT B-NP O
rate NN I-NP O
of IN B-VP O
100 CD O O
to TO O O
110 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
He PRP O O
had VBD B-VP O
decreased VBN O O
episodes NNS B-NP O
of IN B-VP O
more RBR O O
rapid JJ B-NP O
dysrhythmia NN I-NP O
following VBG O O
addition NN B-NP O
of IN B-VP O
beta-blocker NN B-NP B-m
and CC O O
digoxin NN B-NP B-m
to TO O O
his PRP$ O O
medication NN B-NP O
regimen NNS I-NP O
He PRP O O
also RB O O
continues VBZ O O
on IN B-VP O
amiodarone NN B-NP B-m
at IN B-VP O
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
As IN B-VP O
mentioned VBN O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
atrial JJ B-NP B-r
atrial JJ I-NP B-r
clot NN I-NP O
on IN B-VP O
transesophageal JJ B-NP O
echocardiogram NN I-NP O
and CC O O
thus RB O O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
heparin NN I-NP B-m
drip NN I-NP B-mo
and CC O O
transitioned VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
However RB O O
, , O O
after IN B-VP O
a DT B-NP O
substantial JJ I-NP O
discussion NN I-NP O
with IN B-VP O
the DT B-NP O
Congestive NNP I-NP O
Heart NNP I-NP O
Failure NNP I-NP O
Service NNP I-NP O
and CC O O
the DT B-NP O
patient's JJ I-NP O
outpatient NN I-NP O
CHF NNP I-NP O
Care NNP I-NP O
Team NNP I-NP O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT B-NP O
risks NNS I-NP O
of IN B-VP O
Coumadin NNP B-NP B-m
in IN B-VP O
this DT B-NP O
patient NN I-NP O
who WP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
significant JJ B-NP O
noncompliance NN I-NP O
were VBD B-VP O
greater JJR O O
than IN B-VP O
the DT O O
known VBN O O
risk NN B-NP O
of IN B-VP O
thromboembolic JJ B-NP O
disease NN I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
his PRP$ O O
known VBN O O
atrial JJ B-NP B-r
atrial JJ I-NP B-r
clot NN I-NP I-r
clot NN I-NP I-r
and CC O O
thus RB O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
not RB O O
continued VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
anticoagulation NN I-NP O
Rather NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
given VBN O O
aspirin NNS B-NP B-m
and CC O O
Plavix NNP B-NP B-m
at IN B-VP O
full JJ O B-do
full JJ O B-do
doses VBZ O O
The DT B-NP O
use NN I-NP O
of IN B-VP O
Coumadin NNP B-NP B-m
in IN B-VP O
this DT B-NP O
patient NN I-NP O
could MD O O
be VB O O
re-evaluated JJ O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
based VBN O O
on IN B-VP O
the DT B-NP O
patient's JJ I-NP O
follow-up NN I-NP O
as IN B-VP O
deemed VBN O O
appropriate NN B-NP O
by IN B-VP O
his PRP$ O O
outpatient NN B-NP O
providers NNS I-NP O
4 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
on IN B-VP O
stable JJ B-NP O
diabetes NNS I-NP O
mellitus VBP O O
regimen NNS B-NP O
of IN B-VP O
Lantus NNP B-NP B-m
5 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
and CC O O
standing VBG O O
NovoLog NNP B-NP B-m
3 CD O B-do
units NNS B-NP I-do
q.a.c RB O B-f
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
NovoLog NNP I-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
The DT B-NP O
patient's NN I-NP O
insulin NN I-NP B-m
regimen NNS I-NP I-m
can MD O O
be VB O O
adjusted VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
and CC O O
possibly RB O O
oral JJ B-NP B-mo
diabetes NNS I-NP B-m
medications NNS I-NP I-m
restarted VBD B-VP O
5 CD O O
Pulmonary: NNP B-NP O
The DT B-NP O
patient NN I-NP O
remained VBD B-VP O
stable JJ O O
from IN B-VP O
the DT O O
pulmonary JJ O O
with IN B-VP O
good JJ B-NP O
oxygen NN I-NP O
saturations NNS I-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
at IN B-VP O
rest NN B-NP O
and CC O O
with IN B-VP O
ambulation NN B-NP O
6 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
creatinine NN I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
was VBD B-VP O
1.6 CD O O
improved VBN O O
from IN B-VP O
the DT B-NP O
peak NN I-NP O
of IN B-VP O
greater JJR O O
than IN B-VP O
2 CD O O
Renal JJ B-NP O
toxic NN I-NP O
medications NNS I-NP O
were VBD B-VP O
avoided VBN O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
not RB O O
been VBN O O
restarted VBN O O
on IN B-VP O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
, , O O
which WDT O O
could MD O O
be VB O O
done VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
as IN B-VP O
his PRP$ O O
renal JJ B-NP O
function NN I-NP O
stabilizes VBZ O O
His PRP$ O O
electrolytes NNS B-NP O
were VBD B-VP O
monitored VBN O O
and CC O O
repleted VBN O O
aggressively RB O O
7 CD O O
Hematology: NNP B-NP O
As NNP I-NP O
mentioned VBD B-VP O
, , O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
not RB O O
to TO O O
anticoagulate VB O O
the DT B-NP O
patient NN I-NP O
with IN B-VP O
outpatient JJ B-NP O
Coumadin NNP I-NP O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
aspirin NN B-NP B-m
and CC O O
Plavix NNP B-NP B-m
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
decreased VBN O O
platelets NNS B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
heparin JJ B-NP B-m
anticoagulation NN I-NP O
and CC O O
thus RB O O
anti-P4 JJ B-NP O
antibody NN I-NP O
was VBD B-VP O
sent VBN O O
This DT B-NP O
test NN I-NP O
is VBZ O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
the DT B-NP O
dictation NN I-NP O
, , O O
but CC O O
should MD O O
be VB O O
followed VBN O O
up RP O O
by IN B-VP O
the DT B-NP O
patient's JJ I-NP O
outpatient JJ I-NP O
providers NNS I-NP O
as IN B-VP O
it PRP O O
may MD O O
input VB O O
further JJ B-NP O
treatment NN I-NP O
In IN B-VP O
the DT B-NP O
meantime NN I-NP O
, , O O
recommend VBP O O
no DT B-NP O
heparin NN I-NP O
products NNS I-NP O
As IN B-VP O
mentioned VBN O O
, , O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
by IN B-VP O
the DT B-NP O
CHF NNP I-NP O
Team NNP I-NP O
who WP O O
will MD O O
be VB O O
following VBG O O
the DT B-NP O
patient NN I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
not RB O O
to TO O O
continue VB O O
Coumadin NNP B-NP B-m
anticoagulation NN I-NP O
8 CD O O
Neuro: NNP B-NP O
Of IN B-VP O
note NN B-NP O
, , O O
on IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
6/13/05 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
complained VBD B-VP O
of IN B-VP O
left-sided JJ B-NP O
blurry NN I-NP O
vision NN I-NP O
, , O O
which WDT O O
was VBD B-VP O
new JJ O O
for IN B-VP O
the DT B-NP O
patient NN I-NP O
He PRP O O
does VBZ O O
have VB O O
chronic VBN O O
right JJ B-NP O
visual JJ I-NP O
changes NNS I-NP O
In IN B-VP O
light NN B-NP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
known VBN O O
peripheral JJ B-NP O
atherosclerotic JJ I-NP O
disease NN I-NP O
and CC O O
atrial JJ B-NP O
clot NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Stroke NNP I-NP O
Team NNP I-NP O
for IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
acute NN B-NP O
stroke NN I-NP O
He PRP O O
had VBD B-VP O
MRI NNP B-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
which WDT O O
did VBD B-VP O
show VB O O
multiple JJ B-NP O
old JJ I-NP O
infarcts NNS I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
frontal NN I-NP O
, , O O
right JJ B-NP O
occipital NN I-NP O
, , O O
left VBD B-VP O
occipitoparietal JJ O O
, , O O
left VBD B-VP O
posterior JJ B-NP O
frontal JJ I-NP O
areas NNS I-NP O
There EX O O
was VBD B-VP O
, , O O
however RB O O
, , O O
no DT B-NP O
new JJ I-NP O
stroke NN I-NP O
seen VBN O O
on IN B-VP O
the DT B-NP O
MRI NNP I-NP O
The DT B-NP O
left JJ I-NP O
internal JJ I-NP O
carotid NN I-NP O
artery NN I-NP O
was VBD B-VP O
not RB O O
evaluated VBN O O
, , O O
not RB O O
visualized VBN O O
on IN B-VP O
the DT B-NP O
MRI NNP I-NP O
and CC O O
there EX O O
was VBD B-VP O
concern NN B-NP O
for IN B-VP O
left NN B-NP O
carotid NN I-NP O
artery NN I-NP O
occlusion NN I-NP O
versus IN B-VP O
stenosis NN B-NP O
The DT B-NP O
patient NN I-NP O
declined VBD B-VP O
any DT B-NP O
procedure NN I-NP O
such JJ O O
as IN B-VP O
carotid JJ B-NP O
endarterectomy NN I-NP O
or CC O O
carotid NN B-NP O
stenting NN I-NP O
for IN B-VP O
his PRP$ O O
possible JJ B-NP O
carotid NN I-NP O
stenosis NN I-NP O
and CC O O
due JJ O O
to TO O O
this DT O O
denial JJ O O
no DT B-NP O
workup NN I-NP O
with IN B-VP O
the DT B-NP O
CTA NNP I-NP O
was VBD B-VP O
done VBN O O
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
because IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
decline VB O O
any DT B-NP O
intervention NN I-NP O
the DT B-NP O
risk NN I-NP O
of IN B-VP O
contrast NN B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
his PRP$ O O
acute JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
would MD O O
outweigh VB O O
the DT B-NP O
benefits NNS I-NP O
of IN B-VP O
the DT B-NP O
study NN I-NP O
The DT B-NP O
patient NN I-NP O
declined VBD B-VP O
any DT B-NP O
intervention NN I-NP O
for IN B-VP O
his PRP$ O O
carotid NN B-NP O
arteries NNS I-NP O
on IN B-VP O
several JJ B-NP O
occasions NNS I-NP O
A DT B-NP O
carotid NN I-NP O
noninvasives NNS I-NP O
were VBD B-VP O
ordered VBN O O
and CC O O
are VBP O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP O
dictation NN I-NP O
to TO O O
evaluate VB O O
the DT B-NP O
severity NN I-NP O
of IN B-VP O
disease NN B-NP O
9 CD O O
Social: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
sister NN I-NP O
, , O O
Alexis NNP B-NP O
Fernendez NNP I-NP O
, , O O
is VBZ O O
his PRP$ O O
health NN B-NP O
care NN I-NP O
proxy IN B-VP O
The DT B-NP O
patient NN I-NP O
in IN B-VP O
her PRP$ O O
presence NN B-NP O
has VBZ O O
declined VBN O O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting NN I-NP O
and CC O O
heart NN B-NP O
transplant NN I-NP O
evaluation NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
also RB O O
declined VBN O O
further JJ B-NP O
procedure NN I-NP O
for IN B-VP O
his PRP$ O O
probable JJ B-NP O
carotid NN I-NP O
artery NN I-NP O
stenosis NN I-NP O
10 CD O O
Disposition: NNP B-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
discharged VBN O O
to TO O O
the DT B-NP O
Com NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
further JJ B-NP O
rehabilitation NN I-NP O
He PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Kyle NNP I-NP O
Yandle NNP I-NP O
in IN B-VP O
the DT B-NP O
T NNP I-NP O
Las NNP I-NP O
on IN B-VP O
2/28/05 CD O O
at IN B-VP O
08:30 CD O O
a.m NN B-NP O
as RB O O
well RB O O
as IN B-VP O
with IN B-VP O
Dr NNP B-NP O
Clyde NNP I-NP O
Chatampaya NNP I-NP O
of IN B-VP O
Elmert NNP B-NP O
Hospital NNP I-NP O
Cardiology NNP I-NP O
9/26/05 CD O O
He PRP O O
also RB O O
has VBZ O O
a DT B-NP O
follow-up JJ I-NP O
appointment NN I-NP O
with IN B-VP O
TRISTONTERN NNP B-NP O
MEDICAL NNP I-NP O
CENTER NNP I-NP O
PCP NNP I-NP O
, , O O
Raymond NNP B-NP O
Banaag NNP I-NP O
, , O O
on IN B-VP O
10/3/05 CD O O
at IN B-VP O
01:50 CD O O
p.m IN B-VP O
The DT B-NP O
patient NN I-NP O
requires VBZ O O
substantial JJ B-NP O
social JJ I-NP O
support NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
which WDT O O
is VBZ O O
being VBG O O
provided VBN O O
by IN B-VP O
his PRP$ O O
sister NN B-NP O
MEDICATIONS NNP I-NP O
AT NNP I-NP O
THE NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
2 CD O O
Amiodarone NNP B-NP B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
3 CD O O
Digoxin NNP B-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.o.d VBD B-VP B-f
4 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
5 CD O O
Folate NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
6 CD O O
Robitussin NNP B-NP B-m
A-C NNP I-NP I-m
5 CD O B-do
mL NN B-NP I-do
p.o NN I-NP B-mo
q.4h NN I-NP B-f
p.r.n VBD B-VP I-f
cough JJ O B-r
7 CD O O
Hydralazine NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
8 CD O O
Isordil NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
9 CD O O
Lopressor NNP B-NP B-m
12.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.6h VBD B-VP B-f
10 CD O O
Simethicone NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.i.d NN I-NP B-f
p.r.n NN I-NP I-f
upset JJ B-NP B-r
stomach NN I-NP I-r
11 CD O O
Multivitamin NNP B-NP B-m
one CD O B-do
tab NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
12 CD O O
Compazine NNP B-NP B-m
5-10 JJ B-NP B-do
mg NN I-NP I-do
p.o NN I-NP B-mo
q.6h NN I-NP B-f
p.r.n NN I-NP I-f
nausea NN I-NP B-r
13 CD O O
Tessalon NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
p.r.n VBD B-VP I-f
cough JJ O B-r
14 CD O O
Torsemide NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
15 CD O O
Lipitor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
16 CD O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
17 CD O O
Lantus NNP B-NP B-m
5 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
q.p.m RB O B-f
18 CD O O
NovoLog NNP B-NP B-m
3 CD O B-do
units NNS B-NP I-do
subcu VBP O B-mo
a.c JJ B-NP B-f
Instructions NNP I-NP O
, , O O
give VB O O
only RB O O
if IN B-VP O
food NN B-NP O
in IN B-VP O
room NN B-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
eating NN I-NP O
, , O O
hold VBP O O
if IN B-VP O
n.p.o JJ O O
19 CD O O
NovoLog NNP B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
, , O O
please VB O O
do VB O O
not RB O O
give VB O O
any DT O O
sliding VBG O O
scale JJ B-NP O
coverage NN I-NP O
at IN B-VP O
h.s NN B-NP O
but CC O O
do VBP O O
record VB O O
fingerstick VB O O
blood NN B-NP O
glucose NN I-NP O
at IN B-VP O
h.s NN B-NP O
, , O O
hold VBP O O
if IN B-VP O
n.p.o JJ B-NP O
eScription NN I-NP O
document: VBZ O O
3-4123789 JJ B-NP O
CS NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
JANISZEWSKI NNP I-NP O
, , O O
TRAVIS NNP B-NP O
Attending: NNP I-NP O
INNES NNP I-NP O
, , O O
BRITT NNP B-NP O
P NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
7325126 CD O O
D: NNP B-NP O
4/6/05 CD O O
T: NNP B-NP O
4/6/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#700421 VBZ O O
599469946 CD O O
CLKH NNP B-NP O
55995690 CD O O
8330433 CD O O
8/19/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/30/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
ATTENDING: NNP I-NP O
KRIEGE NNP I-NP O
, , O O
DERRICK NNP B-NP O
M.D NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Right NNP I-NP O
thigh NN I-NP O
burn NN I-NP O
, , O O
cellulitis NN B-NP O
and CC O O
diabetic JJ B-NP O
ketoacidosis NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Ms NNP I-NP O
Hesby NNP I-NP O
is VBZ O O
a DT B-NP O
36-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
very RB O O
poorly RB O O
controlled VBN O O
type NN B-NP O
1 CD O O
diabetes NNS B-NP O
and CC O O
extensive JJ B-NP O
end NN I-NP O
organ JJ B-NP O
damage NN I-NP O
including VBG O O
end-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
on IN B-VP O
hemodialysis NN B-NP O
, , O O
right JJ B-NP O
eye NN I-NP O
blindness NN I-NP O
, , O O
lower JJR B-NP O
extremity NN I-NP O
neuropathy NN I-NP O
, , O O
gastroparesis NN B-NP O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
extensive JJ B-NP O
infections NNS I-NP O
including VBG O O
VRE NNP B-NP O
line NN I-NP O
sepsis NN I-NP O
, , O O
MRSA NNP B-NP O
, , O O
abdominal JJ B-NP O
abscesses NNS I-NP O
and CC O O
chronic JJ B-NP O
dermal NN I-NP O
ulcers NNS I-NP O
Due NNP I-NP O
to TO O O
her PRP$ O O
dermal JJ B-NP O
ulcers NNS I-NP O
, , O O
she PRP O O
developed VBD B-VP O
left VBD B-VP O
ankle JJ O O
osteomyelitis IN B-VP O
requiring VBG O O
below-the-knee JJ B-NP O
amputation NN I-NP O
She PRP O O
was VBD B-VP O
transferred VBN O O
from IN B-VP O
Shiredo NNP B-NP O
Sert NNP I-NP O
Of IN B-VP O
Valley NNP B-NP O
on IN B-VP O
3/28/06 CD O O
in IN B-VP O
DKA NNP B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
a DT B-NP O
right JJ I-NP O
thigh NN I-NP O
burn NN I-NP O
and CC O O
possible JJ B-NP O
infection NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
her PRP$ O O
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
she PRP O O
spilled VBD B-VP O
hot JJ B-NP O
broth NN I-NP O
on IN B-VP O
her PRP$ O O
right JJ B-NP O
thigh NN I-NP O
and CC O O
developed VBD B-VP O
a DT B-NP O
painful JJ I-NP O
red JJ I-NP O
bullae NN I-NP O
She PRP O O
presented VBD B-VP O
to TO O O
Path NNP B-NP O
Community NNP I-NP O
Hospital NNP I-NP O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
but CC O O
still RB O O
she PRP O O
had VBD B-VP O
an DT B-NP B-r
infection NN I-NP O
She PRP O O
was VBD B-VP O
given VBN O O
a DT B-NP O
prescription NN I-NP O
for IN B-VP O
antibiotics NNS B-NP B-m
, , O O
which WDT O O
she PRP O O
did VBD B-VP O
not RB O O
fill VB O O
The DT B-NP O
area NN I-NP O
of IN B-VP O
swelling VBG O O
in IN B-VP O
her PRP$ O O
right JJ B-NP O
leg NN I-NP O
did VBD B-VP O
not RB O O
spread VB O O
from IN B-VP O
the DT B-NP O
original JJ I-NP O
blister NN I-NP O
area NN I-NP O
all PDT O O
the DT B-NP O
way NN I-NP O
up IN B-VP O
to TO O O
her PRP$ O O
groin NN B-NP O
and CC O O
grossly RB O O
became VBD B-VP O
more RBR O O
tender NN B-NP O
and CC O O
warm NN B-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
she PRP O O
returned VBD B-VP O
to TO O O
the DT B-NP O
Threei NNP I-NP O
Cent NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Room NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
Of IN B-VP O
note NN B-NP O
, , O O
in IN B-VP O
going VBG O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
, , O O
she PRP O O
missed VBD B-VP O
her PRP O O
regular JJ B-NP O
hemodialysis NN I-NP O
In IN B-VP O
the DT B-NP O
Ingsparks NNP I-NP O
Down NNP I-NP O
Health NNP I-NP O
Emergency NNP I-NP O
room NN I-NP O
, , O O
the DT B-NP O
following JJ I-NP O
vital JJ I-NP O
signs NNS I-NP O
were VBD B-VP O
noted VBN O O
Temperature NNP B-NP O
afebrile NN I-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
60 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
150/50 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
WBC NNP I-NP O
4.3 CD O O
, , O O
hematocrit NN B-NP O
38 CD O O
, , O O
sodium NN B-NP O
126 CD O O
, , O O
potassium NN B-NP O
7.9 CD O O
, , O O
glucose JJ O O
1221 CD O O
, , O O
anion NN B-NP O
gap NN I-NP O
13 CD O O
, , O O
acetone RB O O
negative JJ O O
, , O O
AST NNP B-NP O
385 CD O O
, , O O
ALT NNP B-NP O
127 CD O O
and CC O O
alk VB O O
phos NN B-NP O
411 CD O O
EKG NNP B-NP O
revealed VBD B-VP O
peak JJ B-NP O
Q NNP I-NP O
waves VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
given VBN O O
20 CD O B-do
units NNS B-NP I-do
of IN B-VP O
IV NNP B-NP B-mo
insulin NN I-NP B-m
and CC O O
then RB O O
was VBD B-VP O
started VBN O O
on IN B-VP O
an DT B-NP O
insulin NN I-NP B-m
drip NN I-NP B-mo
8 CD O B-do
units NNS B-NP I-do
per IN B-VP B-f
hour NN B-NP I-f
She PRP O O
also RB O O
received VBD B-VP O
2 CD O B-do
amps NNS B-NP O
of IN B-VP O
calcium NN B-NP B-m
gluconate NN I-NP I-m
as RB O O
well RB O O
as IN B-VP O
Kayexalate NNP B-NP B-m
and CC O O
albuterol VB O B-m
nebs FW O B-mo
A DT B-NP O
repeat NN I-NP O
Chem-7 NNP I-NP O
in IN B-VP O
the DT B-NP O
Amoore NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
ED NNP I-NP O
showed VBD B-VP O
a DT B-NP O
glucose NN I-NP O
of IN B-VP O
1100 CD O O
and CC O O
an DT B-NP O
anion NN I-NP O
gap NN I-NP O
of IN B-VP O
18 CD O O
with IN B-VP O
potassium NN B-NP O
5.4 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
MICU NNP I-NP O
at IN B-VP O
EH NNP B-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
her PRP$ O O
transfer NN B-NP O
, , O O
she PRP O O
noted VBD B-VP O
left-sided JJ B-NP O
headache NN I-NP O
, , O O
a DT B-NP O
warm JJ I-NP O
feeling NN I-NP O
over IN B-VP O
her PRP$ O O
right JJ B-NP O
thigh NN I-NP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
recent JJ I-NP O
fever NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
or CC O O
diarrhea VB O O
She PRP O O
did VBD B-VP O
note NN B-NP O
that IN B-VP O
her PRP$ O O
last JJ B-NP O
bowel JJ I-NP O
movement NN I-NP O
was VBD B-VP O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission VB O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Poor NNP B-NP O
controlled VBD B-VP O
type JJ O O
1 CD O O
diabetes VBZ O O
2 CD O O
End-stage JJ B-NP O
renal JJ I-NP O
disease NN I-NP O
on IN B-VP O
hemodialysis NN B-NP O
Monday NNP I-NP O
, , O O
Wednesday NNP B-NP O
and CC O O
Friday NNP B-NP O
- : O O
left VBD B-VP O
chest JJ B-NP O
hemodialysis NN I-NP O
catheter NN I-NP O
for IN B-VP O
access NN B-NP O
3 CD O O
History NNP B-NP O
of IN B-VP O
VRE NNP B-NP O
line NN I-NP O
sepsis NN I-NP O
4 CD O O
History NNP B-NP O
of IN B-VP O
MRSA NNP B-NP O
5 CD O O
History NNP B-NP O
of IN B-VP O
abdominal JJ B-NP O
abscess NN I-NP O
6 CD O O
Chronic NNP B-NP O
dermal JJ B-NP O
ulcers NNS I-NP O
7 CD O O
CHF NNP B-NP O
8 CD O O
History NNP B-NP O
of IN B-VP O
cardiac JJ B-NP O
murmur NN I-NP O
9 CD O O
Seizure NNP B-NP O
disorder NN I-NP O
10 CD O O
Multiple NNP B-NP O
strokes NNS I-NP O
11 CD O O
Chronic NNP B-NP O
nausea NN I-NP O
12 CD O O
Personality NNP B-NP O
disorder NN I-NP O
, , O O
deemed VBD B-VP O
not RB O O
to TO O O
have VB O O
capacity NN B-NP O
- : O O
guardian NN B-NP O
is VBZ O O
Carlton NNP B-NP O
Wender NNP I-NP O
# # O O
880-357-5648 JJ B-NP O
HOME NNP I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Lantus NNP B-NP B-m
24 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
each DT B-NP B-f
night NN I-NP I-f
2 CD O O
NovoLog NNP B-NP B-m
sliding VBG O B-do
scale JJ O I-do
3 CD O O
PhosLo NNP B-NP B-m
4 CD O O
Nephrocaps NNP B-NP B-m
5 CD O O
Vitamin NNP B-NP B-m
D NNP I-NP I-m
6 CD O O
Sevelamer NNP B-NP B-m
1600 CD O B-do
t.i.d NN B-NP B-f
7 CD O O
Toprol NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
8 CD O O
Lisinopril NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
9 CD O O
Plavix NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
10 CD O O
Keppra NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
11 CD O O
Flovent NNP B-NP B-m
two CD O B-do
puffs NNS B-NP I-do
b.i.d VBD B-VP B-f
12 CD O O
Albuterol NNP B-NP B-m
p.r.n NN I-NP B-f
13 CD O O
Baclofen NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
14 CD O O
Ambien NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
bedtime NN B-NP I-f
p.r.n NN I-NP I-f
TRANSFER NNP I-NP O
MEDICATIONS: NNP I-NP O
None NNP I-NP O
ALLERGIES: NNP I-NP O
Aspirin NNP I-NP O
causes VBZ O O
tongue JJ O O
swelling VBG O O
Codeine NNP B-NP O
, , O O
erythromycin NN B-NP O
beef NN I-NP O
, , O O
poke NN B-NP O
and CC O O
insulin NN B-NP O
all DT O O
caused VBD B-VP O
unknown JJ B-NP O
reactions NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
with IN B-VP O
a DT B-NP O
personal JJ I-NP O
care NN I-NP O
assistant NN I-NP O
and CC O O
her PRP$ O O
daughter NN B-NP O
She PRP O O
has VBZ O O
four CD O O
children NNS B-NP O
ages VBZ O O
5 CD O O
to TO O O
20 CD O O
She PRP O O
denies VBZ O O
tobacco NN B-NP O
use NN I-NP O
or CC O O
alcohol NN B-NP O
use NN I-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
illegal JJ I-NP O
drug NN I-NP O
use NN I-NP O
Guardian NNP I-NP O
is VBZ O O
Malik NNP B-NP O
Conly NNP I-NP O
, , O O
telephone NN B-NP O
number NN I-NP O
880-357-5648 JJ B-NP O
Per NNP I-NP O
court NN I-NP O
order NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
have VB O O
capacity NN B-NP O
to TO O O
make VB O O
medical JJ B-NP O
decisions NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Noncontributory NNP I-NP O
NOTABLE NNP I-NP O
ADMISSION NNP I-NP O
EXAM: NNP I-NP O
Weight NNP I-NP O
70 CD O O
kg NN B-NP O
General NNP I-NP O
, , O O
sleepy NN B-NP O
, , O O
but CC O O
arousable JJ B-NP O
A&amp;O NNP I-NP O
x3 NNP I-NP O
, , O O
conversant NN B-NP O
and CC O O
cooperative JJ B-NP O
HEENT NNP I-NP O
, , O O
blind RB O O
right JJ B-NP O
eye NN I-NP O
, , O O
left VBD B-VP O
eye NN B-NP O
reactive JJ B-NP O
OP NNP I-NP O
clear JJ O O
with IN B-VP O
moist JJ B-NP O
mucous JJ I-NP O
membranes NNS I-NP O
Neck NNP I-NP O
supple NN I-NP O
Chest NNP I-NP O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
No NNP B-NP O
dullness NN I-NP O
Cardiovascular NNP I-NP O
, , O O
JVP NNP B-NP O
flat JJ B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm $ O O
3/6 CD O O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
with IN B-VP O
low JJ B-NP O
rumble NN I-NP O
at IN B-VP O
the DT B-NP O
left NN I-NP O
lower RBR O O
sternal JJ B-NP O
border NN I-NP O
radiating VBG O O
to TO O O
the DT B-NP O
apex NN I-NP O
No NNP I-NP O
delaying NN I-NP O
carotid NN I-NP O
upstrokes JJ B-NP O
Abdomen NNP I-NP O
distended VBD B-VP O
Positive NNP B-NP O
bowel NN I-NP O
sounds VBZ O O
Nontender NNP B-NP O
Visible NNP I-NP O
old JJ B-NP O
peritoneal JJ I-NP O
dialysis NN I-NP O
site NN I-NP O
with IN B-VP O
serosanguinous JJ B-NP O
drainage NN I-NP O
and CC O O
granulation NN B-NP O
, , O O
otherwise RB O O
noninflamed VBN O O
and CC O O
nontender JJ B-NP O
Extremities NNS I-NP O
, , O O
left VBD B-VP O
BKA NNP B-NP O
, , O O
well RB O O
healed VBN O O
Right NNP B-NP O
thigh $ O O
4 CD O O
x JJ B-NP O
5-cm JJ I-NP O
open JJ I-NP O
bullae NN I-NP O
with IN B-VP O
clear JJ B-NP O
drainage NN I-NP O
and CC O O
a DT O O
surrounding VBG O O
tender NN B-NP O
area NN I-NP O
of IN B-VP O
erythema NN B-NP O
and CC O O
warmth NN B-NP O
extending VBG O O
up RP O O
to TO O O
the DT B-NP O
groin NN I-NP O
and CC O O
down RB O O
to TO O O
the DT B-NP O
knee NN I-NP O
, , O O
2+ CD O O
dorsalis NN B-NP O
pedis NN I-NP O
pulse NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
Neurological NNP I-NP O
, , O O
A&amp;O NNP B-NP O
x3 NNP I-NP O
, , O O
cooperative JJ O O
, , O O
anxious JJ O O
about IN B-VP O
getting VBG O O
IV NNP B-NP O
access NN I-NP O
Skin NNP I-NP O
, , O O
multiple JJ B-NP O
excoriation NN I-NP O
, , O O
all DT B-NP O
subcentimeter NN I-NP O
macules NNS I-NP O
NOTABLE NNP I-NP O
LABS: NNP I-NP O
Sodium NNP I-NP O
133 CD O O
, , O O
potassium NN B-NP O
4.3 CD O O
, , O O
chloride RB O O
98 CD O O
, , O O
bicarbonate NN B-NP O
19 CD O O
, , O O
BUN NNP B-NP O
47 CD O O
, , O O
creatinine NN B-NP O
8.3 CD O O
, , O O
calcium NN B-NP O
8.5 CD O O
, , O O
magnesium NN B-NP O
2.1 CD O O
, , O O
phosphate NN B-NP O
2.9 CD O O
, , O O
anion NN B-NP O
gap NN I-NP O
15 CD O O
, , O O
ALT NNP B-NP O
84 CD O O
, , O O
AST NNP B-NP O
186 CD O O
, , O O
alk VBP O O
phos JJ O O
264 CD O O
, , O O
T NNP B-NP O
bili VBD B-VP O
1.0 CD O O
, , O O
troponin NN B-NP O
less JJR O O
than IN B-VP O
assay NN B-NP O
, , O O
BNP NNP B-NP O
4900 CD O O
, , O O
amylase NN B-NP O
and CC O O
lipase NN B-NP O
normal JJ O O
, , O O
serum JJ O O
osms FW O O
337 CD O O
, , O O
lactate NN B-NP O
4.7 CD O O
, , O O
WBC NNP B-NP O
5.3 CD O O
, , O O
hematocrit NN B-NP O
31.6 CD O O
, , O O
platelets NNS B-NP O
208 CD O O
, , O O
000 CD O O
, , O O
INR NNP B-NP O
1.3 CD O O
ABG NNP B-NP O
7.28/42/128 CD O O
EKG NNP B-NP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
74 CD O O
, , O O
normal JJ B-NP O
axis NN I-NP O
, , O O
normal JJ B-NP O
intervals NNS I-NP O
, , O O
no DT B-NP O
ischemia NN I-NP O
, , O O
no DT B-NP O
peak JJ I-NP O
T-waves NNS I-NP O
Echo NNP I-NP O
in IN B-VP O
July NNP B-NP O
2006 CD O O
, , O O
mild FW O O
LVH NNP B-NP O
, , O O
EF NNP B-NP O
65% CD O O
to TO O O
70% CD O O
, , O O
no DT B-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities NNS I-NP O
, , O O
mildly RB O O
enlarged VBD B-VP O
right JJ B-NP O
ventricle NN I-NP O
, , O O
normal JJ B-NP O
RV NNP I-NP O
outflow NN I-NP O
tract NN I-NP O
, , O O
mild JJ O O
left VBD B-VP O
atrial JJ B-NP O
enlargement NN I-NP O
, , O O
mild VB O O
right JJ B-NP O
atrial JJ I-NP O
enlargement NN I-NP O
, , O O
mild JJ B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
, , O O
trace NN B-NP O
mitral JJ B-NP O
regurgitation NN I-NP O
, , O O
trace NN B-NP O
tricuspid JJ B-NP O
regurgitation NN I-NP O
, , O O
pulmonary JJ B-NP O
artery NN I-NP O
pressure NN I-NP O
of IN B-VP O
48 CD O O
, , O O
IVC NNP B-NP O
dilated VBD B-VP O
with IN B-VP O
diminished JJ B-NP O
respirophasic JJ I-NP O
variation NN I-NP O
consistent NN I-NP O
with IN B-VP O
markedly RB O O
elevated VBN O O
right JJ B-NP O
atrial JJ I-NP O
pressure NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
DKA: NNP B-NP B-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
stabilized VBN O O
in IN B-VP O
the DT B-NP O
MICU NNP I-NP O
on IN B-VP O
an DT B-NP O
insulin NN I-NP B-m
drip NN I-NP B-mo
and CC O O
was VBD B-VP O
then RB O O
transferred VBN O O
to TO O O
General NNP B-NP O
Medicine NNP I-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
Causes NNP I-NP O
of IN B-VP O
DKA NNP B-NP O
that WDT O O
were VBD B-VP O
ruled VBN O O
out RP O O
included VBD B-VP O
the DT O O
following JJ O O
- : O O
negative JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
, , O O
unimpressive JJ B-NP O
pancreatic JJ I-NP O
enzymes NNS I-NP O
, , O O
unimpressive JJ B-NP O
lactate NN I-NP O
, , O O
normal JJ B-NP O
LFTs NNP I-NP O
The DT B-NP O
patient's NN I-NP O
DKA NNP I-NP O
was VBD B-VP O
presumed VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
her PRP$ O B-r
right JJ B-NP I-r
thigh NN I-NP I-r
cellulitis NN I-NP I-r
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
a DT B-NP O
local JJ I-NP O
burn NN I-NP O
She PRP O O
initially RB O O
was VBD B-VP O
given VBN O O
500 CD O B-do
mL JJ B-NP I-do
normal JJ I-NP B-m
normal JJ I-NP B-m
saline NN I-NP O
boluses NNS I-NP B-mo
and CC O O
then RB O O
several JJ O O
250 CD O B-do
mL JJ B-NP I-do
boluses NNS I-NP B-mo
As IN B-VP O
she PRP O O
is VBZ O O
aneuric JJ O O
, , O O
her PRP$ O O
boluses NNS B-NP O
were VBD B-VP O
stopped VBN O O
once RB O O
the DT B-NP O
blood NN I-NP O
sugars NNS I-NP O
were VBD B-VP O
below IN B-VP O
500 CD O O
She PRP O O
initially RB O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
insulin NN B-NP B-m
drip NN I-NP B-mo
that WDT O O
was VBD B-VP O
then RB O O
transitioned VBN O O
to TO O O
NPH NNP B-NP B-m
and CC O O
finally RB O O
to TO O O
Lantus NNP B-NP B-m
24 CD O B-do
units NNS B-NP I-do
subcu JJ O B-mo
daily JJ O B-f
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
intermittently RB O O
refused VBD B-VP O
to TO O O
take VB O O
both DT O O
her PRP$ O O
long-acting NN B-NP O
and CC O O
her PRP$ O O
insulin NN B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
As IN B-VP O
a DT B-NP O
result NN I-NP O
, , O O
an DT B-NP O
endocrinology NN I-NP O
consult NN I-NP O
was VBD B-VP O
called VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
ordering VBG O O
extra JJ B-NP O
food NN I-NP O
from IN B-VP O
the DT B-NP O
kitchen NN I-NP O
, , O O
which WDT O O
could MD O O
in IN B-VP O
part NN B-NP O
explain VBP O O
her PRP$ O O
labile JJ B-NP O
sugars NNS I-NP O
Despite IN B-VP O
careful JJ O O
diet JJ O O
and CC O O
glucose JJ B-NP O
control NN I-NP O
efforts NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
still RB O O
had VBD B-VP O
sugars NNS B-NP O
at IN B-VP O
times NNS B-NP O
to TO O O
the DT O O
500s CD O O
Endocrinology NNP B-NP O
continues VBZ O O
to TO O O
leave VB O O
recommendations NNS B-NP O
about IN B-VP O
AC NNP B-NP O
standing VBG O O
insulin NN B-NP O
in IN B-VP O
addition NN B-NP O
to TO O O
her PRP$ O O
NovoLog NNP B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
and CC O O
Lantus NNP B-NP B-m
insulin VBP O I-m
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
gastroparesis NN B-NP O
and CC O O
therefore NN B-NP O
may MD O O
not RB O O
tolerate VB O O
AC NNP B-NP B-f
insulin NN I-NP B-m
very RB O O
well RB O O
The DT B-NP O
patient's NN I-NP O
new JJ O O
covering VBG O O
team NN B-NP O
will MD O O
continue VB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Endocrinology NNP B-NP O
2 CD O O
Right NNP B-NP B-r
Right NNP I-NP B-r
Right NNP I-NP B-r
thigh RB O I-r
thigh RB O I-r
thigh JJ B-NP I-r
cellulitis: NN I-NP I-r
cellulitis: NN I-NP I-r
cellulitis: VBD B-VP I-r
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
Augmentin NNP B-NP B-m
and CC O O
IV NNP B-NP B-mo
IV NNP I-NP B-mo
vancomycin VBD B-VP B-m
Her NNP B-NP O
area NN I-NP O
of IN B-VP O
cellulitis NN B-NP O
has VBZ O O
completely RB O O
resolved VBN O O
at IN B-VP O
the DT B-NP O
present JJ I-NP O
time NN I-NP O
with IN B-VP O
slight JJ B-NP O
sloughing NN I-NP O
of IN B-VP O
the DT O O
overlying VBG O O
skin VBD B-VP O
The DT B-NP O
underlying JJ I-NP O
skin NN I-NP O
is VBZ O O
pink VBN O O
with IN B-VP O
evidence NN B-NP O
of IN B-VP O
good JJ B-NP O
granulation NN I-NP O
and CC O O
no DT B-NP O
further JJ I-NP O
evidence NN I-NP O
of IN B-VP O
infection NN B-NP O
Given NNP I-NP O
that IN B-VP O
her PRP$ O O
IV NNP B-NP O
access NN I-NP O
is VBZ O O
very RB O O
difficult JJ O O
, , O O
the DT B-NP O
patient NN I-NP O
received VBD B-VP O
some DT B-NP O
vancomycin NN I-NP B-m
, , O O
as IN B-VP O
she PRP O O
finishes VBZ O O
hemodialysis NN B-NP O
every DT B-NP B-f
other JJ I-NP I-f
day NN I-NP I-f
3 CD O O
End-stage JJ B-NP O
renal JJ I-NP O
disease: NN I-NP O
The DT B-NP O
patient NN I-NP O
missed VBD B-VP O
her PRP$ O O
dialysis NN B-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
Once NNP I-NP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
her PRP$ O O
potassium NN B-NP O
was VBD B-VP O
very RB O O
difficult JJ O O
to TO O O
control VB O O
in IN B-VP O
part NN B-NP O
due JJ O O
to TO O O
poor JJ B-NP O
adherence NN I-NP O
with IN B-VP O
her PRP$ O O
renal JJ B-NP O
diet NN I-NP O
and CC O O
in IN B-VP O
part NN B-NP O
due JJ O O
to TO O O
her PRP$ O O
very RB O O
labile JJ B-NP O
sugars NNS I-NP O
At IN B-VP O
times NNS B-NP O
, , O O
her PRP$ O O
potassium NN B-NP O
would MD O O
rapidly RB O O
increase VB O O
to TO O O
a DT B-NP O
level NN I-NP O
higher JJR O O
than IN B-VP O
6.5 CD O O
requiring VBG O O
urgent JJ B-NP O
dialysis NN I-NP O
At IN B-VP O
the DT B-NP O
present JJ I-NP O
time NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
dialyzed VBN O O
daily JJ O O
since IN B-VP O
her PRP$ O O
admission NN B-NP O
She PRP O O
is VBZ O O
closely RB O O
followed VBN O O
by IN B-VP O
renal JJ O O
with IN B-VP O
plans NNS B-NP O
to TO O O
continue VB O O
dialysis NN B-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
She PRP O O
should MD O O
not RB O O
receive VB O O
any DT O O
further RB O O
intravenous JJ B-NP O
fluids NNS I-NP O
unless IN B-VP O
she PRP O O
has VBZ O O
evidence NN B-NP O
of IN B-VP O
recurrent NN B-NP O
DKA NNP I-NP O
, , O O
given VBN O O
her PRP$ O O
anuric JJ B-NP O
state NN I-NP O
Should NNP I-NP O
she PRP O O
become VBD B-VP O
acidotic JJ O O
, , O O
the DT B-NP O
patient NN I-NP O
can MD O O
be VB O O
managed VBN O O
with IN B-VP O
sodium NN B-NP B-m
bicarbonate NN I-NP O
and CC O O
D5W NNP B-NP B-m
in IN B-VP O
small JJ B-NP O
boluses NNS I-NP O
4 CD O O
Cardiovascular: NNP B-NP O
Ischemia NNP I-NP O
, , O O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
showed VBN O O
no DT B-NP O
EKG NNP I-NP O
signs NNS I-NP O
of IN B-VP O
ischemia NN B-NP O
Her NNP I-NP O
cardiac NN I-NP O
enzymes NNS I-NP O
remained VBD B-VP O
negative JJ B-NP O
Lipids NNP I-NP O
are VBP O O
pending VBG O O
at IN B-VP O
the DT B-NP O
present JJ I-NP O
time NN I-NP O
Lipid NNP I-NP O
profile NN I-NP O
check NN I-NP O
is VBZ O O
pending VBG O O
at IN B-VP O
the DT B-NP O
present JJ I-NP O
time NN I-NP O
Pump NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
CHF NNP B-NP O
with IN B-VP O
evidence NN B-NP O
of IN B-VP O
right JJ B-NP O
heart NN I-NP O
failure NN I-NP O
likely RB O O
due JJ O O
to TO O O
valvular JJ B-NP O
disease NN I-NP O
in IN B-VP O
some DT B-NP O
aspect NN I-NP O
of IN B-VP O
the DT B-NP O
diastolic JJ I-NP O
dysfunction NN I-NP O
given VBN O O
her PRP$ O O
preserved JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
Her NNP I-NP O
weight NN I-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
70 CD O O
kg NN B-NP O
We PRP O O
did VBD B-VP O
not RB O O
know VB O O
her PRP$ O O
dry JJ B-NP O
weight NN I-NP O
Dialysis NNP I-NP O
is VBZ O O
helping VBG O O
to TO O O
manage VB O O
her PRP$ O O
fluids NNS B-NP O
given VBN O O
her PRP$ O O
aneuric JJ B-NP O
status NN I-NP O
Her NNP I-NP O
O2 NNP I-NP O
sats NNS I-NP O
remained VBD B-VP O
stable JJ O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
throughout IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
Her NNP I-NP B-r
hypertension NN I-NP I-r
has VBZ O O
been VBN O O
somewhat RB O O
poorly RB O O
controlled VBN O O
and CC O O
for IN B-VP O
that DT B-NP O
reason NN I-NP O
she PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
Lopressor NNP B-NP B-m
25 CD O B-do
q.i.d NN B-NP B-f
and CC O O
switched VBD B-VP O
to TO O O
Captopril NNP B-NP B-m
, , O O
which WDT O O
we PRP O O
continued VBD B-VP O
to TO O O
titrate VB O O
at IN B-VP O
the DT B-NP O
present JJ I-NP O
time NN I-NP O
Rhythm NNP I-NP O
, , O O
normal JJ B-NP O
sinus NN I-NP O
rhythm VBD B-VP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
currently RB O O
on IN B-VP O
telemetry NN B-NP O
with IN B-VP O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
arrhythmia NN B-NP O
5 CD O O
Fluids NNP B-NP O
, , O O
electrolytes VBZ O O
, , O O
nutrition: VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP O
cardiac NN I-NP O
, , O O
renal JJ O O
and CC O O
diabetic JJ B-NP O
diet NN I-NP O
She PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
repeatedly RB O O
order NN B-NP O
extra JJ B-NP O
food NN I-NP O
from IN B-VP O
the DT B-NP O
kitchen NN I-NP O
supervisor NN I-NP O
Nutrition NNP I-NP O
endocrinology NN I-NP O
and CC O O
nursing JJ B-NP O
staff NN I-NP O
are VBP O O
all DT O O
aware JJ O O
and CC O O
are VBP O O
working VBG O O
diligently RB O O
to TO O O
prevent VB O O
the DT B-NP O
patient NN I-NP O
from IN B-VP O
receiving VBG O O
more JJR O O
than IN B-VP O
2000 CD O O
calories NNS B-NP O
per VBP O O
day NN B-NP O
as IN B-VP O
specified VBN O O
by IN B-VP O
her PRP$ O O
ADA NNP B-NP O
diet NN I-NP O
She PRP O O
is VBZ O O
continuing VBG O O
her PRP$ O O
Nephrocaps NNP B-NP B-m
and CC O O
sevelamer JJR B-NP B-m
Prophylaxis NNP I-NP B-r
Prophylaxis NNP I-NP B-r
, , O O
heparin NN B-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subcu VBP O B-mo
t.i.d SYM O B-f
- : O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
consistently RB O O
refused VBN O O
her PRP$ O O
heparin NN B-NP B-m
6 CD O O
Consent: NNP B-NP O
All NNP I-NP O
interventions NNS I-NP O
require VBP O O
consent NN B-NP O
from IN B-VP O
the DT B-NP O
patient's NN I-NP O
medical JJ B-NP O
guardian NN I-NP O
, , O O
Stanley NNP B-NP O
Paneque NNP I-NP O
( ( O O
please VB O O
see VB O O
number NN B-NP O
above IN B-VP O
) ) O O
7 CD O O
Code NNP B-NP O
status: VBD B-VP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
full JJ B-NP O
code NN I-NP O
and CC O O
this DT O O
has VBZ O O
been VBN O O
confirmed VBN O O
with IN B-VP O
the DT B-NP O
guardian JJ I-NP O
ADDENDUM NNP I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
on IN B-VP O
the DT B-NP O
night NN I-NP O
of IN B-VP O
1/26/06 CD O O
, , O O
the DT B-NP O
patient NN I-NP O
complained VBD B-VP O
of IN B-VP O
severe JJ B-NP O
cramping NN I-NP O
, , O O
right JJ B-NP O
lower JJR I-NP O
quadrant NN I-NP O
pain NN I-NP O
, , O O
which WDT O O
is VBZ O O
new JJ O O
She PRP O O
noted VBD B-VP O
this DT B-NP O
pain NN I-NP O
has VBZ O O
increased VBN O O
rapidly RB O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
diarrhea JJ B-NP O
Several NNP I-NP O
C NNP I-NP O
diff NN I-NP O
studies NNS I-NP O
, , O O
which WDT O O
were VBD B-VP O
sent VBN O O
recently RB O O
have VBP O O
been VBN O O
negative JJ O O
and CC O O
the DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
no DT B-NP O
blood NN I-NP O
in IN B-VP O
her PRP$ O O
diarrhea NN B-NP B-r
Presumed NNP I-NP O
cause NN I-NP O
is VBZ O O
Augmentin NNP B-NP B-m
, , O O
which WDT O O
has VBZ O O
been VBN O O
stopped VBN O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
continued VBN O O
to TO O O
eat VB O O
freely RB O O
and CC O O
is VBZ O O
passing VBG O O
diarrhea JJ O O
despite IN B-VP O
her PRP$ O O
complaints NNS B-NP O
of IN B-VP O
10/10 CD O O
severe JJ B-NP O
abdominal JJ I-NP O
pain NN I-NP O
A NNP I-NP O
CT NNP I-NP O
scan NN I-NP O
of IN B-VP O
her PRP$ O O
abdomen NNS B-NP O
was VBD B-VP O
ordered VBN O O
, , O O
but CC O O
she PRP O O
refused VBD B-VP O
to TO O O
take VB O O
oral JJ O O
or CC O O
IV NNP B-NP O
contrast VBP O O
The DT B-NP O
results NNS I-NP O
of IN B-VP O
this DT B-NP O
CT NNP I-NP O
scan NN I-NP O
are VBP O O
pending VBG O O
and CC O O
will MD O O
be VB O O
followed VBN O O
up RP O O
by IN B-VP O
the DT B-NP O
new JJ I-NP O
medical JJ I-NP O
team NN I-NP O
eScription NN I-NP O
document: VBD B-VP O
3-4408397 JJ B-NP O
CSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
TARONE NNP I-NP O
, , O O
ANTONIA NNP B-NP O
Attending: NNP I-NP O
JAME NNP I-NP O
CHATTERTON NNP I-NP O
, , O O
M.D NNP B-NP O
LD63 NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
5989686 CD O O
D: NNP B-NP O
11/29/06 CD O O
T: NNP B-NP O
11/29/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#701307 VBZ O O
214970012 CD O O
MH NNP B-NP O
93476909 CD O O
8756858 CD O O
6/21/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/19/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/13/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
DESIATO NNP I-NP O
, , O O
LLOYD NNP B-NP O
443-91-88-7 CD O O
Charljer NNP B-NP O
Ster NNP I-NP O
Po NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
10/22/06 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
STEINHART NNP I-NP O
, , O O
JR NNP B-NP O
, , O O
FEDERICO NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
AMIODARONE NNP I-NP B-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ECASA NNP I-NP B-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ISOSORBIDE NNP I-NP B-m
DINITRATE NNP I-NP I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;100 NN I-NP O
LOPRESSOR NNP I-NP B-m
( ( O I-m
METOPROLOL NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
hr&lt;60 NN I-NP O
, , O O
SBP&lt;100 NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
NITROGLYCERIN NNP I-NP B-m
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
1/150 CD O I-m
( ( O I-m
( ( O I-m
0.4 CD O I-m
0.4 CD O I-m
MG NNP B-NP I-m
MG NNP I-NP I-m
) ) O I-m
) ) O I-m
1 CD O B-do
1 CD O B-do
TAB NNP B-NP I-do
TAB NNP I-NP I-do
SL NNP I-NP B-mo
SL NNP I-NP B-mo
q5min NN I-NP B-f
x NNP I-NP B-du
x VBD B-VP B-du
3 CD O I-du
3 CD O I-du
PRN NNP B-NP O
chest NN I-NP B-r
chest NN I-NP B-r
pain NN I-NP I-r
pain NN I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
KEFLEX NNP B-NP B-m
( ( O I-m
CEPHALEXIN NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
Instructions: NNP I-NP O
for IN B-VP O
chronic JJ B-NP B-r
osteomyelitis NN I-NP I-r
right JJ B-NP I-r
foot NN I-NP I-r
ALTACE NNP I-NP B-m
( ( O I-m
RAMIPRIL NNP B-NP I-m
) ) O I-m
1.25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
0/9/06 CD O O
by IN B-VP O
INGARGIOLA NNP B-NP O
, , O O
CARMINE NNP B-NP O
J NNP I-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
RAMIPRIL NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
RAMIPRIL NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
takes VBZ O O
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Please NNP I-NP O
see VB O O
your PRP$ O O
PCP NNP B-NP O
in IN B-VP O
Own NNP B-NP O
within IN B-VP O
2 CD O O
weeks NNS B-NP O
, , O O
ALLERGY: NNP B-NP O
statins VBZ O O
ADMIT NNP B-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
chest JJS B-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
CAD NNP I-NP O
dyslipidemia NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
ETT NNP B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
66 CD O O
yo NN B-NP O
man NN I-NP O
w/ VBZ O O
CAD NNP B-NP O
s/p NN I-NP O
MI's NNP I-NP O
( ( O O
76 CD O O
, , O O
98 CD O O
) ) O O
, , O O
and CC O O
2v CD O O
CABG NNP B-NP O
5/13 CD O O
and CC O O
stenting VBG O O
to TO O O
grafts VB O O
5/12 CD O O
and CC O O
multiple JJ B-NP O
admits NNS I-NP O
at IN B-VP O
multiple JJ B-NP O
hospitals NNS I-NP O
in IN B-VP O
multiple JJ B-NP O
states NNS I-NP O
for IN B-VP O
CP NNP B-NP O
evals NNS I-NP O
presents NNS I-NP O
with IN B-VP O
10/10 CD O O
CP NNP B-NP O
Just NNP I-NP O
discharged VBD B-VP O
same JJ B-NP O
day NN I-NP O
for IN B-VP O
identical JJ B-NP O
presentation NN I-NP O
at IN B-VP O
SGH NNP B-NP O
where WRB O O
enzymes NNS B-NP O
and CC O O
ekg NN B-NP O
showed VBD B-VP O
no DT B-NP O
ischemia NN I-NP O
despite IN B-VP O
ongoing VBG O O
CP NNP B-NP O
, , O O
and CC O O
adenosine JJ B-NP O
mibi NN I-NP O
was VBD B-VP O
poor JJ B-NP O
study NN I-NP O
but CC O O
could MD O O
not RB O O
rule VB O O
out IN B-VP O
small JJ B-NP O
area NN I-NP O
of IN B-VP O
ischemia NN B-NP O
in IN B-VP O
lat JJ B-NP O
wall NN I-NP O
He PRP O O
was VBD B-VP O
not RB O O
re-cath'd JJ B-NP O
Today NN I-NP O
at IN B-VP O
bus NN B-NP O
stop NN I-NP O
, , O O
developed VBD B-VP O
recurrence NN B-NP O
of IN B-VP O
CP NNP B-NP O
and CC O O
has VBZ O O
not RB O O
been VBN O O
responsive JJ O O
to TO O O
NTG NNP B-NP B-m
, , O O
and CC O O
his PRP$ O O
enzyme NN B-NP O
on IN B-VP O
presentation NN B-NP O
was VBD B-VP O
negative JJ O O
and CC O O
ekg JJ B-NP O
w/ NN I-NP O
only RB O O
nonspecific JJ B-NP O
Tw NNP I-NP O
flat NN I-NP O
in IN B-VP O
II NNP B-NP O
, , O O
III NNP B-NP O
and CC O O
V2-V3 NNP B-NP O
previously RB O O
noted VBD B-VP O
In IN B-VP O
ED: NNP B-NP O
86 CD O O
118/60 CD O O
99% CD O O
Got NNP B-NP O
sl JJ B-NP B-mo
Nitro NNP I-NP B-m
x NNP I-NP B-du
2-&gt;BP JJ O I-du
87/59 CD O O
P86 NNP B-NP O
118/60 CD O O
Got NNP B-NP O
sl JJ O B-mo
ntg RB O B-m
x2-&gt; JJ B-NP B-du
BP NNP I-NP O
87/59 CD O O
cp NN B-NP O
10/10-&gt;4/10 JJ B-NP O
Pt NNP I-NP O
sitting VBG O O
up RP O O
laughing VBG O O
c/o JJ B-NP O
6-7/10 JJ I-NP O
cp NN I-NP B-r
radiating VBG O O
to TO O O
neck VB O O
and CC O O
jaw VB O O
sl JJ O B-mo
ntg JJ O B-m
given VBN O O
w/out RP O O
relief JJ B-NP O
PMH: NNP I-NP O
CAD NNP I-NP O
MI NNP I-NP O
'76 NNP I-NP O
, , O O
'98 NNP B-NP O
( ( O O
HMC NNP B-NP O
) ) O O
, , O O
PCI NNP B-NP O
6/4 CD O O
Poll NNP B-NP O
Hospital NNP I-NP O
Sabeth NNP I-NP O
Otte NNP I-NP O
Den NNP I-NP O
, , O O
s/p VBD B-VP O
2V CD O O
CABG NNP B-NP O
5/13 CD O O
Ocitor's NNP B-NP O
Tianneyvass NNP I-NP O
Gentburke NNP I-NP O
Hospital NNP I-NP O
, , O O
sternal JJ B-NP O
surgery NN I-NP O
for IN B-VP O
Staph NNP B-NP O
infection NN I-NP O
3/24 CD O O
, , O O
PCI NNP B-NP O
to TO O O
grafts VB O O
6/7 CD O O
Stillpen NNP B-NP O
Hospital NNP I-NP O
, , O O
+ NNP B-NP O
ETT NNP I-NP O
w VBD B-VP O
?PCI NNP B-NP O
CC NNP I-NP O
6/25 CD O O
, , O O
PM NNP B-NP O
placement VBD B-VP O
4/10 CD O O
Di NNP B-NP O
Pendsti NNP I-NP O
adenosine-MIBI JJ B-NP O
RCH NNP I-NP O
9/11/06 CD O O
-&gt;LVEF NNP B-NP O
68% CD O O
, , O O
mild-mod JJ B-NP O
lateral JJ I-NP O
wall NN I-NP O
ischemia NN I-NP O
vs NN I-NP O
artifact NN I-NP O
9/9 CD O O
, , O O
obsesity NN B-NP O
, , O O
GERD NNP B-NP O
, , O O
chronic JJ B-NP B-r
osteomyelitis NN I-NP I-r
rt JJ B-NP O
foot NN I-NP O
on IN B-VP O
keflex NN B-NP B-m
, , O O
DM2 NNP B-NP O
( ( O O
'92 POS O O
) ) O O
CHF NNP B-NP O
, , O O
pAF NN B-NP O
( ( O O
no DT B-NP O
t NN I-NP O
on IN B-VP O
coumadin NN B-NP O
) ) O O
, , O O
hyperlipidemia NN B-NP O
, , O O
HTN NNP B-NP O
, , O O
CVA NNP B-NP O
w NN I-NP O
left VBD B-VP O
sided JJ B-NP O
wkns NN I-NP O
meds:ASA NN I-NP B-m
325 CD O B-do
, , O O
amiodarone RB O B-m
200 CD O B-do
bid NN B-NP B-f
, , O O
lopressor VBZ O B-m
50 CD O B-do
bid NN B-NP B-f
, , O O
imdur JJ O B-m
60 CD O B-do
bid NN B-NP B-f
, , O O
plavix NN B-NP B-m
75 CD O B-do
, , O O
protonix NN B-NP B-m
, , O O
keflex VBD B-VP B-m
500 CD O B-do
q4 NN B-NP B-f
, , O O
lasix JJ O B-m
60 CD O B-do
bid NN B-NP B-f
, , O O
kcl VB O B-m
40 CD O B-do
qd NN B-NP B-f
, , O O
metformin RB O B-m
500 CD O B-do
bid NN B-NP B-f
, , O O
micronase VB O B-m
10 CD O B-do
bid NN B-NP B-f
, , O O
tylenol EX O B-m
c JJ B-NP I-m
codeine NN I-NP I-m
, , O O
ativan RB O B-m
5 CD O B-do
mg NNS B-NP I-do
prn JJ B-NP B-f
all: NN I-NP O
?statins NNS I-NP O
SH: NNP I-NP O
divorced VBD B-VP O
x2 NNP B-NP O
, , O O
son NN B-NP O
died VBD B-VP O
from IN B-VP O
HL NNP B-NP O
age NN I-NP O
10; CD O O
son NN B-NP O
living NN I-NP O
in IN B-VP O
Pla NNP B-NP O
Odownde NNP I-NP O
Lake NNP I-NP O
, , O O
quit VBD B-VP O
tob JJ O O
20 CD O O
y NN B-NP O
ago RB O O
, , O O
no DT B-NP O
etoh JJ I-NP O
antique NN I-NP O
dealer NN I-NP O
FH: NNP I-NP O
CAD; NNP I-NP O
PE NNP I-NP O
T NNP I-NP O
97 CD O O
102/62 CD O O
68 CD O O
18 CD O O
98% CD O O
Gen: NNP B-NP O
obese JJ O O
in IN B-VP O
good JJ B-NP O
spirit NN I-NP O
NAD NNP I-NP O
HEENT: NNP I-NP O
JVP NNP I-NP O
flat JJ B-NP O
Cor: NNP I-NP O
RRR NNP I-NP O
, , O O
3/6 CD O O
SM NNP B-NP O
USB NNP I-NP O
Pulm: NNP I-NP O
CTA NNP I-NP O
Abd: NNP I-NP O
benign NN I-NP O
Ext: NNP I-NP O
no DT B-NP O
edema NN I-NP O
, , O O
1 CD O O
cm NN B-NP O
red JJ B-NP O
spot NN I-NP O
rt NN I-NP O
ankle NN I-NP O
nontender; JJ B-NP O
WWP NNP I-NP O
neuro: NN I-NP O
slight VBD B-VP O
dec JJ O O
strenth JJ O O
left VBD B-VP O
side JJ B-NP O
labs: NN I-NP O
Cr NNP I-NP O
1.8 CD O O
( ( O O
bs VB O O
1.5 CD O O
) ) O O
, , O O
CK NNP B-NP O
69 CD O O
, , O O
1.5 CD O O
TnI&lt;ass NNP B-NP O
, , O O
HCT NNP B-NP O
39 CD O O
, , O O
WBC NNP B-NP O
9 CD O O
, , O O
PLT NNP B-NP O
354 CD O O
INR NNP B-NP O
1.0 CD O O
PTT NNP B-NP O
29 CD O O
EKG: NNP B-NP O
NSR NNP I-NP O
68 CD O O
Twave NNP B-NP O
flat JJ B-NP O
II NNP I-NP O
, , O O
III NNP B-NP O
, , O O
V2-V3 NNP B-NP O
no DT B-NP O
new JJ I-NP O
changes NNS I-NP O
Impression: VBP O O
66 CD O O
yo NNS B-NP O
M NNP I-NP O
w VBP O O
h/o NN B-NP O
CAD NNP I-NP O
s/p NN I-NP O
MI NNP I-NP O
, , O O
CABG NNP B-NP O
+ NNP I-NP O
PCI NNP I-NP O
w VBD B-VP O
recent JJ B-NP O
admits NNS I-NP O
for IN B-VP O
same JJ O O
and CC O O
?+ JJ B-NP O
MIBI NNP I-NP O
1/8 CD O O
admitted VBN O O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
high JJ B-NP O
prob NN I-NP O
low-int NN I-NP O
risk NN I-NP O
CP NNP I-NP O
in IN B-VP O
patient NN B-NP O
with IN B-VP O
known VBN O O
CAD NNP B-NP O
and CC O O
ongoing VBG O O
RF's NNP B-NP O
While IN B-VP O
story NN B-NP O
and CC O O
his PRP$ O O
behavior NN B-NP O
and CC O O
presentation NN B-NP O
and CC O O
lack NN B-NP O
of IN B-VP O
response NN B-NP O
to TO O O
antianginal JJ B-NP B-m
therapy NN I-NP I-m
, , O O
argue NN B-NP O
against IN B-VP O
ischemic JJ O O
, , O O
we PRP O O
will MD O O
need VB O O
to TO O O
monitor VB O O
carefully RB O O
1 CD O O
CV NNP B-NP O
( ( O O
I PRP O O
)tele VBP O O
r/o JJ B-NP O
w/ NN I-NP O
enzymes NNS I-NP O
, , O O
ekg JJ B-NP O
heparininze NN I-NP O
until IN B-VP O
ruled VBN O O
out RP O O
, , O O
given VBN O O
ongoing VBG O O
pain NN B-NP O
no DT B-NP O
further JJ I-NP O
sL NN I-NP B-mo
nitro RB O B-m
given VBN O O
no DT B-NP O
relief NN I-NP O
and CC O O
BP NNP B-NP O
drops NNS I-NP O
continue VBP O O
asa RB O B-m
, , O O
plavix NN B-NP B-m
, , O O
oral JJ B-NP B-mo
nitrate NN I-NP B-m
-ETT VBD B-VP O
1/5 CD O O
2 CD O O
min NN B-NP O
stopped VBD B-VP O
2/2 CD O O
chest JJS B-NP O
pain NN I-NP O
no DT B-NP O
ischemic JJ I-NP O
EKG NNP I-NP O
changes NNS I-NP O
( ( O O
P NNP B-NP O
) ) O O
EF NNP B-NP O
68 CD O O
% NN B-NP O
euvolemic JJ B-NP O
cont NN I-NP O
nitrate NN I-NP B-m
( ( O O
R NNP B-NP O
) ) O O
tele VBP O O
cont JJ B-NP O
bblocker NN I-NP B-m
NSR NNP I-NP O
monitor NN I-NP O
for IN B-VP O
pAF NN B-NP O
cont NN I-NP O
amiodarone NN I-NP B-m
2 CD O O
Endo: NNP B-NP O
check NN I-NP O
A1c NNP I-NP O
hold VB O O
oral JJ B-NP B-mo
agents NNS I-NP B-m
SS VBP O O
3 CD O O
Renal: NNP B-NP O
elevated VBD B-VP B-r
BUN/Cr NNP B-NP I-r
gentle JJ B-NP O
hydration NN I-NP O
IVF NNP I-NP B-m
100 CD O B-do
cc/h NN B-NP I-do
trend NN I-NP O
4 CD O O
ID- JJ B-NP O
chronic JJ I-NP B-r
osteomyletis NN I-NP I-r
cont NN I-NP O
keflex NNP I-NP B-m
normal JJ B-NP O
WBC NNP I-NP O
, , O O
afebrile IN B-VP O
no DT B-NP O
sign NN I-NP O
of IN B-VP O
acute JJ B-NP O
infection NN I-NP O
5 CD O O
FEN: NNP B-NP O
NPO NNP I-NP O
cont NN I-NP O
PPI NNP I-NP B-m
for IN B-VP O
GERD NNP B-NP B-r
5 CD O O
ppx: NN B-NP O
PPI NNP I-NP B-m
, , O O
sc VBD B-VP B-mo
hep JJ O B-m
6 CD O O
dispo: NN B-NP O
FC NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
please NN I-NP O
f/u NN I-NP O
with IN B-VP O
your PRP$ O O
PCP NNP B-NP O
in IN B-VP O
Ton NNP B-NP O
Ronatlleighing NNP I-NP O
Rill NNP I-NP O
You PRP O O
will MD O O
need VB O O
to TO O O
discuss VB O O
the DT B-NP O
issue NN I-NP O
starting VBG O O
coumadin JJ B-NP B-m
therapy NN I-NP O
given VBN O O
your PRP$ O O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
FAUPEL NNP I-NP O
, , O O
LAWERENCE NNP B-NP O
K NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
LP51 NNP B-NP O
) ) O O
10/22/06 CD O O
@ $ O O
11:08 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#708298 VBZ O O
649982356 CD O O
BUMC NNP B-NP O
28224594 CD O O
1786897 CD O O
1/3/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/3/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/13/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
BRIGNOLO NNP I-NP O
, , O O
CHUCK NNP B-NP O
753-20-74-1 CD O O
Platnof NNP B-NP O
Ave NNP I-NP O
, , O O
Chibroke NNP B-NP O
Ri NNP I-NP O
Ce NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/5/05 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
ROURK NNP I-NP O
, , O O
BRYON NNP B-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
0/17 CD O O
) ) O O
GLYBURIDE NNP B-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LEVOTHYROXINE NNP I-NP B-m
SODIUM NNP I-NP I-m
75 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5MIN NNP I-NP O
X NNP I-NP B-du
2 CD O I-du
doses NNS B-NP I-du
PRN NNP I-NP O
Chest NNP I-NP B-r
Pain NNP I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
sbp VBZ O O
less JJR O O
than IN B-VP O
100 CD O O
mmHg JJ B-NP O
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LIPITOR NNP I-NP B-m
( ( O I-m
ATORVASTATIN NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
0/17 CD O O
) ) O O
LASIX NNP B-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
80 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
GLUCOPHAGE NNP I-NP B-m
( ( O I-m
METFORMIN NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
BENICAR NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
Fluid NNP I-NP O
restriction: VBD B-VP O
2 CD O O
liters NNS B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Knickrehm NNP I-NP O
on IN B-VP O
February NNP B-NP O
, , O O
2005 CD O O
at IN B-VP O
Bipa NNP B-NP O
Healthcare NNP I-NP O
Center NNP I-NP O
724-105-6354 JJ O O
1:00p CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Gavilanes NNP I-NP O
at IN B-VP O
Nysi NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
You PRP O O
will MD O O
be VB O O
contacted VBN O O
with IN B-VP O
an DT B-NP O
appt NN I-NP O
in IN B-VP O
2-3wks JJ O O
367-645-9837 JJ O O
, , O O
CHF NNP B-NP O
program NN I-NP O
on IN B-VP O
Thurs NNP B-NP O
June NNP I-NP O
with IN B-VP O
Devin NNP B-NP O
Apana NNP I-NP O
at IN B-VP O
Sadeland NNP B-NP O
Hospital NNP I-NP O
367-645-9837 JJ O O
2:30p CD O O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
CHF NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
ischemic VBP O O
cardiomyopathy JJ B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
TYPE NNP I-NP O
IV NNP I-NP O
HYPERCHOLESTEROLEMI NNP I-NP O
SMOKER NNP I-NP O
FHX NNP I-NP O
HTN NNP I-NP O
s/p VBD B-VP O
CABG NNP B-NP O
CAD NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Cardiac NNP I-NP O
catherization NN I-NP O
w/stent NN I-NP O
for IN B-VP O
SVG NNP B-NP O
to TO O O
RPDA NNP B-NP O
and CC O O
LIMA NNP B-NP O
to TO O O
LAD VB O O
OTHER NNP B-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
48 CD O O
M NNP B-NP O
admitted VBD B-VP O
via IN B-VP O
ED NNP B-NP O
with IN B-VP O
2 CD O O
weeks NNS B-NP O
of IN B-VP O
dyspnoea NN B-NP O
on IN B-VP O
exertion NN B-NP O
and CC O O
2 CD O O
days NNS B-NP O
of IN B-VP O
severe JJ B-NP O
peripheral JJ I-NP O
oedema NN I-NP O
HCC NNP I-NP O
: : O O
48 CD O O
N NNP B-NP O
with IN B-VP O
CAD NNP B-NP O
s/p NN I-NP O
CABG NNP I-NP O
1997 CD O O
, , O O
Type NNP B-NP O
II NNP I-NP O
DM NNP I-NP O
, , O O
hypercholesterolaemia NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
EtOH NNP B-NP O
use NN I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
2 CD O O
weeks NNS B-NP O
of IN B-VP O
progressive JJ B-NP O
SOBOE NNP I-NP O
associated VBN O O
with IN B-VP O
2-3 JJ B-NP O
days NNS I-NP O
of IN B-VP O
severe JJ B-NP O
peripheral JJ I-NP O
oedema NN I-NP O
Describes NNP I-NP O
clear JJ B-NP O
history NN I-NP O
of IN B-VP O
orthopnoea NN B-NP O
and CC O O
PND NNP B-NP O
Denies NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
, , O O
palpitations NNS B-NP O
, , O O
light-headedness JJ O O
, , O O
syncope NN B-NP O
, , O O
fevers NNS B-NP O
, , O O
chills NNS B-NP O
, , O O
weight JJ B-NP O
loss NN I-NP O
, , O O
malaise NN B-NP O
or CC O O
other JJ B-NP O
systemic JJ I-NP O
upset JJ I-NP O
PMH NN I-NP O
: : O O
CAD NNP B-NP O
, , O O
Diabetes NNP B-NP O
, , O O
alcohol NN B-NP O
, , O O
CABG NNP B-NP O
1997 CD O O
, , O O
hyperchol NN B-NP O
, , O O
htn JJ B-NP O
DH NNP I-NP O
: : O O
ASA NNP B-NP B-m
, , O O
atenolol RB O B-m
50 CD O B-do
, , O O
benicar NN B-NP B-m
20 CD O B-do
, , O O
lipitor NN B-NP B-m
20 CD O B-do
, , O O
glyburide JJ B-NP B-m
FH NNP I-NP O
: : O O
Nil NN B-NP O
of IN B-VP O
note NN B-NP O
SH NNP I-NP O
: : O O
Smokes NNS B-NP O
1ppd CD O O
, , O O
EtoH NNP B-NP O
6 CD O O
beers/day NN B-NP O
O/E NNP I-NP O
: : O O
Mildly RB O O
SOB NNP B-NP O
, , O O
T NNP B-NP O
97.9 CD O O
, , O O
BP NNP B-NP O
147/105 CD O O
, , O O
HR NNP B-NP O
108 CD O O
, , O O
RR NNP B-NP O
24 CD O O
, , O O
Sats NNP B-NP O
99% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
Facial NNP I-NP O
plethora NN I-NP O
&amp; NNP I-NP O
dusky NN I-NP O
hue NN I-NP O
No NNP I-NP O
jaundice NN I-NP O
, , O O
pallor NN B-NP O
, , O O
clubbing VBG O O
, , O O
lymphadenopathy JJ B-NP O
JVP NNP I-NP O
-&gt; NNP I-NP O
earlobes VBZ O O
HS NNP B-NP O
I PRP O O
+ VBP O O
II NNP B-NP O
+ NNP I-NP O
S3 NNP I-NP O
with IN B-VP O
gallop JJ B-NP O
Occasional NNP I-NP O
bibasal NN I-NP O
coarse NN I-NP O
crackles NNS I-NP O
Abdomen NNP I-NP O
distended VBD B-VP O
with IN B-VP O
shifting VBG O O
dullness NN B-NP O
&amp; NNP I-NP O
mild NN I-NP O
RUQ NNP I-NP O
tenderness NN I-NP O
3+++ CD O O
pitting VBG O O
oedema NN B-NP O
to TO O O
knees VB O O
bilaterally RB O O
Rash NNP B-NP O
behind IN B-VP O
calves NNS B-NP O
LABS NNP I-NP O
: : O O
BNP NN B-NP O
1900 CD O O
, , O O
TnI NNP B-NP O
-ve NNP I-NP O
, , O O
Hct NNP B-NP O
52 CD O O
CXR NNP B-NP O
: : O O
New NNP B-NP O
cardiomegaly VBZ O O
No DT B-NP O
pulmonary JJ I-NP O
oedema NN I-NP O
ECG NNP I-NP O
: : O O
Unchanged VBN O O
TWI NNP B-NP O
V4-V6 NNP I-NP O
Nil NNP I-NP O
acutely RB O O
ischaemic JJ B-NP O
IMPRESSION NN I-NP O
: : O O
1 CD O O
New NNP B-NP O
onset NN I-NP O
R NNP I-NP O
&gt; NNP I-NP O
L NNP I-NP O
dilated VBD B-VP O
heart NN B-NP O
failure NN I-NP O
Most NNP I-NP O
likely RB O O
due JJ O O
to TO O O
ischemic VB O O
dz NN B-NP O
and CC O O
occlusion NN B-NP O
of IN B-VP O
grafts NNS B-NP O
from IN B-VP O
previous JJ B-NP O
cabg NNS I-NP O
Hospital NNP I-NP O
Course: NNP I-NP O
CV: NNP I-NP O
Upon NNP I-NP O
admission NN I-NP O
, , O O
pt's JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
were VBD B-VP O
cycled VBN O O
x RB O O
3 CD O O
w/a JJ B-NP O
troponin NN I-NP O
bump NN I-NP O
on IN B-VP O
second NN B-NP O
set NN I-NP O
which WDT O O
resolved VBN O O
by IN B-VP O
3rd CD O O
set NN B-NP O
He PRP O O
r/o'd VBZ O O
for IN B-VP O
hemochromatosis NN B-NP O
and CC O O
multiple JJ B-NP O
myeloma NN I-NP O
W/u NNP I-NP O
of IN B-VP O
pt's JJ B-NP O
new-onset JJ I-NP O
chf NN I-NP O
included VBD B-VP O
an DT B-NP O
echo NN I-NP O
which WDT O O
showed VBD B-VP O
global JJ B-NP O
hypokinesis NN I-NP O
w/EF VBD B-VP O
20-25% CD O O
The DT B-NP O
pt NN I-NP O
then RB O O
recieved VBD B-VP O
cardiac JJ B-NP O
catherization NN I-NP O
on IN B-VP O
4/29 CD O O
which WDT O O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
1.elevated CD O O
L NNP B-NP O
heart NN I-NP O
filling NN I-NP O
pressures NNS I-NP O
at IN B-VP O
29mmHg CD O O
and CC O O
PA NNP B-NP O
sat VBD B-VP O
fo $ O O
49% CD O O
c/w JJ B-NP O
Lheart NNP I-NP O
failure; NN I-NP O
2 CD O O
LIMA NNP B-NP O
to TO O O
LAD NNP B-NP O
patent NN I-NP O
, , O O
but CC O O
70-80% JJ B-NP O
stenosis NN I-NP O
at IN B-VP O
distal JJ B-NP O
anastomotic JJ I-NP O
site; NN I-NP O
3 CD O O
diminished JJ B-NP O
baseline NN I-NP O
flow NN I-NP O
of IN B-VP O
SVG NNP B-NP O
to TO O O
PDA NNP B-NP O
s/p NN I-NP O
stent NN I-NP O
Pt NNP I-NP O
had VBD B-VP O
transient JJ B-NP O
ST NNP I-NP O
elevation NN I-NP O
during IN B-VP O
cath NN B-NP O
, , O O
relieved VBD B-VP O
w/ng JJ B-NP O
O/N NNP I-NP O
pt NN I-NP O
had VBD B-VP O
a DT B-NP O
couple NN I-NP O
episodes VBZ O O
NSVT NNP B-NP O
Re-cathed NNP I-NP O
on IN B-VP O
10/19 CD O O
as IN B-VP O
planned VBN O O
after IN B-VP O
diuresis NN B-NP O
for IN B-VP O
stenting VBG O O
of IN B-VP O
LIMA NNP B-NP O
to TO O O
LAD NNP B-NP O
There EX O O
was VBD B-VP O
one CD O O
episode NN B-NP O
of IN B-VP O
NSVT NNP B-NP O
one CD O O
day NN B-NP O
following VBG O O
2nd CD O O
cath JJ B-NP O
procedure NN I-NP O
Pt NNP I-NP O
remained VBD B-VP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
w/steady JJ B-NP O
improvement NN I-NP O
qd NN I-NP O
By IN B-VP O
d/c NN B-NP O
, , O O
pt's NN B-NP O
sob NN I-NP O
, , O O
orthopnea NN B-NP O
and CC O O
pnd NN B-NP O
had VBD B-VP O
resolved VBN O O
Jvp NNP B-NP O
was VBD B-VP O
wnl JJ O O
, , O O
hepatic JJ B-NP O
congestion NN I-NP O
resolved VBD B-VP O
, , O O
abd VBZ O O
no RB O O
longer RBR O O
distended VBD B-VP O
, , O O
LE NNP B-NP O
swelling VBG O O
resolved VBD B-VP O
His PRP$ O O
dry JJ B-NP O
d/c NN I-NP O
wt NN I-NP O
was VBD B-VP O
194.0 CD O O
lb JJ B-NP O
Pt NNP I-NP O
to TO O O
f/u VB O O
w/CHF JJ B-NP O
program NN I-NP O
in IN B-VP O
1 CD O O
wk NN B-NP O
, , O O
cardiologist NN B-NP O
in IN B-VP O
2-3wks JJ O O
and CC O O
EP NNP B-NP O
service NN I-NP O
in IN B-VP O
6wks CD O O
Pt NNP B-NP O
needs NNS I-NP O
f/u VBP O O
echo JJ O O
b/4 IN B-VP O
his PRP$ O O
EF NNP B-NP O
appt NN I-NP O
in IN B-VP O
March NNP B-NP O
ENDO: NNP I-NP O
Pt's NNP I-NP O
blood NN I-NP O
sugars NNS I-NP O
were VBD B-VP O
well RB O O
controlled VBN O O
during IN B-VP O
admission NN B-NP O
Upon IN B-VP O
d/c NN B-NP O
, , O O
metformin NN B-NP B-m
was VBD B-VP O
added VBN O O
to TO O O
his PRP$ O O
home NN B-NP O
diabetic JJ B-NP O
regimen NNS I-NP O
FEN: NNP I-NP O
pt NN I-NP O
had VBD B-VP O
a DT B-NP O
nutrition NN I-NP O
consult NN I-NP O
to TO O O
review VB O O
2g CD O O
sodium/2L JJ B-NP O
fluid JJ I-NP O
restriction NN I-NP O
diet JJ B-NP O
PSYCH: NNP I-NP O
Seen NNP I-NP O
by IN B-VP O
the DT B-NP O
addiction NN I-NP O
team NN I-NP O
Had VBD B-VP O
no DT B-NP O
signs/symptoms NNS I-NP O
of IN B-VP O
etoh NN B-NP O
withdrawal NN I-NP O
during IN B-VP O
admission NN B-NP O
Declined VBD B-VP O
antidepressants NNS B-NP B-m
, , O O
nicotine JJ B-NP B-m
patch NN I-NP I-m
but CC O O
agreed VBD B-VP O
to TO O O
counseling VBG O O
as IN B-VP O
outpt JJ B-NP O
Pt NNP I-NP O
encouraged VBD B-VP O
to TO O O
stop VB O O
drinking NN B-NP O
and CC O O
to TO O O
quit VB O O
smoking VBG O O
CONDITION: NNP B-NP O
stable JJ B-NP O
DISPO: NNP I-NP O
home NN I-NP O
w/close NN I-NP O
CHF NNP I-NP O
program NN I-NP O
f/u VBD B-VP O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
call NN I-NP O
md NN I-NP O
for IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
temp NN B-NP O
over IN B-VP O
100.4 CD O O
or CC O O
anything NN B-NP O
concerning VBG O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Echo NNP I-NP O
in IN B-VP O
4-6 JJ B-NP O
wks NN I-NP O
before IN B-VP O
appt JJ B-NP O
w/Dr NN I-NP O
Stith NNP I-NP O
on IN B-VP O
10/30/05 CD O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
RAVE NNP I-NP O
, , O O
VINCE NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
GA516 NNP B-NP O
) ) O O
3/2/04 CD O O
@ $ O O
11:34 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#716292 VBZ O O
149683203 CD O O
EH NNP B-NP O
90044612 CD O O
779283 CD O O
7/5/1991 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/23/1991 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/29/1991 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
61-year-old JJ I-NP O
man NN I-NP O
from IN B-VP O
Dr NNP B-NP O
, , O O
Ro NNP B-NP O
Rouge NNP I-NP O
Berkesti NNP I-NP O
, , O O
South NNP B-NP O
Dakota NNP I-NP O
20513 CD O O
, , O O
with IN B-VP O
a DT B-NP O
his- JJ I-NP O
tory NN I-NP O
of IN B-VP O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
and CC O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
who WP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Ret NNP I-NP O
Health NNP I-NP O
Services NNP I-NP O
for IN B-VP O
transplant JJ B-NP O
evalua- JJ I-NP O
tion NN I-NP O
In IN B-VP O
1975 CD O O
, , O O
he PRP O O
suffered VBD B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
and CC O O
subse- JJ O O
quently RB O O
had VBD B-VP O
exertional JJ B-NP O
angina NN I-NP O
In IN B-VP O
8 CD O O
of IN B-VP O
November NNP B-NP O
he PRP O O
suffered VBD B-VP O
a DT B-NP O
second JJ I-NP O
MI NNP I-NP O
and CC O O
underwent JJ B-NP O
three-vessel JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
in IN B-VP O
21 CD O O
of IN B-VP O
April NNP B-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
his PRP$ O O
ejection NN B-NP O
fraction NN I-NP O
was VBD B-VP O
21% CD O O
Over IN B-VP O
the DT B-NP O
ensuing JJ I-NP O
months NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
noted VBD B-VP O
markedly RB O O
worsening VBG O O
symptoms NNS B-NP O
of IN B-VP O
CHF NNP B-NP O
with IN B-VP O
orthopnea NN B-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
and CC O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
One CD O O
week NN B-NP O
prior RB O O
to TO O O
transfer VB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
Ment NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
management NN B-NP O
of IN B-VP O
his PRP$ O B-r
his PRP$ O B-r
congestive JJ B-NP I-r
congestive JJ I-NP I-r
heart NN I-NP I-r
heart NN I-NP I-r
failure NN I-NP I-r
failure NN I-NP I-r
He PRP O O
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
afterload NN B-NP O
reduction NN I-NP O
, , O O
digoxin NN B-NP B-m
and CC O O
Lasix NNP B-NP B-m
On IN B-VP O
this DT B-NP B-m
regimen NNS I-NP I-m
, , O O
a DT B-NP O
PA NNP I-NP O
line NN I-NP O
was VBD B-VP O
placed VBN O O
with IN B-VP O
the DT O O
following VBG O O
read- JJ B-NP O
ings: JJ I-NP O
RA NNP I-NP O
8 CD O O
, , O O
RV NNP B-NP O
76/4 CD O O
, , O O
TA NNP B-NP O
80/36 CD O O
, , O O
pulmonary JJ B-NP O
capillary JJ I-NP O
wedge NN I-NP O
pres- JJ O O
sure JJ O O
34 CD O O
, , O O
and CC O O
cardiac JJ B-NP O
index NN I-NP O
1.49 CD O O
Echocardiogram NNP B-NP O
revealed VBD B-VP O
dilated VBN O O
left JJ B-NP O
ventricle NN I-NP O
with IN B-VP O
global JJ B-NP O
hypokinesis NN I-NP O
, , O O
tricuspid JJ B-NP O
regurgitation NN I-NP O
, , O O
and CC O O
PA NNP B-NP O
systolic JJ B-NP O
pressure NN I-NP O
80mmHg CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
dobutamine NN B-NP B-m
, , O O
intravenous JJ B-NP B-mo
TNG NNP I-NP B-m
, , O O
and CC O O
nitroprusside RB O B-m
with IN B-VP O
symptomatic JJ B-NP O
relief NN I-NP O
and CC O O
hemodynamic JJ B-NP O
stabilization NN I-NP O
with IN B-VP O
wedge NN B-NP O
pressure NN I-NP O
falling VBG O O
to TO O O
18 CD O O
TNG NNP B-NP B-m
and CC O O
Nipride NNP B-NP B-m
were VBD B-VP O
successfully RB O O
weaned VBN O O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
remained VBD B-VP O
dobutamine JJ B-NP B-m
dependent NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Edpointe NNP I-NP O
Soupied NNP I-NP O
Cantjean NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
evalu- JJ B-NP O
ation NN I-NP O
for IN B-VP O
transplantation NN B-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
he PRP O O
noted VBD B-VP O
dyspnea NN B-NP O
on IN B-VP O
minimal JJ B-NP O
exertion NN I-NP O
but CC O O
not RB O O
at IN B-VP O
rest NN B-NP O
He PRP O O
denied VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
, , O O
palpitations NNS B-NP O
, , O O
lightheadedness NN B-NP O
, , O O
or CC O O
syncope VB O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
married VBN O O
, , O O
and CC O O
worked VBD B-VP O
as IN B-VP O
a DT B-NP O
janitor NN I-NP O
until IN B-VP O
March NNP B-NP O
of IN B-VP O
1991 CD O O
He PRP O O
is VBZ O O
married JJ O O
with IN B-VP O
seven CD O O
children NNS B-NP O
and CC O O
lives NNS B-NP O
in IN B-VP O
S NNP B-NP O
The DT B-NP O
patient's NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
severe JJ B-NP O
abdominal JJ I-NP O
trauma NN I-NP O
many JJ B-NP O
years NNS I-NP O
ago RB O O
, , O O
having VBG O O
been VBN O O
gored VBN O O
by IN B-VP O
a DT B-NP O
bull JJ I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Discharge NNP I-NP O
physical JJ B-NP O
examination NN I-NP O
is VBZ O O
nota- JJ O O
ble JJ O O
for IN B-VP O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
100/50 CD O O
, , O O
a DT B-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
between IN B-VP O
100 CD O O
and CC O O
110 CD O O
, , O O
a DT B-NP O
respiratory JJ I-NP O
rate NN I-NP O
of IN B-VP O
18 CD O O
, , O O
a DT B-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
112/66 CD O O
, , O O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
97.1 CD O O
, , O O
and CC O O
a DT B-NP O
weight NN I-NP O
of IN B-VP O
80.4 CD O O
kilograms NNS B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
in IN B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
occa- JJ B-NP O
sional JJ I-NP O
short JJ I-NP O
bursts NNS I-NP O
of IN B-VP O
ventricular JJ B-NP O
tachycardia NN I-NP O
last JJ O O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
discharge VB O O
LUNGS: NNP B-NP O
Occasional NNP I-NP O
crackles NNS I-NP O
HEART: NNP I-NP O
Sounds NNP I-NP O
distant JJ B-NP O
ABDOMEN: NNP I-NP O
Benign NNP I-NP O
EXTREMITIES: NNP I-NP O
Trace NNP I-NP O
edema VBZ O O
LABORATORY NNP B-NP O
DATA: NNP I-NP O
Discharge NNP I-NP O
sodium NN I-NP O
134 CD O O
, , O O
potassium NN B-NP O
4.2 CD O O
, , O O
BUN NNP B-NP O
32 CD O O
, , O O
creatinine NN B-NP O
1.4 CD O O
White NNP B-NP O
count NN I-NP O
9.8 CD O O
, , O O
hematocrit NN B-NP O
29.2 CD O O
, , O O
platelets NNS B-NP O
253 CD O O
ALT NNP B-NP O
14 CD O O
, , O O
AST NNP B-NP O
8 CD O O
, , O O
LDH NNP B-NP O
223 CD O O
, , O O
total JJ B-NP O
bilirubin NN I-NP O
0.6 CD O O
, , O O
direct JJ B-NP O
bilirubin NN I-NP O
0.3 CD O O
, , O O
albumin RB O O
2.8 CD O O
, , O O
total JJ B-NP O
protein NN I-NP O
5.9 CD O O
, , O O
cholesterol NN B-NP O
106 CD O O
MEDICATIONS NNP B-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
include VBP O O
dobutamine NN B-NP B-m
at IN B-VP O
15 CD O B-do
mcg NNS B-NP O
per IN B-VP O
kilogram NN B-NP O
per IN B-VP B-f
minute; NN B-NP I-f
captopril NN I-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d.; NN I-NP B-f
digoxin NN I-NP B-m
0.125 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.d.; NN I-NP B-f
Lasix NNP I-NP B-m
160 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
potassium NN I-NP B-m
chloride NN I-NP I-m
20 CD O B-do
mEq NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
Coumadin NNP I-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d.; NN I-NP B-f
Atrovent NNP I-NP B-m
, , O O
two CD O B-do
puffs NNS B-NP I-do
q.i.d.; JJ B-NP B-f
Azmacort NNP I-NP B-m
, , O O
eight CD O B-do
puffs NNS B-NP I-do
b.i.d.; VBD B-VP B-f
Pepcid NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; VBD B-VP B-f
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d.; NN I-NP B-f
vancomycin VBD B-VP B-m
1 CD O B-do
gm NN B-NP I-do
q NN I-NP B-f
12 CD O I-f
, , O O
discontinued VBN O O
9-23 CD O O
a.m NNS B-NP O
after IN B-VP O
14 CD O B-du
days; JJ B-NP I-du
ampicillin NN I-NP B-m
2 CD O B-do
gm NN B-NP I-do
IV NNP I-NP B-mo
q VBZ O B-f
6 CD O I-f
( ( O O
24 CD O O
of IN B-VP O
June NNP B-NP O
equals NNS I-NP O
day NN I-NP O
number NN I-NP O
five CD O O
); JJ B-NP O
Halcion NN I-NP B-m
0.125 CD O B-do
p.o NN B-NP B-mo
q.h.s NN I-NP B-f
prn; NN I-NP I-f
Serax NNP I-NP B-m
15 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q VBD B-VP B-f
6 CD O O
hours NNS B-NP O
prn JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
1 CD O O
Transplant NNP B-NP O
Listing: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
listed VBN O O
for IN B-VP O
cardiac JJ B-NP O
transplant NN I-NP O
, , O O
has VBZ O O
had VBN O O
all PDT O O
the DT B-NP O
necessary JJ I-NP O
preoperative JJ I-NP O
workup NN I-NP O
including VBG O O
pulmonary JJ B-NP O
function NN I-NP O
tests NNS I-NP O
and CC O O
tissue NN B-NP O
typing NN I-NP O
Should MD O O
a DT B-NP O
heart NN I-NP O
become VBN O O
avail- JJ O O
able JJ O O
, , O O
he PRP O O
could MD O O
be VB O O
Medivacked VBN O O
back RB O O
to TO O O
the DT B-NP O
Peters NNP I-NP O
Of IN B-VP O
for IN B-VP O
surgery NN B-NP O
The DT B-NP O
patient's JJ I-NP O
hospital NN I-NP O
course NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
the DT B-NP O
following JJ I-NP O
workup: NN I-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
catheterization NN I-NP O
15 CD O O
of IN B-VP O
October NNP B-NP O
, , O O
which WDT O O
showed VBD B-VP O
patent NN B-NP O
grafts NNS I-NP O
and CC O O
occluded VBD B-VP O
native JJ O O
left VBD B-VP O
anterior JJ B-NP O
descending NN I-NP O
and CC O O
obtuse IN B-VP O
marginal JJ B-NP O
branch NN I-NP O
An DT B-NP O
echocardiogram NN I-NP O
on IN B-VP O
28 CD O O
of IN B-VP O
June NNP B-NP O
showed VBD B-VP O
mitral JJ B-NP O
regurg- JJ I-NP O
itation NN I-NP O
, , O O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
less JJR O O
than IN B-VP O
20% CD O O
, , O O
and CC O O
no DT B-NP O
vegeta- JJ I-NP O
tions NNS I-NP O
on IN B-VP O
the DT B-NP O
valve NN I-NP O
The DT B-NP O
patient's NN I-NP O
most RBS O O
significant JJ B-NP O
problem NN I-NP O
during IN B-VP O
his PRP$ O O
hospital JJ B-NP O
course NN I-NP O
included VBD B-VP O
temperatures NNS B-NP O
On IN B-VP O
1 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
he PRP O O
had VBD B-VP O
an DT O O
increased VBN O O
temperature NN B-NP O
to TO O O
101 CD O O
and CC O O
increased VBD B-VP O
white JJ B-NP O
count NN I-NP O
with IN B-VP O
left JJ B-NP O
shift NN I-NP O
His PRP$ O O
central JJ B-NP O
line NN I-NP O
was VBD B-VP O
pulled VBN O O
, , O O
and CC O O
the DT B-NP O
tip NN I-NP O
grew VBD B-VP O
gram JJ B-NP O
positive JJ I-NP O
cocci NN I-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
grew VBD B-VP O
gram JJ B-NP B-r
positive JJ I-NP I-r
cocci NN I-NP I-r
from IN B-VP O
two CD O O
blood NN B-NP O
cultures NNS I-NP O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
vancomycin NN B-NP B-m
and CC O O
defervesced VBN O O
, , O O
and CC O O
has VBZ O O
been VBN O O
afebrile RB O O
for IN B-VP O
four CD O O
days NNS B-NP O
Subsequently RB O O
, , O O
the DT B-NP O
patient NN I-NP O
again RB O O
became VBD B-VP O
febrile JJ O O
approximately RB O O
one CD O O
week NN B-NP O
into IN B-VP O
his PRP$ O O
vancomycin JJ B-NP B-m
course NN I-NP O
At IN B-VP O
this DT B-NP O
point NN I-NP O
he PRP O O
was VBD B-VP O
recul- JJ O O
tured JJ O O
, , O O
and CC O O
those DT B-NP O
cultures NNS I-NP O
grew VBD B-VP O
gram JJ B-NP O
negative JJ I-NP O
rods NNS I-NP O
in IN B-VP O
one CD O O
out IN B-VP O
of IN B-VP O
four CD O O
blood NN B-NP O
culture NN I-NP O
specimens VBZ O O
These DT O O
were VBD B-VP O
gram NNS B-NP B-r
negative JJ B-NP O
enteric JJ I-NP O
rods NNS I-NP O
, , O O
pan-sensitive JJ O O
, , O O
for IN B-VP O
which WDT O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
ampicillin NN B-NP B-m
2 CD O B-do
gm NN B-NP I-do
IV NNP I-NP B-mo
q RB O B-f
6 CD O I-f
This DT O O
was VBD B-VP O
felt VBN O O
most JJS O O
likely JJ O O
secondary JJ O O
to TO O O
a DT B-NP O
urinary JJ I-NP O
tract NN I-NP O
infection NN I-NP O
from IN B-VP O
the DT B-NP O
Foley NNP I-NP O
catheter NN I-NP O
, , O O
which WDT O O
has VBZ O O
been VBN O O
discontinued VBN O O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
stable JJ O O
, , O O
dobutamine JJ B-NP B-m
dependent NN I-NP O
, , O O
without IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
able JJ O O
to TO O O
ambulate VB O O
from IN B-VP O
chair NN B-NP O
to TO O O
commode VB O O
without IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
palpitations NNS B-NP O
, , O O
or CC O O
light- JJ B-NP O
headedness NN I-NP O
He PRP O O
is VBZ O O
eager JJ O O
to TO O O
be VB O O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
Ston NNP I-NP O
area NN I-NP O
to TO O O
await VB O O
heart NN B-NP O
transplant NN I-NP O
With IN B-VP O
any DT B-NP O
questions NNS I-NP O
, , O O
please VB O O
contact JJ B-NP O
Doctor NNP I-NP O
Wilmer NNP I-NP O
Priore NNP I-NP O
Tucap NNP I-NP O
Anathens NNP I-NP O
Sol NNP I-NP O
Health NNP I-NP O
Services NNP I-NP O
265-8948 CD O O
, , O O
beeper IN B-VP O
number NN B-NP O
7217 CD O O
, , O O
the DT B-NP O
patient's NN I-NP O
medical JJ O O
intern VBZ O O
The DT B-NP O
patient's JJ I-NP O
condition NN I-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
is VBZ O O
fair JJ B-NP O
DISPOSITION: NNP I-NP O
Continuing NNP I-NP O
care NN I-NP O
in IN B-VP O
the DT B-NP O
coronary JJ I-NP O
care NN I-NP O
unit NN I-NP O
of IN B-VP O
the DT B-NP O
hospital NN I-NP O
inpatient NN I-NP O
near IN B-VP O
patient's NN B-NP O
home NN I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
under IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
a DT B-NP O
Doctor NNP I-NP O
Daren NNP I-NP O
Swasey NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
JESS NNP I-NP O
HESSER NNP I-NP O
, , O O
M.D NNP B-NP O
MI73 NNP I-NP O
AM887/4014 NNP I-NP O
MCKINLEY NNP I-NP O
STACEY NNP I-NP O
DILLOW NNP I-NP O
, , O O
M.D NNP B-NP O
JR4 NNP I-NP O
D: NNP I-NP O
3/22/91 CD O O
T: NNP B-NP O
3/22/91 CD O O
Batch: NNP B-NP O
O270 NNP I-NP O
Report: NNP I-NP O
KH817R19 NNP I-NP O
T: NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#718365 VBZ O O
593085640 CD O O
BAH NNP B-NP O
60698702 CD O O
952684 CD O O
0/12/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
FAILED NNP I-NP O
RT NNP I-NP O
TOTAL NNP I-NP O
HIP NNP I-NP O
REPLACEMENT NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/13/1998 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/22/1998 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
FAILED NNP I-NP O
HEMIARTHROPLASTY NNP I-NP O
, , O O
RIGHT NNP B-NP O
HIP NNP I-NP O
PRINCIPAL NNP I-NP O
PROCEDURE: NNP I-NP O
CONVERSION NNP I-NP O
OF NNP I-NP O
HEMIARTHROPLASTY NNP I-NP O
TO NNP I-NP O
TOTAL NNP I-NP O
HIP NNP I-NP O
REPLACEMENT NNP I-NP O
OF NNP I-NP O
RIGHT NNP I-NP O
HIP NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT B-NP O
63-year-old JJ I-NP O
female NN I-NP O
is VBZ O O
status NN B-NP O
post NN I-NP O
right RB O O
bipolar JJ B-NP O
hemiarthroplasty NN I-NP O
in IN B-VP O
1992 CD O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
arteriovenous JJ B-NP O
malformation NN I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
until IN B-VP O
9 CD O O
of IN B-VP O
February NNP B-NP O
when WRB O O
she PRP O O
heard VBD B-VP O
a DT B-NP O
large JJ I-NP O
noise NN I-NP O
with IN B-VP O
the DT B-NP O
feeling NN I-NP O
of IN B-VP O
increased JJ B-NP O
pain NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
hip NN I-NP O
The DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
closed JJ I-NP O
reduction NN I-NP O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
and CC O O
was VBD B-VP O
subsequently RB O O
discharged VBN O O
with IN B-VP O
a DT B-NP O
hip NN I-NP O
abduction NN I-NP O
arthrosis IN B-VP O
The DT B-NP O
patient NN I-NP O
presents NNS I-NP O
, , O O
however RB O O
, , O O
here RB O O
for IN B-VP O
conversion NN B-NP O
of IN B-VP O
her PRP$ O O
right JJ B-NP O
bipolar NN I-NP O
to TO O O
a DT B-NP O
right JJ I-NP O
total NN I-NP O
hip NN I-NP O
replacement NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
cholecystectomy NN I-NP O
Status NNP I-NP O
post NN I-NP O
bipolar NN I-NP O
hemiarthroplasty NN I-NP O
in IN B-VP O
1992 CD O O
Status NNP B-NP O
post NN I-NP O
breast NN I-NP O
reduction NN I-NP O
Status NNP I-NP O
post NN I-NP O
left VBD B-VP O
hip JJ B-NP O
revision NN I-NP O
in IN B-VP O
1993 CD O O
of IN B-VP O
the DT B-NP O
femoral JJ I-NP O
component NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
hip NN I-NP O
Status NNP I-NP O
post NN I-NP O
left VBD B-VP O
femoral JJ B-NP O
nerve NN I-NP O
exploration NN I-NP O
in IN B-VP O
1993 CD O O
Status NNP B-NP O
post NN I-NP O
right RB O O
total JJ B-NP O
knee JJ I-NP O
replacement NN I-NP O
in IN B-VP O
1997 CD O O
ALLERGIES: NNP B-NP O
With IN B-VP O
penicillin NN B-NP O
she PRP O O
gets VBZ O O
hives NNS B-NP O
MEDICATIONS: NNP I-NP O
None NNP I-NP O
HABITS: NNP I-NP O
No NNP I-NP O
tobacco NN I-NP O
, , O O
no DT B-NP O
alcohol NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Orthopaedic NNP I-NP O
Floor NNP I-NP O
postoperatively RB O O
for IN B-VP O
pain NN B-NP O
control NN I-NP O
and CC O O
for IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
The DT B-NP O
patient NN I-NP O
rapidly RB O O
progressed VBD B-VP O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
and CC O O
did VBD B-VP O
quite RB O O
well RB O O
She PRP O O
was VBD B-VP O
ambulating VBG O O
with IN B-VP O
assistance NN B-NP O
, , O O
partial JJ O O
weightbearing VBG O O
with IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
without IN B-VP O
difficulty NN B-NP O
Her PRP$ O O
wound NN B-NP O
is VBZ O O
clean JJ O O
, , O O
dry JJ O O
, , O O
and CC O O
intact JJ O O
with IN B-VP O
minimal JJ B-NP O
drainage NN I-NP O
from IN B-VP O
the DT B-NP O
old JJ I-NP O
drain NN I-NP O
site NN I-NP O
She PRP O O
was VBD B-VP O
afebrile RB O O
throughout IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
and CC O O
required VBD B-VP O
one CD O B-do
unit NN B-NP I-do
of IN B-VP O
blood NN B-NP B-m
during IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
to TO O O
maintain VB O O
her PRP$ O O
blood NN B-NP O
count NN I-NP O
greater JJR O O
than IN B-VP O
30 CD O O
She PRP O O
otherwise RB O O
did VBD B-VP O
remarkably RB O O
well RB O O
and CC O O
was VBD B-VP O
quite RB O O
comfortable JJ O O
prior JJ O O
to TO O O
discharge VB O O
Her NNP B-NP O
discharge NN I-NP O
medications NNS I-NP O
were VBD B-VP O
Percocet NNP B-NP B-m
1-2 JJ B-NP B-do
tabs NNS I-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
4-6 JJ I-NP I-f
p.r.n NN I-NP I-f
She PRP O O
was VBD B-VP O
also RB O O
discharged VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
3.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
and CC O O
should MD O O
maintain VB O O
Coumadin NNP B-NP B-m
therapy NN I-NP O
for IN B-VP B-du
for IN B-VP B-du
six CD O I-du
six CD O I-du
weeks NNS B-NP I-du
weeks NNS I-NP I-du
time NN I-NP O
The DT B-NP O
patient NN I-NP O
should MD O O
have VB O O
a DT B-NP O
prothrombin JJ I-NP O
time NN I-NP O
checked VBD B-VP O
biweekly RB O O
to TO O O
maintain VB O O
an DT B-NP O
INR NNP I-NP O
between IN B-VP O
14 CD O O
and CC O O
17 CD O O
She PRP O O
otherwise RB O O
did VBD B-VP O
quite RB O O
well RB O O
and CC O O
we PRP O O
are VBP O O
quite RB O O
pleased JJ O O
with IN B-VP O
her PRP$ O O
progress NN B-NP O
We PRP O O
will MD O O
see VB O O
her PRP$ O O
back NN B-NP O
in IN B-VP O
the DT B-NP O
office NN I-NP O
in IN B-VP O
six CD O O
weeks NNS B-NP O
time NN I-NP O
for IN B-VP O
x-rays NNS B-NP O
and CC O O
follow-up NN B-NP O
Dictated NNP I-NP O
By: NNP I-NP O
JEFFRY NNP I-NP O
CYBULSKI NNP I-NP O
, , O O
M.D NNP B-NP O
MW86 NNP I-NP O
Attending: NNP I-NP O
JAMIE NNP I-NP O
T NNP I-NP O
PERMAN NNP I-NP O
, , O O
M.D NNP B-NP O
EZ96 NNP I-NP O
LT842/4419 NNP I-NP O
Batch: NNP I-NP O
8644 CD O O
Index NNP B-NP O
No NNP I-NP O
ATHCND8508 NNP I-NP O
D: NNP I-NP O
4/29/98 CD O O
T: NNP B-NP O
4/29/98 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#723978 VBZ O O
342590615 CD O O
RHC NNP B-NP O
47454253 CD O O
5842115 CD O O
1/4/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
pneumonia NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/15/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/18/2004 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
STETTLER NNP I-NP O
, , O O
HAL NNP B-NP O
223-66-98-9 CD O O
Well NNP B-NP O
Spo NNP I-NP O
Uxsmouth NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
1/29/04 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP O
evaluation NN I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KOLKMAN NNP I-NP O
, , O O
ISIDRO NNP B-NP O
S NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
AMIODARONE NNP I-NP B-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/19/04 CD O O
by IN B-VP O
MCCRABB NNP B-NP O
, , O O
FREDDY NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
17623917 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitioring VBG O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/19/04 CD O O
by IN B-VP O
STOCKBRIDGE NNP B-NP O
, , O O
TRENT NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
70172290 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/19/04 CD O O
by IN B-VP O
SCHWEINER NNP B-NP O
, , O O
MICHAL NNP B-NP O
H NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
GLIPIZIDE NNP I-NP B-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/19/04 CD O O
by IN B-VP O
SAGUIL NNP B-NP O
, , O O
CLAYTON NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POSSIBLE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
SULFA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
glyburide VBP O B-m
at IN B-VP O
home NN B-NP O
Previous NNP I-NP O
Alert NNP I-NP O
overridden NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/19/04 CD O O
by IN B-VP O
HOBEREK NNP B-NP O
, , O O
JEWELL NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POSSIBLE NNP I-NP O
ALLERGY NNP I-NP O
( ( O O
OR NNP B-NP O
SENSITIVITY NNP I-NP O
) ) O O
to TO O O
SULFA NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
tolerates NNS I-NP O
at IN B-VP O
home NN B-NP O
GUAIFENESIN NNP I-NP B-m
10 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
2/12 CD O O
) ) O O
PRN NNP B-NP O
Other:cough NNP I-NP B-r
ISORDIL NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
DINITRATE NNP I-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;110 NN I-NP O
, , O O
call VB O O
ho NN B-NP O
if IN B-VP O
holding VBG O O
SARNA NNP B-NP B-m
TOPICAL NNP I-NP B-mo
TP NNP I-NP I-mo
QD NNP I-NP B-f
Instructions: NNP I-NP O
to TO O O
lower VB O O
extremities NNS B-NP O
COUMADIN NNP I-NP B-m
COUMADIN NNP I-NP B-m
( ( O I-m
( ( O I-m
WARFARIN NNP B-NP I-m
WARFARIN NNP I-NP I-m
SODIUM NNP I-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
QOD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
2/12 CD O O
) ) O O
Instructions: NNP B-NP O
alternating VBG O O
with IN B-VP O
5mg CD O B-do
qod NNS B-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Alert NNP I-NP O
overridden: VBD B-VP O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
2/19/04 CD O O
by IN B-VP O
DERENTIS NNP B-NP O
, , O O
EDUARDO NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
HYDROCORTISONE NNP I-NP B-m
1% CD O I-m
-TOPICAL NNP B-NP I-m
CREAM NNP I-NP I-m
TP NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
to TO O O
R NNP B-NP B-r
elbow NN I-NP I-r
eczema NN I-NP I-r
LEVOFLOXACIN NNP I-NP B-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
( ( O O
3/0 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-m
products NNS I-NP I-m
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-m
or CC O O
ciprofloxacin NN B-NP B-m
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/19/04 CD O O
by IN B-VP O
DADLANI NNP B-NP O
, , O O
DANNY NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
17623917 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitioring VBG O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/19/04 CD O O
by IN B-VP O
WANDS NNP B-NP O
, , O O
TREY NNP B-NP O
V NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
70172290 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
Previous NNP I-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
2/19/04 CD O O
by IN B-VP O
DUESTERBACK NNP B-NP O
, , O O
CARROL NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
AMIODARONE NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
76482971 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LEVOFLOXACIN NNP I-NP B-m
&amp; NNP I-NP O
AMIODARONE NNP I-NP B-m
HCL NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
NIZORAL NNP I-NP B-m
2% CD O O
SHAMPOO NNP B-NP O
( ( O O
KETOCONAZOLE NNP B-NP O
2% CD O O
SHAMPOO NNP B-NP O
) ) O O
TOPICAL NNP B-NP B-mo
TP NNP I-NP I-mo
tiweek VBD B-VP B-f
SYNALAR NNP B-NP B-m
0.025% CD O O
CREAM NNP B-NP O
( ( O O
FLUOCINOLONE NNP B-NP O
0.025% CD O O
CREAM NNP B-NP O
) ) O O
TOPICAL NNP B-NP B-mo
TP NNP I-NP I-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
` `` O O
apply RB O O
below IN B-VP O
knees NNS B-NP O
on IN B-VP O
both DT B-NP O
legs JJ I-NP O
PLAQUENIL NNP I-NP B-m
( ( O I-m
HYDROXYCHLOROQUINE NNP B-NP I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
NORVASC NNP I-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
DIET: NNP B-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Freed NNP I-NP O
, , O O
Friday NNP B-NP O
August NNP I-NP O
10:30AM CD O O
scheduled VBN O O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
6/1 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
3 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Dewitt NNP B-NP O
Luckhardt NNP I-NP O
, , O O
388-436-1231 JJ B-NP O
ALLERGY: NNP I-NP O
Sotalol NNP I-NP O
, , O O
Procainamide NNP B-NP O
, , O O
Aspirin NNP B-NP O
, , O O
Penicillins NNP B-NP O
, , O O
Sulfa NNP B-NP O
, , O O
Quinaglute NNP B-NP O
, , O O
Asa NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
pneumonia NN I-NP O
, , O O
transient JJ B-NP O
ischemic JJ I-NP O
attack NN I-NP O
vs NN I-NP O
exacerbation NN I-NP O
of IN B-VP O
underlying VBG O O
neurologic JJ B-NP O
deficits NNS I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
pneumonia VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN; NNP I-NP O
CHF;s/p NNP I-NP O
St NNP I-NP O
Jude NNP I-NP O
MVR NNP I-NP O
for IN B-VP O
MS NNP B-NP O
( ( O O
S/P NNP B-NP O
cardiac VBP O O
valve FW O O
replacement NN B-NP O
) ) O O
Hx NNP B-NP O
AFib/flutter NNP I-NP O
( ( O O
H/O NNP B-NP O
atrial JJ B-NP O
fibrillation NN I-NP O
) ) O O
s/p NN B-NP O
IMI NNP I-NP O
( ( O O
S/P NNP B-NP O
myocardial NNP I-NP O
infarction NN I-NP O
) ) O O
NIDDM NNP B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
gout NN B-NP O
( ( O O
gout NN B-NP O
) ) O O
Hx NNP B-NP O
DVT NNP I-NP O
'70 NNP I-NP O
( ( O O
H/O NNP B-NP O
deep RB O O
venous JJ B-NP O
thrombosis NN I-NP O
) ) O O
s/p NN B-NP O
appy JJ O O
( ( O O
S/P NNP B-NP O
appendectomy RB O O
) ) O O
s/p VB O O
umbilical JJ B-NP O
hernia NN I-NP O
repair NN I-NP O
( ( O O
S/P NNP B-NP O
hernia NNP I-NP O
repair NN I-NP O
) ) O O
s/p NN B-NP O
sigmoidectomy NN I-NP O
for IN B-VP O
diverticulitis NN B-NP O
s/p NN I-NP O
L NNP I-NP O
hip NN I-NP O
# # O O
'95 NNP B-NP O
( ( O O
S/P NNP B-NP O
hip NN I-NP O
fracture NN I-NP O
) ) O O
PE NNP B-NP O
( ( O O
pulmonary JJ B-NP O
embolism NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Mrs NNP I-NP O
Marnett NNP I-NP O
is VBZ O O
an DT O O
81 CD O O
y.o NN B-NP O
woman NN I-NP O
who WP O O
presents VBZ O O
with IN B-VP O
one CD O O
day NN B-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
difficulty NN B-NP O
speaking NN I-NP O
, , O O
nausea NN B-NP O
, , O O
and CC O O
lightheadedness NN B-NP O
She PRP O O
had VBD B-VP O
URI NNP B-NP O
symptoms NNS I-NP O
about IN B-VP O
two CD O O
weeks NNS B-NP O
ago RB O O
and CC O O
then RB O O
5d CD O O
pta NN B-NP O
developed VBD B-VP O
minimal JJ B-NP O
ly JJ I-NP O
productive JJ I-NP O
cough NN I-NP O
and CC O O
then RB O O
SOB NNP B-NP O
for IN B-VP O
the DT B-NP O
past JJ I-NP O
2-3 JJ I-NP O
days NNS I-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
noctural JJ I-NP O
dyspnea NN I-NP O
or CC O O
increase VB O O
in IN B-VP O
number NN B-NP O
of IN B-VP O
pillows NNS B-NP O
She PRP O O
lives VBZ O O
alone RB O O
, , O O
and CC O O
a DT B-NP O
reverend NN I-NP O
checks VBZ O O
up RP O O
on IN B-VP O
her PRP O O
daily; VBP O O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
he PRP O O
suggested VBD B-VP O
she PRP O O
go VB O O
to TO O O
the DT B-NP O
hospital NN I-NP O
She PRP O O
does VBZ O O
not RB O O
feel VB O O
that IN B-VP O
she PRP O O
had VBD B-VP O
any DT B-NP O
speech NN I-NP O
difficulties NNS I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
but CC O O
when WRB O O
she PRP O O
awoke VBD B-VP O
she PRP O O
noted VBD B-VP O
heaviness NN B-NP O
of IN B-VP O
her PRP$ O O
tongue NN B-NP O
and CC O O
workd NN B-NP O
finding VBG O O
difficulties NNS B-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
had VBD B-VP O
sweating VBG O O
and CC O O
chest JJS B-NP O
pain NN I-NP O
that WDT O O
radiated VBD B-VP O
to TO O O
her PRP$ O O
shoulder NN B-NP O
( ( O O
L&gt;R NNP B-NP O
) ) O O
, , O O
and CC O O
back RB O O
This DT O O
was VBD B-VP O
different JJ O O
than IN B-VP O
her PRP$ O O
usual JJ B-NP O
anginal JJ I-NP O
symptoms NNS I-NP O
( ( O O
which WDT O O
do VBP O O
not RB O O
involve VB O O
back RB O O
radiation NN B-NP O
) ) O O
The DT B-NP O
pain NN I-NP O
was VBD B-VP O
pleuritic JJ O O
in IN B-VP O
nature NN B-NP O
, , O O
and CC O O
she PRP O O
denied VBD B-VP O
palpitations NNS B-NP O
She PRP O O
also RB O O
noticed VBD B-VP O
nausea NN B-NP O
and CC O O
had VBD B-VP O
several JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
dry JJ O O
heaving VBG O O
While IN B-VP O
leaving VBG O O
the DT B-NP O
bathroom NN I-NP O
she PRP O O
had VBD B-VP O
a DT B-NP O
single JJ I-NP O
episode NN I-NP O
of IN B-VP O
"lightheadness." NN B-NP O
This DT O O
did VBD B-VP O
not RB O O
involve VB O O
any DT B-NP O
sensation NN I-NP O
of IN B-VP O
vertigo NN B-NP O
, , O O
or CC O O
any DT B-NP O
vision NN I-NP O
changes NNS I-NP O
She PRP O O
sat VBD B-VP O
down RB O O
immediately RB O O
, , O O
and CC O O
felt VBD B-VP O
better RBR O O
within IN B-VP O
a DT B-NP O
few JJ I-NP O
seconds NNS I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
fall NN I-NP O
and CC O O
no DT B-NP O
LOC NNP I-NP O
Around IN B-VP O
8am CD O O
, , O O
her PRP$ O O
housekeeper NN B-NP O
came VBD B-VP O
, , O O
and CC O O
immediately RB O O
noticed VBD B-VP O
a DT B-NP O
change NN I-NP O
in IN B-VP O
Mrs NNP B-NP O
Cooney NNP I-NP O
's POS O O
voice NN B-NP O
Mrs NNP I-NP O
Solberg NNP I-NP O
describes VBZ O O
the DT B-NP O
change NN I-NP O
as IN B-VP O
a DT B-NP O
"thickening NN I-NP O
of IN B-VP O
my PRP$ O O
tongue" NN B-NP O
and CC O O
some DT B-NP O
problems NNS I-NP O
finding VBG O O
words NNS B-NP O
She PRP O O
has VBZ O O
been VBN O O
taking VBG O O
all DT O O
of IN B-VP O
her PRP$ O O
medications NNS B-NP O
as IN B-VP O
prescribed VBN O O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
week NN I-NP O
ROS: NNP I-NP O
On IN B-VP O
arrival NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
Mrs NNP B-NP O
Shoman NNP I-NP O
noted VBD B-VP O
a DT O O
raised VBN O O
, , O O
painful JJ B-NP O
area NN I-NP O
on IN B-VP O
her PRP$ O O
L NNP B-NP O
forearm NN I-NP O
She PRP O O
does VBZ O O
not RB O O
recall VB O O
any DT B-NP O
trauma NN I-NP O
to TO O O
the DT B-NP O
area NN I-NP O
She PRP O O
denies VBZ O O
any DT B-NP O
fever NN I-NP O
PMedHx: NNP I-NP O
1 CD O O
H/o NNP B-NP O
agina NN I-NP O
( ( O O
a DT O O
) ) O O
Echo NNP B-NP O
( ( O O
1/29 CD O O
) ) O O
, , O O
EF NNP B-NP O
55% CD O O
, , O O
abnormal JJ B-NP O
septal JJ I-NP O
motion NN I-NP O
, , O O
mild JJ B-NP O
AR NNP I-NP O
, , O O
no DT B-NP O
MR NNP I-NP O
( ( O O
through IN B-VP O
mech NN B-NP O
valve NN I-NP O
) ) O O
, , O O
mod JJ B-NP O
TR NNP I-NP O
( ( O O
b NN B-NP O
) ) O O
Holter $ O O
0/2 CD O O
- : O O
multiform NN B-NP O
VE NNP I-NP O
( ( O O
bigem NN B-NP O
, , O O
cooup NN B-NP O
) ) O O
, , O O
SVE's NNP B-NP O
1st CD O O
degree JJ B-NP O
A-V NNP I-NP O
block NN I-NP O
2 CD O O
D.M NNP B-NP O
AGA1c NNP I-NP O
6.1 CD O O
( ( O O
6/17 CD O O
) ) O O
3 CD O O
subacute JJ B-NP O
thalamic JJ I-NP O
stroke NN I-NP O
noted VBD B-VP O
on IN B-VP O
CT NNP B-NP O
1/29 CD O O
4 CD O O
Afib NNP B-NP B-r
- : O O
on IN B-VP O
coumadin NN B-NP B-m
5 CD O O
Mitral NNP B-NP O
stenosis NN I-NP O
- : O O
MVR NNP B-NP O
St NNP I-NP O
Jude NNP I-NP O
( ( O O
4/27 CD O O
) ) O O
6 CD O O
CHF NNP B-NP O
, , O O
admitted VBD B-VP O
many JJ B-NP O
times NNS I-NP O
, , O O
latest JJS O O
0/29 CD O O
7 CD O O
Restrictive JJ B-NP O
lung NN I-NP O
disease- JJ O O
5/23 CD O O
PFTs NNP B-NP O
FVC NNP I-NP O
1.33 CD O O
, , O O
FEV1 NNP B-NP O
0.98 CD O O
8 CD O O
Sigmoid NNP B-NP O
colostomy NN I-NP O
9 CD O O
Ventral NNP B-NP O
hernia NN I-NP O
repair NN I-NP O
10 CD O O
Bladder NNP B-NP O
calcifications NNS I-NP O
on IN B-VP O
CT NNP B-NP O
urogram NNP I-NP O
( ( O O
1/29 CD O O
) ) O O
- : O O
needs VBZ O O
cystoscopy JJ O O
11 CD O O
HTN NNP B-NP O
12 CD O O
RA NNP B-NP O
13 CD O O
Recent NNP B-NP O
eye NN I-NP O
hemorrhage NN I-NP O
Physical: NNP I-NP O
VS: NNP I-NP O
T NNP I-NP O
98.9 CD O O
P NNP B-NP O
103 CD O O
, , O O
BP NNP B-NP O
160/74 CD O O
, , O O
RR NNP B-NP O
20 CD O O
, , O O
OxySat NNP B-NP O
97% CD O O
2L CD O O
NC NNP B-NP O
, , O O
FSG NNP B-NP O
172 CD O O
Gen: NNP B-NP O
soft JJ B-NP O
voice NN I-NP O
, , O O
audible JJ O O
clicking VBG O O
sound NN B-NP O
, , O O
NAD NNP B-NP O
HEENT: NNP I-NP O
PERRL NNP I-NP O
, , O O
EOMI NNP B-NP O
Card: NNP I-NP O
irregularly RB O O
irregular JJ O O
, , O O
no DT B-NP O
S1 NNP I-NP O
, , O O
mechanical JJ B-NP O
S2 NNP I-NP O
, , O O
II/VI NNP B-NP O
early RB O O
systolic JJ B-NP O
murmur NN I-NP O
, , O O
loudest JJS O O
at IN B-VP O
base NN B-NP O
of IN B-VP O
heart NN B-NP O
Pulm: NNP I-NP O
reduced VBD B-VP O
breath JJ B-NP O
sounds NNS I-NP O
at IN B-VP O
dependant JJ O O
1/3 CD O O
b/l NN B-NP O
No NNP I-NP O
wheezes VBZ O O
heard RB O O
Abd: NNP B-NP O
well RB O O
healed VBD B-VP O
midline JJ B-NP O
scars NNS I-NP O
No DT B-NP O
bruits NNS I-NP O
ascultated VBN O O
, , O O
+BS JJ B-NP O
Soft NNP I-NP O
, , O O
NT NNP B-NP O
, , O O
ND NNP B-NP O
, , O O
no DT B-NP O
masses NNS I-NP O
Integ: NNP I-NP O
diffuse IN B-VP O
macular JJ O O
( ( O O
5-10mm JJ O O
) ) O O
hyperpigmented VBD B-VP O
rash JJ B-NP O
distal NN I-NP O
to TO O O
knees VB O O
b/l JJ B-NP O
Ext: NNP I-NP O
2x3 CD O O
cm NN B-NP O
raised VBN O O
tender NN B-NP O
area NN I-NP O
on IN B-VP O
L NNP B-NP O
forearm NN I-NP O
, , O O
no DT B-NP O
skin NN I-NP O
changes VBZ O O
&lt;3 NNP B-NP O
s NN I-NP O
cap NN I-NP O
refill NN I-NP O
L NNP I-NP O
hand NN I-NP O
Full NNP I-NP O
ROM NNP I-NP O
of IN B-VP O
left JJ B-NP O
fingers NNS I-NP O
( ( O O
with IN B-VP O
pain NN B-NP O
) ) O O
2+ CD O O
PT NNP B-NP O
pulses NNS I-NP O
b/l NN I-NP O
, , O O
1+ CD O O
DP NNP B-NP O
pulses NNS I-NP O
b/l VBP O O
2+ CD O O
radial/ulnar NN B-NP O
pulses NNS I-NP O
b/l VBP O O
Neuro: NNP B-NP O
A&amp;O NNP I-NP O
x NNP I-NP O
3 CD O O
, , O O
attentive JJ O O
, , O O
cooperative.Naming VBG O O
intact JJ O O
, , O O
follows VBZ O O
commands NNS B-NP O
, , O O
repetition NN B-NP O
intact JJ O O
, , O O
fluent JJ B-NP O
English NNP I-NP O
CN NNP I-NP O
2-12: JJ B-NP O
reactive NN I-NP O
pupils NNS I-NP O
, , O O
Eomi NNP B-NP O
, , O O
sensation NN B-NP O
intact JJ O O
throughout IN B-VP O
, , O O
hearing VBG O O
intact JJ O O
to TO O O
finger VB O O
rub NN B-NP O
, , O O
palate NN B-NP O
elevates NNS I-NP O
, , O O
tongue NN B-NP O
midline NN I-NP O
, , O O
full JJ B-NP O
strength NN I-NP O
trap NN I-NP O
and CC O O
SCM NNP B-NP O
Face NNP I-NP O
symmetric JJ B-NP O
Motor: NNP I-NP O
Strength: NNP I-NP O
R NNP I-NP O
arm: VBD B-VP O
5/5 CD O O
Del/Bi/Tri NNP B-NP O
, , O O
L NNP B-NP O
arm VBZ O O
4/5 CD O O
with IN B-VP O
giveway JJ B-NP O
character NN I-NP O
Del/Bi/Tri NNP I-NP O
L NNP I-NP O
leg VBD B-VP O
4-/5 JJ B-NP O
HF NNP I-NP O
5/5 CD O O
KE/PF/DF NNP B-NP O
R NNP I-NP O
leg VBD B-VP O
5/5 CD O O
HF/KE/PF/DFTone: NNP B-NP O
normalCoordination: JJ B-NP O
FNF NNP I-NP O
normal JJ B-NP O
b/l NN I-NP O
, , O O
heel-shin JJ B-NP O
R NNP I-NP O
leg NN I-NP O
normal JJ O O
, , O O
effort NN B-NP O
limited VBD B-VP O
L NNP B-NP O
leg NN I-NP O
Gait: NNP I-NP O
not RB O O
assessed VBD B-VP O
Hospital NNP B-NP O
course NN I-NP O
by IN B-VP O
system: JJ B-NP O
Neuro: NNP I-NP O
Speech NNP I-NP O
difficulties: NN I-NP O
resolved VBN O O
by IN B-VP O
the DT B-NP O
time NN I-NP O
pt NN I-NP O
was VBD B-VP O
in IN B-VP O
ER NNP B-NP O
, , O O
making VBG O O
diagnosis NN B-NP O
difficult JJ B-NP O
Possible JJ I-NP O
etiologies NNS I-NP O
include VBP O O
TIA NNP B-NP O
or CC O O
illness JJ O O
exacerbating VBG O O
deficits NNS B-NP O
from IN B-VP O
old JJ B-NP O
stroke NN I-NP O
Head NNP I-NP O
CT NNP I-NP O
in IN B-VP O
ER NNP B-NP O
showed VBD B-VP O
old JJ B-NP O
infarcts NNS I-NP O
, , O O
but CC O O
no DT B-NP O
acute JJ I-NP O
process NN I-NP O
Patient NNP I-NP O
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP O
speech NN I-NP O
difficulties NNS I-NP O
throughout IN B-VP O
admission NN B-NP O
or CC O O
other JJ B-NP O
neurologic JJ I-NP O
findings NNS I-NP O
CV: NNP I-NP O
ischemia: VBZ O O
No DT B-NP O
ST NNP I-NP O
changes NNS I-NP O
on IN B-VP O
EKG NNP B-NP O
, , O O
one CD O O
set NN B-NP O
of IN B-VP O
cardiac JJ B-NP O
enzymes NNS I-NP O
were VBD B-VP O
negative JJ B-NP O
Given NNP I-NP O
low JJ B-NP O
probability NN I-NP O
of IN B-VP O
ischemia NN B-NP O
, , O O
no DT B-NP O
further JJ I-NP O
enzymes NNS I-NP O
were VBD B-VP O
drawn VBN O O
Pump: NNP B-NP O
EF NNP I-NP O
55% CD O O
, , O O
patient NN B-NP O
was VBD B-VP O
normotensive JJ O O
even RB O O
after IN B-VP O
d/c NN B-NP O
of IN B-VP O
some DT O O
of IN B-VP O
her PRP$ O O
home NN B-NP O
HTN NNP I-NP B-m
meds NNS I-NP I-m
( ( O O
see VB O O
renal NN B-NP O
) ) O O
Rhythm: NNP B-NP O
pt NN I-NP O
was VBD B-VP O
on IN B-VP O
telemetry NN B-NP O
for IN B-VP O
first JJ B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
and CC O O
alternated VBD B-VP O
between IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
and CC O O
afib JJ B-NP O
Pulm: NNP I-NP O
PNA: NNP I-NP O
pt NN I-NP O
had VBD B-VP O
left VBN O O
lower JJR B-NP O
lobe NN I-NP O
opacity NN I-NP O
on IN B-VP O
CXR NNP B-NP O
Decision NNP I-NP O
was VBD B-VP O
made VBN O O
to TO O O
start VB O O
antibiotics NNS B-NP B-m
Pt NNP I-NP O
had VBD B-VP O
a DT B-NP O
positive JJ I-NP O
d-dimer NN I-NP O
, , O O
but CC O O
PE NNP B-NP O
was VBD B-VP O
very RB O O
unlikely JJ O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
therapeutic JJ B-NP O
anticoagulation NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
CHF NNP B-NP O
, , O O
but CC O O
had VBD B-VP O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
CHF NNP B-NP O
on IN B-VP O
exam NN B-NP O
during IN B-VP O
this DT B-NP O
hospitalizaiton NN I-NP O
although IN B-VP O
her PRP$ O O
cxr NN B-NP O
was VBD B-VP O
read VBN O O
as IN B-VP O
mild JJ B-NP O
pulmonary JJ I-NP O
edema NN I-NP O
Renal: NNP I-NP O
ARF: NNP I-NP O
Creatine NNP I-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
1.8 CD O O
, , O O
up RB O O
from IN B-VP O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
1.2-1.3 JJ B-NP O
Given NNP I-NP O
her PRP$ O O
h/o NN B-NP O
poor JJ B-NP O
po NNS I-NP O
intake VBP O O
and CC O O
euvolemic VBP O O
to TO O O
dry VB O O
exam NN B-NP O
, , O O
this DT O O
was VBD B-VP O
thought VBN O O
likely RB O O
due JJ O O
to TO O O
prerenal JJ B-NP O
hypovolemia NN I-NP O
Her NNP I-NP O
lasix NN I-NP B-m
, , O O
lisinopril NN B-NP B-m
and CC O O
colchicine NN B-NP B-m
were VBD B-VP O
held VBN O O
, , O O
as IN B-VP O
they PRP O O
might MD O O
contribute VB O O
to TO O O
further JJ B-NP O
ARF NNP I-NP O
, , O O
and CC O O
she PRP O O
got VBD B-VP O
gentle JJ B-NP O
ivf NN I-NP B-m
( ( O O
approximately RB O B-do
1L CD O I-do
) ) O O
and CC O O
her PRP$ O O
creatinine NN B-NP O
improved VBN O O
However RB O O
, , O O
after IN B-VP O
restarting VBG O O
her PRP$ O O
medications NNS B-NP O
her PRP$ O O
Cr NNP B-NP O
again RB O O
bumped VBD B-VP O
to TO O O
1.8 CD O O
Her NNP B-NP O
UA NNP I-NP O
was VBD B-VP O
unremarkable JJ O O
She PRP O O
was VBD B-VP O
d/c JJ B-NP O
home NN I-NP O
off IN B-VP O
lasix NN B-NP B-m
, , O O
lisinopril NN B-NP B-m
and CC O O
colchicine NN B-NP B-m
with IN B-VP O
a DT B-NP O
Cr NNP I-NP O
of IN B-VP O
1.8 CD O O
presuming VBG O O
that IN B-VP O
sh NN B-NP O
e NN I-NP O
was VBD B-VP O
still RB O O
prerenal JJ O O
The DT B-NP O
plan NN I-NP O
is VBZ O O
for IN B-VP O
VNA NNP B-NP O
to TO O O
check VB O O
her PRP$ O O
chem7 NN B-NP O
in IN B-VP O
3days CD O O
days NNS B-NP O
, , O O
results NNS B-NP O
to TO O O
go VB O O
to TO O O
Dr NNP B-NP O
Skibo NNP I-NP O
for IN B-VP O
monitoring NN B-NP O
and CC O O
deciding VBG O O
when WRB O O
to TO O O
restart VB O O
her PRP$ O O
medications NNS B-NP O
MSK: NNP I-NP O
Pt NNP I-NP O
developed VBD B-VP O
the DT B-NP O
left JJ I-NP O
forearm NN I-NP O
swelling NN I-NP O
and CC O O
pain NN B-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hosp NN I-NP O
for IN B-VP O
the DT B-NP O
first JJ I-NP O
night NN I-NP O
A NNP I-NP O
radiograph NN I-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
fracture NN B-NP O
and CC O O
it PRP O O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
a DT B-NP O
small JJ I-NP O
hematoma NN I-NP O
The DT B-NP O
pain NN I-NP B-r
remitted VBD B-VP O
with IN B-VP O
Tylenol NNP B-NP B-m
At IN B-VP O
discharge NN B-NP O
the DT B-NP O
pain NN I-NP O
was VBD B-VP O
a DT B-NP O
dull JJ I-NP O
ache NN I-NP O
, , O O
and CC O O
the DT B-NP O
swelling NN I-NP O
was VBD B-VP O
reduced VBN O O
Heme: NNP B-NP O
Anticoagulation NNP I-NP O
She PRP O O
was VBD B-VP O
maintained VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
INR NNP B-NP O
was VBD B-VP O
maintained VBN O O
in IN B-VP O
a DT B-NP O
theraputic JJ I-NP O
range NN I-NP O
This DT O O
will MD O O
have VB O O
to TO O O
be VB O O
closely RB O O
monitored VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
while IN B-VP O
on IN B-VP O
levofloxacin IN B-VP B-m
Her NNP B-NP O
INR NNP I-NP O
was VBD B-VP O
3 CD O O
after IN B-VP O
2 CD O B-du
days NNS B-NP O
of IN B-VP O
levofloxacin NN B-NP B-m
and CC O O
will MD O O
be VB O O
checked VBN O O
again RB O O
by IN B-VP O
VNA NNP B-NP O
3 CD O O
days NNS B-NP O
after IN B-VP O
discharge NN B-NP O
, , O O
results NNS B-NP O
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
Sheldon NNP B-NP O
Dingmann NNP I-NP O
Endo: NNP I-NP O
D.M NNP I-NP O
Pt NNP I-NP O
was VBD B-VP O
switched VBN O O
from IN B-VP O
micronase NN B-NP B-m
to TO O O
glipizide VB O B-m
2.5mg CD O B-do
qd NN B-NP B-f
given VBN O O
her PRP$ O O
worsening VBG O O
renal JJ B-NP O
insufficiency NN I-NP O
Fingersticks NNP I-NP O
remained VBD B-VP O
in IN B-VP O
acceptable JJ B-NP O
range NN I-NP O
( ( O O
100-148 JJ O O
) ) O O
during IN B-VP O
admission NN B-NP O
Dispo: NNP I-NP O
to TO O O
home NN B-NP O
with IN B-VP O
close JJ B-NP O
VNA NNP I-NP O
followup NN I-NP O
( ( O O
daily JJ O O
) ) O O
Pt NNP B-NP O
will MD O O
have VB O O
weight NN B-NP O
and CC O O
BP NNP B-NP O
checked VBD B-VP O
qd JJ O O
She PRP O O
will MD O O
have VB O O
Chem-7 NNP B-NP O
and CC O O
INR NNP B-NP O
drawn NN I-NP O
on IN B-VP O
Thursday NNP B-NP O
and CC O O
Monday NNP B-NP O
, , O O
and CC O O
the DT B-NP O
results NNS I-NP O
will MD O O
be VB O O
called VBN O O
to TO O O
Dr NNP B-NP O
Benamati NNP I-NP O
( ( O O
TERT NNP B-NP O
VALLEY NNP I-NP O
HOSPITAL NNP I-NP O
CENTER NNP I-NP O
) ) O O
She PRP O O
will MD O O
finish VB O O
6 CD O B-du
more JJR B-NP I-du
days NNS I-NP I-du
of IN B-VP O
Levo NNP B-NP B-m
( ( O O
total JJ O O
10 CD O O
) ) O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
If IN B-VP O
you PRP O O
develop VBP O O
a DT B-NP O
fever NN I-NP O
, , O O
become VB O O
short JJ O O
of IN B-VP O
breath NN B-NP O
, , O O
have VBP O O
increasing VBG O O
left VBN O O
arm NN B-NP O
pain NN I-NP O
, , O O
or CC O O
any DT B-NP O
other JJ I-NP O
symptoms NNS I-NP O
that IN B-VP O
concern NN B-NP O
you PRP O O
, , O O
call VB O O
your PRP$ O O
doctor NN B-NP O
The DT B-NP O
visiting NN I-NP O
nurse NN I-NP O
is VBZ O O
an DT B-NP O
important JJ I-NP O
followup NN I-NP O
to TO O O
your PRP$ O O
hospitalization.Your NN B-NP O
diabetes VBZ O B-m
medication NN B-NP I-m
was VBD B-VP O
changed VBN O O
to TO O O
glipizide VB O B-m
-stop NNP B-NP O
taking VBG O O
the DT B-NP O
micronase NN I-NP B-m
Your NNP I-NP O
lasix NN I-NP B-m
, , O O
lisinopril NN B-NP B-m
and CC O O
colchicine NN B-NP B-m
have VBP O O
been VBN O O
stopped VBN O O
, , O O
don't JJ O O
restart VB O O
them PRP O O
until IN B-VP O
Dr NNP B-NP O
Schoville NNP I-NP O
tells VBZ O O
you PRP O O
to TO O O
restart VB O O
Your PRP$ O O
othe JJ B-NP O
medications NNS I-NP O
are VBP O O
the DT B-NP O
same JJ I-NP O
Weigh NNP I-NP O
yourself PRP O O
daily RB O O
and CC O O
if IN B-VP O
your PRP$ O O
weight NN B-NP O
increa NN I-NP O
ses VBZ O O
more JJR O O
than IN B-VP O
2lbs CD O O
in IN B-VP O
2 CD O O
days NNS B-NP O
call VB O O
Dr NNP B-NP O
Szesterniak NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
VNA NNP B-NP O
will MD O O
check VB O O
BP NNP B-NP O
and CC O O
weight VBD B-VP O
qd NNS B-NP O
Any NNP I-NP O
BP NNP I-NP O
&gt; VBZ O O
140/90 CD O O
or CC O O
wt JJ B-NP O
gain NN I-NP O
of IN B-VP O
2 CD O O
lbs NNS B-NP O
in IN B-VP O
2 CD O O
days NNS B-NP O
will MD O O
be VB O O
called VBN O O
to TO O O
Dr NNP B-NP O
Kempf NNP I-NP O
( ( O O
BROTHERSCIAL NNP B-NP O
GITER NNP I-NP O
HEALTHCARE NNP I-NP O
OF NNP I-NP O
773-511-3611 NNP I-NP O
) ) O O
2 CD O O
Thursday NNP B-NP O
( ( O O
3 CD O O
of IN B-VP O
May NNP B-NP O
) ) O O
and CC O O
Mon NNP B-NP O
( ( O O
26 CD O O
of IN B-VP O
January NNP B-NP O
) ) O O
VNA NNP B-NP O
will MD O O
draw VB O O
a DT B-NP O
Chem-7 NNP I-NP O
and CC O O
INR NNP B-NP O
and CC O O
call VB O O
results NNS B-NP O
to TO O O
Dr NNP B-NP O
Maria NNP I-NP O
( ( O O
WA NNP B-NP O
ASSPUNX NNP I-NP O
HOSPITAL NNP I-NP O
); NNP I-NP O
INR NNP I-NP O
should MD O O
be VB O O
communicated VBN O O
to TO O O
Blaine NNP B-NP O
Lindquist NNP I-NP O
at IN B-VP O
207-809-4454 JJ O O
3 CD O O
Pt NNP B-NP O
has VBZ O O
followup VBN O O
appointment NN B-NP O
on IN B-VP O
24 CD O O
of IN B-VP O
September NNP B-NP O
at IN B-VP O
10:30am CD O O
with IN B-VP O
Dr NNP B-NP O
Speranza NNP I-NP O
4 CD O O
There EX O O
are VBP O O
6 CD O B-du
more JJR B-NP I-du
days NNS I-NP I-du
of IN B-VP O
Levofloxacin NNP B-NP B-m
course NN I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BIRES NNP I-NP O
, , O O
LESLEY NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
EC039 NNP B-NP O
) ) O O
1/29/04 CD O O
@ $ O O
05 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#731937 VBZ O O
601682374 CD O O
S NNP B-NP O
45082046 CD O O
7656711 CD O O
1/19/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/19/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
ATTENDING: NNP I-NP O
CRUMBLE NNP I-NP O
, , O O
MODESTO NNP B-NP O
LEIF NNP I-NP O
MD NNP I-NP O
INTERIM NNP I-NP O
DICTATION NNP I-NP O
DATE NNP I-NP O
OF NNP I-NP O
SURGERY: NNP I-NP O
9/22/2005 CD O O
PREOPERATIVE NNP B-NP O
DIAGNOSES: NNP I-NP O
Infective NNP I-NP O
endocarditis NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
POSTOPERATIVE NNP I-NP O
DIAGNOSES: NNP I-NP O
Infective NNP I-NP O
endocarditis NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
PROCEDURE: NNP I-NP O
Mitral NNP I-NP O
valve FW O O
replacement NN B-NP O
, , O O
#28Other CC O O
annuloplasty JJ B-NP O
ring NN I-NP O
, , O O
ring VBG O O
annuloplasty NN B-NP O
, , O O
leaflet NN B-NP O
resection NN I-NP O
, , O O
post NN B-NP O
leaflet NN I-NP O
chordoplasty NN I-NP O
with IN B-VP O
Gore-Tex NNP B-NP O
suture NN I-NP O
, , O O
Vegetectomy NNP B-NP O
, , O O
SBE NNP B-NP O
, , O O
CABG NNP B-NP O
x1 NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
64-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
signs NNS B-NP O
of IN B-VP O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
of IN B-VP O
diet-controlled JJ B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
type NN B-NP O
2; CD O O
HTN NNP B-NP O
, , O O
status NN B-NP O
post NN I-NP O
MI NNP I-NP O
with IN B-VP O
RCA NNP B-NP O
stent NN I-NP O
in IN B-VP O
1999 CD O O
who WP O O
presents VBZ O O
to TO O O
ICU NNP B-NP O
from IN B-VP O
emergency NN B-NP O
department NN I-NP O
after IN B-VP O
being VBG O O
found VBD B-VP O
down RB O O
at IN B-VP O
home NN B-NP O
with IN B-VP O
change NN B-NP O
in IN B-VP O
mental JJ B-NP O
status NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
USOH NNP B-NP O
until IN B-VP O
approximately RB O O
six CD O O
to TO O O
seven CD O O
days NNS B-NP O
PTA NNP I-NP O
when WRB O O
he PRP O O
noticed VBD B-VP O
sudden JJ B-NP O
onset NN I-NP O
of IN B-VP O
sharp JJ B-NP O
left JJ I-NP O
shoulder NN I-NP O
pain NN I-NP O
without IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
or CC O O
pressure NN B-NP O
The DT B-NP O
patient NN I-NP O
notes VBZ O O
that IN B-VP O
the DT B-NP O
pain NN I-NP O
in IN B-VP O
his PRP$ O O
body NN B-NP O
all DT O O
over IN B-VP O
and CC O O
his PRP$ O O
shoulder NN B-NP O
continued VBD B-VP O
to TO O O
be VB O O
excruciating VBG O O
and CC O O
without IN B-VP O
relent NN B-NP O
He PRP O O
also RB O O
noted VBD B-VP O
onset NN B-NP O
of IN B-VP O
upper JJ O O
and CC O O
lower JJR B-NP O
extremity NN I-NP O
weakness NN I-NP O
and CC O O
that IN B-VP O
his PRP$ O O
legs NNS B-NP O
felt VBD B-VP O
heavy JJ O O
After IN B-VP O
he PRP O O
did VBD B-VP O
not RB O O
show VB O O
up RP O O
to TO O O
work VB O O
for IN B-VP O
several JJ B-NP O
days NNS I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
down RP O O
in IN B-VP O
his PRP$ O O
house NN B-NP O
incontinent NN I-NP O
of IN B-VP O
urine NN B-NP O
He PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
profound VBN O O
metabolic JJ B-NP O
acidosis NN I-NP O
, , O O
hypertensive JJ O O
, , O O
hypovolemic JJ O O
, , O O
febrile JJ O O
, , O O
covered VBD B-VP O
all DT O O
over IN B-VP O
the DT B-NP O
skin NN I-NP O
with IN B-VP O
hemorrhagic JJ B-NP B-r
rash NN I-NP I-r
and CC O O
required VBN O O
fluid JJ B-NP O
resuscitation NN I-NP O
and CC O O
Levophed NNP B-NP B-m
infusion NN I-NP B-mo
Lumbar NNP I-NP O
puncture NN I-NP O
showed VBD B-VP O
over IN B-VP O
100 CD O O
white JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
Urine NNP I-NP O
was VBD B-VP O
dirty JJ O O
and CC O O
the DT B-NP O
patient NN I-NP O
found VBD B-VP O
to TO O O
have VB O O
rash NN B-NP O
on IN B-VP O
back NN B-NP O
and CC O O
extremities NNS B-NP O
, , O O
which WDT O O
were VBD B-VP O
biopsied VBN O O
by IN B-VP O
dermatologist NN B-NP O
on IN B-VP O
1/30/2005 CD O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
since IN B-VP O
had VBD B-VP O
four CD O O
of IN B-VP O
four CD O O
blood NN B-NP O
cultures NNS I-NP O
positive JJ O O
for IN B-VP O
gram-positive JJ B-NP O
cocci NN I-NP O
in IN B-VP O
clusters( NN B-NP O
preliminary JJ B-NP O
Staphylococcus NNP I-NP O
aureus NN I-NP O
, , O O
MSSA NNP B-NP O
) ) O O
Two CD O O
of IN B-VP O
four CD O O
bottles NNS B-NP O
of IN B-VP O
gram-negative JJ B-NP O
rods NNS I-NP O
enteric JJ O O
and CC O O
pink NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
stenting NN I-NP O
and CC O O
had VBD B-VP O
more JJR O O
than IN B-VP O
1100 CD O O
Staphylococcus NNP B-NP O
aureus NN I-NP O
from IN B-VP O
1/19/2005 CD O O
urine JJ B-NP O
culture NN I-NP O
TTE NNP I-NP O
on IN B-VP O
1/30/2005 CD O O
showing VBG O O
vegetation NN B-NP O
on IN B-VP O
mitral JJ B-NP O
valve NNS I-NP O
PREOPERATIVE NNP I-NP O
CARDIAC NNP I-NP O
STATUS: NNP I-NP O
Urgent: NNP I-NP O
The DT B-NP O
patient NN I-NP O
presented VBN O O
with IN B-VP O
infection NN B-NP O
of IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
in IN B-VP O
March NNP B-NP O
1999 CD O O
requiring VBG O O
hospitalization NN B-NP O
associated VBN O O
with IN B-VP O
prolonged JJ B-NP O
chest NN I-NP O
pain NN I-NP O
The DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
have VB O O
symptoms NNS B-NP O
of IN B-VP O
heart NN B-NP O
failure NN I-NP O
Recent NNP I-NP O
signs NNS I-NP O
and CC O O
symptoms NNS B-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
include VBP O O
pedal JJ O O
edema VBP O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm VBP O O
PREVIOUS NNP B-NP O
CARDIOVASCULAR NNP I-NP O
INTERVENTIONS: NNP I-NP O
Stent NNP I-NP O
in IN B-VP O
March NNP B-NP O
1999 CD O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Stroke NNP I-NP O
, , O O
extremity NN B-NP O
weakness NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
permanent JJ B-NP O
muscle NN I-NP O
weakness NN I-NP O
of IN B-VP O
all DT O O
four CD O O
extremities NNS B-NP O
, , O O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
found VBN O O
at IN B-VP O
home NN B-NP O
unconscious JJ O O
within IN B-VP O
two CD O O
weeks NNS B-NP O
of IN B-VP O
surgery NN B-NP O
, , O O
diabetes VBZ O B-r
mellitus NN B-NP I-r
, , O O
insulin NN B-NP B-m
therapy NN I-NP O
, , O O
infective JJ B-NP B-r
infective JJ I-NP B-r
infective JJ I-NP B-r
infective JJ I-NP B-r
infective JJ I-NP B-r
infective JJ I-NP B-r
endocarditis:active JJ I-NP I-r
endocarditis:active JJ I-NP I-r
endocarditis:active JJ I-NP I-r
endocarditis:active JJ I-NP I-r
endocarditis:active JJ I-NP I-r
endocarditis:active NN I-NP I-r
, , O O
receiving VBG O O
vancomycin NN B-NP B-m
, , O O
levofloxacin NN B-NP B-m
, , O O
Flagyl NNP B-NP B-m
, , O O
ceftazidime NN B-NP B-m
, , O O
gentamicin NN B-NP B-m
, , O O
Nafcillin NNP B-NP B-m
, , O O
hypercholesterolemia NN B-NP O
, , O O
heparin-induced JJ B-NP O
thrombocytopenia NN I-NP O
, , O O
HAT NNP B-NP O
during IN B-VP O
hospitalization NN B-NP O
in IN B-VP O
1999 CD O O
, , O O
creatinine JJ B-NP O
clearance NN I-NP O
158.18 CD O O
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
None NNP I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
use NN I-NP O
ALLERGIES: NNP I-NP O
Heparin NNP I-NP O
, , O O
HIT NNP B-NP O
ADMISSION NNP I-NP O
MEDICATIONS: NNP I-NP O
Heparin NNP I-NP B-m
low JJ B-NP I-m
molecular NN I-NP I-m
weight NN I-NP I-m
last JJ B-NP O
dose NN I-NP O
less JJR O O
than IN B-VP O
24 CD O B-du
hours NNS B-NP I-du
, , O O
enoxaparin NN B-NP B-m
, , O O
Lovenox NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
subcu JJ O B-mo
daily RB O B-f
, , O O
norepinephrine JJ O B-m
3 CD O B-do
mcg NN B-NP I-do
per IN B-VP I-do
kg FW O I-do
per IN B-VP I-do
minute NN B-NP I-do
continuous JJ O I-do
, , O O
simvastatin JJ O B-m
40 CD O B-do
mg JJ O O
p.o JJ O B-mo
daily JJ O B-f
, , O O
Nexium NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
ceftazidime JJ O B-m
2000 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
q8h NN I-NP B-f
, , O O
gentamicin VBP O B-m
560 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
q.24h NN I-NP B-f
, , O O
penicillin NN B-NP B-m
G NNP I-NP I-m
, , O O
potassium NN B-NP B-m
3 CD O B-do
million CD O O
units NNS B-NP O
IV NNP I-NP B-mo
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Height NNP I-NP O
and CC O O
Weight: NNP B-NP O
5 CD O O
feet NNS B-NP O
9 CD O O
inches NNS B-NP O
, , O O
92.7 CD O O
kg NN B-NP O
Vital NNP I-NP O
Signs: NNP I-NP O
Temperature NNP I-NP O
99 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
120 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
right JJ B-NP O
arm NN I-NP O
107/65 CD O O
, , O O
extubated VBN O O
on IN B-VP O
9/0/2005 CD O O
6 CD O O
p.m NN B-NP O
, , O O
FiO2 NNP B-NP O
4 CD O O
L NNP B-NP O
nasal JJ B-NP O
cannula NN I-NP O
, , O O
ambulating VBG O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
99% CD O O
HEENT: NNP B-NP O
PERRLA NNP I-NP O
Dentition NNP I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
infection NN B-NP O
No NNP I-NP O
carotid NN I-NP O
bruits NNS I-NP O
Chest: NNP I-NP O
No NNP I-NP O
incisions NNS I-NP O
Cardiovascular: NNP I-NP O
No NNP I-NP O
murmurs NN I-NP O
Respiratory: NNP I-NP O
Rales NNP I-NP O
present JJ O O
bilaterally RB O O
Abdomen: NNP B-NP O
No NNP I-NP O
incisions NNS I-NP O
, , O O
soft JJ B-NP O
No NNP I-NP O
masses NNS I-NP O
Rectal: NNP I-NP O
Deferred NNP I-NP O
Extremities: NNP I-NP O
Leg NNP I-NP O
edematous JJ O O
1+ CD O O
2+ CD O O
, , O O
diminished VBD B-VP O
muscle NN B-NP O
strength NN I-NP O
4/5 CD O O
Neuro: NNP B-NP O
Alert NNP I-NP O
and CC O O
oriented VBD B-VP O
No NNP B-NP O
focal JJ B-NP O
deficits NNS I-NP O
PREOP NNP I-NP O
LABS: NNP I-NP O
On IN B-VP O
7/9/2005 CD O O
, , O O
sodium NN B-NP O
143 CD O O
, , O O
potassium NN B-NP O
4.1 CD O O
, , O O
chloride RB O O
114 CD O O
, , O O
CO2 NNP B-NP O
21 CD O O
, , O O
BUN NNP B-NP O
11 CD O O
, , O O
creatinine NN B-NP O
0.7 CD O O
, , O O
glucose RB O O
110 CD O O
, , O O
magnesium NN B-NP O
2.1 CD O O
Hematology NNP B-NP O
on IN B-VP O
9/0/2005 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
423 CD O O
, , O O
hematocrit NN B-NP O
32.2 CD O O
, , O O
hemoglobin NN B-NP O
10.9 CD O O
, , O O
platelets NNS B-NP O
73 CD O O
, , O O
PT NNP B-NP O
14.9 CD O O
, , O O
INR NNP B-NP O
1.2 CD O O
, , O O
PTT NNP B-NP O
28.4 CD O O
ABGs; NNP B-NP O
PO2 NNP I-NP O
72 CD O O
, , O O
pH NN B-NP O
7.52 CD O O
, , O O
PCO2 NNP B-NP O
28 CD O O
, , O O
total JJ B-NP O
CO2 NNP I-NP O
23 CD O O
, , O O
base NN B-NP O
excess JJ O O
0 CD O O
Urinalysis NN B-NP O
consisted VBN O O
with IN B-VP O
infection NN B-NP O
CARDIAC NNP I-NP O
CATHETERIZATION NNP I-NP O
DATA: NNP I-NP O
On IN B-VP O
9/0/2005 CD O O
performed VBN O O
at IN B-VP O
N NNP B-NP O
Coronary NNP I-NP O
anatomy VBD B-VP O
50% CD O O
LAD NNP B-NP O
, , O O
45% CD O O
mid NN B-NP O
Ramus NNP I-NP O
, , O O
dominant JJ B-NP O
circulation NN I-NP O
, , O O
LVEDP NNP B-NP O
15 CD O O
mmHg NN B-NP O
Echo NNP I-NP O
on IN B-VP O
1/30/2005 CD O O
, , O O
55% CD O O
ejection NN B-NP O
fraction NN I-NP O
, , O O
mild JJ B-NP O
mitral JJ I-NP O
insufficiency NN I-NP O
, , O O
trivial JJ B-NP O
pulmonic JJ I-NP O
insufficiency NN I-NP O
, , O O
the DT B-NP O
mitral JJ I-NP O
valve NN I-NP O
is VBZ O O
myxomatous JJ O O
There EX O O
is VBZ O O
a DT B-NP O
2-cm JJ I-NP O
focal JJ I-NP O
leaflet NN I-NP O
mass NN I-NP O
on IN B-VP O
the DT B-NP O
mitral JJ I-NP O
leaflet NN I-NP O
that WDT O O
could MD O O
represent VB O O
a DT B-NP O
vegetation NN I-NP O
EKG NNP I-NP O
on IN B-VP O
1/30/2005 CD O O
, , O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
117 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
on IN B-VP O
9/0/2005 CD O O
consistent JJ O O
with IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
and CC O O
left VBD B-VP O
base NN B-NP O
opacity NN I-NP O
, , O O
probably RB O O
atelectasis NN B-NP O
has VBZ O O
worsened VBN O O
There EX O O
is VBZ O O
minimal JJ B-NP O
new JJ I-NP O
right JJ I-NP O
basilar NN I-NP O
atelectasis NN I-NP O
Upper NNP I-NP O
lung NN I-NP O
zones NNS I-NP O
remain VBP O O
clear JJ O O
The DT B-NP O
heart NN I-NP O
is VBZ O O
enlarged VBN O O
with IN B-VP O
vascular JJ B-NP O
engorgement NN I-NP O
, , O O
but CC O O
no DT B-NP O
frank JJ I-NP O
pulmonary JJ I-NP O
edema JJ I-NP O
Central NNP I-NP O
line NN I-NP O
remains VBZ O O
in IN B-VP O
the DT B-NP O
CVC NNP I-NP O
There EX O O
is VBZ O O
no DT B-NP O
pneumothorax NN I-NP O
seen VBN O O
PROCEDURE: NNP B-NP O
MVP NNP I-NP O
#28 NNP I-NP O
Other JJ B-NP O
annuloplasty JJ I-NP O
ring NN I-NP O
, , O O
ring VBG O O
annuloplasty NN B-NP O
, , O O
leaflet NN B-NP O
resection NN I-NP O
, , O O
post NN B-NP O
leaflet NN I-NP O
chordoplasty NN I-NP O
with IN B-VP O
Gore-Tex NNP B-NP O
suture NN I-NP O
, , O O
Vegetectomy NNP B-NP O
, , O O
SBE NNP B-NP O
, , O O
CABG NNP B-NP O
x1 NNP I-NP O
BYPASS: NNP I-NP O
350 CD O O
minutes NNS B-NP O
CROSS NNP I-NP O
CLAMP: NNP I-NP O
288 CD O O
minutes NNS B-NP O
Open JJ O O
chest VBP O O
one CD O O
ventricular NN B-NP O
wire NN I-NP O
, , O O
one CD O O
pericardial NN B-NP O
tube NN I-NP O
, , O O
one CD O O
retrosternal NN B-NP O
tube NN I-NP O
, , O O
two CD O O
pleural JJ B-NP O
tubes NNS I-NP O
Open NNP I-NP O
chest/semarch NN I-NP O
with IN B-VP O
bridge NN B-NP O
fashioned VBN O O
from IN B-VP O
60 CD O O
mL NNS B-NP O
syringe NN I-NP O
and CC O O
single JJ B-NP O
lap NN I-NP O
pad NN I-NP O
left VBD B-VP O
in IN B-VP O
place NN B-NP O
ICU NNP I-NP O
PROGRESS NNP I-NP O
EVENT NNP I-NP O
SUMMARY: NNP I-NP O
POD NNP I-NP O
1 CD O O
on IN B-VP O
7/6/2005 CD O O
; : O O
admitted VBN O O
to TO O O
ICU NNP B-NP O
postop NN I-NP O
with IN B-VP O
open JJ B-NP O
chest NN I-NP O
after IN B-VP O
6 CD O O
hour NN B-NP O
pump NN I-NP O
run.Overnight NN I-NP O
vasodilated VBN O B-r
vasodilated VBD B-VP B-r
vasodilated JJ O B-r
, , O O
requiring VBG O O
pressors NNS B-NP B-m
, , O O
inotrops NNS B-NP B-m
and CC O O
methylene NN B-NP B-m
blue JJ B-NP I-m
POD NNP I-NP O
2 CD O O
, , O O
Weaned VBN O O
of IN B-VP O
onoptrops NNS B-NP B-m
successfully; VBP O O
Cultured VBN O O
from IN B-VP O
OR- JJ B-NP O
Staff NNP I-NP O
, , O O
antibiotics NNS B-NP B-m
changed VBD B-VP O
Previous NNP B-NP O
allergy NN I-NP O
ceftriaxone NN I-NP O
, , O O
gentamicin NN B-NP O
, , O O
levofloxacin JJ O O
discontinued VBN O O
, , O O
one CD O B-do
unit NN B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP I-m
blood NN I-NP I-m
cells NNS I-NP I-m
given VBN O O
, , O O
SVO2 NNP B-NP O
improved; VBP O O
hematocrit NN B-NP O
stable JJ B-NP O
Chest NNP I-NP O
open NN I-NP O
on IN B-VP O
fentanyl NN B-NP B-m
and CC O O
Versed/semarch NNP B-NP B-m
On IN B-VP O
3/28/2005 CD O O
POD NNP B-NP O
3 CD O O
difficult JJ O O
to TO O O
wean VB O O
inotrops JJ B-NP B-m
Culture NN I-NP O
from IN B-VP O
OR NNP B-NP O
staff NN I-NP O
Antibiotics NNS I-NP B-m
changed VBD B-VP O
Previous NNP B-NP O
allergy NN I-NP O
ceftriaxone NN I-NP O
, , O O
gentamicin NN B-NP O
, , O O
levofloxacin JJ O O
discontinued VBN O O
Chest NNP B-NP O
washout NN I-NP O
yesterday NN I-NP O
, , O O
hematocrit NN B-NP O
stable JJ B-NP O
Chest NNP I-NP O
remains; NN I-NP O
open JJ O O
on IN B-VP O
fentanyl NN B-NP B-m
and CC O O
Versed VBD B-VP B-m
;for NNP B-NP O
2ND CD O B-r
2ND CD O B-r
washout+/- JJ B-NP I-r
washout+/- JJ I-NP I-r
closure NN I-NP I-r
closure NN I-NP I-r
later RBR O O
this DT B-NP O
week NN I-NP O
POD NNP I-NP O
4 CD O O
stable JJ O O
, , O O
remains VBZ O O
on IN B-VP O
epi NN B-NP B-m
and CC O O
vaso NN B-NP B-m
, , O O
diuresing.Plan NN B-NP O
to TO O O
close VB O O
chest JJ B-NP O
tomorrow.POD NN I-NP O
5Pressors CD O O
continued VBD B-VP O
, , O O
continued VBD B-VP O
diuresis NN B-NP O
Abx NNP I-NP O
adjustments NNS I-NP O
made VBN O O
per IN B-VP O
ID NNP B-NP O
recommendations NNS I-NP O
, , O O
discontinue NN B-NP O
vancomycin NN I-NP B-m
and CC O O
gentamicin NN B-NP B-m
POD NNP I-NP O
6 CD O O
, , O O
chest NN B-NP O
closed VBD B-VP O
yesterday NN B-NP O
, , O O
ongoing VBG O O
pressor NN B-NP B-m
requirement NN I-NP O
POD NNP I-NP O
7 CD O O
, , O O
ventilation NN B-NP O
weaned VBD B-VP O
to TO O O
pressure VB O O
support NN B-NP O
ventilation NN I-NP O
, , O O
sedation NN B-NP B-m
weaned VBD B-VP O
, , O O
epinephrine NN B-NP B-m
weaned VBD B-VP O
to TO O O
off/ VB O O
, , O O
vasopressin NN B-NP B-m
weaned VBD B-VP O
Coffee-ground NNP B-NP O
output NN I-NP O
via IN B-VP O
nasogastric JJ B-NP O
tube NN I-NP O
today NN I-NP O
POD NNP I-NP O
8 CD O O
, , O O
developed VBD B-VP O
fluctuant JJ B-NP O
collection NN I-NP O
, , O O
left VBD B-VP O
supraclavicular JJ B-NP O
fossa NN I-NP O
CT NNP I-NP O
confirmed VBD B-VP O
probable JJ B-NP O
collection NN I-NP O
in IN B-VP O
clavicular JJ B-NP O
scapular JJ I-NP O
region NN I-NP O
, , O O
no DT B-NP O
bony NN I-NP O
involvement NN I-NP O
Aspiration NNP I-NP O
revealed VBD B-VP O
gram-positive JJ B-NP O
cocci NN I-NP O
Orthopedics NNP I-NP O
aware NN I-NP O
, , O O
will MD O O
review VB O O
today NN B-NP O
, , O O
remains VBZ O O
vasodilated VBN O O
on IN B-VP O
vasopressin NN B-NP B-m
Diuresed VBN O O
well RB O O
POD NNP B-NP O
9 CD O O
, , O O
had VBD B-VP O
I&amp;D NNP B-NP O
of IN B-VP O
collection NN B-NP O
yesterday NN I-NP O
, , O O
hypertensive JJ O O
0f CD O O
pressors NNS B-NP B-m
, , O O
requiring VBG O O
increasing VBG O O
Lopressor NNP B-NP B-m
doses NNS I-NP O
, , O O
now RB O O
on IN B-VP O
minimal JJ B-NP O
ventilator NN I-NP O
support NN I-NP O
POD NNP I-NP O
10 CD O O
, , O O
extubated VBN O O
, , O O
hypertensive JJ O B-r
, , O O
requiring VBG O O
Lopressor NNP B-NP B-m
, , O O
TNG NNP B-NP B-m
, , O O
Hydralazine NNP B-NP B-m
Temperature NNP I-NP O
102 CD O O
, , O O
failed VBD B-VP O
speech JJ B-NP O
evaluation NN I-NP O
POD NNP I-NP O
11 CD O O
, , O O
remains VBZ O O
on IN B-VP O
nicardipine JJ B-NP B-m
drip NN I-NP B-mo
for IN B-VP O
hypertension NN B-NP B-r
, , O O
febrile JJ O O
102 CD O O
POD NNP B-NP O
12 CD O O
, , O O
off RB O O
nicardipine JJ B-NP B-m
drip NN I-NP B-mo
Abscess NNP I-NP O
in IN B-VP O
right JJ B-NP O
thigh NN I-NP O
discharged VBD B-VP O
spontaneously RB O O
PICC NNP B-NP O
line NN I-NP O
now RB O O
in IN B-VP O
Small NNP B-NP O
amount NN I-NP O
of IN B-VP O
fresh JJ B-NP O
blood NN I-NP O
per IN B-VP O
rectum NN B-NP O
No NNP I-NP O
drop NN I-NP O
in IN B-VP O
hematocrit NN B-NP O
Afebrile NNP I-NP O
, , O O
taking VBG O O
p.o JJ B-NP O
diet NN I-NP O
, , O O
diuresing VBG O O
MRSA NNP B-NP O
POD NNP I-NP O
14 CD O O
, , O O
MRSA NNP B-NP B-r
in IN B-VP O
sputum NN B-NP O
, , O O
started VBD B-VP O
on IN B-VP O
vancomycin NN B-NP B-m
Arterial NNP I-NP O
line NN I-NP O
discontinued VBN O O
POD NNP B-NP O
15 CD O O
, , O O
started VBN O O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
hypertensive JJ O O
, , O O
Lopressor NNP B-NP B-m
dose RB O O
reduced VBD B-VP O
to TO O O
50 CD O B-do
POD NNP B-NP O
16 CD O O
, , O O
sputum-growing JJ B-NP O
MRSA NNP I-NP O
Right-sided NNP I-NP O
effusion NN I-NP O
seen VBN O O
on IN B-VP O
chest JJS O O
x-ray JJ O O
with IN B-VP O
elevation NN B-NP O
of IN B-VP O
right NN B-NP O
diaphragm.Pulled VBN O O
out RP O O
dop-hof JJ B-NP O
overnight JJ I-NP O
POD NNP I-NP O
17 CD O O
, , O O
VRE NNP B-NP O
isolated VBD B-VP O
from IN B-VP O
right JJ B-NP O
side NN I-NP O
abscess RB O O
Now RB O O
oriented VBN O O
x3 NN B-NP O
ICU NNP I-NP O
TRANSFER NNP I-NP O
NOTE: NNP I-NP O
Date NNP I-NP O
of IN B-VP O
transfer NN B-NP O
, , O O
7/9/2005 CD O O
SUMMARY NN B-NP O
BY NNP I-NP O
SYSTEM: NNP I-NP O
1 CD O O
Neurologic: NNP B-NP O
Mental NNP I-NP O
status NN I-NP O
intact JJ O O
, , O O
alert JJ O O
, , O O
and CC O O
oriented VBD B-VP O
Neurological NNP B-NP O
exam NN I-NP O
, , O O
no DT B-NP O
focal JJ I-NP O
deficits NNS I-NP O
Now RB O O
oriented VBN O O
to TO O O
place VB O O
, , O O
month NN B-NP O
and CC O O
year NN B-NP O
Marked NNP I-NP O
improvement NN I-NP O
2 CD O O
Cardiovascular: NNP B-NP O
Cardiac NNP I-NP O
medications: NN I-NP O
Aspirin NNP I-NP B-m
, , O O
Lopressor NNP B-NP B-m
, , O O
Heart NNP B-NP O
rate NN I-NP O
, , O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
95 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
120/60 CD O O
ECG NNP B-NP O
, , O O
preop JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
65% CD O O
EF NNP B-NP O
Echo NNP I-NP O
on IN B-VP O
1/30/2005 CD O O
Cardiac NNP B-NP B-m
meds NNS I-NP I-m
, , O O
Lopressor NNP B-NP B-m
37.5 CD O B-do
p.o NN B-NP B-mo
q.6h NN I-NP B-f
Exam NNP I-NP O
, , O O
RRR NNP B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
WNL NNP B-NP O
3 CD O O
Respiratory: NNP B-NP O
Ventilated VBD B-VP O
more JJR O O
than IN B-VP O
24 CD O O
hours NNS B-NP O
postoperatively RB O O
Extubated VBD B-VP O
on IN B-VP O
10/26/2005 CD O O
, , O O
FiO2 NNP B-NP O
3 CD O O
L NNP B-NP O
nasal JJ B-NP O
cannula NN I-NP O
, , O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
Chest NNP I-NP O
x-ray NN I-NP O
findings: NN I-NP O
Extubated VBD B-VP O
on IN B-VP O
10/26/2005 CD O O
, , O O
POD NNP B-NP O
9 CD O O
4 CD O O
GI: NNP B-NP O
Diet NNP I-NP O
Mechanical NNP I-NP O
soft JJ O O
, , O O
liquid JJ B-NP O
consistency NN I-NP O
, , O O
nectar NN B-NP O
, , O O
tube NN B-NP O
feeds NNS I-NP O
, , O O
Jevity NNP B-NP O
1.2 CD O O
tube NN B-NP O
feeds NNS I-NP O
, , O O
rate NN B-NP O
100 CD O O
mL NN B-NP O
/hr NN I-NP O
, , O O
0 CD O O
scoops/day JJ B-NP O
calories NNS I-NP O
5 CD O O
Renal: NNP B-NP O
Fluid NNP I-NP O
in IN B-VP O
1700 CD O O
mL NN B-NP O
24 CD O O
hours NNS B-NP O
, , O O
urine JJ B-NP O
output NN I-NP O
3200 CD O O
mL NN B-NP O
, , O O
balance NN B-NP O
-1500 NNP I-NP O
Weight: NNP I-NP O
Previous NNP I-NP O
day NN I-NP O
weight VBD B-VP O
84.5 CD O O
kg NN B-NP O
6 CD O O
Endocrine: NNP B-NP O
Diabetes NNP I-NP B-r
Diabetes NNP I-NP B-r
Meds NNP I-NP O
, , O O
insulin NN B-NP B-m
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
at IN B-VP O
10 CD O B-f
p.m NN B-NP I-f
, , O O
Lantus NNP B-NP B-m
22 CD O B-do
units NNS B-NP I-do
SC NNP I-NP B-mo
q.p.m RB O B-f
7 CD O O
Heme: NNP B-NP O
Anticoagulation NNP I-NP B-r
Aspirin NNP I-NP B-m
8 CD O O
ID: NNP B-NP O
Septicemia NNP I-NP B-r
Septicemia NNP I-NP B-r
Septicemia NNP I-NP B-r
Septicemia NNP I-NP B-r
Organism NNP I-NP O
, , O O
Staphylococcus NNP B-NP O
aureus NN I-NP O
Antibiotics NNP I-NP B-m
, , O O
vancomycin NN B-NP B-m
started VBD B-VP O
on IN B-VP O
9/22/2005 CD O O
, , O O
penicillin NN B-NP B-m
G NNP I-NP I-m
, , O O
potassium NN B-NP B-m
3 CD O B-do
million CD O I-do
units NNS B-NP I-do
IV NNP I-NP B-mo
Skin NNP I-NP B-r
Skin NNP I-NP B-r
Skin NNP I-NP B-r
lesion NN I-NP I-r
lesion NN I-NP I-r
lesion NN I-NP I-r
infection NN I-NP I-r
infection NN I-NP I-r
infection NN I-NP I-r
Organism NNP I-NP O
, , O O
VRE NNP B-NP O
Antibiotics NNP I-NP B-m
, , O O
ceftriaxone NN B-NP B-m
2000 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
daily RB O B-f
, , O O
penicillin NN B-NP B-m
G NNP I-NP I-m
, , O O
potassium NN B-NP B-m
4 CD O B-do
million CD O I-do
units NNS B-NP I-do
started VBD B-VP O
on IN B-VP O
9/14/2005 CD O O
Current JJ B-NP O
antibiotics NNS I-NP B-m
, , O O
vancomycin JJ B-NP B-m
day NN I-NP O
18 CD O O
for IN B-VP O
Staph NNP B-NP B-r
Staph NNP I-NP B-r
aureus VBZ O I-r
aureus JJ B-NP I-r
septicemia NN I-NP I-r
septicemia NN I-NP I-r
, , O O
penicillin NN B-NP B-m
G NNP I-NP I-m
3 CD O B-do
million CD O I-do
units NNS B-NP I-do
IV NNP I-NP B-mo
, , O O
ceftriaxone NN B-NP B-m
2000 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
daily RB O B-f
, , O O
penicillin NN B-NP B-m
G NNP I-NP I-m
, , O O
potassium NN B-NP B-m
4 CD O B-do
million CD O I-do
units NNS B-NP I-do
day NN I-NP O
13 CD O O
for IN B-VP O
Staph NNP B-NP B-r
Staph NNP I-NP B-r
Staph NNP I-NP B-r
Staph NNP I-NP B-r
aureus NN I-NP O
septicemia NN I-NP O
, , O O
VRE NNP B-NP O
skin FW O O
lesion NN B-NP O
infection NN I-NP O
T-max NNP I-NP O
99.2 CD O O
Fahrenheit NNP B-NP O
ID NNP I-NP O
consult NN I-NP O
declined VBD B-VP O
, , O O
needs VBZ O O
inLineziline NN B-NP O
for IN B-VP O
right JJ B-NP O
side NN I-NP O
abscess RB O O
9 CD O O
Neurologic NNP B-NP O
plan: NN I-NP O
Continue NNP I-NP O
to TO O O
monitor VB O O
neurologic JJ B-NP O
progress NN I-NP O
10 CD O O
Cardiovascular JJ B-NP O
plan: NN I-NP O
Watch NNP I-NP O
blood NN I-NP B-r
pressure NN I-NP I-r
, , O O
titrate NN B-NP B-do
Lopressor NNP I-NP B-m
as IN B-VP O
tolerated VBN O O
while IN B-VP O
diuresing VBG O O
11 CD O O
Respiratory NNP B-NP O
plan:OOB NN I-NP O
with IN B-VP O
PT NNP B-NP O
, , O O
wean JJ B-NP O
oxygen NN I-NP B-m
12 CD O O
Gastrointestinal NNP B-NP O
plan: NN I-NP O
Did NNP I-NP O
well RB O O
with IN B-VP O
oral JJ B-NP O
diet NN I-NP O
yesterday NN I-NP O
Continue NNP I-NP O
to TO O O
encourage VB O O
oral JJ B-NP O
diet NN I-NP O
and CC O O
monitor NN B-NP O
calorie NNS I-NP O
intake VBP O O
13 CD O O
Renal NNP B-NP O
plan: NN I-NP O
Continue NNP I-NP O
gentle JJ B-NP O
diuresis NN I-NP O
14 CD O O
Endocrine: NNP B-NP O
Controlled VBD B-VP O
15 CD O O
Hematologic NNP B-NP O
plan: NN I-NP O
Monitor NNP I-NP O
hematocrit NN I-NP O
Ensue NNP I-NP O
his PRP$ O O
wearing VBG O O
pneumatic JJ B-NP O
boots NNS I-NP O
Minor NNP I-NP O
procedures: NN I-NP O
Bronchoscopy NNP I-NP O
, , O O
therapeutic JJ B-NP O
respiration NN I-NP O
MOST NNP I-NP O
RECENT NNP I-NP O
MEDICATIONS: NNP I-NP O
Lopressor NNP I-NP B-m
37.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.6h NN I-NP B-f
, , O O
Lasix NNP B-NP B-m
20 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
acetylsalicylic JJ O B-m
acid VBP O I-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
, , O O
Naturale NNP B-NP B-m
Tears NNP I-NP I-m
one CD O B-do
drop NN B-NP I-do
O.U NNP I-NP B-mo
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
insulin NN B-NP B-m
regular JJ B-NP I-m
Humulin NNP I-NP I-m
4 CD O B-do
units NNS B-NP I-do
subcu RB O B-mo
, , O O
lactinex JJ B-NP B-m
granules NNS I-NP I-m
2 CD O B-do
tabs NNS B-NP I-do
p.o NN I-NP B-mo
, , O O
magnesium NN B-NP B-m
sulfate NN I-NP I-m
, , O O
sliding VBG O B-do
scale NN B-NP I-do
intravenously RB O B-mo
, , O O
penicillin NN B-NP B-m
G NNP I-NP I-m
, , O O
potassium NN B-NP B-m
4 CD O B-do
million CD O O
units NNS B-NP O
IV NNP I-NP B-mo
, , O O
vancomycin NN B-NP B-m
1000 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
, , O O
Nexium NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily RB O B-f
, , O O
Lantus NNP B-NP B-m
22 CD O B-do
units NNS B-NP I-do
subcu JJ O B-mo
q.p.m RB O B-f
, , O O
NovoLog NNP B-NP B-m
sliding VBG O B-do
scale JJ B-NP I-do
SC NNP I-NP B-mo
eScription NN I-NP O
document: VBD B-VP O
1-4775276 JJ B-NP O
HFFocus NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
GAIN NNP I-NP O
, , O O
LENNY NNP B-NP O
Attending: NNP I-NP O
DITUCCI NNP I-NP O
, , O O
KIETH NNP B-NP O
CLAUD NNP I-NP O
Dictation NNP I-NP O
ID NNP I-NP O
7748550 CD O O
D: NNP B-NP O
7/4/05 CD O O
T: NNP B-NP O
3/15/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#733459 VBZ O O
185449655 CD O O
HMH NNP B-NP O
41698736 CD O O
6101075 CD O O
9/10/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/10/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/12/2005 CD O O
ATTENDING: NNP B-NP O
WUITSCHICK NNP I-NP O
, , O O
LEROY NNP B-NP O
M.D NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Heart NNP I-NP O
failure NN I-NP O
LISTS NNP I-NP O
OF NNP I-NP O
PROBLEMS NNP I-NP O
AND NNP I-NP O
DIAGNOSES: NNP I-NP O
Status NNP I-NP O
post NN I-NP O
cardiac NN I-NP O
transplant NN I-NP O
in IN B-VP O
1993 CD O O
, , O O
obesity NN B-NP O
, , O O
chronic JJ B-NP O
obstructive JJ I-NP O
pulmonary JJ I-NP O
disease NN I-NP O
, , O O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
with IN B-VP O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
creatinine NN B-NP O
of IN B-VP O
1.5 CD O O
, , O O
hepatitis NN B-NP O
B NNP I-NP O
, , O O
hypertension NN B-NP O
, , O O
osteoporosis NN B-NP O
, , O O
status NN B-NP O
post NN I-NP O
L3 NNP I-NP O
compression NN I-NP O
fracture NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
left VBD B-VP O
hip JJ B-NP O
fracture NN I-NP O
with IN B-VP O
replacement NN B-NP O
in IN B-VP O
July NNP B-NP O
2005 CD O O
, , O O
complicated VBN O O
by IN B-VP O
infection NN B-NP O
necessitating VBG O O
removal NN B-NP O
, , O O
debridement NN B-NP O
, , O O
and CC O O
deconditioning VBG O O
BRIEF NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Ms NNP I-NP O
Halnon NNP I-NP O
is VBZ O O
a DT B-NP O
67-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
multiple JJ B-NP O
medical JJ I-NP O
comorbidities NNS I-NP O
and CC O O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
cardiac JJ B-NP O
transplant NN I-NP O
in IN B-VP O
1993 CD O O
, , O O
and CC O O
hip NN B-NP O
replacement NN I-NP O
in IN B-VP O
July NNP B-NP O
2005 CD O O
, , O O
complicated VBN O O
by IN B-VP O
wound NN B-NP O
infection NN I-NP O
, , O O
and CC O O
need VBP O O
for IN B-VP O
prolonged JJ B-NP O
rehabilitation NN I-NP O
who WP O O
presented VBD B-VP O
from IN B-VP O
Port NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
to TO O O
Ephma NNP B-NP O
Mersources NNP I-NP O
Ni NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
with IN B-VP O
three CD O O
days NNS B-NP O
of IN B-VP O
progressive JJ O O
worsening VBG O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
Her NNP I-NP O
chest NN I-NP O
x-ray NN I-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
Ckmond NNP B-NP O
Kinga NNP I-NP O
Quinaualv NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
with IN B-VP O
the DT B-NP O
request NN I-NP O
of IN B-VP O
her PRP$ O O
daughter NN B-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
of IN B-VP O
her PRP$ O O
heart NN B-NP O
failure NN I-NP O
Here RB O O
, , O O
her PRP O O
mental JJ B-NP O
status NN I-NP O
was VBD B-VP O
borderline JJ O O
upon IN B-VP O
admission NN B-NP O
, , O O
but CC O O
it PRP O O
improved VBD B-VP O
with IN B-VP O
discontinuation NN B-NP O
of IN B-VP O
standing VBG O O
analgesic JJ O B-m
and CC O O
decreasing NN B-NP O
of IN B-VP O
her PRP$ O O
clonazepam NN B-NP B-m
A DT B-NP O
head NN I-NP O
CT NNP I-NP O
showed VBD B-VP O
no DT B-NP O
acute NN I-NP O
processes VBZ O O
She PRP O O
had VBD B-VP O
a DT B-NP O
right JJ I-NP O
upper JJ I-NP O
arm NN I-NP O
cellulitis NN I-NP O
and CC O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
on IN B-VP O
screening VBG O O
urinalysis NN B-NP O
She PRP O O
was VBD B-VP O
anemic JJ O O
She PRP O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
vancomycin JJ B-NP O
resistant JJ I-NP O
Enterococcus NNP I-NP O
positive JJ O O
, , O O
but CC O O
repeated VBD B-VP O
cultures NNS B-NP O
demonstrated VBD B-VP O
MRSA NNP B-NP O
negative JJ B-NP O
Her NNP I-NP O
inpatient NN I-NP O
issues NNS I-NP O
included VBD B-VP O
management NN B-NP O
of IN B-VP O
her PRP$ O O
heart NN B-NP O
failure NN I-NP O
, , O O
right JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
cellulitis NN I-NP O
, , O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
, , O O
chronic JJ B-NP O
anemia NN I-NP O
, , O O
diabetes VBZ O O
, , O O
and CC O O
evaluation NN B-NP O
of IN B-VP O
her PRP$ O O
hip NN B-NP O
by IN B-VP O
orthopedics NNS B-NP O
ALLERGIES: NNP I-NP O
She PRP O O
had VBD B-VP O
allergies NNS B-NP O
to TO O O
penicillin VB O O
and CC O O
codeine VB O O
, , O O
but CC O O
the DT B-NP O
reactions NNS I-NP O
are VBP O O
unknown JJ B-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Vitamin NNP I-NP B-m
C NNP I-NP I-m
, , O O
Imuran NNP B-NP B-m
, , O O
PhosLo NNP B-NP B-m
, , O O
iron NN B-NP B-m
sulfate NN I-NP O
, , O O
Deltasone NNP B-NP B-m
, , O O
Coumadin NNP B-NP B-m
, , O O
Aranesp NNP B-NP B-m
, , O O
Dilaudid NNP B-NP B-m
for IN B-VP O
pain NN B-NP B-r
, , O O
lactulose RB O B-m
, , O O
Reglan NNP B-NP B-m
, , O O
Sarna NNP B-NP B-m
topical NN I-NP B-mo
, , O O
Senokot NNP B-NP B-m
, , O O
Ambien NNP B-NP B-m
for IN B-VP O
sleep NN B-NP B-r
, , O O
miconazole JJ B-NP B-m
powder NN I-NP I-m
, , O O
cyclosporine NN B-NP B-m
, , O O
Celexa NNP B-NP B-m
, , O O
and CC O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
once RB O B-f
per IN B-VP O
day NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
She PRP O O
was VBD B-VP O
afebrile IN B-VP O
Her NNP B-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
130/57 CD O O
, , O O
and CC O O
her PRP$ O O
pulse JJ O O
120 CD O O
in IN B-VP O
sinus NN B-NP O
tachycardia NN I-NP O
She PRP O O
was VBD B-VP O
95% CD O O
saturated VBN O O
on IN B-VP O
3 CD O O
liters NNS B-NP O
Physical JJ B-NP O
exam NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
bibasilar JJ B-NP O
crackles NNS I-NP O
in IN B-VP O
her PRP$ O O
lungs NNS B-NP O
2+ CD O O
edema NN B-NP O
in IN B-VP O
her PRP$ O O
legs NN B-NP O
to TO O O
her PRP$ O O
knees NNS B-NP O
A DT O O
5 CD O O
cm NN B-NP O
x VBD B-VP O
5 CD O O
cm JJ B-NP O
area NN I-NP O
of IN B-VP O
warm JJ B-NP O
erythema NN I-NP O
in IN B-VP O
her PRP$ O O
right JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
and CC O O
a DT B-NP O
left JJ I-NP O
hip NN I-NP O
wound NN I-NP O
with IN B-VP O
packing VBG O O
in IN B-VP O
place NN B-NP O
granulation NN I-NP O
tissue NN I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
CT NNP I-NP O
of IN B-VP O
her PRP$ O O
head NN B-NP O
, , O O
which WDT O O
showed VBD B-VP O
no DT B-NP O
acute NN I-NP O
processes VBZ O O
Echocardiogram NNP B-NP O
of IN B-VP O
her PRP$ O O
heart NN B-NP O
showed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
55% CD O O
Normal NNP B-NP O
right JJ B-NP O
ventricle NN I-NP O
and CC O O
structure NN B-NP O
with IN B-VP O
mild JJ O O
to TO O O
moderately RB O O
reduced JJ B-NP O
systolic JJ I-NP O
function NN I-NP O
in IN B-VP O
her PRP$ O O
right JJ B-NP O
ventricle NN I-NP O
Moderately RB O O
dilated VBD B-VP O
left JJ B-NP O
atrium NN I-NP O
, , O O
moderately RB O O
dilated VBD B-VP O
right JJ B-NP O
atrium NN I-NP O
, , O O
normal JJ B-NP O
aortic JJ I-NP O
valve NN I-NP O
, , O O
mild NN B-NP O
to TO O O
moderate VB O O
mitral JJ B-NP O
regurgitation NN I-NP O
, , O O
and CC O O
structurally RB O O
normal JJ B-NP O
tricuspid JJ I-NP O
valve NN I-NP O
Right NNP I-NP O
upper JJ B-NP O
arm NN I-NP O
ultrasound NN I-NP O
, , O O
which WDT O O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
venous JJ B-NP O
obstruction NN I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEM: NNP I-NP O
Ms NNP I-NP O
Gockley NNP I-NP O
's POS O O
inpatient NN B-NP O
issues NNS I-NP O
included VBD B-VP O
management NN B-NP O
of IN B-VP O
her PRP$ O O
heart NN B-NP O
failure NN I-NP O
, , O O
right JJ B-NP O
upper JJ I-NP O
arm NN I-NP O
extremity NN I-NP O
cellulitis NN I-NP O
, , O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
, , O O
chronic JJ B-NP O
anemia NN I-NP O
, , O O
diabetes NNS B-NP O
and CC O O
evaluation NN B-NP O
of IN B-VP O
her PRP$ O O
hip NN B-NP O
by IN B-VP O
orthopedics NNS B-NP O
For IN B-VP O
her PRP$ O B-r
her PRP$ O B-r
her PRP$ O B-r
heart NN B-NP O
failure NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
IV NNP B-NP B-mo
and CC O O
transitioned VBD B-VP O
to TO O O
oral JJ B-NP B-mo
torsemide NN I-NP B-m
torsemide NN I-NP B-m
and CC O O
they PRP O O
entered VBD B-VP O
discharge NN B-NP O
dose NN I-NP O
of IN B-VP O
torsemide JJ O B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
twice RB O B-f
per IN B-VP I-f
day NN B-NP I-f
Her PRP$ O O
admission NN B-NP O
weight NN I-NP O
was VBD B-VP O
133 CD O O
kg NN B-NP O
and CC O O
her PRP$ O O
discharge NN B-NP O
weight VBD B-VP O
122 CD O O
kg NNS B-NP O
She PRP O O
should MD O O
continue VB O O
on IN B-VP O
her PRP O O
current JJ B-NP O
torsemide NN I-NP B-m
and CC O O
limit NN B-NP O
her PRP$ O O
daily JJ B-NP O
salt NN I-NP O
intake NN I-NP O
, , O O
and CC O O
restrict VB O O
herself PRP O O
to TO O O
2 CD O O
liters NNS B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
her PRP$ O O
right JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
cellulitis NN I-NP O
She PRP O O
was VBD B-VP O
given VBN O O
a DT B-NP B-du
five-day JJ I-NP I-du
course NN I-NP I-du
of IN B-VP O
levofloxacin NN B-NP B-m
( ( O O
used VBN O O
to TO O O
address VB O O
recurrent JJ B-NP B-r
UTI NNP I-NP I-r
) ) O O
and CC O O
then RB O O
a DT B-NP B-du
two-day JJ I-NP I-du
course NN I-NP I-du
of IN B-VP O
Ancef NNP B-NP B-m
, , O O
her PRP$ O B-r
cellulitis NN B-NP I-r
cleared VBD B-VP O
with IN B-VP O
this DT B-NP O
regimen NN I-NP O
For IN B-VP O
her PRP$ O B-r
her PRP$ O B-r
urinary JJ B-NP I-r
urinary JJ I-NP I-r
tract NN I-NP I-r
tract JJ B-NP I-r
infection NN I-NP I-r
infection NN I-NP I-r
, , O O
she PRP O O
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
levofloxacin NN B-NP B-m
and CC O O
transitioned VBD B-VP O
to TO O O
Bactrim NNP B-NP B-m
based VBN O O
on IN B-VP O
antibiogram JJ B-NP O
sensitivities NNS I-NP O
A DT B-NP O
long-term JJ I-NP O
Foley NNP I-NP O
catheter NN I-NP O
was VBD B-VP O
removed VBN O O
Repeat NNP B-NP O
cultures NNS I-NP O
showed VBD B-VP O
bacteria NNS B-NP O
in IN B-VP O
her PRP$ O O
urine; JJ O O
however RB O O
, , O O
she PRP O O
was VBD B-VP O
clinically RB O O
asymptomatic JJ O O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
this DT O O
is VBZ O O
more RBR O O
consistent JJ O O
with IN B-VP O
colonization NN B-NP O
and CC O O
no DT B-NP O
further JJ I-NP O
treatment NN I-NP O
was VBD B-VP O
instituted VBN O O
If IN B-VP O
needed VBN O O
for IN B-VP O
further JJ B-NP O
antibiotics NNS I-NP O
, , O O
a DT B-NP O
PICC NNP I-NP O
line NN I-NP O
was VBD B-VP O
placed VBN O O
on IN B-VP O
March NNP B-NP O
, , O O
2005 CD O O
, , O O
after IN B-VP O
her PRP$ O O
prior JJ B-NP O
PICC NNP I-NP O
line NN I-NP O
clotted VBD B-VP O
Prior NNP B-NP O
to TO O O
discharge VB O O
, , O O
a DT B-NP O
new JJ I-NP O
Foley NNP I-NP O
catheter NN I-NP O
was VBD B-VP O
placed VBN O O
and CC O O
she PRP O O
was VBD B-VP O
incontinent NN B-NP O
of IN B-VP O
urine JJ O O
and CC O O
overall JJ O O
more RBR O O
comfortable JJ O O
with IN B-VP O
catheter NN B-NP O
in IN B-VP O
place NN B-NP O
While IN B-VP O
on IN B-VP O
Bactrim NNP B-NP B-m
for IN B-VP O
her PRP$ O B-r
UTI NNP B-NP O
, , O O
her PRP$ O O
creatinine NN B-NP O
rose VBD B-VP O
to TO O O
a DT B-NP O
peak NN I-NP O
of IN B-VP O
2.0 CD O O
, , O O
it PRP O O
was VBD B-VP O
unclear JJ O O
whether IN B-VP O
this DT B-NP O
raise NN I-NP O
was VBD B-VP O
due JJ O O
to TO O O
diuresis VB O O
or CC O O
the DT O O
antibiotic JJ O B-m
With IN B-VP O
cessation NN B-NP O
of IN B-VP O
the DT O O
antibiotic JJ O B-m
, , O O
her PRP$ O O
creatinine NN B-NP O
trended VBD B-VP O
downward RB O O
to TO O O
her PRP$ O O
baseline NN B-NP O
at IN B-VP O
1.6 CD O O
For IN B-VP O
her PRP$ O B-r
her PRP$ O B-r
chronic JJ B-NP I-r
chronic JJ I-NP I-r
anemia NN I-NP I-r
anemia NN I-NP I-r
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
iron NN B-NP B-m
( ( O O
which WDT O O
was VBD B-VP O
increased VBN O O
to TO O O
three CD O B-f
times NNS B-NP I-f
per IN B-VP I-f
day NN B-NP I-f
) ) O O
and CC O O
darbepoetin NN B-NP B-m
, , O O
folate NN B-NP B-m
was VBD B-VP O
added VBN O O
She PRP O O
was VBD B-VP O
asymptomatic JJ O O
from IN B-VP O
her PRP$ O B-r
her PRP$ O B-r
chronic JJ B-NP O
anemia NN I-NP O
She PRP O O
was VBD B-VP O
given VBN O O
two CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
packed NNS I-NP B-m
red JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
in IN B-VP O
March NNP B-NP O
, , O O
2005 CD O O
, , O O
and CC O O
two CD O O
more JJR B-NP O
units NNS I-NP O
on IN B-VP O
February NNP B-NP O
, , O O
2005 CD O O
, , O O
and CC O O
she PRP O O
responded VBD B-VP O
appropriately RB O O
to TO O O
this DT B-NP O
Her NNP I-NP O
discharge NN I-NP O
hematocrit NN I-NP O
was VBD B-VP O
30 CD O O
Her NNP B-NP O
hip NN I-NP O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
orthopedics NNS B-NP O
They PRP O O
felt VBD B-VP O
her PRP O O
hip NN B-NP O
was VBD B-VP O
healing VBG O O
well RB O O
She PRP O O
should MD O O
be VB O O
continued VBN O O
on IN B-VP O
wet-to-dry JJ B-NP O
dressings NNS I-NP O
No DT B-NP O
further JJ I-NP O
orthopedic JJ I-NP O
intervention NN I-NP O
is VBZ O O
planned VBN O O
She PRP O O
can MD O O
bear VB O O
her PRP$ O O
full JJ B-NP O
weight NN I-NP O
on IN B-VP O
her PRP$ O O
hip NN B-NP O
At IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
hemodynamically RB O O
stable JJ O O
, , O O
afebrile JJ O O
, , O O
and CC O O
breathing VBG O O
comfortably RB O O
on IN B-VP O
three CD O B-do
liters NNS B-NP I-do
of IN B-VP O
oxygen NN B-NP B-m
She PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
Naor NNP B-NP O
Viewmor NNP I-NP O
Hospital NNP I-NP O
and CC O O
should MD O O
work VB O O
aggressively RB O O
towards NNS B-NP O
reconditioning VBG O O
DISCHARGE NNP B-NP O
MEDICATIONS: NNP I-NP O
Vitamin NNP I-NP B-m
C NNP I-NP I-m
500 CD O B-do
mg NN B-NP I-do
twice RB O B-f
per IN B-VP I-f
day NN B-NP I-f
, , O O
Imuran NNP B-NP B-m
25 CD O B-do
mg JJ O O
daily RB O B-f
, , O O
PhosLo NNP B-NP B-m
667 CD O B-do
mg NN B-NP I-do
three CD O B-f
times NNS B-NP I-f
per IN B-VP I-f
day NN B-NP I-f
, , O O
clonazepam VBP O B-m
0.25 CD O B-do
mg JJ O I-do
twice RB O B-f
per IN B-VP I-f
day NN B-NP I-f
, , O O
cyclosporine VBP O B-m
50 CD O B-do
mg JJ O I-do
twice RB O B-f
daily RB O I-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
twice RB O B-f
daily RB O I-f
, , O O
iron NN B-NP B-m
sulfate NN I-NP I-m
325 CD O B-do
mg NN B-NP I-do
three CD O B-f
times NNS B-NP I-f
per IN B-VP I-f
day NN B-NP I-f
, , O O
folate VBP O B-m
1 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Dilaudid NNP B-NP B-m
2 CD O B-do
mg NN B-NP I-do
every DT O B-f
six CD O I-f
hours NNS B-NP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
pain NN B-NP B-r
, , O O
please NN B-NP O
hold VB O O
this DT O O
sedated VBN O O
for IN B-VP O
respirations NNS B-NP O
less JJR O O
than IN B-VP O
10 CD O O
per IN B-VP O
minute NN B-NP O
, , O O
insulin NN B-NP B-m
NPH NNP I-NP I-m
14 CD O B-do
units NNS B-NP I-do
every DT B-NP B-f
evening NN I-NP I-f
, , O O
insulin NN B-NP B-m
NPH NNP I-NP I-m
46 CD O B-do
units NNS B-NP I-do
every DT B-NP B-f
morning NN I-NP O
, , O O
lactulose RB O B-m
30 CD O B-do
mL NNS B-NP I-do
four CD O B-f
times NNS B-NP I-f
per RB O I-f
day NN B-NP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
constipation NN B-NP B-r
, , O O
prednisone NN B-NP B-m
5 CD O B-do
mg NN B-NP I-do
every DT B-NP B-f
morning NN I-NP I-f
, , O O
Sarna NNP B-NP B-m
topical JJ O B-mo
every DT B-NP B-f
day NN I-NP O
apply VB O O
to TO O O
affected JJ B-NP O
areas NNS I-NP O
, , O O
multivitamin JJ O B-m
daily RB O B-f
, , O O
Coumadin NNP B-NP B-m
2.5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
goal NN B-NP O
INR NNP I-NP O
2 CD O O
to TO O O
3 CD O O
, , O O
zinc NN B-NP B-m
sulfate NN I-NP I-m
220 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Ambien NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
before RB O B-f
bed VBD B-VP I-f
as IN B-VP I-f
needed VBN O I-f
for IN B-VP O
insomnia NN B-NP B-r
, , O O
torsemide RB O B-m
200 CD O B-do
mg NNS B-NP I-do
by IN B-VP B-mo
mouth NN B-NP I-mo
two CD O B-f
times NNS B-NP O
per IN B-VP O
day NN B-NP O
, , O O
Fosamax NNP B-NP B-m
70 CD O B-do
mg NN B-NP I-do
once RB O B-f
per IN B-VP I-f
week NN B-NP I-f
, , O O
miconazole JJ B-NP B-m
nitrate NN I-NP O
2% CD O O
powder NN B-NP O
topical JJ O B-mo
two CD O O
times NNS B-NP O
per IN B-VP O
day NN B-NP O
apply VB O O
to TO O O
affected JJ B-NP O
areas NNS I-NP O
as IN B-VP O
needed VBN O O
, , O O
Advair NNP B-NP B-m
Diskus NNP I-NP I-m
250/50 CD O I-m
one CD O B-do
puff NN B-NP I-do
inhaled VBD B-VP B-mo
twice RB O B-f
per IN B-VP I-f
day NN B-NP I-f
, , O O
esomeprazole JJ O B-m
20 CD O B-do
mg NN B-NP I-do
once RB O B-f
per IN B-VP I-f
day NN B-NP I-f
, , O O
DuoNeb NNP B-NP B-m
3/0.5 CD O B-do
mg NN B-NP I-do
inhaled VBN O B-mo
every DT O B-f
six CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
shortness NN B-NP B-r
of IN B-VP I-r
breath NN B-NP I-r
, , O O
Aranesp NNP B-NP B-m
50 CD O B-do
mcg NN B-NP I-do
subcutaneously RB O B-mo
once RB O B-f
per IN B-VP I-f
week NN B-NP I-f
, , O O
NovoLog NNP B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
before IN B-VP B-f
meals NNS B-NP I-f
, , O O
Lexapro NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
once RB O B-f
per IN B-VP I-f
day NN B-NP I-f
, , O O
Maalox NNP B-NP B-m
one CD O B-do
to TO O I-do
two CD O I-do
tablets NNS B-NP I-do
every DT O B-f
six CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
upset JJ B-NP B-r
stomach NN I-NP I-r
, , O O
and CC O O
Lipitor NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
once RB O B-f
per IN B-VP O
day NN B-NP O
OUTSTANDING NNP I-NP O
ISSUES: NNP I-NP O
Include NNP I-NP O
following VBG O O
INR NNP B-NP O
the DT B-NP O
goal NN I-NP O
of IN B-VP O
2 CD O O
to TO O O
3 CD O O
, , O O
following VBG O O
weight NN B-NP O
and CC O O
clinical JJ B-NP O
signs NNS I-NP O
of IN B-VP O
volume NN B-NP O
overload NN I-NP O
, , O O
following VBG O O
up RP O O
on IN B-VP O
loose JJ B-NP O
stools NNS I-NP O
for IN B-VP O
possible JJ B-NP O
Clostridium NNP I-NP O
difficile NN I-NP O
infection NN I-NP O
Following VBG O O
clinical JJ B-NP O
signs NNS I-NP O
for IN B-VP O
evidence NN B-NP O
of IN B-VP O
urinary JJ B-NP B-r
tract NN I-NP I-r
infection NN I-NP I-r
treating VBG O O
with IN B-VP O
antibiotics NNS B-NP B-m
as IN B-VP O
necessary JJ B-NP O
PRIMARY NNP I-NP O
CARE NNP I-NP O
PHYSICIAN: NNP I-NP O
Dr NNP I-NP O
Rodolfo NNP I-NP O
Love NNP I-NP O
eScription NN I-NP O
document: VBD B-VP O
0-2962105 JJ B-NP O
SSSten NNP I-NP O
Tel NNP I-NP O
CC: NNP I-NP O
Hyman NNP I-NP O
Footman NNP I-NP O
M.D NNP I-NP O
Delp NNP I-NP O
Coscotaence NNP I-NP O
Las NNP I-NP O
Newsbrid NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
SINOR NNP I-NP O
, , O O
ROGER NNP B-NP O
Attending: NNP I-NP O
BRASSEAUX NNP I-NP O
, , O O
JOSEPH NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6681514 CD O O
D: NNP B-NP O
4/7/05 CD O O
T: NNP B-NP O
4/7/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#734280 VBZ O O
746472700 CD O O
PAMC NNP B-NP O
03453039 CD O O
0162843 CD O O
8/28/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
viral JJ B-NP O
URI NNP I-NP O
, , O O
pulmonary JJ B-NP O
HTN NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/21/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/22/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
LIBRIZZI NNP I-NP O
, , O O
MARIANO NNP B-NP O
915-22-38-9 CD O O
New NNP B-NP O
Hi NNP I-NP O
A NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
2/17/05 CD O O
AT NNP B-NP O
08:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
CADENAS NNP I-NP O
, , O O
HONG NNP B-NP O
BROOKS NNP I-NP O
, , O O
M.D NNP B-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/4/05 CD O O
by IN B-VP O
LEVER NNP B-NP O
, , O O
DARYL NNP B-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ASPIRIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
160 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
GLIPIZIDE NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
OCEAN NNP I-NP B-m
SPRAY NNP I-NP I-m
( ( O I-m
SODIUM NNP B-NP I-m
CHLORIDE NNP I-NP I-m
0.65% CD O I-m
) ) O I-m
2 CD O B-do
SPRAY NNP B-NP I-do
NA NNP I-NP B-mo
QID NNP I-NP B-f
PRN NNP I-NP O
Other:dried NNP I-NP B-r
nasal NN I-NP I-r
mucosa NN I-NP I-r
COUMADIN NNP I-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
NOW NNP I-NP O
, , O O
Within NNP B-NP O
Hour NNP I-NP O
of IN B-VP O
Pharmacy NNP B-NP O
Approval NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/4/05 CD O O
by IN B-VP O
JERICH NNP B-NP O
, , O O
JOSPEH NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
ECASA NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
91585860 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
ASPIRIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ZOLOFT NNP I-NP B-m
( ( O I-m
SERTRALINE NNP B-NP I-m
) ) O I-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
AMBIEN NNP I-NP B-m
( ( O I-m
ZOLPIDEM NNP B-NP I-m
TARTRATE NNP I-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
KCL NNP B-NP B-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
20 CD O B-do
MEQ NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
As IN B-VP O
per IN B-VP O
L NNP B-NP O
Potassium NNP I-NP O
Chloride NNP I-NP O
Policy: NNP I-NP O
each DT O O
20 CD O O
mEq NNS B-NP O
dose VB O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4 CD O O
oz NNS B-NP O
of IN B-VP O
fluid JJ B-NP O
ATROVENT NNP I-NP B-m
NASAL NNP I-NP I-m
0.06% CD O I-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
NASAL NNP I-NP I-m
0.06% CD O I-m
) ) O I-m
2 CD O B-do
SPRAY NNP B-NP I-do
NA NNP I-NP B-mo
TID NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
NEXIUM NNP B-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
TRACLEER NNP I-NP B-m
( ( O I-m
BOSENTAN NNP B-NP I-m
) ) O I-m
125 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
10 CD O I-du
VENTAVIS NNP B-NP B-m
1 CD O B-do
neb NN B-NP I-do
NEB NNP I-NP B-mo
Q3H NNP I-NP B-f
Instructions: NNP I-NP O
during IN B-VP B-du
wake NN B-NP I-du
hours NNS I-NP I-du
ALBUTEROL NNP I-NP B-m
ALBUTEROL NNP I-NP B-m
INHALER NNP I-NP I-m
INHALER NNP I-NP I-m
2 CD O B-do
2 CD O B-do
PUFF NNP B-NP I-do
PUFF NNP I-NP I-do
INH NNP I-NP B-mo
INH NNP I-NP B-mo
Q4H NNP I-NP B-f
Q4H NNP I-NP B-f
PRN NNP I-NP O
Shortness NNP I-NP B-r
of IN B-VP I-r
Breath NNP B-NP I-r
, , O O
Wheezing NNP B-NP B-r
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
4 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
TFHC NNP I-NP O
per IN B-VP O
TLHO NNP B-NP O
team NN I-NP O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
0/1/05 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT B-NP O
perclinic JJ I-NP O
days NNS I-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
prior JJ B-NP O
clinic JJ I-NP O
ALLERGY: NNP I-NP O
Cephalosporins NNP I-NP O
, , O O
ACE NNP B-NP O
Inhibitor NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Viral NNP I-NP O
infection NN I-NP O
, , O O
severe JJ B-NP O
pulmonary JJ I-NP O
hypertension NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
viral JJ B-NP O
URI NNP I-NP O
, , O O
pulmonary JJ B-NP O
HTN NNP I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
H/O NNP I-NP O
PUD NNP I-NP O
dm NN I-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
pulmonary JJ B-NP O
hypertension NN I-NP O
( ( O O
pulmonary JJ B-NP O
hypertension NN I-NP O
) ) O O
osa NN B-NP O
( ( O O
sleep JJ B-NP O
apnea NN I-NP O
) ) O O
gerd NN B-NP O
( ( O O
gastroesophageal JJ B-NP O
reflux NN I-NP O
disease NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
SOB NNP I-NP O
HPI: NNP I-NP O
51 CD O O
F NNP B-NP O
w/ NN I-NP O
h/o NN I-NP O
severe JJ B-NP O
pulmonary JJ I-NP O
HTN NNP I-NP O
, , O O
DM NNP B-NP O
, , O O
OSA NNP B-NP O
, , O O
obesity NN B-NP O
, , O O
on IN B-VP O
chronic JJ B-NP O
home NN I-NP O
O2 NNP I-NP B-m
( ( O O
8L CD O B-do
NC NNP B-NP O
) ) O O
She PRP O O
is VBZ O O
followed VBN O O
by IN B-VP O
the DT B-NP O
AH NNP I-NP O
service NN I-NP O
, , O O
at IN B-VP O
her PRP$ O O
baseline NN B-NP O
until IN B-VP O
about IN B-VP O
one CD O O
week NN B-NP O
ago RB O O
, , O O
having VBG O O
returned VBN O O
from IN B-VP O
Pe NNP B-NP O
Ale NNP I-NP O
two CD O O
weeks NNS B-NP O
ago RB O O
, , O O
she PRP O O
began VBD B-VP O
to TO O O
experience VB O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
and CC O O
chest NN B-NP O
tightness NN I-NP O
She PRP O O
also RB O O
reports VBZ O O
productive JJ B-NP O
cough NN I-NP O
( ( O O
greenish JJ O O
) ) O O
, , O O
rhinorrhea NN B-NP O
, , O O
sinus NN B-NP O
tenderness NN I-NP O
, , O O
N/V NNP B-NP O
, , O O
malaise NN B-NP O
She PRP O O
denies VBZ O O
palpitations NNS B-NP O
or CC O O
radiating VBG O O
chest JJS B-NP O
pain NN I-NP O
The DT B-NP O
day NN I-NP O
PTA NNP I-NP O
, , O O
VNA NNP B-NP O
found VBD B-VP O
the DT B-NP O
patient NN I-NP O
to TO O O
desat VB O O
to TO O O
82% CD O O
with IN B-VP O
exertion NN B-NP O
She PRP O O
went VBD B-VP O
to TO O O
Gas NNP B-NP O
Healthcare NNP I-NP O
, , O O
where WRB O O
she PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
an DT B-NP O
SpO2 NNP I-NP O
of IN B-VP O
99% CD O O
on IN B-VP O
8L CD O O
, , O O
no DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
, , O O
NAD NNP B-NP O
on IN B-VP O
CXR NNP B-NP O
She PRP O O
was VBD B-VP O
hospitalized VBN O O
in IN B-VP O
July NNP B-NP O
2005 CD O O
at IN B-VP O
CRT NNP B-NP O
with IN B-VP O
simlar JJ B-NP O
SOB NNP I-NP O
At IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
she PRP O O
underwent VBD B-VP O
a DT B-NP O
RHC NNP I-NP O
which WDT O O
showed VBD B-VP O
PA NNP B-NP O
pressures NNS I-NP O
70-80% JJ O O
( ( O O
110/40/60-65 JJ O O
) ) O O
of IN B-VP O
sytemic JJ B-NP O
pressures NNS I-NP O
She PRP O O
also RB O O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
MIBI NNP I-NP O
, , O O
negative JJ B-NP O
swallowing NN I-NP O
study NN I-NP O
Since IN B-VP O
discharge NN B-NP O
, , O O
she PRP O O
reports VBZ O O
being VBG O O
med VBN O O
compliant NN B-NP O
, , O O
and CC O O
diet JJ B-NP O
compliant NN I-NP O
Her NNP I-NP O
weight NN I-NP O
has VBZ O O
been VBN O O
stable JJ O O
at IN B-VP O
238 CD O O
lbs NN B-NP O
She PRP O O
feels VBZ O O
that IN B-VP O
her PRP$ O O
depression NN B-NP O
has VBZ O O
been VBN O O
worse JJR O O
of IN B-VP O
late JJ B-NP O
ALL: NNP I-NP O
ACEi NNP I-NP B-m
, , O O
cephalopsporins VBZ O B-m
MEDS: NNP B-NP O
K-Dur NNP I-NP B-m
20 CD O B-do
BID NNP B-NP B-f
, , O O
Nexium NNP B-NP B-m
20 CD O B-do
, , O O
lasix VBD B-VP B-m
160 CD O B-do
BID NNP B-NP B-f
, , O O
tracleer RB O B-m
125 CD O B-do
BID NNP B-NP B-f
, , O O
Glipizide NNP B-NP B-m
80 CD O B-do
BID NNP B-NP B-f
, , O O
Coumadin NNP B-NP B-m
5/7.5 CD O B-do
, , O O
ECASA NNP B-NP B-m
81 CD O B-do
, , O O
Zoloft NNP B-NP B-m
100 CD O B-do
, , O O
MVI NNP B-NP B-m
, , O O
Oceanspray NNP B-NP B-m
, , O O
Ambien NNP B-NP B-m
10 CD O B-do
QHS NNP B-NP B-f
, , O O
Ventavis NNP B-NP B-m
nebs FW O B-mo
Q3H NNP B-NP B-f
PE:96.8 NNP I-NP O
, , O O
83 CD O O
, , O O
114/76 CD O O
, , O O
97-98% CD O O
on IN B-VP O
8L CD O O
NC NNP B-NP O
JVP NNP I-NP O
14 CD O O
, , O O
RRR NNP B-NP O
, , O O
loud JJ B-NP O
P2 NNP I-NP O
, , O O
no DT B-NP O
M NNP I-NP O
CTA NNP I-NP O
Obese NNP I-NP O
Labs: NNP I-NP O
K NNP I-NP O
3.5 CD O O
, , O O
Cr NNP B-NP O
1.4 CD O O
, , O O
WBC NNP B-NP O
8.2 CD O O
, , O O
CK/TNI NNP B-NP O
neg NN I-NP O
, , O O
BNP NNP B-NP O
443 CD O O
****************Hospital JJ B-NP O
Course****************** NNP I-NP O
A/P NNP I-NP O
51F CD O O
with IN B-VP O
sever NN B-NP O
pHTN NN I-NP O
, , O O
OSA NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
obesity NN B-NP O
, , O O
p/w NN B-NP O
SOB NNP I-NP O
and CC O O
URI-type NNP B-NP O
Sx NNP I-NP O
Near NNP I-NP O
pulmonary JJ B-NP O
baseline NN I-NP O
1 CD O O
Pulm: NNP B-NP O
Severe NNP I-NP O
pHTN NN I-NP O
with IN B-VP O
very RB O O
elevated JJ B-NP O
PA NNP I-NP O
pressures NNS I-NP O
Likely NNP I-NP O
subjective JJ B-NP O
SOB NNP I-NP O
in IN B-VP O
the DT B-NP O
context NN I-NP O
of IN B-VP O
viral JJ B-NP O
URI NNP I-NP O
Cont NNP I-NP O
Ilprost NNP I-NP O
, , O O
home NN B-NP O
O2 NNP I-NP B-m
, , O O
tracleer NN B-NP B-m
, , O O
albuterol VBP O B-m
Pulmonary JJ B-NP O
status NN I-NP O
stable JJ O O
, , O O
but CC O O
patient NN B-NP O
is VBZ O O
uneasy JJ O O
with IN B-VP O
going VBG O O
home NN B-NP O
, , O O
and CC O O
so RB O O
will MD O O
stay VB O O
- : O O
stable JJ B-NP O
enought NN I-NP O
to TO O O
go VB O O
home NN B-NP O
2 CD O O
CV: NNP B-NP O
Recent NNP I-NP O
ECHO NNP I-NP O
, , O O
Cath NNP B-NP O
, , O O
probably RB O O
no DT B-NP O
need NN I-NP O
to TO O O
do VB O O
further RB O O
w/u VB O O
ROMI NNP B-NP O
by IN B-VP O
serial JJ B-NP O
enzymes/EKG NN I-NP O
Continue NNP I-NP O
Lasix NNP I-NP B-m
, , O O
KCl NNP B-NP B-m
, , O O
ASA NNP B-NP B-m
81 CD O B-do
3 CD O O
Psych: NNP B-NP O
h/o NN I-NP O
depression NN I-NP B-r
depression NN I-NP B-r
Inpatient NNP I-NP O
psych NN I-NP O
consult NN I-NP O
Cont NNP I-NP O
zoloft NNP I-NP B-m
, , O O
ambien VBZ O B-m
4 CD O O
DM: NNP B-NP O
Will NNP I-NP O
follow VB O O
FSBS NNP B-NP O
5 CD O O
Heme: NNP B-NP O
Coumadin NNP I-NP B-m
for IN B-VP O
pulmonary JJ B-NP B-r
microclots NNS I-NP I-r
on IN B-VP O
Bx NNP B-NP O
in IN B-VP O
past NN B-NP O
WIll NNP I-NP O
increase VB O O
Coumadin NNP B-NP B-m
since IN B-VP O
INR NNP B-NP O
1.9 CD O O
, , O O
recheck NN B-NP O
QD NNP I-NP O
6 CD O O
FEN: NNP B-NP O
low JJ B-NP O
salt NN I-NP O
, , O O
low JJ B-NP O
fat NN I-NP O
diet JJ O O
7 CD O O
ID: NNP B-NP O
Likely JJ B-NP O
viral JJ I-NP O
URI NNP I-NP O
BCx NNP I-NP O
taken VBN O O
WIll NNP B-NP O
recheck VB O O
CXR NNP B-NP O
if IN B-VP O
clinically RB O O
warranted VBD B-VP O
8 CD O O
GI: NNP B-NP O
GERD NNP I-NP B-r
, , O O
nexium NN B-NP B-m
prophylaxis VBP O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
Call NNP I-NP O
you PRP O O
doctor VBP O O
if IN B-VP O
you PRP O O
become VBP O O
more JJR O O
short JJ O O
of IN B-VP O
breath NN B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Satisfactory NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
EVERLY NNP I-NP O
, , O O
ARRON NNP B-NP O
J NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
TC12 NNP B-NP O
) ) O O
2/17/05 CD O O
@ $ O O
07 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#741076 VBZ O O
327485275 CD O O
RHMC NNP B-NP O
26315643 CD O O
1360418 CD O O
10/25/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/2/2004 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/24/2004 CD O O
ATTENDING: NNP B-NP O
LAZARO NNP I-NP O
HINSHAW NNP I-NP O
MD NNP I-NP O
ADMITTING NNP I-NP O
DIAGNOSIS: NNP I-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
LIST NNP I-NP O
OF NNP I-NP O
PROBLEMS NNP I-NP O
AND NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
CHF NNP B-NP O
2 CD O O
CAD NNP B-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
in IN B-VP O
1988 CD O O
3 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
4 CD O O
Type NNP B-NP O
II NNP I-NP O
diabetes VBZ O O
5 CD O O
Glaucoma NNP B-NP O
6 CD O O
Hypercholesterolemia NNP B-NP O
7 CD O O
History NNP B-NP O
of IN B-VP O
bowel NN B-NP O
resection NN I-NP O
for IN B-VP O
diverticulitis NN B-NP O
8 CD O O
Question NN B-NP O
of IN B-VP O
TIA NNP B-NP O
in IN B-VP O
the DT O O
past JJ O O
with IN B-VP O
right-sided JJ B-NP O
numbness JJ I-NP O
BRIEF NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Ms NNP I-NP O
Elter NNP I-NP O
is VBZ O O
an DT B-NP O
83-year-old JJ I-NP O
Spanish-speaking JJ I-NP O
female NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
CAD NNP B-NP O
, , O O
distant JJ B-NP O
three-vessel NN I-NP O
CABG NNP I-NP O
, , O O
CRI NNP B-NP O
, , O O
NSTEMI NNP B-NP O
in IN B-VP O
4/20 CD O O
, , O O
treated VBN O O
with IN B-VP O
just RB O O
medications NNS B-NP O
, , O O
EF NNP B-NP O
of IN B-VP O
75% CD O O
in IN B-VP O
4/20 CD O O
, , O O
who WP O O
presented VBD B-VP O
one CD O O
week NN B-NP O
of IN B-VP O
PND NNP B-NP O
, , O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
and CC O O
chest JJS B-NP O
heaviness NN I-NP O
This DT B-NP O
chest JJS I-NP O
sensation NN I-NP O
did VBD B-VP O
not RB O O
radiate VB O O
and CC O O
was VBD B-VP O
unassociated VBN O O
with IN B-VP O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
diaphoresis NN B-NP O
or CC O O
lightheadedness VB O O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
cough VBN O O
with IN B-VP O
green JJ B-NP O
sputum NN I-NP O
x1 CD O O
year NN B-NP O
, , O O
no DT B-NP O
fevers NNS I-NP O
or CC O O
chills NNS B-NP O
, , O O
no DT B-NP O
sick JJ I-NP O
contacts NNS I-NP O
EMS NNP I-NP O
gave VBD B-VP O
Lasix NNP B-NP B-m
and CC O O
Nitrospray NNP B-NP B-m
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
briefly NN B-NP O
on IN B-VP O
a DT B-NP O
nonrebreather NN I-NP O
mask NN I-NP O
, , O O
responded VBD B-VP O
to TO O O
80 CD O B-do
mg NN B-NP I-do
of IN B-VP O
IV NNP B-NP B-mo
Lasix NNP I-NP B-m
, , O O
K NNP B-NP O
was VBD B-VP O
5.8 CD O O
and CC O O
got VBD B-VP O
Kayexalate NNP B-NP B-m
She PRP O O
became VBD B-VP O
comfortable JJ O O
, , O O
sitting VBG O O
at IN B-VP O
75 CD O O
degrees NNS B-NP O
, , O O
chest JJS B-NP O
pain-free NN I-NP O
Also RB O O
, , O O
noted VBD B-VP O
no DT B-NP O
change NN I-NP O
in IN B-VP O
bowel/bladder NN B-NP O
habits NNS I-NP O
, , O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
meds NNS B-NP O
and CC O O
no DT B-NP O
dietary JJ I-NP O
changes NNS I-NP O
She PRP O O
had VBD B-VP O
positive JJ B-NP O
progressive JJ I-NP O
lower JJR I-NP O
extremity NN I-NP O
edema VBP O O
x2 JJ B-NP O
weeks NNS I-NP O
ALLERGIES: NNP I-NP O
Lisinopril NNP I-NP O
leading VBG O O
to TO O O
hyperkalemia VB O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
Retired NNP I-NP O
textile NN I-NP O
worker NN I-NP O
from IN B-VP O
Ral NNP B-NP O
, , O O
lives VBZ O O
with IN B-VP O
daughter NN B-NP O
, , O O
and CC O O
is VBZ O O
Spanish JJ O O
speaking VBG O O
HOME NNP B-NP O
MEDICATIONS: NNP I-NP O
Aspirin NNP I-NP B-m
, , O O
metoprolol NN B-NP B-m
, , O O
allopurinol NN B-NP B-m
, , O O
valsartan NN B-NP B-m
, , O O
glipizide NN B-NP B-m
, , O O
Lipitor NNP B-NP B-m
, , O O
and CC O O
nifedipine JJ B-NP B-m
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
Temperature NNP I-NP O
was VBD B-VP O
96 CD O O
, , O O
pulse NN B-NP O
was VBD B-VP O
70 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
148/56 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
was VBD B-VP O
20 CD O O
, , O O
and CC O O
saturating VBG O O
100% CD O O
on IN B-VP O
nonrebreather NN B-NP O
and CC O O
eventually RB O O
in IN B-VP O
the DT O O
high JJ O O
90s CD O O
on IN B-VP O
a DT B-NP B-do
couple NN I-NP I-do
of IN B-VP I-do
liters NNS B-NP I-do
of IN B-VP O
oxygen NN B-NP B-m
In IN B-VP O
general JJ O O
, , O O
she PRP O O
was VBD B-VP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
, , O O
JVP NNP B-NP O
12 CD O O
cm NN B-NP O
with IN B-VP O
positive JJ B-NP O
hepatojugular NN I-NP O
reflux NN I-NP O
, , O O
soft JJ B-NP O
bibasilar NN I-NP O
rales NNS I-NP O
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
2-3/6 JJ B-NP O
systolic JJ I-NP O
murmur NN I-NP O
, , O O
loudest JJS O O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
sternal JJ I-NP O
border NN I-NP O
, , O O
( ( O O
mild JJ O O
AS IN B-VP O
on IN B-VP O
echo NN B-NP O
from IN B-VP O
0/21 CD O O
) ) O O
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
, , O O
bowel VB O O
sounds NNS B-NP O
positive JJ B-NP O
Extremities NNS I-NP O
showed VBD B-VP O
3+ CD O O
bilateral JJ O O
pitting VBG O O
ankle JJ B-NP O
edema NN I-NP O
with IN B-VP O
weak JJ B-NP O
distal JJ I-NP O
pulses NNS I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Showed VBD B-VP O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
129 CD O O
, , O O
potassium NN B-NP O
of IN B-VP O
5.7 CD O O
, , O O
creatinine NN B-NP O
of IN B-VP O
2.8 CD O O
with IN B-VP O
a DT B-NP O
baseline NN I-NP O
anywhere RB O O
between IN B-VP O
2 CD O O
and CC O O
3.5 CD O O
, , O O
cardiac JJ O O
enzymes RB O O
negative JJ B-NP O
x1 NN I-NP O
, , O O
BNP NNP B-NP O
of IN B-VP O
1448 CD O O
EKG NNP B-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
73 CD O O
, , O O
septal JJ B-NP O
Qs NNP I-NP O
, , O O
QTC NNP B-NP O
of IN B-VP O
456 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
showed VBD B-VP O
cardiomegaly NNS B-NP O
, , O O
small JJ B-NP O
bilateral JJ I-NP O
effusions NNS I-NP O
, , O O
no DT B-NP O
infiltrate JJ I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEMS: NNP I-NP O
1 CD O O
Cardiovascular: NNP B-NP O
Ischemia: NNP I-NP O
Rule NNP I-NP O
out IN B-VP O
MI NNP B-NP O
by IN B-VP O
enzymes NNS B-NP O
and CC O O
EKG NNP B-NP O
with IN B-VP O
a DT B-NP O
full JJ I-NP O
set NN I-NP O
negative JJ O O
Continued VBD B-VP O
her PRP$ O O
aspirin NN B-NP B-m
, , O O
beta-blockers NNS B-NP B-m
, , O O
and CC O O
statin NN B-NP B-m
for IN B-VP O
coronary JJ B-NP B-r
artery NN I-NP I-r
disease NN I-NP I-r
Pump: NNP I-NP O
CHF NNP I-NP O
flare NN I-NP O
with IN B-VP O
elevated JJ B-NP O
BNP NNP I-NP O
, , O O
volume NN B-NP O
overload NN I-NP O
, , O O
diuresed VBN O O
with IN B-VP O
Lasix NNP B-NP B-m
and CC O O
Diuril; NNP B-NP B-m
salt/water NN I-NP O
restricted VBD B-VP O
, , O O
kept VBD B-VP O
strict JJ B-NP O
I/O NNP I-NP O
with IN B-VP O
moderate JJ B-NP O
diuresis NN I-NP O
After IN B-VP O
load NN B-NP O
reduced VBN O O
with IN B-VP O
ARB NNP B-NP B-m
, , O O
weaned VBD B-VP O
off RP O O
her PRP$ O O
previous JJ B-NP O
home NN I-NP O
calcium NN I-NP B-m
channel NN I-NP O
blocker NN I-NP O
Rhythm: NNP I-NP O
Telemetry NNP I-NP O
showing VBG O O
transient JJ B-NP O
new JJ I-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
with IN B-VP O
a DT B-NP O
maximum JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
less JJR O O
than IN B-VP O
70 CD O O
, , O O
which WDT O O
spontaneously RB O O
resolved VBD B-VP O
after IN B-VP O
several JJ B-NP O
hours NNS I-NP O
An DT B-NP O
echo NN I-NP O
showed VBD B-VP O
stable JJ B-NP O
aortic JJ I-NP O
stenosis NN I-NP O
without IN B-VP O
any DT B-NP O
acute NN I-NP O
worsening NN I-NP O
She PRP O O
also RB O O
had VBD B-VP O
a DT B-NP O
rhythm JJ I-NP O
strip NN I-NP O
on IN B-VP O
the DT B-NP O
telemetry NN I-NP O
showing VBG O O
a DT B-NP O
regular JJ I-NP O
focus NN I-NP O
of IN B-VP O
ventricular JJ B-NP B-r
ectopy NN I-NP I-r
, , O O
also RB O O
spontaneously RB O O
resolving VBG O O
This DT O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
continued JJ B-NP O
beta-blockers NNS I-NP B-m
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
she PRP O O
was VBD B-VP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm VBD B-VP O
2 CD O O
Renal: NNP B-NP O
Chronic NNP I-NP O
renal JJ B-NP O
insufficiency NN I-NP O
with IN B-VP O
baseline JJ B-NP O
creatinine NN I-NP O
of IN B-VP O
2.8 CD O O
to TO O O
3.3 CD O O
, , O O
with IN B-VP O
acute JJ O O
worsening VBG O O
in-house NN B-NP O
, , O O
most RBS O O
likely JJ O O
secondary JJ O O
to TO O O
over IN B-VP O
diuresis NN B-NP O
with IN B-VP O
Diuril/Lasix NNP B-NP B-m
, , O O
also RB O O
some DT B-NP O
prerenal JJ I-NP O
component NN I-NP O
secondary JJ O O
to TO O O
fluid VB O O
restriction NN B-NP O
Her NNP I-NP O
potassium NN I-NP O
was VBD B-VP O
elevated VBN O O
initially RB O O
, , O O
got VBD B-VP O
Kayexalate NNP B-NP B-m
, , O O
and CC O O
then RB O O
was VBD B-VP O
low/low JJ O O
normal JJ O O
after IN B-VP O
Lasix NNP B-NP B-m
Creatinine NNP I-NP O
peaked VBD B-VP O
at IN B-VP O
4.1 CD O O
, , O O
Lasix NNP B-NP B-m
and CC O O
ARBs NNP B-NP B-m
were VBD B-VP O
held VBN O O
Urine NNP B-NP O
study NN I-NP O
showed VBD B-VP O
a DT B-NP O
prerenal JJ I-NP O
component NN I-NP O
, , O O
also RB O O
showed VBD B-VP O
some DT B-NP O
proteinuria NNS I-NP O
Her PRP$ O O
creatinine NN B-NP O
eventually RB O O
improved VBN O O
to TO O O
3.3 CD O O
, , O O
and CC O O
her PRP$ O O
bicarb NN B-NP O
improved VBN O O
from IN B-VP O
17 CD O O
to TO O O
23 CD O O
with IN B-VP O
the DT B-NP O
closing NN I-NP O
of IN B-VP O
her PRP$ O O
acid JJ B-NP O
gap NN I-NP O
from IN B-VP O
17 CD O O
to TO O O
11 CD O O
Potassium NNP B-NP O
was VBD B-VP O
4.5 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
need VB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Dasgupta NNP I-NP O
, , O O
her PRP$ O O
nephrologist NN B-NP O
, , O O
and CC O O
she PRP O O
was VBD B-VP O
set VBN O O
up RP O O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
on IN B-VP O
10/24/04 CD O O
3 CD O O
Endocrine: NNP B-NP O
DM-2 NNP I-NP O
, , O O
she PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
regular JJ O O
sliding VBG O B-do
scale JJ B-NP I-do
insulin NN I-NP O
with IN B-VP O
good JJ B-NP O
blood NN I-NP O
sugar NN I-NP O
control NN I-NP O
Her NNP I-NP O
glipizide NN I-NP B-m
was VBD B-VP O
held VBN O O
given VBN O O
that IN B-VP O
her PRP$ O O
creatinine JJ B-NP O
clearance NN I-NP O
was VBD B-VP O
worsening VBG O O
We PRP O O
did VBD B-VP O
not RB O O
restart VB O O
her PRP$ O O
glipizide NN B-NP B-m
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
until IN B-VP O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Ohlenbusch NNP I-NP O
given VBN O O
her PRP$ O O
overall JJ B-NP O
worsening NN I-NP O
creatinine NN I-NP O
clearance NN I-NP O
4 CD O O
Rheumatology: NNP B-NP O
History NNP I-NP O
of IN B-VP O
gout NN B-NP O
, , O O
change VBP O O
her PRP$ O O
allopurinol NN B-NP B-m
allopurinol NN I-NP B-m
to TO O O
q.72h VB O B-f
from IN B-VP O
q.o.d JJ O B-f
secondary JJ O O
to TO O O
creatinine VB O O
clearance NN B-NP O
She PRP O O
did VBD B-VP O
complain NN B-NP O
of IN B-VP O
some DT B-NP O
left JJ I-NP O
heel NN I-NP O
pain NN I-NP O
and CC O O
left VBD B-VP O
foot NN B-NP O
pain NN I-NP O
, , O O
thought VBD B-VP O
secondary JJ O O
to TO O O
her PRP$ O O
gout NN B-NP O
This DT O O
improved VBN O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
5 CD O O
Heme: NNP B-NP O
Hematocrit NNP I-NP O
dropped VBD B-VP O
from IN B-VP O
29 CD O O
to TO O O
25 CD O O
, , O O
her PRP$ O O
guaiac NN B-NP O
was VBD B-VP O
negative JJ O O
on IN B-VP O
the DT O O
3/20/04 CD O O
She PRP O O
also RB O O
has VBZ O O
epistaxis VBN O B-r
epistaxis RB O B-r
at IN B-VP O
night NN B-NP O
for IN B-VP O
four CD O O
to TO O O
five CD O O
days NNS B-NP O
She PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
humidified JJ B-NP O
room NN I-NP O
air NN I-NP O
given VBN O O
nasal JJ B-NP B-m
saline NN I-NP I-m
sprays NNS I-NP B-mo
and CC O O
Afrin NNP B-NP B-m
Because IN B-VP O
of IN B-VP O
her PRP$ O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
transfused JJ B-NP O
total NN I-NP O
of IN B-VP O
3 CD O O
units NNS B-NP O
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
her PRP$ O O
hospital NN B-NP O
stay NN I-NP O
to TO O O
keep VB O O
her PRP$ O O
hematocrit NN B-NP O
greater JJR O O
than IN B-VP O
30 CD O O
She PRP O O
was VBD B-VP O
given VBN O O
Lasix NNP B-NP B-m
after IN B-VP O
her PRP$ O O
transfusions NNS B-NP O
An DT B-NP O
ENT NNP I-NP O
evaluation NN I-NP O
showed VBD B-VP O
a DT B-NP O
small JJ I-NP O
area NN I-NP O
of IN B-VP O
ulceration NN B-NP O
in IN B-VP O
her PRP$ O O
posterior JJ B-NP O
nasopharynx NN I-NP O
, , O O
which WDT O O
will MD O O
need VB O O
a DT O O
follow VB O O
up RP O O
possibly RB O O
with IN B-VP O
a DT B-NP O
CT NNP I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
to TO O O
rule VB O O
out RP O O
malignancy NN B-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
her PRP$ O O
discharge NN B-NP O
, , O O
her PRP$ O O
hematocrit NN B-NP O
was VBD B-VP O
36 CD O O
Initially NNP B-NP O
, , O O
Coumadin NNP B-NP B-m
was VBD B-VP O
started VBN O O
given VBN O O
her PRP$ O O
new JJ B-NP O
onset NN I-NP O
of IN B-VP O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
After IN B-VP O
consideration NN B-NP O
of IN B-VP O
risks NNS B-NP O
versus JJ B-NP O
benefit NN I-NP O
of IN B-VP O
anticoagulation NN B-NP O
, , O O
her PRP$ O O
transient JJ B-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
which WDT O O
resolved VBD B-VP O
spontaneously RB O O
, , O O
it PRP O O
was VBD B-VP O
decided VBN O O
to TO O O
continue VB O O
any DT B-NP O
further JJ I-NP O
anticoagulation NN I-NP O
and CC O O
send VB O O
her PRP O O
out RP O O
just RB O O
on IN B-VP O
aspirin JJ O B-m
She PRP O O
did VBD B-VP O
receive VB O O
subcutaneous JJ B-NP B-mo
heparin NN I-NP B-m
for IN B-VP O
DVT NNP B-NP B-r
prophylaxis NN I-NP I-r
while IN B-VP B-du
in-house JJ B-NP I-du
GI: NNP I-NP O
The DT B-NP O
patient NN I-NP O
initially RB O O
had VBD B-VP O
some DT B-NP O
constipation NN I-NP B-r
, , O O
which WDT O O
was VBD B-VP O
relieved VBN O O
with IN B-VP O
stool NN B-NP B-m
softeners NNS I-NP I-m
The DT B-NP O
patient's NN I-NP O
stool NN I-NP O
was VBD B-VP O
guaiac JJ O O
negative JJ O O
The DT B-NP O
patient NN I-NP O
received VBD B-VP O
the DT B-NP O
PPI NNP I-NP B-m
DISPOSITION: NNP I-NP O
The DT B-NP O
daughter NN I-NP O
who WP O O
is VBZ O O
the DT B-NP O
patient's NN I-NP O
healthcare NN I-NP O
proxy NN I-NP O
was VBD B-VP O
made VBN O O
aware NN B-NP O
of IN B-VP O
the DT B-NP O
patient's NN I-NP O
status NN I-NP O
and CC O O
disposition NN B-NP O
throughout IN B-VP O
her PRP$ O O
hospital JJ B-NP O
course NN I-NP O
A DT B-NP O
PT NNP I-NP O
evaluation NN I-NP O
indicated VBD B-VP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
benefit VB O O
from IN B-VP O
a DT B-NP O
period NN I-NP O
of IN B-VP O
re-stay NN B-NP O
at IN B-VP O
rehab NN B-NP O
, , O O
however RB O O
the DT B-NP O
patient JJ I-NP O
family NN I-NP O
preferred VBD B-VP O
the DT B-NP O
patient NN I-NP O
to TO O O
go VB O O
home NN B-NP O
and CC O O
was VBD B-VP O
constant JJ O O
that IN B-VP O
they PRP O O
would MD O O
be VB O O
able JJ O O
to TO O O
provide VB O O
24/7 CD O O
support NN B-NP O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
week NN I-NP O
as IN B-VP O
the DT B-NP O
patient NN I-NP O
will MD O O
need VB O O
help NN B-NP O
in IN B-VP O
navigating VBG O O
her PRP$ O O
home NN B-NP O
which WDT O O
included VBD B-VP O
two CD O O
flights NNS B-NP O
of IN B-VP O
stairs NNS B-NP O
PT NNP I-NP O
was VBD B-VP O
comfortable JJ O O
with IN B-VP O
this DT O O
and CC O O
this DT O O
was VBD B-VP O
explained VBN O O
thoroughly RB O O
to TO O O
the DT B-NP O
patient NN I-NP O
and CC O O
her PRP$ O O
family NN B-NP O
with IN B-VP O
regard NN B-NP O
to TO O O
the DT B-NP O
risks NNS I-NP O
versus VBP O O
benefit NN B-NP O
of IN B-VP O
going VBG O O
home NN B-NP O
versus NN I-NP O
going VBG O O
to TO O O
rehab VB O O
The DT B-NP O
patient NN I-NP O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Heingartner NNP I-NP O
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
, , O O
which WDT O O
has VBZ O O
not RB O O
been VBN O O
scheduled VBN O O
, , O O
and CC O O
with IN B-VP O
Dr NNP B-NP O
Tsunoda NNP I-NP O
with IN B-VP O
Nephrology NNP B-NP O
which WDT O O
has VBZ O O
been VBN O O
scheduled VBN O O
for IN B-VP O
10/24/04 CD O O
Communication NN B-NP O
was VBD B-VP O
made VBN O O
with IN B-VP O
Dr NNP B-NP O
Smyth NNP I-NP O
regarding VBG O O
her PRP$ O O
admission NN B-NP O
here RB O O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
sent VBN O O
home NN B-NP O
with IN B-VP O
VNA NNP B-NP O
support NN I-NP O
to TO O O
follow VB O O
up RP O O
on IN B-VP O
her PRP$ O O
weights NNS B-NP O
and CC O O
fluid NN B-NP O
status NN I-NP O
, , O O
she PRP O O
will MD O O
also RB O O
have VB O O
home NN B-NP O
physical JJ B-NP O
therapy NN I-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
MEDICATIONS: NNP I-NP O
1 CD O O
Lasix NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
2 CD O O
Lipitor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
3 CD O O
Metoprolol NNP B-NP B-m
sustained VBD B-VP I-m
release NN B-NP I-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
4 CD O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
p.r.n NN I-NP I-f
for IN B-VP O
constipation NN B-NP B-r
5 CD O O
Allopurinol NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.72h VBD B-VP B-f
4 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d VBD B-VP B-f
5 CD O O
Valsartan NNP B-NP B-m
160 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.d NN I-NP B-f
PRIMARY NNP I-NP O
CARE NNP I-NP O
PHYSICIAN: NNP I-NP O
Buck NNP I-NP O
Kuerbitz NNP I-NP O
, , O O
M.D NNP B-NP O
eScription NN I-NP O
document: VBD B-VP O
3-6433525 JJ B-NP O
BFFocus NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
ZURHEIDE NNP I-NP O
, , O O
EARL NNP B-NP O
Attending: NNP I-NP O
PROPER NNP I-NP O
, , O O
ANDREW NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
8504921 CD O O
D: NNP B-NP O
0/20/04 CD O O
T: NNP B-NP O
1/26/04 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#744366 VBZ O O
411326611 CD O O
CH NNP B-NP O
65470446 CD O O
403034 CD O O
2/29/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/17/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/16/1995 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
50 CD O O
year NN B-NP O
old JJ B-NP O
man NN I-NP O
with IN B-VP O
unstable JJ B-NP O
angina NNS I-NP O
who WP O O
was VBD B-VP O
referred VBN O O
to TO O O
the DT B-NP O
Rhalca NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
and CC O O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting VBG O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
four-year JJ I-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
left-sided JJ B-NP O
chest NN I-NP O
pain NN I-NP O
four CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
He PRP O O
describes VBZ O O
episodes NNS B-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
occurring VBG O O
approximately RB O O
q JJ O O
two CD O O
months NNS B-NP O
as RB O O
well RB O O
as IN B-VP O
evidence NN B-NP O
of IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
although IN B-VP O
he PRP O O
has VBZ O O
a DT B-NP O
noted JJ I-NP O
picture NN I-NP O
of IN B-VP O
chronic JJ B-NP O
obstructive JJ I-NP O
pulmonary JJ I-NP O
disease NN I-NP O
ETT NNP I-NP O
in IN B-VP O
1989 CD O O
was VBD B-VP O
negative JJ O O
and CC O O
he PRP O O
recently RB O O
described VBD B-VP O
progressively RB O O
poor JJ B-NP O
exercise NN I-NP O
tolerance NN I-NP O
to TO O O
the DT B-NP O
point NN I-NP O
that IN B-VP O
he PRP O O
was VBD B-VP O
taking VBG O O
sublingual JJ B-NP B-mo
NTG NNP I-NP B-m
on IN B-VP O
a DT B-NP O
twice JJ I-NP B-f
daily JJ I-NP I-f
basis NN I-NP O
for IN B-VP O
exertional JJ B-NP B-r
angina NN I-NP I-r
One CD O O
week NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
he PRP O O
developed VBD B-VP O
severe JJ B-NP O
substernal JJ I-NP O
chest NN I-NP O
discomfort NN I-NP O
at IN B-VP O
rest NN B-NP O
, , O O
lasting VBG O O
approximately RB O O
10 CD O O
minutes NNS B-NP O
Then RB O O
, , O O
after IN B-VP O
taking VBG O O
a DT B-NP O
sublingual JJ I-NP B-mo
NTG NNP I-NP B-m
, , O O
he PRP O O
reported VBD B-VP O
loss NN B-NP O
of IN B-VP O
consciousness NN B-NP O
for IN B-VP O
a DT B-NP O
duration NN I-NP O
of IN B-VP O
20 CD O O
to TO O O
30 CD O O
seconds NNS B-NP O
at IN B-VP O
which WDT O O
point NN B-NP O
he PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Spena NNP I-NP O
Hospital NNP I-NP O
by IN B-VP O
an DT B-NP O
EMT NNP I-NP O
At IN B-VP O
the DT B-NP O
clinic NN I-NP O
he PRP O O
received VBD B-VP O
intravenous JJ B-NP B-mo
NTG NNP I-NP B-m
, , O O
heparin NN B-NP B-m
and CC O O
Diltiazem NNP B-NP B-m
An DT B-NP O
ETT NNP I-NP O
Thallium NNP I-NP O
demonstrated VBD B-VP O
reperfusion NN B-NP O
abnormalities NNS I-NP O
in IN B-VP O
the DT O O
inferior JJ O O
and CC O O
anterior JJ B-NP O
walls NNS I-NP O
He PRP O O
left VBD B-VP O
the DT B-NP O
Ca NNP I-NP O
Awythe NNP I-NP O
Stosit NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
AMA NNP I-NP O
to TO O O
see VB O O
his PRP$ O O
cardiologist NN B-NP O
on IN B-VP O
the DT B-NP O
11th NNS I-NP O
who WP O O
referred VBD B-VP O
him PRP O O
to TO O O
the DT B-NP O
Troydale NNP I-NP O
Health NNP I-NP O
for IN B-VP O
elective JJ B-NP O
catheterization NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
presentation NN B-NP O
he PRP O O
denied VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
or CC O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
Cardiac NNP I-NP O
risk NN I-NP O
factors NNS I-NP O
are VBP O O
notably RB O O
an DT B-NP O
80-pack JJ I-NP O
year NN I-NP O
smoking NN I-NP O
history NN I-NP O
, , O O
family NN B-NP O
history NN I-NP O
of IN B-VP O
heart NN B-NP O
disease NN I-NP O
, , O O
hypercholesterolemia NN B-NP O
and CC O O
non JJ B-NP O
insulin-dependent JJ I-NP O
diabetes NNS I-NP O
mellitus VBP O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Notable NNP I-NP O
for IN B-VP O
history NN B-NP O
of IN B-VP O
interstitial JJ B-NP O
lung NN I-NP O
disease NN I-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
GE NNP B-NP O
reflux NN I-NP O
, , O O
chronic JJ B-NP O
bronchitis NN I-NP O
and CC O O
obstructive JJ B-NP O
sleep NN I-NP O
apnea NN I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMIT: NNP I-NP O
Cardizem NNP I-NP B-m
120mg CD O B-do
p.o.b.i.d NN B-NP B-mo
, , O O
Mevacor NNP B-NP B-m
20mg CD O B-do
p.o.b.i.d NN B-NP B-mo
, , O O
Pepcid NNP B-NP B-m
40mg CD O B-do
p.o.q.d NN B-NP B-mo
, , O O
Ventolin NNP B-NP B-m
and CC O O
Seldane NNP B-NP B-m
taken VBN O O
on IN B-VP O
a DT B-NP O
prn NN I-NP B-f
prn JJ B-NP B-f
basis NN I-NP O
ALLERGIES: NNP I-NP O
NKDA NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Six NNP I-NP O
centimeters NNS I-NP O
of IN B-VP O
JVD NNP B-NP O
, , O O
normal JJ B-NP O
cardiac JJ I-NP O
examination NN I-NP O
with IN B-VP O
intact JJ B-NP O
distal JJ I-NP O
pulses NNS I-NP O
Diminished NNP I-NP O
breath NN I-NP O
sounds VBZ O O
bilaterally RB O O
LABORATORY NNP B-NP O
EVALUATION: NNP I-NP O
Unremarkable NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiology NNP I-NP O
Service NNP I-NP O
and CC O O
underwent JJ B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
demonstrating VBG O O
80% CD O O
distal JJ B-NP O
stenosis NN I-NP O
of IN B-VP O
the DT B-NP O
left NN I-NP O
main JJ O O
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
origin NN I-NP O
of IN B-VP O
the DT B-NP O
LAD NNP I-NP O
with IN B-VP O
additional JJ B-NP O
occlusion NN I-NP O
of IN B-VP O
the DT B-NP O
midportion NN I-NP O
of IN B-VP O
the DT B-NP O
LAD NNP I-NP O
and CC O O
distal JJ B-NP O
carotid NN I-NP O
, , O O
80% CD O O
stenosis NN B-NP O
of IN B-VP O
midportion NN B-NP O
of IN B-VP O
left JJ B-NP O
circumflex NN I-NP O
and CC O O
proximal JJ B-NP O
occlusion NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
coronary NN I-NP O
Previous NNP I-NP O
pulmonary JJ B-NP O
function NN I-NP O
tests NNS I-NP O
performed VBD B-VP O
in IN B-VP O
March NNP B-NP O
included VBD B-VP O
an DT B-NP O
FEV-1 NNP I-NP O
of IN B-VP O
2.53 CD O O
, , O O
FEV-1/FVC NNP B-NP O
of IN B-VP O
83 CD O O
, , O O
FVC NNP B-NP O
3.05 CD O O
He PRP O O
was VBD B-VP O
seen VBN O O
preoperatively RB O O
by IN B-VP O
the DT B-NP O
Dental NNP I-NP O
Service NNP I-NP O
He PRP O O
was VBD B-VP O
felt VBN O O
to TO O O
have VB O O
a DT B-NP B-r
possible JJ I-NP I-r
periodontal JJ I-NP I-r
abscess NN I-NP I-r
of IN B-VP O
tooth JJ B-NP O
#32 NNP I-NP O
for IN B-VP O
which WDT O O
a DT B-NP B-du
course NN I-NP I-du
of IN B-VP O
p.o JJ B-NP B-mo
penicillin NN I-NP B-m
was VBD B-VP O
recommended VBN O O
and CC O O
completed VBN O O
On IN B-VP O
the DT O O
26 CD O O
of IN B-VP O
May NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
received VBD B-VP O
double JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
including VBG O O
pedicle NN B-NP O
LIMA NNP I-NP O
bypass NN I-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
and CC O O
LAD NNP B-NP O
patch VBP O O
angioplasty NN B-NP O
with IN B-VP O
a DT B-NP O
single JJ I-NP O
aortocoronary JJ I-NP O
saphenous JJ I-NP O
vein NN I-NP O
bypass NN I-NP O
graft NN I-NP O
to TO O O
the DT B-NP O
obtuse NN I-NP O
marginal NN I-NP O
He PRP O O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
He PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
routine JJ B-NP O
fashion NN I-NP O
without IN B-VP O
complications NNS B-NP O
He PRP O O
was VBD B-VP O
stable JJ O O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
He PRP O O
had VBD B-VP O
a DT O O
somewhat RB O O
higher JJR O O
than IN B-VP O
normal JJ B-NP O
O2 NNP I-NP O
requirement NN I-NP O
which WDT O O
diminished VBD B-VP O
with IN B-VP O
diuresis NN B-NP O
His PRP$ O O
hospital NN B-NP O
course NN I-NP O
proceeded VBD B-VP O
without IN B-VP O
complications NNS B-NP O
although IN B-VP O
he PRP O O
did VBD B-VP O
demonstrate VB O O
a DT B-NP B-r
low-grade JJ I-NP I-r
fever NN I-NP I-r
and CC O O
leukocytosis NN B-NP B-r
up RB O O
to TO O O
20 CD O O
, , O O
000 CD O O
for IN B-VP O
which WDT O O
he PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
an DT B-NP O
empiric JJ I-NP O
course NN I-NP O
of IN B-VP O
cefuroxime NN B-NP B-m
cefuroxime NN I-NP B-m
for IN B-VP O
radiographic JJ B-NP O
infiltrate NN I-NP O
although IN B-VP O
his PRP$ O O
sputum NN B-NP O
cultures NNS I-NP O
were VBD B-VP O
not RB O O
definitive JJ O O
He PRP O O
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP O
ID NNP I-NP O
Service NNP I-NP O
and CC O O
cultured VBD B-VP O
appropriately RB O O
with IN B-VP O
continuation NN B-NP O
of IN B-VP O
empiric JJ B-NP B-m
antibiotics NNS I-NP I-m
He PRP O O
continued VBD B-VP O
to TO O O
demonstate VB O O
low-grade JJ B-NP O
fevers NNS I-NP O
during IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
his PRP$ O O
hospital NN B-NP O
stay NN I-NP O
with IN B-VP O
persistent JJ B-NP O
leukocytosis NN I-NP O
in IN B-VP O
the DT B-NP O
range NN I-NP O
of IN B-VP O
14 CD O O
to TO O O
16K CD O O
prior RB O O
to TO O O
discharge VB O O
No NNP B-NP O
definite NNP I-NP O
source NN I-NP O
of IN B-VP O
infection NN B-NP O
was VBD B-VP O
identified VBN O O
All DT O O
of IN B-VP O
his PRP$ O O
wound NN B-NP O
sites VBZ O O
looked JJ O O
clean JJ O O
and CC O O
cultures NNS B-NP O
remained VBD B-VP O
negative JJ O O
He PRP O O
was VBD B-VP O
weaned VBN O O
off RP O O
oxygen NN B-NP B-m
for IN B-VP B-du
some DT B-NP I-du
time NN I-NP I-du
He PRP O O
had VBD B-VP O
no DT B-NP O
productive JJ I-NP O
cough NN I-NP O
On IN B-VP O
the DT O O
24 CD O O
of IN B-VP O
September NNP B-NP O
we PRP O O
discharged VBD B-VP O
him PRP O O
to TO O O
home NN B-NP O
AMA NNP I-NP O
, , O O
although IN B-VP O
encouraged VBN O O
a DT B-NP O
stay NN I-NP O
for IN B-VP O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
his PRP$ O O
fever NN B-NP O
and CC O O
leukocytosis NN B-NP O
DISPOSITION: NNP I-NP O
Aspirin NNP I-NP B-m
325mg CD O B-do
q.d NN B-NP B-f
, , O O
Diltiazem NNP B-NP B-m
120mg CD O B-do
p.o.t.i.d NN B-NP B-mo
, , O O
Colace NNP B-NP B-m
100mg CD O B-do
t.i.d NN B-NP B-f
, , O O
iron NN B-NP B-m
sulfate NN I-NP I-m
300mg CD O B-do
t.i.d NN B-NP B-f
, , O O
Lasix NNP B-NP B-m
80mg CD O B-do
p.o.b.i.d NN B-NP B-mo
, , O O
Mevacor NNP B-NP B-m
20mg CD O B-do
p.o.b.i.d NN B-NP B-mo
, , O O
MVI NNP B-NP B-m
one CD O B-do
p.o.q.d NN B-NP B-mo
, , O O
Percocet NNP B-NP B-m
one CD O B-do
to TO O I-do
two CD O I-do
tabs NNS B-NP I-do
q VBP O B-f
4 CD O I-f
prn NN B-NP I-f
, , O O
KCl NNP B-NP B-m
40mil/eq CD O B-do
p.o.b.i.d NN B-NP B-mo
and CC O O
ciprofloxacin NN B-NP B-m
500mg CD O B-do
p.o.b.i.d NN B-NP B-mo
X NNP I-NP B-du
X NNP I-NP B-du
10 CD O I-du
10 CD O I-du
days NNS B-NP I-du
days NNS I-NP I-du
taken VBN O O
with IN B-VP O
clindamycin JJ O B-m
300mg CD O B-do
p.o.q.i.d NN B-NP B-mo
He PRP O O
was VBD B-VP O
encouraged VBN O O
to TO O O
see VB O O
his PRP$ O O
cardiologist NN B-NP O
for IN B-VP O
follow-up NN B-NP O
over IN B-VP O
the DT B-NP O
following JJ I-NP O
week NN I-NP O
and CC O O
should MD O O
return VB O O
to TO O O
Dr NNP B-NP O
Donnie NNP I-NP O
Daidone NNP I-NP O
office NN I-NP O
during IN B-VP O
this DT B-NP O
interval JJ I-NP O
prior NN I-NP O
to TO O O
completion NN B-NP O
of IN B-VP O
his PRP$ O O
antibiotics NNS B-NP B-m
Dictated VBD B-VP O
By: NNP B-NP O
HARLEY NNP I-NP O
C NNP I-NP O
ARNOLD NNP I-NP O
, , O O
M.D NNP B-NP O
WR30 NNP I-NP O
Attending: NNP I-NP O
ALEXIS NNP I-NP O
E NNP I-NP O
NEWBROUGH NNP I-NP O
, , O O
M.D NNP B-NP O
XS1 NNP I-NP O
LT739/3299 NNP I-NP O
Batch: NNP I-NP O
91766 CD O O
Index NNP B-NP O
No NNP I-NP O
KFACZB580S NNP I-NP O
D: NNP I-NP O
6/19/95 CD O O
T: NNP B-NP O
6/19/95 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#752897 VBZ O O
141305871 CD O O
PH NNP B-NP O
32338118 CD O O
008024 CD O O
8/20/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
5/30/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/17/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
PRUNIER NNP I-NP O
, , O O
VANCE NNP B-NP O
799-40-56-9 CD O O
Ring NNP B-NP O
Hwy NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
1/26/01 CD O O
AT NNP B-NP O
11:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
EC NNP I-NP B-m
ASA NNP I-NP I-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
ATENOLOL NNP I-NP B-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
CIPRO NNP I-NP B-m
( ( O I-m
CIPROFLOXACIN NNP B-NP I-m
) ) O I-m
250 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
3 CD O O
INSULIN NNP B-NP B-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
30 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
INSULIN NNP I-NP B-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
20 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
before IN B-VP B-f
dinner NN B-NP I-f
INSULIN NNP I-NP B-m
REGULAR NNP I-NP I-m
( ( O I-m
HUMAN NNP B-NP I-m
) ) O I-m
18 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
INSULIN NNP I-NP B-m
REGULAR NNP I-NP I-m
( ( O I-m
HUMAN NNP B-NP I-m
) ) O I-m
14 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
before IN B-VP B-f
dinner NN B-NP I-f
LEVOXYL NNP I-NP B-m
( ( O I-m
LEVOTHYROXINE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
75 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5 NNP I-NP O
MIN NNP I-NP O
X NNP I-NP B-du
3 CD O I-du
PRN NNP B-NP O
Chest NNP I-NP B-r
Pain NNP I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;[ NNP I-NP O
] NNP I-NP O
PRAVACHOL NNP I-NP B-m
( ( O I-m
PRAVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
AMLODIPINE NNP B-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
IMDUR NNP B-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONIT.( NNP I-NP I-m
SR NNP I-NP I-m
) ) O I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
WELLBUTRIN NNP B-NP B-m
SR NNP I-NP I-m
( ( O I-m
BUPROPION NNP B-NP I-m
HCL NNP I-NP I-m
SR NNP I-NP I-m
) ) O I-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
2 CD O I-du
CLOPIDOGREL NNP B-NP B-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
Activity NNP I-NP O
- : O O
RETURN NN B-NP O
TO NNP I-NP O
WORK: NNP I-NP O
After IN B-VP O
Appt NNP B-NP O
with IN B-VP O
local JJ B-NP O
physician NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Minear NNP I-NP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
Dr NNP B-NP O
Givens NNP I-NP O
call NN I-NP O
, , O O
ALLERGY: NNP B-NP O
Penicillins NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
cad NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
DEPRESSION NNP I-NP O
CABG( NNP I-NP O
SVG-&gt;LAD NNP I-NP O
) ) O O
1973 CD O O
H/O NNP B-NP O
menorrhagia NN I-NP O
MI NNP I-NP O
1986 CD O O
cabg NN B-NP O
3v CD O O
w/rad JJ O O
art-rca JJ O O
1/5 CD O O
type NN B-NP O
I PRP O O
DM NNP B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
57 CD O O
y.o NN B-NP O
lady NN I-NP O
with IN B-VP O
DM NNP B-NP O
, , O O
HT NNP B-NP O
, , O O
hyperlipidemia NN B-NP O
and CC O O
known VBN O O
CAD NNP B-NP O
S/P NNP I-NP O
CABG NNP I-NP O
25 CD O O
year NN B-NP O
ago RB O O
and CC O O
multiple JJ B-NP O
PCIs NNP I-NP O
presented VBD B-VP O
with IN B-VP O
recent JJ B-NP O
worsening NN I-NP O
of IN B-VP O
exercise NN B-NP O
capacity NN I-NP O
Cath NNP I-NP O
today NN I-NP O
showed VBD B-VP O
severe JJ B-NP O
native JJ I-NP O
TVD NNP I-NP O
, , O O
patent NN B-NP O
LIMA NNP I-NP O
to TO O O
LAD NNP B-NP O
, , O O
occluded VBD B-VP O
SVG-OM NNP B-NP O
and CC O O
radial JJ B-NP O
graft NN I-NP O
to TO O O
PDA VB O O
80% CD O O
stenosis NN B-NP O
PCI NNP I-NP O
of IN B-VP O
radial JJ B-NP O
graft NN I-NP O
lesion NN I-NP O
with IN B-VP O
Nir NNP B-NP O
2.5x15mm CD O O
and CC O O
S660 NNP B-NP O
2.5x12mm CD O O
stents NNS B-NP O
resulting VBG O O
in IN B-VP O
0% CD O O
residual JJ B-NP O
Plan NN I-NP O
for IN B-VP B-du
16 CD O O
hours NNS B-NP O
Integrilin NNP I-NP B-m
and CC O O
30 CD O B-du
days NNS B-NP I-du
Plavix NNP I-NP B-m
Angioseal NNP I-NP O
applied VBD B-VP O
to TO O O
RFA NNP B-NP O
Uncomplicated NNP I-NP O
postop JJ B-NP O
course NN I-NP O
and CC O O
home NN B-NP O
on IN B-VP O
9/9/01 CD O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
call NN I-NP O
for IN B-VP O
any DT B-NP O
further JJ I-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
groin NN B-NP O
pain NN I-NP O
, , O O
swelling VBG O O
or CC O O
bleeding VBG O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
HAROLDSEN NNP I-NP O
, , O O
DANE NNP B-NP O
FLOYD NNP I-NP O
( ( O O
ZN50 NNP B-NP O
) ) O O
1/26/01 CD O O
@ $ O O
10:18 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#758638 VBZ O O
195121411 CD O O
EMC NNP B-NP O
83762037 CD O O
0098987 CD O O
10/6/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
1 CD O O
) ) O O
Angina NNP B-NP O
, , O O
R/o NNP B-NP O
MI NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/6/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/22/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
CONTINENZA NNP I-NP O
, , O O
WHITNEY NNP B-NP O
A NNP I-NP O
042-45-92-1 JJ B-NP O
Rock NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
2/16/05 CD O O
AT NNP B-NP O
01:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
BIRKEY NNP I-NP O
, , O O
MERLIN NNP B-NP O
KEVEN NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
8/7 CD O O
) ) O O
FERROUS NNP B-NP B-m
SULFATE NNP I-NP I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
milk NN I-NP O
and CC O O
antacid JJ B-NP O
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
60 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HYDRALAZINE NNP I-NP B-m
HCL NNP I-NP I-m
90 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
0/12 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt;95 NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
LABETALOL NNP I-NP B-m
HCL NNP I-NP I-m
600 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;90 NN I-NP O
, , O O
hr&lt;50 JJ B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O O
3 CD O O
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
CLARITIN NNP B-NP B-m
( ( O I-m
LORATADINE NNP B-NP I-m
) ) O I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Give VBP O O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
COZAAR NNP B-NP B-m
( ( O I-m
LOSARTAN NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
95 CD O O
Number NNP B-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
3 CD O I-du
METFORMIN NNP B-NP B-m
850 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
VYTORIN NNP I-NP B-m
10/40 CD O I-m
( ( O I-m
EZETIMIBE NNP B-NP I-m
10 CD O I-m
MG NNP B-NP I-m
- : O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
DIET: NNP I-NP O
Patient NNP I-NP O
should MD O O
measure VB O O
weight JJ B-NP O
daily JJ I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
1800 CD O O
cals/dy NN B-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Rob NNP I-NP O
Mulroy NNP I-NP O
1 CD O O
wk NN B-NP O
, , O O
ALLERGY: NNP B-NP O
Latex NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
)Atypical JJ B-NP O
Chest NNP I-NP O
Pain NNP I-NP O
2 CD O O
) ) O O
HTN NNP B-NP O
3 CD O O
) ) O O
NIDDM NNP B-NP O
4 CD O O
) ) O O
Hypercholesterolemia NNP B-NP O
5 CD O O
) ) O O
h/o NN B-NP O
Renal NNP I-NP O
Cell NNP I-NP O
Carcinoma NNP I-NP O
s/p VBZ O O
resection NN B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
1 CD O O
) ) O O
Angina NNP B-NP O
, , O O
R/o NNP B-NP O
MI NNP I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HYPERTENSION NNP I-NP O
S/P NNP I-NP O
MVA NNP I-NP O
-&gt; NNP I-NP O
RLE NNP I-NP O
FRX NNP I-NP O
( ( O O
1977 CD O O
) ) O O
S/P NNP B-NP O
RLE NNP I-NP O
SKIN NNP I-NP O
GRAFT NNP I-NP O
( ( O O
1977 CD O O
) ) O O
MEDICAL NNP B-NP O
NON-COMPLIANCE NNP I-NP O
OBESITY NNP I-NP O
? . B-VP O
HYPERCHOLESTEROLEMIA NNP B-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Adenosine NNP B-NP B-m
MIBI: NNP I-NP O
( ( O O
Preliminary NNP B-NP O
report NN I-NP O
) ) O O
Poor NNP B-NP O
quality NN I-NP O
study NN I-NP O
due JJ O O
to TO O O
body NN B-NP O
habitus VB O O
LVEF NNP B-NP O
44% CD O O
LV NNP B-NP O
dilated VBD B-VP O
No DT B-NP O
perfusion NN I-NP O
defects VBZ O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC:chest NNP I-NP O
pain NN I-NP O
HPI: NNP I-NP O
43 CD O O
yo NN B-NP O
M NNP I-NP O
w/hx NN I-NP O
of IN B-VP O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
p/w VBZ O O
atypical JJ B-NP O
CP NNP I-NP O
, , O O
concerning VBG O O
for IN B-VP O
unstable JJ B-NP O
angina NN I-NP O
P/w NNP I-NP O
1 CD O O
day NN B-NP O
h/o VBD B-VP O
L NNP B-NP O
sided VBD B-VP O
dull JJ B-NP O
CP NNP I-NP O
radiating NN I-NP O
to TO O O
his PRP$ O O
L NNP B-NP O
arm NN I-NP O
, , O O
started VBD B-VP O
6/17 CD O O
Started NNP B-NP O
at IN B-VP O
rest NN B-NP O
, , O O
remained VBD B-VP O
for IN B-VP O
4 CD O O
hrs JJ B-NP O
+Diaphoresis NN I-NP O
, , O O
+nausea NN B-NP O
, , O O
mild JJ B-NP O
SOB NNP I-NP O
Cardiac NNP I-NP O
RF NNP I-NP O
include VBP O O
DM NNP B-NP O
, , O O
HTN NNP B-NP O
, , O O
Hyperchol NNP B-NP O
, , O O
FH NNP B-NP O
, , O O
h/o NN B-NP O
smoking NN I-NP O
TnI NNP I-NP O
at IN B-VP O
ASH NNP B-NP O
neg SYM O O
- : O O
0.04 CD O O
and CC O O
0.05 CD O O
but CC O O
continued VBD B-VP B-r
pain NN B-NP I-r
requiring VBG O O
NTG NNP B-NP B-m
drip NN I-NP B-mo
EKG NNP I-NP O
with IN B-VP O
TWI NNP B-NP O
concerning VBG O O
for IN B-VP O
anterolateral JJ B-NP O
ischemia NN I-NP O
Initiated VBN O O
on IN B-VP O
Heparin NNP B-NP B-m
, , O O
transferred VBD B-VP O
to TO O O
M NNP B-NP O
for IN B-VP O
management NN B-NP O
, , O O
possible JJ B-NP O
cath NN I-NP O
---------------------------------- NNP I-NP O
PMH: NNP I-NP O
CHF NNP I-NP O
( ( O O
dxed JJ O O
1997 CD O O
while IN B-VP O
actively RB O O
using VBG O O
cocaine NN B-NP O
) ) O O
, , O O
HTN NNP B-NP O
, , O O
Hypercholesterolemia NNP B-NP O
, , O O
Renal NNP B-NP O
Cell NNP I-NP O
Carcinoma NNP I-NP O
s/p VBZ O O
resection NN B-NP O
------------ NNP I-NP O
Status: NNP I-NP O
( ( O O
at IN B-VP O
admission NN B-NP O
) ) O O
T100.5 NNP B-NP O
P NNP I-NP O
82 CD O O
R NNP B-NP O
18 CD O O
BP NNP B-NP O
148/70 CD O O
Pox NNP B-NP O
99% CD O O
2L CD O O
Gen: NNP B-NP O
Pleaseant NNP I-NP O
obese JJ B-NP O
M NNP I-NP O
, , O O
NAD NNP B-NP O
CV: NNP I-NP O
RRR NNP I-NP O
, , O O
I/VI NNP B-NP O
SEM NNP I-NP O
LSB NNP I-NP O
, , O O
+S3 NNP B-NP O
Resp: NNP I-NP O
CTAB NNP I-NP O
, , O O
Ab: NNP B-NP O
soft JJ O O
, , O O
NT NNP B-NP O
, , O O
mild NN B-NP O
distended VBD B-VP O
Ext: NNP B-NP O
trace NN I-NP O
edema RB O O
bilateral JJ B-NP O
Guaic NNP I-NP O
, , O O
no DT B-NP O
stool NN I-NP O
in IN B-VP O
vault NN B-NP O
--- NNP I-NP O
Procedures/Tests: NNP I-NP O
Labs: NNP I-NP O
Trop NNP I-NP O
OSH NNP I-NP O
0.04 CD O O
, , O O
0.05 CD O O
, , O O
K2.9 NNP B-NP O
, , O O
Hct NNP B-NP O
35.5 CD O O
, , O O
creat NN B-NP O
2.0 CD O O
EKG: NNP B-NP O
NSR NNP I-NP O
, , O O
LVH NNP B-NP O
with IN B-VP O
repolarization NN B-NP O
, , O O
TWI NNP B-NP O
II NNP I-NP O
, , O O
III NNP B-NP O
, , O O
F NNP B-NP O
V4-6 NNP I-NP O
CXR: NNP I-NP O
9/16: CD O O
Cardiomegaly NNP B-NP O
, , O O
mild JJ B-NP O
pul JJ I-NP O
vasculature NN I-NP O
engorgement NN I-NP O
No NNP I-NP O
acute NN I-NP O
pul NN I-NP O
infiltrate NN I-NP O
Adenosine NNP I-NP O
MIBI: NNP I-NP O
2/3 CD O O
Poor NNP B-NP O
quality NN I-NP O
study NN I-NP O
due JJ O O
to TO O O
body NN B-NP O
habitus VB O O
EF NNP B-NP O
44% CD O O
LV NNP B-NP O
dilated VBD B-VP O
No DT B-NP O
perfusion NN I-NP O
defects VBZ O O
--- NNP B-NP O
A/P: NNP I-NP O
43 CD O O
M NNP B-NP O
admitted VBN O O
with IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
Concern NNP I-NP O
for IN B-VP O
unstable JJ O O
angina/NSTEMI JJ O O
1 CD O O
CV NNP B-NP O
ISCHEMIA: NNP I-NP O
significant JJ B-NP O
cardiac JJ I-NP O
hx NN I-NP O
with IN B-VP O
borderline JJ B-NP O
TNI NNP I-NP O
at IN B-VP O
ASH NNP B-NP O
( ( O O
0.04-0.05 JJ O O
) ) O O
Admitted VBD B-VP O
to TO O O
WO NNP B-NP O
, , O O
started VBD B-VP O
on IN B-VP O
Heparin NNP B-NP B-m
, , O O
ASA NNP B-NP B-m
, , O O
BB NNP B-NP B-m
( ( O O
labetalol NN B-NP O
) ) O O
, , O O
statin UH O B-m
, , O O
ARB NNP B-NP B-m
( ( O I-m
ANGIOEDEMA NNP B-NP I-m
w/ACE NN I-NP I-m
) ) O I-m
, , O O
NTG NNP B-NP B-m
drip NN I-NP B-mo
, , O O
O2 NNP B-NP B-m
Remained VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
free JJ B-NP O
overnight NN I-NP O
On IN B-VP O
8/18 CD O O
, , O O
NTG NNP B-NP B-m
drip NN I-NP B-mo
tapered VBD B-VP O
, , O O
hydralazine NN B-NP B-m
and CC O O
labetalol NN B-NP B-m
increased VBD B-VP O
Pt NNP B-NP O
underwent JJ B-NP O
MIBI NNP I-NP O
, , O O
notable JJ O O
for IN B-VP O
LV NNP B-NP O
dilation NN I-NP O
, , O O
EF NNP B-NP O
44% CD O O
, , O O
no DT B-NP O
perfusion NN I-NP O
defects VBZ O O
Pt NNP B-NP O
remained VBD B-VP O
overnight JJ O O
to TO O O
ensure VB O O
adequate JJ B-NP O
BP NNP I-NP O
with IN B-VP O
new JJ B-NP O
medications NNS I-NP O
Will MD O O
likely RB O O
need VB O O
continued JJ B-NP O
titration NN I-NP O
of IN B-VP O
antihypertensives NNS B-NP B-m
PUMP: NNP I-NP O
CHF: NNP I-NP O
euvolemic; VBD B-VP O
LVEF NNP B-NP O
44% CD O O
via IN B-VP O
MIBI NNP B-NP O
BP NNP I-NP O
control NN I-NP O
as IN B-VP O
above IN B-VP O
RENAL: NNP B-NP O
CRI NNP I-NP O
at IN B-VP O
baseline JJ B-NP O
Cr NNP I-NP O
of IN B-VP O
2.0 CD O O
Renal NNP B-NP O
dose NN I-NP O
meds NNS I-NP O
2 CD O O
ENDO: NNP B-NP O
Metformin NNP I-NP B-m
held VBD B-VP O
, , O O
NPH NNP B-NP B-m
and CC O O
Novolog NNP B-NP B-m
SSI NNP I-NP I-m
initiated VBD B-VP O
for IN B-VP O
BS NNP B-NP B-r
control NN I-NP I-r
FS NNP I-NP O
AC NNP I-NP O
, , O O
excellent JJ B-NP O
BS NNP I-NP O
with IN B-VP O
range NN B-NP O
110-150 JJ O O
3 CD O O
ID: NNP B-NP O
low JJ B-NP O
grade NN I-NP O
temps NNS I-NP O
- : O O
UA NNP B-NP O
negative JJ O O
, , O O
CXR NNP B-NP O
negative JJ B-NP O
No NNP I-NP O
signs NNS I-NP O
of IN B-VP O
systemic JJ B-NP O
illness NN I-NP O
4 CD O O
GI: NNP B-NP O
h/o NN I-NP O
hematochezia NN I-NP O
, , O O
no DT B-NP O
stool NN I-NP O
on IN B-VP O
DRE NNP B-NP O
Guiac NNP I-NP O
stools VBZ O O
x RB O O
3 CD O O
as IN B-VP O
on IN B-VP O
Heparin NNP B-NP B-m
5 CD O O
FEN: NNP B-NP O
SLIV NNP I-NP O
Replete NNP I-NP O
electrolytes VBZ O O
aggressively RB O O
Cardiac NNP B-NP O
diet JJ O O
6 CD O O
Resp: NNP B-NP O
Stable NNP I-NP O
Supp NNP I-NP O
O2 NNP I-NP O
PRN NNP I-NP O
FULL NNP I-NP O
CODE NNP I-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Call NNP I-NP O
Dr NNP I-NP O
Racioppo NNP I-NP O
( ( O O
869 CD O O
) ) O O
959 CD O O
5481 CD O O
upon IN B-VP O
discharge NN B-NP O
to TO O O
schedule VB O O
an DT B-NP O
appt NN I-NP O
within IN B-VP O
1 CD O O
wk NN B-NP O
Bring NNP I-NP O
this DT B-NP O
document NN I-NP O
to TO O O
the DT B-NP O
appt NN I-NP O
Comply NNP I-NP O
with IN B-VP O
low JJ B-NP O
chol NNS I-NP O
, , O O
low JJ B-NP O
fat NN I-NP O
, , O O
&lt;2g NNP B-NP O
sodium NN I-NP O
diet JJ B-NP O
Weigh NNP I-NP O
yourself PRP O O
daily RB O O
, , O O
if IN B-VP O
you PRP O O
gain VBP O O
more JJR O O
than IN B-VP O
2 CD O O
lbs NNS B-NP O
in IN B-VP O
1 CD O O
day NN B-NP O
or CC O O
5 CD O O
lbs NNS B-NP O
in IN B-VP O
a DT B-NP O
week NN I-NP O
contact VB O O
your PRP$ O O
doctor NN B-NP O
as IN B-VP O
this DT O O
is VBZ O O
a DT B-NP O
symptom NN I-NP O
of IN B-VP O
CHF NNP B-NP O
Continue NNP I-NP O
your PRP$ O O
discharge NN B-NP O
medications NNS I-NP O
as IN B-VP O
advised VBN O O
Do NNP B-NP O
not RB O O
resume VB O O
the DT B-NP O
Norvasc NNP I-NP B-m
or CC O O
Enalapril NNP B-NP B-m
until IN B-VP O
instructed VBN O O
to TO O O
do VB O O
so RB O O
by IN B-VP O
Dr NNP B-NP O
Kozola NNP I-NP O
Seek NNP I-NP O
medical JJ B-NP O
attention NN I-NP O
for IN B-VP O
worsening VBG O O
chest JJS B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
marked VBN O O
weight JJ B-NP O
gain NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
1 CD O O
) ) O O
F/u NN B-NP O
with IN B-VP O
Dr NNP B-NP O
Pulfrey NNP I-NP O
within IN B-VP O
1 CD O O
wk NN B-NP O
for IN B-VP O
BP NNP B-NP O
check NN I-NP O
May NNP I-NP O
need VB O O
medication NN B-NP O
titration NN I-NP O
including VBG O O
reinstitution NN B-NP O
of IN B-VP O
Norvasc.Consider NNP B-NP B-m
further JJ B-NP O
w/u NN I-NP O
anemia NN I-NP O
( ( O O
IDA NNP B-NP O
+/- NNP I-NP O
AOCD NNP I-NP O
) ) O O
Pt NNP B-NP O
has VBZ O O
a DT B-NP O
h/o NN I-NP O
hematochezia NN I-NP O
, , O O
unclear JJ O O
when WRB O O
prior RB O O
colonoscopy VBP O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BERNT NNP I-NP O
, , O O
SHON NNP B-NP O
A NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
( ( O O
PA72 NNP B-NP O
) ) O O
2/16/05 CD O O
@ $ O O
11:38 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#762933 VBZ O O
665720079 CD O O
SHS NNP B-NP O
59097921 CD O O
965909 CD O O
6/0/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/25/1995 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/17/1995 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
LEFT NNP I-NP O
LOWER NNP I-NP O
EXTREMITY NNP I-NP O
WOUND NNP I-NP O
INFECTION NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT O O
54 CD O O
year NN B-NP O
old JJ B-NP O
gentleman NN I-NP O
who WP O O
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT O O
four CD O O
vessel NN B-NP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
on IN B-VP O
6/17/95 CD O O
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
The DT B-NP O
patient's NN I-NP O
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
respiratory JJ B-NP O
failure NN I-NP O
secondary JJ O O
to TO O O
presumed VB O O
phrenic JJ B-NP O
nerve NN I-NP O
injury NN I-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
developed VBD B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
undergone JJ B-NP O
embolectomy NN I-NP O
and CC O O
left VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
fasciotomy NN I-NP O
for IN B-VP O
left VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
ischemia NN I-NP O
on IN B-VP O
11/27/95 CD O O
The DT B-NP O
patient NN I-NP O
now RB O O
presents VBZ O O
to TO O O
Dr NNP B-NP O
Jaysura NNP I-NP O
with IN B-VP O
infected JJ O O
left VBD B-VP O
lower JJR B-NP O
leg NN I-NP O
pressure NN I-NP O
ulcer NN I-NP O
with IN B-VP O
open JJ O O
and CC O O
gangrenous JJ B-NP O
muscle NN I-NP O
exposed VBN O O
through IN B-VP O
this DT B-NP O
posterior NN I-NP O
wound IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
at IN B-VP O
the DT B-NP O
rehabilitation NN I-NP O
center NN I-NP O
prior RB O O
to TO O O
this DT B-NP O
transfer NN I-NP O
to TO O O
the DT B-NP O
Wickpro NNP I-NP O
Conch NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT O O
documented VBN O O
febrile NN B-NP O
episodes NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
insulin NN B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP O
fibrillation/flutter NN I-NP O
, , O O
right JJ B-NP O
sacroiliac NN I-NP O
joint NN I-NP O
decubitus NN I-NP O
ulcer NN I-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
As IN B-VP O
above IN B-VP O
Coronary NNP B-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
on IN B-VP O
0/13/95 CD O O
Left NNP B-NP O
lower JJR B-NP O
extremity NN I-NP O
fasciotomy NN I-NP O
on IN B-VP O
11/27/95 CD O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd VBD B-VP B-f
2 CD O O
Digoxin NNP B-NP B-m
0.325 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd VBD B-VP B-f
3 CD O O
Azmacort NNP B-NP B-m
6 CD O B-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
bid NN B-NP B-f
4 CD O O
Heparin NNP B-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
bid NN B-NP B-f
5 CD O O
Zantac NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
bid NN I-NP B-f
6 CD O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qd VBD B-VP B-f
7 CD O O
Capoten NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
q VBD B-VP B-f
8 CD O I-f
8 CD O O
Albuterol NNP B-NP B-m
nebulizers NNS I-NP I-m
0.5 CD O B-do
cc NN B-NP I-do
in IN B-VP O
2.5 CD O O
cc NN B-NP O
normal JJ B-NP B-m
saline NN I-NP I-m
qid NN I-NP B-f
qid VBD B-VP B-f
9 CD O O
NPH NNP B-NP B-m
insulin NN I-NP I-m
38 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
bid NN B-NP B-f
10 CD O O
Nystatin NNP B-NP B-m
swish JJ O O
and CC O O
swallow JJ O O
5 CD O B-do
cc NN B-NP I-do
po NN I-NP O
qid VBD B-VP B-f
11 CD O O
Bactrim NNP B-NP B-m
DS NNP I-NP I-m
one CD O B-do
tab NN B-NP I-do
po NN I-NP B-mo
bid VBD B-VP B-f
THE NNP B-NP O
PATIENT NNP I-NP O
HAS NNP I-NP O
NO NNP I-NP O
KNOWN NNP I-NP O
DRUG NNP I-NP O
ALLERGIES NNP I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
100 CD O O
pack/year JJ B-NP O
history NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
100 CD O O
Blood NNP B-NP O
pressure NN I-NP O
120/47 CD O O
, , O O
pulse RB O O
103 CD O O
, , O O
sinus JJ B-NP O
tachycardia NN I-NP O
In IN B-VP O
general JJ O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
trached VBN O O
and CC O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress VBZ O O
The DT B-NP O
patient's NN I-NP O
skin NN I-NP O
revealed VBD B-VP O
mottled JJ B-NP O
distal JJ I-NP O
extremities NNS I-NP O
HEENT: NNP I-NP O
normocephalic NN I-NP O
, , O O
atraumatic JJ B-NP O
head NN I-NP O
Trach NNP I-NP O
was VBD B-VP O
in IN B-VP O
place NN B-NP O
with IN B-VP O
a DT B-NP O
collar JJ I-NP O
Lungs: NNP I-NP O
bilateral JJ B-NP O
inspiratory NN I-NP O
wheezes NNS I-NP O
, , O O
scattered VBD B-VP O
throughout IN B-VP O
Heart: NNP B-NP O
regular JJ B-NP O
rhythm NN I-NP O
with IN B-VP O
sinus JJ B-NP O
tachycardia NN I-NP O
Distant NNP I-NP O
heart NN I-NP O
sounds VBZ O O
No DT B-NP O
S3 NNP I-NP O
or CC O O
S4 NNP B-NP O
were VBD B-VP O
noted VBN O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
obvious JJ I-NP O
murmurs NNS I-NP O
Abdomen: NNP I-NP O
positive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
obese JJ B-NP O
Abdomen NNP I-NP O
was VBD B-VP O
nontender JJR O O
, , O O
nondistended VBN O O
with IN B-VP O
no DT O O
palpable JJ O O
masses VBZ O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
multiple JJ B-NP O
ecchymoses NNS I-NP O
Neurologic: VBP O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
three CD O O
Cranial NNP B-NP O
nerves NNS I-NP O
II NNP I-NP O
through IN B-VP O
XII NNP B-NP O
grossly RB O O
intact JJ B-NP O
Extremities: NNP I-NP O
right NN I-NP O
buttock NN I-NP O
with IN B-VP O
approximately RB O O
a DT O O
10 CD O O
square JJ B-NP O
centimeter NN I-NP O
decubitus NN I-NP O
ulcer IN B-VP O
The DT B-NP O
patient's NN I-NP O
right RB O O
lower JJR B-NP O
extremity NN I-NP O
revealed VBD B-VP O
a DT B-NP O
previous JJ I-NP O
harvest NN I-NP O
scar NN I-NP O
with IN B-VP O
about IN B-VP O
a DT O O
2 CD O O
cm NN B-NP O
incision NN I-NP O
and CC O O
breakdown NN B-NP O
over IN B-VP O
the DT B-NP O
calf JJ I-NP O
area NN I-NP O
Distal NNP I-NP O
foot NN I-NP O
has VBZ O O
a DT O O
mottled VBN O O
appearance NN B-NP O
but CC O O
has VBZ O O
Dopplerable JJ B-NP O
posterior JJ I-NP O
tibial NN I-NP O
and CC O O
dorsalis NN B-NP O
pedis NN I-NP O
pulses VBZ O O
The DT B-NP O
toes NNS I-NP O
are VBP O O
cool JJ O O
and CC O O
insensate JJ B-NP O
Left NNP I-NP O
lower JJR B-NP O
extremity NN I-NP O
revealed VBD B-VP O
three CD O O
open JJ B-NP O
ulcers NNS I-NP O
with IN B-VP O
marked JJ B-NP O
gangrenous JJ I-NP O
muscle NN I-NP O
exposure NN I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
Dopplerable JJ I-NP O
posterior JJ I-NP O
tibial NN I-NP O
with IN B-VP O
cold JJ B-NP O
pulses NNS I-NP O
but CC O O
no DT B-NP O
Dopplerable NNP I-NP O
dorsalis NN I-NP O
pedis NN I-NP O
pulse IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
insensate JJ O O
distally RB O O
from IN B-VP O
the DT B-NP O
region NN I-NP O
of IN B-VP O
the DT B-NP O
wounds NNS I-NP O
down RP O O
to TO O O
the DT B-NP O
feet NNS I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
on IN B-VP O
7/25/95 CD O O
for IN B-VP O
a DT B-NP O
preoperative JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
a DT B-NP O
left NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
infected JJ B-NP O
pressure NN I-NP O
sore RBR O O
Intraoperatively RB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
necrosis NN B-NP O
of IN B-VP O
both DT B-NP O
heads NNS I-NP O
of IN B-VP O
the DT B-NP O
gastrocnemius JJ I-NP O
muscle NN I-NP O
including VBG O O
the DT B-NP O
soleus NN I-NP O
and CC O O
also RB O O
a DT B-NP O
portion NN I-NP O
of IN B-VP O
the DT B-NP O
lateral JJ I-NP O
compartment NN I-NP O
The DT B-NP O
muscle NN I-NP O
appeared VBD B-VP O
black JJ O O
and CC O O
necrotic JJ O O
and CC O O
there EX O O
was VBD B-VP O
a DT B-NP O
marked JJ I-NP O
amount NN I-NP O
of IN B-VP O
purulence NN B-NP O
Aerobic NNP I-NP O
and CC O O
anaerobic JJ B-NP O
cultures NNS I-NP O
were VBD B-VP O
obtained VBN O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
and CC O O
sent VBD B-VP O
to TO O O
Microbiology NNP B-NP O
for IN B-VP O
gram NN B-NP O
stains NNS I-NP O
and CC O O
cultures VBZ O O
All DT O O
of IN B-VP O
the DT B-NP O
visibly NN I-NP O
blackened VBD B-VP O
and CC O O
necrotic JJ B-NP O
muscle NN I-NP O
was VBD B-VP O
removed VBN O O
and CC O O
the DT B-NP O
wound NN I-NP B-r
was VBD B-VP O
irrigated VBN O B-mo
with IN B-VP O
copious JJ B-NP O
amounts NNS I-NP O
of IN B-VP O
antibiotic-containing JJ B-NP B-m
solution NN I-NP I-m
The DT B-NP O
patient NN I-NP O
appeared VBD B-VP O
to TO O O
tolerate VB O O
the DT B-NP O
procedure NN I-NP O
well RB O O
and CC O O
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
, , O O
given VBN O O
the DT B-NP O
patient's JJ I-NP O
cardiac JJ I-NP O
history NN I-NP O
as RB O O
well RB O O
as IN B-VP O
his PRP$ O O
ventilator NN B-NP O
dependence NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Infectious NNP I-NP O
Disease NNP I-NP O
service NN I-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Ampicillin NNP B-NP B-m
, , O O
Gentamicin NNP B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
empirically RB O O
until IN B-VP B-du
until IN B-VP B-du
until IN B-VP B-du
culture NN B-NP O
results NNS I-NP O
returned VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
back RB O O
on IN B-VP O
2/29/95 CD O O
for IN B-VP O
a DT B-NP O
second JJ I-NP O
irrigation NN I-NP O
and CC O O
debridement JJ B-NP O
procedure NN I-NP O
During IN B-VP O
this DT B-NP O
procedure NN I-NP O
, , O O
some DT B-NP O
necrotic JJ I-NP O
skin NN I-NP O
, , O O
subcutaneous JJ B-NP O
tissue NN I-NP O
and CC O O
fascia NN B-NP O
were VBD B-VP O
noted VBN O O
and CC O O
were VBD B-VP O
sharply RB O O
debrided VBN O O
free JJ O O
The DT B-NP O
wound NN I-NP O
was VBD B-VP O
relatively RB O O
clean JJ O O
upon IN B-VP O
completion NN B-NP O
of IN B-VP O
the DT B-NP O
procedure NN I-NP O
with IN B-VP O
no DT B-NP O
apparent JJ I-NP O
loculations NNS I-NP O
or CC O O
collections NNS B-NP O
or CC O O
purulence VB O O
The DT B-NP O
muscle NN I-NP O
also RB O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
appeared VBD B-VP O
viable JJ O O
and CC O O
it PRP O O
was VBD B-VP O
considered VBN O O
that IN B-VP O
the DT B-NP O
wound NN I-NP O
may MD O O
heal VB O O
on IN B-VP O
its PRP$ O O
own JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Vascular NNP I-NP O
Surgery NNP I-NP O
service NN I-NP O
as RB O O
well RB O O
for IN B-VP O
his PRP$ O O
history NN B-NP O
of IN B-VP O
left NN B-NP O
lower JJR B-NP O
extremity NN I-NP O
ischemia NN I-NP O
and CC O O
for IN B-VP O
his PRP$ O O
loss NN B-NP O
of IN B-VP O
his PRP$ O O
dorsalis NN B-NP O
pedis NN I-NP O
pulse NN I-NP O
on IN B-VP O
his PRP$ O O
left JJ B-NP O
foot NN I-NP O
The DT B-NP O
left JJ I-NP O
foot NN I-NP O
remained VBD B-VP O
cool JJ O O
and CC O O
insensate JJ O O
with IN B-VP O
no DT B-NP O
motor NN I-NP O
function NN I-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
however RB O O
have VB O O
flexion NN B-NP O
and CC O O
extension NN B-NP O
at IN B-VP O
the DT B-NP O
knee NN I-NP O
After IN B-VP O
adequate JJ B-NP O
irrigation NN I-NP O
and CC O O
debridement NN B-NP O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
not RB O O
require VB O O
amputation NN B-NP O
of IN B-VP O
his PRP$ O O
lower JJR B-NP O
extremity NN I-NP O
given VBN O O
the DT B-NP O
viability NN I-NP O
of IN B-VP O
the DT B-NP O
muscle NN I-NP O
NEUROLOGIC NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
awake VB O O
postoperatively RB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
appropriate JJ O O
in IN B-VP O
his PRP$ O O
neurologic JJ B-NP O
status NN I-NP O
The DT B-NP O
patient NN I-NP O
however RB O O
did VBD B-VP O
appear VB O O
to TO O O
have VB O O
some DT B-NP O
episodes NNS I-NP O
of IN B-VP O
anxiety NN B-NP B-r
for IN B-VP O
which WDT O O
he PRP O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
Klonopin NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
tid IN B-VP B-f
The DT B-NP O
patient NN I-NP O
continued VBD B-VP O
to TO O O
do VB O O
well RB O O
and CC O O
had VBD B-VP O
his PRP$ O B-r
pain NN B-NP I-r
adequately RB O O
controlled VBN O O
with IN B-VP O
po NN B-NP B-mo
Percocet NNP I-NP B-m
RESPIRATORY NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
initially RB O O
weaned VBN O O
off RP O O
the DT B-NP O
ventilator NN I-NP O
to TO O O
continue VB O O
his PRP$ O O
positive JJ B-NP O
airway NN I-NP O
pressure NN I-NP O
with IN B-VP O
5 CD O O
of IN B-VP O
PEEP NNP B-NP O
and CC O O
5 CD O O
of IN B-VP O
pressure NN B-NP O
support NN I-NP O
with IN B-VP O
50% CD O O
FIO2 NNP B-NP O
The DT B-NP O
patient's NN I-NP O
tidal JJ B-NP O
volumes NNS I-NP O
were VBD B-VP O
consistently RB O O
elevated VBN O O
over IN B-VP O
600 CD O O
and CC O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
subjective JJ I-NP O
complaints NNS I-NP O
of IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
However RB O O
, , O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#4 NNP I-NP O
and CC O O
#2 NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
noted VBD B-VP O
some DT B-NP O
difficulty NN I-NP O
catching VBG O O
his PRP$ O O
breath NN B-NP O
Pressure NN I-NP O
support NN I-NP O
was VBD B-VP O
increased VBN O O
back RB O O
up RB O O
to TO O O
10 CD O O
This DT B-NP O
inability NN I-NP O
of IN B-VP O
the DT B-NP O
patient NN I-NP O
to TO O O
maintain VB O O
his PRP$ O O
spontaneous JJ B-NP O
tidal JJ I-NP O
volumes NNS I-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
a DT B-NP O
respiratory NN I-NP O
fatigue NN I-NP O
secondary JJ O O
to TO O O
his PRP$ O O
diaphragmatic JJ B-NP O
dysfunction NN I-NP O
However RB O O
because IN B-VP O
the DT B-NP O
patient NN I-NP O
appeared VBD B-VP O
to TO O O
be VB O O
weaning VBG O O
from IN B-VP O
the DT B-NP O
ventilator NN I-NP O
initially RB O O
postop RB O O
, , O O
it PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
should MD O O
have VB O O
his PRP$ O O
diaphragmatic JJ B-NP O
function NN I-NP O
assessed VBD B-VP O
to TO O O
see VB O O
if IN B-VP O
there EX O O
had VBD B-VP O
been VBN O O
any DT B-NP O
change NN I-NP O
The DT B-NP O
patient NN I-NP O
underwent NN I-NP O
a DT B-NP O
fluoroscopy NN I-NP O
study NN I-NP O
to TO O O
assess VB O O
his PRP$ O O
diaphragmatic JJ B-NP O
excursions NNS I-NP O
on IN B-VP O
2/8/95 CD O O
The DT B-NP O
test NN I-NP O
revealed VBD B-VP O
no DT B-NP O
diaphragmatic JJ I-NP O
excursion NN I-NP O
consistent NN I-NP O
with IN B-VP O
phrenic JJ B-NP O
nerve NN I-NP O
injury NN I-NP O
It PRP O O
was VBD B-VP O
decided VBN O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
remain VB O O
on IN B-VP O
his PRP$ O O
previous JJ B-NP O
ventilator NN I-NP O
settings NNS I-NP O
of IN B-VP O
10 CD O O
of IN B-VP O
pressure NN B-NP O
support NN I-NP O
and CC O O
5 CD O O
of IN B-VP O
CPAP NNP B-NP O
and CC O O
50% CD O O
FIO2 NNP B-NP O
and CC O O
no DT B-NP O
further JJ I-NP O
weaning NN I-NP O
would MD O O
be VB O O
attempted VBN O O
GASTROINTESTINAL NNP B-NP O
The DT B-NP O
patient NN I-NP O
arrived VBD B-VP O
on IN B-VP O
tube JJ B-NP O
feedings NNS I-NP O
of IN B-VP O
Promote NNP B-NP O
Because IN B-VP O
we PRP O O
do VBP O O
not RB O O
have VB O O
this DT O O
at IN B-VP O
our PRP$ O O
institution NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
similar JJ I-NP O
formula NN I-NP O
of IN B-VP O
full JJ B-NP O
strength NN I-NP O
Ensure NNP I-NP O
High NNP I-NP O
Protein NNP I-NP O
at IN B-VP O
105 CD O O
cc/hour NN B-NP O
This DT O O
meets VBZ O O
the DT B-NP O
patient's NN I-NP O
full JJ B-NP O
nutritional JJ I-NP O
requirements NNS I-NP O
However RB O O
, , O O
because IN B-VP O
the DT B-NP O
patient NN I-NP O
appears VBZ O O
to TO O O
have VB O O
no DT B-NP O
reason NN I-NP O
for IN B-VP O
not RB O O
encouraging VBG O O
his PRP$ O O
oral JJ B-NP O
intake NN I-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
tube NN I-NP O
feeds NNS I-NP O
were VBD B-VP O
decreased VBN O O
to TO O O
50 CD O O
cc/hour NNS B-NP O
throughout IN B-VP O
the DT B-NP O
day NN I-NP O
for IN B-VP O
a DT O O
12 CD O O
hour NN B-NP O
period NN I-NP O
and CC O O
po JJ B-NP O
intake NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
was VBD B-VP O
encouraged VBN O O
The DT B-NP O
patient NN I-NP O
then RB O O
received VBD B-VP O
12 CD O O
hours NNS B-NP O
of IN B-VP O
his PRP$ O O
tube NN B-NP O
feeds NNS I-NP O
at IN B-VP O
105 CD O O
from IN B-VP O
7 CD O O
p.m NN B-NP O
to TO O O
7 CD O O
a.m PDT O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
placed VBN O O
back RP O O
on IN B-VP O
his PRP$ O O
normal JJ B-NP O
subcutaneous JJ I-NP B-mo
subcutaneous JJ I-NP B-mo
doses NNS I-NP O
of IN B-VP O
insulin NN B-NP B-m
insulin NN I-NP B-m
NPH NNP I-NP O
38 CD O B-do
units NNS B-NP I-do
in IN B-VP B-f
the DT B-NP I-f
morning NN I-NP I-f
and CC O O
38 CD O B-do
units NNS B-NP I-do
at IN B-VP B-f
night NN B-NP I-f
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
treated VBN O O
intermittently RB O O
with IN B-VP O
insulin NN B-NP B-m
drip NN I-NP I-m
for IN B-VP O
control NN B-NP O
of IN B-VP O
his PRP$ O B-r
blood NN B-NP I-r
sugars NNS I-NP I-r
during IN B-VP O
the DT B-NP O
times NNS I-NP O
he PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
and CC O O
from IN B-VP O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
Our PRP$ O O
goal NN B-NP O
for IN B-VP O
this DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
attempt VB O O
to TO O O
encourage VB O O
his PRP$ O O
oral JJ B-NP O
intake NN I-NP O
and CC O O
to TO O O
cycle NN B-NP O
his PRP$ O O
tube NN B-NP O
feeds VBZ O O
only RB O O
at IN B-VP O
night NN B-NP O
The DT B-NP O
patient NN I-NP O
should MD O O
have VB O O
24 CD O O
hour NN B-NP O
calorie NN I-NP O
counts VBZ O O
initiated VBN O O
to TO O O
assess VB O O
the DT B-NP O
adequacy NN I-NP O
of IN B-VP O
this DT B-NP O
oral JJ I-NP O
intake NN I-NP O
GU NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
Foley NNP I-NP O
catheter NN I-NP O
in IN B-VP O
place NN B-NP O
and CC O O
has VBZ O O
good JJ B-NP O
urine NN I-NP O
output NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
excoriations VBN O O
around IN B-VP O
his PRP$ O O
inner NN B-NP O
thighs NNS I-NP O
which WDT O O
prevented VBD B-VP O
us PRP O O
from IN B-VP O
removing VBG O O
his PRP$ O O
Foley NNP B-NP O
in IN B-VP O
case NN B-NP O
the DT B-NP O
pt NN I-NP O
has VBZ O O
episodes NNS B-NP O
of IN B-VP O
urinary JJ B-NP O
incontinence NN I-NP O
Once IN B-VP O
the DT B-NP O
patient's NN I-NP O
inner NN I-NP O
thighs NNS I-NP O
heal NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
may MD O O
have VB O O
the DT B-NP O
Foley NNP I-NP O
removed VBD B-VP O
and CC O O
the DT B-NP O
patient NN I-NP O
may MD O O
be VB O O
able JJ O O
to TO O O
void VB O O
on IN B-VP O
his PRP$ O O
own JJ O O
in IN B-VP O
either CC O O
a DT O O
bedside JJ O O
urinal JJ O O
or CC O O
with IN B-VP O
a DT B-NP O
condom NN I-NP O
cath NN I-NP O
in IN B-VP O
place NN B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
receiving VBG O O
his PRP$ O O
Lasix NNP B-NP B-m
40 CD O B-do
mg VBD B-VP I-do
a DT B-NP B-f
day NN I-NP I-f
CARDIOVASCULAR NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
initially RB O O
ruled VBN O O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
following VBG O O
his PRP$ O O
first JJ B-NP O
operative JJ I-NP O
procedure NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
no DT B-NP O
complaints NNS I-NP O
of IN B-VP O
chest NN B-NP O
pain NN I-NP O
The DT B-NP O
patient's NN I-NP O
cardiovascular NN I-NP O
status NN I-NP O
has VBZ O O
been VBN O O
stable JJ O O
with IN B-VP O
CVP's NNP B-NP O
running VBG O O
in IN B-VP O
the DT O O
12 CD O O
to TO O O
13 CD O O
range NN B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
episodes NNS I-NP O
of IN B-VP O
hypotension NN B-NP O
and CC O O
has VBZ O O
been VBN O O
continued VBN O O
on IN B-VP O
his PRP$ O O
Capoten NNP B-NP B-m
HEMATOLOGIC NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
stable JJ O O
with IN B-VP O
no DT B-NP O
issues NNS I-NP O
The DT B-NP O
patient NN I-NP O
continues VBZ O O
on IN B-VP O
subcutaneous JJ B-NP B-mo
heparin NN I-NP B-m
INFECTIOUS NNP I-NP O
DISEASE NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Ampicillin NNP B-NP B-m
, , O O
Gentamicin NNP B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
The DT B-NP O
patient's NN I-NP O
intraoperative JJ B-NP O
cultures NNS I-NP O
from IN B-VP O
his PRP$ O O
left JJ B-NP O
leg NN I-NP O
ulcer NN I-NP O
grew VBD B-VP O
out RP O O
E NNP B-NP O
coli NNS I-NP O
, , O O
sensitive JJ O O
to TO O O
Ampicillin NNP B-NP O
and CC O O
Ofloxacin NNP B-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
grew VBD B-VP O
out RP O O
Enterococcus NNP B-NP B-r
Enterococcus NNP I-NP B-r
, , O O
sensitive JJ O O
also RB O O
to TO O O
Ampicillin NNP B-NP B-m
and CC O O
Ofloxacin NNP B-NP B-m
and CC O O
Enterobacter NNP B-NP B-r
Enterobacter NNP I-NP B-r
cloacae NN I-NP I-r
cloacae NN I-NP I-r
, , O O
sensitive JJ O O
to TO O O
Gentamicin NNP B-NP B-m
and CC O O
Ofloxacin NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
switched VBN O O
over IN B-VP O
from IN B-VP O
Gentamicin NNP B-NP B-m
to TO O O
Ofloxacin NNP B-NP B-m
to TO O O
continue VB O O
his PRP$ O O
antibiotic JJ B-NP O
course NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
been VBN O O
followed VBN O O
by IN B-VP O
the DT B-NP O
Infectious NNP I-NP O
Disease NNP I-NP O
service NN I-NP O
Because IN B-VP O
of IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
operation NN B-NP O
, , O O
it PRP O O
was VBD B-VP O
considered VBN O O
that IN B-VP O
the DT B-NP O
infectious JJ I-NP O
tissue NN I-NP O
was VBD B-VP O
completely RB O O
debrided VBN O O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
need VB O O
to TO O O
continue VB O O
on IN B-VP O
an DT B-NP O
extensive JJ I-NP O
antibiotic JJ I-NP O
course NN I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
receive VB O O
7 CD O B-du
more JJR B-NP I-du
days NNS I-NP I-du
of IN B-VP O
po JJ B-NP B-mo
Ofloxacin NNP I-NP B-m
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
as IN B-VP O
per IN B-VP O
the DT B-NP O
ID NNP I-NP O
service NN I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
have VB O O
received VBN O O
, , O O
prior RB O O
to TO O O
discharge VB O O
, , O O
a DT O B-du
a DT B-NP B-du
total JJ I-NP I-du
total NN I-NP I-du
of IN B-VP I-du
of IN B-VP I-du
7 CD O I-du
7 CD O I-du
days NNS B-NP I-du
days NNS I-NP I-du
of IN B-VP O
IV NNP B-NP B-mo
IV NNP I-NP B-mo
Ampicillin NNP I-NP B-m
and CC O O
Ofloxacin NNP B-NP B-m
The DT B-NP O
Flagyl NNP I-NP B-m
was VBD B-VP O
discontinued VBN O O
after IN B-VP O
day NN B-NP O
#6 VBD B-VP O
TUBES/LINES/DRAINS NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
triple JJ I-NP O
lumen NNS I-NP O
catheter NN I-NP O
in IN B-VP O
place NN B-NP O
which WDT O O
was VBD B-VP O
removed VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
peripheral JJ I-NP O
IV NNP I-NP O
placed VBD B-VP O
in IN B-VP O
instead RB O O
The DT B-NP O
patient NN I-NP O
will MD O O
not RB O O
be VB O O
receiving VBG O O
any DT B-NP O
IV NNP I-NP O
medications NNS I-NP O
and CC O O
will MD O O
continue VB O O
on IN B-VP O
oral JJ B-NP B-mo
antibiotic JJ I-NP B-m
dosings NNS I-NP O
ADDENDUM NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
The DT B-NP O
patient's NN I-NP O
medication NN I-NP O
upon IN B-VP O
discharge NN B-NP O
which WDT O O
include: VBZ O O
1 CD O O
) ) O O
Tylenol $ O B-m
650 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q4h NN I-NP B-f
p.r.n NN I-NP O
headache NN I-NP B-r
2 CD O O
) ) O O
Aspirin $ O B-m
81 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
qd $ O B-f
3 CD O O
) ) O O
Albuterol NNP B-NP B-m
nebulizer $ O I-m
0.5 CD O B-do
cc NN B-NP I-do
in IN B-VP O
2.5 CD O B-do
cc NN B-NP I-do
of IN B-VP O
normal JJ B-NP B-m
saline JJ I-NP I-m
q.i.d NN I-NP B-f
q.i.d RB O B-f
4 CD O O
) ) O O
Capoten NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
qh $ O B-f
5 CD O O
) ) O O
Chloral NNP B-NP B-m
hydrate $ O I-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q.h.s NN I-NP B-f
p.r.n NN I-NP I-f
insomnia VBP O B-r
6 CD O O
) ) O O
Clonopin NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d IN B-VP B-f
7 CD O O
) ) O O
Digoxin NN B-NP B-m
0.375 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
qd $ O B-f
8 CD O O
) ) O O
Colace NN B-NP B-m
100 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
9 CD O O
) ) O O
Lasix FW O B-m
40 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
d VBZ O I-f
10 CD O O
) ) O O
Heparin NN B-NP B-m
5000 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
b.i.d RB O B-f
11 CD O O
) ) O O
Insulin NNP B-NP B-m
NPH NNP I-NP I-m
38 CD O B-do
units NNS B-NP I-do
subcu VBD B-VP B-mo
b.i.d RB O B-f
12 CD O O
) ) O O
Milk NN B-NP B-m
of IN B-VP I-m
Magnesia NNP B-NP I-m
30 CD O B-do
cc NN B-NP I-do
p.o NN I-NP B-mo
qd NN I-NP B-f
p.r.n NN I-NP I-f
constipation NN I-NP B-r
13 CD O O
) ) O O
Multivitamins VBZ O B-m
one CD O B-do
capsule NN B-NP I-do
p.o NN I-NP B-mo
qd $ O B-f
14 CD O O
) ) O O
Mycostatin NNP B-NP B-m
5 CD O B-do
cc NN B-NP I-do
p.o NN I-NP B-mo
q.i.d $ O B-f
15 CD O O
) ) O O
Percocet NNP B-NP B-m
one CD O B-do
or CC O I-do
two CD O I-do
tabs NNS B-NP I-do
p.o IN B-VP B-mo
q3-4h JJ B-NP B-f
p.r.n NN I-NP I-f
pain NN I-NP B-r
16 CD O O
) ) O O
Metamucil NNP B-NP B-m
one CD O B-do
packet NN B-NP I-do
p.o NN I-NP B-mo
qd $ O B-f
17 CD O O
) ) O O
Azmacort NNP B-NP B-m
six CD O B-do
puffs NNS B-NP I-do
inhaled VBD B-VP B-mo
b.i.d RB O B-f
18 CD O O
) ) O O
Axid $ O B-m
150 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
19 CD O O
) ) O O
Ofloxacin FW O B-m
200 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
x $ O B-du
7 CD O I-du
days NNS B-NP I-du
Dictated VBN O O
By: NNP B-NP O
JOSIAH NNP I-NP O
H NNP I-NP O
OLIVOS NNP I-NP O
, , O O
M.D NNP B-NP O
WE35 NNP I-NP O
Attending: NNP I-NP O
MICHEL NNP I-NP O
STOCKON NNP I-NP O
, , O O
M.D NNP B-NP O
QH94 NNP I-NP O
IM717/6506 NNP I-NP O
Batch: NNP I-NP O
246 CD O O
Index NNP B-NP O
No NNP I-NP O
LYZPS19RL8 NNP I-NP O
D: NNP I-NP O
6/6/95 CD O O
T: NNP B-NP O
6/6/95 CD O O
CC: NNP B-NP O
1 CD O O
NUMBERS NNP B-NP O
CARISTO NNP I-NP O
, , O O
M.D NNP B-NP O
EV45 NNP I-NP O
2 CD O O
DEWAYNE NNP B-NP O
G NNP I-NP O
GETTEL NNP I-NP O
, , O O
M.D NNP B-NP O
XJ6 NNP I-NP O
3 CD O O
REGGIE NNP B-NP O
W NNP I-NP O
MARZETT NNP I-NP O
, , O O
M.D NNP B-NP O
ZK19 NNP I-NP O
4 CD O O
HARPSTRICT NNP B-NP O
A NNP I-NP O
MEMORIAL NNP I-NP O
HOSPITAL NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#767415 VBZ O O
896632781 CD O O
EH NNP B-NP O
70876885 CD O O
395974 CD O O
7/5/1991 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
3/23/1991 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
9/28/1991 CD O O
HISTORY: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
62 CD O O
year NN B-NP O
old JJ B-NP O
rug NN I-NP O
salesman NN I-NP O
admitted VBD B-VP O
with IN B-VP O
increasing VBG O O
angina NN B-NP O
In IN B-VP O
1981 CD O O
he PRP O O
was VBD B-VP O
first RB O O
diagnosed VBN O O
with IN B-VP O
exertional JJ B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
hospitalized VBN O O
for IN B-VP O
a DT O O
strongly RB O O
positive JJ B-NP O
stress NN I-NP O
test NN I-NP O
catheterization NN I-NP O
at IN B-VP O
Gapi NNP B-NP O
Nic, NNP I-NP O
Health NNP I-NP O
with IN B-VP O
an DT O O
80% CD O O
proximal NN B-NP O
circumflex NN I-NP O
and CC O O
50% CD O O
left VBD B-VP O
anterior JJ O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
Since IN B-VP O
that DT B-NP O
time NN I-NP O
he PRP O O
has VBZ O O
been VBN O O
managed VBN O O
medically RB O O
and CC O O
recently RB O O
felt VBD B-VP O
that IN B-VP O
his PRP$ O O
angina NN B-NP O
consisted VBD B-VP O
of IN B-VP O
chest NN B-NP O
aching NN I-NP O
, , O O
throat NN B-NP O
aching NN I-NP O
and CC O O
dryness NN B-NP O
of IN B-VP O
the DT B-NP O
throat NN I-NP O
This DT O O
worsened VBN O O
On IN B-VP O
January NNP B-NP O
, , O O
1991 CD O O
he PRP O O
had VBD B-VP O
an DT B-NP O
exercise NN I-NP O
treadmill NN I-NP O
test NN I-NP O
He PRP O O
went VBD B-VP O
eight CD O O
minutes NNS B-NP O
and CC O O
0 CD O O
seconds NNS B-NP O
and CC O O
attained VBD B-VP O
a DT B-NP O
peak JJ I-NP O
heart NN I-NP O
rate NN I-NP O
of IN B-VP O
110 CD O O
, , O O
70% CD O O
of IN B-VP O
predicted VBN O O
and CC O O
a DT B-NP O
peak JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
198/90 CD O O
The DT B-NP O
test NN I-NP O
was VBD B-VP O
stopped VBN O O
due JJ O O
to TO O O
1 CD O O
mm NNS B-NP O
ST NNP I-NP O
depression NN I-NP O
in IN B-VP O
Leads NNP B-NP O
II NNP I-NP O
, , O O
III NNP B-NP O
, , O O
F NNP B-NP O
and CC O O
V4 NNP B-NP O
to TO O O
V6 VB O O
He PRP O O
developed VBD B-VP O
chest JJS B-NP O
discomfort NN I-NP O
Normal NNP I-NP O
blood NN I-NP O
pressure NN I-NP O
responds VBZ O O
to TO O O
exercise VB O O
and CC O O
the DT B-NP O
ischemic JJ I-NP O
changes NNS I-NP O
were VBD B-VP O
similar JJ O O
to TO O O
previous JJ B-NP O
tests NNS I-NP O
on IN B-VP O
August NNP B-NP O
, , O O
1989 CD O O
but CC O O
a DT B-NP O
lower JJR I-NP O
exercise NN I-NP O
capacity NN I-NP O
His PRP$ O O
exercise NN B-NP O
discomfort NN I-NP O
is VBZ O O
exertional JJ O O
and CC O O
he PRP O O
used VBD B-VP O
to TO O O
notice VB O O
it PRP O O
when WRB O O
he PRP O O
carried VBD B-VP O
his PRP$ O O
golf NN B-NP O
bag VBD B-VP O
up RP O O
a DT B-NP O
hill NN I-NP O
Yesterday NN I-NP O
he PRP O O
noticed VBD B-VP O
more RBR O O
frequent JJ B-NP O
anginal JJ I-NP O
pain NN I-NP O
, , O O
with IN B-VP O
throat NN B-NP O
, , O O
chest NN B-NP O
and CC O O
chest JJ B-NP O
pressure NN I-NP O
and CC O O
both DT B-NP O
arms NNS I-NP O
aching VBG O O
with IN B-VP O
dull JJ B-NP O
pain NN I-NP O
while IN B-VP O
playing VBG O O
golf NN B-NP O
He PRP O O
noticed VBD B-VP O
the DT B-NP O
symptoms NNS I-NP O
around IN B-VP O
the DT B-NP O
third JJ I-NP O
hole NN I-NP O
He PRP O O
was VBD B-VP O
then RB O O
able JJ O O
to TO O O
play VB O O
up RP O O
to TO O O
the DT B-NP O
14th JJ I-NP O
hole NN I-NP O
walking NN I-NP O
He PRP O O
took VBD B-VP O
one CD O B-do
nitroglycerin NN B-NP B-m
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
finish VB O O
to TO O O
the DT O O
18th CD O O
hole NN B-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
he PRP O O
noticed VBD B-VP O
some DT B-NP O
pain NN I-NP O
at IN B-VP O
work NN B-NP O
while IN B-VP O
moving VBG O O
around IN B-VP O
the DT B-NP O
office NN I-NP O
, , O O
but CC O O
it PRP O O
did VBD B-VP O
not RB O O
last JJ O O
long JJ O O
enough RB O O
for IN B-VP O
him PRP O O
to TO O O
take VB O O
a DT B-NP O
nitroglycerin JJ I-NP O
Medications NNP I-NP O
on IN B-VP O
admission; NN B-NP O
LoPressor NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Isordil NNP B-NP B-m
20 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Verapamil NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Xanax NNP B-NP B-m
0.25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
p.r.n NN I-NP I-f
, , O O
one CD O B-do
aspirin NN B-NP B-m
q.d NN I-NP B-f
and CC O O
p.r.n NN B-NP B-f
nitroglycerin JJ B-NP B-m
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
a DT B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
On IN B-VP O
January NNP B-NP O
he PRP O O
had VBD B-VP O
a DT B-NP O
percutaneous JJ I-NP O
transluminal JJ I-NP O
coronary NN I-NP O
angioplasty NN I-NP O
in IN B-VP O
which WDT O O
a DT B-NP O
proximal NN I-NP O
circumflex NN I-NP O
was VBD B-VP O
dilated VBN O O
from IN B-VP O
95% CD O O
to TO O O
20% CD O O
The DT O O
only RB O O
other JJ B-NP O
lesion NN I-NP O
was VBD B-VP O
a DT B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
of IN B-VP O
30% CD O O
The DT B-NP O
patient's NN I-NP O
post NN I-NP O
percutaneous JJ B-NP O
transluminal JJ I-NP O
coronary JJ I-NP O
angioplasty JJ I-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
nausea NN B-NP O
and CC O O
vomiting VBG O O
A NNP B-NP O
KUB NNP I-NP O
was VBD B-VP O
non- JJ O O
specific JJ O O
The DT B-NP O
patient's NN I-NP O
nausea NN I-NP O
and CC O O
vomiting NN B-NP O
resolved VBN O O
over IN B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
two CD O O
days NNS B-NP O
and CC O O
he PRP O O
remained VBD B-VP O
well RB O O
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
tolerate VB O O
p.o NNS B-NP O
intake VB O O
well RB O O
Throughout IN B-VP O
his PRP$ O O
episodes NNS B-NP O
of IN B-VP O
nausea NN B-NP O
and CC O O
vomiting VBG O O
the DT B-NP O
electrocardiogram NN I-NP O
remained VBD B-VP O
unchanged JJ O O
and CC O O
he PRP O O
denied VBD B-VP O
any DT O O
of IN B-VP O
his PRP$ O O
usual JJ B-NP O
anginal JJ I-NP O
symptoms NNS I-NP O
DISPOSITION: VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
excellent JJ B-NP O
condition NN I-NP O
on IN B-VP O
LoPressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
, , O O
Isordil NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
Verapamil NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
, , O O
one CD O B-do
aspirin NN B-NP B-m
q.d NN I-NP B-f
and CC O O
Pepcid NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
Dictated NNP I-NP O
By: NNP I-NP O
REID NNP I-NP O
STULL NNP I-NP O
, , O O
M.D NNP B-NP O
OJ04 NNP I-NP O
KG9 NNP I-NP O
/4067 NNP I-NP O
BARRETT NNP I-NP O
DALLISON NNP I-NP O
, , O O
M.D NNP B-NP O
VP05 NNP I-NP O
D: NNP I-NP O
1/13/91 CD O O
T: NNP B-NP O
4/27/91 CD O O
Batch: NNP B-NP O
Z507 NNP I-NP O
Report: NNP I-NP O
AY580E10 NNP I-NP O
T: NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#767633 VBZ O O
573750392 CD O O
RHMC NNP B-NP O
39369709 CD O O
3307799 CD O O
0/2/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Left NNP I-NP O
leg NN I-NP O
pain NN I-NP O
, , O O
hypocalcemia NN B-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
0/2/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/15/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SMALLIDGE NNP I-NP O
, , O O
JULIUS NNP B-NP O
969-13-74-7 CD O O
Gene NNP B-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
4/2/06 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
HILDEBRANDT NNP I-NP O
, , O O
LESLIE NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
No NNP I-NP O
CPR NNP I-NP O
, , O O
No NNP B-NP O
defib NN I-NP O
, , O O
No DT B-NP O
intubation NN I-NP O
, , O O
No NNP B-NP O
pressors NNS I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
CALCIUM NNP I-NP B-m
CARBONATE NNP I-NP I-m
1 CD O B-do
, , O I-do
500 CD O I-do
MG NNP B-NP I-do
( ( O I-do
600 CD O I-do
MG NNP B-NP I-do
ELEM NNP I-NP I-do
CA NNP I-NP I-do
)/ NNP I-NP I-do
VIT NNP I-NP B-m
D NNP I-NP I-m
200 CD O B-do
IU NNP B-NP O
1 CD O O
TAB NNP B-NP O
PO NNP I-NP B-mo
BID NNP I-NP B-f
ACETYLSALICYLIC NNP I-NP B-m
ACID NNP I-NP I-m
81 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
CALCITRIOL NNP I-NP B-m
0.5 CD O B-do
MCG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PHOSLO NNP I-NP O
( ( O O
CALCIUM NNP B-NP O
ACETATE NNP I-NP O
( ( O O
1 CD O O
GELCAP=667 NNP B-NP O
MG NNP I-NP O
) ) O O
) ) O O
1 CD O B-do
, , O I-do
334 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
4 CD O I-du
NEXIUM NNP B-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
2 CD O O
NEPHROCAPS NNP B-NP B-m
( ( O I-m
NEPHRO-VIT NNP B-NP I-m
RX NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/15/06 CD O O
by IN B-VP O
NOURY NNP B-NP O
, , O O
QUINTON NNP B-NP O
GONZALO NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
SIMVASTATIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
977528686 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
SIMVASTATIN NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Alert NNP B-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/15/06 CD O O
by IN B-VP O
SEESHOLTZ NNP B-NP O
, , O O
SALVATORE NNP B-NP O
HILARIO NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
NIACIN NNP I-NP B-m
, , O O
VIT NNP B-NP B-m
B-3 NNP I-NP I-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
DIET: NNP I-NP O
No NNP I-NP O
Restrictions NNP I-NP O
ACTIVITY: NNP I-NP O
Partial NNP I-NP O
weight-bearing NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Orthopedic NNP I-NP O
clinic JJ B-NP O
Call NNP I-NP O
255-686-8127 NN I-NP O
on IN B-VP O
5/15/06 CD O O
, , O O
Dr NNP B-NP O
Emile NNP I-NP O
Kaanana NNP I-NP O
Please NNP I-NP O
followup VB O O
with IN B-VP O
your PRP$ O O
Primary JJ B-NP O
Provider NN I-NP O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
after IN B-VP O
discharge NN B-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Left NNP I-NP O
fibula/tibia JJ B-NP O
fracture NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Left VBD B-VP O
leg JJ B-NP O
pain NN I-NP O
, , O O
hypocalcemia NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
CAD NNP I-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
CHF NNP B-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
CRF NNP B-NP O
( ( O O
chronic JJ B-NP O
renal JJ I-NP O
dysfunction NN I-NP O
) ) O O
HTN NNP B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
DM NNP B-NP O
( ( O O
diabetes VBZ O O
mellitus VBP O O
type JJ O O
2 CD O O
) ) O O
hypocalcemia NN B-NP O
chronic JJ B-NP O
anemia NN I-NP O
( ( O O
anemia NN B-NP O
) ) O O
vitamin NN B-NP O
D NNP I-NP O
deficiency NN I-NP O
( ( O O
vitamin JJ B-NP O
D NNP I-NP O
deficiency NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
None NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
ESIH NNP I-NP O
ED NNP I-NP O
by IN B-VP O
her PRP$ O O
daughter NN B-NP O
with IN B-VP O
the DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
left JJ B-NP O
leg NN I-NP O
pain NN I-NP O
They PRP O O
were VBD B-VP O
concerned VBN O O
about IN B-VP O
the DT B-NP O
healing NN I-NP O
of IN B-VP O
her PRP$ O O
left JJ B-NP O
fibula/tibia JJ I-NP O
fracture NN I-NP O
--- NNP I-NP O
HPI: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
72-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
CAD NNP B-NP O
s/p NN I-NP O
CABG NNP I-NP O
, , O O
chronic JJ B-NP O
kidney NN I-NP O
disease NN I-NP O
( ( O O
declined VBD B-VP O
HD NNP B-NP O
) ) O O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
( ( O O
EF NNP B-NP O
30% CD O O
) ) O O
, , O O
HTN NNP B-NP O
, , O O
and CC O O
hypocalcemia NN B-NP O
She PRP O O
has VBZ O O
also RB O O
been VBN O O
hospitalized VBN O O
numerous JJ B-NP O
times NNS I-NP O
in IN B-VP O
the DT O O
past JJ O O
two CD O O
years NNS B-NP O
for IN B-VP O
CHF NNP B-NP O
exacerbations NNS I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
NSTEMI NNP B-NP O
She PRP O O
has VBZ O O
preferred VBN O O
not RB O O
to TO O O
take VB O O
any DT O O
of IN B-VP O
her PRP$ O O
prescribed JJ B-NP O
medications NNS I-NP O
despite IN B-VP O
repeated JJ B-NP O
discussions NNS I-NP O
about IN B-VP O
benefits NNS B-NP O
of IN B-VP O
decreased JJ B-NP O
mortality NN I-NP O
, , O O
prevention NN B-NP O
of IN B-VP O
re-hospitalization NN B-NP O
, , O O
and CC O O
symptom JJ B-NP O
management NN I-NP O
In IN B-VP O
May NNP B-NP O
2006 CD O O
she PRP O O
sustained VBD B-VP O
a DT B-NP O
displaced JJ I-NP O
LLE NNP I-NP O
tib/fib NN I-NP O
fx NN I-NP O
after IN B-VP O
banging VBG O O
her PRP$ O O
leg NN B-NP O
into IN B-VP O
her PRP$ O O
bed NN B-NP O
while IN B-VP O
driving VBG O O
her PRP$ O O
motorized JJ B-NP O
scooter NN I-NP O
in IN B-VP O
her PRP$ O O
apartment NN B-NP O
She PRP O O
has VBZ O O
been VBN O O
treated VBN O O
by IN B-VP O
Dr NNP B-NP O
Russel NNP I-NP O
Frausto NNP I-NP O
at IN B-VP O
PCHCOC NNP B-NP O
She PRP O O
initally RB O O
refused VBD B-VP O
surgical JJ B-NP O
repair NN I-NP O
and CC O O
was VBD B-VP O
casted VBN O O
, , O O
but CC O O
subsequent JJ B-NP O
films NNS I-NP O
have VBP O O
shown VBN O O
valgus JJ B-NP O
angulation NN I-NP O
and CC O O
poor JJ B-NP O
healing NN I-NP O
She PRP O O
declined VBD B-VP O
surgery NN B-NP O
( ( O O
and CC O O
was VBD B-VP O
a DT B-NP O
high-risk JJ I-NP O
surgical JJ I-NP O
candidate NN I-NP O
given VBN O O
her PRP$ O O
multiple JJ B-NP O
comorbidities NNS I-NP O
On IN B-VP O
11/5/06 CD O O
the DT B-NP O
cast NN I-NP O
was VBD B-VP O
removed VBN O O
by IN B-VP O
Dr NNP B-NP O
Malhotra NNP I-NP O
and CC O O
has VBZ O O
been VBN O O
in IN B-VP O
a DT B-NP O
walking NN I-NP O
boot NN I-NP O
since IN B-VP O
then RB O O
She PRP O O
states VBZ O O
that IN B-VP O
she PRP O O
has VBZ O O
pain NN B-NP B-r
of IN B-VP O
the DT B-NP O
left NN I-NP O
midleg NN I-NP O
that IN B-VP O
she PRP O O
has VBZ O O
treated VBN O O
with IN B-VP O
Tylenol NNP B-NP B-m
and CC O O
that DT O O
has VBZ O O
limited VBN O O
her PRP$ O O
ability NN B-NP O
to TO O O
try VB O O
and CC O O
bear VB O O
weight NN B-NP O
Her NNP I-NP O
daughter NN I-NP O
brings VBZ O O
her PRP$ O O
in IN B-VP O
today NN B-NP O
because IN B-VP O
of IN B-VP O
concern NN B-NP O
for IN B-VP O
her PRP$ O O
mother's NN B-NP O
left VBD B-VP O
leg VBZ O O
The DT B-NP O
air NN I-NP O
cast NN I-NP O
was VBD B-VP O
taken VBN O O
off RP O O
yesterday NN B-NP O
and CC O O
since IN B-VP O
then RB O O
, , O O
she PRP O O
has VBZ O O
had VBD B-VP O
worsening VBG O O
pain NN B-NP O
of IN B-VP O
the DT B-NP O
leg NN I-NP O
She PRP O O
has VBZ O O
been VBN O O
unable JJ O O
to TO O O
move VB O O
it PRP O O
or CC O O
bear VB O O
any DT B-NP O
wait NN I-NP O
There EX O O
is VBZ O O
a DT B-NP O
valgus JJ I-NP O
deformity NN I-NP O
They PRP O O
are VBP O O
requesting VBG O O
orthopedic JJ B-NP O
evaluation NN I-NP O
She PRP O O
denies VBZ O O
new JJ O O
numbness/tingling VBG O O
or CC O O
weakness NN B-NP O
in IN B-VP O
the DT B-NP O
extremities NNS I-NP O
She PRP O O
also RB O O
notes VBZ O O
multiple JJ B-NP O
chronic JJ I-NP O
problems NNS I-NP O
including VBG O O
decreased VBD B-VP O
appetite NN B-NP O
with IN B-VP O
40lb CD O O
weight JJ B-NP O
loss NN I-NP O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
4-6 JJ I-NP O
months NNS I-NP O
, , O O
lethargy NN B-NP O
, , O O
apathy JJ B-NP O
"I NN I-NP O
just RB O O
want VB O O
to TO O O
be VB O O
able JJ O O
to TO O O
walk VB O O
again RB O O
and CC O O
do VB O O
the DT B-NP O
things NNS I-NP O
I PRP O O
used VBD B-VP O
to TO O O
like VB O O
doing." NN B-NP O
( ( O O
Going VBG O O
to TO O O
the DT B-NP O
horse NN I-NP O
track NN I-NP O
, , O O
walking VBG O O
outside NN B-NP O
) ) O O
She PRP O O
states VBZ O O
that IN B-VP O
she PRP O O
is VBZ O O
NOT NNP B-NP O
depressed JJ O O
but CC O O
sleeps VBZ O O
most JJS O O
of IN B-VP O
the DT B-NP O
day NN I-NP O
The DT B-NP O
family NN I-NP O
has VBZ O O
discussed VBN O O
these DT B-NP O
symptoms NNS I-NP O
with IN B-VP O
her PRP$ O O
PCP NNP B-NP O
In IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
symptoms NNS B-NP O
have VBP O O
been VBN O O
attributed VBN O O
to TO O O
her PRP$ O O
worsening VBG O O
renal JJ B-NP O
failure NN I-NP O
, , O O
cardiac JJ B-NP O
status NN I-NP O
in IN B-VP O
this DT B-NP O
patient NN I-NP O
who WP O O
refuses VBZ O O
to TO O O
take VB O O
any DT B-NP O
medications NNS I-NP O
She PRP O O
has VBZ O O
wanted VBN O O
to TO O O
remain VB O O
home NN B-NP O
yet RB O O
has VBZ O O
had VBN O O
documented VBN O O
discussions NNS B-NP O
with IN B-VP O
PCP NNP B-NP O
about IN B-VP O
the DT B-NP O
benefits NNS I-NP O
of IN B-VP O
placement NN B-NP O
to TO O O
a DT B-NP O
nursing NN I-NP O
home NN I-NP O
for IN B-VP O
longterm JJ B-NP O
care NN I-NP O
Family NNP I-NP O
is VBZ O O
currently RB O O
looking VBG O O
into IN B-VP O
assisted VBN O O
living NN B-NP O
facilities NNS I-NP O
She PRP O O
also RB O O
has VBZ O O
requested VBN O O
DNR/DNI NNP B-NP O
status NN I-NP O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Coronary NNP B-NP O
artery NN I-NP O
disease: NN I-NP O
s/p NN I-NP O
IMI NNP I-NP O
and CC O O
2-V-CABG JJ O O
, , O O
August NNP B-NP O
of IN B-VP O
2001 CD O O
( ( O O
LIMA&gt;LAD NNP B-NP O
, , O O
SVG&gt;PDA NNP B-NP O
) ) O O
Her PRP$ O O
anginal JJ B-NP O
equivalents NNS I-NP O
are VBP O O
N/V NNP B-NP O
but CC O O
not RB O O
CP NNP B-NP O
She PRP O O
is VBZ O O
followed VBN O O
by IN B-VP O
a DT B-NP O
cardiologist NN I-NP O
, , O O
Dr NNP B-NP O
Trent NNP I-NP O
Cannizzo NNP I-NP O
at IN B-VP O
CICGH NNP B-NP O
She PRP O O
is VBZ O O
uninterested JJ O O
in IN B-VP O
pursuing VBG O O
any DT B-NP O
additional JJ I-NP O
cardiac JJ I-NP O
evaluation NN I-NP O
2 CD O O
CHF NNP B-NP O
with IN B-VP O
EF NNP B-NP O
26% CD O O
( ( O O
4/27 CD O O
) ) O O
Mod-Severe NNP B-NP O
MR NNP I-NP O
Several NNP I-NP O
exacerbations NNS I-NP O
over IN B-VP O
past JJ B-NP O
yr NN I-NP O
in IN B-VP O
setting VBG O O
of IN B-VP O
NSTEMI NNP B-NP O
( ( O O
3/23 CD O O
) ) O O
3 CD O O
Hypertension NNP B-NP O
4 CD O O
Diabetes NNP B-NP O
mellitus VBD B-VP O
type JJ O O
2 CD O O
, , O O
non-insulin JJ O O
requiring VBG O O
Her PRP$ O O
most RBS O O
recent JJ B-NP O
hemoglobin NN I-NP O
A1c NNP I-NP O
was VBD B-VP O
less JJR O O
than IN B-VP O
6% CD O O
without IN B-VP O
medications NNS B-NP O
Her NNP I-NP O
diabetic JJ B-NP O
complications NNS I-NP O
include VBP O O
peripheral JJ O O
neuropathy JJ O O
and CC O O
chronic JJ B-NP O
kidney NN I-NP O
disease NN I-NP O
5 CD O O
Chronic NNP B-NP O
kidney NN I-NP O
disease NN I-NP O
2/2 CD O O
DM NNP B-NP O
with IN B-VP O
a DT B-NP O
baseline JJ I-NP O
creatinine NN I-NP O
of IN B-VP O
3.5 CD O O
to TO O O
4 CD O O
She PRP O O
has VBZ O O
no DT B-NP O
interest NN I-NP O
in IN B-VP O
hemodialysis NN B-NP O
6 CD O O
Hypocalcemia NNP B-NP O
secondary JJ O O
to TO O O
chronic VB O O
kidney NN B-NP O
disease NN I-NP O
and CC O O
profound NN B-NP O
vitamin NN I-NP O
D NNP I-NP O
deficiency NN I-NP O
with IN B-VP O
an DT O O
associated VBN O O
myopathy NN B-NP O
and CC O O
bone NN B-NP O
pain NN I-NP O
She PRP O O
also RB O O
has VBZ O O
severe JJ B-NP O
secondary JJ I-NP O
hyperparathyroidism NN I-NP O
7 CD O O
History NNP B-NP O
of IN B-VP O
colon NN B-NP O
cancer NN I-NP O
status NN I-NP O
post VBD B-VP O
a DT B-NP O
partial JJ I-NP O
colectomy NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
requested VBN O O
no DT B-NP O
follow-up NN I-NP O
for IN B-VP O
this DT B-NP O
problem NN I-NP O
8 CD O O
Osteoarthritis NN B-NP O
status NN I-NP O
post NN I-NP O
a DT B-NP O
left JJ I-NP O
total JJ I-NP O
hip NN I-NP O
replacement NN I-NP O
for IN B-VP O
aseptic JJ B-NP O
necrosis NN I-NP O
Since IN B-VP O
that DT B-NP O
time NN I-NP O
she PRP O O
has VBZ O O
a DT B-NP O
leg JJ I-NP O
length NN I-NP O
discrepancy NN I-NP O
and CC O O
uses VBZ O O
crutches NNS B-NP O
to TO O O
ambulate VB O O
until IN B-VP O
a DT B-NP O
recent JJ I-NP O
tib/fib NN I-NP O
fx NN I-NP O
which WDT O O
has VBZ O O
left VBN O O
her PRP$ O O
WC-dependent JJ O O
9 CD O O
Chronic NNP B-NP O
anemia NN I-NP O
secondary JJ O O
to TO O O
chronic VB O O
kidney NN B-NP O
disease NN I-NP O
She PRP O O
does VBZ O O
have VB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
prior JJ B-NP O
upper JJ I-NP O
GI NNP I-NP O
bleeding VBG O O
secondary JJ O O
to TO O O
peptic JJ B-NP O
ulcer JJ I-NP O
disease NN I-NP O
ROS: NNP I-NP O
No NNP I-NP O
recent JJ B-NP O
fevers/chills NNS I-NP O
or CC O O
night NN B-NP O
sweats NNS I-NP O
No NNP I-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
cough NN B-NP O
or CC O O
chest JJS B-NP O
pain NN I-NP O
No DT B-NP O
abdominal JJ I-NP O
pain NN I-NP O
No NNP I-NP O
constipation/diarrhea NN I-NP O
No NNP I-NP O
dysuria NN I-NP O
Denies VBZ O O
numbness CC O O
or CC O O
tingling VBG O O
in IN B-VP O
extremities NNS B-NP O
ALLERGIES: NNP I-NP O
NKDA NNP I-NP O
MEDS: NNP I-NP O
SHE NNP I-NP O
STATES VBD B-VP O
THAT IN B-VP O
SHE NNP B-NP O
CURRENTLY NNP I-NP O
IS VBZ O O
NOT NNP B-NP O
TAKING NNP I-NP O
ANY NNP I-NP O
MEDICINES NNP I-NP O
THE NNP I-NP O
FOLLOWING NNP I-NP O
ARE NNP I-NP O
MEDICATIONS NNP I-NP O
THAT NNP I-NP O
ARE NNP I-NP O
PRESCRIBED NNP I-NP O
TO NNP I-NP O
HER: NNP I-NP O
aspirin VBZ O B-m
81 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qdcalcitriol VBD B-VP B-m
0.5mcg CD O B-do
PO NNP B-NP B-mo
qdcalcium NN I-NP B-m
carbonate NN I-NP I-m
500mg CD O B-do
po NN B-NP B-mo
tidLasix NN I-NP B-m
40 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qdLifeline VBP O O
personal JJ B-NP O
help NN I-NP O
Nephrocaps NNP I-NP B-m
1 CD O B-do
tab NN B-NP I-do
PO NNP I-NP B-mo
qdnitroglycerin VBZ O O
transdermal JJ B-NP B-m
patch NN I-NP B-mo
0.2mg/hr CD O B-do
transdermal JJ B-NP O
q24 NNS I-NP O
hrs.Toprol VBP O B-m
XL $ O I-m
25 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
qdZocor NN I-NP B-f
qdZocor NN I-NP B-m
10mg CD O B-do
po NN B-NP B-mo
qhs JJ B-NP B-f
Social NNP I-NP O
Hx: NNP I-NP O
Lives VBZ O O
alone RB O O
Gets NNP B-NP O
VNA NNP I-NP O
and CC O O
PCA NNP B-NP O
Has NNP I-NP O
been VBN O O
using VBG O O
wheelchair NN B-NP O
to TO O O
ambulate VB O O
Has NNP B-NP O
3 CD O O
kids NNS B-NP O
( ( O O
2 CD O O
daughters NNS B-NP O
and CC O O
son NN B-NP O
) ) O O
Tobacco: NNP B-NP O
Remote NNP I-NP O
Etoh NNP I-NP O
:None NNP I-NP O
Physical NNP I-NP O
Exam: NNP I-NP O
VS NNP I-NP O
T NNP I-NP O
96.8 CD O O
BP NNP B-NP O
130/80 CD O O
HR NNP B-NP O
75 CD O O
RR NNP B-NP O
16 CD O O
Pulsox NNP B-NP O
100% CD O O
RA NNP B-NP O
General: NNP I-NP O
NAD NNP I-NP O
Poor NNP I-NP O
eye NN I-NP O
contact NN I-NP O
, , O O
looking VBG O O
down RP O O
often RB O O
Pale NNP B-NP O
HEENT: NNP I-NP O
EOM NNP I-NP O
full JJ B-NP O
Sclerae NNP I-NP O
anicteric NN I-NP O
OP NNP I-NP O
without IN B-VP O
erythema/thrush JJ B-NP O
No NNP I-NP O
thyromegaly NN I-NP O
No NNP I-NP O
cervical NN I-NP O
, , O O
supraclav NN B-NP O
lymphadenopathy JJ B-NP O
CV: NNP I-NP O
RRR NNP I-NP O
, , O O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
, , O O
2/6 CD O O
HSM NNP B-NP O
at IN B-VP O
apex JJ O O
no DT B-NP O
carotid NN I-NP O
bruits VBZ O O
JVP NNP B-NP O
+ NNP I-NP O
14cm CD O O
Chest: NNP B-NP O
Crackles NNP I-NP O
halfway VBZ O O
up RP O O
bilaterally RB O O
No NNP B-NP O
wheezes VBZ O O
Abd: NNP B-NP O
Soft NNP I-NP O
Nontender NNP I-NP O
, , O O
nondistended VBD B-VP O
Liver NNP B-NP O
edge NN I-NP O
smooth RB O O
Palpated VBD B-VP O
on IN B-VP O
inspiration NN B-NP O
to TO O O
descend VB O O
2cm CD O O
below IN B-VP O
CM NNP B-NP O
Extrem: NNP I-NP O
RLE NNP I-NP O
with IN B-VP O
multiple JJ B-NP O
hyperpigmented JJ I-NP O
nodules NNS I-NP O
with IN B-VP O
superficial JJ B-NP O
excoriations NNS I-NP O
LLE NNP I-NP O
dry NN I-NP O
with IN B-VP O
cracked/flaking VBG O O
skin JJ B-NP O
Foot NNP I-NP O
is VBZ O O
edematous JJ B-NP O
Leg NNP I-NP O
appears VBZ O O
to TO O O
have VB O O
varus NN B-NP O
deformity NN I-NP O
Left NNP I-NP O
foot NN I-NP O
is VBZ O O
edematous JJ O O
There EX O O
is VBZ O O
a DT B-NP O
band NN I-NP O
of IN B-VP O
constriction NN B-NP O
where WRB O O
bandage NN B-NP O
was VBD B-VP O
wrapped VBN O O
Sensation NNP B-NP O
intact JJ O O
to TO O O
light JJ B-NP O
touch NN I-NP O
bilaterally RB O O
Pain NNP B-NP O
elicited VBD B-VP O
on IN B-VP O
movement NN B-NP O
of IN B-VP O
left JJ B-NP O
leg NN I-NP O
Cannot NNP I-NP O
logroll NN I-NP O
left VBD B-VP O
leg NN B-NP O
due JJ O O
to TO O O
pain VB O O
in IN B-VP O
tibia NN B-NP O
that WDT O O
is VBZ O O
elicited VBN O O
Neuro: NNP B-NP O
Aox3 NNP I-NP O
CN NNP I-NP O
II-XII NNP I-NP O
nl POS O O
5/5 CD O O
strength NN B-NP O
in IN B-VP O
UE NNP B-NP O
LLE NNP I-NP O
5/5 CD O O
RLE NNP B-NP O
4/5 CD O O
ankle NN B-NP O
dorsi/plantarflex JJ B-NP O
No NNP I-NP O
asterixis NN I-NP O
Labs: NNP I-NP O
Na NNP I-NP O
140/K CD O O
4.6/ CD O O
Cl108/ NNP B-NP O
Co2 NNP I-NP O
22/ CD O O
BUN NNP B-NP O
59/Cr CD O O
4.0/GLU CD O O
164 CD O O
Mg NNP B-NP O
2.0/ CD O O
Ca NNP B-NP O
5.6/ CD O O
IoCa NNP B-NP O
Unsat/ NNP I-NP O
WBC NNP I-NP O
4.01/HCT CD O O
36.6/PLT CD O O
167 CD O O
MCV NNP B-NP O
83.4 CD O O
RDW NNP B-NP O
16.6 CD O O
PTT NNP B-NP O
27.1/ CD O O
INR NNP B-NP O
1.2 CD O O
LFT's: NNP B-NP O
P NNP I-NP O
EKG: NNP I-NP O
SR NNP I-NP O
with IN B-VP O
first JJ B-NP O
degree NN I-NP O
AVB NNP I-NP O
Q's NNP I-NP O
in IN B-VP O
II NNP B-NP O
, , O O
III NNP B-NP O
, , O O
avF VBZ O O
No NNP B-NP O
change NN I-NP O
from IN B-VP O
prior JJ B-NP O
CXR: NNP I-NP O
Cardiomegaly NNP I-NP O
No NNP I-NP O
evidence NN I-NP O
edema NN I-NP O
or CC O O
infiltrate NN B-NP O
Pain NNP I-NP O
film NN I-NP O
of IN B-VP O
left JJ B-NP O
leg: JJ I-NP O
Transverse NN I-NP O
fractures NNS I-NP O
through IN B-VP O
the DT B-NP O
mid NN I-NP O
tibia NN I-NP O
and CC O O
fibula JJ B-NP O
diaphysis NN I-NP O
with IN B-VP O
mild JJ B-NP O
medial JJ I-NP O
displacement NN I-NP O
, , O O
and CC O O
valgus NN B-NP O
and CC O O
anterior JJ B-NP O
angulation NN I-NP O
, , O O
unchanged JJ B-NP O
_________________________________________ NNP I-NP O
IMPRESSION: NNP I-NP O
72F CD O O
with IN B-VP O
multiple JJ B-NP O
chronic JJ I-NP O
medical JJ I-NP O
problems NNS I-NP O
s/p JJ B-NP O
recent JJ I-NP O
tib/fib NN I-NP O
fx NN I-NP O
( ( O O
non-surg JJ B-NP O
mgmt NN I-NP O
) ) O O
admitted VBD B-VP O
for IN B-VP O
evaluation NN B-NP O
of IN B-VP O
her PRP$ O O
fracture NN B-NP O
She PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
medicine VB O O
for IN B-VP O
"longterm JJ B-NP O
placement." NN I-NP O
Yet NNP I-NP O
upon IN B-VP O
interview NN B-NP O
of IN B-VP O
the DT B-NP O
family NN I-NP O
they PRP O O
intend VBP O O
for IN B-VP O
Ms NNP B-NP O
Pall NNP I-NP O
to TO O O
go VB O O
home NN B-NP O
after IN B-VP O
this DT B-NP O
hospital NN I-NP O
stay NN I-NP O
From IN B-VP O
there RB O O
, , O O
she PRP O O
will MD O O
transition VB O O
to TO O O
assisted VBN O O
living NN B-NP O
Over IN B-VP O
the DT B-NP O
last JJ I-NP O
few JJ I-NP O
months NNS I-NP O
, , O O
she PRP O O
has VBZ O O
declined VBN O O
to TO O O
take VB O O
any DT B-NP O
medications NNS I-NP O
or CC O O
treatment NN B-NP O
for IN B-VP O
her PRP$ O O
chronic JJ B-NP O
kidney NN I-NP O
disease NN I-NP O
or CC O O
cardiac JJ B-NP O
disease NN I-NP O
This DT O O
has VBZ O O
led VBN O O
to TO O O
progressive VB O O
renal JJ B-NP O
disease NN I-NP O
, , O O
electrolyte JJ B-NP O
abnormalities NNS I-NP O
and CC O O
myopathy VB O O
The DT B-NP O
family NN I-NP O
brings VBZ O O
her PRP$ O O
in IN B-VP O
with IN B-VP O
concerns NNS B-NP O
regarding VBG O O
her PRP$ O O
left JJ B-NP O
leg NN I-NP O
While IN B-VP O
they PRP O O
do VBP O O
want VB O O
to TO O O
transition VB O O
to TO O O
assisted JJ B-NP O
living NN I-NP O
, , O O
they PRP O O
do VBP O O
not RB O O
intend VB O O
to TO O O
place VB O O
her PRP$ O O
directly RB O O
from IN B-VP O
DUOMC NNP B-NP O
to TO O O
RH NNP B-NP O
or CC O O
Rehab NNP B-NP O
They PRP O O
hope VBP O O
she PRP O O
will MD O O
go VB O O
home NN B-NP O
after IN B-VP O
this DT B-NP O
hospital NN I-NP O
stay NN I-NP O
and CC O O
continue NN B-NP O
with IN B-VP O
VNA/services NNP B-NP O
ORTHO: NNP I-NP O
Tib/fib NNP I-NP O
fracture NN I-NP O
Non-surgically RB O O
managed VBD B-VP O
Followed NNP B-NP O
by IN B-VP O
Dr NNP B-NP O
Alirez NNP I-NP O
Seen NNP I-NP O
by IN B-VP O
Orthopedic NNP B-NP O
service NN I-NP O
who WP O O
discussed VBD B-VP O
the DT O O
2 CD O O
options: NNS B-NP O
casting VBG O O
with IN B-VP O
patellar JJ B-NP O
tendon NNS I-NP O
bearing VBG O O
cast NN B-NP O
or CC O O
surgery NN B-NP O
As IN B-VP O
before RB O O
, , O O
patient NN B-NP O
declined VBD B-VP O
surgery NN B-NP O
( ( O O
this DT B-NP O
decision NN I-NP O
has VBZ O O
been VBN O O
supported VBN O O
by IN B-VP O
her PRP$ O O
PCP NNP B-NP O
and CC O O
cardiologist NN B-NP O
as IN B-VP O
she PRP O O
is VBZ O O
a DT B-NP O
high JJ I-NP O
risk NN I-NP O
surgical JJ B-NP O
candidate NN I-NP O
) ) O O
There EX O O
were VBD B-VP O
no DT O O
casting VBG O O
technicians NNS B-NP O
in-house RB O O
this DT B-NP O
weekend NN I-NP O
Therefore NNP I-NP O
she PRP O O
will MD O O
followup VB O O
in IN B-VP O
the DT B-NP O
Orthopedics NNP I-NP O
clinic NN I-NP O
on IN B-VP O
Wednesday NNP B-NP O
, , O O
as IN B-VP O
instructed VBN O O
by IN B-VP O
the DT B-NP O
ortho JJ I-NP O
resident NN I-NP O
on IN B-VP O
call NN B-NP O
CKD NNP I-NP O
Monitor NNP I-NP O
renal JJ B-NP O
function NN I-NP O
and CC O O
lytes VBZ O O
Patient NNP B-NP O
agreed VBD B-VP O
to TO O O
take VB O O
vitamin JJ B-NP B-m
supplements NNS I-NP O
such JJ O O
as IN B-VP O
nephrocaps NNS B-NP B-m
Phosphate NNP I-NP B-m
was VBD B-VP O
wnl JJ O O
despite IN B-VP O
not RB O O
taking VBG O O
phoslo NN B-NP O
at IN B-VP O
home NN B-NP O
CHRONIC NNP I-NP B-r
HYPOCALCEMIA: NNP I-NP I-r
Elevated NNP I-NP O
PTH NNP I-NP O
Patient NNP I-NP O
agreed VBD B-VP O
to TO O O
take VB O O
calcitriol NN B-NP B-m
ENDOCRINE: NNP I-NP O
recent JJ O O
elevated VBD B-VP O
TSH NNP B-NP O
T3/T4 NNP I-NP O
pending VBG O O
at IN B-VP O
discharge NN B-NP O
-H/o NNP I-NP O
Diabetes VBZ O O
yet RB O O
with IN B-VP O
progressive JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
does VBZ O O
not RB O O
require VB O O
insulin NN B-NP O
and CC O O
with IN B-VP O
nl JJ B-NP O
A1C NNP I-NP O
CV: NNP I-NP O
EF NNP I-NP O
30% CD O O
, , O O
multiple JJ B-NP O
prior JJ I-NP O
admits NNS I-NP O
for IN B-VP O
CHF NNP B-NP O
Was NNP I-NP O
in IN B-VP O
NOT NNP B-NP O
in IN B-VP O
CHF NNP B-NP O
on IN B-VP O
admission NN B-NP O
and CC O O
had VBD B-VP O
stable JJ B-NP O
O2 NNP I-NP O
saturation NN I-NP O
at IN B-VP O
98-100% CD O O
on IN B-VP O
RA NNP B-NP O
with IN B-VP O
no DT B-NP O
recent JJ I-NP O
increase NN I-NP O
in IN B-VP O
DOE NNP B-NP O
FEN: NNP I-NP O
House NNP I-NP O
diet JJ B-NP O
Needs NNP I-NP O
nutritional JJ B-NP B-m
supplements/boost NN I-NP I-m
Nephrocaps NNP I-NP B-m
DISPO: NNP I-NP O
screen NN I-NP O
for IN B-VP O
assisted JJ B-NP O
living NN I-NP O
-PT NN I-NP O
consult NN I-NP O
-SW NNP I-NP O
consult NN I-NP O
PROPH: NNP I-NP O
Heparin NNP I-NP B-m
TID NNP I-NP B-f
Nexium NNP I-NP B-m
( ( O O
has VBZ O O
h/o VBN O O
esophagitis RB O B-r
esophagitis NN B-NP B-r
) ) O O
CODE: NNP B-NP O
Has NNP I-NP O
been VBN O O
DNR/DNI NNP B-NP O
in IN B-VP O
past JJ B-NP O
Daughter NN I-NP O
wants VBZ O O
to TO O O
discuss VB O O
further JJ O O
with IN B-VP O
mother NN B-NP O
Will NNP I-NP O
discuss VBZ O O
tomorrow NN B-NP O
HC NNP I-NP O
proxy: NN I-NP O
Omar NNP I-NP O
Toting NNP I-NP O
729-547-1855 JJ O O
( ( O O
cell NN B-NP O
) ) O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
No NNP I-NP O
changes NNS I-NP O
were VBD B-VP O
made VBN O O
to TO O O
your PRP$ O O
medications NNS B-NP O
We PRP O O
strongly RB O O
advise VBP O O
you PRP O O
to TO O O
take VB O O
the DT B-NP O
medications NNS I-NP O
that IN B-VP O
your PRP$ O O
cardiologist NN B-NP O
and CC O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
have VBP O O
prescribed VBN O O
You PRP O O
were VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Orthopedic NNP I-NP O
Surgery NNP I-NP O
service NN I-NP O
while IN B-VP O
you PRP O O
were VBD B-VP O
in IN B-VP O
hospital NN B-NP O
and CC O O
the DT B-NP O
recommendation NN I-NP O
is VBZ O O
that IN B-VP O
you PRP O O
are VBP O O
fitted VBN O O
for IN B-VP O
a DT B-NP O
special JJ I-NP O
cast NN I-NP O
called VBD B-VP O
a DT B-NP O
"patellar JJ I-NP O
tendon NN I-NP O
bearing NN I-NP O
cast." NN I-NP O
Please NNP I-NP O
contact VB O O
the DT B-NP O
Orthopedics NNP I-NP O
Clinic NNP I-NP O
first JJ B-NP O
thing NN I-NP O
on IN B-VP O
Tuesday NNP B-NP O
AM NNP I-NP O
260-199-2283 JJ O O
They PRP O O
will MD O O
arrange VB O O
for IN B-VP O
you PRP O O
to TO O O
see VB O O
Dr NNP B-NP O
Paonessa NNP I-NP O
on IN B-VP O
Wednesday NNP B-NP O
for IN B-VP O
casting VBG O O
DISCHARGE NNP B-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
ABREV NNP I-NP O
, , O O
SAMMY NNP B-NP O
R NNP I-NP O
, , O O
MD NNP B-NP O
( ( O O
IX708 NNP B-NP O
) ) O O
4/2/06 CD O O
@ $ O O
03 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#771801 VBZ O O
245615272 CD O O
V NNP B-NP O
24092373 CD O O
8613599 CD O O
0/12/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
cad NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
1/14/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/25/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
CAPLAN NNP I-NP O
, , O O
JARRETT NNP B-NP O
356-18-18-9 CD O O
Lau NNP B-NP O
Room: NNP I-NP O
70G-872 JJ B-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
10/1/06 CD O O
AT NNP B-NP O
11:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
PARADISE NNP I-NP O
, , O O
JARROD NNP B-NP O
ERICH NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
DIGOXIN NNP I-NP B-m
0.25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
EVERY NNP I-NP B-f
OTHER NNP I-NP I-f
DAY NNP I-NP I-f
GLYBURIDE NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
ISORDIL NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
DINITRATE NNP I-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
DILANTIN NNP I-NP B-m
DILANTIN NNP I-NP B-m
DILANTIN NNP I-NP B-m
DILANTIN NNP I-NP B-m
DILANTIN NNP I-NP B-m
DILANTIN NNP I-NP B-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
PHENYTOIN NNP B-NP I-m
PHENYTOIN NNP I-NP I-m
PHENYTOIN NNP I-NP I-m
PHENYTOIN NNP I-NP I-m
PHENYTOIN NNP I-NP I-m
PHENYTOIN NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
200 CD O B-do
MG NNP B-NP I-do
QAM; NNP I-NP B-f
250 CD O B-do
250 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
QPM NNP I-NP B-f
QPM NNP I-NP B-f
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP I-f
BEDTIME NNP I-NP I-f
200 CD O B-do
MG NNP B-NP I-do
QAM NNP I-NP B-f
250 CD O B-do
MG NNP B-NP I-do
QPM NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
11/27 CD O O
) ) O O
Instructions: NNP B-NP O
also RB O O
take VBP O O
200mg CD O B-do
every DT B-NP B-f
afternoon NN I-NP I-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
If IN B-VP O
on IN B-VP O
tube NN B-NP O
feeds NNS I-NP O
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
TOPROL NNP B-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
2 CD O O
NEURONTIN NNP B-NP B-m
( ( O I-m
GABAPENTIN NNP B-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
PLAVIX NNP I-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
BENAZEPRIL NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
GLUCOPHAGE NNP I-NP B-m
( ( O I-m
METFORMIN NNP B-NP I-m
) ) O I-m
850 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
Instructions: NNP I-NP O
resume NN I-NP O
tomorrow NN I-NP O
9/11/06 CD O O
CELONTIN NNP B-NP B-m
( ( O I-m
METHSUXIMIDE NNP B-NP I-m
) ) O I-m
300 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ NNP I-NP O
ADA NNP I-NP O
2100 CD O O
cals/dy NN B-NP O
ACTIVITY: NNP I-NP O
no DT B-NP O
heavy JJ I-NP O
lifting NN I-NP O
for IN B-VP O
3-4 JJ B-NP O
days NNS I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Nehring NNP I-NP O
call NN I-NP O
for IN B-VP O
appointment NN B-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
cad NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
cad VBZ O O
OTHER NNP B-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
dm NN I-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
dyslipidemia NN B-NP O
( ( O O
dyslipidemia NN B-NP O
) ) O O
htn NN B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
cad NN B-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
chf NN B-NP O
( ( O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
) ) O O
s/p NN B-NP O
cabg NN I-NP O
( ( O O
S/P NNP B-NP O
cardiac JJ B-NP O
bypass NN I-NP O
graft NN I-NP O
surgery NN I-NP O
) ) O O
seizure NN B-NP O
( ( O O
seizure JJ B-NP O
disorder NN I-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
s/p VBD B-VP O
cath JJ B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
ID/CC: NNP I-NP O
63M CD O O
transferred VBD B-VP O
from IN B-VP O
LMC NNP B-NP O
with IN B-VP O
positive JJ B-NP O
stress NN I-NP O
test NN I-NP O
HPI NNP I-NP O
Pateint NNP I-NP O
has VBZ O O
h/o VBN O O
CABG NNP B-NP O
LIMA-D1 NNP I-NP O
, , O O
V-OM1 NNP B-NP O
, , O O
V-OM2 NNP B-NP O
, , O O
V NNP B-NP O
Y-graft NNP I-NP O
to TO O O
PDA NNP B-NP O
and CC O O
PLV NNP B-NP O
Presented NNP I-NP O
to TO O O
FAH NNP B-NP O
on IN B-VP O
Monday NNP B-NP O
with IN B-VP O
exertional JJ B-NP O
angina NNS I-NP O
ROMI NNP I-NP O
Nuclear NNP I-NP O
stress NN I-NP O
reveled VBD B-VP O
inferior JJ B-NP O
scar NN I-NP O
and CC O O
small JJ B-NP O
area NN I-NP O
of IN B-VP O
anterior JJ B-NP O
ischemia NN I-NP O
Transferred NNP I-NP O
to TO O O
CTMC NNP B-NP O
for IN B-VP O
cath NN B-NP O
PMH NNP I-NP O
Seizure NNP I-NP O
d/o NN I-NP O
, , O O
DM NNP B-NP O
, , O O
CHF NNP B-NP O
, , O O
CAD NNP B-NP O
, , O O
CABG NNP B-NP O
, , O O
HTN NNP B-NP O
COPD NNP I-NP O
, , O O
Schizo-affecitve NNP B-NP O
disorder NN I-NP O
, , O O
dyslipidemia NN B-NP O
Meds NNP I-NP O
on IN B-VP O
transfer: NN B-NP O
Dilantin300/300/250 NNP I-NP B-m
, , O O
glyburide RB O B-m
10 CD O B-do
BID NNP B-NP B-f
, , O O
metformin VBD B-VP B-m
850 CD O B-do
tid NN B-NP B-f
, , O O
toprol VB O B-m
100 CD O B-do
Daily NNP B-NP B-f
, , O O
ASA NNP B-NP B-m
325 CD O B-do
daily RB O B-f
, , O O
isordil JJ O B-m
20tid CD O B-do
, , O O
lasix VBD B-VP B-m
20 CD O B-do
QOD NNP B-NP B-f
, , O O
lipitor NN B-NP B-m
40 CD O B-do
Daily NNP B-NP B-f
, , O O
neurontin NN B-NP B-m
, , O O
celondin VBP O B-m
300 CD O B-do
TID NNP B-NP B-f
, , O O
digoxin VBZ O B-m
0.25 CD O B-do
Daily NNP B-NP B-f
, , O O
benazepril VBD B-VP B-m
10 CD O B-do
daily JJ B-NP B-f
Allergies: NNP I-NP O
None NNP I-NP O
SH: NNP I-NP O
lives VBZ O O
alone RB O O
****Hospital JJ B-NP O
Course NNP I-NP O
1 CD O O
CV: NNP B-NP O
Cath NNP I-NP O
LIMA-LAD NNP I-NP O
patient NN I-NP O
SVG NNP I-NP O
Y NNP I-NP O
graft NN I-NP O
to TO O O
PDA NNP B-NP O
and CC O O
LV NNP B-NP O
mid VBD B-VP O
50% CD O O
in IN B-VP O
graft NN B-NP O
stenosis NN I-NP O
SVG NNP I-NP O
to TO O O
both DT B-NP O
OM NNP I-NP O
branches NNS I-NP O
occluded VBD B-VP O
RCA NNP B-NP O
100% CD O O
, , O O
LAD NNP B-NP O
mid VBD B-VP O
100% CD O O
, , O O
LCx NNP B-NP O
100%.Patient CD O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
ASA NNP B-NP B-m
resistant JJ O O
will MD O O
change VB O O
to TO O O
plavix VB O B-m
75 CD O B-do
daily RB O B-f
Other JJ B-NP O
meds: NNS I-NP O
Toprol VBP O B-m
100 CD O B-do
daily RB O B-f
, , O O
isordil JJ O B-m
20 CD O B-do
tid NN B-NP B-f
Lasix NNP I-NP B-m
20 CD O B-do
QOD NNP B-NP B-f
atorva RB O B-m
switched VBD B-VP O
to TO O O
simva VB O B-m
in IN B-VP O
house NN B-NP O
, , O O
benazepril NN B-NP B-m
to TO O O
lisinopril VB O B-m
10 CD O B-do
, , O O
digoxin NN B-NP B-m
0.25 CD O B-do
2 CD O O
DM: NNP B-NP O
will MD O O
continue VB O O
to TO O O
hold VB O O
metformin NN B-NP B-m
, , O O
restart VB O O
glyburide NN B-NP B-m
and CC O O
start VB O O
RISS NNP B-NP B-m
3 CD O O
Staying VBG O O
overnight RB O O
as IN B-VP O
he PRP O O
lives VBZ O O
alone RB O O
, , O O
has VBZ O O
no DT B-NP O
way NN I-NP O
of IN B-VP O
getting VBG O O
home NN B-NP O
4 CD O O
Neuro: NNP B-NP O
Cont NNP I-NP O
neurontin RB O B-m
300 CD O B-do
TID NNP B-NP B-f
, , O O
dilantin NN B-NP B-m
200/200/250 CD O B-do
, , O O
celondin- JJ O B-m
listed VBN O O
on IN B-VP O
meds NNS B-NP B-m
on IN B-VP O
discharge NN B-NP O
, , O O
but CC O O
not RB O O
on IN B-VP O
home NN B-NP O
meds NNS I-NP B-m
It PRP O O
is VBZ O O
unclear JJ O O
if IN B-VP O
he PRP O O
should MD O O
be VB O O
on IN B-VP O
this DT O O
or CC O O
not RB O O
0/26/06 CD O O
pt NNS B-NP O
stable JJ O O
and CC O O
ready JJ O O
for IN B-VP O
d/c JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
take VB O O
all DT B-NP O
medications NNS I-NP B-m
as IN B-VP O
prescribed JJ B-NP O
Call NNP I-NP O
with IN B-VP O
any DT B-NP O
questions NNS I-NP O
or CC O O
concerns NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
BEHM NNP I-NP O
, , O O
CRISTOBAL NNP B-NP O
, , O O
PA NNP B-NP O
( ( O O
EY28 NNP B-NP O
) ) O O
10/1/06 CD O O
@ $ O O
10:50 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#781623 VBZ O O
863982363 CD O O
SHO NNP B-NP O
55476585 CD O O
8040272 CD O O
10/1/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Cellulitis NNP I-NP O
and CC O O
foor JJ B-NP O
ulcer- JJ I-NP O
Diabetic NNP I-NP O
foot NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/13/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
11/6/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SZALAY NNP I-NP O
, , O O
RANDY NNP B-NP O
021-73-77-2 CD O O
Amore NNP B-NP O
Sterfield NNP I-NP O
Rouge NNP I-NP O
Service: NNP I-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
0/27/05 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KLEVENE NNP I-NP O
, , O O
CHADWICK NNP B-NP O
F NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
PH.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
BENADRYL NNP I-NP B-m
( ( O I-m
DIPHENHYDRAMINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Itching NNP I-NP B-r
FUROSEMIDE NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;90 VBD B-VP O
GLYBURIDE NNP B-NP B-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LISINOPRIL NNP I-NP B-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
sbp&lt;90 VBD B-VP O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/4/05 CD O O
by IN B-VP O
VIENNEAU NNP B-NP O
, , O O
KENNY NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
38315645 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
LISINOPRIL NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP O
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
pt NN I-NP O
requires VBZ O O
COUMADIN NNP B-NP B-m
( ( O I-m
WARFARIN NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
2.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
Starting NNP I-NP O
NOW NNP I-NP O
, , O O
Within NNP B-NP O
Hour NNP I-NP O
of IN B-VP O
Pharmacy NNP B-NP O
Approval NNP I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
No NNP I-NP O
high JJ B-NP O
Vitamin-K NNP I-NP O
containing VBG O O
foods NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/29/05 CD O O
by IN B-VP O
YEISER NNP B-NP O
, , O O
ALPHONSO NNP B-NP O
L NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
BACTRIM NNP B-NP B-m
DS NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
59937390 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
SULFAMETHOXAZOLE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok VBP O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/4/05 CD O O
by IN B-VP O
PARMS NNP B-NP O
, , O O
WILFORD NNP B-NP O
M NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok JJ B-NP O
SIMVASTATIN NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Starting VBG O O
ON NNP B-NP O
10/11/2005 CD O O
( ( O O
0/7 CD O O
) ) O O
Food/Drug NNP B-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
1/4/05 CD O O
by IN B-VP O
SERVANO NNP B-NP O
, , O O
MAJOR NNP B-NP O
D NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
COUMADIN NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
28522744 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
SIMVASTATIN NNP I-NP B-m
&amp; NNP I-NP O
WARFARIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
ok VBP O O
Previous NNP B-NP O
override IN B-VP O
information: JJ B-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
10/23/05 CD O O
by IN B-VP O
MCCULLORS NNP B-NP O
, , O O
ELDEN NNP B-NP O
RONNIE NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
WARFARIN NNP I-NP B-m
&amp; NNP I-NP O
SIMVASTATIN NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
LINEZOLID NNP B-NP B-m
600 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
This DT B-NP O
order NN I-NP O
has VBZ O O
received VBN O O
infectious JJ B-NP O
disease NN I-NP O
approval NN I-NP O
from IN B-VP O
VANHEKKEN NNP B-NP O
, , O O
RICK NNP B-NP O
VANCE NNP I-NP O
, , O O
M.D NNP B-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
9/29/05 CD O O
by IN B-VP O
SARNACKI NNP B-NP O
, , O O
GABRIEL NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
TRAMADOL NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
LINEZOLID NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: JJ B-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ B-NP O
): NN I-NP O
6 CD O O
DIET: NNP B-NP O
No NNP I-NP O
Restrictions NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
derm NN I-NP O
clinic NN I-NP O
, , O O
vascular JJ B-NP O
surgery NN I-NP O
, , O O
orthopedic JJ B-NP O
surgery NN I-NP O
, , O O
PCP NNP B-NP O
, , O O
Arrange NNP B-NP O
INR NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
on IN B-VP O
8/5/05 CD O O
with IN B-VP O
f/u JJ B-NP O
INR's NNP I-NP O
to TO O O
be VB O O
drawn VBN O O
every DT O O
7 CD O O
days NNS B-NP O
INR's NNP I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
PCP NNP B-NP O
ALLERGY: NNP I-NP O
Penicillins NNP I-NP O
, , O O
Cephalosporins NNP B-NP O
, , O O
QUINOLONES NNP B-NP O
, , O O
CIPROFLOXACIN NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Cellulitis NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Cellulitis NNP B-NP O
and CC O O
foor JJ B-NP O
ulcer- JJ I-NP O
Diabetic NNP I-NP O
foot NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
diabetes NNS I-NP O
( ( O O
diabetes NNS B-NP O
mellitus VBP O O
) ) O O
htn NN B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
edema NN B-NP O
( ( O O
peripheral JJ B-NP O
edema NN I-NP O
) ) O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
recurrent NN B-NP O
cellulitis NN I-NP O
( ( O O
cellulitis NN B-NP O
) ) O O
mitral NN B-NP O
prolapse NN I-NP O
( ( O O
mitral JJ B-NP O
valve NN I-NP O
prolapse NN I-NP O
) ) O O
uti NN B-NP O
( ( O O
urinary JJ B-NP O
tract NN I-NP O
infection NN I-NP O
) ) O O
atopic NN B-NP O
dermatitis NN I-NP O
( ( O O
dermatitis NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
debridement NN I-NP O
of IN B-VP O
R NNP B-NP O
foot NN I-NP O
ulcer NN I-NP O
by IN B-VP O
othopedics NNS B-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
bone NN B-NP O
scan JJ B-NP O
cxr NN I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
ID: NNP I-NP O
60 CD O O
YO NNP B-NP O
female JJ B-NP O
--- NNP I-NP O
CC: NNP I-NP O
RLE NNP I-NP O
ulceration/redness/pain JJ B-NP O
--- NNP I-NP O
DX: NNP I-NP O
Diabetic NNP I-NP O
foot NN I-NP O
ulcer NN I-NP O
--- NNP I-NP O
HPI: NNP I-NP O
60 CD O O
YO NNP B-NP O
female NN I-NP O
with IN B-VP O
DMII NNP B-NP O
, , O O
PVD NNP B-NP O
, , O O
chronic JJ B-NP B-r
AF NNP I-NP I-r
now RB O O
with IN B-VP O
DDI NNP B-NP O
pacer NN I-NP O
on IN B-VP O
coumadin NN B-NP B-m
who WP O O
has VBZ O O
had VBD B-VP O
history NN B-NP O
of IN B-VP O
recurrent NN B-NP O
LE NNP I-NP O
ulcerations NNS I-NP O
and CC O O
infections NNS B-NP O
She PRP O O
had VBD B-VP O
the DT B-NP O
left JJ I-NP O
foot NN I-NP O
amputated VBD B-VP O
9/13 CD O O
and CC O O
has VBZ O O
been VBN O O
considering VBG O O
amputation NN B-NP O
of IN B-VP O
the DT B-NP O
right NN I-NP O
An DT B-NP O
ulcer NN I-NP O
developed VBD B-VP O
2/4 CD O O
treated VBN O O
with IN B-VP O
dressing NN B-NP O
changes NNS I-NP O
and CC O O
local JJ B-NP O
care NN I-NP O
Now RB O O
having VBG O O
swelling/erythema/pain VBN O O
X JJ O O
2 CD O O
days NNS B-NP O
Admitted VBN O O
for IN B-VP O
IV NNP B-NP B-mo
abx NN I-NP B-m
--- NNP I-NP O
STATUS: NNP I-NP O
VS: NNP I-NP O
T:98.4 NNP I-NP O
HR:84 NNP I-NP O
BP:112/70 NNP I-NP O
RR: NNP I-NP O
20 CD O O
SaO2:100%RA NNP B-NP O
GEN: NNP I-NP O
NAD NNP I-NP O
NECK: NNP I-NP O
no DT B-NP O
JVD NNP I-NP O
CHEST: NNP I-NP O
CTA NNP I-NP O
bilaterally RB O O
CV: NNP B-NP O
RRR NNP I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
3/6 CD O O
SEM NNP B-NP O
at IN B-VP O
base NN B-NP O
, , O O
no DT B-NP O
gallop NN I-NP O
ABD: NNP I-NP O
soft JJ O O
, , O O
NT NNP B-NP O
, , O O
ND NNP B-NP O
, , O O
bowel NN B-NP O
sounds NNS I-NP O
present JJ B-NP O
EXT: NNP I-NP O
Left NNP I-NP O
foot NN I-NP O
amputated VBD B-VP O
, , O O
R NNP B-NP O
with IN B-VP O
charcot JJ B-NP O
joint/hindfoot NN I-NP O
varus NN I-NP O
, , O O
erthema NN B-NP O
, , O O
draining VBG O O
ulcer JJ B-NP O
fifth JJ I-NP O
metatarcel NN I-NP O
, , O O
edema FW O O
--- NNP B-NP O
EVENTS: NNP I-NP O
10/16 CD O O
admitted VBD B-VP O
to TO O O
medicine VB O O
--- NNP B-NP O
TESTS/PROCEDURES: NNP I-NP O
10/16 CD O O
- : O O
RLE NN B-NP O
plain NN I-NP O
films NNS I-NP O
- : O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
osteo $ O O
10/16 CD O O
- : O O
MR NNP B-NP O
RLE NNP I-NP O
- : O O
pending VBG O O
--- NNP B-NP O
CONSULTS: NNP I-NP O
5/12 CD O O
ID NNP B-NP O
- : O O
has VBZ O O
multiple JJ B-NP O
allergies NNS I-NP O
and CC O O
has VBZ O O
been VBN O O
on IN B-VP O
several JJ B-NP O
agents NNS I-NP O
in IN B-VP O
the DT O O
past JJ O O
5/12 CD O O
Ortho NNP B-NP O
- : O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Klose NNP I-NP O
--- NNP I-NP O
PROBLEM NNP I-NP O
LIST NNP I-NP O
--- NNP I-NP O
1 CD O O
) ) O O
RLE NNP B-NP O
ulcer JJ O O
- : O O
diabetic JJ B-NP B-r
foot NN I-NP I-r
ulcer NN I-NP I-r
with IN B-VP O
? . B-VP O
osteo NN B-NP O
Plain NNP I-NP O
films NNS I-NP O
negative JJ O O
but CC O O
early JJ B-NP O
signs NNS I-NP O
may MD O O
be VB O O
absent JJ O O
Started VBN O O
on IN B-VP O
unasyn NN B-NP B-m
in IN B-VP O
ED NNP B-NP O
and CC O O
toleratied VBD B-VP O
Allergic NNP B-NP O
to TO O O
quinolones NNS B-NP O
and CC O O
cephlosporins VBZ O O
Bone NNP B-NP O
scan JJ O O
ordered VBD B-VP O
Wound NNP B-NP O
swap NN I-NP O
cx NN I-NP O
grew VBD B-VP O
2+ CD O O
staph NN B-NP O
aureus.Susceptibilities NNS I-NP O
showed VBD B-VP O
MRSA.ID NNP B-NP O
consult NN I-NP O
recommended VBD B-VP O
to TO O O
cont VB O O
unasyn JJ O B-m
and CC O O
switch VB O O
to TO O O
Po NNP B-NP B-mo
linezolid NN I-NP B-m
as IN B-VP O
outpt NN B-NP O
since IN B-VP O
pt NN B-NP O
refused VBD B-VP O
to TO O O
take VB O O
bactrim JJ O B-m
stating VBG O O
allergy NN B-NP O
to TO O O
med VB O O
Ortho NNP B-NP O
consult- NN I-NP O
debrided VBD B-VP O
wound NN B-NP O
to TO O O
vaible JJ B-NP O
tissue NN I-NP O
Pt NNP I-NP O
Was NNP I-NP O
seen VBN O O
by IN B-VP O
Dr NNP B-NP O
Linkous NNP I-NP O
her PRP O O
out RP O O
pt JJ B-NP O
orthopedist- NN I-NP O
will MD O O
have VB O O
out RP O O
pt JJ B-NP O
reconstructive JJ I-NP O
theapy NN I-NP O
of IN B-VP O
her PRP$ O O
right JJ B-NP O
foot NN I-NP O
after IN B-VP O
vascular JJ B-NP O
eval NN I-NP O
On IN B-VP O
10/22 CD O O
pt NN B-NP O
developed VBD B-VP O
rash NN B-NP O
on IN B-VP O
her PRP$ O O
legs NNS B-NP O
and CC O O
attributed VBD B-VP O
it PRP O O
to TO O O
the DT O O
unasyn JJ O B-m
She PRP O O
had VBD B-VP O
no DT O O
breathing VBG O O
difficulty NN B-NP O
or CC O O
any DT B-NP O
other JJ I-NP O
symptoms NNS I-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
benadry NN B-NP B-m
and CC O O
the DT B-NP O
unasyn NN I-NP B-m
was VBD B-VP O
discontinued VBN O O
As IN B-VP O
at IN B-VP O
discharge NN B-NP O
pt NN I-NP O
had VBD B-VP O
shown VBN O O
marked JJ B-NP O
improvement NN I-NP O
of IN B-VP O
both DT B-NP O
cellulitis NN I-NP O
and CC O O
ulcer JJ B-NP O
Pt NNP I-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
out RP O O
patient NN B-NP O
care NN I-NP O
takers NNS I-NP O
--- VBP O O
2 CD O O
) ) O O
DMII NNP B-NP B-r
DMII NNP I-NP B-r
- : O O
on IN B-VP O
glyburide NN B-NP B-m
, , O O
ADA NNP B-NP O
diet NN I-NP O
, , O O
RISS NNP B-NP B-m
--- NNP I-NP O
3 CD O O
) ) O O
AF/SSS NNP B-NP B-r
- : O O
has VBZ O O
DDI VBN O O
PPM NNP B-NP O
in IN B-VP O
and CC O O
is VBZ O O
on IN B-VP O
coumadin NN B-NP B-m
Last JJ B-NP O
INR NNP I-NP O
check NN I-NP O
was VBD B-VP O
subtherapeutic JJ O O
at IN B-VP O
1.3 CD O O
Pt NNP B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
coumadin NN B-NP O
clinic JJ B-NP O
--- NNP I-NP O
4 CD O O
) ) O O
CKD NNP B-NP O
- : O O
likely JJ O O
secondary JJ O O
to TO O O
DM NNP B-NP O
- : O O
at IN B-VP O
baseline NN B-NP O
--- NNP I-NP O
5 CD O O
) ) O O
FULL NNP B-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
your PRP$ O O
PCP NNP B-NP O
in IN B-VP O
1-2 JJ B-NP O
wks NN I-NP O
Please NNP I-NP O
ensure VB O O
your PRP$ O O
right JJ B-NP O
foot NN I-NP O
is VBZ O O
elevated VBN O O
and CC O O
wound IN B-VP O
dressing NN B-NP O
changes NNS I-NP O
are VBP O O
done VBN O O
daily JJ B-NP O
pls NNS I-NP O
follow VBP O O
up RP O O
with IN B-VP O
all DT O O
your PRP$ O O
out RP O O
patient JJ B-NP O
doctors NNS I-NP O
Pls NNP I-NP O
call VB O O
urgent JJ B-NP O
care NN I-NP O
clinic NN I-NP O
on IN B-VP O
thurs NNS B-NP O
at IN B-VP O
6/13/05 CD O O
at IN B-VP O
372 CD O O
568 CD O O
4157 CD O O
to TO O O
have VB O O
a DT B-NP O
doctor NN I-NP O
check VB O O
your PRP$ O O
ulcer JJ B-NP O
pls NN I-NP O
follow VB O O
up RP O O
with IN B-VP O
your PRP$ O O
coumadin NN B-NP O
clinic NN I-NP O
to TO O O
have VB O O
INR NNP B-NP O
checked VBN O O
Pls NNP B-NP O
take VB O O
antibiotics NNS B-NP B-m
for IN B-VP B-du
7 CD O I-du
days NNS B-NP I-du
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
otho NN B-NP O
, , O O
vascular JJ B-NP O
surg NN I-NP O
, , O O
derm NN B-NP O
and CC O O
PCP NNP B-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
coumadin NN B-NP O
clinic JJ B-NP O
Cont NNP I-NP O
daily RB O O
wet VBZ O O
to TO O O
dry VB O O
wound NN B-NP O
dressings VBZ O O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MARRIETTA NNP I-NP O
, , O O
TRENT NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
GD1 NNP B-NP O
) ) O O
0/27/05 CD O O
@ $ O O
12:06 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#787886 VBZ O O
671218080 CD O O
KLCBEH NNP B-NP O
47810552 CD O O
6298900 CD O O
9/0/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
tremor NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/0/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
7/6/2005 CD O O
****** NNP B-NP O
INCOMPLETE NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
RINGHAND NNP I-NP O
, , O O
ISMAEL NNP B-NP O
R NNP I-NP O
345-92-23-0 JJ B-NP O
Tlau NNP I-NP O
Lo NNP I-NP O
Poau NNP I-NP O
, , O O
Wisconsin NNP B-NP O
57220 CD O O
Service: NNP B-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
10/0/05 CD O O
AT NNP B-NP O
03:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
DEPIETRO NNP I-NP O
, , O O
RUSTY NNP B-NP O
ABDUL NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
Incomplete NNP I-NP O
Discharge NNP I-NP O
DISPOSITION: NNP I-NP O
Rehabilitation NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
CEFTRIAXONE NNP I-NP B-m
2 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
IV NNP I-NP B-mo
QD NNP I-NP B-f
DIGOXIN NNP I-NP B-m
0.25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QOD NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QOD NNP I-NP B-f
ISORDIL NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
DINITRATE NNP I-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
PRIMIDONE NNP B-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
VANCOMYCIN NNP I-NP B-m
HCL NNP I-NP I-m
1 CD O B-do
GM NNP B-NP I-do
IV NNP I-NP B-mo
Q36H NNP I-NP B-f
Starting NNP I-NP O
STAT NNP I-NP O
( ( O O
0/17 CD O O
) ) O O
SIMVASTATIN NNP B-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
NORVASC NNP B-NP B-m
( ( O I-m
AMLODIPINE NNP B-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
LOVENOX NNP B-NP B-m
( ( O I-m
ENOXAPARIN NNP B-NP I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
SC NNP I-NP B-mo
QD NNP I-NP B-f
COREG NNP I-NP B-m
( ( O I-m
CARVEDILOL NNP B-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;90 NNP I-NP O
, , O O
HR&lt;50 NNP B-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
Number NNP I-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
2 CD O I-du
FLOMAX NNP B-NP B-m
( ( O I-m
TAMSULOSIN NNP B-NP I-m
) ) O I-m
0.4 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
ESOMEPRAZOLE NNP I-NP B-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
LANTUS NNP I-NP B-m
( ( O I-m
INSULIN NNP B-NP I-m
GLARGINE NNP I-NP I-m
) ) O I-m
7 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QD NNP I-NP B-f
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
Sliding NNP I-NP B-do
Sliding NNP I-NP B-do
Scale NNP I-NP I-do
Scale NNP I-NP I-do
( ( O B-mo
subcutaneously RB O I-mo
) ) O I-mo
SC NNP B-NP I-mo
AC NNP I-NP B-f
AC NNP I-NP B-f
If IN B-VP O
BS NNP B-NP O
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
give VB O O
0 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP O
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
6 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP O
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
INSULIN NNP B-NP B-m
ASPART NNP I-NP I-m
17 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
AC NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
8/5 CD O O
) ) O O
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Not RB O O
Applicable NNP B-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
1 CD O O
week NN B-NP O
after IN B-VP O
d/c NN B-NP O
from IN B-VP O
rehab NN B-NP O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
r/o NN I-NP O
MI NNP I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
tremor NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
htn NN I-NP O
( ( O O
hypertension NN B-NP O
) ) O O
dm NN B-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
afib NN B-NP O
( ( O O
atrial JJ B-NP O
fibrillation NN I-NP O
) ) O O
cad NN B-NP O
( ( O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
) ) O O
bph NN B-NP O
( ( O O
benign JJ B-NP O
prostatic JJ I-NP O
hypertrophy NN I-NP O
) ) O O
gerd NN B-NP O
( ( O O
gastroesophageal JJ B-NP O
reflux NN I-NP O
disease NN I-NP O
) ) O O
hiatal NN B-NP O
hernia NN I-NP O
( ( O O
hiatal JJ B-NP O
hernia NN I-NP O
) ) O O
djd NN B-NP O
( ( O O
degenerative JJ B-NP O
joint NN I-NP O
disease NN I-NP O
) ) O O
pmr NN B-NP O
( ( O O
polymyalgia JJ B-NP O
rheumatica NN I-NP O
) ) O O
diverticulitis NN B-NP O
( ( O O
diverticulitis NN B-NP O
) ) O O
s/p NN B-NP O
AAA NNP I-NP O
repair NN I-NP O
1994 CD O O
( ( O O
10 CD O O
) ) O O
OPERATIONS NN B-NP O
AND CC O O
PROCEDURES: NNP B-NP O
none NN I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
88 CD O O
year NN B-NP O
old JJ B-NP O
man NN I-NP O
who WP O O
comes VBZ O O
in IN B-VP O
from IN B-VP O
rehab NN B-NP O
with IN B-VP O
?hypothermia NN B-NP O
and CC O O
rigors NNS B-NP O
6 CD O O
weeks NNS B-NP O
ago RB O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
diagnosed VBN O O
with IN B-VP O
osteomyelitis NN B-NP O
of IN B-VP O
the DT B-NP O
finger NN I-NP O
He PRP O O
had VBD B-VP O
a DT B-NP O
PICC NNP I-NP O
line NN I-NP O
placed VBD B-VP O
and CC O O
was VBD B-VP O
discharged VBN O O
with IN B-VP O
IV NNP B-NP B-mo
abx NN I-NP B-m
At IN B-VP O
the DT B-NP O
tail JJ I-NP O
end NN I-NP O
of IN B-VP O
his PRP$ O O
antibiotic JJ B-NP B-m
regimen NNS I-NP I-m
he PRP O O
spiked VBD B-VP O
a DT B-NP O
fever NN I-NP O
and CC O O
was VBD B-VP O
admitted VBN O O
to TO O O
VOWH VB O O
His PRP$ O O
course NN B-NP O
of IN B-VP O
antibiotics NNS B-NP B-m
was VBD B-VP O
extended VBN O O
and CC O O
he PRP O O
was VBD B-VP O
discharged VBN O O
to TO O O
rehab VB O O
on IN B-VP O
ceftriaxone NN B-NP B-m
and CC O O
vanc NN B-NP B-m
Today NN I-NP O
at IN B-VP O
the DT B-NP O
nursing NN I-NP O
home NN I-NP O
he PRP O O
was VBD B-VP O
observed VBN O O
to TO O O
be VB O O
"shaking" JJ O O
and CC O O
the DT B-NP O
staff NN I-NP O
was VBD B-VP O
concerned VBN O O
for IN B-VP O
rigors NNS B-NP O
However RB O O
, , O O
the DT B-NP O
patient NN I-NP O
says VBZ O O
his PRP$ O O
hands NNS B-NP O
were VBD B-VP O
just RB O O
quivering VBG O O
At IN B-VP O
the DT B-NP O
time NN I-NP O
, , O O
his PRP$ O O
temp NN B-NP O
at IN B-VP O
rehab NN B-NP O
was VBD B-VP O
92 CD O O
degrees NNS B-NP O
He PRP O O
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
ED NNP I-NP O
for IN B-VP O
evaluation NN B-NP O
In IN B-VP O
the DT B-NP O
ED NNP I-NP O
, , O O
his PRP$ O O
temperature NN B-NP O
was VBD B-VP O
normal JJ O O
He PRP O O
was VBD B-VP O
not RB O O
complaining VBG O O
of IN B-VP O
further JJ B-NP O
chills NNS I-NP O
or CC O O
rigors NNS B-NP O
However RB O O
, , O O
his PRP$ O O
EKG NNP B-NP O
demonstrated VBD B-VP O
new JJ B-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
V3-V5 NNP B-NP O
The DT B-NP O
patient NN I-NP O
denied VBD B-VP O
any DT B-NP O
CP/N/SOB/diaphoresis NNP I-NP O
His PRP$ O O
first JJ B-NP O
set NN I-NP O
of IN B-VP O
enzymes NNS B-NP O
were VBD B-VP O
negative JJ O O
He PRP O O
was VBD B-VP O
given VBN O O
aspirin RP O B-m
PMH: NNP B-NP O
HTN NNP I-NP O
, , O O
CAD NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
AFib NNP B-NP O
, , O O
PMR NNP B-NP O
, , O O
BPH NNP B-NP O
, , O O
DJD NNP B-NP O
, , O O
hiatal JJ B-NP O
hernia NN I-NP O
AAA NNP I-NP O
repair NN I-NP O
and CC O O
sigmoid JJ B-NP O
colectomy NN I-NP O
All: NNP I-NP O
NKDA NNP I-NP O
Medications NNP I-NP O
on IN B-VP O
Admission: NNP B-NP O
Lasix NNP I-NP B-m
20 CD O B-do
qod NN B-NP B-f
, , O O
Isordil NNP B-NP B-m
40 CD O B-do
bid NN B-NP B-f
, , O O
Prednisone NNP B-NP B-m
2 CD O B-do
qd NN B-NP B-f
, , O O
Primidone NNP B-NP B-m
50 CD O B-do
bid NN B-NP B-f
, , O O
Norvasc NNP B-NP B-m
5 CD O B-do
qd NN B-NP B-f
, , O O
Coreg NNP B-NP B-m
25 CD O B-do
bid NN B-NP B-f
, , O O
Flomax NNP B-NP B-m
0.4 CD O B-do
qd NN B-NP B-f
, , O O
Prilosec NNP B-NP B-m
OTC NNP I-NP I-m
20 CD O B-do
qd NN B-NP B-f
, , O O
Lipitor NNP B-NP B-m
20 CD O B-do
qd NN B-NP B-f
, , O O
ISS NNP B-NP B-m
, , O O
Lantus NNP B-NP B-m
7 CD O B-do
qd NN B-NP B-f
, , O O
Novolog NNP B-NP B-m
17 CD O B-do
qac NN B-NP B-f
, , O O
Lovenox NNP B-NP B-m
30 CD O B-do
qd NN B-NP B-f
, , O O
Vancomycin NNP B-NP B-m
1 CD O B-do
gm NN B-NP I-do
qod NN I-NP B-f
, , O O
Ceftriaxone NNP B-NP B-m
2 CD O B-do
gm NN B-NP I-do
qd NN I-NP B-f
, , O O
Digoxin NNP B-NP B-m
0.25 CD O B-do
qod NN B-NP B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
bid NN B-NP B-f
Medications NNS I-NP O
in IN B-VP O
ED: NNP B-NP O
NS NNP I-NP B-m
500 CD O B-do
cc NN B-NP I-do
, , O O
Aspirin NNP B-NP B-m
PE:97.2 NNP I-NP O
150/70 CD O O
76 CD O O
14 CD O O
97 CD O O
RA NNP B-NP O
elderly JJ O O
, , O O
NAD NNP B-NP O
, , O O
NCAT NNP B-NP O
, , O O
JVP NNP B-NP O
flat JJ O O
, , O O
CTAB NNP B-NP O
, , O O
RRR NNP B-NP O
3/6 CD O O
SEM NNP B-NP O
at IN B-VP O
RUSB NNP B-NP O
, , O O
soft JJ O O
, , O O
NT/ND NNP B-NP O
, , O O
guiac NN B-NP O
neg NN I-NP O
, , O O
no DT B-NP O
C/C/E NNP I-NP O
, , O O
fine JJ B-NP O
tremor NN I-NP O
in IN B-VP O
both DT B-NP O
hands NNS I-NP O
( ( O O
not RB O O
pill NN B-NP O
rolling VBG O O
) ) O O
CN NNP B-NP O
grossly RB O O
intact JJ O O
, , O O
no DT B-NP O
rashes NNS I-NP O
*** VBP O O
EKG: NNP B-NP O
new JJ B-NP O
ST NNP I-NP O
depressions NNS I-NP O
laterally RB O O
with IN B-VP O
TWI NNP B-NP O
, , O O
remained VBD B-VP O
unchanged JJ O O
through IN B-VP O
hospital JJ B-NP O
course NN I-NP O
Labs: NNP I-NP O
notable JJ O O
for IN B-VP O
negative JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
x VBP O O
3 CD O O
*** JJ B-NP O
Hospital NNP I-NP O
Course: NNP I-NP O
CV: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
3 CD O O
sets NNS B-NP O
of IN B-VP O
negative JJ O O
cardiac JJ O O
enzymes VBZ O O
His PRP$ O O
EKG NNP B-NP O
remained VBD B-VP O
unchanged JJ O O
It PRP O O
is VBZ O O
not RB O O
clear JJ O O
how WRB O O
old JJ O O
these DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
may MD O O
be VB O O
We PRP O O
recommend VBP O O
outpatient JJ B-NP O
stress NN I-NP O
test NN I-NP O
and CC O O
cardiology NN B-NP O
follow-up VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
bradycardic JJ O O
to TO O O
the DT B-NP O
hi NN I-NP O
30s CD O O
overnight NN B-NP O
without IN B-VP O
symptoms NNS B-NP O
His PRP$ O O
EKG NNP B-NP O
showed VBD B-VP O
A DT B-NP O
Fib NNP I-NP O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
junctional JJ B-NP O
escape NN I-NP O
rhythm NN I-NP O
or CC O O
Digoxin NNP B-NP O
toxicity NN I-NP O
His PRP$ O O
Digoxin NNP B-NP O
level NN I-NP O
was VBD B-VP O
1.9 CD O O
His PRP$ O O
morning NN B-NP B-f
Coreg NNP I-NP B-m
was VBD B-VP O
held VBN O O
and CC O O
his PRP$ O O
HR NNP B-NP O
remained VBD B-VP O
in IN B-VP O
the DT O O
50s CD O O
during IN B-VP O
the DT B-NP O
day NN I-NP O
with IN B-VP O
no DT B-NP O
symptoms NNS I-NP O
voiced VBN O O
by IN B-VP O
the DT B-NP O
patient NN I-NP O
He PRP O O
will MD O O
be VB O O
discharged VBN O O
to TO O O
rehab VB O O
on IN B-VP O
his PRP$ O O
admission NN B-NP O
regimen VBZ O O
The DT B-NP O
patient's NN I-NP O
A NNP I-NP O
Fib NNP I-NP O
is VBZ O O
old JJ O O
and CC O O
he PRP O O
is VBZ O O
currently RB O O
anticoagulated VBN O O
with IN B-VP O
Lovenox NNP B-NP B-m
No NNP I-NP O
changes NNS I-NP O
were VBD B-VP O
made VBN O O
to TO O O
this DT B-NP O
regimen NNS I-NP O
Neuro: VBP O O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
tremor NN B-NP B-r
and CC O O
is VBZ O O
treated VBN O O
with IN B-VP O
Primidone NNP B-NP B-m
No NNP I-NP O
changes NNS I-NP O
were VBD B-VP O
made VBN O O
to TO O O
this DT B-NP O
regimen NNS I-NP O
ID: VBP O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
being VBG O O
treated VBN O O
for IN B-VP O
osteomyelitis NN B-NP B-r
osteomyelitis NN I-NP B-r
His PRP$ O O
Ceftriaxone NN B-NP B-m
and CC O O
Vancomycin NNP B-NP B-m
were VBD B-VP O
continued VBN O O
His PRP$ O O
temperature NN B-NP O
remained VBD B-VP O
normal JJ O O
during IN B-VP O
the DT B-NP O
hospital JJ I-NP O
course NN I-NP O
and CC O O
no DT B-NP O
rigors NNS I-NP O
were VBD B-VP O
observed VBN O O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
complain VB O O
of IN B-VP O
any DT B-NP O
further JJ I-NP O
chills NNS I-NP O
Blood NNP I-NP O
cultures NNS I-NP O
showed VBD B-VP O
NGTD NNP B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
ENDO: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
outpatient JJ B-NP O
regimen NNS I-NP O
of IN B-VP O
Lantus NNP B-NP B-m
, , O O
standing VBG O O
insulin NN B-NP B-m
qAC NN I-NP B-f
and CC O O
insulin NN B-NP B-m
SS NNP I-NP B-do
GU: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
Flomax NNP B-NP B-m
for IN B-VP O
his PRP$ O B-r
BPH NNP B-NP I-r
PPX: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
Lovenox NNP B-NP B-m
and CC O O
required VBN O O
no DT B-NP O
further JJ I-NP O
anticoagulation NN I-NP O
Full NNP I-NP O
Code NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Please NNP I-NP O
follow VB O O
up RP O O
with IN B-VP O
you PRP O O
PCP VBP O O
within IN B-VP O
2 CD O O
weeks NNS B-NP O
No RB O O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
ALLENBACH NNP I-NP O
, , O O
CORDELL NNP B-NP O
W NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.B.A NNP B-NP O
( ( O O
ZG28 NNP B-NP O
) ) O O
10/0/05 CD O O
@ $ O O
02:50 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#789693 VBZ O O
783259770 CD O O
THO NNP B-NP O
08608227 CD O O
2588970 CD O O
4/11/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
Change NNP I-NP O
in IN B-VP O
mental JJ B-NP O
status NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
8/17/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
8/10/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
ALEQUIN NNP I-NP O
, , O O
GARLAND NNP B-NP O
180-38-64-0 CD O O
Troit NNP B-NP O
West NNP I-NP O
Ville NNP I-NP O
, , O O
North NNP B-NP O
Carolina NNP I-NP O
93245 CD O O
Service: NNP B-NP O
MED NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
9/11/06 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
WIXSON NNP I-NP O
, , O O
MATT NNP B-NP O
SAMMIE NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Skilled VBD B-VP O
Nursing NNP B-NP O
Facility NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
VITAMIN NNP I-NP B-m
C NNP I-NP I-m
( ( O I-m
ASCORBIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
CIPROFLOXACIN NNP I-NP B-m
400 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q12H NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/29 CD O O
) ) O O
Instructions: NNP B-NP O
Please NNP I-NP O
take VB O O
until IN B-VP O
3/28/06 CD O O
Number NNP B-NP B-du
of IN B-VP I-du
Doses NNP B-NP I-du
Required NNP I-NP I-du
( ( O I-du
approximate JJ B-NP I-du
): NN I-NP I-du
2 CD O I-du
FOLATE NNP B-NP B-m
( ( O I-m
FOLIC NNP B-NP I-m
ACID NNP I-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LASIX NNP I-NP B-m
( ( O I-m
FUROSEMIDE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
LACTULOSE NNP I-NP B-m
30 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/29 CD O O
) ) O O
Instructions: NNP B-NP O
please NN I-NP O
do VB O O
not RB O O
skip VB O O
doses NNS B-NP O
even RB O O
if IN B-VP O
many JJ B-NP O
loose JJ I-NP O
stools NNS I-NP O
FLAGYL NNP I-NP B-m
( ( O I-m
METRONIDAZOLE NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q8H NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/29 CD O O
) ) O O
Instructions: NNP B-NP O
Stop NNP I-NP O
taking VBG O O
on IN B-VP O
3/28/06 CD O O
ALDACTONE NNP B-NP B-m
( ( O I-m
SPIRONOLACTONE NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
with IN B-VP O
meals NNS B-NP O
Override NNP I-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
5/11/06 CD O O
by IN B-VP O
STARZYNSKI NNP B-NP O
, , O O
DANIEL NNP B-NP O
O NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IV NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
403310506 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
SPIRONOLACTONE NNP I-NP B-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
monitoring NN I-NP O
THIAMINE NNP I-NP B-m
HCL NNP I-NP I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
MULTIVITAMIN NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVI NNP I-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
MSIR NNP I-NP B-m
( ( O I-m
MORPHINE NNP B-NP I-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
7.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
FLOVENT NNP I-NP B-m
HFA NNP I-NP I-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE NNP I-NP I-m
) ) O I-m
220 CD O B-do
MCG NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
CELEXA NNP I-NP B-m
( ( O I-m
CITALOPRAM NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
CELECOXIB NNP I-NP B-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
5/29 CD O O
) ) O O
PRN NNP B-NP O
Pain NNP I-NP B-r
Instructions: NNP I-NP O
Please NNP I-NP O
do VB O O
not RB O O
increasing VBG O O
dosing VBG O O
to TO O O
BID NNP B-NP O
, , O O
given VBN O O
risk NN B-NP O
of IN B-VP O
cardiac JJ B-NP O
side NN I-NP O
effects NNS I-NP O
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
KEPPRA NNP I-NP B-m
( ( O I-m
LEVETIRACETAM NNP B-NP I-m
) ) O I-m
1 CD O B-do
, , O I-do
000 CD O I-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
CALTRATE NNP I-NP B-m
600 CD O I-m
+ NNP B-NP I-m
D NNP I-NP I-m
( ( O I-m
CALCIUM NNP B-NP I-m
CARBONATE NNP I-NP I-m
1 CD O I-m
, , O I-m
500 CD O I-m
MG NNP B-NP I-m
( ( O I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
LIDODERM NNP I-NP B-m
5% CD O I-m
PATCH NNP B-NP I-m
( ( O I-m
LIDOCAINE NNP B-NP I-m
5% CD O I-m
PATCH NNP B-NP I-m
) ) O I-m
TOPICAL NNP B-NP B-mo
TP NNP I-NP I-mo
DAILY NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
5/29 CD O O
) ) O O
Instructions: NNP B-NP O
one CD O O
to TO O O
lumbar VB O O
area NN B-NP O
apply NN I-NP O
for IN B-VP O
12 CD O O
hr NN B-NP O
and CC O O
remove VB O O
for IN B-VP O
12 CD O O
hr NN B-NP O
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
NOVOLOG NNP I-NP B-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
( ( O I-m
INSULIN NNP B-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
INSULIN NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
) ) O I-m
Sliding VBG O B-do
Scale NNP B-NP I-do
( ( O B-mo
subcutaneously RB O I-mo
) ) O I-mo
SC NNP B-NP I-mo
AC NNP I-NP B-f
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
give VB O O
0 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
6 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
MAALOX-TABLETS JJ B-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
VITAMIN NNP I-NP B-m
K NNP I-NP I-m
( ( O I-m
PHYTONADIONE NNP B-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PROTONIX NNP I-NP B-m
( ( O I-m
PANTOPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
TOPROL NNP I-NP B-m
XL NNP I-NP I-m
( ( O I-m
METOPROLOL NNP B-NP I-m
SUCCINATE NNP I-NP I-m
EXTENDED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
MAGNESIUM NNP I-NP B-m
OXIDE NNP I-NP I-m
420 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
2 CD O O
gm NN B-NP O
Na NNP I-NP O
/ NNP I-NP O
low JJ B-NP O
protein NN I-NP O
(I) NN I-NP O
(FDI) NNP I-NP O
DIET: NNP I-NP O
2 CD O O
gram NN B-NP O
Sodium NNP I-NP O
ACTIVITY: NNP I-NP O
Resume NNP I-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Gillogly NNP I-NP O
rheumatology VBZ O O
- : O O
arthritis NN B-NP O
center NN I-NP O
312-483-9315 JJ O O
8/15 CD O O
@ JJ O O
12:30 CD O O
pm NN B-NP O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Mikos NNP I-NP O
IMC NNP I-NP O
6/18 CD O O
@ NNP B-NP O
2:30 CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Cramblit NNP I-NP O
- : O O
please NN B-NP O
call NN I-NP O
for IN B-VP O
appointment NN B-NP O
Next NNP I-NP O
available JJ O O
, , O O
ALLERGY: NNP B-NP O
HALOPERIDOL NNP I-NP O
, , O O
LORAZEPAM NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
Change NNP I-NP O
in IN B-VP O
mental JJ B-NP O
status NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Change NNP B-NP O
in IN B-VP O
mental JJ B-NP O
status NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
s/p JJ B-NP O
gi NNS I-NP O
bleed VBP O O
( ( O O
S/P NNP B-NP O
upper NNP I-NP O
GI NNP I-NP O
bleeding VBG O O
) ) O O
EtOH NNP B-NP O
abuse NN I-NP O
( ( O O
alcohol JJ B-NP O
abuse NN I-NP O
) ) O O
coagulopathy NN B-NP O
cirrhosis NN I-NP O
, , O O
hepatic JJ B-NP O
encephalopathy NN I-NP O
COPD NNP I-NP O
( ( O O
chronic JJ O O
obstructive VBP O O
pulmonary JJ B-NP O
disease NN I-NP O
) ) O O
fracture NN B-NP O
of IN B-VP O
left JJ B-NP O
hand NN I-NP O
- : O O
2nd/3rd CD O O
metacarpals NNS B-NP O
, , O O
4th/5th CD O O
proximal JJ B-NP O
phalanges NNS I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Chest NNP B-NP O
x-ray NN I-NP O
, , O O
head NN B-NP O
CT NNP I-NP O
, , O O
right JJ B-NP O
upper NN I-NP O
quadrant NN I-NP O
ultrasound NN I-NP O
, , O O
right JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
ultrasound JJ B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
Change NNP I-NP O
in IN B-VP O
mental JJ B-NP O
status NN I-NP O
----- NNP I-NP O
HPI: NNP I-NP O
57 CD O O
yo NN B-NP O
F NNP I-NP O
with IN B-VP O
complex JJ B-NP O
PMH NNP I-NP O
including VBG O O
squamous JJ B-NP O
cell NN I-NP O
lung NN I-NP O
cancer NN I-NP O
s/p NN I-NP O
RML NNP I-NP O
lobectomy NN I-NP O
3/29 CD O O
Has NNP B-NP O
h/o VBN O O
cirrhosis NN B-NP O
and CC O O
hepatic JJ B-NP O
encephalopathy NN I-NP O
Came NNP I-NP O
to TO O O
ED NNP B-NP O
obtunded NNP I-NP O
( ( O O
no DT B-NP O
spontaneous JJ I-NP O
conversation NN I-NP O
) ) O O
with IN B-VP O
decreased VBN O O
BP NNP B-NP O
Reportedly RB O O
received VBD B-VP O
all DT O O
of IN B-VP O
her PRP$ O O
medications NNS B-NP O
as IN B-VP O
prescribed VBN O O
in IN B-VP O
morning NN B-NP O
at IN B-VP O
her PRP$ O O
nursing NN B-NP O
home NN I-NP O
In IN B-VP O
ED NNP B-NP O
, , O O
received VBD B-VP O
thiamine NN B-NP B-m
and CC O O
narcan JJ B-NP B-m
Became NNP I-NP O
more RBR O O
responsive JJ O O
and CC O O
uncomfortable JJ O O
after IN B-VP O
narcan JJ B-NP B-m
Ammonia NNP I-NP O
level NN I-NP O
elevated VBD B-VP O
at IN B-VP O
233 CD O O
----- JJ B-NP O
PMH: NNP I-NP O
++Lung NNP I-NP O
cancer NN I-NP O
- : O O
squamous JJ B-NP O
cell NN I-NP O
, , O O
s/p JJ B-NP O
RML NNP I-NP O
lobectomy NN I-NP O
and CC O O
RUL NNP B-NP O
wedge VBP O O
resection NN B-NP O
++Cirrhosis NN I-NP O
- : O O
alcoholic NN B-NP O
and CC O O
hep NN B-NP O
C NNP I-NP O
virus NN I-NP O
, , O O
h/o JJ B-NP O
esophageal NN I-NP O
varices NNS I-NP O
and CC O O
GI NNP B-NP O
bleed VBD B-VP O
++COPD NNP B-NP O
- : O O
not RB O O
on IN B-VP O
home NN B-NP O
oxygen NN I-NP O
++HTN NNP I-NP O
++PVD NNP I-NP O
++Seizure NN I-NP B-r
disorder NN I-NP I-r
- : O O
on IN B-VP O
Keppra NNP B-NP B-m
++h/o NNP I-NP O
SDH NNP I-NP O
- : O O
had VBD B-VP O
craniotomy JJ B-NP O
++large NNP I-NP O
abdominal JJ B-NP O
ventral JJ I-NP O
hernia NN I-NP O
++chronic NNP I-NP O
back RB O O
pain VBP O O
- : O O
known VBN O O
spinal JJ B-NP O
compression NN I-NP O
fractures NNS I-NP O
at IN B-VP O
T8 NNP B-NP O
and CC O O
bilateral JJ B-NP O
sacral JJ I-NP O
insufficiency NN I-NP O
fractures NNS I-NP O
----- VBP O O
SHx: NNP B-NP O
Nursing NNP I-NP O
home NN I-NP O
resident NN I-NP O
for IN B-VP O
past JJ O O
2 CD O O
years NNS B-NP O
30 CD O O
pack-year JJ O O
smoking VBG O O
history NN B-NP O
Significant NNP I-NP O
EtOH NNP I-NP O
history NN I-NP O
Has NNP I-NP O
2 CD O O
daughters NNS B-NP O
involved VBN O O
in IN B-VP O
her PRP$ O O
care NN B-NP O
----- JJ B-NP O
FHx: NNP I-NP O
Mother NNP I-NP O
COPD NNP I-NP O
, , O O
Father NNP B-NP O
prostate NN I-NP O
cancer NN I-NP O
/ NNP I-NP O
CAD NNP I-NP O
----- NNP I-NP O
Admit NNP I-NP O
PE: NNP I-NP O
T NNP I-NP O
96.5 CD O O
P NNP B-NP O
64 CD O O
BP NNP B-NP O
98/53 CD O O
RR NNP B-NP O
14 CD O O
SaO2 NNP B-NP O
93%RA CD O O
97%3L CD O O
Gen NNP B-NP O
- : O O
Awakens NNS B-NP O
briefly VBP O O
when WRB O O
spoken VBN O O
to TO O O
Able VB O O
to TO O O
respond VB O O
only RB O O
with IN B-VP O
single JJ B-NP O
words NNS I-NP O
to TO O O
simple VB O O
questions NNS B-NP O
Appears NNP I-NP O
sedated VBD B-VP O
HEENT NNP B-NP O
- : O O
PERRL NN B-NP O
, , O O
scleral JJ B-NP O
icterus NN I-NP O
NECK NNP I-NP O
- : O O
No DT B-NP O
LAN NNP I-NP O
, , O O
no DT B-NP O
bruits NNS I-NP O
, , O O
JVP NNP B-NP O
flat JJ B-NP O
CHEST NNP I-NP O
- : O O
Bilateral NNP B-NP O
expiratory NN I-NP O
wheezes VBZ O O
HEART NNP B-NP O
- : O O
RRR NNP B-NP O
, , O O
nl JJ B-NP O
S1/S2 NNP I-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
ABD NNP I-NP O
- : O O
Full-appearing NN B-NP O
, , O O
large JJ B-NP O
ventral JJ I-NP O
hernia NN I-NP O
, , O O
multiple JJ B-NP O
scars NNS I-NP O
, , O O
soft JJ O O
, , O O
non-tender JJ O O
, , O O
+BS NNP B-NP O
, , O O
no DT B-NP O
masses NNS I-NP O
, , O O
no DT B-NP O
HSM NNP I-NP O
EXT NNP I-NP O
- : O O
1+ CD O O
edema NN B-NP O
bilaterally RB O O
( ( O O
R&gt;L NNP B-NP O
) ) O O
SKIN NNP B-NP O
- : O O
jaundiced VBD B-VP O
, , O O
palmar NN B-NP O
erythema NN I-NP O
, , O O
bruises VBZ O O
spread VBP O O
diffusely RB O O
RECTAL NNP B-NP O
- : O O
Guaiac NNP B-NP O
pos NN I-NP O
, , O O
light JJ B-NP O
brown JJ I-NP O
soft JJ I-NP O
stool NN I-NP O
NEURO NNP I-NP O
- : O O
Oriented VBN O O
to TO O O
place NN B-NP O
and CC O O
person NN B-NP O
Year NNP I-NP O
is VBZ O O
"1993" JJ B-NP O
Drifting NNP I-NP O
in IN B-VP O
and CC O O
out IN B-VP O
of IN B-VP O
ability NN B-NP O
to TO O O
communicate VB O O
Perseverates NNS B-NP O
on IN B-VP O
answers NNS B-NP O
to TO O O
questions: VB O O
this DT O O
is VBZ O O
a DT O O
"hospital JJ O O
, , O O
hospital NN B-NP O
, , O O
hospital" NN B-NP O
, , O O
CN NNP B-NP O
II NNP I-NP O
through IN B-VP O
XII NNP B-NP O
intact JJ O O
, , O O
DTR's NNP B-NP O
2+ CD O O
symmetric NN B-NP O
in IN B-VP O
LE NNP B-NP O
+ NNP I-NP O
UE NNP I-NP O
, , O O
toes VBZ O O
downgoing VBG O O
bilaterally RB O O
----- JJ B-NP O
Studies: NNP I-NP O
+CXR NNP I-NP O
7/6 CD O O
- : O O
no DT B-NP O
acute JJ I-NP O
cardiopulmonary JJ I-NP O
process NN I-NP O
+Head VBD B-VP O
CT NNP B-NP O
7/6 CD O O
- : O O
negative JJ O O
+RUQ VBP O O
US PRP O O
7/6 CD O O
- : O O
gallstones NNS B-NP O
, , O O
biliary JJ B-NP O
sludge NN I-NP O
+RLE NNP I-NP O
LENI NNP I-NP O
7/6 CD O O
- : O O
neg NN B-NP O
for IN B-VP O
DVT NNP B-NP O
----- NNP I-NP O
Hospital NNP I-NP O
Course: NNP I-NP O
57 CD O O
yo NN B-NP O
F NNP I-NP O
with IN B-VP O
complex JJ B-NP O
medical JJ I-NP O
history NN I-NP O
here RB O O
with IN B-VP O
mental JJ B-NP O
status NN I-NP O
change NN I-NP O
likely RB O O
secondary JJ O O
to TO O O
hepatic JJ B-NP O
encephalopathy NN I-NP O
with IN B-VP O
some DT B-NP O
component NN I-NP O
of IN B-VP O
medication-induced JJ B-NP O
delirium NN I-NP O
( ( O O
from IN B-VP O
opiates NNS B-NP B-m
) ) O O
++Mental VBP O B-r
Status NNP B-NP I-r
- : O O
Avoided VBD B-VP O
increasing VBG O O
narcotics NNS B-NP B-m
Given NNP I-NP O
lactulose VBD B-VP B-m
QID NNP B-NP B-f
Mental NNP I-NP O
status NN I-NP O
improved VBD B-VP O
significantly RB O O
in IN B-VP O
first JJ O O
24 CD O O
hours NNS B-NP O
of IN B-VP O
hospitalization NN B-NP O
Patient NNP I-NP O
then RB O O
remained VBD B-VP O
at IN B-VP O
her PRP$ O O
baseline NN B-NP O
mental NN I-NP O
status NN I-NP O
for IN B-VP O
rest NN B-NP O
of IN B-VP O
hospital NN B-NP O
stay NN I-NP O
++MSK NNP I-NP O
- : O O
Patient NN B-NP O
has VBZ O O
history NN B-NP O
of IN B-VP O
chronic JJ O O
low JJ O O
back RB O O
pain NN B-NP O
that WDT O O
is VBZ O O
likely JJ O O
related VBN O O
to TO O O
bilateral JJ B-NP O
sacral JJ I-NP O
insufficiency NN I-NP O
fractures NNS I-NP O
seen VBN O O
on IN B-VP O
MRI NNP B-NP O
on IN B-VP O
5/1/06 CD O O
We PRP O O
avoided VBD B-VP O
increasing VBG O O
her PRP$ O O
narcotic JJ B-NP B-m
dose NN I-NP O
for IN B-VP O
concern NN B-NP O
of IN B-VP O
her PRP$ O O
altered JJ B-NP O
mental JJ I-NP O
status NN I-NP O
Pain NNP I-NP B-r
was VBD B-VP O
controlled VBN O O
effectively RB O O
with IN B-VP O
MSIR NNP B-NP B-m
prn NN I-NP B-f
, , O O
celecoxib JJ B-NP B-m
daily JJ I-NP B-f
prn NN I-NP I-f
( ( O O
should MD O O
not RB O O
increase VB O O
to TO O O
bid VB O O
given VBN O O
? . B-VP O
increase NN B-NP O
risk NN I-NP O
of IN B-VP O
cardiac JJ B-NP O
side NN I-NP O
effects NNS I-NP O
) ) O O
, , O O
and CC O O
a DT B-NP O
lidoderm JJ I-NP B-m
patch NN I-NP I-m
over IN B-VP O
her PRP$ O O
lower JJR B-NP O
back NN I-NP O
Other JJ B-NP O
NSAIDS NNP I-NP B-m
were VBD B-VP O
avoided VBN O O
given VBN O O
h/o RBR O O
GI NNP B-NP O
bleed NN I-NP O
Patient NNP I-NP O
is VBZ O O
scheduled VBN O O
to TO O O
f/u VB O O
with IN B-VP O
Dr NNP B-NP O
Stayner NNP I-NP O
( ( O O
Rheumatology NNP B-NP O
) ) O O
for IN B-VP O
management NN B-NP O
of IN B-VP O
her PRP$ O O
back NN B-NP O
pain NN I-NP O
and CC O O
consideration NN B-NP O
of IN B-VP O
sacroplasty JJ B-NP O
Patient NNP I-NP O
should MD O O
be VB O O
seen VBN O O
by IN B-VP O
PT NNP B-NP O
at IN B-VP O
her PRP$ O O
nursing NN B-NP O
home NN I-NP O
to TO O O
help VB O O
her PRP$ O O
with IN B-VP O
her PRP$ O O
walking VBG O O
++GI/ID JJ O O
- : O O
Had VBD B-VP O
low-grade JJ B-NP O
fevers NNS I-NP O
overnight MD O O
on IN B-VP O
HD NNP B-NP O
1 CD O O
and CC O O
2 CD O O
Patient NNP B-NP O
had VBD B-VP O
mild VBN O O
RUQ NNP B-NP O
tenderness NN I-NP O
which WDT O O
raised VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
possible JJ B-NP O
GI NNP I-NP O
/ NNP I-NP O
biliary JJ B-NP O
source NN I-NP O
of IN B-VP O
infection NN B-NP O
Blood NNP I-NP O
cultures NNS I-NP O
were VBD B-VP O
positive JJ O O
for IN B-VP O
coag JJ B-NP B-r
coag JJ I-NP B-r
negative JJ I-NP I-r
negative JJ I-NP I-r
staph NN I-NP I-r
staph NN I-NP I-r
in IN B-VP O
2/4 CD O O
bottles NNS B-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Ciprofloxacin NNP B-NP B-m
and CC O O
Metronidazol NNP B-NP B-m
starting VBG O O
on IN B-VP O
HD NNP B-NP O
1 CD O O
, , O O
and CC O O
vancomycin NN B-NP B-m
until IN B-VP B-du
speciation NN B-NP O
of IN B-VP O
blood NN B-NP O
cultures NNS I-NP O
Blood NNP I-NP O
cultures NNS I-NP O
repeated VBD B-VP O
on IN B-VP O
2/3 CD O O
and CC O O
9/5 CD O O
were VBD B-VP O
negative JJ O O
to TO O O
date NN B-NP O
Coag NNP I-NP O
neg CC O O
staph JJ B-NP O
blood NN I-NP O
cultures NNS I-NP O
were VBD B-VP O
thought VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
contamination NN B-NP O
Patient NNP I-NP O
has VBZ O O
remained VBN O O
afebrile JJ O O
and CC O O
abdominal JJ B-NP O
tenderness NN I-NP O
has VBZ O O
resolved VBN O O
over IN B-VP O
hospital JJ B-NP O
stay NN I-NP O
Vancomycin NNP I-NP B-m
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
HD NNP B-NP O
3 CD O O
and CC O O
Cipro NNP B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
were VBD B-VP O
continued VBN O O
She PRP O O
was VBD B-VP O
discharged VBN O O
with IN B-VP O
instructions NNS B-NP O
to TO O O
complete VB O O
a DT B-NP O
14-day JJ I-NP O
course NN I-NP O
of IN B-VP O
Cipro NNP B-NP B-m
and CC O O
Flagyl NNP B-NP B-m
Her NNP I-NP O
WBC NNP I-NP O
count NN I-NP O
and CC O O
platelets NNS B-NP O
decreased VBN O O
gradually RB O O
throughout IN B-VP O
her PRP$ O O
hospital NN B-NP O
stay NN I-NP O
and CC O O
were VBD B-VP O
3.88 CD O O
and CC O O
122 CD O O
respectively RB O O
A NNP B-NP O
CBC NNP I-NP O
should MD O O
be VB O O
checked VBN O O
on IN B-VP O
Monday NNP B-NP O
3/21 CD O O
to TO O O
make VB O O
sure JJ O O
that IN B-VP O
she PRP O O
is VBZ O O
not RB O O
becoming VBG O O
neutropenic JJ O O
or CC O O
thrombocytopenic JJ O O
++Pulm SYM O O
- : O O
The DT B-NP O
possibility NN I-NP O
of IN B-VP O
PE NNP B-NP O
was VBD B-VP O
considered VBN O O
given VBN O O
lower JJR B-NP O
extremity NN I-NP O
swelling NN I-NP O
and CC O O
her PRP$ O O
change NN B-NP O
in IN B-VP O
mental JJ B-NP O
status NN I-NP O
Given VBN O O
that IN B-VP O
she PRP O O
was VBD B-VP O
at IN B-VP O
her PRP$ O O
baseline NN B-NP O
oxygen NN I-NP O
requirement NN I-NP O
and CC O O
had VBD B-VP O
negative JJ B-NP O
LENIs NNP I-NP O
, , O O
PE NNP B-NP O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
low JJ B-NP O
probability NN I-NP O
She PRP O O
remained VBD B-VP O
at IN B-VP O
her PRP$ O O
baseline NN B-NP O
oxygen NN I-NP O
saturation NN I-NP O
( ( O O
93-98% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
) ) O O
for IN B-VP O
the DT B-NP O
duration NN I-NP O
of IN B-VP O
her PRP$ O O
hospitalization NN B-NP O
Given NNP I-NP O
flovent NN I-NP B-m
for IN B-VP O
known VBN O B-r
COPD NNP B-NP I-r
++CV NNP I-NP O
- : O O
EKG NN B-NP O
at IN B-VP O
admission NN B-NP O
was VBD B-VP O
unchanged JJ O O
from IN B-VP O
previous JJ B-NP O
EKGs NNP I-NP O
Patient's NNP I-NP O
dose NN I-NP O
of IN B-VP O
Lopressor NNP B-NP B-m
was VBD B-VP O
decreased VBN O O
, , O O
given VBN O O
her PRP$ O O
low JJ B-NP O
BP NNP I-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
admission NN B-NP O
Her NNP I-NP O
heart NN I-NP O
rate NN I-NP O
and CC O O
blood NN B-NP O
pressure NN I-NP O
remained VBD B-VP O
in IN B-VP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
throughout IN B-VP O
her PRP$ O O
admission NN B-NP O
++Endo: NN I-NP O
MRI NNP I-NP O
read VBD B-VP O
from IN B-VP O
0/12/06 CD O O
showed VBD B-VP O
evidence NN B-NP O
of IN B-VP O
osteoporosis NN B-NP O
Started NNP I-NP O
caltrate NN I-NP B-m
, , O O
vit NN B-NP B-m
D NNP I-NP I-m
Unable NNP I-NP O
to TO O O
give VB O O
fosamax NN B-NP B-m
because IN B-VP O
of IN B-VP O
history NN B-NP O
of IN B-VP O
esophageal JJ B-NP O
varices NNS I-NP O
Giving VBG O O
zometa NN B-NP B-m
x $ O B-du
1 CD O I-du
Corrected NNP B-NP O
calcium NN I-NP O
was VBD B-VP O
normal JJ B-NP O
Will NNP I-NP O
need MD O O
to TO O O
re-check VB O O
calcium NN B-NP B-m
in IN B-VP O
1 CD O B-du
week NN B-NP I-du
++FEN SYM O O
- : O O
Given VBN O O
thiamine NN B-NP B-m
, , O O
folate NN B-NP B-m
, , O O
fluids NNS B-NP B-m
, , O O
Is/Os NNP B-NP O
, , O O
weights NNS B-NP O
++PPX VBP O O
- : O O
Lovenox NNP B-NP B-m
, , O O
nexium NN B-NP B-m
, , O O
aspiration NN B-NP O
precautions NNS I-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
You PRP O O
are VBP O O
being VBG O O
discharged VBN O O
from IN B-VP O
the DT B-NP O
hospital NN I-NP O
to TO O O
your PRP$ O O
nursing NN B-NP O
home NN I-NP O
in IN B-VP O
Smerfortn NNP B-NP O
Blvd NNP I-NP O
, , O O
Stin NNP B-NP O
with IN B-VP O
a DT B-NP O
few JJ I-NP O
changes NNS I-NP O
in IN B-VP O
your PRP$ O O
medications NNS B-NP O
We PRP O O
have VBP O O
changed VBN O O
your PRP$ O O
pain NN B-NP B-m
pain NN I-NP B-r
medication NN I-NP O
to TO O O
MSIR NNP B-NP B-m
every DT O B-f
4 CD O I-f
hr NN B-NP I-f
as IN B-VP I-f
needed VBN O I-f
, , O O
celebrex NN B-NP B-m
, , O O
and CC O O
lidoderm JJ B-NP B-m
patch NN I-NP I-m
Please NNP I-NP O
call VB O O
your PRP$ O O
doctor NN B-NP O
if IN B-VP O
you PRP O O
are VBP O O
feeling VBG O O
that IN B-VP O
your PRP$ O O
thinking NN B-NP O
is VBZ O O
not RB O O
clear JJ O O
or CC O O
if IN B-VP O
you PRP O O
start VBP O O
to TO O O
have VB O O
fevers NNS B-NP O
And CC O O
please VB O O
return NN B-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
if IN B-VP O
you PRP O O
are VBP O O
having VBG O O
increased VBN O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
difficulty NN B-NP O
breathing NN I-NP O
, , O O
or CC O O
other JJ O O
concerning VBG O O
symptoms NNS B-NP O
You PRP O O
should MD O O
have VB O O
your PRP$ O O
blood NN B-NP O
counts NNS I-NP O
checked VBD B-VP O
on IN B-VP O
Monday NNP B-NP O
and CC O O
your PRP$ O O
calcium NN B-NP O
checked VBD B-VP O
next JJ B-NP O
week NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Vargas NNP I-NP O
at IN B-VP O
next JJ B-NP O
available JJ I-NP O
appointment NN I-NP O
Please NNP I-NP O
call VB O O
Dr NNP B-NP O
Megeath NNP I-NP O
office NN I-NP O
to TO O O
schedule NN B-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Blandin NNP I-NP O
and CC O O
Dr NNP B-NP O
Pfleider NNP I-NP O
as IN B-VP O
scheduled JJ B-NP O
Patient NNP I-NP O
should MD O O
be VB O O
seen VBN O O
by IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
at IN B-VP O
her PRP$ O O
nursing NN B-NP O
home NN I-NP O
Patient NNP I-NP O
should MD O O
have VB O O
a DT B-NP O
CBC NNP I-NP O
drawn NN I-NP O
on IN B-VP O
Monday NNP B-NP O
3/21 CD O O
to TO O O
check VB O O
her PRP$ O O
white JJ B-NP O
count NN I-NP O
and CC O O
platements NNS B-NP O
, , O O
which WDT O O
were VBD B-VP O
trending VBG O O
down RP O O
slowly RB O O
throughout IN B-VP O
her PRP$ O O
admission NN B-NP O
and CC O O
recheck VB O O
calcium NN B-NP O
( ( O O
corrected VBN O O
for IN B-VP O
albumin NN B-NP O
) ) O O
in IN B-VP O
one CD O O
week NN B-NP O
No RB O O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MIAH NNP I-NP O
, , O O
RUDY NNP B-NP O
E NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
RX97 NNP B-NP O
) ) O O
9/11/06 CD O O
@ $ O O
11 CD O O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#793453 VBZ O O
331676950 CD O O
SMMC NNP B-NP O
88209373 CD O O
203910 CD O O
9/30/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
Non NNP I-NP O
cardiac JJ B-NP O
chest NN I-NP O
pain NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/29/2002 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/21/2002 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
VANOVER NNP I-NP O
, , O O
JR NNP B-NP O
, , O O
ISAAC NNP B-NP O
034-41-95-4 CD O O
En NNP B-NP O
O NNP I-NP O
Brid NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
3/0/02 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
KLAPPER NNP I-NP O
, , O O
NEWTON NNP B-NP O
FREDRIC NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRN NNP I-NP I-f
constipation NN I-NP B-r
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QAM NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;100 NNP I-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
3/0/02 CD O O
by IN B-VP O
DWIRE NNP B-NP O
, , O O
LINDSEY NNP B-NP O
NORMAN NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
reason: NN I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
4/7/02 CD O O
by IN B-VP O
DEWISPELAERE NNP B-NP O
, , O O
MARION NNP B-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
56599393 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
&amp; NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
will MD O O
follow VB O O
ENALAPRIL NNP B-NP B-m
MALEATE NNP I-NP I-m
10 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QPM NNP I-NP B-f
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;100 NNP I-NP O
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
3/0/02 CD O O
by IN B-VP O
KITZMAN NNP B-NP O
, , O O
JEWELL NNP B-NP O
MICHAEL NNP I-NP O
, , O O
M.D NNP B-NP O
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
&amp; NNP I-NP O
ENALAPRIL NNP I-NP B-m
MALEATE NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
aware JJ B-NP O
ATIVAN NNP I-NP B-m
( ( O I-m
LORAZEPAM NNP B-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
March NNP I-NP O
PRN NNP I-NP O
anxiety NN I-NP B-r
HOLD NNP I-NP O
IF: NNP I-NP O
RR&lt;12 NNP I-NP O
or CC O O
pt NN B-NP O
is VBZ O O
lethargic JJ B-NP O
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
q5min VBD B-VP B-f
x $ O O
3 CD O O
PRN NNP B-NP O
chest NN I-NP B-r
pain NN I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP NNP I-NP O
&lt; VBD B-VP O
100 CD O O
ZOLOFT NNP B-NP B-m
( ( O I-m
SERTRALINE NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ZOCOR NNP I-NP B-m
( ( O I-m
SIMVASTATIN NNP B-NP I-m
) ) O I-m
20 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QHS NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
PLAVIX NNP B-NP B-m
( ( O I-m
CLOPIDOGREL NNP B-NP I-m
) ) O I-m
75 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
VIOXX NNP I-NP B-m
( ( O I-m
ROFECOXIB NNP B-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
with IN B-VP O
food NN B-NP O
ZANTAC NNP I-NP B-m
( ( O I-m
RANITIDINE NNP B-NP I-m
HCL NNP I-NP I-m
) ) O I-m
150 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRN NNP I-NP I-f
dyspepsia NN I-NP B-r
ATENOLOL NNP I-NP B-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
DIET: NNP I-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
Activity NNP I-NP O
- : O O
As IN B-VP O
tolerated JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
Immediately RB O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Bob NNP I-NP O
Yampolsky NNP I-NP O
, , O O
MD NNP B-NP O
2-4 CD O O
wks NN B-NP O
, , O O
ALLERGY: NNP B-NP O
Atarax NNP I-NP O
( ( O O
hydroxyzine JJ B-NP O
hcl NN I-NP O
) ) O O
, , O O
Sulfa NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
chest JJS B-NP O
pain NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Non NNP B-NP O
cardiac JJ B-NP O
chest NN I-NP O
pain NN I-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
HTN NNP I-NP O
( ( O O
) ) O O
CAD NNP B-NP O
( ( O O
prior JJ B-NP O
MI NNP I-NP O
x2 NNP I-NP O
, , O O
4/14 CD O O
( ( O O
) ) O O
high VBP O O
cholesterol NN B-NP O
( ( O O
) ) O O
OSA NNP B-NP O
( ( O O
) ) O O
OA NNP B-NP O
( ( O O
) ) O O
depression NN B-NP O
( ( O O
) ) O O
anxiety NN B-NP O
( ( O O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
Cardiac NNP I-NP O
catheterization NN I-NP O
( ( O O
8/18/02 CD O O
) ) O O
OTHER NNP B-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
44 CD O O
yo NN B-NP O
man NN I-NP O
with IN B-VP O
h/o JJ B-NP O
CAD NNP I-NP O
s/p NN I-NP O
MI NNP I-NP O
x2 VBZ O O
4/14 CD O O
with IN B-VP O
PCI NNP B-NP O
, , O O
in IN B-VP O
stent JJ B-NP O
thrombosis NN I-NP O
, , O O
and CC O O
re-stenting NN B-NP O
subsequently RB O O
admitted VBN O O
multiple JJ B-NP O
times NNS I-NP O
for IN B-VP O
CP NNP B-NP O
, , O O
cath NN B-NP O
performed VBD B-VP O
0/29 CD O O
and CC O O
4/13 CD O O
showed VBD B-VP O
mild JJ B-NP O
CAD NNP I-NP O
, , O O
presented VBD B-VP O
to TO O O
KMH NNP B-NP O
with IN B-VP O
increasing VBG O O
CP NNP B-NP O
at IN B-VP O
rest NN B-NP O
associated VBN O O
with IN B-VP O
fatigue NN B-NP O
and CC O O
SOB NNP B-NP O
Managed NNP I-NP O
on IN B-VP O
Hep NNP B-NP B-m
, , O O
TNG NNP B-NP B-m
gtt NN I-NP B-mo
, , O O
plavix NN B-NP B-m
, , O O
ACE NNP B-NP B-m
, , O O
B NNP B-NP B-m
blocker NN I-NP I-m
, , O O
demerol; JJ B-NP B-m
ROMI'd NNP I-NP O
But CC O O
pain NN B-NP O
recurred VBD B-VP O
, , O O
transferred VBD B-VP O
to TO O O
BVH NNP B-NP O
for IN B-VP O
cath NN B-NP O
Fam NNP I-NP O
Hx: NNP I-NP O
F-MI NNP I-NP O
, , O O
53 CD O O
Soc NNP B-NP O
Hx: NNP I-NP O
past JJ B-NP O
smoker NN I-NP O
( ( O O
40 CD O O
py NN B-NP O
) ) O O
PE: VBD B-VP O
80 CD O O
102/72 CD O O
18 CD O O
93%RA CD O O
CV: NNP B-NP O
RR NNP I-NP O
, , O O
nl JJ B-NP O
S1 NNP I-NP O
S2 NNP I-NP O
, , O O
no DT B-NP O
murm NN I-NP O
, , O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
, , O O
JVP=10 NNP B-NP O
Ext: NNP I-NP O
trace NN I-NP O
edema NN I-NP O
Rectal: NNP I-NP O
trace NN I-NP O
heme NN I-NP O
pos NN I-NP O
Labs: NNP I-NP O
EKG: NNP I-NP O
NSR75; NNP I-NP O
LAE NNP I-NP O
, , O O
TWI NNP B-NP O
1 CD O O
, , O O
L; NNP B-NP O
Q NNP I-NP O
1 CD O O
, , O O
L NNP B-NP O
, , O O
V1-3 NNP B-NP O
CK NNP I-NP O
63; CD O O
TnI NNP B-NP O
.03 NNP I-NP O
CXR:pending NNP I-NP O
Cr NNP I-NP O
.9 NNP I-NP O
CV: NNP I-NP O
Pain NNP I-NP O
may MD O O
not RB O O
be VB O O
cardiac JJ O O
, , O O
but CC O O
poss VBZ O O
cath NN B-NP O
to TO O O
r/o VB O O
ASA NNP B-NP B-m
, , O O
Plavix NNP B-NP B-m
, , O O
Hep NNP B-NP B-m
IV NNP I-NP B-mo
, , O O
B NNP B-NP B-m
Blocker NNP I-NP I-m
, , O O
ACE NNP B-NP B-m
, , O O
Zocor NNP B-NP B-m
Mild NNP I-NP B-r
fluid NN I-NP I-r
overload NN I-NP I-r
, , O O
will MD O O
plan VB O O
Lasix NNP B-NP B-m
to TO O O
keep VB O O
I/0's NNP B-NP O
500-1000cc JJ B-NP O
neg NN I-NP O
Pain NNP I-NP O
could MD O O
represent VB O O
pericarditis NN B-NP O
, , O O
but CC O O
dx NN B-NP O
of IN B-VP O
exclusion NN B-NP O
Cardiomegaly NNP I-NP O
on IN B-VP O
CXR NNP B-NP O
present JJ O O
since IN B-VP O
prev NN B-NP O
echo VBP O O
showing VBG O O
no DT B-NP O
effusion NN I-NP O
Pt NNP I-NP O
has VBZ O O
had VBN O O
mult VBN O O
episodes NNS B-NP O
of IN B-VP O
2-8/10 JJ B-NP O
CP NNP I-NP O
during IN B-VP O
hosp NN B-NP O
without IN B-VP O
EKG NNP B-NP O
changes NNS I-NP O
, , O O
responsive NN B-NP O
to TO O O
NTG NNP B-NP B-m
, , O O
managed VBD B-VP O
with IN B-VP O
prn JJ B-NP B-f
Demerol NNP I-NP B-m
and CC O O
standing VBG O O
Ativan NNP B-NP B-m
to TO O O
pain-free JJ B-NP B-r
Hep NNP I-NP B-m
gtt NN I-NP B-mo
maintained VBD B-VP O
until IN B-VP O
cath JJ B-NP O
Cath NNP I-NP O
8/18/02 CD O O
: : O O
NON-OBSTRUCTIVE JJ B-NP O
CAD NNP I-NP O
LMCA: NNP I-NP O
OK; NNP I-NP O
LAD: NNP I-NP O
prox VBD B-VP O
tubular JJ O O
30%; CD O O
LCx: NNP B-NP O
OK; NNP I-NP O
RCA: NNP I-NP O
OK NNP I-NP O
Pulm: NNP I-NP O
Level NNP I-NP O
of IN B-VP O
suspicion NN B-NP O
for IN B-VP O
PE NNP B-NP O
is VBZ O O
low JJ B-NP O
Will NNP I-NP O
send VB O O
D-dimer; NNP B-NP O
pt NN I-NP O
is VBZ O O
already RB O O
starting VBG O O
Hep NNP B-NP B-m
, , O O
will MD O O
pursue VB O O
CT NNP B-NP O
angio NN I-NP O
if IN B-VP O
necessary JJ B-NP O
D-dimer NNP I-NP O
neg NN I-NP O
, , O O
PE NNP B-NP O
RULED NNP I-NP O
OUT NNP I-NP O
Proph: NNP I-NP O
TEDS NNP I-NP O
, , O O
ambulation NN B-NP O
after IN B-VP O
r/o NN B-NP O
Psych: NNP I-NP O
Ativan NNP I-NP B-m
prn NN I-NP B-f
anxiety NN I-NP B-r
Zoloft NNP I-NP B-m
Ativan NNP I-NP B-m
Ativan NNP I-NP B-m
changed VBD B-VP O
to TO O O
1 CD O B-do
mg NNS B-NP I-do
tid RB O B-f
standing VBG O O
to TO O O
decrease VB O O
anxiety NN B-NP B-r
related JJ B-NP O
factors NNS I-NP O
Given VBN O O
lack NN B-NP O
of IN B-VP O
present JJ B-NP O
sig NN I-NP O
CAD NNP I-NP O
, , O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
PE NNP B-NP O
, , O O
and CC O O
low JJ B-NP O
suspicion NN I-NP O
for IN B-VP O
pericarditis NN B-NP O
, , O O
psychiatric JJ B-NP O
etiology NN I-NP O
for IN B-VP O
CP NNP B-NP O
becomes VBZ O O
more RBR O O
likely JJ O O
, , O O
would MD O O
recommend VB O O
psych NN B-NP O
f/u NN I-NP O
and CC O O
tx NN B-NP O
for IN B-VP O
anxiety NN B-NP O
and CC O O
depression NN B-NP O
ID: NNP I-NP O
WBC NNP I-NP O
count NN I-NP O
increasing VBG O O
4/10 CD O O
but CC O O
no DT B-NP O
other JJ I-NP O
sign/sx JJ I-NP O
infection NN I-NP O
Will NNP I-NP O
monitor NNP I-NP O
CXR NNP I-NP O
no DT B-NP O
infiltrates NNS I-NP O
WBC NNP I-NP O
decreased VBD B-VP O
10/16 CD O O
to TO O O
13.1 CD O O
, , O O
still RB O O
no DT B-NP O
indication NN I-NP O
of IN B-VP O
infection NN B-NP O
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
Please NNP I-NP O
schedule VBD B-VP O
an DT B-NP O
appointment NN I-NP O
with IN B-VP O
your PRP$ O O
primary JJ B-NP O
doctor NN I-NP O
within IN B-VP O
2-4 JJ B-NP O
weeks NNS I-NP O
If IN B-VP O
chest JJS B-NP O
pain NN I-NP O
changes NNS I-NP O
in IN B-VP O
character NN B-NP O
( ( O O
becomes JJ O O
different JJ O O
in IN B-VP O
location NN B-NP O
, , O O
sensation NN B-NP O
) ) O O
or CC O O
is VBZ O O
associated VBN O O
with IN B-VP O
new JJ B-NP O
symptoms NNS I-NP O
( ( O O
such JJ O O
as IN B-VP O
nausea NN B-NP O
and CC O O
vomiting NN B-NP O
, , O O
or CC O O
severe JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
) ) O O
, , O O
notify RB O O
your PRP$ O O
doctor NN B-NP O
or CC O O
call VB O O
911 CD O O
Please NNP B-NP O
give VB O O
a DT B-NP O
copy NN I-NP O
of IN B-VP O
these DT B-NP O
instructions NNS I-NP O
to TO O O
your PRP$ O O
primary JJ B-NP O
doctor NN I-NP O
at IN B-VP O
your PRP$ O O
next JJ B-NP O
visit NN I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
As IN B-VP O
above IN B-VP O
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
MATSUKI NNP I-NP O
, , O O
JAMISON NNP B-NP O
SCOTTY NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
GC93 NNP B-NP O
) ) O O
3/0/02 CD O O
@ $ O O
04:17 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#795740 VBZ O O
315194766 CD O O
VIMC NNP B-NP O
10418500 CD O O
4031002 CD O O
7/27/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
LEFT NNP I-NP O
GROIN NNP I-NP O
INFECTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/27/2003 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/20/2003 CD O O
ATTENDING: NNP B-NP O
ALFRED NNP I-NP O
JUZA NNP I-NP O
MD NNP I-NP O
ATTENDING NNP I-NP O
PHYSICIAN: NNP I-NP O
Johnathon NNP I-NP O
Jamieson NNP I-NP O
, , O O
M.D NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Wizar NNP I-NP O
is VBZ O O
a DT B-NP O
51-year-old JJ I-NP O
man NN I-NP O
who WP O O
was VBD B-VP O
recently RB O O
admitted VBN O O
for IN B-VP O
repair NN B-NP O
of IN B-VP O
left JJ B-NP O
pseudoaneurysm NN I-NP O
in IN B-VP O
his PRP$ O O
groin NN B-NP O
He PRP O O
was VBD B-VP O
in IN B-VP O
home NN B-NP O
and CC O O
doing VBG O O
fine JJ O O
after IN B-VP O
discharge NN B-NP O
from IN B-VP O
Ea NNP B-NP O
Naron NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
5/29/2003 CD O O
One CD O O
week NN B-NP O
later RB O O
, , O O
he PRP O O
noticed VBD B-VP O
pus NN B-NP O
draining VBG O O
from IN B-VP O
his PRP$ O O
wound NN B-NP O
site NN I-NP O
He PRP O O
was VBD B-VP O
doing VBG O O
daily JJ O O
dressing VBG O O
changes NNS B-NP O
at IN B-VP O
home NN B-NP O
He PRP O O
was VBD B-VP O
seen VBN O O
in IN B-VP O
Dr NNP B-NP O
Hearston NNP I-NP O
's POS O O
office NN B-NP O
on IN B-VP O
7/27/2003 CD O O
with IN B-VP O
only JJ B-NP O
mild JJ I-NP O
improvement NN I-NP O
He PRP O O
was VBD B-VP O
admitted VBN O O
from IN B-VP O
clinic NN B-NP O
for IN B-VP O
more RBR O O
aggressive JJ B-NP O
management NN I-NP O
He PRP O O
has VBZ O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
fever NN B-NP O
, , O O
chills NNS B-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
constipation NN B-NP O
, , O O
or CC O O
diarrhea VBZ O O
No DT B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
no DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
exam NN B-NP O
, , O O
he PRP O O
was VBD B-VP O
afebrile JJ B-NP O
Vital JJ I-NP O
sings NNS I-NP O
are VBP O O
stable JJ O O
He PRP O O
is VBZ O O
100% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
He PRP O O
had VBD B-VP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
, , O O
2+ CD O O
femoral JJ O O
, , O O
no DT B-NP O
DP NNP I-NP O
, , O O
monophasic JJ B-NP O
PT NNP I-NP O
pulse NN I-NP O
with IN B-VP O
cold JJ B-NP O
foot NN I-NP O
On IN B-VP O
the DT B-NP O
right NN I-NP O
, , O O
TMA NNP B-NP O
, , O O
warm JJ B-NP O
foot NN I-NP O
, , O O
femoral JJ O O
2+ CD O O
, , O O
DP NNP B-NP O
monophasic NN I-NP O
, , O O
PT NNP B-NP O
monophasic FW O O
Wound NNP B-NP O
site NN I-NP O
with IN B-VP O
some DT B-NP O
erythema NN I-NP O
and CC O O
drainage NN B-NP O
, , O O
nontender NN B-NP O
, , O O
no DT B-NP O
odor NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Includes NNP I-NP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
CABG NNP I-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
aortobifemoral JJ B-NP O
bypass NN I-NP O
and CC O O
status NN B-NP O
post NN I-NP O
femoropopliteal JJ B-NP O
bypass NN I-NP O
, , O O
COPD NNP B-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
failure NN I-NP O
, , O O
and CC O O
diabetes VBZ O O
mellitus NNS B-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Repair NNP I-NP O
of IN B-VP O
pseudoaneurysm NN B-NP O
MEDICATIONS: NNP I-NP O
Aspirin NNP I-NP B-m
325 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
digoxin NN I-NP B-m
0.125 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP O
day; NN I-NP O
Zestril NNP I-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
Ultralente NNP I-NP B-m
Ultralente NNP I-NP B-m
14 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
, , O O
4 CD O B-do
mg NN B-NP I-do
q.p.m.; NN I-NP B-f
Zocor NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
Toprol NNP I-NP B-m
25 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
Imdur NNP I-NP B-m
30 CD O B-do
mg NN B-NP O
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
torsemide RB O B-m
100 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
and CC O O
Dilaudid NNP B-NP B-m
p.r.n VB O B-f
ALLERGY: NNP B-NP O
He PRP O O
has VBZ O O
an DT B-NP O
allergy NN I-NP O
to TO O O
penicillin VB O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
One NNP I-NP O
pack NN I-NP O
a DT B-NP O
day NN I-NP O
smoker NN I-NP O
Occasional NNP I-NP O
alcohol NN I-NP O
EMERGENCY NNP I-NP O
DEPARTMENT NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
IV NNP B-NP B-mo
antibiotics NNS I-NP B-m
and CC O O
further JJ B-NP O
surgical JJ I-NP O
therapy NN I-NP O
with IN B-VP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
dehiscence NN B-NP O
of IN B-VP O
left JJ B-NP B-r
thigh JJ I-NP I-r
bypass NN I-NP I-r
graft NN I-NP I-r
wound NN I-NP I-r
He PRP O O
received VBD B-VP O
wet-to-dry JJ B-NP O
dressing NN I-NP O
changes NNS I-NP O
t.i.d VBP O O
initially RB O O
On IN B-VP O
6/3/2003 CD O O
, , O O
he PRP O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
left JJ B-NP O
groin JJ I-NP O
closure NN I-NP O
with IN B-VP O
flap NN B-NP O
by IN B-VP O
Plastic NNP B-NP O
Surgery NNP I-NP O
and CC O O
Vascular NNP B-NP O
Surgery NNP I-NP O
The DT B-NP O
flap NN I-NP O
initially RB O O
was VBD B-VP O
pink JJ O O
and CC O O
viable JJ O O
, , O O
however RB O O
, , O O
on IN B-VP O
4/20/2003 CD O O
, , O O
there EX O O
were VBD B-VP O
noted VBN O O
some DT B-NP O
pale JJ I-NP O
areas NNS I-NP O
and CC O O
mottling NN B-NP O
of IN B-VP O
the DT B-NP O
flap NN I-NP O
He PRP O O
was VBD B-VP O
injected VBN O O
with IN B-VP O
heparin JJ B-NP B-m
solution NN I-NP I-m
Following VBG O O
this DT O O
, , O O
flap VBZ O O
received VBN O O
serial JJ B-NP O
needle JJ I-NP O
pricks NNS I-NP O
and CC O O
the DT B-NP O
appearance NN I-NP O
gradually RB O O
improved VBN O O
as IN B-VP O
such JJ O O
there EX O O
was VBD B-VP O
no DT B-NP O
further JJ I-NP O
pallor NN I-NP O
or CC O O
mottling VBG O O
The DT B-NP O
patient NN I-NP O
developed VBD B-VP O
diarrhea NN B-NP O
He PRP O O
was VBD B-VP O
on IN B-VP O
vancomycin NN B-NP B-m
, , O O
levofloxacin NN B-NP B-m
, , O O
with IN B-VP O
p.o JJ B-NP B-mo
Flagyl NNP I-NP B-m
for IN B-VP O
empiric JJ B-NP O
treatment NN I-NP O
for IN B-VP O
C NNP B-NP B-r
diff NN I-NP I-r
C NNP I-NP O
diff NN I-NP O
cultures NNS I-NP O
were VBD B-VP O
negative JJ O O
on IN B-VP O
0/7/2003 CD O O
, , O O
in IN B-VP O
addition NN B-NP O
his PRP$ O O
drain NN B-NP O
cultures NNS I-NP O
on IN B-VP O
10/6/2003 CD O O
, , O O
showed VBD B-VP O
rare JJ B-NP O
Staphylococcus NNP I-NP O
aureus NN I-NP O
On IN B-VP O
6/3/2003 CD O O
, , O O
repeat JJ B-NP O
culture NN I-NP O
of IN B-VP O
the DT B-NP O
groin NN I-NP O
were VBD B-VP O
negative JJ O O
He PRP O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
nausea NN B-NP B-r
, , O O
which WDT O O
improved VBD B-VP O
after IN B-VP O
Flagyl NNP B-NP B-m
was VBD B-VP O
discontinued VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Cardiology NNP B-NP O
during IN B-VP O
his PRP$ O O
stay NN B-NP O
here RB O O
On IN B-VP O
postoperative JJ B-NP O
#2 NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
volume NN B-NP O
overloaded VBD B-VP O
His PRP$ O O
torsemide JJ B-NP B-m
torsemide NN I-NP B-m
was VBD B-VP O
increased VBN O O
to TO O O
100 CD O B-do
mg NNS B-NP I-do
b.i.d NN I-NP B-f
with IN B-VP O
goal NN B-NP O
diuresis NN I-NP O
of IN B-VP O
1-2 JJ B-NP O
liters NNS I-NP O
per IN B-VP O
day NN B-NP O
IV NNP I-NP B-mo
Lasix NNP I-NP B-m
was VBD B-VP O
added VBN O O
p.r.n NN B-NP B-f
to TO O O
achieve VB O O
this DT B-NP O
goal NN I-NP O
After IN B-VP O
his PRP$ O O
episode NN B-NP O
of IN B-VP O
nausea NN B-NP O
, , O O
his PRP$ O O
EKG NNP B-NP O
was VBD B-VP O
checked VBN O O
to TO O O
rule VB O O
out RP O O
any DT B-NP O
sort NN I-NP O
of IN B-VP O
cardio NN B-NP O
ischemic JJ B-NP O
cause NN I-NP O
for IN B-VP O
this DT B-NP O
nausea NN I-NP O
, , O O
EKG NNP B-NP O
was VBD B-VP O
normal JJ O O
His PRP$ O O
morphine NN B-NP B-m
was VBD B-VP O
discontinued VBN O O
as IN B-VP O
a DT B-NP O
possible JJ I-NP O
cause NN I-NP O
He PRP O O
did VBD B-VP O
well RB O O
with IN B-VP O
p.o NN B-NP B-mo
pain NN I-NP B-m
medications NNS I-NP O
Renal: NNP I-NP O
His PRP$ O O
Zestril NNP B-NP B-m
was VBD B-VP O
held VBN O O
secondary JJ O O
to TO O O
an DT B-NP O
elevation NN I-NP O
in IN B-VP O
creatinine NN B-NP O
to TO O O
3.3 CD O O
from IN B-VP O
his PRP$ O O
baseline NN B-NP O
of IN B-VP O
1.8 CD O O
This DT O O
gradually RB O O
resolved VBN O O
Creatinine NNP B-NP O
was VBD B-VP O
2.5 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
seen VBN O O
by IN B-VP O
the DT B-NP O
Nutrition NNP I-NP O
and CC O O
recommended VBD B-VP O
supplements NNS B-NP B-m
, , O O
vitamin FW O B-m
C NNP B-NP I-m
, , O O
and CC O O
Zinc NNP B-NP B-m
for IN B-VP O
wound NN B-NP B-r
wound NN I-NP B-r
wound IN B-VP B-r
healing VBG O I-r
healing VBG O I-r
healing NN B-NP I-r
By IN B-VP O
0/7/2003 CD O O
, , O O
the DT B-NP O
patient's NN I-NP O
flap NN I-NP O
was VBD B-VP O
stable JJ O O
, , O O
pink VB O O
, , O O
and CC O O
viable JJ O O
He PRP O O
had VBD B-VP O
lower JJR B-NP O
extremity NN I-NP O
pulses NNS I-NP O
that WDT O O
were VBD B-VP O
Dopplerable NNP B-NP O
He PRP O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
with IN B-VP O
services NNS B-NP O
Discharge NNP I-NP O
medications NNS I-NP O
include VBP O O
enteric-coated JJ O B-m
aspirin JJ O I-m
325 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP O
day; NN I-NP O
digoxin NN I-NP B-m
0.125 CD O B-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
Ultralente NNP I-NP B-m
Ultralente NNP I-NP B-m
16 CD O B-do
units NNS B-NP I-do
q.a.m RB O B-f
, , O O
4 CD O B-do
units NNS B-NP O
q.p.m.; VBD B-VP B-f
Zocor NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
Toprol NNP I-NP B-m
25 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
Imdur NNP I-NP B-m
30 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
torsemide RB O B-m
100 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
lisinopril NN I-NP B-m
2.5 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day; NN I-NP I-f
colace; NN I-NP B-m
and CC O O
Percocet NNP B-NP B-m
eScription NN I-NP O
document: VBD B-VP O
3-1417736 JJ B-NP O
BF NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
DEVIVO NNP I-NP O
, , O O
REYES NNP B-NP O
DARRYL NNP I-NP O
Attending: NNP I-NP O
OVERLY NNP I-NP O
, , O O
DALTON NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
6036613 CD O O
D: NNP B-NP O
11/15/03 CD O O
T: NNP B-NP O
9/9/03 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#796843 VBZ O O
621798787 CD O O
CUC NNP B-NP O
35982795 CD O O
444950 CD O O
7/11/1994 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
10/1/1994 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
6/16/1994 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
CONGESTIVE NNP I-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
SECONDARY NNP I-NP O
DIAGNOSES: NNP I-NP O
1 CD O O
PULMONARY NNP B-NP O
EMBOLUS NNP I-NP O
2 CD O O
DILATED NNP B-NP O
CARDIOMYOPATHY NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
65 CD O O
year NN B-NP O
old JJ B-NP O
woman NN I-NP O
with IN B-VP O
dilated VBN O O
cardiomyopathy JJ O O
secondary JJ O O
to TO O O
Adriamycin NNP B-NP B-m
Adriamycin NNP I-NP B-m
, , O O
status NN B-NP O
post NN I-NP O
recent JJ B-NP O
admission NN I-NP O
for IN B-VP O
increased JJ B-NP O
shortness NN I-NP B-r
of IN B-VP O
breath NN B-NP O
and CC O O
left VBD B-VP B-r
pleural JJ B-NP I-r
effusion NN I-NP I-r
He PRP O O
returns VBZ O O
now RB O O
with IN B-VP O
increased VBN O O
cough NN B-NP O
productive NN I-NP O
of IN B-VP O
white JJ B-NP O
phlegm NN I-NP O
and CC O O
progressive JJ B-NP O
dyspnea NN I-NP O
on IN B-VP O
exertion NN B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
breast NN B-NP O
carcinoma NN I-NP O
in IN B-VP O
1989 CD O O
, , O O
treated VBN O O
with IN B-VP O
left JJ B-NP O
lumpectomy NN I-NP O
x VBD B-VP O
2 CD O O
and CC O O
XRT NNP B-NP O
, , O O
accompanied VBN O O
by IN B-VP O
chemotherapy NN B-NP O
completed VBN O O
in IN B-VP O
early JJ O O
1990 CD O O
The DT B-NP O
patient NN I-NP O
then RB O O
presented VBN O O
in IN B-VP O
August NNP B-NP O
of IN B-VP O
1992 CD O O
with IN B-VP O
progressive JJ B-NP O
dyspnea NN I-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
found VBN O O
to TO O O
have VB O O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
17% CD O O
She PRP O O
was VBD B-VP O
diagnosed VBN O O
with IN B-VP O
cardiomyopathy JJ O O
felt VBD B-VP O
secondary JJ O O
to TO O O
Adriamycin NNP B-NP B-m
toxicity NN I-NP O
She PRP O O
was VBD B-VP O
then RB O O
treated VBN O O
with IN B-VP O
Digoxin NNP B-NP B-m
, , O O
Lasix NNP B-NP B-m
, , O O
Captopril NNP B-NP B-m
and CC O O
Coumadin NNP B-NP B-m
with IN B-VP O
good JJ B-NP O
result NN I-NP O
She PRP O O
had VBD B-VP O
subsequent JJ B-NP O
development NN I-NP O
of IN B-VP O
SVT NNP B-NP O
with IN B-VP O
a DT B-NP O
rapid JJ I-NP O
ventricular JJ I-NP O
rate NN I-NP O
of IN B-VP O
approximately RB O O
180 CD O O
The DT B-NP O
patient NN I-NP O
eventually RB O O
underwent JJ B-NP O
EPEP NNP I-NP O
studies NNS I-NP O
with IN B-VP O
therapeutic JJ B-NP O
ablation NN I-NP O
Subsequently NNP I-NP O
she PRP O O
had VBD B-VP O
done VBN O O
quite RB O O
well RB O O
until IN B-VP O
February NNP B-NP O
of IN B-VP O
1994 CD O O
when WRB O O
she PRP O O
presented VBD B-VP O
with IN B-VP O
mild JJ B-NP B-r
cough JJ I-NP I-r
productive NN I-NP O
of IN B-VP O
white JJ B-NP O
phlegm NN I-NP O
and CC O O
increasing VBG O O
symptoms NNS B-NP O
of IN B-VP O
right JJ O O
and CC O O
left-sided JJ B-NP B-r
left-sided JJ I-NP B-r
heart NN I-NP I-r
heart NN I-NP I-r
failure NN I-NP I-r
failure NN I-NP I-r
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
increased JJ B-NP O
Lasix NNP I-NP B-m
Lasix NNP I-NP B-m
and CC O O
Digoxin NNP B-NP B-m
and CC O O
an DT B-NP O
empiric JJ I-NP O
course NN I-NP O
of IN B-VP O
amoxicillin NN B-NP B-m
with IN B-VP O
little JJ B-NP O
change NN I-NP O
in IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
She PRP O O
was VBD B-VP O
then RB O O
admitted VBN O O
on IN B-VP O
0/29 CD O O
after IN B-VP O
she PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
large JJ I-NP O
left-sided JJ I-NP O
pleural JJ I-NP O
effusion NN I-NP O
The DT B-NP O
patient JJ I-NP O
underwent NN I-NP O
ultrasound NN I-NP O
guided VBD B-VP O
thoracentesis NN B-NP O
complicated VBN O O
by IN B-VP O
a DT B-NP O
pneumothorax NN I-NP O
requiring VBG O O
chest JJS B-NP O
tube NN I-NP O
placement JJ B-NP O
Evaluation NN I-NP O
of IN B-VP O
the DT B-NP O
pleural JJ I-NP O
fluid NN I-NP O
revealed VBD B-VP O
a DT B-NP O
transudative JJ I-NP B-r
effusion NN I-NP I-r
with IN B-VP O
all DT B-NP O
cultures NNS I-NP O
and CC O O
cytology NN B-NP O
remaining VBG O O
negative JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Ancef NNP B-NP B-m
for IN B-VP B-du
approximately RB O O
7 CD O O
days NNS B-NP O
while IN B-VP O
the DT B-NP O
chest JJS I-NP O
tube NN I-NP O
was VBD B-VP O
in IN B-VP O
place NN B-NP O
and CC O O
then RB O O
discharged VBD B-VP O
on IN B-VP O
11/30/94 CD O O
Since IN B-VP O
that DT B-NP O
time NN I-NP O
the DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
no DT B-NP O
improvement NN I-NP O
in IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
but CC O O
rather RB O O
notes NNS B-NP O
increasing VBG O O
cough NN B-NP O
which WDT O O
remains VBZ O O
productive JJ O O
of IN B-VP O
white JJ B-NP O
sputum NN I-NP O
with IN B-VP O
occasional JJ B-NP O
"specks NNS I-NP O
of IN B-VP O
red" NN B-NP O
and CC O O
progression NN B-NP O
of IN B-VP O
her PRP$ O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
She PRP O O
is VBZ O O
now RB O O
unable JJ O O
to TO O O
go VB O O
greater JJR O O
than IN B-VP O
six CD O O
steps NNS B-NP O
of IN B-VP O
stair NN B-NP O
without IN B-VP O
significant JJ B-NP O
dyspnea NN I-NP O
This DT O O
is VBZ O O
a DT B-NP O
significant JJ I-NP O
change NN I-NP O
from IN B-VP O
approximately RB O O
one CD O O
month NN B-NP O
ago IN B-VP O
where WRB O O
she PRP O O
was VBD B-VP O
able JJ O O
to TO O O
go VB O O
two CD O O
flights NNS B-NP O
without IN B-VP O
extreme NN B-NP O
difficulty NN I-NP O
She PRP O O
has VBZ O O
stable JJ O O
3 CD O O
+ JJ B-NP O
pillow JJ I-NP O
orthopnea NN I-NP O
and CC O O
pedal JJ B-NP O
edema NN I-NP O
Her NNP I-NP O
weight NN I-NP O
has VBZ O O
increased VBN O O
only RB O O
slightly RB O O
recently RB O O
She PRP O O
denies VBZ O O
any DT B-NP O
fever NN I-NP O
, , O O
chills NNS B-NP O
, , O O
sweats NNS B-NP O
, , O O
chest JJS B-NP O
discomfort NN I-NP O
or CC O O
pleuritic JJ B-NP O
chest NN I-NP O
pain NN I-NP O
She PRP O O
does VBZ O O
not RB O O
anorexia VB O O
and CC O O
malaise VB O O
without IN B-VP O
myalgias NN B-NP O
or CC O O
arthralgias VB O O
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Dilated NNP B-NP O
cardiomyopathy NN I-NP O
as IN B-VP O
above IN B-VP O
2 CD O O
Breast NNP B-NP O
carcinoma NN I-NP O
as IN B-VP O
above IN B-VP O
3 CD O O
Hypothyroid $ O O
4 CD O O
Depression NNP B-NP O
ALLERGIES: NNP I-NP O
No NNP I-NP O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
Habits NNP I-NP O
, , O O
distant JJ B-NP O
tobacco NN I-NP O
use NN I-NP O
, , O O
none NN B-NP O
since IN B-VP O
1967 CD O O
, , O O
no DT B-NP O
ETOH NNP I-NP O
MEDICATIONS: NNP I-NP O
Digoxin NNP I-NP B-m
0.25 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
day NN I-NP I-f
, , O O
Lasix NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
day NN I-NP I-f
, , O O
Capoten NNP B-NP B-m
50 CD O B-do
mg NN B-NP O
t.i.d NN I-NP B-f
, , O O
aspirin VBP O B-m
one CD O B-do
per IN B-VP B-f
day NN B-NP I-f
, , O O
Synthroid NNP B-NP B-m
2 CD O B-do
gr NN B-NP I-do
per IN B-VP B-f
day NN B-NP I-f
, , O O
Tamoxifen NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Elavil NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
q NN I-NP B-f
day NN I-NP I-f
, , O O
K-Dur NNP B-NP B-m
1 CD O B-do
q NN B-NP B-f
day NN I-NP I-f
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
with IN B-VP O
her PRP$ O O
boyfriend NN B-NP O
, , O O
she PRP O O
is VBZ O O
widowed VBN O O
without IN B-VP O
children NNS B-NP O
She PRP O O
is VBZ O O
a DT B-NP O
semi-retired JJ I-NP O
Accounts NNP I-NP O
Manager NNP I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
There EX O O
is VBZ O O
no DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
cardiac JJ B-NP O
disease NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Temperature NNP I-NP O
100.6 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
116/65 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
is VBZ O O
100 CD O O
, , O O
respiratory NN B-NP O
rate NN I-NP O
18 CD O O
02 CD O O
saturation NN B-NP O
90% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
alert JJ O O
, , O O
responsive JJ O O
, , O O
febrile JJ O O
and CC O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
Her NNP I-NP O
conjunctiva NN I-NP O
are VBP O O
clear JJ O O
, , O O
extraocular JJ B-NP O
movements NNS I-NP O
intact JJ O O
, , O O
her PRP$ O O
oropharynx NN B-NP O
is VBZ O O
clear JJ O O
She PRP O O
has VBZ O O
no DT B-NP O
lymphadenopathy JJ I-NP O
Jugular NNP I-NP O
venous JJ B-NP O
pressure NN I-NP O
is VBZ O O
approximately RB O O
8 CD O O
cm NNS B-NP O
at IN B-VP O
30 CD O O
degrees NNS B-NP O
Lung NNP I-NP O
examination NN I-NP O
is VBZ O O
remarkable JJ O O
for IN B-VP O
a DT B-NP O
few JJ I-NP O
rales NNS I-NP O
at IN B-VP O
the DT B-NP O
left JJ I-NP O
base NN I-NP O
, , O O
decreased VBN O O
breath NN B-NP O
sounds NNS I-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
base NN I-NP O
with IN B-VP O
dullness NN B-NP O
to TO O O
percussion NN B-NP O
Cardiac NNP I-NP O
examination NN I-NP O
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
normal JJ B-NP O
SI NNP I-NP O
, , O O
SII NNP B-NP O
, , O O
positive JJ B-NP O
SIII NNP I-NP O
Abdomen NNP I-NP O
is VBZ O O
soft JJ O O
and CC O O
non-tender JJ O O
, , O O
slightly RB O O
distended VBN O O
She PRP O O
has VBZ O O
pitting VBG O O
edema RB O O
almost RB O O
to TO O O
the DT B-NP O
knees NNS I-NP O
bilaterally RB O O
Neurological NNP B-NP O
examination NN I-NP O
is VBZ O O
non JJ B-NP O
focal JJ I-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
SMA-7 NNP I-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
a DT B-NP O
potassium NN I-NP O
of IN B-VP O
5.4 CD O O
and CC O O
creatinine NN B-NP O
of IN B-VP O
1.2 CD O O
with IN B-VP O
a DT B-NP O
BUN NNP I-NP O
of IN B-VP O
20 CD O O
CBC NNP B-NP O
demonstrated VBD B-VP O
a DT B-NP O
white JJ I-NP O
count NN I-NP O
of IN B-VP O
14 CD O O
, , O O
hematocrit NN B-NP O
of IN B-VP O
42.9 CD O O
, , O O
platelets NNS B-NP O
289 CD O O
, , O O
Digoxin NNP B-NP O
level NN I-NP O
was VBD B-VP O
1.2 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
showed VBD B-VP O
a DT B-NP O
left JJ I-NP O
pleural JJ I-NP O
effusion NN I-NP O
which WDT O O
is VBZ O O
unchanged JJ O O
, , O O
a DT B-NP O
new JJ I-NP O
right JJ I-NP O
pleural JJ I-NP O
effusion NN I-NP O
+- JJ B-NP O
consolidation NN I-NP O
EKG NNP I-NP O
showed VBD B-VP O
sinus JJ B-NP O
rhythm NN I-NP O
at IN B-VP O
98 CD O O
, , O O
left VBD B-VP O
axis JJ B-NP O
deviation NN I-NP O
, , O O
normal JJ B-NP O
intervals NNS I-NP O
, , O O
low JJ B-NP O
voltage NN I-NP O
with IN B-VP O
poor JJ B-NP O
R NNP I-NP O
wave NN I-NP O
progression NN I-NP O
, , O O
no DT B-NP O
significant JJ I-NP O
change NN I-NP O
compared VBN O O
with IN B-VP O
2/12/94 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
with IN B-VP O
a DT B-NP O
picture NN I-NP O
of IN B-VP O
chronic JJ B-NP O
productive JJ I-NP O
cough NN I-NP O
, , O O
progressive JJ B-NP O
dyspnea NN I-NP O
with IN B-VP O
low JJ B-NP O
grade NN I-NP O
fevers NNS I-NP O
and CC O O
increased VBD B-VP O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
, , O O
in IN B-VP O
addition NN B-NP O
to TO O O
new JJ B-NP O
opacity NN I-NP O
on IN B-VP O
chest JJS B-NP O
x-ray NN I-NP O
This DT B-NP O
clinical JJ I-NP O
picture NN I-NP O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
mostly RB O O
from IN B-VP O
a DT B-NP O
progressive JJ I-NP O
infectious JJ I-NP O
process NN I-NP O
superimposed VBN O O
on IN B-VP O
underlying VBG O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
versus IN B-VP O
post-obstructive JJ B-NP O
infection NN I-NP O
versus IN B-VP O
atelectasis NN B-NP O
with IN B-VP O
an DT B-NP O
endobronchial JJ I-NP O
lesion NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
empiric JJ B-NP O
course NN I-NP O
of IN B-VP O
antibiotics NNS B-NP B-m
including VBG O O
cefotaxime NN B-NP B-m
and CC O O
clarithromycin NN B-NP B-m
She PRP O O
was VBD B-VP O
seen VBN O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
the DT B-NP O
Pulmonary NNP I-NP O
Service NNP I-NP O
which WDT O O
felt VBD B-VP O
that IN B-VP O
a DT B-NP O
therapeutic JJ I-NP O
trial NN I-NP O
of IN B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
was VBD B-VP O
warranted VBN O O
prior RB O O
to TO O O
any DT O O
more RBR O O
aggressive JJ B-NP O
intervention NN I-NP O
such JJ O O
as IN B-VP O
bronchoscopy NN B-NP O
or CC O O
repeat NN B-NP O
thoracentesis IN B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
thus RB O O
treated VBN O O
with IN B-VP O
aggressive JJ B-NP O
IV NNP I-NP O
diuresis NN I-NP O
with IN B-VP O
excellent JJ B-NP O
symptomatic JJ I-NP O
result NN I-NP O
As IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
and CC O O
chest JJS B-NP O
x-ray JJ I-NP O
cleared NN I-NP O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
a DT B-NP O
chest NN I-NP O
CT NNP I-NP O
would MD O O
be VB O O
valuable JJ O O
in IN B-VP O
evaluating VBG O O
her PRP$ O O
left JJ B-NP O
lower JJR I-NP O
lobe NN I-NP O
for IN B-VP O
possible JJ B-NP O
endobronchial JJ I-NP O
lesion NN I-NP O
leading VBG O O
to TO O O
volume NN B-NP O
loss NN I-NP O
She PRP O O
thus RB O O
underwent VBD B-VP O
a DT B-NP O
chest NN I-NP O
CT NNP I-NP O
on IN B-VP O
5/16/94 CD O O
with IN B-VP O
demonstration NN B-NP O
of IN B-VP O
a DT B-NP O
large JJ I-NP O
peripheral NN I-NP O
, , O O
red JJ O O
, , O O
right JJ B-NP O
lower JJR I-NP O
lobe NN I-NP O
opacity NN I-NP O
, , O O
highly RB O O
suggestive JJ O O
of IN B-VP O
a DT B-NP O
right JJ I-NP O
lower JJR I-NP O
lobe NN I-NP O
pulmonary JJ B-NP O
infarction NN I-NP O
No NNP I-NP O
endobronchial JJ B-NP O
lesions NNS I-NP O
or CC O O
lymphadenopathy NNS B-NP O
were VBD B-VP O
noted VBN O O
Given NNP B-NP O
the DT B-NP O
patient's JJ I-NP O
history NN I-NP O
of IN B-VP O
dilated VBN O O
cardiomyopathy NN B-NP O
, , O O
off RB O O
anticoagulation NN B-NP O
, , O O
an DT B-NP O
extensive JJ I-NP O
discussion NN I-NP O
of IN B-VP O
the DT B-NP O
chest JJS I-NP O
CT JJ I-NP O
findings NNS I-NP O
with IN B-VP O
the DT B-NP O
Chest NNP I-NP O
Radiologist NNP I-NP O
and CC O O
Pulmonary NNP B-NP O
Consult NNP I-NP O
Team NNP I-NP O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
should MD O O
be VB O O
treated VBN O O
empirically RB O O
for IN B-VP O
a DT B-NP O
pulmonary JJ I-NP B-r
embolus NN I-NP I-r
She PRP O O
was VBD B-VP O
thus RB O O
started VBN O O
on IN B-VP O
IV NNP B-NP B-mo
Heparin NNP I-NP B-m
with IN B-VP O
achievement NN B-NP O
of IN B-VP O
therapeutic JJ B-NP O
PTT NNP I-NP O
prior RB O O
to TO O O
switching VBG O O
to TO O O
oral JJ B-NP B-mo
Coumadin NNP I-NP B-m
without IN B-VP O
complications NNS B-NP O
In IN B-VP O
addition NN B-NP O
the DT B-NP O
patient NN I-NP O
underwent NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
non-invasives NNS I-NP O
which WDT O O
were VBD B-VP O
negative JJ O O
for IN B-VP O
deep JJ B-NP O
venous JJ I-NP O
thrombosis NN I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
cardiac NN I-NP O
echocardiogram NN I-NP O
which WDT O O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
RV NNP B-NP O
strain NN I-NP O
or CC O O
right JJ B-NP O
ventricular JJ I-NP O
thrombus NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
this DT B-NP O
echocardiogram NN I-NP O
again RB O O
demonstrated VBD B-VP O
moderately RB O O
large JJ O O
left VBD B-VP O
ventricle NN B-NP O
with IN B-VP O
severely RB O O
depressed JJ B-NP O
systolic JJ I-NP O
function NN I-NP O
and CC O O
an DT O O
estimated VBN O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
15-20% JJ O O
Though IN B-VP O
the DT B-NP O
possibility NN I-NP O
that IN B-VP O
the DT B-NP O
wedge NN I-NP O
shaped VBD B-VP O
opacification NN B-NP O
seen VBN O O
on IN B-VP O
CT NNP B-NP O
was VBD B-VP O
due JJ O O
to TO O O
pneumonia VB O O
rather RB O O
than IN B-VP O
infarction NN B-NP O
, , O O
it PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
given VBN O O
the DT B-NP O
patient's NN I-NP O
low JJ B-NP O
ejection NN I-NP O
fraction NN I-NP O
she PRP O O
would MD O O
need VB O O
to TO O O
be VB O O
anticoagulated VBN O O
on IN B-VP O
this DT B-NP O
basis NN I-NP O
alone RB O O
, , O O
and CC O O
thus RB O O
pulmonary JJ B-NP O
angiogram NN I-NP O
or CC O O
VQ NNP B-NP O
scan NNS I-NP O
would MD O O
not RB O O
be VB O O
likely RB O O
to TO O O
alter VB O O
management NN B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
DISPOSITION: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
MEDICATIONS: NNP B-NP O
Elavil NNP I-NP B-m
75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
h.s.; NN I-NP I-f
Captopril NNP I-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d.; NN I-NP B-f
Biaxin NNP I-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
Digoxin NNP I-NP B-m
Digoxin NNP I-NP B-m
0.125 CD O B-do
0.125 CD O B-do
mg NNS B-NP I-do
alternating VBG O B-mo
with IN B-VP O
0.25 CD O O
mg NNS B-NP O
q JJ B-NP B-f
q JJ I-NP B-f
day; NN I-NP I-f
day; NN I-NP I-f
Lasix NNP I-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
Tamoxifen NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
Thyroid NNP I-NP B-m
2 CD O B-do
grains NNS B-NP I-do
p.o JJ B-NP B-mo
q JJ I-NP B-f
day; NN I-NP I-f
Coumadin NNP I-NP B-m
5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day; JJ I-NP I-f
K-Dur NNP I-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d.; NN I-NP B-f
Ambien NNP I-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
h.s NN I-NP I-f
Followup NNP I-NP O
with IN B-VP O
Dr NNP B-NP O
Gunsolus NNP I-NP O
at IN B-VP O
the DT B-NP O
Leyer NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
AHMED NNP I-NP O
M NNP I-NP O
HEILIGER NNP I-NP O
, , O O
M.D NNP B-NP O
GW87 NNP I-NP O
Attending: NNP I-NP O
ELWOOD NNP I-NP O
A NNP I-NP O
COGGSDALE NNP I-NP O
, , O O
M.D NNP B-NP O
VG9 NNP I-NP O
GF161/5805 NNP I-NP O
Batch: NNP I-NP O
7200 CD O O
Index NNP B-NP O
No NNP I-NP O
BRLF3LS21 NNP I-NP O
D: NNP I-NP O
10/25/94 CD O O
T: NNP B-NP O
10/4/94 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#797772 VBZ O O
670298908 CD O O
MH NNP B-NP O
16618177 CD O O
720662 CD O O
8/17/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
SYNCOPE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2/21/1999 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/13/1999 CD O O
SERVICE: NNP B-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
cared VBN O O
for IN B-VP O
on IN B-VP O
Cardiology NNP B-NP O
Team NNP I-NP O
Pro NNP I-NP O
Tampi NNP I-NP O
Corp NNP I-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS: NNP I-NP O
Syncope NNP I-NP O
ADDITIONAL NNP I-NP O
DIAGNOSES NNP I-NP O
INCLUDE: NNP I-NP O
1 CD O O
Coronary NNP B-NP O
artery NN I-NP O
disease NN I-NP O
2 CD O O
Bradycardia NNP B-NP O
3 CD O O
Diabetes NNP B-NP O
mellitus VBD B-VP O
4 CD O O
Hypertension NNP B-NP O
5 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
74-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
acute JJ B-NP O
inferior JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
in IN B-VP O
February NNP B-NP O
of IN B-VP O
1998 CD O O
, , O O
with IN B-VP O
total JJ B-NP O
occlusion NN I-NP O
of IN B-VP O
the DT B-NP O
mid NN I-NP O
circumflex NN I-NP O
, , O O
with IN B-VP O
fresh JJ B-NP O
thrombus NN I-NP O
which WDT O O
was VBD B-VP O
percutaneous JJ B-NP O
transluminal JJ I-NP O
coronary NN I-NP O
angioplastied VBD B-VP O
and CC O O
stented VBD B-VP O
At IN B-VP O
catheterization NN B-NP O
in IN B-VP O
February NNP B-NP O
, , O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
50 CD O O
percent NN B-NP O
right RB O O
coronary JJ O O
artery RB O O
, , O O
as IN B-VP O
well RB O O
His PRP$ O O
hospital NN B-NP O
course NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
atrial JJ B-NP B-r
fibrillation NN I-NP I-r
with IN B-VP O
Mobitz NNP B-NP O
type NN I-NP O
I PRP O O
block VBP O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
loaded VBN O O
on IN B-VP O
procainamide NN B-NP B-m
He PRP O O
also RB O O
had VBD B-VP O
several JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
Echocardiogram NNP I-NP O
in IN B-VP O
February NNP B-NP O
showed VBD B-VP O
right JJ B-NP O
ventricular JJ I-NP O
dysfunction NN I-NP O
At IN B-VP O
discharge NN B-NP O
, , O O
a DT B-NP O
submaximum JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
went VBD B-VP O
three CD O O
minutes NNS B-NP O
and CC O O
twenty-one JJ B-NP O
seconds NNS I-NP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
ischemia NN B-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
cardiac JJ B-NP O
rehabilitation NN I-NP O
class NN I-NP O
when WRB O O
he PRP O O
became VBD B-VP O
light-headed JJ O O
while IN B-VP O
seated VBN O O
and CC O O
lost VBN O O
consciousness NN B-NP O
for IN B-VP O
approximately RB O O
five CD O O
seconds NNS B-NP O
He PRP O O
regained VBD B-VP O
full JJ B-NP O
consciousness NN I-NP O
He PRP O O
denied VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
chest NN B-NP O
tightness NN I-NP O
, , O O
fever NN B-NP O
, , O O
chills NNS B-NP O
, , O O
nausea NN B-NP O
or CC O O
vomiting NN B-NP O
He PRP O O
had VBD B-VP O
no DT B-NP O
urine NN I-NP O
or CC O O
stool NN B-NP O
incontinence NN I-NP O
, , O O
and CC O O
no DT B-NP O
focal JJ I-NP O
abnormal JJ I-NP O
motor NN I-NP O
movements NNS I-NP O
were VBD B-VP O
noted VBN O O
by IN B-VP O
observers NNS B-NP O
A NNP I-NP O
code NN I-NP O
blue NN I-NP O
was VBD B-VP O
called VBN O O
, , O O
and CC O O
he PRP O O
went VBD B-VP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
Electrocardiogram NNP I-NP O
showed VBD B-VP O
old JJ B-NP O
inferior JJ I-NP O
Qs NNP I-NP O
, , O O
PRWP NNP B-NP O
, , O O
and CC O O
slightly RB O O
elevated VBD B-VP O
T NNP B-NP O
wave NN I-NP O
in IN B-VP O
V2 NNP B-NP O
with IN B-VP O
left JJ B-NP O
anterior JJ I-NP O
fascicular JJ I-NP O
block NN I-NP O
with IN B-VP O
heart NN B-NP O
rate NN I-NP O
of IN B-VP O
49 CD O O
Initial JJ B-NP O
CK NNP I-NP O
was VBD B-VP O
39 CD O O
with IN B-VP O
a DT B-NP O
Troponin NNP I-NP O
I PRP O O
of IN B-VP O
0.02 CD O O
He PRP O O
was VBD B-VP O
admitted VBN O O
to TO O O
Wa NNP B-NP O
T NNP I-NP O
S NNP I-NP O
for IN B-VP O
further JJ B-NP O
workup NN I-NP O
and CC O O
treatment NN B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Coronary NNP B-NP O
artery NN I-NP O
disease NN I-NP O
2 CD O O
Diabetes NNPS B-NP B-r
mellitus NN I-NP O
on IN B-VP O
insulin NN B-NP B-m
3 CD O O
Hypertension NNP B-NP O
4 CD O O
Status NNP B-NP O
post NN I-NP O
bilateral JJ B-NP O
knee NN I-NP O
replacements NNS I-NP O
5 CD O O
Asbestos NNP B-NP O
exposure NN I-NP O
6 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
ALLERGIES: NNP I-NP O
Allergies NNP I-NP O
to TO O O
penicillin VB O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
2 CD O O
Captopril NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
3 CD O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
insulin NN I-NP I-m
insulin NN I-NP I-m
18 CD O B-do
q.a.m NN B-NP B-f
and CC O O
8 CD O B-do
q.p.m NN B-NP B-f
4 CD O O
Procainamide NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
5 CD O O
Simvastatin NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
A NNP I-NP O
40 CD O O
pack NN B-NP O
year NN I-NP O
history NN I-NP O
, , O O
quit VB O O
four CD O O
years NNS B-NP O
ago RB O O
Denies VBZ O O
alcohol NN B-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
A NNP I-NP O
well-appearing JJ B-NP O
gentleman NN I-NP O
, , O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
Vital NNP I-NP O
signs NNS I-NP O
, , O O
afebrile NN B-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
50 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
111/87 CD O O
, , O O
respirations NNS B-NP O
16 CD O O
, , O O
98 CD O O
percent NN B-NP O
on IN B-VP O
two CD O O
liters NNS B-NP O
HEENT NNP I-NP O
, , O O
atraumatic JJ O O
, , O O
normocephalic JJ O O
, , O O
oropharynx JJ B-NP O
clear JJ I-NP O
Neck NNP I-NP O
, , O O
carotids VBZ O O
2+ CD O O
, , O O
no DT B-NP O
bruits NNS I-NP O
, , O O
no DT B-NP O
cervical JJ I-NP O
adenopathy NN I-NP O
with IN B-VP O
the DT B-NP O
exception NN I-NP O
of IN B-VP O
a DT O O
2.0 CD O O
centimeter NN B-NP O
node NN I-NP O
in IN B-VP O
the DT B-NP O
occipital JJ I-NP O
region NN I-NP O
Chest NNP I-NP O
, , O O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
Cardiovascular NNP B-NP O
, , O O
bradycardic NN B-NP O
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
Abdomen NNP I-NP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
soft JJ O O
, , O O
non-tender JJ O O
, , O O
nondistended JJ O O
, , O O
no DT B-NP O
hepatosplenomegaly NN I-NP O
Extremities NNS I-NP O
, , O O
no DT B-NP O
edema NN I-NP O
, , O O
no DT B-NP O
other JJ I-NP O
lymphadenopathy JJ I-NP O
Neurological NNP I-NP O
examination NN I-NP O
, , O O
alert NN B-NP O
and CC O O
oriented VBD B-VP O
x NNP B-NP O
three CD O O
, , O O
non-focal JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
Admission NNP I-NP O
laboratory NN I-NP O
is VBZ O O
significant JJ O O
for IN B-VP O
a DT B-NP O
creatinine NN I-NP O
of IN B-VP O
1.6 CD O O
and CC O O
a DT B-NP O
potassium NN I-NP O
of IN B-VP O
5.1 CD O O
Blood NNP B-NP O
count NN I-NP O
were VBD B-VP O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
5.5 CD O O
, , O O
hematocrit NN B-NP O
44.6 CD O O
, , O O
platelets NNS B-NP O
233 CD O O
CK NNP B-NP O
39 CD O O
, , O O
cardiac JJ B-NP O
Troponin NNP I-NP O
I PRP O O
0.02 VBP O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
74-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
acute JJ B-NP O
inferior JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
in IN B-VP O
February NNP B-NP O
, , O O
complicated VBN O O
by IN B-VP O
postmyocardial JJ B-NP O
infarction NN I-NP O
atrial JJ B-NP O
fibrillation NN I-NP O
and CC O O
Mobitz NNP B-NP O
type NN I-NP O
I PRP O O
block VBP O O
, , O O
now RB O O
admitted VBN O O
following VBG O O
syncopal JJ O O
episode IN B-VP O
The DT B-NP O
Electrophysiology NNP I-NP O
Service NNP I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
prior JJ O O
to TO O O
electrophysiology VB O O
study VB O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
evaluation NN I-NP O
for IN B-VP O
possible JJ B-NP O
ischemic JJ I-NP O
causes NNS I-NP O
of IN B-VP O
an DT B-NP O
arrhythmia NN I-NP O
He PRP O O
was VBD B-VP O
initially RB O O
ruled VBN O O
out RP O O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
by IN B-VP O
serial JJ B-NP O
enzymes NNS I-NP O
and CC O O
electrocardiograms NNS B-NP O
On IN B-VP O
standard JJ B-NP O
Bruce NNP I-NP O
protocol NN I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
mibi NN I-NP O
, , O O
May NNP B-NP O
, , O O
1999 CD O O
, , O O
the DT O O
patient JJ O O
went VBD B-VP O
four CD O O
minutes NNS B-NP O
and CC O O
thirty JJ B-NP O
seconds NNS I-NP O
, , O O
maximum JJ B-NP O
heart NN I-NP O
rate NN I-NP O
121 CD O O
, , O O
maximum JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
210/85 CD O O
He PRP O O
had VBD B-VP O
typical JJ B-NP O
chest NN I-NP O
pain NN I-NP O
for IN B-VP O
angina NN B-NP O
and CC O O
chest JJS B-NP O
tightness NN I-NP O
at IN B-VP O
peak NN B-NP O
exercise NN I-NP O
which WDT O O
was VBD B-VP O
relieved VBN O O
with IN B-VP O
rest NN B-NP O
There EX O O
were VBD B-VP O
no DT B-NP O
electrocardiogram NN I-NP O
changes VBZ O O
He PRP O O
remained VBD B-VP O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
Mibi NNP I-NP O
images VBZ O O
showed VBD B-VP O
a DT B-NP O
mixed JJ I-NP O
MI NNP I-NP O
in IN B-VP O
basilar JJ B-NP O
half NN I-NP O
of IN B-VP O
the DT B-NP O
inferior JJ I-NP O
wall NN I-NP O
in IN B-VP O
4/20 CD O O
segments NNS B-NP O
, , O O
mild JJ B-NP O
peri-infarct JJ I-NP O
ischemia NN I-NP O
in IN B-VP O
3/20 CD O O
segments NNS B-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
territory NN I-NP O
He PRP O O
had VBD B-VP O
normal JJ B-NP O
left JJ I-NP O
ventricular JJ I-NP O
function NN I-NP O
, , O O
normal JJ O O
left VBD B-VP O
ventricular JJ B-NP O
volume NN I-NP O
, , O O
and CC O O
global JJ B-NP O
systolic NN I-NP O
left VBD B-VP O
ventricular JJ B-NP O
function NN I-NP O
with IN B-VP O
left JJ B-NP O
ventricular JJ I-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
55 CD O O
percent NN B-NP O
, , O O
wall JJ B-NP O
motion NN I-NP O
abnormalities NNS I-NP O
and CC O O
severe JJ B-NP O
inferior NN I-NP O
wall NN I-NP O
hypokinesis NN I-NP O
and CC O O
mild JJ B-NP O
septal JJ I-NP O
hypokinesis NN I-NP O
Based VBN O O
on IN B-VP O
the DT B-NP O
results NNS I-NP O
of IN B-VP O
the DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
mibi NN I-NP O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
on IN B-VP O
May NNP B-NP O
, , O O
1999 CD O O
which WDT O O
revealed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
left NN I-NP O
main JJ O O
, , O O
left VBD B-VP O
anterior RP O O
descending VBG O O
artery NN B-NP O
with IN B-VP O
minor JJ B-NP O
irregularities NNS I-NP O
, , O O
left VBD B-VP O
circumflex NN B-NP O
with IN B-VP O
90 CD O O
percent JJ B-NP O
in-stent JJ I-NP O
restenosis NN I-NP O
in IN B-VP O
proximal JJ B-NP O
segment NN I-NP O
with IN B-VP O
a DT B-NP O
dominant JJ I-NP O
left NN I-NP O
circumflex NN I-NP O
, , O O
and CC O O
right RB O O
coronary JJ B-NP O
artery NN I-NP O
with IN B-VP O
a DT B-NP O
mid NN I-NP O
50 CD O O
percent NN B-NP O
lesion NN I-NP O
The DT B-NP O
patient NN I-NP O
underwent JJ B-NP O
successful JJ I-NP O
percutaneous JJ I-NP O
transluminal JJ I-NP O
coronary JJ I-NP O
angioplasty NN I-NP O
of IN B-VP O
the DT B-NP B-r
in-stent JJ I-NP O
restenosis NN I-NP O
He PRP O O
was VBD B-VP O
subsequently RB O O
continued VBN O O
on IN B-VP O
aspirin IN B-VP B-m
The DT B-NP O
Electrophysiology NNP I-NP O
Service NNP I-NP O
recommended VBD B-VP O
that IN B-VP O
the DT B-NP O
patient's NN I-NP O
procainamide RB O B-m
be VB O O
stopped VBN O O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient's NN I-NP O
QT NNP I-NP O
interval NN I-NP O
was VBD B-VP O
not RB O O
prolonged VBN O O
while IN B-VP O
on IN B-VP O
procainamide NN B-NP B-m
After IN B-VP O
the DT B-NP O
procainamide NN I-NP B-m
was VBD B-VP O
held VBN O O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
electrophysiology NN I-NP O
study NN I-NP O
on IN B-VP O
March NNP B-NP O
, , O O
1999 CD O O
revealing VBG O O
normal JJ B-NP O
sinus NN I-NP O
node JJ B-NP O
recovery NN I-NP O
time NN I-NP O
, , O O
impaired JJ B-NP O
AV NNP I-NP O
nodal JJ B-NP O
conduction NN I-NP O
, , O O
no DT O O
inducible JJ O O
sustained VBD B-VP O
ventricular JJ B-NP O
tachycardia NN I-NP O
, , O O
and CC O O
no DT B-NP O
inducible JJ I-NP O
supraventricular JJ I-NP O
tachycardia NN I-NP O
or CC O O
atrial JJ B-NP O
fibrillation NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
with IN B-VP O
plans NNS B-NP O
to TO O O
follow-up NN B-NP O
with IN B-VP O
his PRP$ O O
primary JJ B-NP O
cardiologist NN I-NP O
, , O O
perhaps RB O O
with IN B-VP O
a DT B-NP O
Holter NNP I-NP O
or CC O O
event NN B-NP O
monitor NN I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
INCLUDE: NNP I-NP O
1 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
q.d NN I-NP B-f
2 CD O O
Captopril NNP B-NP B-m
75 CD O B-do
mg NN B-NP I-do
t.i.d NN I-NP B-f
3 CD O O
NPH NNP B-NP B-m
NPH NNP I-NP B-m
Humulin NNP I-NP I-m
Humulin NNP I-NP I-m
insulin NN I-NP I-m
insulin NN I-NP I-m
18 CD O B-do
units NNS B-NP I-do
q.a.m RB O B-f
and CC O O
8 CD O B-do
units NNS B-NP I-do
q.p.m RB O B-f
4 CD O O
Nitroglycerin NNP B-NP B-m
sublingual JJ B-NP I-m
tablets NNS I-NP I-m
5 CD O O
Vitamin NNP B-NP B-m
E NNP I-NP O
6 CD O O
Simvastatin NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
q.h.s NN I-NP B-f
FOLLOW-UP: NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD O O
be VB O O
followed VBN O O
up RP O O
by IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
doctor NN I-NP O
, , O O
in IN B-VP O
particular JJ O O
the DT B-NP O
posterior JJ I-NP O
cervical JJ I-NP O
single JJ I-NP O
lymph NN I-NP O
node NN I-NP O
should MD O O
be VB O O
followed VBN O O
up RP O O
by IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician NN I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
WOODROW NNP I-NP O
BEAUDINE NNP I-NP O
, , O O
M.D NNP B-NP O
UU390 NNP I-NP O
Attending: NNP I-NP O
TYREE NNP I-NP O
R NNP I-NP O
CAPELLAN NNP I-NP O
, , O O
M.D NNP B-NP O
JJ5 NNP I-NP O
RB352/3807 NNP I-NP O
Batch: NNP I-NP O
77762 CD O O
Index NNP B-NP O
No NNP I-NP O
I2QFIO8GCI NNP I-NP O
D: NNP I-NP O
5/21/99 CD O O
T: NNP B-NP O
9/7/99 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#799726 VBZ O O
418921992 CD O O
DCH NNP B-NP O
35725579 CD O O
2107440 CD O O
0/14/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
CORONARY NNP I-NP O
ARTERY NNP I-NP O
DISEASE NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/16/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/2/2006 CD O O
ATTENDING: NNP B-NP O
FUGATE NNP I-NP O
, , O O
TIM NNP B-NP O
MD NNP I-NP O
SERVICE: NNP I-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
Mr NNP I-NP O
Lewter NNP I-NP O
is VBZ O O
a DT B-NP O
65-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
non-insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
dyslipidemia NN B-NP O
, , O O
and CC O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
who WP O O
presented VBD B-VP O
to TO O O
Tci NNP B-NP O
Prosamp NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
5/1/06 CD O O
with IN B-VP O
unstable JJ O O
angina VBP O O
The DT B-NP O
patient NN I-NP O
reports NNS I-NP O
that IN B-VP O
he PRP O O
had VBD B-VP O
been VBN O O
having VBG O O
intermittent JJ B-NP O
left-sided JJ I-NP O
chest NN I-NP O
pressure NN I-NP O
at IN B-VP O
rest NN B-NP O
over IN B-VP O
the DT O O
past JJ O O
three CD O O
days NNS B-NP O
associated VBN O O
with IN B-VP O
shortness NN B-NP O
of IN B-VP O
breath NN B-NP O
, , O O
each DT B-NP O
episode NN I-NP O
lasting VBG O O
approximately RB O O
10 CD O O
minutes NNS B-NP O
EKG NNP I-NP O
on IN B-VP O
admission NN B-NP O
revealed VBN O O
sinus JJ B-NP O
tachycardia NN I-NP O
with IN B-VP O
a DT O O
new JJ O O
incomplete JJ O O
left VBN O O
bundle-branch JJ B-NP O
block NN I-NP O
and CC O O
downsloping VBG O O
1-1.5 JJ B-NP O
mm NN I-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-VP O
V3 NNP B-NP O
through IN B-VP O
V6 NNP B-NP O
and CC O O
1 CD O O
mm NN B-NP O
depression NN I-NP O
in IN B-VP O
aVL PDT O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
deemed VBN O O
to TO O O
have VB O O
a DT B-NP O
NSTEMI NNP I-NP O
and CC O O
unstable JJ B-NP O
angina NN I-NP O
He PRP O O
was VBD B-VP O
not RB O O
heparinized VBN O O
due JJ O O
to TO O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
he PRP O O
was VBD B-VP O
on IN B-VP O
Coumadin NNP B-NP B-m
for IN B-VP O
peripheral JJ B-NP B-r
vascular JJ I-NP I-r
disease NN I-NP I-r
with IN B-VP O
a DT B-NP O
therapeutic JJ I-NP O
INR NNP I-NP O
On IN B-VP O
9/18/06 CD O O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
, , O O
which WDT O O
revealed VBD B-VP O
the DT B-NP O
following: NN I-NP O
Left NNP I-NP O
circumflex NN I-NP O
coronary JJ B-NP O
artery NN I-NP O
with IN B-VP O
an DT O O
ostial JJ O O
100% CD O O
stenosis NN B-NP O
, , O O
left VBD B-VP O
anterior RP O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
with IN B-VP O
a DT O O
proximal JJ O O
60% CD O O
stenosis NN B-NP O
and CC O O
a DT O O
mid JJ O O
50% CD O O
stenosis NN B-NP O
, , O O
right JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
with IN B-VP O
a DT O O
proximal JJ O O
80% CD O O
stenosis NN B-NP O
and CC O O
a DT O O
mid JJ O O
60% CD O O
stenosis NN B-NP O
, , O O
right JJ B-NP O
dominant JJ I-NP O
circulation NN I-NP O
, , O O
ejection NN B-NP O
fraction NN I-NP O
of IN B-VP O
30% CD O O
, , O O
collateral NN B-NP O
flow NN I-NP O
from IN B-VP O
the DT B-NP O
second JJ I-NP O
diagonal NN I-NP O
to TO O O
the DT B-NP O
third JJ I-NP O
marginal NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
posterior NN I-NP O
left VBD B-VP O
ventricular JJ B-NP O
branch NN I-NP O
to TO O O
the DT B-NP O
second JJ I-NP O
marginal NN I-NP O
, , O O
left VBD B-VP O
ventricular JJ B-NP O
hypokinesis NN I-NP O
, , O O
severe JJ B-NP O
inferior NN I-NP O
and CC O O
apical JJ B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
AND NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
with IN B-VP O
a DT B-NP O
peak JJ I-NP O
CK NNP I-NP O
of IN B-VP O
87 CD O O
, , O O
troponin NN B-NP O
0.48 CD O O
, , O O
history NN B-NP O
of IN B-VP O
class NN B-NP O
IV NNP I-NP O
angina NN I-NP O
with IN B-VP O
inability NN B-NP O
to TO O O
carry VB O O
on IN B-VP O
any DT B-NP O
physical JJ I-NP O
activity NN I-NP O
, , O O
history NN B-NP O
of IN B-VP O
class NN B-NP O
II NNP I-NP O
heart NN I-NP O
failure NN I-NP O
with IN B-VP O
slight JJ B-NP O
limitation NN I-NP O
of IN B-VP O
physical JJ B-NP O
activity NN I-NP O
, , O O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
hypertension NN B-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
bilateral JJ B-NP O
fem-pop JJ I-NP O
bypass NN I-NP O
and CC O O
status NN B-NP O
post NN I-NP O
bilateral JJ B-NP O
transmetatarsal NN I-NP O
amputations NNS I-NP O
, , O O
non-insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
dyslipidemia NN B-NP O
, , O O
history NN B-NP O
of IN B-VP O
gastrointestinal JJ B-NP O
bleeding NN I-NP O
, , O O
anxiety NN B-NP O
disorder NN I-NP O
, , O O
eosinophilia NN B-NP O
, , O O
chronic JJ O O
back RB O O
pain NN B-NP O
, , O O
anemia NN B-NP O
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
MEDICATIONS NNP I-NP O
AT NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
ADMISSION: NNP I-NP O
Lopressor NNP I-NP B-m
37.5 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
aspirin RB O B-m
325 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Pepcid NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
q.12h NN I-NP B-f
, , O O
insulin NN B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
, , O O
atorvastatin RB O B-m
80 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
glipizide NN B-NP B-m
, , O O
Avandia NNP B-NP B-m
, , O O
Zestril NNP B-NP B-m
, , O O
metformin NN B-NP B-m
, , O O
meclizine NN B-NP B-m
, , O O
lactulose RB O B-m
, , O O
vitamin FW O B-m
C NNP B-NP I-m
, , O O
Protonix NNP B-NP B-m
, , O O
Niaspan NNP B-NP B-m
, , O O
Neurontin NNP B-NP B-m
, , O O
Zincate NNP B-NP B-m
, , O O
Coumadin NNP B-NP B-m
for IN B-VP O
peripheral JJ B-NP B-r
vascular JJ I-NP I-r
disease NN I-NP I-r
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Cardiac NNP I-NP O
exam: VBZ O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
lifts NNS B-NP O
or CC O O
heaves VBZ O O
Peripheral NNP B-NP O
vascular JJ O O
2+ CD O O
pulses NNS B-NP O
bilaterally RB O O
in IN B-VP O
the DT B-NP O
carotid NN I-NP O
, , O O
radial JJ O O
, , O O
femoral JJ B-NP O
pulses NNS I-NP O
and CC O O
1+ CD O O
bilaterally RB O O
in IN B-VP O
the DT B-NP O
dorsalis NN I-NP O
pedis NN I-NP O
and CC O O
posterior JJ B-NP O
tibialis NN I-NP O
pulses NNS I-NP O
Respiratory: NNP I-NP O
Breath NNP I-NP O
sounds VBZ O O
clear JJ O O
bilaterally RB O O
Allen's NNP B-NP O
test NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
, , O O
abnormal JJ B-NP O
intermittent NN I-NP O
waveform NN I-NP O
with IN B-VP O
radial NN B-NP O
occluded VBD B-VP O
using VBG O O
a DT B-NP O
pulse JJ I-NP O
oximeter NN I-NP O
, , O O
right JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
abnormal JJ B-NP O
poor JJ I-NP O
intermittent NN I-NP O
wave NN I-NP O
form NN I-NP O
with IN B-VP O
the DT B-NP O
radial NN I-NP O
occluded VBD B-VP O
, , O O
also RB O O
with IN B-VP O
a DT B-NP O
pulse JJ I-NP O
oximeter NN I-NP O
Physical NNP I-NP O
exam NN I-NP O
otherwise NN I-NP O
is VBZ O O
noncontributory JJ B-NP O
ADMISSION NNP I-NP O
LABS: NNP I-NP O
Sodium NNP I-NP O
128 CD O O
, , O O
potassium NN B-NP O
4.2 CD O O
, , O O
chloride NN B-NP O
of IN B-VP O
99 CD O O
, , O O
CO2 NNP B-NP O
21 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
23 CD O O
, , O O
creatinine NN B-NP O
1.1 CD O O
, , O O
glucose NN B-NP O
of IN B-VP O
201 CD O O
, , O O
magnesium NN B-NP O
1.7 CD O O
, , O O
WBC NNP B-NP O
5.81 CD O O
, , O O
hematocrit NN B-NP O
28.6 CD O O
, , O O
hemoglobin NN B-NP O
10.2 CD O O
, , O O
platelets NNS B-NP O
of IN B-VP O
132 CD O O
, , O O
PT NNP B-NP O
of IN B-VP O
18.2 CD O O
, , O O
PT/INR NNP B-NP O
1.5 CD O O
, , O O
PTT NNP B-NP O
of IN B-VP O
33.7 CD O O
HOSPITAL NNP B-NP O
COURSE: NNP I-NP O
Mr NNP I-NP O
Jana NNP I-NP O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
7/28/06 CD O O
where WRB O O
he PRP O O
underwent VBD B-VP O
a DT B-NP O
coronary JJ I-NP O
artery NN I-NP O
bypass NN I-NP O
graft NN I-NP O
x3 NN I-NP O
with IN B-VP O
left JJ B-NP O
internal JJ I-NP O
mammary JJ I-NP O
artery NN I-NP O
to TO O O
left VB O O
anterior RP O O
descending VBG O O
coronary JJ B-NP O
artery NN I-NP O
, , O O
a DT B-NP O
sequential JJ I-NP O
graft NN I-NP O
and CC O O
a DT B-NP O
vein NN I-NP O
graft NN I-NP O
connecting VBG O O
from IN B-VP O
the DT B-NP O
aorta NN I-NP O
to TO O O
the DT B-NP O
second JJ I-NP O
obtuse NN I-NP O
marginal JJ B-NP O
coronary JJ I-NP O
artery NN I-NP O
and CC O O
then RB O O
to TO O O
the DT B-NP O
left NN I-NP O
ventricular JJ B-NP O
branch NN I-NP O
Total NNP I-NP O
bypass NN I-NP O
time NN I-NP O
was VBD B-VP O
55 CD O O
minutes NNS B-NP O
, , O O
total JJ B-NP O
crossclamp NN I-NP O
time NN I-NP O
was VBD B-VP O
46 CD O O
minutes NNS B-NP O
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
intraoperatively RB O O
, , O O
came VBD B-VP O
off RP O O
bypass NN B-NP O
without IN B-VP O
incident NN B-NP O
, , O O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
and CC O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
Postoperatively RB O O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
His PRP$ O O
CK-MB NN B-NP O
trended VBD B-VP O
down RB O O
and CC O O
EKG NNP B-NP O
normalized VBD B-VP O
The DT B-NP O
patient's NN I-NP O
postop JJ B-NP O
chest NN I-NP O
x-ray NN I-NP O
revealed VBD B-VP O
moderate-to-severe JJ B-NP O
pulmonary JJ I-NP O
venous JJ I-NP O
congestion NN I-NP O
bibasally RB O O
requiring VBG O O
vigorous JJ B-NP O
pulmonary JJ I-NP O
toilet NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
extubated VBN O O
on IN B-VP O
10/3/06 CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
followed VBN O O
by IN B-VP O
the DT B-NP O
Diabetes NNP I-NP O
Mellitus NNP I-NP O
Service NNP I-NP O
for IN B-VP O
his PRP$ O O
non-insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus VBD B-VP O
His PRP$ O O
blood NN B-NP O
glucoses NNS I-NP O
were VBD B-VP O
well RB O O
controlled VBN O O
He PRP O O
was VBD B-VP O
started VBN O O
back RP O O
on IN B-VP O
his PRP$ O O
oral JJ B-NP B-mo
medication NN I-NP O
of IN B-VP O
glipizide JJ O B-m
5 CD O B-do
mg NN B-NP I-do
and CC O O
was VBD B-VP O
covered VBN O O
with IN B-VP O
a DT B-NP O
NovoLog NNP I-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
transfused VBN O O
3 CD O B-do
units NNS B-NP I-do
of IN B-VP O
packed JJ B-NP B-m
red JJ I-NP O
blood NN I-NP O
cells NNS I-NP O
postoperatively RB O O
, , O O
and CC O O
was VBD B-VP O
re-started VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
for IN B-VP O
his PRP$ O B-r
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
The DT B-NP O
patient's NN I-NP O
platelet NN I-NP O
count NN I-NP O
dropped VBD B-VP O
to TO O O
as RB O O
low JJ O O
as IN B-VP O
59 CD O O
, , O O
000 CD O O
He PRP O O
had VBD B-VP O
a DT B-NP O
HIT NNP I-NP O
panel NN I-NP O
sent VBD B-VP O
off RP O O
which WDT O O
came VBD B-VP O
back RB O O
negative JJ O O
and CC O O
platelets NNS B-NP O
trended VBD B-VP O
up RP O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
to TO O O
143 CD O O
, , O O
000 CD O O
Mr NNP B-NP O
Gier NNP I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Step-Down JJ I-NP O
Unit NNP I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#3 VB O O
His PRP$ O O
pacing VBG O O
wires NNS B-NP O
were VBD B-VP O
removed VBN O O
, , O O
and CC O O
he PRP O O
was VBD B-VP O
screened VBN O O
for IN B-VP O
rehabilitation NN B-NP O
for IN B-VP O
discharge NN B-NP O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
some DT B-NP B-r
urinary JJ I-NP I-r
retention NN I-NP I-r
postoperatively RB O O
and CC O O
did VBD B-VP O
require VB O O
Foley NNP B-NP O
reinsertion NN I-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Flomax NNP B-NP B-m
0.4 CD O B-do
mg NN B-NP I-do
once RB O B-f
a DT B-NP I-f
day NN I-NP I-f
He PRP O O
failed VBD B-VP O
a DT B-NP O
second JJ I-NP O
voiding NN I-NP O
trial NN I-NP O
and CC O O
will MD O O
be VB O O
discharged VBN O O
with IN B-VP O
a DT B-NP O
leg NN I-NP O
bag NN I-NP O
and CC O O
follow VB O O
up RP O O
in IN B-VP O
the DT B-NP O
Urology NNP I-NP O
Clinic NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
and CC O O
continue VB O O
on IN B-VP O
his PRP$ O O
Flomax NNP B-NP B-m
until IN B-VP B-du
that DT B-NP I-du
time NN I-NP I-du
DISCHARGE NNP I-NP O
LABS: NNP I-NP O
The DT B-NP O
discharge NN I-NP O
labs NN I-NP O
for IN B-VP O
Mr NNP B-NP O
Howlingwolf NNP I-NP O
were VBD B-VP O
as IN B-VP O
follows: JJ B-NP O
Glucose NNP I-NP O
of IN B-VP O
150 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
39 CD O O
, , O O
creatinine NN B-NP O
1.2 CD O O
, , O O
sodium NN B-NP O
138 CD O O
, , O O
potassium NN B-NP O
3.6 CD O O
, , O O
chloride RB O O
103 CD O O
, , O O
CO2 NNP B-NP O
23 CD O O
, , O O
magnesium NN B-NP O
1.9 CD O O
, , O O
WBC NNP B-NP O
8.6 CD O O
, , O O
hemoglobin NN B-NP O
11 CD O O
, , O O
hematocrit NN B-NP O
31.4 CD O O
, , O O
platelets NNS B-NP O
of IN B-VP O
143 CD O O
, , O O
PT NNP B-NP O
of IN B-VP O
17.1 CD O O
, , O O
PT/INR NNP B-NP O
of IN B-VP O
1.4 CD O O
Urinalysis NN B-NP O
from IN B-VP O
11/21/06 CD O O
was VBD B-VP O
negative JJ B-NP O
Urine JJ I-NP O
culture NN I-NP O
is VBZ O O
no DT B-NP O
growth NN I-NP O
so RB O O
far RB O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Enteric-coated NNP I-NP B-m
aspirin VBZ O I-m
81 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
, , O O
Colace NNP B-NP B-m
100 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
while IN B-VP O
taking VBG O O
Dilaudid NNP B-NP B-m
, , O O
Lasix NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
x3 NNP I-NP B-du
doses VBZ O I-du
, , O O
glipizide RB O B-m
5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Dilaudid NNP B-NP B-m
2-4 CD O B-do
mg NN B-NP I-do
every DT O B-f
three CD O I-f
hours NNS B-NP I-f
p.r.n VBP O I-f
pain NN B-NP B-r
, , O O
lisinopril VBZ O B-m
2.5 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Niferex NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
, , O O
Toprol-XL NNP B-NP B-m
150 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
, , O O
Lipitor NNP B-NP B-m
80 CD O B-do
mg JJ O I-do
daily RB O B-f
, , O O
Flomax NNP B-NP B-m
0.4 CD O B-do
mg NN B-NP I-do
QD NNP I-NP B-f
, , O O
potassium NN B-NP B-m
chloride NN I-NP O
slow JJ B-NP O
release NN I-NP O
10 CD O B-do
mEq NN B-NP I-do
QD NNP I-NP B-f
x3 NNP I-NP B-du
doses VBZ O I-du
with IN B-VP O
Lasix NNP B-NP B-m
and CC O O
Coumadin NNP B-NP B-m
QD NNP I-NP B-f
per IN B-VP I-f
INR NNP B-NP I-f
result VBP O I-f
The DT B-NP O
patient NN I-NP O
will MD O O
receive VB O O
4 CD O B-do
mg NN B-NP I-do
of IN B-VP O
Coumadin NNP B-NP B-m
this DT B-NP B-f
evening NN I-NP I-f
for IN B-VP O
his PRP$ O B-r
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
His PRP$ O O
Coumadin NNP B-NP B-m
dosing NN I-NP O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Dr NNP B-NP O
Kurt NNP I-NP O
Goodwill NNP I-NP O
at IN B-VP O
( ( O O
320 CD O O
) ) O O
582-9691 JJ B-NP O
FOLLOW-UP JJ I-NP O
PLANS: NNP I-NP O
He PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr NNP B-NP O
Bert NNP I-NP O
Levering NNP I-NP O
in IN B-VP O
six CD O O
weeks NNS B-NP O
, , O O
his PRP$ O O
cardiologist NN B-NP O
Dr NNP I-NP O
Reuben NNP I-NP O
Duttinger NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
, , O O
his PRP$ O O
heart NN B-NP O
failure NN I-NP O
cardiologist NN I-NP O
Dr NNP I-NP O
Wilton NNP I-NP O
Durkee NNP I-NP O
on IN B-VP O
11/10/06 CD O O
at IN B-VP O
1:30 CD O O
in IN B-VP O
the DT B-NP O
afternoon NN I-NP O
, , O O
and CC O O
Urology NNP B-NP O
Clinic NNP I-NP O
at IN B-VP O
the DT B-NP O
Centsson NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
his PRP$ O O
urinary JJ B-NP O
retention NN I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
Clinic NNP I-NP O
number NN I-NP O
( ( O O
427 CD O O
) ) O O
363-3236 CD O O
DISPOSITION: NNP B-NP O
Mr NNP I-NP O
Fagin NNP I-NP O
is VBZ O O
discharged VBN O O
to TO O O
rehab VB O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
eScription NN I-NP O
document: VBZ O O
0-3585478 JJ B-NP O
EMSSten NNP I-NP O
Tel NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
ARROWOOD NNP I-NP O
, , O O
TIM NNP B-NP O
Attending: NNP I-NP O
ARRANTS NNP I-NP O
, , O O
CLIFTON NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
3130923 CD O O
D: NNP B-NP O
9/15/06 CD O O
T: NNP B-NP O
9/15/06 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#801284 VBZ O O
515984806 CD O O
DH NNP B-NP O
10446912 CD O O
685016 CD O O
9/26/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
s/p JJ B-NP O
PTCA NNP I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/26/2001 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
4/27/2001 CD O O
****** NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
LAPINSKY NNP I-NP O
, , O O
DARREN NNP B-NP O
S NNP I-NP O
312-34-40-6 JJ B-NP O
Encin NNP I-NP O
Service: NNP I-NP O
CAR NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
1/26/01 CD O O
AT NNP B-NP O
04:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL MD O O
D/C VB O O
ORDER NNP B-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
GUDERJAHN NNP I-NP O
, , O O
AUGUSTUS NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Home NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
ALBUTEROL NNP I-NP B-m
INHALER NNP I-NP I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
PRN NNP I-NP I-f
SOB NNP I-NP B-r
ECASA NNP I-NP B-m
( ( O I-m
ASPIRIN NNP B-NP I-m
ENTERIC NNP I-NP I-m
COATED NNP I-NP I-m
) ) O I-m
325 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
ATENOLOL NNP I-NP B-m
50 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
LISINOPRIL NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
NITROGLYCERIN NNP I-NP B-m
1/150 CD O I-m
( ( O I-m
0.4 CD O I-m
MG NNP B-NP I-m
) ) O I-m
1 CD O B-do
TAB NNP B-NP I-do
SL NNP I-NP B-mo
Q5 NNP I-NP B-f
MIN NNP I-NP O
X NNP I-NP O
3 CD O O
PRN NNP B-NP O
Chest NNP I-NP B-r
Pain NNP I-NP I-r
HOLD NNP I-NP O
IF: NNP I-NP O
SBP&lt;[ NNP I-NP O
] NNP I-NP O
Instructions: NNP I-NP O
As IN B-VP O
per IN B-VP O
chest NN B-NP O
pain NN I-NP O
protocol NN I-NP O
TERBUTALINE NNP I-NP B-m
( ( O I-m
TERBUTALINE NNP B-NP I-m
SULFATE NNP I-NP I-m
) ) O I-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
AZMACORT NNP I-NP B-m
( ( O I-m
TRIAMCINOLONE NNP B-NP I-m
ACETONIDE NNP I-NP I-m
) ) O I-m
2 CD O B-do
PUFF NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
KEFLEX NNP I-NP B-m
( ( O I-m
CEPHALEXIN NNP B-NP I-m
) ) O I-m
500 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
IMDUR NNP I-NP B-m
( ( O I-m
ISOSORBIDE NNP B-NP I-m
MONONIT.( NNP I-NP I-m
SR NNP I-NP I-m
) ) O I-m
) ) O I-m
30 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
QD NNP I-NP B-f
Food/Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
DIET: NNP B-NP O
House NNP I-NP O
/ VBD B-VP O
Low NNP B-NP O
chol/low NN I-NP O
sat VBD B-VP O
fat JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK: NNP I-NP O
After IN B-VP O
Appt NNP B-NP O
with IN B-VP O
local JJ B-NP O
physician NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
Dr NNP I-NP O
Ned NNP I-NP O
Wendt NNP I-NP O
, , O O
Cardiology NNP B-NP O
3/30/01 CD O O
scheduled VBN O O
, , O O
Dr NNP B-NP O
Elias NNP I-NP O
Forgey NNP I-NP O
, , O O
SMH NNP B-NP O
, , O O
ALLERGY: NNP B-NP O
Shellfish NNP I-NP O
, , O O
Morphine NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
s/p VBD B-VP O
PTCA NNP B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
s/p VBP O O
PTCA NNP B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
hodgkins VBZ O O
lymphoma FW O O
( ( O O
Hodgkins NNP B-NP O
disease NN I-NP O
) ) O O
Asthma NNP B-NP O
( ( O O
asthma NN B-NP O
) ) O O
R NNP B-NP O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
( ( O O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
) ) O O
septic JJ B-NP O
joint NN I-NP O
( ( O O
total JJ B-NP O
hip NN I-NP O
replacement NN I-NP O
) ) O O
non NN B-NP O
Q NNP I-NP O
wave NN I-NP O
MI NNP I-NP O
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
Cardiac NNP B-NP O
catheterization NN I-NP O
, , O O
11/17/01: CD O O
1 CD O O
) ) O O
Chronic NNP B-NP O
total JJ B-NP O
occlusion NN I-NP O
of IN B-VP O
the DT B-NP O
proximal JJ I-NP O
L.circumflex NNP I-NP O
artery NN I-NP O
with IN B-VP O
collaterals NNS B-NP O
to TO O O
distal JJ B-NP O
vessels NNS I-NP O
2 CD O O
) ) O O
RCA NNP B-NP O
ostial JJ B-NP O
discrete NN I-NP O
45% CD O O
lesion NN B-NP O
Unsuccessful NNP I-NP O
angioplasty NN I-NP O
of IN B-VP O
LCX; NNP B-NP O
no DT O O
stenting VBG O O
3 CD O O
) ) O O
No DT B-NP O
significant JJ I-NP O
LM NNP I-NP O
or CC O O
LAD NNP B-NP O
lesions NNS I-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
Mr NNP I-NP O
Sherburn NNP I-NP O
is VBZ O O
a DT B-NP O
58 JJ I-NP O
yo NN I-NP O
man NN I-NP O
w/a VBZ O O
hx NN B-NP O
of IN B-VP O
Hodgkins NNP B-NP O
lymphoma FW O O
s/p NN B-NP O
radiation NN I-NP O
tx NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
and CC O O
non-Q JJ B-NP O
wave NN I-NP O
MI NNP I-NP O
admiited VBD B-VP O
to TO O O
LMC NNP B-NP O
for IN B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
and CC O O
observation NN B-NP O
s/p NNS I-NP O
cath VBP O O
Catheterization NNP B-NP O
results NNS I-NP O
as IN B-VP O
above IN B-VP O
Mr NNP B-NP O
Muthart NNP I-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB O O
without IN B-VP O
adverse JJ B-NP O
event NN I-NP O
or CC O O
complication NN B-NP O
at IN B-VP O
the DT B-NP O
groin NN I-NP O
site NN I-NP O
He PRP O O
remained VBD B-VP O
afebrile JJ O O
, , O O
with IN B-VP O
stable JJ B-NP O
electrolytes NNS I-NP O
, , O O
hematocrit NN B-NP O
and CC O O
WBC NNP B-NP O
EKG NNP I-NP O
was VBD B-VP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
acute JJ B-NP O
ischemia NN I-NP O
and CC O O
cardiac JJ B-NP O
enzymes NNS I-NP O
remained VBD B-VP O
flat JJ O O
His PRP$ O B-r
SBP NNP B-NP I-r
ran NN I-NP O
in IN B-VP O
the DT O O
90's CD O O
to TO O O
low VB O O
100's CD O O
and CC O O
his PRP$ O O
Lisinopril NNP B-NP B-m
was VBD B-VP O
decreased VBN O O
as IN B-VP O
a DT B-NP O
result NN I-NP O
Imdur NNP I-NP B-m
was VBD B-VP O
also RB O O
added VBN O O
to TO O O
his PRP$ O O
cardiac JJ B-NP B-m
regimen NNS I-NP I-m
ADDITIONAL NNP I-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
COFFER NNP I-NP O
, , O O
RANDALL NNP B-NP O
P NNP I-NP O
, , O O
M.D NNP B-NP O
, , O O
M.P.H NNP B-NP O
( ( O O
BN01 NNP B-NP O
) ) O O
1/26/01 CD O O
@ $ O O
03:37 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#802249 VBZ O O
142488549 CD O O
EMH NNP B-NP O
11717781 CD O O
168608 CD O O
9/27/1996 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
9/27/1996 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
1/11/1997 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS: NNP I-NP O
UNSTABLE NNP I-NP O
ANGINA NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
a DT O O
60 CD O O
year-old JJ B-NP O
woman NN I-NP O
with IN B-VP O
adult NN B-NP O
onset VBN O O
diabetes NNS B-NP O
mellitus RBR O O
, , O O
hypertension NN B-NP O
admitted VBN O O
with IN B-VP O
chest NN B-NP O
pain NN I-NP O
, , O O
bradycardia NN B-NP O
, , O O
decreased VBD B-VP O
blood NN B-NP O
pressure NN I-NP O
, , O O
no DT B-NP O
previous JJ I-NP O
history NN I-NP O
of IN B-VP O
chest NN B-NP O
symptoms NNS I-NP O
Risk NNP I-NP O
factors NNS I-NP O
include VBP O O
positive JJ B-NP O
adult NN I-NP O
onset NN I-NP O
diabetes VBZ O O
mellitus RBS O O
, , O O
hypertension NN B-NP O
, , O O
smoker NN B-NP O
, , O O
elevated VBN O O
cholesterol NN B-NP O
, , O O
no DT B-NP O
family NN I-NP O
history NN I-NP O
Her PRP$ O O
present JJ B-NP O
history NN I-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
mid JJ B-NP O
sternal JJ I-NP O
chest NN I-NP O
pressure NN I-NP O
at IN B-VP O
three CD O O
out IN B-VP O
of IN B-VP O
ten NNS B-NP O
while IN B-VP O
sitting VBG O O
and CC O O
watching VBG O O
television NN B-NP O
The DT B-NP O
pain NN I-NP O
did VBD B-VP O
not RB O O
radiate VB O O
There EX O O
was VBD B-VP O
no DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
diaphoresis NN B-NP O
or CC O O
nausea NN B-NP O
, , O O
except IN B-VP O
for IN B-VP O
pressure NN B-NP O
on IN B-VP O
left JJ B-NP O
side NN I-NP O
of IN B-VP O
neck NN B-NP O
which WDT O O
is VBZ O O
typical JJ O O
for IN B-VP O
her PRP$ O O
when WRB O O
her PRP$ O B-r
blood NN B-NP I-r
pressure NN I-NP I-r
is VBZ O O
elevated VBN O O
The DT B-NP O
patient NN I-NP O
took VBD B-VP O
Nifedipine NNP B-NP B-m
without IN B-VP O
relief NN B-NP O
and CC O O
went VBD B-VP O
to TO O O
the DT B-NP O
bedroom NN I-NP O
to TO O O
rest VB O O
There EX O O
the DT B-NP O
pressure NN I-NP O
became VBD B-VP O
pain NN B-NP B-r
, , O O
three CD O O
to TO O O
four CD O O
out IN B-VP O
of IN B-VP O
ten NN B-NP O
She PRP O O
took VBD B-VP O
Cardizem NNP B-NP B-m
without IN B-VP O
relief NN B-NP O
She PRP O O
called VBD B-VP O
EMS NNP B-NP O
The DT B-NP O
pain NN I-NP B-r
was VBD B-VP O
relieved VBN O O
with IN B-VP O
the DT B-NP O
EMTs NNP I-NP O
gave VBD B-VP O
nitroglycerin JJ B-NP B-m
times NNS I-NP B-du
two CD O I-du
This DT O O
lasted VBD B-VP O
30 CD O O
minutes NNS B-NP O
EMTs NNP I-NP O
found VBD B-VP O
her PRP$ O O
to TO O O
have VB O O
blood NN B-NP O
pressure NN I-NP O
of IN B-VP O
190/100 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
76 CD O O
, , O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
They PRP O O
gave VBD B-VP O
two CD O B-do
nitrospray NN B-NP B-m
, , O O
blood NN B-NP B-r
pressure NN I-NP I-r
decreased VBD B-VP O
to TO O O
150/80 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
76 CD O O
and CC O O
after IN B-VP O
two CD O O
minutes NNS B-NP O
in IN B-VP O
the DT B-NP O
vehicle NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
sinus VBN O O
bradycardia NN B-NP O
at IN B-VP O
30-40 JJ O O
, , O O
blood NN B-NP B-r
pressure NN I-NP I-r
120/80 CD O O
She PRP O O
was VBD B-VP O
given VBN O O
0.5 CD O B-do
mg NN B-NP I-do
of IN B-VP O
Atropine NNP B-NP B-m
times CC O B-du
one CD O I-du
without IN B-VP O
any DT O O
affect JJ O O
She PRP O O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
Chcine NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
but CC O O
initially RB O O
she PRP O O
was VBD B-VP O
normotensive JJ O O
with IN B-VP O
a DT B-NP O
systolic JJ I-NP O
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
100 CD O O
Then RB O O
suddenly RB O O
she PRP O O
had VBD B-VP O
bradycardia VBN O O
with IN B-VP O
heart NN B-NP O
rate NN I-NP O
of IN B-VP O
30-40 JJ O O
and CC O O
systolic JJ B-NP B-r
blood NN I-NP O
pressure NN I-NP O
of IN B-VP O
75 CD O O
She PRP O O
was VBD B-VP O
given VBN O O
intravenous JJ B-NP B-m
intravenous JJ I-NP B-mo
fluids NNS I-NP I-m
and CC O O
Atropine NNP B-NP B-m
0.5 CD O B-do
mg NN B-NP O
times NNS I-NP B-du
one CD O I-du
This DT B-NP O
lead NN I-NP O
to TO O O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
her PRP$ O O
blood NN B-NP O
pressure NN I-NP O
systolic NN I-NP O
of IN B-VP O
100 CD O O
and CC O O
her PRP$ O O
heart NN B-NP O
rate NN I-NP O
increased VBD B-VP O
to TO O O
60 CD O O
On IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
without IN B-VP O
chest JJS B-NP O
pain NN I-NP O
, , O O
normotensive JJ O O
and CC O O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
REVIEW NNP I-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
She PRP O O
denies VBZ O O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
, , O O
orthopnea NN B-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
, , O O
fever NN B-NP O
, , O O
chills NNS B-NP O
, , O O
cough NN B-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
) ) O O
Adult NNP B-NP O
onset MD O O
diabetes VBZ O B-r
mellitus NNS B-NP I-r
on IN B-VP O
Glucotrol NNP B-NP B-m
2 CD O O
) ) O O
Hypertension NNP B-NP O
3 CD O O
) ) O O
Palpitations NNS B-NP O
4 CD O O
) ) O O
Cerebrovascular JJ B-NP O
accident NN I-NP O
about IN B-VP O
four CD O O
months NNS B-NP O
ago IN B-VP O
The DT B-NP O
history NN I-NP O
of IN B-VP O
this DT O O
is VBZ O O
unclear JJ O O
She PRP O O
is VBZ O O
followed VBN O O
by IN B-VP O
Chang NNP B-NP O
Stoudmire NNP I-NP O
at IN B-VP O
the DT B-NP O
Wooci NNP I-NP O
Warmso NNP I-NP O
Rai NNP I-NP O
Community NNP I-NP O
Hospital NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
) ) O O
Nifedipine NN B-NP B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
p.r.n NN I-NP B-f
for IN B-VP O
elevated JJ B-NP B-r
blood NN I-NP I-r
pressure NN I-NP I-r
2 CD O O
) ) O O
Lasix FW O B-m
20 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
3 CD O O
) ) O O
Glucotrol NNP B-NP B-m
15 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
4 CD O O
) ) O O
Cardizem NNP B-NP B-m
300 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
5 CD O O
) ) O O
Coumadin NNP B-NP B-m
3.75 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
6 CD O O
) ) O O
Colace NN B-NP B-m
100 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
b.i.d IN B-VP B-f
7 CD O O
) ) O O
Iron NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
lives VBZ O O
in IN B-VP O
Angelesrangego NNP B-NP O
She PRP O O
is VBZ O O
married JJ O O
She PRP O O
is VBZ O O
unemployed JJ O O
She PRP O O
has VBZ O O
eight CD O O
children NNS B-NP O
She PRP O O
has VBZ O O
no DT B-NP O
alcohol NN I-NP O
use NN I-NP O
She PRP O O
was VBD B-VP O
a DT B-NP O
smoker NN I-NP O
, , O O
discontinued VBN O O
three CD O O
months NNS B-NP O
ago IN B-VP O
She PRP O O
smoked VBD B-VP O
three CD O O
cigarettes NNS B-NP O
per IN B-VP O
day NN B-NP O
times NNS I-NP O
43 CD O O
years NNS B-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
Vital NNP I-NP O
signs: VBD B-VP O
Temperature NNP B-NP O
97.9 CD O O
degrees NNS B-NP O
, , O O
heart NN B-NP O
rate NN I-NP O
62 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
144/86 CD O O
, , O O
SAO2 NNP B-NP O
96% CD O O
on IN B-VP O
two CD O O
liters NNS B-NP O
General: NNP I-NP O
Well NNP I-NP O
appearing VBG O O
, , O O
Spanish JJ O O
speaking VBG O O
woman NN B-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP O
distress NN I-NP O
HEENT NNP I-NP O
was VBD B-VP O
normocephalic JJ O O
, , O O
atraumatic JJ B-NP O
Pupils NNS I-NP O
were VBD B-VP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ B-NP O
Oropharynx NNP I-NP O
revealed VBD B-VP O
lower JJR O O
and CC O O
upper JJ B-NP O
dentures NNS I-NP O
Neck NNP I-NP O
with IN B-VP O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
, , O O
supple NN B-NP O
, , O O
jugular JJ B-NP O
venous JJ I-NP O
pressure NN I-NP O
8 CD O O
cm NN B-NP O
, , O O
carotids NNS B-NP O
2+ CD O O
, , O O
no DT B-NP O
bruits NNS I-NP O
Chest NNP I-NP O
revealed VBD B-VP O
basilar JJ B-NP O
rales NNS I-NP O
bilaterally RB O O
Cardiovascular NNP B-NP O
was VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NNS I-NP O
Abdomen NNP I-NP O
was VBD B-VP O
non-tender JJ O O
, , O O
no DT B-NP O
hepatosplenomegaly NN I-NP O
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Extremities NNS B-NP O
revealed VBD B-VP O
no DT B-NP O
clubbing NN I-NP O
, , O O
cyanosis NN B-NP O
or CC O O
edema NN B-NP O
, , O O
2+ CD O O
dorsalis NN B-NP O
pedis NN I-NP O
and CC O O
posterior JJ B-NP O
tibial JJ I-NP O
pulses NNS I-NP O
bilaterally RB O O
Neurological NNP B-NP O
revealed VBD B-VP O
motor NN B-NP O
in IN B-VP O
upper JJ B-NP O
extremities NNS I-NP O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
at IN B-VP O
five CD O O
out IN B-VP O
of IN B-VP O
five CD O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
three CD O O
LABORATORY: NNP B-NP O
Laboratory NNP I-NP O
studies NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
sodium NN I-NP O
of IN B-VP O
143 CD O O
, , O O
potassium NN B-NP O
4.1 CD O O
, , O O
chloride RB O O
100 CD O O
, , O O
bicarbonate NN B-NP O
47 CD O O
, , O O
BUN NNP B-NP O
26 CD O O
, , O O
creatinine NN B-NP O
1.1 CD O O
, , O O
glucose RB O O
244 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
9 CD O O
, , O O
hematocrit NN B-NP O
33.9 CD O O
, , O O
platelets NNS B-NP O
276 CD O O
Troponin NNP B-NP O
was VBD B-VP O
0.0 CD O O
CK NNP B-NP O
was VBD B-VP O
75 CD O O
PT NNP B-NP O
14.7 CD O O
, , O O
INR NNP B-NP O
1.5 CD O O
, , O O
PTT NNP B-NP O
32 CD O O
Chest NNP B-NP O
x-ray NN I-NP O
showed VBD B-VP O
cardiomegaly NNS B-NP O
, , O O
no DT B-NP O
congestive JJ I-NP O
heart NN I-NP O
failure NN I-NP O
, , O O
no DT B-NP O
infiltrates NNS I-NP O
EKG NNP I-NP O
revealed VBD B-VP O
sinus JJ B-NP O
bradycardia NN I-NP O
at IN B-VP O
58 CD O O
, , O O
0.158/092/0.47 CD O O
, , O O
no DT B-NP O
ST NNP I-NP O
or CC O O
T-wave NNP B-NP O
changes NNS I-NP O
, , O O
no DT B-NP O
Q-waves NNS I-NP O
, , O O
no DT B-NP O
old JJ I-NP O
EKG NNP I-NP O
for IN B-VP O
comparison NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
on IN B-VP O
a DT B-NP O
standard JJ I-NP O
Bruce NNP I-NP O
protocol NN I-NP O
She PRP O O
completed VBD B-VP O
6 CD O O
minutes NNS B-NP O
, , O O
32 CD O O
seconds NNS B-NP O
but CC O O
stopped VBD B-VP O
secondary JJ O O
to TO O O
leg VB O O
fatigue NN B-NP O
She PRP O O
has VBZ O O
no DT B-NP O
chest NN I-NP O
pain NN I-NP O
EKG NNP I-NP O
was VBD B-VP O
without IN B-VP O
changes NNS B-NP O
during IN B-VP O
exercise NN B-NP O
, , O O
but CC O O
at IN B-VP O
recovery NN B-NP O
, , O O
developed VBD B-VP O
EKG NNP B-NP O
changes NNS I-NP O
in IN B-VP O
both DT O O
inferior JJ O O
and CC O O
lateral JJ B-NP O
leads NNS I-NP O
This DT O O
was VBD B-VP O
consistent JJ O O
but CC O O
not RB O O
diagnostic JJ O O
of IN B-VP O
ischemia NN B-NP O
She PRP O O
underwent VBD B-VP O
angiography NN B-NP O
which WDT O O
showed VBD B-VP O
left VBD B-VP O
main JJ B-NP O
OK NNP I-NP O
, , O O
LAD NNP B-NP O
proximal VBZ O O
20% CD O O
, , O O
D2 NNP B-NP O
60% CD O O
, , O O
ostial JJ O O
90% CD O O
mid NN B-NP O
, , O O
left VBD B-VP O
circumflex JJ B-NP O
mid NN I-NP O
30% CD O O
, , O O
OM2 NNP B-NP O
distal JJ O O
60-70% JJ O O
, , O O
OM1 NNP B-NP O
mild NN I-NP O
diffuse NN I-NP O
disease NN I-NP O
She PRP O O
underwent JJ B-NP O
PTCA NNP I-NP O
of IN B-VP O
her PRP$ O O
diagonal JJ O O
two CD O O
which WDT O O
went VBD B-VP O
from IN B-VP O
90% CD O O
to TO O O
0% CD O O
stenosis NN B-NP B-r
She PRP O O
received VBD B-VP O
Heparin NNP B-NP B-m
overnight MD O B-du
and CC O O
the DT B-NP O
sheaths NNS I-NP O
were VBD B-VP O
pulled VBN O O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O O
underwent JJ B-NP O
modification NN I-NP O
of IN B-VP O
her PRP$ O O
medical JJ B-NP O
regimen NN I-NP O
She PRP O O
was VBD B-VP O
given VBN O O
aspirin RB O B-m
, , O O
Beta NNP B-NP B-m
blocker NN I-NP I-m
, , O O
Isordil NNP B-NP B-m
, , O O
and CC O O
ACE NNP B-NP B-m
inhibitor NN I-NP I-m
MEDICATIONS NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
1 CD O O
) ) O O
Aspirin $ O B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
2 CD O O
) ) O O
Atenolol $ O B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
3 CD O O
) ) O O
Lisinopril FW O B-m
10 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
4 CD O O
) ) O O
Pravachol VBD B-VP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
5 CD O O
) ) O O
Glucotrol NNP B-NP B-m
XL $ O I-m
15 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q NN I-NP B-f
AM NNP I-NP I-f
6 CD O O
) ) O O
Lasix FW O B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
q JJ B-NP B-f
day NN I-NP I-f
7 CD O O
) ) O O
Nitroglycerin NNP B-NP B-m
tablets VBZ O I-m
sublingual JJ B-NP B-mo
p.r.n NN I-NP B-f
chest JJS B-NP B-r
pain NN I-NP I-r
FOLLOW-UP: CD O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
to TO O O
follow-up JJ O O
in IN B-VP O
the DT B-NP O
VERAREA NNP I-NP O
UNIVERSITY NNP I-NP O
HOSPITAL NNP I-NP O
Clinic NNP I-NP O
with IN B-VP O
Dr NNP B-NP O
Van NNP I-NP O
Rothenberg NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
ZACHARIAH NNP I-NP O
TINGSTROM NNP I-NP O
, , O O
M.D NNP B-NP O
KP59 NNP I-NP O
Attending: NNP I-NP O
BRICE NNP I-NP O
LEZO NNP I-NP O
, , O O
M.D NNP B-NP O
MK60 NNP I-NP O
TN341/1946 NNP I-NP O
Batch: NNP I-NP O
19920 CD O O
Index NNP B-NP O
No NNP I-NP O
HCGD2C3J1P NNP I-NP O
D: NNP I-NP O
1/13/97 CD O O
T: NNP B-NP O
10/6/97 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#808959 VBZ O O
022039090 CD O O
UGH NNP B-NP O
34853160 CD O O
4624027 CD O O
7/5/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
RULE NNP I-NP O
OUT NNP I-NP O
MYCOCARDIAL NNP I-NP O
INFARCTION NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
4/17/2005 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
10/6/2005 CD O O
ATTENDING: NNP B-NP O
WEISSMANN NNP I-NP O
, , O O
RORY NNP B-NP O
M.D NNP I-NP O
DATE NNP I-NP O
OF NNP I-NP O
SURGERY: NNP I-NP O
2/11/05 CD O O
HISTORY NNP B-NP O
AND NNP I-NP O
PHYSICAL: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
74-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
on IN B-VP O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
mellitus NN I-NP O
, , O O
hypertension NN B-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
with IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
which WDT O O
had VBD B-VP O
been VBN O O
increasing VBG O O
for IN B-VP O
the DT B-NP O
month NN I-NP O
prior RB O O
to TO O O
surgery VB O O
He PRP O O
denies VBZ O O
any DT B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
, , O O
PND NNP B-NP O
or CC O O
orthopnea NN B-NP O
He PRP O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
three-vessel JJ B-NP O
disease NN I-NP O
on IN B-VP O
catheterization NN B-NP O
back RB O O
in IN B-VP O
1996 CD O O
, , O O
status NN B-NP O
post NN I-NP O
angioplasty NN I-NP O
without IN B-VP O
stenting VBG O O
He PRP O O
reportedly RB O O
had VBD B-VP O
an DT B-NP O
abnormal JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
in IN B-VP O
1996 CD O O
and CC O O
in IN B-VP O
1999 CD O O
He PRP O O
was VBD B-VP O
admitted VBN O O
via IN B-VP O
his PRP$ O O
primary JJ B-NP O
care NN I-NP O
physician's NN I-NP O
office NN I-NP O
on IN B-VP O
6/13/05 CD O O
with IN B-VP O
substernal JJ B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
T NNP B-NP O
wave VBP O O
inversions NNS B-NP O
in IN B-VP O
leads NNS B-NP O
V3 NNP I-NP O
and CC O O
V4 NNP B-NP O
Enzymes NNP I-NP O
were VBD B-VP O
cycled VBN O O
and CC O O
they PRP O O
were VBD B-VP O
negative JJ O O
x4 IN B-VP O
The DT B-NP O
patient NN I-NP O
went VBD B-VP O
to TO O O
the DT B-NP O
cath NN I-NP O
on IN B-VP O
0/18/05 CD O O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
He PRP O O
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
CABG NNP B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Hypertension NNP B-NP O
2 CD O O
Diabetes NNP B-NP B-r
mellitus NN I-NP I-r
, , O O
on IN B-VP O
insulin NN B-NP B-m
therapy NN I-NP O
3 CD O O
Hypercholesterolemia NNP B-NP O
PAST NNP I-NP O
SURGICAL NNP I-NP O
HISTORY: NNP I-NP O
Unknown NNP I-NP O
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION: NNP I-NP O
1 CD O O
Lopressor NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
2 CD O O
Lisinopril NNP B-NP B-m
40 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
3 CD O O
Aspirin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
4 CD O O
Hydrochlorothiazide/triamterene NNP B-NP B-m
one CD O B-do
tablet NN B-NP I-do
daily RB O B-f
5 CD O O
Atorvastatin NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
6 CD O O
Lantus NNP B-NP B-m
50 CD O B-do
cc JJ B-NP I-do
daily JJ I-NP B-f
ALLERGIES: NNP I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT O O
known VBN O O
drug NN B-NP O
allergies NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
known VBN O O
social JJ B-NP O
history NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
No NNP I-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
stands VBZ O O
5 CD O O
feet NNS B-NP O
6 CD O O
inches NNS B-NP O
tall JJ O O
, , O O
weighs VBZ O O
97.9 CD O O
kg NN B-NP O
Temperature NN I-NP O
was VBD B-VP O
97 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
was VBD B-VP O
62 CD O O
, , O O
and CC O O
blood NN B-NP O
pressure NN I-NP O
was VBD B-VP O
110/64 CD O O
He PRP O O
was VBD B-VP O
on IN B-VP O
a DT B-NP O
face NN I-NP O
mask NN I-NP O
with IN B-VP O
an DT B-NP O
oxygen NN I-NP O
saturation NN I-NP O
at IN B-VP O
95% CD O O
On IN B-VP O
physical JJ B-NP O
examination NN I-NP O
, , O O
he PRP O O
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBN O O
, , O O
with IN B-VP O
no DT B-NP O
focal JJ I-NP O
deficits NNS I-NP O
HEENT NNP I-NP O
showed VBD B-VP O
PERRLA NNP B-NP O
No NNP I-NP O
teeth NN I-NP O
, , O O
both DT O O
upper JJ O O
and CC O O
lower JJR O O
dentures VBZ O O
No DT B-NP O
carotid NN I-NP O
bruits VBZ O O
Cardiovascular: NNP B-NP O
Regular NNP I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
with IN B-VP O
no DT B-NP O
murmurs NNS I-NP O
, , O O
rubs NNS B-NP O
or CC O O
gallops VB O O
His PRP$ O O
Allen's NNP B-NP O
test NN I-NP O
on IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
was VBD B-VP O
normal JJ O O
, , O O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
was VBD B-VP O
normal JJ B-NP O
Respiratory: NNP I-NP O
He PRP O O
had VBD B-VP O
clear JJ B-NP O
breath NN I-NP O
sounds VBZ O O
bilaterally RB O O
Adomen: NNP B-NP O
Soft NNP I-NP O
, , O O
nontender NN B-NP O
, , O O
no DT B-NP O
masses NNS I-NP O
, , O O
noted VBD B-VP O
to TO O O
be VB O O
obese JJ B-NP O
Extremities: NNP I-NP O
Without NNP I-NP O
scarring NN I-NP O
, , O O
varicosities NNS B-NP O
or CC O O
edema NN B-NP O
Pulses NNS I-NP O
, , O O
carotid NN B-NP O
left VBD B-VP O
and CC O O
right JJ O O
were VBD B-VP O
2+ CD O O
, , O O
radial JJ B-NP O
left NN I-NP O
and CC O O
right NN B-NP O
were VBD B-VP O
2+ CD O O
, , O O
femoral JJ B-NP O
left NN I-NP O
and CC O O
right NN B-NP O
were VBD B-VP O
2+ CD O O
, , O O
dorsalis NNS B-NP O
pedis VBP O O
were VBD B-VP O
left VBN O O
and CC O O
right JJ B-NP O
present NN I-NP O
by IN B-VP O
Doppler NNP B-NP O
, , O O
and CC O O
posterior JJ B-NP O
tibial NN I-NP O
were VBD B-VP O
left VBN O O
and CC O O
right JJ B-NP O
present NN I-NP O
by IN B-VP O
Doppler NNP B-NP O
ADMISSION NNP I-NP O
LABORATORY NNP I-NP O
VALUES: NNP I-NP O
Sodium NNP I-NP O
of IN B-VP O
137 CD O O
, , O O
K NNP B-NP O
of IN B-VP O
4.2 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
35 CD O O
, , O O
and CC O O
creatinine NN B-NP O
of IN B-VP O
1.3 CD O O
White NNP B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
was VBD B-VP O
7 CD O O
, , O O
hematocrit NN B-NP O
was VBD B-VP O
38 CD O O
, , O O
and CC O O
platelet NN B-NP O
count NN I-NP O
was VBD B-VP O
179 CD O O
, , O O
000 CD O O
INR NNP B-NP O
was VBD B-VP O
1.1 CD O O
His PRP$ O O
UA NN B-NP O
was VBD B-VP O
described VBN O O
as IN B-VP O
contaminated JJ B-NP O
Cardiac NNP I-NP O
cath NN I-NP O
from IN B-VP O
0/18/05 CD O O
, , O O
which WDT O O
was VBD B-VP O
performed VBN O O
at IN B-VP O
the DT B-NP O
Adli NNP I-NP O
Corn11 NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
, , O O
showed VBD B-VP O
a DT O O
95% CD O O
ostial JJ B-NP O
LAD NNP I-NP O
lesion NN I-NP O
, , O O
a DT O O
60% CD O O
mid NN B-NP O
LAD NNP I-NP O
lesion NN I-NP O
, , O O
an DT O O
80% CD O O
distal NN B-NP O
LAD NNP I-NP O
lesion NN I-NP O
, , O O
a DT O O
70% CD O O
proximal JJ B-NP O
D1 NNP I-NP O
lesion NN I-NP O
, , O O
a DT O O
40% CD O O
proximal JJ B-NP O
circumflex JJ I-NP O
lesion NN I-NP O
, , O O
a DT O O
90% CD O O
ostial JJ B-NP O
OM1 NNP I-NP O
lesion NN I-NP O
, , O O
a DT O O
100% CD O O
proximal JJ B-NP O
RCA NNP I-NP O
lesion NN I-NP O
, , O O
and CC O O
a DT B-NP O
right JJ I-NP O
dominant JJ I-NP O
circulation NN I-NP O
Echo NNP I-NP O
from IN B-VP O
4/26/05 CD O O
showed VBD B-VP O
a DT O O
60% CD O O
ejection NN B-NP O
fraction NN I-NP O
, , O O
with IN B-VP O
trace NN B-NP O
to TO O O
mild VB O O
mitral JJ B-NP O
regurgitation NN I-NP O
, , O O
no DT B-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities VBZ O O
An DT B-NP O
EKG NNP I-NP O
on IN B-VP O
0/18/05 CD O O
showed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
with IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
52 CD O O
, , O O
inverted VBN O O
T NNP B-NP O
waves NNS I-NP O
in IN B-VP O
V3 NNP B-NP O
, , O O
V4 NNP B-NP O
, , O O
V5 NNP B-NP O
and CC O O
V6 NNP B-NP O
A NNP I-NP O
chest JJ B-NP O
x-ray NN I-NP O
from IN B-VP O
4/27/05 CD O O
was VBD B-VP O
read VBN O O
out RP O O
as IN B-VP O
normal JJ B-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
to TO O O
Surgery NNP B-NP O
on IN B-VP O
2/11/05 CD O O
The DT B-NP O
preoperative JJ I-NP O
diagnosis NN I-NP O
was VBD B-VP O
unstable JJ B-NP O
angina NN I-NP O
, , O O
three-vessel JJ B-NP O
disease NN I-NP O
and CC O O
morbid NN B-NP O
obesity NN I-NP O
The DT B-NP O
procedure NN I-NP O
was VBD B-VP O
a DT B-NP O
CABG NNP I-NP O
x3 VBZ O B-du
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT B-NP O
anaphylactoid JJ I-NP O
response NN I-NP O
to TO O O
aprotinin VB O B-m
and CC O O
subsequently RB O O
had VBD B-VP O
an DT O O
all DT B-NP O
vein JJ I-NP O
CABG NNP I-NP O
There EX O O
was VBD B-VP O
a DT B-NP O
Y NNP I-NP O
graft NN I-NP O
, , O O
SVG1 NNP B-NP O
connecting VBG O O
SVG2 NNP B-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
, , O O
SVG2 NNP B-NP O
connecting VBG O O
the DT B-NP O
aorta NN I-NP O
to TO O O
OM1 NNP B-NP O
, , O O
and CC O O
SVG3 NNP B-NP O
connecting VBG O O
to TO O O
PDA VB O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
brought VBN O O
up RP O O
from IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgery NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
He PRP O O
was VBD B-VP O
extubated VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#1 IN B-VP O
He PRP O O
did VBD B-VP O
well RB O O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
He PRP O O
had VBD B-VP O
some DT B-NP O
intermittent JJ I-NP O
confusion NN I-NP O
, , O O
but CC O O
neuro JJ B-NP O
exam NN I-NP O
was VBD B-VP O
essentially RB O O
nonfocal JJ O O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Step-Down JJ I-NP O
Unit NNP I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#4 VB O O
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
neurologically RB O O
, , O O
he PRP O O
was VBD B-VP O
intact JJ O O
Of IN B-VP O
note NN B-NP O
, , O O
he PRP O O
had VBD B-VP O
a DT B-NP O
ventricular JJ I-NP O
fibrillation NN I-NP O
arrest NN I-NP O
in IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
because IN B-VP O
of IN B-VP O
the DT B-NP O
aprotinin JJ I-NP O
reaction NN I-NP O
in IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
with IN B-VP O
systolic JJ B-NP O
pressures NNS I-NP O
in IN B-VP O
the DT O O
40s CD O O
Open NNP B-NP O
cardiac JJ B-NP O
massage NN I-NP O
was VBD B-VP O
required VBN O O
, , O O
and CC O O
he PRP O O
was VBD B-VP O
defibrillated VBN O O
They PRP O O
used VBD B-VP O
lidocaine NN B-NP B-m
and CC O O
amiodarone NN B-NP B-m
during IN B-VP B-du
the DT B-NP O
code NN I-NP O
His PRP$ O O
CK-MB NNP B-NP O
rose VBD B-VP O
to TO O O
37.5 CD O O
, , O O
and CC O O
his PRP$ O O
CK NN B-NP O
was VBD B-VP O
1646 CD O O
After IN B-VP O
his PRP$ O O
procedure NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
wake VB O O
up RP O O
and CC O O
was VBD B-VP O
neurologically RB O O
intact JJ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
on IN B-VP O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
He PRP O O
had VBD B-VP O
had VBN O O
problems NNS B-NP O
with IN B-VP O
abdominal JJ B-NP O
distention NN I-NP O
, , O O
but CC O O
this DT O O
had VBD B-VP O
resolved VBN O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
also RB O O
been VBN O O
noted VBN O O
to TO O O
have VB O O
an DT O O
increased VBN O O
creatinine NN B-NP O
However RB O O
, , O O
this DT O O
also RB O O
resolved VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
a DT O B-r
a DT O B-r
known VBN O I-r
known VBN O I-r
diabetic JJ B-NP I-r
diabetic NN I-NP I-r
and CC O O
was VBD B-VP O
on IN B-VP O
NovoLog NNP B-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
, , O O
and CC O O
also RB O O
receiving VBG O O
Lantus NNP B-NP B-m
The DT B-NP O
patient NN I-NP O
has VBZ O O
no DT B-NP O
infectious JJ I-NP O
disease NN I-NP O
issues NNS I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
in IN B-VP O
the DT B-NP O
Step-Down JJ I-NP O
Unit NNP I-NP O
, , O O
and CC O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#5 NNP I-NP O
, , O O
he PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
spike VB O O
Cultures NNS B-NP O
were VBD B-VP O
sent VBN O O
off RP O O
which WDT O O
grew VBD B-VP O
out RP O O
3+ CD O O
Gram-native JJ B-NP O
rods NNS I-NP O
He PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
Flagyl NNP B-NP B-m
for IN B-VP O
presumed JJ B-NP B-r
aspiration NN I-NP O
pneumonia NN I-NP O
He PRP O O
also RB O O
is VBZ O O
noted VBN O O
to TO O O
have VB O O
a DT B-NP B-r
positive JJ I-NP I-r
UTI NNP I-NP I-r
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
levofloxacin NN B-NP B-m
at IN B-VP O
that DT B-NP O
time NN I-NP O
He PRP O O
also RB O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
rise NN I-NP O
in IN B-VP O
his PRP$ O O
creatinine NN B-NP O
and CC O O
this DT O O
was VBD B-VP O
followed VBN O O
as RB O O
well RB O O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#8 NNP I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
again RB O O
spiked VBN O O
up RP O O
to TO O O
101 CD O O
Pancultures NNS B-NP O
were VBD B-VP O
sent VBN O O
out RP O O
as RB O O
well RB O O
He PRP O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP O
beta-lactamase-resistant JJ I-NP O
E NN I-NP O
coli NNS I-NP O
in IN B-VP O
his PRP$ O O
urine NN B-NP O
This DT O O
prompted VBD B-VP O
an DT B-NP O
ID NNP I-NP O
consult NN I-NP O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
nitrofurantoin NN B-NP B-m
Also RB O O
, , O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
around IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#9 NNP I-NP O
, , O O
it PRP O O
was VBD B-VP O
noted VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
began VBD B-VP O
to TO O O
have VB O O
some DT B-NP O
serous JJ I-NP O
drainage NN I-NP O
from IN B-VP O
his PRP$ O O
sternal JJ B-NP O
wound NN I-NP O
He PRP O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
Infectious JJ B-NP O
Disease NNP I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
and CC O O
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
, , O O
it PRP O O
was VBD B-VP O
discovered VBN O O
that IN B-VP O
the DT B-NP O
wound NN I-NP O
grew VBD B-VP O
out RP O O
Gram-negative JJ B-NP O
rods NNS I-NP O
A NNP I-NP O
Plastic NNP I-NP O
Surgery NNP I-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
for IN B-VP O
the DT B-NP O
patient NN I-NP O
after IN B-VP O
a DT B-NP O
CT NNP I-NP O
scan NN I-NP O
showed VBD B-VP O
some DT B-NP O
nonunion NN I-NP O
of IN B-VP O
the DT B-NP O
sternal JJ I-NP O
table NN I-NP O
and CC O O
collection NN B-NP O
of IN B-VP O
fluid JJ O O
underneath IN B-VP O
the DT B-NP O
sternum NN I-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#11 NNP I-NP O
, , O O
it PRP O O
was VBD B-VP O
decided VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
would MD O O
benefit VB O O
from IN B-VP O
incision NN B-NP O
and CC O O
drainage NN B-NP O
plus CC O O
pectoral JJ B-NP O
flap NN I-NP O
or CC O O
omental JJ B-NP O
flap NN I-NP O
for IN B-VP O
sternal JJ B-NP O
wound NN I-NP O
infection NN I-NP O
, , O O
so IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
taken VBN O O
back RB O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
6/29/05 CD O O
for IN B-VP O
incision NN B-NP O
and CC O O
drainage NN B-NP O
of IN B-VP O
a DT B-NP O
deep JJ I-NP O
sternal NN I-NP O
wound NN I-NP O
infection NN I-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
surgery NN B-NP O
, , O O
a DT B-NP O
purulent NN I-NP O
liquid JJ B-NP O
material NN I-NP O
was VBD B-VP O
expressed VBN O O
through IN B-VP O
the DT B-NP O
skin NN I-NP O
The DT B-NP O
incision NN I-NP O
was VBD B-VP O
made VBN O O
The DT B-NP O
sternum NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
totally RB O O
separated VBN O O
with IN B-VP O
most JJS O O
of IN B-VP O
the DT B-NP O
wires NNS I-NP O
having VBG O O
been VBN O O
pulled VBN O O
through IN B-VP O
The DT B-NP O
wound NN I-NP O
was VBD B-VP O
irrigated VBN O O
, , O O
and CC O O
an DT B-NP O
omental JJ I-NP O
flap NN I-NP O
with IN B-VP O
pectoral JJ B-NP O
advancement NN I-NP O
was VBD B-VP O
performed VBN O O
The DT B-NP O
patient NN I-NP O
returned VBD B-VP O
from IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
to TO O O
the DT B-NP O
Surgery NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
where WRB O O
he PRP O O
was VBD B-VP O
again RB O O
confused JJ O O
, , O O
however RB O O
, , O O
was VBD B-VP O
able JJ O O
to TO O O
be VB O O
easily RB O O
returned VBN O O
to TO O O
baseline VB O O
Following VBG O O
these DT B-NP O
recommendations NNS I-NP O
, , O O
the DT B-NP O
nitrofurantoin NN I-NP B-m
was VBD B-VP O
discontinued VBN O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
imipenem NN B-NP B-m
Also RB O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
growing VBG O O
Enterobacter NNP B-NP B-r
in IN B-VP O
his PRP$ O O
urine NN B-NP O
and CC O O
he PRP O O
was VBD B-VP O
started VBN O O
no DT B-NP O
ceftazidime NN I-NP B-m
The DT B-NP O
patient NN I-NP O
did VBD B-VP O
well RB O O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
He PRP O O
improved VBD B-VP O
from IN B-VP O
a DT B-NP O
neuro NN I-NP O
status NN I-NP O
His PRP$ O O
chest NN B-NP O
wound NN I-NP O
healed VBD B-VP O
without IN B-VP O
difficulty NN B-NP O
He PRP O O
had VBD B-VP O
one CD O O
brief NN B-NP O
episode NN I-NP O
of IN B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
during IN B-VP O
a DT B-NP O
coughing NN I-NP O
spell NN I-NP O
, , O O
but CC O O
this DT O O
also RB O O
resolved VBN O O
, , O O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O O
antihypertensive JJ B-NP B-m
medication NN I-NP I-m
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
deemed VBN O O
fit NN B-NP O
for IN B-VP O
transfer NN B-NP O
on IN B-VP O
a DT B-NP O
postoperative JJ I-NP O
day NN I-NP O
#18 NNP I-NP O
back RB O O
from IN B-VP O
the DT B-NP O
ICU NNP I-NP O
once RB O O
again RB O O
to TO O O
the DT B-NP O
Step-Down JJ I-NP O
Unit NNP I-NP O
SUMMARY NNP I-NP O
BY NNP I-NP O
SYSTEM: NNP I-NP O
1 CD O O
Neurologically NNP B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
Spanish-speaking VBG O O
only RB O O
He PRP O O
is VBZ O O
intact JJ O O
, , O O
moving VBG O O
all DT B-NP O
extremities NNS I-NP O
, , O O
getting VBG O O
in IN B-VP O
and CC O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
, , O O
and CC O O
very RB O O
independent JJ O O
2 CD O O
Cardiovascular: NNP B-NP O
The DT B-NP O
patient's JJ I-NP O
heart NN I-NP O
rate NN I-NP O
is VBZ O O
in IN B-VP O
70 CD O O
to TO O O
80 CD O O
, , O O
sinus VBD B-VP O
Blood NNP B-NP O
pressure NN I-NP O
is VBZ O O
100s CD O O
to TO O O
150s CD O O
, , O O
means NNS B-NP O
are VBP O O
70s CD O O
to TO O O
100s CD O O
He PRP O O
is VBZ O O
on IN B-VP O
Lopressor NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
q.6h NN I-NP B-f
and CC O O
on IN B-VP O
amlodipine JJ O B-m
5 CD O B-do
mg NN B-NP I-do
b.i.d NN I-NP B-f
3 CD O O
Respiratory: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
saturating VBG O O
98% CD O O
4 CD O O
GI: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
advanced JJ O O
diet JJ O O
as IN B-VP O
tolerated VBN O O
, , O O
having VBG O O
bowel NN B-NP O
movements NNS I-NP O
, , O O
on IN B-VP O
a DT O O
diabetic JJ O O
diet JJ O O
5 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient's NN I-NP O
Foley NNP I-NP O
is VBZ O O
out RP O O
, , O O
running VBG O O
negative JJ O O
340 CD O O
for IN B-VP O
the DT B-NP O
day NN I-NP O
before IN B-VP O
, , O O
on IN B-VP O
Lasix NNP B-NP B-m
20 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d NN I-NP B-f
Recommendations NNP I-NP O
would MD O O
be VB O O
to TO O O
have VB O O
an DT B-NP O
extra JJ I-NP O
dose NN I-NP O
or CC O O
so RB O O
of IN B-VP O
Lasix NNP B-NP B-m
since IN B-VP O
chest JJS B-NP O
x-ray NN I-NP O
this DT B-NP O
morning NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
slightly RB O O
wet JJ O O
6 CD O O
Endocrine: NNP B-NP O
He PRP O O
is VBZ O O
a DT O O
diabetic JJ O O
He PRP O O
is VBZ O O
on IN B-VP O
Lantus NNP B-NP B-m
, , O O
NovoLog NNP B-NP B-m
, , O O
insulin NN B-NP B-m
, , O O
and CC O O
Diabetes NNP B-NP B-r
Diabetes NNP I-NP B-r
Diabetes NNP I-NP B-r
Management NNP I-NP I-r
Management NNP I-NP I-r
Management NNP I-NP I-r
is VBZ O O
following VBG O O
7 CD O O
Heme: NNP B-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
on IN B-VP O
aspirin NN B-NP B-m
and CC O O
atorvastatin NN B-NP B-m
He PRP O O
still RB O O
has VBZ O O
chest NN B-NP O
drains NNS I-NP O
, , O O
which WDT O O
are VBP O O
being VBG O O
followed VBN O O
by IN B-VP O
Plastics NNS B-NP O
who WP O O
wants VBZ O O
to TO O O
keep VB O O
them PRP O O
in IN B-VP O
8 CD O O
ID: NNP B-NP O
He PRP O O
has VBZ O O
got VBD B-VP O
a DT B-NP B-r
deep JJ I-NP I-r
sternal JJ I-NP I-r
infection NN I-NP I-r
with IN B-VP O
E NNP B-NP O
coli NNS I-NP O
and CC O O
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT B-NP O
pectus NN I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
omental JJ I-NP O
flap NN I-NP O
closure NN I-NP O
Imipenem NNP I-NP B-m
was VBD B-VP O
started VBN O O
on IN B-VP O
2/22/05 CD O O
per IN B-VP O
ID's NNP B-NP O
recommendation NN I-NP O
, , O O
needs VBZ O O
to TO O O
continue VB O O
for IN B-VP B-du
six CD O I-du
weeks NNS B-NP I-du
UTI NNP I-NP O
growing VBG O O
out RP O O
Klebsiella NNP B-NP O
and CC O O
Enterobacter NNP B-NP O
Imipenem NNP I-NP B-m
was VBD B-VP O
stared VBN O O
on IN B-VP O
2/22/05 CD O O
, , O O
again RB O O
, , O O
this DT O O
will MD O O
need VB O O
to TO O O
be VB O O
continued VBN O O
for IN B-VP B-du
six CD O I-du
weeks NNS B-NP I-du
The DT B-NP O
patient NN I-NP O
is VBZ O O
also RB O O
on IN B-VP O
vancomycin NN B-NP B-m
for IN B-VP O
his PRP$ O B-r
sternal JJ B-NP O
wound NN I-NP O
infection NN I-NP O
This DT O O
was VBD B-VP O
started VBN O O
on IN B-VP O
6/29/05 CD O O
and CC O O
needs NNS B-NP O
to TO O O
continue VB O O
for IN B-VP B-du
six CD O I-du
weeks NNS B-NP I-du
Currently RB O O
, , O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
afebrile JJ B-NP O
White NNP I-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
is VBZ O O
10 CD O O
The DT B-NP O
chest NN I-NP O
wound NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
small JJ I-NP O
area NN I-NP O
of IN B-VP O
erythema NN B-NP O
, , O O
however RB O O
, , O O
it PRP O O
is VBZ O O
intact JJ O O
, , O O
and CC O O
he PRP O O
is VBZ O O
being VBG O O
followed VBN O O
by IN B-VP O
Plastics NNPS B-NP O
The DT B-NP O
rest NN I-NP O
of IN B-VP O
the DT B-NP O
dictation NN I-NP O
will MD O O
follow VB O O
when WRB O O
the DT B-NP O
patient NN I-NP O
is VBZ O O
discharged VBN O O
eScription NN B-NP O
document: VBZ O O
6-3812703 JJ B-NP O
EMS NNP I-NP O
Dictated NNP I-NP O
By: NNP I-NP O
WESTERMEIER NNP I-NP O
, , O O
SIMON NNP B-NP O
Attending: NNP I-NP O
BERLINGHOF NNP I-NP O
, , O O
WINFRED NNP B-NP O
Dictation NNP I-NP O
ID NNP I-NP O
3963571 CD O O
D: NNP B-NP O
10/9/05 CD O O
T: NNP B-NP O
10/9/05 CD O O
[report_end] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#809465 VBZ O O
997937050 CD O O
R NNP B-NP O
11953807 CD O O
994292 CD O O
11/22/1990 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
11/22/1990 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Unsigned NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
3/7/1990 CD O O
DISCHARGE NNP B-NP O
DIAGNOSIS: NNP I-NP O
1 CD O O
)MYOCARDIAL NNP B-NP O
INFARCTION NNP I-NP O
2 CD O O
)CONGESTIVE NNP B-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
3 CD O O
)HYPERTENSION NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT B-NP O
patient NN I-NP O
is VBZ O O
a DT B-NP O
60-year-old JJ I-NP O
white JJ I-NP O
male NN I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
a DT O O
two CD O O
week NN B-NP O
history NN I-NP O
of IN B-VP O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
and CC O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
admitted VBN O O
with IN B-VP O
new JJ B-NP O
EKG NNP I-NP O
changes NNS I-NP O
consistent VBP O O
with IN B-VP O
myocardial JJ B-NP O
infarction NN I-NP O
for IN B-VP O
rule NN B-NP O
out IN B-VP O
MI NNP B-NP O
The DT B-NP O
patient's NN I-NP O
cardiac JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
are VBP O O
diabetes NNS B-NP O
, , O O
hypertension NN B-NP O
, , O O
distant JJ B-NP O
smoking NN I-NP O
history NN I-NP O
There EX O O
is VBZ O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
increased VBN O O
cholesterol NN B-NP O
and CC O O
no DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
heart NN B-NP O
disease NN I-NP O
The DT B-NP O
patient NN I-NP O
noted VBD B-VP O
the DT B-NP O
onset NN I-NP O
of IN B-VP O
exertional JJ B-NP O
shortness NN I-NP O
of IN B-VP O
breath NN B-NP O
around IN B-VP O
the DT B-NP O
beginning NN I-NP O
of IN B-VP O
7 CD O O
of IN B-VP O
August NNP B-NP O
At IN B-VP O
that DT B-NP O
time NN I-NP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
experiencing VBG O O
increased JJ B-NP O
stress NN I-NP O
because IN B-VP O
of IN B-VP O
the DT B-NP O
recent JJ I-NP O
death NN I-NP O
of IN B-VP O
the DT B-NP O
patient's JJ I-NP O
sister-in-law NN I-NP O
The DT B-NP O
patient NN I-NP O
consulted VBD B-VP O
his PRP$ O O
local JJ B-NP O
physician NN I-NP O
, , O O
Dr NNP B-NP O
Bret NNP I-NP O
Langner NNP I-NP O
, , O O
on IN B-VP O
7 CD O O
of IN B-VP O
April NNP B-NP O
An DT B-NP O
EKG NNP I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
showed VBD B-VP O
no DT B-NP O
change NN I-NP O
from IN B-VP O
an DT B-NP O
EKG NNP I-NP O
of IN B-VP O
a DT B-NP O
year NN I-NP O
earlier RB O O
Over IN B-VP O
the DT B-NP O
next JJ I-NP O
week NN I-NP O
the DT B-NP O
patient NN I-NP O
reported VBD B-VP O
feeling JJ O O
weak JJ O O
, , O O
general JJ B-NP O
malaise NN I-NP O
, , O O
experienced VBD B-VP O
occasional JJ B-NP O
chills NNS I-NP O
with IN B-VP O
continuing VBG O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
There EX O O
was VBD B-VP O
one CD O O
event NN B-NP O
on IN B-VP O
20 CD O O
of IN B-VP O
February NNP B-NP O
where WRB O O
the DT B-NP O
patient NN I-NP O
experienced VBD B-VP O
chest JJS B-NP O
pain NN I-NP O
with IN B-VP O
severe JJ B-NP O
diaphoresis NN I-NP O
and CC O O
a DT B-NP O
chill NN I-NP O
which WDT O O
he PRP O O
attributed VBD B-VP O
to TO O O
the DT B-NP O
flu NN I-NP O
although IN B-VP O
the DT B-NP O
patient NN I-NP O
did VBD B-VP O
not RB O O
seek VB O O
medical JJ B-NP O
attention NN I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
Over IN B-VP O
the DT O O
last JJ O O
10 CD O O
to TO O O
14 CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission VB O O
the DT B-NP O
patient NN I-NP O
noted VBD B-VP O
increasing VBG O O
exertional JJ B-NP O
dyspnea NN I-NP O
, , O O
three CD O O
episodes NNS B-NP O
of IN B-VP O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
associated VBN O O
with IN B-VP O
right JJ B-NP O
chest NN I-NP O
discomfort NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
nausea NN I-NP O
, , O O
vomiting VBG O O
, , O O
diaphoresis NN B-NP O
, , O O
cyanosis VBP O O
The DT B-NP O
patient NN I-NP O
also RB O O
noted VBD B-VP O
edema NN B-NP O
in IN B-VP O
his PRP$ O O
lower JJR B-NP O
extremities NNS I-NP O
over IN B-VP O
the DT O O
last JJ O O
two CD O O
weeks NNS B-NP O
The DT B-NP O
last JJ I-NP O
episode NN I-NP O
of IN B-VP O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
was VBD B-VP O
this DT B-NP O
past JJ I-NP O
weekend NN I-NP O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
the DT B-NP O
patient NN I-NP O
saw VBD B-VP O
Dr NNP B-NP O
Mugrage NNP I-NP O
once RB O O
again RB O O
and CC O O
EKG NNP B-NP O
demonstrated VBD B-VP O
marked JJ B-NP O
anterolateral JJ I-NP O
changes NNS I-NP O
that WDT O O
were VBD B-VP O
new JJ O O
since IN B-VP O
the DT B-NP O
EKG NNP I-NP O
taken VBN O O
on IN B-VP O
7 CD O O
of IN B-VP O
April NNP B-NP O
The DT B-NP O
patient NN I-NP O
presented VBD B-VP O
to TO O O
the DT B-NP O
Lacon NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Ward NNP I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Significant NNP I-NP O
for IN B-VP O
hypertension NN B-NP O
of IN B-VP O
approximately RB O O
10 CD O O
years NNS B-NP O
, , O O
non-insulin JJ B-NP O
dependent NN I-NP O
diabetes VBZ O O
mellitus NN B-NP O
of IN B-VP O
approximately RB O O
12 CD O O
years NNS B-NP O
, , O O
left VBD B-VP O
Bell's NNP B-NP O
palsy NN I-NP O
in IN B-VP O
1985 CD O O
treated VBD B-VP O
with IN B-VP O
prednisone NN B-NP B-m
, , O O
type NN B-NP O
IV NNP I-NP O
hypolipoproteinemia VBZ O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
also RB O O
admitted VBN O O
for IN B-VP O
right JJ B-NP O
face NN I-NP O
and CC O O
arm NN B-NP O
pain NN I-NP O
at IN B-VP O
the DT B-NP O
Skastem, NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
in IN B-VP O
1 CD O O
of IN B-VP O
October NNP B-NP O
This DT O O
was VBD B-VP O
attributed VBN O O
to TO O O
TIA NNP B-NP O
Carotid NNP I-NP O
non-invasives NNS I-NP O
at IN B-VP O
that DT B-NP O
time NN I-NP O
along IN B-VP O
with IN B-VP O
a DT B-NP O
head NN I-NP O
CT NNP I-NP O
were VBD B-VP O
reportedly RB O O
negative JJ O O
The DT B-NP O
patient NN I-NP O
also RB O O
had VBD B-VP O
a DT B-NP O
right JJ I-NP O
cranial NN I-NP O
nerve NN I-NP O
III NNP I-NP O
palsy NN I-NP O
in IN B-VP O
30 CD O O
of IN B-VP O
April NNP B-NP O
MEDICATIONS: NNP I-NP B-m
Micronase NNP I-NP B-do
10 CD O I-do
mg NN B-NP B-mo
po NN I-NP B-f
bid NN I-NP O
, , O B-m
Persantine NNP B-NP B-do
60 CD O I-do
mg NN B-NP B-mo
po NN I-NP O
tid NN I-NP B-f
, , O O
aspirin VBP O B-m
one CD O B-do
po NN B-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Lisinopril NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
and CC O O
Atenolol NNP B-NP B-m
50 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
ALLERGIES: NNP I-NP O
None NNP I-NP O
known VBN O O
SOCIAL NNP B-NP O
HISTORY: NNP I-NP O
There EX O O
is VBZ O O
approximately RB O O
20 CD O O
pack JJ B-NP O
year NN I-NP O
history NN I-NP O
of IN B-VP O
smoking VBG O O
The DT B-NP O
patient NN I-NP O
quit NN I-NP O
cigarettes VBZ O O
20 CD O O
years NNS B-NP O
ago RB O O
Ethanol NNP B-NP O
history NN I-NP O
was VBD B-VP O
social JJ O O
The DT B-NP O
patient NN I-NP O
is VBZ O O
married VBN O O
, , O O
has VBZ O O
two CD O O
grown JJ B-NP O
children NNS I-NP O
He PRP O O
currently RB O O
works VBZ O O
in IN B-VP O
a DT B-NP O
short JJ I-NP O
term NN I-NP O
storage NN I-NP O
warehouse NN I-NP O
office NN I-NP O
, , O O
apparently RB O O
recently RB O O
lost VBD B-VP O
his PRP$ O O
tobacco NN B-NP O
shop NN I-NP O
business NN I-NP O
and CC O O
there EX O O
is VBZ O O
certainly RB O O
a DT B-NP O
potential JJ I-NP O
stress NN I-NP O
regarding VBG O O
his PRP$ O O
employment NN B-NP O
situation NN I-NP O
and CC O O
recent JJ B-NP O
death NN I-NP O
of IN B-VP O
his PRP$ O O
sister-in-law NN B-NP O
following VBG O O
a DT B-NP O
prolonged JJ I-NP O
illness NN I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
reports VBZ O O
his PRP$ O O
parents NNS B-NP O
are VBP O O
still RB O O
living VBG O O
, , O O
has VBZ O O
single JJ B-NP O
sibling NN I-NP O
who WP O O
is VBZ O O
alive JJ O O
and CC O O
well RB O O
He PRP O O
denies VBZ O O
family NN B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
, , O O
hypertension NN B-NP O
or CC O O
diabetes VBZ O O
REVIEW NNP B-NP O
OF NNP I-NP O
SYSTEMS: NNP I-NP O
Non-contributory NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
a DT B-NP O
thin JJ I-NP O
white JJ I-NP O
male NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
sitting VBG O O
up RP O O
on IN B-VP O
the DT B-NP O
stretcher NN I-NP O
Vital NNP I-NP O
signs NNS I-NP O
demonstrated VBD B-VP O
he PRP O O
was VBD B-VP O
afebrile RB O O
, , O O
blood NN B-NP O
pressure NN I-NP O
140/90 CD O O
, , O O
pulse RB O O
88 CD O O
, , O O
respirations NNS B-NP O
18 CD O O
His PRP$ O O
room NN B-NP O
air NN I-NP O
O2 NNP I-NP O
sat VBD B-VP O
was VBD B-VP O
96% CD O O
HEENT NNP B-NP O
exam NN I-NP O
normocephalic NN I-NP O
, , O O
atraumatic JJ B-NP O
Left NNP I-NP O
pupil NN I-NP O
was VBD B-VP O
5 CD O O
mm NN B-NP O
and CC O O
contracted VBD B-VP O
to TO O O
3; CD O O
right JJ B-NP O
pupil NN I-NP O
was VBD B-VP O
4 CD O O
mm NN B-NP O
and CC O O
contracted VBD B-VP O
to TO O O
3 CD O O
His PRP$ O O
extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ B-NP O
Fundi NNP I-NP O
were VBD B-VP O
poorly RB O O
visualized VBN O O
secondary JJ O O
to TO O O
possible JJ B-NP O
partial JJ I-NP O
cataract NN I-NP O
Oropharynx NNP I-NP O
was VBD B-VP O
only RB O O
remarkable JJ O O
for IN B-VP O
extensive JJ B-NP O
upper JJ I-NP O
bridge NN I-NP O
work NN I-NP O
Neck NNP I-NP O
was VBD B-VP O
supple JJ O O
, , O O
no DT O O
adenopathy JJ O O
His PRP$ O O
carotids NNS B-NP O
were VBD B-VP O
1+ CD O O
bilaterally RB O O
without IN B-VP O
bruits NNS B-NP O
His PRP$ O O
chest JJS B-NP O
exam NN I-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
decreased JJ B-NP O
breath NN I-NP O
sounds VBZ O O
halfway VBZ O O
up RP O O
, , O O
right RB O O
greater JJR O O
than IN B-VP O
left VBD B-VP O
, , O O
with IN B-VP O
absent JJ B-NP O
breath NN I-NP O
sounds NNS I-NP O
at IN B-VP O
the DT B-NP O
bases NNS I-NP O
The DT B-NP O
chest NN I-NP O
was VBD B-VP O
dull JJ O O
to TO O O
percussion VB O O
halfway RB O O
up RP O O
, , O O
however RB O O
, , O O
there EX O O
were VBD B-VP O
no DT B-NP O
rales NNS I-NP O
, , O O
wheezes VBZ O O
or CC O O
rhonchi VB O O
noted JJ B-NP O
Cardiac NNP I-NP O
exam NN I-NP O
revealed VBD B-VP O
jugular JJ B-NP O
venous JJ I-NP O
pulse NN I-NP O
was VBD B-VP O
approximately RB O O
7 CD O O
cm NNS B-NP O
at IN B-VP O
30 CD O O
degrees NNS B-NP O
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
with IN B-VP O
loud JJ B-NP O
S4 NNP I-NP O
, , O O
otherwise RB O O
no DT B-NP O
murmur NN I-NP O
or CC O O
rub VB O O
Abdominal NNP B-NP O
exam NN I-NP O
demonstrated VBD B-VP O
bowel JJ B-NP O
sounds NNS I-NP O
were VBD B-VP O
present JJ O O
, , O O
non-tender JJ O O
, , O O
liver RB O O
span VBZ O O
8 CD O O
cm NN B-NP O
in IN B-VP O
midclavicular JJ B-NP O
line NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
spleen JJ I-NP O
tip NN I-NP O
palpable JJ B-NP O
Rectal NNP I-NP O
exam NN I-NP O
normal JJ B-NP O
tone NN I-NP O
with IN B-VP O
a DT B-NP O
firm NN I-NP O
prostate NN I-NP O
without IN B-VP O
masses NNS B-NP O
and CC O O
stool NN B-NP O
was VBD B-VP O
guaiac JJ B-NP O
negative JJ I-NP O
Back NNP I-NP O
exam NN I-NP O
revealed VBD B-VP O
no DT B-NP O
spinal NN I-NP O
or CC O O
CVA NNP B-NP O
tenderness RB O O
noted VBD B-VP O
There EX O O
was VBD B-VP O
slight JJ B-NP O
buffalo NN I-NP O
hump NN I-NP O
present NN I-NP O
, , O O
however RB O O
Extremities NNP B-NP O
- : O O
Radial JJ B-NP O
pulses NNS I-NP O
3+ CD O O
, , O O
femoral JJ O O
2+ CD O O
, , O O
posterior JJ O O
tibial JJ O O
2+ CD O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
and CC O O
1+ CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
, , O O
dorsal NN B-NP O
pedis VBD B-VP O
1+ CD O O
bilaterally RB O O
There EX O O
are VBP O O
no DT B-NP O
femoral JJ I-NP O
bruits NNS I-NP O
There EX O O
was VBD B-VP O
1+ CD O O
pitting VBG O O
ankle NN B-NP O
edema NN I-NP O
bilaterally RB O O
Neuro NNP B-NP O
exam NN I-NP O
was VBD B-VP O
non-focal JJ B-NP O
LABORATORY NNP I-NP O
DATA: NNP I-NP O
On IN B-VP O
admission NN B-NP O
sodium NN I-NP O
141 CD O O
, , O O
potassium NN B-NP O
4.6 CD O O
, , O O
chloride RB O O
105 CD O O
, , O O
CO2 NNP B-NP O
24 CD O O
, , O O
BUN NNP B-NP O
19 CD O O
, , O O
creatinine NN B-NP O
0.9 CD O O
, , O O
glucose VBD B-VP O
178 CD O O
ALT NNP B-NP O
20 CD O O
, , O O
AST NNP B-NP O
18 CD O O
, , O O
LDH NNP B-NP O
177 CD O O
CK NNP B-NP O
107 CD O O
Alk NNP B-NP O
phos NN I-NP O
98 CD O O
, , O O
bili VBD B-VP O
total JJ O O
0.5 CD O O
, , O O
direct JJ O O
0.2 CD O O
Cholesterol NNP B-NP O
236 CD O O
, , O O
triglycerides VBZ O O
320 CD O O
Total NNP B-NP O
protein NN I-NP O
7.0 CD O O
, , O O
globulin NN B-NP O
4.6 CD O O
, , O O
albumin RB O O
2.4 CD O O
, , O O
calcium NN B-NP O
9.9 CD O O
, , O O
phosphate NN B-NP O
3.8 CD O O
White NNP B-NP O
count NN I-NP O
6.6 CD O O
, , O O
Hct NNP B-NP O
39.8 CD O O
, , O O
platelets NNS B-NP O
260 CD O O
, , O O
000 CD O O
, , O O
three CD O O
point NN B-NP O
differential NN I-NP O
revealed VBD B-VP O
26% CD O O
lymphocytes NNS B-NP O
, , O O
5.8% CD O O
monocytes NNS B-NP O
, , O O
68.2% CD O O
granulocytes NNS B-NP O
PT NNP I-NP O
was VBD B-VP O
12.6 CD O O
, , O O
PTT NNP B-NP O
31.0 CD O O
UA NNP B-NP O
was VBD B-VP O
pending VBG O O
EKG NNP B-NP O
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
84 CD O O
, , O O
PR NNP B-NP O
interval NN I-NP O
160 CD O O
, , O O
QRS NNP B-NP O
84 CD O O
, , O O
QTC NNP B-NP O
0.44 CD O O
, , O O
axis RB O O
+30 VBZ O O
The DT B-NP O
EKG NNP I-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
Q NNP B-NP O
wave VBP O O
in IN B-VP O
T NNP B-NP O
and CC O O
F NNP B-NP O
and CC O O
extensively RB O O
across IN B-VP O
the DT B-NP O
precordium NN I-NP O
, , O O
T NNP B-NP O
wave VBP O O
inversions NNS B-NP O
in IN B-VP O
1 CD O O
, , O O
2 CD O O
, , O O
and CC O O
R NNP B-NP O
ST NNP I-NP O
elevations NNS I-NP O
of IN B-VP O
2 CD O O
to TO O O
3 CD O O
mm NNS B-NP O
in IN B-VP O
V2 NNP B-NP O
, , O O
V3 NNP B-NP O
, , O O
and CC O O
V4 NNP B-NP O
with IN B-VP O
T NNP B-NP O
wave VBP O O
inversion NN B-NP O
in IN B-VP O
V2 NNP B-NP O
through IN B-VP O
V6 NNP B-NP O
, , O O
all DT O O
of IN B-VP O
these DT B-NP O
changes NNS I-NP O
new JJ O O
since IN B-VP O
1 CD O O
of IN B-VP O
October NNP B-NP O
Portable NNP I-NP O
chest JJS B-NP O
x-ray NN I-NP O
demonstrated VBD B-VP O
bilateral JJ B-NP O
pleural JJ I-NP O
effusions NNS I-NP O
with IN B-VP O
fluid NN B-NP O
in IN B-VP O
the DT B-NP O
minor JJ I-NP O
fissures NNS I-NP O
, , O O
question NN B-NP O
of IN B-VP O
cardiomegaly NN B-NP O
, , O O
increasing VBG O O
pulmonary JJ B-NP O
vascular JJ I-NP O
redistribution NN I-NP O
consistent NN I-NP O
with IN B-VP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
General NNP I-NP O
Medical NNP I-NP O
Service NNP I-NP O
Ri NNP I-NP O
Jotonmavilleceance NNP I-NP O
Lisker NNP I-NP O
and CC O O
subsequently RB O O
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP O
by IN B-VP O
enzymes VBG O O
His PRP$ O O
initial JJ B-NP O
CK NNP I-NP O
was VBD B-VP O
107 CD O O
Eight NNP B-NP O
hours NNS I-NP O
later RB O O
his PRP$ O O
CK NNP B-NP O
drawn NN I-NP O
was VBD B-VP O
45 CD O O
and CC O O
final JJ B-NP O
CK NNP I-NP O
was VBD B-VP O
89 CD O O
However RB O O
, , O O
the DT B-NP O
patient JJ I-NP O
underwent JJ I-NP O
echocardiography NN I-NP O
and CC O O
the DT B-NP O
echocardiogram NN I-NP O
demonstrated VBD B-VP O
a DT O O
moderately RB O O
dilated JJ O O
left VBD B-VP O
ventricle NN B-NP O
with IN B-VP O
decreased JJ B-NP O
global JJ I-NP O
contractile NN I-NP O
function NN I-NP O
, , O O
roughly RB O O
estimated VBN O O
at IN B-VP O
around IN B-VP O
25% CD O O
There EX O O
were VBD B-VP O
extensive JJ B-NP O
wall NN I-NP O
motion NN I-NP O
abnormalities NNS I-NP O
with IN B-VP O
mid NN B-NP O
to TO O O
distal JJ B-NP O
septal JJ I-NP O
akinesis NN I-NP O
, , O O
anterior RB O O
, , O O
anterolateral JJ O O
, , O O
and CC O O
septal JJ B-NP O
apex NN I-NP O
dyskinesis NN I-NP O
consistent NN I-NP O
with IN B-VP O
a DT B-NP O
large JJ I-NP O
anterior JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
However RB O O
, , O O
there EX O O
was VBD B-VP O
no DT B-NP O
mural JJ I-NP O
thrombus NN I-NP O
seen VBN O O
although IN B-VP O
occult NN B-NP O
thrombi NNS I-NP O
could MD O O
not RB O O
be VB O O
excluded VBN O O
at IN B-VP O
that DT B-NP O
time NN I-NP O
Because IN B-VP O
of IN B-VP O
the DT B-NP O
echocardiogram JJ I-NP O
result NN I-NP O
and CC O O
the DT B-NP O
fact NN I-NP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
ruled VBD B-VP O
out RP O O
for IN B-VP O
a DT B-NP O
recent JJ I-NP O
MI NNP I-NP O
the DT B-NP O
clinical JJ I-NP O
picture NN I-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
an DT B-NP O
evolved JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
within IN B-VP O
the DT B-NP O
time NN I-NP O
between IN B-VP O
the DT B-NP O
patient's JJ I-NP O
initial JJ I-NP O
presentation NN I-NP O
to TO O O
Dr NNP B-NP O
Connelley NNP I-NP O
in IN B-VP O
7 CD O O
of IN B-VP O
August NNP B-NP O
and CC O O
the DT B-NP O
patient's JJ I-NP O
presentation NN I-NP O
in IN B-VP O
21 CD O O
of IN B-VP O
January NNP B-NP O
Consequently NNP I-NP O
the DT B-NP O
plan NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
manage VB O O
the DT B-NP O
patient NN I-NP O
with IN B-VP O
gentle JJ B-NP O
Lasix NNP I-NP B-m
diuresis NN I-NP O
The DT B-NP O
patient's NN I-NP O
beta NN I-NP B-m
blocker NN I-NP I-m
was VBD B-VP O
held VBN O O
because IN B-VP O
of IN B-VP O
the DT B-NP O
concern NN I-NP O
for IN B-VP O
wall NN B-NP O
motion NN I-NP O
abnormalities NNS I-NP O
and CC O O
possible JJ B-NP O
aneurysm NN I-NP O
formation NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
anticoagulated VBN O O
on IN B-VP O
heparin NN B-NP B-m
and CC O O
subsequently RB O O
was VBD B-VP O
loaded VBN O O
on IN B-VP O
Coumadin NNP B-NP B-m
In IN B-VP O
addition NN B-NP O
the DT B-NP B-r
patient's NN I-NP I-r
afterload NN I-NP I-r
reduction NN I-NP I-r
was VBD B-VP O
increased VBN O O
and CC O O
changed VBN O O
to TO O O
Captopril NNP B-NP B-m
In IN B-VP O
addition NN B-NP O
the DT B-NP O
patient NN I-NP O
underwent VBD B-VP O
an DT B-NP O
exercise NN I-NP O
tolerance NN I-NP O
test NN I-NP O
with IN B-VP O
thallium NN B-NP O
scan NN I-NP O
on IN B-VP O
26 CD O O
of IN B-VP O
January NNP B-NP O
During IN B-VP O
this DT B-NP O
procedure NN I-NP O
the DT B-NP O
patient NN I-NP O
exercised VBD B-VP O
for IN B-VP O
6 CD O O
minutes NNS B-NP O
on IN B-VP O
modified JJ B-NP O
Bruce NNP I-NP O
protocol NN I-NP O
The DT B-NP O
test NN I-NP O
was VBD B-VP O
stopped VBN O O
secondary JJ O O
to TO O O
leg VB O O
fatigue VB O O
The DT B-NP O
patient's JJ I-NP O
heart NN I-NP O
rate NN I-NP O
rose VBD B-VP O
from IN B-VP O
98 CD O O
to TO O O
150 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
rose VBD B-VP O
from IN B-VP O
126/72 CD O O
to TO O O
148/76 CD O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
chest JJS I-NP O
pain NN I-NP O
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
ischemia NN B-NP O
Thallium NN I-NP O
images NNS I-NP O
showed VBD B-VP O
a DT O O
moderately RB O O
severe JJ B-NP O
perfusion NN I-NP O
defect NN I-NP O
at IN B-VP O
the DT B-NP O
apex NN I-NP O
sustained VBD B-VP O
to TO O O
the DT B-NP O
low JJ I-NP O
anterior NN I-NP O
wall NN I-NP O
, , O O
inferolateral JJ B-NP O
wall NN I-NP O
, , O O
and CC O O
septum VB O O
This DT B-NP O
defect NN I-NP O
was VBD B-VP O
unchanged JJ O O
on IN B-VP O
late JJ B-NP O
images NNS I-NP O
There EX O O
were VBD B-VP O
, , O O
therefore RB O O
, , O O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
ischemia NN B-NP O
, , O O
however RB O O
, , O O
there EX O O
was VBD B-VP O
some DT B-NP O
mild JJ I-NP O
transient JJ I-NP O
loss NN I-NP O
of IN B-VP O
uptake JJ O O
consistent JJ O O
with IN B-VP O
CHF NNP B-NP O
The DT B-NP O
overall JJ I-NP O
impression NN I-NP O
was VBD B-VP O
of IN B-VP O
a DT B-NP O
fixed JJ I-NP O
defect JJ I-NP O
consistent NN I-NP O
with IN B-VP O
an DT B-NP O
evolved JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
Because IN B-VP O
of IN B-VP O
the DT B-NP O
evidence NN I-NP O
for IN B-VP O
an DT B-NP O
evolved JJ I-NP O
myocardial JJ I-NP O
infarction NN I-NP O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
that IN B-VP O
this DT B-NP O
patient NN I-NP O
would MD O O
not RB O O
be VB O O
a DT B-NP O
candidate NN I-NP O
for IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
bypass NN I-NP O
grafting NN I-NP O
and CC O O
so RB O O
cardiac JJ B-NP O
catheterization NN I-NP O
was VBD B-VP O
deferred VBN O O
at IN B-VP O
this DT B-NP O
time NN I-NP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
on IN B-VP O
19 CD O O
of IN B-VP O
April NNP B-NP O
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
a DT B-NP O
UA NNP I-NP O
and CC O O
sediment NN B-NP O
were VBD B-VP O
pending VBG O O
DISPOSITION: NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
Lasix NNP I-NP B-m
40 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Captopril NNP B-NP B-m
37.5 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
tid NN I-NP B-f
, , O O
Ecotrin NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
d NN I-NP I-f
, , O O
Coumadin NNP B-NP B-m
5 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
q NN I-NP B-f
h.s NN I-NP I-f
, , O O
magnesium NN B-NP B-m
oxide RB O I-m
two CD O B-do
tablets NNS B-NP I-do
po VBP O B-mo
q JJ B-NP B-f
d NN I-NP I-f
, , O O
Isordil NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
tid NN I-NP B-f
with IN B-VP O
meals NNS B-NP O
, , O O
and CC O O
Micronase NNP B-NP B-m
10 CD O B-do
mg NN B-NP I-do
po NN I-NP B-mo
bid NN I-NP B-f
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE: NNP I-NP O
Stable NNP I-NP O
FOLLOW-UP: NNP I-NP O
With IN B-VP O
Dr NNP B-NP O
Luciano NNP I-NP O
Catignani NNP I-NP O
in IN B-VP O
his PRP$ O O
office NN B-NP O
on IN B-VP O
Tuesday NNP B-NP O
, , O O
15 CD O O
of IN B-VP O
October NNP B-NP O
, , O O
at IN B-VP O
3 CD O O
p.m JJ B-NP O
________________________________ NNP I-NP O
BH523/9938 NNP I-NP O
BRIAN NNP I-NP O
S NNP I-NP O
MORE NNP I-NP O
, , O O
M.D NNP B-NP O
HQ7 NNP I-NP O
D: NNP I-NP O
5/15/90 CD O O
Batch: NNP B-NP O
7967 CD O O
Report: NNP B-NP O
M9636S2 NNP I-NP O
T: NNP I-NP O
3/1/90 CD O O
Dictated NNP B-NP O
By: NNP I-NP O
TERRY NNP I-NP O
SCALESE NNP I-NP O
HXM5 NNP I-NP O
cc: VBD B-VP O
1 CD O O
HUBERT NNP B-NP O
GRIM NNP I-NP O
, , O O
M.D NNP B-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#810190 VBZ O O
194535648 CD O O
THC NNP B-NP O
12782558 CD O O
3516041 CD O O
9/6/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
bacteremia NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
7/0/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
2/23/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
MORELL NNP I-NP O
, , O O
PARKER NNP B-NP O
L NNP I-NP O
918-56-28-4 CD O O
Verl NNP B-NP O
Tri NNP I-NP O
Nard NNP I-NP O
, , O O
Maryland NNP B-NP O
Service: NNP I-NP O
ONC NNP I-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP O
ON: NNP I-NP O
8/6/06 CD O O
AT NNP B-NP O
11:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
SNF/rehab NNP I-NP O
WILL NNP I-NP O
D/C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D/C NNP I-NP O
SUMMARY: NNP I-NP O
YES NNP I-NP O
Attending: NNP I-NP O
RIOJAS NNP I-NP O
, , O O
HANS NNP B-NP O
B NNP I-NP O
, , O O
M.D NNP B-NP O
CODE NNP I-NP O
STATUS: NNP I-NP O
Full NNP I-NP O
code NN I-NP O
DISPOSITION: NNP I-NP O
Skilled VBD B-VP O
Nursing NNP B-NP O
Facility NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS: NNP I-NP O
TYLENOL NNP I-NP B-m
TYLENOL NNP I-NP B-m
TYLENOL NNP I-NP B-m
( ( O I-m
( ( O I-m
( ( O I-m
ACETAMINOPHEN NNP B-NP I-m
ACETAMINOPHEN NNP I-NP I-m
ACETAMINOPHEN NNP I-NP I-m
) ) O I-m
) ) O I-m
) ) O I-m
650 CD O B-do
650 CD O B-do
650 CD O B-do
MG NNP B-NP I-do
MG NNP I-NP I-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
PO NNP I-NP B-mo
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
Q6H NNP I-NP B-f
Q6H NNP I-NP B-f
PRN NNP I-NP O
Pain NNP I-NP B-r
, , O O
Temperature NNP B-NP B-r
greater JJR B-NP O
than:101 NN I-NP O
, , O O
Other:transfusion NNP B-NP B-r
premedication NN I-NP O
ALBUTEROL NNP I-NP B-m
NEBULIZER NNP I-NP I-m
2.5 CD O B-do
MG NNP B-NP I-do
INH NNP I-NP B-mo
Q4H NNP I-NP B-f
PRN NNP I-NP I-f
Wheezing NNP I-NP B-r
TESSALON NNP I-NP B-m
PERLES NNP I-NP I-m
( ( O I-m
BENZONATATE NNP B-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
TID NNP I-NP B-f
PRN NNP I-NP O
Other:congestion NNP I-NP B-r
CALTRATE NNP I-NP B-m
600 CD O I-m
+ NNP B-NP I-m
D NNP I-NP I-m
( ( O I-m
CALCIUM NNP B-NP I-m
CARBONATE NNP I-NP I-m
1 CD O I-m
, , O I-m
500 CD O I-m
MG NNP B-NP I-m
( ( O I-m
) ) O I-m
2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PERIDEX NNP I-NP B-m
MOUTHWASH NNP I-NP I-m
( ( O I-m
CHLORHEXIDINE NNP B-NP I-m
MOUTHWASH NNP I-NP I-m
0.12% CD O I-m
) ) O I-m
15 CD O B-do
MILLILITERS NNP B-NP I-do
MO NNP I-NP B-mo
BID NNP I-NP B-f
Instructions: NNP I-NP O
pls NN I-NP O
use NN I-NP O
this DT O O
or CC O O
nystatin JJ B-NP B-m
s+s NN I-NP O
BENADRYL NNP I-NP B-m
( ( O I-m
DIPHENHYDRAMINE NNP B-NP I-m
) ) O I-m
12.5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
x1 NNP I-NP B-f
PRN NNP I-NP O
Other:pre-transfusion NNP I-NP B-r
COLACE NNP I-NP B-m
( ( O I-m
DOCUSATE NNP B-NP I-m
SODIUM NNP I-NP I-m
) ) O I-m
100 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
ENOXAPARIN NNP I-NP B-m
40 CD O B-do
MG NNP B-NP I-do
SC NNP I-NP B-mo
DAILY NNP I-NP B-f
NEXIUM NNP I-NP B-m
( ( O I-m
ESOMEPRAZOLE NNP B-NP I-m
) ) O I-m
40 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
FLOVENT NNP I-NP B-m
HFA NNP I-NP I-m
( ( O I-m
FLUTICASONE NNP B-NP I-m
PROPIONATE NNP I-NP I-m
) ) O I-m
110 CD O B-do
MCG NNP B-NP I-do
INH NNP I-NP B-mo
BID NNP I-NP B-f
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
INSULIN NNP I-NP B-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
ASPART NNP I-NP I-m
Sliding NNP I-NP O
Scale NNP I-NP O
( ( O O
subcutaneously RB O O
) ) O O
SC NNP B-NP O
AC NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
3/24 CD O O
) ) O O
If IN B-VP O
BS NNP B-NP B-r
is VBZ O I-r
less JJR O I-r
than IN B-VP I-r
125 CD O I-r
, , O O
then RB O O
give VB O O
0 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O I-r
125-150 JJ O I-r
, , O O
then RB O O
give VB O O
2 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O I-r
151-200 CD O I-r
, , O O
then RB O O
give VB O O
3 CD O B-do
units NNS B-NP I-do
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP B-r
is VBZ O I-r
201-250 JJ O I-r
, , O O
then RB O O
give VB O O
4 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O I-r
251-300 JJ O I-r
, , O O
then RB O O
give VB O O
6 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O I-r
301-350 JJ O I-r
, , O O
then RB O O
give VB O O
8 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
If IN B-VP O
BS NNP B-NP B-r
is VBZ O I-r
351-400 CD O I-r
, , O O
then RB O O
give VB O O
10 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
BS NNP B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
INSULIN NNP B-NP B-m
NPH NNP I-NP I-m
HUMAN NNP I-NP I-m
10 CD O B-do
UNITS NNP B-NP I-do
SC NNP I-NP B-mo
QAM NNP I-NP B-f
ATROVENT NNP I-NP B-m
NEBULIZER NNP I-NP I-m
( ( O I-m
IPRATROPIUM NNP B-NP I-m
NEBULIZER NNP I-NP I-m
) ) O I-m
0.5 CD O B-do
MG NNP B-NP I-do
INH NNP I-NP B-mo
QID NNP I-NP B-f
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
IMMED NNP I-NP I-m
REL NNP I-NP I-m
( ( O I-m
KCL NNP B-NP I-m
IMMEDIATE NNP I-NP I-m
) ) O I-m
***LOW VBP O O
KCL NNP B-NP B-m
IMMEDIATE NNP I-NP I-m
RELEASE NNP I-NP I-m
REPLACEMENT NNP I-NP O
SCALE NNP I-NP O
ORAL NNP I-NP B-mo
ORAL NNP I-NP B-mo
PO NNP I-NP I-mo
PO NNP I-NP I-mo
Scale NNP I-NP O
Frequency NNP I-NP O
1 CD O O
Only RB O O
KCL NNP B-NP B-m
Immediate NNP I-NP I-m
Release NNP I-NP I-m
products NNS I-NP O
may MD O O
be VB O O
used VBN O O
for IN B-VP O
KCL NNP B-NP O
scales NNS I-NP O
2 CD O O
Do NNP B-NP O
not RB O O
use VB O O
sustained-release JJ B-NP O
potassium NN I-NP O
for IN B-VP O
KCL NNP B-NP O
scale NN I-NP O
doses VBZ O O
3 CD O O
Replace NNP B-NP O
KCL NNP I-NP O
based VBN O O
on IN B-VP O
lab NN B-NP O
values NNS I-NP O
4 CD O O
As IN B-VP O
per IN B-VP O
NM NNP B-NP O
Potassium NNP I-NP B-m
Chloride NNP I-NP I-m
Policy: NNP I-NP O
each DT O O
20 CD O B-do
mEq NN B-NP I-do
dose NN I-NP O
is VBZ O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4 CD O O
oz NNS B-NP O
of IN B-VP O
fluid NN B-NP O
5 CD O O
A NNP B-NP O
serum NN I-NP O
creatinine NN I-NP O
must MD O O
be VB O O
ordered VBN O O
and CC O O
checked VBN O O
daily RB O O
while IN B-VP O
patient NN B-NP O
is VBZ O O
ordered VBN O O
for IN B-VP O
a DT O O
K-scale JJ O O
6 CD O O
K-scale JJ B-NP O
cannot NN I-NP O
be VB O O
used VBN O O
on IN B-VP O
patients NNS B-NP O
with: JJ O O
* VBP O O
A DT B-NP O
serum NN I-NP O
creatinine NN I-NP O
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
2.0 CD O O
mg/dl; NN B-NP O
or CC O O
* VB O O
A DT B-NP O
serum NN I-NP O
creatinine JJ B-NP O
increase NN I-NP O
of IN B-VP O
0.5 CD O O
mg/dl NNS B-NP O
within IN B-VP O
24 CD O O
hours NNS B-NP O
* VBP O O
Hold NNP B-NP O
scale NN I-NP O
and CC O O
contact NN B-NP O
MD NNP I-NP O
if IN B-VP O
SCr NNP B-NP O
greater JJR O O
than IN B-VP O
2.0 CD O O
----------------------------------------------------------- JJ B-NP O
----------- NN I-NP O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
less JJR O O
than IN B-VP O
3.1 CD O O
then RB O O
call VB O O
H.O NNP B-NP O
If IN B-VP O
K+ NNP B-NP B-r
Level NNP I-NP I-r
is VBZ O O
3.1-3.3 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
KCL NNP I-NP B-m
40 CD O B-do
40 CD O B-do
meq NN B-NP I-do
meq NN I-NP I-do
orally RB O B-mo
orally RB O B-mo
followed VBN O O
by IN B-VP O
20 CD O O
meq NNS B-NP O
orally RB O O
2 CD O O
hours NNS B-NP O
later RB O O
Recheck NNP B-NP O
K+ NNP I-NP O
Level NNP I-NP O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dose NN B-NP O
was VBD B-VP O
given VBN O O
If IN B-VP O
K+ NNP B-NP B-r
Level NNP I-NP I-r
is VBZ O O
3.4-3.6 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
40 CD O B-do
meq NN B-NP I-do
orally RB O B-mo
Recheck NNP B-NP O
K+ NNP I-NP O
Level NNP I-NP O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dose NN B-NP O
was VBD B-VP O
given VBN O O
If IN B-VP O
K+ NNP B-NP B-r
Level NNP I-NP I-r
is VBZ O O
3.7-4.0 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
20 CD O B-do
meq NN B-NP I-do
orally RB O B-mo
Recheck NNP B-NP O
K+ NNP I-NP O
Level NNP I-NP O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dose NN B-NP O
was VBD B-VP O
given VBN O O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
4.1-5.0 JJ O O
, , O O
then RB O O
DO NNP B-NP O
NOT NNP I-NP O
administer VB O O
KCL NNP B-NP O
Recheck NNP I-NP O
K+ NNP I-NP O
Level NNP I-NP O
in IN B-VP O
QAM NNP B-NP O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
5.0 CD O O
then RB O O
call VB O O
H.O NNP B-NP O
----------------------------------------------------------- NNP I-NP O
----------- NNP I-NP O
POTASSIUM NNP I-NP B-m
CHLORIDE NNP I-NP I-m
SLOW NNP I-NP I-m
REL NNP I-NP I-m
( ( O I-m
KCL NNP B-NP I-m
SLOW NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
40 CD O B-do
MEQ NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
As IN B-VP O
per IN B-VP O
EKMC NNP B-NP O
Potassium NNP I-NP B-m
Chloride NNP I-NP I-m
Policy: NNP I-NP O
each DT O O
20 CD O B-do
mEq NNS B-NP I-do
dose VB O O
to TO O O
be VB O O
given VBN O O
with IN B-VP O
4 CD O O
oz NNS B-NP O
of IN B-VP O
fluid NN B-NP O
LACTULOSE NNP I-NP B-m
30 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
ATIVAN NNP I-NP B-m
( ( O I-m
LORAZEPAM NNP B-NP I-m
) ) O I-m
0.5-1 CD O B-do
MG NNP B-NP I-do
IV NNP I-NP B-mo
Q8H NNP I-NP B-f
PRN NNP I-NP I-f
Nausea NNP I-NP B-r
HOLD NNP I-NP O
IF: NNP I-NP O
sedate NN I-NP O
or CC O O
rr&lt;10 VB O O
MAALOX-TABLETS NNP B-NP B-m
QUICK NNP I-NP I-m
DISSOLVE/CHEWABLE NNP I-NP I-m
1-2 JJ B-NP B-do
TAB NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP O
Upset NNP I-NP B-r
Stomach NNP I-NP I-r
MAGNESIUM NNP I-NP B-m
GLUCONATE NNP I-NP I-m
Sliding NNP I-NP B-do
Scale NNP I-NP I-do
PO NNP I-NP B-mo
( ( O I-mo
orally RB O I-mo
) ) O I-mo
DAILY NNP B-NP B-f
-&gt; NNP I-NP O
Mg-scales NNP I-NP O
cannot NN I-NP O
be VB O O
used VBN O O
and CC O O
magnesium JJ B-NP O
doses NNS I-NP O
must MD O O
be VB O O
individualized VBN O O
for IN B-VP O
patients NNS B-NP O
who WP O O
have: VBP O O
- : O O
a DT B-NP O
serum JJ I-NP O
creatinine NN I-NP O
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
2.0 CD O O
mg/dL; NN B-NP O
or CC O O
- : O O
a DT B-NP O
serum JJ I-NP O
creatinine NN I-NP O
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
1.5 CD O O
mg/dL NN B-NP O
and CC O O
an DT B-NP O
increase NN I-NP O
of IN B-VP O
0.5mg/dL CD O O
within IN B-VP O
24 CD O O
hours NNS B-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
less JJR O O
than IN B-VP O
0.8 CD O O
If IN B-VP O
Mg NNP B-NP B-r
level NN I-NP I-r
is VBZ O O
less JJR O O
than IN B-VP O
1 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
Gluconate NNP I-NP I-m
orally RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
If IN B-VP O
Mg NNP B-NP B-r
level NN I-NP I-r
is VBZ O O
1.0-1.5 JJ O O
, , O O
then RB O O
give VB O O
2 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
Gluconate NNP I-NP I-m
orally RB O B-mo
If IN B-VP O
Mg NNP B-NP B-r
level NN I-NP I-r
is VBZ O O
1.6-1.9 JJ O O
, , O O
then RB O O
give VB O O
1 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
Gluconate NNP I-NP I-m
orally RB O B-mo
If IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
2.0-2.5 JJ O O
, , O O
then RB O O
Do NNP B-NP O
Not RB O O
administer VB O O
Mg NNP B-NP O
Gluconate NNP I-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
2.5 CD O O
MAGNESIUM NNP B-NP B-m
SULFATE NNP I-NP I-m
Sliding NNP I-NP B-do
Scale NNP I-NP I-do
IV NNP I-NP B-mo
( ( O I-mo
intravenously RB O I-mo
) ) O I-mo
DAILY NNP B-NP B-f
----------------------------------------------------------- NNP I-NP O
------ NNP I-NP O
Physician NNP I-NP O
Instructions: NNP I-NP O
Magnesium NNP I-NP O
scales VBZ O O
cannot RB O O
be VB O O
used VBN O O
on IN B-VP O
patients NNS B-NP O
with: JJ O O
-&gt; VBP O O
A DT B-NP O
serum NN I-NP O
creatinine NN I-NP O
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
2.0 CD O O
mg/dL; NN B-NP O
or CC O O
-&gt; VB O O
A DT B-NP O
serum NN I-NP O
creatinine JJ B-NP O
increase NN I-NP O
of IN B-VP O
0.5 CD O O
mg/dL NNS B-NP O
within IN B-VP O
24 CD O O
hours NNS B-NP O
----------------------------------------------------------- JJ B-NP O
-------- NNP I-NP O
Call NNP I-NP O
HO NNP I-NP O
if IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
less JJR O O
than IN B-VP O
1.2 CD O O
Hold JJ B-NP O
order NN I-NP O
if IN B-VP O
creatinine NN B-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
1.9 CD O O
If IN B-VP O
serum JJ B-NP B-r
Mg NNP I-NP I-r
level NN I-NP I-r
is VBZ O O
less JJR O O
than IN B-VP O
1.4 CD O O
, , O O
then RB O O
give VB O O
5 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
Sulfate NNP I-NP O
intravenously RB O B-mo
and CC O O
call VB O O
HO NNP B-NP O
If IN B-VP O
serum JJ B-NP B-r
Mg NNP I-NP I-r
level NN I-NP I-r
is VBZ O O
less JJR O O
than IN B-VP O
1.6 CD O O
, , O O
then RB O O
give VB O O
4 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
sulfate NN I-NP O
intravenously RB O B-mo
If IN B-VP O
serum JJ B-NP B-r
Mg NNP I-NP I-r
level NN I-NP I-r
is VBZ O O
less JJR O O
than IN B-VP O
1.8 CD O O
, , O O
then RB O O
give VB O O
3 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
Sulfate NNP I-NP O
intravenously RB O B-mo
If IN B-VP O
serum JJ B-NP B-r
Mg NNP I-NP I-r
level NN I-NP I-r
is VBZ O O
less JJR O O
than IN B-VP O
2.0 CD O O
, , O O
then RB O O
give VB O O
2 CD O B-do
gm NN B-NP I-do
Mg NNP I-NP B-m
Sulfate NNP I-NP O
intravenously RB O B-mo
Call NNP B-NP O
HO NNP I-NP O
if IN B-VP O
Mg NNP B-NP O
level NN I-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
2.5 CD O O
MS NNP B-NP B-m
CONTIN NNP I-NP I-m
( ( O I-m
MORPHINE NNP B-NP I-m
CONTROLLED NNP I-NP I-m
RELEASE NNP I-NP I-m
) ) O I-m
15 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
3/24 CD O O
) ) O O
HOLD NNP B-NP O
IF: NNP I-NP O
rr&lt;10 NN I-NP O
or CC O O
very RB O O
sleepy JJ B-NP O
NYSTATIN NNP I-NP B-m
SUSPENSION NNP I-NP I-m
10 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
QID NNP I-NP B-f
Instructions: NNP I-NP O
use NN I-NP O
this DT O O
or CC O O
chlorhexidine VB O B-m
ZOFRAN NNP B-NP B-m
( ( O I-m
POST-OP NNP B-NP I-m
N/V NNP I-NP I-m
) ) O I-m
( ( O I-m
ONDANSETRON NNP B-NP I-m
HCL NNP I-NP I-m
( ( O I-m
POST- NNP B-NP I-m
) ) O I-m
1 CD O B-do
MG NNP B-NP I-do
IV NNP I-NP B-mo
Q6H NNP I-NP O
X NNP I-NP B-du
2 CD O I-du
doses NNS B-NP I-du
PRN NNP I-NP O
Nausea NNP I-NP B-r
OXYCODONE NNP I-NP B-m
5 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Pain NNP I-NP B-r
KCL NNP I-NP B-m
( ( O I-m
POTASSIUM NNP B-NP I-m
CHLORIDE NNP I-NP I-m
) ) O I-m
***MODERATE VBP O O
KCL NNP B-NP B-m
REPLACEMENT NNP I-NP B-do
SCALE NNP I-NP I-do
10 CD O I-do
mEq/HR NN B-NP I-do
IV NNP I-NP B-mo
Scale NNP I-NP O
Frequency NNP I-NP O
1 CD O O
Replace NNP B-NP O
KCL NNP I-NP B-m
based VBN O O
on IN B-VP O
lab NN B-NP O
values NNS I-NP O
2 CD O O
An DT B-NP O
infusion NN I-NP O
pump NN I-NP O
is VBZ O O
required VBN O O
for IN B-VP O
all DT B-NP O
intermittent JJ I-NP O
bolus NN I-NP O
infusions NNS I-NP O
3 CD O O
KCL NNP B-NP B-m
10 CD O B-do
mEq/100ml/hr NN B-NP I-do
is VBZ O O
intermittent JJ B-NP O
bolus JJ I-NP O
infusion NN I-NP O
standard VBD B-VP O
4 CD O O
A NNP B-NP O
serum NN I-NP O
creatinine NN I-NP O
must MD O O
be VB O O
ordered VBN O O
and CC O O
checked VBN O O
daily RB O O
while IN B-VP O
patient NN B-NP O
is VBZ O O
ordered VBN O O
for IN B-VP O
a DT O O
K-scale JJ O O
5 CD O O
K-scale JJ B-NP O
cannot NN I-NP O
be VB O O
used VBN O O
on IN B-VP O
patients NNS B-NP O
with: JJ O O
* VBP O O
A DT B-NP O
serum NN I-NP O
creatinine NN I-NP O
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
2.0 CD O O
mg/dl; NN B-NP O
or CC O O
* VB O O
A DT B-NP O
serum NN I-NP O
creatinine JJ B-NP O
increase NN I-NP O
of IN B-VP O
0.5 CD O O
mg/dl NNS B-NP O
within IN B-VP O
24 CD O O
hours NNS B-NP O
* VBP O O
Hold NNP B-NP O
scale NN I-NP O
and CC O O
contact NN B-NP O
MD NNP I-NP O
if IN B-VP O
SCr NNP B-NP O
greater JJR O O
than IN B-VP O
2.0 CD O O
----------------------------------------------------------- JJ B-NP O
----------- NN I-NP O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
less JJR O O
than IN B-VP O
3.1 CD O O
then RB O O
call VB O O
H.O NNP B-NP O
If IN B-VP O
K+ NNP B-NP B-r
Level NNP I-NP I-r
is VBZ O O
3.1-3.3 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
10 CD O B-do
meq NN B-NP I-do
x5 NNP I-NP B-du
Recheck NNP I-NP O
K+ NNP I-NP O
Level NNP I-NP O
1 CD O O
to TO O O
4 CD O O
hours NNS B-NP O
after IN B-VP O
infusion NN B-NP O
finished VBN O O
If IN B-VP O
K+ NNP B-NP B-r
Level NNP I-NP I-r
is VBZ O O
3.4-3.6 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
10 CD O B-do
meq NN B-NP I-do
x4 NNP I-NP B-du
Recheck NNP I-NP O
K+ NNP I-NP O
Level NNP I-NP O
1 CD O O
to TO O O
4 CD O O
hours NNS B-NP O
after IN B-VP O
infusion NN B-NP O
finished VBN O O
If IN B-VP O
K+ NNP B-NP B-r
Level NNP I-NP I-r
is VBZ O O
3.7-4.0 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
10 CD O B-do
meq NN B-NP I-do
x3 NNP I-NP B-du
Recheck NNP I-NP O
K+ NNP I-NP O
Level NNP I-NP O
1 CD O O
to TO O O
4 CD O O
hours NNS B-NP O
after IN B-VP O
infusion NN B-NP O
finished VBN O O
If IN B-VP O
K+ NNP B-NP B-r
Level NNP I-NP I-r
is VBZ O O
4.1-4.5 JJ O O
, , O O
then RB O O
administer RB O O
KCL NNP B-NP B-m
10 CD O B-do
meq NN B-NP I-do
x2 NNP I-NP B-du
Recheck NNP I-NP O
K+ NNP I-NP O
Level NNP I-NP O
1 CD O O
to TO O O
4 CD O O
hours NNS B-NP O
after IN B-VP O
infusion NN B-NP O
finished VBN O O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
4.6-5.0 JJ O O
, , O O
then RB O O
DO NNP B-NP O
NOT NNP I-NP O
administer VB O O
KCL NNP B-NP O
Recheck NNP I-NP O
K+ NNP I-NP O
Level NNP I-NP O
in IN B-VP O
QAM NNP B-NP O
If IN B-VP O
K+ NNP B-NP O
Level NNP I-NP O
is VBZ O O
greater JJR O O
than IN B-VP O
5.0 CD O O
then RB O O
call VB O O
H.O NNP B-NP O
----------------------------------------------------------- NNP I-NP O
----------- NNP I-NP O
SENNA NNP I-NP B-m
TABLETS NNP I-NP I-m
( ( O I-m
SENNOSIDES NNP B-NP I-m
) ) O I-m
2 CD O B-do
TAB NNP B-NP I-do
PO NNP I-NP B-mo
BID NNP I-NP B-f
PRN NNP I-NP I-f
Constipation NNP I-NP B-r
ZOLOFT NNP I-NP B-m
( ( O I-m
SERTRALINE NNP B-NP I-m
) ) O I-m
25 CD O B-do
MG NNP B-NP I-do
PO NNP I-NP B-mo
BEDTIME NNP I-NP B-f
Starting VBG O O
Today NNP B-NP O
( ( O O
3/24 CD O O
) ) O O
Override NNP B-NP O
Notice: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
6/18/06 CD O O
by IN B-VP O
HAGON NNP B-NP O
, , O O
AUBREY NNP B-NP O
R NNP I-NP O
, , O O
M.D NNP B-NP O
on IN B-VP O
order NN B-NP O
for IN B-VP O
GEODON NNP B-NP B-m
PO NNP I-NP B-mo
( ( O O
ref JJ O O
# # O O
639530057 CD O O
) ) O O
SERIOUS NNP B-NP O
INTERACTION: NNP I-NP O
SERTRALINE NNP I-NP B-m
HCL NNP I-NP I-m
&amp; NNP I-NP O
ZIPRASIDONE NNP I-NP B-m
HCL NNP I-NP I-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
MULTIVITAMIN NNP I-NP B-m
THERAPEUTIC NNP I-NP I-m
( ( O I-m
THERAPEUTIC NNP B-NP I-m
MULTIVI NNP I-NP I-m
) ) O I-m
5 CD O B-do
MILLILITERS NNP B-NP I-do
PO NNP I-NP B-mo
DAILY NNP I-NP B-f
VANCOMYCIN NNP I-NP B-m
HCL NNP I-NP I-m
1 CD O B-do
GM NNP B-NP I-do
IV NNP I-NP B-mo
Q12H NNP I-NP B-f
Instructions: NNP I-NP O
plan NN I-NP O
14 CD O B-du
days NNS B-NP I-du
, , O O
started VBD B-VP O
2/22 CD O O
, , O O
end VBP O O
7/25 CD O O
COMPAZINE NNP B-NP B-m
( ( O I-m
PROCHLORPERAZINE NNP B-NP I-m
) ) O I-m
5-10 JJ B-NP B-do
MG NNP I-NP I-do
PO NNP I-NP B-mo
Q6H NNP I-NP B-f
PRN NNP I-NP I-f
Nausea NNP I-NP B-r
Alert NNP I-NP O
overridden: NNP I-NP O
Override NNP I-NP O
added VBD B-VP O
on IN B-VP O
8/6/06 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP O
INTERACTION: NNP I-NP O
IPRATROPIUM NNP I-NP B-m
BROMIDE NNP I-NP I-m
&amp; NNP I-NP O
PROCHLORPERAZINE NNP I-NP B-m
Reason NNP I-NP O
for IN B-VP O
override: NN B-NP O
md NN I-NP O
aware JJ B-NP O
DIET: NNP I-NP O
No NNP I-NP O
Restrictions NNP I-NP O
ACTIVITY: NNP I-NP O
Walking NNP I-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT( NNP I-NP O
S NNP I-NP O
): NNP I-NP O
pls NN I-NP O
f/u NN I-NP O
with IN B-VP O
primary JJ B-NP O
oncologist NN I-NP O
as IN B-VP O
scheduled VBN O O
, , O O
ALLERGY: NNP B-NP O
NKA NNP I-NP O
ADMIT NNP I-NP O
DIAGNOSIS: NNP I-NP O
hypotension NN I-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
;Responsible JJ O O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
bacteremia NN B-NP O
OTHER NNP I-NP O
DIAGNOSIS;Conditions NNP I-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment/Stay NNP B-NP O
iddm NN I-NP O
( ( O O
diabetes VBZ O O
mellitus NN B-NP O
) ) O O
hypercholesterolemia NN B-NP O
( ( O O
elevated VBN O O
cholesterol NN B-NP O
) ) O O
htn NN B-NP O
( ( O O
hypertension NN B-NP O
) ) O O
asthma NN B-NP O
( ( O O
asthma NN B-NP O
) ) O O
arthritis NN B-NP O
( ( O O
arthritis NN B-NP O
) ) O O
obesity NN B-NP O
( ( O O
obesity NN B-NP O
) ) O O
s/p NN B-NP O
ccy NN I-NP O
( ( O O
S/P NNP B-NP O
cholecystectomy NN I-NP O
) ) O O
metastatic JJ B-NP O
breast NN I-NP O
cancer NN I-NP O
( ( O O
breast JJ B-NP O
cancer NN I-NP O
) ) O O
pulmonary JJ B-NP O
embolism NN I-NP O
( ( O O
pulmonary JJ B-NP O
embolism NN I-NP O
) ) O O
depression NN B-NP O
( ( O O
depression NN B-NP O
) ) O O
OPERATIONS NNP B-NP O
AND NNP I-NP O
PROCEDURES: NNP I-NP O
OTHER NNP I-NP O
TREATMENTS/PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R NNP I-NP O
) ) O O
na VBP O O
BRIEF JJ B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE: NNP I-NP O
CC: NNP I-NP O
Tachycardia NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT B-NP O
59-year-old JJ I-NP O
woman NN I-NP O
from IN B-VP O
Vi NNP B-NP O
Ca NNP I-NP O
Beth NNP I-NP O
presents NNS I-NP O
with IN B-VP O
fever NN B-NP O
and CC O O
tachycardia NN B-NP O
since IN B-VP O
10/5/06 CD O O
It PRP O O
is VBZ O O
very RB O O
difficult JJ O O
to TO O O
elicit VB O O
a DT B-NP O
clear JJ I-NP O
story NN I-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
had VBN O O
cough VBN O O
productive NN B-NP O
of IN B-VP O
variably RB O O
colored VBN O O
sputum NN B-NP O
( ( O O
yellow JJ O O
to TO O O
green VB O O
to TO O O
orange VB O O
, , O O
without IN B-VP O
hemoptysis NN B-NP O
) ) O O
but CC O O
it PRP O O
seems VBZ O O
she PRP O O
may MD O O
have VB O O
had VBD B-VP O
a DT B-NP O
similar JJ I-NP O
cough NN I-NP O
for IN B-VP O
months NNS B-NP O
Similarly RB O O
, , O O
she PRP O O
notes VBZ O O
dysuria NNS B-NP O
and CC O O
increased VBD B-VP O
frequency NN B-NP O
which WDT O O
it PRP O O
seems VBZ O O
has VBZ O O
also RB O O
been VBN O O
present JJ O O
for IN B-VP O
weeks NNS B-NP O
to TO O O
months NNS B-NP O
She PRP O O
is VBZ O O
not RB O O
short JJ O O
of IN B-VP O
breath NN B-NP O
and CC O O
has VBZ O O
no DT B-NP O
headache NN I-NP O
, , O O
chest NN B-NP O
pain NN I-NP O
, , O O
hemoptysis NN B-NP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , O O
nausea NN B-NP O
, , O O
vomiting VBG O O
, , O O
diarrhea NN B-NP O
, , O O
numbness RB O O
, , O O
LE NNP B-NP O
swelling VBG O O
, , O O
LE NNP B-NP O
pain NN I-NP O
, , O O
rash NN B-NP O
She PRP O O
does VBZ O O
have VB O O
some DT B-NP O
bumps NNS I-NP O
on IN B-VP O
her PRP$ O O
abdominal JJ B-NP O
wall NN I-NP O
which WDT O O
are VBP O O
painful-it JJ B-NP O
sounds NNS I-NP O
like IN B-VP O
these DT O O
are VBP O O
a DT B-NP O
direct JJ I-NP O
result NN I-NP O
of IN B-VP O
the DT B-NP O
enoxaprin NN I-NP B-m
she PRP O O
had VBD B-VP O
been VBN O O
getting VBG O O
for IN B-VP O
a DT B-NP O
PE NNP I-NP O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
this DT B-NP O
year NN I-NP O
The DT B-NP O
ZH NNP I-NP O
ER NNP I-NP O
doctor NN I-NP O
spoke VBD B-VP O
with IN B-VP O
Senz NNP B-NP O
at IN B-VP O
the DT B-NP O
nursing NN I-NP O
home NN I-NP O
She PRP O O
said VBD B-VP O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
an DT O O
x-ray JJ O O
two CD O O
days NNS B-NP O
ago RB O O
which WDT O O
revealed VBD B-VP O
pneumonia NN B-NP O
, , O O
and CC O O
her PRP$ O O
referral JJ B-NP O
states NNS I-NP O
that IN B-VP O
the DT B-NP B-r
pneumonia NN I-NP I-r
was VBD B-VP O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
lobe NN I-NP O
and CC O O
left VBD B-VP O
lower JJR O O
lobe; IN B-VP O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
started VBN O O
on IN B-VP O
Levaquin NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP O
that DT B-NP O
time NN I-NP O
In IN B-VP O
the DT B-NP O
FMC NNP I-NP O
emergency NN I-NP O
room NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
hydrated VBN O O
with IN B-VP O
3 CD O B-do
liters NNS B-NP I-do
of IN B-VP O
normal JJ B-NP B-m
saline NN I-NP I-m
and CC O O
her PRP$ O O
pulse NN B-NP O
still RB O O
remains VBZ O O
in IN B-VP O
the DT O O
130s CD O O
She PRP O O
was VBD B-VP O
given VBN O O
Levofloxacin NNP B-NP B-m
500 CD O B-do
mg NN B-NP I-do
IV NNP I-NP B-mo
The DT B-NP O
ER NNP I-NP O
physician NN I-NP O
was VBD B-VP O
worried VBN O O
about IN B-VP O
a DT B-NP O
pulmonary JJ I-NP O
embolus NN I-NP O
, , O O
did VBD B-VP O
not RB O O
do VB O O
a DT B-NP O
chest NN I-NP O
CT NN I-NP O
here RB O O
because IN B-VP O
of IN B-VP O
her PRP$ O O
elevated JJ B-NP O
creatinine NN I-NP O
of IN B-VP O
1.9 CD O O
She PRP O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Chamvine NNP I-NP O
Tionbradvar NNP I-NP O
General NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
an DT B-NP O
MRA NNP I-NP O
to TO O O
rule VB O O
out RP O O
PE NNP B-NP O
In IN B-VP O
ER NNP B-NP O
here RB O O
, , O O
IJ NNP B-NP O
central JJ B-NP O
line NN I-NP O
placed VBN O O
( ( O O
CVP~20 NNP B-NP O
) ) O O
and CC O O
patient JJ O O
given VBN O O
1L CD O O
NS NNP B-NP O
Blood NNP I-NP B-r
pressure NN I-NP I-r
systolic VBD B-VP O
initially RB O O
120s CD O O
but CC O O
decreased VBD B-VP O
to TO O O
90s CD O O
( ( O O
MAPS&gt;70 NNP B-NP O
) ) O O
, , O O
and CC O O
norepinephrine NN B-NP B-m
started VBD B-VP O
The DT B-NP O
NE NNP I-NP O
was VBD B-VP O
discontinued VBN O O
promptly RB O O
given VBN O O
BP NNP B-NP O
improvement NN I-NP O
immediately RB O O
, , O O
and CC O O
continued VBD B-VP O
SBP&gt;100 NNP B-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
Metastatic NNP I-NP O
breast VBD B-VP O
CA-bone NNP B-NP O
scan JJ O O
which WDT O O
revealed VBD B-VP O
widespread JJ B-NP O
osseous JJ I-NP O
metastasis NN I-NP O
, , O O
and CC O O
CNS NNP B-NP O
involvement NN I-NP O
on IN B-VP O
head NN B-NP O
CT NNP I-NP O
, , O O
bone NN B-NP O
marrow NN I-NP O
bx NN I-NP O
with IN B-VP O
invasive JJ B-NP O
disease NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
brain NN I-NP O
radiotherapy NN I-NP O
10/5 CD O O
diabetes NNS B-NP O
, , O O
PE NNP B-NP O
5/13 CD O O
, , O O
tx NN B-NP O
with IN B-VP O
enoxaprin NN B-NP O
through IN B-VP O
0/7 CD O O
( ( O O
discontinued VBN O O
because IN B-VP O
of IN B-VP O
doubt NN B-NP O
over IN B-VP O
original JJ B-NP O
dx NN I-NP O
and CC O O
significant JJ B-NP O
pain NN I-NP O
at IN B-VP O
injection NN B-NP O
sites NNS I-NP O
) ) O O
, , O O
hypertension NN B-NP O
, , O O
arthritis NN B-NP O
, , O O
depression NN B-NP O
, , O O
bipolar JJ B-NP O
disorder NN I-NP O
, , O O
asthma NN B-NP O
, , O O
high JJ B-NP O
cholesterol NN I-NP O
, , O O
anemia NN B-NP O
, , O O
and CC O O
obesity NN B-NP O
ONC NNP I-NP O
HISTORY: NNP I-NP O
Pt NNP I-NP O
presented VBD B-VP O
with IN B-VP O
grade NN B-NP O
III NNP I-NP O
, , O O
ER/PR/HER2-negative NNP B-NP O
in IN B-VP O
March NNP B-NP O
2004 CD O O
In IN B-VP O
March NNP B-NP O
2004 CD O O
, , O O
she PRP O O
underwent VBD B-VP O
right JJ B-NP O
breast NN I-NP O
lumpectomy NN I-NP O
with IN B-VP O
pathology NN B-NP O
demonstrating VBG O O
4.1 CD O O
cm NN B-NP O
IDC NNP I-NP O
, , O O
no DT B-NP O
LVI NNP I-NP O
, , O O
negative JJ B-NP O
sentinel NN I-NP O
lymph NN I-NP O
nodes IN B-VP O
She PRP O O
underwent JJ B-NP O
partial JJ I-NP O
breast NN I-NP O
radiation NN I-NP O
in IN B-VP O
March NNP B-NP O
2004 CD O O
and CC O O
deferred VBD B-VP O
on IN B-VP O
adjuvant JJ B-NP O
therapy NN I-NP O
In IN B-VP O
November NNP B-NP O
2005 CD O O
, , O O
she PRP O O
presented VBD B-VP O
with IN B-VP O
atypical JJ B-NP O
chest NN I-NP O
wall NN I-NP O
pain NN I-NP O
and CC O O
imaging NN B-NP O
showed VBD B-VP O
bilateral JJ B-NP O
pulmonary JJ I-NP O
nodules NNS I-NP O
, , O O
thoracic NN B-NP O
lymphadenopathy NN I-NP O
, , O O
and CC O O
pleural JJ B-NP O
effusion NN I-NP O
consistent NN I-NP O
with IN B-VP O
metastatic JJ B-NP O
disease NN I-NP O
A NNP I-NP O
bone NN I-NP O
scan NN I-NP O
showed VBD B-VP O
wide JJ B-NP O
spread NN I-NP O
osseous JJ B-NP B-r
metastatic JJ I-NP I-r
disease NN I-NP I-r
and CC O O
head NN B-NP O
CT NNP I-NP O
demonstrated VBD B-VP O
a DT B-NP O
CNS NNP I-NP O
involvement NN I-NP O
She PRP O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
whole JJ B-NP O
brain NN I-NP O
radiotherapy NN I-NP O
in IN B-VP O
March NNP B-NP O
2006 CD O O
and CC O O
with IN B-VP O
weekly JJ B-NP B-f
Taxol NNP I-NP B-m
She PRP O O
continued VBD B-VP O
through IN B-VP O
March NNP B-NP O
2006 CD O O
Restaging NNP B-NP O
studies NNS I-NP O
showed VBD B-VP O
stable JJ B-NP O
visceral JJ I-NP O
disease NN I-NP O
but CC O O
progression NN B-NP O
of IN B-VP O
bony NN B-NP B-r
metastatic JJ B-NP I-r
disease NN I-NP I-r
Therefore NNP I-NP O
on IN B-VP O
January NNP B-NP O
, , O O
2006 CD O O
, , O O
she PRP O O
initiated VBD B-VP O
a DT B-NP O
second-line JJ I-NP O
Navelbine NNP I-NP B-m
Navelbine NNP I-NP B-m
therapy NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
VITAL NNP I-NP O
SIGNS: NNP I-NP O
Temperature NNP I-NP O
99.3po CD O O
, , O O
pulse RB O O
112 CD O O
regular JJ O O
, , O O
BP NNP B-NP O
120/75 CD O O
, , O O
respirations NNS B-NP O
18 CD O O
, , O O
sO2=100% NN B-NP O
on IN B-VP O
ambient NN B-NP O
air NN I-NP O
GENERAL NNP I-NP O
APPEARANCE: NNP I-NP O
Laying NNP I-NP O
in IN B-VP O
bed NN B-NP O
, , O O
coughing VBG O O
paroxysms NNS B-NP O
No NNP I-NP O
use NN I-NP O
of IN B-VP O
accessory NN B-NP O
muscles NNS I-NP O
HEENT: NNP I-NP O
Mucosa NNP I-NP O
dry VBZ O O
No NNP B-NP O
jaundice NN I-NP O
+conjunctival NNP I-NP O
pallor NN I-NP O
Pupils NNP I-NP O
reactive VBP O O
bilaterally RB O O
NECK: NNP B-NP O
Supple NNP I-NP O
and CC O O
nontender RB O O
Right NNP B-NP O
IJ NNP I-NP O
in IN B-VP O
place NN B-NP O
HEART: NNP I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
tachycardic NN B-NP O
without IN B-VP O
murmurs VBZ O O
No DT B-NP O
heaves NNS I-NP O
LUNGS: NNP I-NP O
Crackles NNP I-NP O
in IN B-VP O
the DT B-NP O
left NN I-NP O
lower JJR O O
chest JJS O O
posteriorly RB O O
, , O O
and CC O O
diffuse VB O O
expiratory NN B-NP O
wheezes NNS I-NP O
ABDOMEN: NNP I-NP O
Soft NNP I-NP O
and CC O O
nontender VB O O
Small NNP B-NP O
nodule JJ B-NP O
RUQ NNP I-NP O
subcutaneous JJ O O
, , O O
mildly RB O O
tender NN B-NP O
to TO O O
palpation VB O O
BACK: NNP B-NP O
No NNP I-NP O
CVAT NNP I-NP O
NEUROLOGIC: NNP I-NP O
A&amp;Ox4 NNP I-NP O
, , O O
but CC O O
somewhat RB O O
sedate JJ O O
and CC O O
with IN B-VP O
poor JJ B-NP O
attention NN I-NP O
Radial NNP I-NP O
and CC O O
DP NNP B-NP O
pulses NNS I-NP O
are VBP O O
2+ CD O O
Sensation NNP B-NP O
and CC O O
strength NN B-NP O
are VBP O O
grossly RB O O
intact JJ B-NP O
EXTREMITIES: NNP I-NP O
No NNP I-NP O
calf NN I-NP O
warmth NN I-NP O
, , O O
erythema NN B-NP O
, , O O
or CC O O
tenderness NN B-NP O
Mild NNP I-NP O
right JJ B-NP O
heel NN I-NP O
and CC O O
Achilles NNP B-NP O
tendon VBP O O
tenderness JJ B-NP O
LABORATORY NNP I-NP O
RESULTS NNP I-NP O
AT NNP I-NP O
DMC NNP I-NP O
WBC NNP I-NP O
3.2 CD O O
, , O O
hemoglobin VBD B-VP O
7.5 CD O O
MCV=76 NNP B-NP O
, , O O
platelets VBZ O O
482 CD O O
, , O O
neutrophils RB O O
61% CD O O
, , O O
sodium NN B-NP O
141 CD O O
, , O O
potassium NN B-NP O
3.2 CD O O
, , O O
chloride RB O O
122 CD O O
, , O O
CO2 NNP B-NP O
17 CD O O
, , O O
BUN NNP B-NP O
20 CD O O
, , O O
creatinine NN B-NP O
1.5 CD O O
, , O O
glucose VBD B-VP O
181 CD O O
LDH NNP B-NP O
542 CD O O
, , O O
Ca NNP B-NP O
6.7 CD O O
Alb NNP B-NP O
2.2 CD O O
Urinalysis: NNP B-NP O
3+ CD O O
heme NN B-NP O
, , O O
WBC NNP B-NP O
25-50 CD O O
, , O O
RBC NNP B-NP O
15-25 CD O O
, , O O
bacteria NNS B-NP O
1+ CD O O
, , O O
2+LE CD O O
, , O O
neg JJ B-NP O
nitrites NNS I-NP O
INR VBP O O
2.0 CD O O
PTT NNP B-NP O
43.3 CD O O
LABORATORY NNP B-NP O
RESULTS NNP I-NP O
AT NNP I-NP O
MR NNP I-NP O
WBC NNP I-NP O
3.5 CD O O
, , O O
hemoglobin NN B-NP O
9 CD O O
, , O O
hematocrit NN B-NP O
28 CD O O
, , O O
platelets NNS B-NP O
592 CD O O
, , O O
neutrophils RB O O
68% CD O O
, , O O
sodium NN B-NP O
142 CD O O
, , O O
potassium NN B-NP O
3.5 CD O O
, , O O
chloride RB O O
111 CD O O
, , O O
CO2 NNP B-NP O
14 CD O O
, , O O
BUN NNP B-NP O
23 CD O O
, , O O
creatinine NN B-NP O
1.9 CD O O
, , O O
glucose RB O O
217 CD O O
, , O O
alkaline JJ B-NP O
phosphatase NN I-NP O
261 CD O O
, , O O
AST NNP B-NP O
26 CD O O
, , O O
ALT NNP B-NP O
27 CD O O
Urinalysis: NNP B-NP O
Large NNP I-NP O
heme NN I-NP O
, , O O
WBC NNP B-NP O
6-10 CD O O
, , O O
RBC NNP B-NP O
0-2 CD O O
, , O O
bacteria NNS B-NP O
trace VBP O O
Blood NNP B-NP O
cultures: NN I-NP O
Pending NNP I-NP O
Urine NNP I-NP O
culture NN I-NP O
9/13/06: CD O O
No NNP B-NP O
growth NN I-NP O
Chest NNP I-NP O
x-ray: NN I-NP O
Revealed NNP I-NP O
questionable JJ O O
left VBD B-VP O
lobe JJ B-NP O
infiltrate NN I-NP O
with IN B-VP O
metastasis NN B-NP O
EKG: NNP I-NP O
120 CD O O
per IN B-VP O
minute NN B-NP O
, , O O
sinus JJ B-NP O
tachycardia NN I-NP O
CXR: NNP I-NP O
LLL NNP I-NP O
opacity NN I-NP O
, , O O
LUL NNP B-NP O
opacity NN I-NP O
Hilar NNP I-NP O
fullness NN I-NP O
on IN B-VP O
the DT B-NP O
righT&gt;l NN I-NP O
, , O O
and CC O O
prominent JJ B-NP O
bronchi NN I-NP O
( ( O O
?cuffing VBG O O
) ) O O
on IN B-VP O
right JJ B-NP O
Vertebral NNP I-NP O
fractures NNS I-NP O
LLL NNP I-NP O
unchanged JJ O O
from IN B-VP O
0/0 CD O O
, , O O
and CC O O
LUL NNP B-NP O
improved VBD B-VP O
C/w NNP B-NP O
known VBN O O
metastatic JJ B-NP O
disease NN I-NP O
ASSESSMENT: NNP I-NP O
59 CD O O
year-old JJ B-NP O
woman NN I-NP O
with IN B-VP O
metastatic JJ B-NP O
breast NN I-NP O
cancer NN I-NP O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
pulmonary JJ B-NP O
embolus NN I-NP O
presenting VBG O O
with IN B-VP O
one CD O O
week NN B-NP O
of IN B-VP O
fatigue NN B-NP O
, , O O
lethargy NN B-NP O
, , O O
tachycardia NN B-NP O
and CC O O
fever JJ B-NP O
History NNP I-NP O
notable JJ O O
for IN B-VP O
productive JJ B-NP O
cough NN I-NP O
and CC O O
dysuria NN B-NP O
, , O O
although IN B-VP O
the DT B-NP O
chronicity NN I-NP O
of IN B-VP O
these DT B-NP O
issues NNS I-NP O
is VBZ O O
unclear JJ O O
Now RB O O
growing VBG O O
1 CD O O
bottle NN B-NP O
from IN B-VP O
WBH NNP B-NP O
as RB O O
well RB O O
as IN B-VP O
NBH NNP B-NP O
of IN B-VP O
GPC NNP B-NP O
in IN B-VP O
clusters NNS B-NP O
empirically RB O O
on IN B-VP O
Vanco NNP B-NP B-m
, , O O
now RB O O
looks VBZ O O
to TO O O
be VB O O
coag NNS B-NP O
neg.Discussed VBN O O
with IN B-VP O
ID NNP B-NP O
, , O O
would MD O O
like VB O O
to TO O O
keep VB O O
vanco NN B-NP B-m
PLAN: NNP I-NP O
*Tachycardia: VBZ O O
Most JJS O O
likely JJ O O
secondary JJ O O
to TO O O
an DT B-NP O
infection NN I-NP O
, , O O
either DT O O
pulmonary JJ O O
or CC O O
urinary JJ O O
With IN B-VP O
improvement NN B-NP O
in IN B-VP O
Cr NNP B-NP O
PE NNP I-NP O
CT NNP I-NP O
was VBD B-VP O
obtained VBN O O
which WDT O O
was VBD B-VP O
negative.Stable JJ B-NP O
d/c JJ I-NP O
ASA NNP I-NP B-m
and CC O O
statin NN B-NP B-m
as IN B-VP O
no DT B-NP O
role NN I-NP O
for IN B-VP O
long JJ B-NP O
term NN I-NP O
risk NN I-NP O
reduction NN I-NP O
at IN B-VP O
this DT B-NP O
time NN I-NP O
*Cough: VBZ O O
Productive JJ B-NP O
cough NN I-NP O
, , O O
yellow VB O O
to TO O O
green JJ B-NP O
sputum NN I-NP O
Seems NNPS I-NP O
to TO O O
have VB O O
been VBN O O
present JJ O O
for IN B-VP O
months NNS B-NP O
, , O O
and CC O O
it PRP O O
is VBZ O O
unclear JJ O O
how WRB O O
much RB O O
this DT O O
has VBZ O O
changed VBN O O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
week NN I-NP O
May NNP I-NP O
be VB O O
chronic JJ O O
secondary JJ O O
to TO O O
tumor VB O O
, , O O
or CC O O
may MD O O
represent VB O O
acute JJ B-NP O
infection NN I-NP O
Aspiration NNP I-NP O
plausible JJ O O
given VBN O O
mental JJ B-NP O
status NN I-NP O
The DT B-NP O
CT NNPS I-NP O
did VBD B-VP O
not RB O O
demonstrate VB O O
any DT B-NP O
acute JJ I-NP O
etiology NN I-NP O
for IN B-VP O
her PRP$ O O
symptoms NNS B-NP O
*Dysuria: NN I-NP O
Again NNP I-NP O
, , O O
chronicity NN B-NP O
unclear JJ B-NP O
UA NNP I-NP O
and CC O O
urine JJ B-NP O
culture NN I-NP O
at IN B-VP O
HNH NNP B-NP O
not RB O O
very RB O O
suggestive JJ O O
of IN B-VP O
UTI NNP B-NP O
, , O O
but CC O O
UA NNP B-NP O
here RB O O
with IN B-VP O
25 CD O O
wbc NNS B-NP O
and CC O O
LE+ NNP B-NP O
Has NNP I-NP O
been VBN O O
on IN B-VP O
levofloxacin NN B-NP B-m
, , O O
so RB O O
will MD O O
treat VB O O
until IN B-VP O
cultures NNS B-NP O
return VBP O O
with IN B-VP O
ceftazidime NN B-NP B-m
( ( O O
d/c JJ O O
0/7 CD O O
) ) O O
*Bacteremia: NN B-NP O
coag NN I-NP O
neg JJ B-NP O
staph NN I-NP O
x2 NN I-NP O
, , O O
Vanc NNP B-NP O
Sens NNP I-NP O
, , O O
plan NN B-NP O
to TO O O
treat VB O O
via IN B-VP O
PICC NNP B-NP O
w/Vancomycin VBP O B-m
x14days NNS B-NP B-du
*Oncology: VB O O
Discussion NNP B-NP O
with IN B-VP O
Dr NNP B-NP O
Clusky NNP I-NP O
, , O O
her PRP$ O O
primary JJ B-NP O
oncologic JJ I-NP O
fellow NN I-NP O
, , O O
who WP O O
noted VBD B-VP O
that IN B-VP O
from IN B-VP O
my PRP$ O O
description NN B-NP O
the DT B-NP O
patient NN I-NP O
does VBZ O O
not RB O O
sound VB O O
much RB O O
different JJ O O
from IN B-VP O
her PRP$ O O
baseline NN B-NP O
state NN I-NP O
She PRP O O
is VBZ O O
mildly RB O O
tachycardic JJ O O
at IN B-VP O
baseline NN B-NP O
( ( O O
although IN B-VP O
not RB O O
to TO O O
this DT B-NP O
degree NN I-NP O
) ) O O
, , O O
and CC O O
has VBZ O O
chronic JJ B-NP O
productive JJ I-NP O
cough NN I-NP O
and CC O O
dysuria NN B-NP O
5 CD O O
Renal: NNP B-NP O
ARF NNP I-NP O
, , O O
improving VBG O O
with IN B-VP O
IVF NNP B-NP B-m
Likely NNP I-NP O
prerenal JJ B-NP O
azotemia NN I-NP O
6.Heme: CD O O
Chronic NNP B-NP O
anemia NN I-NP O
Given NNP I-NP O
1UPRBC CD O B-m
in IN B-VP O
ER NNP B-NP O
Unfortuantely NNP I-NP O
, , O O
the DT B-NP O
blood NN I-NP O
was VBD B-VP O
given VBN O O
before IN B-VP O
hemolysis NN B-NP O
or CC O O
iron NN B-NP O
studies NNS I-NP O
sent VBD B-VP O
Would MD O O
be VB O O
indicated VBN O O
, , O O
especially RB O O
in IN B-VP O
setting VBG O O
of IN B-VP O
markedly RB O O
elevated VBN O O
PT NNP B-NP O
Should MD O O
be VB O O
sent VBN O O
in IN B-VP O
future JJ O O
I PRP O O
have VBP O O
called VBN O O
and CC O O
added VBN O O
on IN B-VP O
a DT B-NP O
peripheral JJ I-NP O
manual JJ I-NP O
blood NN I-NP O
smear NN I-NP O
Last JJ B-NP O
INR NNP I-NP O
similarly RB O O
elevated VBD B-VP O
( ( O O
but CC O O
I PRP O O
believe VBP O O
patient NN B-NP O
was VBD B-VP O
on IN B-VP O
enoxaprin NN B-NP B-m
at IN B-VP O
that DT B-NP O
time NN I-NP O
) ) O O
Not RB O O
on IN B-VP O
enoxaprin NN B-NP O
or CC O O
warfarin NN B-NP B-m
now RB O O
May NNP B-NP O
be VB O O
dues NNS B-NP O
to TO O O
malnutrition NN B-NP O
, , O O
but CC O O
concerning VBG O O
for IN B-VP O
DIC NNP B-NP O
or CC O O
liver RB O B-r
disease.Administered VBN O I-r
vitamin NN B-NP B-m
vitamin NN I-NP B-m
K NNP I-NP O
7.Psych: CD O O
Resumed NNP B-NP O
home NN I-NP O
zoloft NN I-NP B-m
, , O O
restart VB O O
geodon NN B-NP B-m
prn JJ O B-f
8.Goals CD O O
of IN B-VP O
care: NNS B-NP O
Discussed VBN O O
with IN B-VP O
the DT B-NP O
patient NN I-NP O
and CC O O
Dr NNP B-NP O
Pinion NNP I-NP O
The DT B-NP O
patient NN I-NP O
expresses VBZ O O
that IN B-VP O
she PRP O O
wants VBZ O O
to TO O O
be VB O O
intubated VBN O O
or CC O O
have VBP O O
defibrillation NN B-NP O
if IN B-VP O
needed VBN O O
Dr NNP B-NP O
Ellestad NNP I-NP O
has VBZ O O
discussed VBN O O
this DT B-NP O
numerous JJ I-NP O
times NNS I-NP O
with IN B-VP O
her PRP O O
, , O O
and CC O O
will MD O O
readdress VB O O
ADDITIONAL NNP B-NP O
COMMENTS: NNP I-NP O
DISCHARGE NNP I-NP O
CONDITION: NNP I-NP O
Stable NNP I-NP O
TO NNP I-NP O
DO/PLAN: NNP I-NP O
f/u NN I-NP O
with IN B-VP O
primary JJ B-NP O
oncologist NN I-NP O
call NN I-NP O
oncologist NN I-NP O
or CC O O
return NN B-NP O
to TO O O
ed VB O O
with IN B-VP O
any DT B-NP O
change NN I-NP O
in IN B-VP O
symptoms JJ B-NP O
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY: NNP I-NP O
FENCEROY NNP I-NP O
, , O O
TAYLOR NNP B-NP O
C NNP I-NP O
, , O O
M.D NNP B-NP O
( ( O O
PN858 NNP B-NP O
) ) O O
8/6/06 CD O O
@ $ O O
11:03 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
[report_end] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
RECORD NNP I-NP O
#811352 VBZ O O
466605453 CD O O
FMIH NNP B-NP O
88455449 CD O O
7789103 CD O O
7/9/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
HEART NNP I-NP O
FAILURE NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date: NNP I-NP O
6/29/2006 CD O O
Report NNP B-NP O
Status: NNP I-NP O
Signed NNP I-NP O
Discharge NNP I-NP O
Date: NNP I-NP O
5/15/2006 CD O O
ATTENDING: NNP B-NP O
KAPPLER NNP I-NP O
, , O O
TRINIDAD NNP B-NP O
MD NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT: NNP I-NP O
Shortness NNP I-NP O
of IN B-VP O
breath JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS: NNP I-NP O
This DT O O
is VBZ O O
a DT B-NP O
70-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
an DT B-NP O
ischemic JJ I-NP O
cardiomyopathy NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
35% CD O O
and CC O O
also RB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
MI NNP I-NP O
, , O O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
and CC O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
who WP O O
presented VBD B-VP O
with IN B-VP O
volume NN B-NP O
overloaded VBD B-VP O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
recently RB O O
discharged VBN O O
after IN B-VP O
a DT B-NP O
9-day JJ I-NP O
admission NN I-NP O
from IN B-VP O
3/30/2006 CD O O
to TO O O
05 CD O O
for IN B-VP O
a DT B-NP O
CHF NNP I-NP O
exacerbation NN I-NP O
During IN B-VP O
the DT B-NP O
previous JJ I-NP O
admission NN I-NP O
, , O O
she PRP O O
had VBD B-VP O
been VBN O O
diuresed VBN O O
with IN B-VP O
a DT B-NP O
Lasix NNP I-NP B-m
drip NN I-NP B-mo
and CC O O
then RB O O
started VBD B-VP O
on IN B-VP O
amiodarone NN B-NP B-m
and CC O O
Coumadin NNP B-NP B-m
for IN B-VP O
a DT O B-r
a DT B-NP B-r
new JJ I-NP O
paroxysmal JJ I-NP O
atrial JJ I-NP O
fibrillation NN I-NP O
After IN B-VP O
discharge NN B-NP O
, , O O
she PRP O O
presented VBD B-VP O
to TO O O
NSCHC NNP B-NP O
Cardiology NNP I-NP O
Clinic NNP I-NP O
on IN B-VP O
9/28/2006 CD O O
with IN B-VP O
a DT B-NP O
jugular JJ I-NP O
venous JJ I-NP O
pressure NN I-NP O
at IN B-VP O
15 CD O O
cm NN B-NP O
and CC O O
severe JJ B-NP O
bilateral JJ I-NP O
lower JJR I-NP O
extremity NN I-NP O
edema NN I-NP O
and CC O O
a DT B-NP O
BNP NNP I-NP O
of IN B-VP O
2500 CD O O
The DT B-NP O
assessment NN I-NP O
in IN B-VP O
clinic NN B-NP O
was VBD B-VP O
that IN B-VP O
she PRP O O
had VBD B-VP O
been VBN O O
under IN B-VP O
diuresed VBN O O
in IN B-VP O
the DT B-NP O
previous JJ I-NP O
admission NN I-NP O
and CC O O
therefore RB O O
she PRP O O
was VBD B-VP O
directly RB O O
admitted VBN O O
to TO O O
Poredtiesbarre NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
reinitiation NN B-NP O
of IN B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
recently RB O O
changed VBN O O
from IN B-VP O
Lasix NNP B-NP B-m
to TO O O
torsemide VB O B-m
after IN B-VP O
the DT B-NP O
last JJ I-NP O
discharge NN I-NP O
as IN B-VP O
her PRP$ O O
outpatient JJ B-NP O
medication NN I-NP O
She PRP O O
endorsed VBD B-VP O
worsened JJ B-NP O
orthopnea NN I-NP O
, , O O
dyspnea NN B-NP O
on IN B-VP O
exertion NN B-NP O
, , O O
paroxysmal JJ B-NP O
nocturnal JJ I-NP O
dyspnea NN I-NP O
as RB O O
well RB O O
as IN B-VP O
early JJ B-NP O
satiety NN I-NP O
She PRP O O
denied VBD B-VP O
any DT B-NP O
chest JJS I-NP O
pain NN I-NP O
or CC O O
other JJ B-NP O
anginal JJ I-NP O
equivalents NNS I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY: NNP I-NP O
1 CD O O
Ischemic NNP B-NP O
cardiomyopathy NN I-NP O
with IN B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
30%-35% JJ O O
2 CD O O
Paroxysmal NNP B-NP B-r
Paroxysmal NNP I-NP B-r
atrial JJ B-NP I-r
atrial JJ I-NP I-r
fibrillation NN I-NP I-r
fibrillation NN I-NP I-r
, , O O
newly RB O O
on IN B-VP O
Coumadin NNP B-NP B-m
and CC O O
amiodarone RB O B-m
3 CD O O
Coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
MI NNP I-NP O
4 CD O O
Peripheral NNP B-NP O
vascular JJ B-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
left VBD B-VP O
tibial JJ B-NP O
bypass NN I-NP O
and CC O O
fem-pop JJ B-NP O
bypass NN I-NP O
5 CD O O
Hypertension NNP B-NP O
6 CD O O
Hyperlipidemia NNP B-NP O
7 CD O O
Glaucoma NNP B-NP O
8 CD O O
Diabetes VBZ O O
with IN B-VP O
retinopathy JJ O O
9 CD O O
Osteoarthritis NNP B-NP O
10 CD O O
Anemia NNP B-NP O
11 CD O O
Obesity NNP B-NP O
12 CD O O
Chronic NNP B-NP O
renal JJ B-NP O
insufficiency NN I-NP O
with IN B-VP O
a DT B-NP O
baseline JJ I-NP O
creatinine NN I-NP O
of IN B-VP O
2.9 CD O O
followed VBN O O
by IN B-VP O
SVMC NNP B-NP O
Renal NNP I-NP O
Clinic NNP I-NP O
MEDICATIONS NNP I-NP O
AT NNP I-NP O
HOME: NNP I-NP O
1 CD O O
Torsemide NNP B-NP B-m
Torsemide NNP I-NP B-m
100 CD O B-do
mg NN B-NP I-do
q.a.m NN I-NP B-f
and CC O O
50 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
2 CD O O
Ativan NNP B-NP B-m
0.5 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d NN I-NP B-f
p.r.n NN I-NP I-f
anxiety NN I-NP B-r
3 CD O O
Folate NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
4 CD O O
Lipitor NNP B-NP B-m
80 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
at IN B-VP B-f
bedtime JJ O I-f
5 CD O O
Lantus NNP B-NP B-m
18 CD O B-do
units NNS B-NP I-do
subcutaneously RB O B-mo
nightly RB O B-f
6 CD O O
Coumadin NNP B-NP B-m
1 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
7 CD O O
Lopressor NNP B-NP B-m
25 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
b.i.d VBD B-VP B-f
8 CD O O
Procrit NNP B-NP B-m
40 CD O B-do
, , O I-do
000 CD O I-do
units NNS B-NP I-do
subcutaneously RB O B-mo
every DT B-NP B-f
other JJ I-NP I-f
week NN I-NP I-f
9 CD O O
Nitroglycerin NNP B-NP B-m
sublingual JJ B-NP B-mo
p.r.n NN I-NP B-f
chest NN I-NP B-r
pain NN I-NP I-r
10 CD O O
Aspirin NNP B-NP B-m
81 CD O B-do
mg NN B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
11 CD O O
Vitamin NNP B-NP B-m
B12 NNP I-NP I-m
subcutaneous JJ B-NP B-mo
injections NNS I-NP I-mo
at IN B-VP O
clinic JJ O O
12 CD O O
Amiodarone $ O B-m
200 CD O B-do
mg JJ O I-do
p.o JJ O B-mo
daily JJ O B-f
13 CD O O
Iron NNP B-NP B-m
325 CD O B-do
mg NN B-NP I-do
p.o NN I-NP B-mo
t.i.d VBD B-VP B-f
14 CD O O
Metolazone NNP B-NP B-m
p.r.n NN I-NP B-f
ALLERGIES: NNP I-NP O
Lisinopril NNP I-NP O
and CC O O
nonsteroidal JJ B-NP O
anti-inflammatory JJ I-NP O
agents NNS I-NP O
SOCIAL NNP I-NP O
HISTORY: NNP I-NP O
The DT B-NP O
patient NN I-NP O
is VBZ O O
married JJ O O
and CC O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
with IN B-VP O
her PRP$ O O
husband NN B-NP O
She PRP O O
quit VBD B-VP O
tobacco NN B-NP O
with IN B-VP O
rare JJ B-NP O
alcohol NN I-NP O
use NN I-NP O
and CC O O
no DT B-NP O
drugs NNS I-NP O
FAMILY NNP I-NP O
HISTORY: NNP I-NP O
Noncontributory NNP I-NP O
There EX O O
is VBZ O O
no DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
cardiac JJ B-NP O
disease NN I-NP O
PHYSICAL NNP I-NP O
EXAMINATION: NNP I-NP O
On IN B-VP O
admission NN B-NP O
, , O O
temperature NN B-NP O
was VBD B-VP O
98.9 CD O O
, , O O
heart NN B-NP O
rate NN I-NP O
70 CD O O
, , O O
blood NN B-NP O
pressure NN I-NP O
104/50 CD O O
, , O O
respiratory JJ B-NP O
rate NN I-NP O
of IN B-VP O
20 CD O O
, , O O
oxygen NN B-NP O
saturation NN I-NP O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
In IN B-VP O
general JJ O O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
comfortable JJ O O
in IN B-VP O
no DT B-NP O
acute NN I-NP O
distress NN I-NP O
HEENT NNP I-NP O
, , O O
Pupils NNP B-NP O
were VBD B-VP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ B-NP O
Oropharynx NNP I-NP O
was VBD B-VP O
clear JJ O O
The DT B-NP O
JVP NNP I-NP O
was VBD B-VP O
greater JJR O O
than IN B-VP O
15 CD O O
cm NN B-NP O
, , O O
chest NN B-NP O
exam NN I-NP O
showed VBD B-VP O
bilateral JJ B-NP O
crackles NNS I-NP O
at IN B-VP O
the DT B-NP O
bases NNS I-NP O
with IN B-VP O
bibasilar JJ B-NP O
dullness NN I-NP O
well RB O O
as RB O O
well RB O O
as IN B-VP O
right NN B-NP O
greater JJR O O
than IN B-VP O
left JJ B-NP O
base NN I-NP O
Cardiovascular NNP I-NP O
was VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT B-NP O
S3 NNP I-NP O
and CC O O
no DT B-NP O
murmur JJ I-NP O
Abdomen NNP I-NP O
soft NN I-NP O
, , O O
nontender NN B-NP O
, , O O
nondistended VBN O O
with IN B-VP O
a DT B-NP O
nonpulsatile JJ I-NP O
liver NN I-NP O
Extremities NNS I-NP O
showed VBD B-VP O
3+ CD O O
pitting VBG O O
edema NN B-NP O
bilaterally RB O O
to TO O O
the DT B-NP O
hips NNS I-NP O
with IN B-VP O
bilateral JJ B-NP O
changes NNS I-NP O
of IN B-VP O
arterial JJ O O
and CC O O
venous JJ B-NP O
insufficiency NN I-NP O
Laboratory NNP I-NP O
studies NNS I-NP O
were VBD B-VP O
significant JJ O O
for IN B-VP O
an DT B-NP O
INR NNP I-NP O
of IN B-VP O
1.6 CD O O
, , O O
BUN NNP B-NP O
of IN B-VP O
110 CD O O
, , O O
creatinine NN B-NP O
3 CD O O
, , O O
white JJ B-NP O
blood NN I-NP O
cell NN I-NP O
count NN I-NP O
of IN B-VP O
11.7 CD O O
and CC O O
a DT B-NP O
hematocrit NN I-NP O
of IN B-VP O
27.9 CD O O
EKG NNP B-NP O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
with IN B-VP O
evidence NN B-NP O
of IN B-VP O
a DT B-NP O
previous JJ I-NP O
anterior JJ I-NP O
MI NNP I-NP O
with IN B-VP O
lateral JJ B-NP O
repolarization NN I-NP O
, , O O
ST NNP B-NP O
and CC O O
T NNP B-NP O
wave VBP O O
abnormalities NNS B-NP O
, , O O
and CC O O
possible JJ B-NP O
LVH NNP I-NP O
Chest NNP I-NP O
x-ray NN I-NP O
showed VBD B-VP O
bilateral JJ B-NP O
effusions NNS I-NP O
, , O O
left VBD B-VP O
greater JJR O O
than IN B-VP O
right JJ O O
with IN B-VP O
increased JJ B-NP O
vascular JJ I-NP O
markings NNS I-NP O
and CC O O
fluid NN B-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
fissure NN I-NP O
, , O O
but CC O O
no DT O O
discrete JJ O O
infiltrates VBZ O O
IMPRESSION: NNP B-NP O
This DT O O
is VBZ O O
a DT B-NP O
70-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
with IN B-VP O
an DT B-NP O
EF NNP I-NP O
of IN B-VP O
35% CD O O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
status NN I-NP O
post NN I-NP O
MI NNP I-NP O
, , O O
insulin-dependent JJ B-NP O
diabetes NNS I-NP O
, , O O
peripheral JJ B-NP O
vascular JJ I-NP O
disease NN I-NP O
, , O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
who WP O O
presented VBD B-VP O
in IN B-VP O
volume NN B-NP O
overload NN I-NP O
after IN B-VP O
a DT B-NP O
recent JJ I-NP O
admission NN I-NP O
with IN B-VP O
insufficient JJ B-NP O
diuresis NN I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
BY NNP I-NP O
PROBLEM: NNP I-NP O
1 CD O O
Cardiovascular NNP B-NP O
In IN B-VP O
terms NNS B-NP O
of IN B-VP O
pump NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
clearly RB O O
in IN B-VP O
gross JJ B-NP O
volume NN I-NP O
overload NN I-NP O
from IN B-VP O
both CC O O
the DT B-NP O
right NN I-NP O
sided VBD B-VP O
and CC O O
left-sided JJ B-NP O
failure NN I-NP O
on IN B-VP O
presentation NN B-NP O
Her NNP I-NP O
blood NN I-NP O
pressure NN I-NP O
was VBD B-VP O
stable JJ O O
and CC O O
she PRP O O
had VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
severely RB O O
decreased JJ B-NP O
cardiac JJ I-NP O
output NN I-NP O
or/and VBP O O
organ JJ B-NP O
perfusion NN I-NP O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
the DT B-NP O
Lasix NNP I-NP B-m
drip NN I-NP I-m
at IN B-VP O
10 CD O B-do
mg NNS B-NP I-do
per IN B-VP B-f
hour NN B-NP I-f
and CC O O
Zaroxolyn NNP B-NP B-m
at IN B-VP O
2.5 CD O B-do
mg NNS B-NP I-do
p.o JJ O B-mo
daily JJ O B-f
Her PRP$ O O
Lopressor NNP B-NP B-m
was VBD B-VP O
held VBN O O
for IN B-VP O
a DT B-NP B-r
decompensated JJ I-NP O
heart NN I-NP O
failure NN I-NP O
She PRP O O
initially RB O O
diuresed VBD B-VP O
well RB O O
overnight; JJ O O
however RB O O
, , O O
on IN B-VP O
the DT B-NP O
second JJ I-NP O
day NN I-NP O
her PRP$ O B-r
her PRP$ O B-r
diuresis NN B-NP I-r
diuresis NN I-NP I-r
tapered VBD B-VP O
off RB O O
and CC O O
her PRP$ O O
Lasix NNP B-NP B-m
drip NN I-NP I-m
drip NN I-NP B-mo
was VBD B-VP O
turned VBN O O
up RP O O
to TO O O
20 CD O B-do
mg NNS B-NP I-do
per IN B-VP B-f
hour NN B-NP I-f
and CC O O
the DT B-NP O
Zaroxolyn NNP I-NP B-m
was VBD B-VP O
increased VBN O O
to TO O O
b.i.d VB O B-f
She PRP O O
met VBD B-VP O
her PRP O O
I&amp;O NNP B-NP O
goal NN I-NP O
of IN B-VP O
greater JJR O O
than IN B-VP O
1 CD O O
liter JJ O O
negative JJ O O
overnight VBD B-VP O
the DT B-NP O
following JJ I-NP O
night NN I-NP O
, , O O
however RB O O
, , O O
a DT B-NP O
day NN I-NP O
later RB O O
, , O O
she PRP O O
again RB O O
had VBD B-VP O
poor JJ B-NP O
diuresis NN I-NP O
and CC O O
the DT B-NP O
Zaroxolyn NNP I-NP B-m
was VBD B-VP O
changed VBN O O
to TO O O
Diuril NNP B-NP B-m
At IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
a DT B-NP O
repeat NN I-NP O
chest NN I-NP O
x-ray NN I-NP O
showed VBD B-VP O
a DT O O
very RB O O
little JJ B-NP O
change NN I-NP O
in IN B-VP O
her PRP$ O O
bilateral JJ B-NP O
pleural JJ I-NP O
effusions NNS I-NP O
, , O O
so IN B-VP O
her PRP$ O O
diuresis NN B-NP O
up RB O O
to TO O O
this DT B-NP O
point NN I-NP O
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
insufficient JJ O O
After IN B-VP O
the DT B-NP O
transition NN I-NP O
from IN B-VP O
Zaroxolyn NNP B-NP B-m
to TO O O
Diuril NNP B-NP B-m
, , O O
which WDT O O
was VBD B-VP O
given VBN O O
250 CD O B-do
mg JJ B-NP I-do
IV NNP I-NP B-mo
b.i.d NN I-NP B-f
, , O O
she PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
creatinine NN B-NP O
from IN B-VP O
2.9 CD O O
gradually RB O O
up RB O O
to TO O O
3.2; CD O O
however RB O O
, , O O
remained VBD B-VP O
stable JJ O O
for IN B-VP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
days NNS I-NP O
and CC O O
the DT B-NP O
patient NN I-NP O
was VBD B-VP O
able JJ O O
to TO O O
maintain VB O O
good JJ B-NP O
diuresis NN I-NP O
on IN B-VP O
this DT B-NP O
regimen NNS I-NP O
without IN B-VP O
bump NN B-NP O
in IN B-VP O
her PRP$ O O
creatinine NN B-NP O
On IN B-VP O
6/27/2006 CD O O
, , O O
she PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
greatly RB O O
improved VBN O O
lower JJR B-NP O
extremity NN I-NP O
edema NN I-NP O
and CC O O
that DT O O
improved VBD B-VP O
lung NN B-NP O
exam NN I-NP O
and CC O O
she PRP O O
had VBD B-VP O
met VBN O O
her PRP$ O O
goal NN B-NP O
weight NN I-NP O
of IN B-VP O
less JJR O O
than IN B-VP O
85 CD O O
kilograms NNS B-NP O
Lasix NNP I-NP B-m
drip NN I-NP B-mo
was VBD B-VP O
discontinued VBN O O
in IN B-VP O
the DT B-NP O
afternoon NN I-NP O
on IN B-VP O
6/27/2006 CD O O
and CC O O
she PRP O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP O
p.o NN I-NP O
torsemide IN B-VP B-m
torsemide JJ B-NP B-m
regimen NNS I-NP I-m
regimen NNS I-NP I-m
of IN B-VP O
100 CD O B-do
mg NNS B-NP I-do
p.o JJ B-NP B-mo
q.a.m NN I-NP B-f
and CC O O
50 CD O B-do
mg NN B-NP O
p.o NN I-NP B-mo
q.p.m NN I-NP B-f
for IN B-VP O
anticipated JJ B-NP O
discharge NN I-NP O
home NN I-NP O
on IN B-VP O
5/15/2006 CD O O
The DT B-NP O
Diuril NNP I-NP B-m
was VBD B-VP O
also RB O O
discontinued VBN O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
anticipated VBN O O
to TO O O
be VB O O
stable JJ O O
on IN B-VP O
b.i.d JJ B-NP B-f
torsemide NN I-NP B-m
and CC O O
p.o NN B-NP B-mo
on IN B-VP O
metolazone NN B-NP B-m
at IN B-VP O
home NN B-NP O
Her NNP I-NP O
new JJ B-NP O
dry JJ I-NP O
weight NN I-NP O
on IN B-VP O
this DT B-NP O
admission NN I-NP O
was VBD B-VP O
established VBN O O
at IN B-VP O
85 CD O O
kilograms NNS B-NP O
and CC O O
this DT O O
should MD O O
be VB O O
at IN B-VP O
a DT B-NP O
goal NN I-NP O
for IN B-VP O
diuresis NN B-NP O
should MD O O
she PRP O O
require VB O O
admission NN B-NP O
in IN B-VP O
the DT B-NP O
future NN I-NP O
She PRP O O
will MD O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
CSH NNP B-NP O
cardiologist NN I-NP O
for IN B-VP O
further JJ B-NP O
monitoring NN I-NP O
of IN B-VP O
her PRP$ O O
volume NN B-NP O
status NN I-NP O
after IN B-VP O
discharge NN B-NP O
In IN B-VP O
terms NNS B-NP O
of IN B-VP O
rhythm NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
new JJ I-NP O
presentation NN I-NP O
of IN B-VP O
atrial JJ B-NP B-r
atrial JJ I-NP B-r
fibrillation NN I-NP I-r
fibrillation NN I-NP I-r
on IN B-VP O
the DT B-NP O
prior JJ I-NP O
admission NN I-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
amiodarone NN B-NP B-m
and CC O O
Coumadin NNP B-NP B-m
at IN B-VP O
that DT B-NP O
time NN I-NP O
She PRP O O
was VBD B-VP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
on IN B-VP O
presentation NN B-NP O
at IN B-VP O
this DT B-NP O
admission NN I-NP O
and CC O O
remained VBD B-VP O
in IN B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
throughout IN B-VP O
the DT B-NP O
admission NN I-NP O
and CC O O
was VBD B-VP O
monitored VBN O O
on IN B-VP O
telemetry NN B-NP O
with IN B-VP O
no DT B-NP O
other JJ I-NP O
events NNS I-NP O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O O
home NN B-NP B-do
dose NN I-NP I-do
of IN B-VP O
amiodarone NN B-NP B-m
and CC O O
continued VBN O O
on IN B-VP O
Coumadin; NNP B-NP B-m
Coumadin; NNP I-NP B-m
however RB O O
despite IN B-VP O
the DT B-NP O
dose NN I-NP O
being VBG O O
decreased VBN O O
from IN B-VP O
her PRP$ O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
1 CD O B-do
mg NNS B-NP I-do
q.p.m RB O B-f
to TO O O
a DT O O
0.5 CD O B-do
mg NN B-NP I-do
q.p.m NN I-NP B-f
, , O O
her PRP$ O O
INR NNP B-NP O
continued VBD B-VP O
to TO O O
rise VB O O
and CC O O
was VBD B-VP O
eventually RB O O
3.5 CD O O
Her NNP B-NP O
Coumadin NNP I-NP B-m
was VBD B-VP O
discontinued VBN O O
She PRP O O
was VBD B-VP O
recommended VBN O O
to TO O O
be VB O O
discharged VBN O O
off RP O O
Coumadin NNP B-NP B-m
and CC O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
provider NN I-NP O
during IN B-VP O
the DT B-NP O
week NN I-NP O
following VBG O O
discharge NN B-NP O
to TO O O
recheck VB O O
her PRP$ O O
INR NNP B-NP O
and CC O O
restart VB O O
her PRP$ O O
Coumadin NNP B-NP B-m
when WRB O O
it PRP O O
falls VBZ O O
below IN B-VP O
2.5 CD O O
In IN B-VP O
terms NNS B-NP O
of IN B-VP O
ischemia NN B-NP O
, , O O
the DT B-NP O
patient NN I-NP O
had VBD B-VP O
no DT B-NP O
acute JJ I-NP O
evidence NN I-NP O
of IN B-VP O
ischemia NN B-NP O
on IN B-VP O
presentation NN B-NP O
Denied NNP I-NP O
any DT B-NP O
chest NN I-NP O
pain NN I-NP O
and CC O O
had VBD B-VP O
no DT B-NP O
changes NNS I-NP O
consistent VBP O O
with IN B-VP O
ischemia NN B-NP O
on IN B-VP O
her PRP$ O O
EKG NNP B-NP O
She PRP O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
aspirin NN B-NP B-m
and CC O O
Lipitor NNP B-NP B-m
throughout IN B-VP B-du
throughout IN B-VP B-du
the DT O I-du
the DT B-NP I-du
admission NN I-NP I-du
admission NN I-NP I-du
2 CD O O
Renal: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
chronic JJ B-NP O
renal JJ I-NP O
insufficiency NN I-NP O
at IN B-VP O
baseline NN B-NP O
Her NNP I-NP O
creatinine NN I-NP O
did VBD B-VP O
increase VB O O
from IN B-VP O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
2.9 CD O O
to TO O O
3.2 CD O O
During IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
however RB O O
, , O O
remained VBD B-VP O
stable JJ O O
after IN B-VP O
that DT B-NP O
point NN I-NP O
She PRP O O
continued VBD B-VP O
on IN B-VP O
renally-dosed JJ B-NP O
medications NNS I-NP O
and CC O O
actually RB O O
required JJ B-NP O
repletion NN I-NP O
of IN B-VP O
both DT B-NP O
potassium NN I-NP B-m
and CC O O
magnesium NN B-NP B-m
despite IN B-VP O
her PRP$ O O
renal JJ B-NP O
insufficiency NN I-NP O
throughout IN B-VP B-du
the DT B-NP I-du
admission NN I-NP I-du
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
aggressive JJ B-NP O
diuresis NN I-NP O
Her PRP$ O O
electrolytes NNS B-NP O
were VBD B-VP O
stable JJ O O
prior JJ O O
to TO O O
discharge VB O O
home NN B-NP O
She PRP O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
the DT B-NP O
LCH NNP I-NP O
Renal NNP I-NP O
Clinic NNP I-NP O
with IN B-VP O
whom WP O O
she PRP O O
has VBZ O O
had VBD B-VP O
a DT B-NP O
previous JJ I-NP O
conversations NNS I-NP O
about IN B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
hemodialysis NN B-NP O
in IN B-VP O
the DT B-NP O
future NN I-NP O
and CC O O
she PRP O O
will MD O O
see VB O O
them PRP O O
shortly RB O O
after IN B-VP O
this DT B-NP O
discharge: NN I-NP O
3 CD O O
Pulmonary: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
dyspnea VBN O O
on IN B-VP O
exertion NN B-NP O
and CC O O
bilateral JJ B-NP O
pleural JJ I-NP O
effusions NNS I-NP O
on IN B-VP O
her PRP$ O O
chest JJS B-NP O
x-ray NN I-NP O
on IN B-VP O
admission NN B-NP O
This DT O O
was VBD B-VP O
all DT O O
felt VBD B-VP O
to TO O O
be VB O O
consistent JJ O O
with IN B-VP O
her PRP$ O O
heart NN B-NP O
failure NN I-NP O
She PRP O O
did VBD B-VP O
have VB O O
no DT B-NP O
signs NNS I-NP O
or CC O O
symptoms NNS B-NP O
of IN B-VP O
any DT B-NP O
infectious JJ I-NP O
etiology NN I-NP O
either CC O O
on IN B-VP O
imaging NN B-NP O
or CC O O
as IN B-VP O
a DT B-NP O
part NN I-NP O
of IN B-VP O
her PRP$ O O
clinical JJ B-NP O
picture NN I-NP O
Her NNP I-NP O
dyspnea NN I-NP O
on IN B-VP O
exertion NN B-NP O
and CC O O
her PRP$ O O
lung NN B-NP O
exam IN B-VP O
both DT O O
improved JJ O O
with IN B-VP O
her PRP$ O O
aggressive JJ B-NP O
diuresis NN I-NP O
4 CD O O
Endocrine: NNP B-NP O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
erratic JJ B-NP O
fingersticks NNS I-NP O
early RB O O
in IN B-VP O
the DT B-NP O
admission NN I-NP O
with IN B-VP O
a DT O O
very RB O O
low JJ B-NP O
fingerstick NN I-NP O
blood NN I-NP O
glucoses NNS I-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
initially RB O O
, , O O
so IN B-VP O
her PRP$ O O
p.m NN B-NP O
Lantus NNP I-NP B-m
Lantus NNP I-NP B-m
dose NN I-NP O
was VBD B-VP O
decreased VBN O O
from IN B-VP O
18 CD O B-do
units NNS B-NP O
to TO O O
16 CD O B-do
units NNS B-NP I-do
and CC O O
the DT B-NP O
NovoLog NNP I-NP B-m
sliding VBG O B-do
scale NN B-NP I-do
was VBD B-VP O
started VBN O O
On IN B-VP O
0/12/2006 CD O O
, , O O
she PRP O O
was VBD B-VP O
noted VBN O O
to TO O O
continue VB O O
to TO O O
have VB O O
lower JJR B-NP O
sugars NNS I-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
, , O O
but CC O O
routinely RB O O
elevated JJ B-NP O
sugars NNS I-NP O
in IN B-VP O
the DT B-NP O
afternoon NN I-NP O
greater JJR O O
than IN B-VP O
200 CD O O
She PRP O O
was VBD B-VP O
started VBN O O
on IN B-VP O
q.a.c NN B-NP B-f
NovoLog NNP I-NP B-m
regimen NNS I-NP I-m
However RB O O
, , O O
on IN B-VP O
this DT B-NP O
regimen NN I-NP O
, , O O
she PRP O O
was VBD B-VP O
found VBN O O
1 CD O O
morning NN B-NP O
to TO O O
have VB O O
a DT B-NP O
fingerstick JJ I-NP O
blood NN I-NP O
glucose NN I-NP O
of IN B-VP O
33 CD O O
and CC O O
to TO O O
be VB O O
hypothermic JJ O O
with IN B-VP O
a DT B-NP O
temperature NN I-NP O
of IN B-VP O
94 CD O O
taken VBN O O
rectally RB O O
This DT O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
hypoglycemia VB O O
which WDT O O
may MD O O
have VB O O
progressed VBN O O
over IN B-VP O
several JJ B-NP O
hours NNS I-NP O
prior RB O O
to TO O O
assessment NN B-NP O
and CC O O
her PRP$ O O
temperature NN B-NP O
returned VBN O O
to TO O O
normal JJ O O
at IN B-VP O
98 CD O O
after IN B-VP O
her PRP$ O O
blood NN B-NP O
glucose NN I-NP O
was VBD B-VP O
aggressively RB O O
repleted VBN O O
It PRP O O
was VBD B-VP O
felt VBN O O
that IN B-VP O
the DT B-NP O
patient NN I-NP O
likely RB O O
had VBD B-VP O
decreased VBN O O
metabolism NN B-NP O
of IN B-VP O
her PRP$ O O
injected JJ B-NP O
insulin NN I-NP B-m
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
worsening VBG O O
renal JJ B-NP O
failure NN I-NP O
, , O O
so RB O O
, , O O
her PRP O O
Lantus NNP B-NP B-m
was VBD B-VP O
decreased VBN O O
in IN B-VP O
accordance NN B-NP O
with IN B-VP O
a DT B-NP O
curbside JJ I-NP O
consultation NN I-NP O
with IN B-VP O
the DT B-NP O
diabetes NNS I-NP O
management NN I-NP O
service NN I-NP O
She PRP O O
will MD O O
be VB O O
discharged VBN O O
home NN B-NP O
on IN B-VP O
a DT B-NP O
similar JJ I-NP O
regimen NN I-NP O
to TO O O
her PRP$ O O
home NN B-NP B-m
regimen NNS I-NP I-m
simply RB O O
with IN B-VP O
a DT B-NP O
decreased JJ I-NP O
Lantus NNP I-NP B-m
Lantus NNP I-NP B-m
dose VBD B-VP O
down RB O O
to TO O O
12 CD O B-do
units NNS B-NP I-do
nightly RB O B-f
She PRP O O
should MD O O
continue VB O O
to TO O O
monitor VB O O
her PRP$ O O
fingerstick JJ B-NP O
blood NN I-NP O
glucoses NNS I-NP O
at IN B-VP O
home NN B-NP O
We PRP O O
were VBD B-VP O
hesitant JJ O O
to TO O O
change VB O O
the DT B-NP O
types NNS I-NP O
or CC O O
timing NN B-NP O
of IN B-VP O
her PRP$ O O
insulin NN B-NP B-m
during IN B-VP B-du
this DT B-NP I-du
hospitalization NN I-NP I-du
I PRP O O
left VBD B-VP O
that DT B-NP O
item NN I-NP O
to TO O O
be VB O O
further RB O O
managed VBN O O
by IN B-VP O
her PRP$ O O
primary JJ B-NP O
care NN I-NP O
provider NN I-NP O
after IN B-VP O
discharge: NN B-NP O
5 CD O O
Hematologic: NNP B-NP O
The DT B-NP O
patient NN I-NP O
has VBZ O O
a DT B-NP O
